Citrus Sinensis ID: 014985

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-----
Protein Sequence
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHccEEcccccEEEEEEEEcccccEEEEEEEcccccccccccHHHHHHHHHHHccccccEEEEEEEEEccEEEEEEEccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEcccccccccccccccccccEEEEEccccHHcccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccHHcccccccHHHHHHHHHcccccccccccHHHHHcccccccccccccccccccccHHHccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccEEccEEEEEEEEccccccEEEEEEcccccEEEEEEEccEccccEccHHHHHHHHHHcccccccEccEEEEEEccccEEEEEEcccEEHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccHHHccccHcccccccccHHHccccccHHHHHHHHHHccccHHHcccHHHHHccHHHcccccHHHcccccccccccHcccccccHcccccccccHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRlgkqkegvnfTALREIKLLKelksphiielidafphkgnlhLVFEFMETDLETVIRntniflspaDIKSYMQMTLKGLAFCHKKwvlhrdmkpnnlligshgqlkladfglarifgspdrrftHQVFARWYrapellfgakqygagVDVWAAGCIFAELlnrrpflqgssdIDQLGKIFAAfgtatpsqwpdlaylpdyveyqyvaapplrslfpsasDDALDLLSKmftydpkaRITAQQALEHryfssaplptepnklprpatkraskasdfnpqegptvlspprktrrvmpdregfegnanrTDKIEehagetknadgeiagrneqvptsvdfsifaarppsrptinsadrSHLKRKLdlefqhpe
Flexible Loop (DISEMBL)
maevdlskkvadrylkrevlgegtygvvykaidtktgqtvaikkirlgkqkegvnfTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFssaplptepnklpRPATKraskasdfnpqegptvlspprktrrvmpdregfegnanrtdkieehagetknadgeiagrneqVPTSVDFSifaarppsrptinsadrshLKRKLDLEFQHPE
Low Complexity Region (SEG)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE
Disordered region (IsUnstruct)
**********ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ*********************************************************************************************************************************
Disordered Region (DISOPRED)
************RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE****************************************************************************************************LKRKLDL******
Disordered Region (DISEMBL)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNK*********************TVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE
Disordered Region (DISPRO)
******SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT*PNKLPRPATK*******************************************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	415	2.2.26 [Sep-21-2011]
P29620	424	Cyclin-dependent kinase D	yes	no	0.978	0.957	0.758	1e-180
A2Y4B6	424	Cyclin-dependent kinase D	N/A	no	0.978	0.957	0.758	1e-180
Q9LMT0	391	Cyclin-dependent kinase D	yes	no	0.930	0.987	0.750	1e-176
Q9C9U2	398	Cyclin-dependent kinase D	no	no	0.946	0.987	0.740	1e-172
Q9C9M7	348	Cyclin-dependent kinase D	no	no	0.802	0.956	0.773	1e-153
P50613	346	Cyclin-dependent kinase 7	yes	no	0.759	0.910	0.572	1e-104
P20911	352	Cyclin-dependent kinase 7	N/A	no	0.720	0.849	0.596	1e-103
Q03147	346	Cyclin-dependent kinase 7	yes	no	0.759	0.910	0.562	1e-102
P51952	329	Cyclin-dependent kinase 7	yes	no	0.751	0.948	0.561	1e-101
P51953	344	Cyclin-dependent kinase 7	N/A	no	0.725	0.875	0.567	5e-97

>sp|P29620|CDKD1_ORYSJ Cyclin-dependent kinase D-1 OS=Oryza sativa subsp. japonica GN=CDKD-1 PE=1 SV=1

 Score =  632 bits (1631), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 314/414 (75%), Positives = 350/414 (84%), Gaps = 8/414 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K+VADRYLKREVLGEGTYGVV+KA+DTKTG TVAIKKIRLGK KEGVNFTALREIKLLKE
Sbjct: 13  KRVADRYLKREVLGEGTYGVVFKAVDTKTGNTVAIKKIRLGKYKEGVNFTALREIKLLKE 72

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK  +IIELIDAFP+KGNLHLVFEFMETDLE VIR+ NI LSPAD KSY+QM LKGLAFC
Sbjct: 73  LKDSNIIELIDAFPYKGNLHLVFEFMETDLEAVIRDRNIVLSPADTKSYIQMMLKGLAFC 132

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           HKKWVLHRDMKPNNLLIG+ GQLKLADFGLARIFGSP+R FTHQVFARWYRAPELLFG K
Sbjct: 133 HKKWVLHRDMKPNNLLIGADGQLKLADFGLARIFGSPERNFTHQVFARWYRAPELLFGTK 192

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QYG+ VD+WAAGCIFAELL RRPFLQGSSDIDQLGKIFAAFGT   SQWPD+ YLPDYVE
Sbjct: 193 QYGSAVDIWAAGCIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKSSQWPDMVYLPDYVE 252

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
           YQ+V+APPLRSLFP ASDDALDLLS+MFTYDPKARITAQQALEHRYF S P PT+P++LP
Sbjct: 253 YQFVSAPPLRSLFPMASDDALDLLSRMFTYDPKARITAQQALEHRYFLSVPAPTKPSQLP 312

Query: 308 RPATKRAS---KASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKN 364
           RP  K  S   K  D N Q+GP VLSPPRK RRV    EG E + +R D+ EEH    ++
Sbjct: 313 RPPPKGDSGNNKIPDLNLQDGPVVLSPPRKLRRVTA-HEGMEVHMHRADRTEEHPSGARH 371

Query: 365 ADGEIAGRNEQVPTSVDF-SIFAARPPSRPTINSADRSHLKRKLDL--EFQHPE 415
            D +++ ++ ++P SVD  +IF  RP  RPT+NSAD+S LKRKLD+  EF + E
Sbjct: 372 MD-DMSSQSSRIPMSVDVGAIFGTRPAPRPTLNSADKSRLKRKLDMDPEFGYTE 424

CDK-activating kinase that may control G1/S phase progression. May control the rate of cell differentiation to accomplish proper development of organs, or in response to a changing environment. Forms a complex with cyclin CYCH1-1 that phosphorylates CDKA-1 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.
Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|A2Y4B6|CDKD1_ORYSI Cyclin-dependent kinase D-1 OS=Oryza sativa subsp. indica GN=CDKD-1 PE=2 SV=1

 Score =  630 bits (1626), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 314/414 (75%), Positives = 349/414 (84%), Gaps = 8/414 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K+VADRYLKREVLGEGTYGVV+KA DTKTG TVAIKKIRLGK KEGVNFTALREIKLLKE
Sbjct: 13  KRVADRYLKREVLGEGTYGVVFKADDTKTGNTVAIKKIRLGKYKEGVNFTALREIKLLKE 72

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK  +IIELIDAFP+KGNLHLVFEFMETDLE VIR+ NI LSPAD KSY+QM LKGLAFC
Sbjct: 73  LKDSNIIELIDAFPYKGNLHLVFEFMETDLEAVIRDRNIVLSPADTKSYIQMMLKGLAFC 132

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           HKKWVLHRDMKPNNLLIG+ GQLKLADFGLARIFGSP+R FTHQVFARWYRAPELLFG K
Sbjct: 133 HKKWVLHRDMKPNNLLIGADGQLKLADFGLARIFGSPERNFTHQVFARWYRAPELLFGTK 192

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QYG+ VD+WAAGCIFAELL RRPFLQGSSDIDQLGKIFAAFGT   SQWPD+ YLPDYVE
Sbjct: 193 QYGSAVDIWAAGCIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKSSQWPDMVYLPDYVE 252

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
           YQ+V+APPLRSLFP ASDDALDLLS+MFTYDPKARITAQQALEHRYF S P PT+P++LP
Sbjct: 253 YQFVSAPPLRSLFPMASDDALDLLSRMFTYDPKARITAQQALEHRYFLSVPAPTKPSQLP 312

Query: 308 RPATKRAS---KASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKN 364
           RP  K  S   K  D N Q+GP VLSPPRK RRV    EG E + +R D+ EEH    ++
Sbjct: 313 RPPPKGDSGNNKIPDLNLQDGPVVLSPPRKLRRVTA-HEGMEVHMHRADRTEEHPSGARH 371

Query: 365 ADGEIAGRNEQVPTSVDF-SIFAARPPSRPTINSADRSHLKRKLDL--EFQHPE 415
            D +++ ++ ++P SVD  +IF  RP  RPT+NSAD+S LKRKLD+  EF + E
Sbjct: 372 MD-DMSSQSSRIPMSVDVGAIFGTRPAPRPTLNSADKSRLKRKLDMDPEFGYTE 424

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9LMT0|CDKD3_ARATH Cyclin-dependent kinase D-3 OS=Arabidopsis thaliana GN=CDKD-3 PE=1 SV=1

 Score =  619 bits (1597), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 304/405 (75%), Positives = 335/405 (82%), Gaps = 19/405 (4%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           KKVADRYLK+EVLG+GTYGVV+KA DTKT QTVAIKKIRLGKQ+EGVN TALREIK+LKE
Sbjct: 6   KKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREIKMLKE 65

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK PHII LIDAFPHK NLHLVFEFMETDLE VIR++NIFLSPADIKSY+ MT KGLA+C
Sbjct: 66  LKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFKGLAYC 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H KWVLHRDMKPNNLLIG  GQLKLADFGLARIFGSP+R+FTHQVFARWYRAPELLFGAK
Sbjct: 126 HDKWVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPELLFGAK 185

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QYGA VDVWA  CIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPDL  LPDYVE
Sbjct: 186 QYGAAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKLPDYVE 245

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
           YQ+V AP LRSLFP+ SDDALDLLSKMFTYDPKARI+ +QALEHRYF+SAP PT+P KLP
Sbjct: 246 YQFVPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFTSAPAPTDPAKLP 305

Query: 308 RPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADG 367
           +P  K+  K+S +   E  TV SPPRK RRVMP+R        R D ++ H         
Sbjct: 306 KPVPKQDGKSS-YGKHEAITVQSPPRKLRRVMPER-------GRVDSLKSH--------- 348

Query: 368 EIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQ 412
               +++Q P S+DF+I A RPP+RPTI SADRSHLKRKLDLEFQ
Sbjct: 349 --VDKDQQAPMSLDFTILAERPPNRPTITSADRSHLKRKLDLEFQ 391

May form a stable complex with cyclin CYCH1-1 that phosphorylates human CDK2 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9C9U2|CDKD1_ARATH Cyclin-dependent kinase D-1 OS=Arabidopsis thaliana GN=CDKD-1 PE=1 SV=1

 Score =  606 bits (1562), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 299/404 (74%), Positives = 334/404 (82%), Gaps = 11/404 (2%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           KKVADRYLKREVLG+GTYGVV+KA DTK G+TVAIKKIRLGK+KEGVN TALREIKLLKE
Sbjct: 5   KKVADRYLKREVLGQGTYGVVFKATDTKNGETVAIKKIRLGKEKEGVNVTALREIKLLKE 64

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           LK PHIIELIDAFPHK NLH+VFEFMETDLE VIR+ N++LSP D+KSY+QM LKGL +C
Sbjct: 65  LKHPHIIELIDAFPHKENLHIVFEFMETDLEAVIRDRNLYLSPGDVKSYLQMILKGLEYC 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H KWVLHRDMKPNNLLIG +GQLKLADFGLARIFGSP R+FTHQVFARWYRAPELLFGAK
Sbjct: 125 HGKWVLHRDMKPNNLLIGPNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAPELLFGAK 184

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           QY   VDVWAAGCIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPD+  LPDYVE
Sbjct: 185 QYDGAVDVWAAGCIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDMICLPDYVE 244

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
           YQ+V AP LRSL P+ S+DALDLLSKMFTYDPK+RI+ QQAL+HRYF+SAP PT+P KLP
Sbjct: 245 YQFVPAPSLRSLLPTVSEDALDLLSKMFTYDPKSRISIQQALKHRYFTSAPSPTDPLKLP 304

Query: 308 RPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADG 367
           RP +K+ +K+SD +  E   VLSP  K RRVMPDR G  GN  +   ++       + DG
Sbjct: 305 RPVSKQDAKSSD-SKLEAIKVLSPAHKFRRVMPDR-GKSGNGFKDQSVD--VMRQASHDG 360

Query: 368 EIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEF 411
                  Q P S+DF+I A RPP+RPTI SADRSHLKRKLDLEF
Sbjct: 361 -------QAPMSLDFTILAERPPNRPTITSADRSHLKRKLDLEF 397

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9C9M7|CDKD2_ARATH Cyclin-dependent kinase D-2 OS=Arabidopsis thaliana GN=CDKD-2 PE=1 SV=1

 Score =  540 bits (1391), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 263/340 (77%), Positives = 293/340 (86%), Gaps = 7/340 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            DRYL+R++LGEGTYGVVYKA DTKTG+TVA+KKIRLG QKEGVNFTALREIKLLKEL  
Sbjct: 10  VDRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALREIKLLKELNH 69

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           PHI+ELIDAFPH G+LHLVFE+M+TDLE VIR+ NIFLSP DIKSYM MTLKGLA+CHKK
Sbjct: 70  PHIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTLKGLAYCHKK 129

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           WVLHRDMKPNNLLIG +G LKLADFGLAR+FGSP+RRFTHQVFA WYRAPELLFG++QYG
Sbjct: 130 WVLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPELLFGSRQYG 189

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
           AGVDVWAAGCIFAELL RRPFL GS++IDQLGKIF AFGT  PSQW D+ YLPDY+E+ Y
Sbjct: 190 AGVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIYLPDYMEFSY 249

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPA 310
             APPLR++FP ASDDALDLL+KMF YDP+ RIT QQAL+HRYFSS+P PTEP KL  PA
Sbjct: 250 TPAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFSSSPSPTEPGKLQIPA 309

Query: 311 TKRAS---KASDFNPQEG--PTVLSPPRKTRRVMPDREGF 345
           +K  +   KAS+ N Q G  P VLSPP K RRVM   EGF
Sbjct: 310 SKGDALEPKASEQN-QHGNSPAVLSPPGKMRRVM-GPEGF 347

Forms a stable complex with cyclin CYCH1-1 that phosphorylates human CDK2 and the C-terminal domain (CTD) of the large subunit of RNA polymerase II.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P50613|CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens GN=CDK7 PE=1 SV=1

 Score =  379 bits (974), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 182/318 (57%), Positives = 229/318 (72%), Gaps = 3/318 (0%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
           YV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ +YFS+ P PT   
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305

Query: 305 KLPRPATKRASKASDFNP 322
           +LPRP     +     NP
Sbjct: 306 QLPRPNCPVETLKEQSNP 323

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P20911|CDK7_XENLA Cyclin-dependent kinase 7 OS=Xenopus laevis GN=cdk7 PE=1 SV=1

 Score =  375 bits (962), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 180/302 (59%), Positives = 223/302 (73%), Gaps = 3/302 (0%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKE 67
           A +Y K + LGEG +  VYKA D  T + VAIKKI+LG + E   G+N TALREIKLL+E
Sbjct: 15  AKQYEKLDFLGEGQFATVYKARDKNTDRIVAIKKIKLGHRAEANDGINRTALREIKLLQE 74

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L  P+II L+DAF HK N+ LVF+FMETDLE +I++T++ L+PA IKSYM MTL+GL + 
Sbjct: 75  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDTSLVLTPAHIKSYMLMTLQGLEYL 134

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H  W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYR+PELLFGA+
Sbjct: 135 HHLWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRIYTHQVVTRWYRSPELLFGAR 194

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWP ++ LPDYV 
Sbjct: 195 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPGMSSLPDYVA 254

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
           ++     PL  +F +A DD L+LL  +FT++P AR TA QAL  RYFS+ P PT  N LP
Sbjct: 255 FKSFPGTPLHLIFIAAGDDLLELLQGLFTFNPCARCTASQALRKRYFSNRPAPTPGNLLP 314

Query: 308 RP 309
           RP
Sbjct: 315 RP 316

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of cdk1/cyclin-B during G2-M transition, and for activation of cdk2/cyclins during G1-S transition (but not complex formation). cdk7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. CAK activates the cyclin-associated kinases cdk1, cdk2, cdk4 and cdk6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (polr2a), allowing its escape from the promoter and elongation of the transcripts (By similarity). Involved in negative regulation of the meiotic maturation of Xenopus oocytes.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q03147|CDK7_MOUSE Cyclin-dependent kinase 7 OS=Mus musculus GN=Cdk7 PE=1 SV=2

 Score =  373 bits (958), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 179/318 (56%), Positives = 228/318 (71%), Gaps = 3/318 (0%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
           YV ++     PL+ +F +A DD L+L+  +F ++P  R TA QAL+ +YFS+ P PT   
Sbjct: 246 YVTFKSFPGVPLQHIFIAAGDDLLELIQGLFLFNPCTRTTASQALKTKYFSNRPGPTPGC 305

Query: 305 KLPRPATKRASKASDFNP 322
           +LPRP     +     NP
Sbjct: 306 QLPRPNCPVEALKEPANP 323

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P51952|CDK7_RAT Cyclin-dependent kinase 7 (Fragment) OS=Rattus norvegicus GN=Cdk7 PE=2 SV=2

 Score =  370 bits (949), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 177/315 (56%), Positives = 226/315 (71%), Gaps = 3/315 (0%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKE 67
           A+R  K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+E
Sbjct: 1   ANRNEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 60

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + 
Sbjct: 61  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 120

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+  +THQV  RWYRAPELLFGA+
Sbjct: 121 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGAR 180

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV 
Sbjct: 181 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 240

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
           ++     PL+ +F +A DD L+L+  +F ++P  RITA QAL  +YFS+ P PT   +LP
Sbjct: 241 FKSFPGIPLQHIFIAAGDDLLELIQGLFLFNPCTRITASQALRTKYFSNRPGPTPGCQLP 300

Query: 308 RPATKRASKASDFNP 322
           RP     +     NP
Sbjct: 301 RPNCPVEALKEQSNP 315

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P51953|CDK7_CARAU Cyclin-dependent kinase 7 OS=Carassius auratus GN=cdk7 PE=2 SV=1

 Score =  354 bits (909), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 173/305 (56%), Positives = 219/305 (71%), Gaps = 4/305 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A  Y K + LGEG +  VYKA D  T   VAIKKI++G +   K+G+N TALREIKL
Sbjct: 6   KSRAKLYEKLDFLGEGQFATVYKARDKTTNTIVAIKKIKVGHRTEAKDGINRTALREIKL 65

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ L+  FMETDLE +I++T++ L+PA+IK+Y+ M+L+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLLC-FMETDLEVIIKDTSLVLTPANIKAYILMSLQGL 124

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H  W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct: 125 EYMHNHWILHRDLKPNNLLLDENGVLKLADFGLAKAFGSPNRVYTHQVVTRWYRAPELLF 184

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA G I AELL R PFL G SD+DQL  IF A GT T   WP ++ LPD
Sbjct: 185 GARMYGVGVDMWAVGSILAELLLRVPFLAGDSDLDQLTGIFEALGTPTEETWPGMSNLPD 244

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
           YV ++     PL  +F +A DD L+LL  +FT++P  R TA QAL+ RYFS  P PT   
Sbjct: 245 YVSFKLFPGTPLEHIFSAAGDDLLELLKGLFTFNPCTRTTASQALKMRYFSIRPGPTPGP 304

Query: 305 KLPRP 309
           +LPRP
Sbjct: 305 QLPRP 309

Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of cdk1/cyclin-B during G2-M transition, and for activation of cdk2/cyclins during G1-S transition (but not complex formation). cdk7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. CAK activates the cyclin-associated kinases cdk1, cdk2, cdk4 and cdk6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminus domain (CTD) of its large subunit (polr2a), allowing its escape from the promoter and elongation of the transcripts.

Carassius auratus (taxid: 7957)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	415
356524652	413	PREDICTED: LOW QUALITY PROTEIN: cyclin-d	0.995	1.0	0.826	0.0
449439111	418	PREDICTED: cyclin-dependent kinase D-1-l	0.995	0.988	0.815	0.0
356513008	412	PREDICTED: cyclin-dependent kinase D-1-l	0.992	1.0	0.817	0.0
15419985	412	CDK-activating kinase [Medicago sativa s	0.992	1.0	0.813	0.0
225456067	422	PREDICTED: cyclin-dependent kinase D-1 [	1.0	0.983	0.811	0.0
356531164	411	PREDICTED: cyclin-dependent kinase D-1-l	0.990	1.0	0.822	0.0
356520635	411	PREDICTED: LOW QUALITY PROTEIN: cyclin-d	0.990	1.0	0.822	0.0
224118722	416	predicted protein [Populus trichocarpa]	0.995	0.992	0.818	0.0
255583528	399	cak1, putative [Ricinus communis] gi|223	0.951	0.989	0.842	0.0
156104834	411	CDK activating kinase [Nicotiana tabacum	0.975	0.985	0.804	0.0

>gi|356524652|ref|XP_003530942.1| PREDICTED: LOW QUALITY PROTEIN: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  718 bits (1853), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/415 (82%), Positives = 376/415 (90%), Gaps = 2/415 (0%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M+++D SKKVADRYLKREVLGEGTYGVVYKAIDT TGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MSDMDPSKKVADRYLKREVLGEGTYGVVYKAIDTHTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+I+ELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSP+D KSY+QMT
Sbjct: 61  EIKLLKELKDPNIVELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPSDTKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA+CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAYCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARMFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGAKQYG GVDVWAAGCIFAELL RRPFLQG+SDIDQLGKIF+AFGT T SQWPD+ 
Sbjct: 181 ELLFGAKQYGPGVDVWAAGCIFAELLLRRPFLQGTSDIDQLGKIFSAFGTPTASQWPDMV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           YLPDYVEYQYV APPLRSLFP  +DDALDLLSKMFTYDPKARI+ QQALEHRYFSSAPLP
Sbjct: 241 YLPDYVEYQYVPAPPLRSLFPMVTDDALDLLSKMFTYDPKARISVQQALEHRYFSSAPLP 300

Query: 301 TEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAG 360
           ++P+KLPRPA KR S+ SDFN QEGPTVLSPPRK+RRVMP R+GFEG++ + DK++   G
Sbjct: 301 SDPDKLPRPAPKRESRTSDFNLQEGPTVLSPPRKSRRVMPGRDGFEGSSLQADKVDASFG 360

Query: 361 ETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE 415
           +    D    G+NE  P SV+FSIF  +PP+RPTINSADRS+LKRKLDLEFQ PE
Sbjct: 361 DFNXDDN--TGKNESAPMSVEFSIFGLKPPNRPTINSADRSYLKRKLDLEFQQPE 413

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439111|ref|XP_004137331.1| PREDICTED: cyclin-dependent kinase D-1-like [Cucumis sativus] gi|449497514|ref|XP_004160424.1| PREDICTED: cyclin-dependent kinase D-1-like [Cucumis sativus]

 Score =  715 bits (1845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/418 (81%), Positives = 370/418 (88%), Gaps = 5/418 (1%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MA++D SKKVADRYLKREVLGEGTYGVVYKAIDT+TGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MADLDPSKKVADRYLKREVLGEGTYGVVYKAIDTQTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK  +IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSPADIKSY+QMT
Sbjct: 61  EIKLLKELKDSNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPADIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA+CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLARIFGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAYCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG+ VDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT TPSQWPD+ 
Sbjct: 181 ELLFGTKQYGSAVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPTPSQWPDML 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           YLPDYVE+QYV APPLRSLFP ASDD LDLLSKMF YDPK+RIT QQALEHRYF+SAPLP
Sbjct: 241 YLPDYVEFQYVPAPPLRSLFPMASDDTLDLLSKMFAYDPKSRITIQQALEHRYFTSAPLP 300

Query: 301 TEPNKLPRPATKRA-----SKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKI 355
           T+P+KLPRP +KR      S+  D N  +GPTVLSPPRK+RRVMPDRE FEGNA R D++
Sbjct: 301 TDPSKLPRPTSKREPTNSNSRVLDLNSNDGPTVLSPPRKSRRVMPDREAFEGNAYRADRL 360

Query: 356 EEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQH 413
           ++H  E +        +NE  P S+DFS+F  +PP+RPTINSADRSHLKRKLDLEFQ 
Sbjct: 361 DDHVNEVRELAAGNTSKNEAAPMSLDFSVFGGKPPNRPTINSADRSHLKRKLDLEFQQ 418

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513008|ref|XP_003525206.1| PREDICTED: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  711 bits (1836), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/412 (81%), Positives = 370/412 (89%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M ++D SKKVADRYLKREVLGEGTYGVVYKAIDT TGQTVAIKKIRLGK+KEGVNFTALR
Sbjct: 1   MTDMDHSKKVADRYLKREVLGEGTYGVVYKAIDTHTGQTVAIKKIRLGKRKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+I+ELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSP D KSY+QMT
Sbjct: 61  EIKLLKELKDPNIVELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPGDTKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA+CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAYCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARMFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGAKQYG GVDVWAAGCIFAELL RRPFLQG+SDIDQLGKIF+AFG  T  QWPD+ 
Sbjct: 181 ELLFGAKQYGPGVDVWAAGCIFAELLLRRPFLQGTSDIDQLGKIFSAFGIPTAPQWPDMV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           YLPDYVEYQYV APPLRSLFP A+DDALDLLSKMFTYDPK RI+  QALEHRYFSSAPLP
Sbjct: 241 YLPDYVEYQYVLAPPLRSLFPMATDDALDLLSKMFTYDPKTRISVHQALEHRYFSSAPLP 300

Query: 301 TEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAG 360
           ++P+KLPRPA KR S+ SDFN QEGPT+LSPPRK+RRVMP R+GFEGN+ + DK++   G
Sbjct: 301 SDPDKLPRPAPKRESRVSDFNSQEGPTILSPPRKSRRVMPGRDGFEGNSLQADKVDASFG 360

Query: 361 ETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQ 412
           + +    +  G+NE  P SVDFSIF  +PP+RPTINSADRS+LKRKLDLEFQ
Sbjct: 361 DFRQTTDDNTGKNESAPMSVDFSIFGLKPPNRPTINSADRSYLKRKLDLEFQ 412

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15419985|gb|AAK97227.1|AF302013_1 CDK-activating kinase [Medicago sativa subsp. x varia]

 Score =  704 bits (1818), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/412 (81%), Positives = 366/412 (88%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M E+D SKKVADRYLKREVLGEGTYGVVYKAIDT+TGQTVAIKKIR+GKQKEGVNFTALR
Sbjct: 1   MTELDPSKKVADRYLKREVLGEGTYGVVYKAIDTQTGQTVAIKKIRIGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELID FPHKGNLHLVFEFMETDLE VIR+ NIFL+P DIKSY+QMT
Sbjct: 61  EIKLLKELKDPNIIELIDCFPHKGNLHLVFEFMETDLEAVIRDRNIFLAPGDIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKW+LHRDMKPNNLLIG +GQLKLADFGLARIFGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAHCHKKWILHRDMKPNNLLIGPNGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT +PSQWPD+ 
Sbjct: 181 ELLFGTKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPSPSQWPDMV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           YLPDYVEYQ+V APPLRSLFP A+DDALDLLSKMFTYDPK RI+ QQALEHRYF+  P P
Sbjct: 241 YLPDYVEYQFVPAPPLRSLFPMATDDALDLLSKMFTYDPKDRISVQQALEHRYFTCPPQP 300

Query: 301 TEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAG 360
           T+P KLPRPA K+  K SD NP EGPTVLSPPRKTRRVMP R+G EGN+ + D+++++ G
Sbjct: 301 TDPVKLPRPAPKKEIKPSDLNPPEGPTVLSPPRKTRRVMPGRDGLEGNSLQGDRVDDNHG 360

Query: 361 ETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQ 412
             K   G+  G+NE  P S+DFS+F  +PP+RPTINSADRSHLKRKLDLEFQ
Sbjct: 361 NLKQTGGDNTGKNEPAPMSLDFSVFGLKPPNRPTINSADRSHLKRKLDLEFQ 412

Source: Medicago sativa subsp. x varia

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456067|ref|XP_002280613.1| PREDICTED: cyclin-dependent kinase D-1 [Vitis vinifera] gi|297734275|emb|CBI15522.3| unnamed protein product [Vitis vinifera]

 Score =  701 bits (1810), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/420 (81%), Positives = 366/420 (87%), Gaps = 5/420 (1%)

Query: 1   MAEVD--LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA 58
           M+EV    SKKVADRYLKREVLGEGTYGVV KAIDTKTGQ VAIKKIRLGK KEGVNFTA
Sbjct: 1   MSEVPNVFSKKVADRYLKREVLGEGTYGVVSKAIDTKTGQIVAIKKIRLGKHKEGVNFTA 60

Query: 59  LREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LREIKLLKELK PHIIELIDAFPHKGNLHLVFEFMETDLE VIR+ NI LS ADIKS++Q
Sbjct: 61  LREIKLLKELKDPHIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIVLSLADIKSFLQ 120

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           MTLKGLAFCHKKWVLHRDMKPNNLLIG  GQLKLADFGLARIFGSPDR+FTHQVFARWYR
Sbjct: 121 MTLKGLAFCHKKWVLHRDMKPNNLLIGDKGQLKLADFGLARIFGSPDRKFTHQVFARWYR 180

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APELLFG+KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT  P+QWPD
Sbjct: 181 APELLFGSKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPKPAQWPD 240

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
           + YLPDYVEYQ+V APPLRSLFP ASDDALDLLSKMFTYDPK RI+ QQALEHRYF+S P
Sbjct: 241 MVYLPDYVEYQFVPAPPLRSLFPMASDDALDLLSKMFTYDPKTRISVQQALEHRYFTSGP 300

Query: 299 LPTEPNKLPRPATKRAS---KASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKI 355
           LPTEP KLPRP  KR S   + SDFN QEGPTVLSPPRK+RRVMP R+GFE NA++ +K 
Sbjct: 301 LPTEPAKLPRPHPKRESLNTRVSDFNQQEGPTVLSPPRKSRRVMPQRDGFEENAHQVEKS 360

Query: 356 EEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE 415
           +EH  + + A GE    NE  P S+DFS+F +RPP RPTINSAD+S LKRKLDLEFQ P+
Sbjct: 361 DEHVNDIRQATGERMSWNEHAPMSIDFSVFGSRPPPRPTINSADKSRLKRKLDLEFQQPD 420

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356531164|ref|XP_003534148.1| PREDICTED: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  701 bits (1810), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/411 (82%), Positives = 365/411 (88%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MAE+DLSKKVADRYLKREVLGEGTYGVVYKAIDT+TGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MAELDLSKKVADRYLKREVLGEGTYGVVYKAIDTQTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NI LSP DIKSY+QMT
Sbjct: 61  EIKLLKELKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIVLSPGDIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAICHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARVFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT + SQWPD+ 
Sbjct: 181 ELLFGTKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPSASQWPDMI 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           +LPDYVEYQ+V APPLRSLFP ASDDALDLLSKMFTYDPKARI+ QQALEHRYFSSAPL 
Sbjct: 241 FLPDYVEYQHVPAPPLRSLFPMASDDALDLLSKMFTYDPKARISVQQALEHRYFSSAPLL 300

Query: 301 TEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAG 360
           T+P KLPRPA K+ SK SD    EGPTVLSPPRK+RRVMP R+G EGN+ + DK ++   
Sbjct: 301 TDPVKLPRPAPKKESKVSDVISNEGPTVLSPPRKSRRVMPGRDGSEGNSLQGDKFDDSVV 360

Query: 361 ETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEF 411
             + A G+  G+NE  P S+DFS+F  +PP+RP I SADRSHLKRKLDLEF
Sbjct: 361 SVRQAAGDNTGKNEPAPMSLDFSLFGLKPPNRPMITSADRSHLKRKLDLEF 411

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520635|ref|XP_003528966.1| PREDICTED: LOW QUALITY PROTEIN: cyclin-dependent kinase D-1-like [Glycine max]

 Score =  701 bits (1809), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/411 (82%), Positives = 365/411 (88%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MAE+DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MAELDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NI LSP+DIKSY+QMT
Sbjct: 61  EIKLLKELKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIVLSPSDIKSYLQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLAR+FGSPDRRFTHQVFARWYRAP
Sbjct: 121 LKGLAICHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARVFGSPDRRFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYG GVDVWAA CIFAELL RRPFLQGSSDIDQLGKIFAAFGT + SQWPD+ 
Sbjct: 181 ELLFGTKQYGPGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFAAFGTPSASQWPDMI 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           +LPDYVEYQ+V APPLRSLFP ASDDALDLL KMFTYDPKARI+  QALEHRYFSSAPLP
Sbjct: 241 FLPDYVEYQHVPAPPLRSLFPMASDDALDLLXKMFTYDPKARISVPQALEHRYFSSAPLP 300

Query: 301 TEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAG 360
           T+P KL RPA K+ SK SD    EGPTVLSPPRK+RRVMP R+G EGN+ + DK ++   
Sbjct: 301 TDPVKLSRPAPKKESKVSDVISNEGPTVLSPPRKSRRVMPGRDGSEGNSLQGDKFDDSVV 360

Query: 361 ETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEF 411
             + A G+  G+NE  P S+DFS+F  +PP+RPTI SADRSHLKRKLDLEF
Sbjct: 361 SVRQAAGDNMGKNEPAPMSLDFSLFGLKPPNRPTITSADRSHLKRKLDLEF 411

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118722|ref|XP_002317890.1| predicted protein [Populus trichocarpa] gi|222858563|gb|EEE96110.1| predicted protein [Populus trichocarpa]

 Score =  699 bits (1805), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/418 (81%), Positives = 364/418 (87%), Gaps = 5/418 (1%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M+E D+ KKVADRYLKRE+LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MSENDVEKKVADRYLKREILGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKELK P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSP DIKSY QMT
Sbjct: 61  EIKLLKELKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDPNIFLSPGDIKSYFQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGL  CHKKWVLHRDMKPNNLLIGS+GQLKLADFGLARIFGSP R+FTHQVFARWYRAP
Sbjct: 121 LKGLLVCHKKWVLHRDMKPNNLLIGSNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFGAKQYGAGVDVWAAGCI AELLNRRPFLQG SDIDQLGKIF   GT TPSQWPDL 
Sbjct: 181 ELLFGAKQYGAGVDVWAAGCILAELLNRRPFLQGDSDIDQLGKIFQKLGTPTPSQWPDLE 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           +LPD+VEY    A P R L P+ASDDALDLLSK+FTYDPK RIT QQALEHRYF+S PLP
Sbjct: 241 WLPDFVEYSSQTAQPWRKLCPTASDDALDLLSKLFTYDPKTRITVQQALEHRYFTSVPLP 300

Query: 301 TEPNKLPRPATKRAS---KASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEE 357
           T+P KLPRPA KR S   + SD +  EGPTVLSP +K RRVMPDRE F+GNA   DKI++
Sbjct: 301 TDPAKLPRPAPKRESHNPRTSDLH--EGPTVLSPKKKARRVMPDREVFDGNAYHVDKIDQ 358

Query: 358 HAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE 415
           H GE + A G+   RNEQVP SVDFSIF A+P SRPTINSADRSHLKRKLDLEFQHPE
Sbjct: 359 HGGEIRWAAGDNTSRNEQVPMSVDFSIFGAKPMSRPTINSADRSHLKRKLDLEFQHPE 416

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583528|ref|XP_002532521.1| cak1, putative [Ricinus communis] gi|223527752|gb|EEF29855.1| cak1, putative [Ricinus communis]

 Score =  687 bits (1772), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/399 (84%), Positives = 354/399 (88%), Gaps = 4/399 (1%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M+E D  KKVADRYLKRE+LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR
Sbjct: 1   MSENDGEKKVADRYLKREILGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLKE+K P+IIELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSPADIKSY QMT
Sbjct: 61  EIKLLKEIKDPNIIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPADIKSYFQMT 120

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           LKGLA CHKKWVLHRDMKPNNLLI  +GQLKLADFGLARIFGSPDR+FTHQVFARWYRAP
Sbjct: 121 LKGLAVCHKKWVLHRDMKPNNLLIAPNGQLKLADFGLARIFGSPDRKFTHQVFARWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELLFG KQYGAGVDVWAA CIFAELL RRPFLQGSSDIDQLGKIF AFGT +PSQWPDL 
Sbjct: 181 ELLFGTKQYGAGVDVWAAACIFAELLLRRPFLQGSSDIDQLGKIFQAFGTPSPSQWPDLV 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           YLPDYVEYQ V A P R LFP ASDDALDLL KMFTYDPKARITA+QALEHRYFSSAPLP
Sbjct: 241 YLPDYVEYQSVPAQPWRKLFPMASDDALDLLIKMFTYDPKARITAEQALEHRYFSSAPLP 300

Query: 301 TEPNKLPRPATKRA---SKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEE 357
           TEP KLPRPA KR    S+ASDFNP EGPTVLSPPRKTRRVMP+REGF GNA + DK +E
Sbjct: 301 TEPAKLPRPAPKRESLNSRASDFNPLEGPTVLSPPRKTRRVMPEREGFAGNAYQVDKNDE 360

Query: 358 HAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTIN 396
           H G+ K A G   GR+EQ P S+DFS+F +RP SRPTIN
Sbjct: 361 H-GDVKQAAGNYTGRSEQAPMSIDFSVFGSRPMSRPTIN 398

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|156104834|dbj|BAF75824.1| CDK activating kinase [Nicotiana tabacum]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/420 (80%), Positives = 367/420 (87%), Gaps = 15/420 (3%)

Query: 1   MAEVD--LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA 58
           M EVD  L+KKVADRYLKREVLGEGTYGVV+KAIDTK+GQTVAIKKIRLGKQKEGVNFTA
Sbjct: 1   MTEVDNLLTKKVADRYLKREVLGEGTYGVVFKAIDTKSGQTVAIKKIRLGKQKEGVNFTA 60

Query: 59  LREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LREIKLLKELK PH+IELIDAFPHKGNLHLVFEFMETDLE VIR+ NIFLSPADIKSY+Q
Sbjct: 61  LREIKLLKELKDPHVIELIDAFPHKGNLHLVFEFMETDLEAVIRDRNIFLSPADIKSYIQ 120

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           MTLKGLAFCHKK+VLHRDMKPNNLLIG  GQLKLADFGLAR+FGSPD RFTHQVFARWYR
Sbjct: 121 MTLKGLAFCHKKYVLHRDMKPNNLLIGPKGQLKLADFGLARLFGSPD-RFTHQVFARWYR 179

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APELLFGAKQYG GVDVWAA CIFAELL RRPFLQG+SDIDQLGKIFAAFGT  PSQW D
Sbjct: 180 APELLFGAKQYGPGVDVWAAACIFAELLLRRPFLQGNSDIDQLGKIFAAFGTPKPSQWAD 239

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
           + YLPDYVEYQYV   PL++LFP+A++DALDLLSKMF+YDPKARI+AQQALEHRYFSS P
Sbjct: 240 MVYLPDYVEYQYVPGQPLKTLFPTATEDALDLLSKMFSYDPKARISAQQALEHRYFSSGP 299

Query: 299 LPTEPNKLPRPATKRAS---KASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKI 355
           LPTEP  LPRP  KR S   + SDFN ++GP VLSPPRK+RRVMP REGFE N  R +K+
Sbjct: 300 LPTEPVLLPRPPPKRESANPRVSDFNSRDGPVVLSPPRKSRRVMPQREGFEANM-RPEKM 358

Query: 356 EEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEFQHPE 415
           ++H        G    R+EQVP S+DFS+F  RPP+RPTINSADRSHLKRKLDLEFQ  E
Sbjct: 359 DDH--------GNAGERSEQVPMSLDFSVFGMRPPTRPTINSADRSHLKRKLDLEFQPEE 410

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	415
TAIR|locus:2194045	391	CDKD1;3 "cyclin-dependent kina	0.840	0.892	0.78	5.3e-160
TAIR|locus:2027819	398	CDKD1;1 "cyclin-dependent kina	0.946	0.987	0.740	1.8e-156
TAIR|locus:2033349	348	CAK4 "CDK-activating kinase 4"	0.8	0.954	0.775	4.9e-140
UNIPROTKB|P50613	346	CDK7 "Cyclin-dependent kinase	0.759	0.910	0.572	6.8e-95
UNIPROTKB|Q08DX5	346	CDK7 "Cyclin-dependent kinase	0.766	0.919	0.562	3e-94
UNIPROTKB|C9K505	346	CDK7 "Uncharacterized protein"	0.766	0.919	0.562	3.8e-94
MGI|MGI:102956	346	Cdk7 "cyclin-dependent kinase	0.734	0.881	0.576	1e-93
ZFIN|ZDB-GENE-010320-2	345	cdk7 "cyclin-dependent kinase	0.727	0.875	0.583	2.1e-93
RGD|621124	329	Cdk7 "cyclin-dependent kinase	0.751	0.948	0.561	3.9e-92
UNIPROTKB|P51952	329	Cdk7 "Cyclin-dependent kinase	0.751	0.948	0.561	3.9e-92

TAIR|locus:2194045 CDKD1;3 "cyclin-dependent kinase D1;3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1418 (504.2 bits), Expect = 5.3e-160, Sum P(2) = 5.3e-160
 Identities = 273/350 (78%), Positives = 300/350 (85%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
             KKVADRYLK+EVLG+GTYGVV+KA DTKT QTVAIKKIRLGKQ+EGVN TALREIK+LKE
Sbjct:     6 KKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREIKMLKE 65

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             LK PHII LIDAFPHK NLHLVFEFMETDLE VIR++NIFLSPADIKSY+ MT KGLA+C
Sbjct:    66 LKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFKGLAYC 125

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H KWVLHRDMKPNNLLIG  GQLKLADFGLARIFGSP+R+FTHQVFARWYRAPELLFGAK
Sbjct:   126 HDKWVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPELLFGAK 185

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
             QYGA VDVWA  CIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPDL  LPDYVE
Sbjct:   186 QYGAAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKLPDYVE 245

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
             YQ+V AP LRSLFP+ SDDALDLLSKMFTYDPKARI+ +QALEHRYF+SAP PT+P KLP
Sbjct:   246 YQFVPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFTSAPAPTDPAKLP 305

Query:   308 RPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEE 357
             +P  K+  K+S +   E  TV SPPRK RRVMP+R   +   +  DK ++
Sbjct:   306 KPVPKQDGKSS-YGKHEAITVQSPPRKLRRVMPERGRVDSLKSHVDKDQQ 354

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000280 "nuclear division" evidence=RCA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0051225 "spindle assembly" evidence=RCA

TAIR|locus:2027819 CDKD1;1 "cyclin-dependent kinase D1;1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1525 (541.9 bits), Expect = 1.8e-156, P = 1.8e-156
 Identities = 299/404 (74%), Positives = 334/404 (82%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
             KKVADRYLKREVLG+GTYGVV+KA DTK G+TVAIKKIRLGK+KEGVN TALREIKLLKE
Sbjct:     5 KKVADRYLKREVLGQGTYGVVFKATDTKNGETVAIKKIRLGKEKEGVNVTALREIKLLKE 64

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             LK PHIIELIDAFPHK NLH+VFEFMETDLE VIR+ N++LSP D+KSY+QM LKGL +C
Sbjct:    65 LKHPHIIELIDAFPHKENLHIVFEFMETDLEAVIRDRNLYLSPGDVKSYLQMILKGLEYC 124

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H KWVLHRDMKPNNLLIG +GQLKLADFGLARIFGSP R+FTHQVFARWYRAPELLFGAK
Sbjct:   125 HGKWVLHRDMKPNNLLIGPNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAPELLFGAK 184

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
             QY   VDVWAAGCIFAELL RRPFLQG+SDIDQL KIFAAFGT    QWPD+  LPDYVE
Sbjct:   185 QYDGAVDVWAAGCIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDMICLPDYVE 244

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
             YQ+V AP LRSL P+ S+DALDLLSKMFTYDPK+RI+ QQAL+HRYF+SAP PT+P KLP
Sbjct:   245 YQFVPAPSLRSLLPTVSEDALDLLSKMFTYDPKSRISIQQALKHRYFTSAPSPTDPLKLP 304

Query:   308 RPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTDKIEEHAGETKNADG 367
             RP +K+ +K+SD +  E   VLSP  K RRVMPDR G  GN  +   ++       + DG
Sbjct:   305 RPVSKQDAKSSD-SKLEAIKVLSPAHKFRRVMPDR-GKSGNGFKDQSVD--VMRQASHDG 360

Query:   368 EIAGRNEQVPTSVDFSIFAARPPSRPTINSADRSHLKRKLDLEF 411
                    Q P S+DF+I A RPP+RPTI SADRSHLKRKLDLEF
Sbjct:   361 -------QAPMSLDFTILAERPPNRPTITSADRSHLKRKLDLEF 397

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030154 "cell differentiation" evidence=TAS

GO:0051726 "regulation of cell cycle" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

TAIR|locus:2033349 CAK4 "CDK-activating kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1370 (487.3 bits), Expect = 4.9e-140, P = 4.9e-140
 Identities = 263/339 (77%), Positives = 293/339 (86%)

Query:    12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
             DRYL+R++LGEGTYGVVYKA DTKTG+TVA+KKIRLG QKEGVNFTALREIKLLKEL  P
Sbjct:    11 DRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALREIKLLKELNHP 70

Query:    72 HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
             HI+ELIDAFPH G+LHLVFE+M+TDLE VIR+ NIFLSP DIKSYM MTLKGLA+CHKKW
Sbjct:    71 HIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTLKGLAYCHKKW 130

Query:   132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
             VLHRDMKPNNLLIG +G LKLADFGLAR+FGSP+RRFTHQVFA WYRAPELLFG++QYGA
Sbjct:   131 VLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPELLFGSRQYGA 190

Query:   192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
             GVDVWAAGCIFAELL RRPFL GS++IDQLGKIF AFGT  PSQW D+ YLPDY+E+ Y 
Sbjct:   191 GVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIYLPDYMEFSYT 250

Query:   252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPAT 311
              APPLR++FP ASDDALDLL+KMF YDP+ RIT QQAL+HRYFSS+P PTEP KL  PA+
Sbjct:   251 PAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFSSSPSPTEPGKLQIPAS 310

Query:   312 KRAS---KASDFNPQEG--PTVLSPPRKTRRVMPDREGF 345
             K  +   KAS+ N Q G  P VLSPP K RRVM   EGF
Sbjct:   311 KGDALEPKASEQN-QHGNSPAVLSPPGKMRRVMGP-EGF 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0000079 "regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0042023 "DNA endoreduplication" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

UNIPROTKB|P50613 CDK7 "Cyclin-dependent kinase 7" [Homo sapiens (taxid:9606)]

 Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
 Identities = 182/318 (57%), Positives = 229/318 (72%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
             K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct:     6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query:    65 LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct:    66 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query:   125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
              + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct:   126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query:   185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct:   186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query:   245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
             YV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ +YFS+ P PT   
Sbjct:   246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305

Query:   305 KLPRPATKRASKASDFNP 322
             +LPRP     +     NP
Sbjct:   306 QLPRPNCPVETLKEQSNP 323

GO:0005524 "ATP binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA

GO:0003713 "transcription coactivator activity" evidence=NAS

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=NAS

GO:0050681 "androgen receptor binding" evidence=NAS

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IDA;TAS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0008022 "protein C-terminus binding" evidence=IPI

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IDA

GO:0030521 "androgen receptor signaling pathway" evidence=NAS

GO:0005675 "holo TFIIH complex" evidence=IDA

GO:0008094 "DNA-dependent ATPase activity" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=TAS

GO:0000079 "regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006281 "DNA repair" evidence=TAS

GO:0006283 "transcription-coupled nucleotide-excision repair" evidence=TAS

GO:0006289 "nucleotide-excision repair" evidence=TAS

GO:0006360 "transcription from RNA polymerase I promoter" evidence=TAS

GO:0006361 "transcription initiation from RNA polymerase I promoter" evidence=TAS

GO:0006362 "transcription elongation from RNA polymerase I promoter" evidence=TAS

GO:0006363 "termination of RNA polymerase I transcription" evidence=TAS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=TAS

GO:0006368 "transcription elongation from RNA polymerase II promoter" evidence=TAS

GO:0006370 "7-methylguanosine mRNA capping" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0016032 "viral reproduction" evidence=TAS

GO:0050434 "positive regulation of viral transcription" evidence=TAS

GO:0000080 "G1 phase of mitotic cell cycle" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0000718 "nucleotide-excision repair, DNA damage removal" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0005739 "mitochondrion" evidence=IDA

UNIPROTKB|Q08DX5 CDK7 "Cyclin-dependent kinase 7" [Bos taurus (taxid:9913)]

 Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
 Identities = 181/322 (56%), Positives = 231/322 (71%)

Query:     4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALR 60
             VD+  + A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALR
Sbjct:     3 VDVKSR-AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query:    61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
             EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MT
Sbjct:    62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query:   121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
             L+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP R +THQV  RWYRAP
Sbjct:   122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPSRAYTHQVVTRWYRAP 181

Query:   181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
             ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+ 
Sbjct:   182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query:   241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
              LPD+V ++     PL+ +F +A DD LDL+  +F ++P  RITA QAL+ +YFS+ P P
Sbjct:   242 SLPDFVTFKSFPGIPLQHIFIAAGDDLLDLIQGLFLFNPCTRITATQALKTKYFSNRPGP 301

Query:   301 TEPNKLPRPATKRASKASDFNP 322
             T   +LPRP     +     NP
Sbjct:   302 TPGCQLPRPNCPAEALKEQSNP 323

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0008094 "DNA-dependent ATPase activity" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0005675 "holo TFIIH complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|C9K505 CDK7 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
 Identities = 181/322 (56%), Positives = 232/322 (72%)

Query:     4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALR 60
             VD+  + A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALR
Sbjct:     3 VDVKSR-AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query:    61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
             EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MT
Sbjct:    62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query:   121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
             L+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAP
Sbjct:   122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query:   181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
             ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+ 
Sbjct:   182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query:   241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
              LPD+V ++     PL+ +F +A DD LDL+  +F ++P  RITA QAL+ +YFS+ P P
Sbjct:   242 SLPDFVTFKSFPGIPLQHIFIAAGDDLLDLIQGLFLFNPCTRITATQALKTKYFSNRPGP 301

Query:   301 TEPNKLPRPATKRASKASDFNP 322
             T   +LPRP     +     NP
Sbjct:   302 TPGCQLPRPNCPVEALKEQSNP 323

GO:0005634 "nucleus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:102956 Cdk7 "cyclin-dependent kinase 7" [Mus musculus (taxid:10090)]

 Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
 Identities = 178/309 (57%), Positives = 228/309 (73%)

Query:     4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALR 60
             VD+  + A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALR
Sbjct:     3 VDVKSR-AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query:    61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
             EIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MT
Sbjct:    62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query:   121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
             L+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAP
Sbjct:   122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query:   181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
             ELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+ 
Sbjct:   182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query:   241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
              LPDYV ++     PL+ +F +A DD L+L+  +F ++P  R TA QAL+ +YFS+ P P
Sbjct:   242 SLPDYVTFKSFPGVPLQHIFIAAGDDLLELIQGLFLFNPCTRTTASQALKTKYFSNRPGP 301

Query:   301 TEPNKLPRP 309
             T   +LPRP
Sbjct:   302 TPGCQLPRP 310

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO;ISS

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005675 "holo TFIIH complex" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005829 "cytosol" evidence=ISO

GO:0005856 "cytoskeleton" evidence=ISO

GO:0006281 "DNA repair" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;ISS;IDA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007049 "cell cycle" evidence=ISS

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008094 "DNA-dependent ATPase activity" evidence=ISO

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO

GO:0016020 "membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032403 "protein complex binding" evidence=ISO

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0051301 "cell division" evidence=IEA

ZFIN|ZDB-GENE-010320-2 cdk7 "cyclin-dependent kinase 7" [Danio rerio (taxid:7955)]

 Score = 930 (332.4 bits), Expect = 2.1e-93, P = 2.1e-93
 Identities = 178/305 (58%), Positives = 226/305 (74%)

Query:     8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
             K  A RY K + LGEG +  VYKA D  T   VAIKKI++G +   K+G+N TALREIKL
Sbjct:     6 KSRAKRYEKLDFLGEGQFATVYKARDKTTNTIVAIKKIKVGHRTEAKDGINRTALREIKL 65

Query:    65 LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             L+EL  P+II L+DAF HK N+ LVF++METDLE +I++T++ L+PA+IK+Y+ MTL+GL
Sbjct:    66 LQELSHPNIIGLLDAFGHKSNISLVFDYMETDLEVIIKDTSLVLTPANIKAYILMTLQGL 125

Query:   125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
              + H  W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLF
Sbjct:   126 EYMHNHWILHRDLKPNNLLLDENGVLKLADFGLAKAFGSPNRVYTHQVVTRWYRAPELLF 185

Query:   185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             GA+ YG GVD+WA GCI AELL R PFL G SD+DQL KIF A GT T   WP ++ LPD
Sbjct:   186 GARMYGVGVDMWAVGCILAELLLRVPFLAGDSDLDQLTKIFEALGTPTDEIWPGMSSLPD 245

Query:   245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
             YV ++     PL  +F +A DD L+LL  +FTY+P +R TA QAL+ +YFS+ P PT   
Sbjct:   246 YVSFKPFPGTPLEHIFSAAGDDLLELLRGLFTYNPCSRTTAMQALKMKYFSNRPGPTPGP 305

Query:   305 KLPRP 309
             +LPRP
Sbjct:   306 QLPRP 310

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

RGD|621124 Cdk7 "cyclin-dependent kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
 Identities = 177/315 (56%), Positives = 226/315 (71%)

Query:    11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKE 67
             A+R  K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+E
Sbjct:     1 ANRNEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 60

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             L  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + 
Sbjct:    61 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 120

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+  +THQV  RWYRAPELLFGA+
Sbjct:   121 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGAR 180

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
              YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV 
Sbjct:   181 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 240

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
             ++     PL+ +F +A DD L+L+  +F ++P  RITA QAL  +YFS+ P PT   +LP
Sbjct:   241 FKSFPGIPLQHIFIAAGDDLLELIQGLFLFNPCTRITASQALRTKYFSNRPGPTPGCQLP 300

Query:   308 RPATKRASKASDFNP 322
             RP     +     NP
Sbjct:   301 RPNCPVEALKEQSNP 315

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=TAS

GO:0004672 "protein kinase activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005675 "holo TFIIH complex" evidence=ISO;ISS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=ISO

GO:0005829 "cytosol" evidence=IDA

GO:0005856 "cytoskeleton" evidence=IDA

GO:0006281 "DNA repair" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006366 "transcription from RNA polymerase II promoter" evidence=ISO;ISS

GO:0006468 "protein phosphorylation" evidence=ISO;IDA

GO:0007049 "cell cycle" evidence=TAS

GO:0007126 "meiosis" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0008094 "DNA-dependent ATPase activity" evidence=ISO;ISS

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO;ISS

GO:0016020 "membrane" evidence=IDA

GO:0016301 "kinase activity" evidence=ISO

GO:0016310 "phosphorylation" evidence=ISO

GO:0032403 "protein complex binding" evidence=IDA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|P51952 Cdk7 "Cyclin-dependent kinase 7" [Rattus norvegicus (taxid:10116)]

 Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
 Identities = 177/315 (56%), Positives = 226/315 (71%)

Query:    11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKE 67
             A+R  K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+E
Sbjct:     1 ANRNEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 60

Query:    68 LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             L  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + 
Sbjct:    61 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 120

Query:   128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+  +THQV  RWYRAPELLFGA+
Sbjct:   121 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNWAYTHQVVTRWYRAPELLFGAR 180

Query:   188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
              YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV 
Sbjct:   181 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 240

Query:   248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
             ++     PL+ +F +A DD L+L+  +F ++P  RITA QAL  +YFS+ P PT   +LP
Sbjct:   241 FKSFPGIPLQHIFIAAGDDLLELIQGLFLFNPCTRITASQALRTKYFSNRPGPTPGCQLP 300

Query:   308 RPATKRASKASDFNP 322
             RP     +     NP
Sbjct:   301 RPNCPVEALKEQSNP 315

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
A2Y4B6	CDKD1_ORYSI	2, ., 7, ., 1, 1, ., 2, 3	0.7584	0.9783	0.9575	N/A	no
P50613	CDK7_HUMAN	2, ., 7, ., 1, 1, ., 2, 3	0.5723	0.7590	0.9104	yes	no
P29620	CDKD1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.7584	0.9783	0.9575	yes	no
Q9LMT0	CDKD3_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.7506	0.9301	0.9872	yes	no
Q9C9U2	CDKD1_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.7400	0.9469	0.9874	no	no
P51952	CDK7_RAT	2, ., 7, ., 1, 1, ., 2, 3	0.5619	0.7518	0.9483	yes	no
Q03147	CDK7_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.5628	0.7590	0.9104	yes	no
Q9C9M7	CDKD2_ARATH	2, ., 7, ., 1, 1, ., 2, 3	0.7735	0.8024	0.9568	no	no
P54685	CDK7_DICDI	2, ., 7, ., 1, 1, ., 2, 3	0.5324	0.7325	0.8444	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.979
3rd Layer	2.7.11.23	0.979
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017765001 SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (422 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	415
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	0.0
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-151
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-136
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-127
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-121
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-120
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-110
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-108
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-107
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-107
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-103
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-103
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-102
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-101
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-99
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-95
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-95
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-95
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-94
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-94
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-92
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-92
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-87
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-86
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-85
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-85
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-83
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-78
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-75
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-74
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-74
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-73
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-72
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-71
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-71
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-70
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-69
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-69
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-67
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-65
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-64
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-62
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-60
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-59
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-59
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-59
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-58
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-57
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-55
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-52
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-51
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-51
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-50
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-49
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-49
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-47
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-44
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-43
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-41
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-39
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-39
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-38
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-37
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-34
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-33
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-33
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-32
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-31
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-31
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-30
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-29
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-27
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-27
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-26
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-26
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-25
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-24
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-24
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-20
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-18
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-17
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-17
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-15
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-14
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-13
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.002

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  556 bits (1436), Expect = 0.0
 Identities = 199/298 (66%), Positives = 237/298 (79%), Gaps = 3/298 (1%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKELK 69
           RY K + LGEGTY VVYKA D +TG+ VAIKKI+LG++KE   G+NFTALREIKLL+ELK
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+II L+D F HK N++LVFEFMETDLE VI++ +I L+PADIKSYM MTL+GL + H 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            W+LHRD+KPNNLLI S G LKLADFGLAR FGSP+R+ THQV  RWYRAPELLFGA+ Y
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G GVD+W+ GCIFAELL R PFL G SDIDQLGKIF A GT T   WP +  LPDYVE++
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK 240

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
                PL+ +FP+ASDDALDLL ++ T +P  RITA+QALEH YFS+ P PT P++LP
Sbjct: 241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQLP 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  429 bits (1106), Expect = e-151
 Identities = 147/282 (52%), Positives = 187/282 (66%), Gaps = 1/282 (0%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K E LGEGTYGVVYKA D KTG+ VA+KKIRL  ++EG+  TALREI LLKELK P+I
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L+D    +  L+LVFE+ + DL+  +      LSP  IKS M   L+GLA+CH   +L
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP N+LI   G LKLADFGLAR FG P R +TH+V   WYRAPE+L G+K Y   V
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAV 180

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQYVA 252
           D+W+ GCIFAE++  +P   G S+IDQL KIF   GT T   WP +  LPDY   +    
Sbjct: 181 DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              L  + P    + +DLLSKM  Y+P  RI+A++AL+H YF
Sbjct: 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  390 bits (1004), Expect = e-136
 Identities = 167/283 (59%), Positives = 196/283 (69%), Gaps = 2/283 (0%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K   +GEGTYGVVYKA D  TG+ VAIKKI+L  + EG+  TALREIKLLKEL  P+I
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           I+L+D F HKG+L+LVFEFM+TDL  +I++    L  + IKSY+   L+GLAFCH   +L
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP NLLI + G LKLADFGLAR FGSP R +TH V  RWYRAPELL G K Y   V
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY--VEYQYV 251
           D+W+ GCIFAELL+RRP   G S+IDQL KIF   GT  P  WP    L       +   
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           A  PL  LFP+AS  ALDLLS+M  YDP  RITA+QAL H YF
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  368 bits (946), Expect = e-127
 Identities = 139/285 (48%), Positives = 190/285 (66%), Gaps = 3/285 (1%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     +GEG +G+V+KA D +TG+TVA+KK+ L + + G+   ALREIK L+  + P+
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +++L+D FPH     LV E+M +DL  V+R+    L  A +KSYM+M LKG+A+ H   +
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FTHQVFARWYRAPELLFGAKQYGA 191
           +HRD+KP NLLI + G LK+ADFGLAR+F   + R ++HQV  RWYRAPELL+GA++Y  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           GVD+WA GCIFAELLN  P   G +DI+QL  +F   GT     WP L  LPDY +  + 
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240

Query: 252 AAPP--LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + P  L  +FP AS +ALDLL  +  YDP  R++A +AL H YF
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  354 bits (910), Expect = e-121
 Identities = 131/287 (45%), Positives = 184/287 (64%), Gaps = 6/287 (2%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K   +GEGTYG VYKA + KTG+ VA+KKIR+  +KEG   TA+REIKLL++L+ P+I
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 74  IELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L +      KG++++VFE+M+ DL  ++ +  +  + + IK YM+  L+GL + H   
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           +LHRD+K +N+LI + G LKLADFGLAR +       +T++V   WYR PELL GA +YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ GCI AEL   +P  QGS++++QL KIF   G+ T   WP ++ LP +   + 
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240

Query: 251 VAAPP--LRSLFPSASD-DALDLLSKMFTYDPKARITAQQALEHRYF 294
                  LR  F    D  ALDLL K+ T DPK RI+A QAL+H YF
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  350 bits (899), Expect = e-120
 Identities = 150/283 (53%), Positives = 190/283 (67%), Gaps = 2/283 (0%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K E +GEGTYGVVYKA D  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P+I
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L+D    +  L+LVFEF++ DL+  + ++    L P  IKSY+   L+G+A+CH   V
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI   G LKLADFGLAR FG P R +TH+V   WYRAPE+L G++QY   
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTP 180

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYV 251
           VD+W+ GCIFAE++NRRP   G S+IDQL +IF   GT     WP +  LPDY   +   
Sbjct: 181 VDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW 240

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           A   L  + P+  +D LDLLSKM  YDP  RI+A+ AL+H YF
Sbjct: 241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  323 bits (831), Expect = e-110
 Identities = 140/284 (49%), Positives = 185/284 (65%), Gaps = 3/284 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y K E +GEGTYGVVYK  + KTGQ VA+KKIRL  ++EGV  TA+REI LLKEL+ P+I
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L D    +  L+L+FEF+  DL+  + +     ++    +KSY+   L+G+ FCH + 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G+ +Y  
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQY 250
            VD+W+ G IFAE+  ++P   G S+IDQL +IF   GT T   WP +  LPDY   +  
Sbjct: 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                LRS   +  +D LDLL KM  YDP  RI+A++AL H YF
Sbjct: 242 WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  321 bits (824), Expect = e-108
 Identities = 128/288 (44%), Positives = 182/288 (63%), Gaps = 24/288 (8%)

Query: 22  EGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL----- 76
           EGTYGVVY+A D KTG+ VA+KK+++ K+KEG   T+LREI +L +L+ P+I+ +     
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 77  ---IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
              +D       +++V E++E DL++++         +++K  M   L G+A  H  W+L
Sbjct: 75  GSNLD------KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL 128

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K +NLL+ + G LK+ DFGLAR +GSP + +T  V   WYRAPELL GAK+Y   +
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAI 188

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP-----DYVEY 248
           D+W+ GCIFAELL ++P   G S+IDQL KIF   GT T   WP  + LP      + +Y
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248

Query: 249 QYVAAPPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            Y     LR  FP  S SD+  DLL+++ TYDP  RI+A+ AL+H YF
Sbjct: 249 PYN---QLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  320 bits (822), Expect = e-107
 Identities = 134/328 (40%), Positives = 194/328 (59%), Gaps = 28/328 (8%)

Query: 7   SKKVADRYL-KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------------G 53
           S  +++RY+ K   LGEGTYG V KA DT TG+ VAIKK+++ +               G
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 54  VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADI 113
           ++FT LRE+K++ E+K  +I+ L+D +     ++LV + M +DL+ V+ +  I L+ + +
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV-DRKIRLTESQV 121

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG----------- 162
           K  +   L GL   HK + +HRD+ P N+ I S G  K+ADFGLAR +G           
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 163 ---SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID 219
                    T +V   WYRAPELL GA++Y   VD+W+ GCIFAELL  +P   G ++ID
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241

Query: 220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDP 279
           QLG+IF   GT     WP    LP Y E+       L+++FP+ASDDA+DLL  +   +P
Sbjct: 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301

Query: 280 KARITAQQALEHRYFSSAPLPTEPNKLP 307
             RI+A++AL+H YF S PLP +P++LP
Sbjct: 302 LERISAKEALKHEYFKSDPLPCDPSQLP 329

Length = 335

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  317 bits (814), Expect = e-107
 Identities = 141/281 (50%), Positives = 181/281 (64%), Gaps = 2/281 (0%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P+I++
Sbjct: 4   KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L+D    +  L+LVFEF+  DL+  +  + +  +    IKSY+   L+GLAFCH   VLH
Sbjct: 64  LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y   VD
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 183

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQYVAA 253
           +W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  LPDY   +   A 
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWAR 243

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                + P   +D  DLLS+M  YDP  RI+A+ AL H +F
Sbjct: 244 QDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  308 bits (790), Expect = e-103
 Identities = 143/287 (49%), Positives = 190/287 (66%), Gaps = 5/287 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D+Y K E +GEGTYGVVYKA D  T +T+A+KKIRL ++ EGV  TA+REI LLKE++  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFL-SPADIKSYMQMTLKGLAFCHKK 130
           +I+ L D    +  L+LVFE+++ DL+  + ++  F  +P  IK+Y+   L+G+A+CH  
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+KP NLLI      LKLADFGLAR FG P R FTH+V   WYRAPE+L G++ Y
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE++N++P   G S+ID+L KIF   GT     WP +  LPDY    
Sbjct: 182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS-A 240

Query: 250 YVAAPP--LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +   PP  L ++ P+     +DLLSKM   DP  RITA+ ALEH YF
Sbjct: 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  307 bits (787), Expect = e-103
 Identities = 137/284 (48%), Positives = 180/284 (63%), Gaps = 2/284 (0%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  +
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ L D       L LVFE+ + DL+    + N  + P  +KS+M   LKGLAFCH   V
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI  +G+LKLADFGLAR FG P R ++ +V   WYR P++LFGAK Y   
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180

Query: 193 VDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-QY 250
           +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T   WP ++ LPDY  Y  Y
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            A   L ++ P  +    DLL  +   +P  RI+A++AL+H YF
Sbjct: 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  305 bits (782), Expect = e-102
 Identities = 132/305 (43%), Positives = 179/305 (58%), Gaps = 23/305 (7%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
             Y     LGEGT+G VYKA   KTG+ VA+KKI +  +K+G   TALREIK+LK+LK P
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67

Query: 72  HIIELID-AFPH-------KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +++ LID A          +G++++V  +M+ DL  ++ N ++ L+ + IK YM   L+G
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEG 127

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQV 172
           + + H+  +LHRD+K  N+LI + G LK+ADFGLAR +           G   R++T+ V
Sbjct: 128 INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
             RWYR PELL G ++Y   VD+W  GC+FAE+  RRP LQG SDIDQL  IF   GT T
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247

Query: 233 PSQWPDLAYLPDYVEYQYVAA---PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
              WP    LP   E  +        L   F     + LDLLSK+ + DP  R+TA  AL
Sbjct: 248 EETWPGWRSLPGC-EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306

Query: 290 EHRYF 294
           EH YF
Sbjct: 307 EHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  303 bits (777), Expect = e-101
 Identities = 127/298 (42%), Positives = 182/298 (61%), Gaps = 4/298 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K   +GEGTYG+VY+A DT +G+ VA+KK+R+  +++G+  ++LREI LL  L+ P+I
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 74  IELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +EL +     H  ++ LV E+ E DL +++ N     S + +K  M   L+GL + H+ +
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           ++HRD+K +NLL+   G LK+ADFGLAR +G P +  T +V   WYRAPELL G   Y  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+WA GCI AELL  +P L G S+I+QL  I    GT   S WP  + LP   ++   
Sbjct: 189 AIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLP 248

Query: 252 AAP--PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
             P   L+  FP  S+  L LL+ +  YDPK R TA++ALE  YF   PLP EP  +P
Sbjct: 249 KQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMP 306

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  298 bits (766), Expect = 3e-99
 Identities = 122/305 (40%), Positives = 167/305 (54%), Gaps = 32/305 (10%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR-------LGKQKEGVNFTALREIKLL 65
           RY   + +G G YGVV  A+D +TG+ VAIKKI          K+        LREIKLL
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-------ILREIKLL 53

Query: 66  KELKSPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           + L+  +II L+D            +++V E METDL  VI+ +   L+   I+ ++   
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQYFLYQI 112

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQVFARWY 177
           L+GL + H   V+HRD+KP+N+L+ S+  LK+ DFGLAR     +      T  V  RWY
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           RAPELL  + +Y   +D+W+ GCIFAELL R+P   G   IDQL  I    GT +     
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE--- 229

Query: 238 DLAYLPD-----YVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           DL ++       Y++        PL  LFP AS +A+DLL KM  +DPK RITA +AL H
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289

Query: 292 RYFSS 296
            Y + 
Sbjct: 290 PYLAQ 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  295 bits (758), Expect = 5e-99
 Identities = 108/282 (38%), Positives = 151/282 (53%), Gaps = 29/282 (10%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   E LGEG++G VY A D KTG+ VAIK I+  K K+      LREIK+LK+LK P+I
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE-RILREIKILKKLKHPNI 59

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L D F  +  L+LV E+ E  DL  +++     LS  + + Y++  L  L + H K +
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           +HRD+KP N+L+   G +KLADFGLAR     ++  T  V    Y APE+L G K YG  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLG-KGYGKA 176

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           VD+W+ G I  ELL  +P   G    DQL ++F   G   P   P               
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP-------------- 219

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                      S +A DL+ K+   DP+ R+TA++AL+H +F
Sbjct: 220 -------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  286 bits (735), Expect = 3e-95
 Identities = 123/287 (42%), Positives = 171/287 (59%), Gaps = 18/287 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-----EGVNFTALREIKLLKELKS-P 71
           + LG+GT+G VY A + +TG+ VAIKK+   K+K     E +N   LRE+K L++L   P
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMN---LREVKSLRKLNEHP 58

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L + F     L+ VFE+ME +L  ++++      S + I+S +   L+GLA  HK 
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
              HRD+KP NLL+     +K+ADFGLAR I   P   +T  V  RWYRAPE+L  +  Y
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSY 176

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
            + VD+WA GCI AEL   RP   GSS+IDQL KI +  GT T   WP+   L   + ++
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236

Query: 250 --YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               A   L  L P+AS +A+DL+  M  +DPK R TA QAL+H YF
Sbjct: 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  286 bits (734), Expect = 4e-95
 Identities = 127/284 (44%), Positives = 176/284 (61%), Gaps = 4/284 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + + E LGEGTY  VYK  +  TG+ VA+K+I L  + EG   TA+REI L+KELK  +I
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENI 60

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETV--IRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L D    +  L LVFE+M+ DL+           L P  +KS+    LKG+AFCH+  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR FG P   F+++V   WYRAP++L G++ Y  
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQY 250
            +D+W+ GCI AE++  RP   G+++ DQL KIF   GT T S WP ++ LP+Y   +  
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                L+ LFP A    +DLL ++   +P+ RI+A  AL+H +F
Sbjct: 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  286 bits (733), Expect = 5e-95
 Identities = 123/284 (43%), Positives = 169/284 (59%), Gaps = 12/284 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIEL 76
           +GEG YG VYKA D  TG+ VA+KK+R+   +EG+  + LREI LLK+L+S   P+I+ L
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 77  ID--AFPHKGN---LHLVFEFMETDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +D    P       L LVFE ++ DL T +       L P  IK  M+  L+G+ F H  
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH 126

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP N+L+ S GQ+K+ADFGLARI+   +   T  V   WYRAPE+L  +  Y 
Sbjct: 127 RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVVTLWYRAPEVLLQS-SYA 184

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ GCIFAEL  RRP  +G+S+ DQL KIF   G  +  +WP    LP    +  
Sbjct: 185 TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-RSSFPS 243

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                 +S  P   ++ LDLL KM T++P  RI+A +AL+H YF
Sbjct: 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  284 bits (728), Expect = 2e-94
 Identities = 99/278 (35%), Positives = 140/278 (50%), Gaps = 23/278 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG G++G VYKA    TG+ VA+K ++   +K   + TA REI++L+ L  P+I+ LI
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           DAF  K +L+LV E+ E  DL   +       S  + K      L+GL + H   ++HRD
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLHSNGIIHRD 123

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +KP N+L+  +G +K+ADFGLA+         T  V   WY APE+L G   YG  VDVW
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVW 183

Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           + G I  ELL  +P   G + +DQL  I    G       P                   
Sbjct: 184 SLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW----------------- 226

Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                S S++A DL+ K    DP  R TA++ L+H +F
Sbjct: 227 ----SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  284 bits (729), Expect = 2e-94
 Identities = 123/289 (42%), Positives = 177/289 (61%), Gaps = 6/289 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            + Y K + LGEG+Y  VYK     TGQ VA+K+IRL + +EG  FTA+RE  LLK+LK 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIREASLLKDLKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +I+ L D    K  L LVFE+++TDL+  + +    LS  +++ ++   L+GLA+CH++
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+ +Y 
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             +D+W  GCIF E+   RP   GS+D+ DQL KIF   GT T   WP ++  P++  Y 
Sbjct: 183 TSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242

Query: 250 YVAAPP--LRSLFPSASD--DALDLLSKMFTYDPKARITAQQALEHRYF 294
           +   PP  L +  P         +L  K   Y+PK RI+A +A++H YF
Sbjct: 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  280 bits (717), Expect = 2e-92
 Identities = 133/294 (45%), Positives = 177/294 (60%), Gaps = 11/294 (3%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KS 70
           D Y K E +GEGTYG VYKA D  TG+ VA+KK RL   +EG+  TALREI LL+ L +S
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 71  PHIIELIDAF-----PHKGNLHLVFEFMETDLETVI----RNTNIFLSPADIKSYMQMTL 121
            +I+ L+D         K +L+LVFE++++DL+  +    R     L    IKS+M   L
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           KG+A CHK  V+HRD+KP NLL+    G LK+AD GL R F  P + +TH++   WYRAP
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E+L G+  Y   VD+W+ GCIFAE+  ++P   G S++ QL  IF   GT T   WP ++
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            L D+ E+       L    P  S + LDLL KM  YDP  RI+A+ AL H YF
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  279 bits (715), Expect = 3e-92
 Identities = 119/288 (41%), Positives = 160/288 (55%), Gaps = 5/288 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y    V+GEG YGVV K  +  TG+ VAIKK +  +  E V  TALRE+K+L++L+  
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L +AF  KG L+LVFE++E  L  ++  +   L P  ++SY+   L+ +A+CH   
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           ++HRD+KP N+L+   G LKL DFG AR +   P    T  V  RWYRAPELL G   YG
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VDVWA GCI AELL+  P   G SDIDQL  I    G   PS     +  P +    +
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240

Query: 251 VAAP---PLRSLFPSASDD-ALDLLSKMFTYDPKARITAQQALEHRYF 294
                   L   +P      ALD L      DPK R+T  + L+H YF
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  266 bits (682), Expect = 5e-87
 Identities = 123/299 (41%), Positives = 171/299 (57%), Gaps = 16/299 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K   +G+GT+G V+KA   KT Q VA+KK+ +  +KEG   TALREIK+L+ LK  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 72  HIIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +++ LI+     A P+   KG+ +LVFEF E DL  ++ N N+  + ++IK  M+M L G
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----RFTHQVFARWYRA 179
           L + H+  +LHRDMK  N+LI   G LKLADFGLAR F         R+T++V   WYR 
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP +
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 240 AYLPDYVEYQYVA----APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             L  + + +           R         ALDL+ K+   DP  RI A  AL H +F
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  266 bits (681), Expect = 1e-86
 Identities = 118/308 (38%), Positives = 166/308 (53%), Gaps = 34/308 (11%)

Query: 21  GEGTYGVVYKAI--DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELI 77
           G GTYG VYKA   + K G+  AIKK +  K Q  G++ +A REI LL+ELK  +++ L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 78  DAFPHKGN--LHLVFEFMETDLETVI----RNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + F    +  ++L+F++ E DL  +I    +   + + P+ +KS +   L G+ + H  W
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128

Query: 132 VLHRDMKPNNLLIGS----HGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLF 184
           VLHRD+KP N+L+       G +K+ D GLAR+F +P +        V   WYRAPELL 
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL 188

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAFGTATPSQ 235
           GA+ Y   +D+WA GCIFAELL   P  +G             DQL +IF   GT T   
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKD 248

Query: 236 WPDLAYLPDY---VEYQYVAAPPLRSL------FPSASDDALDLLSKMFTYDPKARITAQ 286
           WPD+  +P+Y   ++       P  SL               DLL K+  YDP  RITA+
Sbjct: 249 WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE 308

Query: 287 QALEHRYF 294
           +ALEH YF
Sbjct: 309 EALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  261 bits (669), Expect = 3e-85
 Identities = 127/299 (42%), Positives = 181/299 (60%), Gaps = 17/299 (5%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K+  D++     +GEGTYG VYKA D  TG+ VA+KK+RL  +KEG   TA+REIK+L++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 68  LKSPHIIEL----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           L   +I+ L          +D    KG  +LVFE+M+ DL  ++ +  +  S   IKS+M
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FTHQVFARW 176
           +  L+GL +CHKK  LHRD+K +N+L+ + GQ+KLADFGLAR++ S + R +T++V   W
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YR PELL G ++YG  +DVW+ GCI  EL  ++P  Q + ++ QL  I    G+  P+ W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242

Query: 237 PDLAYLPDY----VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           PD+  LP +     + QY     LR  F      ALDLL  M T DP  R TA++AL  
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRR--LREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  262 bits (672), Expect = 4e-85
 Identities = 127/330 (38%), Positives = 181/330 (54%), Gaps = 43/330 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-------- 59
           K +  +Y   + LG+G YG+V+KAID +T + VA+KKI          F A         
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQR 52

Query: 60  --REIKLLKELKS-PHIIELIDAFPHKGN--LHLVFEFMETDLETVIRNTNIFLSPADIK 114
             REI  L+EL   P+I++L++    + +  ++LVFE+METDL  VIR  NI L     +
Sbjct: 53  TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR-ANI-LEDVHKR 110

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------GSPDRR 167
             M   LK L + H   V+HRD+KP+N+L+ S  ++KLADFGLAR          +P   
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV-- 168

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
            T  V  RWYRAPE+L G+ +Y  GVD+W+ GCI  E+L  +P   G+S ++QL KI   
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228

Query: 228 FGTATPSQWPDLAYL-PDYVEYQYVAAP-----PLRSLFPSASDDALDLLSKMFTYDPKA 281
            G  +     D+  +   +      + P     PL  L P ASDDALDLL K+  ++P  
Sbjct: 229 IGPPSAE---DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK 285

Query: 282 RITAQQALEHRYFSSAPLPTEPNKLPRPAT 311
           R+TA++ALEH Y +    P++   LP P T
Sbjct: 286 RLTAEEALEHPYVAQFHNPSDEPVLPYPIT 315

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  256 bits (655), Expect = 4e-83
 Identities = 123/288 (42%), Positives = 165/288 (57%), Gaps = 7/288 (2%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y K   +GEG+YGVV+K  + +TGQ VAIKK    +    +   ALREI++LK+LK P
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++ LI+ F  K  LHLVFE+ + T L  + +N    +    IK  +  TL+ + FCHK 
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
             +HRD+KP N+LI   GQ+KL DFG ARI   P   +T  V  RWYRAPELL G  QYG
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VDVWA GC+FAELL  +P   G SD+DQL  I    G   P +   +     + +   
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQFFKGLS 238

Query: 251 VAAP----PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +  P    PL S FP+ S  AL  L      DP  R++ ++ LEH YF
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  246 bits (629), Expect = 1e-78
 Identities = 118/323 (36%), Positives = 170/323 (52%), Gaps = 35/323 (10%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-------LRE 61
            V  RY   E +G G YGVV  AIDT++G+ VAIKKI          F         LRE
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRE 54

Query: 62  IKLLKELKSPHIIELIDAFPHKGNL----HLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           +K+L+  K  +II + D     G      ++V + ME+DL  +I  ++  L+   I+ ++
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYFL 113

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD---RRFTHQVF 173
              L+GL + H   V+HRD+KP+NLL+    +L++ DFG+AR +  SP       T  V 
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            RWYRAPELL    +Y   +D+W+ GCIFAE+L RR    G + + QL  I +  G  +P
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG--SP 231

Query: 234 SQ------WPDLAYLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
           S+        D      Y++        P   +FP AS +ALDLLS+M  +DP+ RIT +
Sbjct: 232 SEEVLNRIGSDRVR--KYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289

Query: 287 QALEHRYFSSAPLPT-EPNKLPR 308
           QAL+H + +    P  EP   P 
Sbjct: 290 QALQHPFLAQYHDPDDEPTCPPP 312

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  234 bits (599), Expect = 8e-75
 Identities = 129/289 (44%), Positives = 170/289 (58%), Gaps = 6/289 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A  YL  E LGEG+Y  VYK I    GQ VA+K I + K +EGV FTA+RE  LLK LK 
Sbjct: 4   ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIREASLLKGLKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +I+ L D    K  L  VFE+M TDL   +      L P +++ +M   L+GLA+ H +
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            +LHRD+KP NLLI   G+LKLADFGLAR    P + ++ +V   WYR P++L GA  Y 
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDY-VEY 248
           + +D+W AGCIF E+L  +P   G SD+ +QL KI+   G  T   WP ++ LP+Y  E+
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242

Query: 249 QYVAAPP-LRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                P  LR ++   S    A DL S+M    PK RI+AQ AL H YF
Sbjct: 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  233 bits (596), Expect = 2e-74
 Identities = 116/285 (40%), Positives = 172/285 (60%), Gaps = 3/285 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  V+K     T   VA+K+IRL + +EG   TA+RE+ LLK LK  
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKNLKHA 63

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    +  L LVFE++++DL+  + N    +S  ++K +M   L+GL++CHK+ 
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           +LHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+ +Y  
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W  GCI  E+   RP   GS+  ++L  IF   GT T   WP +    ++  Y + 
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243

Query: 252 A--APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              A PL +  P    D +DLLS +  Y+ K+RI+A+ AL H YF
Sbjct: 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  233 bits (597), Expect = 8e-74
 Identities = 123/333 (36%), Positives = 174/333 (52%), Gaps = 34/333 (10%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A    TG  VAIKKI    + +      LREIK+L+  K
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFK 61

Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II ++D     +F    ++++V E METDL  +I+  +  LS   I+ ++   L+GL
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQILRGL 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRF-THQVFARWYRAPE 181
            + H   VLHRD+KP+NLL+ ++  LK+ DFGLARI         F T  V  RWYRAPE
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  +K Y   +D+W+ GCI AE+L+ RP   G   + QL  I    G  TPSQ  DL  
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG--TPSQ-EDLNC 236

Query: 242 LP-----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY-- 293
           +      +Y++   +    P   LFP+A   ALDLL KM T++P  RIT ++AL H Y  
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296

Query: 294 ---------FSSAPLPTE---PNKLPRPATKRA 314
                     +  P P +    + LP+   K  
Sbjct: 297 QYHDPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  231 bits (590), Expect = 2e-73
 Identities = 117/298 (39%), Positives = 177/298 (59%), Gaps = 5/298 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  VYK     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 64

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    + +L LVFE+++ DL+  + +    ++  ++K ++   L+GL +CH++ 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+  Y  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY- 250
            +D+W  GCIF E+   RP   GS+  +QL  IF   GT T   WP +    ++  Y Y 
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244

Query: 251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
              A  L +  P    D  +LLSK+  ++ + RI+A++A++H YF    L    +KLP
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC--LGERIHKLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  229 bits (586), Expect = 1e-72
 Identities = 119/298 (39%), Positives = 181/298 (60%), Gaps = 5/298 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K E LGEGTY  V+K     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 64

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D      +L LVFE+++ DL+  + +    +S  ++K ++   L+GLA+CH++ 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + ++++V   WYR P++L G+ +Y  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY- 250
            +D+W  GCIF E+ + RP   GS+  D+L  IF   GT T   WP ++   ++  Y + 
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244

Query: 251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
                PL +  P    + ++LL+K   Y+ K RI+A++A++H YF S  L T  + LP
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS--LGTRIHSLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  225 bits (576), Expect = 2e-71
 Identities = 113/292 (38%), Positives = 161/292 (55%), Gaps = 15/292 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y    ++GEG+YG+V K    +TGQ VAIKK    +  + V   A+REI++LK+L+  
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++ LI+ F  K  L+LVFEF++ T L+ + +  N  L  + ++ Y+   L+G+ FCH  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH 119

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP N+L+   G +KL DFG AR   +P   +T  V  RWYRAPELL G  +YG
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP------SQWPDLA--YL 242
             VD+WA GC+  E+L   P   G SDIDQL  I    G   P       + P  A   L
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           P+  E       PL   FP  S   LDL  +    DP  R ++ Q L H +F
Sbjct: 240 PEVKE-----IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  226 bits (577), Expect = 7e-71
 Identities = 113/300 (37%), Positives = 166/300 (55%), Gaps = 19/300 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKE 67
           V  +Y+  + +G G YG+V  A +++T + VAIKKI      +        LREIKLL+ 
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRH 60

Query: 68  LKSPHIIELIDAF--PHKGN---LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           L   ++I + D    PH+     +++V+E M+TDL  +IR++   LS    + ++   L+
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLYQLLR 119

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   VLHRD+KP+NLL+ ++  LK+ DFGLAR         T  V  RWYRAPEL
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L    +Y   +DVW+ GCIFAELL R+P   G   + QL  I    G+ +     DL ++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE---DLGFI 236

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
            +    +Y+ + P         LFP A+  A+DLL KM  +DP  RIT ++AL H Y +S
Sbjct: 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  221 bits (566), Expect = 6e-70
 Identities = 117/288 (40%), Positives = 153/288 (53%), Gaps = 25/288 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKELKS-PHII 74
           +GEGT+  V KA   KTG+  AIK +   K+     E VN   LREI+ L+ L   P+I+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM---KKHFKSLEQVN--NLREIQALRRLSPHPNIL 61

Query: 75  ELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            LI+       G L LVFE M+ +L  +I+     L    +KSYM   LK L   H+  +
Sbjct: 62  RLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
            HRD+KP N+LI     LKLADFG  R I+  P   +T  +  RWYRAPE L     YG 
Sbjct: 122 FHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGP 178

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+WA GC+F E+L+  P   G++++DQ+ KI    GT        L          Y 
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV---LKKFRKSRHMNY- 234

Query: 252 AAPP-----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             P      LR L P+AS + LDLL K+  YDP  RITA+QAL H YF
Sbjct: 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  222 bits (568), Expect = 1e-69
 Identities = 116/296 (39%), Positives = 161/296 (54%), Gaps = 27/296 (9%)

Query: 20  LGEGTYGVVYKA--IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIEL 76
           LG+G YG+V  A   +T   +TVAIKKI     K+ +   ALRE+KLL+  +   +I  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 77  ID---AFPHKGN-LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            D    FP   N L+L  E ME DL  +IR +   L+ A  +S++   L GL + H   V
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANV 126

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR----IFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           LHRD+KP NLL+ +  +LK+ DFGLAR      G      T  V  RWYRAPE++   + 
Sbjct: 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS 186

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT---------ATPSQWPDL 239
           Y   +DVW+ GCI AELL R+P  +G   +DQL +I    GT          +P     +
Sbjct: 187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYI 246

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             LP+  +       P  S+FP+A+  ALDLL K+  +DP  RI+ ++ALEH Y +
Sbjct: 247 RSLPNIPKK------PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  221 bits (564), Expect = 2e-69
 Identities = 122/293 (41%), Positives = 170/293 (58%), Gaps = 6/293 (2%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           AD Y K E LGEG+Y  VYK      G+ VA+K IRL +++EG  FTA+RE  LLK LK 
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +I+ L D    K  L LVFE++ TDL   +      L P ++K ++   L+GL++ H++
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           ++LHRD+KP NLLI   G+LKLADFGLAR    P   ++++V   WYR P++L G+ +Y 
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             +D+W  GCIF E++       G  DI DQL +IF   GT     WP +  LP +   +
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242

Query: 250 YV--AAPPLRSLFPSAS--DDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
           +   +   LR  +   S  + A DL SK+    PK R++AQ AL H YFS  P
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  214 bits (545), Expect = 8e-67
 Identities = 113/284 (39%), Positives = 164/284 (57%), Gaps = 12/284 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIEL 76
           +G G YG VYKA D  +G  VA+K +R+   ++G+  + +RE+ LLK L++   P+I+ L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 77  IDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +D         +  + LVFE ++ DL T +        PA+ IK  M+  L+GL F H  
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y 
Sbjct: 128 CIVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRAPEVLLQST-YA 185

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP    +  
Sbjct: 186 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG-AFSP 244

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               P++S+ P   +    LL +M T++P  RI+A +AL+H +F
Sbjct: 245 RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  212 bits (542), Expect = 2e-65
 Identities = 112/313 (35%), Positives = 156/313 (49%), Gaps = 18/313 (5%)

Query: 4   VDLSKK---VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
            +L+K    V DRY     +G G YG V  A DTKTG+ VAIKK+    Q         R
Sbjct: 4   QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63

Query: 61  EIKLLKELKSPHIIELIDAF-PHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIK 114
           E++LLK +   ++I L+D F P         ++LV   M  DL  +++     LS   I+
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQ 121

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA 174
             +   L+GL + H   ++HRD+KP+N+ +    +LK+ DFGLAR     D   T  V  
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT 178

Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++     Y   VD+W+ GCI AELL  +    GS  IDQL +I    GT    
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238

Query: 235 --QWPDLAYLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             Q        +Y++    +     + +F  A+  A+DLL KM   DP  RITA +AL H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298

Query: 292 RYFSSAPLPT-EP 303
            Y +    P  EP
Sbjct: 299 PYLAEYHDPEDEP 311

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  207 bits (529), Expect = 2e-64
 Identities = 114/285 (40%), Positives = 160/285 (56%), Gaps = 13/285 (4%)

Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +       +    IK  M   L+GL F H 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQS-SY 186

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 245

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             +A P+        +   DLL K  T++P  RI+A  AL H YF
Sbjct: 246 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  202 bits (516), Expect = 8e-62
 Identities = 124/315 (39%), Positives = 173/315 (54%), Gaps = 22/315 (6%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY  +EV+G+G+YGVV  AIDT TG+ VAIKKI    +        LREIKLL+ L+ P 
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 73  IIEL--IDAFPHK---GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           I+E+  I   P +    ++++VFE ME+DL  VI+  N  L+P   + ++   L+ L + 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYI 119

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRF-THQVFARWYRAPELL- 183
           H   V HRD+KP N+L  +  +LK+ DFGLAR+    +P   F T  V  RWYRAPEL  
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 184 -FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL--- 239
            F +K Y   +D+W+ GCIFAE+L  +P   G + + QL  I    GT +P     +   
Sbjct: 180 SFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238

Query: 240 ---AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
               YL    + Q V   P    FP+A   AL LL ++  +DPK R TA++AL   YF  
Sbjct: 239 KARRYLSSMRKKQPV---PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295

Query: 297 -APLPTEPNKLPRPA 310
            A +  EP+  P   
Sbjct: 296 LAKVEREPSAQPITK 310

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  195 bits (497), Expect = 2e-60
 Identities = 72/188 (38%), Positives = 108/188 (57%), Gaps = 3/188 (1%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LGEG +G VY A D KTG+ VAIK I+       +    LREI++LK+L  P+I++L   
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59

Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F  + +L+LV E+ E   L+ +++     LS  +I   +   L+GL + H   ++HRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 139 PNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           P N+L+ S +G++KLADFGL+++  S        V    Y APE+L G   Y    D+W+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 198 AGCIFAEL 205
            G I  EL
Sbjct: 180 LGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  197 bits (502), Expect = 1e-59
 Identities = 109/300 (36%), Positives = 156/300 (52%), Gaps = 21/300 (7%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           ++ +RY   + +G G YG V  AID +TG+ VAIKK+    Q E     A RE+ LLK +
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71

Query: 69  KSPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           +  ++I L+D F    +        LV  +M+TDL+ ++ +    LS   ++  +   L 
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLC 128

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AE+L  +   +G   +DQL +I    G   P     +  L
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF---VQKL 242

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
            D     Y+ + P        +LFP AS  A+DLL KM   D   R+TA +ALEH YF S
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  195 bits (496), Expect = 6e-59
 Identities = 111/303 (36%), Positives = 164/303 (54%), Gaps = 18/303 (5%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + +RY+  + +G G +G+V  A D  TGQ VAIKKI        +     RE+KLLK L+
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 70  SPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             +II L D F  P + +++ V E + TDL  ++ +    L    I+ ++   L+GL + 
Sbjct: 68  HENIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYV 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   V+HRD+KP+N+LI  +  LK+ DFGLARI    D + T  V  R+YRAPE++   +
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQ 181

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT------ATPSQWPDLAY 241
           +Y   VD+W+AGCIFAE+L  +P   G   ++Q   I    GT       T      L +
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
           +    + + V   P    F +A   A+DLL KM  +DP+ RI+A +AL H Y +    PT
Sbjct: 242 VQSLPKREPV---PFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298

Query: 302 -EP 303
            EP
Sbjct: 299 DEP 301

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  193 bits (492), Expect = 6e-59
 Identities = 107/281 (38%), Positives = 153/281 (54%), Gaps = 6/281 (2%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+GEG YGVV K    +T + VAIKK +  ++ E V  T LRE+K+L+ LK  +I+EL +
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           AF  +G L+LVFE++E ++  ++      + P  ++SY+   +K + +CHK  ++HRD+K
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGS-PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           P NLLI  +  LKL DFG AR      +  +T  V  RWYR+PELL GA  YG  VD+W+
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWS 186

Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY--VEYQYVAAPP 255
            GCI  EL + +P   G S+IDQL  I    G     Q       P +  + +  V  P 
Sbjct: 187 VGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246

Query: 256 L--RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              R      S   LDL+  +   +P  R   +Q L H  F
Sbjct: 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  194 bits (495), Expect = 1e-58
 Identities = 117/311 (37%), Positives = 165/311 (53%), Gaps = 20/311 (6%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V DRY   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK +
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71

Query: 69  KSPHIIELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    +L      +LV  FM TDL  ++++    LS   I+  +   LK
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQMLK 129

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEV 186

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AE+L  +P  +G   +DQL +I     T TPS+   +  L
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV--TGTPSK-EFVQKL 243

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                  YV   P       RSL P+A+  A+++L KM   D ++RITA +AL H YF  
Sbjct: 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Query: 297 APLPTEPNKLP 307
              P +  + P
Sbjct: 304 FHDPEDETEAP 314

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  192 bits (490), Expect = 2e-57
 Identities = 101/290 (34%), Positives = 151/290 (52%), Gaps = 23/290 (7%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +GVV+   D + G+ VA+KK+    Q         RE+K+L   K  +++  +D 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 80  F--PHKGNLHLVF---EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
              PH      ++   E M++DL  +I  +   LS   +K ++   L+GL + H   +LH
Sbjct: 68  LQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILH 126

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+KP NLL+ S+  LK+ DFGLAR+   PD  +  T +V  ++YRAPE+L G++ Y + 
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSA 185

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD-----LAYLPDYVE 247
           VD+W+ GCIFAELL RR   Q  S I QL  I    GT +            A++     
Sbjct: 186 VDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI----- 240

Query: 248 YQYVAAPPLRS----LFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
            +    PP       L   A+ +A+ LL +M  +DP  RI+A  AL H Y
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  189 bits (482), Expect = 8e-57
 Identities = 104/306 (33%), Positives = 163/306 (53%), Gaps = 30/306 (9%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY+    LG G+ G+V+ A+D+   + VA+KKI L    + V   ALREIK+++ L   +
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVK-HALREIKIIRRLDHDN 63

Query: 73  IIELIDAFPHKGN--------------LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           I+++ +     G+              +++V E+METDL  V+      LS    + +M 
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP--LSEEHARLFMY 121

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQ------ 171
             L+GL + H   VLHRD+KP N+ I +    LK+ DFGLARI    D  ++H+      
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEG 178

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           +  +WYR+P LL     Y   +D+WAAGCIFAE+L  +P   G+ +++Q+  I  +    
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 232 TPSQWPD-LAYLPDYV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
                 + L  +P +V         PLR L P  + +ALD L ++ T++P  R+TA++AL
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298

Query: 290 EHRYFS 295
            H Y S
Sbjct: 299 MHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  183 bits (467), Expect = 2e-55
 Identities = 86/292 (29%), Positives = 143/292 (48%), Gaps = 42/292 (14%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSP 71
            + + E+LG G++G VY A+D  TG+ +A+K + L    E     AL REI++L  L+ P
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHP 59

Query: 72  HIIELIDAF--PHKGNLHLVFEFM-ETDLETVIRNTNIF--LSPADIKSYMQMTLKGLAF 126
           +I+    +     K  L++  E++    L ++++    F  L    I+ Y +  L+GLA+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAY 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVF--ARWYRAPELL 183
            H   ++HRD+K  N+L+ S G +KLADFG A+  G  +    T  V     W  APE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM-APEVI 175

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G ++YG   D+W+ GC   E+   + P+ +  + +  L KI        P        +
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEPP-------EI 225

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           P+++                 S++A D L K    DPK R TA + L+H + 
Sbjct: 226 PEHL-----------------SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  178 bits (453), Expect = 3e-53
 Identities = 81/290 (27%), Positives = 137/290 (47%), Gaps = 48/290 (16%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y   + +G+G++G VY       G+   +K+I L    E     AL E+K+LK+L  P+
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYM-QMTLKGLAFC 127
           II+  ++F  KG L +V E+ +  DL   I+             I  +  Q+ L  L + 
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL-ALKYL 119

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPE 181
           H + +LHRD+KP N+ + S+G +KL DFG++++  S          A+      +Y +PE
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS------TVDLAKTVVGTPYYLSPE 173

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           L    K Y    D+W+ GC+  EL   + PF +G + ++   KI                
Sbjct: 174 LCQN-KPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKI---------------- 215

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                ++ QY   PP+ S +   S +  +L+S +   DP+ R +  Q L+
Sbjct: 216 -----LKGQY---PPIPSQY---SSELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  178 bits (451), Expect = 6e-52
 Identities = 93/339 (27%), Positives = 139/339 (41%), Gaps = 38/339 (11%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-TALREIKLLKELKSP- 71
           Y     LGEG++G VY A D K    VA+K +    + +       LREI++L  L  P 
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRN--TNIFLSPADIKSYMQMTLKGLAFCH 128
           +I++L D F  +G+L+LV E+++   LE +++       LS ++    +   L  L + H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 129 KKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFA------RWYRAPE 181
            K ++HRD+KP N+L+   G  +KL DFGLA++   P    +             Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 182 LLFG--AKQYGAGVDVWAAGCIFAELLN-RRPF--LQGSSDIDQLGKIFAAFGTATPSQW 236
           +L G       +  D+W+ G    ELL    PF   + SS   Q  KI     T      
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT------ 232

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                         +A+P   S     S  A DLL K+   DPK R+++   L H   + 
Sbjct: 233 ------------PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280

Query: 297 APLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKT 335
             L              A       P     + S     
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLA 319

Length = 384

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  176 bits (447), Expect = 2e-51
 Identities = 112/311 (36%), Positives = 157/311 (50%), Gaps = 38/311 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT----ALREIKLL 65
           V  RY   + +G G  G+V  A DT TGQ VAIKK+     +   N T    A RE+ L+
Sbjct: 14  VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL----SRPFQNVTHAKRAYRELVLM 69

Query: 66  KELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYM-- 117
           K +   +II L++ F P K      +++LV E M+ +L  VI    + L    + SY+  
Sbjct: 70  KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---QMDLDHERM-SYLLY 125

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
           QM L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+Y
Sbjct: 126 QM-LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYY 183

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           RAPE++ G   Y   VD+W+ GCI  E++       G+  IDQ  KI    GT +     
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 238 DLAY-LPDYVE----YQYVAAPPL--RSLFPSASDD--------ALDLLSKMFTYDPKAR 282
            L   + +YVE    Y   +   L    LFP  S+         A DLLSKM   DP+ R
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 283 ITAQQALEHRY 293
           I+   AL+H Y
Sbjct: 303 ISVDDALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  175 bits (445), Expect = 2e-51
 Identities = 110/312 (35%), Positives = 154/312 (49%), Gaps = 21/312 (6%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 69  KSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 131

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 188

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        L  +
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL---LKKI 245

Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                  Y+ +          ++F  A+  A+DLL KM   D   RITA QAL H YF+ 
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Query: 297 APLP-TEPNKLP 307
              P  EP   P
Sbjct: 306 YHDPDDEPVADP 317

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  173 bits (440), Expect = 1e-50
 Identities = 105/309 (33%), Positives = 158/309 (51%), Gaps = 15/309 (4%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DT+  Q VA+KK+    Q         RE++LLK +
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 69  KSPHIIELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    ++      +LV   M  DL  +++     LS   ++  +   L+
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLIYQLLR 129

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRWYRAPEI 186

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA-- 240
           +     Y   VD+W+ GCI AELL  +    G+  IDQL +I    GT +P     ++  
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246

Query: 241 YLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
           +   Y++   ++    L+ +F  A+  A+DLL KM   D   RI+A +AL H YFS    
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306

Query: 300 PT-EPNKLP 307
           P  EP   P
Sbjct: 307 PEDEPEAEP 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  169 bits (430), Expect = 1e-49
 Identities = 89/301 (29%), Positives = 139/301 (46%), Gaps = 62/301 (20%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   E +GEG  G VYKA D  TG+ VAIKK+RL KQ + +      EI ++K+ K P+I
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN---EILIMKDCKHPNI 77

Query: 74  IELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           ++  D++     L +V E+M+    TD   +I    + ++   I    +  L+GL + H 
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTD---IITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + V+HRD+K +N+L+   G +KLADFG A        +    V   ++ APE++   K Y
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD+W+ G +  E+       +G                            P Y+   
Sbjct: 194 GPKVDIWSLGIMCIEM------AEGE---------------------------PPYLRE- 219

Query: 250 YVAAPPLRSLF-------P------SASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
               PPLR+LF       P        S +  D L+K    DP+ R +A++ L+H +   
Sbjct: 220 ----PPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Query: 297 A 297
           A
Sbjct: 276 A 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  167 bits (425), Expect = 2e-49
 Identities = 87/282 (30%), Positives = 141/282 (50%), Gaps = 32/282 (11%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +   E +G+G +G VYKA   +TG+ VAIK I+L  +++      + EI++LK+ K P+I
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI--INEIQILKKCKHPNI 59

Query: 74  IELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++   ++  K  L +V EF     L+ ++++TN  L+ + I    +  LKGL + H   +
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           +HRD+K  N+L+ S G++KL DFGL+    S  +     V   ++ APE++ G K Y   
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPEVING-KPYDYK 177

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
            D+W+ G    EL   +P         +L  + A F  AT                    
Sbjct: 178 ADIWSLGITAIELAEGKP------PYSELPPMKALFKIAT------------------NG 213

Query: 253 APPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRY 293
            P LR+  P   SD+  D L K    +P+ R TA+Q L+H +
Sbjct: 214 PPGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  169 bits (429), Expect = 2e-49
 Identities = 111/313 (35%), Positives = 157/313 (50%), Gaps = 42/313 (13%)

Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G GTYG VYKA   D K  +  A+K+I    +  G++ +A REI LL+ELK P++I L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 78  DAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIKSYMQMTLKGLAFC 127
             F    +  + L+F++ E DL  +I+           + L    +KS +   L G+ + 
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAP 180
           H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +        V   WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQ-GSSDI--------DQLGKIFAAFGTA 231
           ELL GA+ Y   +D+WA GCIFAELL   P       DI        DQL +IF   G  
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 232 TPSQWPDLAYLP-------DYVEYQYVAAPPLRSLFP---SASDDALDLLSKMFTYDPKA 281
               W D+  +P       D+    Y     ++ +          A  LL K+ T DP  
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 304

Query: 282 RITAQQALEHRYF 294
           RIT++QA++  YF
Sbjct: 305 RITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  169 bits (429), Expect = 3e-49
 Identities = 112/313 (35%), Positives = 160/313 (51%), Gaps = 42/313 (13%)

Query: 20  LGEGTYGVVYKA--IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G GTYG VYKA   D K  +  A+K+I    +  G++ +A REI LL+ELK P++I L 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 78  DAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIKSYMQMTLKGLAFC 127
             F    +  + L+F++ E DL  +I+           + L  + +KS +   L G+ + 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAP 180
           H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +        V   WYRAP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQ-GSSDI--------DQLGKIFAAFGTA 231
           ELL GA+ Y   +D+WA GCIFAELL   P       DI        DQL +IF+  G  
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 232 TPSQWPDLAYLPDYVEYQ-------YVAAPPLRSLFP---SASDDALDLLSKMFTYDPKA 281
               W D+  +P+Y   Q       Y  +  ++ +             LL K+ T DP  
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTK 304

Query: 282 RITAQQALEHRYF 294
           RIT++QAL+  YF
Sbjct: 305 RITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  162 bits (412), Expect = 2e-47
 Identities = 86/287 (29%), Positives = 137/287 (47%), Gaps = 38/287 (13%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
            Y   +++G G +GVVYK ++ +TG  VAIK+I L K KE    + ++EI LLK LK P+
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I++ I +     +L+++ E+ E   L  +I+    F   + +  Y+   L+GLA+ H++ 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGLAYLHEQG 119

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K  N+L    G +KLADFG+A       +     V   ++ APE++       +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-----EMS 174

Query: 192 GV----DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           G     D+W+ GC   ELL   P      D++ +  +F       P        LP    
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHP-------PLP---- 220

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                           S +  D L + F  DP  R TA+Q L+H + 
Sbjct: 221 -------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  157 bits (398), Expect = 2e-44
 Identities = 107/323 (33%), Positives = 158/323 (48%), Gaps = 25/323 (7%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY + + +G G  G+V  A DT  G  VA+KK+    Q +     A RE+ L
Sbjct: 14  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 73

Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK +   +II L++ F P K      +++LV E M+ +L  VI   ++ L    +   + 
Sbjct: 74  LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLY 130

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR     +   T  V  R+YR
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYR 189

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  EL+      QG+  IDQ  K+    GT +      
Sbjct: 190 APEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248

Query: 239 LA-----YLPDYVEYQYVAAPPLRS--LFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  ++   L    +FPS S+        A DLLSKM   DP  RI+
Sbjct: 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS 308

Query: 285 AQQALEHRYFSSAPLPTEPNKLP 307
             +AL H Y +    P E    P
Sbjct: 309 VDEALRHPYITVWYDPAEAEAPP 331

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  156 bits (396), Expect = 2e-43
 Identities = 105/327 (32%), Positives = 170/327 (51%), Gaps = 29/327 (8%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           M + D+++     Y    ++G G++GVVY+AI   T + VAIKK+    Q +       R
Sbjct: 55  MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------R 108

Query: 61  EIKLLKELKSPHIIELIDAF------PHKGN--LHLVFEFMETDLETVIR---NTNIFLS 109
           E+ ++K L   +II L D +       ++ N  L++V EF+   +   ++     N  L 
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168

Query: 110 PADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRF 168
              +K Y     + LA+ H K++ HRD+KP NLLI  +   LKL DFG A+   +  R  
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228

Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
           ++ + +R+YRAPEL+ GA  Y   +D+W+ GCI AE++   P   G S +DQL +I    
Sbjct: 229 SY-ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287

Query: 229 GTATPSQWPDLAYLPDYVEYQY--VAAPPLRSLFPSAS-DDALDLLSKMFTYDPKARITA 285
           GT T  Q  ++   P+Y + ++  V    L+ +FP  + DDA++ +S+   Y+P  R+  
Sbjct: 288 GTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345

Query: 286 QQALEHRYFSS-----APLPTEPNKLP 307
            +AL   +F         LP   +KLP
Sbjct: 346 IEALADPFFDDLRDPCIKLPKYIDKLP 372

Length = 440

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  148 bits (375), Expect = 4e-41
 Identities = 107/323 (33%), Positives = 158/323 (48%), Gaps = 25/323 (7%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 126

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 185

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 239 LA-----YLPDYVEYQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L      Y+ +  +Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 285 AQQALEHRYFSSAPLPTEPNKLP 307
             +AL+H Y +    P E    P
Sbjct: 305 VDEALQHPYINVWYDPAEVEAPP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  145 bits (366), Expect = 1e-39
 Identities = 107/330 (32%), Positives = 158/330 (47%), Gaps = 35/330 (10%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76

Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310

Query: 284 TAQQALEHRYF--------SSAPLPTEPNK 305
           +  +AL+H Y         + AP P  P+K
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIPDK 340

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  141 bits (357), Expect = 3e-39
 Identities = 80/281 (28%), Positives = 131/281 (46%), Gaps = 40/281 (14%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           VLG+G+ GVVYK     TG+  A+KKI +   +E      LRE+K L+  +SP++++   
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-QLLRELKTLRSCESPYVVKCYG 66

Query: 79  AFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRD 136
           AF  +G + +V E+M+   L  +++          +    +  LKGL + H K+ ++HRD
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKI-PEPVLAYIARQILKGLDYLHTKRHIIHRD 125

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPELLFGAKQYGA 191
           +KP+NLLI S G++K+ADFG++++  +     T      +     Y +PE + G + Y  
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTFVGTVTYMSPERIQG-ESYSY 179

Query: 192 GVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             D+W+ G    E    + PFL                    P   P    L   +    
Sbjct: 180 AADIWSLGLTLLECALGKFPFL--------------------PPGQPSFFELMQAI--CD 217

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              P L +     S +  D +S     DPK R +A + L+H
Sbjct: 218 GPPPSLPA--EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  137 bits (347), Expect = 7e-38
 Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 43/284 (15%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIELI 77
           LG+G++G V       TG+  A+K ++  K  +++ V  T L E  +L  +  P I++L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT-LTERNILSRINHPFIVKLH 59

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVLHR 135
            AF  +  L+LV E+    +L + +     F S    + Y  ++ L  L + H   +++R
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF-SEERARFYAAEIVL-ALEYLHSLGIIYR 117

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP N+L+ + G +KL DFGLA+   S   R         Y APE+L G K YG  VD 
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDW 176

Query: 196 WAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           W+ G +  E+L  + PF   + D  ++                          Y+ +   
Sbjct: 177 WSLGVLLYEMLTGKPPFY--AEDRKEI--------------------------YEKILKD 208

Query: 255 PLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALE---HRYF 294
           PLR  FP   S +A DL+S +   DP  R+ +  A E   H +F
Sbjct: 209 PLR--FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  135 bits (341), Expect = 7e-37
 Identities = 85/298 (28%), Positives = 133/298 (44%), Gaps = 65/298 (21%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP 81
           G YG V+ A    TG   AIK I +    ++      L E  +L + +SP++++L  +F 
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 82  HKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWVLHRDMKP 139
            K NL+LV E++   DL +++ N        D+ + Y+   +  L + H   ++HRD+KP
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSL--DEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 140 NNLLIGSHGQLKLADFGLA-------------------RIFGSPDRRFTHQVFARWYRAP 180
           +N+LI S+G LKL DFGL+                   RI G+PD           Y AP
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD-----------YIAP 170

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++ G + +   VD W+ GCI  E L   P   G +  +    I          +WP+  
Sbjct: 171 EVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI-----LNGKIEWPE-- 222

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRYFS 295
                                  SD+A+DL+SK+   DP+ R+ A+   E   H +F 
Sbjct: 223 -------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (325), Expect = 1e-34
 Identities = 93/308 (30%), Positives = 154/308 (50%), Gaps = 69/308 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL---------GKQKEGVNFTALR-EI 62
           +++K E++G+GTYG VY A++  TG+ +A+K++ L          +QK+ V   ALR EI
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVK--ALRSEI 59

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD----LETV--------IRNTNIFLSP 110
           + LK+L   +I++           +L FE  E      LE V        +R    F   
Sbjct: 60  ETLKDLDHLNIVQ-----------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EE 107

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR----IFGSPDR 166
             ++ + +  L+GLA+ H K +LHRD+K +NLL+ + G  K++DFG+++    I+ + D+
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN-DQ 166

Query: 167 RFTHQVFARWYRAPELLFGAKQ-YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKI 224
             + Q    W  APE++    Q Y A VD+W+ GC+  E+   RRP+    SD + +  +
Sbjct: 167 NMSMQGSVFWM-APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW----SDEEAIAAM 221

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS-LFPSASDDALDLLSKMFTYDPKARI 283
           F      +                    APP+   +  + S  ALD L+  FT +P  R 
Sbjct: 222 FKLGNKRS--------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Query: 284 TAQQALEH 291
           TA++ L+H
Sbjct: 262 TARELLQH 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  129 bits (326), Expect = 1e-34
 Identities = 86/306 (28%), Positives = 132/306 (43%), Gaps = 61/306 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELK-SPHI 73
           +++GEG++  V  A + +T +  AIK   K +L K+K+ V +    E ++L  L   P I
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKY-VKIEKEVLTRLNGHPGI 64

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+L   F  + NL+ V E+    +L   IR     L     + Y    L  L + H K +
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGI 123

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--------------------RRFTHQV 172
           +HRD+KP N+L+     +K+ DFG A++                         RRF   V
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
               Y +PELL   K  G   D+WA GCI  ++L  +P  +GS++     KI        
Sbjct: 184 GTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL----- 237

Query: 233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-- 290
                         EY +   PP    FP    DA DL+ K+   DP+ R+   +  +  
Sbjct: 238 --------------EYSF---PP---NFP---PDAKDLIEKLLVLDPQDRLGVNEGYDEL 274

Query: 291 --HRYF 294
             H +F
Sbjct: 275 KAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  125 bits (316), Expect = 2e-33
 Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 42/291 (14%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           R+ +   +G GT+G VY A++  TG+ +A+K+IR+             E+K+L+ LK P+
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           +++      H+  +++   FME      LE ++ +  I L    I+ Y    L+GLA+ H
Sbjct: 61  LVKYYGVEVHREKVYI---FMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLH 116

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPELL 183
              ++HRD+KP N+ +  +G +KL DFG A    +       +          Y APE++
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM-GEEVQSLAGTPAYMAPEVI 175

Query: 184 FGAKQ--YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            G K   +G   D+W+ GC+  E+   +RP+    S++D   +I    G       PD  
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW----SELDNEFQIMFHVGAGHKPPIPDSL 231

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            L                     S +  D L +    DPK R TA + L+H
Sbjct: 232 QL---------------------SPEGKDFLDRCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  124 bits (314), Expect = 3e-33
 Identities = 83/297 (27%), Positives = 133/297 (44%), Gaps = 69/297 (23%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E LGEG+YG VYKAI  +TGQ VAIK + +    E      ++EI +LK+  SP+I++  
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 78  DAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            ++    +L +V E+      +D+   ++ TN  L+  +I + +  TLKGL + H    +
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDI---MKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLA-----------RIFGSPDRRFTHQVFARWYRAPEL 182
           HRD+K  N+L+   GQ KLADFG++            + G+P           ++ APE+
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP-----------FWMAPEV 170

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA-----AFGTATPSQWP 237
           +     Y    D+W+ G    E+   +P     SDI  +  IF          + P +W 
Sbjct: 171 IQEIG-YNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIPNKPPPTLSDPEKW- 225

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                                     S +  D + K    DP+ R +A Q L+H + 
Sbjct: 226 --------------------------SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  125 bits (315), Expect = 4e-33
 Identities = 75/289 (25%), Positives = 122/289 (42%), Gaps = 43/289 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G+G++G V K      G+ +  K+I  G   E      + E+ +L+ELK P+I+   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 78  DAFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK 130
           D    + N  L++V E+ E  DL  +I+         +     +   Q+ L  L  CH +
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL-ALYECHNR 124

Query: 131 W-----VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLF 184
                 VLHRD+KP N+ + ++  +KL DFGLA+I G  D  F    V   +Y +PE L 
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGTPYYMSPEQLN 183

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
               Y    D+W+ GC+  EL    P     + +    KI          + P       
Sbjct: 184 HMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----KEGKFRRIP------- 231

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
              Y+Y             S +  +++  M   DP  R + ++ L+   
Sbjct: 232 ---YRY-------------SSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 4e-32
 Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 54/289 (18%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           G +G VY A    TG   AIK ++   +  + +  N  A R I ++ + +SP++ +L  +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYYS 65

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F  K  L+LV E++   D  ++I+     L     K Y+   + G+   H++ ++HRD+K
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 139 PNNLLIGSHGQLKLADFGLAR-------IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           P NLLI   G LKL DFGL+R         G+PD           Y APE + G      
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----------YLAPETILGVGDDKM 173

Query: 192 GVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             D W+ GC+  E L    PF   + D      +F     +    WP+            
Sbjct: 174 S-DWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNI-LSRRINWPEEV---------- 216

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRYFSS 296
                        S +A+DL++++   DP  R+ A    E   H +F S
Sbjct: 217 ---------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 8e-32
 Identities = 77/284 (27%), Positives = 126/284 (44%), Gaps = 34/284 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA   +TG   A K I++  ++E  +F  + EI +L E K P+I+ L +A
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDF--MVEIDILSECKHPNIVGLYEA 70

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           + ++  L ++ EF +   L++++      L+   I+   +  L+ L F H   V+HRD+K
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL----FGAKQYGAGVD 194
             N+L+   G +KLADFG++    S  ++    +   ++ APE++    F    Y    D
Sbjct: 131 AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKAD 190

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           +W+ G    EL    P                          P     P  V  + + + 
Sbjct: 191 IWSLGITLIELAQMEP--------------------------PHHELNPMRVLLKILKSE 224

Query: 255 PLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
           P     PS  S    D L      DP  R TA + L+H + S  
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  121 bits (304), Expect = 1e-31
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-----GKQKEGVNFTALREIKLLKELKSPHII 74
           +G+G + VVYKAI    G+ VA+KK+++      K ++      L+EI LLK+L  P++I
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ----DCLKEIDLLKQLDHPNVI 65

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHK 129
           + + +F     L++V E  +  DL  +I++      +       K ++Q+    L   H 
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC-SALEHMHS 124

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K ++HRD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-Y 183

Query: 190 GAGVDVWAAGCIFAELLN-RRPF 211
               D+W+ GC+  E+   + PF
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  120 bits (303), Expect = 1e-31
 Identities = 79/289 (27%), Positives = 140/289 (48%), Gaps = 44/289 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL---GKQKEGVNFTALREIKLLKELK 69
           R+ K E+LG G++G VY+ ++   G   A+K++ L   G+  +       +EI LL +L+
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P+I++ +     + NL++  E +    L  +++    F  P  I+ Y +  L GL + H
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-IRLYTRQILLGLEYLH 119

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPEL 182
            +  +HRD+K  N+L+ ++G +KLADFG+A       ++     FA+      ++ APE+
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPEV 172

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     YG   D+W+ GC   E+   +P     S ++ +  +F   G +      +L  +
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKP---PWSQLEGVAAVF-KIGRS-----KELPPI 223

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           PD++                 SD+A D + K    DP  R TA + LEH
Sbjct: 224 PDHL-----------------SDEAKDFILKCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  120 bits (302), Expect = 2e-31
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +     +G+G++GVV+K +     +  A+K+I L K        A+ E ++L +L S +I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI--KSYMQMTLKGLAFCHKK 130
           I   ++F  KG L++V E+ E  DL  +++       P D   + ++Q+ L GLA  H K
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-GLAHLHSK 120

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPELLF 184
            +LHRD+K  NL + ++  +K+ D G+A++         +  FA       +Y +PEL  
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS------DNTNFANTIVGTPYYLSPELC- 173

Query: 185 GAKQYGAGVDVWAAGCIFAEL-LNRRPF 211
             K Y    DVWA G +  E    + PF
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-30
 Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 47/292 (16%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G+G YG V+ A    TG+ VA+K  K  L  +   V    L E  +L   KS  +++L+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTTTKSEWLVKLL 67

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            AF     L+L  E++   D  T++ N  + LS    + YM    + +   H+   +HRD
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 137 MKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           +KP N LI + G +KL DFGL++        + GSPD           Y APE+L G K 
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD-----------YMAPEVLRG-KG 174

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y   VD W+ GC+  E L   P   GS+  +    +           W +    P Y + 
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKETLQRPVYDDP 225

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRYFSSAPL 299
           ++           + SD+A DL++K+   DP  R  + +    H +F     
Sbjct: 226 RF-----------NLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVDW 265

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  117 bits (296), Expect = 1e-30
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPH 72
           + LGEG +G VYK        K    VA+K ++    ++ +  F  LRE +++++L  P+
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHPN 62

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++L+     +  L++V E+ME  DL + +R     LS +D+ S+     +G+ +   K 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAKQ 188
            +HRD+   N L+G +  +K++DFGL+R     D  +  +   +  RW  APE L    +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWM-APESLK-EGK 179

Query: 189 YGAGVDVWAAGCIFAELLNR 208
           + +  DVW+ G +  E+   
Sbjct: 180 FTSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 1e-29
 Identities = 83/300 (27%), Positives = 139/300 (46%), Gaps = 57/300 (19%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + +   E +G+G++G VYKAID +T Q VAIK I L + ++ +     +EI+ L + +SP
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDL-------ETVIRNTNIFLSPADIKSYMQMT 120
           +I +   +F     L ++ E+       DL       ET I         A I   ++  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI---------AFI---LREV 107

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRA 179
           L GL + H++  +HRD+K  N+L+   G +KLADFG++ ++  +  +R T  V   ++ A
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMA 166

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++  +  Y    D+W+ G    EL    P L   SD+  +  +F              
Sbjct: 167 PEVIKQSG-YDEKADIWSLGITAIELAKGEPPL---SDLHPMRVLFL------------- 209

Query: 240 AYLPDYVEYQYVAAPPL--RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
             +P          PP    + F   S    D +S     DPK R +A++ L+H++   A
Sbjct: 210 --IPK-------NNPPSLEGNKF---SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  115 bits (289), Expect = 1e-29
 Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 38/288 (13%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSP 71
           +    V+G+G +G V       T +  A+K +   K  +K  V    L E ++L+EL  P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-NVLNERRILQELNHP 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  +F  + N++LV + +   DL   +     F S   +K ++   +  L + H K
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF-SEEQVKFWICEIVLALEYLHSK 119

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP+N+L+   G + + DF +A    +PD   T       Y APE+L     Y 
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTSGTPGYMAPEVLCRQG-YS 177

Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W+ G    E L  +RP+   S  I     I A   TA                  
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ--IRAKQETADV---------------- 219

Query: 250 YVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI--TAQQALEHRYF 294
                    L+P+  S +A+D ++K+   DP+ R+    +    H YF
Sbjct: 220 ---------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  114 bits (288), Expect = 2e-29
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPH 72
           + LGEG +G VYK             VA+K ++    ++ +  F  LRE +++++L  P+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHPN 62

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKK 130
           I++L+     +  L +V E+M   DL   +R      LS +D+ S+     +G+ +   K
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
             +HRD+   N L+G +  +K++DFGL+R     D  +  +   +  RW  APE L    
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWM-APESLK-EG 179

Query: 188 QYGAGVDVWAAGCIFAELLNR 208
           ++ +  DVW+ G +  E+   
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  114 bits (288), Expect = 2e-29
 Identities = 85/292 (29%), Positives = 138/292 (47%), Gaps = 37/292 (12%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL----GKQKEGVNFTALREIKLLKELK 69
           +LK + LG G +   Y+A D KTG  +A+K++        ++E V     +EI+L+  L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            PHII ++ A     + +L  E+M    +  ++     F     I  Y +  L+GL++ H
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN-YTEQLLRGLSYLH 120

Query: 129 KKWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRR---FTHQVFAR-WYRAPELL 183
           +  ++HRD+K  NLLI S GQ L++ADFG A    +       F  Q+     + APE+L
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA-AFGTATPSQWPDLAYL 242
            G +QYG   DVW+ GC+  E+   +P        + L  IF  A  T  PS       +
Sbjct: 181 RG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS-------I 232

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           P+++      +P LR           D+  +     P+ R  +++ L+H  F
Sbjct: 233 PEHL------SPGLR-----------DVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  114 bits (287), Expect = 5e-29
 Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY AID  TGQ VAIK++ L +Q  KE +    + EI +++E K 
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI----INEILVMRENKH 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 192

Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 6e-29
 Identities = 79/299 (26%), Positives = 143/299 (47%), Gaps = 51/299 (17%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL------GKQKEGVNFTAL-REIKLL 65
           +++K  ++G G++G VY  ++  +G+ +A+K++ L       K ++     AL REI LL
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           KEL+  +I++ + +     +L++  E++       + N         ++++++  LKGL 
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-------IFGSPDRRFTHQVFARWYR 178
           + H + ++HRD+K  N+L+ + G +K++DFG+++          +   R + Q    W  
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM- 179

Query: 179 APELLFGAKQ--YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE++   KQ  Y    D+W+ GC+  E+L  + PF     D  QL  IF     A+P  
Sbjct: 180 APEVV---KQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKIGENASPE- 231

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                                    PS  S +A+D L K F  D   R TA + L+H +
Sbjct: 232 ------------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (285), Expect = 6e-29
 Identities = 84/290 (28%), Positives = 128/290 (44%), Gaps = 43/290 (14%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
                LG G  GVV K +   TG+ +A+K IRL    E +    LRE+ +L +  SP+I+
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIV 62

Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHKKW-V 132
               AF + G++ +  E+M+      I        P  I   + +  LKGL + H+K  +
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           +HRD+KP+N+L+ S GQ+KL DFG++ ++  S  + F   V    Y APE + G   Y  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPERIQGND-YSV 178

Query: 192 GVDVWAAGCIFAEL-LNRRPFLQ----GSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
             D+W+ G    EL   R P+           + L  I                      
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------------------- 216

Query: 247 EYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               V  PP R   PS   S D  D ++     DP+ R + ++ LEH + 
Sbjct: 217 ----VNEPPPR--LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (278), Expect = 6e-28
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 17/193 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           + LGEG +G VYK         T   VA+K ++ G  ++E   F  L E  ++K+L  P+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF--LEEASIMKKLSHPN 62

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+        L++V E+M   DL   +R     L+  D+        KG+ +   K 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQ----VFARWYRAPELLFGA 186
            +HRD+   N L+  +  +K++DFGL+R I+     R        +  +W  APE L   
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI--KWM-APESLKDG 179

Query: 187 KQYGAGVDVWAAG 199
           K + +  DVW+ G
Sbjct: 180 K-FTSKSDVWSFG 191

Length = 258

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  109 bits (274), Expect = 3e-27
 Identities = 75/202 (37%), Positives = 115/202 (56%), Gaps = 12/202 (5%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G V+ AID  TGQ VAIK+I L KQ  KE +    + EI ++KELK+
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI----INEILVMKELKN 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D+F     L +V E++    L  V+  T   +  A I +  +  L+ L F H 
Sbjct: 76  PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHA 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
             V+HRD+K +N+L+G  G +KL DFG  A+I     +R T  V   ++ APE++   K 
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV-TRKA 191

Query: 189 YGAGVDVWAAGCIFAELLNRRP 210
           YG  VD+W+ G +  E++   P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  108 bits (273), Expect = 3e-27
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 27/220 (12%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIR-----LGKQKEGVNFTALREIKLLKELKSPHII 74
           LG G +G V         +T A+K ++        Q+E +      E ++L+E   P I+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI----FSEKEILEECNHPFIV 56

Query: 75  ELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L   F  K  ++++ E+    +L T++R+  +F      + Y+   +    + H + ++
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIACVVLAFEYLHNRGII 115

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT-----HQVFARWYRAPELLFGAKQ 188
           +RD+KP NLL+ S+G +KL DFG A+   S  + +T            Y APE++   K 
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE------YVAPEIILN-KG 168

Query: 189 YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA 227
           Y   VD W+ G +  ELL  R PF  G  D D + +I+  
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF--GEDDEDPM-EIYND 205

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 18/206 (8%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKS 70
           + Y   + +G GTYG VYKA D  TG+ VAIK I+L   + G +F  ++ EI +LKE + 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL---EPGDDFEIIQQEISMLKECRH 59

Query: 71  PHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           P+I+    ++  +  L +V E+       D+  V R     LS   I    + TLKGLA+
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAY 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFG 185
            H+   +HRD+K  N+L+   G +KLADFG+ A++  +  +R +      W  APE+   
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM-APEVAAV 175

Query: 186 AKQ--YGAGVDVWAAG--CI-FAELL 206
            ++  Y    D+WA G   I  AEL 
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 7e-27
 Identities = 84/320 (26%), Positives = 135/320 (42%), Gaps = 67/320 (20%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKEL 68
           D +   +V+G G +G V+   D  TGQ  A+K +R   + K+ +  +  A R+I  L + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LADA 58

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAF 126
            SP I++L  +F  + +L+LV E+M   DL  ++   ++F  P +  + Y+   +  L  
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF--PEETARFYIAELVLALDS 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-------------QVF 173
            HK   +HRD+KP+N+LI + G +KLADFGL +       R  +              V 
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 174 ARW----------------YRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSS 216
            R                 Y APE+L G   YG   D W+ G I  E+L    PF   + 
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT 276
                 KI           W +    P                    S +A+DL+ ++  
Sbjct: 236 QETYN-KI---------INWKESLRFPPDPPV---------------SPEAIDLICRLLC 270

Query: 277 YDPKARIT-AQQALEHRYFS 295
            DP+ R+   ++   H +F 
Sbjct: 271 -DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 42/296 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y   EV+G G   VVY AI     + VAIK+I L K +  V+    +E++ + +   P
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIR--NTNIFLSPADIKSYMQMTLKGLAFCH 128
           ++++   +F     L LV  ++    L  +++       L  A I + ++  LKGL + H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDR----RFTHQVFARWYRAPELL 183
               +HRD+K  N+L+G  G +K+ADFG+ A +    DR    R T  V    + APE++
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPEVM 178

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                Y    D+W+ G    EL                     A G A  S++P +  L 
Sbjct: 179 EQVHGYDFKADIWSFGITAIEL---------------------ATGAAPYSKYPPMKVLM 217

Query: 244 DYVEYQYVAAPPLRSLFPSASDDAL-----DLLSKMFTYDPKARITAQQALEHRYF 294
             ++      PP  SL   A           ++S     DP  R TA++ L+H++F
Sbjct: 218 LTLQ----NDPP--SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 20/199 (10%)

Query: 18  EVLGEGTYGVVYKA-IDTKTGQT--VAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHI 73
           + LGEG +G VYK  +  K G+T  VA+K ++    +E   +F  L+E +++K+L  P++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF--LKEARVMKKLGHPNV 58

Query: 74  IELIDAFPHKGNLHLVFEFME-TDLETVIRNTNI--------FLSPADIKSYMQMTLKGL 124
           + L+     +  L+LV E+ME  DL   +R +           LS  D+ S+     KG+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQ--VFARWYRAPE 181
            +   K  +HRD+   N L+G    +K++DFGL+R ++     R      +  RW  APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APE 177

Query: 182 LLFGAKQYGAGVDVWAAGC 200
            L     + +  DVW+ G 
Sbjct: 178 SLKD-GIFTSKSDVWSFGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 83/296 (28%), Positives = 143/296 (48%), Gaps = 44/296 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A D  TG+ VA+KK+ L KQ+         E+ ++++ + P
Sbjct: 22  DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHP 76

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +I+E+  ++     L +V EF+E    TD+ T  R     ++   I +     LK L+F 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFL 131

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS--PDRRFTHQVFARWYRAPELLFG 185
           H + V+HRD+K +++L+ S G++KL+DFG         P R+    V   ++ APE++  
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEVI-S 188

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              YG  VD+W+ G +  E+++  P       +  + +I             D   LP  
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------RDN--LPPK 234

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
           ++  +  +P LRS            L +M   DP  R TA + L H + + A  P+
Sbjct: 235 LKNLHKVSPRLRS-----------FLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  107 bits (269), Expect = 2e-26
 Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 14/202 (6%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIE 75
           RE+ G G++G VY A D +T + VAIKK+   GKQ        ++E++ L++L+ P+ IE
Sbjct: 21  REI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 76  LIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
               +  +    LV E+     +D+  V +     L   +I +     L+GLA+ H    
Sbjct: 80  YKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYLHSHER 136

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYG 190
           +HRD+K  N+L+   G +KLADFG A +  SP   F   V   ++ APE++      QY 
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLV-SPANSF---VGTPYWMAPEVILAMDEGQYD 192

Query: 191 AGVDVWAAGCIFAELLNRRPFL 212
             VDVW+ G    EL  R+P L
Sbjct: 193 GKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  105 bits (264), Expect = 4e-26
 Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 38/278 (13%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G+YG VYK       Q  A+K++ LG   +     A+ EI++L  +  P+II   +A
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIF--LSPADI--KSYMQMTLKGLAFCHKKWVLH 134
           F     L +V E+    DL   I        L P     + ++Q+ L+GL   H++ +LH
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL-LRGLQALHEQKILH 126

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-QVFARWYRAPELLFGAKQYGAGV 193
           RD+K  N+L+ ++  +K+ D G++++           Q+    Y APE+  G + Y    
Sbjct: 127 RDLKSANILLVANDLVKIGDLGISKVLKK---NMAKTQIGTPHYMAPEVWKG-RPYSYKS 182

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GC+  E+                    A F  A P +   +  L    + Q    
Sbjct: 183 DIWSLGCLLYEM--------------------ATF--APPFEARSMQDL--RYKVQRGKY 218

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           PP+  ++   S D  + +  M    PK R    + L  
Sbjct: 219 PPIPPIY---SQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  104 bits (262), Expect = 6e-26
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 6/203 (2%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K  V+G G +G+V+        + V IK+I + +  +     A  E ++LK L  P+
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           IIE  + F     L +V E+    T  E + +  N  L    I  +    L  L   H K
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            +LHRD+K  N+L+  H   +K+ DFG+++I  S  + +T  V    Y +PEL  G K Y
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEG-KPY 178

Query: 190 GAGVDVWAAGCIFAELLN-RRPF 211
               D+WA GC+  EL + +R F
Sbjct: 179 NQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  104 bits (261), Expect = 8e-26
 Identities = 69/207 (33%), Positives = 109/207 (52%), Gaps = 7/207 (3%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y    V+GEG++G         + Q  A+K+IRL K    V   + +E  LL ++K P+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPN 59

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCHK 129
           I+   ++F   G+L++V E+ +  DL   I+     L P D  ++ ++QM L G+   H+
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL-GVQHIHE 118

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K VLHRD+K  N+ +  +G++KL DFG AR+  SP       V   +Y  PE ++    Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWENMPY 177

Query: 190 GAGVDVWAAGCIFAELLN-RRPFLQGS 215
               D+W+ GCI  EL   + PF   S
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  105 bits (263), Expect = 8e-26
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS 134

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 193

Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  105 bits (262), Expect = 1e-25
 Identities = 70/202 (34%), Positives = 113/202 (55%), Gaps = 12/202 (5%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY AID  TGQ VAIK++ L +Q  KE +    + EI +++E K+
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI----INEILVMRENKN 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHS 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
             V+HRD+K +N+L+G  G +KL DFG  A+I     +R T  V   ++ APE++   K 
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV-TRKA 191

Query: 189 YGAGVDVWAAGCIFAELLNRRP 210
           YG  VD+W+ G +  E++   P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-25
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 11/239 (4%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---S 70
           Y + E++G G YG VY+     TG+ VA+K I L    + V+    RE+ LL +L+    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQP 61

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I +   ++     L ++ E+ E   + T+++   I  +   I   ++  L  L + HK
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI--AEKYISVIIREVLVALKYIHK 119

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K  N+L+ + G +KL DFG+A +      + +  V   ++ APE++   K Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
               D+W+ G    E+    P     SD+D   +       + P +  D  Y     E+
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY---SDVDAF-RAMMLIPKSKPPRLEDNGYSKLLREF 234

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 86/285 (30%), Positives = 126/285 (44%), Gaps = 32/285 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G  G V K     TG  +A K + +G  K  V    LRE++++ E +SP+I+    A
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDM 137
           F ++ N+ +  EFM+   L+ + +     +    +       ++GL + +    ++HRD+
Sbjct: 72  FLNENNICMCMEFMDCGSLDRIYKKGGP-IPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130

Query: 138 KPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           KP+N+L+ S GQ+KL DFG++  +  S    F   V    Y +PE + G K Y    DVW
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINSIADTF---VGTSTYMSPERIQGGK-YTVKSDVW 186

Query: 197 AAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           + G    EL L + PF   + D D         G   P    DL         Q V  PP
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDD---------GQDDPMGILDLL-------QQIVQEPP 230

Query: 256 LR---SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
            R   S FP    D  D +      DP  R T QQ      F  A
Sbjct: 231 PRLPSSDFPE---DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  102 bits (254), Expect = 2e-24
 Identities = 66/196 (33%), Positives = 101/196 (51%), Gaps = 7/196 (3%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIELID 78
           +G G++G VY A ++ T + VA+KK+   GKQ        ++E+K L++LK P+ IE   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
            +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HRD+K
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDVW 196
             N+L+   GQ+KLADFG A    SP   F   V   ++ APE++      QY   VDVW
Sbjct: 149 AGNILLTEPGQVKLADFGSASK-SSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVW 204

Query: 197 AAGCIFAELLNRRPFL 212
           + G    EL  R+P L
Sbjct: 205 SLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 73/217 (33%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKEL 68
              +   EV+GEGTYG VYKA   KTGQ VAIK   I   +++E        E  +L++ 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-----IKEEYNILRKY 59

Query: 69  KS-PHIIELIDAF---PHKGN---LHLVFEFME----TDLETVIRNTNIFLSPADIKSYM 117
            + P+I     AF      GN   L LV E       TDL   +R     L    I   +
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
           + TL+GLA+ H+  V+HRD+K  N+L+  + ++KL DFG++    S   R    +   ++
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 178 RAPELLFGAKQ----YGAGVDVWAAGCIFAELLNRRP 210
            APE++   +Q    Y A  DVW+ G    EL + +P
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  100 bits (252), Expect = 4e-24
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 35/211 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKK------IRLGKQKEGVNFTALREIKLL 65
           D +   + LG G++G V       +G+  A+K       ++L KQ E V      E ++L
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-KQVEHVL----NEKRIL 55

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKG 123
           + ++ P ++ L  +F    NL+LV E++   +L + +R +  F  P   + Y  Q+ L  
Sbjct: 56  QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-VARFYAAQVVL-A 113

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFAR 175
           L + H   +++RD+KP NLL+ S G +K+ DFG A+        + G+P+          
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE---------- 163

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            Y APE++   K YG  VD WA G +  E+L
Sbjct: 164 -YLAPEIILS-KGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  101 bits (252), Expect = 5e-24
 Identities = 77/235 (32%), Positives = 117/235 (49%), Gaps = 11/235 (4%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIE 75
           RE+ G G++G VY A D +T + VAIKK+   GKQ        ++E+K L+ +K P+ IE
Sbjct: 31  REI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HR
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGV 193
           D+K  N+L+   GQ+KLADFG A I  SP   F   V   ++ APE++      QY   V
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASI-ASPANSF---VGTPYWMAPEVILAMDEGQYDGKV 205

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG-TATPSQWPDLAYLPDYVE 247
           DVW+ G    EL  R+P L   + +  L  I      T   ++W D  Y  ++V+
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD--YFRNFVD 258

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 99.5 bits (248), Expect = 6e-24
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 5/197 (2%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y+K + +GEG++G        + G+   IK+I + K        + +E+ +L  +K P+
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCHK 129
           I++  ++F   GNL++V ++ E  DL   I      L P D  +  ++Q+ L  L   H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL-ALKHVHD 119

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + +LHRD+K  N+ +   G +KL DFG+AR+  S        +   +Y +PE+    + Y
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC-ENRPY 178

Query: 190 GAGVDVWAAGCIFAELL 206
               D+WA GC+  E+ 
Sbjct: 179 NNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.9 bits (249), Expect = 6e-24
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 45/287 (15%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ----KEGVNFTALR-EIKLLKELKSPHII 74
           LG+G +G VY   D  TG+ +A+K++         K+ VN  AL  EI+LLK L+   I+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN--ALECEIQLLKNLQHERIV 67

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +          L +  E+M    ++  ++     L+    + Y +  L+G+ + H   ++
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLA------RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           HRD+K  N+L  S G +KL DFG +         G+  +  T      ++ +PE++ G +
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG---TPYWMSPEVISG-E 182

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG   DVW+ GC   E+L  +P                         W +  +      
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKP------------------------PWAE--FEAMAAI 216

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           ++    P    L    S DA + L + F  + K R +A++ L H + 
Sbjct: 217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 99.4 bits (248), Expect = 6e-24
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 34/282 (12%)

Query: 13  RYLKREVLGEGTYG--VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            Y+   VLG+G +G   +Y+   T+    V  K++ L +  E     AL EI +L  L+ 
Sbjct: 1   HYIPIRVLGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 71  PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+II   + F     L +  E+    T  + ++R          +  Y+   +  +++ H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           K  +LHRD+K  N+ +   G +KL DFG+++I GS        V   +Y +PEL  G  +
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VK 177

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y    D+WA GC+  ELL  +     ++ ++ + KI     T   S +            
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY------------ 225

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          S + + L+  +   DP+ R TA + L+
Sbjct: 226 ---------------SSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 99.6 bits (248), Expect = 9e-24
 Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 13/200 (6%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +E+LG G  G VYKA    T + +A+K I L    E +    + E+++L +  SP+II  
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGF 64

Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT-LKGLAFCHKKWVLHR 135
             AF  +  + +  EFM+     V R       P  +   + +  +KGL +     +LHR
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVYRKI-----PEHVLGRIAVAVVKGLTYLWSLKILHR 119

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N+L+ + GQ+KL DFG++  +  S  + +   V    Y APE + G +QYG   D
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISG-EQYGIHSD 175

Query: 195 VWAAGCIFAEL-LNRRPFLQ 213
           VW+ G  F EL L R P+ Q
Sbjct: 176 VWSLGISFMELALGRFPYPQ 195

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 82/290 (28%), Positives = 122/290 (42%), Gaps = 50/290 (17%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI------RLGKQKEGVNFTALREIKLLKELKSPHI 73
           LGEG  G V K     TG   A+K I       L KQ        LRE+++ K  KSP+I
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ-------ILRELEINKSCKSPYI 61

Query: 74  IELIDAF--PHKGNLHLVFEFMET-DLETV---IRNTNIFLSPADIKSYMQMTLKGLAFC 127
           ++   AF      ++ +  E+ E   L+++   ++     +    +    +  LKGL++ 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG-SPDRRFTHQVFARWYRAPELLFGA 186
           H + ++HRD+KP+N+L+   GQ+KL DFG++     S    FT   F   Y APE + G 
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---YMAPERIQG- 177

Query: 187 KQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           K Y    DVW+ G    E+  NR PF         LG I                   + 
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPP--EGEPPLGPI-------------------EL 216

Query: 246 VEYQYVAAPPLRSLFPSA----SDDALDLLSKMFTYDPKARITAQQALEH 291
           + Y      P     P      S++  D + +    DP  R T    LEH
Sbjct: 217 LSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 98.1 bits (244), Expect = 3e-23
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 45/294 (15%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI------RLGKQKEGVNFTALRE-IKLLK 66
           + K EVLG+G YG VY  + T  GQ +A+K++       L  +KE   +  L+E + LLK
Sbjct: 2   WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKE---YEKLQEEVDLLK 57

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            LK  +I++ +        + +  EF+    + +++        P     Y +  L G+A
Sbjct: 58  SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV-FCKYTKQILDGVA 116

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRA 179
           + H   V+HRD+K NN+++  +G +KL DFG AR         TH    +      ++ A
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++     YG   D+W+ GC   E+   +P L   + +D+L  +F              
Sbjct: 177 PEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMFYIGAHRGL------ 226

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                         P L   F   S  A+D ++   T D   R +A Q L H +
Sbjct: 227 -------------MPRLPDSF---SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 98.0 bits (244), Expect = 4e-23
 Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 50/296 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D     + LG+G YG VYK +   TG T+A+K+IRL   +   N   + E+ +L +  SP
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN-QIIMELDILHKAVSP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFMET---------DLETVIRNTNIFLSPADIKSYMQMTLK 122
           +I++   AF  +G +++  E+M+           + T     ++      I   +   LK
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL---RRITYAVVKGLK 116

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPE 181
            L   H   ++HRD+KP N+L+  +GQ+KL DFG++  +  S  +     +  + Y APE
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIGCQSYMAPE 171

Query: 182 LL-----FGAKQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
            +          Y    DVW+ G    E+ L R P+   +        IFA         
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQ-------- 218

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 L   V+      PP  +L    SDDA D ++K     P  R T  Q LEH
Sbjct: 219 ------LSAIVD----GDPP--TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 98.2 bits (244), Expect = 5e-23
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 8/199 (4%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIE 75
           RE+ G G++G VY A D +  + VAIKK+   GKQ        ++E++ L++L+ P+ I+
Sbjct: 21  REI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGV 193
           D+K  N+L+   G +KL DFG A I  +P   F   V   ++ APE++      QY   V
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIM-APANXF---VGTPYWMAPEVILAMDEGQYDGKV 195

Query: 194 DVWAAGCIFAELLNRRPFL 212
           DVW+ G    EL  R+P L
Sbjct: 196 DVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 39/281 (13%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G  G VYK I   TG+  A+K I  G  ++ V     REI++L+++  P++++  D 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F H G + ++ EFM+   LE        FL  AD+    +  L G+A+ H++ ++HRD+K
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFL--ADVA---RQILSGIAYLHRRHIVHRDIK 195

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE-----LLFGAKQYGAGV 193
           P+NLLI S   +K+ADFG++RI           V    Y +PE     L  GA    AG 
Sbjct: 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG- 254

Query: 194 DVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D+W+ G    E  L R PF  G                       D A L   +      
Sbjct: 255 DIWSLGVSILEFYLGRFPFGVGRQG--------------------DWASLMCAICMSQPP 294

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             P      +AS +    +S     +P  R +A Q L+H +
Sbjct: 295 EAP-----ATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++  + EI++L     P+I++L+ A
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--MVEIEILATCNHPYIVKLLGA 77

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F   G L ++ EF     ++ ++   +  L+   I+   +  L+ L + H   ++HRD+K
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ----YGAGVD 194
             N+L+   G +KLADFG++       +R    +   ++ APE++         Y    D
Sbjct: 138 AGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           +W+ G    E+    P     + +  L KI  +     + PS+W                
Sbjct: 198 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW---------------- 241

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                      S +  D L       P+ R +A Q LEH + SS
Sbjct: 242 -----------SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 43/303 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           LG+G +G V       TG+  A KK+   RL K+++G    AL E K+L+++ S  I+ L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQM-ALNEKKILEKVSSRFIVSL 58

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLH 134
             AF  K +L LV   M   DL+  I N        A    Y    + GL   H++ +++
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLFGAKQYGAGV 193
           RD+KP N+L+  HG ++++D GLA        +          Y APE+L G + Y   V
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQG-EVYDFSV 175

Query: 194 DVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D +A GC   E++  R PF Q    +++              +      L   VEY    
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEK--------------EELKRRTLEMAVEYPDKF 221

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPT-EPNKL 306
           +P  +           DL   +   DP+ R+     +A +  EH  F        E   L
Sbjct: 222 SPEAK-----------DLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGML 270

Query: 307 PRP 309
             P
Sbjct: 271 EPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 86/310 (27%), Positives = 139/310 (44%), Gaps = 35/310 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV K +   +G  +A K I L + K  +    +RE+K+L E  SP
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSP 59

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P +I   + +  L+GL +  +
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PENILGKISIAVLRGLTYLRE 117

Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 173

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLP-- 243
            Y    D+W+ G    E+   R +     D  +L  +F               ++  P  
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR-YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 244 -----------DYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALE 290
                      DY+    V  PP +   PS   SD+  D + K    +PK R   ++  +
Sbjct: 233 SPRPMAIFELLDYI----VNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286

Query: 291 HRYFSSAPLP 300
           H +   A L 
Sbjct: 287 HPFIKRAELE 296

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 91.2 bits (226), Expect = 6e-21
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 6/191 (3%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELID 78
           +G G +  VY+A      + VA+KK+++ +  +       ++EI LLK+L  P++I+ +D
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 79  AFPHKGNLHLVFEFMET-DLETVI---RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           +F     L++V E  +  DL  +I   +     +    +  Y       +   H + V+H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y    D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 188

Query: 195 VWAAGCIFAEL 205
           +W+ GC+  E+
Sbjct: 189 IWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.0 bits (228), Expect = 7e-21
 Identities = 76/295 (25%), Positives = 143/295 (48%), Gaps = 44/295 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K   +GEG+ G+V  A +  +G+ VA+K + L KQ+         E+ ++++ +  
Sbjct: 24  ENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQ 78

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+  ++     L ++ EF++    TD+ +  R     L+   I +  +  L+ L + 
Sbjct: 79  NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYL 133

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGS-PDRRFTHQVFARWYRAPELLFG 185
           H + V+HRD+K +++L+   G++KL+DFG  A+I    P R+    V   ++ APE++  
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVI-S 190

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              YG  VD+W+ G +  E+++  P                 + + +P Q   +  L D 
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEP----------------PYFSDSPVQ--AMKRLRD- 231

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 + PP        S    D L +M T +P+ R TAQ+ L+H +     LP
Sbjct: 232 ------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 91.6 bits (227), Expect = 7e-21
 Identities = 73/294 (24%), Positives = 136/294 (46%), Gaps = 40/294 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 77

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+ +++     L +V EF+E    TD+ T  R     ++   I +     LK L+  
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVL 132

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H + V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+    
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRL 191

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG  VD+W+ G +  E+++  P       +  +  I                 LP  ++
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPKLK 237

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             +  +P L+             L ++   DP  R TA + L+H + + A  P+
Sbjct: 238 NLHKVSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 90.8 bits (225), Expect = 8e-21
 Identities = 70/290 (24%), Positives = 131/290 (45%), Gaps = 40/290 (13%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKT--GQTVAI-KKIRLGKQKEGVNFTALREIKLLKELK 69
           RY+ ++ LG+G++G VY   D K    + + + K+I +G+        A +E +LL +L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR----NTNIFLSPADIKSYMQMTLKGL 124
            P I++   +F  +    ++ E+ E  DL+  +                + ++Q+ L G+
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL-GV 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELL 183
            + H++ +LHRD+K  N+ +  +  LK+ DFG++R + GS D   T      +Y +PE L
Sbjct: 120 HYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTF-TGTPYYMSPEAL 177

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
              + Y +  D+W+ GCI  E+       +G + +  + +I       TPS       LP
Sbjct: 178 -KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---PTPS-------LP 226

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
           +    Q  +                 ++  M   DP  R +A + L + +
Sbjct: 227 ETYSRQLNS-----------------IMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 91.2 bits (226), Expect = 8e-21
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 36/283 (12%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 70

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+   I+   + TL+ L + H+  ++HRD+K
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF----GAKQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 131 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 190

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 191 VWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 234

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                      S +  D L K    +  AR T  Q L+H + +
Sbjct: 235 -----------SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 7/204 (3%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY   + +GEG++G +Y A      +   IK+I L K        + +E+ LL ++K P+
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFME-TDLETVI-RNTNIFLSPADIKS-YMQMTLKGLAFCHK 129
           I+    +F   G L +V E+ +  DL   I R   +  S   I S ++Q++L GL   H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL-GLKHIHD 119

Query: 130 KWVLHRDMKPNNLLIGSHGQL-KLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           + +LHRD+K  N+ +  +G + KL DFG+AR            V   +Y +PE+    + 
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC-QNRP 178

Query: 189 YGAGVDVWAAGCIFAELLN-RRPF 211
           Y    D+W+ GC+  EL   + PF
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 33/206 (16%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKK------IRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +G GT+G V+   D  +    A+K       IRL KQ++ V+     E ++LKE+  P I
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-KQEQHVH----NEKRVLKEVSHPFI 63

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L      +  L+++ E++   +L + +RN+  F S +    Y    +  L + H K +
Sbjct: 64  IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF-SNSTGLFYASEIVCALEYLHSKEI 122

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRAPELLF 184
           ++RD+KP N+L+   G +KL DFG A+        + G+P+           Y APE++ 
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE-----------YLAPEVI- 170

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRP 210
            +K +   VD WA G +  E+L   P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 75/294 (25%), Positives = 139/294 (47%), Gaps = 40/294 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A +  TG+ VA+KK+ L KQ+         E+ ++++    
Sbjct: 25  DSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHE 79

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++++ +++     L +V EF+E    TD+ T  R     ++   I +     L+ L++ 
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYL 134

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H + V+HRD+K +++L+ S G++KL+DFG          +    V   ++ APE++    
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRL 193

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            YG  VD+W+ G +  E+++  P       +  + +I                 LP  V+
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN--------------LPPRVK 239

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             +  +  LR          LDL   M   +P  R TAQ+ L+H +   A  P+
Sbjct: 240 DSHKVSSVLRGF--------LDL---MLVREPSQRATAQELLQHPFLKLAGPPS 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 23/208 (11%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +R VLG+GTYG+VY A D  T   +AIK+I     +         EI L   LK  +I++
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL--HEEIALHSYLKHRNIVQ 69

Query: 76  LIDAFPHKGNLHLVFEFMET----DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHK 129
            + +    G   +   FME      L  ++R+    +  +   I  Y +  L+GL + H 
Sbjct: 70  YLGSDSENGFFKI---FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 130 KWVLHRDMKPNNLLIGSH-GQLKLADFG----LARIFGSP-DRRFTHQVFARWYRAPELL 183
             ++HRD+K +N+L+ ++ G +K++DFG    LA I  +P    FT  +    Y APE++
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTL---QYMAPEVI 181

Query: 184 -FGAKQYGAGVDVWAAGCIFAELLNRRP 210
             G + YGA  D+W+ GC   E+   +P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP 209

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 89.9 bits (223), Expect = 6e-20
 Identities = 97/364 (26%), Positives = 143/364 (39%), Gaps = 73/364 (20%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKEL 68
             +  + ++G G +G V    +  TG   A+K ++   L  Q+    F   R+I  L   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDI--LSIS 58

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            SP I +L  AF  K NL+LV E+    DL +++            + Y+   +  +   
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFG-LARI-----------FGSPDRRFTHQVFAR 175
           H+   +HRD+KP N+LI   G +KLADFG  AR+            G+PD          
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD---------- 168

Query: 176 WYRAPELL-----FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFG 229
            Y APE+L      G   YG   D W+ G I  E++  R PF +G+S       I     
Sbjct: 169 -YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-AKTYNNI----- 221

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSL-FPS---ASDDALDLLSKMFTYDPKARITA 285
                           + +Q       R L FP     S D LDL+  +     K R+  
Sbjct: 222 ----------------MNFQ-------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGY 257

Query: 286 QQALEHRYFSSAPLPTEPNKLPR--PATKRASKASDFNPQEGPTVLSPPRKTRRVMPDRE 343
           +    H +FS        N LP   P  K     S+F+  E  +       T ++ P   
Sbjct: 258 EGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKP--N 315

Query: 344 GFEG 347
           GF G
Sbjct: 316 GFSG 319

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 88.6 bits (219), Expect = 6e-20
 Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 31/278 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIELID 78
           +G GTYG VYKA +  TG+  AIK I+L   + G +F  ++ EI ++K+ K  +I+    
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           ++  +  L +  EF        I +    LS + I    + TL+GL + H K  +HRD+K
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133

Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDV 195
             N+L+  +G +KLADFG+ A+I  +  +R +  +   ++ APE+    ++  Y    D+
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRKSF-IGTPYWMAPEVAAVERKGGYNQLCDI 192

Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           WA G    EL   +P +    D+  +  +F    T +  Q P L    D +++       
Sbjct: 193 WAVGITAIELAELQPPM---FDLHPMRALF--LMTKSNFQPPKLK---DKMKW------- 237

Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                   S+     +    T +PK R TA++ L+H +
Sbjct: 238 --------SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 88.6 bits (219), Expect = 7e-20
 Identities = 64/195 (32%), Positives = 104/195 (53%), Gaps = 8/195 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIELID 78
           +G GTYG VYKA +  TG+  A+K I+L   + G +F+ ++ EI ++KE K  +I+    
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL---EPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           ++  +  L +  E+        I +    LS   I    + TL+GLA+ H K  +HRD+K
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133

Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDV 195
             N+L+  +G +KLADFG+ A+I  +  +R +  +   ++ APE+    K   Y    D+
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSF-IGTPYWMAPEVAAVEKNGGYNQLCDI 192

Query: 196 WAAGCIFAELLNRRP 210
           WA G    EL   +P
Sbjct: 193 WAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.0 bits (218), Expect = 8e-20
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 70

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130

Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 187

Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 88.7 bits (220), Expect = 9e-20
 Identities = 86/297 (28%), Positives = 131/297 (44%), Gaps = 57/297 (19%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKIR-----LGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           G YG VY     +T Q  A+KKI      L  Q + V     R+I    E  +P ++ + 
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV--FVERDILTFAE--NPFVVSMF 67

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWVLHR 135
            +F  K +L +V E++E  D  T+++N      P D+ + Y   T+  L + H   ++HR
Sbjct: 68  CSFETKRHLCMVMEYVEGGDCATLLKNIGAL--PVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGLARI-------------FGSPDRRFT-HQVFAR-WYRAP 180
           D+KP+NLLI S G +KL DFGL++I                  R F   QV     Y AP
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++   + YG  VD WA G I  E L       G +  +  G++      +   +WP+  
Sbjct: 186 EVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-----SDDIEWPEGD 239

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRYF 294
                       A P          DA DL+S++   +P  R+    A +  +HR+F
Sbjct: 240 -----------EALP---------ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 30/280 (10%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T Q VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +     F     I + ++  LKGL + H +  +
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 182

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P    +SD+  +  +F                +P          
Sbjct: 183 DIWSLGITAIELAKGEP---PNSDMHPMRVLF---------------LIPKN------NP 218

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
           P L   F   S    + +      DP  R TA++ L+H++
Sbjct: 219 PTLTGEF---SKPFKEFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 98/357 (27%), Positives = 153/357 (42%), Gaps = 72/357 (20%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKEL--KSPHII 74
           VLG+G++G V  A    T +  A+K ++     Q + V  T + E ++L  L  K P + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVL-ALAGKHPFLT 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L   F  K  L  V E++   DL   I+ +  F  P       ++ L GL F H++ ++
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-GLQFLHERGII 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPEL 182
           +RD+K +N+L+ S G +K+ADFG+             F G+PD           Y APE+
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD-----------YIAPEI 167

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     YG  VD WA G +  E+L  + PF     + D   ++F +              
Sbjct: 168 LSYQP-YGPAVDWWALGVLLYEMLAGQSPF-----EGDDEDELFQSI------------- 208

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSS 296
           L D V Y        R L    S +A  +L    T +P+ R+       Q    H +F  
Sbjct: 209 LEDEVRYP-------RWL----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Query: 297 ---APLPTEPNKLP-RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG 347
                L  +  K P +P  K     S+F+ +  +   VL+PP +      D+E F G
Sbjct: 258 IDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRG 314

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 72/280 (25%), Positives = 129/280 (46%), Gaps = 30/280 (10%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G VYK ID +T + VAIK I L + ++ +     +EI +L +  SP+I
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYI 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
                ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERKI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y    
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDFKA 182

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P    +SD+  +  +F     + P+           +E QY  +
Sbjct: 183 DIWSLGITAIELAKGEP---PNSDLHPMRVLFLIPKNSPPT-----------LEGQY--S 226

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
            P +           + +      DP+ R TA++ L+H++
Sbjct: 227 KPFK-----------EFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 16/214 (7%)

Query: 12  DRYLKR-EVLGEGTYGVVYKA----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            R+LK  + LGEG +G V       +   TG+ VA+K +     +E       REI++L+
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFEREIEILR 61

Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L   +I++   +   P   +L L+ E++ +  L   ++     ++   +  +     KG
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRA 179
           + +   +  +HRD+   N+L+ S   +K++DFGLA++       +      +    WY A
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFL 212
           PE L  +K   A  DVW+ G    EL     P  
Sbjct: 181 PECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQ 213

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.0 bits (213), Expect = 4e-19
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKI-------RLGKQKEGVNFTAL-REIKLLKE- 67
           E LG G +G VYK      GQ  +A+K+I          K++   +   +  E+ ++KE 
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-----TDLETVIRNTNIFLSPADIKSYMQMTLK 122
           L+ P+I+     F     L++V + +E         ++      F        ++QM L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124

Query: 123 GLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            L + HK K ++HRD+ PNN+++G   ++ + DFGLA+    P+ + T  V    Y  PE
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTILYSCPE 183

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           ++   + YG   DVWA GCI  ++   +P
Sbjct: 184 IVKN-EPYGEKADVWAFGCILYQMCTLQP 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 99/352 (28%), Positives = 151/352 (42%), Gaps = 66/352 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK  K  +  + + V  T +    L    + P +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F  K +L  V E++   DL   I+++  F   A  + Y    + GL F HKK +++R
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF-DEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+L+   G +K+ADFG+ +             G+PD           Y APE+L 
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD-----------YIAPEILK 169

Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           G K Y   VD W+ G +  E+L  + PF     D D+L   F +     P       + P
Sbjct: 170 GQK-YNESVDWWSFGVLLYEMLIGQSPF--HGEDEDEL---FDSILNDRP-------HFP 216

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-TAQQALEHRYFSSAPLPT- 301
            ++                 S +A D LSK+F  DP  R+       +H +F        
Sbjct: 217 RWI-----------------SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259

Query: 302 EPNKLP---RPATKRASKASDFNPQ---EGPTVLSPPRKTRRVMPDREGFEG 347
           E  ++P   +P  K  S AS+F+ +   E    LSP  K      D+E F G
Sbjct: 260 EKREIPPPFKPKVKSPSDASNFDREFTNEKVR-LSPVDKKLLASMDQEQFRG 310

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 86.3 bits (213), Expect = 5e-19
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKA 182

Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 183 DIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 6/191 (3%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELID 78
           +G G +  VY+A     G  VA+KK+++    +       ++EI LLK+L  P++I+   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 79  AFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           +F     L++V E  +  DL  +I++       +    +  Y       L   H + V+H
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y    D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 188

Query: 195 VWAAGCIFAEL 205
           +W+ GC+  E+
Sbjct: 189 IWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 44/288 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FTALR-EIKLLKELKSPHII 74
           ++LG+G +G VY   D  TG+ +A+K+++   +    +    AL  EI+LLK L    I+
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 75  ELIDAF--PHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +       P +  L +  E M    ++  +++    L+    + Y +  L+G+++ H   
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHSNM 126

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLAR------IFGSPDRRFTHQVFARWYRAPELLFG 185
           ++HRD+K  N+L  S G +KL DFG ++      + G+  +  T      ++ +PE++ G
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG---TPYWMSPEVISG 183

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
            + YG   D+W+ GC   E+L  +P     ++ + +  IF      T    P        
Sbjct: 184 -EGYGRKADIWSVGCTVVEMLTEKP---PWAEFEAMAAIFKIATQPTNPVLP-------- 231

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                          P  SD   D L ++F  + K R +A + L H +
Sbjct: 232 ---------------PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 53/297 (17%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-------S 70
           E LG G YGVV K     TG  +A+K+IR       VN    +  +LL +L         
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQK--RLLMDLDISMRSVDC 59

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNT---NIFLSPADIKSYMQMTL-KGLAF 126
           P+ +    A   +G++ +  E M+T L+   +      + + P DI   + +++ K L +
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTI-PEDILGKIAVSIVKALEY 118

Query: 127 CHKKW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLF 184
            H K  V+HRD+KP+N+LI  +GQ+KL DFG++  +  S  +  T     + Y APE + 
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERIN 176

Query: 185 G---AKQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
                K Y    DVW+ G    EL   R P+    +   QL                   
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK------------------ 218

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
                   Q V  P  +      S +  D ++K    + K R    + L+H +F   
Sbjct: 219 --------QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 84/313 (26%), Positives = 139/313 (44%), Gaps = 35/313 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 63

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT-LKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 121

Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 177

Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQW---------- 236
            Y    D+W+ G    E+ + R P      D  +L  +F       P++           
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPI--PPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235

Query: 237 -PDLAYLPD-------YVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQ 286
            P  +Y PD       +    Y+   P   L PS     +  D ++K    +P  R   +
Sbjct: 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLK 294

Query: 287 QALEHRYFSSAPL 299
           Q + H +   +  
Sbjct: 295 QLMVHAFIKRSEA 307

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G  GVV K     +G  +A K I L + K  +    +RE+++L E  SP+I+    A
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT-LKGLAFCHKK-WVLHRD 136
           F   G + +  E M+   L+ V++       P +I   + +  L+GLA+  +K  ++HRD
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAVLRGLAYLREKHQIMHRD 129

Query: 137 MKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           +KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G   Y    D+
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT-HYSVQSDI 185

Query: 196 WAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFA 226
           W+ G    EL + R P      D  +L  IF 
Sbjct: 186 WSMGLSLVELAIGRYPI--PPPDAKELEAIFG 215

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 83.6 bits (206), Expect = 4e-18
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 44/288 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FTALR-EIKLLKELKSPHII 74
           ++LG+G +G VY   D  TG+ +A K+++   +    +   +AL  EI+LLK L+   I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 75  ELIDAFPHKG--NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +       +    L +  E+M              L+ +  + Y +  L+G+++ H   +
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR------IFGSPDRRFTHQVFARWYRAPELLFGA 186
           +HRD+K  N+L  S G +KL DFG ++      + G+  R  T      ++ +PE++ G 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG---TPYWMSPEVISG- 183

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + YG   DVW+ GC   E+L  +P     ++ + +  IF                     
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKP---PWAEYEAMAAIFK-------------------- 220

Query: 247 EYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRY 293
               +A  P     PS  S+ A D L  +F  + + R +A++ L H +
Sbjct: 221 ----IATQPTNPQLPSHISEHARDFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)

Query: 17  REVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGK----QKEGVNFTALREIKLLKELK 69
            +VLG+G YG V+   K     TG+  A+K ++       QK+  +  A R I  L+ +K
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVK 58

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKS-YMQMTLKGLAFC 127
            P I++LI AF   G L+L+ E++   +L   +    IF+   D    Y+      L   
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME--DTACFYLSEISLALEHL 116

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
           H++ +++RD+KP N+L+ + G +KL DFGL +     G+    F   +    Y APE+L 
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI---EYMAPEILM 173

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRP 210
            +  +G  VD W+ G +  ++L   P
Sbjct: 174 RSG-HGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 42/285 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRL--GKQKEGVNFTALR-EIKLLKELKSPHII 74
           ++LG G +G VY   D  TG+ +A+K++      Q+      AL  EI+LLK L+   I+
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 75  ELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +       P +  L +  E+M              L+    + Y +  L+G+++ H   +
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR------IFGSPDRRFTHQVFARWYRAPELLFGA 186
           +HRD+K  N+L  S G +KL DFG ++      + G+  +  T      ++ +PE++ G 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG---TPYWMSPEVISG- 183

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + YG   DVW+  C   E+L  +P     ++ + +  IF      T    PD        
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKP---PWAEYEAMAAIFKIATQPTKPMLPD-------- 232

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                            SD   D L ++F  + K R TA+  L H
Sbjct: 233 ---------------GVSDACRDFLKQIF-VEEKRRPTAEFLLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 81/294 (27%), Positives = 122/294 (41%), Gaps = 52/294 (17%)

Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSP 71
            E LG G++G V  A    TG+  AIK     +I   KQ + V     +E  +L EL  P
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV----AQEKSILMELSHP 78

Query: 72  HIIELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHK 129
            I+ ++ +F  +  ++ + EF +  +L T +R    F  P D+ K Y    +    + H 
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF--PNDVAKFYHAELVLAFEYLHS 136

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K +++RD+KP NLL+ + G +K+ DFG A+    PDR FT       Y APE++  +K +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCGTPEYLAPEVI-QSKGH 192

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G  VD W  G +  E +   P     +      KI A                       
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG---------------------- 230

Query: 250 YVAAPPLRSLFPSASDD-ALDLLSKMFTYDPKARITA-----QQALEHRYFSSA 297
                  R  FP+  D  A DL+  +   D   R+            H YF  A
Sbjct: 231 -------RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277

Length = 329

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 14/204 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V +      G+    VAIK ++ G   K+ ++F  L E  ++ +   P+I
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF--LTEASIMGQFDHPNI 67

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ E+ME   L+  +R  +   +   +   ++    G+ +  +   
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAKQY 189
           +HRD+   N+L+ S+   K++DFGL+R     +  +T +   +  RW  APE +   +++
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAPEAI-AYRKF 185

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW+ G +  E+++   RP+
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 65/198 (32%), Positives = 96/198 (48%), Gaps = 10/198 (5%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           LG+G +G V       TG+  A KK+   RL  +K+     AL E ++L+++ SP I+ L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL--KKKSGEKMALLEKEILEKVNSPFIVNL 58

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             AF  K +L LV   M   DL+  I N     L    +  Y      G+   H   +++
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RDMKP N+L+   G  +L+D GLA +     +  T +     Y APE+L   + Y   VD
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILK-EEPYSYPVD 176

Query: 195 VWAAGC-IFAELLNRRPF 211
            +A GC I+  +  R PF
Sbjct: 177 WFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 31/221 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-------KSPH 72
           +G G +G V K +   +G  +A+K+IR              + +LL +L         P+
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRS-------TVDEKEQKRLLMDLDVVMRSSDCPY 64

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETV------IRNTNIFLSPADIKSYMQM-TLKGLA 125
           I++   A   +G+  +  E M+  L+        +  + I   P +I   + + T+K L 
Sbjct: 65  IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALN 121

Query: 126 FCHKKW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELL 183
           +  ++  ++HRD+KP+N+L+  +G +KL DFG++ ++  S  +  T     R Y APE +
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERI 179

Query: 184 --FGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQL 221
                  Y    DVW+ G    E+   + P+ + +S  DQL
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 83/315 (26%), Positives = 130/315 (41%), Gaps = 52/315 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E    G  G  +  ID KT + V IK      Q+ G       E  +L+ +  P II+L 
Sbjct: 98  ETFTPGAEGFAFACIDNKTCEHVVIK----AGQRGG----TATEAHILRAINHPSIIQLK 149

Query: 78  DAFPHKGNLHLVFEFMETDLETVI---RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             F +     L+    +TDL   +   RN  I     DI +  +  L+ + + H+  ++H
Sbjct: 150 GTFTYNKFTCLILPRYKTDLYCYLAAKRNIAI----CDILAIERSVLRAIQYLHENRIIH 205

Query: 135 RDMKPNNLLIGSHGQLKLADFGLA---------RIFGSPDRRFTHQVFARWYRAPELLFG 185
           RD+K  N+ I   G + L DFG A         + +G      T+        APELL  
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN--------APELL-A 256

Query: 186 AKQYGAGVDVWAAGCIFAEL------LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
              YG  VD+W+AG +  E+      L  +  L G  D D+  K+        P+++P  
Sbjct: 257 RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316

Query: 240 AYLPDYVEYQYVAA-------PPLRSLFPSASDDALD---LLSKMFTYDPKARITAQQAL 289
           A     ++  Y+         P  R L+ +  +  +D   L+ KM  +D   R +A+  L
Sbjct: 317 A--QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374

Query: 290 EHRYFSSAPLPTEPN 304
           +   F   P P  PN
Sbjct: 375 DFAAFQDIPDPY-PN 388

Length = 391

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 83/326 (25%), Positives = 144/326 (44%), Gaps = 62/326 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+G++G V+ A    T Q  AIK ++  +    + V  T + +  L    + P +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  K NL  V E++   DL   I++ + F  P     Y    + GL F H K +++
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA-TFYAAEIICGLQFLHSKGIVY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ + G +K+ADFG+ +             G+PD           Y APE+L
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD-----------YIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G K Y   VD W+ G +  E+L  + PF       D+  ++F +     P         
Sbjct: 169 LGQK-YNTSVDWWSFGVLLYEMLIGQSPF----HGHDE-EELFQSIRMDNP-------CY 215

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL-EHRYFSS---AP 298
           P ++                   +A D+L K+F  +P+ R+  +  + +H +F     + 
Sbjct: 216 PRWLTR-----------------EAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSA 258

Query: 299 LPTEPNKLP-RPATKRASKASDFNPQ 323
           L     + P +P  K A+  S+F+ +
Sbjct: 259 LEEREIEPPFKPKVKSANDCSNFDKE 284

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 53/294 (18%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHPFLTA 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F     L  V E+    +L   +    +F S    + Y    +  L + H   V++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR---IFGSPDRRF--THQVFARWYRAPELLFGAKQY 189
           RD+K  NL++   G +K+ DFGL +     G+  + F  T +     Y APE+L     Y
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----YLAPEVL-EDNDY 172

Query: 190 GAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           G  VD W  G +  E++  R PF   + D ++L                          +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKL--------------------------F 204

Query: 249 QYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
           + +    +R  FP   S +A  LL+ +   DPK R+      A++ +EHR+F+S
Sbjct: 205 ELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 6/196 (3%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y    V+G+G+YG V        G+   IKK+ L          A +E +LL +LK P+I
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 74  IELIDAFP-HKGNLHLVFEFMET-DLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCHK 129
           +   +++    G L++V  F E  DL   ++     L P +  ++ ++Q+ +  L + H+
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM-ALQYLHE 120

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K +LHRD+K  N+ +     +K+ D G+AR+  +     +  +   +Y +PE LF  K Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPY 179

Query: 190 GAGVDVWAAGCIFAEL 205
               DVWA GC   E+
Sbjct: 180 NYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 70/237 (29%), Positives = 116/237 (48%), Gaps = 15/237 (6%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELKSPHIIELID 78
           +G GT G VYK    KTG  +A+K++R    KE  N   L ++  +LK    P+I++   
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHKKW-VLHRD 136
            F    ++ +  E M T L+ +++     + P DI   M +  +K L +  +K  V+HRD
Sbjct: 82  YFITDSDVFICMELMSTCLDKLLKRIQGPI-PEDILGKMTVAIVKALHYLKEKHGVIHRD 140

Query: 137 MKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELL---FGAKQYGAG 192
           +KP+N+L+ + G +KL DFG++ R+  S  +  T       Y APE +       +Y   
Sbjct: 141 VKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIR 198

Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
            DVW+ G    EL   + P+    ++ + L KI        PS  P+  + PD+  +
Sbjct: 199 ADVWSLGISLVELATGQFPYKNCKTEFEVLTKI---LQEEPPSLPPNEGFSPDFCSF 252

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 96/358 (26%), Positives = 150/358 (41%), Gaps = 74/358 (20%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK  K  +  Q + V  T + +  L    K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +  Y      GL F H K +++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHSKGIIYR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR--IF---------GSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ + G +K+ADFG+ +  IF         G+PD           Y APE++ 
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD-----------YIAPEII- 173

Query: 185 GAKQ-YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
            A Q YG  VD WA G +  E+L  +P   G  D D+L   F +      S         
Sbjct: 174 -AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDEL---FQSIMEHNVS--------- 219

Query: 244 DYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI----TAQQAL-EHRYFSS- 296
                           +P S S +A+ +   + T  P  R+    T ++ + EH +F   
Sbjct: 220 ----------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263

Query: 297 -----APLPTEPNKLPRPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG 347
                     +P   P+   +R   A +F+      P VL+PP K      D+  F+G
Sbjct: 264 DWEKLERREIQPPFKPKVKGRR--SAENFDKFFTREPPVLTPPDKLVIANIDQSEFQG 319

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 59

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S  +++ Y    + GL   H ++V
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF-SEKEMRFYATEIILGLEHMHNRFV 118

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSS 176

Query: 193 VDVWAAGCIFAELL-NRRPFLQ 213
            D ++ GC+  +LL    PF Q
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 84/313 (26%), Positives = 141/313 (45%), Gaps = 43/313 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +VLG+G++G V  A     G+  A+K ++  +    + V  T + +  L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVL 133
           L   F  K +L  V EF+   DL   I++   F L  A    Y    + GL F H K ++
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQFLHSKGII 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           +RD+K +N+++   G +K+ADFG+ +  +FG  D R +       Y APE+L G K Y  
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQGLK-YTF 175

Query: 192 GVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
            VD W+ G +  E+L  + PF     D D+L   F +    TP       + P ++    
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF--HGDDEDEL---FESIRVDTP-------HYPRWI---- 219

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-HRYFSSAPLPT-EPNKLPR 308
                        + ++ D+L K+F  DP  R+     +  H +F +      E  +L  
Sbjct: 220 -------------TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDP 266

Query: 309 PATKRASKASDFN 321
           P   +    SD++
Sbjct: 267 PFKPKVKSPSDYS 279

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 28/217 (12%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK ++  +  Q + V  T + +  L  + K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++++ GL F H++ +++R
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-GLFFLHRRGIIYR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+           R F G+PD           Y APE++ 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD-----------YIAPEII- 173

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
             + YG  VD WA G +  E+L  +P   G  D D+L
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.5 bits (196), Expect = 9e-16
 Identities = 76/273 (27%), Positives = 111/273 (40%), Gaps = 45/273 (16%)

Query: 36  TGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSPHIIELID---AFPHKGNLHLVFE 91
           TG  VAIK +R    +E        RE  L   L  P+I+ L+D   A P  G L  VFE
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP--GLLFAVFE 59

Query: 92  FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-- 148
           ++    L  V+      L   +    M   L  LA  H + ++HRD+KP N+++   G  
Sbjct: 60  YVPGRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 149 -QLKLADFGLARI---FGSPDR----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGC 200
              K+ DFG+  +       D     R T  +    Y APE L G +      D++A G 
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGL 177

Query: 201 IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF 260
           IF E L  +  +QG+S  + L +  +          P    LP      ++A  PL    
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLS----------PVDVSLP-----PWIAGHPLG--- 219

Query: 261 PSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                    +L K    DP+ R  +  AL  R+
Sbjct: 220 --------QVLRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 88/320 (27%), Positives = 130/320 (40%), Gaps = 53/320 (16%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIELI 77
           +G+G++G V +     T +  A+K IR      +  V  T L E  +L ++  P I+ L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT-LAERTVLAQVNCPFIVPLK 59

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            +F     L+LV  F+   +L   ++    F   +  + Y    L  L   HK  V++RD
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRF-DLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +KP N+L+   G + L DFGL ++    D +         Y APELL G   Y   VD W
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWW 177

Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-----YQYV 251
             G +  E+L   P                                P Y E     Y+ +
Sbjct: 178 TLGVLLYEMLTGLP--------------------------------PFYDENVNEMYRKI 205

Query: 252 AAPPLRSLFPSASD-DALDLLSKMFTYDPKARI---TAQQALEHRYFSSAPLPTEPNK-- 305
              PLR  FP   D DA DLL  + + DP  R+    AQ+   H +FS         K  
Sbjct: 206 LQEPLR--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGI 263

Query: 306 LP--RPATKRASKASDFNPQ 323
            P  +PA   A   S+F+ +
Sbjct: 264 QPPFKPAVSSAIDTSNFDEE 283

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 20  LGEGTYGVVYKA---IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +G G +G+V+        K    VAIK IR G   E  +F  + E +++ +L  P +++L
Sbjct: 12  IGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEE-DF--IEEAQVMMKLSHPKLVQL 64

Query: 77  IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKWV 132
                 +  + LVFEFME   L   +R      S    ++ + M L   +G+A+     V
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSNV 121

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV---FARWYRAPELLFGAKQY 189
           +HRD+   N L+G +  +K++DFG+ R     D ++T      F   + +PE +F   +Y
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPE-VFSFSKY 178

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW+ G +  E+ +  + P+
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 42/292 (14%)

Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSP 71
           +VLG G YG V+   K     TG+  A+K ++   L ++ + V  T      L    +SP
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF  +  LHL+ +++   ++ T +   + F S  +++ Y    +  L   HK 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF-SEDEVRFYSGEIILALEHLHKL 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQY 189
            +++RD+K  N+L+ S G + L DFGL++ F S ++  T+       Y APE++ G   +
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 190 GAGVDVWAAGCIFAELLN-RRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           G  VD W+ G +  ELL    PF L+G  +              T S+          V 
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERN--------------TQSE----------VS 220

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYF 294
            + +   P          +A DLL K+   DPK R+      A +  EH +F
Sbjct: 221 RRILKCDP--PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 30/202 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-----KQKEGVNFTALREIKLLKELKSPH 72
           E +G+G +G VYK +  K    VA+K  R       K+K       L+E ++LK+   P+
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRK------FLQEAEILKQYDHPN 53

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK---GLAFCH 128
           I++LI     K  +++V E +    L T +R     L+   +K  +QM+L    G+ +  
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLE 110

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELL 183
            K  +HRD+   N L+G +  LK++DFG++R     I+   D     Q+  +W  APE L
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL--KQIPIKW-TAPEAL 167

Query: 184 -FGAKQYGAGVDVWAAGCIFAE 204
            +G  +Y +  DVW+ G +  E
Sbjct: 168 NYG--RYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 98/357 (27%), Positives = 149/357 (41%), Gaps = 73/357 (20%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
            VLG+G++G V  A   ++G+  A+K ++  +  Q + V  T   +  L      P + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F     L  V EF+   DL   I+ +  F   A  + Y       L F H K +++
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEITSALMFLHDKGIIY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IF---------GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+   G  KLADFG+ +  IF         G+PD           Y APE+L
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD-----------YIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                YG  VD WA G +  E+L    PF   + D      +F A              L
Sbjct: 169 -QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAI-------------L 209

Query: 243 PDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITA------QQALEHRYFS 295
            D V Y            P+  S DA+D+L    T +P  R+ +      +  L H +F 
Sbjct: 210 NDEVVY------------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257

Query: 296 S---APLPTEPNKLP-RPATKRASKASDFNP---QEGPTVLSPPRKTRRVMPDREGF 345
                 L     + P RP  K     S+F+P   +E P VL+P  ++   M +++ F
Sbjct: 258 ELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDP-VLTPIEESLLPMINQDEF 313

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE---IKLLKELKSPH 72
           ++G G +G VY      TG+  A+K   K R+ K K+G    AL E   + L+     P 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETL-ALNERIMLSLVSTGDCPF 58

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ +  AF     L  + + M   DL   +    +F S A+++ Y    + GL   H ++
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEAEMRFYAAEIILGLEHMHNRF 117

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDS 175

Query: 192 GVDVWAAGCIFAELLN-RRPFLQ 213
             D ++ GC+  +LL    PF Q
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A KK+   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--EAMALNEKQILEKVNSRFVVS 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I N  N          Y      GL   H++ ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+  +G ++++D GLA      +     +V    Y APE++   ++Y    
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVV-KNERYTFSP 182

Query: 194 DVWAAGCIFAELLN-RRPFLQ 213
           D W  GC+  E++  + PF Q
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           RYLK+  VLGEG +G V    Y   +  TG+ VA+K +   K++ G   T+   +EI +L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL---KRECGQQNTSGWKKEINIL 60

Query: 66  KELKSPHIIELIDAFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK 122
           K L   +I++       +G   L L+ E++    L   +    + L  A +  + Q   +
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQICE 118

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR------W 176
           G+A+ H +  +HRD+   N+L+ +   +K+ DFGLA+    P+    ++V         W
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFW 176

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
           Y A E L   K   A  DVW+ G    ELL  
Sbjct: 177 Y-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 88/353 (24%), Positives = 146/353 (41%), Gaps = 65/353 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK ++  +  Q + V  T + +  L    K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++ + GL F H K +++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-GLFFLHSKGIIYR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+ +             G+PD           Y APE++ 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD-----------YIAPEII- 173

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             + YG  VD WA G +  E+L  +   +G  D D+L +       A P           
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPK---------- 222

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPL 299
                            S S +A+ +   + T  P  R+       +   EH +F     
Sbjct: 223 -----------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265

Query: 300 PT-EPNKLPRPATKRAS--KASDFNP--QEGPTVLSPPRKTRRVMPDREGFEG 347
              E  ++  P   +A    A +F+      P VL+PP +   +  D+  FEG
Sbjct: 266 EKLERKEVQPPYKPKACGRDAENFDKFFTRHPPVLTPPDQEVIMNLDQSEFEG 318

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 67/232 (28%), Positives = 99/232 (42%), Gaps = 38/232 (16%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
            L  K  D +   +V+G G +G V       + Q  A+K   K  + K+ +   F   R+
Sbjct: 37  KLRMKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQM 119
           I  +    S  I++L  AF     L++V E+M   DL  ++ N +I   P    + Y   
Sbjct: 96  I--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKWARFYTAE 150

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF---------GLAR---IFGSPDRR 167
            +  L   H    +HRD+KP+N+L+   G LKLADF         G+ R     G+PD  
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD-- 208

Query: 168 FTHQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGS 215
                    Y +PE+L    G   YG   D W+ G    E+L    PF   S
Sbjct: 209 ---------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 22/262 (8%)

Query: 51  KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSP 110
           K G   T L E  LL+ +  P +I + D         +V     +DL T +   +  L  
Sbjct: 97  KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI 156

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH 170
                  +  L+GL + H + ++HRD+K  N+ I    Q+ + D G A+ F      F  
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG 215

Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL----------NRRPFLQGSSDIDQ 220
                   APE+L   K Y +  D+W+AG +  E+L             P     S    
Sbjct: 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274

Query: 221 LGKIFAAFGTATPSQW---PDLAYLPDYVEYQYVAAPPLRSLFPSAS-----DDALDLLS 272
           L KI +      P ++   P    +  ++EY  +   P  + +P         D   L+ 
Sbjct: 275 LLKIISTLKV-HPEEFPRDPGSRLVRGFIEYASLERQP-YTRYPCFQRVNLPIDGEFLVH 332

Query: 273 KMFTYDPKARITAQQALEHRYF 294
           KM T+D   R +A++ L +  F
Sbjct: 333 KMLTFDAAMRPSAEEILNYPMF 354

Length = 357

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 16/207 (7%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTA-LREIKLLKELKS 70
           K +VLG G +G VYK +    G+     VAIK +R  ++         L E  ++  +  
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMASVDH 68

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           PH++ L+        + L+ + M    L   +RN    +    + ++     KG+++  +
Sbjct: 69  PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGA 186
           K ++HRD+   N+L+ +   +K+ DFGLA++    ++ +     +V  +W  A E +   
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESILHR 186

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
             Y    DVW+ G    EL+    +P+
Sbjct: 187 I-YTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 81/301 (26%), Positives = 124/301 (41%), Gaps = 40/301 (13%)

Query: 20  LGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           L  G+ G V+  + TK G    + V +K +  GK          REI +LK +    II 
Sbjct: 100 LTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPG-------REIDILKTISHRAIIN 150

Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
           LI A+  K  + +V    + DL T +  +   L      +  +  L+ LA+ H + ++HR
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGRGIIHR 209

Query: 136 DMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARW-----YRAPELLFGAKQY 189
           D+K  N+ +       L DFG A ++   PD   T Q +  W       +PELL     Y
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPD---TPQCYG-WSGTLETNSPELL-ALDPY 264

Query: 190 GAGVDVWAAGCIFAELL-NRRPFL--QGSSDIDQLGKIFAAFGTATPSQWP---DLAYLP 243
            A  D+W+AG +  E+          Q  S   QL  I        P ++P         
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQNGSTNLCK 323

Query: 244 DYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
            + +Y  V  PP      +R        D   L++KM T+D + R +AQ  L    F+  
Sbjct: 324 HFKQYAIVLRPPYTIPPVIRKYGMHM--DVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381

Query: 298 P 298
           P
Sbjct: 382 P 382

Length = 392

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 17/221 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIEL 76
           E +G+GTYG VYK  + K G   A+K +        V+     E  +L+ L + P++++ 
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKF 84

Query: 77  IDAFPHK-----GNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
              F        G L LV E       T+L   +      L  A I   +   L GL   
Sbjct: 85  YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H   ++HRD+K NN+L+ + G +KL DFG++    S   R    V   ++ APE++   +
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204

Query: 188 Q----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
           Q    Y A  DVW+ G    EL +  P L     +  L KI
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV+     +    VAIK I  G   E  +F  + E K++ +L  P +++L   
Sbjct: 12  LGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSEE-DF--IEEAKVMMKLSHPKLVQLYGV 67

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  L++V EFME   L   +R     LS   + S  Q   +G+ +  +   +HRD+ 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+ S G +K++DFG+ R     D  +T    A++   +  PE +F   +Y +  DV
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPE-VFNFSKYSSKSDV 184

Query: 196 WAAGCIFAELLN--RRPF 211
           W+ G +  E+    + PF
Sbjct: 185 WSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 70

Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 191 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 6/215 (2%)

Query: 17  REVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
            +VLG+G++G V+   K      GQ  A+K ++    K         E  +L E+  P I
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   +
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGI 119

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +   
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQS 178

Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
            D W+ G +  E+L      QG    + +  I  A
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 46/231 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGV-NFTALREIKLLKELKSPHII 74
           +V+G G +G V       TG   A+KK+R  +  +KE V +  A R+I  L E  +P ++
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWVV 64

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  +F  +  L+L+ E++   D+ T++   + F +  + + Y+  T+  +   HK   +
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF-TEEETRFYIAETILAIDSIHKLGYI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV--------------------- 172
           HRD+KP+NLL+ + G +KL+DFGL        R   +++                     
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183

Query: 173 -FARW----------------YRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               W                Y APE +F    Y    D W+ G I  E+L
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LKR   LGEG +G V    Y      TG+ VA+K ++       +     +EI++L+ 
Sbjct: 4   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRN 62

Query: 68  LKSPHIIELIDAFPHKGN--LHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTLKG 123
           L   +I++        G   + L+ EF+ +    E + RN N       +K  +Q+  KG
Sbjct: 63  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC-KG 121

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFARWY 177
           + +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +    +T +      VF  WY
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF--WY 179

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K Y A  DVW+ G    ELL
Sbjct: 180 -APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 39/286 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G+G++G V  A     G   A+K   K  + K+KE  +  A R + LLK LK P ++
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F     L+ V +++   +L   ++    FL P   + Y       + + H   ++
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFYAAEVASAIGYLHSLNII 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+ S G + L DFGL +    P+   +       Y APE+L   + Y   V
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL-RKEPYDRTV 177

Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D W  G +  E+L   P    S D+ Q+                          Y  +  
Sbjct: 178 DWWCLGAVLYEMLYGLPPFY-SRDVSQM--------------------------YDNILH 210

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYFS 295
            PL+ L    +  A DLL  +   D + R+ A     +   H +FS
Sbjct: 211 KPLQ-LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 75/290 (25%), Positives = 116/290 (40%), Gaps = 42/290 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIEL 76
           E +G+GTYG V+K ++ K G   A+K +        ++     E  +LK L   P++++ 
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 77  IDAFPHKG-----NLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
              +  K       L LV E       TDL          +    I   +   L GL   
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H    +HRD+K NN+L+ + G +KL DFG++    S   R    V   ++ APE++   +
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200

Query: 188 Q----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           Q    Y A  DVW+ G    EL +  P L     +  L KI        P   P   + P
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI--------PRNPPPTLHQP 252

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
           +                   S++  D + K  T D + R T    L+H +
Sbjct: 253 EL-----------------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 59/237 (24%), Positives = 115/237 (48%), Gaps = 16/237 (6%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           K++V+G G +G V++ I    G+    VAIK ++ G  +K+  +F  L E  ++ +    
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF--LSEASIMGQFSHH 66

Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +II L           ++ E+ME   L+  +R+ +   S   +   ++    G+ +    
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGA 186
             +HRD+   N+L+ S+ + K++DFGL+R+    P+  +T    ++  RW  APE +   
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW-TAPEAI-AY 184

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +++ +  DVW+ G +  E+++   RP+   S+  + +  I   F    P   P   Y
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-EVMKAINDGFRLPAPMDCPSAVY 240

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A K++   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNSQFVVN 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I N  N          Y    L GL   H++  +
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+  +G ++++D GLA      +     +V    Y APE+L   ++Y    
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVL-NNQRYTLSP 182

Query: 194 DVWAAGCIFAELLN-RRPF 211
           D W  GC+  E++  + PF
Sbjct: 183 DYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 40/289 (13%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A KK+   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVS 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I +             Y      GL   H++ ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+  HG ++++D GLA +     +    +V    Y APE++   ++Y    
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSP 182

Query: 194 DVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D WA GC+  E++  + PF Q    I +                 ++  L   V+ +Y  
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRKKKIKR----------------EEVERLVKEVQEEYSE 226

Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
                      S DA  L   +   DPK R+      A++  EH  F  
Sbjct: 227 ---------KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 11/190 (5%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV+     +    VAIK IR G   E  +F  + E K++ +L  P++++L   
Sbjct: 12  LGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSED-DF--IEEAKVMMKLSHPNLVQLYGV 67

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + +V E+M    L   +R     L    +        + + +      +HRD+ 
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G    +K++DFGLAR     D ++T     ++   +  PE+   ++ + +  DV
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDV 184

Query: 196 WAAGCIFAEL 205
           W+ G +  E+
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 19/200 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++GEG +G V +     TGQ VA+K I+     +      L E  ++ +L   +++ L+
Sbjct: 12  EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAF----LEETAVMTKLHHKNLVRLL 65

Query: 78  DAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKWVL 133
               H G L++V E M + +L   +R     L    +   +Q +L   +G+ +   K ++
Sbjct: 66  GVILHNG-LYIVMELMSKGNLVNFLRTRGRALVS--VIQLLQFSLDVAEGMEYLESKKLV 122

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+   N+L+   G  K++DFGLAR+          ++  +W  APE L   K++ +  
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKW-TAPEAL-KHKKFSSKS 178

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  E+ +  R P+
Sbjct: 179 DVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 15/194 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E+LG+G +G V+K    K    VA+K  +    +E +    L E ++LK+   P+I++LI
Sbjct: 1   ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLI 58

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  +++V E +   D  + +R     L    +  +      G+A+   K  +HRD
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118

Query: 137 MKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELL-FGAKQYG 190
           +   N L+G +  LK++DFG++R     I+ S   +   Q+  +W  APE L +G  +Y 
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK---QIPIKW-TAPEALNYG--RYS 172

Query: 191 AGVDVWAAGCIFAE 204
           +  DVW+ G +  E
Sbjct: 173 SESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 33/215 (15%)

Query: 18  EVLGEGTYGVVYKA-----IDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELK 69
           E LGEG +G VYK       +  +  +VAIK ++     K ++   F   +E +L+ +L+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFR--QEAELMSDLQ 66

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNI--------------FLSPADI 113
            P+I+ L+     +    ++FE++   DL E ++RN+                 L  +D 
Sbjct: 67  HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQV 172
                    G+ +      +HRD+   N L+G    +K++DFGL+R   S D  R   + 
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 173 F--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
               RW     +L+G  ++    D+W+ G +  E+
Sbjct: 187 LLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 26/213 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIE 75
           EV+G GTYG VYK    KTGQ  AIK + + + +E        EI +LK+  S H  I  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE---EIKLEINMLKKY-SHHRNIAT 77

Query: 76  LIDAF------PHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYM-QMTLKGL 124
              AF       H   L LV EF      TDL   ++NT       D  +Y+ +  L+GL
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL---VKNTKGNALKEDWIAYICREILRGL 134

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELL 183
           A  H   V+HRD+K  N+L+  + ++KL DFG+ A++  +  RR T  +   ++ APE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVI 193

Query: 184 FGAKQ----YGAGVDVWAAGCIFAELLNRRPFL 212
              +     Y    D+W+ G    E+    P L
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQK--EGVNFTALREIKLLKELKSPHII 74
           LG+G +G V       TG+  A KK+   RL K+K  EG    A+ E ++L ++ S  I+
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEG----AMVEKRILAKVHSRFIV 56

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLAFCHK 129
            L  AF  K +L LV   M   DL   I N +     F  P     Y    + GL   H+
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRAC-FYTAQIISGLEHLHQ 115

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + +++RD+KP N+L+ + G ++++D GLA        +         + APELL G ++Y
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174

Query: 190 GAGVDVWAAGCIFAELLNRR-PF 211
              VD +A G    E++  R PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 15/199 (7%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E   F  + E K++ +L    +++L   
Sbjct: 12  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED-EF--IEEAKVMMKLSHEKLVQLYGV 67

Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  +++V E+M    L   +R       P+ +    +   +G+A+   K  +HRD+ 
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127

Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPELLFGAKQYGAGVD 194
             N L+   G +K++DFGL+R     D  +T  V +    RW   PE+L  +K + +  D
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRW-SPPEVLLYSK-FSSKSD 183

Query: 195 VWAAGCIFAEL--LNRRPF 211
           VWA G +  E+  L + P+
Sbjct: 184 VWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIE 75
           +VLG+G++G V  A    T +  AIK ++     Q + V+ T   +  L    K P +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  K  L  V E++   DL   I+ +  F  P       ++TL  L F H+  V++
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHGVIY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ + G  KLADFG+ +             G+PD           Y APE+L
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD-----------YIAPEIL 168

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID 219
               +YG  VD WA G +  E++  +P  +  ++ D
Sbjct: 169 -QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 74/259 (28%), Positives = 111/259 (42%), Gaps = 51/259 (19%)

Query: 12  DRYLKREVLGEGTYGVVY------------KAIDTKTGQ--TVAIKKIRLGKQKEGVNFT 57
            +   +E LGEG +G V+            +      GQ   VA+K +R    K   N  
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-D 63

Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKS- 115
            L+EIK++  LK+P+II L+        L ++ E+ME  DL       N FLS  +I+S 
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-------NQFLSQREIEST 116

Query: 116 ----------------YMQMTL-KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
                           YM + +  G+ +      +HRD+   N L+G+H  +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 159 RIFGSPD--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAE---LLNRRPF- 211
           R   S D  R     V   RW     +L G  ++    DVWA G    E   L   +P+ 
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYS 234

Query: 212 -LQGSSDIDQLGKIFAAFG 229
            L     I+  G+ F   G
Sbjct: 235 LLSDEQVIENTGEFFRNQG 253

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLK 66
           A+ Y   +V+G G +G V + +  K+ Q V     + K  + K+ +   F   R+I    
Sbjct: 42  AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
              SP +++L  AF     L++V E+M   DL  ++ N ++    A  K Y    +  L 
Sbjct: 101 --NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLALD 156

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA------------RIFGSPDRRFTHQVF 173
             H   ++HRD+KP+N+L+  HG LKLADFG                 G+PD        
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD-------- 208

Query: 174 ARWYRAPELLF---GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGS 215
              Y +PE+L    G   YG   D W+ G  +F  L+   PF   S
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.1 bits (176), Expect = 2e-13
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 34/234 (14%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G V+     +T +    K I     KE      + E+ +++ELK  +I+  ID 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 80  FPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT---LKGLAFCHK---- 129
           F +K N  L+++ EF +  DL   I+         +  + + +T   L  LA+CH     
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 130 ---KWVLHRDMKPNNLLIGSH----GQL-------------KLADFGLARIFGSPDRRFT 169
              + VLHRD+KP N+ + +     G++             K+ DFGL++  G       
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI--ESMA 198

Query: 170 HQ-VFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
           H  V   +Y +PELL    K Y    D+WA GCI  EL + +     +++  QL
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKELKSPHII 74
            LGEG +G V KA   +         + +   KE  + + LR    E  LLK++  PH+I
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 75  ELIDAFPHKGNLHLVFEFME-TDLETVIR----------------NTNIFLSP------- 110
           +L  A    G L L+ E+ +   L + +R                N++   +P       
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD---RR 167
            D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     D   +R
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              ++  +W  A E LF    Y    DVW+ G +  E++
Sbjct: 187 SKGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++    +   +F   REI++LK
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILK 60

Query: 67  ELKSPHIIELIDAFPHKG--------NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM 117
            L+  +I++      +KG        NL LV E++    L   ++     L    +  Y 
Sbjct: 61  SLQHDNIVK------YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------ 171
               KG+ +   K  +HRD+   N+L+ S  ++K+ DFGL ++       +  +      
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
           +F  WY APE L  +K +    DVW+ G +  EL
Sbjct: 175 IF--WY-APESLTESK-FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 31/225 (13%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQ---TVAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+ +      G+    VAIK +      +E + F  L E  ++KE 
Sbjct: 10  LIRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF--LNEASVMKEF 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNT------NIFLSPADIKSYMQMTL 121
              H++ L+          +V E M + DL++ +R+       N  L P  ++ ++QM  
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 122 ---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGS----PDRRFTHQVF 173
               G+A+   K  +HRD+   N ++     +K+ DFG+ R I+ +       +    V 
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV- 185

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSS 216
            RW  APE L     +    DVW+ G +  E+  L  +P+ QG S
Sbjct: 186 -RWM-APESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPY-QGLS 226

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 73/269 (27%), Positives = 113/269 (42%), Gaps = 42/269 (15%)

Query: 12  DRYLKREVLGEGTYGVVYK--------------AIDTKTGQT--VAIKKIRLGKQKEGVN 55
            R   +E LGEG +G V+               ++D    Q   VA+K +R    K   N
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL----------ETVIRNT 104
              L+EIK++  LK P+II L+        L ++ E+ME  DL          E   +  
Sbjct: 65  -DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 105 NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
            + +S + +         G+ +      +HRD+   N L+G +  +K+ADFG++R   S 
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Query: 165 D--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---RRPFLQGSSD- 217
           D  R     V   RW     +L G  ++    DVWA G    E+L     +P+ Q S + 
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241

Query: 218 -IDQLGKIFAAFGTAT----PSQWPDLAY 241
            I+  G+ F   G       P+  PD  Y
Sbjct: 242 VIENTGEFFRDQGRQVYLPKPALCPDSLY 270

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.6 bits (167), Expect = 5e-13
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKS-PHIIE 75
           E++G GTYG VYK    KTGQ  AIK + + G ++E +     +EI +LK+     +I  
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK----QEINMLKKYSHHRNIAT 67

Query: 76  LIDAFPHKG------NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFC 127
              AF  K        L LV EF     +  +I+NT       +  +Y+ +  L+GL+  
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H+  V+HRD+K  N+L+  + ++KL DFG+ A++  +  RR T  +   ++ APE++   
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACD 186

Query: 187 KQ----YGAGVDVWAAGCIFAELLNRRPFL 212
           +     Y    D+W+ G    E+    P L
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 8/192 (4%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKE---LKSPHII 74
           +G+GT+G VY+     T +  A+K +  +    K+ V  T + E  +L      +SP I+
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHT-IGERNILVRTLLDESPFIV 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F    +L+LV ++M   +L   ++    F S    K Y+   +  L   HK  ++
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRF-SEDRAKFYIAELVLALEHLHKYDIV 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+ + G + L DFGL++   + ++          Y APE+L   K Y   V
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 194 DVWAAGCIFAEL 205
           D W+ G +  E+
Sbjct: 179 DFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 7/148 (4%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G+G +G V       TG+  A+K   K  + K+ +  +  A R++  L E  SP ++
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAESDSPWVV 64

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F     L+L+ EF+   DL T++   + F S    + YM   +  +   HK   +
Sbjct: 65  SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF-SEDVTRFYMAECVLAIEAVHKLGFI 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF 161
           HRD+KP+N+LI   G +KL+DFGL+  F
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 51/297 (17%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG G YG V+   K      G+  A+K ++    + K K   +    R++ L    + P
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV-LEAVRRCP 65

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF     LHL+ +++   +L T +     F + ++++ Y+   +  L   H+ 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF-TESEVRVYIAEIVLALDHLHQL 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQ- 188
            +++RD+K  N+L+ S G + L DFGL++ F + +    +       Y APE++ G    
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 189 YGAGVDVWAAGCIFAELLN-RRPF-LQG----SSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +   VD W+ G +  ELL    PF + G     S+I +  +I                  
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--RILK---------------- 226

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRYFSS 296
                    + PP        S +A D + K+   DPK R+    A +   H +F  
Sbjct: 227 ---------SKPPFPKTM---SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 91/353 (25%), Positives = 150/353 (42%), Gaps = 62/353 (17%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS----PHII 74
           VLG G +G V  A   KTG+  AIK ++ G         +L   K + E  +    P ++
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L   F  + ++  V E+    DL   I +T++F  P     Y    + GL + H+  ++
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPR-AVFYAACVVLGLQYLHENKIV 123

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARI---FGSPDRRF--THQVFARWYRAPELLFGAKQ 188
           +RD+K +NLL+ + G +K+ADFGL +    FG     F  T +     + APE+L     
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE-----FLAPEVLTE-TS 177

Query: 189 YGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           Y   VD W  G  I+  L+   PF  G    D   ++F +              + D V 
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPF-PG----DDEEEVFDSI-------------VNDEVR 219

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPTE 302
           Y        R L    S +A+ ++ ++   +P+ R+      A+   +  +F        
Sbjct: 220 YP-------RFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268

Query: 303 PNKLPR----PATKRASKASDFNP---QEGPTVLSPPRKTRRVMP-DREGFEG 347
             +  +    P  K     S+F+     E P VL+PPR+ R +   ++E F G
Sbjct: 269 LARKIKPPFVPTIKGPEDVSNFDEEFTSEAP-VLTPPREPRLLTEEEQELFRG 320

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 3/148 (2%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKS 70
           D +   +V+G G +G V       TG   A+K +R     E      +R E  +L E   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
             ++++  +F  K NL+L+ EF+   D+ T++   +  LS    + Y+  T+  +   H+
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQ 119

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL 157
              +HRD+KP+NLL+ + G +KL+DFGL
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 45/142 (31%), Positives = 77/142 (54%), Gaps = 3/142 (2%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIEL 76
           +V+G G +G V       TG   A+K +R     E      +R E  +L E  S  ++++
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
             +F  K NL+L+ EF+   D+ T++   +  L+  + + Y+  T+  +   H+   +HR
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 136 DMKPNNLLIGSHGQLKLADFGL 157
           D+KP+NLL+ S G +KL+DFGL
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 55/321 (17%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +V+G+G++G V  A     G+  A+K    KI L + KE  +  A R + LLK +K P +
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNV-LLKNVKHPFL 58

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L  +F     L+ V +F+   +L   ++    F  P   + Y       L + H   +
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR-ARFYAAEIASALGYLHSINI 117

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ-YGA 191
           ++RD+KP N+L+ S G + L DFGL +   +     T       Y APE++   KQ Y  
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQPYDN 175

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD W  G +  E+L   P                      P    D+A + D + ++  
Sbjct: 176 TVDWWCLGAVLYEMLYGLP----------------------PFYCRDVAEMYDNILHK-- 211

Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL----EHRYFSSAP-LPTEPNKL 306
              PL  L P AS  A  +L ++   D + R+ A++      EH +F S      E  K+
Sbjct: 212 ---PL-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267

Query: 307 PRPATKRASKASDFNPQ-EGP 326
           P P          FNP  EGP
Sbjct: 268 PPP----------FNPNVEGP 278

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 61/233 (26%), Positives = 115/233 (49%), Gaps = 19/233 (8%)

Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           L+ EV LG+G +G V+      T + VAIK ++ G          L+E +++K+L+   +
Sbjct: 8   LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKL 63

Query: 74  IELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++L  A   +  +++V E+M     L+ +      +L    +         G+A+  +  
Sbjct: 64  VQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGAK 187
            +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G  
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG-- 178

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           ++    DVW+ G +  EL    R P+  G  + + L ++   +    P + P+
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPE 230

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G+G++G V  A     G+  A+K   K  + K+KE  +  A R + LLK +K P ++ 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F     L+ V +++   +L   ++    F  P   + Y       L + H   +++
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA-RFYAAEIASALGYLHSLNIIY 119

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAG 192
           RD+KP N+L+ S G + L DFGL +     +   T   F     Y APE+L   + Y   
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRT 176

Query: 193 VDVWAAGCIFAELLNRRP 210
           VD W  G +  E+L   P
Sbjct: 177 VDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSPHI 73
           L+R+ LG G +G V++ +  K    VAIK +   K  + +      +E++ LK L+  H+
Sbjct: 10  LERK-LGSGYFGEVWEGL-WKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL--------KGLA 125
           I L         ++++ E ME        +   FL   + +     +L        +G+A
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKG------SLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI----FGSPDRRFTHQVFARWYRAPE 181
           +  ++  +HRD+   N+L+G     K+ADFGLAR+              ++  +W  APE
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS---DKKIPYKW-TAPE 174

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNR 208
                  +    DVW+ G +  E+   
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 43/289 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTA 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  AF     L  V E+    +L   +    +F +    + Y    +  L + H + V++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSRDVVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG  VD
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYGRAVD 177

Query: 195 VWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
            W  G +  E++  R PF   + D ++L                          ++ +  
Sbjct: 178 WWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FELILM 209

Query: 254 PPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
             +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 210 EEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQT----VAIKKI--RLGKQKEGVNFTALREIKL-LKEL 68
           K ++LG G +G V+K I    G +    VAIK I  R G+Q     F  + +  L +  L
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ----TFQEITDHMLAMGSL 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
              +I+ L+   P   +L LV +      L   +R     L P  + ++     KG+ + 
Sbjct: 67  DHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQVFARWYRAPELLF 184
            +  ++HR++   N+L+ S   +++ADFG+A +    D+++    H+   +W     +LF
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLN 207
           G  +Y    DVW+ G    E+++
Sbjct: 186 G--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 7/197 (3%)

Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G+G++G V  A    + K      ++K  + K+KE  +  + R + LLK +K P ++
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  +F     L+ V +++   +L   ++    FL P   + Y       L + H   ++
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASALGYLHSLNIV 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+ S G + L DFGL +     +   +       Y APE+L   + Y   V
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-KQPYDRTV 177

Query: 194 DVWAAGCIFAELLNRRP 210
           D W  G +  E+L   P
Sbjct: 178 DWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 5e-12
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)

Query: 15  LKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           LKRE LGEG +G V     Y     +    VA+K ++        +F   RE +LL  L+
Sbjct: 9   LKRE-LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQ 65

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR------------NTNIFLSPADIKSY 116
             HI++          L +VFE+M+  DL   +R            N    L+ + +   
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA 174
            Q    G+ +   +  +HRD+   N L+G +  +K+ DFG++R   S D  R   H +  
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 175 -RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSD 217
            RW     +++  +++    DVW+ G +  E+    ++P+ Q S++
Sbjct: 186 IRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 13/194 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G +G V+          VA+K  R     + +    L+E ++LK+   P+I+ LI
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 59

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                K  +++V E ++  D  T +R     L   ++   ++    G+ +   K  +HRD
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119

Query: 137 MKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELL-FGAKQYG 190
           +   N L+     LK++DFG++R     ++ S       Q+  +W  APE L +G  +Y 
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG--MKQIPVKW-TAPEALNYG--RYS 174

Query: 191 AGVDVWAAGCIFAE 204
           +  DVW+ G +  E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 89/375 (23%), Positives = 150/375 (40%), Gaps = 94/375 (25%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK----LLKELK 69
           ++K + LG G +G V  A    T    A+K +R   +K+ +N   +  +K    +L E  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR---KKDVLNRNQVAHVKAERDILAEAD 59

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSY--MQMTLKGLAF 126
           +  +++L  +F  K NL+ V +++   D+ +++    +F  P  +  +   ++TL  +  
Sbjct: 60  NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVF--PEVLARFYIAELTL-AIES 116

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFAR 175
            HK   +HRD+KP+N+LI   G +KL DFGL   F           GS  R+ + +    
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 176 W------------------------------------YRAPELLFGAKQYGAGVDVWAAG 199
           W                                    Y APE+L   K Y    D W+ G
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVG 235

Query: 200 CIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS 258
            I  E+L  + PFL  +    QL  I           W +  ++P  V+           
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVI----------NWENTLHIPPQVKL---------- 275

Query: 259 LFPSASDDALDLLSKM--FTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKRAS- 315
                S +A+DL++K+     +   R  A     H +FS     ++    P P   + S 
Sbjct: 276 -----SPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISH 330

Query: 316 --KASDFNP--QEGP 326
               S+F+P  +E P
Sbjct: 331 PMDTSNFDPVEEESP 345

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.3 bits (159), Expect = 6e-12
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G V +    +  K    VAIK ++ G  +K+  +F  L E  ++ +   P+I
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDF--LSEASIMGQFDHPNI 67

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ EFME   L++ +R  +   +   +   ++    G+ +  +   
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVFARWYRAPELLFGA 186
           +HRD+   N+L+ S+   K++DFGL+R     + D  +T     ++  RW  APE +   
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEAI-AY 185

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++ +  DVW+ G +  E+++   RP+
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 7e-12
 Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 47/290 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  +G+  A+K  K  +   K+ V  T L E ++LK  + P +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT-LTESRVLKNTRHPFLTS 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F  K  L  V E++   +L   +    +F S    + Y    +  L + H   +++
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVF-SEDRTRFYGAEIVSALDYLHSGKIVY 118

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAG 192
           RD+K  NL++   G +K+ DFGL +  G  D   T + F     Y APE+L     YG  
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGITDAA-TMKTFCGTPEYLAPEVL-EDNDYGRA 175

Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VD W  G +  E++  R PF     +     K+F            +L  + D       
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF------------ELILMEDIK----- 213

Query: 252 AAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFS 295
                   FP + S DA  LLS +   DP  R+      A++ + H +F+
Sbjct: 214 --------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 53/227 (23%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+G G+Y  V      KT +  A+K I+    KE VN     +I  ++  K  H+ E   
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIK----KELVNDD--EDIDWVQTEK--HVFETAS 53

Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK---------------G 123
             P    LH  F+  E+ L  VI     F+S  D+  +MQ   K                
Sbjct: 54  NHPFLVGLHSCFQ-TESRLFFVIE----FVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQV 172
           L F H++ +++RD+K +N+L+ + G +KL D+G+ +             G+P+       
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN------- 161

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPF-LQGSSD 217
               Y APE+L G + YG  VD WA G +  E++  R PF + G SD
Sbjct: 162 ----YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 18/200 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIKLLKELKSPH-- 72
            LG G +G V +A      ++ A+ K+ +   K   + +     + E+K++  L   H  
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL-GNHEN 100

Query: 73  IIELIDAFPHKGNLHLVFEF-METDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           I+ L+ A    G + ++ E+    DL   + R    FL+  D+ S+     KG+AF   K
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160

Query: 131 WVLHRDMKPNNLLIGSHGQL-KLADFGLARIFGSPDRRFTHQVFAR----WYRAPELLFG 185
             +HRD+   N+L+ +HG++ K+ DFGLAR   + D  +  +  AR    W  APE +F 
Sbjct: 161 NCIHRDLAARNVLL-THGKIVKICDFGLARDIMN-DSNYVVKGNARLPVKWM-APESIFN 217

Query: 186 AKQYGAGVDVWAAGCIFAEL 205
              Y    DVW+ G +  E+
Sbjct: 218 C-VYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 46/190 (24%), Positives = 90/190 (47%), Gaps = 7/190 (3%)

Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V K +    K+ +TVA+K ++       +    LRE  ++++L +P+I+ +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
                  +  LV E  E          N  ++  +I   +     G+ +  +   +HRD+
Sbjct: 63  -GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N+L+ +    K++DFGL++  G+ +  +  +   +W   + APE +   K + +  D
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSD 180

Query: 195 VWAAGCIFAE 204
           VW+ G +  E
Sbjct: 181 VWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.5 bits (159), Expect = 8e-12
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 26/269 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A+K ++  L    E +++    +    +    P ++ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWW 180

Query: 197 AAGCIFAELL-NRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           A G +  E++  R PF + GSSD               P Q  +     DY+ +Q +   
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSD--------------NPDQNTE-----DYL-FQVILEK 220

Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARI 283
            +R +  S S  A  +L      DPK R+
Sbjct: 221 QIR-IPRSLSVKAASVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 35/221 (15%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 37  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 96  IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 151

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA------------RIFGSPDRRF 168
           +  L   H    +HRD+KP+N+L+   G LKLADFG                 G+PD   
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--- 208

Query: 169 THQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELL 206
                   Y +PE+L    G   YG   D W+ G    E+L
Sbjct: 209 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGK-QKEGVNFTALREIKLLKEL-KS 70
           + LGEG +G V KA    +D      TVA+K ++    +K+  +   + E++++K + K 
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL--VSEMEMMKMIGKH 75

Query: 71  PHIIELIDAFPHKGNLHLVFEF---------------METDLETVI-RNTNIFLSPADIK 114
            +II L+     +G L++V E+                         R     L+  D+ 
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
           S+     +G+ F   K  +HRD+   N+L+     +K+ADFGLAR     D  R+ T+  
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 196 LPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 14/162 (8%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKS 70
           ++K + +G G +G V       T    A+K +R   +  + +  +  A R+I  L E  +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADN 60

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCH 128
             +++L  +F  K NL+ V +++   D+ +++    IF    D+ + Y+      +   H
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIF--EEDLARFYIAELTCAIESVH 118

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH 170
           K   +HRD+KP+N+LI   G +KL DFGL   F     R+TH
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTH 155

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 31/231 (13%)

Query: 9   KVADRYLKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LKRE LGEG +G V     Y    TK    VA+K ++        +F   RE +
Sbjct: 3   KRRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ--REAE 59

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR----NTNIFLSPADIKSYMQ 118
           LL  L+  HI++          L +VFE+M+  DL   +R    +  I +     ++  +
Sbjct: 60  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 119 MTLK-----------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           + L            G+ +   +  +HRD+   N L+G++  +K+ DFG++R   S D  
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 166 RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQ 213
           R   H +   RW     +++  +++    DVW+ G I  E+    ++P+ Q
Sbjct: 180 RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQ 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 12/200 (6%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           VLG+G +G V       TG+  A KK+   R+ K+K      AL E ++L+++ S  ++ 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--EAMALNEKRILEKVNSRFVVS 64

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           L  A+  K  L LV   M   DL+  I N  N          Y      GL    ++ ++
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVFARWYRAPELLFGAKQYGAG 192
           +RD+KP N+L+   G ++++D GLA     P+      +V    Y APE++   K Y   
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGRVGTVGYMAPEVINNEK-YTFS 181

Query: 193 VDVWAAGCIFAELLN-RRPF 211
            D W  GC+  E++  + PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 20  LGEGTYGVVYKAI-DTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V K +   +  Q  VAIK ++   +K  V    +RE +++ +L +P+I+ +I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                   L LV E      L   +      ++ +++   M     G+ +   K  +HRD
Sbjct: 62  -GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           +   N+L+ +    K++DFGL++  G+ D  +  +   +W   + APE +   K + +  
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRS 179

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G    E  +  ++P+
Sbjct: 180 DVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 28/262 (10%)

Query: 20  LGEGTYGVVYKAI-----DTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           LG+G++G+VY+ I       +    VAIK +      +E + F  L E  ++KE    H+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEFNCHHV 71

Query: 74  IELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT---LKG 123
           + L+          ++ E M   DL++ +R+       N   +P  +K  +QM      G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWYRAP 180
           +A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   RW    
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P   PD
Sbjct: 192 SLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEGGLLDKPDNCPD 248

Query: 239 LAYLPDYVEYQYVAAPPLRSLF 260
           + +    + +QY   P +R  F
Sbjct: 249 MLFELMRMCWQY--NPKMRPSF 268

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 46/256 (17%)

Query: 13  RYLKREVLGEGTYGVVYKA--------------IDTKTGQT--VAIKKIRLGKQKEGVNF 56
             L +E LGEG +G V+                 + + G+   VA+K +R    K   N 
Sbjct: 6   HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN- 64

Query: 57  TALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET----------DLETVIRNTNI 106
             L+E+K+L  LK P+II L+     +  L ++ E+ME            L+    N N 
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 107 FLSPA------DIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL 157
            + PA         S + + L+   G+ +      +HRD+   N L+G +  +K+ADFG+
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 158 ARIFGSPD--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELL---NRRPF 211
           +R   + D  R     V   RW     +L G  ++    DVWA G    E+L     +P+
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 212 LQGSSD--IDQLGKIF 225
            + + +  I+  G+ F
Sbjct: 243 GELTDEQVIENAGEFF 258

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 10/198 (5%)

Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELK-SP 71
           +VLG G YG V+   K     +G+  A+K ++     QK         E ++L+ ++ SP
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF     LHL+ +++   +L T +     F    +++ Y    +  L   HK 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-KEQEVQIYSGEIVLALEHLHKL 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQ- 188
            +++RD+K  N+L+ S+G + L DFGL++ F   +    +       Y AP+++ G    
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 189 YGAGVDVWAAGCIFAELL 206
           +   VD W+ G +  ELL
Sbjct: 185 HDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 26/271 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      K  Q  A+K ++  L    E +++    +    +   +P ++ L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F     L LV E++              L     + Y       L F H++ +++RD
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ + G +KL D+G+ +    P    +       Y APE+L G ++YG  VD W
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWW 180

Query: 197 AAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           A G +  E++  R PF     DI               +  PD+    DY+ +Q +   P
Sbjct: 181 ALGVLMFEMMAGRSPF-----DI--------------ITDNPDMN-TEDYL-FQVILEKP 219

Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
           +R +    S  A  +L      DPK R+  Q
Sbjct: 220 IR-IPRFLSVKASHVLKGFLNKDPKERLGCQ 249

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 24/238 (10%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           L R+ LG G +G V++ +   T   VA+K ++ G      +F  L E +++K+L+ P +I
Sbjct: 10  LLRK-LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPK-DF--LAEAQIMKKLRHPKLI 64

Query: 75  ELIDAFPHKGNLHLVFEFM--ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           +L      +  +++V E M   + LE +       L    +         G+A+   +  
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL----FG 185
           +HRD+   N+L+G +   K+ADFGLAR+       +  +  A++   + APE      F 
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAALYNRFS 182

Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            K      DVW+ G +  E++   R P+  G ++ + L ++   +    P   P   Y
Sbjct: 183 IKS-----DVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGYRMPCPPGCPKELY 234

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)

Query: 15  LKR-EVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG--VNFTALREIKLLKELKS 70
           LKR +VLG G +G VYK I    G+TV I   I++  +  G   N   + E  ++  +  
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           PH++ L+        + LV + M     L+ V  + +   S   +   +Q+  KG+ +  
Sbjct: 69  PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA-KGMMYLE 126

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFG 185
           ++ ++HRD+   N+L+ S   +K+ DFGLAR+    ++ +     ++  +W     + + 
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY- 185

Query: 186 AKQYGAGVDVWAAGCIFAELL 206
            +++    DVW+ G    EL+
Sbjct: 186 -RKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 39/143 (27%), Positives = 76/143 (53%), Gaps = 9/143 (6%)

Query: 23  GTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL----LKELKSPHIIELID 78
           G +G VY        +  A+K +   K+ + +N   + +++     L   KSP I+ L  
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVV---KKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           +     N++LV E++   D+++++     F     +K   ++ L  L + H+  ++HRD+
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL-ALDYLHRHGIIHRDL 130

Query: 138 KPNNLLIGSHGQLKLADFGLARI 160
           KP+N+LI + G +KL DFGL+++
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 15/202 (7%)

Query: 18  EVLGEGTYGVVYKA--IDT-KTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
            V+G+G +G VY    ID+       A+K + R+   +E   F  L+E  ++K+   P++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF--LKEGIIMKDFSHPNV 58

Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+    P +G+  +V  +M+  DL   IR+     +  D+  +     KG+ +   K 
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      + S       ++  +W  A E L   
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM-ALESL-QT 176

Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+GEG +G V +A+  K G     AIK ++    + +  +F    E+ L K    P+II
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66

Query: 75  ELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYMQ 118
            L+ A  ++G L++  E+               +ETD      + T   L+   +  +  
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
               G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW  
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
              L +    Y    DVW+ G +  E+++
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 15/204 (7%)

Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHII 74
           V+G G +G V      +  K    VAIK ++ G  +K+  +F  L E  ++ +   P+II
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF--LSEASIMGQFDHPNII 68

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L         + +V E+ME   L+  +R  +   +   +   ++    G+ +      +
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQY 189
           HRD+   N+L+ S+   K++DFGL+R+    P+  +T    ++  RW  APE +   +++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAI-AYRKF 186

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW+ G +  E+++   RP+
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 12/199 (6%)

Query: 16  KREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK I    G+     VAIK +R     +  N   L E  ++  + SP
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSP 69

Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++  L+        + LV + M    L   +R     +   D+ ++     KG+++  + 
Sbjct: 70  YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGAK 187
            ++HRD+   N+L+ S   +K+ DFGLAR+    +  +     +V  +W     +L   +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL--HR 186

Query: 188 QYGAGVDVWAAGCIFAELL 206
           ++    DVW+ G    EL+
Sbjct: 187 RFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 15/189 (7%)

Query: 20  LGEGTYGVVYKAI-DTKTGQ--TVAIKKIRLGKQKEGVNFTA--LREIKLLKELKSPHII 74
           LG G +G V K +   K+G+   VA+K +   KQ+         LRE  ++ +L  P I+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL---KQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 75  ELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            LI     +  L LV E      L   ++        +D+K        G+A+   K  +
Sbjct: 60  RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKHFV 117

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYG 190
           HRD+   N+L+ +  Q K++DFG++R  G+    +      RW   + APE +   K + 
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FS 176

Query: 191 AGVDVWAAG 199
           +  DVW+ G
Sbjct: 177 SKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +G V+          VAIK ++ G          L E  L+K+L+ P ++ L 
Sbjct: 12  KKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLVRL- 66

Query: 78  DAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
            A   +  ++++ E+ME    ++ +     I L+   +        +G+AF  +K  +HR
Sbjct: 67  YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGA- 191
           D++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A  YG  
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----AINYGTF 180

Query: 192 --GVDVWAAGCIFAELLN--RRPF 211
               DVW+ G +  E++   R P+
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 14/193 (7%)

Query: 20  LGEGTYG-VVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           LG G++G V+      +    VAIK   K ++ KQK+  +     E K+L  +  P  + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH--VFSERKILNYINHPFCVN 95

Query: 76  LIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKS-YMQMTLKGLAFCHKKWVL 133
           L  +F  +  L+LV EF +  +  T +R    F  P D+   Y    +    +     ++
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF--PNDVGCFYAAQIVLIFEYLQSLNIV 153

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP NLL+   G +K+ DFG A++    D R         Y APE+L     +G   
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVG-HGKAA 209

Query: 194 DVWAAGCIFAELL 206
           D W  G    E+L
Sbjct: 210 DWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 45/205 (21%), Positives = 80/205 (39%), Gaps = 36/205 (17%)

Query: 26  GVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKSPHIIELIDAFPHKG 84
            +V+ A    T   VA+KKI L    +  +   L +EI   ++L+ P+I+  + +F    
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72

Query: 85  NLHLVFEFME----TDL----------ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            L++V   M      DL          E  I               ++  L  L + H K
Sbjct: 73  ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFI------------LKDVLNALDYIHSK 120

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT-------HQVFARWYRAPELL 183
             +HR +K +++L+   G++ L+    +       +R           V    + +PE+L
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 184 FGAKQ-YGAGVDVWAAGCIFAELLN 207
               Q Y    D+++ G    EL N
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELAN 205

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 20  LGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +G+G +G V++A     +  +    VA+K ++     + +     RE  L+ E   P+I+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDHPNIV 71

Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF----------------LSPADIKSYM 117
           +L+        + L+FE+M   DL   +R+ +                  L+P  +    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 118 QMTLK-----GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
           Q+ +      G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   S D     + 
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 173 FA---RWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
            A   RW   PE +F  + Y    DVWA G +  E+
Sbjct: 192 DAIPIRWM-PPESIFYNR-YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 64/300 (21%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           ++LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTA 59

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVL 133
           L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +K V+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSEKNVV 118

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPEL 182
           +RD+K  NL++   G +K+ DFGL +             G+P+           Y APE+
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------YLAPEV 167

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     YG  VD W  G +  E++  R PF     +     K+F                
Sbjct: 168 L-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF---------------- 205

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
             + +  + +  P  R+L P A      LLS +   DPK R+      A++ ++H++F+ 
Sbjct: 206 --ELILMEEIRFP--RTLSPEAK----SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 16/171 (9%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK---QKEGVNFTALREIKLLKELKS 70
           ++K + LG G +G V  A    T    A+K +R      + +  +  A R+I  L E  +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI--LAEADN 60

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCH 128
             ++ L  +F  K NL+ V +++   D+ +++    IF  P D+ + Y+      +   H
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIF--PEDLARFYIAELTCAVESVH 118

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           K   +HRD+KP+N+LI   G +KL DFGL   F     R+TH   +++Y++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD--SKYYQS 162

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 38/204 (18%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL--- 76
           LG G +G V+      T + VA+K ++ G       F  L+E +++K+L+   +++L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPE-AF--LQEAQIMKKLRHDKLVQLYAV 69

Query: 77  ---------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
                    +  +  KG+L    +F+++     +R   +    A I         G+A+ 
Sbjct: 70  CSEEEPIYIVTEYMSKGSL---LDFLKSGEGKKLRLPQLVDMAAQIAE-------GMAYL 119

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLF 184
             +  +HRD+   N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE   
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPE--- 174

Query: 185 GAKQYGA---GVDVWAAGCIFAEL 205
            A  YG      DVW+ G +  E+
Sbjct: 175 -AANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 26/209 (12%)

Query: 20  LGEGTYGVVYK--AID---TKTG-QTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           LG G +G VY+  A D     +G   VA+K +R G   +E   F  L+E  L+     P+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF--LKEAHLMSNFNHPN 60

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI--FLSPA-DIKSYMQMTL---KGLA 125
           I++L+         +++ E ME  DL + +R+  +  F  P   +K  + + L   KG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGSPD---RRFTHQVFARWY 177
           +  +   +HRD+   N L+   G      +K+ DFGLAR     D   +     +  RW 
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L   K +    DVW+ G +  E+L
Sbjct: 181 -APESLLDGK-FTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+II
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59

Query: 75  ELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF---------------LSPADIKSYMQ 118
            L+ A  H+G L+L  E+    +L   +R + +                LS   +  +  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
              +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW  
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
              L +    Y    DVW+ G +  E+++
Sbjct: 180 IESLNYSV--YTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ +V LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 8   LRLDVKLGQGCFGEVW--MGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDK 62

Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L  A   +  +++V EFM     L+ +      +L    +         G+A+  + 
Sbjct: 63  LVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 178

Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
            ++    DVW+ G +  EL+ +
Sbjct: 179 -RFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 17/196 (8%)

Query: 20  LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG G +G V+    T  G T VA+K ++ G        + L E +++K+L+   +++L  
Sbjct: 14  LGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLVQLY- 67

Query: 79  AFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   +  +++V E+M     L+ +       L   ++         G+A+  +   +HRD
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 127

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGAKQYGAG 192
           ++  N+L+G     K+ADFGLAR+    D  +T +  A++   + APE  L+G  ++   
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG--RFTIK 183

Query: 193 VDVWAAGCIFAELLNR 208
            DVW+ G +  EL+ +
Sbjct: 184 SDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 21/198 (10%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
                +G+G +G V        GQ VA+K ++         F  L E  ++  L+ P+++
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKCLK-DDSTAAQAF--LAEASVMTTLRHPNLV 63

Query: 75  ELIDAFPHKGNLHLVFEFMETD-----LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           +L+        L++V E+M        L +  R        A    +     +G+ +  +
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL---AQQLGFALDVCEGMEYLEE 120

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV--FARWYRAPELLFGAK 187
           K  +HRD+   N+L+      K++DFGLA+     +             + APE L   K
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REK 174

Query: 188 QYGAGVDVWAAGCIFAEL 205
           ++    DVW+ G +  E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 35/228 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       TGQ  A+K   K  + K+ E   F   R++  L       I 
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWIT 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + NL+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFG-LARI-----------FGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG   R+            G+PD           Y +PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD-----------YISPE 173

Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKI 224
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V         +  A+K   K  + K+ E   F   R++  L    +  I 
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWIT 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + NL+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 134 HRDMKPNNLLIGSHGQLKLADFG------------LARIFGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG             +   G+PD           Y +PE
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-----------YISPE 173

Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 23/203 (11%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+ A   K  + VA+K ++ G          L E  ++K L+   +++L  A
Sbjct: 14  LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKL-HA 68

Query: 80  FPHKGNLHLVFEFMET-DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              K  ++++ EFM    L   +++   +    P  I    Q+  +G+AF  ++  +HRD
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA-EGMAFIEQRNYIHRD 127

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           ++  N+L+ +    K+ADFGLAR+    D  +T +  A++   + APE    A  +G+  
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE----AINFGSFT 181

Query: 194 ---DVWAAGCIFAELLN--RRPF 211
              DVW+ G +  E++   R P+
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 30/233 (12%)

Query: 9   KVADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           K  D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +
Sbjct: 3   KRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAE 59

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNI---FLSPADIKSYMQM 119
           LL  L+  HI+           L +VFE+M   DL   +R+       L+  +  +  Q+
Sbjct: 60  LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119

Query: 120 TL-----------KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR 167
           TL            G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 168 FTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
              +     RW     +L+  +++    D+W+ G +  E+    ++P+ Q S+
Sbjct: 180 VGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + K +VLG G +G VYK +    G+     VAIK++R     +  N   L E  ++  + 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVD 67

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +PH+  L+        + L+ + M     L+ V  + +   S   +   +Q+  KG+ + 
Sbjct: 68  NPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA-KGMNYL 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLF 184
            ++ ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +     +V  +W     +L 
Sbjct: 126 EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL- 184

Query: 185 GAKQYGAGVDVWAAGCIFAELL 206
             + Y    DVW+ G    EL+
Sbjct: 185 -HRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 67/257 (26%), Positives = 98/257 (38%), Gaps = 54/257 (21%)

Query: 17  REVLGEGTYGVVY-------KAIDTKTGQT---------VAIKKIRLGKQKEGVN-FTAL 59
            E LGEG +G V+       +    K             VA+K +R          F  L
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF--L 67

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLS--------- 109
           +E+K+L  L  P+I  L+        L ++ E+ME  DL       N FL          
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-------NQFLQKHVAETSGL 120

Query: 110 PADIKSYMQMTLK--------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF 161
             + KS    TL         G+ +      +HRD+   N L+G +  +K+ADFG++R  
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 162 GSPD--RRFTHQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---RRPFLQGS 215
            S D  R         RW  A E +   K +    DVWA G    E+L     +P+   +
Sbjct: 181 YSSDYYRVQGRAPLPIRWM-AWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 216 SD--IDQLGKIFAAFGT 230
               I+  G  F   G 
Sbjct: 239 DQQVIENAGHFFRDDGR 255

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 16/220 (7%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +K+ A +Y    VLG G  G V  A     G+  A+K + +    E     A  E+  L 
Sbjct: 27  AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL 86

Query: 67  ELKSPHIIELIDAFPHKGN--------LHLVFEFMET-DLETVIRN---TNIFLSPADIK 114
                 I++  + F  K          + LV ++    DL   I++   TN      +  
Sbjct: 87  NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF- 173
                 L  +   H K ++HRD+K  N+L+ S+G +KL DFG ++++ +       + F 
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 174 -ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPF 211
              +Y APE ++  K Y    D+++ G +  ELL  +RPF
Sbjct: 207 GTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 15  LKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIKLL 65
           LKRE LGEG +G V+             + VA+K +     KE  +  A     RE +LL
Sbjct: 9   LKRE-LGEGAFGKVFLGECYHLEPENDKELVAVKTL-----KETASNDARKDFEREAELL 62

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR----NTNIFLSPAD------IK 114
              +  +I++            +VFE+ME  DL   +R    +     SP        + 
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 115 SYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFT 169
             +Q+ ++   G+ +   +  +HRD+   N L+G    +K+ DFG++R   + D  R   
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182

Query: 170 HQVFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGS 215
           H +   RW     +++   ++    DVW+ G +  E+    ++P+   S
Sbjct: 183 HTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 48/215 (22%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 18  EVLGEGTYGVVYKA----IDTKTGQTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPH 72
           E LGE  +G +YK           Q VAIK ++ +   ++   F   +E  L+ EL  P+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ--QEASLMAELHHPN 68

Query: 73  IIELIDAFPHKGNLHLVFEFM-ETDLET--VIRNTN-----------IFLSPADIKSYMQ 118
           I+ L+     +  + ++FE++ + DL    ++R+ +              S  D   ++ 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 119 MTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVF- 173
           + ++   G+ +    + +H+D+   N+LIG    +K++D GL+R I+ +   R   +   
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 174 -ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             RW     +++G  ++ +  D+W+ G +  E+ +
Sbjct: 189 PIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 26/223 (11%)

Query: 18  EVLGEGTYGVVYKAI-DTKTGQT--VAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHI 73
           + LG+G++GVV +    T  G+   VA+K ++  K  + + +F  L+E  ++  L   ++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF--LKEAAIMHSLDHENL 58

Query: 74  IEL---IDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           I L   +   P    L +V E     + L+ + ++       + +  Y      G+ +  
Sbjct: 59  IRLYGVVLTHP----LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV-----FARWYRAPELL 183
            K  +HRD+   N+L+ S  ++K+ DFGL R     +  +  +      FA W  APE L
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WC-APESL 172

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKI 224
              + +    DVW  G    E+      P+  G S    L KI
Sbjct: 173 -RTRTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 81

Query: 72  HIIELIDAFPHKGNLHLVFEF-----------------METDLETVIRNTNIFLSPADIK 114
           +II L+ A    G L+++ E+                 ME   + + R  +  ++  D+ 
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-IARVPDEQMTFKDLV 140

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
           S      +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+  
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 201 LPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 54/241 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           RY    ++G+G  G VY A D    + VA+KKIR    +   +    LRE K+  +L  P
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLK----- 122
            I+ +         ++    ++E   L++++++             K+ +   L      
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 123 --GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA---------------------- 158
              + + H K VLHRD+KP+N+L+G  G++ + D+G A                      
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 159 -------RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRP 210
                  +I G+PD           Y APE L G        D++A G I  ++L    P
Sbjct: 183 SSMTIPGKIVGTPD-----------YMAPERLLGVPA-SESTDIYALGVILYQMLTLSFP 230

Query: 211 F 211
           +
Sbjct: 231 Y 231

Length = 932

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 21/232 (9%)

Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+      + + VA+K ++ G          L E  L+K L+   ++ L   
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLVRLYAV 69

Query: 80  FPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              +  ++++ E+M      D         + L P  I    Q+  +G+A+  +K  +HR
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIA-EGMAYIERKNYIHR 127

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGA 191
           D++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE + FG+  +  
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGS--FTI 183

Query: 192 GVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             DVW+ G +  E++   + P+  G S+ D +  +   +        PD  Y
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGYRMPRMENCPDELY 234

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 64/290 (22%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHI 73
             +GEG +G VY+ +          VA+K  +          F  L+E  ++++   PHI
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF--LQEAYIMRQFDHPHI 69

Query: 74  IELIDA-----------FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++LI                 G L     +++ +  +        L  A +  Y      
Sbjct: 70  VKLIGVITENPVWIVMELAPLGELR---SYLQVNKYS--------LDLASLILYSYQLST 118

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA---RWYRA 179
            LA+   K  +HRD+   N+L+ S   +KL DFGL+R     +  +         +W  A
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWM-A 176

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           PE +   +++ +  DVW  G    E+L    +PF QG  + D +G+I        P   P
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPF-QGVKNNDVIGRIENGERLPMPPNCP 234

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                           P L S           L++K + YDP  R    +
Sbjct: 235 ----------------PTLYS-----------LMTKCWAYDPSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       T +  A+K   K  + K+ E   F   R +  L       I 
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWIT 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWV 132
            L  AF  +  L+LV ++ +  DL T++      L P D+ + Y+   +  +   H+   
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYIAEMVLAIHSIHQLHY 123

Query: 133 LHRDMKPNNLLIGSHGQLKLADFG------------LARIFGSPDRRFTHQVFARWYRAP 180
           +HRD+KP+N+L+  +G ++LADFG             +   G+PD           Y +P
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD-----------YISP 172

Query: 181 ELLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKI 224
           E+L     G  +YG   D W+ G C++  L    PF    S ++  GKI
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKI 220

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKA----IDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G V  A    +D +       VA+K ++    ++ ++   + E+++
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 76

Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   +R                    
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196

Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 197 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)

Query: 12  DRYLKREVLGEGTYGVVYKAI--DTKTG--QTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           DR    ++L EGT+G ++  I  D K G  + V +K ++    +  V    L+E  LL  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL-LQESCLLYG 64

Query: 68  LKSPHI-------IELID------AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK 114
           L   +I       IE  +       + + GNL L   F+         N    LS   + 
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKL---FL-QQCRLGEANNPQALSTQQLV 120

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IF-------GSPDR 166
                   G+++ HK+ V+H+D+   N +I    Q+K+ D  L+R +F       G  + 
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDID 219
           R       +W  A E L   K+Y +  DVW+ G +  EL  L + P++    +ID
Sbjct: 181 RPV-----KWM-ALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV----EID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 3/156 (1%)

Query: 51  KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSP 110
           K G   +++ E +LL+ L  P ++ L+D     G   LV     +DL T +      L  
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGL 259

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFT 169
           A + +  +  L  + + H + ++HRD+K  N+L+     + L DFG A    GS    F 
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319

Query: 170 HQVFARW-YRAPELLFGAKQYGAGVDVWAAGCIFAE 204
           + +       APE+L G   Y   VD+W+AG +  E
Sbjct: 320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 77/342 (22%), Positives = 123/342 (35%), Gaps = 77/342 (22%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           ++LG+G  G V+      TG+  A+K   K  + K+ +       +EI  L  L  P + 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLP 64

Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVI--RNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
            L  +F  +  L LV ++    +L  ++  +      S    + Y    L  L + H   
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCL-SEEVARFYAAEVLLALEYLHLLG 123

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGL-------------ARIFGSPDRRFTHQVFARW-- 176
           +++RD+KP N+L+   G + L+DF L             A   GS            +  
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 177 --------------YRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQL 221
                         Y APE++ G   +G+ VD W  G +  E+L    PF +GS+  +  
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF-KGSNRDETF 241

Query: 222 GKIFAAFGTAT-PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPK 280
             I       T P   P                          S  A DL+ K+   DP 
Sbjct: 242 SNILK--KEVTFPGSPPV-------------------------SSSARDLIRKLLVKDPS 274

Query: 281 ARI----TAQQALEHRYFSSAPLP----TEPNKLPRPATKRA 314
            R+     A +  +H +F          T P  +PRP     
Sbjct: 275 KRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDDGID 316

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 25/223 (11%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+    D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 10  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 67  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSD 217
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+
Sbjct: 187 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSN 227

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 20/208 (9%)

Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +LG+G +G V +A    +  + Q VA+K ++            LRE   +KE   P++I+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 76  LIDAFPH---KGNL---HLVFEFME-TDLETVIRNTNIFLSPADIK-----SYMQMTLKG 123
           LI        KG L    ++  FM+  DL T +  + I   P  +       +M     G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD---RRFTHQVFARWYRAP 180
           + +   K  +HRD+   N ++  +  + +ADFGL++   S D   +    ++  +W    
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNR 208
            L      Y    DVWA G    E++ R
Sbjct: 186 SL--ADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 107 FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD 165
            L+  D+  Y     KG+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+  PD
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 234

Query: 166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
             R+   ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 235 YVRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 5/102 (4%)

Query: 107 FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD 165
            L+  D+ SY     +G+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+  PD
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 228

Query: 166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
             R+   ++  +W  APE +F  K Y    DVW+ G +  E+
Sbjct: 229 YVRKGDARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 20  LGEGTYGVVYKA----ID---TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID        TVA+K ++     + ++   + E++++K + K  
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHK 78

Query: 72  HIIELIDAFPHKGNLHLVFEF-----------------METDLETVIRNTNIFLSPADIK 114
           +II L+ A    G L+++ E+                 M+   +T  +     L+  D+ 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC-KLPEEQLTFKDLV 137

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
           S      +G+ +   +  +HRD+   N+L+     +K+ADFGLAR   + D  ++ T+  
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
               + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 198 LPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 5/103 (4%)

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD- 165
           L+  D+  Y     +G+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+  PD 
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230

Query: 166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            R+ + ++  +W  APE +F  K Y    DVW+ G +  E+ +
Sbjct: 231 VRKGSARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKSPH 72
           ++LGEG +G V +     D  +   VA+K ++L      E   F  L E   +K+   P+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF--LSEAACMKDFDHPN 62

Query: 73  IIELIDAFPHKGNLH------LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK--- 122
           +++LI       +L       ++  FM+  DL + +  + +   P  +   +Q  LK   
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP--LQTLLKFMV 120

Query: 123 ----GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTH--QVFAR 175
               G+ +   +  +HRD+   N ++     + +ADFGL++   S D  R     ++  +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
           W  A E L   + Y +  DVWA G    E+  R
Sbjct: 181 WI-AIESL-ADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 17/195 (8%)

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-V 172
           ++ M+  L  + + H K ++HRD+K  N+ +   G++ L DFG A  F      F +  V
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR--PFLQGSSDI-DQLGKIFAAFG 229
                 +PE+L G   Y    D+W+ G I  ++L+    P   G      QL KI  +  
Sbjct: 330 GTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL- 387

Query: 230 TATPSQWPD-----LAYLPDYVEYQYV--AAPPL-RSLFPSASDDALDLLSKMFTYDPKA 281
           +    ++PD       Y+ D  E  +   + PPL R+L   A  D    L KM T+D   
Sbjct: 388 SVCDEEFPDPPCKLFDYI-DSAEIDHAGHSVPPLIRNLGLPA--DFEYPLVKMLTFDWHL 444

Query: 282 RITAQQALEHRYFSS 296
           R  A + L    FS+
Sbjct: 445 RPGAAELLALPLFSA 459

Length = 501

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 18  EVLGEGTYGVVYKA--IDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           E LGE  +G VYK     T  G   Q VAIK ++  K +  +      E  +   L+ P+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 73  IIELIDAFPHKGNLHLVF---------EFM----------ETDLETVIRNTNIFLSPADI 113
           I+ L+     +  L ++F         EF+           TD +  +++T   L PAD 
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST---LEPADF 126

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQ 171
              +     G+ F     V+H+D+   N+L+     +K++D GL R   + D  +   + 
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186

Query: 172 VFA-RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +   RW     +++G  ++    D+W+ G +  E+ +
Sbjct: 187 LLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 30/222 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKA----IDTKTGQ---TVAIKKIR-LGKQKEGVNFTALREIK 63
           DR +  + LGEG +G V +A    ID        TVA+K ++     K+  +  +  E++
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS--EME 69

Query: 64  LLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET----------------DLETVIRNTNI 106
           L+K + K  +II L+     +G L+++ E+                       + +    
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 107 FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD- 165
            LS  D+ S      +G+ +   +  +HRD+   N+L+     +K+ADFGLAR     D 
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189

Query: 166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            ++ ++      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 190 YKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 34/167 (20%)

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFG 185
           H + ++HRD+K  N+ +   G +KL DFG ++ +           F    +Y APE L+ 
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWE 244

Query: 186 AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            K+Y    D+W+ G I  ELL   RPF +G S  + + ++   +G   P           
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVL--YGKYDP----------- 290

Query: 245 YVEYQYVAAPPLRSLFPSASDDALD-LLSKMFTYDPKARITAQQALE 290
                          FP      +  LL  + + +P  R T QQ L 
Sbjct: 291 ---------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 35/216 (16%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT--VAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + LGEG +G V +    +      VA+K  KI +  + E  +F  L E   +KE   P++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF--LSEAVCMKEFDHPNV 62

Query: 74  IELI---------DAFP---------HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
           + LI         + +P           G+LH    F+   L + + +   +L    +  
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLH---SFL---LYSRLGDCPQYLPTQMLVK 116

Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF-- 173
           +M     G+ +   K  +HRD+   N ++  +  + +ADFGL++   + D     ++   
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 174 -ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
             +W     L    + Y    DVW+ G    E+  R
Sbjct: 177 PVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 22/46 (47%), Positives = 30/46 (65%)

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
           IK  M+  L GL   H+  ++HRD+KP NLL+   GQ+K+ DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 58/242 (23%), Positives = 96/242 (39%), Gaps = 25/242 (10%)

Query: 20  LGEGTYGVVYKA-IDTKTGQT-VAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIEL 76
           +G G +G V          +  V +K++R      E + F  L+E++  +EL  P++++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLF--LQEVQPYRELNHPNVLQC 60

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM----TLKGLAFCHKKW 131
           +          LV EF    DL+  +R+    ++    K  +Q        GL + H+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL------ 182
            +H D+   N  + +   +K+ D+GLA      D   T   H V  RW  APEL      
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQ 179

Query: 183 -LFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
            L    Q     ++W+ G    EL     +P+    SD   L ++        P    DL
Sbjct: 180 DLLPKDQTKKS-NIWSLGVTMWELFTAADQPYPD-LSDEQVLKQVVREQDIKLPKPQLDL 237

Query: 240 AY 241
            Y
Sbjct: 238 KY 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 13/130 (10%)

Query: 92  FMETDLETVI-RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL 150
           +++ D+ + I     + L   D+ S+     KG++F   K  +HRD+   N+L+ +HG++
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL-THGRI 252

Query: 151 -KLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            K+ DFGLAR   + D  +  +  AR    + APE +F    Y    DVW+ G +  E+ 
Sbjct: 253 TKICDFGLARDIRN-DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEI- 309

Query: 207 NRRPFLQGSS 216
               F  GSS
Sbjct: 310 ----FSLGSS 315

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G +G V   +    G  VA+K I+     +   F A  E  ++ +L+  ++++L+
Sbjct: 12  QTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQA--FLA--EASVMTQLRHSNLVQLL 65

Query: 78  DAF-PHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKKWVLH 134
                 KG L++V E+M +  L   +R+    +   D      + + + + +      +H
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+   N+L+      K++DFGL +   S     T ++  +W  APE L   K++    D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEAL-REKKFSTKSD 181

Query: 195 VWAAGCIFAEL--LNRRPF 211
           VW+ G +  E+    R P+
Sbjct: 182 VWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 22/195 (11%)

Query: 26  GVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH 82
           GV+ K +   DT+T QT  +K +R   +         RE   +     P+++ L      
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSSEYS-------RERLTIIPHCVPNMVCLHKYIVS 56

Query: 83  KGNLHLVFEFME--TDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDMKP 139
           + ++ LV +  E       + +  NI   P + +K +    +  L   H++ ++ RD+ P
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNI---PEECVKRWAAEMVVALDALHREGIVCRDLNP 113

Query: 140 NNLLIGSHGQLKLADFG-LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAA 198
           NN+L+   G ++L  F   + +  S D     +     Y APE + G  +     D W+ 
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVEDSCDG----EAVENMYCAPE-VGGISEETEACDWWSL 168

Query: 199 GCIFAELLNRRPFLQ 213
           G I  ELL  +  ++
Sbjct: 169 GAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 9/169 (5%)

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDR 166
           L+  D+ S+     +G+ F   K  +HRD+   N+L+     +K+ DFGLAR I    + 
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 167 RFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLG 222
                 F   +W  APE +F    Y    DVW+ G +  E+  L   P+     D     
Sbjct: 294 VSKGSTFLPVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351

Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
           KI + +  A P       Y  D +   + + P  R  F   SD    LL
Sbjct: 352 KIKSGYRMAKPDHATQEVY--DIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 36/115 (31%), Positives = 53/115 (46%), Gaps = 6/115 (5%)

Query: 95  TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD 154
           T  +T+I N +  LS  D+  +      G+ F   K  +HRD+   N+LI     +K+ D
Sbjct: 224 TRRDTLI-NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 155 FGLAR-IFGSPDRRFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           FGLAR I    +       F   +W  APE +F    Y    DVW+ G +  E+ 
Sbjct: 283 FGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 10/110 (9%)

Query: 110 PADIKSYMQMTLK---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR 166
           P D+   ++ + +   G+ F   K  +HRD+   N+L+      K+ DFGLAR   + D 
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN-DS 266

Query: 167 RFTHQVFARW---YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPF 211
            +  +  AR    + APE +F    Y    DVW+ G +  E+  L + P+
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 46/198 (23%)

Query: 132 VLHRDMKPNNLLIGSHG----------------QLKLADFGLARIFGSPDRRF--THQVF 173
           ++H D+KP N+L+ +                  ++++ D G     G  D R   T  V 
Sbjct: 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-----GCCDERHSRTAIVS 307

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            R YR+PE++ G   +    D+W+ GCI  EL   +       +++ L  +    G   P
Sbjct: 308 TRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR-LP 365

Query: 234 SQWP-------------DLAYLPDYVEYQYVA----APPLRSLFPSASDDAL-DLLSKMF 275
           S+W                  L    + +++A    A P+R +     DD L DL+  + 
Sbjct: 366 SEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI---RDDLLCDLIYGLL 422

Query: 276 TYDPKARITAQQALEHRY 293
            YD + R+ A+Q   H Y
Sbjct: 423 HYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 20  LGEGTYG-VVYKAIDTKTGQT-VAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +G G +G V+   I T TG   V +K+++     KE   F  L++    + L+ P+I++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEF--LQQGDPYRILQHPNILQC 60

Query: 77  I----DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK---GLAFCH 128
           +    +A P+     LVFE+ E  DL++ +         + +    +M  +   G+   H
Sbjct: 61  LGQCVEAIPYL----LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH--QVFARWYRAPEL---- 182
           K   LH D+   N  + S   +K+ D+G+       D   T   +     + APEL    
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 183 ---LFGAKQYGAGVDVWAAGCIFAELL 206
              L  A+Q     +VWA G    EL 
Sbjct: 177 HGGLITAEQTKPS-NVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 19/162 (11%)

Query: 19  VLGEGTYGVVYKAI-----DTKTGQTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPH 72
            LG G +G VY+ +            VA+K +     +++  +F  L E  ++ +    +
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDF--LMEALIMSKFNHQN 70

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVI---RNTNIFLSPADIKSYMQMTL---KGLA 125
           I+ LI     +    ++ E M   DL++ +   R      S   +K  +       KG  
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLAR-IFGS 163
           +  +   +HRD+   N L+   G     K+ADFG+AR I+ +
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.5 bits (93), Expect = 0.002
 Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 104 TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFG 162
               LS A++K  ++  ++ L   HK  ++H D+K  N+L   +  ++ L D+GL +I G
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161

Query: 163 SP---DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PF 211
           +P   D   T   F     +PE + G   Y    D WA G +  ELL  + PF
Sbjct: 162 TPSCYDG--TLDYF-----SPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	415
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK10345	210	hypothetical protein; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
KOG3087	229	consensus Serine/threonine protein kinase [General	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.21
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.14
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.13
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.04
COG4248	637	Uncharacterized protein with protein kinase and he	98.96
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.9
PRK09902	216	hypothetical protein; Provisional	98.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.79
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.49
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.43
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
PLN02876	822	acyl-CoA dehydrogenase	98.38
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.26
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.25
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.18
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
KOG2270	520	consensus Serine/threonine protein kinase involved	98.04
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.93
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.88
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.87
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.82
PRK05231	319	homoserine kinase; Provisional	97.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.73
PRK10593	297	hypothetical protein; Provisional	97.66
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.46
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.43
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.39
PLN02236	344	choline kinase	97.36
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.35
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.34
PRK12396	409	5-methylribose kinase; Reviewed	97.29
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.23
PLN02756	418	S-methyl-5-thioribose kinase	97.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.07
PTZ00384	383	choline kinase; Provisional	96.98
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.63
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.58
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.56
PTZ00296	442	choline kinase; Provisional	96.4
PRK06148	1013	hypothetical protein; Provisional	96.06
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.02
PRK11768	325	serine/threonine protein kinase; Provisional	95.96
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.34
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.17

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5e-75  Score=507.91  Aligned_cols=300  Identities=73%  Similarity=1.202  Sum_probs=293.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|...++||+|.||.||+|+|..+|+.||||+|......+..+..+.|||+.|+.++|+||+.++|+|.+.+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++.||...|+.....++..+++.|+.|+++||+|||+++|+||||||.|+||+++|.+||+|||+|+.++.+....++.
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~  161 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ  161 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      +.|+||+|||.++|++.|+..+||||+|||+.||+.|.|+|.|.++.+++..|+..+|++++++||++..++++.++++.
T Consensus       162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~  241 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF  241 (318)
T ss_pred             eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCcc
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPAT  311 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~  311 (415)
                      ..++...+++..+.++.||+.+||.+||.+|+|+.|+|+|+||++.+.++.+...|.|..
T Consensus       242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence            999999999999999999999999999999999999999999999999999988887765

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-65  Score=459.67  Aligned_cols=304  Identities=43%  Similarity=0.808  Sum_probs=279.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee--cCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~   87 (415)
                      -.+.|++++.|++|+||.||+|+|++++..||+|.++....++......+|||.+|.+++|||||.+-++..  +-+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            467899999999999999999999999999999999999888888888899999999999999999987764  345799


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||||+.||..++..-..++...+++.++.|++.||+|||.++|+||||||+|+|++..|-+||+|||+|+.++++-..
T Consensus       154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ++..+.|.||+|||.++|.+.|++++|+||+|||+.||+++.|.|.|.++.+++.+|+..+|.++...||+...++.+-.
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999887644


Q ss_pred             cccc--cCCCccccCCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCcccc
Q 014985          248 YQYV--AAPPLRSLFPSAS--DDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKR  313 (415)
Q Consensus       248 ~~~~--~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~~~~~  313 (415)
                      ..+.  .-..++..|+.++  +...+|+..+|.+||.+|.||+|+|+|.||...+.+..|...|.-+.+.
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~  383 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKS  383 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCcccc
Confidence            4443  3445777777655  9999999999999999999999999999999988888777666544443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.6e-66  Score=457.54  Aligned_cols=285  Identities=41%  Similarity=0.706  Sum_probs=256.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++.-+.........++||+++|++++|+|+|.++++|.....+++|||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            68999999999999999999999999999999998776666677778999999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ||+.++++.+......+++..++.|++|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+..+...++.+
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY  161 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY  161 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence            99999999998877779999999999999999999999999999999999999999999999999999998888899999


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc-
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY-  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-  250 (415)
                      +.|+||+|||.+.|..+|+..+||||+||++.||++|.|+|.|.++.+++..|...+|...|+...-....+-+..... 
T Consensus       162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP  241 (396)
T KOG0593|consen  162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP  241 (396)
T ss_pred             hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence            9999999999999988999999999999999999999999999999999999999999877653221111111111111 


Q ss_pred             --ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          251 --VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       251 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                        ....+++..+|.++.-+.||+..||..||.+|++.+|+|.|+||.+
T Consensus       242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence              1234567788999999999999999999999999999999999954

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-64  Score=472.94  Aligned_cols=301  Identities=45%  Similarity=0.827  Sum_probs=272.8

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--C
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--G   84 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~   84 (415)
                      ...-.+.|+.+++||+|+||.||+|++..+|+.||+|+++.....+.....+.|||.||++|+||||++|.+...+.  +
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            34457889999999999999999999999999999999999988888887888999999999999999999987665  7


Q ss_pred             eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .+|||||||+.||..++......+++.+++.|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus       192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            89999999999999999998889999999999999999999999999999999999999999999999999999987554


Q ss_pred             C-CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          165 D-RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       165 ~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ..++..+.|.||+|||+|+|...|+.++|+||+||||.||++|+|+|.|.++.+++..|++..|.+++..|+ ...+|
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP  350 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLP  350 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCC
Confidence            4 358889999999999999999999999999999999999999999999999999999999999999999999 66666


Q ss_pred             cchhccccc--CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 014985          244 DYVEYQYVA--APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPR  308 (415)
Q Consensus       244 ~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~  308 (415)
                      .+..+....  ...+++.+..++..+.+|+..||..||.+|.||.++|+|+||+..+.+..+..+|.
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~  417 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPK  417 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCC
Confidence            544333222  23456667888999999999999999999999999999999988777777666654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-63  Score=467.68  Aligned_cols=288  Identities=40%  Similarity=0.704  Sum_probs=261.1

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC-eE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG-NL   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~-~~   86 (415)
                      .+.+||.++++||.|+||.||+|..+.+|..||||.+...... .....-+||++.|++|+ |||||++.+++.+.. ++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            4679999999999999999999999999999999998754332 22223468999999999 999999999998877 99


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |+|||||+.+|+++++.++..+++..++.|++||++||+|+|++|+.|||||||||||.....+||+|||+|+...+ ..
T Consensus        86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-kp  164 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-KP  164 (538)
T ss_pred             eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc-CC
Confidence            99999999999999999999999999999999999999999999999999999999999888999999999998744 45


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .++.++.|+||+|||+|+....|+.++||||+|||++|+.+-+|+|.|.++.|++.+|...+|++....|+....+....
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            67889999999999999998999999999999999999999999999999999999999999999999999876666666


Q ss_pred             hcccccC--CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          247 EYQYVAA--PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       247 ~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ++++...  .++..+.|.++.++.+||.+||.+||.+||||.|+|+||||+...
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            6665544  457788899999999999999999999999999999999998643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.1e-61  Score=438.73  Aligned_cols=289  Identities=50%  Similarity=0.838  Sum_probs=266.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC-eeeEEeeeecCC-----
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKG-----   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~-----   84 (415)
                      .+.|..+++||+|+||+||+|+++.+|+.||+|+++.....+.....+.+|+.+|+.++|+| |+.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            56688899999999999999999999999999999998877788888999999999999999 999999998776     


Q ss_pred             -eEEEEeecccCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           85 -NLHLVFEFMETDLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        85 -~~~lv~e~~~g~L~~~i~~~~---~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                       .+++||||++-+|..++....   ..++...++.+++||+.||+|||++||+||||||+||||+++|.+||+|||+|+.
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence             899999999999999998876   3588899999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      +.-+...+++.++|.||+|||++.++..|+..+||||+|||++||+++++.|.+.++.+++.+|+..+|++....||...
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            88888889999999999999999999899999999999999999999999999999999999999999999999999999


Q ss_pred             CCccchh-ccccc-CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          241 YLPDYVE-YQYVA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       241 ~~~~~~~-~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      .++++-. +.... ...+....+..++++.+++.+||+++|.+|.|+..+|+||||...+.
T Consensus       250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            9988763 22222 44566677788889999999999999999999999999999987543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-62  Score=448.91  Aligned_cols=269  Identities=31%  Similarity=0.498  Sum_probs=230.8

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-----CccchHHHHHHHHHhcCCCCeeeEEeeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-----GVNFTALREIKLLKELKSPHIIELIDAFP   81 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   81 (415)
                      ++.+.+.|.+.+.||+|+||.|-+|.++++|+.||||++.+.....     .......+|+++|++|+|||||+++++|+
T Consensus       167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~  246 (475)
T KOG0615|consen  167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE  246 (475)
T ss_pred             cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence            4568899999999999999999999999999999999998765332     12233568999999999999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeecc
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGL  157 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~  157 (415)
                      .....||||||++ |+|++.+... +.+.+...+.+++|++.|+.|||++||+||||||+|||+..+   -.+||+|||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999 5888888764 458999999999999999999999999999999999999876   6799999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH-HHHHHHHHhCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-QLGKIFAAFGTATPS  234 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  234 (415)
                      |+..+ ....+.+.|||+.|.|||++.+.  ..|..++|||||||+||-+++|.|||.++.... ..++|.++-....+.
T Consensus       326 AK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  326 AKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             hhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            99887 45567789999999999999652  335568999999999999999999999886554 666676653333333


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      .|                        ..+|+++++||.+||..||++|||++|+|+||||+.++..+
T Consensus       405 ~w------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  405 QW------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hh------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence            33                        35699999999999999999999999999999999866433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-60  Score=455.43  Aligned_cols=259  Identities=28%  Similarity=0.461  Sum_probs=233.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCC-ccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+|...++||+|||+.||.+++..+|..||+|++.+.. .+......+.+||+|.++|+|||||+++++|++..++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            47999999999999999999999999999999998754 34455567889999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+|. |+|..+++ ..+.++|.+|+.|++||+.||.|||+++|+|||||..|||++++.+|||+|||+|+.+..+..+-.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            9999 56666665 667799999999999999999999999999999999999999999999999999999987777788


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      +.||||.|.|||++.. ..++..+||||+|||||.||+|+|||...+-.+++.+|...-.                    
T Consensus       177 TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--------------------  235 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--------------------  235 (592)
T ss_pred             eecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--------------------
Confidence            8999999999999986 6689999999999999999999999999999999999866411                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                              ..+..+|.++++||.+||+.||.+|||++++|.|+||+..-.|
T Consensus       236 --------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  236 --------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             --------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence                    1112569999999999999999999999999999999655443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-60  Score=437.09  Aligned_cols=272  Identities=28%  Similarity=0.440  Sum_probs=238.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|+++++||+|+||+||+++.+.+++.||+|++++....+. .....+.|..||..++||+||+++..|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            37899999999999999999999999999999999988765443 34456789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |+||+.| +|...+.+ .+.+++..++.|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+........
T Consensus       103 Vld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            9999996 66666654 455999999999999999999999999999999999999999999999999999976666666


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..+.|||+.|||||++.+ ..|+.++|+|||||++|||++|.+||.+.+......+|...-.                  
T Consensus       182 t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------------  242 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------------  242 (357)
T ss_pred             cccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------------
Confidence            677899999999999988 5799999999999999999999999999999999998876521                  


Q ss_pred             cccccCCCccccCCC-CCHHHHHHHHHhcCCCCCCCC----CHHHHhcCCCCCCCCCCCCCCCCCCCcc
Q 014985          248 YQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARI----TAQQALEHRYFSSAPLPTEPNKLPRPAT  311 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rp----t~~e~l~h~~~~~~~~~~~~~~~~~~~~  311 (415)
                                ...|. +|.++++||.++|+.||++|.    ++++|.+||||.+..|.........|+.
T Consensus       243 ----------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF  301 (357)
T KOG0598|consen  243 ----------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPF  301 (357)
T ss_pred             ----------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence                      12233 699999999999999999996    6899999999999988765544444433

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-60  Score=431.66  Aligned_cols=292  Identities=39%  Similarity=0.673  Sum_probs=252.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-----   82 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----   82 (415)
                      ..+..+|..++.||.|+||.|+.|.++.+|+.||||++...........+..||+++|+.++|+||+.+++.+..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            345677888899999999999999999999999999998554444444567799999999999999999999865     


Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      -..+|+|+|+|+.||.+.+++... +++..++.+++||+.||+|+|+.||+||||||.|+|++.+..+||||||+|+...
T Consensus        98 f~DvYiV~elMetDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen   98 FNDVYLVFELMETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             cceeEEehhHHhhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence            347999999999999999886543 9999999999999999999999999999999999999999999999999999875


Q ss_pred             C--CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          163 S--PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       163 ~--~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .  .....+..+.|+||+|||++.....|+.++||||+||||.||++|+|.|.|.+..+++..|+..+|++.++.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3  34456888999999999999988999999999999999999999999999999999999999999998765443322


Q ss_pred             ---CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          241 ---YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                         ..+...........++..++|++++.+.||+.+||.+||.+|+|++|+|+|||+.....+
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence               111111233345556788999999999999999999999999999999999999865433

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-58  Score=380.98  Aligned_cols=286  Identities=48%  Similarity=0.833  Sum_probs=271.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ..|...++||+|+||+||++++..+++.||+|.++.....+.....+++|+-+|+.++|.|||++++....+..+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            46778899999999999999999999999999999999889999899999999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ||..+|..++.+.++.++.+.++.++.|++.||.|||++++.||||||.|+||+.+|.+||+|||+|+.++-+-+-++..
T Consensus        82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999888888889


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      +.|.||++|.+++|.+-|++..|+||.|||+.|+.. |.|.|.|++..+++.+|+..+|.++..+||.+..++++..+..
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            999999999999999999999999999999999986 8999999999999999999999999999999999999987755


Q ss_pred             ccC-CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          251 VAA-PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       251 ~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      +.+ ..+..+.|.++...+||++++|.-+|.+|++++.+++||||++.
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            443 45778889999999999999999999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=433.06  Aligned_cols=264  Identities=30%  Similarity=0.452  Sum_probs=233.1

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCe
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGN   85 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~   85 (415)
                      .+-..+|...+.||.|+|++|++|+++.+++.||||++.+.-.. +.....+.+|-.+|.+| .||.|++|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34567899999999999999999999999999999999765432 22233455799999999 89999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      +|+|+||++ |+|+.+|.+- +.+++..++.|+.||+.||+|||++|||||||||||||++.+|++||+|||.|+.+...
T Consensus       149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            999999999 8999999876 45999999999999999999999999999999999999999999999999999876422


Q ss_pred             C-----------Cc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          165 D-----------RR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       165 ~-----------~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      .           ..  ...++||..|.+||+|.. ...+..+|||+||||||.|+.|.|||.+.++..+..+|+..-.  
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y--  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY--  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc--
Confidence            1           11  256899999999999976 6689999999999999999999999999999999999988622  


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                                                .+.+++++.+.|||.++|..||.+|+|++||.+||||.++.|..
T Consensus       305 --------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  305 --------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             --------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                                      22345689999999999999999999999999999999988865

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-57  Score=413.00  Aligned_cols=257  Identities=28%  Similarity=0.462  Sum_probs=217.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe-EEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN-LHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~~lv   89 (415)
                      .++.+.++.||+|..|+||+|+|+.+++.+|+|++... ..+....++.+|+++++.++|||||.+|++|.+.+. ++|+
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            45788899999999999999999999999999999443 444555678899999999999999999999999994 9999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||+| +|...+.. .+.++|.....++.++++||.|||+ .+||||||||+||||+..|.|||||||.+..+.+.  .
T Consensus       157 mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~  233 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I  233 (364)
T ss_pred             hhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence            999995 55555554 4669999999999999999999995 89999999999999999999999999999887544  5


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-----CcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-----SDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..+.+||..|||||.+.+ ..|+.++||||||++++||++|+-||...     +..+.+..|...    .+...|..   
T Consensus       234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----ppP~lP~~---  305 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----PPPRLPEG---  305 (364)
T ss_pred             cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----CCCCCCcc---
Confidence            578899999999999988 57999999999999999999999888775     233344333321    11111110   


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                         ..|+++++||..||++||.+|+++.|+++|||+....
T Consensus       306 -------------------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  306 -------------------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             -------------------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence                               2599999999999999999999999999999998643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.8e-56  Score=423.35  Aligned_cols=267  Identities=29%  Similarity=0.468  Sum_probs=228.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|++++.||+|+||.||+|+.+.||.+||+|++++.... .......+.|-.+|....+|+||+||..|++.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            368999999999999999999999999999999999887633 3334457789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC----
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS----  163 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~----  163 (415)
                      ||||++ ||+..++.+.+. |++..+++|+.+++.|++.||+.|+|||||||+|+|||..|++||+|||++.-+..    
T Consensus       219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            999999 588888876554 99999999999999999999999999999999999999999999999999853210    


Q ss_pred             ---------------------C-----C-----------------CcccccccccceeCcccccCCcCCCCcccHHHHHH
Q 014985          164 ---------------------P-----D-----------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGC  200 (415)
Q Consensus       164 ---------------------~-----~-----------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~  200 (415)
                                           .     .                 ......+|||.|||||++.+ +.|+..+|+|||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGC  376 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHH
Confidence                                 0     0                 00124579999999999998 66999999999999


Q ss_pred             HHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCC
Q 014985          201 IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPK  280 (415)
Q Consensus       201 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  280 (415)
                      |+||||.|.|||.+++..++..+|+..-.+..   +|                     ....++++++|||.+||. ||+
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---fP---------------------~~~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLK---FP---------------------EEVDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---CC---------------------CcCcccHHHHHHHHHHhc-CHH
Confidence            99999999999999999999999976522111   00                     011347999999999999 999


Q ss_pred             CCCC---HHHHhcCCCCCCCCCCCCC
Q 014985          281 ARIT---AQQALEHRYFSSAPLPTEP  303 (415)
Q Consensus       281 ~Rpt---~~e~l~h~~~~~~~~~~~~  303 (415)
                      +|..   ++||..||||.++.|....
T Consensus       432 ~RLG~~G~~EIK~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  432 NRLGSKGAEEIKKHPFFKGVDWDHLR  457 (550)
T ss_pred             HhcCcccHHHHhcCCccccCCcchhh
Confidence            9985   8999999999999987643

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-56  Score=409.84  Aligned_cols=285  Identities=37%  Similarity=0.657  Sum_probs=245.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----   84 (415)
                      ...=.|.-.+++|.|+||.||+|....+++.+|||++-....-      --+|+.+|+.++|||||++..+|....    
T Consensus        21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3455789999999999999999999999999999998644321      127999999999999999998885422    


Q ss_pred             -eEEEEeecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccce
Q 014985           85 -NLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR  159 (415)
Q Consensus        85 -~~~lv~e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~  159 (415)
                       +..+||||++-+|...++.   .+..++.-.++-|++||+.||.|||+.||+||||||.|||||.+ |.+||||||.|+
T Consensus        95 ~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   95 VYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             hHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence             4568999999999999985   35669999999999999999999999999999999999999976 999999999999


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .+..... ..+.+.|++|+|||.++|+..|+.++||||.||++.||+.|+|.|.|.+..+++..|++.+|.++.+....+
T Consensus       175 ~L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  175 VLVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            8755443 367788999999999999999999999999999999999999999999999999999999999988776655


Q ss_pred             CCCccchhcccccCCCccc-cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRS-LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      ...-....+..+...++.. +....++++.+|+.++|+++|++|.++.|++.||||.....+
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            4443334444455555545 667899999999999999999999999999999999865443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=397.19  Aligned_cols=263  Identities=26%  Similarity=0.398  Sum_probs=231.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .-.++|+.++.||.|+||.|.+++++.+|..||+|++.+... +-...+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            346889999999999999999999999999999999977652 2223345668999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++| .|..++++.+ ++++..++.|+.||+.||+|||+++|++|||||||||||.+|++||+|||+|+....   
T Consensus       121 mvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             EEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999995 6777777654 599999999999999999999999999999999999999999999999999998633   


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ...+.||||.|+|||++.. +.|+.++|+|||||++|||+.|.+||...+...++++|.++--                 
T Consensus       197 rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-----------------  258 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-----------------  258 (355)
T ss_pred             cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----------------
Confidence            3567899999999999976 7899999999999999999999999999999999999987621                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPTEPN  304 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~~~~~  304 (415)
                                 .+++..+.+++|||.++|+.|-.+|.     ...+|..||||.+..|.....
T Consensus       259 -----------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~  310 (355)
T KOG0616|consen  259 -----------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQ  310 (355)
T ss_pred             -----------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhh
Confidence                       11224589999999999999999994     578999999999988865433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-55  Score=401.79  Aligned_cols=262  Identities=32%  Similarity=0.520  Sum_probs=227.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...++|.+.+.||.|+||+||+|+++.++..||||.+.+........+.+..|+++|+.++|||||.++++++.++++|+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            45789999999999999999999999999999999998776544455567789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC------CcEEEeeeccceec
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH------GQLKLADFGLARIF  161 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~------~~vkL~DFG~a~~~  161 (415)
                      |||||. |||..++++.+ .+++..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+.+
T Consensus        87 VMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999 68888888765 49999999999999999999999999999999999999875      35999999999987


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      . +.....+.||++.|||||++.. .+|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.....          
T Consensus       166 ~-~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~----------  233 (429)
T KOG0595|consen  166 Q-PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV----------  233 (429)
T ss_pred             C-chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc----------
Confidence            5 3455677899999999999965 679999999999999999999999999999888887654431111          


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                     ......++....+|+...|+.++..|.+..+-+.|++....+
T Consensus       234 ---------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  234 ---------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ---------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                           011112366778999999999999999999999999987655

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.5e-54  Score=407.10  Aligned_cols=283  Identities=41%  Similarity=0.778  Sum_probs=244.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||.|+||+||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            4679999999999999999999999999999999875432 223345678999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||+.|+|...+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        83 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          83 EYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             eCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            99999999998877767899999999999999999999999999999999999999999999999999876554444556


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|+.......+..+.+
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF  242 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence            67889999999987766789999999999999999999999999999999999999999998888887654433332221


Q ss_pred             c--cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 V--AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .  ...+.....+.++.++++||.+||++||.+|||++|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1  1122233456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.3e-56  Score=396.47  Aligned_cols=291  Identities=44%  Similarity=0.772  Sum_probs=250.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCc----EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-CC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~   84 (415)
                      ....|+++.+||+|+||.||+|..+.++.    .||||++...+........+.||+.+++.++||||+.+..+|-. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            35689999999999999999996555443    68999999888878888899999999999999999999999876 88


Q ss_pred             eEEEEeecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC----CcEEEeeec
Q 014985           85 NLHLVFEFMETDLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFG  156 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~----~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~----~~vkL~DFG  156 (415)
                      .+|+++||++.||+..|+-.    ...++...++.++.||+.|+.|||+++|+||||||.||||..+    |.|||+|||
T Consensus       102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            99999999999999999653    2458999999999999999999999999999999999999887    899999999


Q ss_pred             cceecCCCCCc---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---------cHHHHHHH
Q 014985          157 LARIFGSPDRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---------DIDQLGKI  224 (415)
Q Consensus       157 ~a~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~~~i  224 (415)
                      +++.+.++-..   ....+.|.||+|||.++|...|+.++||||+|||+.||++-.|.|.+..         ..+++.+|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            99998766543   3446779999999999999999999999999999999999999998753         45889999


Q ss_pred             HHHhCCCCCCCCCCCCCCccchh-cccc-----cCCCcc---ccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          225 FAAFGTATPSQWPDLAYLPDYVE-YQYV-----AAPPLR---SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      ++.+|.++...||++..+|++.. .+..     ..-.+.   .....-++.+.+|+.+||++||.+|+|++|+|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            99999999999999999999832 1111     111111   12223466799999999999999999999999999999


Q ss_pred             CCCCC
Q 014985          296 SAPLP  300 (415)
Q Consensus       296 ~~~~~  300 (415)
                      ..+.|
T Consensus       342 ~d~lp  346 (438)
T KOG0666|consen  342 EDPLP  346 (438)
T ss_pred             cCCCC
Confidence            87665

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-57  Score=388.88  Aligned_cols=264  Identities=32%  Similarity=0.485  Sum_probs=237.3

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ....+.+.|.+.+.||+|.|+.||++.+..+|+.||+|.+...+......+.+.+|+.|.+.|+|||||++++.+.+.+.
T Consensus         5 ~~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    5 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             cccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            45567899999999999999999999999999999999998776666666778899999999999999999999999999


Q ss_pred             EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeeccceec
Q 014985           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIF  161 (415)
Q Consensus        86 ~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~a~~~  161 (415)
                      .|+|||++.| +|...|..+ ..+++..+..+++||++||+|||.+||||||+||+|+|+.+.   ..+||+|||+|..+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             eEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999995 788877765 448999999999999999999999999999999999999754   35999999999998


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      + ........+|||.|||||++.. .+|+..+|||+.|||||-|+.|.+||.+.+....+++|+++-....+.+|     
T Consensus       164 ~-~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w-----  236 (355)
T KOG0033|consen  164 N-DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW-----  236 (355)
T ss_pred             C-CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-----
Confidence            7 4556678899999999999977 67999999999999999999999999999999999999887554444444     


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                         +.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus       237 -------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  237 -------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             -------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                               456999999999999999999999999999999975

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-55  Score=426.92  Aligned_cols=309  Identities=23%  Similarity=0.355  Sum_probs=249.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~   87 (415)
                      -.++|.++++||+|+||+|+++..+.+++.||||++++...- ....+..+.|..|+.... ||+++.++.+|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            368999999999999999999999999999999999987643 334445677888888775 999999999999999999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      +||||+.|+.+..+. +...+++..++.|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+|+..-.....
T Consensus       446 fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~  524 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR  524 (694)
T ss_pred             EEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence            999999975533333 3355999999999999999999999999999999999999999999999999999986655667


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .++.|||+.|||||++.+ ..|+.++|+|||||+|||||.|.+||.|+++.++...|..-           ..       
T Consensus       525 TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----------~~-------  585 (694)
T KOG0694|consen  525 TSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----------EV-------  585 (694)
T ss_pred             cccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------CC-------
Confidence            889999999999999987 67999999999999999999999999999999999888652           11       


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCCcc----cccCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLPTEPNKLPRPAT----KRASKAS  318 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~~~~~~~~~~~~----~~~~~~~  318 (415)
                                .++-.+|.++.++++++|++||++|..     +++|..||||....|....++...|+.    +.....+
T Consensus       586 ----------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~s  655 (694)
T KOG0694|consen  586 ----------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVS  655 (694)
T ss_pred             ----------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhc
Confidence                      111245999999999999999999985     588999999999988665444333332    2223334


Q ss_pred             CCCC--CCCCcccCCcccccCCCCCCCCCCCC
Q 014985          319 DFNP--QEGPTVLSPPRKTRRVMPDREGFEGN  348 (415)
Q Consensus       319 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (415)
                      .+..  ..+.+++.|+........+++.+.+.
T Consensus       656 nFd~eFt~e~p~Lt~~~~~~l~~~~q~~F~~F  687 (694)
T KOG0694|consen  656 NFDEEFTSEKPALTPSDPRPLTEEEQEAFRDF  687 (694)
T ss_pred             ccchhhhcCCCccCCCCccccchhhHHHhcCc
Confidence            4432  23444555544444444445555444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-55  Score=415.60  Aligned_cols=256  Identities=32%  Similarity=0.517  Sum_probs=231.8

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+.....+.+|++|++.++|||||.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            68999999999999999999999999999999999887776666678899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ||.|+|..++.. ++.++|+.++.++.+++.||.|||+++|.|||+||.|||++.+|++|+||||+|+..+....-.+..
T Consensus        82 ~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi  160 (808)
T KOG0597|consen   82 YAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI  160 (808)
T ss_pred             hhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence            999988888876 4559999999999999999999999999999999999999999999999999999988777777778


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      -|||.|||||++.+ ..|+..+|+||||||+|||+.|+|||-..+-......|..-     +..||              
T Consensus       161 kGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d-----~v~~p--------------  220 (808)
T KOG0597|consen  161 KGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD-----PVKPP--------------  220 (808)
T ss_pred             cCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-----CCCCc--------------
Confidence            89999999999986 77999999999999999999999999988777766666442     12222              


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                               +.+|..++.|+..+|.+||.+|+|+.+++.|||+++.
T Consensus       221 ---------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  221 ---------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ---------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                     2568999999999999999999999999999998754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-54  Score=413.13  Aligned_cols=259  Identities=33%  Similarity=0.490  Sum_probs=228.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---CCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      ...++|.+.+.||+|+||+|++|.+..+|..||+|++......   ......+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            5678999999999999999999999999999999977765222   133445668999999999 999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccceecC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFG  162 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~~~~  162 (415)
                      .+|+|||||. |+|++.+.+ .+++.+..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999 599999998 6679999999999999999999999999999999999999999 999999999999875


Q ss_pred             CCCCcccccccccceeCcccccCCc-CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .......+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|..||...+......+|...--            
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~------------  240 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF------------  240 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc------------
Confidence            4556778899999999999998855 446899999999999999999999999887777777654310            


Q ss_pred             CccchhcccccCCCccccCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                      .+...+ |.++++||.+||..||.+|+|+.++++||||+.
T Consensus       241 ----------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  241 ----------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                            111233 899999999999999999999999999999986

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.3e-54  Score=418.46  Aligned_cols=289  Identities=33%  Similarity=0.573  Sum_probs=236.4

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-C-----CCeeeEEeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-S-----PHIIELIDAF   80 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-h-----p~Iv~l~~~~   80 (415)
                      .+.+..+|.+.++||+|+||.|.+|+|.+|++.||||+++...   ........|+.+|..|+ |     -|||+++|+|
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            4557779999999999999999999999999999999997543   23335667999999997 3     4899999999


Q ss_pred             ecCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC--cEEEeeecc
Q 014985           81 PHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGL  157 (415)
Q Consensus        81 ~~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~--~vkL~DFG~  157 (415)
                      ...+|+|||+|.++-+|.++++..+ ..++...++.++.||+.||.+||+.||||+|||||||||...+  .|||+|||.
T Consensus       258 ~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  258 YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999999999999999998764 3489999999999999999999999999999999999998654  699999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ++....   ....++.+++|+|||+++| .+|+.++||||||||++||++|.|+|.|+++.+++..|++.+|.+++.-..
T Consensus       338 Sc~~~q---~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  338 SCFESQ---RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccCC---cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            997533   2337888999999999999 679999999999999999999999999999999999999999976553111


Q ss_pred             ---CC-------CCCccch-hcc----------------------cc-cCCCccccCC-CCCHHHHHHHHHhcCCCCCCC
Q 014985          238 ---DL-------AYLPDYV-EYQ----------------------YV-AAPPLRSLFP-SASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       238 ---~~-------~~~~~~~-~~~----------------------~~-~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R  282 (415)
                         ..       ...+... +..                      .. ....+....+ .....+.|||.+||.+||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence               00       1111100 000                      01 1112222223 344567999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCCCC
Q 014985          283 ITAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       283 pt~~e~l~h~~~~~~~~~~~  302 (415)
                      +|+.|+|+||||+.......
T Consensus       494 ~tp~qal~Hpfl~~~~~~~~  513 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSLERR  513 (586)
T ss_pred             CCHHHHhcCccccccccccc
Confidence            99999999999997655443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-54  Score=415.34  Aligned_cols=265  Identities=28%  Similarity=0.448  Sum_probs=236.3

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecC-CccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...+-|++.+.||.|+.|.|-+|+|..||+..|||++.+. ...+.....+.+||.||+.+.||||+++|+.|++..++|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            3466799999999999999999999999999999999887 445556667889999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|.||+. |.|++++..++. +++.++..+++||+.|+.|||..+|+||||||+|+|++..+++||+|||+|..- .++.
T Consensus        89 lvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~gk  166 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPGK  166 (786)
T ss_pred             EEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-cCCc
Confidence            9999999 689998887654 899999999999999999999999999999999999999999999999999864 4456


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ...+.||++.|.|||++.|..+.+.++||||.|||||.||+|+.||++.+-...+.++..+.-                 
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-----------------  229 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-----------------  229 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----------------
Confidence            677899999999999999988889999999999999999999999998888888888766411                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP  303 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~  303 (415)
                                 .....+|.++.+||.+||..||++|+|.+||++|||+.+..-....
T Consensus       230 -----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  230 -----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             -----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence                       2224679999999999999999999999999999999876544433

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-52  Score=398.65  Aligned_cols=287  Identities=42%  Similarity=0.746  Sum_probs=236.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            57899999999999999999999999999999998754322 22335678999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||+.++|...+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++............
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            99999999999887777999999999999999999999999999999999999999999999999999866544444556


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-HHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+++.|+|||++.+...++.++|||||||++|+|++|.+||.+..+ .+.+..+...++.+....|+.....+......
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            77899999999987766789999999999999999999999988654 46677777777777666666544332221111


Q ss_pred             c--ccCCCccccCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 Y--VAAPPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~--~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      +  .....+...+.  ..+.++.+||.+||+.||++|||+.|+++||||.+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0  11111111111  2467899999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-55  Score=386.10  Aligned_cols=251  Identities=28%  Similarity=0.495  Sum_probs=217.7

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEe-eeecCC-e
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID-AFPHKG-N   85 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~~~-~   85 (415)
                      ..-..+|++.++||.|.||+||++.+..+|..+|.|.+...............|+.+|++|+|||||++++ .|..+. -
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            34466799999999999999999999999999999999876666666667889999999999999999998 454444 4


Q ss_pred             EEEEeeccc-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh--CC--ccccCCCCCcEEEecCCcEEEeeecc
Q 014985           86 LHLVFEFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHK--KW--VLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~--~~--ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      ++||||||+ |||.++|+.   .+..+++..+|.++.|++.||.+||+  ..  |+||||||.||+|+.+|.+||+|||+
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            899999999 798888754   45679999999999999999999998  44  99999999999999999999999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ++.+.+......+.+|||+||+||.+.+ ..|+.++||||+||++|||+.-++||.|.+-.....+|..+--.+.     
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~-----  248 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL-----  248 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC-----
Confidence            9999887777888999999999999987 6799999999999999999999999999977777777755411111     


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA  285 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~  285 (415)
                           |+                ...|.++..||..|+..||+.||+.
T Consensus       249 -----p~----------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  249 -----PD----------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             -----cH----------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence                 10                1248899999999999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-51  Score=393.62  Aligned_cols=286  Identities=40%  Similarity=0.779  Sum_probs=246.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            47899999999999999999999999999999998765432 22335678999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||++++|...+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            99999999998877777899999999999999999999999999999999999999999999999999876554444455


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.......+..+.+
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            67788999999987766789999999999999999999999999999999999999999888888876654433332222


Q ss_pred             cc--CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          251 VA--APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       251 ~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ..  ........+.++.++++||.+||+.||.+|||+.|+++||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            11  112233456789999999999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.8e-51  Score=386.39  Aligned_cols=280  Identities=41%  Similarity=0.751  Sum_probs=233.6

Q ss_pred             ccEeeeeeecccCceEEEEEEECC-CCcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEeeee-----c
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFP-----H   82 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~-----~   82 (415)
                      ++|++.+.||+|+||+||+|.+.. +++.||+|.+......+.......+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999865 467899999876654444444566788877766   6999999999874     3


Q ss_pred             CCeEEEEeecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           83 KGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      ...+++||||+.++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            4579999999999999988764 345899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ... .......|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+.++.+.+..+....+.+.+..|+....
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            433 33345678899999999976 5688999999999999999999999999999999999999988887777765543


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ++... +......++....+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchh-ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            33221 11222334445667789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-51  Score=388.20  Aligned_cols=282  Identities=37%  Similarity=0.660  Sum_probs=228.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++............+.+|+.+++.++||||++++++|..++.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            57999999999999999999999999999999998665444445567789999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Ccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTH  170 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~~~~  170 (415)
                      |++++++..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE  160 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence            99998888877666679999999999999999999999999999999999999999999999999998764332 22334


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+......+......+.......
T Consensus       161 ~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         161 YVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             cccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            578899999999977 4589999999999999999999999999888887777766655433222111100000000000


Q ss_pred             cc----CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 VA----APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ..    ..........+|.++.+||.+||+.||++|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00    000112233468999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-52  Score=386.92  Aligned_cols=259  Identities=30%  Similarity=0.500  Sum_probs=213.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC--eEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--NLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~l   88 (415)
                      ..+|...+.||+|+||+||++.+.++|..+|||.+.......  ...+.+|+.+|++++|||||+.++......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            456889999999999999999999999999999987662222  334678999999999999999999754444  6999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceecCC---
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGS---  163 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~~~---  163 (415)
                      +|||+. |+|.+++.+.++.+++..++.+.+||++||+|||++||+||||||+||||+. +|.+||+|||+++....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999 5888888876657999999999999999999999999999999999999999 79999999999987653   


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .........||+.|||||++.+....+.++|||||||++.||+||.+||... ...+.+..+..   ..           
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~~-----------  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---ED-----------  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---cC-----------
Confidence            2233446789999999999985222335999999999999999999999874 22222222211   11           


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                  ..+.+...+|.++++||.+||..||++||||+++|+|||....
T Consensus       240 ------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  240 ------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             ------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                        1123444679999999999999999999999999999999764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-52  Score=399.74  Aligned_cols=260  Identities=28%  Similarity=0.472  Sum_probs=228.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -...|....+||+|+.|.||.|+...+++.||||.+.+..+..  .+.+++|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            3578899999999999999999999999999999998876554  34578999999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||++|+.+..+.... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+........
T Consensus       349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            9999964444444333 399999999999999999999999999999999999999999999999999999887777888


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      +.+||++|||||++.. +.|+.++||||||++++||+-|.|||-..+....+..|... |.+..                
T Consensus       428 TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l----------------  489 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL----------------  489 (550)
T ss_pred             cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc----------------
Confidence            9999999999999976 77999999999999999999999999988888777776543 22221                


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                              .....+|..+++|+.+||+.|+.+|+++.++|+||||..+.
T Consensus       490 --------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  490 --------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             --------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence                    22345799999999999999999999999999999996543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-53  Score=372.14  Aligned_cols=268  Identities=29%  Similarity=0.494  Sum_probs=235.3

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCcc------chHHHHHHHHHhc-CCCCeeeEEe
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN------FTALREIKLLKEL-KSPHIIELID   78 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~------~~~~~E~~il~~l-~hp~Iv~l~~   78 (415)
                      ..+.+.+.|.-.+.||.|..++|-+|.++.+|+.+|+|++..........      +.-.+|+.||+++ .||+|+++.|
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            35667889999999999999999999999999999999997654322211      2234799999998 6999999999


Q ss_pred             eeecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           79 AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        79 ~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      .|+.+..+++|+|.|. |.|.+++.+. ..+++...+.+++||++|+.|||.++||||||||+|||++++.++||+|||+
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence            9999999999999999 8899988765 3499999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccC-----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      |+.+. +..+....||||+|+|||.+..     ...|+..+|+||+|||+|.|+.|.|||......-.+..|+++--...
T Consensus       170 a~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  170 ACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             eeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            99874 4567788999999999999853     45689999999999999999999999998888888888888866666


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ..+|.|                        +|.+++|||.+||+.||.+|+|++|+|.||||.....
T Consensus       249 speWad------------------------is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  249 SPEWAD------------------------ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             Ccchhh------------------------ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            666654                        4889999999999999999999999999999965433

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-51  Score=380.67  Aligned_cols=265  Identities=25%  Similarity=0.340  Sum_probs=226.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++++.||.|.-|+||+|+...++..+|+|++.+.... .....++.-|-.||+.++||+++.||..|+.+...|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            56889999999999999999999999999999999877644 33334566799999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC----
Q 014985           90 FEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS----  163 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~----  163 (415)
                      ||||.| +|..+.+++ +..+++..++.|+.+++.||+|||-.|||+||||||||||.++|+|-|+||.++.....    
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~  235 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL  235 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence            999995 777777655 45699999999999999999999999999999999999999999999999998642100    


Q ss_pred             -------------------------------C---------------------CCcccccccccceeCcccccCCcCCCC
Q 014985          164 -------------------------------P---------------------DRRFTHQVFARWYRAPELLFGAKQYGA  191 (415)
Q Consensus       164 -------------------------------~---------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~  191 (415)
                                                     .                     ..+...++||-.|+|||++.| ...+.
T Consensus       236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgs  314 (459)
T KOG0610|consen  236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGS  314 (459)
T ss_pred             eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCc
Confidence                                           0                     012234678899999999998 55799


Q ss_pred             cccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHH
Q 014985          192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL  271 (415)
Q Consensus       192 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  271 (415)
                      ++|||+|||++|||+.|..||.|.+..+++.+|+..--     ..                     ...+.+|..++|||
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-----~F---------------------p~~~~vs~~akDLI  368 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-----KF---------------------PEEPEVSSAAKDLI  368 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-----cC---------------------CCCCcchhHHHHHH
Confidence            99999999999999999999999999999988865311     11                     11235689999999


Q ss_pred             HHhcCCCCCCCCC----HHHHhcCCCCCCCCCCCC
Q 014985          272 SKMFTYDPKARIT----AQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       272 ~~~L~~dP~~Rpt----~~e~l~h~~~~~~~~~~~  302 (415)
                      +++|.+||.+|+.    |+||.+||||.+..|.-.
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLi  403 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALI  403 (459)
T ss_pred             HHHhccChhhhhccccchHHhhcCccccCCChhhe
Confidence            9999999999998    999999999999999743

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-52  Score=388.79  Aligned_cols=265  Identities=28%  Similarity=0.424  Sum_probs=222.2

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC------------ccchHHHHHHHHHhcCCCCee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------------VNFTALREIKLLKELKSPHII   74 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------------~~~~~~~E~~il~~l~hp~Iv   74 (415)
                      .....++|++.+.||+|.||.|-+|++..+++.||||++.+......            ..+...+||.||++|.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            34568999999999999999999999999999999999976542211            123567899999999999999


Q ss_pred             eEEeeeec--CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEE
Q 014985           75 ELIDAFPH--KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (415)
Q Consensus        75 ~l~~~~~~--~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL  152 (415)
                      +|+++..+  .+.+|||+|||..+-..+.-.....+++.+++.|++.++.||+|||.+|||||||||+|+||+++|++||
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            99999855  5689999999995544444333333899999999999999999999999999999999999999999999


Q ss_pred             eeeccceecCC-----CCCcccccccccceeCcccccCC---cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q 014985          153 ADFGLARIFGS-----PDRRFTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI  224 (415)
Q Consensus       153 ~DFG~a~~~~~-----~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  224 (415)
                      +|||.+..+..     ........+|||.|+|||.+.+.   ...+.+.|||||||+||.|+.|+.||.++...++..+|
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            99999987622     22344557899999999999762   33578899999999999999999999999999999988


Q ss_pred             HHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ....-.                          -...|.+..+++|||.+||.+||++|++..++..|||....
T Consensus       332 vn~pL~--------------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  332 VNDPLE--------------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hcCccc--------------------------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            653111                          12234568899999999999999999999999999998754

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-52  Score=361.02  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=230.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|++.+.||+|.||.||+|+.++++..+|+|++.++.. .......+.+|++|...|+||||+++|++|-++..+|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            47899999999999999999999999999999999987763 33455567799999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           89 VFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ++||.. |.++..+... ...+++..+..|++|++.||.|||.++|+||||||+|+|++..|.+||+|||.+...  ++.
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--p~~  177 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSN  177 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec--CCC
Confidence            999998 7898888854 455999999999999999999999999999999999999999999999999998764  366


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      +..+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||...+..+.+.+|.+.--                 
T Consensus       178 kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-----------------  239 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-----------------  239 (281)
T ss_pred             CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-----------------
Confidence            7778999999999999987 6689999999999999999999999999998899988876411                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                 .+...++.++.|||.+||..+|.+|.+..|++.|||...
T Consensus       240 -----------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  240 -----------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -----------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                       112467999999999999999999999999999999853

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=390.96  Aligned_cols=263  Identities=34%  Similarity=0.544  Sum_probs=234.3

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      ...+.+.|++.+.||.|.||.||+|.++.+|+.+|+|++.+...... ....+.+|+.+|++++ |||||.+++.|++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            45678899999999999999999999999999999999987765433 2346779999999998 999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC----CcEEEeeeccce
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLAR  159 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~----~~vkL~DFG~a~  159 (415)
                      .+|+|||+|. |.|++.+...  .+++..+..+++||+.|++|||+.||+||||||+|+|+...    +.+|++|||++.
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999 5899888877  39999999999999999999999999999999999999753    479999999999


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|..+-.....      
T Consensus       188 ~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~------  259 (382)
T KOG0032|consen  188 FIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS------  259 (382)
T ss_pred             EccC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC------
Confidence            8866 667788999999999999976 67999999999999999999999999999988888877665333333      


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                        ..++.+|..+++||.+||..||.+|+|+.++|+|||+.+.
T Consensus       260 ------------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  260 ------------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ------------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                              3445669999999999999999999999999999998865

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-50  Score=381.32  Aligned_cols=282  Identities=48%  Similarity=0.837  Sum_probs=239.2

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||+|+||.||+|.+..+|+.+|+|.+............+.+|+.+++.++||||+++++++.+...+|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            58999999999999999999999999999999976544444445677899999999999999999999999999999999


Q ss_pred             ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccc
Q 014985           93 METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (415)
Q Consensus        93 ~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~  172 (415)
                      ++++|...+.+....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV  160 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence            99999999887667799999999999999999999999999999999999999999999999999987665555555667


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      ++..|+|||++.+...++.++|||||||++|+|++|. |+|.+.+..+.+..++..++......|+.....++...+...
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07839         161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY  240 (284)
T ss_pred             cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence            7888999999877666899999999999999999876 557777778888888888887766666655444443222111


Q ss_pred             cC-CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          252 AA-PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       252 ~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .. ..+....+.++.++.+||.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            11 11234456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-53  Score=367.80  Aligned_cols=290  Identities=41%  Similarity=0.746  Sum_probs=254.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-------   82 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------   82 (415)
                      ....|+...+||+|.||.||+|+.+.+|+.||+|++.....++.....+++|+++|..|+|+|++.+++.+..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            4678999999999999999999999999999999998888888888889999999999999999999887643       


Q ss_pred             -CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           83 -KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 -~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                       ...+|+||.+|+.||..++......++..+++.++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||+|+.+
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence             2358999999999999999888888999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC----CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          162 GSPD----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       162 ~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ....    ..++..+.|.||++||.++|...|+.+.|||..|||+.||++|.|.|.++++..++..|....|..+++.||
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            4332    357788889999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccchhcccccCCC-ccccCC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPP-LRSLFP------SASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~-~~~~~~------~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      +...++-+........+. -....+      .-++++.||+.+||..||.+|+++.+++.|.||...+.
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            998877665443221110 000111      12568999999999999999999999999999986543

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-50  Score=404.48  Aligned_cols=280  Identities=34%  Similarity=0.617  Sum_probs=226.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------   83 (415)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+|+.++||||++++++|...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3568999999999999999999999999999999885432      1234799999999999999999876432      


Q ss_pred             --CeEEEEeecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeecc
Q 014985           84 --GNLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGL  157 (415)
Q Consensus        84 --~~~~lv~e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~  157 (415)
                        ..+++||||+++++..++..   .+..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+
T Consensus       138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence              25779999999998777653   355699999999999999999999999999999999999999665 699999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      |+.+.... .....++|+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+.++...++.+....+.
T Consensus       218 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        218 AKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             chhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            98764322 33456789999999998876679999999999999999999999999999999999999888876543332


Q ss_pred             CCCCCccch--hcccccCCCccccCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          238 DLAYLPDYV--EYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       238 ~~~~~~~~~--~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ...  +.+.  .+.......+...+| ..+.++++||.+||++||.+|||+.|+++||||....
T Consensus       297 ~~~--~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        297 EMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             Hhc--hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            211  1111  111112222333333 5789999999999999999999999999999997643

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.9e-50  Score=381.08  Aligned_cols=286  Identities=39%  Similarity=0.753  Sum_probs=241.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            57899999999999999999999999999999998755432 22335678999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||++++|...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++............
T Consensus        84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence            99999999999877777999999999999999999999999999999999999999999999999999876544444455


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.......+..+..
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY  243 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence            66788899999987766688999999999999999999999999988888888988888887777765433222211111


Q ss_pred             c--cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          251 V--AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       251 ~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .  .........+.+++++++||.+||+.||.+|||++|+++||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            1  1112233445678999999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.4e-50  Score=380.58  Aligned_cols=292  Identities=67%  Similarity=1.151  Sum_probs=255.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+......   ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999999999999999866543   23344566899999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||+.|+|..++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT  160 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcccc
Confidence            99998899998877654699999999999999999999999999999999999999999999999999988766555555


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||.+.+...++.++|+|||||++|+|++|.++|.+.++.+.+.++...++.+....|+.....+.+....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         161 HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccc
Confidence            56678889999998765668899999999999999999999999999999999998888888777787776666666555


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN  304 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~  304 (415)
                      .....+....+..++..+.+||.+||+.||++|||+.++++|+||.+.+.++.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~  295 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS  295 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence            5555556667778899999999999999999999999999999999877766443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-50  Score=390.00  Aligned_cols=286  Identities=38%  Similarity=0.643  Sum_probs=228.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----CeEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----GNLH   87 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~   87 (415)
                      +|.+.++||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            69999999999999999999999999999999875433333334577899999999999999999987433     3589


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--  165 (415)
                      +|||||+++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus        81 lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            999999999998887644 48999999999999999999999999999999999999999999999999998643221  


Q ss_pred             -CcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 -RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 -~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                       ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+.......
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  239 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK  239 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence             123456789999999998642 468899999999999999999999999988888887777776665443222111000


Q ss_pred             c--ch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          244 D--YV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       244 ~--~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      .  .. ........++...++.+++++.+||.+||+.||++|||++++++||||.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            0  00 01111122334456678899999999999999999999999999999986443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=376.83  Aligned_cols=270  Identities=28%  Similarity=0.376  Sum_probs=224.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+.|++.++||.|..++||+|+...++.+||||++...+.... -..+.+|+..|+.++||||++++..|..+..+|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            6899999999999999999999999999999999998877665 446789999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--  166 (415)
                      .||. |++++.+... ...++|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.....  
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            9999 6888888764 23499999999999999999999999999999999999999999999999997665433222  


Q ss_pred             --cccccccccceeCcccc-cCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 --RFTHQVFARWYRAPELL-FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 --~~~~~~~t~~y~aPE~l-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                        .+.+.+||++|||||++ .....|+.|+||||||++..||.+|..||........+-.-+++   .+|...  ...++
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn---~pp~~~--t~~~~  258 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN---DPPTLL--TSGLD  258 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC---CCCCcc--cccCC
Confidence              22567999999999995 44457999999999999999999999999887776665443222   221110  11111


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      +             ......+..++.+|..||+.||++|||++++|+|+||+....
T Consensus       259 ~-------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  259 K-------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             h-------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            0             111234678999999999999999999999999999987643

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.2e-50  Score=376.43  Aligned_cols=279  Identities=40%  Similarity=0.758  Sum_probs=231.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEeeeec-----CC
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFPH-----KG   84 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~-----~~   84 (415)
                      +|++.+.||+|+||+||+|.+..+|+.||+|.+..............+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58999999999999999999999999999999876544444444556788777766   69999999998754     34


Q ss_pred             eEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .+++||||+.++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            689999999999998887643 3589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+.++....+......|+.....+
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             c-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            2 22344567888999999976 568999999999999999999999999999999999999888877766666533222


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .. .+............+.++..+.+||.+||+.||++|||+.|++.||||
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 RG-AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cc-ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            11 111112233445567789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-49  Score=378.05  Aligned_cols=295  Identities=42%  Similarity=0.789  Sum_probs=249.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~   87 (415)
                      -.++|.+.+.||.|+||.||+|.+..+|..||+|++..............+|+.++++++|+||+++++++...  +.+|
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            35789999999999999999999999999999999976554444444566899999999999999999998654  5689


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      +||||++++|..++......+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus        85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            99999999999988876677999999999999999999999999999999999999999999999999999887654444


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|++....+....
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK  244 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence            44556678899999997766789999999999999999999999999999999999999988888777777655554332


Q ss_pred             cccc--cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 014985          248 YQYV--AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN  304 (415)
Q Consensus       248 ~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~  304 (415)
                      +...  ....+...++..++++.+||.+||+.||++|||+++++.||||...+++..+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~  303 (309)
T cd07845         245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE  303 (309)
T ss_pred             ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCC
Confidence            2221  11122233445689999999999999999999999999999999877765443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-49  Score=374.82  Aligned_cols=282  Identities=50%  Similarity=0.870  Sum_probs=239.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58999999999999999999999999999999876544444445677899999999999999999999999999999999


Q ss_pred             ccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           93 METDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        93 ~~g~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      +.++|..++....  ..+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++...+........
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH  160 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence            9999988886543  56899999999999999999999999999999999999999999999999999876555544556


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc-c
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-Q  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~  249 (415)
                      ..++..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..++..++......|+......++... .
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (285)
T cd07861         161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP  240 (285)
T ss_pred             CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence            677888999999876566789999999999999999999999999988888888888887777777665544443211 1


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .............++.++++||.+||..||.+|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            111112223345679999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.4e-50  Score=384.02  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=220.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ....++|.+.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++..++.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            33468999999999999999999999999999999999754321 22234567899999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+. |+|...+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus        94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999998 4777777654 458999999999999999999999999999999999999999999999999998764322


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                         ...+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....                
T Consensus       173 ---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----------------  232 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL----------------  232 (329)
T ss_pred             ---ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc----------------
Confidence               34578999999999976 5578999999999999999999999988877666666543200                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                                  .+...++..+++||.+||+.||.+|++     +++++.||||....+.
T Consensus       233 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        233 ------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                        011234788999999999999999997     7999999999875543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.6e-49  Score=383.16  Aligned_cols=283  Identities=34%  Similarity=0.543  Sum_probs=224.1

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----   84 (415)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||++++++|....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4689999999999999999999999999999999998765443344446778999999999999999999986543    


Q ss_pred             --eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 --~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                        .+|+||||+++++...+..   .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence              5799999999998887753   38899999999999999999999999999999999999999999999999997643


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      . ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...++.+....+......
T Consensus       175 ~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         175 T-NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             c-CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            2 223345678899999999977 56899999999999999999999999998888887777776665432211110000


Q ss_pred             --------ccchhcc------cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          243 --------PDYVEYQ------YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       243 --------~~~~~~~------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                              +......      ....+.........+.++++||.+||+.||++|||+.|+|+||||..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                    0000000      00000011112234678999999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5e-50  Score=384.98  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=212.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccC-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-   95 (415)
                      +.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||++++++|...+.+|+||||+.| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4799999999999999999999999999754321 22233566899999999999999999999999999999999995 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR  175 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~  175 (415)
                      +|...+.. +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            67666654 45689999999999999999999999999999999999999999999999999986544344445567999


Q ss_pred             ceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCC
Q 014985          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (415)
Q Consensus       176 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (415)
                      .|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+....                           
T Consensus       160 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------------------------  211 (323)
T cd05571         160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------------------------  211 (323)
T ss_pred             cccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence            9999999976 568999999999999999999999998776655555443210                           


Q ss_pred             ccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          256 LRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       256 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                       ..+...++.++.+||.+||..||++||     ++.++++||||....+.
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence             011234589999999999999999999     89999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-50  Score=377.83  Aligned_cols=256  Identities=26%  Similarity=0.343  Sum_probs=217.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            5799999999999999999999999999999998754321 122335678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            9998 5788877654 45899999999999999999999999999999999999999999999999999865332   23


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....                    
T Consensus       157 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------------------  215 (291)
T cd05612         157 TLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--------------------  215 (291)
T ss_pred             cccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--------------------
Confidence            4578999999999876 5689999999999999999999999998877776666543210                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                              .+...++..+++||.+||+.||.+|++     ++++++||||....+.
T Consensus       216 --------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         216 --------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             --------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                    111234789999999999999999995     9999999999876553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.4e-50  Score=390.83  Aligned_cols=286  Identities=34%  Similarity=0.575  Sum_probs=230.4

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-----eEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NLH   87 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~   87 (415)
                      +|.+.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999999999999998654322223345778999999999999999999998776     799


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-C
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-R  166 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~  166 (415)
                      +||||+.++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            99999999998888654 458999999999999999999999999999999999999999999999999998654322 2


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC-ccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL-PDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  245 (415)
                      .....++++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...++.+....+...... ...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  239 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH  239 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence            3344567889999999987667899999999999999999999999999999999999888876654332211000 000


Q ss_pred             hhcccccCCC---ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          246 VEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       246 ~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ........+.   ........++++.+||.+||+.||++|||+.|+++||||....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  296 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL  296 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence            0000000111   11223456899999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-50  Score=375.10  Aligned_cols=290  Identities=29%  Similarity=0.504  Sum_probs=231.0

Q ss_pred             cccccccc-ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-----C---CCee
Q 014985            4 VDLSKKVA-DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----S---PHII   74 (415)
Q Consensus         4 ~~~~~~~~-~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-----h---p~Iv   74 (415)
                      +-+++.+. .||.++++||+|.|++||+|+|+.+.+.||+|+.+..   ....+.++.||++|++++     |   .+||
T Consensus        69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            44566776 9999999999999999999999999999999998643   233456789999999983     3   4799


Q ss_pred             eEEeeeec----CCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEE----
Q 014985           75 ELIDAFPH----KGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLI----  144 (415)
Q Consensus        75 ~l~~~~~~----~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi----  144 (415)
                      +|+|.|..    +.|+|||+|+++.+|+.+|.+.+ ..++...+++|++||+.||+|||+ +||||.||||+|||+    
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            99999965    45999999999999999998864 459999999999999999999996 689999999999999    


Q ss_pred             --------------------------------------------------------------------------------
Q 014985          145 --------------------------------------------------------------------------------  144 (415)
Q Consensus       145 --------------------------------------------------------------------------------  144 (415)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------e-----------------------------------------------
Q 014985          145 --------------------------------G-----------------------------------------------  145 (415)
Q Consensus       145 --------------------------------~-----------------------------------------------  145 (415)
                                                      .                                               
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                            0                                               


Q ss_pred             ---cCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC------
Q 014985          146 ---SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------  216 (415)
Q Consensus       146 ---~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------  216 (415)
                         .+-+|||+|||.|+++   ...++..+.|+.|+|||++.| ..|++.+||||++|++|||+||..+|...+      
T Consensus       386 ~~~~di~vKIaDlGNACW~---~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r  461 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWV---HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR  461 (590)
T ss_pred             CCccceeEEEeeccchhhh---hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence               0013899999999985   556788899999999999999 459999999999999999999998887653      


Q ss_pred             cHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc-------ccCCCcccc------CC-CCCHHHHHHHHHhcCCCCCCC
Q 014985          217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY-------VAAPPLRSL------FP-SASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       217 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~------~~-~~s~~~~~li~~~L~~dP~~R  282 (415)
                      +.++++.|++.+|..+....-.-.+..++++..-       ....++...      ++ .-..++.+||.-||+++|++|
T Consensus       462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence            8899999999999765532222222222221100       000111000      11 123467899999999999999


Q ss_pred             CCHHHHhcCCCCCCCCCC
Q 014985          283 ITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       283 pt~~e~l~h~~~~~~~~~  300 (415)
                      +||.++|+|||+.....+
T Consensus       542 ~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  542 PTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             ccHHHHhcCccccCCCCC
Confidence            999999999999876554

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-51  Score=373.76  Aligned_cols=256  Identities=29%  Similarity=0.517  Sum_probs=228.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .+.-+|++.+.||+|+||.|-+|.+...|+.||||.|++.+.+.. ....+.+||.||..|+||||+.+|++|++.+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            467899999999999999999999999999999999998875543 3446789999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |||||.. |+|++++..++ .+++.+++.+++||..|+.|||+++++|||||.+|||+|.++++||+|||++..+.. ..
T Consensus       130 ivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~k  207 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-KK  207 (668)
T ss_pred             EEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-cc
Confidence            9999998 68999988765 499999999999999999999999999999999999999999999999999987743 55


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ...++||++.|.+||++.|..+-+..+|.|||||+||.|+.|..||+|.+....+.+|..+-...               
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---------------  272 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---------------  272 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---------------
Confidence            67789999999999999997777899999999999999999999999998888877776542211               


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                    |.-+.++.-||+.||..||++|.|+++|-.|=|.+
T Consensus       273 --------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  273 --------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             --------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                          22256789999999999999999999999997754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-49  Score=373.22  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=216.5

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .|.+.+.||+|+||+||+|.+..+|+.||+|.+....... .....+.+|+.+++.++|+||++++++|...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3788999999999999999999999999999987654322 222346789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+. |+|...+... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            998 5676666543 345899999999999999999999999999999999999999999999999999875332 2334


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+........                 
T Consensus       160 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------  221 (285)
T cd05631         160 GRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-----------------  221 (285)
T ss_pred             CCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------------
Confidence            5678999999999976 5689999999999999999999999988765443333333221110                 


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLPT  301 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~~  301 (415)
                             ..+...++.++.+||.+||+.||++||+     ++++++||||.+..+..
T Consensus       222 -------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         222 -------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             -------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence                   1122345899999999999999999997     89999999998866543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-49  Score=388.05  Aligned_cols=278  Identities=25%  Similarity=0.330  Sum_probs=218.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|....        ..+.+|+.++++++||||++++++|......++|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            4689999999999999999999999999999997432        23568999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC-CCccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-DRRFT  169 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~-~~~~~  169 (415)
                      |++.++|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .....
T Consensus       163 e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        163 PRYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence            999999998887654 4899999999999999999999999999999999999999999999999999754322 22344


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-------CcHHHHHHHHHHhCCCCCCCCCCCCC-
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-------SDIDQLGKIFAAFGTATPSQWPDLAY-  241 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~-  241 (415)
                      ..+||+.|+|||++.+ ..++.++|||||||++|||++|..||...       ....++..+....+..+.....+... 
T Consensus       242 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        242 GWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             cccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            5679999999999976 56899999999999999999998655432       23456777777766543322111100 


Q ss_pred             Cccch-h--cccccCCC---ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          242 LPDYV-E--YQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       242 ~~~~~-~--~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      +.... .  ......+.   .......++.++.+||.+||++||.+|||++|+|+||||...+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            00000 0  00000000   0011123567899999999999999999999999999998754

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.4e-49  Score=385.20  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=215.6

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.++..++|+||+++++.|.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999999754322 222335668999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC---
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---  166 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~---  166 (415)
                      |||+| +|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......   
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99984 777777654 4599999999999999999999999999999999999999999999999999875432110   


Q ss_pred             --------------------------------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 014985          167 --------------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG  214 (415)
Q Consensus       167 --------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  214 (415)
                                                      .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            0124579999999999976 5689999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCC---CCCCHHHHhcC
Q 014985          215 SSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPK---ARITAQQALEH  291 (415)
Q Consensus       215 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rpt~~e~l~h  291 (415)
                      .+..+...++........   .                 ++    ...+++++++||.+|+. +|.   .||+++|+++|
T Consensus       239 ~~~~~~~~~i~~~~~~~~---~-----------------p~----~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQETYKKVMNWKETLI---F-----------------PP----EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHHHHHHHHcCcCccc---C-----------------CC----cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            887777766654211000   0                 00    11358999999999875 455   45899999999


Q ss_pred             CCCCCCCCCC
Q 014985          292 RYFSSAPLPT  301 (415)
Q Consensus       292 ~~~~~~~~~~  301 (415)
                      |||.+..+..
T Consensus       294 p~f~~~~~~~  303 (363)
T cd05628         294 PFFEGVDWEH  303 (363)
T ss_pred             CCCCCCCHHH
Confidence            9999876643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-50  Score=384.33  Aligned_cols=257  Identities=28%  Similarity=0.478  Sum_probs=237.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe-EEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN-LHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~~lv   89 (415)
                      .++|.+++++|+|+||.+++++++..++.|++|.+......+.....+.+|+.+++++.|||||.+.+.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            578999999999999999999999999999999999988887777788999999999999999999999999888 9999


Q ss_pred             eeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |+||+ |++.+.|.+.+ ..++++.+..|+.|++.||.|||+++|+|||||+.|||++.++.|||.|||+|+..+.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999 58888887776 67999999999999999999999999999999999999999999999999999999887777


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..+.+||+.||+||++.+ .+|+.++|||||||++|||++-++.|.+.+-.....+|+.....+.+.             
T Consensus       163 a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~-------------  228 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS-------------  228 (426)
T ss_pred             hheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc-------------
Confidence            888999999999999987 789999999999999999999999999999999999998876444333             


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                    ..|.+++.+|..||..+|..||++.++|.+|...
T Consensus       229 --------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  229 --------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             --------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence                          3489999999999999999999999999998764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=378.63  Aligned_cols=263  Identities=28%  Similarity=0.453  Sum_probs=239.6

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..|..=|.+.+.||+|.|++|-+|+|-.+|..||||++.+.+..+-....+++|+..|+.++|||||+||++...+..+|
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            35778899999999999999999999999999999999998887777778899999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceecCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~~~~~  165 (415)
                      +|+|+-. |+|.++|.+....+.+..+++|++||+.|+.|||+..+|||||||+||.+-+ -|-|||+|||++..+. +.
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG  172 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PG  172 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-Cc
Confidence            9999998 6999999999888999999999999999999999999999999999997764 5899999999998774 56


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ...++.||+..|.|||+++|..+..+++||||||||||.|++|++||...++.+.+-.|+.+-.                
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----------------  236 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----------------  236 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc----------------
Confidence            6788899999999999999977666789999999999999999999999999999998877521                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                                  .....+|.++++||..||..||++|.+.++|..|+|++....
T Consensus       237 ------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  237 ------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                        112245999999999999999999999999999999987644

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-49  Score=381.92  Aligned_cols=264  Identities=26%  Similarity=0.346  Sum_probs=221.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++|+||+++++++......|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            5799999999999999999999999999999999865431 222334668999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~  168 (415)
                      ||++ |+|..++.+....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            9997 688888887656799999999999999999999999999999999999999999999999999987644332 22


Q ss_pred             cccccccceeCcccccC-----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          169 THQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ....||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+..+......   ..+       
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---~~~-------  230 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---LKF-------  230 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---cCC-------
Confidence            34578999999999863     345789999999999999999999999988877776666542110   000       


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                                    ...+.++.++.+||.+||. +|.+|||+++++.||||....+.
T Consensus       231 --------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         231 --------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                          1123468999999999998 99999999999999999876554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.8e-49  Score=382.18  Aligned_cols=284  Identities=33%  Similarity=0.536  Sum_probs=228.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||++++++|...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            467899999999999999999999999999999999876544444444677899999999999999999987543     


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ..+|+||||+++++...+..   .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             35899999999999888764   37899999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...++.+.+..+......
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            32 22345678899999999977 56899999999999999999999999999999999888888776654332222111


Q ss_pred             c--------cchhcc------cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 P--------DYVEYQ------YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~--------~~~~~~------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .        .+..+.      ....+.........+..+++||.+||+.||.+|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            0        000000      000000111122346789999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-49  Score=383.57  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=215.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||++++++|.+..++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            5799999999999999999999999999999999754322 222334668999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC---
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~---  166 (415)
                      |||. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....   
T Consensus        81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            9998 4677777654 4599999999999999999999999999999999999999999999999999875432110   


Q ss_pred             -----------------------------------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCC
Q 014985          167 -----------------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF  211 (415)
Q Consensus       167 -----------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p  211 (415)
                                                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCC
Confidence                                               1113468999999999876 5689999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC---HHHH
Q 014985          212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQA  288 (415)
Q Consensus       212 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~  288 (415)
                      |.+.+..+....+.......   ..+                     ....+++++++||.+||. +|.+|++   ++++
T Consensus       239 f~~~~~~~~~~~i~~~~~~~---~~~---------------------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l  293 (364)
T cd05599         239 FCSDNPQETYRKIINWKETL---QFP---------------------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI  293 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCcc---CCC---------------------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence            99888776666554321000   000                     011358999999999997 9999998   9999


Q ss_pred             hcCCCCCCCCC
Q 014985          289 LEHRYFSSAPL  299 (415)
Q Consensus       289 l~h~~~~~~~~  299 (415)
                      ++||||....+
T Consensus       294 l~h~~~~~~~~  304 (364)
T cd05599         294 KSHPFFKGVDW  304 (364)
T ss_pred             hcCCCcCCCCH
Confidence            99999987655

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-48  Score=369.37  Aligned_cols=284  Identities=46%  Similarity=0.803  Sum_probs=240.8

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCe-----
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGN-----   85 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~-----   85 (415)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            5799999999999999999999999999999998765544444456778999999995 5999999999877665     


Q ss_pred             EEEEeecccCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeecccee
Q 014985           86 LHLVFEFMETDLETVIRNTN----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARI  160 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~----~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~  160 (415)
                      .|+||||++++|..++....    ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            89999999999988886542    35899999999999999999999999999999999999998 88999999999987


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      +...........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..++..++.+....|+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            65554455556778889999998765668999999999999999999999999999999999998888877777776655


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      .......+............+.++..+.+||.+||..||.+||++.+++.||||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            5544443332222333444567899999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.1e-49  Score=385.41  Aligned_cols=262  Identities=26%  Similarity=0.356  Sum_probs=212.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||++++++|.+.+++|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            689999999999999999999999999999999764322 2223456789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-----
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-----  165 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-----  165 (415)
                      ||+ |+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++..+....     
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            998 5777777654 458999999999999999999999999999999999999999999999999976431100     


Q ss_pred             ------------------------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHH
Q 014985          166 ------------------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFA  203 (415)
Q Consensus       166 ------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~  203 (415)
                                                                ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHH
Confidence                                                      00123578999999999976 56899999999999999


Q ss_pred             HHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcC--CCCCC
Q 014985          204 ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT--YDPKA  281 (415)
Q Consensus       204 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dP~~  281 (415)
                      ||++|.+||...+..+....+.......   .+                     .....+++++++||.+||.  .++..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~---------------------~~~~~~s~~~~dli~~ll~~~~~~~~  295 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTL---HI---------------------PPQVKLSPEAVDLITKLCCSAEERLG  295 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHcccccc---CC---------------------CCCCCCCHHHHHHHHHHccCcccccC
Confidence            9999999998877666555543211100   00                     0112458999999999665  45556


Q ss_pred             CCCHHHHhcCCCCCCCCCC
Q 014985          282 RITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       282 Rpt~~e~l~h~~~~~~~~~  300 (415)
                      |+++++++.||||....+.
T Consensus       296 R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         296 RNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             CCCHHHHhcCcccCCCChh
Confidence            9999999999999876553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-48  Score=366.72  Aligned_cols=283  Identities=49%  Similarity=0.912  Sum_probs=245.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            58999999999999999999999999999999987654444455678999999999999999999999999999999999


Q ss_pred             ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Cccccc
Q 014985           93 METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQ  171 (415)
Q Consensus        93 ~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~~~~~  171 (415)
                      ++++|...+......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ  160 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence            9779999988776779999999999999999999999999999999999999999999999999998765433 234456


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      .++.+|+|||++.+...++.++|||||||++|+|++|.++|.+.++...+..+...++......|+......++....+.
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07832         161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP  240 (286)
T ss_pred             cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence            78889999999877666789999999999999999999999999999999999999888887778776655554333222


Q ss_pred             cCC--CccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          252 AAP--PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       252 ~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      ...  .+...++..+.++.+||.+||..||.+|||++++++||||.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            222  23455677889999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-49  Score=382.43  Aligned_cols=284  Identities=35%  Similarity=0.609  Sum_probs=228.9

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||++++++|...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            467899999999999999999999999999999999875433322334566899999999999999999988543     


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ...|+++++++++|...+..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence             35799999998898877753  348999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+...+..+......
T Consensus       170 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         170 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             C---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            3   2345678999999999987667899999999999999999999999998888888888877766543322211100


Q ss_pred             cc--ch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PD--YV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~--~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ..  +. .........+...+...++.+.+||.+||..||.+|||+.|+++||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            00  00 000111112233445667889999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.6e-48  Score=379.42  Aligned_cols=284  Identities=33%  Similarity=0.542  Sum_probs=226.9

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|.+.+.||+|+||.||+|.+..+++.+|+|++............+.+|+.+++.++||||++++++|...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            468999999999999999999999999999999999876544433344567899999999999999999988543     


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ..+|+||||+++++...+..   .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             35799999999998888764   38899999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...++.+.++.+......
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            32 22345678899999999976 56899999999999999999999999999888888888887776554332221100


Q ss_pred             --------ccchhc------ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 --------PDYVEY------QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 --------~~~~~~------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                              +.+...      .....+.........+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                    000000      0000000111222346789999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-48  Score=384.21  Aligned_cols=262  Identities=25%  Similarity=0.362  Sum_probs=214.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+|+++++||+|+||+||+|++..+++.||+|++..... .......+.+|+.++++++||||+++++.|.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            369999999999999999999999999999999875432 1222335678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----  165 (415)
                      |||+ |+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+....    
T Consensus        81 E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          81 DYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            9998 5788877654 458999999999999999999999999999999999999999999999999975321000    


Q ss_pred             -------------------------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHH
Q 014985          166 -------------------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIF  202 (415)
Q Consensus       166 -------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il  202 (415)
                                                                 ......+||+.|+|||++.+ ..|+.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHH
Confidence                                                       00123478999999999976 5689999999999999


Q ss_pred             HHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCC
Q 014985          203 AELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       203 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  282 (415)
                      |||++|.+||.+.+..+....+........                        ......+++++.+||.+|+ .+|.+|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~s~~~~~li~~l~-~~p~~R  293 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH------------------------IPPQAKLSPEASDLIIKLC-RGPEDR  293 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcC------------------------CCCcccCCHHHHHHHHHHc-cCHhHc
Confidence            999999999998877666655543211000                        0111345899999999987 599999


Q ss_pred             CC---HHHHhcCCCCCCCCCC
Q 014985          283 IT---AQQALEHRYFSSAPLP  300 (415)
Q Consensus       283 pt---~~e~l~h~~~~~~~~~  300 (415)
                      ++   ++++++||||....+.
T Consensus       294 ~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         294 LGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             CCCCCHHHHhcCCCcCCcChH
Confidence            97   9999999999876553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-48  Score=373.95  Aligned_cols=274  Identities=38%  Similarity=0.702  Sum_probs=216.6

Q ss_pred             eeeecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--CCeEEEEeec
Q 014985           17 REVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNLHLVFEF   92 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv~e~   92 (415)
                      .++||+|+||+||+|.+.  .+++.||+|.+....    ....+.+|+.+++.++||||++++++|..  +..+|+||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999865  467899999986432    22356789999999999999999998854  5678999999


Q ss_pred             ccCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE----ecCCcEEEeeecccee
Q 014985           93 METDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARI  160 (415)
Q Consensus        93 ~~g~L~~~i~~~--------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi----~~~~~vkL~DFG~a~~  160 (415)
                      ++++|..++...        ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            999998887642        2248999999999999999999999999999999999999    4567899999999987


Q ss_pred             cCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---------HHHHHHHHHHh
Q 014985          161 FGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAF  228 (415)
Q Consensus       161 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~  228 (415)
                      ......   .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .+.+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            654322   234567899999999998766789999999999999999999999976543         46677888888


Q ss_pred             CCCCCCCCCCCCCCccchhcc----c--ccC----CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          229 GTATPSQWPDLAYLPDYVEYQ----Y--VAA----PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~----~--~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      +.+....|......+......    .  ...    ..+.......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            877776666554433221100    0  000    00111122346789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-51  Score=379.94  Aligned_cols=258  Identities=29%  Similarity=0.456  Sum_probs=220.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ...|..+++||+|.||.||+|.+..+++.||+|++........ .+.+.+|+.+|.+++++||.++|+.|-.+..+|++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            4568888999999999999999999999999999988765443 346788999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||.| ++++++. .+..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+...........
T Consensus        91 ey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   91 EYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            99996 5555555 455569999999999999999999999999999999999999999999999999988877776678


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      +.+||++|||||++.+ ..|+.++||||||++.|||++|.||+..-.....+..|-+                       
T Consensus       170 tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-----------------------  225 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-----------------------  225 (467)
T ss_pred             cccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-----------------------
Confidence            8999999999999985 6799999999999999999999999976654222111100                       


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                        ..||  .+-...|+.+++||..||++||+.||+|.++|+|+|++...
T Consensus       226 --~~PP--~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  226 --SAPP--RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             --CCCC--ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence              0111  11125589999999999999999999999999999998744

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-48  Score=379.12  Aligned_cols=262  Identities=29%  Similarity=0.456  Sum_probs=220.9

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.++..++||||++++++|.+++++|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            57999999999999999999999999999999997643222 23345678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----  165 (415)
                      ||+. |+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            9998 5788887765 569999999999999999999999999999999999999999999999999998764433    


Q ss_pred             -------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH
Q 014985          166 -------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ  220 (415)
Q Consensus       166 -------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  220 (415)
                                               ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                     23345678999999999977 4689999999999999999999999998887766


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCCCCC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-AQQALEHRYFSSAPL  299 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~l~h~~~~~~~~  299 (415)
                      ..++.........                        ...+.+++++.+||.+||. ||.+|++ ++++++||||....+
T Consensus       239 ~~~i~~~~~~~~~------------------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         239 YNKIINWKESLRF------------------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHhccCCcccC------------------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            6665442111000                        0111258999999999997 9999999 999999999987655


Q ss_pred             C
Q 014985          300 P  300 (415)
Q Consensus       300 ~  300 (415)
                      .
T Consensus       294 ~  294 (350)
T cd05573         294 E  294 (350)
T ss_pred             H
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-49  Score=379.98  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=217.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCC-cEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..++|.+.+.||+|+||.||+|.+..++ ..||+|++..... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            4678999999999999999999876655 6899999875432 2223335678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||+. |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......  
T Consensus       108 lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            9999998 5777777654 45899999999999999999999999999999999999999999999999999876432  


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+.....                 
T Consensus       185 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-----------------  245 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-----------------  245 (340)
T ss_pred             -cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-----------------
Confidence             235678999999999976 5588999999999999999999999998877766666543210                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                                 .+.+.++..+.+||.+||+.||++|+     +++++++||||.+..+.
T Consensus       246 -----------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        246 -----------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                       11234588999999999999999995     89999999999876553

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-48  Score=372.78  Aligned_cols=256  Identities=24%  Similarity=0.378  Sum_probs=212.8

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHH---HhcCCCCeeeEEeeeecCCeEEEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLL---KELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il---~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      |++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++   +.++||||++++++|...+++|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999754321 22223455666555   566899999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||+.| +|...+..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999995 66665543  358999999999999999999999999999999999999999999999999987644333444


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....                   
T Consensus       159 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-------------------  218 (324)
T cd05589         159 STFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-------------------  218 (324)
T ss_pred             cccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence            55678999999999976 5689999999999999999999999998887777666543210                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                               .....++.++.+||.+||+.||.+||     ++.++++||||.+..+.
T Consensus       219 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         219 ---------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             ---------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence                     11124588999999999999999999     79999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-48  Score=374.65  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=211.3

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccC-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-   95 (415)
                      +.||+|+||.||++++..+|+.||+|++...... ......+.+|+.+++.++||||++++++|...+.+|+||||++| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4799999999999999999999999999764321 22223456799999999999999999999999999999999995 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR  175 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~  175 (415)
                      +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            66666554 44689999999999999999999999999999999999999999999999999886444344445567899


Q ss_pred             ceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCC
Q 014985          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (415)
Q Consensus       176 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (415)
                      .|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....                           
T Consensus       160 ~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------------------------  211 (323)
T cd05595         160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------------------------  211 (323)
T ss_pred             CcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------------------
Confidence            9999999976 568999999999999999999999998877666555543210                           


Q ss_pred             ccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          256 LRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       256 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                       ..+...+++++.+||.+||..||++|+     ++.++++|+||....+
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence             011224589999999999999999998     8999999999987554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-48  Score=382.44  Aligned_cols=261  Identities=28%  Similarity=0.401  Sum_probs=212.9

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||++++++|.+..++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            579999999999999999999999999999999875432 1222234668999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC---
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~---  166 (415)
                      ||++ |+|..++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9998 5787777654 4589999999999999999999999999999999999999999999999999863311000   


Q ss_pred             --------------------------------------------cccccccccceeCcccccCCcCCCCcccHHHHHHHH
Q 014985          167 --------------------------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIF  202 (415)
Q Consensus       167 --------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il  202 (415)
                                                                  .....+||+.|+|||++.+ ..++.++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil  238 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhh
Confidence                                                        0012468999999999976 5689999999999999


Q ss_pred             HHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCC
Q 014985          203 AELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       203 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  282 (415)
                      |||++|.+||.+.+..+.+..+......   -.+++                     ...++.++++||.+||. +|.+|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~---------------------~~~~s~~~~dli~~lL~-~~~~r  293 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRET---LYFPD---------------------DIHLSVEAEDLIRRLIT-NAENR  293 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCc---cCCCC---------------------CCCCCHHHHHHHHHHhc-CHhhc
Confidence            9999999999988776666665432100   00110                     11358899999999998 77765


Q ss_pred             ---CCHHHHhcCCCCCCCCC
Q 014985          283 ---ITAQQALEHRYFSSAPL  299 (415)
Q Consensus       283 ---pt~~e~l~h~~~~~~~~  299 (415)
                         +++.+++.||||.+..+
T Consensus       294 ~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         294 LGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             CCCCCHHHHhcCCCcCCCCH
Confidence               59999999999987554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-48  Score=364.88  Aligned_cols=283  Identities=42%  Similarity=0.795  Sum_probs=236.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++|+||+++++++......|+||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            57899999999999999999999999999999998754322 22234668999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            99999999988877667899999999999999999999999999999999999999999999999998765433333334


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC-cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.+.+..|+............
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            4567789999998765668899999999999999999999997766 566777777887777777776665444433322


Q ss_pred             c--ccCCCccccCCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 Y--VAAPPLRSLFPSAS--DDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~--~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .  .....+....+.++  .++.++|.+||+.||++|||+.++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            2  12222334444556  899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.4e-48  Score=371.74  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=211.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.++..+ +||||++++++|...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999875432 222233456788888876 699999999999999999999999995


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence             677666554 459999999999999999999999999999999999999999999999999988654333344556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-------------------------  213 (320)
T cd05590         160 PDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-------------------------  213 (320)
T ss_pred             ccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence            99999999976 5689999999999999999999999998887777766643210                         


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~h~~~~~~~~  299 (415)
                         .....++.++.+||.+||+.||++|+++      ++++.||||....+
T Consensus       214 ---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         214 ---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence               0112358899999999999999999998      99999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.6e-48  Score=365.77  Aligned_cols=282  Identities=50%  Similarity=0.879  Sum_probs=238.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||.|+||.||+|.+..+|+.||||.+............+.+|++++++++||||+++++++.+....|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999999876554444445678899999999999999999999999999999999


Q ss_pred             ccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           93 METDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        93 ~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      +.++|..++... +..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++.............
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE  160 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence            999988888654 3568999999999999999999999999999999999999999999999999998765554455556


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh-ccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~  250 (415)
                      .++..|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+.++...++.+....|+.....+.+.. +..
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07860         161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK  240 (284)
T ss_pred             cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence            6788899999987766678899999999999999999999999998888888888888776666654433332221 111


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .....+....+.++.+++++|.+||+.||++|||+++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            11222334456678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.8e-49  Score=377.42  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=211.1

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccC-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-   95 (415)
                      +.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+.+|+||||++| 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999764322 22233567899999999999999999999999999999999985 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR  175 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~  175 (415)
                      +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            67666654 44689999999999999999999999999999999999999999999999999986443333445567899


Q ss_pred             ceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCC
Q 014985          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (415)
Q Consensus       176 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (415)
                      .|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....                           
T Consensus       160 ~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---------------------------  211 (328)
T cd05593         160 EYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---------------------------  211 (328)
T ss_pred             CccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---------------------------
Confidence            9999999976 568999999999999999999999998776655554432110                           


Q ss_pred             ccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          256 LRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       256 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                       ..+...++.++.+||.+||..||++|+     ++.++++|+||.+..+
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         212 -IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             -ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence             011234589999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.6e-48  Score=372.06  Aligned_cols=294  Identities=44%  Similarity=0.814  Sum_probs=249.8

Q ss_pred             ccccccEee-eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC------------ccchHHHHHHHHHhcCCCCee
Q 014985            8 KKVADRYLK-REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------------VNFTALREIKLLKELKSPHII   74 (415)
Q Consensus         8 ~~~~~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------------~~~~~~~E~~il~~l~hp~Iv   74 (415)
                      ..+.++|.. .+.||.|+||+||+|.+..+++.||+|++........            ....+.+|+.+++.++|+||+
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            456889975 5779999999999999999999999999875433221            112467899999999999999


Q ss_pred             eEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEee
Q 014985           75 ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        75 ~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                      +++++|..++..|+||||+.|+|...+... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             eeeEEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECC
Confidence            999999999999999999999999888654 4589999999999999999999999999999999999999999999999


Q ss_pred             eccceecCC--------------CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH
Q 014985          155 FGLARIFGS--------------PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ  220 (415)
Q Consensus       155 FG~a~~~~~--------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  220 (415)
                      ||++.....              .........++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.++.+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999987651              112223345677899999997766679999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      +..++..++.+....|+.....+.+..+............+..+.++.+||.+||+.+|++|||+++++.||||.....+
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            99999999988888888877666665555555555556667789999999999999999999999999999999876655


Q ss_pred             CC
Q 014985          301 TE  302 (415)
Q Consensus       301 ~~  302 (415)
                      ..
T Consensus       323 ~~  324 (335)
T PTZ00024        323 CD  324 (335)
T ss_pred             CC
Confidence            43

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-48  Score=376.45  Aligned_cols=263  Identities=28%  Similarity=0.407  Sum_probs=219.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..++||||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4799999999999999999999999999999999764322 122335678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++ |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ...
T Consensus        81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            9998 5777777654 4589999999999999999999999999999999999999999999999999986543   334


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+.........                
T Consensus       157 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------------  219 (333)
T cd05600         157 SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR----------------  219 (333)
T ss_pred             CcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC----------------
Confidence            5678999999999977 47899999999999999999999999988777766665432111000                


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                          +........+++++.+||.+||..+|.+||+++++++||||....+
T Consensus       220 ----~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         220 ----PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             ----CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                0000111346899999999999999999999999999999987554

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-47  Score=361.20  Aligned_cols=283  Identities=42%  Similarity=0.734  Sum_probs=229.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            58999999999999999999999999999999987554333334456789999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++++++..+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY  160 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence            99988777776666669999999999999999999999999999999999999999999999999998775544344455


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC---CCCCCCCccchhc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ---WPDLAYLPDYVEY  248 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~~~  248 (415)
                      .++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++...+..   +............
T Consensus       161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07847         161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP  240 (286)
T ss_pred             ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence            6788899999987756688999999999999999999999999888888777776655433211   0000000000000


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ......+.....+.++..+.+||.+||+.||++||++.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0001112233456778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-49  Score=374.16  Aligned_cols=249  Identities=29%  Similarity=0.428  Sum_probs=210.1

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L   97 (415)
                      ||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||++++++|...+..|+||||+. |+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999999999999999875432 12223346689999999999999999999999999999999998 577


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccce
Q 014985           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (415)
Q Consensus        98 ~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y  177 (415)
                      ...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            7777654 458999999999999999999999999999999999999999999999999998654434444556789999


Q ss_pred             eCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcc
Q 014985          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR  257 (415)
Q Consensus       178 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (415)
                      +|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...     +                       .
T Consensus       160 ~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----~-----------------------~  210 (312)
T cd05585         160 LAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----P-----------------------L  210 (312)
T ss_pred             CCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----C-----------------------C
Confidence            99999976 56899999999999999999999999887766655554321     0                       0


Q ss_pred             ccCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCCC
Q 014985          258 SLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRYFSSAP  298 (415)
Q Consensus       258 ~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~l~h~~~~~~~  298 (415)
                      .+...+++++.+||.+||..||.+||   ++.+++.||||....
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            11234588999999999999999997   589999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.8e-48  Score=370.32  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=215.8

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCC-CeeeEEeeeecCCeEEEEe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSP-HIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lv~   90 (415)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+..|+.++..+.|+ +|++++++|...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999976432 122233566799999999775 6888999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++ |+|...+... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            9998 5777777654 4589999999999999999999999999999999999999999999999999876443344445


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....                    
T Consensus       160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------------------  218 (324)
T cd05587         160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------------------  218 (324)
T ss_pred             eecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            5678999999999976 5689999999999999999999999998887777666543210                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPL  299 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~h~~~~~~~~  299 (415)
                              .+...++.++.+||.+||..||.+|++.     +++++||||....+
T Consensus       219 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         219 --------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                    1122458899999999999999999976     89999999987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.8e-48  Score=378.56  Aligned_cols=264  Identities=25%  Similarity=0.324  Sum_probs=219.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++.+...+|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3678999999999999999999999999999999997543221 222345689999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      ||||++ |+|..++...  .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ 
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            999998 5777776543  489999999999999999999999999999999999999999999999999987643322 


Q ss_pred             cccccccccceeCcccccCC---cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .....+||+.|+|||++.+.   ..++.++|||||||++|||++|.+||.+.+....+..+......   ..++      
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~------  269 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS---LTFP------  269 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc---CCCC------
Confidence            23456789999999998653   24789999999999999999999999988877776666542110   0011      


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPL  299 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~  299 (415)
                                     ..+.+|.++++||.+||+.+|.+  |++++++++||||.+..+
T Consensus       270 ---------------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         270 ---------------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ---------------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                           11245899999999999999988  999999999999987554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-48  Score=382.46  Aligned_cols=261  Identities=24%  Similarity=0.351  Sum_probs=213.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+|+.++||||+++++.|.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            379999999999999999999999999999999865432 1222345678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC-----
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-----  164 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~-----  164 (415)
                      |||+ |+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+...     
T Consensus        81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9998 5788877654 45899999999999999999999999999999999999999999999999998532100     


Q ss_pred             --------------------------------------CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHH
Q 014985          165 --------------------------------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL  206 (415)
Q Consensus       165 --------------------------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell  206 (415)
                                                            .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehh
Confidence                                                  000123578999999999976 56899999999999999999


Q ss_pred             cCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC---
Q 014985          207 NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---  283 (415)
Q Consensus       207 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---  283 (415)
                      +|.+||.+.+..+....+........   .                     .....++.++.+||.+|+ .+|.+|+   
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~---~---------------------~~~~~~s~~~~~li~~l~-~~p~~R~~~~  293 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWETTLH---I---------------------PSQAKLSREASDLILRLC-CGAEDRLGKN  293 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCcccc---C---------------------CCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence            99999998877666555432110000   0                     011245899999999987 5999999   


Q ss_pred             CHHHHhcCCCCCCCCC
Q 014985          284 TAQQALEHRYFSSAPL  299 (415)
Q Consensus       284 t~~e~l~h~~~~~~~~  299 (415)
                      ++.++++||||....+
T Consensus       294 t~~ell~h~~~~~~~~  309 (376)
T cd05598         294 GADEIKAHPFFKGIDF  309 (376)
T ss_pred             CHHHHhCCCCcCCCCH
Confidence            9999999999987544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.7e-48  Score=376.13  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=217.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||++++++|.++..+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            368999999999999999999999999999999998753322 2223346689999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||||. |+|..++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........ 
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999998 5788877643  489999999999999999999999999999999999999999999999999987643322 


Q ss_pred             cccccccccceeCcccccCC---cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .....+||+.|+|||++.+.   ..++.++|||||||++|+|++|.+||.+.+....+..+.......   .++.     
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~p~-----  270 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL---NFPE-----  270 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc---CCCC-----
Confidence            23456799999999998653   237889999999999999999999999888777777665431110   1110     


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPL  299 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~  299 (415)
                                      ...++..+++||..||+.++.+  |++++|+++||||....+
T Consensus       271 ----------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         271 ----------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             ----------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                            1235889999999999865543  899999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-48  Score=379.26  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=216.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++..++||||+++++.|.+.+++|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            579999999999999999999999999999999975432 2223345678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----  165 (415)
                      |||.| +|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......    
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99984 777777654 458999999999999999999999999999999999999999999999999987542211    


Q ss_pred             -------------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCC
Q 014985          166 -------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG  214 (415)
Q Consensus       166 -------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  214 (415)
                                                     ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCC
Confidence                                           01124578999999999976 5689999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcC
Q 014985          215 SSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---TAQQALEH  291 (415)
Q Consensus       215 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~l~h  291 (415)
                      .+.......+.......   .+                 +    ....++.++++||.+|+. ||.+|+   +++++++|
T Consensus       239 ~~~~~~~~~i~~~~~~~---~~-----------------p----~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYRKVMNWKETL---VF-----------------P----PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHHHHHcCCCce---ec-----------------C----CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            88777666654321000   00                 0    011358999999999875 999998   58999999


Q ss_pred             CCCCCCCCCC
Q 014985          292 RYFSSAPLPT  301 (415)
Q Consensus       292 ~~~~~~~~~~  301 (415)
                      |||.+..|..
T Consensus       294 p~f~~~~~~~  303 (360)
T cd05627         294 PFFEGVDWGH  303 (360)
T ss_pred             CCCCCCCHHH
Confidence            9999876644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.4e-48  Score=371.46  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=217.2

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      +|.+.+.||+|+||.||+|++..+++.||+|++...... .........|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            588999999999999999999999999999999864322 22223455688888777 5799999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++ |+|...+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            9998 5777777654 4589999999999999999999999999999999999999999999999999986544344445


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+.....                    
T Consensus       160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------------------  218 (323)
T cd05616         160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------------------  218 (323)
T ss_pred             cCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence            6678999999999976 5689999999999999999999999998887777766654210                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLPT  301 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~~  301 (415)
                              .....++.++.+||.+||+.||.+|++     ..++++||||....+..
T Consensus       219 --------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         219 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             --------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence                    111245899999999999999999997     48999999998766543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.1e-48  Score=370.25  Aligned_cols=253  Identities=26%  Similarity=0.376  Sum_probs=211.0

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|.+..+++.||+|++...... ........+|+.++..+ +||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999864322 22233456788898887 699999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|+
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence             676666554 469999999999999999999999999999999999999999999999999997643333334456789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      ..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-------------------------  213 (318)
T cd05570         160 PDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-------------------------  213 (318)
T ss_pred             ccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            99999999976 5689999999999999999999999988876666555432100                         


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPLP  300 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~h~~~~~~~~~  300 (415)
                         .....++.++.+||.+||..||.+||++     .++++||||....+.
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         214 ---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             ---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence               0112358899999999999999999999     999999999886553

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.2e-48  Score=366.27  Aligned_cols=284  Identities=45%  Similarity=0.833  Sum_probs=241.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~l   88 (415)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.+............+.+|+.++++++||||+++++++...  ...|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4689999999999999999999999999999999986654444444567899999999999999999998777  89999


Q ss_pred             EeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        89 v~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||||++++|..++......+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++..........
T Consensus        84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            99999999999888766679999999999999999999999999999999999999999999999999998876654445


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.+....|+....++.....
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            55667888999999877566789999999999999999999999999999999999988888777777655444333221


Q ss_pred             c--cccCCCccccCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 Q--YVAAPPLRSLFPS--ASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~--~~~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .  ......+...++.  +++.+.+||.+||+.||++|||+.|+++|+||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            1  1112223344554  48999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-47  Score=363.07  Aligned_cols=286  Identities=49%  Similarity=0.850  Sum_probs=241.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|.+.+.||+|++|+||+|.+..+|+.||+|.+............+.+|+++++.++||||+++++++....+.|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            68999999999999999999999999999999987654444444467789999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceecCCCCCccc
Q 014985           92 FMETDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+++++...+..... .+++..++.++.||+.||+|||++|++|+||||+||+++. ++.+||+|||++...........
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (294)
T PLN00009         82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT  161 (294)
T ss_pred             cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence            999999888865443 3688899999999999999999999999999999999985 56799999999987655444445


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++..++.+....|.+...++++....
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T PLN00009        162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF  241 (294)
T ss_pred             cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence            56778889999998775668899999999999999999999999988888888888888888877777666665553211


Q ss_pred             c-ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          250 Y-VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       250 ~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      . ..........+.++.++.++|.+||+.+|++||++.++++||||.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            1 11122233456789999999999999999999999999999999864

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.7e-48  Score=369.91  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=212.9

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      ++||+|+||.||+|.+..+++.||+|++..... .......+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999876432 222233456788888866 799999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence             777777654 458999999999999999999999999999999999999999999999999998654444444566789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....                         
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-------------------------  213 (321)
T cd05591         160 PDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-------------------------  213 (321)
T ss_pred             ccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            99999999876 5689999999999999999999999999888777776654210                         


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCC-------CHHHHhcCCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARI-------TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-------t~~e~l~h~~~~~~~~~  300 (415)
                         .....++.++.+||.+||+.||++|+       +++++++||||....+.
T Consensus       214 ---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         214 ---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence               01123478999999999999999999       99999999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=360.64  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=228.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|..+++||+|.||.|.+|+.+.+++.||+|++++...-. .....-+.|-.+|+..+||++..+-..|+..+++|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            4788999999999999999999999999999999998765322 222234568899999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||+.| .|...+.+ ...+++..++.|...|+.||.|||+++||+||||.+|+|+|.+|++||+|||+|+.--.....
T Consensus       246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            9999996 55555544 445999999999999999999999999999999999999999999999999999986666677


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..+.||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+.......|+..--                  
T Consensus       325 ~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~------------------  385 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL------------------  385 (516)
T ss_pred             eccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc------------------
Confidence            888999999999999976 6799999999999999999999999998877777777655310                  


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPTEP  303 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~~~~  303 (415)
                                .+...+|++++.|+..+|.+||.+|.     .+.||.+|+||.+..|....
T Consensus       386 ----------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~  436 (516)
T KOG0690|consen  386 ----------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATY  436 (516)
T ss_pred             ----------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence                      12235799999999999999999997     48899999999999886543

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-47  Score=366.82  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=208.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHh-cCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKE-LKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      ++||+|+||+||+|.+..+++.||+|++...... .........|..++.. .+||||+++++++...+.+|+||||++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999764322 2222234567777765 489999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           95 TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        95 g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      |+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            4676666654 458999999999999999999999999999999999999999999999999998754444445566789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....                          
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------------------  212 (316)
T cd05592         160 PDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--------------------------  212 (316)
T ss_pred             ccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            99999999976 558999999999999999999999999888766666553210                          


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-~e~l~h~~~~~~~~  299 (415)
                        ..+...++.++.+||.+||..||++|+++ .++++||||....+
T Consensus       213 --~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         213 --PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence              01112358899999999999999999986 58889999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.5e-47  Score=366.71  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHh-cCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKE-LKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      +.||+|+||.||+|.+..+|+.||+|++...... .........|..++.. ++||||++++++|...+++|+||||+. 
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999764321 2223345668888775 489999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           95 TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        95 g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      |+|...+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            4777777654 458999999999999999999999999999999999999999999999999987543333444567789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....                          
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--------------------------  212 (316)
T cd05620         160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--------------------------  212 (316)
T ss_pred             cCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            99999999976 568999999999999999999999998877666555543210                          


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-~e~l~h~~~~~~~~  299 (415)
                        ..+...++.++.+||.+||..||++|+++ +++++||||....+
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         213 --PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence              01112358899999999999999999997 58889999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-48  Score=372.30  Aligned_cols=253  Identities=25%  Similarity=0.385  Sum_probs=210.4

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccC-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-   95 (415)
                      +.||+|+||.||+|.+..+|+.||+|++...... ........+|+.+++.++||||++++++|...+.+|+||||++| 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999999999999999764322 12223456799999999999999999999999999999999995 


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++............+||
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            66655554 4468999999999999999999997 799999999999999999999999999998654334444456789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....                          
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--------------------------  212 (325)
T cd05594         160 PEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------------------------  212 (325)
T ss_pred             cccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--------------------------
Confidence            99999999976 568999999999999999999999998877655555442210                          


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                        ..+...+++++.+||.+||+.||++|+     ++.++++||||.+..+.
T Consensus       213 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         213 --IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence              011124588999999999999999997     89999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6e-48  Score=371.91  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=210.7

Q ss_pred             cEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCcc--CCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNL   86 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~--~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~   86 (415)
                      +|++.+.||+|+||+||+|++.   .+++.||+|++......  ......+.+|+.+++.++ ||||++++++|...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999764   47899999998754321  222334668999999994 89999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+. |+|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999998 5787777654 458999999999999999999999999999999999999999999999999998653332


Q ss_pred             -CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       166 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+........            
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------------  227 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD------------  227 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC------------
Confidence             2233567899999999998755688999999999999999999999975433222222211111000            


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                                  ..+.+.++..+.+||.+||+.||++||     +++++++||||....+
T Consensus       228 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         228 ------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                        012234688999999999999999999     8899999999987544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-47  Score=367.87  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+ +||||++++++|.....+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999997643322 2223466899999988 699999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence             777666544 469999999999999999999999999999999999999999999999999997543333344556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc--------HHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--------IDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|..||.....        .+.+.+....   .               
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~---------------  220 (329)
T cd05588         160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---K---------------  220 (329)
T ss_pred             ccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---C---------------
Confidence            99999999976 5689999999999999999999999964211        1111111110   0               


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRYFSSAPL  299 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------~~e~l~h~~~~~~~~  299 (415)
                               ...+...++.++.+||.+||+.||.+|++      ++++++||||....+
T Consensus       221 ---------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         221 ---------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                     00122346889999999999999999987      799999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-47  Score=386.39  Aligned_cols=276  Identities=24%  Similarity=0.389  Sum_probs=215.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC------CCeeeEEeeeecC-
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS------PHIIELIDAFPHK-   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~~~~~-   83 (415)
                      .++|.+.++||+|+||+||+|.+..+++.||||+++....   .......|+.+++.+.|      .++++++++|... 
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            5789999999999999999999999999999999864321   12234568888777754      4588999998764 


Q ss_pred             CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCC--------------
Q 014985           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHG--------------  148 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~--------------  148 (415)
                      .++|+|||+++++|+.++.+. ..+++..++.++.||+.||+|||+ .|||||||||+|||++.++              
T Consensus       205 ~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             ceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            589999999999999988765 458999999999999999999998 5999999999999998765              


Q ss_pred             --cEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHH
Q 014985          149 --QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       149 --~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  226 (415)
                        .+||+|||.+....   ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus       284 ~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        284 PCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence              49999999886532   23345688999999999987 5689999999999999999999999999999998888888


Q ss_pred             HhCCCCCCCCCCCCCCcc---chhc--------------ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014985          227 AFGTATPSQWPDLAYLPD---YVEY--------------QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l  289 (415)
                      .++..+. .|........   ....              .......+...  ..++.+.|||.+||++||.+|||++|+|
T Consensus       360 ~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        360 TLGRLPS-EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV--IRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HcCCCCH-HHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh--hchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            7775532 2211100000   0000              00000000000  1256788999999999999999999999


Q ss_pred             cCCCCCCC
Q 014985          290 EHRYFSSA  297 (415)
Q Consensus       290 ~h~~~~~~  297 (415)
                      +||||...
T Consensus       437 ~Hp~~~~~  444 (467)
T PTZ00284        437 THPYVLKY  444 (467)
T ss_pred             cCcccccc
Confidence            99999763

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-47  Score=367.70  Aligned_cols=266  Identities=24%  Similarity=0.331  Sum_probs=217.6

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|++.+.||+|+||+||++++..+++.||+|++.+... .......+.+|+.+++.++|+||++++++|..++++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            579999999999999999999999999999999875322 2222334668999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~  168 (415)
                      ||+. |+|..++.+....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            9997 588888877666799999999999999999999999999999999999999999999999999976543332 22


Q ss_pred             cccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ...+||+.|+|||++.+    ...++.++|||||||++|+|++|..||.+.+..+....+.......             
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------  227 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF-------------  227 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-------------
Confidence            33568999999999863    2457889999999999999999999998887777666654321100             


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~~  300 (415)
                                .+....+.++.++++||.+||..++++  |++++++++||||.+..+.
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         228 ----------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             ----------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence                      011122346899999999999764443  7899999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-49  Score=401.53  Aligned_cols=284  Identities=25%  Similarity=0.369  Sum_probs=237.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|.++++||+|+||.|.+++++.+++.||+|.+.+.... .....-+..|-.+|..-+.+=|+.++.+|+++.++|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            68999999999999999999999999999999998764322 22233456789999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC-CCCCc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG-SPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~-~~~~~  167 (415)
                      |||+. |||+.++.+.. .+++..+++|+..|+.||+.||+.|+|||||||+|||||..|++||+|||.|-.+. ++...
T Consensus       154 MdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             EecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            99998 68999988877 79999999999999999999999999999999999999999999999999998776 44556


Q ss_pred             ccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          168 FTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ....+|||.|.|||+|..    ...|+..+|+|||||++|||+.|..||...+-.+++.+|+..-....   +|+     
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~---FP~-----  304 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS---FPD-----  304 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC---CCc-----
Confidence            678899999999999842    24689999999999999999999999999999999999987511110   110     


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCC--CCcccccCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRYFSSAPLPTEPNKLP--RPATKRASKAS  318 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~h~~~~~~~~~~~~~~~~--~~~~~~~~~~~  318 (415)
                                      ...+|.++++||++++. +|+.|..   ++++..||||.+..|.......|  -|........+
T Consensus       305 ----------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTs  367 (1317)
T KOG0612|consen  305 ----------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTS  367 (1317)
T ss_pred             ----------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccc
Confidence                            01369999999999886 8899998   99999999999999954432222  23333334455


Q ss_pred             CC
Q 014985          319 DF  320 (415)
Q Consensus       319 ~~  320 (415)
                      +|
T Consensus       368 nF  369 (1317)
T KOG0612|consen  368 NF  369 (1317)
T ss_pred             cc
Confidence            55

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.1e-48  Score=369.28  Aligned_cols=253  Identities=26%  Similarity=0.441  Sum_probs=211.1

Q ss_pred             eeeecccCceEEEEEEEC---CCCcEEEEEEeecCCcc--CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           17 REVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++.||+|+||.||+|++.   .+++.||+|++......  ......+.+|+.+|+.++||||++++++|..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   47889999998754321  1222345689999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |+.| +|...+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus        81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          81 YLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            9995 67666655 445889999999999999999999999999999999999999999999999999865444444445


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+....+..+....                      
T Consensus       160 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~----------------------  216 (323)
T cd05584         160 FCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK----------------------  216 (323)
T ss_pred             cCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            678999999999976 557899999999999999999999999887776666654321                      


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                            ..+.+.+++++.+||.+||+.||++||     +++++++||||....+
T Consensus       217 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         217 ------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                  012234588999999999999999999     8999999999987544

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-47  Score=360.05  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=209.1

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L   97 (415)
                      ||+|+||+||++.+..+++.||+|++........ ....+..|+.+++.++|+||++++++|.....+|+||||++ |+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999875433221 22345679999999999999999999999999999999998 467


Q ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           98 ETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        98 ~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      ...+..   .+..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..............||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            666543   34568999999999999999999999999999999999999999999999999998765544444456788


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+........                      
T Consensus       161 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------  217 (280)
T cd05608         161 PGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----------------------  217 (280)
T ss_pred             cCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC----------------------
Confidence            99999999977 5688999999999999999999999987654322222222111000                      


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~~  301 (415)
                        ..+.+.++.++.+|+.+||+.||++||     +++++++||||++..+..
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         218 --VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             --CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence              012234689999999999999999999     889999999998865543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.8e-47  Score=363.14  Aligned_cols=285  Identities=45%  Similarity=0.793  Sum_probs=239.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-------   82 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------   82 (415)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+..............+|+.+++.++||||+++++++..       
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            3689999999999999999999999999999999987655444444466789999999999999999988743       


Q ss_pred             -CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           83 -KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 -~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                       ...+|+|+||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus        86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence             3357999999999999988876667999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCC-----------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCC
Q 014985          162 GSPDR-----------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT  230 (415)
Q Consensus       162 ~~~~~-----------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  230 (415)
                      .....           ..+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            33221           2234466788999999877666899999999999999999999999999999999999998888


Q ss_pred             CCCCCCCCCCCCccchhcc--cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          231 ATPSQWPDLAYLPDYVEYQ--YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ..+..|++...++......  ....+.+...+..++.++.+||.+||+.||++|||+.+++.||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            8887777766555543211  111122334455677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.3e-48  Score=369.57  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=209.1

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHH-HHHhcCCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|.+..+|+.||+|++....... .....+..|.. +++.++||||++++++|...+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999987543221 12223445554 56789999999999999999999999999995


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.. +..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence             67666655 4468999999999999999999999999999999999999999999999999997654444444556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+....                          
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------------------  212 (323)
T cd05575         160 PEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--------------------------  212 (323)
T ss_pred             hhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            99999999976 568999999999999999999999998877666665554320                          


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~h~~~~~~~~  299 (415)
                        ....+.++..+.+||.+||+.||.+||++    .++++||||....+
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence              11234568999999999999999999987    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.6e-47  Score=356.59  Aligned_cols=283  Identities=45%  Similarity=0.767  Sum_probs=230.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++..+...|+||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4789999999999999999999999999999999865432 223335678999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||+.++++..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++...........
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            99999999888776666889999999999999999999999999999999999999999999999999865444444445


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-HHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.++ .+.+..+...++.+....++.....+++....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            56788899999987655678899999999999999999999977653 56677777777766666555544444332221


Q ss_pred             ccc--CCCccccCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVA--APPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~--~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ...  .........  ..+.++.+|+.+||..||++|||+.|++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            111  111111111  126789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.2e-47  Score=358.19  Aligned_cols=281  Identities=45%  Similarity=0.842  Sum_probs=235.5

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||.|++|.||+|.+..+|..||+|++...... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            589999999999999999999999999999998765432 2234567899999999999999999999999999999999


Q ss_pred             ccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           93 METDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        93 ~~g~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ++|+|..++....  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            9999999887654  45899999999999999999999999999999999999999999999999999876554444455


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh-cc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQ  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~  249 (415)
                      ..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....++.....+....|......+.+.. +.
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP  239 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence            66788899999987756678999999999999999999999999988888888888877776666655443332211 11


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ...........+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            111112233455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.9e-48  Score=369.32  Aligned_cols=253  Identities=26%  Similarity=0.429  Sum_probs=213.3

Q ss_pred             eeeecccCceEEEEEEE---CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           17 REVLGEGTYGVVYKAID---TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~---~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      ++.||+|+||.||++++   ..+|+.||+|++..............+|+.++++++||||++++++|...+.+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999976   357899999999765433333345668999999999999999999999999999999999


Q ss_pred             c-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccc
Q 014985           94 E-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (415)
Q Consensus        94 ~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~  172 (415)
                      + |+|...+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            8 577777755 44589999999999999999999999999999999999999999999999999987655444445667


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (415)
                      |++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....                       
T Consensus       160 g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-----------------------  215 (318)
T cd05582         160 GTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-----------------------  215 (318)
T ss_pred             CChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence            8999999999976 5678999999999999999999999998877766666543210                       


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 014985          253 APPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPL  299 (415)
Q Consensus       253 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~  299 (415)
                           .+...++.++.+||.+||+.||++||+     +++++.||||....+
T Consensus       216 -----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         216 -----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence                 112245889999999999999999999     788999999987654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-47  Score=357.82  Aligned_cols=281  Identities=53%  Similarity=0.934  Sum_probs=238.4

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      |++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67889999999999999999999999999999766544444456778999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccc
Q 014985           94 ETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (415)
Q Consensus        94 ~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~  172 (415)
                      +++|..++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...........+..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  160 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV  160 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccc
Confidence            999988887654 3589999999999999999999999999999999999999999999999999987654444445566


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh-cccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYV  251 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~  251 (415)
                      ++..|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..++..++.+....|+.....++... +...
T Consensus       161 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd07835         161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKW  240 (283)
T ss_pred             cccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccc
Confidence            788899999987755678999999999999999999999999988888888888887777666655544443321 1112


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .........+.++..+.++|.+||+.||.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         241 ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            2233344566788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.9e-47  Score=359.57  Aligned_cols=285  Identities=42%  Similarity=0.731  Sum_probs=230.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-----
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   84 (415)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            467899999999999999999999999999999998765444444445678999999999999999999876543     


Q ss_pred             ---eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           85 ---NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        85 ---~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                         ..|+||||+++++...+...+..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence               46999999999999998877667999999999999999999999999999999999999999999999999999866


Q ss_pred             CCCCC----cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          162 GSPDR----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       162 ~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      .....    ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+...+..++
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            43321    22345667889999998775567889999999999999999999999988888888887777776666666


Q ss_pred             CCCCCccchhcccccCCC--c-ccc-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPP--L-RSL-FPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~--~-~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      +......+..........  . ..+ ....+..+.+||.+||..||.+|||++++++||||
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            543322211111111000  0 000 11236788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.6e-47  Score=362.46  Aligned_cols=274  Identities=39%  Similarity=0.718  Sum_probs=215.4

Q ss_pred             eeeecccCceEEEEEEECC--CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee--cCCeEEEEeec
Q 014985           17 REVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKGNLHLVFEF   92 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~lv~e~   92 (415)
                      ..+||+|+||+||+|.+..  ++..||+|.+....    ....+.+|+.+++.++||||+++++++.  .+..+|+||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            4689999999999998653  66899999886432    2235678999999999999999999884  45678999999


Q ss_pred             ccCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE----ecCCcEEEeeecccee
Q 014985           93 METDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARI  160 (415)
Q Consensus        93 ~~g~L~~~i~~~--------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi----~~~~~vkL~DFG~a~~  160 (415)
                      ++++|...+...        ...+++..++.++.||+.||.|||++||+||||||+|||+    +.++++||+|||+++.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            999998887532        2248899999999999999999999999999999999999    4567899999999987


Q ss_pred             cCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---------HHHHHHHHHHh
Q 014985          161 FGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------IDQLGKIFAAF  228 (415)
Q Consensus       161 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~~~~~~i~~~~  228 (415)
                      ......   .....++|..|+|||++.+...++.++|||||||++|||++|.+||....+         ...+..++..+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            654332   233457788999999997766789999999999999999999999976532         35677778888


Q ss_pred             CCCCCCCCCCCCCCccchhccc------ccCCC----ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          229 GTATPSQWPDLAYLPDYVEYQY------VAAPP----LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      +......|.+....+.+.....      .....    ........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            8777777766544333221110      00000    111122356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-47  Score=358.29  Aligned_cols=264  Identities=25%  Similarity=0.375  Sum_probs=217.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .|++.++||+|+||+||++.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++..+.++|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4889999999999999999999999999999987543322 222345689999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+. |+|...+... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccc
Confidence            998 5777776553 3468999999999999999999999999999999999999999999999999998753322 223


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+...+....                 
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------  221 (285)
T cd05605         160 GRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-----------------  221 (285)
T ss_pred             cccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-----------------
Confidence            4578889999999976 5588999999999999999999999988765544444433221111                 


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~~~  302 (415)
                             ....+.++..+.+||.+||..||++||     +++++++||||....+...
T Consensus       222 -------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~  272 (285)
T cd05605         222 -------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL  272 (285)
T ss_pred             -------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence                   011234588999999999999999999     9999999999987655433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-47  Score=371.97  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=216.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++..+..+|+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            368999999999999999999999999999999998753321 2222345689999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-C
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-R  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~  166 (415)
                      |||||+ |+|..++...  .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++....... .
T Consensus       121 v~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            999998 5777777543  48999999999999999999999999999999999999999999999999998764332 2


Q ss_pred             cccccccccceeCcccccCCc---CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFTHQVFARWYRAPELLFGAK---QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .....+||+.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+.......+........   +       
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~-------  268 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F-------  268 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C-------
Confidence            234567999999999986532   378999999999999999999999998887777666654211100   1       


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPL  299 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~  299 (415)
                                    ...+.++..+++||..||..++.+  |++++++++|+||.+..+
T Consensus       269 --------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         269 --------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             --------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                          112346899999999999844433  789999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-47  Score=369.85  Aligned_cols=257  Identities=27%  Similarity=0.419  Sum_probs=207.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++|+||++++++|...+.+|+||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            5788999999999999999999999999999999864432 223345778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+.| +|..     ....++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus       152 e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        152 EFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             ecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence            99996 4432     22367888899999999999999999999999999999999999999999999987654443445


Q ss_pred             ccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ..+||..|+|||++..    ...++.++|||||||++|||++|+.||......+....+........             
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  293 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-------------  293 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-------------
Confidence            5678999999999743    13345789999999999999999999975433222222211100000             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                 ......++.++++||.+||+.||++|||+.|+++||||...
T Consensus       294 -----------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        294 -----------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                       11223458899999999999999999999999999999864

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-47  Score=364.07  Aligned_cols=257  Identities=25%  Similarity=0.361  Sum_probs=214.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEEEEe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~   90 (415)
                      +|...+.||+|+||+||+|.++.+|+.||+|++...... .........|+.++..+.| ++|++++++|...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            478899999999999999999999999999998764321 2222345678888888865 77888999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++ |+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            9998 5777776554 4599999999999999999999999999999999999999999999999999986543333344


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.....                    
T Consensus       160 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------------------  218 (323)
T cd05615         160 TFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------------------  218 (323)
T ss_pred             CccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence            5678999999999976 5689999999999999999999999998877776666654210                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPL  299 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~  299 (415)
                              .....++.++.+|+.+||+.||.+|++     .+++++||||....+
T Consensus       219 --------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         219 --------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             --------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                    111245889999999999999999997     579999999997654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.3e-47  Score=363.87  Aligned_cols=283  Identities=25%  Similarity=0.400  Sum_probs=215.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||.||++.+..+|..+|+|.+..... ......+.+|+.++++++||||+++++++..++.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            5899999999999999999999999999999999875422 223345778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||++| +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......  ..
T Consensus        83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  159 (331)
T cd06649          83 EHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (331)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence            99995 777777654 4589999999999999999999986 5999999999999999999999999999765332  23


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc-----
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP-----  243 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-----  243 (415)
                      ....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+...........+......+     
T Consensus       160 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         160 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             ccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            34578889999999976 568999999999999999999999997765544322211100000000000000000     


Q ss_pred             -----------cc--hh-cccc-cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          244 -----------DY--VE-YQYV-AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       244 -----------~~--~~-~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                 ..  .. .... ............+.++++||.+||+.||++|||+.++++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                       00  00 0000 00000011124688999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.2e-47  Score=362.36  Aligned_cols=253  Identities=26%  Similarity=0.411  Sum_probs=209.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHh-cCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKE-LKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      +.||+|+||+||+|.+..+++.||+|++...... .........|..++.. ++||||+++++++.+.+.+|+||||++ 
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999764321 2222345567888876 489999999999999999999999998 


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           95 TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        95 g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      |+|...+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            5787777654 458999999999999999999999999999999999999999999999999998654334444556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      ..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....  .                       
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~-----------------------  213 (316)
T cd05619         160 PDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--P-----------------------  213 (316)
T ss_pred             ccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C-----------------------
Confidence            99999999976 568999999999999999999999998877666555543210  0                       


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQ-QALEHRYFSSAPLP  300 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~-e~l~h~~~~~~~~~  300 (415)
                         .....++.++.+||.+||+.||++|+++. ++++||||....+.
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence               01123478999999999999999999996 89999999886553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-47  Score=366.79  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=204.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++.++ +||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998653322 2223456788888776 799999999999999999999999995


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence             67666654 4469999999999999999999999999999999999999999999999999997643333344556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC--------cHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS--------DIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ..|+|||++.+ ..++.++|||||||++|+|++|..||....        ..+.+.+....   .               
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---~---------------  220 (329)
T cd05618         160 PNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---K---------------  220 (329)
T ss_pred             ccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---C---------------
Confidence            99999999976 568899999999999999999999995311        11111111110   0               


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRYFSSAPL  299 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------~~e~l~h~~~~~~~~  299 (415)
                               ...+...++..+.+||.+||+.||++|++      ++++++||||....+
T Consensus       221 ---------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         221 ---------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                     00122356889999999999999999998      589999999987655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-47  Score=367.30  Aligned_cols=253  Identities=24%  Similarity=0.373  Sum_probs=209.0

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHH-HHHHhcCCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREI-KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~-~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|++..+++.||+|++...... ......+..|. .+++.++||||++++++|...+.+|+||||+.|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999998754321 11222334444 456789999999999999999999999999995


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence             67666654 4458899999999999999999999999999999999999999999999999998654444444566789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....                          
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--------------------------  212 (325)
T cd05602         160 PEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------------------------  212 (325)
T ss_pred             ccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------------------
Confidence            99999999976 568999999999999999999999999887776666654320                          


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCHH----HHhcCCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQ----QALEHRYFSSAPLP  300 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~----e~l~h~~~~~~~~~  300 (415)
                        ....+.++..+.+||.+||+.||.+|+++.    ++++|+||....+.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         213 --LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             --cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence              012245689999999999999999999865    89999999876553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.8e-47  Score=356.37  Aligned_cols=283  Identities=37%  Similarity=0.694  Sum_probs=229.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            57999999999999999999999899999999986554433344457789999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++++++..+......+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++.............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY  160 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence            99987666665555568999999999999999999999999999999999999999999999999998765554445556


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh---c
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE---Y  248 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~  248 (415)
                      .++..|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+....+...++.............+....   .
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T cd07846         161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP  240 (286)
T ss_pred             cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence            7888999999987656678899999999999999999999998888888878777665432211100000000000   0


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ............+.++..+.+|+.+||..+|++||++.++++|+||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0001112233456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.7e-47  Score=365.52  Aligned_cols=266  Identities=23%  Similarity=0.322  Sum_probs=218.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||+||++++..+++.||+|++..... .......+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999875322 1222234567999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~  168 (415)
                      ||+. |+|..++.+....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            9998 588888877666799999999999999999999999999999999999999999999999999987644332 22


Q ss_pred             cccccccceeCcccccCC----cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          169 THQVFARWYRAPELLFGA----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ...+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......             
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------  227 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF-------------  227 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-------------
Confidence            345789999999998642    347889999999999999999999999887777666654321100             


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~~  300 (415)
                                .+......++.++++||.+||..++.+  |++++++++|+||....+.
T Consensus       228 ----------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         228 ----------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             ----------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                      011222346899999999999876654  4689999999999876553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-47  Score=367.07  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=208.3

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHH-HHHhcCCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|.+..+|+.||+|++...... ......+..|.. +++.++||||++++++|...+..|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999999999999999998754321 122233445554 57789999999999999999999999999995


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++............+||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence             66666654 4569999999999999999999999999999999999999999999999999997654434444566789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+....                          
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--------------------------  212 (325)
T cd05604         160 PEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--------------------------  212 (325)
T ss_pred             hhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence            99999999976 568899999999999999999999998877666655554310                          


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~h~~~~~~~~  299 (415)
                        ....+.++..+.++|.+||..||.+||++    .++++||||....+
T Consensus       213 --~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         213 --LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             --ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence              01224568899999999999999999976    69999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-47  Score=368.48  Aligned_cols=275  Identities=24%  Similarity=0.350  Sum_probs=214.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+|.+.+.||+|+||.||+|.+..++..||+|+....        ....|+.+++.++||||+++++++......|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            35799999999999999999999999999999974321        2346999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||+.|+|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus       137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~~~~~~  215 (357)
T PHA03209        137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-APAFLG  215 (357)
T ss_pred             EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-Cccccc
Confidence            9999999999988777899999999999999999999999999999999999999999999999999975422 222344


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCc---------HHHHHHHHHHhCCCCCCCCCCC-
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSD---------IDQLGKIFAAFGTATPSQWPDL-  239 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~-  239 (415)
                      ..||..|+|||++.+ ..++.++|||||||++|||+++ .++|.....         ...+..+...++..+. .++.. 
T Consensus       216 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~  293 (357)
T PHA03209        216 LAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE-EFPRDP  293 (357)
T ss_pred             ccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh-hcCCCC
Confidence            668899999999977 5689999999999999999974 566654321         2334445555444322 22210 


Q ss_pred             --CCCccchhcccccCCCccc----cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          240 --AYLPDYVEYQYVAAPPLRS----LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       240 --~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                        .....+..+......+...    ....++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence              0011111111111111100    11245788999999999999999999999999999975

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5e-47  Score=365.56  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=218.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.++||+|+||+||++++..+++.||+|++.+... .......+.+|+.++..++|+||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            579999999999999999999999999999999865322 1222233567999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~  168 (415)
                      ||+. |+|..++.+....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            9998 688888887666799999999999999999999999999999999999999999999999999976533222 22


Q ss_pred             cccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ...+||+.|+|||++.+    ...++.++|||||||++|||++|+.||.+.+..+.+..+.......             
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------  227 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-------------  227 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-------------
Confidence            34578999999999863    3457899999999999999999999999888777776664321100             


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~~  300 (415)
                                .+......++.++++||.+||..++.+  |++++++++||||.+..+.
T Consensus       228 ----------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         228 ----------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             ----------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence                      001112346899999999999765544  6899999999999886654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.6e-47  Score=364.11  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHH-HHHHhcCCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREI-KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~-~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      ++||+|+||+||+|++..+++.||+|++...... ......+.+|+ .+++.++||||++++++|.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999998754321 12222344555 467889999999999999999999999999995


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++............+||
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence             66666654 4558999999999999999999999999999999999999999999999999988644444444556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...     +                     
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----~---------------------  212 (321)
T cd05603         160 PEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-----P---------------------  212 (321)
T ss_pred             cccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----C---------------------
Confidence            99999999876 56899999999999999999999999888766655554321     0                     


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~h~~~~~~~~  299 (415)
                        ..+.+..+.++.++|.+||+.||.+|+++    .++++|+||....+
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence              01123457899999999999999999875    59999999987554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-46  Score=356.40  Aligned_cols=287  Identities=43%  Similarity=0.774  Sum_probs=240.3

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC---
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---   84 (415)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++....   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            44678999999999999999999999999999999999765544444446678999999999999999999886654   


Q ss_pred             -------eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           85 -------NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        85 -------~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                             .+|+|+||+++++...+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                   7999999999999988887666799999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCC-cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          158 ARIFGSPDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       158 a~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      +........ ......++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+....+...+..|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            987644332 2233455777999999876556788999999999999999999999999999999999998888888888


Q ss_pred             CCCCCCccchhccc--ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          237 PDLAYLPDYVEYQY--VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       237 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ++....+.+.....  ......+..+..++..+.+||.+||+.||.+||++.++++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            77655443321111  11112233455678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-47  Score=361.95  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=211.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcE-EEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-eEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-NLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~l   88 (415)
                      .+...+.+.||.|+||+||++..  .|.. +|+|.+............+.+|+.+|.+++|||||++++++.... .+++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            44555667799999999999954  4566 999999866544444557889999999999999999999998877 7999


Q ss_pred             Eeeccc-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCC-ccccCCCCCcEEEecCC-cEEEeeeccceecCCC
Q 014985           89 VFEFME-TDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSP  164 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~-~~~~l~~~~~~~i~~qil~aL~~lH~~~-ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~  164 (415)
                      ||||++ |+|..++.. .+..++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999 678888877 3778999999999999999999999999 99999999999999998 9999999999987554


Q ss_pred             CCcccccccccceeCcccccC-CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          165 DRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ....+...||..|||||++.+ ...|+.++||||||+++|||+||..||.+.........+......+.           
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-----------  266 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-----------  266 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence            344555789999999999985 36799999999999999999999999999888555555543211111           


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     +....++.+..|+.+||..||.+||+..+++.
T Consensus       267 ---------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 ---------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ---------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                           11124788999999999999999999999876

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-46  Score=361.95  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=206.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++.++ .||||++++++|.....+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999998654322 2223466899999888 699999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence             676666544 459999999999999999999999999999999999999999999999999998644334444567789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC------cHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++|.+||....      ..+.+......   ..                
T Consensus       160 ~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~----------------  219 (327)
T cd05617         160 PNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---KP----------------  219 (327)
T ss_pred             cccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---CC----------------
Confidence            99999999976 568999999999999999999999996432      11222222111   00                


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT------AQQALEHRYFSSAPLP  300 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------~~e~l~h~~~~~~~~~  300 (415)
                              ..+...++..+.++|.+||..||++|++      .+++++||||....+.
T Consensus       220 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         220 --------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                    0122345889999999999999999997      5799999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.1e-47  Score=364.47  Aligned_cols=289  Identities=38%  Similarity=0.670  Sum_probs=234.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||||.+............+.+|+.+++.++|+||+++++++...     
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            357799999999999999999999999999999999875433333334567899999999999999999987644     


Q ss_pred             CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..+|+|+||++++|...+... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            358999999999998888754 4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC-
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL-  242 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  242 (415)
                      .........++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...++......+...... 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            4333445567888999999876556889999999999999999999999988877888888887777665544221110 


Q ss_pred             -ccchh-cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          243 -PDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       243 -~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                       ..+.. ......+......+.++.++.+||.+||+.||++|||++++++||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence             00000 011112233445667899999999999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-47  Score=364.99  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=206.7

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhc---CCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKEL---KSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      ||+|+||+||+|++..+++.||+|++...... .........|..++..+   .||||++++++|.....+|+||||+.|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999998653321 11222344577777665   699999999999999999999999984


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|...+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence             67766664 4568999999999999999999999999999999999999999999999999997654444444556789


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      ..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.....     .++                 
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~-----------------  217 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-----RFP-----------------  217 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-----CCC-----------------
Confidence            9999999997756689999999999999999999999988776665555432100     000                 


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCC----CHHHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARI----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----t~~e~l~h~~~~~~~~  299 (415)
                           ...+++++.+||.+||..||.+||    ++.++++||||....+
T Consensus       218 -----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         218 -----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             -----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence                 013488999999999999999998    7999999999987543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=375.98  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=223.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+.|.++..||.|+||.||+|.++.++-..|.|+|...  .+...+.++-||.||..+.||+||+|++.|..++.+||+.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            46788999999999999999999988888888988643  2333445778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||+| -....+..-+..+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+......-....
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99996 46666677777899999999999999999999999999999999999999999999999999876655555667


Q ss_pred             ccccccceeCccccc----CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          170 HQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .++|||+|||||++.    ...+|++++||||||++|.||..+.||...-+...++-+|.+.-   +             
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe---P-------------  252 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---P-------------  252 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---C-------------
Confidence            899999999999974    34679999999999999999999999988888777776665421   1             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                               +..--....+..+.||+.+||..||..||+++|+|+||||++++
T Consensus       253 ---------PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  253 ---------PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             ---------CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                     11111223488999999999999999999999999999998654

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9e-50  Score=354.56  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=226.5

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +.=.+-|.++++||+|+||.||+|.|+.+|..+|||.+....    ..+++.+|+.|+.+++.|+||++|+.|-....+|
T Consensus        29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW  104 (502)
T KOG0574|consen   29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW  104 (502)
T ss_pred             CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence            334667889999999999999999999999999999986433    2346778999999999999999999888888999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||||||+ |+..+.++.++..+++.++..+++..++||+|||...-+|||||..|||++.+|..||+|||.|-.+.+.-.
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            9999999 899999999999999999999999999999999999999999999999999999999999999988877777


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ...+.+||+.|||||++.. ..|+.++||||||++..||..|+||+..-.....   |+... +                
T Consensus       185 KRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIP-T----------------  243 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIP-T----------------  243 (502)
T ss_pred             hhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccce---eEecc-C----------------
Confidence            7788999999999999976 6799999999999999999999999876443221   11111 1                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                           ..|+........|.++.|||+.||.++|++|.|+.++++|+|.++++...
T Consensus       244 -----~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  244 -----KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             -----CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence                 11111122223489999999999999999999999999999999876543

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-46  Score=351.77  Aligned_cols=283  Identities=42%  Similarity=0.737  Sum_probs=232.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999999999999999987655444445567899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTH  170 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~~~  170 (415)
                      |++++++..+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            999888877766666699999999999999999999999999999999999999999999999999987655443 3445


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      .+++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++...+..+........+.....
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF  240 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence            67788899999998754789999999999999999999999999888888888777766555443332221111111000


Q ss_pred             ccC---CCccccCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 VAA---PPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~~~---~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ...   ......++. ++.++.+||.+||..+|++|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000   001112233 48999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-46  Score=370.03  Aligned_cols=283  Identities=26%  Similarity=0.335  Sum_probs=221.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..+..+|.+.+.||+|+||.||+|...  .++..||+|.+....       ...+|+.+|+.++||||++++++|.....
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            345678999999999999999999754  356789999875432       34579999999999999999999999999


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      +|+|||++.++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       161 ~~lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99999999999999884 34569999999999999999999999999999999999999999999999999998664432


Q ss_pred             C--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---DIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       166 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .  ......||..|+|||++.+ ..|+.++|||||||++|||++|..||.+..   ....+..+...++........+..
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2  2234678999999999976 568999999999999999999998887653   456677777776654332211110


Q ss_pred             C--CccchhcccccCCCc--ccc--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          241 Y--LPDYVEYQYVAAPPL--RSL--FPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       241 ~--~~~~~~~~~~~~~~~--~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      .  ...+..+.....++.  ...  ....+.++.+||.+||+.||++|||+.++|.||||...++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            0  000011111111110  011  1135778999999999999999999999999999986544

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-46  Score=372.26  Aligned_cols=275  Identities=23%  Similarity=0.299  Sum_probs=214.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||....        ....+|+.+|++++|+|||++++++..++..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            5689999999999999999999999999999996321        23568999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--cc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RF  168 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~  168 (415)
                      |++.++|..++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......  ..
T Consensus       240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            9999999999887666799999999999999999999999999999999999999999999999999987533221  12


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCC------cHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSS------DIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ....||..|+|||++.+ ..++.++|||||||+||||++|. ++|....      ....+.+++...+.... .++....
T Consensus       320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~-~~~~~~~  397 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD-EFPQHAG  397 (461)
T ss_pred             cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc-cCCCCcc
Confidence            24568999999999977 56899999999999999999876 4554432      13445555544332221 1111100


Q ss_pred             Cccchhcc---------cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVEYQ---------YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~~~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ......+.         ....+.+ ..+..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            00000000         0000111 112246778999999999999999999999999999974

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-45  Score=385.89  Aligned_cols=268  Identities=26%  Similarity=0.398  Sum_probs=218.7

Q ss_pred             ccccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-
Q 014985            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-   82 (415)
Q Consensus         4 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-   82 (415)
                      .+.++...++|++++.||+|+||+||+|++..++..||+|++............+.+|+.+|+.|+|||||+++++|.. 
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3456677899999999999999999999999999999999997665444444567889999999999999999998854 


Q ss_pred             -CCeEEEEeeccc-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC-------CccccCCCCCcEEEecC---
Q 014985           83 -KGNLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKK-------WVLHRDMKPNNLLIGSH---  147 (415)
Q Consensus        83 -~~~~~lv~e~~~-g~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~-------~ivHrDlkp~NILi~~~---  147 (415)
                       ...+||||||+. |+|..++...   ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             457999999999 5888888653   34699999999999999999999984       49999999999999642   


Q ss_pred             --------------CcEEEeeeccceecCCCCCcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCC
Q 014985          148 --------------GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFL  212 (415)
Q Consensus       148 --------------~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf  212 (415)
                                    +.+||+|||++....... .....+||+.|+|||++.+. ..++.++||||||||||+|++|.+||
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                          348999999998764322 23456789999999998653 45889999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014985          213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (415)
Q Consensus       213 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~  292 (415)
                      ...+....+...+...   +.                        ...+..+.++.+||..||..+|.+||++.|+|.|+
T Consensus       244 ~~~~~~~qli~~lk~~---p~------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~  296 (1021)
T PTZ00266        244 HKANNFSQLISELKRG---PD------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQ  296 (1021)
T ss_pred             CcCCcHHHHHHHHhcC---CC------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence            8776655544332210   00                        00123478999999999999999999999999999


Q ss_pred             CCCCCCC
Q 014985          293 YFSSAPL  299 (415)
Q Consensus       293 ~~~~~~~  299 (415)
                      |+.....
T Consensus       297 ~ik~i~~  303 (1021)
T PTZ00266        297 IIKNVGP  303 (1021)
T ss_pred             HHhhcCC
Confidence            9986543

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-46  Score=351.93  Aligned_cols=281  Identities=59%  Similarity=0.980  Sum_probs=239.3

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      |.+.+.||.|++|.||+|.+..+|+.+++|.+............+.+|+.+++.++|+||+++++++..+..+|+|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999999999999999998765544344456778999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccc
Q 014985           94 ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (415)
Q Consensus        94 ~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  173 (415)
                      ++++...+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  160 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV  160 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence            99999999887677999999999999999999999999999999999999999999999999999877655434455677


Q ss_pred             ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc--c
Q 014985          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY--V  251 (415)
Q Consensus       174 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~  251 (415)
                      +..|+|||.+.+...++.++|+|||||++|+|++|+++|.+.+..+.+..+...++...+..|+............+  .
T Consensus       161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05118         161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK  240 (283)
T ss_pred             cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence            88899999997755789999999999999999999999999999999988888888777766665443222222211  1


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .........+.++.++.+||.+||+.||.+||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1222234456678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-46  Score=356.83  Aligned_cols=282  Identities=41%  Similarity=0.774  Sum_probs=226.2

Q ss_pred             cEeeeeeecccCceEEEEEEECC--CCcEEEEEEeecCC-ccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLH   87 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~~~avK~i~~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~   87 (415)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+.... ........+.+|+.+++.++||||+++++++...  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  89999999988644 2223334567899999999999999999999888  8899


Q ss_pred             EEeecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec----CCcEEEeeeccce
Q 014985           88 LVFEFMETDLETVIRNT----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLAR  159 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~----~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~----~~~vkL~DFG~a~  159 (415)
                      +||||+++++...+...    ...+++..++.++.||+.||.|||++||+||||||+|||++.    ++.+||+|||++.
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            99999999988877543    236899999999999999999999999999999999999999    8999999999998


Q ss_pred             ecCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH---------HHHHHHHHH
Q 014985          160 IFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---------DQLGKIFAA  227 (415)
Q Consensus       160 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~~~  227 (415)
                      .......   ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+....         ..+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV  240 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence            7644332   2233467888999999877667899999999999999999999999876543         356677777


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccC------CCcccc---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAA------PPLRSL---FPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ++...+..|++...++++........      ..+...   ....+.++.++|.+||+.||++|||+.|+++||||
T Consensus       241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            77666665655444444332110000      000000   11567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.7e-46  Score=360.76  Aligned_cols=290  Identities=38%  Similarity=0.669  Sum_probs=233.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec----CCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~   85 (415)
                      +.++|.+.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||++++++|..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            5689999999999999999999999999999999987644333334456789999999999999999998753    457


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      +|+||||++|+|...+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          83 VYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            8999999999988887654 449999999999999999999999999999999999999999999999999998754332


Q ss_pred             C----cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 R----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .    .....+++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+.+..+.....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            2    123457788999999987655689999999999999999999999999888888888888777665443322111


Q ss_pred             C--ccch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          242 L--PDYV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       242 ~--~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      .  .... .+......++....+..+.++.+||.+||+.+|++||++++++.||||.....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence            0  0000 011111222334456779999999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-47  Score=350.79  Aligned_cols=259  Identities=34%  Similarity=0.538  Sum_probs=215.6

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      |++++.||+|+||+||++.+..+++.||+|.+..............+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999877655444434456999999999999999999999999999999999


Q ss_pred             cC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccc
Q 014985           94 ET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (415)
Q Consensus        94 ~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~  172 (415)
                      .+ +|..++. ....+++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            97 8888887 344589999999999999999999999999999999999999999999999999987544455566778


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (415)
                      ++..|+|||++.....++.++||||||+++|+|++|..||......+....+...........+                
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------  223 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----------------  223 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc----------------
Confidence            8999999999873467899999999999999999999999887444444443332211100000                


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       253 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                           ......+..+.++|.+||+.||++||++.++++||||
T Consensus       224 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  224 -----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                 0000113789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-46  Score=358.88  Aligned_cols=287  Identities=39%  Similarity=0.680  Sum_probs=227.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----C
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----G   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~   84 (415)
                      +.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            56899999999999999999999999999999999864322 22334567899999999999999999876543     3


Q ss_pred             eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .+|+|+||+++++...+...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            68999999999998887643  4899999999999999999999999999999999999999999999999999875433


Q ss_pred             CC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 DR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..   .....+++..|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...++.+.++.+.....
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            22   123356788999999986656689999999999999999999999998887777777777766554433321111


Q ss_pred             Ccc--ch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          242 LPD--YV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~--~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...  +. ........++....+.++.++.+||.+||+.||++|||+.++++||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            000  00 00000111122344567899999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-46  Score=350.04  Aligned_cols=281  Identities=52%  Similarity=0.904  Sum_probs=241.2

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      |++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67789999999999999999999999999999876544444556778999999999999999999999999999999999


Q ss_pred             cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccc
Q 014985           94 ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (415)
Q Consensus        94 ~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  173 (415)
                      +++|..++.+....+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||.+..............+
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV  160 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcccc
Confidence            99999999887566999999999999999999999999999999999999999999999999999877655545555666


Q ss_pred             ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc-chhccccc
Q 014985          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD-YVEYQYVA  252 (415)
Q Consensus       174 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  252 (415)
                      +..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+.++...++......|+....... ...+....
T Consensus       161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd07829         161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP  240 (282)
T ss_pred             CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence            78899999987755788999999999999999999999999999999999998888877777766555441 11112222


Q ss_pred             CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       253 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .......++.++..+.++|.+||..||++||++.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            223345566778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-46  Score=358.41  Aligned_cols=286  Identities=42%  Similarity=0.687  Sum_probs=238.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-----eEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NLH   87 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~   87 (415)
                      +|.+.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            689999999999999999999999999999998765433334446778999999999999999999987765     789


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--  165 (415)
                      +||||++++|...+.+.. .+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......  
T Consensus        81 lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            999999998888887544 69999999999999999999999999999999999999999999999999998875543  


Q ss_pred             -CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC--CCCC
Q 014985          166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD--LAYL  242 (415)
Q Consensus       166 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--~~~~  242 (415)
                       .......++.+|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.+.+..+..  ....
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA  239 (330)
T ss_pred             cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence             2344567788999999998754789999999999999999999999999999999999998888776654432  1111


Q ss_pred             ccchh-cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          243 PDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       243 ~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      .++.. ........+....+.++.++.+||.+||+.+|.+|||+++++.||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            11111 1111222344556778999999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.6e-46  Score=375.24  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=218.3

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC---
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---   84 (415)
                      ....++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.++..++|+||+++++.+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            44578999999999999999999999999999999999766544444445678999999999999999988775432   


Q ss_pred             -----eEEEEeeccc-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeee
Q 014985           85 -----NLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (415)
Q Consensus        85 -----~~~lv~e~~~-g~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DF  155 (415)
                           .+++||||+. |+|.+.+...   ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 4789999999 6888887643   346899999999999999999999999999999999999999999999999


Q ss_pred             ccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          156 GLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       156 G~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      |+++.+....  ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.....    
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----  262 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----  262 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----
Confidence            9998764322  22345678999999999976 5689999999999999999999999988776666555433210    


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                             ..+.+.+++++.+||.+||..||.+||++.++++|||+..
T Consensus       263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence                                   1123456899999999999999999999999999999764

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=347.61  Aligned_cols=281  Identities=46%  Similarity=0.834  Sum_probs=235.4

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeEEEEee
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHLVFE   91 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~e   91 (415)
                      |.+.+.||.|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++|+|++++++++...  +..|+|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6789999999999999999999999999999987653344445677899999999999999999999888  89999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTH  170 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~~~  170 (415)
                      |++++|..++......+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN  160 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence            999999999887766799999999999999999999999999999999999999999999999999987654432 2334


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||.+.+...++.++|||||||++|+|++|.+||...+..+.+..+....+......|+....+........
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07840         161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP  240 (287)
T ss_pred             cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence            56677899999887656688999999999999999999999999998888899988888887777776554422111111


Q ss_pred             c--cCCCccccCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 V--AAPPLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~--~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .  ....+...+... +..+.++|.+||..||.+||++.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            0  011122233333 8899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.2e-46  Score=360.11  Aligned_cols=284  Identities=35%  Similarity=0.548  Sum_probs=224.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||++++++|...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            468999999999999999999999999999999999865433333334566899999999999999999988543     


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ..+|+||||+.++|...+...   +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             357999999999999887643   8999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...++.+....+......
T Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         170 TSF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCC-CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            432 2334567888999999977 56899999999999999999999999998888888888877776543221111100


Q ss_pred             ccc-hhc-ccccCCCcccc-------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDY-VEY-QYVAAPPLRSL-------------FPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~-~~~-~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ... ... ......++...             ....+..+.+||.+||+.||++|||+.|+|.||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence            000 000 00000000000             11346678999999999999999999999999998743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=354.85  Aligned_cols=275  Identities=26%  Similarity=0.380  Sum_probs=227.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.+.|..-++||+|+||.||-|....||+-||+|++.+...+. .-...+++|-.||.+++.++||.+-.+|++.+.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3567888999999999999999999999999999987655332 233457799999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           89 VFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||..|+| ||...|.+.+ ..+++..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|+|..+.... 
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-  341 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-  341 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC-
Confidence            9999995 6666665543 469999999999999999999999999999999999999999999999999999885543 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||.+|||||++.+.. |+...|+|||||++|||+.|+.||........-+.+-......+ .            
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-~------------  407 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-E------------  407 (591)
T ss_pred             ccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-h------------
Confidence            334559999999999998854 99999999999999999999999988765544433322211111 1            


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCCCCCCCCCCc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPTEPNKLPRPA  310 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~~~~~~~~~~~  310 (415)
                                 .+....|+++++|.+.+|+.||++|.     +++++.+||||++.+|.........|+
T Consensus       408 -----------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PP  465 (591)
T KOG0986|consen  408 -----------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPP  465 (591)
T ss_pred             -----------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCC
Confidence                       11224599999999999999999998     578999999999998876543333333

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-45  Score=356.12  Aligned_cols=278  Identities=26%  Similarity=0.418  Sum_probs=212.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.++||+|+||.||++.+..++..+|+|.+..... ......+.+|+++++.++||||++++++|..++.+|+||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            5899999999999999999999999999999998875432 223345778999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||+. |+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++.......  .
T Consensus        83 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~  159 (333)
T cd06650          83 EHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A  159 (333)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--c
Confidence            9998 5787777654 4589999999999999999999975 79999999999999999999999999987653321  2


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch--
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV--  246 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--  246 (415)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+.. .++   +......+......+...  
T Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         160 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMF---GCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHh---cCcccCCccccccCcccCCc
Confidence            33568888999999976 56889999999999999999999999766543332 221   111110000000000000  


Q ss_pred             -----h--------------cccccCCCcccc-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          247 -----E--------------YQYVAAPPLRSL-FPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       247 -----~--------------~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                           .              ............ ....+.++++||.+||+.||++|||+.|++.|+||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                 0              000000000000 12357899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-45  Score=346.64  Aligned_cols=257  Identities=26%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L   97 (415)
                      ||+|+||.||++.+..+|+.||+|++........ ....+..|+.+++.++||||++++++|..+.++|+||||+. |+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999875433221 22234569999999999999999999999999999999998 577


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccc
Q 014985           98 ETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW  176 (415)
Q Consensus        98 ~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~  176 (415)
                      ...+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......++..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence            77765433 358899999999999999999999999999999999999999999999999998764322 2334567888


Q ss_pred             eeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCc
Q 014985          177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL  256 (415)
Q Consensus       177 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (415)
                      |+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.......                       ..
T Consensus       160 y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------~~  215 (277)
T cd05607         160 YMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-----------------------EV  215 (277)
T ss_pred             ccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-----------------------cc
Confidence            999999977 458999999999999999999999997654322222222111000                       00


Q ss_pred             cccCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCC
Q 014985          257 RSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYFSSAPLPT  301 (415)
Q Consensus       257 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~h~~~~~~~~~~  301 (415)
                      ......++.++.+||.+||+.||++||++    ++++.|+||....++.
T Consensus       216 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence            01112458899999999999999999999    6788999998766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=340.34  Aligned_cols=264  Identities=27%  Similarity=0.390  Sum_probs=214.7

Q ss_pred             ccccccEee-eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCe
Q 014985            8 KKVADRYLK-REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGN   85 (415)
Q Consensus         8 ~~~~~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~   85 (415)
                      ..+.+-|.+ .+.||+|+|+.|-.|....+|..||||+|.+...  -...++++|++++.+++ |+||++|+++|+++..
T Consensus        73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            446677766 5678999999999999999999999999986532  23346789999999995 9999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEEEeeeccceec
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF  161 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vkL~DFG~a~~~  161 (415)
                      +|+|||.+. |.|+..|.+... +++.++..++.+|+.||+|||.+||.||||||+|||....+   .||||||.+..-.
T Consensus       151 FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            999999998 578888887654 89999999999999999999999999999999999997654   4899999887532


Q ss_pred             C--C-----CCCcccccccccceeCccccc----CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-------------
Q 014985          162 G--S-----PDRRFTHQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-------------  217 (415)
Q Consensus       162 ~--~-----~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------------  217 (415)
                      .  .     ......+.+|+..|||||++.    ....|+.++|.||||||||-||.|++||.|.-.             
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            1  1     123455678888999999962    234689999999999999999999999988631             


Q ss_pred             --HHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          218 --IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       218 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                        ....+.|.++-...+.                        ..+..+|.+++|||+.+|..|+.+|.++.++++|||+.
T Consensus       310 CQ~~LFesIQEGkYeFPd------------------------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPD------------------------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             HHHHHHHHHhccCCcCCh------------------------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence              1222222222111222                        22345799999999999999999999999999999998


Q ss_pred             CCC
Q 014985          296 SAP  298 (415)
Q Consensus       296 ~~~  298 (415)
                      ...
T Consensus       366 ~~~  368 (463)
T KOG0607|consen  366 RCA  368 (463)
T ss_pred             ccc
Confidence            654

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-45  Score=346.40  Aligned_cols=277  Identities=40%  Similarity=0.670  Sum_probs=221.2

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecC--CeEEEEe
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK--GNLHLVF   90 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~~~lv~   90 (415)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+....... ......+|+.++.++. |+||+++++++.+.  +.+++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            678999999999999999999999999999986543222 2223457999999885 99999999999887  8999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||++|+++..+......+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++....... ....
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~  157 (282)
T cd07831          80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE  157 (282)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence            99999999999876667999999999999999999999999999999999999999 999999999998764322 2234


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc-
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ-  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-  249 (415)
                      ..++..|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+..+....+........... ......+. 
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  236 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR-KSRHMNYNF  236 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc-ccccccccC
Confidence            5678889999987655667889999999999999999999999988888777777665544331100000 00000000 


Q ss_pred             -cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 -YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                       ......+....+.++.++.+||.+||..||++||+++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence             001111233345678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.9e-45  Score=338.18  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=213.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-CCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e   91 (415)
                      +|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.+++.++|+|++++++.+.. ...+|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999999999999999987654433344457789999999999999999998864 446899999


Q ss_pred             ccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+. ++|.+.+... ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            998 5788877764 34589999999999999999999999999999999999999999999999999987755444445


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.....                    
T Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------------------  219 (257)
T cd08223         161 TLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------------------  219 (257)
T ss_pred             cccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------------------
Confidence            5677888999999876 5678899999999999999999999987665554444433211                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                             ......++..+.+||.+||+.||.+|||+.++++||||
T Consensus       220 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   01112357899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-47  Score=337.19  Aligned_cols=256  Identities=26%  Similarity=0.435  Sum_probs=213.6

Q ss_pred             ccccEee-eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec----C
Q 014985           10 VADRYLK-REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH----K   83 (415)
Q Consensus        10 ~~~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~   83 (415)
                      +.++|.+ .++||-|-.|.|-.|.++.+|++||+|++....       ++++|+++.-.. .|||||.++|+|++    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            7888977 567899999999999999999999999986432       466888886555 69999999999865    3


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeeccc
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLA  158 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~a  158 (415)
                      ..+.+|||+++ |+|++.|.+++ ..++|.++..|++||..|+.|||+.+|.||||||+|+|....   ..+||+|||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            46789999999 58999888764 469999999999999999999999999999999999999754   46999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc----HHHHHHHHHHhCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD----IDQLGKIFAAFGTATPS  234 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  234 (415)
                      +.... .....+.+.|++|.|||++.. ..|+..+|+||+||++|-||+|.|||..+.-    ...-.+|..+-...+.+
T Consensus       212 K~t~~-~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  212 KETQE-PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccCC-CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            97644 445667889999999999955 5699999999999999999999999987653    33344444433323333


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      +                        +..+|.+++|+|+.+|..+|++|.|++++++|||+++..
T Consensus       290 E------------------------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  290 E------------------------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             h------------------------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            3                        345699999999999999999999999999999998643

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-45  Score=347.50  Aligned_cols=261  Identities=26%  Similarity=0.382  Sum_probs=210.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .|++.+.||+|+||.||++.+..+++.||+|.+........ ....+.+|+.+++.++|++|+++++.+...+..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999875433222 12345679999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+. |+|...+... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  159 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIK  159 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-ccc
Confidence            998 5777776543 3358999999999999999999999999999999999999999999999999987653322 223


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...|+..|+|||++.+ ..++.++|||||||++|+|++|.+||....................                 
T Consensus       160 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----------------  221 (285)
T cd05630         160 GRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-----------------  221 (285)
T ss_pred             CCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-----------------
Confidence            4578889999999976 5589999999999999999999999987543221111111100000                 


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPL  299 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~  299 (415)
                             ......+++++.+||.+||+.||++|||     ++|+++||||....+
T Consensus       222 -------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         222 -------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             -------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                   0112345789999999999999999999     999999999976433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-45  Score=346.31  Aligned_cols=263  Identities=27%  Similarity=0.394  Sum_probs=215.4

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|.+....  ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            3688999999999999999999999999999999986432  22233466899999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||++| +|...+.+....+++..+..++.||+.||.|||++|++||||||+||+++.++++||+|||++..........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            999996 5666666656668999999999999999999999999999999999999999999999999987654433334


Q ss_pred             cccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ....++..|+|||++.+    ...++.++|||||||++|+|++|.+||...+......++...   ..+           
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-----------  233 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPP-----------  233 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCc-----------
Confidence            45567888999999853    234688999999999999999999999876654444333211   000           


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                                 .......++.++.+||.+||..||++||+++++++||||.....
T Consensus       234 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         234 -----------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             -----------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                       00112245788999999999999999999999999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=347.95  Aligned_cols=284  Identities=29%  Similarity=0.535  Sum_probs=229.0

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC--CC----eeeEEee
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PH----IIELIDA   79 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h--p~----Iv~l~~~   79 (415)
                      .++.+.++|.++..+|+|+||.|-.++|..++..+|||+++...   ...+.++-|+++|.++.+  |+    +|.+.++
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            45778999999999999999999999999999999999987432   333456679999999943  33    7888999


Q ss_pred             eecCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-----------
Q 014985           80 FPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-----------  147 (415)
Q Consensus        80 ~~~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-----------  147 (415)
                      |...++.|||+|.++-++.+++...+ .+++...++.+.+||+.+++|||+.+++|.||||||||+.+.           
T Consensus       160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            99999999999999999999998754 569999999999999999999999999999999999998432           


Q ss_pred             ---------CcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH
Q 014985          148 ---------GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI  218 (415)
Q Consensus       148 ---------~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  218 (415)
                               -.|+|+|||.|+.-....   +..+.|+.|+|||++++ -+++.++||||+||||+||.+|..+|.++++.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     248999999998743322   56788999999999998 66999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCC----------------CCCCCCCCccchhcccccCCCccccCCCCCH---HHHHHHHHhcCCCC
Q 014985          219 DQLGKIFAAFGTATPS----------------QWPDLAYLPDYVEYQYVAAPPLRSLFPSASD---DALDLLSKMFTYDP  279 (415)
Q Consensus       219 ~~~~~i~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~~li~~~L~~dP  279 (415)
                      ++++-|...+|..+..                .|++...-.+ ..+.+....++......-+.   .+.|||++||.+||
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~-~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK-SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc-chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            9998777777743221                2333222211 11222222333333333333   47799999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 014985          280 KARITAQQALEHRYFSSA  297 (415)
Q Consensus       280 ~~Rpt~~e~l~h~~~~~~  297 (415)
                      .+|+|+.|+|.||||...
T Consensus       395 ~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARL  412 (415)
T ss_pred             cccccHHHHhcCHHhhcC
Confidence            999999999999999763

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-45  Score=370.31  Aligned_cols=256  Identities=22%  Similarity=0.341  Sum_probs=214.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ...|.+.+.||+|+||.||+|.+..+ +..+|+|.+.....  .....+.+|+.+|+.++||||++++++|...+++|+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            44599999999999999999998887 78899997654322  2223466799999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           90 FEFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||+. |+|...+..   ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99998 588777653   24468999999999999999999999999999999999999999999999999998764432


Q ss_pred             C--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......             
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------------  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-------------  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence            2  2345678999999999876 56899999999999999999999999888776666665432110             


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                    .....++.++.+||.+||..||++||++++++.|+|+..
T Consensus       290 --------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        290 --------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             --------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                          111245789999999999999999999999999999753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=359.59  Aligned_cols=259  Identities=29%  Similarity=0.419  Sum_probs=223.6

Q ss_pred             cccEee--eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLK--REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~--~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..-|++  .++||+|.||+||-++++++|+.||||+|.+.+........+.+|+.||..+.||.||.+-..|+..+.++.
T Consensus       561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence            344444  678999999999999999999999999999888776666778899999999999999999999999999999


Q ss_pred             EeecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeeccceecCCC
Q 014985           89 VFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSP  164 (415)
Q Consensus        89 v~e~~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~a~~~~~~  164 (415)
                      |||.+.||.+..|.+. .+.+++...+.++.||+.||.|||.+||+|+||||+|||+.+.   -++||||||+|+..+..
T Consensus       641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            9999999999998765 5679999999999999999999999999999999999999765   36999999999998764


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      . .....+||+.|+|||++.+ +.|+...|+||+|||+|--+.|.-||...  +++-.+|...--..++..|        
T Consensus       721 s-FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW--------  788 (888)
T KOG4236|consen  721 S-FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPW--------  788 (888)
T ss_pred             h-hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCch--------
Confidence            3 4456899999999999987 77999999999999999999999777654  3444444433222233333        


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                      ..+|++++|||..+|+..-++|.+.++.|.|||+++-
T Consensus       789 ----------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  789 ----------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ----------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                            3458999999999999999999999999999999763

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-45  Score=339.10  Aligned_cols=255  Identities=25%  Similarity=0.461  Sum_probs=211.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC---ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      +.|.+.+.||+|++|.||+|.+..+++.+|+|.+........   ....+.+|+.++++++||||+++++++..+..+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999875543221   12346789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |+||+.| +|.+.+... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++........
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999985 677777654 45899999999999999999999999999999999999999999999999999765332211


Q ss_pred             ---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          168 ---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       168 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                         .....++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.....               
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------  224 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT---------------  224 (263)
T ss_pred             cccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC---------------
Confidence               123457788999999987 4588999999999999999999999987665544443322100               


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                 .......++..+.+||.+||..+|.+|||+.++++|+||
T Consensus       225 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 -----------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             -----------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                       011223458899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.2e-45  Score=336.69  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=216.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            48899999999999999999999999999999876544444445677899999999999999999999999999999999


Q ss_pred             cc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           93 ME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        93 ~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      +. ++|..++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            98 5888887764 456899999999999999999999999999999999999999999999999999877655444445


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+.....                     
T Consensus       161 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------  218 (256)
T cd08529         161 IVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF---------------------  218 (256)
T ss_pred             cccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence            677888999999976 4578999999999999999999999988776555544432110                     


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                            ......++.++.++|.+||+.+|++||++.++++|||+
T Consensus       219 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 ------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  01111347889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-45  Score=355.63  Aligned_cols=290  Identities=40%  Similarity=0.696  Sum_probs=231.1

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC--
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK--   83 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--   83 (415)
                      ...+.++|.+.+.||+|+||.||+|.+..+|..+|+|++............+.+|+.+++++ +||||++++++|...  
T Consensus         2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            45678999999999999999999999999999999999865332222333566899999999 999999999998643  


Q ss_pred             CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ...|+||||+.++|...+...  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            468999999999998888764  588999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          164 PD-----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       164 ~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      ..     ......+++.+|+|||++.+...++.++|||||||++|+|++|++||.+.+..+...++....+......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            32     1233456788999999987656688999999999999999999999999888888888877765443222111


Q ss_pred             CCCC-c-cch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          239 LAYL-P-DYV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       239 ~~~~-~-~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      +... . ... ..............+.++.++.+||.+||+.||++|||+.++++||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence            1000 0 000 0011112223344566799999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.8e-45  Score=343.66  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=216.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+........ ....+.+|+.+++.++|+||+.++++|..++..|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47888999999999999999999999999999876443222 22345689999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+.| +|...+... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            9995 677666543 346999999999999999999999999999999999999999999999999999765332 2234


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........+.........                
T Consensus       160 ~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~----------------  222 (285)
T cd05632         160 GRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE----------------  222 (285)
T ss_pred             CCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc----------------
Confidence            4578899999999976 55899999999999999999999999887665555444332211110                


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                              ...+.++.++.+|+.+||+.||++||+     +.+++.|+||....+.
T Consensus       223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         223 --------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             --------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                    112345789999999999999999999     8999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.3e-45  Score=352.88  Aligned_cols=284  Identities=35%  Similarity=0.654  Sum_probs=221.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------   83 (415)
                      +..+|.+.+.||.|+||.||+|.+..+|+.||+|++.....  .....+.+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            56899999999999999999999999999999999865443  2234567899999999999999999876543      


Q ss_pred             --------CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEee
Q 014985           84 --------GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLAD  154 (415)
Q Consensus        84 --------~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~D  154 (415)
                              ...|+||||++++|...+..  ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    35899999999988887754  34899999999999999999999999999999999999984 56789999


Q ss_pred             eccceecCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          155 FGLARIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       155 FG~a~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      ||++........   ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999986533221   11234567889999988665668899999999999999999999999888777776666554332


Q ss_pred             CCCCCCCCC-CCccchh-cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          232 TPSQWPDLA-YLPDYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       232 ~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .+..+.... .++.... .......+.....+.++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            221111110 0001000 01111222334556789999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-45  Score=353.62  Aligned_cols=284  Identities=37%  Similarity=0.616  Sum_probs=227.2

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----   84 (415)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||+|++......+.....+.+|+.+++.++||||++++++|....    
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            3578999999999999999999999999999999998764433333445778999999999999999999986543    


Q ss_pred             --eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 --~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                        .+|+|+||+.+++.....   ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          92 FQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             CceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence              569999999987766542   348999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   ......++..|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+.+..+......
T Consensus       169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            2   2234567888999999876556889999999999999999999999998888888888877665544322211110


Q ss_pred             ccch---hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ....   .........+...++.++.++.+||.+||+.||.+||++++++.||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0000   0001111223344567889999999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=346.02  Aligned_cols=311  Identities=26%  Similarity=0.350  Sum_probs=255.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..+|-.+.+||+|+||.|-+|..+.+.+.||||++++...... ..+--+.|-++|.... -|++++++.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            5678889999999999999999999999999999987653222 2222346777877764 5899999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||+. |+|...|++-+ ++-+..+..|+.+|+-||-+||++||++||||.+|||++.+|++||+|||+++.--.....
T Consensus       428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            999999 57777777654 5889999999999999999999999999999999999999999999999999976666677


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..+.+||+.|+|||++.- ++|+.++|+||+||+||||+.|++||+|.++.+....|+....                  
T Consensus       507 TkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv------------------  567 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV------------------  567 (683)
T ss_pred             eeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC------------------
Confidence            778999999999999975 7799999999999999999999999999999999998877521                  


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCCCCCCCCCCCCcccccC----CCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPLPTEPNKLPRPATKRAS----KAS  318 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~----~~~  318 (415)
                                .+..++|.++.++...+|...|.+|...     .+|-+||||....|....+...+|+.++..    ..+
T Consensus       568 ----------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~e  637 (683)
T KOG0696|consen  568 ----------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAE  637 (683)
T ss_pred             ----------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchh
Confidence                      2233669999999999999999999853     689999999999887654444444433322    333


Q ss_pred             CCCC--CCCCcccCCcccccCCCCCCCCCCCCCCc
Q 014985          319 DFNP--QEGPTVLSPPRKTRRVMPDREGFEGNANR  351 (415)
Q Consensus       319 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (415)
                      ++..  ...++.+.||.+--...-+++.+.|.+..
T Consensus       638 NFD~~Ft~~~~~lTPpD~~v~~nldq~eF~gFsfv  672 (683)
T KOG0696|consen  638 NFDKFFTREPTDLTPPDKLVMMNLDQSEFEGFSFV  672 (683)
T ss_pred             hhhHHHhcCCCCCCCchHHHHhcCchhhcCceeee
Confidence            3332  45677788888776666777777776543

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-45  Score=344.10  Aligned_cols=260  Identities=28%  Similarity=0.410  Sum_probs=216.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||.|+||.||++.+..++..+|+|.+.....  .....+.+|+.+++.++||||+++++.+......|+||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE--EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            4789999999999999999999988999999999864322  22235668999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++| +|..++.+....+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99995 77777777666799999999999999999999999999999999999999999999999999876654444444


Q ss_pred             ccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ...++..|+|||++..    ...++.++|+|||||++|+|++|.+||.+.+....+..+....   .    +        
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~----~--------  226 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---P----P--------  226 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC---C----C--------
Confidence            5678888999999852    2446789999999999999999999998776555544442210   0    0        


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                .......++.++.+||.+||+.+|.+||+++++++|+||...
T Consensus       227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 ----------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ----------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                      001112357899999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5e-45  Score=352.43  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=198.3

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK-   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-   83 (415)
                      .++|++.++||+|+||.||+|.+.     .+++.||+|++..... ......+.+|+.++..+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            479999999999999999999752     3456899999864322 22234577899999999 899999999988654 


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC---------------------------------------------------------
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN---------------------------------------------------------  105 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~---------------------------------------------------------  105 (415)
                      +.+|+||||++ |+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999 68888876432                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--cccccccccceeC
Q 014985          106 ----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRA  179 (415)
Q Consensus       106 ----~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~a  179 (415)
                          ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......++..|+|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence                2377888899999999999999999999999999999999999999999999986532221  1223345667999


Q ss_pred             cccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccc
Q 014985          180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS  258 (415)
Q Consensus       180 PE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (415)
                      ||++.+ ..++.++|||||||++|||++ |.+||.+....+.+...+..-.   .                       ..
T Consensus       245 PE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~-----------------------~~  297 (338)
T cd05102         245 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT---R-----------------------MR  297 (338)
T ss_pred             cHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC---C-----------------------CC
Confidence            999976 568999999999999999996 9999987654433333222100   0                       01


Q ss_pred             cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          259 LFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       259 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ....+++++.+||.+||..||++|||+.++++
T Consensus       298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         298 APENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11245789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=339.61  Aligned_cols=278  Identities=44%  Similarity=0.803  Sum_probs=226.0

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEeeeecCCe-----
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFPHKGN-----   85 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~-----   85 (415)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++++   +|+||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6789999999999999999988899999999976544443344566788877766   59999999999987776     


Q ss_pred             EEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      ++++|||+.++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            99999999999988887643 35899999999999999999999999999999999999999999999999999876443


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      . ......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.+++...+......|+.......
T Consensus       161 ~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         161 M-ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             c-ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            2 2233456778999999977 4588999999999999999999999999999999999988776655444443322111


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      . .+............+.++..+.+||.+||+.||.+||++.+++.||||
T Consensus       239 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 S-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             h-hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            1 011111122234445678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-45  Score=353.87  Aligned_cols=288  Identities=36%  Similarity=0.606  Sum_probs=231.2

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe-
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN-   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-   85 (415)
                      ...+.++|.+.+.||+|+||.||+|++..++..||+|++............+.+|+.+++.+.||||+++++++...+. 
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            3457899999999999999999999999999999999986543333333456689999999999999999998866554 


Q ss_pred             -----EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           86 -----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        86 -----~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                           .|+|+||++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        90 ~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          90 EDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             cccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence                 899999999999888875  3489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ....   .....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+.+..+....
T Consensus       168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         168 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             cccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            5432   3445678889999998765567899999999999999999999999988888888887776554433222111


Q ss_pred             CCc--cchh-cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          241 YLP--DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       241 ~~~--~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...  .+.. ......+.+...++.++..+.+||.+||..||++|||+.++++||||.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence            000  0000 0111122233445567999999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9e-45  Score=341.56  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=213.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +.|++.+.||+|+||.||++.+..++..+++|.+.....  .....+.+|+.+++.++||||++++++|...+..|+|+|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457889999999999999999999999999999864322  222346789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |+.| +|...+.+....+++..+..++.||+.||.|||+.|++||||||+|||++.++++||+|||++............
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9995 566666655567999999999999999999999999999999999999999999999999999765443333445


Q ss_pred             cccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          171 QVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ..++..|+|||++..    ...++.++|||||||++|+|++|.+||...+..+....+.......               
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  227 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT---------------  227 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC---------------
Confidence            567888999999842    2457789999999999999999999998877666555543321100               


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                ......++.++.+||.+||..||.+||+++++++||||...
T Consensus       228 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 ----------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                      00112347899999999999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=358.00  Aligned_cols=264  Identities=26%  Similarity=0.438  Sum_probs=218.8

Q ss_pred             cccccccEeee-----eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee
Q 014985            7 SKKVADRYLKR-----EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP   81 (415)
Q Consensus         7 ~~~~~~~y~~~-----~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   81 (415)
                      ++.+.-.|+..     -+||+|+||+||-|+|..+....|||.+.....  ...+-+..||.+.++|+|.|||++++.+.
T Consensus       565 ne~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~s  642 (1226)
T KOG4279|consen  565 NEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVS  642 (1226)
T ss_pred             ccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccC
Confidence            44455555543     369999999999999999999999999864322  23335678999999999999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeecc
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTNIFL--SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGL  157 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~~~l--~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~  157 (415)
                      .++++-|.||-++ |+|..+++...+++  .+..+..|.+||++||.|||++.|||||||-+||||+. .|.+||+|||.
T Consensus       643 enGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGT  722 (1226)
T KOG4279|consen  643 ENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGT  722 (1226)
T ss_pred             CCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEeccccc
Confidence            9999999999999 57888888888888  88999999999999999999999999999999999986 58999999999


Q ss_pred             ceecCCCCCcccccccccceeCccccc-CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLF-GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ++.+..-+.-..++.||..|||||++. |...|+.++|||||||++.||.||+|||.........  +++. |.      
T Consensus       723 sKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-Gm------  793 (1226)
T KOG4279|consen  723 SKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-GM------  793 (1226)
T ss_pred             chhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-cc------
Confidence            998765555566788999999999994 4567999999999999999999999999765443321  2221 10      


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                      ...-..+...+|.+++.||.+|+..||.+||++.++|..||++..
T Consensus       794 ----------------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  794 ----------------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             ----------------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                            000112333568999999999999999999999999999999876

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-44  Score=334.77  Aligned_cols=254  Identities=25%  Similarity=0.484  Sum_probs=215.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++++...++.|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            68999999999999999999999999999999876443333344677899999999999999999999999999999999


Q ss_pred             cc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           93 ME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        93 ~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      +. ++|...+... ...+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            98 5888888664 335899999999999999999999999999999999999999999999999999876554433344


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+......                    
T Consensus       161 ~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------------------  219 (256)
T cd08218         161 CIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--------------------  219 (256)
T ss_pred             ccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--------------------
Confidence            567888999999876 45788999999999999999999999877666665555332100                    


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                             ......+.++.++|.+||+.+|.+||++.++++||||
T Consensus       220 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         220 -------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                   1112347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.2e-45  Score=349.77  Aligned_cols=278  Identities=20%  Similarity=0.233  Sum_probs=207.8

Q ss_pred             eeeeeccc--CceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           16 KREVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        16 ~~~~LG~G--~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      ++++||+|  +|++||++.++.+|+.||+|.+............+.+|+.+++.++||||++++++|..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56889999  7899999999999999999998765444444445678999999999999999999999999999999999


Q ss_pred             c-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-----
Q 014985           94 E-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-----  166 (415)
Q Consensus        94 ~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-----  166 (415)
                      + |+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            9 5777777653 34589999999999999999999999999999999999999999999999987544321111     


Q ss_pred             --cccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC----
Q 014985          167 --RFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL----  239 (415)
Q Consensus       167 --~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~----  239 (415)
                        ......++..|+|||++.+. ..++.++|||||||++|+|++|.+||...............   ..+......    
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  238 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG---TVPCLLDTTTIPA  238 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC---Cccccccccchhh
Confidence              11223456679999998753 35889999999999999999999999876554433332211   111000000    


Q ss_pred             -------------CCCccchhcc----cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          240 -------------AYLPDYVEYQ----YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       240 -------------~~~~~~~~~~----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   ..........    .............+++++.+||.+||+.||++|||++++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                         0000000000    00000111122346789999999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-44  Score=338.15  Aligned_cols=257  Identities=27%  Similarity=0.394  Sum_probs=209.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++......  ....+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999998754322  2234668999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+++ +|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99995 777776554 4689999999999999999999999999999999999999999999999999987654444444


Q ss_pred             ccccccceeCccccc--CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          170 HQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ...|+..|+|||++.  ....++.++|+|||||++|+|++|.+||........+..+...  ...+..+           
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~-----------  231 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQPPKL-----------  231 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCCCCcc-----------
Confidence            567888999999974  2245788999999999999999999888665543333222111  0000000           


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                                .....++..+.+||.+||..+|++||+++++++|||
T Consensus       232 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         232 ----------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ----------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                      001134788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.1e-44  Score=331.96  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=218.2

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||.|+||.||.+++..++..+++|.+............+.+|+.++++++|+||+++++++.+.+.+++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            69999999999999999999999999999999876554444445677899999999999999999999999999999999


Q ss_pred             cc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           93 ME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        93 ~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      +. |+|.+.+.+. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++............
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            98 5888888765 456899999999999999999999999999999999999999999999999999876554434445


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+...  ..                   
T Consensus       161 ~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~-------------------  218 (256)
T cd08221         161 VVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY-------------------  218 (256)
T ss_pred             cCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC-------------------
Confidence            678889999999876 44788999999999999999999999887766666655432  00                   


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                            ....+.++.++.++|.+||..+|.+||++.++++|+|+
T Consensus       219 ------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 ------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                  01113457899999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-45  Score=350.85  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=209.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ...|+++++||+||.+.||++.... ...||+|++............+.+|+.+|.+|+ |.+||+||||-..++.+|||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            5679999999999999999997543 466777776655555555566889999999995 79999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc--
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--  167 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~--  167 (415)
                      |||=+.||...+.+...-++.-.++.|..|++.|+.++|..||||.||||.|+|+- .|.+||+|||+|.......+.  
T Consensus       439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccccee
Confidence            99999999999998877676679999999999999999999999999999999995 578999999999877554433  


Q ss_pred             ccccccccceeCcccccCCc----------CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          168 FTHQVFARWYRAPELLFGAK----------QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~----------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ...++||+.|||||.+....          ..++++||||||||||+|+.|++||....  ..+.++........     
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~-----  590 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNH-----  590 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCc-----
Confidence            34689999999999985311          14688999999999999999999996432  22333322211111     


Q ss_pred             CCCCCccchhcccccCCCccccCCCC--CHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                                         .-.||.+  ..++.++++.||.+||.+||+..++|+|||++..+.
T Consensus       591 -------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i  635 (677)
T KOG0596|consen  591 -------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI  635 (677)
T ss_pred             -------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence                               1112222  234999999999999999999999999999976444

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-44  Score=350.19  Aligned_cols=286  Identities=39%  Similarity=0.628  Sum_probs=225.3

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----   84 (415)
                      .+.++|.+.+.||+|+||.||++.+..+|..||+|.+............+.+|+.+++.++||||++++++|....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3688999999999999999999999999999999998654333333345778999999999999999999987654    


Q ss_pred             --eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 --~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                        .+++||||++++|..++..  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              4689999998888877764  348999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..   .....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+..++...+......+......
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         170 SE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            32   234466888999999876556889999999999999999999999988877777777665443221111100000


Q ss_pred             --ccch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          243 --PDYV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       243 --~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                        ..+. .........+....+.++..+.++|.+||..||++|||+.+++.||||.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence              0000 00001111223345677899999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-44  Score=340.51  Aligned_cols=257  Identities=29%  Similarity=0.504  Sum_probs=213.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ...+|.+.+.||+|+||.||++.+..+++.+|+|.+......  ....+.+|+.+++.+.|+||+++++.|..+.+.|+|
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            467999999999999999999999999999999998764432  234577899999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||+.| +|..++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        96 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             ecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence            999985 777776543  47899999999999999999999999999999999999999999999999988654444344


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+..+... +..   .             
T Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~---~-------------  235 (296)
T cd06654         174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP---E-------------  235 (296)
T ss_pred             CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC---C-------------
Confidence            45678889999999876 55789999999999999999999999877654433322110 000   0             


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                              ......++..+.+||.+||..||++|||+.++++|+||..
T Consensus       236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence                    0112245788999999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.9e-44  Score=339.18  Aligned_cols=258  Identities=32%  Similarity=0.519  Sum_probs=215.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+|.+.+.||.|+||.||++.+..+|+.||+|.+.....  .....+.+|+.+++.++||||+++++++.....+|+|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4689999999999999999999999999999999875432  22345678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+.| +|..++...  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...........
T Consensus        96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          96 EYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            99985 666655432  489999999999999999999999999999999999999999999999999886654443344


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+.......+... ....                 
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~-----------------  234 (296)
T cd06655         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE-----------------  234 (296)
T ss_pred             CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------------
Confidence            5577888999999876 55789999999999999999999999887765554443221 0000                 


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                             ......+++.+.+||.+||..||.+||++.+++.||||....
T Consensus       235 -------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 -------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             -------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                   011124578899999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=343.38  Aligned_cols=265  Identities=26%  Similarity=0.395  Sum_probs=219.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|.+....... .....+.+|+.+++.++|+||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            57999999999999999999999999999999997654332 23335678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--
Q 014985           91 EFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        91 e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--  166 (415)
                      ||+.| +|..++... +..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            99985 788877653 35689999999999999999999999999999999999999999999999999875432211  


Q ss_pred             ---------------------------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH
Q 014985          167 ---------------------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID  219 (415)
Q Consensus       167 ---------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  219 (415)
                                                 .....+|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                       1123467888999999976 457899999999999999999999998887666


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC----HHHHhcCCCCC
Q 014985          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT----AQQALEHRYFS  295 (415)
Q Consensus       220 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~e~l~h~~~~  295 (415)
                      .+..+....     ..++                     ....++..+.+||.+||..||++|||    +++++.||||.
T Consensus       240 ~~~~~~~~~-----~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         240 TFSNILKKE-----VTFP---------------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             HHHHHhcCC-----ccCC---------------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            655543210     0010                     01125889999999999999999999    99999999999


Q ss_pred             CCCCCCCC
Q 014985          296 SAPLPTEP  303 (415)
Q Consensus       296 ~~~~~~~~  303 (415)
                      +..++...
T Consensus       294 ~~~~~~~~  301 (316)
T cd05574         294 GVNWALIR  301 (316)
T ss_pred             cCChhhcc
Confidence            87765543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=337.80  Aligned_cols=256  Identities=28%  Similarity=0.415  Sum_probs=215.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|.+.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++|+||+++++++..+..+|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc-hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            5799999999999999999999999999999998754322 222346789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |+.| +|...+...  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++...........
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            9985 777777654  6899999999999999999999999999999999999999999999999999887655444556


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+.....    ...+             
T Consensus       158 ~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~-------------  219 (274)
T cd06609         158 FVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP----PSLE-------------  219 (274)
T ss_pred             ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC----CCCc-------------
Confidence            678888999999977 4489999999999999999999999987665444433322100    0000             


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                               ...++.++.++|.+||..||++|||++++++||||...
T Consensus       220 ---------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         220 ---------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             ---------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence                     01147889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-44  Score=346.54  Aligned_cols=285  Identities=39%  Similarity=0.626  Sum_probs=226.8

Q ss_pred             cEeeeeeecccCceEEEEEEECCC--CcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec----CCe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKT--GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH----KGN   85 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~~~   85 (415)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+............+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  89999999875433333334567899999999 59999999987432    346


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      +|+++||++++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            8999999999999888654 458999999999999999999999999999999999999999999999999998654322


Q ss_pred             C----cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 R----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .    .....+|+..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++..++.+....+.....
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence            1    223356888999999987656689999999999999999999999999888889999888888654332221111


Q ss_pred             Cccc---hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          242 LPDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       242 ~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ....   ..........+....+.++..+.+||.+||+.||++|||+.+++.|||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            0000   00111122233445566789999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-44  Score=336.24  Aligned_cols=256  Identities=27%  Similarity=0.372  Sum_probs=209.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC-----
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK-----   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-----   83 (415)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.....   ....+.+|+.+++.+ +|+||++++++|...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            35789999999999999999999999999999999875432   223567899999998 699999999998642     


Q ss_pred             -CeEEEEeeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           84 -GNLHLVFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        84 -~~~~lv~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                       ..+|+||||+. |+|..++... ...+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence             46899999998 5787777764 34689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCCcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ............|+..|+|||++.+    ...++.++|||||||++|+|++|.+||...........+...    .    
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~----~----  232 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----P----  232 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC----C----
Confidence            6544444455678889999999863    235788999999999999999999999765544333222110    0    


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                        ........++.++.+||.+||..||.+|||+.++++||||
T Consensus       233 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                              0001112357899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-44  Score=349.40  Aligned_cols=286  Identities=36%  Similarity=0.574  Sum_probs=226.8

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            457999999999999999999999999999999999875433332334567899999999999999999988543     


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ...|+++++++++|...+...  .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        94 ~~~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             357899999988888777543  48999999999999999999999999999999999999999999999999988643


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+...+..+......
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         172 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2   2234567888999999876566889999999999999999999999988877777777777665544333222111


Q ss_pred             ccch---hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ....   .........+.......++++.+||.+||+.||.+|+++.++++||||.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence            0000   00011111122223346889999999999999999999999999999986443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-44  Score=336.35  Aligned_cols=261  Identities=28%  Similarity=0.379  Sum_probs=209.3

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++......  ....+.+|+.+++.++||||+++++++...+.+
T Consensus         4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            444577899999999999999999999999999999998644221  123466899999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999995 677766543 458999999999999999999999999999999999999999999999999998765443


Q ss_pred             CcccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 RRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .......++..|+|||.+.+  ...++.++|+|||||++|+|++|.+||......+....+...       .+       
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------~~-------  226 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------NF-------  226 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------CC-------
Confidence            33345567888999999843  244778999999999999999999888654433222111100       00       


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                              ..+.. .....++..+.+||.+||+.||++|||++++++|+|
T Consensus       227 --------~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         227 --------QPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             --------CCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                    00000 111245789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.6e-44  Score=338.09  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=206.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.++||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            478999999999999999999999999999999875432 2223357789999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++|+.+....    .+++..+..++.|++.||+|||++||+|+||||+|||++.++.++|+|||++......  .....
T Consensus        80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            99975444332    3789999999999999999999999999999999999999999999999999876433  23345


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH---HHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID---QLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      +++..|+|||++.+ ..++.++|+|||||++|+|++|..||......+   .............+.              
T Consensus       154 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------  218 (279)
T cd06619         154 VGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--------------  218 (279)
T ss_pred             CCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--------------
Confidence            78888999999976 558899999999999999999999986532111   011111111111000              


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                              .......+.++.+||.+||+.||++||+++++++||||...
T Consensus       219 --------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         219 --------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             --------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence                    00112357899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-44  Score=341.58  Aligned_cols=261  Identities=30%  Similarity=0.489  Sum_probs=214.7

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .....+|.+.+.||+|+||.||++.+..+++.||+|.+......  ....+.+|+.+++.++|+||++++++|..+...|
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            34568999999999999999999999999999999998754332  2345678999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++| +|..++.+.  .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus        93 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             EeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999985 777776543  478999999999999999999999999999999999999999999999999987654444


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+... +.+               
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~---------------  233 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP---------------  233 (297)
T ss_pred             CcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCC---------------
Confidence            4445678888999999976 56789999999999999999999999776543322211100 000               


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                               .......++..+.+||.+||..||++||+++++++||||....
T Consensus       234 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         234 ---------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                     0011224578899999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.7e-44  Score=339.84  Aligned_cols=256  Identities=26%  Similarity=0.403  Sum_probs=216.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++...... ......+.+|++++++++||||+++++++..+..+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            5799999999999999999999999999999998754322 222345678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+. |+|.+.+... ..+++..+..++.||+.||.|||++|++|+||+|.||||+.++.+||+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            9996 6888887765 45899999999999999999999999999999999999999999999999999876443   33


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+....                     
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  214 (290)
T cd05580         157 TLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK---------------------  214 (290)
T ss_pred             CCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------------
Confidence            4567888999999876 457889999999999999999999998777555554443210                     


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                             ..+...++..+.++|.+||..||.+|+     +++++++||||....+.
T Consensus       215 -------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 -------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                   011223478999999999999999999     99999999999876543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6e-44  Score=343.45  Aligned_cols=286  Identities=36%  Similarity=0.599  Sum_probs=226.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-CCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~   87 (415)
                      .+.++|.+.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||++++++|.. ....|
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            36889999999999999999999999999999999987544333344457789999999999999999999865 56799


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      +|+||++++|...+...  .+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||.+.....   .
T Consensus        87 lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          87 FVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EEeehhccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            99999998888777643  478899999999999999999999999999999999999999999999999875432   2


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC---CCCcc
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL---AYLPD  244 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---~~~~~  244 (415)
                      .....++..|+|||.+.+...++.++|||||||++|+|++|.+||.+.........+.+.++..+.+.+...   ....-
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            234566778999999866566899999999999999999999999988776666666666665432211100   00000


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ..........+.....+.++..+.++|.+||+.+|++|||+++++.||||.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            0001111112223445677899999999999999999999999999999975443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-44  Score=332.45  Aligned_cols=258  Identities=31%  Similarity=0.415  Sum_probs=214.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++......  ....+.+|+.+++.++||||+++++++.....+|++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            47899999999999999999999999999999998754332  3346778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++| +|..++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...........
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            99995 67777766556799999999999999999999999999999999999999999999999999987654433444


Q ss_pred             ccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          170 HQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ...++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||.+.+.......+...-  ..+.             
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~--~~~~-------------  224 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN--FPPP-------------  224 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCc-------------
Confidence            56778889999998653  257889999999999999999999998876555544332210  0000             


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                              .....+..+.++.+||.+||..+|.+|||+.+++.|+|
T Consensus       225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 --------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                    00111234678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=338.39  Aligned_cols=279  Identities=43%  Similarity=0.719  Sum_probs=231.4

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEEEeec
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      |.+.+.||+|+||+||+|.+..+++.||+|.+...... .......+|+..++.++ |+||+++++++..++..|+||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            67899999999999999999989999999998654332 11223457999999999 99999999999999999999999


Q ss_pred             ccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           93 METDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        93 ~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ++|+|...+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~  158 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDY  158 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcCCC
Confidence            9999999887764 46899999999999999999999999999999999999999999999999999876432 223445


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      .++..|+|||++.+...++.++|+|||||++|+|++|.++|...+..+.+..+...++.+....|++...+.........
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            67888999999876566889999999999999999999999999999999999888888776666544333222222111


Q ss_pred             --cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          252 --AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       252 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                        .........+..+.++.+||.+||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence              1112233445568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.9e-44  Score=342.70  Aligned_cols=279  Identities=26%  Similarity=0.412  Sum_probs=211.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|.+.+.||+|+||.||++.+..++..+|+|.+..... ......+.+|++++++++||||++++++|..++.+|+|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            479999999999999999999999999999998864322 2223357789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |++| +|..++.+. ..+++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||++......  ...
T Consensus        80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~  156 (308)
T cd06615          80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  156 (308)
T ss_pred             ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence            9985 777777654 558999999999999999999997 58999999999999999999999999998765332  223


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCC-CCCC---CCCCC---
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP-SQWP---DLAYL---  242 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~---~~~~~---  242 (415)
                      ..+++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+... ...++........ ....   .....   
T Consensus       157 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         157 SFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCcc
Confidence            4577888999999876 558899999999999999999999997665333 2222221110000 0000   00000   


Q ss_pred             -----ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 -----PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 -----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                           .....+.....++ ......++.++.+||.+||..||++|||+.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         235 RPMAIFELLDYIVNEPPP-KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             chhhHHHHHHHHhcCCCc-cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                 0000000000000 00011357899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-46  Score=356.52  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=220.6

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..|.-++.||.|+||.||-|++..+...||||++..+.. .......+++|+..|++++|||+|.+-++|-.+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            456778899999999999999999999999999987654 4455667899999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |||-|+-.+++.-...++.+-++..|+.+.+.||+|||+.+.||||||..|||+.+.|.|||+|||.|......    ..
T Consensus       106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----ns  181 (948)
T KOG0577|consen  106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----NS  181 (948)
T ss_pred             HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch----hc
Confidence            99999777777666667999999999999999999999999999999999999999999999999999876443    46


Q ss_pred             cccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          171 QVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ++|||+|||||+++.  ..+|+-++||||||+++.||.-++||....+....+..|...-...                 
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt-----------------  244 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-----------------  244 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC-----------------
Confidence            899999999999853  4679999999999999999999998877666665555554321110                 


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                             +.  -+..|+.+..||..||++-|.+|||.+++|.|+|......
T Consensus       245 -------Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  245 -------LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             -------CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence                   00  1233889999999999999999999999999999865443

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.9e-44  Score=333.06  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=214.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|.+.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+......|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            57999999999999999999998899999999987544333 34467789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-
Q 014985           92 FMET-DLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-  167 (415)
                      |+.| +|..++....  ..+++..++.++.||+.||.|||++|++|+||||+||++++++.++|+|||++......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            9985 7777776542  45899999999999999999999999999999999999999999999999998776443322 


Q ss_pred             ---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          168 ---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       168 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                         ....+++..|+|||++.....++.++|+|||||++|+|++|..||...+....+.++...   .. ..++.      
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~------  229 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP-PSLET------  229 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC-CCcCC------
Confidence               133467888999999876546889999999999999999999999877665554444322   00 00000      


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                  ......++..+.+|+.+||..||++||++.++++||||
T Consensus       230 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         230 ------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                        00123568899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.4e-44  Score=333.79  Aligned_cols=253  Identities=25%  Similarity=0.503  Sum_probs=208.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-------ccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-------VNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-------~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      +|.+.+.||+|+||.||+|.+..+++.+|+|.+........       ....+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            57889999999999999999999999999998875433221       11346689999999999999999999999999


Q ss_pred             EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .++||||++| +|..++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            9999999985 777777654 45899999999999999999999999999999999999999999999999999876422


Q ss_pred             C------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          165 D------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       165 ~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      .      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.....         
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  229 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---------  229 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---------
Confidence            1      11123456778999999876 4578899999999999999999999987665444433322100         


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                        ......++..+.++|.+||+.||.+||++.++++||||
T Consensus       230 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         230 ------------------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                              01122457899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-44  Score=336.46  Aligned_cols=258  Identities=27%  Similarity=0.412  Sum_probs=207.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHH-HHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|.+........ ...+..|+.+ ++.+.||||+++++++..++.+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            579999999999999999999999999999999876533222 2244556665 66778999999999999999999999


Q ss_pred             ecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           91 EFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        91 e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||++|+|..++..   .+..+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++....... 
T Consensus        80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            9999988877754   334689999999999999999999997 99999999999999999999999999998654322 


Q ss_pred             cccccccccceeCcccccCC---cCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 RFTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ......++..|+|||++.+.   ..++.++|+|||||++|+|++|..||... ...+.+..+.....   + .       
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~-~-------  227 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS---P-Q-------  227 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---C-C-------
Confidence            22335678889999988542   34788999999999999999999998643 23333333322100   0 0       


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                     .....++.++.+||.+||..+|.+||++.++++||||...
T Consensus       228 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         228 ---------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             ---------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence                           0011357899999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-44  Score=332.62  Aligned_cols=254  Identities=30%  Similarity=0.467  Sum_probs=213.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+++.+++|.+.....    ...+.+|+.+++.++|+||+++++++.....+|+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            3689999999999999999999998899999999865432    346778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+.| +|.+.+......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99995 77777776667799999999999999999999999999999999999999999999999999987655443444


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+..    .....              
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~--------------  218 (256)
T cd06612         158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPPPT--------------  218 (256)
T ss_pred             cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----CCCCC--------------
Confidence            4567788999999876 4688999999999999999999999987654433322111    00000              


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                             ....+.++.++.+||.+||+.||.+|||+.|+++||||
T Consensus       219 -------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         219 -------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                   01112357889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.6e-46  Score=318.07  Aligned_cols=276  Identities=32%  Similarity=0.648  Sum_probs=222.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecC--CeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHK--GNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~~~   87 (415)
                      .++|++.+++|+|.|+.||.|++..++..++||+++..+.     ..+.+|++||..|. ||||+++++...+.  ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk-----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK-----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH-----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            7899999999999999999999999999999999865433     36789999999997 99999999998664  4677


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccceecCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPD  165 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~~~~~~~  165 (415)
                      +|+||++. +...+...    ++...++.++++|++||+|||++||+|||+||.|++|+.. ..++|+|+|+|.++ .+.
T Consensus       112 LiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY-Hp~  186 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG  186 (338)
T ss_pred             hHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc-CCC
Confidence            99999996 44444332    8889999999999999999999999999999999999965 56999999999876 456


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCC---CCC
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPD---LAY  241 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~  241 (415)
                      ..+...+.+++|.-||.+...+.|+.+.|+|||||+|..|+..+ |+|.|.++.+++.+|.+.+|+.....+-+   +..
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            66777889999999999988888999999999999999999865 89999999999999999988632211100   000


Q ss_pred             Cccchh-cccccCCCccccCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVE-YQYVAAPPLRSLFP-----SASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~-~~~~~~~~~~~~~~-----~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      .+.+-. .......++..+.+     -.++++.||+.++|.+|..+|+|+.|++.||||..
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            000000 00011111222111     24799999999999999999999999999999964

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-45  Score=353.17  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=226.3

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .-...|.+.+.||+|.|++|.++++..++..||||.+.+............+|+++|+.++|||||+++.+.+.+..+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34678999999999999999999999999999999998877665555567899999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||+. |.+.+++.+.+ .+.+..++.++.|++.|++|||+++|||||||.+|||++.+.++||+|||++..+. ....
T Consensus       133 V~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~  210 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLM  210 (596)
T ss_pred             EEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-cccc
Confidence            999998 57888887655 47779999999999999999999999999999999999999999999999999886 4566


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..+.+|++.|.|||++.+.++.+..+|+||+|+++|.|+.|..||++.+-.+.-.+.+...                   
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-------------------  271 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-------------------  271 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-------------------
Confidence            7789999999999999998878899999999999999999999999876544433322110                   


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                               ..+.-.++-++.+||+++|..+|.+|++.+++.+|.|....
T Consensus       272 ---------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  272 ---------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             ---------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence                     01112358899999999999999999999999999998754

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-44  Score=366.89  Aligned_cols=289  Identities=21%  Similarity=0.289  Sum_probs=209.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCc-EEEEEEee--------------cC-CccCCccchHHHHHHHHHhcCCC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQ-TVAIKKIR--------------LG-KQKEGVNFTALREIKLLKELKSP   71 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-~~avK~i~--------------~~-~~~~~~~~~~~~E~~il~~l~hp   71 (415)
                      ..+.++|++++.||+|+||+||+|..+.... ..+.|.+.              +. .........+.+|+.+|+.++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            4567899999999999999999987644322 22222111              00 01111223456899999999999


Q ss_pred             CeeeEEeeeecCCeEEEEeecccCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC
Q 014985           72 HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTN----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (415)
Q Consensus        72 ~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~----~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~  147 (415)
                      ||+++++++...+..|+|++++.++++.++....    .......++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999988876432    223466788899999999999999999999999999999999


Q ss_pred             CcEEEeeeccceecCCCCC-cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCC--CcHHHHHH
Q 014985          148 GQLKLADFGLARIFGSPDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGS--SDIDQLGK  223 (415)
Q Consensus       148 ~~vkL~DFG~a~~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~--~~~~~~~~  223 (415)
                      |.+||+|||+++.+..... .....+||..|+|||++.+ ..++.++|||||||++|||++|. +||.+.  +....+.+
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            9999999999987654332 2234678999999999977 56899999999999999999987 444433  34455666


Q ss_pred             HHHHhCCCCCCCCCCCC-CCccchhccccc--CCCccccC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          224 IFAAFGTATPSQWPDLA-YLPDYVEYQYVA--APPLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ++..++.. ...+++.. .+.+++......  ...+....  ..++.++.++|.+||++||.+|||+.|+|.||||+...
T Consensus       383 ~~~~~~~~-~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        383 IIDSLSVC-DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHHhcccC-hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            66555432 22233211 000111000000  00111111  13577899999999999999999999999999998643

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7.6e-44  Score=331.01  Aligned_cols=254  Identities=28%  Similarity=0.478  Sum_probs=212.6

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee--cCCeEEEEe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKGNLHLVF   90 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~lv~   90 (415)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+............+.+|+.+++.++|+||+++++++.  .....|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            589999999999999999999999999999998765444444445778999999999999999999775  345789999


Q ss_pred             eccc-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhh-----hCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           91 EFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCH-----KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        91 e~~~-g~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH-----~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      ||++ ++|..++...   ...+++..++.++.||+.||.|||     +.+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9998 5788777653   456899999999999999999999     999999999999999999999999999999887


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ...........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....             
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  226 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-------------  226 (265)
T ss_pred             cCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-------------
Confidence            554443445678889999999876 457899999999999999999999998876544443332210             


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                    .......++..+.+++.+||..+|++||++.++++|||+
T Consensus       227 --------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 --------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                          111223457899999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-44  Score=341.51  Aligned_cols=263  Identities=24%  Similarity=0.435  Sum_probs=215.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...+.|.....||+|+||.||++.+..++..||||.+.....  .....+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            345777778889999999999999999999999999865332  223346789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||++| +|..++..  ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.........
T Consensus        97 v~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658          97 VMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             EEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            9999996 55555433  34899999999999999999999999999999999999999999999999998765443333


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .....++..|+|||.+.+ ..++.++|+|||||++|||++|..||...+....+..+...+....               
T Consensus       175 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------  238 (292)
T cd06658         175 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV---------------  238 (292)
T ss_pred             CceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc---------------
Confidence            345678889999999866 5578999999999999999999999987776655544433211100               


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                                .....++..+.+||.+||..||.+|||++++++||||.....+.
T Consensus       239 ----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         239 ----------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ----------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                      01123478899999999999999999999999999998765544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=346.90  Aligned_cols=245  Identities=25%  Similarity=0.414  Sum_probs=210.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +.+.+++.||+|.||.||+|....+ ..||+|.+......   ...+.+|+++|++|+|++||++++++..++.+|||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            3456788999999999999976432 47999998765332   2356789999999999999999999999889999999


Q ss_pred             ccc-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~-~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |+. |+|+++++. .+..+.......++.||++|++||+++++|||||-..||||++++.+||+|||+|+...+..  ++
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~--Y~  359 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE--YT  359 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc--ee
Confidence            999 899999997 56679999999999999999999999999999999999999999999999999999654333  22


Q ss_pred             cccc---ccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          170 HQVF---ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       170 ~~~~---t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ...+   ..-|.|||.+.. ..++.+||||||||+||||+| |+.|+.+.+..+.+..+-++...+.|..+         
T Consensus       360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C---------  429 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC---------  429 (468)
T ss_pred             ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC---------
Confidence            2222   234999999976 458999999999999999998 89999999999999999888776666554         


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                        ++++.+++..|+..+|++|||.+.+..
T Consensus       430 ------------------P~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  430 ------------------PDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             ------------------CHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                              678999999999999999999987654

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-44  Score=337.05  Aligned_cols=259  Identities=28%  Similarity=0.425  Sum_probs=210.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++++.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++|+||+++++++...+..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            579999999999999999999999999999999865322 2223457789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           92 FMET-DLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        92 ~~~g-~L~~~i~~~--~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |+.| +|..++...  ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.+||+|||++.......  
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            9996 676666553  2358999999999999999999997 599999999999999999999999999997653322  


Q ss_pred             ccccccccceeCcccccCCc-----CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          168 FTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .....++..|+|||++.+..     .++.++|||||||++|+|++|..||...........+........          
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  227 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP----------  227 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC----------
Confidence            23346777899999985422     357899999999999999999999976654443333322211111          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                    ....+.++.++.+||.+||..+|++||+++++++||||...
T Consensus       228 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         228 --------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             --------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                          11223458999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.6e-44  Score=329.40  Aligned_cols=250  Identities=29%  Similarity=0.465  Sum_probs=210.4

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.+++.++|+||+++++.|..++.+|+||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            589999999999999999999999999999998754332 2234567899999999999999999999999999999999


Q ss_pred             cc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           93 ME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        93 ~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ++ |+|...+... +..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++............
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            98 5888887653 445899999999999999999999999999999999999999999999999999877554444445


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+......                    
T Consensus       160 ~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------  218 (255)
T cd08219         160 YVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------------------  218 (255)
T ss_pred             ccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------------------
Confidence            678888999999876 55889999999999999999999999877655555444322110                    


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                             .....++..+.+||.+||+.||++||++.+++.-
T Consensus       219 -------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 -------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   1112347889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-43  Score=334.33  Aligned_cols=256  Identities=28%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeee------c
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP------H   82 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~------~   82 (415)
                      -.+.|++.+.||.|+||.||+|.+..+++.+|+|.+.....   ....+..|+.+++.+ +|+||++++++|.      .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH---HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            35799999999999999999999999999999999865321   223466799999998 6999999999984      3


Q ss_pred             CCeEEEEeecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           83 KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        83 ~~~~~lv~e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ...+|++|||+++ +|..++... +..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            4678999999985 787777653 34588999999999999999999999999999999999999999999999999886


Q ss_pred             cCCCCCcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ............++..|+|||++..    ...++.++|+|||||++|+|++|.+||........+..+...    .+   
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~----~~---  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PP---  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC----CC---
Confidence            5443333445678888999999853    245788999999999999999999999766544333222110    00   


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                         .......++.++.+||.+||+.||.+|||+.|+++||||
T Consensus       244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 -------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                               001112357899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.5e-43  Score=326.42  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            58999999999999999999999999999999986554444455677899999999999999999999999999999999


Q ss_pred             ccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccceecCCCCCccc
Q 014985           93 MET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        93 ~~g-~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ++| +|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++....... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence            985 8888887643 458999999999999999999999999999999999999865 458999999998765432 223


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......                   
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  219 (256)
T cd08220         160 TVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-------------------  219 (256)
T ss_pred             ccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-------------------
Confidence            3567788999999976 45788999999999999999999999887666555554332110                   


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                              .....++.++.++|.+||..||++|||+.|+++||||
T Consensus       220 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 --------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                    1112357899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=331.20  Aligned_cols=257  Identities=30%  Similarity=0.417  Sum_probs=210.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC-----
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK-----   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-----   83 (415)
                      -.++|++.+.||.|+||.||+|.+..+++.+++|++.....   ....+.+|+.+++++ .|+||++++++|...     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            36899999999999999999999999999999999875432   234577899999999 699999999998654     


Q ss_pred             -CeEEEEeecccC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           84 -GNLHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        84 -~~~~lv~e~~~g-~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                       ..+|+||||+++ +|.+++...   +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence             458999999995 666666542   456899999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ..............++..|+|||++..    ...++.++|||||||++|+|++|.+||...+....+..+....    ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~  236 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP----PP  236 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC----CC
Confidence            876554444455678888999998753    2346789999999999999999999998765555544433210    00


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      .+                     ......+.++.+||.+||..||++|||+.++++|||+
T Consensus       237 ~~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TL---------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CC---------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            00                     0011247889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=359.98  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=201.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeee-ec---C--
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAF-PH---K--   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~-~~---~--   83 (415)
                      .-+++|.++|.+|||+.||+|.+...|..||+|.+...  .+.....+.+||.+|+.|+ |+|||.++|.. ..   .  
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            45678999999999999999999988899999998755  3333446779999999997 99999999932 11   1  


Q ss_pred             -CeEEEEeeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           84 -GNLHLVFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        84 -~~~~lv~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                       -.++|+||||. |+|.+++..+ ...|++.++.+|++++++|+.+||...  |||||||-|||||..+|+.||||||.|
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence             24789999999 6999999754 334999999999999999999999998  999999999999999999999999999


Q ss_pred             eecCCCCC---------cccccccccceeCcccc--cCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHH
Q 014985          159 RIFGSPDR---------RFTHQVFARWYRAPELL--FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA  227 (415)
Q Consensus       159 ~~~~~~~~---------~~~~~~~t~~y~aPE~l--~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  227 (415)
                      +-.....+         .......|+.|+|||++  ......++|+|||+|||+||.|+....||.......++.-    
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng----  269 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG----  269 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec----
Confidence            75322221         12234468889999997  4446789999999999999999999999987643322211    


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                         .|.   .    .-+|.+|..+++||+.||+.||.+||++.|++++
T Consensus       270 -------------------~Y~---~----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  270 -------------------NYS---F----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -------------------ccc---C----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                               111   1    1135669999999999999999999999999875

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.2e-43  Score=331.67  Aligned_cols=258  Identities=28%  Similarity=0.404  Sum_probs=209.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC-----
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK-----   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~-----   83 (415)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++....   .....+.+|+.++..+ +||||++++++|...     
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            5789999999999999999999999999999999986432   2233456799999998 899999999998643     


Q ss_pred             CeEEEEeecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           84 GNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        84 ~~~~lv~e~~~g-~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      +..|+||||++| +|.+++..   .+..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            468999999985 77776643   34568999999999999999999999999999999999999999999999999988


Q ss_pred             ecCCCCCcccccccccceeCcccccCCc----CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAK----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      .............++..|+|||++....    .++.++|||||||++|+|++|.+||........+..+....   .+ .
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~  252 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP---PP-T  252 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC---CC-C
Confidence            7654433334456788899999985432    36789999999999999999999998776655554432210   00 0


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      .                     ......+..+.+||.+||+.+|++||++.++++||||.
T Consensus       253 ~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 L---------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C---------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            0                     00123467899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-43  Score=330.82  Aligned_cols=258  Identities=29%  Similarity=0.508  Sum_probs=208.2

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      +|+..+.||+|+||.||++.+..+++.+|+|++........    ....+.+|+++++.++|+||+++++++.+.++.++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            48889999999999999999999999999999875432211    23456789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeeccceecCCCCC
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDR  166 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~~~  166 (415)
                      ||||+.| +|.+++.+ ...+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999995 67666654 44689999999999999999999999999999999999998776 599999999877644321


Q ss_pred             c----ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 R----FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .    .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+........          
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  228 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----------  228 (268)
T ss_pred             cCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC----------
Confidence            1    123456778999999876 5678999999999999999999999976544333333322111000          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                   .....+.++.++.+++.+||..+|.+||++.++++||||.
T Consensus       229 -------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         229 -------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                         0112234578999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.9e-43  Score=335.55  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=215.5

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ....++|.+.+.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            445678999999999999999999999999999999986543222 2223567899999999999999999999999999


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |+||||+.|++.+.+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......  
T Consensus        91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            999999999999888766667999999999999999999999999999999999999999999999999998765322  


Q ss_pred             cccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                        ....++..|+|||++.+  ...++.++|||||||++|+|++|.+||.+.+.......+...   ..+ ..        
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~-~~--------  234 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSP-TL--------  234 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---CCC-CC--------
Confidence              23466778999999852  345788999999999999999999999877655544333211   000 00        


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                    .....+..+.+||.+||..||++||++.+++.||||...
T Consensus       235 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         235 --------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             --------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                          001247789999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-43  Score=331.92  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=207.5

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeee-----e
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAF-----P   81 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~-----~   81 (415)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|++....   .....+.+|+.+++.+ +||||+++++++     .
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            346889999999999999999999999999999999875422   1223466899999999 699999999987     3


Q ss_pred             cCCeEEEEeecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           82 HKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        82 ~~~~~~lv~e~~~g-~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      .++.+|+||||++| +|..++..   .+..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence            45679999999985 77766642   345688999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      +..............|+..|+|||++..    ...++.++|||||||++|+|++|.+||...+....+..+...    ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~----~~  246 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN----PP  246 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc----CC
Confidence            9876544334445578889999999853    234788999999999999999999998776544433222110    00


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ..                     .......+..+.+||.+||+.||++|||+.++++|+||
T Consensus       247 ~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 PT---------------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             Cc---------------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            00                     00011236789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-43  Score=330.59  Aligned_cols=251  Identities=17%  Similarity=0.221  Sum_probs=203.5

Q ss_pred             cccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+.||+|+||.||+|.+.   ..+..||+|.+...... .....+.+|+.+++.++||||+++++++..++..|
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            467999999999999999999765   45668999998754322 22345678999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++| +|..++......+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||.+........
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            99999995 67767766556789999999999999999999999999999999999999999999999998765422211


Q ss_pred             -cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 -RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 -~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......              
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------------  227 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL--------------  227 (266)
T ss_pred             hcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC--------------
Confidence             1112334567999999876 568999999999999999774 99999888776666555322110              


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                   ...+.++..+.+++.+||+.+|.+||++++|++
T Consensus       228 -------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 -------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                         112234788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-43  Score=335.48  Aligned_cols=258  Identities=23%  Similarity=0.319  Sum_probs=201.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECC----------------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK----------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv   74 (415)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+...... .....+.+|+.+++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-NARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-HHHHHHHHHHHHHhhcCCCCee
Confidence            5789999999999999999997532                3447999998754322 2233577899999999999999


Q ss_pred             eEEeeeecCCeEEEEeeccc-CCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 014985           75 ELIDAFPHKGNLHLVFEFME-TDLETVIRNTN------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHR  135 (415)
Q Consensus        75 ~l~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHr  135 (415)
                      ++++++...+..|+||||+. |+|.+++....                  ..+++..+..++.||+.||.|||++||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999998 58888775432                  236778899999999999999999999999


Q ss_pred             CCCCCcEEEecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc--CCCC
Q 014985          136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPF  211 (415)
Q Consensus       136 Dlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~p  211 (415)
                      ||||+|||++.++.+||+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++  +..|
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999986543321  1223345677999999876 558999999999999999986  5678


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       212 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      |.+.+..+.+..+...+.......                    .....+..+..+.+||.+||+.||++|||+.++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQV--------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccc--------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            877766666555433221110000                    00112345789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.6e-43  Score=334.63  Aligned_cols=261  Identities=29%  Similarity=0.441  Sum_probs=212.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+..++++|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4799999999999999999999999999999998755321 122235668999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----  165 (415)
                      ||++| +|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......    
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99985 677777654 458999999999999999999999999999999999999999999999999986421110    


Q ss_pred             -----------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          166 -----------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       166 -----------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                                 .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+......    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~----  234 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE----  234 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----
Confidence                       01112356778999999876 56899999999999999999999999887766655554332100    


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRYFSSAPL  299 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~h~~~~~~~~  299 (415)
                       ++                    ...+.++.++.+||.+||+.||++||+   +.++++||||....+
T Consensus       235 -~~--------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         235 -WP--------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             -CC--------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence             00                    011235789999999999999999997   799999999976544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=318.09  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=214.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +...+..||.|+.|+||+++.+.+|...|||.++.....++.. +++..+.++... .+|+||+.+++|..+..+++.||
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~k-RILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENK-RILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHH-HHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            4456778999999999999999999999999998776555443 455566655544 58999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      .+..-...+++.-..+++|..+-.+...+++||.||.. +||+|||+||+|||+|+.|++||||||++-.+.+ +...+.
T Consensus       172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-SkAhtr  250 (391)
T KOG0983|consen  172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-SKAHTR  250 (391)
T ss_pred             HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec-cccccc
Confidence            99977777777777779999999999999999999986 5799999999999999999999999999987644 333455


Q ss_pred             cccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          171 QVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..|.+.|||||.+.-  ...|+.++||||||++++||.||+.||.+. .+.+.+.++....                   
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-------------------  311 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-------------------  311 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-------------------
Confidence            678888999999843  346899999999999999999999999885 5778888776521                   


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                            |+......+.|+++.+|+..||++|+.+||...++|+|||+..
T Consensus       312 ------PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  312 ------PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             ------CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence                  1111112236999999999999999999999999999999864

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.2e-43  Score=328.21  Aligned_cols=255  Identities=25%  Similarity=0.462  Sum_probs=204.8

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC---ccchHHHHHHHHHhcCCCCeeeEEeeeec--CCeE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKELKSPHIIELIDAFPH--KGNL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~   86 (415)
                      .+|.+.+.||+|+||.||+|.+..++..||+|++........   ....+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368999999999999999999999999999999875543221   22346689999999999999999998865  3678


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++++||+.| +|...+.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            999999985 7777776544 48999999999999999999999999999999999999999999999999987653221


Q ss_pred             ---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                         .......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+..   ....         
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~---------  227 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN---------  227 (266)
T ss_pred             ccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC---------
Confidence               12223457788999999976 5688999999999999999999999987654443333211   1100         


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                    ..+...++..+.+|| +||..+|++||+++|+++||||+
T Consensus       228 --------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         228 --------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             --------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                          011223578899999 67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.7e-44  Score=337.67  Aligned_cols=262  Identities=24%  Similarity=0.451  Sum_probs=214.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ...|.....||+|+||.||+|.+..+++.||+|.+......  ....+.+|+.+++.+.||||+++++.|..++..|+||
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            34455667899999999999999999999999998654322  2345678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++| +|...+..  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus        98 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659          98 EFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             ecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            99995 66665543  3489999999999999999999999999999999999999999999999999976544443444


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+...    ...               
T Consensus       176 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----~~~---------------  235 (297)
T cd06659         176 SLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPP---------------  235 (297)
T ss_pred             ceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----CCC---------------
Confidence            5678889999999976 45789999999999999999999999877666555443211    000               


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~  302 (415)
                            .......++..+.++|.+||+.+|.+||++.++++||||.....+..
T Consensus       236 ------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         236 ------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             ------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence                  01112345788999999999999999999999999999987655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.8e-43  Score=326.61  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=205.9

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC----CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE----GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+.......    .....+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 478899999987543211    112346789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC---
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP---  164 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~---  164 (415)
                      |+||+.| +|..++.+. ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......   
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999985 777777654 45899999999999999999999999999999999999999999999999998764221   


Q ss_pred             ---CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 ---DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                         ........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....+.           
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-----------  226 (265)
T ss_pred             ccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-----------
Confidence               112234567888999999876 55789999999999999999999999776544433222211000           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                    .......++.++.+||.+||..+|.+||++.++++||||
T Consensus       227 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 --------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          011223458899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.8e-43  Score=330.25  Aligned_cols=252  Identities=26%  Similarity=0.421  Sum_probs=199.0

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-cchHHHHHHHHH---hcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLK---ELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~E~~il~---~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      +||+|+||.||++.+..+++.+|+|.+......... .....+|..+++   ...||||+.+++++...+..|+||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998765432221 122334444333   3479999999999999999999999999


Q ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccc
Q 014985           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (415)
Q Consensus        95 g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  173 (415)
                      | +|...+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......  .....+
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG  157 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCC
Confidence            5 676666544 459999999999999999999999999999999999999999999999999997654322  234568


Q ss_pred             ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH--HHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI--DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       174 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      +..|+|||.+.+...++.++||||+||++|+|++|..||......  ..+......   .                    
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---~--------------------  214 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---V--------------------  214 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---C--------------------
Confidence            889999999865456889999999999999999999999764322  111111100   0                    


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                          .....+.++.++.+||.+||..||++|+     +++++++||||.+..+.
T Consensus       215 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         215 ----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             ----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence                0112234689999999999999999999     69999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3e-43  Score=326.04  Aligned_cols=254  Identities=28%  Similarity=0.506  Sum_probs=213.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||.|+||.||++.+..+|..+|+|.+............+.+|+.+++.++|+||+++++.+...+..|+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58999999999999999999999999999999876543333344567899999999999999999999999999999999


Q ss_pred             cc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc-EEEeeeccceecCCCCCccc
Q 014985           93 ME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        93 ~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~-vkL~DFG~a~~~~~~~~~~~  169 (415)
                      +. ++|..++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            98 58888776543 35799999999999999999999999999999999999998864 69999999987655443344


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+....                     
T Consensus       161 ~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------  218 (257)
T cd08225         161 TCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---------------------  218 (257)
T ss_pred             ccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---------------------
Confidence            4567888999999866 457899999999999999999999998766555444332210                     


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                            .....+.++.++.++|.+||..+|++|||+.+++.||||
T Consensus       219 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  011234568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-43  Score=346.04  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=200.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC-----cEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|++.+.||+|+||.||+|.+...|     ..||+|++....... ....+.+|+.+++.+ +|+||+++++++...+
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-EREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-HHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            568999999999999999999865443     579999987543222 234577899999999 8999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC----------------------------------------------------------
Q 014985           85 NLHLVFEFME-TDLETVIRNTN----------------------------------------------------------  105 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~----------------------------------------------------------  105 (415)
                      .+|+|||||. |+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999998 68888875421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc--ccccc
Q 014985          106 -----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--FTHQV  172 (415)
Q Consensus       106 -----------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~--~~~~~  172 (415)
                                 ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........  .....
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                       24788889999999999999999999999999999999999999999999999875433221  11223


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      ++..|+|||++.+ ..++.++|||||||++|+|++ |.+||........+..+.......                    
T Consensus       276 ~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--------------------  334 (374)
T cd05106         276 LPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--------------------  334 (374)
T ss_pred             CccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------------
Confidence            4556999999876 568999999999999999997 999998765544433333210000                    


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                            .....++.++.++|.+||+.||.+|||+.++++
T Consensus       335 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 ------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                  011124789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.7e-43  Score=324.17  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=210.4

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC---CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +|+..+.||+|+||+||+|.+..++..|++|.+.......   .....+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888999999999999999998899999999987544221   2233567899999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      +||++| +|.+++.+. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA  158 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence            999985 777777654 458999999999999999999999999999999999999999999999999988754433 23


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....++..|+|||.+.....++.++|+|||||++|+|++|.+||......+....+....                    
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------------------  218 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--------------------  218 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--------------------
Confidence            345678889999998663348899999999999999999999998766444443332210                    


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                            ......+.++.++.+|+.+||+.+|.+||++.+++.|||+
T Consensus       219 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                  0011223458899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-43  Score=328.95  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=210.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +|.+.+.||.|+||.||+|.+..+++.||+|++....... .....+.+|+.++++++||||+++++.+......|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999999999999997654322 333467789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |+.| +|...+.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            9985 677776654 568999999999999999999999999999999999999999999999999988764432 2334


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc--HHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--IDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.  .+.+.....   ..                 
T Consensus       159 ~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-----------------  217 (258)
T cd05578         159 TSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TA-----------------  217 (258)
T ss_pred             cCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---cc-----------------
Confidence            567778999999876 4588999999999999999999999987764  222222111   00                 


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH--HHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA--QQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~--~e~l~h~~~  294 (415)
                             .....+.++.++.++|.+||..||.+||++  .++++||||
T Consensus       218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         218 -------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                   011223457899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=346.74  Aligned_cols=271  Identities=24%  Similarity=0.372  Sum_probs=234.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -..+..++..||-|+||.|-++........+|+|.+++... .....+.+..|-.||..+..|+||++|..|.++.++|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            35667888999999999999997666555699999876553 33445567889999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      +||-|- |.++..+++++ .+++..++.|+..+++|++|||++|||+|||||+|.|++.+|.+||.|||+|+..+.... 
T Consensus       498 LmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-  575 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-  575 (732)
T ss_pred             hHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence            999987 67888887755 489999999999999999999999999999999999999999999999999999877554 


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .-++|||+.|.|||++++ +..+.++|.||||+++|||++|.|||.+.+...++..|++++...                
T Consensus       576 TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------------  638 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------------  638 (732)
T ss_pred             eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------
Confidence            446899999999999998 668999999999999999999999999999999999998874321                


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLPTEPNKLPRP  309 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~~~~~~~~~~  309 (415)
                                .++..++..+.+||++++..+|.+|..     +.+|..|.||.+..|..-......|
T Consensus       639 ----------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~p  695 (732)
T KOG0614|consen  639 ----------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPP  695 (732)
T ss_pred             ----------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCC
Confidence                      122356889999999999999999985     8999999999998887654443333

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=328.63  Aligned_cols=255  Identities=25%  Similarity=0.464  Sum_probs=210.5

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC---CCCeeeEEeeeecCCeEEEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.+.   ||||+++++++..+...|+|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            588899999999999999999999999999998754322 22335668999999996   99999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||+.| +|..++.. + .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~-~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKA-G-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHc-c-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            999985 67666654 3 58999999999999999999999999999999999999999999999999998876555444


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.........+.    ...+.              
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~----~~~~~--------------  220 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP----KSKPP--------------  220 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc----cCCCC--------------
Confidence            556788889999998765667899999999999999999999998765433222110    00000              


Q ss_pred             ccccCCCccccCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          249 QYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       249 ~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                               .+.. .++.++.+|+.+||+.||++||++.+++.|+||...
T Consensus       221 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         221 ---------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence                     0111 247899999999999999999999999999999754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.3e-43  Score=324.76  Aligned_cols=255  Identities=26%  Similarity=0.477  Sum_probs=205.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC---ccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKELKSPHIIELIDAFPHK--GNL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~---~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~   86 (415)
                      ++|.+.+.||+|+||.||++.+..+|+.||+|.+........   ....+.+|+.+++.+.||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999999865332211   123566899999999999999999998763  468


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||++| +|.+++.+. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            899999985 777777654 448999999999999999999999999999999999999999999999999987653211


Q ss_pred             ---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                         .......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+.   .....         
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~---------  227 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN---------  227 (265)
T ss_pred             ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC---------
Confidence               12233567888999999876 557899999999999999999999998765444433321   11100         


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                    ....+.++..+.++|.+|+. +|++||+++++++|||+.
T Consensus       228 --------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         228 --------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             --------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                          11123457889999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4e-43  Score=343.72  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=200.9

Q ss_pred             cccEeeeeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|++.+.||+|+||+||+|.+     ..++..||+|++...... .....+.+|+.+++.+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            46899999999999999999964     345678999998643322 2234567899999999 8999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC----------------------------------------------------------
Q 014985           85 NLHLVFEFME-TDLETVIRNTN----------------------------------------------------------  105 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~----------------------------------------------------------  105 (415)
                      ..|+|||||. |+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999 68888886532                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc--
Q 014985          106 ----------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR--  167 (415)
Q Consensus       106 ----------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~--  167 (415)
                                      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                            14678889999999999999999999999999999999999999999999999876433221  


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||..........+....-..                
T Consensus       273 ~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------  335 (375)
T cd05104         273 KGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR----------------  335 (375)
T ss_pred             cCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------------
Confidence            112334556999999976 568999999999999999997 88999876554443333221000                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                .......+.++.+||.+||+.||++||++.++++.
T Consensus       336 ----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 ----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                      00011236789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-43  Score=330.14  Aligned_cols=254  Identities=29%  Similarity=0.481  Sum_probs=210.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+.....+|+|+|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            4788999999999999999999999999999998765432 333457789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |++ ++|.+++......+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  157 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--  157 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence            999 58888887665679999999999999999999999 99999999999999999999999999998765332221  


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC-----cHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-----DIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||....     ..+.+..+..   ...+           
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~-----------  222 (265)
T cd06605         158 TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPP-----------  222 (265)
T ss_pred             cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCC-----------
Confidence            2667778999999876 468999999999999999999998886542     1122222211   1100           


Q ss_pred             chhcccccCCCccccCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   ..... ++.++.+||.+||..||++|||+.+++.||||+.
T Consensus       223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         223 -------------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             -------------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence                         01111 5889999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.6e-43  Score=330.83  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=212.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ...|...+.||.|+||.||+|.+..++..+|+|.+...... .....+.+|+.+++.+.|+||+++++++......|+||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46788999999999999999999999999999998754322 22345678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++| +|.+.+..  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            99985 77777654  3489999999999999999999999999999999999999999999999999987654443334


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+...    .                 
T Consensus       160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~-----------------  217 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN----N-----------------  217 (277)
T ss_pred             cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC----C-----------------
Confidence            4567888999999876 45789999999999999999999999876654443322110    0                 


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                            .......++..+.+||.+||..+|++||++.+++.|+||....
T Consensus       218 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         218 ------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                  0111223478899999999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.7e-43  Score=322.07  Aligned_cols=254  Identities=28%  Similarity=0.503  Sum_probs=216.2

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            58999999999999999999999999999999976554444445677899999999999999999999999999999999


Q ss_pred             ccC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           93 MET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        93 ~~g-~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ++| +|...+...   +..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            985 788888765   3679999999999999999999999999999999999999999999999999998775554334


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..+....+.....                   
T Consensus       161 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  220 (258)
T cd08215         161 KTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-------------------  220 (258)
T ss_pred             cceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-------------------
Confidence            44567888999999876 4588999999999999999999999987765544444322110                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                              ..+....+..+.+++.+||..+|++|||+.++++||||
T Consensus       221 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 --------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                    11122457899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.8e-43  Score=327.93  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=199.4

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-cchHHHH---HHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALRE---IKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~E---~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      .||+|+||.||+|.+..+++.||+|.+......... ......|   +.+++...||+|++++++|...+..|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998765432221 1122333   344555689999999999999999999999998


Q ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccc
Q 014985           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (415)
Q Consensus        95 g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  173 (415)
                      | +|..++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+....  ....+|
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG  157 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCC
Confidence            5 56665554 4569999999999999999999999999999999999999999999999999987653322  234578


Q ss_pred             ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       174 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      +..|+|||++.+...++.++||||+||++|+|++|..||.+......... ........                     
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~---------------------  215 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMA---------------------  215 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhccC---------------------
Confidence            88999999997645688999999999999999999999987632211111 01000000                     


Q ss_pred             CCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          254 PPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       254 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                         .......+.++.++|.+||..+|.+|+     ++.++++||||....+.
T Consensus       216 ---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         216 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             ---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence               011223488999999999999999999     99999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-42  Score=323.06  Aligned_cols=257  Identities=28%  Similarity=0.471  Sum_probs=209.2

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            69999999999999999999999999999999876654433445678899999999999999999999999999999999


Q ss_pred             ccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc--
Q 014985           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT--  169 (415)
Q Consensus        93 ~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~--  169 (415)
                      +.+ +|.+++.. +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...........  
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            995 67776665 44589999999999999999999999999999999999999999999999999987654433222  


Q ss_pred             --ccccccceeCcccccCCc--CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          170 --HQVFARWYRAPELLFGAK--QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       170 --~~~~t~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                        ...++..|+|||++.+..  .++.++|||||||++|+|++|..||...............   ......+        
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~--------  228 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIP--------  228 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCC--------
Confidence              245677899999987632  3788999999999999999999999765433222211111   1110111        


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                   ....++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus       229 -------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         229 -------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -------------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                         112347889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3e-43  Score=332.06  Aligned_cols=262  Identities=21%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|...+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. |+||+++++++...+..+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            35677889999999999999999999999999998754332 22335678999999996 99999999999999999999


Q ss_pred             eecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           90 FEFMETDLETVIR----NTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        90 ~e~~~g~L~~~i~----~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      |||+.+++..+..    .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++......
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            9999976655432    2235689999999999999999999974 9999999999999999999999999999765432


Q ss_pred             CCcccccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          165 DRRFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      . ......++..|+|||++.+.  ..++.++|||||||++|+|++|.+||.....  ....+........+..       
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-------  231 (288)
T cd06616         162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL-------  231 (288)
T ss_pred             C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC-------
Confidence            2 22334678889999999764  3688999999999999999999999976542  2222222111111000       


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   .......++.++.+||.+||+.||++|||+++++.||||..
T Consensus       232 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         232 -------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             -------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence                         00111345889999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-42  Score=326.99  Aligned_cols=258  Identities=27%  Similarity=0.469  Sum_probs=213.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+|...+.||+|++|.||++.+..+++.+++|++.....  .....+.+|+.+++.++||||+++++++...+..|+|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            3567777899999999999999999999999998864322  22334678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||+.| +|.+.+..  ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+...........
T Consensus        96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648          96 EFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             eccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            99985 77777765  4589999999999999999999999999999999999999999999999998876544333334


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.....    ..              
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~----~~--------------  234 (285)
T cd06648         174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP----PK--------------  234 (285)
T ss_pred             cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC----CC--------------
Confidence            4568889999999876 4588999999999999999999999987766555554433210    00              


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                             ......++..+.+||.+||+.+|++||++.++++|+||....
T Consensus       235 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         235 -------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             -------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence                   011123578999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-42  Score=325.21  Aligned_cols=259  Identities=27%  Similarity=0.472  Sum_probs=208.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC--------ccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--------VNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--------~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+........        ....+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            58899999999999999999999999999998865322111        1124567999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..++||||+. |+|...+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            9999999998 5777777665 4689999999999999999999999999999999999999999999999999976533


Q ss_pred             CCC--cccccccccceeCcccccCCc-CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          164 PDR--RFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       164 ~~~--~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...  ......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||........+..+...   .....     
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~-----  232 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK---RSAPP-----  232 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc---ccCCc-----
Confidence            211  123345677899999986533 4788999999999999999999999765544333322111   00000     


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                    ......+.++.++.+||.+||..+|.+|||++++++||||
T Consensus       233 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         233 --------------IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             --------------CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                          0112234568999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6e-43  Score=328.36  Aligned_cols=255  Identities=28%  Similarity=0.405  Sum_probs=206.0

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L   97 (415)
                      ||+|+||+||+|.+..+|+.||+|.+....... .....+.+|+.+++.++||||++++++|...+..|+||||++ ++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999987643222 223345689999999999999999999999999999999999 578


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccc
Q 014985           98 ETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW  176 (415)
Q Consensus        98 ~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~  176 (415)
                      ...+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..... ........++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCC
Confidence            77776644 3589999999999999999999999999999999999999999999999999876533 223334566778


Q ss_pred             eeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCc
Q 014985          177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL  256 (415)
Q Consensus       177 y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (415)
                      |+|||++.+ ..++.++|||||||++|+|++|..||...........+.......                        .
T Consensus       160 y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~  214 (277)
T cd05577         160 YMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM------------------------A  214 (277)
T ss_pred             cCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc------------------------c
Confidence            999999876 448899999999999999999999997765422222221110000                        0


Q ss_pred             cccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          257 RSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       257 ~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                      ....+.+++.+.++|.+||+.||.+||     ++.++++||||....+.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence            112234589999999999999999999     89999999999876553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.2e-42  Score=330.43  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=216.9

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ....+.|...+.||+|+||+||+|.+..+|..|++|++....... .....+.+|+.+++.++|||++++++++.+....
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            335667888899999999999999999999999999987653322 2223567899999999999999999999999999


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |+||||+.|++...+......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.....   
T Consensus        97 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633          97 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            99999999999999887777799999999999999999999999999999999999999999999999999865322   


Q ss_pred             cccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       .....++..|+|||++..  ...++.++|||||||++|+|++|.+||...+....+..+.....   +           
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~-----------  238 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS---P-----------  238 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---C-----------
Confidence             234567888999999842  24578899999999999999999999887766555554432100   0           


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                  ....+.++..+.+||.+||+.+|.+||++.+++.||||....
T Consensus       239 ------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         239 ------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             ------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                        001123467899999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.2e-43  Score=331.17  Aligned_cols=259  Identities=30%  Similarity=0.498  Sum_probs=213.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|.+.....  .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            36899999999999999999999988999999999864322  2234577899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      +||+. ++|..++.+.  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus        95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            99998 5777777643  37899999999999999999999999999999999999999999999999987765444444


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+..+.+..+... +  . ..             
T Consensus       173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~--~-~~-------------  234 (293)
T cd06647         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G--T-PE-------------  234 (293)
T ss_pred             ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-C--C-CC-------------
Confidence            45578888999999876 45789999999999999999999999876654433222110 0  0 00             


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                              ......++..+.+||.+||..+|++||++.+++.|+||....
T Consensus       235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         235 --------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             --------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                    011123477899999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-44  Score=345.78  Aligned_cols=266  Identities=26%  Similarity=0.407  Sum_probs=218.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +-...|+.++.||-|+||.|.+++...|...||+|.+++... ........+.|-+||..-.++-||+||..|++.+++|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            346789999999999999999999888989999999986543 2233334567999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC----
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG----  162 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~----  162 (415)
                      +||+|+. ||+..++.+.+. +.|..+++|+.++..|+++.|++|+|||||||+|||||.+|++||+|||+|+-+.    
T Consensus       706 FVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            9999999 589998887665 8999999999999999999999999999999999999999999999999996321    


Q ss_pred             -----CCC---------------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHH
Q 014985          163 -----SPD---------------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAE  204 (415)
Q Consensus       163 -----~~~---------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~e  204 (415)
                           ..+                                 ......+||+.|+|||++.. ..|+..+|+||.||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHH
Confidence                 000                                 01224578999999999987 669999999999999999


Q ss_pred             HHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-
Q 014985          205 LLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-  283 (415)
Q Consensus       205 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-  283 (415)
                      |+.|++||...+..+...++.         +|.....++               ....+|.++.++|.+++. +++.|+ 
T Consensus       864 m~~g~~pf~~~tp~~tq~kv~---------nw~~~l~~~---------------~~~~ls~e~~~li~kLc~-sad~RLG  918 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGETQYKVI---------NWRNFLHIP---------------YQGNLSKEALDLIQKLCC-SADSRLG  918 (1034)
T ss_pred             HhhCCCCccCCCCCcceeeee---------ehhhccccc---------------cccccCHHHHHHHHHHhc-Chhhhhc
Confidence            999999999887665544432         222211111               112569999999999765 788887 


Q ss_pred             --CHHHHhcCCCCCCCCCCC
Q 014985          284 --TAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       284 --t~~e~l~h~~~~~~~~~~  301 (415)
                        .++|+..||||+++.+..
T Consensus       919 kng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  919 KNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             ccchhhhhcCccccccchHh
Confidence              478899999999987754

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-43  Score=332.47  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +.+.|...+.||+|+||.||+|.+..++..||+|.+....... ....+.+|+.+++.++||||+++++++......|+|
T Consensus         2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            3567888999999999999999999999999999886543222 233567899999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||++| +|...+..  ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          81 MEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             EEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            999995 66666643  358999999999999999999999999999999999999999999999999998765443333


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...........+...    .+               
T Consensus       159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~~---------------  218 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN----SP---------------  218 (277)
T ss_pred             hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC----CC---------------
Confidence            44567888999999876 45789999999999999999999998765443333221110    00               


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                              ......++.++.++|.+||+.+|++||++.++++||||..
T Consensus       219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         219 --------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             --------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence                    0111235788999999999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.6e-43  Score=328.82  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=206.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC-----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|++.+.||+|+||.||+|.+...+     ..+|+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468999999999999999999876555     6799998864322 2223356789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc
Q 014985           86 LHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~  149 (415)
                      .|++|||++ |+|.+++....               ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence            999999998 58888886542               35788999999999999999999999999999999999999999


Q ss_pred             EEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHH
Q 014985          150 LKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       150 vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  226 (415)
                      +||+|||++.......  .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999998653332  12334456778999999876 458999999999999999997 9999988777666555433


Q ss_pred             HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ...                           .......+.++.+|+.+||+.||.+||++.+++++
T Consensus       242 ~~~---------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         242 RQL---------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCc---------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            210                           01123457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.5e-42  Score=322.45  Aligned_cols=254  Identities=27%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      ......||+|+||.||+|.+..++..||+|.+......  ....+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            33456899999999999999999999999987644321  2235678999999999999999999999999999999999


Q ss_pred             c-CCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceecCCCCCccc
Q 014985           94 E-TDLETVIRNTNIFL--SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        94 ~-g~L~~~i~~~~~~l--~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      . ++|...+......+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            8 58888887654445  88889999999999999999999999999999999986 67999999999987644333333


Q ss_pred             ccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...++..|+|||++.+. ..++.++|+|||||++|+|++|.+||.................                   
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  228 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-------------------  228 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-------------------
Confidence            44577889999998653 3478899999999999999999999875433221111000000                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                            ....+...+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus       229 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                  0011122457899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-42  Score=322.41  Aligned_cols=256  Identities=29%  Similarity=0.499  Sum_probs=213.8

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+.++..++|+||+++++++.....+|+|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            4789999999999999999999999999999998765432 334467789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |++ ++|...+... ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999 5777777654 568999999999999999999999 9999999999999999999999999999987755444434


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC--c-HHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS--D-IDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||....  . .+....+..    ...             
T Consensus       159 ~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~-------------  220 (264)
T cd06623         159 TFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPP-------------  220 (264)
T ss_pred             ceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CCC-------------
Confidence            5567788999999876 468899999999999999999999997764  2 222222211    000             


Q ss_pred             hcccccCCCccccCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                ...... ++..+.++|.+||..+|++||++.++++|||++..
T Consensus       221 ----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         221 ----------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             ----------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence                      011122 57899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-42  Score=322.14  Aligned_cols=253  Identities=25%  Similarity=0.437  Sum_probs=204.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            6899999999999999999999999999999988654322 222334678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           91 EFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||++ |+|..++..   ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            9999 477766643   334589999999999999999999999999999999999999999999999999987654443


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-HHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ...+.......+.+ +            
T Consensus       162 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~------------  227 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP-P------------  227 (267)
T ss_pred             HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC-C------------
Confidence            3344567888999999876 4578999999999999999999988865432 22222211110100 0            


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  ......+..+.+||.+||..+|++||++.++++
T Consensus       228 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         228 ------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                        001134688999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-42  Score=322.44  Aligned_cols=251  Identities=25%  Similarity=0.437  Sum_probs=207.2

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L   97 (415)
                      ||.|+||.||+|.+..+++.+|+|++...... ......+.+|+.+++.++||||+++++.+.++..+|+|+||+. ++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999765432 2233457789999999999999999999999999999999998 578


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccce
Q 014985           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (415)
Q Consensus        98 ~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y  177 (415)
                      .+.+.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....... ......++..|
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            7777654 448999999999999999999999999999999999999999999999999998764432 22345678889


Q ss_pred             eCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC--cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCC
Q 014985          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS--DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (415)
Q Consensus       178 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (415)
                      +|||.+.+ ..++.++|+|||||++|+|++|..||....  ..+....+......                         
T Consensus       159 ~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------  212 (262)
T cd05572         159 VAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-------------------------  212 (262)
T ss_pred             cChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-------------------------
Confidence            99999865 557899999999999999999999998776  33444433321000                         


Q ss_pred             ccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCC
Q 014985          256 LRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPL  299 (415)
Q Consensus       256 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~  299 (415)
                       .......+.++.++|.+||..||++|++     ++|+++||||++..+
T Consensus       213 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         213 -LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             -CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence             0111233789999999999999999999     999999999986543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.2e-42  Score=326.43  Aligned_cols=261  Identities=20%  Similarity=0.331  Sum_probs=206.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ..++|.+.+.||+|+||.||+|.++.     .+..||+|.+...... .....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35799999999999999999997542     3458999987643221 12234678999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEee
Q 014985           85 NLHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~---------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                      ..|+||||+. |+|..++.+..         ...+...+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999998 68888886532         2346678899999999999999999999999999999999999999999


Q ss_pred             eccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          155 FGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       155 FG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      ||+++.......  ......++..|+|||.+.+ ..++.++|+|||||++|||++ |.+||.+.+..+....+.....  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~--  239 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY--  239 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999986533221  1122344567999999876 558899999999999999998 7889988766665544432100  


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------CCCCCCCCC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE------HRYFSSAPL  299 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~------h~~~~~~~~  299 (415)
                                               .......+..+.+++.+||+.||++|||+.++++      ||||.++.|
T Consensus       240 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         240 -------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence                                     0011134688999999999999999999999987      899987643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-42  Score=325.22  Aligned_cols=256  Identities=26%  Similarity=0.425  Sum_probs=211.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+-|.+.+.||+|+||.||+|.+..++..+|+|.+...... .....+.+|+.+++.++||||+++++++..+...|+||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            35578899999999999999999999999999987644322 22335678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||++| +|..++..  ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          82 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            99995 67666653  3489999999999999999999999999999999999999999999999999987654433334


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||.+.+ ...+.++|+|||||++|+|++|.+||...+.......+...    ..                
T Consensus       160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~----------------  218 (277)
T cd06641         160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN----NP----------------  218 (277)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC----CC----------------
Confidence            4567888999999876 45788999999999999999999999876654444433111    00                


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                             ......++.++.++|.+||..+|.+||++.++++||||...
T Consensus       219 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         219 -------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                   01122457889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.1e-42  Score=330.01  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=215.1

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .....|...+.||+|+||.||++.+..++..+|+|++...... ......+.+|+.+++.++|||++++++++..+...|
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence            3456688999999999999999999999999999998754322 222335678999999999999999999999999999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      +||||+.|++.+.+......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......   
T Consensus       102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            99999999998888776677999999999999999999999999999999999999999999999999998754322   


Q ss_pred             ccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 FTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                       ....++..|+|||++..  ...++.++|||||||++|+|++|.+||...+....+..+.......              
T Consensus       179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  243 (317)
T cd06635         179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------------  243 (317)
T ss_pred             -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence             23467788999999742  2457889999999999999999999988776555555543321100              


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                  ......+..+.+||.+||+.+|.+||++.++++|+|+..
T Consensus       244 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 ------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                        001134778999999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-42  Score=319.72  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||.||++... .+..+|+|.+.....   ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            56899999999999999999764 456899998763322   22357789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc-c
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-T  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~-~  169 (415)
                      |++ |+|.+.+......+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.++......... .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            998 68888887655668999999999999999999999999999999999999999999999999988653322211 1


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...++..|+|||++.+ ..++.++|+|||||++|+|++ |++||...+..+.+..+.......                 
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-----------------  221 (256)
T cd05114         160 GAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-----------------  221 (256)
T ss_pred             CCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-----------------
Confidence            2234456999999876 568899999999999999999 899998887766666654321100                 


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                .....+..+.+|+.+||..||++||+++++++
T Consensus       222 ----------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         222 ----------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                      00123678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-42  Score=326.91  Aligned_cols=260  Identities=26%  Similarity=0.380  Sum_probs=208.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||++.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            4789999999999999999999999999999998865432 233446778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||++| +|..++.+ ...+++..+..++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.......  .
T Consensus        83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~  159 (284)
T cd06620          83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--A  159 (284)
T ss_pred             ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--c
Confidence            99995 66666654 4458999999999999999999997 689999999999999999999999999987643222  2


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH----HHH---HHHHHhCCCCCCCCCCCCC
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID----QLG---KIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~---~i~~~~~~~~~~~~~~~~~  241 (415)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+    ...   ..........+...     
T Consensus       160 ~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  233 (284)
T cd06620         160 DTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL-----  233 (284)
T ss_pred             CccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC-----
Confidence            23567888999999876 468899999999999999999999998765421    111   11111000000000     


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                       ....++.++.+||.+||+.||.+|||+.++++|+||...
T Consensus       234 -----------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         234 -----------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             -----------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                             001246789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-42  Score=326.46  Aligned_cols=247  Identities=19%  Similarity=0.180  Sum_probs=199.4

Q ss_pred             ccEeee--eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-cchHHHHHHHHHhcCCCCeeeEEeeeec----CC
Q 014985           12 DRYLKR--EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKSPHIIELIDAFPH----KG   84 (415)
Q Consensus        12 ~~y~~~--~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~   84 (415)
                      +++...  ..||+|++|.||+|..  +|+.||+|++......... ...+.+|+.+|++++||||+++++++.+    ..
T Consensus        18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~   95 (283)
T PHA02988         18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP   95 (283)
T ss_pred             HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence            344444  6789999999999976  6899999998765332211 2345689999999999999999999866    45


Q ss_pred             eEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 ~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      .+++||||+.| +|..++.+. ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         96 RLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             ceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            78999999995 677777654 4589999999999999999999984 89999999999999999999999999998654


Q ss_pred             CCCCcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ...   ...+++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+.......          
T Consensus       175 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------  241 (283)
T PHA02988        175 SPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----------  241 (283)
T ss_pred             ccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence            322   245678889999998652 468999999999999999999999999887666665554321110          


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                      ......+.++++||.+||+.||++|||+.++++
T Consensus       242 ----------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 ----------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ----------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                            011234789999999999999999999999986

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=317.46  Aligned_cols=253  Identities=32%  Similarity=0.526  Sum_probs=214.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+............+.+|++++++++|+|++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58899999999999999999999999999999976654334445678999999999999999999999999999999999


Q ss_pred             ccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        93 ~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ++| +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            986 676666554 568999999999999999999999999999999999999999999999999998876555444456


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      .++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.......+...   .                    
T Consensus       160 ~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~--------------------  215 (254)
T cd06627         160 VGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---D--------------------  215 (254)
T ss_pred             ccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---C--------------------
Confidence            67888999999876 44789999999999999999999999876654444333210   0                    


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                          .....+.++..+.++|.+||..+|++|||+.+++.||||
T Consensus       216 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                011223457899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-42  Score=320.58  Aligned_cols=244  Identities=23%  Similarity=0.344  Sum_probs=196.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TD   96 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~   96 (415)
                      +.||+|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++++......|+||||+. ++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            468999999999999999999999998764322 2233457789999999999999999999999999999999998 57


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc--cccccc
Q 014985           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF--THQVFA  174 (415)
Q Consensus        97 L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~t  174 (415)
                      |.+++......+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........  .....+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            888887666668999999999999999999999999999999999999999999999999987643221111  111123


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      ..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+......                       
T Consensus       160 ~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-----------------------  215 (252)
T cd05084         160 VKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-----------------------  215 (252)
T ss_pred             eeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-----------------------
Confidence            45999999876 458899999999999999997 88888776655444433221100                       


Q ss_pred             CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       254 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                          ......+..+.+|+.+||+.+|++|||+.++++
T Consensus       216 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 ----PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                011234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.8e-42  Score=321.39  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             ccccEeeeeee--cccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeE
Q 014985           10 VADRYLKREVL--GEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~L--G~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..++|.+.+.+  |+|+||.||++.++.++..+|+|.+.......       .|+.....+ +||||++++++|...+.+
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            34677777776  99999999999999999999999986543221       133222222 799999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeeccceecCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSP  164 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~  164 (415)
                      |+||||++ |+|..++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            99999998 58888887654 699999999999999999999999999999999999999998 9999999999876432


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH-HHHHHHHhCCCCCCCCCCCCCCc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-LGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .    ...++..|+|||++.+ ..++.++|||||||++|+|++|..||......+. ...+.... ...           
T Consensus       164 ~----~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-----------  226 (267)
T PHA03390        164 S----CYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK-----------  226 (267)
T ss_pred             c----cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc-----------
Confidence            2    3457788999999976 5588999999999999999999999986543322 12221111 000           


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-AQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~l~h~~~~~  296 (415)
                                   ....+.++..+.+||.+||+.||.+|++ .+++|+||||.+
T Consensus       227 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        227 -------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                         0122356899999999999999999996 599999999963

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-42  Score=325.55  Aligned_cols=262  Identities=31%  Similarity=0.485  Sum_probs=219.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +...+.|++.+.||+|+||.||++.+..++..|++|++.....   ....+.+|+.+++.++|+||+++++++......|
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            4567889999999999999999999998999999999875443   3345678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|+||++ ++|.+++......++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999 588888877654699999999999999999999999999999999999999999999999999876544433


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.... .   ..           
T Consensus       172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~---~~-----------  235 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-I---PP-----------  235 (286)
T ss_pred             hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-C---CC-----------
Confidence            3344567788999999876 458899999999999999999999998776655444432210 0   00           


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                ......++.++.+||.+||+.+|.+||++.++++|+||....
T Consensus       236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         236 ----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             ----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                      011122478899999999999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=318.01  Aligned_cols=310  Identities=24%  Similarity=0.339  Sum_probs=238.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-cchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..+|.++++||+|+|+.|.+++++++.+.||+|++++....+.. ......|-.+..+- +||++|-++.+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            57899999999999999999999999999999999876543332 22345577777665 68999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |.||++ |+|...+.++. +++++.++.|...|+.||.|||+.||++||||.+|+|++..|++||+|+|+++..-.+...
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            999999 57777776554 4999999999999999999999999999999999999999999999999999987777777


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCC-------CCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-------SSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .++.+||+.|.|||++.+ ..|+..+|+|+|||+++||+.|+.||+-       .+..+.+.+++-.-..          
T Consensus       408 tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----------  476 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----------  476 (593)
T ss_pred             cccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----------
Confidence            889999999999999988 6799999999999999999999999962       1223333333221111          


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC------CHHHHhcCCCCCCCCCCCCCCCCCCCcccc-
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI------TAQQALEHRYFSSAPLPTEPNKLPRPATKR-  313 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~-  313 (415)
                                       .+..++|-.+..+++..|++||.+|.      ...++..|+||....|..-..+...|+..+ 
T Consensus       477 -----------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~  539 (593)
T KOG0695|consen  477 -----------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQ  539 (593)
T ss_pred             -----------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCc
Confidence                             22335577888999999999999997      468999999999888765433333333322 


Q ss_pred             ---cCCCCCCCCC--CCCcccCCcccccCCCCCCCCCCCCC
Q 014985          314 ---ASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEGNA  349 (415)
Q Consensus       314 ---~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (415)
                         .-....+..+  .++..++|-..-.....+++.++|..
T Consensus       540 i~~d~~l~~fd~qft~e~~qltpdd~d~i~ridqsefegfe  580 (593)
T KOG0695|consen  540 ITDDYGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGFE  580 (593)
T ss_pred             cccccCccccccccccCCcccCCCCHHHHHhcchhhcCcce
Confidence               2222233322  33444444433333334555555554

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-42  Score=323.09  Aligned_cols=261  Identities=27%  Similarity=0.415  Sum_probs=204.9

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--CCeEEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNLHLV   89 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv   89 (415)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+++++.++||||++++++|..  .+.+|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            5799999999999999999999999999999998754332 233457789999999999999999998854  3478999


Q ss_pred             eecccC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           90 FEFMET-DLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        90 ~e~~~g-~L~~~i~---~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||++| +|.+++.   .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999984 7766553   234558999999999999999999999999999999999999999999999999987653322


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-----HHHHHHHHHHhCCCCCCCCCCCC
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-----IDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .  ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.....     .+....+..    ......+.  
T Consensus       160 ~--~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--  230 (287)
T cd06621         160 A--GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD--  230 (287)
T ss_pred             c--ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc--
Confidence            1  23456778999999866 5688999999999999999999999986622     222221111    00000000  


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                     ....-...++.+.+||.+||..||.+|||+.|+++||||...
T Consensus       231 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         231 ---------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             ---------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence                           000001236789999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=321.07  Aligned_cols=252  Identities=20%  Similarity=0.336  Sum_probs=205.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+.||+|+||+||+|.+..+   ...+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            36799999999999999999987654   45799998865432 222335678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||+. |+|..++......+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            9999998 588888877666799999999999999999999999999999999999999999999999999987753222


Q ss_pred             ccc--ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFT--HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ...  ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.......            
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------  228 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP------------  228 (266)
T ss_pred             ceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence            222  2233567999999876 568899999999999999997 999987766665555443221100            


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                     .....+..+.+|+.+||+.+|++||++.+++++
T Consensus       229 ---------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 ---------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                           012347889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=321.27  Aligned_cols=252  Identities=29%  Similarity=0.435  Sum_probs=201.4

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHH-HHhcCCCCeeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKL-LKELKSPHIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      +.||.|+||.||+|.+..+|+.||+|++....... ........|..+ ....+|+||+++++++...+.+|+|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999987543211 111223345444 4456899999999999999999999999985


Q ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 -DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 -~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                       +|..++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....    .....++
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence             777776654 4589999999999999999999999999999999999999999999999999876433    2234567


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      ..|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+.....     .++                 
T Consensus       157 ~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~-----------------  213 (260)
T cd05611         157 PDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI-----NWP-----------------  213 (260)
T ss_pred             cCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-----CCC-----------------
Confidence            789999998774 488999999999999999999999988776665555432210     010                 


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCCC
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRYFSSAPL  299 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~h~~~~~~~~  299 (415)
                        ....+.++.++.++|.+||+.||++||+   ++|++.||||....|
T Consensus       214 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         214 --EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             --CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence              0112245889999999999999999995   589999999987544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-42  Score=331.01  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcE----EEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..+|++.+.||+|+||+||+|.+..++..    ||+|++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46799999999999999999987666654    89998864322 22334577899999999999999999998764 57


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++|+||+. |+|.+.+......++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            78999998 78999988776678999999999999999999999999999999999999999999999999998765433


Q ss_pred             Cccc--ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 RRFT--HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ....  ...++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.. .+..... .    +      
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~-~----~------  230 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGE-R----L------  230 (316)
T ss_pred             cceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCC-C----C------
Confidence            2221  2233557999999976 568999999999999999997 99999876554432 3322100 0    0      


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                     ...+..+.++.+++.+||..||.+||++.+++.+
T Consensus       231 ---------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                           1112346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=341.40  Aligned_cols=243  Identities=27%  Similarity=0.448  Sum_probs=204.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHH-hcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK-ELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..+.|.+...+|.|+|+.|-.+.+..+++.+++|++......      ..+|+.++. .-+||||+++++.+.+..+.|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence            578899999999999999999999999999999999766221      124665544 4479999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE-ecCCcEEEeeeccceecCCCCC
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi-~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |||.+.| .+++.+..... +. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++.....  
T Consensus       394 v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999996 56666665442 33 7888899999999999999999999999999999 58899999999999876433  


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                       ..+.+.|..|.|||++.. ..|+.++||||||++||+||+|+.||...... +++.+|    +.+...           
T Consensus       470 -~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s-----------  532 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS-----------  532 (612)
T ss_pred             -hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc-----------
Confidence             455677888999999975 77999999999999999999999999887665 333332    222111           


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                     ..+|+.+++||.+||+.||.+|+++.+++.||||
T Consensus       533 ---------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ---------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                           3569999999999999999999999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=316.88  Aligned_cols=281  Identities=35%  Similarity=0.558  Sum_probs=231.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----   84 (415)
                      .+..||.-+..+|.|.- .|-.|.|...++.||+|++........-...+.+|..++..++|+||++++.+|.-..    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            45779999999999998 8889999999999999998766443333445778999999999999999999985433    


Q ss_pred             --eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 --~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                        .+|+|||++..+|-+.+...   ++-..++.+++|++.|++|||+.||+||||||+||++..++.+||.|||+|+.-+
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILME---LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence              68999999999999998833   7788999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC-
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY-  241 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  241 (415)
                      .. -..+..+.|++|+|||++.+.. |.+.+||||+||++.||++|..+|.|....++..++...+|++.+....++.. 
T Consensus       170 ~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  170 TD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             cc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            43 5677889999999999999854 99999999999999999999999999999999999999999877754333211 


Q ss_pred             -------Cccchhcccc------cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          242 -------LPDYVEYQYV------AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       242 -------~~~~~~~~~~------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                             .+.+..+.+.      ..+....-.+.-+..+.+|+.+||..||++|.+++++|+|||++
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                   1111111110      01111111123356789999999999999999999999999997

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.9e-42  Score=319.61  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ...|.+.+.||+|+||.||+|.+..+++.+|+|.+....   .....+.+|+.+++.++|+||+++++++..++.+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            456999999999999999999999999999999876432   11235678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||+. |+|.+.+.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9998 68888876543 458999999999999999999999999999999999999999999999999998764432211


Q ss_pred             c-ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          169 T-HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       169 ~-~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      . ...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......                
T Consensus       162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  224 (263)
T cd05052         162 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM----------------  224 (263)
T ss_pred             cCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------
Confidence            1 1223456999999866 568899999999999999998 89999877655544443221110                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 .....++.++.++|.+||+.||++||++.++++
T Consensus       225 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         225 -----------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                       112345789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=305.58  Aligned_cols=255  Identities=26%  Similarity=0.352  Sum_probs=199.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-----e
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----N   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~   85 (415)
                      .+||++++.||+|||+-||++++..+++.||+|++.-...  .....+++|++..++++||||++++++...+.     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~--~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ--EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch--HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            6899999999999999999999999999999999976552  23446889999999999999999998864433     4


Q ss_pred             EEEEeeccc-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           86 LHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      .|++++|.. |+|++.+...   +..+++.++..|+.+|+.||++||+..  ++||||||.|||+.+.+.++|.|||.++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999988 8899988654   446999999999999999999999999  9999999999999999999999999987


Q ss_pred             ecCCCC---------CcccccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHh
Q 014985          160 IFGSPD---------RRFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF  228 (415)
Q Consensus       160 ~~~~~~---------~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  228 (415)
                      ...-.-         ........|..|+|||.+.-.  ...++++|||||||+||+|+.|..||...         +..-
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~G  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQG  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcC
Confidence            542111         112233346669999998431  23678999999999999999999998632         1100


Q ss_pred             CCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      +....           .+....+..|    ..+.+|..+.+||..||+.||.+||++.+++.+
T Consensus       249 gSlaL-----------Av~n~q~s~P----~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  249 GSLAL-----------AVQNAQISIP----NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             CeEEE-----------eeeccccccC----CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            00000           0000000000    112368999999999999999999999999874

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.2e-42  Score=327.80  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=214.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..-.+.|...+.||+|+||.||+|++..++..+|+|.+...... ......+.+|+.+++.++|+|++++++++......
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            44566788899999999999999999999999999998754322 22223466899999999999999999999999999


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |+||||+.|++...+......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......  
T Consensus        91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            999999999998888776667899999999999999999999999999999999999999999999999998865432  


Q ss_pred             cccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                        ....++..|+|||++.+  ...++.++|||||||++|+|++|..||...+..+....+.....   +           
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~-----------  232 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---P-----------  232 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC---C-----------
Confidence              23467788999999853  24578899999999999999999988876654444433322100   0           


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                  .......+..+.+||.+||..+|.+||+++++++|+|+...
T Consensus       233 ------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         233 ------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                        00112347889999999999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-42  Score=324.37  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=204.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|.+.+.||+|+||.||+|.+..     +++.||+|.+...... .....+.+|+++++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4679999999999999999997643     4578999998654322 123467789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEE
Q 014985           86 LHLVFEFME-TDLETVIRNTN-------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~-------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      .|+||||+. |+|..++...+             ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence            999999998 57888876542             3478889999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHh
Q 014985          152 LADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF  228 (415)
Q Consensus       152 L~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  228 (415)
                      |+|||++.......  .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            99999997653322  11223345677999999976 568999999999999999998 999998777666655554221


Q ss_pred             CCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..                           .....++..+.+||.+||+.||.+||++.|+++
T Consensus       242 ~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         242 LL---------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            10                           111235789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.2e-42  Score=322.57  Aligned_cols=253  Identities=21%  Similarity=0.335  Sum_probs=202.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|++...... .....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            57899999999999999999998642     3568999987543211 12334678999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEee
Q 014985           85 NLHLVFEFME-TDLETVIRNTNI---------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~---------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                      ..++||||+. |+|.+++.+...         .++...+..++.|++.||+|||+.|++|+||||+|||++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999998 588888765322         356788899999999999999999999999999999999999999999


Q ss_pred             eccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          155 FGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       155 FG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      ||+++.......  ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.....  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~--  239 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL--  239 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--
Confidence            999876533221  1122344677999999876 558999999999999999998 7889988766655544432100  


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                               .......+..+.+||.+||+.||++|||+.+++++
T Consensus       240 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 -------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     01112347889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.4e-42  Score=323.80  Aligned_cols=250  Identities=22%  Similarity=0.359  Sum_probs=203.5

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|.+.+.||+|+||+||++.+.     .++..+|+|.+....  ......+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            568999999999999999999752     345679999886432  1223356789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEE
Q 014985           86 LHLVFEFME-TDLETVIRNTN------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL  152 (415)
                      +|+||||+. |+|.+++....            ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999998 68888876543            24899999999999999999999999999999999999999999999


Q ss_pred             eeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhC
Q 014985          153 ADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (415)
Q Consensus       153 ~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  229 (415)
                      +|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~  240 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  240 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999986533221  1223344667999999876 568899999999999999998 8999988776666655543210


Q ss_pred             CCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .                           ......+.++.+|+.+||+.||.+|||+.+++.
T Consensus       241 ~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         241 L---------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             C---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0                           011234788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8e-42  Score=317.06  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=202.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||++.+.. +..+|+|.+.....   ....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3579999999999999999997643 45699998764322   1235778999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-c
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-F  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-~  168 (415)
                      ||+. |+|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.++........ .
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            9998 5788888765557899999999999999999999999999999999999999999999999998865433211 1


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.......                
T Consensus       159 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  221 (256)
T cd05113         159 VGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY----------------  221 (256)
T ss_pred             CCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC----------------
Confidence            12234456999999976 458899999999999999998 999998777666555553321110                


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                 .....+..+.+++.+||..||.+||++.+++++
T Consensus       222 -----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         222 -----------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                       011237899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-42  Score=325.06  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=210.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ..|....+||+|+||.||++.+..++..+|+|++.....  .....+.+|+.+++.++|+||+++++.|...++.|+|||
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            344455789999999999999999999999998854322  223456789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |+++ +|..++. . ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        98 ~~~~~~L~~~~~-~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657          98 FLEGGALTDIVT-H-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cCCCCcHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            9996 5555443 3 34899999999999999999999999999999999999999999999999998766443333344


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      ..++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+....+....+.....    ..               
T Consensus       176 ~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----~~---------------  235 (292)
T cd06657         176 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----PK---------------  235 (292)
T ss_pred             cccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC----cc---------------
Confidence            567888999999865 4578899999999999999999999987766555444332211    00               


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                            ......++..+.++|.+||+.||.+||++.++++||||.....
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         236 ------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                  0112345788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-41  Score=316.52  Aligned_cols=252  Identities=29%  Similarity=0.494  Sum_probs=205.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999987543322 22445778999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           91 EFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||++ |+|..++..   .+..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            9998 588877754   234589999999999999999999999999999999999999999999999999987654443


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc--HHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--IDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....  .+....+.....               
T Consensus       162 ~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------  225 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY---------------  225 (267)
T ss_pred             ccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC---------------
Confidence            3445567888999999876 5588999999999999999999998865431  112222111100               


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                               ++  ...+..+..+.++|.+||..+|++|||+.++++
T Consensus       226 ---------~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         226 ---------PP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------CC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                     00  001144788999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=316.22  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=205.8

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---CCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~   86 (415)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+......   ......+.+|+.+++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999999999999999988643211   12223567899999999999999999998664  568


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++|+||+.| +|.+.+...+ .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            899999985 7777776544 48999999999999999999999999999999999999999999999999998653211


Q ss_pred             ---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                         .......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||..........++.   .....         
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~---------  227 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK---------  227 (264)
T ss_pred             ccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC---------
Confidence               12234567888999999976 457899999999999999999999998765444433321   11111         


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                    ..+.+.+++.+.++|.+||+ +|.+||++.++++|||.
T Consensus       228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                          12233568999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.6e-42  Score=316.68  Aligned_cols=252  Identities=27%  Similarity=0.452  Sum_probs=212.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      +|.+.++||.|+||.||++.+..+++.+|+|.+............+.+|+.+++.++|+||+++++++......|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            58999999999999999999999999999999876554444445667899999999999999999999999999999999


Q ss_pred             ccC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           93 MET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        93 ~~g-~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ++| +|..++...   ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~  158 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA  158 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence            985 787777652   345899999999999999999999999999999999999999999999999999876544  23


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+..+....+....       +            
T Consensus       159 ~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------~------------  218 (256)
T cd08530         159 KTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------Y------------  218 (256)
T ss_pred             ccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------C------------
Confidence            34567888999999976 557889999999999999999999998876554443332210       0            


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                              ......++.++.++|.+||..+|++||++.++++||++
T Consensus       219 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         219 --------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             --------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                    11112457889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.7e-42  Score=323.59  Aligned_cols=253  Identities=32%  Similarity=0.508  Sum_probs=212.8

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ++|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.+. |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            579999999999999999999999999999999876432 2222345678999999998 99999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC---
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD---  165 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~---  165 (415)
                      |||+. ++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++.......   
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99996 68888887654 59999999999999999999999999999999999999999999999999998764433   


Q ss_pred             -----------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHh
Q 014985          166 -----------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF  228 (415)
Q Consensus       166 -----------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  228 (415)
                                       .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+....+..+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence                             12233456788999999876 457889999999999999999999999877655554443210


Q ss_pred             CCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCC
Q 014985          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYF  294 (415)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~h~~~  294 (415)
                                                  ......++..+.+||.+||+.||.+||++    +++++||||
T Consensus       239 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 ----------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             ----------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                                        11223447899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=321.59  Aligned_cols=282  Identities=35%  Similarity=0.642  Sum_probs=230.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-----eE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----NL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~   86 (415)
                      -+.+-.+.||.|+||.||.+.|..+|+.+|+|++..-.+.-.....+.+|+++|..++|.|++..+|..+-..     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3445678899999999999999999999999998765544434446789999999999999999888765432     46


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC-C
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-D  165 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~-~  165 (415)
                      |.|.|.+..||...|.+.. .++...++-+++||+.||+|||+.||.||||||.|+|++++..+||||||+|+..... .
T Consensus       133 YV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            8899999999999888755 4899999999999999999999999999999999999999999999999999976433 3


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ..++..+.|.+|+|||++.|...|+.++||||+|||+.||+.++-+|...+..+++..|...+|+++.+....   --+.
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~---ACEG  288 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY---ACEG  288 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH---Hhhh
Confidence            4567788899999999999999999999999999999999999999999999999999999999876542110   0000


Q ss_pred             h----hcccccCCCccccCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 V----EYQYVAAPPLRSLFP-----SASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~----~~~~~~~~~~~~~~~-----~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .    -..-...|.+..++.     ....++.+++..+|..||++|++.++++.|++....
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            0    001111222222222     223578899999999999999999999999997654

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=317.26  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=203.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .+|++.+.||+|+||.||++.+. ++..+|+|.+.....   ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            46889999999999999999875 467899998764322   22356789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc-c
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-T  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~-~  169 (415)
                      |++ ++|.+++......+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            998 57888887665678999999999999999999999999999999999999999999999999998654322111 1


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...++.+....+......                  
T Consensus       160 ~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  220 (256)
T cd05059         160 GTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL------------------  220 (256)
T ss_pred             CCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC------------------
Confidence            1122346999999876 568899999999999999998 88999887776666554332111                  


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                               ......+..+.+++.+||..+|++|||+.++++.
T Consensus       221 ---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 ---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                     1112347899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-41  Score=311.95  Aligned_cols=252  Identities=32%  Similarity=0.508  Sum_probs=210.1

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      .|.+.+.||+|++|.||++.+..+++.+++|++.....  .....+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            48899999999999999999998999999999876543  2334677899999999999999999999999999999999


Q ss_pred             cc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           93 ME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        93 ~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ++ ++|.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence            99 577777776656799999999999999999999999999999999999999999999999999987654432 3445


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      .++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+...    .....+              
T Consensus       158 ~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~--------------  218 (253)
T cd05122         158 VGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN----GPPGLR--------------  218 (253)
T ss_pred             ecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----CCCCcC--------------
Confidence            67788999999876 44788999999999999999999999876554444333221    000000              


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                             ....++..+.++|.+||+.||++|||+.++++|||
T Consensus       219 -------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         219 -------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                   00113788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.1e-42  Score=332.68  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=198.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec-C
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-K   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~-~   83 (415)
                      .++|++.+.||.|+||.||+|.+..     +++.||+|++...... .....+.+|+.++.++ +|+||+++++++.. +
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4689999999999999999997433     4578999998643322 1223467899999999 89999999998754 4


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC---------------------------------------------------------
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN---------------------------------------------------------  105 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~---------------------------------------------------------  105 (415)
                      ..++++|||+. |+|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            67899999999 57877775421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--cccccccccceeCc
Q 014985          106 ---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAP  180 (415)
Q Consensus       106 ---~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aP  180 (415)
                         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....  ......++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               2578899999999999999999999999999999999999999999999999987533221  12233456679999


Q ss_pred             ccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcccc
Q 014985          181 ELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL  259 (415)
Q Consensus       181 E~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (415)
                      |++.+ ..++.++|||||||++|||++ |.+||.+....+.+...+.... .                         ...
T Consensus       245 E~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~-------------------------~~~  297 (337)
T cd05054         245 ESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R-------------------------MRA  297 (337)
T ss_pred             HHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC-C-------------------------CCC
Confidence            99977 568999999999999999997 9999987654444333322100 0                         001


Q ss_pred             CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          260 FPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       260 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ....++++.+++.+||+.+|++||++.++++|
T Consensus       298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            12347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.9e-42  Score=321.69  Aligned_cols=251  Identities=20%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             ccEeeeeeecccCceEEEEEEEC----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDT----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ++|++.+.||+|+||+||+|.+.    .++..+|+|.+...... .....+.+|+.+++.++||||+++++++......|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            67899999999999999999853    45678999998643322 12235678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcE
Q 014985           88 LVFEFME-TDLETVIRNTN----------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~----------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~v  150 (415)
                      +||||+. |+|..++....                ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            9999998 58888775321                237888899999999999999999999999999999999999999


Q ss_pred             EEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHH
Q 014985          151 KLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (415)
Q Consensus       151 kL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  227 (415)
                      ||+|||+++......  .......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998653322  11233344567999999876 458999999999999999998 99999887665555444321


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ..                           ......++..+.+++.+||+.||.+||++.+++++
T Consensus       243 ~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         243 QL---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             Cc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            00                           01112347899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.1e-42  Score=331.57  Aligned_cols=278  Identities=22%  Similarity=0.264  Sum_probs=204.3

Q ss_pred             eeeeccc--CceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           17 REVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        17 ~~~LG~G--~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      ...||+|  +||+||+|.+..+|+.||+|++............+.+|+.+++.++||||++++++|..++..|+||||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3456766  99999999999999999999987654333333456789999999999999999999999999999999999


Q ss_pred             -CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-----
Q 014985           95 -TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-----  167 (415)
Q Consensus        95 -g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-----  167 (415)
                       |++..++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+.........     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence             57877776542 34899999999999999999999999999999999999999999999999865432111110     


Q ss_pred             --ccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          168 --FTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       168 --~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                        .....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+...+.....   ..+ +....+.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~  238 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY---SPL-DITTFPC  238 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC---CCc-cccccch
Confidence              0011234569999998763 34789999999999999999999999887655544443322110   000 0000000


Q ss_pred             ch-hc---------------------ccccCCCcc-ccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          245 YV-EY---------------------QYVAAPPLR-SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       245 ~~-~~---------------------~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      .. ..                     .......+. ......++.+.+||.+||+.||++|||+.++++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            00 00                     000000000 11123578899999999999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.3e-42  Score=356.02  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=200.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|++.++||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            6899999999999999999999999999999998754322 222345778999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           91 EFMET-DLETVIRNT----------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        91 e~~~g-~L~~~i~~~----------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      ||++| +|..++...          ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            99985 777777532          1235667788999999999999999999999999999999999999999999998


Q ss_pred             ecCCCC------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q 014985          160 IFGSPD------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL  221 (415)
Q Consensus       160 ~~~~~~------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  221 (415)
                      ......                  ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            652111                  11123568999999999977 56899999999999999999999999775433222


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       222 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ...  ..  ..+.                     .......+++.+.+++.+||..||++|++..+.+.
T Consensus       241 ~~~--~i--~~P~---------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        241 YRD--VI--LSPI---------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhh--hc--cChh---------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            110  00  0000                     00112345788999999999999999987666554

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.4e-42  Score=327.65  Aligned_cols=274  Identities=20%  Similarity=0.221  Sum_probs=200.1

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCHHHHHH
Q 014985           24 TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR  102 (415)
Q Consensus        24 ~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L~~~i~  102 (415)
                      ++|.||++++..+++.||+|++............+.+|+.+++.++|+||++++++|...+..|++|||++ |++..++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            45667777778899999999998654333344567889999999999999999999999999999999999 57777776


Q ss_pred             hc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-------cccccccc
Q 014985          103 NT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-------RFTHQVFA  174 (415)
Q Consensus       103 ~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-------~~~~~~~t  174 (415)
                      .. ...+++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||.+........       ......++
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence            53 34589999999999999999999999999999999999999999999999999875532211       12234456


Q ss_pred             cceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCC--CCCCCCCCCCccc----hh
Q 014985          175 RWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT--PSQWPDLAYLPDY----VE  247 (415)
Q Consensus       175 ~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~----~~  247 (415)
                      ..|+|||++.+. ..++.++|||||||++|+|++|..||........+...........  ...++........    ..
T Consensus       172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (314)
T cd08216         172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE  251 (314)
T ss_pred             ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence            779999998653 3588999999999999999999999987655443322221110000  0000000000000    00


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ...............++.++.+||.+||+.||++|||++++|+||||...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence            00000000111122356789999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-42  Score=316.04  Aligned_cols=245  Identities=28%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             eeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           18 EVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      +.||+|+||.||+|.+...   +..+|+|.+....... ....+.+|+.+++.++|+||+++++++.....+++||||+.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4799999999999998866   8899999987654433 34467789999999999999999999999999999999996


Q ss_pred             -CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           95 -TDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        95 -g~L~~~i~~~--------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                       |+|..++...        ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence             6888888776        4679999999999999999999999999999999999999999999999999998765433


Q ss_pred             --CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 --RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 --~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                        .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.....             
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------  225 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR-------------  225 (262)
T ss_pred             ccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence              22334556778999999876 468999999999999999998 6999988876666555433110             


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                    ......++.++.+++.+||..||++|||+.|++++
T Consensus       226 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         226 --------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                          01123447899999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.4e-42  Score=322.30  Aligned_cols=264  Identities=24%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             cEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCcc--CCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~--~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~   86 (415)
                      +|++.+.||+|+||.||+|.+.   .+|..||+|++......  ......+.+|+.+++.+ +|+||++++++|+.+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999874   47899999998754322  12234466899999999 589999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+. ++|...+... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999 4787777654 458999999999999999999999999999999999999999999999999998754332


Q ss_pred             -CcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 -RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 -~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                       .......++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+........+          
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----------  229 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP----------  229 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC----------
Confidence             222345678889999998653 34678999999999999999999998754433222333222111100          


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~~  301 (415)
                                    .....++..+.+|+.+||+.||++|+     ++++++.||||....+..
T Consensus       230 --------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         230 --------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             --------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence                          11123578899999999999999997     899999999998876533

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-41  Score=316.52  Aligned_cols=248  Identities=20%  Similarity=0.343  Sum_probs=203.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.++||+|+||.||+|.+. .+..||+|.+.....   ....+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            578999999999999999999864 557799998754322   2345778999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-  167 (415)
                      ||+. |+|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......... 
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            9997 5888888654 456889999999999999999999999999999999999999999999999999876433221 


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+......                
T Consensus       161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  223 (261)
T cd05072         161 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------------  223 (261)
T ss_pred             cCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            122334567999999876 557889999999999999998 99999887766665554322110                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 .....++.++.+||.+||..+|++||+++++++
T Consensus       224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 -----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       111235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-42  Score=319.19  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=198.9

Q ss_pred             EeeeeeecccCceEEEEEEECC---CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe-----
Q 014985           14 YLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN-----   85 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-----   85 (415)
                      |.+.+.||+|+||.||+|....   ++..||+|.+............+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5688999999999999998754   34789999987543333333457789999999999999999998755443     


Q ss_pred             -EEEEeeccc-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           86 -LHLVFEFME-TDLETVIRNT-----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        86 -~~lv~e~~~-g~L~~~i~~~-----~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                       .++||||+. |+|...+...     ...+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             799999999 5777776442     235899999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCCccc--ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          159 RIFGSPDRRFT--HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       159 ~~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      +..........  ...++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.....      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------  233 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR------  233 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            87643322111  1223456999999865 568999999999999999998 8899988776665554432210      


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                           .......+..+.++|.+||+.||.+|||+.+++++
T Consensus       234 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ---------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ---------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 01123457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.7e-42  Score=319.05  Aligned_cols=249  Identities=21%  Similarity=0.349  Sum_probs=207.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+|.+.+.||.|+||.||+|.+.. +..+|+|++......  ....+.+|+.+++.++|+||+++++++......++||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            4679999999999999999999877 889999998654321  2335678999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||++ |+|.+++.+. +..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            9998 5898888764 3458999999999999999999999999999999999999999999999999998764433333


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......                 
T Consensus       162 ~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  223 (261)
T cd05148         162 SDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-----------------  223 (261)
T ss_pred             cCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------------
Confidence            33345567999999876 568899999999999999998 89999887766666655432111                 


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                .....++.++.++|.+||+.||.+|||+.++++
T Consensus       224 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3e-41  Score=312.03  Aligned_cols=255  Identities=29%  Similarity=0.532  Sum_probs=211.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeEEEEe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHLVF   90 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~   90 (415)
                      +|.+.+.||+|++|.||+|.+..+++.+++|++............+.+|+.++++++|+||+++++.+...  ..+++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            58889999999999999999999999999999876654333445677899999999999999999999888  8999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--c
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--R  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~  167 (415)
                      ||+. ++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            9996 57777776654 689999999999999999999999999999999999999999999999999987755443  1


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+..  ..+.....                  
T Consensus       160 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~------------------  218 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AALYKIGS------------------  218 (260)
T ss_pred             ccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHhccc------------------
Confidence            344567788999999876 447899999999999999999999998776221  12211110                  


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                           ......+...++..+.+||.+||..||.+||++.+++.||||
T Consensus       219 -----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 -----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                 000112223447899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-41  Score=319.69  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=200.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc----EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|++.++||+|+||+||+|.+..++.    .||+|++..... ......+.+|+.+++.+.||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            5789999999999999999998877766    489998864322 2223456789999999999999999999865 457


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++++||++ |+|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            89999998 78988888766679999999999999999999999999999999999999999999999999998764332


Q ss_pred             Cc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 RR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..  .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+... ...           
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-----------  230 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERL-----------  230 (279)
T ss_pred             ceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC-----------
Confidence            21  112233567999999976 458899999999999999998 88999776554443332211 000           


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     ...+..+.++.++|.+||..||++||++.++++
T Consensus       231 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 ---------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ---------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           111234789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.7e-42  Score=323.32  Aligned_cols=260  Identities=24%  Similarity=0.359  Sum_probs=209.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|.+.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.++... .|+||+++++++......|+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            3688999999999999999999999899999999987543222 223455677766666 59999999999999999999


Q ss_pred             EeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||+++.+..++......+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++........ 
T Consensus        92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-  170 (296)
T cd06618          92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-  170 (296)
T ss_pred             EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence            99999998888887766679999999999999999999997 5999999999999999999999999999876543322 


Q ss_pred             ccccccccceeCcccccCC---cCCCCcccHHHHHHHHHHHHcCCCCCCCCC-cHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          168 FTHQVFARWYRAPELLFGA---KQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .....++..|+|||.+.+.   ..++.++|||||||++|+|++|..||.... +.+.+..+.....    ..++      
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~------  240 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PSLP------  240 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CCCC------
Confidence            2334567789999998653   247889999999999999999999997533 2334443322110    0000      


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                     ....++.++.+||.+||..||.+||+++++++|+||..
T Consensus       241 ---------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         241 ---------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             ---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence                           00134788999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.8e-42  Score=318.66  Aligned_cols=254  Identities=25%  Similarity=0.454  Sum_probs=204.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ++|.+.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++|+||++++++|...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57999999999999999999999999999999886543222 22335678999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           91 EFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        91 e~~~g-~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||+.| +|..++..   ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99995 78777753   244589999999999999999999999999999999999999999999999999987654443


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.....  ..+...+....   ++         
T Consensus       162 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~---~~---------  226 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCD---YP---------  226 (267)
T ss_pred             ccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhcCC---CC---------
Confidence            3445578888999999866 557889999999999999999999887653221  11111110000   00         


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                              +  ......+..+.+||.+||..||.+|||+.++++
T Consensus       227 --------~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         227 --------P--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             --------C--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                    0  001135789999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.3e-42  Score=317.73  Aligned_cols=253  Identities=26%  Similarity=0.447  Sum_probs=206.5

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc---cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +|.+.+.||+|+||.||++.+..++..+++|++.....   .......+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            69999999999999999999988877777777654332   222233456799999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           90 FEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||+.+ +|...+..   .+..+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999985 77766653   3456899999999999999999999999999999999999975 679999999998765444


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+....   .             
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~---~-------------  222 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP---T-------------  222 (260)
T ss_pred             ccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC---C-------------
Confidence            44445567788999999865 557889999999999999999999998766555544443210   0             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                 ......++.++.++|.+||..||++||++.++++||||
T Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 -----------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -----------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                       01122457899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-41  Score=323.39  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=199.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCc--EEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~--~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ++|.+.+.||+|+||.||+|.+..++.  .+++|.+..... ......+.+|+.++.++ +||||+++++++...+.+|+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            689999999999999999999877765  468887653221 12233567899999999 79999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEE
Q 014985           89 VFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL  152 (415)
                      ||||+. |+|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999998 68888886532               24888999999999999999999999999999999999999999999


Q ss_pred             eeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          153 ADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       153 ~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      +|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...... 
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~-  237 (297)
T cd05089         161 ADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM-  237 (297)
T ss_pred             CCcCCCccccceec-cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence            99999864322111 111222446999999876 568999999999999999997 99999887766655544221110 


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                                .....++.++.+||.+||..+|.+||+++++++.
T Consensus       238 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 --------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      1112357899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.3e-42  Score=318.59  Aligned_cols=252  Identities=32%  Similarity=0.543  Sum_probs=207.3

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccC-CH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-~L   97 (415)
                      ||.|+||.||++.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++.+......|+|+||+.| +|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999998654321 22334577899999999999999999999999999999999985 77


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--------ccc
Q 014985           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--------RFT  169 (415)
Q Consensus        98 ~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--------~~~  169 (415)
                      ..++.+.+ .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........        ...
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            77776644 689999999999999999999999999999999999999999999999999876533311        233


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....+...  .   ..++.           
T Consensus       160 ~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~---~~~~~-----------  222 (265)
T cd05579         160 RIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K---IEWPE-----------  222 (265)
T ss_pred             CcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---cCCCc-----------
Confidence            4567778999999876 44788999999999999999999999877766655554321  0   00110           


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA---QQALEHRYFSSAPL  299 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~e~l~h~~~~~~~~  299 (415)
                                ...++..+.+||.+||+.+|++|||+   .++++||||+...|
T Consensus       223 ----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         223 ----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                      01137899999999999999999999   99999999986543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-41  Score=334.55  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-----CcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      .++|++.++||+|+||.||+|.+...     +..||+|++..... ......+.+|+.+++.+. ||||+++++++...+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            57888999999999999999987533     34799999865432 222345778999999996 999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC----------------------------------------------------------
Q 014985           85 NLHLVFEFME-TDLETVIRNTN----------------------------------------------------------  105 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~----------------------------------------------------------  105 (415)
                      .+|+|||||. |+|.+++.+..                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999998 68887775421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC
Q 014985          106 -------------------------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG  148 (415)
Q Consensus       106 -------------------------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~  148 (415)
                                                           ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence                                                 2367788899999999999999999999999999999999999


Q ss_pred             cEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHH
Q 014985          149 QLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIF  225 (415)
Q Consensus       149 ~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  225 (415)
                      .+||+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.............
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            999999999987543222  2223445677999999876 568999999999999999996 888887654333332222


Q ss_pred             HHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..-.  .                        ......++.++.++|.+||+.||++||++.++.+
T Consensus       354 ~~~~--~------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 KSGY--R------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hcCC--C------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            1100  0                        0011245789999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.5e-42  Score=324.92  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=199.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcE--EEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+.||+|+||.||+|.+..++..  +|+|.+.... .......+.+|+.++.++ +|+||+++++++..++.+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            56899999999999999999998887764  4666654322 122233567899999999 8999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEE
Q 014985           88 LVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      +||||+. |+|..++....               ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence            9999998 68888886542               2478999999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCC
Q 014985          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT  230 (415)
Q Consensus       152 L~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  230 (415)
                      |+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....  
T Consensus       165 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--  240 (303)
T cd05088         165 IADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--  240 (303)
T ss_pred             eCccccCcccchhh-hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--
Confidence            99999986432111 1112223456999998865 558899999999999999998 999998776655444331110  


Q ss_pred             CCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                       .   +                     ......+.++.+||.+||+.+|++||++++++.+
T Consensus       241 -~---~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 -R---L---------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -c---C---------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             0   0                     0111347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-41  Score=319.31  Aligned_cols=253  Identities=19%  Similarity=0.296  Sum_probs=202.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      -.++|.+.+.||+|+||.||+|.+..     ++..||+|.+...... .....+.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            35789999999999999999999876     7788999987543221 12235678999999999999999999999989


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEEEee
Q 014985           85 NLHLVFEFME-TDLETVIRNTNI------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLAD  154 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vkL~D  154 (415)
                      ..++||||+. |+|..++.....      .+++..+..++.||+.||.|||++|++||||||+|||++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999997 588888866532      488999999999999999999999999999999999998765   599999


Q ss_pred             eccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          155 FGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       155 FG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      ||+++.......  .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---  238 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG---  238 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Confidence            999987532221  1112233456999999976 458999999999999999996 999998876655444332210   


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .                        ....+.++..+.+|+.+||+.+|++||++.++++|
T Consensus       239 ~------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 R------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             c------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0                        01123457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=318.20  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=202.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC-----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|.+.+.||+|+||.||++.+...+     ..||+|.+...... .....+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            578999999999999999999876543     78999997543211 222356789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeee
Q 014985           86 LHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~---------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DF  155 (415)
                      .|+||||+. |+|.+++....         ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence            999999998 68888876432         23678899999999999999999999999999999999999999999999


Q ss_pred             ccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          156 GLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       156 G~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      |+++......  .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+... ..  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~--  239 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH--  239 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC--
Confidence            9987654332  12233455677999999866 458899999999999999998 99999877665554443311 00  


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                              .......+.++.+||.+||+.+|++|||+.++++
T Consensus       240 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 ------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                    0111223788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=338.49  Aligned_cols=254  Identities=21%  Similarity=0.292  Sum_probs=209.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..+...+...||+|.||+||+|++-   ..||||++..........+.+++|+..+++-+|.||+=+.+++...+. .||
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             CHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            4567788999999999999999665   349999998877666666778899999999999999999999988877 999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC--CCC
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS--PDR  166 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~--~~~  166 (415)
                      ..+|+| +|+..++....++.....+.|++||++|+.|||.++|||||||..|||+.+++.|||+|||++..-..  ...
T Consensus       466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            999998 78888888888899999999999999999999999999999999999999999999999999975322  223


Q ss_pred             cccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ......|...|||||++..  ..+|+..+|||||||++|||++|..||..+....++..+-.+                 
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG-----------------  608 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG-----------------  608 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-----------------
Confidence            3444556667999999853  356999999999999999999999999854444333222111                 


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                            +..+.........+.++++|+..||.+++++||...+||.
T Consensus       609 ------~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  609 ------YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                  1112222333345679999999999999999999999987

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.4e-43  Score=358.67  Aligned_cols=258  Identities=29%  Similarity=0.476  Sum_probs=204.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-------   82 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------   82 (415)
                      ...+|+.+++||+||||.||+|+++-+|..||||+|.... ......++.+|+.+|.+|+|||||+++..|.+       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            5678899999999999999999999999999999998876 55566678999999999999999998744300       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 014985           83 -----------------------------------------------------------------------K--------   83 (415)
Q Consensus        83 -----------------------------------------------------------------------~--------   83 (415)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CeEEEEeecccCCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHhhh
Q 014985           84 ---------------------------------GNLHLVFEFMETDLETVIRNTNIFL-SPADIKSYMQMTLKGLAFCHK  129 (415)
Q Consensus        84 ---------------------------------~~~~lv~e~~~g~L~~~i~~~~~~l-~~~~~~~i~~qil~aL~~lH~  129 (415)
                                                       ..+||=||||+.+++..+...+... ....+|.+++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             1268889999988887777666544 578899999999999999999


Q ss_pred             CCccccCCCCCcEEEecCCcEEEeeeccceec------------------CCCCCcccccccccceeCcccccCCc--CC
Q 014985          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF------------------GSPDRRFTHQVFARWYRAPELLFGAK--QY  189 (415)
Q Consensus       130 ~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~------------------~~~~~~~~~~~~t~~y~aPE~l~~~~--~~  189 (415)
                      +|||||||||.||++++++.|||+|||+|+..                  +......+..+||..|+|||++.+..  .|
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            99999999999999999999999999999861                  11223567789999999999997766  69


Q ss_pred             CCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHH
Q 014985          190 GAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDAL  268 (415)
Q Consensus       190 ~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  268 (415)
                      +.|+||||||+|||||+.-   |... .....+..+..+   ..|.. +                    .++-.--+.-.
T Consensus       796 n~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g---~iP~~-~--------------------~f~~~~~~~e~  848 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKG---SIPEP-A--------------------DFFDPEHPEEA  848 (1351)
T ss_pred             cchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccC---CCCCC-c--------------------ccccccchHHH
Confidence            9999999999999999853   4332 222222222211   11111 0                    11111134577


Q ss_pred             HHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          269 DLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       269 ~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      .+|..||+.||.+||||.|+|.+.||.
T Consensus       849 slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  849 SLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            899999999999999999999999985

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-41  Score=314.82  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=200.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.++||+|+||.||+|.+..+ ..+|+|.+.....   ....+.+|+.+++.++||||+++++.+. ....|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence            47899999999999999999988655 4699999875332   2235678999999999999999999875 45689999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||+. |+|.+++.+. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+..........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9998 5888888753 3458899999999999999999999999999999999999999999999999998764433221


Q ss_pred             -cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          169 -THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       169 -~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+......                
T Consensus       160 ~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------  222 (262)
T cd05071         160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------  222 (262)
T ss_pred             ccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------------
Confidence             12334567999999866 558999999999999999999 88999887766665554321100                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 ...+.++..+.+||.+||+.||++||++.++++
T Consensus       223 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                       011234788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-41  Score=323.44  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=201.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC-------CCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeee
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP   81 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~   81 (415)
                      ..++|.+.+.||+|+||.||+|.+..       ++..+|+|.+..... ......+.+|+.+++.+ +||||+++++++.
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            35899999999999999999998643       235799998875422 22233567899999999 7999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~  145 (415)
                      ..+..|+||||+. |+|.+++....               ..++...+..++.|++.||+|||++|++||||||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            9999999999998 68988887642               2478899999999999999999999999999999999999


Q ss_pred             cCCcEEEeeeccceecCCCCCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHH
Q 014985          146 SHGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG  222 (415)
Q Consensus       146 ~~~~vkL~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  222 (415)
                      .++.+||+|||+++........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+...
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999765432211  112233457999999876 558899999999999999998 889987765544443


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .+.....                           ......++.++.+||.+||..+|.+|||+.+++++
T Consensus       254 ~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 LLKEGHR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHcCCC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3321100                           01122457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-41  Score=315.73  Aligned_cols=242  Identities=22%  Similarity=0.354  Sum_probs=194.9

Q ss_pred             eecccCceEEEEEEE--CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-C
Q 014985           19 VLGEGTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-T   95 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g   95 (415)
                      .||+|+||.||+|.+  ..++..+|+|++............+.+|+.+++.+.||||+++++++. ....++||||++ |
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964  457789999998654433333445778999999999999999999885 456789999999 5


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc---ccccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQV  172 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~---~~~~~  172 (415)
                      +|..++... ..+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++.........   .....
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            677777654 45899999999999999999999999999999999999999999999999999876443321   12223


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      ++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.....                      
T Consensus       160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~----------------------  216 (257)
T cd05116         160 WPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER----------------------  216 (257)
T ss_pred             CCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----------------------
Confidence            3567999999865 458889999999999999997 9999988766655555432110                      


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                           ....+.++.++.+||.+||+.||++||++++|.+
T Consensus       217 -----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 -----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                 0112245889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=322.12  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-----CcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|.+.+.||+|+||.||++.+...     ...+|+|.+...... .....+.+|+.+++.+ +|+||+++++++..++
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            57899999999999999999987643     368999988754322 2223467899999999 8999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG  148 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~---------------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~  148 (415)
                      .+|++|||+. |+|..++...               ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~  169 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH  169 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence            9999999998 6888887542               34588999999999999999999999999999999999999999


Q ss_pred             cEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHH
Q 014985          149 QLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIF  225 (415)
Q Consensus       149 ~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  225 (415)
                      .+||+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            999999999987643321  1122233456999999866 568899999999999999997 889998776655554432


Q ss_pred             HHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ....                           .......+.++.+|+.+||..||++|||+.+++++
T Consensus       249 ~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         249 EGYR---------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             cCCc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2110                           01112347889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7e-42  Score=321.93  Aligned_cols=251  Identities=21%  Similarity=0.295  Sum_probs=202.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCC-----CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .+|.+.+.||+|+||.||+|.+..+     ++.||+|++..... ......+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            5688999999999999999987543     57899999874332 12233567899999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcE
Q 014985           87 HLVFEFME-TDLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~---------------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~v  150 (415)
                      ++++||+. ++|..++...               ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence            99999998 5777776432               2247888899999999999999999999999999999999999999


Q ss_pred             EEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHH
Q 014985          151 KLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (415)
Q Consensus       151 kL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  227 (415)
                      ||+|||+++.......  ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+...
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999886533221  1233445678999999876 458899999999999999998 88899887776666655432


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ...                           ......+..+.+|+.+||+.+|.+||++++++..
T Consensus       243 ~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         243 QVL---------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CcC---------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            111                           1112457889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-41  Score=317.81  Aligned_cols=250  Identities=20%  Similarity=0.297  Sum_probs=197.6

Q ss_pred             EeeeeeecccCceEEEEEEECCCCc--EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC------Ce
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK------GN   85 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~--~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~~   85 (415)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.+............+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999877765  699998876543333344577899999999999999999876321      25


Q ss_pred             EEEEeeccc-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           86 LHLVFEFME-TDLETVIRNT-----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~-----~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      .++||||+. |+|...+...     ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            789999998 6787776432     2348899999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          160 IFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       160 ~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ........  .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-------  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            76433221  122334567999999876 568999999999999999998 7899988766555444432100       


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                          ....+.++..+.++|.+||+.||++|||+.+++++
T Consensus       233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 --------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                01123457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=313.18  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=203.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+. .++.||+|.+.....   ....+.+|+.++++++||||+++++++...+..|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            477999999999999999999865 457899999865432   2235778999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||+. ++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9996 68888887654 458999999999999999999999999999999999999999999999999998765322111


Q ss_pred             -cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          169 -THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       169 -~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+......                
T Consensus       161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  223 (261)
T cd05068         161 REGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM----------------  223 (261)
T ss_pred             cCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence             11122346999999876 568899999999999999998 99999887766666555332110                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 ......+..+.+++.+||+.+|.+||++.++++
T Consensus       224 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 -----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                       011234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=368.24  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=216.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +.=++....+||.|.||.||.|.+..+|...|+|.+............+.+|.+++..++|||+|++|++=.+.+.++|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            44577788999999999999999999999999999987665544444567899999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----  165 (415)
                      ||||+|+.+..+...++-.++...+.|..|++.|+.|||+.|||||||||+|||++.+|-+|++|||.|.......    
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            9999965554455555558888899999999999999999999999999999999999999999999998775443    


Q ss_pred             CcccccccccceeCcccccCCc--CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 RRFTHQVFARWYRAPELLFGAK--QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ....+..||+.|||||++.+.+  ....+.|||||||++.||+||+.||...++.-   .|+...+..            
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~g------------ 1457 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAG------------ 1457 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhcc------------
Confidence            2345678999999999997743  45678999999999999999999987654332   222222222            


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                 ..+.++..+|.+..|||.+||..||++|+++.|+++|.|-+.
T Consensus      1458 -----------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1458 -----------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             -----------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                       122333357999999999999999999999999999998654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.5e-41  Score=354.19  Aligned_cols=148  Identities=24%  Similarity=0.468  Sum_probs=131.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|.+.++||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++....++|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999998754322 12224567899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      |||+. |+|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99997 5788777654 458999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=326.80  Aligned_cols=264  Identities=29%  Similarity=0.476  Sum_probs=213.9

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-----cCCccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-----KEGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      ..+.++|.++.+||+|||+.||+|.|....++||+|+-...+.     ++.....+.+|..|.+.|.||.||++||+|.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            4578999999999999999999999999999999998655442     22334457799999999999999999999965


Q ss_pred             -CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecC---CcEEEeeec
Q 014985           83 -KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSH---GQLKLADFG  156 (415)
Q Consensus        83 -~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~---~~vkL~DFG  156 (415)
                       ...+|-|+|||+|+-++++.+.+..+++.+++.|+.||+.||.||....  |||-||||.|||+...   |.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence             4568899999999766666667778999999999999999999999875  9999999999999653   779999999


Q ss_pred             cceecCCCCCc-------ccccccccceeCcccccC---CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-HHHHH--H
Q 014985          157 LARIFGSPDRR-------FTHQVFARWYRAPELLFG---AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-IDQLG--K  223 (415)
Q Consensus       157 ~a~~~~~~~~~-------~~~~~~t~~y~aPE~l~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~--~  223 (415)
                      +++.+......       .....||.||++||.+.-   ....+.++||||+|||||.++.|+.||..+.. .+++.  .
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            99987554422       334678999999999843   24478899999999999999999999976532 22221  1


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      |++.                  .+.+|..       -|.+|.++++||++||++--++|....|+-.||||..
T Consensus       699 IlkA------------------tEVqFP~-------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  699 ILKA------------------TEVQFPP-------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhcc------------------eeccCCC-------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            2111                  1112111       2456999999999999999999999999999999853

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-43  Score=334.39  Aligned_cols=287  Identities=33%  Similarity=0.540  Sum_probs=230.7

Q ss_pred             ccccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC------CCeeeEE
Q 014985            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS------PHIIELI   77 (415)
Q Consensus         4 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~   77 (415)
                      +.+++.|-.+|.+....|+|-|++|..|.|...|..||||+|+.....   +..-++|+.||++|+.      -|.++++
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            456778899999999999999999999999999999999999865432   2234579999999953      4899999


Q ss_pred             eeeecCCeEEEEeecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEee
Q 014985           78 DAFPHKGNLHLVFEFMETDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLAD  154 (415)
Q Consensus        78 ~~~~~~~~~~lv~e~~~g~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~D  154 (415)
                      ..|.+..|+|||||-+.-+|...+++-+  ..|....++.|+.|++.||..|..+||+|.||||+||||++. ..+||||
T Consensus       501 r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             HHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence            9999999999999999999999998753  458889999999999999999999999999999999999976 5699999


Q ss_pred             eccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       155 FG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ||.|...+.  ...+.+..++.|+|||+++| ..|+...|+||+||+||||.||+-.|.|.++-+.+...+.+-|..+..
T Consensus       581 fGSA~~~~e--neitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  581 FGSASFASE--NEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             Ccccccccc--ccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            999987643  44566777888999999999 679999999999999999999999999999999999988887765432


Q ss_pred             CCC-----CCCC----Cccchhccccc----------CCCcccc---------C----CCCCHHHHHHHHHhcCCCCCCC
Q 014985          235 QWP-----DLAY----LPDYVEYQYVA----------APPLRSL---------F----PSASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       235 ~~~-----~~~~----~~~~~~~~~~~----------~~~~~~~---------~----~~~s~~~~~li~~~L~~dP~~R  282 (415)
                      -.-     +.-+    ..-+.+...+.          ..|.+.+         +    +.+-..+.+|+.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            111     1000    00000000000          0110000         1    1122457899999999999999


Q ss_pred             CCHHHHhcCCCCCC
Q 014985          283 ITAQQALEHRYFSS  296 (415)
Q Consensus       283 pt~~e~l~h~~~~~  296 (415)
                      .|..|+|.||||+.
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999974

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-41  Score=316.66  Aligned_cols=251  Identities=21%  Similarity=0.326  Sum_probs=203.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|++.+.||+|+||.||+|.+..++.   .+|+|.+..... ......+.+|+.+++.++||||+++++++..++.+|
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            4689999999999999999998865543   799998864332 122335678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ |+|..++......+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++........
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            9999998 578888877666789999999999999999999999999999999999999999999999999987644322


Q ss_pred             cc---cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 RF---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+......            
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------  228 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL------------  228 (267)
T ss_pred             eeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC------------
Confidence            11   12223456999999976 568999999999999999886 99999877665555544322110            


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     ......+..+.+++.+||+.+|.+||++.++++
T Consensus       229 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 ---------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                           011234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.6e-41  Score=313.19  Aligned_cols=248  Identities=21%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+......   ...+.+|+.+++.++|+||+++++++. ....|+|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence            3578999999999999999999765 5667999998754322   235778999999999999999999885 4568999


Q ss_pred             eeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||+. ++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            99998 5888888654 345899999999999999999999999999999999999999999999999999876433221


Q ss_pred             -ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 -FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 -~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                       .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---------------  222 (260)
T ss_pred             cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence             122234556999999866 558899999999999999998 89999887766666554322110               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  ......+..+.+|+.+||..||++|||++++++
T Consensus       223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 ------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                        011234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-41  Score=317.51  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=197.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcE----EEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|++.+.||+|+||+||+|.+..++..    +++|.+..... ......+..|+.+++.+.||||+++++++. ....
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            46899999999999999999998777764    66676642211 112234567888999999999999999875 4567


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++++||+. |+|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            88999998 79999998777779999999999999999999999999999999999999999999999999998764332


Q ss_pred             C--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .  ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.........+...  ...+         
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~~~---------  231 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG--ERLA---------  231 (279)
T ss_pred             cccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--CcCC---------
Confidence            2  2223445667999999876 458999999999999999998 99999876544433222111  0000         


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                      .....+.++.+++.+||..||++|||+.++++
T Consensus       232 ----------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         232 ----------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                            00113568899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.3e-41  Score=314.71  Aligned_cols=251  Identities=21%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|...+.||+|+||.||+|.+..++.   .+|+|.+..... ......+.+|+.+++.++|+||+++++++...+..|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            4688999999999999999999876655   799998864322 122335678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ ++|..++......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            9999999 578788776666789999999999999999999999999999999999999999999999999986643222


Q ss_pred             cc-c--ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 RF-T--HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~~-~--~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. .  ....+..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+......+.          
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~----------  231 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA----------  231 (268)
T ss_pred             cceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC----------
Confidence            11 1  1122346999999876 557899999999999999987 9999987776666555533211000          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                       ....+.++.+|+.+||+.+|++||++.++++
T Consensus       232 -----------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         232 -----------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                             1123678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.9e-41  Score=312.24  Aligned_cols=248  Identities=22%  Similarity=0.366  Sum_probs=202.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.++||+|+||.||+|... +++.||+|.+.....   ....+.+|+.+++.++|+||+++++++. .+.+|+|
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            4688999999999999999999854 578899999864332   2235778999999999999999999874 4678999


Q ss_pred             eeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||+. |+|.+.+... +..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            99998 6888887654 34689999999999999999999999999999999999999999999999999987642221 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......               
T Consensus       159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---------------  222 (260)
T ss_pred             cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---------------
Confidence            1222344567999999866 457889999999999999998 99999888766665554322111               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  ......+.++.++|.+||..+|++||+++++++
T Consensus       223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                        011234788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-43  Score=338.80  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=209.9

Q ss_pred             cccE-eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc--cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe--
Q 014985           11 ADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN--   85 (415)
Q Consensus        11 ~~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--   85 (415)
                      ..|| +...+||+|+|-+||+|.|..+|..||.-.+.....  .....+.+..|+.+|+.|+||||+++|++|.+...  
T Consensus        38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            4566 567889999999999999999999999776654433  33333677899999999999999999999987665  


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecC-CcEEEeeeccceec
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSH-GQLKLADFGLARIF  161 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~-~~vkL~DFG~a~~~  161 (415)
                      +-+|.|.+. |+|..+.++ .+.++...++.|++||++||.|||++.  |+|||||-+||+|+.+ |.|||+|+|+|+..
T Consensus       118 in~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            778999999 666666665 455899999999999999999999986  9999999999999865 99999999999987


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ....  ..+.+|||.|||||+..  ..|+..+||||||..+.||+|+..|+..= +..+++.++..+.......      
T Consensus       197 r~s~--aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~------  266 (632)
T KOG0584|consen  197 RKSH--AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS------  266 (632)
T ss_pred             hccc--cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh------
Confidence            4433  44589999999999986  57999999999999999999999877653 4455566665543221111      


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                          .--.+++++||.+||.. .++|+|+.|+|.||||...
T Consensus       267 --------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  267 --------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             --------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                11168999999999999 9999999999999999864

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.5e-41  Score=319.17  Aligned_cols=258  Identities=23%  Similarity=0.298  Sum_probs=205.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC----------------cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG----------------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~----------------~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv   74 (415)
                      .++|++.+.||+|+||.||+|.+...+                ..+|+|.+...... .....+.+|+.+++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence            468999999999999999999876544                45899988754332 2233567899999999999999


Q ss_pred             eEEeeeecCCeEEEEeeccc-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEE
Q 014985           75 ELIDAFPHKGNLHLVFEFME-TDLETVIRNTN----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (415)
Q Consensus        75 ~l~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~----------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NIL  143 (415)
                      ++++++..++..++||||+. ++|..++....          ..+++..++.++.|++.||+|||++||+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99999999999999999998 57888776543          25899999999999999999999999999999999999


Q ss_pred             EecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc--CCCCCCCCCcHH
Q 014985          144 IGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDID  219 (415)
Q Consensus       144 i~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~  219 (415)
                      ++.++.++|+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++  |..||...+..+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999986533321  1223445677999999876 458999999999999999997  678887766666


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       220 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .+..+...+.....                    .......+.++.++.+||.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDDGR--------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccccc--------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            65554332211100                    0001112345789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-41  Score=311.43  Aligned_cols=242  Identities=21%  Similarity=0.342  Sum_probs=194.8

Q ss_pred             eeecccCceEEEEEEECCCC---cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           18 EVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      ++||+|+||.||+|....++   ..+|+|.+...... .....+.+|+.+++.+.|+||+++++++. ....++||||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            47999999999999876555   78999998755433 23345778999999999999999999876 456899999998


Q ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc--
Q 014985           95 -TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ--  171 (415)
Q Consensus        95 -g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~--  171 (415)
                       |+|.+++.... .+++..+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||+++............  
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence             58888887654 68999999999999999999999999999999999999999999999999998764433322211  


Q ss_pred             -ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          172 -VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       172 -~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                       .++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......                   
T Consensus       158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------  217 (257)
T cd05060         158 GRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-------------------  217 (257)
T ss_pred             ccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-------------------
Confidence             22346999999866 558999999999999999997 99999877665544443221100                   


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                              .....++..+.++|.+||..+|++||++.++++
T Consensus       218 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         218 --------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             --------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                    111234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-41  Score=318.83  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=203.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~   82 (415)
                      ...++|.+.+.||+|+||.||++.+     ..++..+|+|.+..... ......+.+|+.+++++ +||||+++++++..
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            3467999999999999999999975     23456899998865432 22233567899999999 79999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      .+..|+||||+. |+|..++.... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999998 68888887543 3489999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          161 FGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       161 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+......... ..      
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-~~------  262 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-YR------  262 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-Cc------
Confidence            543321  1122344667999999876 458899999999999999998 999998776555443333210 00      


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         .......+..+.+|+.+||..+|++|||+.++++
T Consensus       263 -------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 -------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                               0011234789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.4e-41  Score=317.05  Aligned_cols=250  Identities=20%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..+|++.++||+|+||.||++...     .++..+|+|.+....  ......+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            578999999999999999999642     346689999876432  2223357789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcE
Q 014985           86 LHLVFEFME-TDLETVIRNTN--------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~--------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~v  150 (415)
                      .++||||+. |+|..++....              ..+++..+..++.||+.||+|||++|++||||||+|||+++++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            999999998 58888876543              247889999999999999999999999999999999999999999


Q ss_pred             EEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHH
Q 014985          151 KLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (415)
Q Consensus       151 kL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  227 (415)
                      ||+|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+...
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG  240 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence            9999999976533221  1122334567999999876 558999999999999999998 89999877666655544322


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ...                           .....+++.+.+||.+||+.||.+||+++++++
T Consensus       241 ~~~---------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         241 REL---------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             ccC---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            110                           111235788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.9e-41  Score=318.36  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=202.1

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..+|.+.+.||+|+||.||+|.+.     .++..+++|.+......  ....+.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH--HHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            457999999999999999999754     34557888887543221  12346789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc
Q 014985           86 LHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~  149 (415)
                      .++||||+. ++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999998 68888886532               34789999999999999999999999999999999999999999


Q ss_pred             EEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHH
Q 014985          150 LKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       150 vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  226 (415)
                      ++|+|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  240 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ  240 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence            99999999976543321  2234456778999999876 568899999999999999998 9999987776665544322


Q ss_pred             HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..       ++                    ......+..+.+|+.+||+.||++|||+.++++
T Consensus       241 ~~-------~~--------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         241 GR-------VL--------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CC-------CC--------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            10       00                    011234788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.2e-41  Score=318.99  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=204.3

Q ss_pred             ccccccEeeeeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEee
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDT-------KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDA   79 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~   79 (415)
                      ....++|.+.+.||+|+||.||+|++.       ..+..+|+|.+..... ......+.+|+.+++.+ +||||++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            345889999999999999999999753       2345799998764322 22234577899999999 89999999999


Q ss_pred             eecCCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEE
Q 014985           80 FPHKGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (415)
Q Consensus        80 ~~~~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NIL  143 (415)
                      +.....+|+||||+. |+|..++.+..               ..++...+..++.||+.||.|||++|++||||||+|||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            999999999999998 58888887532               24778889999999999999999999999999999999


Q ss_pred             EecCCcEEEeeeccceecCCCCCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHH
Q 014985          144 IGSHGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ  220 (415)
Q Consensus       144 i~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  220 (415)
                      ++.++.+||+|||+++........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999876443322  222344567999999976 558899999999999999998 7888988766655


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ...+.....                           .......+.++.+||.+||..+|.+|||+.++++.
T Consensus       249 ~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            554422100                           00112457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-41  Score=310.42  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=204.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|.+.+.||+|+||+||+|.+. .+..+|+|.+.....   ....+.+|+.+++.++|+||+++++++......++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            3689999999999999999999875 457899999874332   223577899999999999999999999998999999


Q ss_pred             eeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||+. ++|.+.+.... ..++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99998 58888887643 46899999999999999999999999999999999999999999999999999876432111


Q ss_pred             -ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 -FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 -~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                       .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+...+...              
T Consensus       160 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------  224 (261)
T cd05034         160 AREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP--------------  224 (261)
T ss_pred             hhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence             111223456999999876 558899999999999999998 999998887777666654432111              


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                   .....+.++.+++.+||+.+|++||+++++++
T Consensus       225 -------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         225 -------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                         11223678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.9e-41  Score=316.92  Aligned_cols=267  Identities=13%  Similarity=0.156  Sum_probs=199.0

Q ss_pred             CCcccccccccccEeeeeeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCcc---------chHHHHHHHHHhc
Q 014985            1 MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVN---------FTALREIKLLKEL   68 (415)
Q Consensus         1 m~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~---------~~~~~E~~il~~l   68 (415)
                      |..+.+.+...++|.+.++||+|+||+||+|.+..+   +..+|+|+...........         .....+...+..+
T Consensus         1 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~   80 (294)
T PHA02882          1 MEGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI   80 (294)
T ss_pred             CCCeeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC
Confidence            777888888899999999999999999999998777   6677888654332111000         0112234455667


Q ss_pred             CCCCeeeEEeeeecCC----eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE
Q 014985           69 KSPHIIELIDAFPHKG----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI  144 (415)
Q Consensus        69 ~hp~Iv~l~~~~~~~~----~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi  144 (415)
                      .|++|+++++++....    ..++++|++..++...+... ...++..++.++.|++.||+|||+++|+||||||+|||+
T Consensus        81 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill  159 (294)
T PHA02882         81 DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV  159 (294)
T ss_pred             CCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            8999999998765443    45788998887777666543 336788899999999999999999999999999999999


Q ss_pred             ecCCcEEEeeeccceecCCCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc
Q 014985          145 GSHGQLKLADFGLARIFGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (415)
Q Consensus       145 ~~~~~vkL~DFG~a~~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  217 (415)
                      +.++.++|+|||+|+.+.....       ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            9999999999999987643221       1123468999999999876 5689999999999999999999999987743


Q ss_pred             -HHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          218 -IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       218 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                       ..........+-....                     ......+..+.++.+++..|++.+|++||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLH---------------------EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             chHHHHHhHHHHHHHhh---------------------hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             2222211110000000                     000112344788999999999999999999999875

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.5e-41  Score=320.42  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=201.4

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC-------CCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeee
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP   81 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~   81 (415)
                      -.++|.+.+.||+|+||.||+|.+..       ....+|+|.+..... ......+.+|+.+++.+ .||||+++++++.
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            35799999999999999999997632       345799998764322 22233567899999999 6999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~  145 (415)
                      ..+.+|+||||+. |+|..++....               ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence            9999999999998 68888886532               3478899999999999999999999999999999999999


Q ss_pred             cCCcEEEeeeccceecCCCCCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHH
Q 014985          146 SHGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG  222 (415)
Q Consensus       146 ~~~~vkL~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  222 (415)
                      .++.+||+|||+++........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+...
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999865432211  112233456999999876 568999999999999999998 889998776655555


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .+.....                           ......++.++.+||.+||..||++|||+.++++
T Consensus       248 ~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 LLREGHR---------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4432100                           0112244788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-40  Score=309.66  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=199.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+ ..+|+|.+.....   ....+.+|+.+++.++|+|++++++++. ....|+||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence            47899999999999999999987654 4699998764322   2335678999999999999999999885 45689999


Q ss_pred             eccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-
Q 014985           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-  167 (415)
                      ||+. |+|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++......... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9998 58888887643 34889999999999999999999999999999999999999999999999999876433211 


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+..+.+....+......                
T Consensus       160 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM----------------  222 (260)
T ss_pred             cCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            122334567999998866 458899999999999999999 89999887766665554322110                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 ......+..+.+|+.+||..||++||+++++++
T Consensus       223 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       111234788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-41  Score=309.54  Aligned_cols=243  Identities=24%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TD   96 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~   96 (415)
                      ++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|++++++++|+||+++++++......|+||||+. ++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            479999999999999877 999999988754433 233457789999999999999999999999999999999997 57


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc--cccccc
Q 014985           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF--THQVFA  174 (415)
Q Consensus        97 L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~--~~~~~t  174 (415)
                      |.+++.+....+++..+..++.+++.||+|||++|++||||||+|||++.++.+||+|||++..........  .....+
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            888887766678999999999999999999999999999999999999999999999999998654222111  112224


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      ..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+......                       
T Consensus       159 ~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~-----------------------  214 (251)
T cd05041         159 IKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-----------------------  214 (251)
T ss_pred             eccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC-----------------------
Confidence            55999999876 468999999999999999998 78898877655544443221100                       


Q ss_pred             CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       254 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                          ......+..+.+|+.+||..+|.+|||+.++++
T Consensus       215 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 ----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                001134788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=309.22  Aligned_cols=244  Identities=21%  Similarity=0.331  Sum_probs=201.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||.|+||.||+|.+  .|+.+|+|.+.....   ....+.+|+.+++.++|+||+++++++......|+||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            46899999999999999999975  478999999865433   2345778999999999999999999999899999999


Q ss_pred             eccc-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||++ ++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.++.......  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999 588888876542 589999999999999999999999999999999999999999999999999987633221  


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                       ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.....                  
T Consensus       158 -~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------  217 (256)
T cd05039         158 -SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR------------------  217 (256)
T ss_pred             -cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence             2333456999999875 457889999999999999997 9999987765554443322100                  


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                               .......++++.++|.+||..+|++||++.++++
T Consensus       218 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         218 ---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                     0111234789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.3e-40  Score=308.45  Aligned_cols=248  Identities=24%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+......   ...+.+|+++++.++||||+++++++......|+|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            47899999999999999999875 4678999987643322   2356789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-cc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-FT  169 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-~~  169 (415)
                      |+.| +|...+......+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++......... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9985 777777766666899999999999999999999999999999999999999999999999999865433211 11


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+.+..+.......                 
T Consensus       160 ~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  221 (256)
T cd05112         160 GTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-----------------  221 (256)
T ss_pred             CCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-----------------
Confidence            2234557999999876 568899999999999999998 999998777666555543221000                 


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                .....+..+.+|+.+||..+|++|||+.+++++
T Consensus       222 ----------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         222 ----------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                      001237889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-41  Score=312.59  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=202.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+|.+.+.||+|+||.||+|.+..+++   .||+|.+.... .......+.+|+.+++.++||||+++++++..+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            3568999999999999999999887665   59999886432 2222345778999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++| +|..++......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999985 78778776666789999999999999999999999999999999999999999999999999876533221


Q ss_pred             --ccccccc---ccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          167 --RFTHQVF---ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       167 --~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                        ......+   +..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+......          
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~----------  230 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL----------  230 (269)
T ss_pred             ccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC----------
Confidence              1111121   346999999876 568899999999999999886 99999877666555554221110          


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                       ...+..+..+.+++.+||..+|.+||++++++.
T Consensus       231 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         231 -----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             011234788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.6e-41  Score=310.09  Aligned_cols=242  Identities=21%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             eecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-C
Q 014985           19 VLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-T   95 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g   95 (415)
                      .||+|+||.||+|.+.  ..+..+|+|++..... ......+.+|+.++++++||||++++++++ ....++||||++ |
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            3899999999999765  4456799998865422 222345778999999999999999999885 457899999998 5


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc---cccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQV  172 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~---~~~~  172 (415)
                      +|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........   ....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            7888877666679999999999999999999999999999999999999999999999999998654332211   1222


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      ++..|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+.....                      
T Consensus       160 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------  216 (257)
T cd05115         160 WPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR----------------------  216 (257)
T ss_pred             CCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----------------------
Confidence            3457999999876 458899999999999999996 9999988776665544432210                      


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                           ....+..++++.++|.+||..||++||++.++.+
T Consensus       217 -----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 -----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                 0112344789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.1e-41  Score=316.82  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             cEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+...... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            57899999999999999998653     2357888887643322 11235678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEE
Q 014985           88 LVFEFME-TDLETVIRNT-----------------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~-----------------------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NIL  143 (415)
                      +|+||+. |+|..++...                       ...+++..+..++.|++.||.|||++|++||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999 5787776542                       124788899999999999999999999999999999999


Q ss_pred             EecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHH
Q 014985          144 IGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ  220 (415)
Q Consensus       144 i~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  220 (415)
                      ++.++.+||+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999986533221  1122334567999999866 558899999999999999998 9999987765554


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ...+......                           ......+.++.+|+.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRM---------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            4333211100                           011234789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-41  Score=317.11  Aligned_cols=258  Identities=25%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC--------------CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT--------------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL   76 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~--------------~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l   76 (415)
                      .++|++.+.||+|+||.||+|++..+              ...||+|.+..... ......+.+|+++++.++|+||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            46899999999999999999987543              23589999865422 2222356789999999999999999


Q ss_pred             EeeeecCCeEEEEeeccc-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE
Q 014985           77 IDAFPHKGNLHLVFEFME-TDLETVIRNTN-----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI  144 (415)
Q Consensus        77 ~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~-----------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi  144 (415)
                      ++++...+..|+||||+. ++|.+++....           ..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            999999999999999998 57877775432           136788899999999999999999999999999999999


Q ss_pred             ecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc--CCCCCCCCCcHHH
Q 014985          145 GSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQ  220 (415)
Q Consensus       145 ~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~  220 (415)
                      +.++.+||+|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++  |..||...+..+.
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            9999999999999976533221  1122344667999999876 458999999999999999987  6678888776666


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      +..+...+.......                    .....+..+..+.+||.+||+.||++||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQI--------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccc--------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            555433221110000                    00112235789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.2e-41  Score=325.05  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=195.9

Q ss_pred             cccEeeeeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec-C
Q 014985           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-K   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~-~   83 (415)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||.++..... .....+.+|+.++..+ .||||+++++++.. +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            47899999999999999999974     356789999998654322 2233577899999999 67999999998754 4


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC---------------------------------------------------------
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN---------------------------------------------------------  105 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~---------------------------------------------------------  105 (415)
                      ..+++|||||+ |+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56899999999 68888876432                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--cccccccc
Q 014985          106 ---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFA  174 (415)
Q Consensus       106 ---------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t  174 (415)
                               ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ......++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                     1357778889999999999999999999999999999999999999999999986532221  11223345


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      ..|+|||++.+ ..++.++|||||||++|+|++ |..||.+............. +..                      
T Consensus       245 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~----------------------  300 (343)
T cd05103         245 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTR----------------------  300 (343)
T ss_pred             cceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cCC----------------------
Confidence            66999999876 568999999999999999996 88998775433332222111 000                      


Q ss_pred             CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       254 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                         .......++++.+++.+||+.||++|||+.++++|
T Consensus       301 ---~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               00011246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=307.66  Aligned_cols=245  Identities=29%  Similarity=0.472  Sum_probs=205.5

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL   97 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L   97 (415)
                      ||.|+||.||++.+..+++.+|+|.+........ ....+.+|+.+++.++|+||+++++.++.+...|+||||+. ++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999998999999999876543322 33456789999999999999999999999999999999996 688


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccce
Q 014985           98 ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (415)
Q Consensus        98 ~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y  177 (415)
                      .+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............++..|
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            88876553 58999999999999999999999999999999999999999999999999998765443334456677889


Q ss_pred             eCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcc
Q 014985          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR  257 (415)
Q Consensus       178 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (415)
                      +|||.+.+ ...+.++|+|||||++|+|++|..||...+.......+...  .                          .
T Consensus       160 ~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--------------------------~  210 (250)
T cd05123         160 LAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--P--------------------------L  210 (250)
T ss_pred             cChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--C--------------------------C
Confidence            99999876 44788999999999999999999999776654444443320  0                          0


Q ss_pred             ccCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCCCC
Q 014985          258 SLFPSASDDALDLLSKMFTYDPKARITA---QQALEHRYF  294 (415)
Q Consensus       258 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~---~e~l~h~~~  294 (415)
                      .....++..+.+||.+||..||++||++   +++++||||
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            1122337889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-40  Score=315.86  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=199.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECC----------------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK----------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv   74 (415)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|++..... ......+.+|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcc
Confidence            4689999999999999999985432                345799998864422 22233567899999999999999


Q ss_pred             eEEeeeecCCeEEEEeeccc-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEE
Q 014985           75 ELIDAFPHKGNLHLVFEFME-TDLETVIRNTN----------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (415)
Q Consensus        75 ~l~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~----------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NIL  143 (415)
                      ++++++...+.+|+||||+. |+|..++....          ..+++..+..++.||+.||+|||++|++|+||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999998 58888876542          23677889999999999999999999999999999999


Q ss_pred             EecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc--CCCCCCCCCcHH
Q 014985          144 IGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDID  219 (415)
Q Consensus       144 i~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~  219 (415)
                      ++.++.++|+|||+++.+.....  ......++..|+|||+..+ ..++.++|||||||++|||++  |..||...+..+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999986533221  1122334567999998766 458999999999999999998  678887766655


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       220 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ........+......                    ......+..+..+.+|+.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQ--------------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhcccc--------------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            554432221110000                    000112235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2e-40  Score=307.47  Aligned_cols=243  Identities=21%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee-ecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~~~lv   89 (415)
                      .++|.+.+.||+|+||.||++..  .|..+|+|.+....    ....+.+|+.+++.++|+||+++++++ ..++..|+|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            35899999999999999999965  47889999875432    223567899999999999999999875 456679999


Q ss_pred             eeccc-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||++ |+|.+++.+... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99998 588888876543 48899999999999999999999999999999999999999999999999988653322  


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....                 
T Consensus       157 -~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------  217 (256)
T cd05082         157 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------  217 (256)
T ss_pred             -CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------------
Confidence             22233456999999866 568899999999999999997 9999887655554444322110                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                ....+.++..+.++|.+||..+|++|||+.++++
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         218 ----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                      0112345789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-41  Score=314.34  Aligned_cols=239  Identities=16%  Similarity=0.246  Sum_probs=190.3

Q ss_pred             eeecccCceEEEEEEECCCCc-------EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQ-------TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~-------~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      +.||.|+||.||+|.+...+.       .+|+|.+....  ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999998765443       48888765332  122335678999999999999999999999989999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc--------EEEeeeccceec
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--------LKLADFGLARIF  161 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~--------vkL~DFG~a~~~  161 (415)
                      ||+. |+|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9998 5788888776667899999999999999999999999999999999999988765        699999998754


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...    ....++..|+|||++.+...++.++|||||||++|+|++|. +||...+........ ..   .         
T Consensus       159 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~---~---------  221 (258)
T cd05078         159 LPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED---R---------  221 (258)
T ss_pred             CCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc---c---------
Confidence            322    23456777999999977566899999999999999999984 676655444332211 10   0         


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                      .......+.++.+||.+||+.||++|||++++++.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 ----------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                            01112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-40  Score=326.87  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=202.0

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      .++|.+.++||+|+||.||+|++.     .+++.||+|++...... .....+.+|+.+|..+. ||||+++++++...+
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            578999999999999999999853     35578999999754322 22235778999999997 999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC----------------------------------------------------------
Q 014985           85 NLHLVFEFME-TDLETVIRNTN----------------------------------------------------------  105 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~----------------------------------------------------------  105 (415)
                      .+|+|||||. |+|.+++....                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999 68888886432                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec
Q 014985          106 ---------------------------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (415)
Q Consensus       106 ---------------------------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~  146 (415)
                                                             ..++...+..++.||+.||+|||++||+||||||+|||++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~  274 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE  274 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence                                                   13566778889999999999999999999999999999999


Q ss_pred             CCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHH
Q 014985          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  223 (415)
                      ++.+||+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|||++ |..||......+.+..
T Consensus       275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence            99999999999986533221  2223456778999999976 457899999999999999998 8888877665554443


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .... +. .                        ......++.++.+|+.+||..+|.+||++.+|++.
T Consensus       354 ~~~~-~~-~------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 AIKR-GY-R------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHc-CC-C------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3221 00 0                        01122457899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-40  Score=311.89  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=194.8

Q ss_pred             cccE-eeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--C
Q 014985           11 ADRY-LKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--K   83 (415)
Q Consensus        11 ~~~y-~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~   83 (415)
                      .++| .+.+.||+|+||+||++.    ...++..||+|.+..... ......+.+|+.+++.++||||+++++++..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            4566 999999999999998864    335678999999865422 1223456789999999999999999998765  3


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      ..+|+||||+. |+|..++...  .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            46899999999 5777777653  38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCc---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          163 SPDRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       163 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .....   .....++..|+|||++.+ ..++.++|||||||++|+|++|..||......  ...+...   . ...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~---~-~~~~~~~  231 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGP---K-QGQMTVV  231 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcc---c-ccccchh
Confidence            33221   112234556999999876 45789999999999999999999887654321  1111100   0 0000000


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                       .+.+..     ............+..+.+|+.+||..||++|||++++++
T Consensus       232 -~~~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         232 -RLIELL-----ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -hhhhhh-----hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             000000     000001122346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=311.47  Aligned_cols=250  Identities=23%  Similarity=0.373  Sum_probs=202.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc----EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|.+.+.||+|+||+||+|.+..+|.    .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            5789999999999999999998876665    589998765432 2223456789999999999999999999876 789


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++||||+. |+|.+.+.+....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            99999998 68998888776679999999999999999999999999999999999999999999999999998764333


Q ss_pred             Cccc--ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 RRFT--HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ....  ...++..|+|||.+.+ ..++.++|+|||||++|||++ |.+||.+....+....+......            
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------  230 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL------------  230 (279)
T ss_pred             cceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC------------
Confidence            2221  1222456999999865 567899999999999999998 99999887665554444321100            


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     ...+..+.++.+++.+||..||.+||++.++++
T Consensus       231 ---------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 ---------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                           111234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-40  Score=314.52  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=200.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|++.+.||.|+||.||+|.+..     ++..+|+|.+...... .....+.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4789999999999999999998753     6789999988643321 122346789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEE
Q 014985           86 LHLVFEFME-TDLETVIRNTN---------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL  143 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~---------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NIL  143 (415)
                      .|+||||+. |+|..++....                     ..+++..+..++.||+.||.|||++|++||||||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            999999999 58888886432                     24778889999999999999999999999999999999


Q ss_pred             EecCCcEEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHH
Q 014985          144 IGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ  220 (415)
Q Consensus       144 i~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  220 (415)
                      ++.++.++|+|||++.......  ........+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999987653322  11222334556999999876 568999999999999999997 8778877666555


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ...+.....                           .......+.++.+||.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         242 IYYVRDGNV---------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            544322100                           0111234789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-40  Score=314.60  Aligned_cols=265  Identities=23%  Similarity=0.384  Sum_probs=206.9

Q ss_pred             cEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCcc--CCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~--~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~   86 (415)
                      +|.+.+.||+|+||.||++.+.   .+++.||+|++......  ......+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999854   46789999998754322  12223466899999999 589999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+.| +|...+... ..+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            999999984 777777654 458999999999999999999999999999999999999999999999999987654332


Q ss_pred             C-cccccccccceeCcccccCCc-CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 R-RFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~-~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.......            
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------  227 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------------  227 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc------------
Confidence            2 122345778899999986533 36789999999999999999999986543222222221111000            


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT---AQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~l~h~~~~~~~~~~~  302 (415)
                                  .......++.++.++|.+||+.||++|||   +.++|+||||+...+...
T Consensus       228 ------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         228 ------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             ------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence                        00112335788999999999999999998   577899999998776443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-40  Score=310.31  Aligned_cols=239  Identities=20%  Similarity=0.286  Sum_probs=187.2

Q ss_pred             eeecccCceEEEEEEECC------------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           18 EVLGEGTYGVVYKAIDTK------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~------------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      +.||+|+||.||++....            ....+++|++....  ......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999997432            22358888865432  2233356778999999999999999999999999


Q ss_pred             EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc-------EEEeeecc
Q 014985           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-------LKLADFGL  157 (415)
Q Consensus        86 ~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~-------vkL~DFG~  157 (415)
                      .++||||+++ .|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            9999999995 566666555667999999999999999999999999999999999999987664       89999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHH-cCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      +......    ....++..|+|||++.+...++.++|||||||++|+|+ +|..||......+.. .+...   ..    
T Consensus       159 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---~~----  226 (262)
T cd05077         159 PITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---QC----  226 (262)
T ss_pred             CccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---Cc----
Confidence            8765322    23456777999999875567899999999999999998 588888765433221 11110   00    


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                           ......+.++.+||.+||+.||.+||++.+|+++
T Consensus       227 ---------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 ---------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ---------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                                 0011225789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.9e-41  Score=313.15  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=195.6

Q ss_pred             eeeeeecccCceEEEEEEEC----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           15 LKREVLGEGTYGVVYKAIDT----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+.+.||.|.||.||+|...    ..+..|+||.+.... .......+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeecccccccccccccccccccccccccccccc
Confidence            46789999999999999877    345689999985422 2222456788999999999999999999999888899999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--  166 (415)
                      |||. |+|.+++... ...+++..+..++.||+.||.|||+++++|++|++.|||++.++.+||+|||++........  
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9998 6899999887 56699999999999999999999999999999999999999999999999999987632221  


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ..........|+|||.+.+ ..++.++||||||+++|||++ |..||...+..+....+......               
T Consensus       161 ~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~---------------  224 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL---------------  224 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET---------------
T ss_pred             ccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc---------------
Confidence            1222344566999999876 348999999999999999999 67899888777766666332111               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  ......+..+.++|..||..||++|||+.++++
T Consensus       225 ------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  225 ------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                        111235788999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.5e-40  Score=305.47  Aligned_cols=243  Identities=23%  Similarity=0.386  Sum_probs=196.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TD   96 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~   96 (415)
                      ++||+|+||.||++... ++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..++||||+. |+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            47899999999999854 678999998765432 1223356789999999999999999999999999999999998 58


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc-ccccccc
Q 014985           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-THQVFAR  175 (415)
Q Consensus        97 L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~t~  175 (415)
                      |..++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....++.
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            888887666668999999999999999999999999999999999999999999999999987643222111 1123345


Q ss_pred             ceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCC
Q 014985          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP  254 (415)
Q Consensus       176 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (415)
                      .|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.....                         
T Consensus       159 ~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------  212 (250)
T cd05085         159 KWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-------------------------  212 (250)
T ss_pred             cccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence            6999999865 557899999999999999998 9999987766555544432110                         


Q ss_pred             CccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       255 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                        ......++..+.+|+.+||..+|++||++.++++
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 --MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence              0112245789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=328.16  Aligned_cols=237  Identities=25%  Similarity=0.387  Sum_probs=196.5

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      ..-++.||+|+.|.||++  +-.++.||||+++..+.         .+|+-|++|+||||+.+.++|...-.+|||||||
T Consensus       126 IsELeWlGSGaQGAVF~G--rl~netVAVKKV~elkE---------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLG--RLHNETVAVKKVRELKE---------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhhhccCcccceeee--eccCceehhHHHhhhhh---------hhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            345778999999999999  45689999998753221         3888999999999999999999999999999999


Q ss_pred             c-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccc
Q 014985           94 E-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV  172 (415)
Q Consensus        94 ~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~  172 (415)
                      . |-|...++. +..+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... .....++
T Consensus       195 a~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFa  272 (904)
T KOG4721|consen  195 AQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFA  272 (904)
T ss_pred             ccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhh
Confidence            9 677777765 445899999999999999999999999999999999999999999999999999887555 3445689


Q ss_pred             cccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccccc
Q 014985          173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA  252 (415)
Q Consensus       173 ~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (415)
                      ||..|||||++.+ .+.+.++|||||||+|||||||.-|+..-+...+   | -+.|...                    
T Consensus       273 GTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---I-wGVGsNs--------------------  327 (904)
T KOG4721|consen  273 GTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---I-WGVGSNS--------------------  327 (904)
T ss_pred             hhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchhee---E-EeccCCc--------------------
Confidence            9999999999987 6789999999999999999999988865332211   1 1222111                    


Q ss_pred             CCCccc-cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          253 APPLRS-LFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       253 ~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                         +.- .....++.++-||+.||+..|..||+..|||.|
T Consensus       328 ---L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  328 ---LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ---ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence               111 112346789999999999999999999999988

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-40  Score=306.49  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=199.2

Q ss_pred             eeecccCceEEEEEEECC-CCc--EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           18 EVLGEGTYGVVYKAIDTK-TGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~-~~~--~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      +.||+|++|.||+|.+.. +++  .+|+|.+...... .....+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999998765 333  6999998765543 334457789999999999999999999988 88999999997


Q ss_pred             -CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc---cc
Q 014985           95 -TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FT  169 (415)
Q Consensus        95 -g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~---~~  169 (415)
                       |+|...+.+.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........   ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence             68888887755 56899999999999999999999999999999999999999999999999999876443221   11


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+....     ..+            
T Consensus       159 ~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~------------  220 (257)
T cd05040         159 HLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-----ERL------------  220 (257)
T ss_pred             CCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CcC------------
Confidence            2345667999999866 568899999999999999998 999998777766655554310     000            


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                               ......+..+.+++.+||..+|++||++.++++
T Consensus       221 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 ---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                     011234788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-40  Score=306.09  Aligned_cols=248  Identities=25%  Similarity=0.404  Sum_probs=203.4

Q ss_pred             EeeeeeecccCceEEEEEEECCCC----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +++.+.||.|+||.||++.+...+    ..+|+|++....... ....+.+|+.+++.++|+||+++++++...+..|++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            357889999999999999988766    899999986543221 234577899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~-l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||+. ++|.+.+...... +++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            99998 5888887765544 899999999999999999999999999999999999999999999999999876543221


Q ss_pred             cc-ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 FT-HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 ~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .. ...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......               
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------  223 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL---------------  223 (258)
T ss_pred             ccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence            11 2235677999999854 568999999999999999998 88999887666665554332100               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  ......+.++.+++.+||..||++|||+.|+++
T Consensus       224 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      224 ------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                        111235789999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-40  Score=319.84  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=200.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-------CcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-------~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~   82 (415)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.+..... ......+.+|+.+++++ +||||+++++++..
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            46899999999999999999976432       23689998764322 22233577899999999 79999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~  146 (415)
                      .+.+|++|||+. |+|.+++.+..               ..++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            999999999998 58888886532               23677888999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccceecCCCCCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHH
Q 014985          147 HGQLKLADFGLARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  223 (415)
                      ++.+||+|||+++........  .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999876433221  122233456999999976 568899999999999999998 8899988766555544


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      +.....                           .......+.++.+||.+||+.+|.+||++.+++++
T Consensus       249 ~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         249 LKEGHR---------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHcCCC---------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            422100                           01112347889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-40  Score=308.94  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=202.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+.||+|+||.||+|.+...   ...+|+|....... ......+.+|+.+++.++||||+++++++.. ...|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            56799999999999999999987544   34689998764432 2223457789999999999999999998875 5678


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||+. |+|.+++......+++..+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||++........
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            9999998 688888877665689999999999999999999999999999999999999999999999999986543321


Q ss_pred             c-ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 R-FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      . .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......              
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--------------  227 (270)
T cd05056         163 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL--------------  227 (270)
T ss_pred             eecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--------------
Confidence            1 112223456999999865 568899999999999999985 99999888776666554321100              


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                   ...+.++..+.+||.+||..+|.+|||+.+++..
T Consensus       228 -------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         228 -------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         1123457899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.9e-40  Score=304.61  Aligned_cols=248  Identities=20%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|.+.+.||+|+||.||++.+. .+..+|+|.+.....   ....+.+|+.+++.++|+||+++++.+.. ...|++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh---HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            4689999999999999999999754 456799998764321   23356789999999999999999999887 788999


Q ss_pred             eeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||++ |+|.+++.+. +..++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            99998 6898888764 44578889999999999999999999999999999999999999999999999986543221 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+......               
T Consensus       159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------------  222 (260)
T ss_pred             cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---------------
Confidence            1122334566999999876 558889999999999999998 89999887766655544322110               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  .....++.++.+++.+||+.+|++||++.++++
T Consensus       223 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                        111345789999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-40  Score=308.78  Aligned_cols=243  Identities=26%  Similarity=0.380  Sum_probs=191.9

Q ss_pred             eeecccCceEEEEEEECCCCc--EEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~--~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      +.||+|+||.||+|.+..++.  .+++|.+..... ......+.+|+.++.++ .||||+++++++...+.+|+||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            468999999999999888776  468887753321 12223567899999999 79999999999999999999999998


Q ss_pred             -CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           95 -TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        95 -g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                       |+|.+++....               ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence             68888886532               24789999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ....... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....        
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------  229 (270)
T cd05047         160 RGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--------  229 (270)
T ss_pred             cccchhh-hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC--------
Confidence            6332111 1112223456999999865 568899999999999999996 9999987665554444321100        


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         ......++.++.+|+.+||..||.+|||+.+++.
T Consensus       230 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         230 -------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                               0011234788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-40  Score=310.49  Aligned_cols=238  Identities=19%  Similarity=0.247  Sum_probs=186.5

Q ss_pred             eecccCceEEEEEEECC------------------------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCee
Q 014985           19 VLGEGTYGVVYKAIDTK------------------------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII   74 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~------------------------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv   74 (415)
                      .||+|+||.||++....                        ....+|+|++.....  .....+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            69999999999996422                        123588888754321  2233566789999999999999


Q ss_pred             eEEeeeecCCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-----
Q 014985           75 ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----  148 (415)
Q Consensus        75 ~l~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-----  148 (415)
                      ++++++......|+||||++| +|...+......+++..+..++.||+.||+|||++||+||||||+|||++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999995 66666666566789999999999999999999999999999999999998654     


Q ss_pred             --cEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHH-cCCCCCCCCCcHHHHHHHH
Q 014985          149 --QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIF  225 (415)
Q Consensus       149 --~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~  225 (415)
                        .+||+|||++......    ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||.+....+....+.
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  235 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE  235 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence              3899999988654222    22356677999999876566899999999999999995 6899998765544322111


Q ss_pred             HHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ...                             ......+..+.++|.+||+.+|++|||+.+++++
T Consensus       236 ~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         236 KKH-----------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             hcc-----------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            100                             0011235689999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.3e-40  Score=309.30  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=199.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECC----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-CCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~   85 (415)
                      .++|.+.+.||+|+||.||+|.+..    ++..+++|.+.... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            6899999999999999999998876    35789999876332 22223456789999999999999999998655 567


Q ss_pred             EEEEeeccc-CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           86 LHLVFEFME-TDLETVIRNTN-------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~-------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      .++++||+. |+|..++....       ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            899999998 68888876532       3489999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          158 ARIFGSPDRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       158 a~~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ++.+......  .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....   . 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~-  238 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR---L-  238 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC---C-
Confidence            9865332211  112334556999999876 558999999999999999998 9999987765554433322110   0 


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                             .....+++++.+++.+||..||++|||+.++++
T Consensus       239 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 -----------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                   001124688999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.3e-40  Score=307.50  Aligned_cols=249  Identities=21%  Similarity=0.296  Sum_probs=190.9

Q ss_pred             eeecccCceEEEEEEECC--CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      +.||+|+||.||+|....  ....+|+|.+..... ......+.+|+.+++.++|+||+++++.+.....+|+||||+. 
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            368999999999996432  345788887654322 2223346789999999999999999999999999999999998 


Q ss_pred             CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--cc
Q 014985           95 TDLETVIRNTNI----FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RF  168 (415)
Q Consensus        95 g~L~~~i~~~~~----~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~  168 (415)
                      |+|.+++.....    ..++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++........  ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            588888866432    246778889999999999999999999999999999999999999999999875422211  11


Q ss_pred             cccccccceeCcccccC------CcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          169 THQVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ....++..|+|||++..      ...++.++|||||||++|||++ |.+||....+.+.+..+........+.       
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------  232 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-------  232 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC-------
Confidence            22344567999999742      2356889999999999999998 788998877776666554332111110       


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     ......++..+.+++..|+ .||++|||++++++
T Consensus       233 ---------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         233 ---------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ---------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                           1122345788899999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-40  Score=310.75  Aligned_cols=266  Identities=21%  Similarity=0.328  Sum_probs=196.9

Q ss_pred             ccEeeeeeecccCceEEEEEEE----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--Ce
Q 014985           12 DRYLKREVLGEGTYGVVYKAID----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GN   85 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~   85 (415)
                      .-|++++.||+|+||.||+|..    ..++..||+|.+..... ......+.+|+.+++.++||||+++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            3468999999999999999974    45788999999864432 22234577899999999999999999998775  57


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .++||||++ ++|..++.+....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            899999998 5788887665556899999999999999999999999999999999999999999999999999876443


Q ss_pred             CCc---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 DRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ...   .....++..|+|||++.+ ..++.++|||||||++|+|+++..++....  ...   ....+.......     
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~--~~~---~~~~~~~~~~~~-----  231 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPM--TLF---LKMIGPTHGQMT-----  231 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCcccc--chh---hhhccccccccc-----
Confidence            221   123345567999999876 458899999999999999999875543211  000   011110000000     


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .......  ............++..+.+||.+||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         232 VTRLVRV--LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHH--HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            0000000  00000011223568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-40  Score=313.28  Aligned_cols=251  Identities=21%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc----EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|+..+.||+|+||.||+|.+..+|.    .+|+|.+..... ......+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            5788999999999999999999877776    468887754322 22223567899999999999999999988654 56


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++++||+. |+|.+.+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            78999998 68988888766678999999999999999999999999999999999999999999999999998764332


Q ss_pred             Cc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 RR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..  .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+... +..... ..          
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~-~~----------  230 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGE-RL----------  230 (303)
T ss_pred             cccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCC-CC----------
Confidence            21  222334567999999876 568999999999999999997 888887765433322 222100 00          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                     ...+..+..+.+++.+||..+|++||++.++++.
T Consensus       231 ---------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         231 ---------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           0112346789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=318.63  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=200.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-eEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-NLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~lv   89 (415)
                      .++|.-.+.||+|+||.||+|.-. +|..||||.+.......  ..++.+|+.++.+++|||+|+|++||.+.+ +.+||
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            578888899999999999999754 44899999776544332  335889999999999999999999999888 59999


Q ss_pred             eeccc-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCC---ccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           90 FEFME-TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKW---VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~---ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      +||+. |+|.+.+..... .+++.....|+.+++.||+|||...   ||||||||+|||+|++.+.||+|||+|+.....
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999 799999887765 7999999999999999999999854   999999999999999999999999999765431


Q ss_pred             CCccccc-ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC--cHHHHHHH-HHHhCCCCCCCCCCCC
Q 014985          165 DRRFTHQ-VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS--DIDQLGKI-FAAFGTATPSQWPDLA  240 (415)
Q Consensus       165 ~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i-~~~~~~~~~~~~~~~~  240 (415)
                      ....... .||.+|+|||.+.. ...+.++|||||||+|.||++|+.+.+...  ....+... ...+.......+.|  
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD--  307 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD--  307 (361)
T ss_pred             ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC--
Confidence            2222222 78999999999865 568999999999999999999998777542  11111111 11211111111111  


Q ss_pred             CCccchhcccccCCCcc-ccCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          241 YLPDYVEYQYVAAPPLR-SLFP--SASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~-~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                   +.+. ..++  ..-..+..+..+|++.+|.+||++.|+++
T Consensus       308 -------------~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  308 -------------PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -------------CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                         1111 1111  01223678899999999999999999765

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.5e-40  Score=305.25  Aligned_cols=249  Identities=20%  Similarity=0.258  Sum_probs=190.0

Q ss_pred             eeecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      +.||+|+||.||+|...  .++..+|+|.++..... .....+.+|+.+++.++||||+++++++.+...+++||||++ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999754  35568999987654322 122356789999999999999999999999999999999999 


Q ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--cc
Q 014985           95 TDLETVIRNTN----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RF  168 (415)
Q Consensus        95 g~L~~~i~~~~----~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~  168 (415)
                      |+|.+++....    ...++..+..++.|++.||.|||++|++|+||||+||+++.++++||+|||+++.......  ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            68888876532    2356778889999999999999999999999999999999999999999999976433221  11


Q ss_pred             cccccccceeCcccccCC------cCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          169 THQVFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ....++..|+|||++.+.      ..++.++|||||||++|||++ |.+||......+.............+        
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  231 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP--------  231 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC--------
Confidence            234566779999998542      135789999999999999996 99999876655543332221110000        


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    ........+..+.+++.+|+ .+|++|||+++++.
T Consensus       232 --------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         232 --------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             --------------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                          00111234778999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.4e-40  Score=305.35  Aligned_cols=244  Identities=21%  Similarity=0.315  Sum_probs=190.0

Q ss_pred             eeecccCceEEEEEEECC---CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee-cCCeEEEEeecc
Q 014985           18 EVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLVFEFM   93 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~e~~   93 (415)
                      +.||+|+||.||+|.+..   .+..+|+|.+..... ......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998643   345799998753221 112235668999999999999999999764 456789999999


Q ss_pred             c-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----Ccc
Q 014985           94 E-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----RRF  168 (415)
Q Consensus        94 ~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----~~~  168 (415)
                      . |+|..++.+....++...+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++......    ...
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            8 68888887766667888889999999999999999999999999999999999999999999997653221    111


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+......                 
T Consensus       160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------  221 (262)
T cd05058         160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-----------------  221 (262)
T ss_pred             ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence            22344567999999876 468899999999999999999 56788776655544433221000                 


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                .....++..+.+++.+||..+|++||++.++++
T Consensus       222 ----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         222 ----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                      001124678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-40  Score=307.58  Aligned_cols=266  Identities=21%  Similarity=0.355  Sum_probs=196.1

Q ss_pred             cccEeeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--CC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~   84 (415)
                      ..+|++.+.||+|+||.||++.    +..++..||+|.+.....  .....+.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            3589999999999999999997    456788999999764322  222356789999999999999999987643  45


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .+++||||+. |+|..++.+....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            7899999998 688888877666689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcc---cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          164 PDRRF---THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       164 ~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .....   ....++..|+|||++.+ ..++.++|||||||++|||++|..++..... ...    ...+......    .
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~----~~~~~~~~~~----~  230 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFM----RMMGNDKQGQ----M  230 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhh----hhcccccccc----c
Confidence            32211   11223345999999876 5588999999999999999998766543221 111    0001000000    0


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ......+  .............++.++.+||.+||..+|++|||+.++++
T Consensus       231 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         231 IVYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             chHHHHH--HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0000000  00000011123456889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.8e-40  Score=303.11  Aligned_cols=242  Identities=24%  Similarity=0.398  Sum_probs=197.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||++.  .+++.||+|.+....    ....+.+|+.+++.++||||+++++++... ..|+||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            4679999999999999999984  578899999985432    223567899999999999999999998664 479999


Q ss_pred             eccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||+. |+|..++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......   
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9998 58888887653 358999999999999999999999999999999999999999999999999997643221   


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+......                 
T Consensus       155 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------  216 (254)
T cd05083         155 DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-----------------  216 (254)
T ss_pred             CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC-----------------
Confidence            12233456999999865 468899999999999999997 99999887665554443221100                 


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                .....++..+.+|+.+||+.+|.+||+++++++
T Consensus       217 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         217 ----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      011245789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-39  Score=304.65  Aligned_cols=251  Identities=26%  Similarity=0.441  Sum_probs=202.3

Q ss_pred             cEeeeeeecccCceEEEEEEECC-CCcEEEEEEeecCCcc--------CCccchHHHHHHHHHh-cCCCCeeeEEeeeec
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQK--------EGVNFTALREIKLLKE-LKSPHIIELIDAFPH   82 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~--------~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~   82 (415)
                      .|.+.+.||+|+||.||++.+.. +++.+|+|.+......        ......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999887 6789999988654321        1122335678888765 799999999999999


Q ss_pred             CCeEEEEeecccC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           83 KGNLHLVFEFMET-DLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        83 ~~~~~lv~e~~~g-~L~~~i~---~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      .+..++||||++| +|.+++.   .....+++..++.++.|++.||.|||+ .|++|+||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999985 7776663   344568999999999999999999996 7899999999999999999999999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      +....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+......+.     
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  233 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-----  233 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-----
Confidence            98765443 3445667888999999976 4578999999999999999999999987665555444432211100     


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                           .....+.++.+||.+||+.||++||++.|+.++
T Consensus       234 ---------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 ---------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                 011347899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.2e-40  Score=303.96  Aligned_cols=228  Identities=22%  Similarity=0.318  Sum_probs=185.9

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCHHHHH
Q 014985           23 GTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVI  101 (415)
Q Consensus        23 G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L~~~i  101 (415)
                      |.||.||+|++..+++.||+|.+.....       ..+|...+....||||+++++++......|+||||+. |+|.+.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            8999999999999999999999875431       2245555666679999999999999999999999999 5788887


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCcc
Q 014985          102 RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE  181 (415)
Q Consensus       102 ~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE  181 (415)
                      .+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+......   .....++..|+|||
T Consensus        77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          77 SKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             HHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence            6543 4899999999999999999999999999999999999999999999999988765432   22344566799999


Q ss_pred             cccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCC
Q 014985          182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP  261 (415)
Q Consensus       182 ~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (415)
                      .+.+ ..++.++|+||+||++|+|++|.++|.......                 ..               .....+.+
T Consensus       153 ~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~---------------~~~~~~~~  199 (237)
T cd05576         153 VGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NT---------------HTTLNIPE  199 (237)
T ss_pred             ccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cc---------------ccccCCcc
Confidence            9865 457889999999999999999998765331100                 00               00001223


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCC
Q 014985          262 SASDDALDLLSKMFTYDPKARITA-----QQALEHRYF  294 (415)
Q Consensus       262 ~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~h~~~  294 (415)
                      .++..+.+||.+||+.||++|+++     ++++.||||
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            458899999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.7e-40  Score=303.19  Aligned_cols=236  Identities=19%  Similarity=0.267  Sum_probs=186.8

Q ss_pred             eeecccCceEEEEEEECCCC----------cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           18 EVLGEGTYGVVYKAIDTKTG----------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~----------~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +.||+|+||.||+|.+..++          ..+++|.+......   ...+.+|+.+++.++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            46899999999999988776          34777776533221   4467789999999999999999999887 7789


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-------cEEEeeeccce
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-------QLKLADFGLAR  159 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-------~vkL~DFG~a~  159 (415)
                      +||||+. |+|..++......++...+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999 577777776554789999999999999999999999999999999999999888       79999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ....    .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+........ ..   .  ..+ 
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~---~--~~~-  225 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QD---Q--HRL-  225 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hc---C--CCC-
Confidence            7543    1233455669999998764 368899999999999999998 56777665432222111 10   0  000 


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                            .......+.+||.+||..+|.+|||+.++++
T Consensus       226 ----------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 ----------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ----------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                  0011378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.4e-40  Score=304.93  Aligned_cols=244  Identities=25%  Similarity=0.402  Sum_probs=194.8

Q ss_pred             eeecccCceEEEEEEECCCC------cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           18 EVLGEGTYGVVYKAIDTKTG------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~------~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +.||+|+||.||+|.+....      ..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            46899999999999876443      6899998764322 1223457789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-----cEEEeeeccce
Q 014985           92 FME-TDLETVIRNT------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----QLKLADFGLAR  159 (415)
Q Consensus        92 ~~~-g~L~~~i~~~------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-----~vkL~DFG~a~  159 (415)
                      |+. |+|..++...      ...+++..+..++.||+.||.|||+++++|+||||+||+++.++     .++|+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            998 5888888652      23478899999999999999999999999999999999999887     89999999997


Q ss_pred             ecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          160 IFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       160 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      .......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.....       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------  231 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-------  231 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-------
Confidence            6533221  1122344567999999976 457999999999999999998 9999987766655444321100       


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                          ......++..+.+||.+||..+|.+||++.++++
T Consensus       232 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 --------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                0112245788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.7e-39  Score=304.31  Aligned_cols=252  Identities=19%  Similarity=0.332  Sum_probs=201.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ++|++.+.||+|+||.||+|+.+.     ..+.+++|.+..... ......+.+|+.++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            789999999999999999998654     346799998754322 11234577899999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           87 HLVFEFME-TDLETVIRNTN--------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~--------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      |+||||++ |+|.+++....        ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            99999999 68888876543        1589999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCC-CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          158 ARIFGSPD-RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       158 a~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      +....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||....+...+..+.....     .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~-----~  237 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL-----E  237 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc-----C
Confidence            87543221 22333455677999999876 457889999999999999998 7888877666555444322100     0


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      |+                     .....+..+.++|.+||..||++|||+.+++.+
T Consensus       238 ~~---------------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LP---------------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC---------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            10                     112347899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-39  Score=304.00  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=195.8

Q ss_pred             EeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 014985           14 YLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------   84 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------   84 (415)
                      |.+.+.||+|+||.||+|.+.   .++..+|||++............+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999854   45789999998765444333445778999999999999999999875432      


Q ss_pred             eEEEEeeccc-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           85 NLHLVFEFME-TDLETVIRNT-----NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~-----~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                      ..++++||+. |+|..++...     ...++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            3478899998 6777666432     124788999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          159 RIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       159 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      +.......  ......++..|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------  233 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR------  233 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc------
Confidence            86543221  1223344567999999866 457889999999999999998 8899987765544443322100      


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                           ....+..+..+.+++.+||+.+|++||++.+++.+
T Consensus       234 ---------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         234 ---------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 00112347899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=327.82  Aligned_cols=269  Identities=26%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC------e
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------N   85 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~   85 (415)
                      .-+...+.||+|+||.||+++++.+|+.||||.++..... .......+|+++|++++|+|||++++.=+...      .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~-r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL-RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc-chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            4457789999999999999999999999999999875422 22335668999999999999999998765543      5


Q ss_pred             EEEEeeccc-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec--CCc--EEEeeeccc
Q 014985           86 LHLVFEFME-TDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQ--LKLADFGLA  158 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~--~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~--~~~--vkL~DFG~a  158 (415)
                      ..+|||||. |+|...+.+.  ...+++.++..++..+..||.|||++||+||||||+||++-.  +|+  -||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            679999999 6888888764  345999999999999999999999999999999999999853  343  799999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +.+.+.. .+...+||+.|++||++...+.|+..+|.|||||++|+++||..||...........++...-+..+....-
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            9886544 888999999999999998657899999999999999999999988876543321111111111111111000


Q ss_pred             --CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC
Q 014985          239 --LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI  283 (415)
Q Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  283 (415)
                        ......-++++..... ...+.+.+-.-+-..+..+|..+|++|.
T Consensus       251 ~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence              0000001111111111 1122222333455788999999999998

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-39  Score=304.20  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=198.8

Q ss_pred             cccEeeeeeecccCceEEEEEEEC----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--CC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~   84 (415)
                      .++|.+.+.||+|+||.||+|...    .+++.+|+|++...... .....+.+|+++++.++|+||+++++++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            357888999999999999999854    35789999998754432 234467789999999999999999999877  55


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..++||||++ |+|..++......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            8999999998 588888877665699999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCccc---ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH-----------HHHHHHHhC
Q 014985          164 PDRRFT---HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-----------LGKIFAAFG  229 (415)
Q Consensus       164 ~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-----------~~~i~~~~~  229 (415)
                      ......   ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||........           ...+...+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            222111   1233456999999876 4588999999999999999999988765322110           111111100


Q ss_pred             CCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..                       .........+.++.+|+.+||..+|++|||+.++++
T Consensus       241 ~~-----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EG-----------------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cC-----------------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00                       000111234688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8e-39  Score=298.98  Aligned_cols=249  Identities=20%  Similarity=0.231  Sum_probs=189.9

Q ss_pred             eeecccCceEEEEEEECCC--CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDTKT--GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~--~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      +.||+|+||.||++.....  ...+++|.+...... .....+.+|+.+++.++||||+++++.+......|+||||+. 
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            3689999999999975432  235667766543221 223467789999999999999999999999999999999999 


Q ss_pred             CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--Cccc
Q 014985           95 TDLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFT  169 (415)
Q Consensus        95 g~L~~~i~~~~---~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--~~~~  169 (415)
                      |+|..++.+..   ...++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++.......  ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            58888887542   336677888999999999999999999999999999999999999999999986432211  1223


Q ss_pred             ccccccceeCcccccCC------cCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          170 HQVFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ...++..|+|||++.+.      ..++.++|||||||++|||++ |.+||...++.+.+..+........+.        
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------  231 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK--------  231 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC--------
Confidence            45677789999997431      235788999999999999996 578888877777666654431111000        


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    .......++.+.+++..|+ .+|.+||+++++++
T Consensus       232 --------------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         232 --------------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             --------------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                          1112235788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=319.19  Aligned_cols=251  Identities=21%  Similarity=0.339  Sum_probs=206.7

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCc---E-EEEEEeecCC-ccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ---T-VAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~-~avK~i~~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ++-.+.++||+|+||.||+|.-+..+.   . ||+|...... ........+++|+++|++++|||||++|++...+..+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            445566999999999999998665432   3 8999887532 3344455688999999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+|||+|. |+|.+++++....++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++....-.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence            99999999 58999999877779999999999999999999999999999999999999999999999999987543111


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHH-hCCCCCCCCCCCCCCc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA-FGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~  243 (415)
                      ......-....|+|||.+.. ..|+.++|||||||++||+.+ |..||.+.+..+...+|... .....+          
T Consensus       317 ~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~----------  385 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP----------  385 (474)
T ss_pred             eccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC----------
Confidence            11111112345999999976 479999999999999999997 88999999999998888443 222211          


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                       ...+.++..++.+|+..||++||++.++.+
T Consensus       386 -----------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  386 -----------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -----------------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                             133678999999999999999999998876

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.6e-39  Score=331.40  Aligned_cols=270  Identities=24%  Similarity=0.361  Sum_probs=182.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCC----CcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEee---
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKT----GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDA---   79 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~----~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~---   79 (415)
                      -.++|.+.+.||+|+||.||+|.+..+    +..||+|++.....         .|+.+...+   .+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------~e~~~~e~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------VEIWMNERVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------hHHHHHHHHHhhchhhHHHHHHhhhc
Confidence            367999999999999999999999988    89999998753221         122222222   22222222222   


Q ss_pred             ---eecCCeEEEEeeccc-CCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 014985           80 ---FPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------LSPADIKSYMQMTLKGLAFCHKKWVLHRD  136 (415)
Q Consensus        80 ---~~~~~~~~lv~e~~~-g~L~~~i~~~~~~-------------------l~~~~~~~i~~qil~aL~~lH~~~ivHrD  136 (415)
                         .......++|+||++ ++|.+++......                   .....++.++.||+.||.|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               245668999999999 5777777654321                   12345678999999999999999999999


Q ss_pred             CCCCcEEEec-CCcEEEeeeccceecCCCC-CcccccccccceeCcccccCCc---------------------CCCCcc
Q 014985          137 MKPNNLLIGS-HGQLKLADFGLARIFGSPD-RRFTHQVFARWYRAPELLFGAK---------------------QYGAGV  193 (415)
Q Consensus       137 lkp~NILi~~-~~~vkL~DFG~a~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~---------------------~~~~~~  193 (415)
                      |||+|||++. ++.+||+|||+|+.+.... ......++++.|+|||++....                     .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5899999999998653322 2234567889999999764321                     234567


Q ss_pred             cHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcc---ccCCCCCHHHHHH
Q 014985          194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR---SLFPSASDDALDL  270 (415)
Q Consensus       194 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~~l  270 (415)
                      |||||||+||||+++..  ...++...+..++...+... ..|...      ..  ....+.+.   .........+.+|
T Consensus       361 DVwSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~-~~~~~~------~~--~~~~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDL-VAWRKL------VE--PRASPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             ccHHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcH-HHHHHh------hc--cccchhhhhhhhhccccchHHHHH
Confidence            99999999999998654  34444444444444322110 001000      00  00000111   1111224567799


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          271 LSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       271 i~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      |.+||+.||++|||+.|+|+||||.....
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999999999999987543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=323.90  Aligned_cols=265  Identities=28%  Similarity=0.405  Sum_probs=219.1

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeee--
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP--   81 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~--   81 (415)
                      |....=.+-|++.++||.|.+|.||++++.++++..|+|+.......   .+++.-|.++|+.. .|||++.+|++|.  
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            33344478899999999999999999999999999999998755433   33566789999987 5799999999984  


Q ss_pred             ---cCCeEEEEeecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeec
Q 014985           82 ---HKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (415)
Q Consensus        82 ---~~~~~~lv~e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG  156 (415)
                         .++.+|||||||+| +.-++++.. +..+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence               35689999999995 555555433 5569999999999999999999999999999999999999999999999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccCCc----CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAK----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      .+..++..-.+..+.+||++|||||++....    .|+.++|+||||++..||.-|.||+-.......+..|-       
T Consensus       169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-------  241 (953)
T KOG0587|consen  169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------  241 (953)
T ss_pred             eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-------
Confidence            9999888888888999999999999996533    36789999999999999999999987765544443321       


Q ss_pred             CCCCCCCCCCccchhcccccCCCcc-ccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLR-SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                         ..|+.. ..+...+..+.+||..||.+|-.+||+..++|+|||.+..+
T Consensus       242 -------------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  242 -------------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             -------------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence                               111111 11234589999999999999999999999999999998443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=333.66  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=212.3

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCC-----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP   81 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   81 (415)
                      ...=.+.-.+.+.||+|+||.||.|.-....     ..||+|.+..... ......+++|..+|+.++|||||++++.+-
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            3344567788999999999999999754432     2499998876533 333457889999999999999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEee
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNT------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                      +.+..+|++|||+ |||+.++++.      ...++..+...++.+|++|+.||+++++|||||-..|+|++....+||+|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence            9999999999999 7999999988      66799999999999999999999999999999999999999999999999


Q ss_pred             eccceecCCCCC-ccccc-ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          155 FGLARIFGSPDR-RFTHQ-VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       155 FG~a~~~~~~~~-~~~~~-~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      ||+|+..-..+. ..... .-..-|||||.+.. ..++.++|||||||+|||+++ |..||.+.++.+++.-....-...
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD  924 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence            999995432221 11111 11234999999986 679999999999999999998 889999999998887666654333


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .|..+                           ++.+.+++..||+.+|++||+...|++
T Consensus       925 ~P~~C---------------------------P~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYC---------------------------PEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCC---------------------------ChHHHHHHHHHccCChhhCccHHHHHh
Confidence            33333                           567889999999999999999999998

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=294.70  Aligned_cols=263  Identities=21%  Similarity=0.337  Sum_probs=207.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHH-HhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL-KELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++.+-+..||.|+||+|++..++.+|+..|||.|+..... ....+++.|.+.. +.-++||||++|++.-.++..||
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            355666678899999999999999999999999999876552 2233456677654 44578999999999889999999


Q ss_pred             EeecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           89 VFEFMETDLETVIRN----TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        89 v~e~~~g~L~~~i~~----~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .||.|.-++..+.+.    .+..++|+.+-.+...++.||+||... .|||||+||+|||++..|.+||||||++-.+..
T Consensus       141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            999999877666543    244589999999999999999999864 699999999999999999999999999876533


Q ss_pred             CCCcccccccccceeCcccccCCc-CCCCcccHHHHHHHHHHHHcCCCCCCCCC-cHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                       +..-+...|.+.|||||.+.... .|+.++|+||||++|||+.||.-|+.+-+ ..+++..+..+   -+|.-..+   
T Consensus       221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g---dpp~l~~~---  293 (361)
T KOG1006|consen  221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG---DPPILLFD---  293 (361)
T ss_pred             -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC---CCCeecCc---
Confidence             23345677888899999996533 49999999999999999999998877643 33444443322   11111111   


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                      ...-..|..+..||..||.+|-+.||...+++++||+..
T Consensus       294 ----------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  294 ----------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             ----------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence                            111135889999999999999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-39  Score=325.43  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=210.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..+.+..+.||+|+||+||+|+-..     ....||||.++.... ......+.||+.++..|+|||||+|++.+..++.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            4456778999999999999996443     335799998864322 2244578899999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCC-------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEE
Q 014985           86 LHLVFEFME-TDLETVIRNTNI-------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~-------------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      +|+|||||. |||..+++....             .++..+...|+.||+.|+.||-++.+|||||-..|+||.++-.||
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence            999999999 999999976432             278889999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCCC-Cccc-ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHh
Q 014985          152 LADFGLARIFGSPD-RRFT-HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF  228 (415)
Q Consensus       152 L~DFG~a~~~~~~~-~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  228 (415)
                      |+|||+++..-+.+ .+.. +..-...|||||.+.. ..|++++||||+||+|||+++ |.-|+.+.++.+.++.|.++-
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~  722 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ  722 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence            99999998753322 2222 2333456999999976 569999999999999999996 889999999999999997764


Q ss_pred             CCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      -...|+.+                           +.++.+|+..||+.+|++||+..||-.
T Consensus       723 lL~~Pe~C---------------------------P~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  723 LLSCPENC---------------------------PTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             cccCCCCC---------------------------CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            44444433                           678999999999999999999999743

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-37  Score=305.83  Aligned_cols=267  Identities=25%  Similarity=0.399  Sum_probs=186.4

Q ss_pred             cccEeeeeeecccCceEEEEEEEC----------------CCCcEEEEEEeecCCccC------------CccchHHHHH
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT----------------KTGQTVAIKKIRLGKQKE------------GVNFTALREI   62 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~----------------~~~~~~avK~i~~~~~~~------------~~~~~~~~E~   62 (415)
                      .++|.+.++||+|+||+||+|.+.                ..++.||||.+.......            ........|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            679999999999999999999642                345689999986533211            1122334577


Q ss_pred             HHHHhcCCCCe-----eeEEeeeec--------CCeEEEEeeccc-CCHHHHHHhcC-----------------------
Q 014985           63 KLLKELKSPHI-----IELIDAFPH--------KGNLHLVFEFME-TDLETVIRNTN-----------------------  105 (415)
Q Consensus        63 ~il~~l~hp~I-----v~l~~~~~~--------~~~~~lv~e~~~-g~L~~~i~~~~-----------------------  105 (415)
                      .++.+++|.++     ++++++|..        .+..|+||||++ |+|.+++....                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            88888877654     566776643        356899999999 57777765321                       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-cccccccccceeCccccc
Q 014985          106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRAPELLF  184 (415)
Q Consensus       106 ~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~t~~y~aPE~l~  184 (415)
                      ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ ......+++.|+|||++.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            1235677889999999999999999999999999999999999999999999976533221 112233478899999985


Q ss_pred             CCcC-------------------CC--CcccHHHHHHHHHHHHcCCC-CCCCCCcHHH----HHHHHHHhCCCCCCCCCC
Q 014985          185 GAKQ-------------------YG--AGVDVWAAGCIFAELLNRRP-FLQGSSDIDQ----LGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       185 ~~~~-------------------~~--~~~DiwSlG~il~ell~g~~-pf~~~~~~~~----~~~i~~~~~~~~~~~~~~  238 (415)
                      ....                   |+  .+.||||+|||+|+|++|.. +|.+......    .......        |..
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--------~r~  455 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--------WRM  455 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--------HHh
Confidence            4211                   12  24799999999999999874 6643211111    0000000        000


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDP---KARITAQQALEHRYFSS  296 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rpt~~e~l~h~~~~~  296 (415)
                               +  .....--..+...++.++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       456 ---------~--~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 ---------Y--KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ---------h--cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                     0  00000011244568999999999999876   68999999999999953

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.9e-38  Score=293.53  Aligned_cols=281  Identities=32%  Similarity=0.540  Sum_probs=218.5

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECC---CCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      ..+.+.|.++++||.|+|++||++.+..   .++.||+|.+.......    .+.+|+.+|..+ .+.||+++.+++..+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~----ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS----RILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch----HHHHHHHHHHHhccchhhhcchhhhccC
Confidence            4578899999999999999999998877   78899999987654433    477899999999 479999999999999


Q ss_pred             CeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceec
Q 014985           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIF  161 (415)
Q Consensus        84 ~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~  161 (415)
                      +++.+|+||++. .-.+++..    ++...++.|++.++.||.++|.+|||||||||.|+|.+. .++-.|+|||+|...
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence            999999999996 55555543    778999999999999999999999999999999999985 477899999999621


Q ss_pred             C----------------CC-----------------C-----------CcccccccccceeCcccccCCcCCCCcccHHH
Q 014985          162 G----------------SP-----------------D-----------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWA  197 (415)
Q Consensus       162 ~----------------~~-----------------~-----------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwS  197 (415)
                      .                .+                 .           .......||++|+|||++..+..-+.++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            0                00                 0           01223458999999999998888899999999


Q ss_pred             HHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCC---CC------C---CCccc-hhcccccCCC--------
Q 014985          198 AGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWP---DL------A---YLPDY-VEYQYVAAPP--------  255 (415)
Q Consensus       198 lG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~---~~------~---~~~~~-~~~~~~~~~~--------  255 (415)
                      .|||+..++++. |+|...++.+.+..|...+|...-+...   +.      .   ..++. ..|.......        
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            999999999976 7788888999999988888863322111   11      0   00000 0111110000        


Q ss_pred             -c-cccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          256 -L-RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       256 -~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                       . +......+..+.||+.+||..||.+|+|++++|.||||..
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence             1 1111234568999999999999999999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-36  Score=277.15  Aligned_cols=243  Identities=40%  Similarity=0.628  Sum_probs=199.0

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccC-CHHHHHH
Q 014985           24 TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR  102 (415)
Q Consensus        24 ~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g-~L~~~i~  102 (415)
                      +||.||+|.+..+|+.+|+|++........ ...+.+|+..++.++|+||+++++.+......++++||+++ +|..++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999998999999999875543321 34677899999999999999999999999999999999996 8888877


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCccc
Q 014985          103 NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL  182 (415)
Q Consensus       103 ~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~  182 (415)
                      .... ++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus        80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       80 KRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             hccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            6544 8999999999999999999999999999999999999999999999999998765432 3445667778999999


Q ss_pred             ccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCC
Q 014985          183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS  262 (415)
Q Consensus       183 l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (415)
                      +.+ ..++.++||||||+++|+|++|..||....+.+........   .....                     ......
T Consensus       158 ~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~~~~~---------------------~~~~~~  212 (244)
T smart00220      158 LLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---PKPPF---------------------PPPEWK  212 (244)
T ss_pred             Hcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---cCCCC---------------------cccccc
Confidence            875 45788999999999999999999999774443333332221   10000                     000111


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          263 ASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       263 ~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ++.++.+++.+||..+|++||++.++++||||
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            47889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=296.50  Aligned_cols=257  Identities=25%  Similarity=0.312  Sum_probs=209.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+...++++||+|-||.|.+|.-. .+..||+|.++....... ...+.+|+++|.+|+||||++++++|..++.+++|+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~-r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNA-RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhH-HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            566788999999999999999643 368999999886654433 336789999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--
Q 014985           91 EFME-TDLETVIRNTNIFL-SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l-~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--  166 (415)
                      ||++ |+|.+++.....+. .-.....++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+-..+.  
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999 89999998774433 4455667999999999999999999999999999999999999999999996533332  


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHH--cCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      -....+....|||+|.+.. ..+++++|+|+||+++||++  +...||...++.+..+..-..+.......++       
T Consensus       695 vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l-------  766 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL-------  766 (807)
T ss_pred             eecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec-------
Confidence            1223344566999999876 45899999999999999986  5678898888888887776665544333221       


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                   ...+..+..+.+|+.+|+..|-++||+.+++..
T Consensus       767 -------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  767 -------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                         223345788999999999999999999999865

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=298.31  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             ccEeeeeeecccCceEEEEEEECC--CCc--EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTK--TGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~--~~~--~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +...+.++||.|.||.||.|....  .|+  .||||+-+.....+ ..+.++.|..+|+.++|||||++++.+.+ ...|
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            344566789999999999996432  333  58899876654433 36689999999999999999999999954 5789


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||||.+. |.|..++......++......|+.||+.||.|||++++|||||-..|||+.+..-|||+|||+++.+.+...
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            9999999 999999999888899999999999999999999999999999999999999998899999999998755432


Q ss_pred             ccccccc--ccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~~~~~--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ....|  ..-|||||.+.- ..++.++|||.|||.+||++. |..||.+-.+.+.+..|-++-..+            
T Consensus       547 Y-kaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------------  612 (974)
T KOG4257|consen  547 Y-KASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------------  612 (974)
T ss_pred             h-hccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------------
Confidence            2 22222  334999999853 668999999999999999875 999999988888777665543322            


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l  289 (415)
                                     ..|..++.+..|+.+||.++|.+||...++.
T Consensus       613 ---------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  613 ---------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ---------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                           2345578899999999999999999877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=308.50  Aligned_cols=262  Identities=26%  Similarity=0.365  Sum_probs=221.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      =.++|+++..+|+|+||.||+++|+.+++..|+|+++......  ...+.+|+-+++.++|||||.+++.|.....+|++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            3789999999999999999999999999999999998754332  22355799999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||||+|+.++.+....+.+++.++..+++..++||+|||++|-+|||||-.|||+++.|.+|++|||.+..++..-.+..
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99999877777777778899999999999999999999999999999999999999999999999999988877777788


Q ss_pred             ccccccceeCcccc--cCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          170 HQVFARWYRAPELL--FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       170 ~~~~t~~y~aPE~l--~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .++||++|||||+.  .....|...+|||++|+...|+-.-+||.........+..+-+..-.  +..            
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q--pp~------------  236 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ--PPT------------  236 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC--CCc------------
Confidence            89999999999996  23356999999999999999999888775555444444443222111  100            


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                               ..--...++.+.+|++.+|..+|++||+++.+|.|||.+.
T Consensus       237 ---------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  237 ---------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ---------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                     1111233788999999999999999999999999999865

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=295.07  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=209.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+....++||.|.||.||.+.+++..-.||||.++-..   -..++++.|+.+|+.++|||+|+|+++|..+..+|||.
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            445677899999999999999999999999999875332   22346889999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTNIF-LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~-l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||. |+|+++++.++.. ++.-...+++.||..|+.||..+++|||||-..|.|+.++..||++|||+++++....  +
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--Y  420 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--Y  420 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--e
Confidence            9998 9999999998754 5556667888899999999999999999999999999999999999999999874332  2


Q ss_pred             ccccc---ccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          169 THQVF---ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       169 ~~~~~---t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      +.-.|   ..-|.|||.|.- ..++.++|||+|||+|||+.| |-.|+.|-+-...+..+-+.+....|+.+        
T Consensus       421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC--------  491 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC--------  491 (1157)
T ss_pred             ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC--------
Confidence            22233   334999999854 568899999999999999987 88999998888877777666655555444        


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         ++.+..|+..||+++|.+||+.+++-+
T Consensus       492 -------------------PpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  492 -------------------PPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             -------------------CHHHHHHHHHHhcCCcccCccHHHHHH
Confidence                               678999999999999999999887643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=304.06  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=219.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ....+.++||.|.||.|++++-+..|+   .||||.++.. ..+.....++.|+.||-+++||||++|.++......+.|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            345788999999999999999887664   6999998755 344555678899999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-C
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-R  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~  166 (415)
                      |.|||+ |.|..++++..+.++.-+...+++.|+.|++||-++|+|||||-..||||+.+-.+|++|||+++.+.+.. .
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            999999 89999999999999999999999999999999999999999999999999999999999999999874444 3


Q ss_pred             ccccccc--ccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFTHQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~~~~~--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .+++.-|  ...|.|||.+.. ..++.++||||+|+++||.++ |..|+-.-++.+.+..|..++..++|-.+       
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC-------  859 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC-------  859 (996)
T ss_pred             cccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC-------
Confidence            3333333  245999999976 558999999999999999874 88888889999999999988777766554       


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                          +..+.+|+..||++|-.+||...||+.+
T Consensus       860 --------------------P~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  860 --------------------PAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             --------------------cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                5789999999999999999999999873

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=295.75  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=208.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-CCc--EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-TGQ--TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .+...+.++||+|.||.|++|.++. +|+  .||||.++...... ....+++|+.+|.+|+|+|+++||+...+ ....
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            5567788999999999999997765 344  68999998665443 34468899999999999999999999876 6788


Q ss_pred             EEeeccc-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           88 LVFEFME-TDLETVIRN-TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~-~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      +|||++. |+|++.+++ ....|-......|+.||++|+.||.++++|||||-..|||+-....|||||||+.+-++...
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999 899999988 45568888999999999999999999999999999999999999999999999999887655


Q ss_pred             Ccccc---cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 RRFTH---QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..+..   .-....|+|||.|.. ..++.++|+|++||++|||++ |..||.|-...+++.+|-+.-....+        
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP--------  337 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP--------  337 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCC--------
Confidence            44321   111235999999977 568999999999999999997 78999999999998887543222222        


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         +..+.++.+++..||..+|.+|||...|.+
T Consensus       338 -------------------k~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  338 -------------------KYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -------------------CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence                               234889999999999999999999988753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=304.01  Aligned_cols=248  Identities=29%  Similarity=0.420  Sum_probs=192.2

Q ss_pred             eeeeeecccCce-EEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEEeec
Q 014985           15 LKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        15 ~~~~~LG~G~~g-~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      .-.+.+|.|+-| .||+|  ...|+.||||.+....     ...+.+|+..|... .|||||++|+.-++..+.||..|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G--~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRG--VYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             ccHHHcccCCCCcEEEEE--eeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            345678888775 57888  5678999999875332     22567899999987 699999999999999999999999


Q ss_pred             ccCCHHHHHHhcCC--C-CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---C--CcEEEeeeccceecCCC
Q 014985           93 METDLETVIRNTNI--F-LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---H--GQLKLADFGLARIFGSP  164 (415)
Q Consensus        93 ~~g~L~~~i~~~~~--~-l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~--~~vkL~DFG~a~~~~~~  164 (415)
                      |..+|.+++.....  . ...-..+.++.|+++||++||+.+||||||||.||||+.   +  .+++|+|||+++.+...
T Consensus       585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            99999999987411  1 111446789999999999999999999999999999986   3  46999999999987654


Q ss_pred             CCc---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          165 DRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       165 ~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...   .....||-+|+|||++.... -+.++|||||||++|+.++| ..||..+-.  .-.+|..+..        .  
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~--------~--  731 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNY--------T--  731 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCcc--------c--
Confidence            433   44567889999999997744 46799999999999999886 788865432  2223322100        0  


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                     +-.+.+....++.|||.+||..+|..||+|.++|.||||...
T Consensus       732 ---------------L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  732 ---------------LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ---------------eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence                           011111112289999999999999999999999999999753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=321.36  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=187.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ...|...++||+|+||.||+|.+..++..||+|.+.....      ....|++++++++|||||++++++.+....|+||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3557778899999999999999999999999998864321      1235789999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH---KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH---~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||++ |+|.+++..    +++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.+.....   
T Consensus       763 Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---  834 (968)
T ss_pred             eCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence            9998 578777753    789999999999999999999   6799999999999999998888775 666543321   


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHH-HhCCCCCCCCCCCCCCcc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFA-AFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~~~~~~~~~  244 (415)
                       .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..... .........|.+      
T Consensus       835 -~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  906 (968)
T PLN00113        835 -DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID------  906 (968)
T ss_pred             -CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC------
Confidence             123367888999999876 56899999999999999999999998543211 11111111 000000000100      


Q ss_pred             chhcccccCCCccc---cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          245 YVEYQYVAAPPLRS---LFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       245 ~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                               +.+..   ..+....++.+++.+||+.||++|||+.|+++.
T Consensus       907 ---------~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        907 ---------PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ---------ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                     00000   001112457889999999999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-36  Score=252.16  Aligned_cols=215  Identities=27%  Similarity=0.434  Sum_probs=176.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .+.......||+|+||.|-+.++..+|...|+|.++.... .....+.++|+++..+. .+|++|.+|+.+...+.+|+.
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            3455567789999999999999999999999999876543 22233456788876654 689999999999999999999


Q ss_pred             eecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           90 FEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        90 ~e~~~g~L~~~i~---~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ||.+..+|..+.+   +.+..++|..+-.++..++.||.|||++ .++|||+||+||||+.+|++|+||||++-.+.+.-
T Consensus       124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            9999988776654   4577799999999999999999999987 69999999999999999999999999998764322


Q ss_pred             CcccccccccceeCcccccC---CcCCCCcccHHHHHHHHHHHHcCCCCCCC-CCcHHHHHHHHHH
Q 014985          166 RRFTHQVFARWYRAPELLFG---AKQYGAGVDVWAAGCIFAELLNRRPFLQG-SSDIDQLGKIFAA  227 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~  227 (415)
                       .-+...|...|||||.+..   ...|+-++||||||++++||.+++.|+.. .+..+++.++.+.
T Consensus       204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence             2233566677999999843   34799999999999999999999977654 4667777777653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=286.15  Aligned_cols=200  Identities=29%  Similarity=0.378  Sum_probs=176.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc------cchHHHHHHHHHhcC---CCCeeeEEeeee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------NFTALREIKLLKELK---SPHIIELIDAFP   81 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~------~~~~~~E~~il~~l~---hp~Iv~l~~~~~   81 (415)
                      ...|.....||.|+||.|++|.++.+...|+||.|.+.+.-...      --.+-.||+||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            34599999999999999999999999999999999877632221      122346999999997   999999999999


Q ss_pred             cCCeEEEEeeccc-C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           82 HKGNLHLVFEFME-T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      +++++||+||-.+ | +|.++|..+ ..++|.+++.|++|++.|+++||+.||||||||-+|++++.+|-+||+|||.|.
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence            9999999999988 5 888888754 459999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQ  213 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~  213 (415)
                      ...  +..+...+||..|.|||++.|.++.+..-|||+||++||.++....||.
T Consensus       719 ~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            753  4456788999999999999998888899999999999999998876653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-36  Score=261.68  Aligned_cols=258  Identities=27%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEe-eeecCCeE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELID-AFPHKGNL   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~-~~~~~~~~   86 (415)
                      .+.|.|.+.+.||+|.||.+-+|+|+.++..+++|.+......   ...+.+|..---.|. |.||+..|+ .|+..+.+
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            3689999999999999999999999999999999998754332   234566776555554 799998887 58999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec--CCcEEEeeeccceecCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGS  163 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~--~~~vkL~DFG~a~~~~~  163 (415)
                      .+++||++ |+|...+...+  +.|...+.++.|++.|+.|||++++||||||.+||||-.  ..+|||||||..+..+.
T Consensus        98 vF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             EEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999999 89998887644  889999999999999999999999999999999999964  35899999999987654


Q ss_pred             CCCcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH-HHHHHHHHhCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-QLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  238 (415)
                      .-.... .  +-.|.+||++..    .-.....+|+|.||+|+|.++||.+||......+ -+.+.              
T Consensus       176 tV~~~~-~--~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~--------------  238 (378)
T KOG1345|consen  176 TVKYLE-Y--VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW--------------  238 (378)
T ss_pred             eehhhh-h--hcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH--------------
Confidence            332211 1  223999998743    2235678999999999999999999997543221 12222              


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR---ITAQQALEHRYFS  295 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~e~l~h~~~~  295 (415)
                             ..+.....+.++..|..+|+.+..+.++-|..++++|   .++..-....|..
T Consensus       239 -------~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  239 -------EQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             -------HHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence                   2233334445566777789999999999999999999   5555555566643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=288.14  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=201.4

Q ss_pred             ccEeeeeeecccCceEEEEEEEC---C----CCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDT---K----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~---~----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      ++..+.+.||+|.||.|++|.-.   .    ....||||.+...... .....+..|+++|+.+ .|+||+.+++++...
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            33456679999999999999632   1    1357999988765544 4455788999999998 599999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~  147 (415)
                      +.+++|+|||. |+|+.+++...               ..++......+..||+.|++||+++.+|||||-..||||..+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence            99999999999 89999998876               348889999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccceecCCCCCcc-ccccc--ccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCC-cHHHHH
Q 014985          148 GQLKLADFGLARIFGSPDRRF-THQVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSS-DIDQLG  222 (415)
Q Consensus       148 ~~vkL~DFG~a~~~~~~~~~~-~~~~~--t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~-~~~~~~  222 (415)
                      ..+||+|||+|+......... ....+  ...|||||.+.. ..|+.++||||+||+|||+++ |..|+.+-. ..+.+.
T Consensus       455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            999999999999653332211 22222  223999999987 679999999999999999997 789998754 444444


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .+..+.....|                           ...++++.+++..|++.+|++||+..++.+
T Consensus       534 ~l~~G~r~~~P---------------------------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 FLKEGNRMEQP---------------------------EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHhcCCCCCCC---------------------------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            44433222222                           133789999999999999999999999876

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-34  Score=281.29  Aligned_cols=247  Identities=24%  Similarity=0.341  Sum_probs=206.3

Q ss_pred             EeeeeeecccCceEEEEEEECCCCc----EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .+..++||+|+||+||++.+.-.|+    .||+|++..... .....++++|+-+|.++.|||+++|++++..+. +.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            4567899999999999998766565    578888765432 333457889999999999999999999998766 8899


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ++|++ |.|+++++.....+.......|..||++|+.|||.+++|||||-..||||.+-.++||+|||+|+........+
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999 89999999988889999999999999999999999999999999999999999999999999999987777666


Q ss_pred             cccccc--cceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          169 THQVFA--RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       169 ~~~~~t--~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ....|.  .-|||-|.+.. ..|+.++||||+||++||++| |..|+.+....++-..+..+...               
T Consensus       856 ~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL---------------  919 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL---------------  919 (1177)
T ss_pred             cccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC---------------
Confidence            665553  34888888866 569999999999999999987 88898887766655444332111               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  .-.|..+-++..++.+||..|+..||+++++-.
T Consensus       920 ------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  920 ------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ------------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                        223455789999999999999999999988754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=266.18  Aligned_cols=193  Identities=28%  Similarity=0.375  Sum_probs=159.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHH--hcCCCCeeeEEeeeecCC----
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK--ELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~--~l~hp~Iv~l~~~~~~~~----   84 (415)
                      .+...+.++||+|.||.||+|  .-+++.||||++....     ...+.+|-+|.+  .++|+||++++++-+...    
T Consensus       209 l~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CCchhhHHHhhcCccceeehh--hccCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            445677899999999999999  5677999999986433     223445555554  568999999998876555    


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---------CCccccCCCCCcEEEecCCcEEEee
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK---------KWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~---------~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                      .++||++|.+ |+|-+++...-  +++.....++..++.||+|||+         ..|+|||||..||||..|+++.|+|
T Consensus       282 eywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            7999999999 88888887654  8999999999999999999994         3499999999999999999999999


Q ss_pred             eccceecCC--CCCcccccccccceeCcccccCCcCCC-----CcccHHHHHHHHHHHHcCCCCC
Q 014985          155 FGLARIFGS--PDRRFTHQVFARWYRAPELLFGAKQYG-----AGVDVWAAGCIFAELLNRRPFL  212 (415)
Q Consensus       155 FG~a~~~~~--~~~~~~~~~~t~~y~aPE~l~~~~~~~-----~~~DiwSlG~il~ell~g~~pf  212 (415)
                      ||+|..+..  +.......+||..|||||+|.+.....     .+.||||+|.+||||+++...+
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            999988742  334455689999999999998765544     4689999999999999876554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.8e-32  Score=242.14  Aligned_cols=213  Identities=39%  Similarity=0.649  Sum_probs=184.3

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCHH
Q 014985           20 LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLE   98 (415)
Q Consensus        20 LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L~   98 (415)
                      ||+|.+|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......++++||+. ++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999998889999999987554321 23457789999999999999999999999999999999999 6888


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceecCCCCCcccccccccce
Q 014985           99 TVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQVFARWY  177 (415)
Q Consensus        99 ~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y  177 (415)
                      .++......++...++.++.+++.+|.+||++|++|+||+|.||+++. +++++|+|||.+..............+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            887765456899999999999999999999999999999999999999 8999999999998765543223445566779


Q ss_pred             eCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcc
Q 014985          178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR  257 (415)
Q Consensus       178 ~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (415)
                      ++||.+.....++.++|+|++|+++++|                                                    
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------------  187 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------------  187 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------------
Confidence            9999987643678899999999999999                                                    


Q ss_pred             ccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014985          258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (415)
Q Consensus       258 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~  292 (415)
                             ..+.+++..||..||++||++.++++|+
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   1378899999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-32  Score=254.06  Aligned_cols=189  Identities=25%  Similarity=0.383  Sum_probs=155.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHH--hcCCCCeeeEEeeeecC---
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK--ELKSPHIIELIDAFPHK---   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~--~l~hp~Iv~l~~~~~~~---   83 (415)
                      .+..+.++++.||+|.||.||+|  ...|..||||++.....     ...++|.+|..  .|+|+||+.++..-..+   
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeec--cccCCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            46788999999999999999999  56689999999864322     13345555554  56999999998765332   


Q ss_pred             -CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-----CC---ccccCCCCCcEEEecCCcEEEe
Q 014985           84 -GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-----KW---VLHRDMKPNNLLIGSHGQLKLA  153 (415)
Q Consensus        84 -~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-----~~---ivHrDlkp~NILi~~~~~vkL~  153 (415)
                       .++|||.+|.+ |+|.+++...  .++.+....++..++.||++||.     +|   |.|||||..||||..+|.+-|+
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence             27999999999 8999999874  38999999999999999999993     23   9999999999999999999999


Q ss_pred             eeccceecCCCC----CcccccccccceeCcccccCCcCC-----CCcccHHHHHHHHHHHH
Q 014985          154 DFGLARIFGSPD----RRFTHQVFARWYRAPELLFGAKQY-----GAGVDVWAAGCIFAELL  206 (415)
Q Consensus       154 DFG~a~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~-----~~~~DiwSlG~il~ell  206 (415)
                      |+|+|....+..    ......+||..|||||+|....+.     -..+||||||.++||++
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            999998765442    345678999999999999653321     24689999999999997

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=4.3e-33  Score=297.22  Aligned_cols=202  Identities=14%  Similarity=0.204  Sum_probs=149.6

Q ss_pred             HHhcCC-CCeeeEEeee-------ecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 014985           65 LKELKS-PHIIELIDAF-------PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD  136 (415)
Q Consensus        65 l~~l~h-p~Iv~l~~~~-------~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrD  136 (415)
                      .+.++| .||++++++|       .+...++++|||++++|..++......+++..++.+++||+.||+|||++||+|||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            344556 6888888888       23346788899999999999987666799999999999999999999999999999


Q ss_pred             CCCCcEEEecCCc-------------------EEEeeeccceecCCCC----------------CcccccccccceeCcc
Q 014985          137 MKPNNLLIGSHGQ-------------------LKLADFGLARIFGSPD----------------RRFTHQVFARWYRAPE  181 (415)
Q Consensus       137 lkp~NILi~~~~~-------------------vkL~DFG~a~~~~~~~----------------~~~~~~~~t~~y~aPE  181 (415)
                      |||+||||+..|.                   +||+|||+++......                ......+||++|||||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            9999999965444                   5555666554321100                0011246789999999


Q ss_pred             cccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCC
Q 014985          182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP  261 (415)
Q Consensus       182 ~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (415)
                      ++.+ ..|+.++|||||||+||||++|.+++....  .....+....   .+..                        ..
T Consensus       186 ~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~---~~~~------------------------~~  235 (793)
T PLN00181        186 EDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV---LPPQ------------------------IL  235 (793)
T ss_pred             hhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh---cChh------------------------hh
Confidence            9977 568999999999999999999988765321  1222221110   0000                        00


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          262 SASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       262 ~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      .......+++.+||..||.+||++.|+++||||..
T Consensus       236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        236 LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            11355778999999999999999999999999975

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=5e-31  Score=238.55  Aligned_cols=210  Identities=37%  Similarity=0.563  Sum_probs=176.2

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++++......++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            56789999999999999999988999999998765433 12345678999999999999999999999989999999999


Q ss_pred             cC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Cccccc
Q 014985           94 ET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQ  171 (415)
Q Consensus        94 ~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~~~~~  171 (415)
                      .+ +|.+.+......+++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            96 8888887654437899999999999999999999999999999999999999999999999998765432 122345


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCC-CCcH-HHHHHH
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-SSDI-DQLGKI  224 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~-~~~~~i  224 (415)
                      .++..|++||.+.+...++.++|+||||+++|+|++|++||.. .++. .....+
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~  214 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW  214 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence            6677799999984335677899999999999999999999977 3443 444444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.1e-29  Score=221.92  Aligned_cols=166  Identities=21%  Similarity=0.274  Sum_probs=130.2

Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           95 TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        95 g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      |+|.+++.+.+..+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||++.......     ..||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            6888888876777999999999999999999999998      999999999999999  99998764422     2678


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      +.|+|||++.+ ..|+.++|||||||++|||++|.+||...... ..+..+........+..                  
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------  128 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------------  128 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------------
Confidence            89999999977 56899999999999999999999998765432 23333332211110000                  


Q ss_pred             CCccccCCCCCH--HHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          254 PPLRSLFPSASD--DALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       254 ~~~~~~~~~~s~--~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                         +.....++.  .+.+||.+||..||.+||++.++++|+|+.
T Consensus       129 ---~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 ---RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ---cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence               000011233  699999999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-30  Score=265.21  Aligned_cols=271  Identities=26%  Similarity=0.366  Sum_probs=206.3

Q ss_pred             cccE-eeeeeecccCceEEEEEEECCCCcEEEEEEeecC----CccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG----KQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .+.| ....++|.|++|.|+.+......+.++.|..+..    .........+..|+-+-..+.|||++..+..+.+...
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence            4556 5688899999999999988877777777766521    1111112224567778888899999988887776665


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      .+-+||||++||..++... .+++..++..++.||+.||+|+|++||.||||||+|+++..+|.+||+|||.+..+..+.
T Consensus       396 ~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             chhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            5556999999888777764 458999999999999999999999999999999999999999999999999998775444


Q ss_pred             C----cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 R----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .    .....+|+..|+|||++.+.......+||||.|++++.|++|+-||.-....+....-      .....+     
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~-----  543 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQ-----  543 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hccccc-----
Confidence            3    3456788889999999988655566789999999999999999888765433222100      000000     


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                              .........+...++...+.+|.+||+.||.+|.|+++|++.+||.....+.
T Consensus       544 --------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~  595 (601)
T KOG0590|consen  544 --------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH  595 (601)
T ss_pred             --------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence                    0011112233345678899999999999999999999999999998765443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=7.5e-29  Score=228.25  Aligned_cols=251  Identities=18%  Similarity=0.237  Sum_probs=195.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC-----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee-ecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~   84 (415)
                      .+|+++..++-+|+||.||.|++....     +.+-+|.+...... -....++.|--++..+.|||+..+.+.. ++..
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~-iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ-IQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH-HHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            678899999999999999999655322     34555655433222 1222456788888888999999998875 4556


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeec
Q 014985           85 NLHLVFEFME-TDLETVIRNTNI-------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~-------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG  156 (415)
                      ..+.++.+.+ |+|..++..+.+       .++-.+...++.|++.|++|||+.|+||.||-..|.+|++.-++||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            7888899998 899999884321       25666778899999999999999999999999999999999999999999


Q ss_pred             cceecCCCCCcccc--cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          157 LARIFGSPDRRFTH--QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       157 ~a~~~~~~~~~~~~--~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      +++.+...+...-.  .....-|||||.+.+ ..|+.++|+|||||++|||+| |+.|+..-+..+...-+..+.....|
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence            99876444322111  111234999999987 679999999999999999997 88999888877777666665444444


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      -++                           ++++..++.-||..+|++||+.+|+..
T Consensus       521 ~NC---------------------------PDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  521 FNC---------------------------PDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCC---------------------------cHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            333                           678999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=9.1e-27  Score=221.05  Aligned_cols=262  Identities=33%  Similarity=0.504  Sum_probs=206.8

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCC-CeeeEEeeeecCCeEEEEee
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSP-HIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      |.+...||.|+||.||++.+.   ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999887   8899999876655443 455678899999999988 79999999988888899999


Q ss_pred             cccC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeeccceecCCCCC-
Q 014985           92 FMET-DLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~~~-  166 (415)
                      ++.| ++...+....  ..+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+........ 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9995 5664554433  2699999999999999999999999999999999999999988 799999999986644432 


Q ss_pred             -----cccccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---HHHHHHHHHHhCCC-CCCC
Q 014985          167 -----RFTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTA-TPSQ  235 (415)
Q Consensus       167 -----~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~~  235 (415)
                           .....+++..|+|||.+.+.  ..+....|+||+|++++++++|..||.....   .......+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 34677899999999999774  4688899999999999999999988887764   33333333332221 0000


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ...                   .........+.+++..++..+|..|.+..+...++|....
T Consensus       239 ~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSP-------------------SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCc-------------------cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            000                   0001223578999999999999999999999988665543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=244.76  Aligned_cols=247  Identities=27%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             eecccCceEEEEEEE---CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEEEeeccc
Q 014985           19 VLGEGTYGVVYKAID---TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~---~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      ++|.|+||.|++++.   ...|..||+|+..+.............|..++..++ ||++|+++.+|+.++..|++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999999852   235678999998876654444444456888999887 9999999999999999999999999


Q ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccc
Q 014985           95 T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF  173 (415)
Q Consensus        95 g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~  173 (415)
                      | ++...+. ....+.+..++.+...++-+++++|+.||+|||+|++||+++.+|++++.|||+.+..-.....    ||
T Consensus        81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cg  155 (612)
T KOG0603|consen   81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CG  155 (612)
T ss_pred             cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----cc
Confidence            6 5555444 4445788899999999999999999999999999999999999999999999999876443322    89


Q ss_pred             ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       174 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      |..|||||++.+   ...++|+||+|++.|+|++|..||.+    ++..+|...--                        
T Consensus       156 t~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~------------------------  204 (612)
T KOG0603|consen  156 TYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL------------------------  204 (612)
T ss_pred             chhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc------------------------
Confidence            999999999973   67889999999999999999999987    56666654211                        


Q ss_pred             CCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCCCCCC
Q 014985          254 PPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLPTEPNK  305 (415)
Q Consensus       254 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~~~~~~  305 (415)
                          .....++..+.+++..++..+|.+|..     +.++++|+||+...|......
T Consensus       205 ----~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r  257 (612)
T KOG0603|consen  205 ----EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEAR  257 (612)
T ss_pred             ----CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhc
Confidence                112245789999999999999999975     589999999999887644333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=4.1e-28  Score=232.66  Aligned_cols=167  Identities=23%  Similarity=0.332  Sum_probs=129.7

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECC-CCcEEEEEEeecCCc---cCCccchHHHHHHHHHhcCCCCeee-EEeeeec
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHIIE-LIDAFPH   82 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~-l~~~~~~   82 (415)
                      ..+.++|.+.+.||+|+||+||+|.+.. ++..+|||++.....   .......+.+|+.+|++++|+||+. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4578999999999999999999998876 677889998753311   1112334779999999999999985 5432   


Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC-CCCcEEEecCCcEEEeeeccceec
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM-KPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDl-kp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                       +..|+|||||+|..+..+..    ..   ...++.|++.||.|||++||+|||| ||+|||++.++++||+|||+|+.+
T Consensus        91 -~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             45799999999754443221    11   1468899999999999999999999 999999999999999999999976


Q ss_pred             CCCCC--------cccccccccceeCcccccC
Q 014985          162 GSPDR--------RFTHQVFARWYRAPELLFG  185 (415)
Q Consensus       162 ~~~~~--------~~~~~~~t~~y~aPE~l~~  185 (415)
                      .....        ..++.++++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            44331        1235567778999999843

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2e-26  Score=220.76  Aligned_cols=253  Identities=22%  Similarity=0.231  Sum_probs=196.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCC-cEEEEEEeecCCccCCccchHHHHHHHHHhcCC----CCeeeEEeee-ecCCeE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS----PHIIELIDAF-PHKGNL   86 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~-~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h----p~Iv~l~~~~-~~~~~~   86 (415)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|+..........  .+..|+.++..+..    +++..+++.+ ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            8999999999999999999988775 67899987654332211  45679999999873    6999999999 578899


Q ss_pred             EEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-----CcEEEeeeccce-
Q 014985           87 HLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-----GQLKLADFGLAR-  159 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-----~~vkL~DFG~a~-  159 (415)
                      |+||+.++.+|.++..... ..++...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+|+ 
T Consensus        97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            9999999999999886554 779999999999999999999999999999999999999865     359999999998 


Q ss_pred             -ecCCCC-------Cc-ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCC
Q 014985          160 -IFGSPD-------RR-FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT  230 (415)
Q Consensus       160 -~~~~~~-------~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  230 (415)
                       .+....       +. .....||..|.++.+..+ ...+.+.|+||++.++.+|+.|..||.+.........+......
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence             331111       11 223458999999999877 55799999999999999999999999877654443333222111


Q ss_pred             CCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .....                       .....+..+.++...+-..+...+|....+...
T Consensus       256 ~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            10000                       112234677777777777899999988776553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-26  Score=210.13  Aligned_cols=212  Identities=22%  Similarity=0.308  Sum_probs=181.6

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~   86 (415)
                      -.+.-.|++.++||.|+||..|.+.+..++..||||.-.......    .+..|....+.|. .++|..+|.+.+.+-+-
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            467889999999999999999999999999999999765433222    4567888888885 59999999888888888


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-----cEEEeeeccceec
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----QLKLADFGLARIF  161 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-----~vkL~DFG~a~~~  161 (415)
                      .||+|+++.+|.+++.-++..++...+..++.|++.-++|+|++.+|+|||||+|+||...+     .+.|+|||+|+.+
T Consensus       100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            99999999999999999999999999999999999999999999999999999999998654     4999999999987


Q ss_pred             CCCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHH
Q 014985          162 GSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---DIDQLGKI  224 (415)
Q Consensus       162 ~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i  224 (415)
                      .++.+       ......||..||+=-..+| ..-+.+-|+-|||.+|++.|-|..||.|..   ..+.+++|
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI  251 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI  251 (449)
T ss_pred             cCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence            66543       3445678999999888888 445889999999999999999999999864   34444444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-26  Score=200.08  Aligned_cols=247  Identities=21%  Similarity=0.254  Sum_probs=198.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l   88 (415)
                      +...|.++++||+|+||.+|++....+|..||||+-.......    .+..|.++.+.|++ ..|..+..++.+..+-.+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            4889999999999999999999999999999999865443333    45679999999987 778888888888889999


Q ss_pred             EeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeeccceecCCC-
Q 014985           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSP-  164 (415)
Q Consensus        89 v~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~a~~~~~~-  164 (415)
                      ||+.++.+|.+++.-+...++...+.-++-|++.-++|+|.++++||||||+|+|..-+   ..+.|+|||+|+.+-+. 
T Consensus        89 VMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   89 VMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             eeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            99999999999998888889999999999999999999999999999999999999754   46999999999876432 


Q ss_pred             ------CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHHHHHhCCCCCCC
Q 014985          165 ------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---DIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       165 ------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~  235 (415)
                            .+......||..|.+=-...+ ..-+.+-|+-|+|.+|.++.-|..||.+-.   ..+.+++|.+.--      
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~------  241 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM------  241 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc------
Confidence                  344556788988998777665 335788999999999999999999999864   3344555544311      


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT  284 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  284 (415)
                                       ..++..+..+.+.++.-.+..|=..--++-|.
T Consensus       242 -----------------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  242 -----------------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             -----------------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence                             11223344455677777777776666666665

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=1.5e-26  Score=236.27  Aligned_cols=226  Identities=27%  Similarity=0.408  Sum_probs=173.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|..++.|..|+||.||+++|+.+.+.+|+| +.+...       +.+-  ++..-..|++|               
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee---------------
Confidence            4678999999999999999999999999999994 432211       1111  33333344444               


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC----
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----  165 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~----  165 (415)
                           ||-...++..+ .++...        +.+++|+|+.||+|||+||+|+||..-|++|++|||+.+......    
T Consensus       136 -----gDc~tllk~~g-~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG-PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhcccCC-CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 66555555433 244433        679999999999999999999999999999999999986431110    


Q ss_pred             -----------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          166 -----------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       166 -----------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                                 -.....+||+.|+|||++.. +.|+..+|||++|+|+||.+.|..||.+.+.++.+..++.-.......
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence                       01223589999999999987 679999999999999999999999999999999988877654332222


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCCCCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI---TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~l~h~~~~~~~~~  300 (415)
                      .                         ..+.++++++|.++|+.+|..|.   .+-++.+|+||....|.
T Consensus       281 d-------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  281 D-------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             C-------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            2                         12378999999999999999995   57788899999877665

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1.7e-25  Score=197.49  Aligned_cols=143  Identities=22%  Similarity=0.201  Sum_probs=109.9

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-------c-----------------chHHHHHHHHHhcCCCC
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-------N-----------------FTALREIKLLKELKSPH   72 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-------~-----------------~~~~~E~~il~~l~hp~   72 (415)
                      ...||+|+||.||+|.+. +|+.||+|+++........       .                 ....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999986 8999999999865322111       0                 11235999999998877


Q ss_pred             eeeEEeeeecCCeEEEEeecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCcEEEecCCcE
Q 014985           73 IIELIDAFPHKGNLHLVFEFMETDLE-TVIRNTNIFLSPADIKSYMQMTLKGLAFC-HKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        73 Iv~l~~~~~~~~~~~lv~e~~~g~L~-~~i~~~~~~l~~~~~~~i~~qil~aL~~l-H~~~ivHrDlkp~NILi~~~~~v  150 (415)
                      +.....+.. .. .+|||||++|+.+ ..... ...+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.+
T Consensus        81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            644333222 22 3899999997533 33332 35689999999999999999999 799999999999999998 5789


Q ss_pred             EEeeeccceecCCC
Q 014985          151 KLADFGLARIFGSP  164 (415)
Q Consensus       151 kL~DFG~a~~~~~~  164 (415)
                      +|+|||+|.....+
T Consensus       157 ~LiDFG~a~~~~~~  170 (190)
T cd05147         157 YIIDVSQSVEHDHP  170 (190)
T ss_pred             EEEEccccccCCCc
Confidence            99999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=3.4e-25  Score=198.15  Aligned_cols=175  Identities=12%  Similarity=0.104  Sum_probs=132.6

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCcc-ch------HHHHHHHHHhcCCCCeeeEEee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FT------ALREIKLLKELKSPHIIELIDA   79 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~-~~------~~~E~~il~~l~hp~Iv~l~~~   79 (415)
                      .+.+.++|++.++||.|+||.||++.+  ++..+|+|+++......... ..      +.+|+..+.++.|++|..+.++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            355789999999999999999999754  47789999987544322211 11      4589999999999999999888


Q ss_pred             eecC--------CeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcE
Q 014985           80 FPHK--------GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        80 ~~~~--------~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~v  150 (415)
                      +...        +..++||||++| +|.+...     +++    ....+++.+|..||+.|++|||+||+||+++.+| +
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence            6543        358899999998 5554421     333    2456999999999999999999999999999999 9


Q ss_pred             EEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHH
Q 014985          151 KLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL  206 (415)
Q Consensus       151 kL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell  206 (415)
                      +|+|||............            ..+.. ..|+.++|+||||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~d------------~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKD------------RIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhHH------------HHHHH-hHhcccccccceeEeehHHH
Confidence            999999887542211100            02222 45778999999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=2.2e-24  Score=198.60  Aligned_cols=235  Identities=20%  Similarity=0.270  Sum_probs=148.3

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-cchHHHHHHHHHhcCC----------CCeeeEEeee-
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-NFTALREIKLLKELKS----------PHIIELIDAF-   80 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~E~~il~~l~h----------p~Iv~l~~~~-   80 (415)
                      .+...+.||.|+++.||.+.|..+|+.+|+|++......... ...+.+|.-....+.+          -.++-.++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            557789999999999999999999999999998766532222 2223333323322221          1122222221 


Q ss_pred             --------ec---CC-----eEEEEeecccCCHHHHHH---hcCCC---CCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 014985           81 --------PH---KG-----NLHLVFEFMETDLETVIR---NTNIF---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMK  138 (415)
Q Consensus        81 --------~~---~~-----~~~lv~e~~~g~L~~~i~---~~~~~---l~~~~~~~i~~qil~aL~~lH~~~ivHrDlk  138 (415)
                              ..   ..     +.+++|+-+.++|..++.   .....   +.......+..|+++.+++||+.|++|+|||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                    11   11     347889988988877754   22211   2222334556899999999999999999999


Q ss_pred             CCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCC-------cCCCCcccHHHHHHHHHHHHcCCCC
Q 014985          139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLNRRPF  211 (415)
Q Consensus       139 p~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~ell~g~~p  211 (415)
                      |+|++++.+|.++|+||+.....+...   .....+..|.+||.....       -.++.+.|.|+||+++|.|++|..|
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999887654322   213444669999987432       2478899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCC
Q 014985          212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       212 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  282 (415)
                      |.......                .++               ..+.... .+++.+++||..+|+.||.+|
T Consensus       250 f~~~~~~~----------------~~~---------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEA----------------DPE---------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGS----------------TSG---------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccc----------------ccc---------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            87542210                000               0122223 668999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=4.5e-24  Score=188.88  Aligned_cols=143  Identities=18%  Similarity=0.171  Sum_probs=112.0

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc------------------------cchHHHHHHHHHhcCCC
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------------------------NFTALREIKLLKELKSP   71 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~------------------------~~~~~~E~~il~~l~hp   71 (415)
                      +.+.||+|+||.||+|.+. +|+.||||+++........                        .....+|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999999865321100                        11134789999999999


Q ss_pred             CeeeEEeeeecCCeEEEEeecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCc
Q 014985           72 HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQ  149 (415)
Q Consensus        72 ~Iv~l~~~~~~~~~~~lv~e~~~g~-L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~  149 (415)
                      +|.....+....  .|+||||++|. +...... ...++...+..++.|++.+|.++|+ +||+||||||+|||++ ++.
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            875444333222  48999999975 3333222 3457889999999999999999999 9999999999999998 889


Q ss_pred             EEEeeeccceecCC
Q 014985          150 LKLADFGLARIFGS  163 (415)
Q Consensus       150 vkL~DFG~a~~~~~  163 (415)
                      ++|+|||+|.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999987644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=7.4e-24  Score=185.70  Aligned_cols=188  Identities=18%  Similarity=0.140  Sum_probs=137.0

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC--ccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEEEEee
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--VNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      .+...|++|+||+||++.  ..+.+++.+.+........  ....+.+|+++|++|.| ++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            467889999999999884  3677888776654433211  11236789999999965 889999886    34699999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC-CCCcEEEecCCcEEEeeeccceecCCCCCcc--
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM-KPNNLLIGSHGQLKLADFGLARIFGSPDRRF--  168 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDl-kp~NILi~~~~~vkL~DFG~a~~~~~~~~~~--  168 (415)
                      |+.|..+.....      .. ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|..........  
T Consensus        79 yI~G~~L~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            999854432211      11 2357889999999999999999999 7999999999999999999998654433210  


Q ss_pred             -----------cccccccceeCcccccCCcCCC-CcccHHHHHHHHHHHHcCCCCCCCC
Q 014985          169 -----------THQVFARWYRAPELLFGAKQYG-AGVDVWAAGCIFAELLNRRPFLQGS  215 (415)
Q Consensus       169 -----------~~~~~t~~y~aPE~l~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~  215 (415)
                                 .-..+++.|++|+.-.-....+ ...++++.|+.+|.++||..++-+.
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                       0112466688887643222223 5679999999999999999776544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=6.9e-24  Score=217.11  Aligned_cols=248  Identities=26%  Similarity=0.325  Sum_probs=180.0

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCcc--chHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      +|...+.||++.|=+|.+|+|.  ...|+||++-+....-...  .+.+.|++ ...+++||.+++.-+-..+...|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            7888999999999999999764  3349999987655332221  22334555 66679999999988887888899999


Q ss_pred             ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC--CCC-Cc
Q 014985           91 EFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG--SPD-RR  167 (415)
Q Consensus        91 e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~--~~~-~~  167 (415)
                      +|+..+|++.+.. ...+..-+.+.|+.||+.||.-||+.||+|||||.|||||+.=+=+.|+||..-+-.-  ..+ ..
T Consensus       101 qyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            9999999998875 4458888999999999999999999999999999999999987779999997654321  111 11


Q ss_pred             ccccccc----cceeCcccccCCc---------C-CCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          168 FTHQVFA----RWYRAPELLFGAK---------Q-YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       168 ~~~~~~t----~~y~aPE~l~~~~---------~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      ++-+.-|    ..|.|||.+....         . .+++-||||+||+++||++ |+|+|.-       .++++--... 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~~-  251 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSGN-  251 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhccC-
Confidence            2222222    2499999984311         1 4577899999999999987 7999962       2221110000 


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                             ...+..         .++.   --+..++.+|..|++.||++|.++++.|+.
T Consensus       252 -------~~~~e~---------~Le~---Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 -------ADDPEQ---------LLEK---IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -------ccCHHH---------HHHh---CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                   000000         0000   114578999999999999999999999985

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=7.6e-23  Score=189.33  Aligned_cols=194  Identities=25%  Similarity=0.302  Sum_probs=140.4

Q ss_pred             CCCCeeeEEeeeecC---------------------------CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHH
Q 014985           69 KSPHIIELIDAFPHK---------------------------GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL  121 (415)
Q Consensus        69 ~hp~Iv~l~~~~~~~---------------------------~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil  121 (415)
                      +|||||++..+|.++                           ..+|+||.-...+|..++..+.  .+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence            499999998877321                           2489999999999999998765  67888889999999


Q ss_pred             HHHHHhhhCCccccCCCCCcEEEec--CC--cEEEeeeccceecCCC-----C-CcccccccccceeCcccccCCcC---
Q 014985          122 KGLAFCHKKWVLHRDMKPNNLLIGS--HG--QLKLADFGLARIFGSP-----D-RRFTHQVFARWYRAPELLFGAKQ---  188 (415)
Q Consensus       122 ~aL~~lH~~~ivHrDlkp~NILi~~--~~--~vkL~DFG~a~~~~~~-----~-~~~~~~~~t~~y~aPE~l~~~~~---  188 (415)
                      +|+.|||++||.|||||.+||||.-  |+  .+.|+|||+|---...     . ......-|...-||||+......   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999953  32  4899999987532211     1 11222334555899999743221   


Q ss_pred             --CCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHH
Q 014985          189 --YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDD  266 (415)
Q Consensus       189 --~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  266 (415)
                        .-.++|.|+.|.+.||+++...||.+..+.                       ..+...|+...-|+   +....++.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------------------~L~~r~Yqe~qLPa---lp~~vpp~  485 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------------------LLDTRTYQESQLPA---LPSRVPPV  485 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchh-----------------------eechhhhhhhhCCC---CcccCChH
Confidence              124799999999999999998887653211                       11111233323222   33355789


Q ss_pred             HHHHHHHhcCCCCCCCCCH---HHHhc
Q 014985          267 ALDLLSKMFTYDPKARITA---QQALE  290 (415)
Q Consensus       267 ~~~li~~~L~~dP~~Rpt~---~e~l~  290 (415)
                      +.+|+..+|+.||++|++.   +.+|+
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHHH
Confidence            9999999999999999984   44444

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.1e-21  Score=174.82  Aligned_cols=134  Identities=16%  Similarity=0.158  Sum_probs=105.3

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-----CCCCeeeEEeeeecCC---eEE
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-----KSPHIIELIDAFPHKG---NLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~---~~~   87 (415)
                      -.+.||+|+||.||.  +..++.. +||++......  ....+.+|+.+++.+     .||||++++++++++.   .++
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            357899999999995  7777666 69998764322  234578999999999     5799999999998873   444


Q ss_pred             -EEeeccc---CCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHhhhCCccccCCCCCcEEEecC----CcEEEeeeccc
Q 014985           88 -LVFEFME---TDLETVIRNTNIFLSPADIKSYMQMTLKGL-AFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLA  158 (415)
Q Consensus        88 -lv~e~~~---g~L~~~i~~~~~~l~~~~~~~i~~qil~aL-~~lH~~~ivHrDlkp~NILi~~~----~~vkL~DFG~a  158 (415)
                       +|+||++   |+|.+++.+.  .+++.  ..++.|++.++ +|||+++|+||||||+|||++..    ++++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             7899955   5888888653  36655  35678888887 99999999999999999999743    37999995444

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=6.2e-22  Score=180.67  Aligned_cols=146  Identities=20%  Similarity=0.195  Sum_probs=112.9

Q ss_pred             cEeeeeeecccCceEEEEEE-ECCCCcEEEEEEeecCCccCC----------------------ccchHHHHHHHHHhcC
Q 014985           13 RYLKREVLGEGTYGVVYKAI-DTKTGQTVAIKKIRLGKQKEG----------------------VNFTALREIKLLKELK   69 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~-~~~~~~~~avK~i~~~~~~~~----------------------~~~~~~~E~~il~~l~   69 (415)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|+++.......                      ....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 778999999999976432110                      0112457999999997


Q ss_pred             CC--CeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC-ccccCCCCCcEEEec
Q 014985           70 SP--HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDMKPNNLLIGS  146 (415)
Q Consensus        70 hp--~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~-ivHrDlkp~NILi~~  146 (415)
                      +.  .+.++++.    ...++||||++|+.+.........+....+..++.||+.+|.+||++| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  34455543    234899999998544333223344667778899999999999999999 99999999999999 


Q ss_pred             CCcEEEeeeccceecCC
Q 014985          147 HGQLKLADFGLARIFGS  163 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~  163 (415)
                      ++.++|+|||.|...+.
T Consensus       184 ~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      184 DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCEEEEEChhhhccCC
Confidence            88999999999886543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=9.4e-22  Score=204.85  Aligned_cols=191  Identities=23%  Similarity=0.329  Sum_probs=157.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC---CCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~   87 (415)
                      .+.|-|.+.||+|+||.||+|.+.. |+.||+|+-......+...     =.+++.+|+   -+.|..+..++...+.-+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            6889999999999999999999877 9999999866555444322     233444444   356667777777777788


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-------CcEEEeeeccce
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-------GQLKLADFGLAR  159 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-------~~vkL~DFG~a~  159 (415)
                      +|+||.+ |+|++++. .+..+++..+..+..|++..++.||.++|||+||||+|+||...       --++|+|||.+-
T Consensus       771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            9999999 99999998 45559999999999999999999999999999999999999532       249999999986


Q ss_pred             ec--CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC
Q 014985          160 IF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR  209 (415)
Q Consensus       160 ~~--~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~  209 (415)
                      .+  ......+...++|-.+-++|+..| ..+++.+|.|.|+.+++-||.|+
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence            54  233456777888888999999988 77999999999999999999997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.7e-22  Score=175.68  Aligned_cols=240  Identities=17%  Similarity=0.228  Sum_probs=187.6

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      .+..+|.+...|..|++++.  |..+++|++............+..|.-.|+-+.||||+.+++.+....++.++..|++
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            45667888999999999654  5566778877666666666677789999999999999999999999999999999999


Q ss_pred             -CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEe--eeccceecCCCCCcc
Q 014985           95 -TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLA--DFGLARIFGSPDRRF  168 (415)
Q Consensus        95 -g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~--DFG~a~~~~~~~~~~  168 (415)
                       |+|+..+..... .++..++..++.+++.|++|||+..  |.---|....++||++-+.+|.  |--++  +..     
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--fqe-----  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQE-----  343 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--eec-----
Confidence             899999987643 4677889999999999999999875  5555788999999999876663  32221  111     


Q ss_pred             cccccccceeCcccccCCcC--CCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          169 THQVFARWYRAPELLFGAKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....++.||+||.+.....  .-.++|+|||++++|||.|+..||..-+..+.-.+|.-. |                 
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale-g-----------------  405 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE-G-----------------  405 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc-c-----------------
Confidence            12344677999999966332  235789999999999999999999988777665554211 0                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL  289 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l  289 (415)
                              -.-.+.|++|..+..|+.-|+..||.+||..+.++
T Consensus       406 --------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  406 --------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             --------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                    01245678999999999999999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=4.1e-22  Score=203.35  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=206.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-CcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...|.+.+.||+|+|+.|-++....+ ...+|.|.+............+..|..+-+.+. |.|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            45788899999999999999876443 346777766554433333344556888888887 9999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCcEEEecCC-cEEEeeeccceecCC-
Q 014985           89 VFEFMET-DLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGS-  163 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH-~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~-  163 (415)
                      +++|..| ++...+...+. ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+ .++++|||+|..+.. 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            9999885 66666623333 6888899999999999999999 99999999999999999999 999999999988755 


Q ss_pred             C--CCccccccc-ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          164 P--DRRFTHQVF-ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       164 ~--~~~~~~~~~-t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .  .......+| ++.|+|||...+........|+||.|+++..|++|..|+......+..                   
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------------------  239 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------------------  239 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-------------------
Confidence            2  234455678 899999999987666788999999999999999999887655433211                   


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                          +..+...........+..++..+.+++.+++..+|..|.+.+++..++|+..
T Consensus       240 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 ----YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ----ceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                0001000111112334467899999999999999999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.4e-19  Score=161.35  Aligned_cols=139  Identities=22%  Similarity=0.271  Sum_probs=107.3

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC--------------------ccchHHHHHHHHHhcCCC--
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--------------------VNFTALREIKLLKELKSP--   71 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--------------------~~~~~~~E~~il~~l~hp--   71 (415)
                      |.+.+.||+|+||.||++.+. +|+.+|||+++.......                    ......+|+.++..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999864 799999999875431100                    011245789999999777  


Q ss_pred             CeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEE
Q 014985           72 HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        72 ~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      .++..++.    ...++||||++|..+..+..      ......++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            44555442    34589999999754433321      134567889999999999999999999999999999999999


Q ss_pred             EeeeccceecCC
Q 014985          152 LADFGLARIFGS  163 (415)
Q Consensus       152 L~DFG~a~~~~~  163 (415)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.2e-19  Score=161.51  Aligned_cols=135  Identities=19%  Similarity=0.267  Sum_probs=109.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCC------ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +.||+|++|.||+|.+  .|..+++|+.........      ......+|+.++..+.|++|.....++......++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999976  678899997653322111      11235679999999999998877777767778899999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      |++| +|.+.+....    . ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9986 6766665422    2 7788999999999999999999999999999999 78899999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=6.2e-21  Score=183.38  Aligned_cols=177  Identities=28%  Similarity=0.416  Sum_probs=132.5

Q ss_pred             CeEEEEeeccc-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           84 GNLHLVFEFME-TDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~--~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      .++||.|++|. ++|.++++..  ....+......++.|+..|++|   +|.+|+|+||.||+...+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            36899999999 6888888643  3346778889999999999999   9999999999999999999999999999987


Q ss_pred             cCCCC------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          161 FGSPD------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       161 ~~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      .....      ...+..+||.+||+||++.+ ..|+.++||||||+|||||+.- .-.|.   ....+..+..       
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~-------  474 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRD-------  474 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhc-------
Confidence            64433      35677899999999999988 6799999999999999999962 11111   0111111110       


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                      ..||                    ..+-.--+.-.+|+.+||...|.+||++.+.-.|.|.
T Consensus       475 g~ip--------------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  475 GIIP--------------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCCC--------------------hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            1111                    0000113456789999999999999977666556654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=8.7e-19  Score=156.20  Aligned_cols=131  Identities=21%  Similarity=0.298  Sum_probs=101.6

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEeecCCccCC------ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeec
Q 014985           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      .||+|+||.||++.  ..|..+++|+.........      ....+.+|+.++..+.|+++....-++......++||||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            48999999999997  4678899998654321111      113456799999999988765544444556667899999


Q ss_pred             ccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           93 MET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        93 ~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ++| +|...+....     .   .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~-----~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-----H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            986 5655544321     1   7899999999999999999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=5.3e-19  Score=173.04  Aligned_cols=205  Identities=24%  Similarity=0.315  Sum_probs=154.9

Q ss_pred             HHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCc-cccCCCCCcE
Q 014985           65 LKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV-LHRDMKPNNL  142 (415)
Q Consensus        65 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~i-vHrDlkp~NI  142 (415)
                      |+.+.|.|+.++++.+-++...++|.+||. |+|.+.+......++..-...++++|+.||.|+|+-.| .|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999 89999998878788888899999999999999998765 9999999999


Q ss_pred             EEecCCcEEEeeeccceecCCCC--CcccccccccceeCcccccCCcC------CCCcccHHHHHHHHHHHHcCCCCCCC
Q 014985          143 LIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQ------YGAGVDVWAAGCIFAELLNRRPFLQG  214 (415)
Q Consensus       143 Li~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~------~~~~~DiwSlG~il~ell~g~~pf~~  214 (415)
                      +++....+||+|||+........  .......-...|.|||.+.+...      .+.+.|+||+|+++||+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            99999999999999987653210  11111112334999999966311      36679999999999999999988876


Q ss_pred             CC----cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          215 SS----DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       215 ~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..    ..+.+..+.. .+..+.  -|+                 +.... ...+++..++.+|+..+|.+||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~-~~~~~~--rP~-----------------i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKK-GGSNPF--RPS-----------------IELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHh-cCCCCc--Ccc-----------------hhhhh-hcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            32    1223333222 111111  111                 00000 23457999999999999999999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=1.3e-18  Score=153.56  Aligned_cols=138  Identities=25%  Similarity=0.320  Sum_probs=99.6

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccch----------------------HHHHHHHHHhcCCCC--
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT----------------------ALREIKLLKELKSPH--   72 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~----------------------~~~E~~il~~l~hp~--   72 (415)
                      .+.||+|+||+||+|.+. +|+.||||++............                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999876 8899999998764322111111                      134666666665433  


Q ss_pred             eeeEEeeeecCCeEEEEeecccCC-HH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCc
Q 014985           73 IIELIDAFPHKGNLHLVFEFMETD-LE-TVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQ  149 (415)
Q Consensus        73 Iv~l~~~~~~~~~~~lv~e~~~g~-L~-~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~  149 (415)
                      +.+.+++.    ..++||||++|+ +. ..+....  .. ..++.++.+++.++.++|. .||+|+||||+||+++ ++.
T Consensus        81 ~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          81 VPKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCceEecC----CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            44455432    358999999972 21 1111111  11 6678899999999999999 9999999999999999 899


Q ss_pred             EEEeeeccceecCC
Q 014985          150 LKLADFGLARIFGS  163 (415)
Q Consensus       150 vkL~DFG~a~~~~~  163 (415)
                      ++|+|||.+.....
T Consensus       153 ~~liDfg~a~~~~~  166 (187)
T cd05119         153 VYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEEECcccccccC
Confidence            99999999976533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.5e-18  Score=175.81  Aligned_cols=139  Identities=19%  Similarity=0.236  Sum_probs=108.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC------CccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~------~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ...|...+.||+|+||+||++....  ..+++|+........      .....+.+|+.+++.++|++|+....++....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            4455678999999999999997543  344555432211111      01234668999999999999988877777777


Q ss_pred             eEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        85 ~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      ..++||||++| +|.+.+.         ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            78999999996 6666554         346789999999999999999999999999999 6788999999999763

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=3e-17  Score=150.10  Aligned_cols=136  Identities=24%  Similarity=0.314  Sum_probs=102.6

Q ss_pred             eeeec-ccCceEEEEEEECCCCcEEEEEEeecCCc-----c------CCccchHHHHHHHHHhcCCCCe--eeEEeeeec
Q 014985           17 REVLG-EGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-----K------EGVNFTALREIKLLKELKSPHI--IELIDAFPH   82 (415)
Q Consensus        17 ~~~LG-~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-----~------~~~~~~~~~E~~il~~l~hp~I--v~l~~~~~~   82 (415)
                      ...|| .|+.|+||.+..  .+..++||.+.....     .      ......+.+|+.++..|.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34677 889999999965  378899998854221     1      1122346789999999998775  667766433


Q ss_pred             C-Ce---EEEEeecccC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeec
Q 014985           83 K-GN---LHLVFEFMET--DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (415)
Q Consensus        83 ~-~~---~~lv~e~~~g--~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG  156 (415)
                      . +.   .++|||+++|  +|..++...  .+++..    +.+|+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            2 22   3599999996  676666542  355543    5689999999999999999999999999999999999999


Q ss_pred             ccee
Q 014985          157 LARI  160 (415)
Q Consensus       157 ~a~~  160 (415)
                      .+..
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            9875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.6e-18  Score=167.31  Aligned_cols=260  Identities=22%  Similarity=0.237  Sum_probs=201.4

Q ss_pred             ccccccEeeeeeecc--cCceEEEEEEE--CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec
Q 014985            8 KKVADRYLKREVLGE--GTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~--G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~   82 (415)
                      ......+.+...+|.  |.+|.||.+.-  ...+..+|+|.-............-.+|+...+.+ .|+|.++.+..|+.
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            335667788899999  99999999987  77889999998444333222222334677777776 48999999999999


Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHhhhCCccccCCCCCcEEEecC-CcEEEeeecc
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK----GLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGL  157 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~----aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~  157 (415)
                      .+..|+-+|+|+.+|..+.......+++..++.++.+...    ||.++|+.+++|-|+||+||++..+ ..++++|||+
T Consensus       190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             CCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            9999999999999999999888888999999999999999    9999999999999999999999999 8899999999


Q ss_pred             ceecCCCCCcccc-----cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          158 ARIFGSPDRRFTH-----QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       158 a~~~~~~~~~~~~-----~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      ...++...-....     ..+..-|++||.+.+  -++...|+++||.++.+-.++...+....                
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~----------------  331 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGK----------------  331 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCC----------------
Confidence            9888665522221     245556999999865  47889999999999999988864433220                


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ...|-.......           -.++....+.++...+..|++.+|..|++++.++.|++...
T Consensus       332 ~~~W~~~r~~~i-----------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  332 NSSWSQLRQGYI-----------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CCCccccccccC-----------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            011111100000           01222234666777999999999999999999999999764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=6.3e-17  Score=136.69  Aligned_cols=132  Identities=19%  Similarity=0.220  Sum_probs=109.8

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC--CCeeeEEeeeecCCeEEEEeecc
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      +.+.||.|.++.||++....  ..+++|.......    ...+.+|+.+++.+.+  .++++++.++...+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            46789999999999997643  7899998754432    3357789999999987  58999999998888999999999


Q ss_pred             cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           94 ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK---WVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        94 ~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~---~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      .|.....+       +......++.+++.+|+++|..   +++|+||+|+||+++..+.++++|||.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            97533322       4566677889999999999984   799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=2.7e-17  Score=169.07  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=204.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.+.+.+.+-+-+|.++.++.+.-..+|..++.|+......... ....+..+-.++-...+|.++.....|.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            35778888899999999999998888888888887654332221 12233344445544556778877666777888999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC---
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP---  164 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~---  164 (415)
                      |++|++ +++...++... ..+.+.++.++..+..+++|||...+.|+|++|.|+|+..+|+.+++|||.....+..   
T Consensus       882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999998 57888777655 4788889999999999999999999999999999999999999999999844321100   


Q ss_pred             ----------------------------CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q 014985          165 ----------------------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS  216 (415)
Q Consensus       165 ----------------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  216 (415)
                                                  .......++|+.|.+||.+.+ ...+..+|+|++|++++|.++|.+||....
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                                        011234567888999999988 456888999999999999999999999887


Q ss_pred             cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCCC
Q 014985          217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRY  293 (415)
Q Consensus       217 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---e~l~h~~  293 (415)
                      .......|...     ...||+.                    .-..+.++.+++.++|..+|.+|..+.   ++-.|+|
T Consensus      1040 pq~~f~ni~~~-----~~~~p~g--------------------~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1040 PQQIFENILNR-----DIPWPEG--------------------PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred             hhhhhhccccC-----CCCCCCC--------------------ccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence            77666554332     1223322                    123478999999999999999999877   8888999


Q ss_pred             CCCCCCCCCC
Q 014985          294 FSSAPLPTEP  303 (415)
Q Consensus       294 ~~~~~~~~~~  303 (415)
                      |+...|....
T Consensus      1095 ~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1095 FQDVDWENLA 1104 (1205)
T ss_pred             cCCCCccccc
Confidence            9998876543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.59  E-value=1.5e-14  Score=126.79  Aligned_cols=142  Identities=18%  Similarity=0.183  Sum_probs=102.9

Q ss_pred             eeeecccCceEEEEEEECC------CCcEEEEEEeecCCc-----------cCCc---------c----chHHHHHHHHH
Q 014985           17 REVLGEGTYGVVYKAIDTK------TGQTVAIKKIRLGKQ-----------KEGV---------N----FTALREIKLLK   66 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~------~~~~~avK~i~~~~~-----------~~~~---------~----~~~~~E~~il~   66 (415)
                      ...||.|.-+.||.|....      .+..+|||+.+....           ....         .    ..+.+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999997543      357999998754321           0000         0    11237999999


Q ss_pred             hcCC--CCeeeEEeeeecCCeEEEEeecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCcE
Q 014985           67 ELKS--PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFC-HKKWVLHRDMKPNNL  142 (415)
Q Consensus        67 ~l~h--p~Iv~l~~~~~~~~~~~lv~e~~~g~-L~~~i~~~~~~l~~~~~~~i~~qil~aL~~l-H~~~ivHrDlkp~NI  142 (415)
                      ++..  -++.+++++    ...+|||||++|+ +.....+ +..+++..+..+..+++.+|..| |+.||||+||++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            9854  456666654    3467999999964 2221111 22356667778889999999999 899999999999999


Q ss_pred             EEecCCcEEEeeeccceecCCC
Q 014985          143 LIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus       143 Li~~~~~vkL~DFG~a~~~~~~  164 (415)
                      |+. ++.+.|+|||.+.....+
T Consensus       157 L~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             EEE-CCcEEEEECCCceeCCCC
Confidence            996 577999999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.58  E-value=2.8e-14  Score=141.54  Aligned_cols=178  Identities=22%  Similarity=0.344  Sum_probs=131.9

Q ss_pred             eeecccCceEEE-EEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccCC
Q 014985           18 EVLGEGTYGVVY-KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD   96 (415)
Q Consensus        18 ~~LG~G~~g~Vy-~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g~   96 (415)
                      ...+-++.+ +| .|..+.++..+.|.+......  .....+.+-++-|+.++||||+++++.++.++..|+|+|-+.. 
T Consensus        18 e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-   93 (690)
T KOG1243|consen   18 EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-   93 (690)
T ss_pred             ccccCCCcc-cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-
Confidence            333444443 33 355567888888888765544  2233467889999999999999999999999999999999873 


Q ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--ccccccc
Q 014985           97 LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVF  173 (415)
Q Consensus        97 L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH-~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~  173 (415)
                      |..++.+    ++...+...++||+.||-||| +++++|++|.-.-|+|+..|+.||++|.++........  .....+.
T Consensus        94 l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~  169 (690)
T KOG1243|consen   94 LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIE  169 (690)
T ss_pred             HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhh
Confidence            2222222    336777888999999999997 67899999999999999999999999998876533221  1111222


Q ss_pred             ccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC
Q 014985          174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR  208 (415)
Q Consensus       174 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g  208 (415)
                        .|..|+.+-.   -+-..|.|-|||+++|++.|
T Consensus       170 --s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  170 --SFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence              2777776532   22457999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=3.9e-15  Score=149.51  Aligned_cols=146  Identities=17%  Similarity=0.276  Sum_probs=95.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---------------------C-----------Cccc-
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---------------------E-----------GVNF-   56 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---------------------~-----------~~~~-   56 (415)
                      +...|.. +.||+|++|.||+|+.+.+|+.||||+++.....                     .           +... 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456766 7899999999999999888999999999754210                     0           0011 


Q ss_pred             -----hHHHHHHHHHhcC----CCCeeeEEeee-ecCCeEEEEeecccC-CHHHH--HHhcCC---CCCHHHHHHHHHHH
Q 014985           57 -----TALREIKLLKELK----SPHIIELIDAF-PHKGNLHLVFEFMET-DLETV--IRNTNI---FLSPADIKSYMQMT  120 (415)
Q Consensus        57 -----~~~~E~~il~~l~----hp~Iv~l~~~~-~~~~~~~lv~e~~~g-~L~~~--i~~~~~---~l~~~~~~~i~~qi  120 (415)
                           .+.+|+..+.++.    +...+.+-..| ......++||||+.| .+.+.  +...+.   .+.+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                 1223444333332    22222222222 223456799999997 45432  222221   24455556666665


Q ss_pred             HHHHHHhhhCCccccCCCCCcEEEecCC----cEEEeeeccceecCC
Q 014985          121 LKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLARIFGS  163 (415)
Q Consensus       121 l~aL~~lH~~~ivHrDlkp~NILi~~~~----~vkL~DFG~a~~~~~  163 (415)
                      +       ..|++|+|+||.||+++.+|    +++++|||++..+..
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            5       58999999999999999988    999999999987644

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=2.1e-14  Score=142.44  Aligned_cols=142  Identities=20%  Similarity=0.261  Sum_probs=93.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-----------------------c---------------cchH
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-----------------------V---------------NFTA   58 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----------------------~---------------~~~~   58 (415)
                      .+.||+|++|.||+|+. .+|+.||||+.+......-                       .               ...+
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            36799999999999985 4789999999865421100                       0               0123


Q ss_pred             HHHHHHHHhcC-----CCCeeeEEeeeecCCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHhhhCC
Q 014985           59 LREIKLLKELK-----SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKW  131 (415)
Q Consensus        59 ~~E~~il~~l~-----hp~Iv~l~~~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~-aL~~lH~~~  131 (415)
                      .+|+..+.++.     +++|.-..-++...+..++||||++| ++.+..........   ...++..++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            34555555552     34332222222334457899999997 44444332211122   2345555554 478899999


Q ss_pred             ccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985          132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus       132 ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      ++|+|+||.||+++.+|+++|+|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=9.4e-15  Score=143.48  Aligned_cols=252  Identities=19%  Similarity=0.165  Sum_probs=184.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEEC-CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDT-KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...+|-.+..||.|.|+.|+.+.-. .++..|++|.+.............+.|+-+...+ .|.+++..+..|....+.|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4567888999999999999998644 5678999998877665555444556788887776 5899999999888888889


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~~~~~~~~  166 (415)
                      +=.|||+|....+-....-.+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.++.+.-.  
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--  420 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--  420 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--
Confidence            999999853333222222337888999999999999999999999999999999999886 78899999998642111  


Q ss_pred             ccccccccccee-CcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYR-APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~-aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                       .......-++. ..|++.....+..++|++|||.-+.+.+++.++-.....   ...|+.                   
T Consensus       421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~-------------------  477 (524)
T KOG0601|consen  421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRS-------------------  477 (524)
T ss_pred             -cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeec-------------------
Confidence             11122222344 366665556788999999999999999999864221110   000000                   


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                               ......++....+..+...++..++..|+.+.++..|.=|.
T Consensus       478 ---------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  478 ---------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ---------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                     00112233456788899999999999999999998876654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=8.2e-14  Score=120.62  Aligned_cols=128  Identities=20%  Similarity=0.163  Sum_probs=94.4

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEEeecccC
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      .+.|+.|.++.||++...  +..|++|.......   ......+|+.+++.+.+.++ .+++....  ...++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence            467899999999999754  78899998654321   12245689999999866554 44555443  335799999998


Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCc-----cccCCCCCcEEEecCCcEEEeeecccee
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV-----LHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~i-----vHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ..+...        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            433211        01123456799999999999885     9999999999998 67899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=1.7e-14  Score=131.48  Aligned_cols=238  Identities=16%  Similarity=0.211  Sum_probs=150.1

Q ss_pred             EEEEEEECCCCcEEEEEEeecCCccCCccch--HHHHHHHHHhcCCCCeeeEEeeeecCC-----eEEEEeeccc-CCHH
Q 014985           27 VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKSPHIIELIDAFPHKG-----NLHLVFEFME-TDLE   98 (415)
Q Consensus        27 ~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~--~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~~lv~e~~~-g~L~   98 (415)
                      .||++.++..|..++.-.++....++.....  ...-..-|-++-|.|||+++.||.+..     ...++.||+. |.+-
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            3455555555555544333322211111111  112334566667999999999986543     5788999999 7777


Q ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEeeeccceecCC----CCCccc
Q 014985           99 TVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFGS----PDRRFT  169 (415)
Q Consensus        99 ~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~----~~~~~~  169 (415)
                      +++++.   ...+....-++|+.||+.||.|||+..  |+|+.+...-|++..+|-+|+.--........    ......
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            777543   445788888999999999999999886  99999999999999888777642211111000    001111


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCC-CCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRP-FLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+-++|.|||.=.. ...+.++|||++|....+|..+.. +-.+.+....-..+...                     
T Consensus       241 ~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~---------------------  298 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV---------------------  298 (458)
T ss_pred             ccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh---------------------
Confidence            2234456999987433 345678999999999999987652 22222222111111111                     


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                ++..-.+.-.++|.+||+-.|..||++..++.||..-.
T Consensus       299 ----------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  299 ----------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             ----------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence                      00001123456899999999999999999999997543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.37  E-value=2.6e-11  Score=117.17  Aligned_cols=213  Identities=14%  Similarity=0.186  Sum_probs=157.4

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec----CCeEEEEeecccC--CH
Q 014985           24 TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KGNLHLVFEFMET--DL   97 (415)
Q Consensus        24 ~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~~lv~e~~~g--~L   97 (415)
                      .-.+.|+|....+|..|++|.+...+.....  ....-+++++++.|+|||++.++|..    +..+++|++|.++  +|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            3478999999999999999999544332221  23457899999999999999998863    3468999999984  67


Q ss_pred             HHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           98 ETVIRN--------------TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        98 ~~~i~~--------------~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      +++.-.              .+.+.++..+|.|+.||..||.++|+.|+..+-|.|.+||++.+.+++|...|.......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            776532              233578899999999999999999999999999999999999988999988887766543


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCC-CCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..            .  |-+.+    -.+-|.=.||.+++.|.||..= +........                      
T Consensus       446 d~------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----------------------  485 (655)
T KOG3741|consen  446 DP------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS----------------------  485 (655)
T ss_pred             CC------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH----------------------
Confidence            32            0  11212    2356999999999999999631 000111110                      


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                  .++.+.+..|.++.++|..+...++++ -++.+++.+
T Consensus       486 ------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  486 ------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                        112334455889999999999999886 666776654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=6.5e-12  Score=106.76  Aligned_cols=131  Identities=18%  Similarity=0.317  Sum_probs=92.7

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCC--ccCCccc-----hHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNF-----TALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~--~~~~~~~-----~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..+++|+-+.+|.+.  ..|..+++|. +..+  ..+...+     ...+|+.++.++.--.|...+=++.+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~--~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTD--FLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeee--ccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence            467899999999994  3555666664 3222  1222222     2347999999986544444333444556677999


Q ss_pred             ecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           91 EFMETDLET-VIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        91 e~~~g~L~~-~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ||++|.++. .+...        .-.+++.+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999997766 44433        144666777778899999999999999999997655 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.35  E-value=1.5e-11  Score=104.17  Aligned_cols=143  Identities=20%  Similarity=0.229  Sum_probs=106.4

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCcc-----chHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVN-----FTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~-----~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ...+|-+|+-+.|+++  ...|+.+.||.-..... .+...     ...++|+++|.++.--.|.-..-+|.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            6788899999999999  56788888886432221 12111     2345799999998654554444455555666799


Q ss_pred             eecccC--CHHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc---EEEeeecccee
Q 014985           90 FEFMET--DLETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARI  160 (415)
Q Consensus        90 ~e~~~g--~L~~~i~~~~~~l~~~~~-~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~---vkL~DFG~a~~  160 (415)
                      |||++|  ++.+++......-.+... ..+++.|-..+.-||.++|+|+||..+||++..+|.   +.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999998  788888776433333333 788999999999999999999999999999987653   58999999865

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=2e-11  Score=110.22  Aligned_cols=140  Identities=19%  Similarity=0.268  Sum_probs=101.6

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCC--CeeeEEeeeecC---CeEEEEee
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP--HIIELIDAFPHK---GNLHLVFE   91 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~~~~~---~~~~lv~e   91 (415)
                      .+.||.|.++.||++... +|+.|++|........ .....+.+|+.+++.+.+.  .+.+++.+....   +..++|||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            367899999999999764 3688999987654322 2334577899999999763  456777776553   36789999


Q ss_pred             cccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q 014985           92 FMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-----------------------------------------  129 (415)
Q Consensus        92 ~~~g~-L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-----------------------------------------  129 (415)
                      |++|. +...+..  ..+++.....++.+++.+|..||+                                         
T Consensus        81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99974 3332211  235666666677777777777763                                         


Q ss_pred             ---------------CCccccCCCCCcEEEec--CCcEEEeeecccee
Q 014985          130 ---------------KWVLHRDMKPNNLLIGS--HGQLKLADFGLARI  160 (415)
Q Consensus       130 ---------------~~ivHrDlkp~NILi~~--~~~vkL~DFG~a~~  160 (415)
                                     ..++|+|++|.|||++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23699999999999998  56789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=7.4e-11  Score=103.18  Aligned_cols=129  Identities=26%  Similarity=0.348  Sum_probs=83.4

Q ss_pred             EEEEEEECCCCcEEEEEEeecCCccC-----------C-------------ccchHHHHHHHHHhcCCC--CeeeEEeee
Q 014985           27 VVYKAIDTKTGQTVAIKKIRLGKQKE-----------G-------------VNFTALREIKLLKELKSP--HIIELIDAF   80 (415)
Q Consensus        27 ~Vy~~~~~~~~~~~avK~i~~~~~~~-----------~-------------~~~~~~~E~~il~~l~hp--~Iv~l~~~~   80 (415)
                      .||.|.. ..|..+|+|..+.....-           .             ......+|...|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899976 467799999876432100           0             012245799999999765  566777554


Q ss_pred             ecCCeEEEEeeccc--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-hhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           81 PHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF-CHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        81 ~~~~~~~lv~e~~~--g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~-lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      .    .+|||||++  |..+..+....  ++......++.+++..+.. +|+.||+|+||.+.|||++.+ .+.|+|||.
T Consensus        80 ~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 R----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             T----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             C----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence            2    359999999  74444444332  2245566777888885555 589999999999999999887 899999999


Q ss_pred             ceecCC
Q 014985          158 ARIFGS  163 (415)
Q Consensus       158 a~~~~~  163 (415)
                      +.....
T Consensus       153 av~~~~  158 (188)
T PF01163_consen  153 AVDSSH  158 (188)
T ss_dssp             EEETTS
T ss_pred             ceecCC
Confidence            886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=5.2e-10  Score=103.64  Aligned_cols=132  Identities=16%  Similarity=0.071  Sum_probs=92.7

Q ss_pred             EEEEEEECCCCcEEEEEEeecCCccC---------CccchHHHHHHHHHhcCCCCe--eeEEeeeec-----CCeEEEEe
Q 014985           27 VVYKAIDTKTGQTVAIKKIRLGKQKE---------GVNFTALREIKLLKELKSPHI--IELIDAFPH-----KGNLHLVF   90 (415)
Q Consensus        27 ~Vy~~~~~~~~~~~avK~i~~~~~~~---------~~~~~~~~E~~il~~l~hp~I--v~l~~~~~~-----~~~~~lv~   90 (415)
                      .|+++  ...|+.|.||........+         .-...+.+|...+..|..-+|  ++++.+++.     ...-++|+
T Consensus        37 rvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            45555  3457789999664322111         011136789998888843332  334444432     23578999


Q ss_pred             ecccC--CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-------CCcEEEeeecccee
Q 014985           91 EFMET--DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-------HGQLKLADFGLARI  160 (415)
Q Consensus        91 e~~~g--~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-------~~~vkL~DFG~a~~  160 (415)
                      |+++|  +|.+++... ....+......++.+++..+.-||+.||+|+||++.|||++.       ++.+.|+||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99997  577776532 233566778899999999999999999999999999999985       46799999998864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=2.7e-11  Score=121.06  Aligned_cols=158  Identities=20%  Similarity=0.315  Sum_probs=116.7

Q ss_pred             HHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC----cccc-----cccccceeCcccccCCcC
Q 014985          119 MTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----RFTH-----QVFARWYRAPELLFGAKQ  188 (415)
Q Consensus       119 qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~----~~~~-----~~~t~~y~aPE~l~~~~~  188 (415)
                      +...|+.|+|. .++||+.|.|++|.++.+|..||+.|+++.....+..    .+..     ......|.|||.+.+ ..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            33489999996 4799999999999999999999999998865433221    1111     111235999999987 56


Q ss_pred             CCCcccHHHHHHHHHHHH-cCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHH
Q 014985          189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDA  267 (415)
Q Consensus       189 ~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  267 (415)
                      .+.++|++||||++|.+. .|++.+.+++.......-....+.                        ........++.++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~------------------------~~~~~s~~~p~el  241 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA------------------------GAFGYSNNLPSEL  241 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc------------------------ccccccccCcHHH
Confidence            788999999999999998 677888776544333322111110                        0111224568999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          268 LDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       268 ~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      ++-+.++|..++..||++.+++..+||++....+
T Consensus       242 ~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~a  275 (700)
T KOG2137|consen  242 RESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKA  275 (700)
T ss_pred             HHHHHHHhcCCcccCcchhhhhcccccCCchhhh
Confidence            9999999999999999999999999999876543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.13  E-value=2.1e-10  Score=103.34  Aligned_cols=140  Identities=24%  Similarity=0.298  Sum_probs=103.2

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC------------C--------ccchHHHHHHHHHhcCCC--
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------------G--------VNFTALREIKLLKELKSP--   71 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~------------~--------~~~~~~~E~~il~~l~hp--   71 (415)
                      +.+...||-|.-+.||.|.+. .|..+|||.=+.....-            .        ....+.+|..+|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356789999999999999865 78999999654322100            0        012356899999999655  


Q ss_pred             CeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEE
Q 014985           72 HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        72 ~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      .|.+.+++-    ...+||||++|-.+..+.     ++......++..|+.-+.-+-..||||+|+.+-|||++++|.+.
T Consensus       172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAWN----RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCccccc----cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            677777554    456999999995444333     23455566677777777777799999999999999999999999


Q ss_pred             EeeeccceecCC
Q 014985          152 LADFGLARIFGS  163 (415)
Q Consensus       152 L~DFG~a~~~~~  163 (415)
                      ++||--+...+.
T Consensus       243 vIDwPQ~v~~~h  254 (304)
T COG0478         243 VIDWPQAVPISH  254 (304)
T ss_pred             EEeCcccccCCC
Confidence            999976655433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=4.1e-09  Score=94.33  Aligned_cols=126  Identities=19%  Similarity=0.243  Sum_probs=90.1

Q ss_pred             CCCcEEEEEEeecCCccC-----CccchHHHHHHHHHhcCCCC--eeeEEeeeecC----CeEEEEeecccC--CHHHHH
Q 014985           35 KTGQTVAIKKIRLGKQKE-----GVNFTALREIKLLKELKSPH--IIELIDAFPHK----GNLHLVFEFMET--DLETVI  101 (415)
Q Consensus        35 ~~~~~~avK~i~~~~~~~-----~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~----~~~~lv~e~~~g--~L~~~i  101 (415)
                      ..++.|-+|.........     -....+.+|...+..|..-.  +.+.+.+.+..    ...++|+|+++|  +|..++
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence            345566666543221111     22335678888888875332  34445444432    245899999997  577777


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEEEeeeccceec
Q 014985          102 RNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF  161 (415)
Q Consensus       102 ~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vkL~DFG~a~~~  161 (415)
                      ..... .+......++.++...+.-||++||+|+|+++.|||++.++   .+.|+||+-++..
T Consensus       110 ~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  110 QQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             Hhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            65333 67778889999999999999999999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.96  E-value=3.2e-08  Score=93.98  Aligned_cols=192  Identities=14%  Similarity=0.104  Sum_probs=129.7

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHh-cCCCCeeeEEe------eeecCC-eE
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE-LKSPHIIELID------AFPHKG-NL   86 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~------~~~~~~-~~   86 (415)
                      ...+.||+|+-+.+|-.-.  -+. .+.|+.......-    .. +-+..|.. -.||-+-.-+.      +..+.+ ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~----~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAA----QA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeecch--hhc-hhheeecCCCchH----HH-HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            4567899999999998732  222 3447665433211    11 12222332 24554432111      112222 36


Q ss_pred             EEEeecccC--CHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           87 HLVFEFMET--DLETVIR-----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        87 ~lv~e~~~g--~L~~~i~-----~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      -++|..+.|  ....++.     +......+.-.....+.|+.+.+.||..|.+-+|+.++|+|+.+++.|.|.|=..-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            788999886  3333332     222346778888999999999999999999999999999999999999999865443


Q ss_pred             ecCCCCCcccccccccceeCccccc-C---CcCCCCcccHHHHHHHHHHHHcC-CCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLF-G---AKQYGAGVDVWAAGCIFAELLNR-RPFLQGS  215 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~-~---~~~~~~~~DiwSlG~il~ell~g-~~pf~~~  215 (415)
                      .. .....+...+|...|.+||... +   .-.-+...|.|.||+++|+|+.| +.||.|-
T Consensus       166 i~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         166 IN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            33 3455667788999999999863 1   12246678999999999999876 8998773

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.90  E-value=1.4e-08  Score=90.75  Aligned_cols=142  Identities=22%  Similarity=0.193  Sum_probs=98.3

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc----------------------cchHHHHHHHHHhcCC--CC
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV----------------------NFTALREIKLLKELKS--PH   72 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~----------------------~~~~~~E~~il~~l~h--p~   72 (415)
                      ...|++|.-+.||+|.. ..+..+|+|+.+........                      .....+|+.-|+++..  -.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677899999999964 56889999998654321110                      1123367777777743  44


Q ss_pred             eeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEE
Q 014985           73 IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        73 Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      +.+.+.++.    ..|||||++....-.=+-....+...++..+..++++.+.-|-. .|+||+||..-|||+. ++.+.
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            556665553    35999999954111111112224444788888999999988877 8999999999999998 78899


Q ss_pred             EeeeccceecCCC
Q 014985          152 LADFGLARIFGSP  164 (415)
Q Consensus       152 L~DFG~a~~~~~~  164 (415)
                      |+|||-|....++
T Consensus       207 iID~~QaV~~~hp  219 (268)
T COG1718         207 IIDVSQAVTIDHP  219 (268)
T ss_pred             EEECccccccCCC
Confidence            9999998766543

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=3.8e-08  Score=86.76  Aligned_cols=137  Identities=14%  Similarity=0.072  Sum_probs=100.0

Q ss_pred             cccCceEEEEEEECCCCcEEEEEEeecCC----ccCCccchHHHHHHHHHhcCCCC--eeeEEeeee---c--CCeEEEE
Q 014985           21 GEGTYGVVYKAIDTKTGQTVAIKKIRLGK----QKEGVNFTALREIKLLKELKSPH--IIELIDAFP---H--KGNLHLV   89 (415)
Q Consensus        21 G~G~~g~Vy~~~~~~~~~~~avK~i~~~~----~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~---~--~~~~~lv   89 (415)
                      |+||.+.|+....  .|+.|=+|.-....    ....-...+.+|+..|..|..-+  +.++. ++.   .  .-..+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            6689999999843  44467788654211    11223446789999999985422  44444 332   1  1246799


Q ss_pred             eecccC--CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc--EEEeeecccee
Q 014985           90 FEFMET--DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARI  160 (415)
Q Consensus        90 ~e~~~g--~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~--vkL~DFG~a~~  160 (415)
                      +|-++|  +|.+++.+.. ...++.....++.+++..+.-||+.|+.|+|+-+.|||++.+|.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            999985  7887775532 24577777899999999999999999999999999999987777  99999987764

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.79  E-value=4.3e-08  Score=86.77  Aligned_cols=142  Identities=18%  Similarity=0.228  Sum_probs=91.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCcc-------chHHHHHHHHHhcCC---CCeeeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-------FTALREIKLLKELKS---PHIIELI   77 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~-------~~~~~E~~il~~l~h---p~Iv~l~   77 (415)
                      +.+..+|.+.+++-.....-|.+.  ...|+.+++|..+.........       ....+++..+..+..   -.++.++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            446788999999998888888877  4677999999876432111100       012234444444422   2222222


Q ss_pred             ee-----eecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEE
Q 014985           78 DA-----FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (415)
Q Consensus        78 ~~-----~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL  152 (415)
                      -+     +......++||||++|--+..+..    +++.    +...|.+++.-||+.|++|+|.+|.|+++..++ +++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~i  175 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRI  175 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEE
Confidence            22     222344668999999843322211    2332    445677789999999999999999999998655 999


Q ss_pred             eeecccee
Q 014985          153 ADFGLARI  160 (415)
Q Consensus       153 ~DFG~a~~  160 (415)
                      +||+..+.
T Consensus       176 ID~~~k~~  183 (229)
T PF06176_consen  176 IDTQGKRM  183 (229)
T ss_pred             EECccccc
Confidence            99987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=2.1e-07  Score=84.36  Aligned_cols=134  Identities=20%  Similarity=0.199  Sum_probs=83.4

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEeeeecCCeEEEEeecccC
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      ..||+|..+.||+.    .|..+++|......    ....+.+|.++++.+..-.  +.+.+++....+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            67899999999984    25568888865322    2234678999999986433  46778787777788899999998


Q ss_pred             C-H-H--------------HHH-------HhcC-CCCCHHH-HHHHHHH----------HHH-HHHHhh----hCCcccc
Q 014985           96 D-L-E--------------TVI-------RNTN-IFLSPAD-IKSYMQM----------TLK-GLAFCH----KKWVLHR  135 (415)
Q Consensus        96 ~-L-~--------------~~i-------~~~~-~~l~~~~-~~~i~~q----------il~-aL~~lH----~~~ivHr  135 (415)
                      . . .              ..+       +... ....... ...+..+          +.. ...+|.    ...++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            4 1 1              111       1100 0011110 0001000          001 111221    1237899


Q ss_pred             CCCCCcEEEecCCcEEEeeecccee
Q 014985          136 DMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       136 Dlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      |+.|.||+++.++ +.|+||+.+..
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999888 99999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.68  E-value=4.6e-09  Score=104.26  Aligned_cols=248  Identities=16%  Similarity=0.145  Sum_probs=168.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC-eeeEEeeeecCCeEEEEe
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~   90 (415)
                      ..|...+-+++|+++.+++.+...+.... .+.+...       ....-++++|.+++||| .+..++-++.+...++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            34555667899999999999877664444 5555432       23446999999999999 777777777888999999


Q ss_pred             ecccCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~g~--L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      +++.+.  ....+......+..-+...+.+.-+.+|+++|+.--+|+|    ||+..+ +..+..||+.+..+.... ..
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~  387 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP  387 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence            999954  3322222222244455566777788899999998778999    887755 669999999988765443 45


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ....+++.++|||+..+ ..+....|.|++|+-..+|.-|.+|-...  ....    ...|..     ++-..+.+...+
T Consensus       388 ~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~----~~~g~~-----p~s~~L~~~~aw  455 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVL----PMIGNG-----PNSPMLTDKSAW  455 (829)
T ss_pred             ccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCC--cccc----CCCCCC-----CCccccchhhhc
Confidence            56788999999998866 55788999999998877888887775431  0000    000000     000000000000


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                                    -..+-.++...|+...|..|+....++-|.+|.+-+.
T Consensus       456 --------------~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  456 --------------SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             --------------CcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence                          0011115778899999999999999999988876543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1.3e-07  Score=94.92  Aligned_cols=141  Identities=18%  Similarity=0.322  Sum_probs=89.6

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-----------------------c---------------cchHH
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-----------------------V---------------NFTAL   59 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-----------------------~---------------~~~~~   59 (415)
                      +-|+.++-|.||+|.-. +|+.||||+.+..-...-                       .               ...+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999864 499999999754321100                       0               01122


Q ss_pred             HHHHHHHhcC-----CCCeeeEEeeeecCCeEEEEeecccC-CHHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 014985           60 REIKLLKELK-----SPHIIELIDAFPHKGNLHLVFEFMET-DLETV--IRNTNIFLSPADIKSYMQMTLKGLAFCHKKW  131 (415)
Q Consensus        60 ~E~~il~~l~-----hp~Iv~l~~~~~~~~~~~lv~e~~~g-~L~~~--i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~  131 (415)
                      +|..-+.++.     .++|.-..=+++..+.-.++|||++| .+.+.  +...+  ++...+...+.++  -+..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~--f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRA--FLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHH--HHHHHHhcC
Confidence            4555555542     34443333344545667899999998 33333  33322  4433333222221  123333589


Q ss_pred             ccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985          132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus       132 ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.49  E-value=1.8e-06  Score=79.29  Aligned_cols=71  Identities=21%  Similarity=0.209  Sum_probs=49.4

Q ss_pred             eecccCc-eEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEEEeecccCC
Q 014985           19 VLGEGTY-GVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHLVFEFMETD   96 (415)
Q Consensus        19 ~LG~G~~-g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~g~   96 (415)
                      .|-.|.. +.||++..  .+..+.+|......     .....+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            3444544 89999953  34678888764332     224567999988884 334667788777777789999999984

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=1.9e-06  Score=73.19  Aligned_cols=129  Identities=19%  Similarity=0.183  Sum_probs=91.0

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCee-eEEeeeecCCeEEEEeecc
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv-~l~~~~~~~~~~~lv~e~~   93 (415)
                      .+.+.||+|++|.||++.  ..|..+|+|+-+....    ...+..|+++|..++--++. ++|.|..+    ++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEee--ccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence            457789999999999995  5677999998654333    33567899999999876664 45554433    3559999


Q ss_pred             cC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC-CCcEEEecCCcEEEeeeccceec
Q 014985           94 ET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK-PNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        94 ~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlk-p~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      .| .|.......    +    +.-+..++++.--|-..||-|+.|. |..++|..++.+.|+||..|+.-
T Consensus        95 ~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            98 666554421    1    2233455666566778899999986 55555556668999999999843

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.43  E-value=1.6e-06  Score=91.91  Aligned_cols=196  Identities=18%  Similarity=0.250  Sum_probs=134.9

Q ss_pred             HHHHHHHhcCCCCeeeEEeeeecCCeE----EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 014985           60 REIKLLKELKSPHIIELIDAFPHKGNL----HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH  134 (415)
Q Consensus        60 ~E~~il~~l~hp~Iv~l~~~~~~~~~~----~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivH  134 (415)
                      .|+..+..+.|+|++.++.|.-.....    .+..++|.+ ++...+.. -..++...++.+..++++||+|+|+....|
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~  309 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEH  309 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence            477788888999999998876443322    244577776 55555544 455899999999999999999999996666


Q ss_pred             cCCCCC---cEEEecCCcEEEe--eeccceecCCCCCcccccccccceeCcccccCCcCCC--CcccHHHHHHHHHHHHc
Q 014985          135 RDMKPN---NLLIGSHGQLKLA--DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG--AGVDVWAAGCIFAELLN  207 (415)
Q Consensus       135 rDlkp~---NILi~~~~~vkL~--DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~--~~~DiwSlG~il~ell~  207 (415)
                      .-|...   +-.++..+.+.+.  ||+....+......... ..+..|.++|.... ..+.  ...|+|.+|..+..+..
T Consensus       310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~-~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD-LLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             eEEecccccccccCccceeecchhhhcccccCCCcccchhh-cCcccccccccccc-ccchhhhhhHHHHHHHHHhhhhh
Confidence            555444   4444555667776  89888877655544333 33344788887754 2233  34699999999999988


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCH-HHHHHHHHhcCCCCCCCCCHH
Q 014985          208 RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASD-DALDLLSKMFTYDPKARITAQ  286 (415)
Q Consensus       208 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~Rpt~~  286 (415)
                      |..+-.-..      .+                                ..+.+..+. ...+++.+|+.-++++|+++.
T Consensus       388 ~~~i~~~~~------~~--------------------------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  388 GEDISEKSA------VP--------------------------------VSLLDVLSTSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             cCccccccc------ch--------------------------------hhhhccccchhhhhhhhhhcchhhhhccchh
Confidence            764311100      00                                011111122 678899999999999999999


Q ss_pred             HHhcCCCCCC
Q 014985          287 QALEHRYFSS  296 (415)
Q Consensus       287 e~l~h~~~~~  296 (415)
                      +++.|+|...
T Consensus       430 ~ll~~~f~~~  439 (1351)
T KOG1035|consen  430 ELLTHPFLRF  439 (1351)
T ss_pred             hhhhchhccc
Confidence            9999999764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=3.7e-06  Score=76.17  Aligned_cols=138  Identities=18%  Similarity=0.238  Sum_probs=78.4

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEeee---ecCCeEEEEee
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAF---PHKGNLHLVFE   91 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~---~~~~~~~lv~e   91 (415)
                      ++.|+.|..+.||++....  ..+++|.....    .....+.+|..+++.+....  +.+++...   ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            5789999999999997654  58999986533    22335667888888885332  45555533   33445799999


Q ss_pred             cccCC-HHH-------------------HHHhcC---CCCCHHH------HHHH---------------HHHHHH-HHHH
Q 014985           92 FMETD-LET-------------------VIRNTN---IFLSPAD------IKSY---------------MQMTLK-GLAF  126 (415)
Q Consensus        92 ~~~g~-L~~-------------------~i~~~~---~~l~~~~------~~~i---------------~~qil~-aL~~  126 (415)
                      +++|. +..                   .+....   .......      ....               ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            99984 333                   011110   0000000      0000               011111 2333


Q ss_pred             hh-------hCCccccCCCCCcEEEe-cCCcEEEeeecccee
Q 014985          127 CH-------KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARI  160 (415)
Q Consensus       127 lH-------~~~ivHrDlkp~NILi~-~~~~vkL~DFG~a~~  160 (415)
                      ++       ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            33       24599999999999999 667778999998763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.38  E-value=3.3e-06  Score=90.99  Aligned_cols=80  Identities=18%  Similarity=0.270  Sum_probs=56.5

Q ss_pred             eeeeecccCceEEEEEEECCCC--cEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCe--eeEEeeeecC---CeEE
Q 014985           16 KREVLGEGTYGVVYKAIDTKTG--QTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHI--IELIDAFPHK---GNLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~--~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~I--v~l~~~~~~~---~~~~   87 (415)
                      .++.|+.|.++.+|+......+  ..+++|+........ ....+.+|+.+|+.+. |.+|  .+++.++.+.   +..|
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            4677899999999998764432  467888754332211 1235678999999995 6664  7777777654   4688


Q ss_pred             EEeecccCC
Q 014985           88 LVFEFMETD   96 (415)
Q Consensus        88 lv~e~~~g~   96 (415)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            999999984

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=1.9e-05  Score=69.23  Aligned_cols=128  Identities=26%  Similarity=0.272  Sum_probs=88.1

Q ss_pred             cccEeeeeeecccCc-eEEEEEEECCCCcEEEEEEeecCC---c-------c--C-------CccchHHHHHHHHHhc--
Q 014985           11 ADRYLKREVLGEGTY-GVVYKAIDTKTGQTVAIKKIRLGK---Q-------K--E-------GVNFTALREIKLLKEL--   68 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~-g~Vy~~~~~~~~~~~avK~i~~~~---~-------~--~-------~~~~~~~~E~~il~~l--   68 (415)
                      ...++.++.||.|.- |.||+++  -.|+.||+|++..-.   .       .  +       ....-+..|.....+|  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            478999999999999 9999994  567899999943211   0       0  0       0111234566665555  


Q ss_pred             -CCCCe--eeEEeeeecC------------------CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh
Q 014985           69 -KSPHI--IELIDAFPHK------------------GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC  127 (415)
Q Consensus        69 -~hp~I--v~l~~~~~~~------------------~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~l  127 (415)
                       .+.++  |+.++|..-.                  ....||.||+...-         .++...    +.+|+.-+..+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~  180 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKIL  180 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHH
Confidence             45566  8888886211                  12458888887543         133333    35667778899


Q ss_pred             hhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985          128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus       128 H~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                      |+.||+-+|+++.|..   +  =||+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc---C--CEEEecccC
Confidence            9999999999999985   3  389999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.26  E-value=2.5e-05  Score=68.98  Aligned_cols=129  Identities=19%  Similarity=0.319  Sum_probs=91.5

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCC--------------ccCCccchHHHHHHHHHhcC------CCCeeeE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--------------QKEGVNFTALREIKLLKELK------SPHIIEL   76 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~--------------~~~~~~~~~~~E~~il~~l~------hp~Iv~l   76 (415)
                      ...||+|+.-.||.-  . .+....||++....              ..........+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            467999999999976  3 34557789887665              11111233456776666665      7899999


Q ss_pred             EeeeecCCeEEEEeeccc---C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-
Q 014985           77 IDAFPHKGNLHLVFEFME---T----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-  148 (415)
Q Consensus        77 ~~~~~~~~~~~lv~e~~~---g----~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-  148 (415)
                      +++.+++...-+|+|.+.   |    +|.+++.+.  .+++ ....   .+-+-.+||-+.+|+.+||+|.||++...+ 
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999999999999999874   3    466666443  2555 3333   334455788899999999999999997543 


Q ss_pred             ---cEEEee
Q 014985          149 ---QLKLAD  154 (415)
Q Consensus       149 ---~vkL~D  154 (415)
                         .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence               477776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.25  E-value=1e-05  Score=81.16  Aligned_cols=152  Identities=21%  Similarity=0.300  Sum_probs=93.5

Q ss_pred             cccccccccEee--eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc----------------------------
Q 014985            5 DLSKKVADRYLK--REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV----------------------------   54 (415)
Q Consensus         5 ~~~~~~~~~y~~--~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~----------------------------   54 (415)
                      |++..+.+-|..  .+.||..+.|.||+|+-+. |..||||+-+..-...-.                            
T Consensus       152 ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE  230 (538)
T KOG1235|consen  152 ELGAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDE  230 (538)
T ss_pred             HhCCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHH
Confidence            345555555533  4679999999999998654 999999985432211100                            


Q ss_pred             -------cchHHHHHHHHHhc----CCCC------eeeEEeeeecCCeEEEEeecccC---CHHHHHHhcCCCCCHHHHH
Q 014985           55 -------NFTALREIKLLKEL----KSPH------IIELIDAFPHKGNLHLVFEFMET---DLETVIRNTNIFLSPADIK  114 (415)
Q Consensus        55 -------~~~~~~E~~il~~l----~hp~------Iv~l~~~~~~~~~~~lv~e~~~g---~L~~~i~~~~~~l~~~~~~  114 (415)
                             ...+.+|.+-..++    .|-+      |.++|  +.....-.|+||||+|   +-++.+.+.+  ++...+.
T Consensus       231 ~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~  306 (538)
T KOG1235|consen  231 IAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDIL  306 (538)
T ss_pred             HHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHH
Confidence                   01112333322222    3333      33443  2234457799999998   4456666655  5666544


Q ss_pred             HHHHHHHHHHHHhhhCCccccCCCCCcEEEec----CCcEEEeeeccceecCC
Q 014985          115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIFGS  163 (415)
Q Consensus       115 ~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~----~~~vkL~DFG~a~~~~~  163 (415)
                      ..+.+..  +.-|-..|++|+|=+|.||++..    ++.+.+.|||+......
T Consensus       307 ~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  307 NKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            4333322  12233578999999999999994    57899999999886543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.18  E-value=1.2e-07  Score=102.14  Aligned_cols=215  Identities=13%  Similarity=0.003  Sum_probs=147.5

Q ss_pred             ccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeEEEEeeccc-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHh
Q 014985           54 VNFTALREIKLLKELKSPHIIELIDAFPHK--GNLHLVFEFME-TDLETVIRNTNI---FLSPADIKSYMQMTLKGLAFC  127 (415)
Q Consensus        54 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~e~~~-g~L~~~i~~~~~---~l~~~~~~~i~~qil~aL~~l  127 (415)
                      ..+....|.+.++...|+++.....-....  ...|.+++||. |++...+.+...   .+....+.....+.+.+..-+
T Consensus      1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            333444566677778999998877666443  35689999999 788888876533   234444544555546777777


Q ss_pred             hhCC-----ccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHH
Q 014985          128 HKKW-----VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIF  202 (415)
Q Consensus       128 H~~~-----ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il  202 (415)
                      |+..     .+|++||+-|.+|..+.++|+.++|+.+.........+..++++.|++|++... ..++.++|+|..|+-+
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSL 1430 (2724)
T ss_pred             hhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHH
Confidence            7542     799999999999999999999999999965555566677788889999998755 5577889999999999


Q ss_pred             HHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCC
Q 014985          203 AELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       203 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  282 (415)
                      |++..|.++|...     +..++++.-.                      ......+....+.++......+|-+.-..|
T Consensus      1431 y~rs~~n~~fi~f-----lq~~Lkgiid----------------------n~tf~sIe~l~pgdaNve~~~~Ll~K~~~r 1483 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFF-----LQPALKGIID----------------------NHTFFSIEKLKPGDANVEALHRLLWKYMER 1483 (2724)
T ss_pred             HHHhcccHHHHHH-----HHHHHcCccc----------------------ccccccccccCCCcccHHHHHHHHHHhhhc
Confidence            9999998776432     2222221110                      001111111123445555555666666789


Q ss_pred             CCHHHHhcCCCCCC
Q 014985          283 ITAQQALEHRYFSS  296 (415)
Q Consensus       283 pt~~e~l~h~~~~~  296 (415)
                      |.-...+.-+.|..
T Consensus      1484 p~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1484 PGQYISLSRDHFAV 1497 (2724)
T ss_pred             chhhhhcccccccc
Confidence            99888888777654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.13  E-value=4.3e-05  Score=69.65  Aligned_cols=72  Identities=17%  Similarity=0.247  Sum_probs=47.0

Q ss_pred             eeeecccCceEEEEEEECC-CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC-eeeEEeeeecCCeEEEEeeccc
Q 014985           17 REVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      ++.|..|-...+|++.... .++.|++|.......   ......+|+.+++.+.... .++++..+..    .+||||++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence            4678889999999996433 357888997543211   1123447999999885433 4455544432    37999998


Q ss_pred             C
Q 014985           95 T   95 (415)
Q Consensus        95 g   95 (415)
                      |
T Consensus        76 G   76 (235)
T cd05157          76 G   76 (235)
T ss_pred             C
Confidence            7

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=1.5e-05  Score=72.76  Aligned_cols=70  Identities=13%  Similarity=0.137  Sum_probs=43.2

Q ss_pred             eeeecccCce-EEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCC---CeeeEEeeeecC---CeEEEE
Q 014985           17 REVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP---HIIELIDAFPHK---GNLHLV   89 (415)
Q Consensus        17 ~~~LG~G~~g-~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~~~~~---~~~~lv   89 (415)
                      ++.|+.|+.. .||++     +..+++|......    ....+.+|++++..+...   -+.++++.....   +..|+|
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            3567777765 59987     2357778643211    223577899999888532   344445444332   245889


Q ss_pred             eecccC
Q 014985           90 FEFMET   95 (415)
Q Consensus        90 ~e~~~g   95 (415)
                      |++++|
T Consensus        73 ~~~i~G   78 (235)
T cd05155          73 YRWLEG   78 (235)
T ss_pred             EEeecC
Confidence            999987

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.04  E-value=2.2e-05  Score=74.12  Aligned_cols=146  Identities=23%  Similarity=0.250  Sum_probs=99.6

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCC----ccCC--------------------ccchHHHHHHHHHhcCC
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK----QKEG--------------------VNFTALREIKLLKELKS   70 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~----~~~~--------------------~~~~~~~E~~il~~l~h   70 (415)
                      .+...|..|.-+.||.|. ..+|..+|||++.-+-    ..+.                    ....+..|+.-|++|..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            355678899999999996 4578889999874321    0000                    01224468888888865


Q ss_pred             CCeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCcEEEecCCc
Q 014985           71 PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC-HKKWVLHRDMKPNNLLIGSHGQ  149 (415)
Q Consensus        71 p~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~l-H~~~ivHrDlkp~NILi~~~~~  149 (415)
                      ..|.-.--..-  ....|||+|++++-+..-+-.+..++...+..+-.|++.-+.-| |.+++||.||.--|+|+ .+|.
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            44322111111  12459999999654433333455588888898888888888877 46789999999999999 5678


Q ss_pred             EEEeeeccceecCCC
Q 014985          150 LKLADFGLARIFGSP  164 (415)
Q Consensus       150 vkL~DFG~a~~~~~~  164 (415)
                      +.|+|.+-+.....+
T Consensus       303 lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  303 LYIIDVSQSVEHDHP  317 (520)
T ss_pred             EEEEEccccccCCCh
Confidence            999999877654443

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.93  E-value=5.7e-05  Score=69.92  Aligned_cols=133  Identities=21%  Similarity=0.224  Sum_probs=77.1

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEEeecccCCH
Q 014985           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVFEFMETDL   97 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv~e~~~g~L   97 (415)
                      .+..|-.+.+|++.  ..++.+++|.........  .....+|..+++.+....+ .+++....    -++||||++|..
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            35678888999985  556788898754322111  1234679999999864333 34444332    258999999732


Q ss_pred             HH---------------HH---HhcC---CCCCHH-HHHHHHHHH---------HHHHHHhhh--------CCccccCCC
Q 014985           98 ET---------------VI---RNTN---IFLSPA-DIKSYMQMT---------LKGLAFCHK--------KWVLHRDMK  138 (415)
Q Consensus        98 ~~---------------~i---~~~~---~~l~~~-~~~~i~~qi---------l~aL~~lH~--------~~ivHrDlk  138 (415)
                      ..               .+   +...   ..++.. .+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            21               11   1111   111211 122222121         111222211        248999999


Q ss_pred             CCcEEEecCCcEEEeeecccee
Q 014985          139 PNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       139 p~NILi~~~~~vkL~DFG~a~~  160 (415)
                      |.||+++.++ +.|+||+.|..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999999877 88999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.93  E-value=6.2e-05  Score=71.68  Aligned_cols=137  Identities=14%  Similarity=0.101  Sum_probs=79.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEeee------ecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAF------PHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~------~~~~~~~l   88 (415)
                      .+.++.|....+|++..  ++..+++|.......    ...+..|+.++..|....  +.+++...      ...+..++
T Consensus        27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEe--CCCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            56677887789999853  344688897654221    123446777777774322  34444321      23456789


Q ss_pred             EeecccCCH-----H----------HHHHhcCCCCCH-------HHHH----------------HHHHHHHHHHHHhh--
Q 014985           89 VFEFMETDL-----E----------TVIRNTNIFLSP-------ADIK----------------SYMQMTLKGLAFCH--  128 (415)
Q Consensus        89 v~e~~~g~L-----~----------~~i~~~~~~l~~-------~~~~----------------~i~~qil~aL~~lH--  128 (415)
                      |++|++|..     .          ..+......++.       ...+                .....+...++++.  
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            999998721     1          111111110100       0000                00112233455553  


Q ss_pred             -----hCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985          129 -----KKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus       129 -----~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                           ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                 2679999999999999988877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.88  E-value=0.00035  Score=68.39  Aligned_cols=77  Identities=18%  Similarity=0.143  Sum_probs=52.4

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCc---c--CCccchHHHHHHHHHhcC---CCCeeeEEeeeecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---K--EGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~---~--~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.||.|.+..||++.+...++.++||.-.....   .  .-.......|...|+.+.   -.++.+++.+.  .+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            5678999999999998864445899998542111   0  112234556888888863   24577777663  456789


Q ss_pred             EeecccC
Q 014985           89 VFEFMET   95 (415)
Q Consensus        89 v~e~~~g   95 (415)
                      ||||+++
T Consensus       109 VME~L~~  115 (401)
T PRK09550        109 VMEDLSD  115 (401)
T ss_pred             EEecCCC
Confidence            9999985

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.87  E-value=6.6e-05  Score=71.02  Aligned_cols=137  Identities=16%  Similarity=0.092  Sum_probs=80.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEee------eecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDA------FPHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~------~~~~~~~~l   88 (415)
                      .+.|..|....+|++..  .+..+++|+...     .....+..|+.++..+.+..  +.+++..      ....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            56778888889999853  345788998653     11223556888888874322  4444432      233456789


Q ss_pred             EeecccCCHH---------------HHHHhcCCCCCH--------HHHH------------HHHHHHHHHHHHhhh----
Q 014985           89 VFEFMETDLE---------------TVIRNTNIFLSP--------ADIK------------SYMQMTLKGLAFCHK----  129 (415)
Q Consensus        89 v~e~~~g~L~---------------~~i~~~~~~l~~--------~~~~------------~i~~qil~aL~~lH~----  129 (415)
                      |++|++|...               ..++.....+..        ....            .....+..++.++.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999987321               111111000000        0000            011112233444442    


Q ss_pred             ---CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 ---KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ---~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                         .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence               4699999999999999887778999998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.82  E-value=5.8e-05  Score=66.29  Aligned_cols=98  Identities=18%  Similarity=0.176  Sum_probs=77.5

Q ss_pred             HHHHHHHhcCC-CCeeeEEeeeecCCeEEEEeeccc-CCHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCc
Q 014985           60 REIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFME-TDLETVI--RNTNIFLSPADIKSYMQMTLKGLAFCHK---KWV  132 (415)
Q Consensus        60 ~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~e~~~-g~L~~~i--~~~~~~l~~~~~~~i~~qil~aL~~lH~---~~i  132 (415)
                      .|.-+++.+++ +++.++++++.+    ++|.||++ +.+....  ...-..-++.....++.++++.+.+++.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58889999987 799999999943    47899998 4453210  0011225788999999999999999987   447


Q ss_pred             cccCCCCCcEEEecCCcEEEeeeccceec
Q 014985          133 LHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus       133 vHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      .-.|++|+|+-|+++|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            78999999999999999999999887543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.79  E-value=0.00029  Score=67.44  Aligned_cols=31  Identities=26%  Similarity=0.312  Sum_probs=26.4

Q ss_pred             CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      .|+||+|+.|.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999998665558999998863

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.73  E-value=0.00029  Score=66.90  Aligned_cols=72  Identities=18%  Similarity=0.274  Sum_probs=46.8

Q ss_pred             eeeecccCceEEEEEEECC------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEE
Q 014985           17 REVLGEGTYGVVYKAIDTK------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLV   89 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv   89 (415)
                      ++.|..|-...||++....      .++.|++|.......   ......+|+.+++.+....+ .+++.++..    .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            4567788888999996433      257899998654321   12245679988888854333 455555542    258


Q ss_pred             eecccC
Q 014985           90 FEFMET   95 (415)
Q Consensus        90 ~e~~~g   95 (415)
                      +||++|
T Consensus        76 ~e~i~G   81 (302)
T cd05156          76 EEFIPS   81 (302)
T ss_pred             hheeCC
Confidence            999887

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=97.66  E-value=0.00089  Score=63.38  Aligned_cols=77  Identities=17%  Similarity=0.148  Sum_probs=53.5

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC---CCeeeEEeeeec---CCeE
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIELIDAFPH---KGNL   86 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~~~~---~~~~   86 (415)
                      .-.-.+.||.|..+.||.....  +..+++|..+. .   .....+..|...|+.+..   -.+.++++++..   .+..
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC--CCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            4455678999999999999532  23566776432 1   112256689999998853   357788877644   4668


Q ss_pred             EEEeecccC
Q 014985           87 HLVFEFMET   95 (415)
Q Consensus        87 ~lv~e~~~g   95 (415)
                      ++|||+++|
T Consensus        89 ~LVmE~i~G   97 (297)
T PRK10593         89 VLLLERLRG   97 (297)
T ss_pred             EEEEeccCC
Confidence            999999986

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.46  E-value=8e-05  Score=69.39  Aligned_cols=141  Identities=18%  Similarity=0.268  Sum_probs=94.5

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---------------CCc-----cchHHHHHHHHHhcCCC-
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---------------EGV-----NFTALREIKLLKELKSP-   71 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---------------~~~-----~~~~~~E~~il~~l~hp-   71 (415)
                      -|.+.+.||-|.-+.||.+-+ ..|..+++|.-+.....               ...     ...+.+|...|+.|... 
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            356788999999999999975 46788999864332210               000     01234788888887532 


Q ss_pred             -CeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcE
Q 014985           72 -HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        72 -~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~v  150 (415)
                       -|.+.+++.    ..++|||++.|--+..++.-      ..+..+...+..-+--|-.+|+||+|+.--||+|++++.+
T Consensus       172 fpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDHN----RHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCccccc----ceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence             244555443    46799999998433332221      1223444555556667788999999999999999999999


Q ss_pred             EEeeeccceecCCC
Q 014985          151 KLADFGLARIFGSP  164 (415)
Q Consensus       151 kL~DFG~a~~~~~~  164 (415)
                      +++||--+.....+
T Consensus       242 ~vIDFPQmvS~sh~  255 (465)
T KOG2268|consen  242 VVIDFPQMVSTSHP  255 (465)
T ss_pred             EEeechHhhccCCC
Confidence            99999765444333

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.43  E-value=0.0024  Score=61.42  Aligned_cols=75  Identities=16%  Similarity=0.136  Sum_probs=48.2

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEeecCC-----ccCCccchHHHHHHHHHhcCC--C-CeeeEEeeeecCCeEEEEe
Q 014985           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-----QKEGVNFTALREIKLLKELKS--P-HIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~-----~~~~~~~~~~~E~~il~~l~h--p-~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .||.|....||++.+...++-++||.-..-.     ...-...+...|...|+...-  | ++.++|. | +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence            4799999999999975444689999753211     112223345568888877642  5 4445543 3 455566999


Q ss_pred             ecccC
Q 014985           91 EFMET   95 (415)
Q Consensus        91 e~~~g   95 (415)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99963

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.39  E-value=0.0022  Score=61.70  Aligned_cols=140  Identities=18%  Similarity=0.272  Sum_probs=80.6

Q ss_pred             EeeeeeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLV   89 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv   89 (415)
                      -...+.|..|-...+|++.....   +..|++|+......   ......+|..+++.+..-++ .++++++.. +   +|
T Consensus        16 ~i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i   88 (330)
T PLN02421         16 DFSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MI   88 (330)
T ss_pred             ceEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Ee
Confidence            34456666688899999965432   34788997654321   12234579999999876555 455666632 2   58


Q ss_pred             eecccCCHH-----------HHH-------HhcCCC----C-CHHHHHHHHHHH-------------------------H
Q 014985           90 FEFMETDLE-----------TVI-------RNTNIF----L-SPADIKSYMQMT-------------------------L  121 (415)
Q Consensus        90 ~e~~~g~L~-----------~~i-------~~~~~~----l-~~~~~~~i~~qi-------------------------l  121 (415)
                      .+|++|..+           ..+       +.....    . -...+..+..++                         +
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            888886321           111       111100    1 112222222221                         1


Q ss_pred             HHHH-HhhhCC----ccccCCCCCcEEEec-CCcEEEeeecccee
Q 014985          122 KGLA-FCHKKW----VLHRDMKPNNLLIGS-HGQLKLADFGLARI  160 (415)
Q Consensus       122 ~aL~-~lH~~~----ivHrDlkp~NILi~~-~~~vkL~DFG~a~~  160 (415)
                      ..+. .+...+    ++|+|+.+.|||+++ ++.++++||+.|..
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1111 121222    799999999999975 47899999998853

>PLN02236 choline kinase

Probab=97.36  E-value=0.0026  Score=61.56  Aligned_cols=140  Identities=16%  Similarity=0.211  Sum_probs=81.4

Q ss_pred             EeeeeeecccCceEEEEEEECC----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTK----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHL   88 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~l   88 (415)
                      ..-...|-.|-...+|++....    .++.|++|......   .......+|..+++.+..-++ .++++.+..+    .
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            3445566668889999986422    34689999765432   122233579999998865444 3556666433    5


Q ss_pred             EeecccCCHHH-----------H-------HHhcCCC-----CCHHHHHHHHHHHH--------------------HHHH
Q 014985           89 VFEFMETDLET-----------V-------IRNTNIF-----LSPADIKSYMQMTL--------------------KGLA  125 (415)
Q Consensus        89 v~e~~~g~L~~-----------~-------i~~~~~~-----l~~~~~~~i~~qil--------------------~aL~  125 (415)
                      |.+|++|..+.           .       +++....     .....+..++.++.                    ..|.
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            78888862211           1       1111100     11122323322211                    1111


Q ss_pred             H-h----hhCCccccCCCCCcEEEec-CCcEEEeeecccee
Q 014985          126 F-C----HKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARI  160 (415)
Q Consensus       126 ~-l----H~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~  160 (415)
                      . +    +...++|+|+++.|||++. ++.+.|+||..|..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1 1    1235899999999999986 47899999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.35  E-value=0.0036  Score=59.52  Aligned_cols=29  Identities=21%  Similarity=0.400  Sum_probs=25.8

Q ss_pred             CCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus       130 ~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999999775

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.34  E-value=0.00037  Score=68.72  Aligned_cols=172  Identities=22%  Similarity=0.288  Sum_probs=109.3

Q ss_pred             hHHHHHHHHHhcCCCCeeeEEeeeec-CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 014985           57 TALREIKLLKELKSPHIIELIDAFPH-KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR  135 (415)
Q Consensus        57 ~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHr  135 (415)
                      .++-...+++.+.|+|....+++-.. .....+|||+++-++.+......  +-..       +++       .+|+.|-
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~~-------~~~~~~~   91 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDE-------SLL-------AHGVLHL   91 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchh-------hhc-------cccccee
Confidence            45567888999999999999887643 34588999999999999887654  1111       111       2222221


Q ss_pred             CCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q 014985          136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS  215 (415)
Q Consensus       136 Dlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  215 (415)
                           |       .++++| -++..                |  |-      ..++++||||+|.++.++..|...+...
T Consensus        92 -----~-------~~~~td-~~~t~----------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   92 -----N-------IIYITD-HFLTK----------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             -----h-------hhhccc-ccccc----------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence                 1       234444 11110                1  11      1225899999999999999999888777


Q ss_pred             CcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       216 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      ...+.+..+.+..-.....       . .....        ..+.-.++....+++.+|+...|..||...++.+++-|.
T Consensus       135 ~~s~~l~~i~k~~~~d~~~-------~-~~a~e--------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~  198 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQEL-------L-STAME--------HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT  198 (725)
T ss_pred             HHHHHHHHHHHhccCchhH-------H-HHHHH--------HHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence            7777776665542211000       0 00000        000112356678899999999999999999999999887


Q ss_pred             CC
Q 014985          296 SA  297 (415)
Q Consensus       296 ~~  297 (415)
                      .+
T Consensus       199 ev  200 (725)
T KOG1093|consen  199 EV  200 (725)
T ss_pred             HH
Confidence            54

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.29  E-value=0.0021  Score=62.54  Aligned_cols=77  Identities=14%  Similarity=0.115  Sum_probs=50.3

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecC----CccCCccchHHHHHHHHHhcC--CC-CeeeEEeeeecCCeEEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG----KQKEGVNFTALREIKLLKELK--SP-HIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~----~~~~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~~~~~~~~~lv   89 (415)
                      .+.||.|.-.-||++.+...++-++||.-..-    ....-...+..-|..+|+...  .| ++.++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            67889999999999987544567999964321    111222234556888888774  25 45555433  45556788


Q ss_pred             eecccC
Q 014985           90 FEFMET   95 (415)
Q Consensus        90 ~e~~~g   95 (415)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999863

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.23  E-value=0.0018  Score=60.67  Aligned_cols=30  Identities=27%  Similarity=0.558  Sum_probs=25.7

Q ss_pred             CccccCCCCCcEEEecCCc-EEEeeecccee
Q 014985          131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARI  160 (415)
Q Consensus       131 ~ivHrDlkp~NILi~~~~~-vkL~DFG~a~~  160 (415)
                      .++|+|++|.|||++.+++ +-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997565 46999999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.13  E-value=0.0089  Score=58.52  Aligned_cols=76  Identities=20%  Similarity=0.209  Sum_probs=51.9

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCc--cC---CccchHHHHHHHHHhcC---CCCeeeEEeeeecCCeEE
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KE---GVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~--~~---~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.||.|....||++.+.  ++.++||.-.....  ..   -...+...|...|+.+.   ..++.+++.+.+  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678899999999999763  45688997542221  11   12334556777777764   247888887776  4467


Q ss_pred             EEeecccC
Q 014985           88 LVFEFMET   95 (415)
Q Consensus        88 lv~e~~~g   95 (415)
                      ++|||+++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.07  E-value=0.0066  Score=57.81  Aligned_cols=30  Identities=13%  Similarity=0.187  Sum_probs=27.8

Q ss_pred             CccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          131 WVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       131 ~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      +++|+|+.+.|||++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.98  E-value=0.0081  Score=58.83  Aligned_cols=78  Identities=15%  Similarity=0.209  Sum_probs=46.4

Q ss_pred             eeeeeecccCceEEEEEEECCC-CcEEEEEEe-e-cCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEEe
Q 014985           15 LKREVLGEGTYGVVYKAIDTKT-GQTVAIKKI-R-LGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVF   90 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~-~~~~avK~i-~-~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv~   90 (415)
                      ...+.|..|-...+|++..... +..+.+|.+ . .............+|+.+++.+...++ .++++.|..    ++|.
T Consensus        53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            4455666798999999964332 223333321 1 111222222234579999999976554 566777753    4999


Q ss_pred             ecccCC
Q 014985           91 EFMETD   96 (415)
Q Consensus        91 e~~~g~   96 (415)
                      ||++|.
T Consensus       129 efIeGr  134 (383)
T PTZ00384        129 EWVEGN  134 (383)
T ss_pred             EEeccc
Confidence            999973

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.90  E-value=0.011  Score=55.92  Aligned_cols=145  Identities=16%  Similarity=0.178  Sum_probs=81.0

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC--CCeeeEEeeeecCC--eEEEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHKG--NLHLV   89 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~--~~~lv   89 (415)
                      ..+++.+..|....+|...+.  ++.+++. ...............+|..+++.+.-  .-+...+.++..+.  ..|.|
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            345556555655566666443  7888888 33211222223345578888888743  22334455555444  67999


Q ss_pred             eecccCC----------HH-HHHH--------h---c---CCC-------CCHHHHHHHHHHH--------------HHH
Q 014985           90 FEFMETD----------LE-TVIR--------N---T---NIF-------LSPADIKSYMQMT--------------LKG  123 (415)
Q Consensus        90 ~e~~~g~----------L~-~~i~--------~---~---~~~-------l~~~~~~~i~~qi--------------l~a  123 (415)
                      |+|++|.          .. ....        .   -   +..       ....++..+..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            9999981          11 1111        0   0   000       0111111111111              112


Q ss_pred             HHHhhh--------CCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985          124 LAFCHK--------KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus       124 L~~lH~--------~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      ..+++.        -.++|+|+.+.||+|+.++-+=|.||+++...
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            333332        23899999999999999988999999999753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.63  E-value=0.036  Score=52.08  Aligned_cols=75  Identities=20%  Similarity=0.154  Sum_probs=47.5

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC---CCCeeeEEeeeecCCeEEEEe
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+-.+.++.|....+|+..  .+++.|.||+-.     ......+..|..-|+.|.   .-.+.+++.+....+..||||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            3456778999999999985  777899999865     122234567888888883   345778888887777789999


Q ss_pred             ecccC
Q 014985           91 EFMET   95 (415)
Q Consensus        91 e~~~g   95 (415)
                      ||++.
T Consensus        92 e~l~~   96 (288)
T PF03881_consen   92 EFLEM   96 (288)
T ss_dssp             E----
T ss_pred             EeecC
Confidence            99873

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.58  E-value=0.0048  Score=55.21  Aligned_cols=30  Identities=40%  Similarity=0.691  Sum_probs=21.5

Q ss_pred             CccccCCCCCcEEE-ecCCcEEEeeecccee
Q 014985          131 WVLHRDMKPNNLLI-GSHGQLKLADFGLARI  160 (415)
Q Consensus       131 ~ivHrDlkp~NILi-~~~~~vkL~DFG~a~~  160 (415)
                      -++|+||.|.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.56  E-value=0.008  Score=57.26  Aligned_cols=73  Identities=26%  Similarity=0.307  Sum_probs=56.5

Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      ..+.|++|++-++.+...-.     ...+++..++.+.+..++-+..+ ..-|||+.-.||||+ +|+|.|+||-+++.-
T Consensus       298 ~~y~yl~~kdhgt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDHGTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecCCceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34677888887776543221     34577788888887777777665 389999999999999 999999999999853

>PTZ00296 choline kinase; Provisional

Probab=96.40  E-value=0.041  Score=54.95  Aligned_cols=74  Identities=12%  Similarity=0.233  Sum_probs=47.3

Q ss_pred             eeeeecccCceEEEEEEECC--------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCee-eEEeeeecCCeE
Q 014985           16 KREVLGEGTYGVVYKAIDTK--------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-ELIDAFPHKGNL   86 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~--------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv-~l~~~~~~~~~~   86 (415)
                      -++.|..|-...+|++....        .++.|.+++......  .. ....+|..+++.+..-+|- ++++.|..    
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~g----  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--EL-YNPISEFEVYKTMSKYRIAPQLLNTFSG----  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--ce-eCHHHHHHHHHHHHHCCCCCceEEEeCC----
Confidence            56778888889999996442        256788887643221  11 1345688888888654543 45666532    


Q ss_pred             EEEeecccCC
Q 014985           87 HLVFEFMETD   96 (415)
Q Consensus        87 ~lv~e~~~g~   96 (415)
                      +.|.||++|.
T Consensus       182 g~I~efi~g~  191 (442)
T PTZ00296        182 GRIEEWLYGD  191 (442)
T ss_pred             CEEEEeeCCc
Confidence            3578888864

>PRK06148 hypothetical protein; Provisional

Probab=96.06  E-value=0.067  Score=59.19  Aligned_cols=31  Identities=32%  Similarity=0.513  Sum_probs=26.7

Q ss_pred             CCccccCCCCCcEEEecCC--cEE-Eeeecccee
Q 014985          130 KWVLHRDMKPNNLLIGSHG--QLK-LADFGLARI  160 (415)
Q Consensus       130 ~~ivHrDlkp~NILi~~~~--~vk-L~DFG~a~~  160 (415)
                      .++||+|+.+.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999999875  565 999998864

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.02  E-value=0.029  Score=49.94  Aligned_cols=102  Identities=20%  Similarity=0.231  Sum_probs=64.5

Q ss_pred             EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHH
Q 014985           39 TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ  118 (415)
Q Consensus        39 ~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~  118 (415)
                      ...+|+++.....-. ...+.++..++.++.  .|+++..=  ..-.+-++.|+|-.--            ... ..++.
T Consensus        87 ~L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~-~N~i~  148 (308)
T PF07387_consen   87 PLFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INF-SNFIT  148 (308)
T ss_pred             hhhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cch-hHHHH
Confidence            445666654332211 112356788888764  57777622  3335668999986210            000 11112


Q ss_pred             HHHHHHHHhhh--CCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985          119 MTLKGLAFCHK--KWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus       119 qil~aL~~lH~--~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                      .=+++|.-.|+  .+.+|+|..|+||+-|..|.+||.|-+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            22567888894  45999999999999999999999998754

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.96  E-value=0.12  Score=49.56  Aligned_cols=70  Identities=20%  Similarity=0.193  Sum_probs=41.0

Q ss_pred             cCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEE---e--eeecCCeEEEEeecccC
Q 014985           23 GTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELI---D--AFPHKGNLHLVFEFMET   95 (415)
Q Consensus        23 G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~---~--~~~~~~~~~lv~e~~~g   95 (415)
                      +.-..||++.. .+|..+++|+.+...   .....+..|+..+..|....  ++...   +  ....++..+.|+++++|
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            34468999853 456679999875332   12334557888887773211  22211   1  12335678889999887


Q ss_pred             C
Q 014985           96 D   96 (415)
Q Consensus        96 ~   96 (415)
                      .
T Consensus       112 ~  112 (325)
T PRK11768        112 R  112 (325)
T ss_pred             C
Confidence            3

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.34  E-value=0.11  Score=46.67  Aligned_cols=73  Identities=16%  Similarity=0.151  Sum_probs=48.9

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEeeeecCCeEEEEee
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +..+.+..|.--..|.+.+  ....|.+|+=.     ......+..|+.-|..|   +.-.|.+++.+..+.++.|+|||
T Consensus        19 ~er~~v~gG~inea~~v~d--g~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle   91 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD--GTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE   91 (286)
T ss_pred             hcccccCCccccceeEeec--CCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence            3345566666666776643  33578888622     22222445577666666   44568888999999999999999


Q ss_pred             ccc
Q 014985           92 FME   94 (415)
Q Consensus        92 ~~~   94 (415)
                      |++
T Consensus        92 ~L~   94 (286)
T COG3001          92 YLP   94 (286)
T ss_pred             ecc
Confidence            998

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.17  E-value=0.024  Score=53.25  Aligned_cols=137  Identities=18%  Similarity=0.200  Sum_probs=90.4

Q ss_pred             eeeeecccCceEEEEEEEC-------C---CCcEEEEEEeecCC----------------------ccCCc--cchHHHH
Q 014985           16 KREVLGEGTYGVVYKAIDT-------K---TGQTVAIKKIRLGK----------------------QKEGV--NFTALRE   61 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~-------~---~~~~~avK~i~~~~----------------------~~~~~--~~~~~~E   61 (415)
                      +...|..|.-+.|+.|.-.       .   ....+|||+++-..                      +....  ...+.+|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            4567889999999998321       0   23468888763210                      00000  0112245


Q ss_pred             HHHHHhc-----CCCCeeeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh-hhCCcccc
Q 014985           62 IKLLKEL-----KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC-HKKWVLHR  135 (415)
Q Consensus        62 ~~il~~l-----~hp~Iv~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~l-H~~~ivHr  135 (415)
                      ..-|.++     .+|-+|.+-..       .+||-|++.+-...-+-.+..++..+.+....|+..++.-| |.+-+||-
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkkh-------vLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA  408 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKKH-------VLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA  408 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeecc-------eEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence            5556655     36778877543       48999998532222222344588888888889998888777 56789999


Q ss_pred             CCCCCcEEEecCCcEEEeeecccee
Q 014985          136 DMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       136 Dlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ||.--|+|...+ .|-++|..-+..
T Consensus       409 DlSEyN~Lw~~g-Kvw~IDVsQsve  432 (531)
T KOG2269|consen  409 DLSEYNLLWTPG-KVWVIDVSQSVE  432 (531)
T ss_pred             chhhhhheecCC-ceEEEechhccC
Confidence            999999999775 799999866543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	415
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-105
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-78
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-78
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-76
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-75
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-75
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-75
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-75
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-75
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-75
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-75
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-75
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-75
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-75
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-74
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-74
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-74
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-74
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-74
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-74
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-74
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-74
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-74
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-74
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-74
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-74
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-74
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-74
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-74
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-74
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-74
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-74
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-74
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-74
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-74
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-74
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-74
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-74
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-73
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-73
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-73
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-72
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-71
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-67
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-61
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-61
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-60
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-60
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-60
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-59
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-56
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-52
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-52
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-51
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-50
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-50
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-50
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-49
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-49
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-49
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-49
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-48
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-48
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-48
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-48
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-48
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-48
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-48
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-48
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-48
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-48
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-48
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-48
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-48
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-48
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-48
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-48
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-48
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-48
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-48
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-48
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-48
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-48
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-48
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-47
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-47
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-46
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-46
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-45
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-45
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-45
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-45
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-44
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-44
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-43
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-43
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-43
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-43
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-43
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-43
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-43
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-43
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-43
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-43
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-43
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-43
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-43
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-43
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-43
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-43
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-43
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-43
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-43
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-43
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-43
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-43
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-43
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-43
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-43
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-43
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-43
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-43
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-43
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-43
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-43
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-43
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-43
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-43
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-43
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-43
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-43
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-43
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-43
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-43
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-43
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-43
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-43
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-43
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-43
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-43
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-43
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-43
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-43
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-43
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-43
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-42
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-42
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-42
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-42
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-42
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-42
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-42
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-42
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-42
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-42
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-42
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-42
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-42
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-42
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-42
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-42
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-41
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-41
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-41
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-41
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-41
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-41
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-41
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-41
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-41
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-41
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-41
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-41
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-41
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-41
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-41
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-41
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-41
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-41
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-41
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-41
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-41
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-39
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-38
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-38
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-38
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-38
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-38
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-37
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-37
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-37
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-37
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-37
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-37
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-37
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-37
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-37
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-37
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-37
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-37
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-37
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-36
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-36
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-36
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-36
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-36
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-36
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-36
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-36
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-36
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-36
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-35
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-35
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-35
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-35
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-35
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-34
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-33
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-31
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-31
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-31
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-31
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-30
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-30
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-30
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-29
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-29
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-29
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-29
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-29
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-28
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-28
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-28
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-28
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-28
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-27
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-27
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-27
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-27
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-27
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-27
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-27
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-27
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-26
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-26
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-24
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-24
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-24
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-24
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-24
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-24
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-24
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-23
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-23
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-23
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-23
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-23
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-23
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-23
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-23
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-23
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-23
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-22
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-22
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-22
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-22
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-22
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-22
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-22
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-22
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-22
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-22
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-22
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-22
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-22
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-22
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-22
3soa_A	444	Full-Length Human Camkii Length = 444		7e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-22
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-22
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-21
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-21
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-21
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-21
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-21
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-21
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-20
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-20
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-20
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-19
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-19
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-19
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-19
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-18
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-18
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-18
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-18
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-17
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-17
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-17
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-17
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-17
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-17
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-16
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-16
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-15
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-15
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-15
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-13
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-13
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-13
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		4e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-09
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-08

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  377 bits (968), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 181/318 (56%), Positives = 228/318 (71%), Gaps = 3/318 (0%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKL 64
           K  A RY K + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKL
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R + HQV  RWYRAPELLF
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           GA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPD
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
           YV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ +YFS+ P PT   
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 305
Query: 305 KLPRPATKRASKASDFNP 322
           +LPRP     +     NP
Sbjct: 306 QLPRPNCPVETLKEQSNP 323

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  288 bits (737), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 140/287 (48%), Positives = 189/287 (65%), Gaps = 3/287 (1%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + ++Y K E +GEGTYGVVYKA D++ G+ VA+K+IRL  + EG+  TA+REI LLKEL 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+I+ LID    +  L LVFEFME DL+ V+      L  + IK Y+   L+G+A CH+
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             +LHRD+KP NLLI S G LKLADFGLAR FG P R +TH+V   WYRAP++L G+K+Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-- 247
              VD+W+ GCIFAE++  +P   G +D DQL KIF+  GT  P +WP +  LP + +  
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +Q     P  S+ P    + +DLLS M  +DP  RI+A+ A+ H YF
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  288 bits (737), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 140/287 (48%), Positives = 189/287 (65%), Gaps = 3/287 (1%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + ++Y K E +GEGTYGVVYKA D++ G+ VA+K+IRL  + EG+  TA+REI LLKEL 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+I+ LID    +  L LVFEFME DL+ V+      L  + IK Y+   L+G+A CH+
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             +LHRD+KP NLLI S G LKLADFGLAR FG P R +TH+V   WYRAP++L G+K+Y
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-- 247
              VD+W+ GCIFAE++  +P   G +D DQL KIF+  GT  P +WP +  LP + +  
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +Q     P  S+ P    + +DLLS M  +DP  RI+A+ A+ H YF
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  281 bits (719), Expect = 5e-76,   Method: Compositional matrix adjust.
 Identities = 144/300 (48%), Positives = 187/300 (62%), Gaps = 2/300 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P    +L RP
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRLERP 306

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  278 bits (712), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 142/297 (47%), Positives = 185/297 (62%), Gaps = 2/297 (0%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLK
Sbjct: 5   SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLA 125
           EL  P+I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLA
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH   VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
            K Y   VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 246 V-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
              +   A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  278 bits (710), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 142/297 (47%), Positives = 185/297 (62%), Gaps = 2/297 (0%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLK
Sbjct: 5   SPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLA 125
           EL  P+I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLA
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH   VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
            K Y   VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 246 V-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
              +   A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  278 bits (710), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  278 bits (710), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  278 bits (710), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+T +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  278 bits (710), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  278 bits (710), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  277 bits (709), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  277 bits (708), Expect = 9e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  277 bits (708), Expect = 9e-75,   Method: Compositional matrix adjust.
 Identities = 141/292 (48%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFE +  DL+T +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  276 bits (707), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 183/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GL+FCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+ KIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+ KIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  275 bits (704), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  275 bits (704), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  275 bits (704), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  275 bits (704), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  275 bits (704), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 140/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  275 bits (702), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/285 (48%), Positives = 181/285 (63%), Gaps = 2/285 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 242
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F
Sbjct: 243 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  273 bits (699), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 136/284 (47%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA     G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH+V   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y     V
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 252 AAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             P P  S      +  +DLLSKM   DP  RITA+QALEH YF
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  273 bits (698), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 136/284 (47%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA     G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH+V   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y     V
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 252 AAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             P P  S      +  +DLLSKM   DP  RITA+QALEH YF
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  273 bits (697), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 135/284 (47%), Positives = 180/284 (63%), Gaps = 2/284 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA     G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH++   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y     V
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 252 AAP-PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             P P  S      +  +DLLSKM   DP  RITA+QALEH YF
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  273 bits (697), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 139/292 (47%), Positives = 182/292 (62%), Gaps = 2/292 (0%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFE ++ DL+  +  + +   P   IKSY+   L+GLAFCH  
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R + H+V   WYRAPE+L G K Y 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P 
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 139/285 (48%), Positives = 181/285 (63%), Gaps = 2/285 (0%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + V
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI  +G+LKLADFGLAR FG P R ++ +V   WYR P++LFGAK Y   
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-QY 250
           +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  Y
Sbjct: 183 IDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            A   L ++ P  +    DLL  +   +P  RI+A++AL+H YFS
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  267 bits (682), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 138/285 (48%), Positives = 181/285 (63%), Gaps = 2/285 (0%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + V
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           LHRD+KP NLLI  +G+LKLA+FGLAR FG P R ++ +V   WYR P++LFGAK Y   
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 193 VDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-QY 250
           +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  Y
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            A   L ++ P  +    DLL  +   +P  RI+A++AL+H YFS
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  251 bits (642), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 136/291 (46%), Positives = 181/291 (62%), Gaps = 8/291 (2%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           DRY +   LGEGTYG VYKAIDT T +TVAIK+IRL  ++EGV  TA+RE+ LLKEL+  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +IIEL     H   LHL+FE+ E DL+  + + N  +S   IKS++   + G+ FCH + 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 132 VLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            LHRD+KP NLL+          LK+ DFGLAR FG P R+FTH++   WYR PE+L G+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + Y   VD+W+  CI+AE+L + P   G S+IDQL KIF   G    + WP +  LPD+ 
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272
Query: 247 EY--QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
           +   ++      R L     D+ LDLL+ M   DP  RI+A+ ALEH YFS
Sbjct: 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  231 bits (589), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 126/308 (40%), Positives = 182/308 (59%), Gaps = 16/308 (5%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
             +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 71  PHIIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            +++ LI+     A P+   KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L 
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYR 178
           GL + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP+
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 256
Query: 239 LAYLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRYF 294
           +     Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H +F
Sbjct: 257 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316
Query: 295 SSAPLPTE 302
            S P+P++
Sbjct: 317 WSDPMPSD 324

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  230 bits (587), Expect = 9e-61,   Method: Compositional matrix adjust.
 Identities = 126/308 (40%), Positives = 182/308 (59%), Gaps = 16/308 (5%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
             +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 71  PHIIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            +++ LI+     A P+   KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYR 178
           GL + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 195
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP+
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255
Query: 239 LAYLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRYF 294
           +     Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H +F
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315
Query: 295 SSAPLPTE 302
            S P+P++
Sbjct: 316 WSDPMPSD 323

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  230 bits (587), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 126/306 (41%), Positives = 182/306 (59%), Gaps = 16/306 (5%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 73  IIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++ LI+     A P+   KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L GL
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRAP 180
            + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++ 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 241 YLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRYFSS 296
               Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H +F S
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318
Query: 297 APLPTE 302
            P+P++
Sbjct: 319 DPMPSD 324

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 119/297 (40%), Positives = 173/297 (58%), Gaps = 14/297 (4%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           + ++ + E LG GTY  VYK ++  TG  VA+K+++L  + EG   TA+REI L+KELK 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKH 62
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-----IKSYMQMTLKGLA 125
            +I+ L D    +  L LVFEFM+ DL+  + +  +  +P       +K +    L+GLA
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH+  +LHRD+KP NLLI   GQLKL DFGLAR FG P   F+ +V   WYRAP++L G
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           ++ Y   +D+W+ GCI AE++  +P   G++D +QL  IF   GT   S WP +  LP Y
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 246 VEYQYVAAPP--LRSLFPSASDDAL-----DLLSKMFTYDPKARITAQQALEHRYFS 295
                   PP  LR +    + + L     D L  +   +P  R++A+QAL H +F+
Sbjct: 243 -NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  228 bits (581), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 125/306 (40%), Positives = 181/306 (59%), Gaps = 16/306 (5%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 73  IIELID-----AFPH---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++ LI+     A P+   K +++LVF+F E DL  ++ N  +  + ++IK  MQM L GL
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRAP 180
            + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+ ++V   WYR P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++ 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 241 YLPDYVEYQYVAAP--PLRSLFPSASDD--ALDLLSKMFTYDPKARITAQQALEHRYFSS 296
               Y + + V      ++    +   D  ALDL+ K+   DP  RI +  AL H +F S
Sbjct: 259 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 318
Query: 297 APLPTE 302
            P+P++
Sbjct: 319 DPMPSD 324

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  226 bits (577), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 121/307 (39%), Positives = 180/307 (58%), Gaps = 5/307 (1%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  VYK     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 60
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    + +L LVFE+++ DL+  + +    ++  ++K ++   L+GLA+CH++ 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + + ++V   WYR P++L G+  Y  
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY- 250
            +D+W  GCIF E+   RP   GS+  +QL  IF   GT T   WP +    ++  Y Y 
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240
Query: 251 -VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
              A  L S  P    D  DLL+K+  ++ + RI+A+ A++H +F S  L    +KLP  
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS--LGERIHKLPDT 298
Query: 310 ATKRASK 316
            +  A K
Sbjct: 299 TSIFALK 305

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  214 bits (546), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 120/298 (40%), Positives = 166/298 (55%), Gaps = 19/298 (6%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + ++Y K   +GEG+YGVV+K  +  TGQ VAIKK    +    +   ALREI++LK+LK
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF---LSPADIKSYMQMTLKGLAF 126
            P+++ L++ F  K  LHLVFE+ +    TV+   + +   +    +KS    TL+ + F
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCD---HTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           CHK   +HRD+KP N+LI  H  +KL DFG AR+   P   +  +V  RWYR+PELL G 
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP--------SQWPD 238
            QYG  VDVWA GC+FAELL+  P   G SD+DQL  I    G   P        +Q+  
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
              +PD  + +     PL   FP+ S  AL LL      DP  R+T +Q L H YF +
Sbjct: 238 GVKIPDPEDME-----PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 115/285 (40%), Positives = 161/285 (56%), Gaps = 13/285 (4%)
Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +        P + IK  M   L+GL F H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS-Y 196
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 255
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             +A P+        +   DLL K  T++P  RI+A  AL H YF
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  201 bits (510), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 115/285 (40%), Positives = 161/285 (56%), Gaps = 13/285 (4%)
Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +        P + IK  M   L+GL F H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS-Y 196
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 255
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             +A P+        +   DLL K  T++P  RI+A  AL H YF
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 115/285 (40%), Positives = 161/285 (56%), Gaps = 13/285 (4%)
Query: 20  LGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIE 75
           +GEG YG V+KA D K G + VA+K++R+   +EG+  + +RE+ +L+ L++   P+++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 76  LIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHK 129
           L D         +  L LVFE ++ DL T +        P + IK  M   L+GL F H 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE+L  +  Y
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSS-Y 196
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    LP    + 
Sbjct: 197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FH 255
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             +A P+        +   DLL K  T++P  RI+A  AL H YF
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  196 bits (498), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 112/291 (38%), Positives = 163/291 (56%), Gaps = 12/291 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-- 70
           RY     +G G YG VYKA D  +G  VA+K +R+   +EG+  + +RE+ LL+ L++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 71  -PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKG 123
            P+++ L+D         +  + LVFE ++ DL T +        PA+ IK  M+  L+G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L F H   ++HRD+KP N+L+ S G +KLADFGLARI+ S        V   WYRAPE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALAPVVVTLWYRAPEVL 183
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               +      P++S+ P   +    LL +M T++P  RI+A +AL+H Y 
Sbjct: 243 RGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  196 bits (497), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 112/291 (38%), Positives = 163/291 (56%), Gaps = 12/291 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-- 70
           RY     +G G YG VYKA D  +G  VA+K +R+   +EG+  + +RE+ LL+ L++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 71  -PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKG 123
            P+++ L+D         +  + LVFE ++ DL T +        PA+ IK  M+  L+G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L F H   ++HRD+KP N+L+ S G +KLADFGLARI+ S        V   WYRAPE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEVL 183
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               +      P++S+ P   +    LL +M T++P  RI+A +AL+H Y 
Sbjct: 243 RGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 112/291 (38%), Positives = 163/291 (56%), Gaps = 12/291 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-- 70
           RY     +G G YG VYKA D  +G  VA+K +R+   +EG+  + +RE+ LL+ L++  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFE 64
Query: 71  -PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTLKG 123
            P+++ L+D         +  + LVFE ++ DL T +        PA+ IK  M+  L+G
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L F H   ++HRD+KP N+L+ S G +KLADFGLARI+      F   V   WYRAPE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP-VVVTLWYRAPEVL 183
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP    LP
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               +      P++S+ P   +    LL +M T++P  RI+A +AL+H Y 
Sbjct: 243 RGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 121/324 (37%), Positives = 165/324 (50%), Gaps = 27/324 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           ++  +  + +LGEG YGVV  A    TG+ VAIKKI     K       LREIK+LK  K
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFK 67
Query: 70  SPHIIELI-----DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II +      D+F +   ++++ E M+TDL  VI      LS   I+ ++  TL+ +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAV 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP----------DRRFTHQVFA 174
              H   V+HRD+KP+NLLI S+  LK+ DFGLARI                  T  V  
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF   G  TP 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG--TPH 243
Query: 235 QWPDLAYLPDYVEYQYVA------APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
              DL  +      +Y+       A PL  +FP  +   +DLL +M  +DP  RITA++A
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 289 LEHRYFSSAPLPT-EPNKLPRPAT 311
           LEH Y  +   P  EP   P P +
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPS 327

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 106/295 (35%), Positives = 157/295 (53%), Gaps = 19/295 (6%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y    ++GEG+YG+V K  +  TG+ VAIKK       + V   A+REIKLLK+L+  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCH 128
           +++ L++    K   +LVFEF++    T++ +  +F +  D   ++ Y+   + G+ FCH
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVD---HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
              ++HRD+KP N+L+   G +KL DFG AR   +P   +  +V  RWYRAPELL G  +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP------SQWPDLA-- 240
           YG  VDVWA GC+  E+    P   G SDIDQL  I    G   P      ++ P  A  
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            LP+  E +     PL   +P  S+  +DL  K    DP  R    + L H +F 
Sbjct: 262 RLPEIKERE-----PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  193 bits (490), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 121/324 (37%), Positives = 165/324 (50%), Gaps = 27/324 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           ++  +  + +LGEG YGVV  A    TG+ VAIKKI     K       LREIK+LK  K
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFK 67
Query: 70  SPHIIELI-----DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II +      D+F +   ++++ E M+TDL  VI      LS   I+ ++  TL+ +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAV 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP----------DRRFTHQVFA 174
              H   V+HRD+KP+NLLI S+  LK+ DFGLARI                  T  V  
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF   G  TP 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG--TPH 243
Query: 235 QWPDLAYLPDYVEYQYVA------APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
              DL  +      +Y+       A PL  +FP  +   +DLL +M  +DP  RITA++A
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 289 LEHRYFSSAPLPT-EPNKLPRPAT 311
           LEH Y  +   P  EP   P P +
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPS 327

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 122/324 (37%), Positives = 168/324 (51%), Gaps = 27/324 (8%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           ++  +  + +LGEG YGVV  A    TG+ VAIKKI     K       LREIK+LK  K
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFK 67
Query: 70  SPHIIELI-----DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II +      D+F +   ++++ E M+TDL  VI      LS   I+ ++  TL+ +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAV 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQ-------VFA 174
              H   V+HRD+KP+NLLI S+  LK+ DFGLARI     + +   T Q       V  
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF   G  TP 
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG--TPH 243
Query: 235 QWPDLAYLPDYVEYQYVA------APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
              DL  +      +Y+       A PL  +FP  +   +DLL +M  +DP  RITA++A
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 289 LEHRYFSSAPLPT-EPNKLPRPAT 311
           LEH Y  +   P  EP   P P +
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPS 327

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 165/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLAFR 81
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 255
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 256 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 295 SSAPLPTE 302
           +    P++
Sbjct: 316 AQYYDPSD 323

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 81
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 255
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 256 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 295 SSAPLPTE 302
                P++
Sbjct: 316 EQYYDPSD 323

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 254 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 SSAPLPTE 302
                P++
Sbjct: 314 EQYYDPSD 321

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 99
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 157
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 158 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 216
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 273
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 274 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 295 SSAPLPTE 302
                P++
Sbjct: 334 EQYYDPSD 341

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 29  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 87
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 145
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 146 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 204
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 261
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 262 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321
Query: 295 SSAPLPTE 302
                P++
Sbjct: 322 EQYYDPSD 329

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 254 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 SSAPLPTE 302
                P++
Sbjct: 314 EQYYDPSD 321

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  189 bits (480), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 254 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 SSAPLPTE 302
                P++
Sbjct: 314 EQYYDPSD 321

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 254 XIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 SSAPLPTE 302
                P++
Sbjct: 314 EQYYDPSD 321

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 84
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 142
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 143 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 201
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 258
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 259 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 295 SSAPLPTE 302
                P++
Sbjct: 319 EQYYDPSD 326

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 27  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 85
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 144 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 202
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 259
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 260 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319
Query: 295 SSAPLPTE 302
                P++
Sbjct: 320 EQYYDPSD 327

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 18  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 76
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 134
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 135 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 193
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 250
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 251 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310
Query: 295 SSAPLPTE 302
                P++
Sbjct: 311 EQYYDPSD 318

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 SSAPLPTE 302
                P++
Sbjct: 318 EQYYDPSD 325

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 77
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 136 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 194
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 251
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 252 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 295 SSAPLPTE 302
                P++
Sbjct: 312 EQYYDPSD 319

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  189 bits (479), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 SSAPLPTE 302
                P++
Sbjct: 318 EQYYDPSD 325

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD   T      V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 SSAPLPTE 302
                P++
Sbjct: 318 EQYYDPSD 325

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 26  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 84
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 142
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD   T      V  RWYRAP
Sbjct: 143 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAP 201
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 258
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 259 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 295 SSAPLPTE 302
                P++
Sbjct: 319 EQYYDPSD 326

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 SSAPLPTE 302
                P++
Sbjct: 318 EQYYDPSD 325

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 21  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 79
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 138 KYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 196
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 253
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 254 XIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 295 SSAPLPTE 302
                P++
Sbjct: 314 EQYYDPSD 321

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 SSAPLPTE 302
                P++
Sbjct: 318 EQYYDPSD 325

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 114/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAI+KI   + +     T LREIK+L   +
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 141
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 200
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 257
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 295 SSAPLPTE 302
                P++
Sbjct: 318 EQYYDPSD 325

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 114/301 (37%), Positives = 164/301 (54%), Gaps = 15/301 (4%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL---GKQKEGVNFTALREI 62
           L      RY     +G G YG VYKA D  +G  VA+K +R+   G    G+  + +RE+
Sbjct: 3   LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 63  KLLKELKS---PHIIELIDAFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPAD-I 113
            LL+ L++   P+++ L+D         +  + LVFE ++ DL T +        PA+ I
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF 173
           K  M+  L+GL F H   ++HRD+KP N+L+ S G +KLADFGLARI+ S     T  V 
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVV 181
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             WYRAPE+L  +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G    
Sbjct: 182 TLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             WP    LP    +      P++S+ P   +    LL +M T++P  RI+A +AL+H Y
Sbjct: 241 DDWPRDVSLPRGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 294 F 294
Sbjct: 300 L 300

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  187 bits (476), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 115/308 (37%), Positives = 164/308 (53%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLAFR 81
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 140 KYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 198
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 255
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 256 CGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 295 SSAPLPTE 302
           +    P++
Sbjct: 316 AQYYDPSD 323

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  187 bits (475), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 116/320 (36%), Positives = 171/320 (53%), Gaps = 26/320 (8%)
Query: 2   AEVDLSK----KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT 57
            EV++ K     V  RY + + +GEG YG+V  A D      VAIKKI   + +     T
Sbjct: 29  GEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRT 88
Query: 58  ALREIKLLKELKSPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
            LREI++L   +  ++I + D           ++++V + METDL  ++++    LS   
Sbjct: 89  -LREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ--LSNDH 145
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----F 168
           I  ++   L+GL + H   VLHRD+KP+NLLI +   LK+ DFGLARI   P+       
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARI-ADPEHDHTGFL 204
Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
           T  V  RWYRAPE++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    
Sbjct: 205 TEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 264
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKAR 282
           G  +PSQ  DL  + +     Y+ + P ++      LFP +   ALDLL +M T++P  R
Sbjct: 265 G--SPSQ-EDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKR 321
Query: 283 ITAQQALEHRYFSSAPLPTE 302
           IT ++AL H Y      PT+
Sbjct: 322 ITVEEALAHPYLEQYYDPTD 341

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 114/308 (37%), Positives = 163/308 (52%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 19  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 77
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           ++++V + METDL  +++  +  LS   I  ++   L+GL
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 136 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 194
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +P Q  DL 
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPEQ-EDLN 251
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 252 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 295 SSAPLPTE 302
                P++
Sbjct: 312 EQYYDPSD 319

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 114/308 (37%), Positives = 161/308 (52%), Gaps = 22/308 (7%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +     T LREIK+L   +
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 99
Query: 70  SPHIIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           +++LV   M  DL  +++  +  LS   I  ++   L+GL
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGL 157
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR----FTHQVFARWYRAP 180
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+   PD       T  V  RWYRAP
Sbjct: 158 KYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAP 216
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PSQ  DL 
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPSQ-EDLN 273
Query: 241 YLPDYVEYQYVAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            + +     Y+ + P ++      LFP+A   ALDLL KM T++P  RI  +QAL H Y 
Sbjct: 274 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 295 SSAPLPTE 302
                P++
Sbjct: 334 EQYYDPSD 341

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 112/320 (35%), Positives = 167/320 (52%), Gaps = 21/320 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D++  V D Y   E +G G YGVV  A    TGQ VAIKKI             LRE+K+
Sbjct: 48  DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 107
Query: 65  LKELKSPHIIELIDA------FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK  K  +II + D       +    ++++V + ME+DL  +I ++   L+   ++ ++ 
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP-LTLEHVRYFLY 166
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR---FTHQVFA 174
             L+GL + H   V+HRD+KP+NLL+  + +LK+ DFG+AR +  SP       T  V  
Sbjct: 167 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPEL+    +Y   +D+W+ GCIF E+L RR    G + + QL  I    GT +P+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 235 QWPDL------AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
               +      AY+      Q V   P  +++P A   AL LL +M  ++P ARI+A  A
Sbjct: 287 VIQAVGAERVRAYIQSLPPRQPV---PWETVYPGADRQALSLLGRMLRFEPSARISAAAA 343
Query: 289 LEHRYFSSAPLP-TEPNKLP 307
           L H + +    P  EP+  P
Sbjct: 344 LRHPFLAKYHDPDDEPDCAP 363

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  182 bits (461), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 112/320 (35%), Positives = 167/320 (52%), Gaps = 21/320 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D++  V D Y   E +G G YGVV  A    TGQ VAIKKI             LRE+K+
Sbjct: 47  DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 106
Query: 65  LKELKSPHIIELIDA------FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK  K  +II + D       +    ++++V + ME+DL  +I ++   L+   ++ ++ 
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP-LTLEHVRYFLY 165
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRR---FTHQVFA 174
             L+GL + H   V+HRD+KP+NLL+  + +LK+ DFG+AR +  SP       T  V  
Sbjct: 166 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPEL+    +Y   +D+W+ GCIF E+L RR    G + + QL  I    GT +P+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 235 QWPDL------AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
               +      AY+      Q V   P  +++P A   AL LL +M  ++P ARI+A  A
Sbjct: 286 VIQAVGAERVRAYIQSLPPRQPV---PWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342
Query: 289 LEHRYFSSAPLP-TEPNKLP 307
           L H + +    P  EP+  P
Sbjct: 343 LRHPFLAKYHDPDDEPDCAP 362

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 152/302 (50%), Gaps = 21/302 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  AID ++G+ VAIKK+    Q E     A RE+ LLK ++  ++I L+D 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    +L      +LV  FM+TDL+ ++    +  S   I+  +   LKGL + H   V+
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWMHYNQTV 205
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AE+L  +   +G   +DQL +I    G         +  L D     Y+ +
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF---VQKLNDKAAKSYIQS 262
Query: 254 PP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
            P         LFP AS  A DLL KM   D   R+TA QAL H +F     P E  +  
Sbjct: 263 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ 322
Query: 308 RP 309
           +P
Sbjct: 323 QP 324

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 152/302 (50%), Gaps = 21/302 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  AID ++G+ VAIKK+    Q E     A RE+ LLK ++  ++I L+D 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    +L      +LV  FM+TDL+ ++    +  S   I+  +   LKGL + H   V+
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPEVILSWMHYNQTV 223
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AE+L  +   +G   +DQL +I    G         +  L D     Y+ +
Sbjct: 224 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF---VQKLNDKAAKSYIQS 280
Query: 254 PP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
            P         LFP AS  A DLL KM   D   R+TA QAL H +F     P E  +  
Sbjct: 281 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQ 340
Query: 308 RP 309
           +P
Sbjct: 341 QP 342

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  179 bits (453), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 112/309 (36%), Positives = 162/309 (52%), Gaps = 36/309 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--VNFTA--------LREIK 63
           Y  +  +  G+YG V   +D++ G  VAIK++      +G  VN  +        LREI+
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRV-FNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 64  LLKELKSPHIIELIDAFPH-----KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LL     P+I+ L D F H        L+LV E M TDL  VI +  I +SP  I+ +M 
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L GL   H+  V+HRD+ P N+L+  +  + + DF LAR   + D   TH V  RWYR
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE-DTADANKTHYVTHRWYR 200
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT-------- 230
           APEL+   K +   VD+W+AGC+ AE+ NR+   +GS+  +QL KI    GT        
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 231 -ATPSQWPDLAYLPDYV--EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
            ++PS         DY+      V A    ++ P+A   ALDL++KM  ++P+ RI+ +Q
Sbjct: 261 FSSPSA-------RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 288 ALEHRYFSS 296
           AL H YF S
Sbjct: 314 ALRHPYFES 322

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 112/309 (36%), Positives = 162/309 (52%), Gaps = 36/309 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--VNFTA--------LREIK 63
           Y  +  +  G+YG V   +D++ G  VAIK++      +G  VN  +        LREI+
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRV-FNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 64  LLKELKSPHIIELIDAFPH-----KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LL     P+I+ L D F H        L+LV E M TDL  VI +  I +SP  I+ +M 
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L GL   H+  V+HRD+ P N+L+  +  + + DF LAR   + D   TH V  RWYR
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE-DTADANKTHYVTHRWYR 200
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT-------- 230
           APEL+   K +   VD+W+AGC+ AE+ NR+   +GS+  +QL KI    GT        
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260
Query: 231 -ATPSQWPDLAYLPDYV--EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
            ++PS         DY+      V A    ++ P+A   ALDL++KM  ++P+ RI+ +Q
Sbjct: 261 FSSPSA-------RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 288 ALEHRYFSS 296
           AL H YF S
Sbjct: 314 ALRHPYFES 322

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 116/349 (33%), Positives = 164/349 (46%), Gaps = 65/349 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y+ + ++G G+YG VY A D  T + VAIKK+    +        LREI +L  LK
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 70  SPHIIELID-AFPHK----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           S +II L D   P        L++V E  ++DL+ + + T IFL+   IK+ +   L G 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGE 142
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------- 165
            F H+  ++HRD+KP N L+     +K+ DFGLAR   S                     
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 166 ---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-----------NRRPF 211
              ++ T  V  RWYRAPEL+   + Y   +D+W+ GCIFAELL           NR P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 212 LQGS-----------------SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
             GS                 S+ DQL  IF   GT T     ++   P+ +  +Y+   
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK-PEVI--KYIKLF 319
Query: 255 P------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
           P      L+  +PS SDD ++LL  M  ++P  RIT  QAL+H Y    
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 114/347 (32%), Positives = 176/347 (50%), Gaps = 54/347 (15%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           + + V  +Y   + LG+G YG+V+K+ID +TG+ VA+KKI    Q         REI +L
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 66  KELKS-PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            EL    +I+ L++     +  +++LVF++METDL  VIR  NI L P   +  +   +K
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR-ANI-LEPVHKQYVVYQLIK 120
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ----------- 171
            + + H   +LHRDMKP+N+L+ +   +K+ADFGL+R F +  RR T+            
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI-RRVTNNIPLSINENTEN 179
Query: 172 -----------VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ 220
                      V  RWYRAPE+L G+ +Y  G+D+W+ GCI  E+L  +P   GSS ++Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 221 LGKIFAAF---------GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF----------- 260
           L +I                +P     +  L + VE   +     R +F           
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVE---IRQSNKRDIFTKWKNLLLKIN 296
Query: 261 --PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT-EPN 304
                +++ALDLL K+  ++P  RI+A  AL+H + S    P  EPN
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPN 343

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 155
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 212
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 273 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 328

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +  A  Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 156
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 213
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 329

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 260 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 107/296 (36%), Positives = 151/296 (51%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 146
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 203
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 263
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 264 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 319

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 113/320 (35%), Positives = 158/320 (49%), Gaps = 42/320 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +G GTYG VYKA           A+K+I    +  G++ +A REI LL+ELK P++I L 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 78  DAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIKSYMQMTLKGLAFC 127
             F    +  + L+F++ E DL  +I+           + L    +KS +   L G+ + 
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 128 HKKWVLHRDMKPNNLLIGSHG----QLKLADFGLARIFGSPDRRFTH---QVFARWYRAP 180
           H  WVLHRD+KP N+L+   G    ++K+AD G AR+F SP +        V   WYRAP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG-SSDI--------DQLGKIFAAFGTA 231
           ELL GA+ Y   +D+WA GCIFAELL   P       DI        DQL +IF   G  
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 232 TPSQWPDLAYLP-------DYVEYQYVAAPPLRSLFPSA---SDDALDLLSKMFTYDPKA 281
               W D+  +P       D+    Y     ++ +          A  LL K+ T DP  
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 282 RITAQQALEHRYFSSAPLPT 301
           RIT++QA++  YF   PLPT
Sbjct: 325 RITSEQAMQDPYFLEDPLPT 344

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 169/299 (56%), Gaps = 33/299 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVV++A   ++ + VAIKK+   K+ +       RE+++++ +K P++
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKHPNV 94
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRNTNIF------LSPADIKSYMQMTL 121
           ++L   F   G+      L+LV E++    ETV R +  +      +    IK YM   L
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIF--GSPDRRFTHQVFARWYR 178
           + LA+ H   + HRD+KP NLL+    G LKL DFG A+I   G P+      + +R+YR
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSXICSRYYR 208
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APEL+FGA  Y   +D+W+ GC+ AEL+  +P   G S IDQL +I    GT +  Q   
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 239 LAYLPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +   P+Y+E+++  +   P   +F P    DA+DL+S++  Y P AR+TA +AL H +F
Sbjct: 269 MN--PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 155/310 (50%), Gaps = 15/310 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+    
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 300 P-TEPNKLPR 308
           P  EP   PR
Sbjct: 314 PDDEPVADPR 323

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 156
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGXVATRWYRAPEI 213
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 329

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 311

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 315

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 152/301 (50%), Gaps = 21/301 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A D +  Q VA+KK+    Q         RE++LLK LK  ++I L+D 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    ++      +LV   M  DL  ++++    LS   ++  +   L+GL + H   ++
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKSQA--LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AELL  +    GS  IDQL +I    GT +P     LA +       Y+ +
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAKISSEHARTYIQS 267
Query: 254 PP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT-EPNKL 306
            P      L S+F  A+  A+DLL +M   D   R++A +AL H YFS    P  EP   
Sbjct: 268 LPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE 327
Query: 307 P 307
           P
Sbjct: 328 P 328

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 159
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 216
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 332

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  ++++    L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGL R     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 148
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 205
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 321

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 148
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 205
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 321

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 311

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 311

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 315

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 133
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 190
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 306

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 156/312 (50%), Gaps = 21/312 (6%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  + D K+G  +A+KK+    Q         RE++LLK +
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 69  KSPHIIELIDAFPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    +L      +LV   M  DL  +++     L+   ++  +   L+
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 165
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 222
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  I+QL +I    GT   S    ++ +
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASV---ISRM 279
Query: 243 PDYVEYQYVAAPP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
           P +    Y+ + P         +F  A+  A+DLL KM   D   RITA +AL H YFS 
Sbjct: 280 PSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339
Query: 297 APLP-TEPNKLP 307
              P  EP   P
Sbjct: 340 YHDPDDEPESEP 351

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 104/289 (35%), Positives = 152/289 (52%), Gaps = 20/289 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK ++  ++I L+D 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F     L      +LV  FM TDL  ++++    L    I+  +   LKGL + H   ++
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP NL +    +LK+ DFGLAR     D      V  RWYRAPE++    +Y   V
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVVTRWYRAPEVILNWMRYTQTV 207
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AE++  +   +GS  +DQL +I    GT  P+++  +  L       Y+  
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP-PAEF--VQRLQSDEAKNYMKG 264
Query: 254 PP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
            P        S+  +AS  A++LL KM   D + R+TA +AL H YF S
Sbjct: 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 314

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 199
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 315

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 148
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 205
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 321

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 147
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 204
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 320

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 138
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 195
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 311

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 155
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 212
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 273 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 328

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 314

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 156
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 213
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 274 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 329

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 135
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 192
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 252
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 253 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 308

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 134
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 191
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 251
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 252 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 307

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 314

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 147
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 204
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 320

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 141
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 198
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 314

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 133
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 190
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 251 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 306

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEI 189
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +A  P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 250 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 151/301 (50%), Gaps = 21/301 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A D +  Q VA+KK+    Q         RE++LLK LK  ++I L+D 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    ++      +LV   M  DL  +++     LS   ++  +   L+GL + H   ++
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQA--LSDEHVQFLVYQLLRGLKYIHSAGII 153
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 154 HRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AELL  +    GS  IDQL +I    GT +P     LA +       Y+ +
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAKISSEHARTYIQS 267
Query: 254 PP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT-EPNKL 306
            P      L S+F  A+  A+DLL +M   D   R++A +AL H YFS    P  EP   
Sbjct: 268 LPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE 327
Query: 307 P 307
           P
Sbjct: 328 P 328

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 151/301 (50%), Gaps = 21/301 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V  A D +  Q VA+KK+    Q         RE++LLK LK  ++I L+D 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 80  FPHKGNL------HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           F    ++      +LV   M  DL  +++     LS   ++  +   L+GL + H   ++
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQA--LSDEHVQFLVYQLLRGLKYIHSAGII 145
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+KP+N+ +    +L++ DFGLAR     D   T  V  RWYRAPE++     Y   V
Sbjct: 146 HRDLKPSNVAVNEDCELRILDFGLAR---QADEEMTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ GCI AELL  +    GS  IDQL +I    GT +P     LA +       Y+ +
Sbjct: 203 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEV---LAKISSEHARTYIQS 259
Query: 254 PP------LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT-EPNKL 306
            P      L S+F  A+  A+DLL +M   D   R++A +AL H YFS    P  EP   
Sbjct: 260 LPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE 319
Query: 307 P 307
           P
Sbjct: 320 P 320

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 150/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D+GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 159
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D      V  RWYRAPE+
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGYVATRWYRAPEI 216
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 332

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 103/316 (32%), Positives = 163/316 (51%), Gaps = 30/316 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +  RY+  + LG G  G+V+ A+D    + VAIKKI L   +   +  ALREIK+++ L 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH--ALREIKIIRRLD 66
Query: 70  SPHIIELIDAFPHKGN--------------LHLVFEFMETDLETVIRNTNIFLSPADIKS 115
             +I+++ +     G+              +++V E+METDL  V+    +    A  + 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA--RL 124
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQ--- 171
           +M   L+GL + H   VLHRD+KP NL I +    LK+ DFGLARI    D  ++H+   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHL 181
Query: 172 ---VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
              +  +WYR+P LL     Y   +D+WAAGCIFAE+L  +    G+ +++Q+  I  + 
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 229 GTATPSQWPD-LAYLPDYVEYQYVA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                    + L+ +P Y+         PL  L P  S +A+D L ++ T+ P  R+TA+
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 287 QALEHRYFSSAPLPTE 302
           +AL H Y S    P +
Sbjct: 302 EALSHPYMSIYSFPMD 317

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DF LAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 103/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+  GK  +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 143
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE+
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEI 200
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+  FGLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  167 bits (424), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 103/296 (34%), Positives = 161/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+  GK  +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+ +  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 252 -PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 105/296 (35%), Positives = 149/296 (50%), Gaps = 14/296 (4%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 69  KSPHIIELIDAF-PHK-----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F P +      +++LV   M  DL  +++     L+   ++  +   L+
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 136
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ D GLAR     D   T  V  RWYRAPE+
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGYVATRWYRAPEI 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 309

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 103/296 (34%), Positives = 160/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+  GK  +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+ +  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 252 -PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 226
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 285
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 286 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 111
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 172 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 228
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 287
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 288 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 342

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 113
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 174 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 230
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 289
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 290 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 344

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 103
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 164 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 220
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 279
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 280 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 334

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 154
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 215 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 271
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 330
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 331 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 385

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 109
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 226
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 285
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 286 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 80
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 141 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 197
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 256
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 257 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 311

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 162/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 88
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 149 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 205
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 264
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 265 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 319

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 204
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 263
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 264 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 94
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 155 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 211
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 270
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 271 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 325

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 168/310 (54%), Gaps = 30/310 (9%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+  +   + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F    
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL- 309
Query: 299 LPTEPN-KLP 307
              +PN KLP
Sbjct: 310 --RDPNVKLP 317

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 83
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 144 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 200
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 259
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 260 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 314

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 26/296 (8%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 87
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 148 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 204
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 263
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F
Sbjct: 264 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 167/310 (53%), Gaps = 30/310 (9%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F    
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL- 309
Query: 299 LPTEPN-KLP 307
              +PN KLP
Sbjct: 310 --RDPNVKLP 317

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 167/310 (53%), Gaps = 30/310 (9%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 79
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 140 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 196
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 255
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F    
Sbjct: 256 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL- 313
Query: 299 LPTEPN-KLP 307
              +PN KLP
Sbjct: 314 --RDPNVKLP 321

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 167/310 (53%), Gaps = 30/310 (9%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F    
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL- 309
Query: 299 LPTEPN-KLP 307
              +PN KLP
Sbjct: 310 --RDPNVKLP 317

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 167/310 (53%), Gaps = 30/310 (9%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 76
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 137 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 193
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 252
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F    
Sbjct: 253 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL- 310
Query: 299 LPTEPN-KLP 307
              +PN KLP
Sbjct: 311 --RDPNVKLP 318

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 167/310 (53%), Gaps = 30/310 (9%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE++++++L   +I
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNI 75
Query: 74  IELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           + L   F   G       L+LV +++   +  V R+       L    +K YM    + L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 AFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE 181
           A+ H   + HRD+KP NLL+      LKL DFG A+  + G P+      + +R+YRAPE
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRAPE 192
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q  ++  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN- 251
Query: 242 LPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
            P+Y E+++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F    
Sbjct: 252 -PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL- 309
Query: 299 LPTEPN-KLP 307
              +PN KLP
Sbjct: 310 --RDPNVKLP 317

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 112/355 (31%), Positives = 163/355 (45%), Gaps = 73/355 (20%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           ++ DRY  R ++G G+YG V +A D    + VAIKKI    +        LREI +L  L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 69  KSPHIIELIDAFPHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
              H+++++D    K       L++V E  ++D + + R T ++L+   IK+ +   L G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVG 168
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------ 165
           + + H   +LHRD+KP N L+     +K+ DFGLAR    P+                  
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 166 ---------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--------- 207
                    R+ T  V  RWYRAPEL+   + Y   +DVW+ GCIFAELLN         
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 208 --RRPFLQGSS--------------------DIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
             R P   GSS                    + DQL  IF   G  TPS+  D+  L   
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG--TPSE-EDIEALEKE 345
Query: 246 VEYQYVAAPPLR------SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              +Y+   P R        FP++S DA+ LL +M  ++P  RIT  + L H +F
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 112/353 (31%), Positives = 158/353 (44%), Gaps = 68/353 (19%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           KV D Y  + ++G G+YG VY A D    + VAIKK+    +        LREI +L  L
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 69  KSPHIIELID-AFPHK----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           KS +II L D   P        L++V E  ++DL+ + + T IFL+   +K+ +   L G
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEQHVKTILYNLLLG 143
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------ 165
             F H+  ++HRD+KP N L+     +K+ DFGLAR   S                    
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 166 -------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-----------N 207
                  ++ T  V  RWYRAPEL+   + Y   +D+W+ GCIFAELL           N
Sbjct: 204 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTN 263
Query: 208 RRPFLQGS-----------------SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
           R P   GS                 S+ DQL  IF   GT  P +  DL  +      +Y
Sbjct: 264 RFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTP-PEE--DLKCITKQEVIKY 320
Query: 251 VAAPPLRS------LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
           +   P R        + S S + +DLL  M  ++ + RIT  +AL H Y    
Sbjct: 321 IKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDV 373

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 111/323 (34%), Positives = 160/323 (49%), Gaps = 25/323 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY + + +G G  G+V  A DT  G  VA+KK+    Q +     A RE+ L
Sbjct: 15  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 74
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK +   +II L++ F P K      +++LV E M+ +L  VI   ++ L    +   + 
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLY 131
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR   S +   T  V  R+YR
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ASTNFMMTPYVVTRYYR 190
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  EL+      QG+  IDQ  K+    GT +      
Sbjct: 191 APEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 249
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +A   L    +FPS S+        A DLLSKM   DP  RI+
Sbjct: 250 LQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 309
Query: 285 AQQALEHRYFSSAPLPTEPNKLP 307
             +AL H Y +    P E    P
Sbjct: 310 VDEALRHPYITVWYDPAEAEAPP 332

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 312 VDDALQHPYINVWYDPAE 329

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 312 VDDALQHPYINVWYDPAE 329

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 110/323 (34%), Positives = 159/323 (49%), Gaps = 25/323 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY + + +G G  G+V  A DT  G  VA+KK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           LK +   +II L++ F P K      +++LV E M+ +L  VI   ++ L    +   + 
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR     +   T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y A VD+W+ GCI  EL+      QG+  IDQ  K+    GT +      
Sbjct: 193 APEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAA 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +    L    +FPS S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 311
Query: 285 AQQALEHRYFSSAPLPTEPNKLP 307
             +AL H Y +    P E    P
Sbjct: 312 VDEALRHPYITVWYDPAEAEAPP 334

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLY 126
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 185
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 305 VDDALQHPYINVWYDPAE 322

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 171
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 230
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 231 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 350 VDDALQHPYINVWYDPAE 367

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 312 VDDALQHPYINVWYDPAE 329

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 171
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 230
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 231 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 350 VDDALQHPYINVWYDPAE 367

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 106/311 (34%), Positives = 155/311 (49%), Gaps = 25/311 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRYFS 295
              AL+H Y +
Sbjct: 312 VDDALQHPYIN 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 134
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 313 VDDALQHPYINVWYDPAE 330

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 134
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 313 VDDALQHPYINVWYDPAE 330

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 312 VDDALQHPYINVWYDPAE 329

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 16  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 75
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 132
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 191
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 192 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 310
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 311 VDDALQHPYINVWYDPAE 328

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 127
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 186
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 187 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 306 VDDALQHPYINVWYDPAE 323

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 126
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 185
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 305 VDDALQHPYINVWYDPAE 322

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 108/318 (33%), Positives = 157/318 (49%), Gaps = 25/318 (7%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 127
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 186
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 187 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305
Query: 285 AQQALEHRYFSSAPLPTE 302
              AL+H Y +    P E
Sbjct: 306 VDDALQHPYINVWYDPAE 323

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 106/311 (34%), Positives = 155/311 (49%), Gaps = 25/311 (8%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      +++LV E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 LA-YLPDYVE----YQYVAAPPL--RSLFPSASD-------DALDLLSKMFTYDPKARIT 284
           L   + +YVE    Y  +  P L   SLFP+ S+        A DLLSKM   DP  RI+
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311
Query: 285 AQQALEHRYFS 295
              AL+H Y +
Sbjct: 312 VDDALQHPYIN 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T +V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPEVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNALKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 134
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 194 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 312 SVDEALQHPYINVWYDPSEAEAPPPKIP 339

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 22  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 81
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 138
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 197
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 198 APEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 256
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 257 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 315
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 316 SVDEALQHPYINVWYDPSEAEAPPPKIP 343

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 106/328 (32%), Positives = 160/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+       +V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMEPEVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P+    
Sbjct: 193 APEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKK 251
Query: 239 LA-----YL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRNYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 127
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYR 186
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 187 APEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 246 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 304
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 305 SVDEALQHPYINVWYDPSEAEAPPPKIP 332

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 106/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+       +V  R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMEPEVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 193 APEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 106/328 (32%), Positives = 158/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 19  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 78
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLY 135
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+        V  R+YR
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMVPFVVTRYYR 194
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ GCI  E++       G+  IDQ  K+    GT  P     
Sbjct: 195 APEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 253
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 254 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 312
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 313 SVDEALQHPYINVWYDPSEAEAPPPKIP 340

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 106/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ G I  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 106/328 (32%), Positives = 159/328 (48%), Gaps = 31/328 (9%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 65  LKELKSPHIIELIDAF-PHKG-----NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F P K      ++++V E M+ +L  VI+   + L    +   + 
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHERMSYLLY 133
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G+     T  V  R+YR
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTRYYR 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G   Y   VD+W+ G I  E++       G+  IDQ  K+    GT +P     
Sbjct: 193 APEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 239 L-----AYL---PDYVEYQYVAAPPLRSLFPSASD-------DALDLLSKMFTYDPKARI 283
           L      Y+   P Y  Y +    P   LFP+ S+        A DLLSKM   D   RI
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 284 TAQQALEHRYFSSAPLPTE----PNKLP 307
           +  +AL+H Y +    P+E    P K+P
Sbjct: 311 SVDEALQHPYINVWYDPSEAEAPPPKIP 338

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 97/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+ +       REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNK-----IKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 101/383 (26%), Positives = 174/383 (45%), Gaps = 67/383 (17%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           + +Y   + LG G++G+V +  D ++G+  A+KK+    + +       RE+ ++K L  
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN------RELDIMKVLDH 59
Query: 71  PHIIELIDAFPHKGN--------------------------------------LHLVFEF 92
            +II+L+D F   G+                                      L+++ E+
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 93  METDLETVIRNTNIFLS-----PADIKS-YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS 146
           +   L  V+++   F+      P ++ S Y+    + + F H   + HRD+KP NLL+ S
Sbjct: 120 VPDTLHKVLKS---FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 147 H-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL 205
               LKL DFG A+    P       + +R+YRAPEL+ GA +Y   +D+W+ GC+F EL
Sbjct: 177 KDNTLKLCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 206 LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY--VAAPPLRSLFPSA 263
           +  +P   G + IDQL +I    GT T  Q   +   P Y E ++  + A   R + P  
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEG 293
Query: 264 SDD-ALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP-----NKLPRPATKRASKA 317
           +   A+DLL ++  Y+P  RI   +A+ H +F       E      +  P    +   + 
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353
Query: 318 SDFNPQEGPTVLSPPRKTRRVMP 340
            +F+P E   +  P     R++P
Sbjct: 354 FNFSPYELSII--PGNVLNRILP 374

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 101/323 (31%), Positives = 154/323 (47%), Gaps = 30/323 (9%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S+K  DR+    + G+GT+G V    +  TG +VAIKK+    Q        L+ ++ L 
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLA 74
Query: 67  ELKSPHIIELIDAFPHKGN-------LHLVFEFMETDLETVIRN---TNIFLSPADIKSY 116
            L  P+I++L   F   G        L++V E++   L    RN     +   P  IK +
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 117 MQMTLKGLAFCH--KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVF 173
           +   ++ +   H     V HRD+KP+N+L+  + G LKL DFG A+   SP       + 
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVAYIC 193
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           +R+YRAPEL+FG + Y   VD+W+ GCIFAE++   P  +G +   QL +I    G  + 
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSAS----DDALDLLSKMFTYDPKARITAQQAL 289
                L      V+       P  ++F   S     +A DLLS +  Y P+ R+   +AL
Sbjct: 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313
Query: 290 EHRYFSSAPLPTEPNKLPRPATK 312
            H YF         ++L  PATK
Sbjct: 314 CHPYF---------DELHDPATK 327

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 96/292 (32%), Positives = 147/292 (50%), Gaps = 35/292 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 142
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F +  ++   ++   +Y APE+L 
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLH 201
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW        
Sbjct: 202 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-------- 251
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                              S+ A DL+ KM TY P  RI+A+ AL+H +  +
Sbjct: 252 ----------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 96/292 (32%), Positives = 146/292 (50%), Gaps = 35/292 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 106
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 165
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F    ++   ++   +Y APE+L 
Sbjct: 166 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH 224
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW        
Sbjct: 225 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-------- 274
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                              S+ A DL+ KM TY P  RI+A+ AL+H +  +
Sbjct: 275 ----------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 310

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 96/292 (32%), Positives = 146/292 (50%), Gaps = 35/292 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 107
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 166
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F    ++   ++   +Y APE+L 
Sbjct: 167 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH 225
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW        
Sbjct: 226 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-------- 275
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                              S+ A DL+ KM TY P  RI+A+ AL+H +  +
Sbjct: 276 ----------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 311

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/292 (32%), Positives = 147/292 (50%), Gaps = 35/292 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 89
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I++L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYM 148
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F    ++   ++   +Y APE+L 
Sbjct: 149 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVLH 207
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW  +     
Sbjct: 208 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----- 260
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                              S+ A DL+ KM TY P  RI+A+ AL+H +  +
Sbjct: 261 -------------------SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 100/302 (33%), Positives = 156/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + VA+K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVAVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N+LI   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVLIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/292 (32%), Positives = 145/292 (49%), Gaps = 35/292 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKEL 68
           +DRY  + VLG+G++G V    D  TGQ  A+K I  R  KQK     + LRE++LLK+L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLREVQLLKQL 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFE-FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P+I +L + F  KG  +LV E +   +L   I +   F S  D    ++  L G+ + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYX 142
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +++ DFGL+  F +  ++   ++   +Y APE+L 
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKXKDKIGTAYYIAPEVLH 201
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
           G   Y    DVW+ G I   LL+  P   G+++ D L K+     T    QW        
Sbjct: 202 GT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-------- 251
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                              S+ A DL+ K  TY P  RI+A+ AL+H +  +
Sbjct: 252 ----------------KKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQT 287

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 93/310 (30%), Positives = 143/310 (46%), Gaps = 38/310 (12%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK+L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L +      + ++V E        + +I+      S  D    ++    G+ + H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 129 KKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           K  ++HRD+KP N+L+ S  +   +K+ DFGL+  F   + +   ++   +Y APE+L G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              Y    DVW+AG I   LL+  P   G ++ D L ++          QW         
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH----RYFSSAPLPT 301
                           + SDDA DL+ KM T+ P  RITA Q LEH    +Y S  P  +
Sbjct: 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291
Query: 302 EPNKLPRPAT 311
           +   L    T
Sbjct: 292 DLPSLESAMT 301

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 101/324 (31%), Positives = 149/324 (45%), Gaps = 43/324 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTAL-REIKLLKEL 68
           D Y   EV+G+G + VV + I+ +TGQ  A+K + + K     G++   L RE  +   L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDL--ETVIR-NTNIFLSPADIKSYMQMTLKGL 124
           K PHI+EL++ +   G L++VFEFM+  DL  E V R +     S A    YM+  L+ L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +CH   ++HRD+KP N+L+ S      +KL DFG+A   G        +V    + APE
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++   + YG  VDVW  G I   LL+      G+ +    G I   +    P QW  +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KMNPRQWSHI-- 259
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH-------RYF 294
                                 S+ A DL+ +M   DP  RIT  +AL H       RY 
Sbjct: 260 ----------------------SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 295 SSAPLPTEPNKLPRPATKRASKAS 318
               LP    +L +   +R  K +
Sbjct: 298 YKIHLPETVEQLRKFNARRKLKGA 321

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 152/290 (52%), Gaps = 25/290 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    +     ++ +   K        RE+K+L+ L+   +II+LID
Sbjct: 46  LGRGKYSEVFEAINITNNE-----RVVVKILKPVKKKKIKREVKILENLRGGTNIIKLID 100
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE++  TD + + +     L+  DI+ YM   LK L +CH K ++HR
Sbjct: 101 TVKDPVSKTPALVFEYINNTDFKQLYQ----ILTDFDIRFYMYELLKALDYCHSKGIMHR 156
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 157 DVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLD 215
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           +W+ GC+ A ++ RR PF  G  + DQL +I    GT     +    ++     +  +  
Sbjct: 216 MWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILG 275
Query: 254 PPLRSLFPS---------ASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              R  + +          S +ALDLL K+  YD + R+TA++A+EH YF
Sbjct: 276 QHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 153/291 (52%), Gaps = 27/291 (9%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    +     ++ +   K        RE+K+L+ L+   +II+LID
Sbjct: 51  LGRGKYSEVFEAINITNNE-----RVVVKILKPVKKKKIKREVKILENLRGGTNIIKLID 105
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE++  TD + + +     L+  DI+ YM   LK L +CH K ++HR
Sbjct: 106 TVKDPVSKTPALVFEYINNTDFKQLYQ----ILTDFDIRFYMYELLKALDYCHSKGIMHR 161
Query: 136 DMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP+N++I  H Q  L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +
Sbjct: 162 DVKPHNVMI-DHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDYSL 219
Query: 194 DVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D+W+ GC+ A ++ RR PF  G  + DQL +I    GT     +    ++     +  + 
Sbjct: 220 DMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDIL 279
Query: 253 APPLRSLFPS---------ASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               R  + +          S +ALDLL K+  YD + R+TA++A+EH YF
Sbjct: 280 GQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 98/301 (32%), Positives = 153/301 (50%), Gaps = 41/301 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
               P      LVFE +       +R T   L+  DI+ YM   LK L +CH   ++HRD
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLRQT---LTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 137 MKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           +KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D+
Sbjct: 157 VKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 196 WAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVAA 253
           W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y     
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIELD 266
Query: 254 PPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
           P    +                     S +ALD L K+  YD ++R+TA++A+EH YF +
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 326
Query: 297 A 297
Sbjct: 327 V 327

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 135/286 (47%), Gaps = 34/286 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK+L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L +      + ++V E        + +I+      S  D    ++    G+ + H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 129 KKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           K  ++HRD+KP N+L+ S  +   +K+ DFGL+  F   + +   ++   +Y APE+L G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              Y    DVW+AG I   LL+  P   G ++ D L ++          QW         
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                           + SDDA DL+ KM T+ P  RITA Q LEH
Sbjct: 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 135/286 (47%), Gaps = 34/286 (11%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK+L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L +      + ++V E        + +I+      S  D    ++    G+ + H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH 138
Query: 129 KKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           K  ++HRD+KP N+L+ S  +   +K+ DFGL+  F   + +   ++   +Y APE+L G
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
              Y    DVW+AG I   LL+  P   G ++ D L ++          QW         
Sbjct: 198 T--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW--------- 246
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                           + SDDA DL+ KM T+ P  RITA Q LEH
Sbjct: 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 101/344 (29%), Positives = 161/344 (46%), Gaps = 59/344 (17%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G++G V KA D K  Q VA+K +R  K+    +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLR 151
Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L E + +N     S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G+  +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAP 268
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ----- 235
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G   PSQ     
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG--MPSQKLLDA 325
Query: 236 ---WPDLAYLPDYVEYQYVA--------------------APPLRSLFPSA---SDDA-- 267
                +      Y  Y  V                      PP    + +A    DD   
Sbjct: 326 SKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 268 LDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPAT 311
           LD L +   +DP  R+T  QAL H        P    +LP+P T
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRH--------PWLRRRLPKPPT 421

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 97
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 212
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 263
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 296 SA 297
           + 
Sbjct: 324 TV 325

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 98
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 264
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 296 SA 297
           + 
Sbjct: 325 TV 326

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 98
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 264
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324
Query: 296 SA 297
           + 
Sbjct: 325 TV 326

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 325
Query: 296 SA 297
           + 
Sbjct: 326 TV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 155/302 (51%), Gaps = 43/302 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 50  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 104
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 105 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 160
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 161 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 219
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 220 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 270
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF 
Sbjct: 271 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 330
Query: 296 SA 297
           + 
Sbjct: 331 TV 332

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 98/299 (32%), Positives = 154/299 (51%), Gaps = 43/299 (14%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELID 78
           LG G Y  V++AI+    + V +K ++  K+K        REIK+L+ L+  P+II L D
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILENLRGGPNIITLAD 99
Query: 79  AF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
               P      LVFE +  TD + + +     L+  DI+ YM   LK L +CH   ++HR
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 136 DMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           D+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL   + Y   +D
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 195 VWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQYVA 252
           +W+ GC+ A ++ R+ PF  G  + DQL +I    GT           L DY++ Y    
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED---------LYDYIDKYNIEL 265
Query: 253 APPLRSLFPS-----------------ASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            P    +                     S +ALD L K+  YD ++R+TA++A+EH YF
Sbjct: 266 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 98/342 (28%), Positives = 158/342 (46%), Gaps = 55/342 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G +G V KA D K  Q VA+K +R  K+    +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLR 151
Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L E + +N     S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G+  +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYXXIQSRFYRAP 268
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA------TPS 234
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G           
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASK 327
Query: 235 QWPDLAYLPDYVEYQYVA--------------------APPLRSLFPSA---SDDA--LD 269
           +  +      Y  Y  V                      PP    + +A    DD   LD
Sbjct: 328 RAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 270 LLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPAT 311
            L +   +DP  R+T  QAL H        P    +LP+P T
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRH--------PWLRRRLPKPPT 421

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 96/324 (29%), Positives = 154/324 (47%), Gaps = 51/324 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G++G V KA D K  Q VA+K +R  K+    +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLR 151
Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L E + +N     S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G+  +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTXIQSRFYRAP 268
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ----- 235
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G   PSQ     
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG--MPSQKLLDA 325
Query: 236 ---WPDLAYLPDYVEYQYVA--------------------APPLRSLFPSA---SDDA-- 267
                +      Y  Y  V                      PP    + +A    DD   
Sbjct: 326 SKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 268 LDLLSKMFTYDPKARITAQQALEH 291
           LD L +   +DP  R+T  QAL H
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRH 409

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 99/324 (30%), Positives = 148/324 (45%), Gaps = 43/324 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTAL-REIKLLKEL 68
           D Y   EV+G+G + VV + I+ +TGQ  A+K + + K     G++   L RE  +   L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDL--ETVIR-NTNIFLSPADIKSYMQMTLKGL 124
           K PHI+EL++ +   G L++VFEFM+  DL  E V R +     S A    YM+  L+ L
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +CH   ++HRD+KP+ +L+ S      +KL  FG+A   G        +V    + APE
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 205
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++   + YG  VDVW  G I   LL+      G+ +    G I   +    P QW  +  
Sbjct: 206 VV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KMNPRQWSHI-- 261
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH-------RYF 294
                                 S+ A DL+ +M   DP  RIT  +AL H       RY 
Sbjct: 262 ----------------------SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 299
Query: 295 SSAPLPTEPNKLPRPATKRASKAS 318
               LP    +L +   +R  K +
Sbjct: 300 YKIHLPETVEQLRKFNARRKLKGA 323

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 131/249 (52%), Gaps = 33/249 (13%)
Query: 70  SPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +C
Sbjct: 106 GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 162
Query: 128 HKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 221
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           + Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +     AYL   
Sbjct: 222 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----AYLN-- 274
Query: 246 VEYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQA 288
            +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A
Sbjct: 275 -KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEA 333
Query: 289 LEHRYFSSA 297
           + H YF   
Sbjct: 334 MTHPYFQQV 342

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 99/324 (30%), Positives = 148/324 (45%), Gaps = 43/324 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTAL-REIKLLKEL 68
           D Y   EV+G+G + VV + I+ +TGQ  A+K + + K     G++   L RE  +   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDL--ETVIR-NTNIFLSPADIKSYMQMTLKGL 124
           K PHI+EL++ +   G L++VFEFM+  DL  E V R +     S A    YM+  L+ L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +CH   ++HRD+KP+ +L+ S      +KL  FG+A   G        +V    + APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++   + YG  VDVW  G I   LL+      G+ +    G I   +    P QW  +  
Sbjct: 204 VV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY-KMNPRQWSHI-- 259
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH-------RYF 294
                                 S+ A DL+ +M   DP  RIT  +AL H       RY 
Sbjct: 260 ----------------------SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 295 SSAPLPTEPNKLPRPATKRASKAS 318
               LP    +L +   +R  K +
Sbjct: 298 YKIHLPETVEQLRKFNARRKLKGA 321

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 37/300 (12%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG------KQKEGVNFTALR 60
           +K+   +Y  ++V+G G   VV + +   TG   A+K + +       +Q E V     R
Sbjct: 89  AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 61  EIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           E  +L+++   PHII LID++     + LVF+ M            + LS  + +S M+ 
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L+ ++F H   ++HRD+KP N+L+  + Q++L+DFG +     P  +         Y A
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRELCGTPGYLA 267
Query: 180 PELLFGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           PE+L  +       YG  VD+WA G I   LL   P       I  L  I       +  
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +W D                         S    DL+S++   DP+AR+TA+QAL+H +F
Sbjct: 328 EWDD------------------------RSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 131/251 (52%), Gaps = 33/251 (13%)
Query: 68  LKSPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +  P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L 
Sbjct: 83  MGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 126 FCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           +CH + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 198
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             + Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL 
Sbjct: 199 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN 253
Query: 244 DYVEYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQ 286
              +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA 
Sbjct: 254 ---KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 310
Query: 287 QALEHRYFSSA 297
           +A+ H YF   
Sbjct: 311 EAMTHPYFQQV 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 33/248 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 143
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 254
Query: 247 EYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A+
Sbjct: 255 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 314
Query: 290 EHRYFSSA 297
            H YF   
Sbjct: 315 THPYFQQV 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 130/249 (52%), Gaps = 33/249 (13%)
Query: 70  SPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +C
Sbjct: 85  GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 141
Query: 128 HKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           + Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL   
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN-- 253
Query: 246 VEYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQA 288
            +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A
Sbjct: 254 -KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEA 312
Query: 289 LEHRYFSSA 297
           + H YF   
Sbjct: 313 MTHPYFQQV 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 33/248 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRYFSSA 297
            H YF   
Sbjct: 314 THPYFQQV 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 33/248 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 143
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 254
Query: 247 EYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A+
Sbjct: 255 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 314
Query: 290 EHRYFSSA 297
            H YF   
Sbjct: 315 THPYFQQV 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 33/248 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRYFSSA 297
            H YF   
Sbjct: 314 THPYFQQV 321

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 130/249 (52%), Gaps = 33/249 (13%)
Query: 70  SPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +C
Sbjct: 85  GPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYC 141
Query: 128 HKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           + Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL   
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN-- 253
Query: 246 VEYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQA 288
            +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A
Sbjct: 254 -KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEA 312
Query: 289 LEHRYFSSA 297
           + H YF   
Sbjct: 313 MTHPYFQQV 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 33/248 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 144
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 255
Query: 247 EYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A+
Sbjct: 256 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 315
Query: 290 EHRYFSSA 297
            H YF   
Sbjct: 316 THPYFQQV 323

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/248 (31%), Positives = 130/248 (52%), Gaps = 33/248 (13%)
Query: 71  PHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P+I++L+D     H     L+FE++      V+  T   L+  DI+ Y+   LK L +CH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + ++HRD+KP+N++I     +L+L D+GLA  F  P + +  +V +R+++ PELL   +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 188 QYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y   +D+W+ GC+FA ++ R+ PF  G  + DQL KI    GT   +      YL    
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLN-----VYLN--- 253
Query: 247 EYQYVAAPPLRSL-----------FPSASD------DALDLLSKMFTYDPKARITAQQAL 289
           +Y+    P L +L           F +A +      +A+D L K+  YD + R+TA +A+
Sbjct: 254 KYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAM 313
Query: 290 EHRYFSSA 297
            H YF   
Sbjct: 314 THPYFQQV 321

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/300 (31%), Positives = 137/300 (45%), Gaps = 43/300 (14%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-----------GKQKEGVNFT 57
           K+ + Y K   LG G YG V    +       AIK I+             K  E  +  
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSY 116
              EI LLK L  P+II+L D F  K   +LV EF E  +L   I N + F    D  + 
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANI 151
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL---KLADFGLARIFGSPDRRFTHQVF 173
           M+  L G+ + HK  ++HRD+KP N+L+ +   L   K+ DFGL+  F S D +   ++ 
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDRLG 210
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             +Y APE+L   K+Y    DVW+ G I   LL   P   G +D D + K+         
Sbjct: 211 TAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG------ 262
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                  Y  D+ +++ +            SD+A +L+  M TYD   R TA++AL  R+
Sbjct: 263 ------KYYFDFNDWKNI------------SDEAKELIKLMLTYDYNKRCTAEEALNSRW 304

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/289 (31%), Positives = 135/289 (46%), Gaps = 37/289 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKEL 68
           ++DRY + + LG G YG V    D  TG   AIK I+        N  AL  E+ +LK+L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             P+I++L + F  K N +LV E     E   E ++R      S  D    M+  L G  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTT 135
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP NLL+ S  +   +K+ DFGL+  F     +   ++   +Y APE+
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEV 194
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K+Y    DVW+ G I   LL   P   G +D + L ++     +  P  W  +   
Sbjct: 195 L--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV--- 249
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                SD+A  L+  M TY+P  RI+A++AL H
Sbjct: 250 ---------------------SDEAKQLVKLMLTYEPSKRISAEEALNH 277

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 136/287 (47%), Gaps = 34/287 (11%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +++ Y + + LG G YG V    D  T    AIK IR        N   L E+ +LK L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+I++L D F  K N +LV E  +     + +I       +  D    ++  L G+ + 
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYL 152
Query: 128 HKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           HK  ++HRD+KP NLL+ S  +   +K+ DFGL+ +F +  ++   ++   +Y APE+L 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL- 210
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             K+Y    DVW+ G I   LL   P   G +D + L K+     T    +W ++     
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----- 264
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                              S+ A DL+ +M  +D + RI+AQQALEH
Sbjct: 265 -------------------SEGAKDLIKQMLQFDSQRRISAQQALEH 292

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 91/289 (31%), Positives = 134/289 (46%), Gaps = 37/289 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKEL 68
           ++DRY + + LG G YG V    D  TG   AIK I+        N  AL  E+ +LK+L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             P+I++L + F  K N +LV E     E   E ++R      S  D    M+  L G  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTT 118
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP NLL+ S  +   +K+ DFGL+  F     +   ++   +Y APE+
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEV 177
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K+Y    DVW+ G I   LL   P   G +D + L ++     +  P  W      
Sbjct: 178 L--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDW------ 229
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                SD+A  L+  M TY+P  RI+A++AL H
Sbjct: 230 ------------------TQVSDEAKQLVKLMLTYEPSKRISAEEALNH 260

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 143/298 (47%), Gaps = 31/298 (10%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           + E  L+K+  + +   E LGEG+YG VYKAI  +TGQ VAIK++ +    + +    ++
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IK 73
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM 119
           EI ++++  SPH+++   ++    +L +V E+     +  +IR  N  L+  +I + +Q 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           TLKGL + H    +HRD+K  N+L+ + G  KLADFG+A        +    +   ++ A
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++     Y    D+W+ G    E+   +P     +DI  +  IF       P+  P  
Sbjct: 194 PEVI-QEIGYNCVADIWSLGITAIEMAEGKP---PYADIHPMRAIFM-----IPTNPPPT 244
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
              P+                   SD+  D + +     P+ R TA Q L+H +  SA
Sbjct: 245 FRKPEL-----------------WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 99/336 (29%), Positives = 154/336 (45%), Gaps = 58/336 (17%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           +K  DRY    ++G+G++G V KA D    + VAIK I   K K+     A  E++LL E
Sbjct: 31  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLL-E 86
Query: 68  LKSPH-------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNI-FLSPADIKSYMQM 119
           L + H       I+ L   F  + +L LVFE +  +L  ++RNTN   +S    + + Q 
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 146
Query: 120 TLKGLAFCH--KKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFAR 175
               L F    +  ++H D+KP N+L+ +     +K+ DFG +   G   +R    + +R
Sbjct: 147 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSR 203
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           +YR+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G   P+ 
Sbjct: 204 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP-PAH 261
Query: 236 WPDLA--------YLPDYV-----------EYQYVAAPPLRSLFPSASD----------- 265
             D A         LPD             EY+      L ++    +            
Sbjct: 262 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 321
Query: 266 ----DAL---DLLSKMFTYDPKARITAQQALEHRYF 294
               D L   DL+ +M  YDPK RI    AL+H +F
Sbjct: 322 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 357

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 141/302 (46%), Gaps = 53/302 (17%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKL 64
           +SK+    Y+ RE LGEG++G V  A   KT Q VA+K I R   +K  ++    REI  
Sbjct: 3   ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           LK L+ PHII+L D      ++ +V E+   +L   I      ++  + + + Q  +  +
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFA 174
            +CH+  ++HRD+KP NLL+  +  +K+ADFGL+ I           GSP+         
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--------- 172
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             Y APE++ G    G  VDVW+ G + +  L+ R PF     D + +  +F    +   
Sbjct: 173 --YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF-----DDEFIPNLFKKVNSC-- 223
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                +  +PD++                 S  A  L+ +M   DP  RIT Q+     +
Sbjct: 224 -----VYVMPDFL-----------------SPGAQSLIRRMIVADPMQRITIQEIRRDPW 261
Query: 294 FS 295
           F+
Sbjct: 262 FN 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 99/336 (29%), Positives = 154/336 (45%), Gaps = 58/336 (17%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           +K  DRY    ++G+G++G V KA D    + VAIK I   K K+     A  E++LL E
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLL-E 105
Query: 68  LKSPH-------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNI-FLSPADIKSYMQM 119
           L + H       I+ L   F  + +L LVFE +  +L  ++RNTN   +S    + + Q 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 120 TLKGLAFCH--KKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFAR 175
               L F    +  ++H D+KP N+L+ +     +K+ DFG +   G   +R    + +R
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSR 222
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           +YR+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G   P+ 
Sbjct: 223 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP-PAH 280
Query: 236 WPDLA--------YLPDYV-----------EYQYVAAPPLRSLFPSASD----------- 265
             D A         LPD             EY+      L ++    +            
Sbjct: 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340
Query: 266 ----DAL---DLLSKMFTYDPKARITAQQALEHRYF 294
               D L   DL+ +M  YDPK RI    AL+H +F
Sbjct: 341 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 99/336 (29%), Positives = 154/336 (45%), Gaps = 58/336 (17%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           +K  DRY    ++G+G++G V KA D    + VAIK I   K K+     A  E++LL E
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLL-E 105
Query: 68  LKSPH-------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNI-FLSPADIKSYMQM 119
           L + H       I+ L   F  + +L LVFE +  +L  ++RNTN   +S    + + Q 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 120 TLKGLAFCH--KKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFAR 175
               L F    +  ++H D+KP N+L+ +     +K+ DFG +   G   +R    + +R
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG---QRIYQXIQSR 222
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           +YR+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G   P+ 
Sbjct: 223 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP-PAH 280
Query: 236 WPDLA--------YLPDYV-----------EYQYVAAPPLRSLFPSASD----------- 265
             D A         LPD             EY+      L ++    +            
Sbjct: 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340
Query: 266 ----DAL---DLLSKMFTYDPKARITAQQALEHRYF 294
               D L   DL+ +M  YDPK RI    AL+H +F
Sbjct: 341 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 105/204 (51%), Gaps = 24/204 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L D
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
               K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD+K
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 140
Query: 139 PNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           P NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G   
Sbjct: 141 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGKLY 189
Query: 189 YGAGVDVWAAGCIFAELLNRR-PF 211
            G  VDVW+ G I   +L RR PF
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 105/204 (51%), Gaps = 24/204 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L D
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
               K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD+K
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 130
Query: 139 PNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           P NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G   
Sbjct: 131 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGKLY 179
Query: 189 YGAGVDVWAAGCIFAELLNRR-PF 211
            G  VDVW+ G I   +L RR PF
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS 134
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV-TRKAY 193
Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           + LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            D    K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRD 137
Query: 137 MKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGA 186
           +KP NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G 
Sbjct: 138 LKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGK 186
Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PF 211
              G  VDVW+ G I   +L RR PF
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 105/204 (51%), Gaps = 24/204 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LGEG++G V  A  T TGQ VA+K I +    K  +     REI  L+ L+ PHII+L D
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
               K  + +V E+   +L   I   +  +S  + + + Q  +  + +CH+  ++HRD+K
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 134
Query: 139 PNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           P NLL+  H  +K+ADFGL+ I           GSP+           Y APE++ G   
Sbjct: 135 PENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVISGKLY 183
Query: 189 YGAGVDVWAAGCIFAELLNRR-PF 211
            G  VDVW+ G I   +L RR PF
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS 134
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRKAY 193
Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 77
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS 135
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRKAY 194
Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS 134
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 193
Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 95/344 (27%), Positives = 149/344 (43%), Gaps = 51/344 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 122
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 242 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 294 FSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRR 337
                +  +   L     +  +K         P VL+ P  +R+
Sbjct: 278 LQDEDMKRKFQDLLSEENESTAK---------PQVLAQPSTSRK 312

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 10/201 (4%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS 70
           +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K+
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENKN 77
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+  +D++     L +V E++    L  V+  T   +    I +  +  L+ L F H 
Sbjct: 78  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS 135
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
             V+HR++K +N+L+G  G +KL DFG          + +  V   ++ APE++   K Y
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 194
Query: 190 GAGVDVWAAGCIFAELLNRRP 210
           G  VD+W+ G +  E++   P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEP 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 42/301 (13%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 65  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 121
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 180
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 240
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 241 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 276
Query: 294 F 294
Sbjct: 277 L 277

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 42/301 (13%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 122
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 242 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 294 F 294
Sbjct: 278 L 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 42/301 (13%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 122
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 181
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 242 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 294 F 294
Sbjct: 278 L 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 135/301 (44%), Gaps = 42/301 (13%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E         E
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 71
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 72  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 128
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 187
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 247
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H +
Sbjct: 248 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRHPW 283
Query: 294 F 294
Sbjct: 284 L 284

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAI+     K  +G  +E         E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 247
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 306
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 367 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 400

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 141/296 (47%), Gaps = 41/296 (13%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REI 62
           ++ S K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE 
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREA 79
Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQM 119
           ++ ++L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQ 136
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR- 175
            L+ +A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H      
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTP 194
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
            Y +PE+L     Y   VD+WA G I +  L+   PF     D DQ  +++A        
Sbjct: 195 GYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA-- 246
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                        Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 247 -------------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 284

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 102 YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 158
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 159 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 215
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 255
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 256 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 128/295 (43%), Gaps = 56/295 (18%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPH 72
           Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + PH
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           II+L        ++ +V E++      + + +N    L   + +   Q  L G+ +CH+ 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH 135
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAP 180
            V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+           Y AP
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPN-----------YAAP 184
Query: 181 ELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E++ G    G  VD+W++G I +A L    PF     D D +  +F             +
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKKICDG-------I 232
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
            Y P Y             L PS     + LL  M   DP  R T +   EH +F
Sbjct: 233 FYTPQY-------------LNPS----VISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGV-NFTALRE 61
           K + D Y+  + LG G  G V  A + KT + VAI+     K  +G  +E         E
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQM 119
           I++LK+L  P II++ + F  + + ++V E ME     + V+ N    L  A  K Y   
Sbjct: 205 IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ 261
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW 176
            L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G      T       
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPT 320
Query: 177 YRAPELLF--GAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           Y APE+L   G   Y   VD W+ G I F  L    PF +  + +    +I +      P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 380
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 381 EVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 414

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 36/293 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + D Y   E LG+G + VV + +   TGQ  A K I   K     +    RE ++ + LK
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 70  SPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            P+I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +Q  L+ +  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVNH 118
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           CH   ++HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                YG  VD+WA G I +  L+   PF     D  +L +   A     PS        
Sbjct: 179 -RKDPYGKPVDMWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPS-------- 227
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                      P   ++ P A     DL++KM T +P  RITA +AL+H +  
Sbjct: 228 -----------PEWDTVTPEAK----DLINKMLTINPAKRITASEALKHPWIC 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLL 65
           S K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE ++ 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARIC 59
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q  L+
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILE 116
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR-WYR 178
            +A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H       Y 
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           +PE+L     Y   VD+WA G I +  L+   PF     D DQ  +++A           
Sbjct: 175 SPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA----- 223
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                     Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 224 ----------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 93  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 149
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 150 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 206
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 207 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 246
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 247 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 36/293 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + D Y   E LG+G + VV + +   TGQ  A K I   K     +    RE ++ + LK
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 70  SPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            P+I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +Q  L+ +  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVNH 118
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           CH   ++HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+L
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                YG  VD+WA G I +  L+   PF     D  +L +   A     PS        
Sbjct: 179 -RKDPYGKPVDMWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPS-------- 227
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                      P   ++ P A     DL++KM T +P  RITA +AL+H +  
Sbjct: 228 -----------PEWDTVTPEAK----DLINKMLTINPAKRITASEALKHPWIC 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLL 65
           S K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE ++ 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARIC 59
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q  L+
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILE 116
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR-WYR 178
            +A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H       Y 
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYL 174
Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           +PE+L     Y   VD+WA G I +  L+   PF     D DQ  +++A           
Sbjct: 175 SPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA----- 223
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                     Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 224 ----------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 261

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 77  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 190
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 230
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 231 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 132/285 (46%), Gaps = 36/285 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E LG+G + VV + +    GQ  A K I   K     +    RE ++ + LK P+I+ L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 78  DAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           D+   +G+ +L+F+ +   E   + V R    + S AD    +Q  L+ +  CH+  V+H
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMGVVH 144
Query: 135 RDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           RD+KP NLL+ S      +KLADFGLA       + +        Y +PE+L     YG 
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGK 203
Query: 192 GVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
            VD+WA G I +  L+   PF     D  +L +   A     PS                
Sbjct: 204 PVDLWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFPS---------------- 245
Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
              P   ++ P A     DL++KM T +P  RITA +AL+H + S
Sbjct: 246 ---PEWDTVTPEAK----DLINKMLTINPSKRITAAEALKHPWIS 283

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 81  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 137
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 194
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 234
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 235 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 81  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 137
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 194
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 234
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 235 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 75  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 131
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 132 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 188
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 189 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 228
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 229 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 102 YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 158
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 159 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDL 215
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 216 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 255
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 256 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 138/291 (47%), Gaps = 41/291 (14%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKE 67
           K +D Y  +E LG+G + VV + +   TG   A K I   K+    +F  L RE ++ ++
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRK 60
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+ P+I+ L D+   +   +LVF+ +   E   + V R    F S AD    +Q  L+ +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESI 117
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR-WYRAP 180
           A+CH   ++HR++KP NLL+ S  +   +KLADFGLA      D    H       Y +P
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSP 175
Query: 181 ELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L     Y   VD+WA G I +  L+   PF     D DQ  +++A             
Sbjct: 176 EVL-KKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQ-HRLYAQIKAGA------- 222
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                   Y Y  +P   ++ P A      L+  M T +PK RITA QAL+
Sbjct: 223 --------YDY-PSPEWDTVTPEAK----SLIDSMLTVNPKKRITADQALK 260

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/311 (29%), Positives = 148/311 (47%), Gaps = 39/311 (12%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           K E+LG G +G V+K  +T TG  +A K  K R  K KE V      EI ++ +L   ++
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK----NEISVMNQLDHANL 148
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+L DAF  K ++ LV E+++  +L   I + +  L+  D   +M+   +G+   H+ ++
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208
Query: 133 LHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           LH D+KP N+L  +    Q+K+ DFGLAR +  P  +         + APE++       
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPEVV-NYDFVS 266
Query: 191 AGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              D+W+ G I   LL+   PFL G +D + L  I A        +W     L D     
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILAC-------RWD----LED----- 309
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
                     F   S++A + +SK+   +   RI+A +AL+H + S   L +  +   + 
Sbjct: 310 --------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS--AQK 359
Query: 310 ATKRASKASDF 320
              R S A DF
Sbjct: 360 KKNRGSDAQDF 370

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 137/313 (43%), Gaps = 34/313 (10%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++  +  TG   A K +    + +    T  +EI+ +  L+
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLR 212
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL   H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 129 KKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +   +H D+KP N++  +    +LKL DFGL      P +          + APE+  G 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 330
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           K  G   D+W+ G +   LL+      G +D + L  + +         W     + D  
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------DWN----MDD-- 377
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKL 306
                      S F   S+D  D + K+   DP  R+T  QALEH + +    P   +++
Sbjct: 378 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 307 PRPATKRASKASD 319
           P   + R +K  D
Sbjct: 427 P---SSRYTKIRD 436

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 137/313 (43%), Gaps = 34/313 (10%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++  +  TG   A K +    + +    T  +EI+ +  L+
Sbjct: 49  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLR 106
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL   H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 129 KKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +   +H D+KP N++  +    +LKL DFGL      P +          + APE+  G 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 224
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           K  G   D+W+ G +   LL+      G +D + L  + +         W     + D  
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-------DWN----MDD-- 271
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKL 306
                      S F   S+D  D + K+   DP  R+T  QALEH + +    P   +++
Sbjct: 272 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 320
Query: 307 PRPATKRASKASD 319
           P   + R +K  D
Sbjct: 321 P---SSRYTKIRD 330

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 80  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 136
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 137 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 193
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 194 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 233
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 234 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 77  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEMIEG-RMHDEKVDL 190
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 230
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 231 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A +  +   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDSTRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKKVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  D   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 131/293 (44%), Gaps = 38/293 (12%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y     +G G++G V  A+   T    A KKI     ++   F   +EI+++K L  P+I
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLDHPNI 68
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L + F    +++LV E     +L   + +  +F   +D    M+  L  +A+CHK  V
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF-RESDAARIMKDVLSAVAYCHKLNV 127
Query: 133 LHRDMKPNNLLI---GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            HRD+KP N L         LKL DFGLA  F  P +    +V   +Y +P++L G   Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLEGL--Y 184
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G   D W+AG +   LL   P     +D + + KI     T     W ++          
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV---------- 234
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF----SSAP 298
                         S  A  L+ ++ T  PK RIT+ QALEH +F    SS+P
Sbjct: 235 --------------SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 34/293 (11%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTAL 59
           +AE+   K   D +     LG+G +G VY A + +    +A+K +   + +KEGV     
Sbjct: 4   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 63
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQ 118
           REI++   L+ P+I+ + + F  +  ++L+ EF    +L   ++    F       ++M+
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFME 122
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
                L +CH++ V+HRD+KP NLL+G  G+LK+ADFG +    +P  R         Y 
Sbjct: 123 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYL 180
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PE++ G K +   VD+W AG +  E L   P     S  +   +I             D
Sbjct: 181 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------D 229
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           L +            PP        SD + DL+SK+  Y P  R+  +  +EH
Sbjct: 230 LKF------------PPF------LSDGSKDLISKLLRYHPPQRLPLKGVMEH 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 81  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 137
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE + G + +   VD+
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIEG-RXHDEKVDL 194
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 195 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 234
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 235 --------TEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 34/293 (11%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTAL 59
           +AE+   K   D +     LG+G +G VY A + +    +A+K +   + +KEGV     
Sbjct: 3   LAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQ 118
           REI++   L+ P+I+ + + F  +  ++L+ EF    +L   ++    F       ++M+
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFME 121
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
                L +CH++ V+HRD+KP NLL+G  G+LK+ADFG +    +P  R         Y 
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYL 179
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PE++ G K +   VD+W AG +  E L   P     S  +   +I             D
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------D 228
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           L +            PP        SD + DL+SK+  Y P  R+  +  +EH
Sbjct: 229 LKF------------PPF------LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 78  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 134
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+A+FG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 135 DIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 191
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 231
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 232 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 132/293 (45%), Gaps = 38/293 (12%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           Y     +G G++G V  A+   T    A KKI     ++   F   +EI+++K L  P+I
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLDHPNI 85
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L + F    +++LV E     +L   + +  +F   +D    M+  L  +A+CHK  V
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF-RESDAARIMKDVLSAVAYCHKLNV 144
Query: 133 LHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            HRD+KP N L  +      LKL DFGLA  F  P +    +V   +Y +P++L G   Y
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSPQVLEGL--Y 201
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
           G   D W+AG +   LL   P     +D + + KI     T     W ++          
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV---------- 251
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF----SSAP 298
                         S  A  L+ ++ T  PK RIT+ QALEH +F    SS+P
Sbjct: 252 --------------SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 290

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 31/279 (11%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +LG+G++  VY+A    TG  VAIK I +    K G+      E+K+  +LK P I+EL 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           + F     ++LV E     ++   ++N     S  + + +M   + G+ + H   +LHRD
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +  +NLL+  +  +K+ADFGLA     P  +         Y +PE+      +G   DVW
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA-TRSAHGLESDVW 196
Query: 197 AAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL 256
           + GC+F  LL  RP                 F T T     +   L DY        P  
Sbjct: 197 SLGCMFYTLLIGRP----------------PFDTDTVKNTLNKVVLADY------EMPSF 234
Query: 257 RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            S+      +A DL+ ++   +P  R++    L+H + S
Sbjct: 235 LSI------EAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 78  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 134
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 135 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDL 191
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 192 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 231
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 232 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+A+FG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + +    +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 73  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 129
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 130 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 186
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 187 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 226
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 227 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 77  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDL 190
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 230
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 231 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 76  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDL 189
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 190 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 229
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 230 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 138/302 (45%), Gaps = 37/302 (12%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MA +  ++   + Y   E LG+G + VV + +    GQ  A   I   K     +    R
Sbjct: 1   MATITCTR-FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER 59
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYM 117
           E ++ + LK P+I+ L D+   +G+ +L+F+ +   E   + V R    + S AD    +
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCI 116
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFA 174
           Q  L+ +  CH+  V+HR++KP NLL+ S      +KLADFGLA       + +      
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             Y +PE+L     YG  VD+WA G I +  L+   PF     D  +L +   A     P
Sbjct: 177 PGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFW--DEDQHRLYQQIKAGAYDFP 233
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
           S                   P   ++ P A     DL++KM T +P  RITA +AL+H +
Sbjct: 234 S-------------------PEWDTVTPEAK----DLINKMLTINPSKRITAAEALKHPW 270
Query: 294 FS 295
            S
Sbjct: 271 IS 272

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 80  YFHDATRVYLILEY--APLGTVYRELQK-LSRFDEQRTATYITELANALSYCHSKRVIHR 136
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS+G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+
Sbjct: 137 DIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDL 193
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L   P  +  +  +   +I     T            PD+V         
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----------FPDFV--------- 233
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++   R+T  + LEH
Sbjct: 234 --------TEGARDLISRLLKHNASQRLTLAEVLEH 261

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 79  YFHDATRVYLILEY--APLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHR 135
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDL 192
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L  +P  + ++  +   +I     T            PD+V         
Sbjct: 193 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV--------- 232
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                   ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 233 --------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 132/287 (45%), Gaps = 32/287 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y++ + +GEG++G       T+ G+   IK+I + +        + RE+ +L  +K P
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCH 128
           +I++  ++F   G+L++V ++ E  DL   I      L   D  +  ++Q+ L  L   H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL-ALKHVH 142
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
            + +LHRD+K  N+ +   G ++L DFG+AR+  S        +   +Y +PE+    K 
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC-ENKP 201
Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y    D+WA GC+  EL   +   +  S  + + KI +             ++ P  + Y
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG------------SFPPVSLHY 249
Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            Y               D   L+S++F  +P+ R +    LE  + +
Sbjct: 250 SY---------------DLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 135/279 (48%), Gaps = 34/279 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            F     ++L+ E+    ++   ++  + F       +Y+      L++CH K V+HRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + +   VD+W+
Sbjct: 140 KPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWS 196
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            G +  E L  +P  + ++  +   +I     T            PD+V           
Sbjct: 197 LGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV----------- 234
Query: 258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                 ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 235 ------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 40/297 (13%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           + D ++ +  LG G +G V+   +  +G    IK I   K +  V    +  EI++LK L
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPMEQIEAEIEVLKSL 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETD--LETVI--RNTNIFLSPADIKSYMQMTLKGL 124
             P+II++ + F    N+++V E  E    LE ++  +     LS   +   M+  +  L
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           A+ H + V+H+D+KP N+L      H  +K+ DFGLA +F S D   T+      Y APE
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGTALYMAPE 196
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +    +      D+W+AG +   LL    PF                    T +   ++ 
Sbjct: 197 VF--KRDVTFKCDIWSAGVVMYFLLTGCLPF--------------------TGTSLEEVQ 234
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
               Y E  Y  A   R L P A    +DLL +M T DP+ R +A Q L H +F  A
Sbjct: 235 QKATYKEPNY--AVECRPLTPQA----VDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 139/308 (45%), Gaps = 49/308 (15%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           +D Y+ +E +G G+Y    + +   T    A+K I   K+          EI+ LL+  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQ 79
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+II L D +    +++LV E M     L+ ++R    F S  +    +    K + + 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL 137
Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           H + V+HRD+KP+N+L     G+   L++ DFG A+   + +       +   + APE+L
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQ--LGKIFAAFGTATPSQWPDLA 240
              + Y  G D+W+ G +   +L    PF  G SD  +  L +I +   T +   W    
Sbjct: 198 -KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN--- 253
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                                + S+ A DL+SKM   DP  R+TA+Q L+H      P  
Sbjct: 254 ---------------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQH------PWV 286
Query: 301 TEPNKLPR 308
           T+ +KLP+
Sbjct: 287 TQKDKLPQ 294

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/308 (26%), Positives = 139/308 (45%), Gaps = 49/308 (15%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           +D Y+ +E +G G+Y    + +   T    A+K I   K+          EI+ LL+  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS------EEIEILLRYGQ 79
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+II L D +    +++LV E M     L+ ++R    F S  +    +    K + + 
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL 137
Query: 128 HKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           H + V+HRD+KP+N+L     G+   L++ DFG A+   + +       +   + APE+L
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQ--LGKIFAAFGTATPSQWPDLA 240
              + Y  G D+W+ G +   +L    PF  G SD  +  L +I +   T +   W    
Sbjct: 198 -KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWN--- 253
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                                + S+ A DL+SKM   DP  R+TA+Q L+H      P  
Sbjct: 254 ---------------------TVSETAKDLVSKMLHVDPHQRLTAKQVLQH------PWV 286
Query: 301 TEPNKLPR 308
           T+ +KLP+
Sbjct: 287 TQKDKLPQ 294

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 133/289 (46%), Gaps = 36/289 (12%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + D Y   E +G+G + VV + +   TG   A K I   K     +    RE ++ + LK
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 70  SPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
             +I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +Q  L+ +  
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLH 118
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           CH+  V+HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+L
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
              + YG  VD+WA G I +  L+   PF     D  +L +   A     PS        
Sbjct: 179 -RKEAYGKPVDIWACGVILYILLVGYPPFW--DEDQHKLYQQIKAGAYDFPS-------- 227
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      P   ++ P A     +L+++M T +P  RITA +AL+H
Sbjct: 228 -----------PEWDTVTPEAK----NLINQMLTINPAKRITAHEALKH 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 38/276 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD---IKSYMQMTLKGLAFCHKKWVLHR 135
            F     ++L+ E+    L TV R     LS  D     +Y+      L++CH K V+HR
Sbjct: 80  YFHDATRVYLILEY--APLGTVYRELQK-LSRFDEQRTATYITELANALSYCHSKRVIHR 136
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP NLL+GS+G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+
Sbjct: 137 DIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDL 193
Query: 196 WAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           W+ G +  E L   P  +  +  +   +I     T            PD+V         
Sbjct: 194 WSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----------FPDFV--------- 233
Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                   ++ A DL+S++  ++   R+T  + LEH
Sbjct: 234 --------TEGARDLISRLLKHNASQRLTLAEVLEH 261

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 134/279 (48%), Gaps = 34/279 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + ++   +A+K + +   +K GV     RE+++   L+ P+I+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            F     ++L+ E+    ++   ++  + F       +Y+      L++CH K V+HRD+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKF-DEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           KP NLL+GS G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+W+
Sbjct: 140 KPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEMIEG-RMHDEKVDLWS 196
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            G +  E L  +P  + ++  +   +I     T            PD+V           
Sbjct: 197 LGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV----------- 234
Query: 258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                 ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 235 ------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIELID 78
           +G G++G VY A D +  + VAIKK+   GKQ        ++E++ L++L+ P+ I+   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
            +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HRD+K
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDVW 196
             N+L+   G +KL DFG A I  +P   F   V   ++ APE++      QY   VDVW
Sbjct: 182 AGNILLSEPGLVKLGDFGSASIM-APANXF---VGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 197 AAGCIFAELLNRRP 210
           + G    EL  R+P
Sbjct: 238 SLGITCIELAERKP 251

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 34/294 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   K  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                                 SD A D +  +   DP+ R T +QAL+H + +
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLKELKSPHIIELID 78
           +G G++G VY A D +  + VAIKK+   GKQ        ++E++ L++L+ P+ I+   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
            +  +    LV E+       ++      L   +I +     L+GLA+ H   ++HRD+K
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDVW 196
             N+L+   G +KL DFG A I  +P   F   V   ++ APE++      QY   VDVW
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIM-APANXF---VGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 197 AAGCIFAELLNRRP 210
           + G    EL  R+P
Sbjct: 199 SLGITCIELAERKP 212

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 31/285 (10%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++ ++  TG+    K I      +   +T   EI ++ +L 
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLH 106
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P +I L DAF  K  + L+ EF+   +L   I   +  +S A++ +YM+   +GL   H
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 129 KKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +  ++H D+KP N++  +     +K+ DFGLA    +PD           + APE++   
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIV-DR 224
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           +  G   D+WA G +   LL+      G  D++ L  +           W          
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDW---------- 267
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
           E+   A       F S S +A D +  +   +P+ R+T   ALEH
Sbjct: 268 EFDEDA-------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 137/306 (44%), Gaps = 56/306 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +E++ P+II L D F +K ++ L+ E +              L+  +   +++  L G+ 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 126 FCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFTHQ 171
           + H K + H D+KP N+++        ++KL DFG+A           IFG+P+      
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE------ 176
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT 230
                + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A    
Sbjct: 177 -----FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA---- 225
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          V Y +         F + S+ A D + ++   DPK R+T  Q+LE
Sbjct: 226 ---------------VNYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 291 HRYFSS 296
           H +  +
Sbjct: 266 HSWIKA 271

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 34/294 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   +  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                                 SD A D +  +   DP+ R T +QAL+H + +
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 141/293 (48%), Gaps = 40/293 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y+K   +GEG+ G+V  A +  +G+ VA+K + L KQ+         E+ ++++ +  
Sbjct: 48  DSYVK---IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHF 102
Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+  ++     L ++ EF++    TD+ + +R     L+   I +  +  L+ LA+ 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYL 157
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H + V+HRD+K +++L+   G++KL+DFG          +    V   ++ APE++    
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRS 216
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            Y   VD+W+ G +  E+++  P     S +  + ++       +P         P  ++
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-----RDSP---------PPKLK 262
Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
             +  +P LR           D L +M   DP+ R TAQ+ L+H +     LP
Sbjct: 263 NSHKVSPVLR-----------DFLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 34/294 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   +  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                                 SD A D +  +   DP+ R T +QAL+H + +
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 34/294 (11%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   +  EG   +   EI +L 
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KEALEGKEGSMENEIAVLH 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K P+I+ L D +   G+L+L+ + +      + ++     F +  D    +   L  +
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 129
Query: 125 AFCHKKWVLHRDMKPNNLL---IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   ++HRD+KP NLL   +    ++ ++DFGL+++   P    +       Y APE
Sbjct: 130 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-EDPGSVLSTACGTPGYVAPE 188
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+  
Sbjct: 189 VL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-- 245
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                                 SD A D +  +   DP+ R T +QAL+H + +
Sbjct: 246 ----------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 145/311 (46%), Gaps = 44/311 (14%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLK 66
           K+  +YL  ++LGEG+YG V + +D++T    A+K ++  K +   N  A   +EI+LL+
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67  ELKSPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTNIFLSP-ADIKSYMQMTLKG 123
            L+  ++I+L+D      K  +++V E+    ++ ++ +      P      Y    + G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI---FGSPDRRFTHQVFARWYRAP 180
           L + H + ++H+D+KP NLL+ + G LK++  G+A     F + D   T Q  +  ++ P
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPP 180
Query: 181 ELLFGAKQY-GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+  G   + G  VD+W+AG     +       +G    D + K+F   G  + +   D 
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIGKGSYAIPGD- 235
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF----- 294
                         PPL            DLL  M  Y+P  R + +Q  +H +F     
Sbjct: 236 ------------CGPPLS-----------DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272
Query: 295 -SSAPLPTEPN 304
            + AP+P  P+
Sbjct: 273 PAEAPVPIPPS 283

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++    EI++L     P+I++L+ A
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHPYIVKLLGA 84
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           + H G L ++ EF     ++ ++   +  L+   I+   +  L+ L F H K ++HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ----YGAGV 193
             N+L+   G ++LADFG+ A+   +  +R +  +   ++ APE++         Y    
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYV 251
           D+W+ G    E+    P     + +  L KI  +      TPS+W         VE++  
Sbjct: 204 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS--------VEFR-- 253
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                            D L      +P+ R +A Q LEH + SS
Sbjct: 254 -----------------DFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 38/285 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +TG   A K I    ++E  ++    EI++L     P+I++L+ A
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATCDHPYIVKLLGA 76
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           + H G L ++ EF     ++ ++   +  L+   I+   +  L+ L F H K ++HRD+K
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 139 PNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAKQ----YGAGV 193
             N+L+   G ++LADFG+ A+   +  +R +  +   ++ APE++         Y    
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYV 251
           D+W+ G    E+    P     + +  L KI  +      TPS+W         VE++  
Sbjct: 196 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS--------VEFR-- 245
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                            D L      +P+ R +A Q LEH + SS
Sbjct: 246 -----------------DFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 56/306 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +E++ P+II L D F +K ++ L+ E +              L+  +   +++  L G+ 
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 126 FCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFTHQ 171
           + H K + H D+KP N+++        ++KL DFG+A           IFG+P+      
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE------ 183
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT 230
                + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A    
Sbjct: 184 -----FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA---- 232
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          V Y +         F + S+ A D + ++   DPK R+   Q+LE
Sbjct: 233 ---------------VNYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272
Query: 291 HRYFSS 296
           H +  +
Sbjct: 273 HSWIKA 278

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/313 (23%), Positives = 141/313 (45%), Gaps = 57/313 (18%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK---------------------- 49
           ++Y  ++ +G+G+YGVV  A +       A+K +   K                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 50  --QKEGVNFTALREIKLLKELKSPHIIELIDAF--PHKGNLHLVFEFMETDLETVIRNTN 105
             Q  G      +EI +LK+L  P++++L++    P++ +L++VFE +       +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD 165
             LS    + Y Q  +KG+ + H + ++HRD+KP+NLL+G  G +K+ADFG++  F   D
Sbjct: 133 P-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 166 RRFTHQVFARWYRAPELLFGAKQY--GAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLG 222
              ++ V    + APE L   ++   G  +DVWA G  ++  +  + PF+      D+  
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM------DERI 245
Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR 282
               +   +   ++PD                      P  ++D  DL+++M   +P++R
Sbjct: 246 MCLHSKIKSQALEFPDQ---------------------PDIAEDLKDLITRMLDKNPESR 284
Query: 283 ITAQQALEHRYFS 295
           I   +   H + +
Sbjct: 285 IVVPEIKLHPWVT 297

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 56/306 (18%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +E++ P+II L D F +K ++ L+ E +              L+  +   +++  L G+ 
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 126 FCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFTHQ 171
           + H K + H D+KP N+++        ++KL DFG+A           IFG+P+      
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE------ 197
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGT 230
                + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A    
Sbjct: 198 -----FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA---- 246
Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                          V Y +         F + S+ A D + ++   DPK R+   Q+LE
Sbjct: 247 ---------------VNYDFD-----EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286
Query: 291 HRYFSS 296
           H +  +
Sbjct: 287 HSWIKA 292

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 133/286 (46%), Gaps = 32/286 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 208
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 326
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 372
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
            +P L+             L ++   DP  R TA + L+H + + A
Sbjct: 373 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKA 407

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 38/296 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L+++   P+II+L D +       LVF+ M+           + LS  + +  M+  L+ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE++
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 195
Query: 184 FGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             +       YG  VD+W+ G I   LL   P       +  L  I +        +W D
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                                    SD   DL+S+     P+ R TA++AL H +F
Sbjct: 256 Y------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 38/296 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L+++   P+II+L D +       LVF+ M+           + LS  + +  M+  L+ 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE++
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEII 195
Query: 184 FGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             +       YG  VD+W+ G I   LL   P       +  L  I +        +W D
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 255
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                                    SD   DL+S+     P+ R TA++AL H +F
Sbjct: 256 Y------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 104/231 (45%), Gaps = 14/231 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P+I+   D 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 80  FPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK-- 130
              + N  L++V E+ E  DL +VI          D    ++   Q+TL  L  CH++  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRSD 132
Query: 131 ---WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
               VLHRD+KP N+ +     +KL DFGLARI    +      V   +Y +PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM-NRM 191
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            Y    D+W+ GC+  EL    P     S  +  GKI        P ++ D
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 38/296 (12%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L+++   P+II+L D +       LVF+ M+           + LS  + +  M+  L+ 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE++
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEII 182
Query: 184 FGAKQ-----YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
             +       YG  VD+W+ G I   LL   P       +  L  I +        +W D
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 242
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                                    SD   DL+S+     P+ R TA++AL H +F
Sbjct: 243 Y------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 130/303 (42%), Gaps = 72/303 (23%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIR----LGKQKEGVNFTALREIKL 64
           Y+  + LG GT+G V       TG  VA+K     KIR    +GK K        REI+ 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--------REIQN 64
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLK 122
           LK  + PHII+L        +  +V E++      + + ++  +     + +   Q  L 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV--EEMEARRLFQQILS 122
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQV 172
            + +CH+  V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+       
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPN------- 175
Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
               Y APE++ G    G  VD+W+ G I +A L    PF     D + +  +F      
Sbjct: 176 ----YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRGG 226
Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  + Y+P+Y+          RS+          LL  M   DP  R T +   EH
Sbjct: 227 -------VFYIPEYLN---------RSV--------ATLLMHMLQVDPLKRATIKDIREH 262
Query: 292 RYF 294
            +F
Sbjct: 263 EWF 265

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 39/290 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 83
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 141
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 197
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            Y    D+W+ G    E+ + R P   GS  +     IF                L DY+
Sbjct: 198 HYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSM----AIFE---------------LLDYI 238
Query: 247 EYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               V  PP +   PS   S +  D ++K    +P  R   +Q + H + 
Sbjct: 239 ----VNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 130/303 (42%), Gaps = 72/303 (23%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIR----LGKQKEGVNFTALREIKL 64
           Y+  + LG GT+G V       TG  VA+K     KIR    +GK K        REI+ 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--------REIQN 64
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLK 122
           LK  + PHII+L        +  +V E++      + + ++  +     + +   Q  L 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV--EEMEARRLFQQILS 122
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQV 172
            + +CH+  V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+       
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN------- 175
Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
               Y APE++ G    G  VD+W+ G I +A L    PF     D + +  +F      
Sbjct: 176 ----YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRGG 226
Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  + Y+P+Y+          RS+          LL  M   DP  R T +   EH
Sbjct: 227 -------VFYIPEYLN---------RSV--------ATLLMHMLQVDPLKRATIKDIREH 262
Query: 292 RYF 294
            +F
Sbjct: 263 EWF 265

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 136/315 (43%), Gaps = 53/315 (16%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G   +VY+     T +  A+K ++    K+ V      EI +L  L  P+II+L + 
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEI 116
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F     + LV E + T  E   R     + S  D    ++  L+ +A+ H+  ++HRD+K
Sbjct: 117 FETPTEISLVLELV-TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 139 PNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFAR------WYRAPELLFGAKQY 189
           P NLL  +      LK+ADFGL++I         HQV  +       Y APE+L G   Y
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKI-------VEHQVLMKTVCGTPGYCAPEILRGC-AY 227
Query: 190 GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           G  VD+W+ G I +  L    PF     D     +I                      EY
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC-------------------EY 268
Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP-----LPTEP 303
            +++       +   S +A DL+ K+   DPK R+T  QAL+H + +        + T  
Sbjct: 269 YFIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQ 323
Query: 304 NKLPRPATKRASKAS 318
            KL     +R  KA+
Sbjct: 324 KKLQEFNARRKLKAA 338

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 29/282 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +GEG+ G+V  A +  TG+ VA+KK+ L KQ+         E+ ++++    +++++  +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKP 139
           +     L +V EF+E    T I  T+  ++   I +     L+ L++ H + V+HRD+K 
Sbjct: 111 YLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 140 NNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAG 199
           +++L+ S G++KL+DFG          +    V   ++ APE++     YG  VD+W+ G
Sbjct: 170 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI-SRLPYGTEVDIWSLG 228
Query: 200 CIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL 259
            +  E+++  P       +  + +I  +              LP  V+  +  +  LR  
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRDS--------------LPPRVKDLHKVSSVLRGF 274
Query: 260 FPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
                   LDL   M   +P  R TAQ+ L H +   A  P+
Sbjct: 275 --------LDL---MLVREPSQRATAQELLGHPFLKLAGPPS 305

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 130/290 (44%), Gaps = 36/290 (12%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +  D Y   E LG+G + VV + +     Q  A K I   K     +    RE ++ + L
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           K P+I+ L D+   +G  +LVF+ +   E   + V R    + S AD    +   L+ + 
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIHQILESVN 144
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
             H+  ++HRD+KP NLL+ S  +   +KLADFGLA       + +        Y +PE+
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 183 LFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     YG  VD+WA G I +  L+   PF     D  +L +   A     PS       
Sbjct: 205 L-RKDPYGKPVDIWACGVILYILLVGYPPFW--DEDQHKLYQQIKAGAYDFPS------- 254
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       P   ++ P A     +L+++M T +P  RITA QAL+H
Sbjct: 255 ------------PEWDTVTPEAK----NLINQMLTINPAKRITADQALKH 288

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 134/290 (46%), Gaps = 32/290 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 131
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 249
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 295
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
            +P L+             L ++   DP  R TA + L+H + + A  P 
Sbjct: 296 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 334

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 126
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 184
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 240
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 241 HYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 102
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H   ++HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----KQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 266
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                      S +  D L K    +  AR T  Q L+H + +
Sbjct: 267 -----------SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 88
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 206
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 207 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 252
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
            +P L+             L ++   DP  R TA + L+H + + A  P
Sbjct: 253 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKAGPP 290

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 133/286 (46%), Gaps = 32/286 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 86
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 204
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 205 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 250
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
            +P L+             L ++   DP  R TA + L+H + + A
Sbjct: 251 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKA 285

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 14/231 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P+I+   D 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 80  FPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK-- 130
              + N  L++V E+ E  DL +VI          D    ++   Q+TL  L  CH++  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRSD 132
Query: 131 ---WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
               VLHRD+KP N+ +     +KL DFGLARI           V   +Y +PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM-NRM 191
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            Y    D+W+ GC+  EL    P     S  +  GKI        P ++ D
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 102
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H   ++HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----KQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 266
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                      S +  D L K    +  AR T  Q L+H + +
Sbjct: 267 -----------SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 14/231 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P+I+   D 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 80  FPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPAD----IKSYMQMTLKGLAFCHKK-- 130
              + N  L++V E+ E  DL +VI          D    ++   Q+TL  L  CH++  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRSD 132
Query: 131 ---WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
               VLHRD+KP N+ +     +KL DFGLARI           V   +Y +PE +    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM-NRM 191
Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            Y    D+W+ GC+  EL    P     S  +  GKI        P ++ D
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P+I++L+DA
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKLLDA 102
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           F ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H   ++HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----KQYGAGVD 194
             N+L    G +KLADFG++       +R    +   ++ APE++       + Y    D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF--GTATPSQWPDLAYLPDYVEYQYVA 252
           VW+ G    E+    P     + +  L KI  +     A PS+W                
Sbjct: 223 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---------------- 266
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                      S +  D L K    +  AR T  Q L+H + +
Sbjct: 267 -----------SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 298

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + +   LG G  GVV K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 74
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P +I   + +  L+GLA+  +
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI--PEEILGKVSIAVLRGLAYLRE 132
Query: 130 K-WVLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y APE L G  
Sbjct: 133 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMAPERLQGT- 188
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    EL + R P 
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 134/289 (46%), Gaps = 32/289 (11%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 195
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 241
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
            +P L+             L ++   DP  R TA + L+H + + A  P
Sbjct: 242 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 137/302 (45%), Gaps = 32/302 (10%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D ++K   +GEG+ G+V  A    +G+ VA+KK+ L KQ+         E+ ++++ +  
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHE 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++E+ +++     L +V EF+E    T I  T+  ++   I +     L+ L+  H + 
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           V+HRD+K +++L+   G++KL+DFG          R    V   ++ APEL+     YG 
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 199
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD+W+ G +  E+++  P       +  +  I                 LP  ++  + 
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------LPPRLKNLHK 245
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPAT 311
            +P L+             L ++   DP  R TA + L+H + + A  P     L R   
Sbjct: 246 VSPSLKG-----------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNR 294
Query: 312 KR 313
            R
Sbjct: 295 TR 296

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 91
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 149
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 205
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 150/358 (41%), Gaps = 57/358 (15%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  D Y  +E +G G+Y V  + I   T    A+K I   K+      T   EI LL+
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEI-LLR 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
             + P+II L D +     +++V E M+    L+ ++R    F S  +  + +    K +
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTV 129
Query: 125 AFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            + H + V+HRD+KP+N+L     G+   +++ DFG A+   + +       +   + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L   + Y A  D+W+ G +   +L    PF  G  D  +  +I A  G+   S     
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGKFSLSG-- 244
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                               + S SD A DL+SKM   DP  R+TA   L H      P 
Sbjct: 245 ------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH------PW 280
Query: 300 PTEPNKLPRPATKR-----------ASKASDFNPQEGPTVLSPPRKTRRVMPDREGFE 346
               ++LP+    R           A+  S  N  + P VL P    R  +  R G +
Sbjct: 281 IVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSP-VLEPV--GRSTLAQRRGIK 335

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 64
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  ++HRD+KP+N+L+ S G++KL DFG++ ++  S    F   V  R Y +PE L G  
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGT- 178
Query: 188 QYGAGVDVWAAGCIFAEL-LNRRPF 211
            Y    D+W+ G    E+ + R P 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHII 74
           R VLG+GTYG+VY   D      +AIK+I  R  +  + ++     EI L K LK  +I+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH----EEIALHKHLKHKNIV 82
Query: 75  ELIDAFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCH 128
           + + +F   G + +   FME      L  ++R+    L   +  I  Y +  L+GL + H
Sbjct: 83  QYLGSFSENGFIKI---FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL-FGA 186
              ++HRD+K +N+LI ++ G LK++DFG ++     +           Y APE++  G 
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 187 KQYGAGVDVWAAGCIFAELLNRRP 210
           + YG   D+W+ GC   E+   +P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  SP
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSP 67
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQM-TLKGLAFCHK 129
           +I+    AF   G + +  E M+   L+ V++       P  I   + +  +KGL +  +
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 125
Query: 130 KW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           K  ++HRD+KP+N+L+ S G++KL DFG++      D      V  R Y +PE L G   
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDEMANEFVGTRSYMSPERLQGT-H 182
Query: 189 YGAGVDVWAAGCIFAEL-LNRRP 210
           Y    D+W+ G    E+ + R P
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 7/210 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELID 78
           +G G +  VY+A     G  VA+KK+++    +       ++EI LLK+L  P++I+   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 79  AFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           +F     L++V E  +  DL  +I++       +    +  Y       L   H + V+H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMH 159
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KP N+ I + G +KL D GL R F S        V   +Y +PE +     Y    D
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 218
Query: 195 VWAAGCIFAELLN-RRPFLQGSSDIDQLGK 223
           +W+ GC+  E+   + PF     ++  L K
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHII 74
           R VLG+GTYG+VY   D      +AIK+I  R  +  + ++     EI L K LK  +I+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH----EEIALHKHLKHKNIV 68
Query: 75  ELIDAFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPAD--IKSYMQMTLKGLAFCH 128
           + + +F   G + +   FME      L  ++R+    L   +  I  Y +  L+GL + H
Sbjct: 69  QYLGSFSENGFIKI---FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 129 KKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL-FGA 186
              ++HRD+K +N+LI ++ G LK++DFG ++     +           Y APE++  G 
Sbjct: 126 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 187 KQYGAGVDVWAAGCIFAELLNRRP 210
           + YG   D+W+ GC   E+   +P
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKP 209

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 34/284 (11%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           +E LG G +  V  A +  TG+  A+K I   K  +G   +   EI +L+++K  +I+ L
Sbjct: 27  KETLGTGAFSEVVLAEEKATGKLFAVKCIP-KKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 77  IDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
            D +    +L+LV + +      + ++     F +  D  + ++  L  + + H+  ++H
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKG--FYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 135 RDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           RD+KP NLL  S     ++ ++DFGL+++ G  D   T       Y APE+L   K Y  
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST-ACGTPGYVAPEVL-AQKPYSK 201
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            VD W+ G I   LL   P     +D     +I  A        W D+            
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDI------------ 249
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                       SD A D +  +   DP  R T +QA  H + +
Sbjct: 250 ------------SDSAKDFIRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELK 69
           Y  ++ +G+G +  V  A    TG+ VA+K I     K  +N T+L    RE++++K L 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKII----DKTQLNPTSLQKLFREVRIMKILN 72
Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            P+I++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           K+++HRD+K  NLL+     +K+ADFG +  F   ++  T    +  Y APEL  G K  
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTF-CGSPPYAAPELFQGKKYD 191
Query: 190 GAGVDVWAAGCIFAELLN 207
           G  VDVW+ G I   L++
Sbjct: 192 GPEVDVWSLGVILYTLVS 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 82
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 141
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKA 200
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 201 DIWSLGITAIELARGEP 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 14/218 (6%)
Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG+G YG V+   K     TG+  A+K ++    +   K+  +  A R I  L+E+K P
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            I++LI AF   G L+L+ E++   +L   +    IF+         ++++  L   H+K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM-ALGHLHQK 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQY 189
            +++RD+KP N+++   G +KL DFGL +     D   TH       Y APE+L  +   
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
            A VD W+ G +  ++L   P   G +    + KI   
Sbjct: 200 RA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 14/218 (6%)
Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG+G YG V+   K     TG+  A+K ++    +   K+  +  A R I  L+E+K P
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            I++LI AF   G L+L+ E++   +L   +    IF+         ++++  L   H+K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM-ALGHLHQK 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQY 189
            +++RD+KP N+++   G +KL DFGL +     D   TH       Y APE+L  +   
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHXFCGTIEYMAPEILMRSGHN 199
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
            A VD W+ G +  ++L   P   G +    + KI   
Sbjct: 200 RA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 181
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 182 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 228
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 229 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
Query: 289 LEH 291
           L+H
Sbjct: 269 LQH 271

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 134/328 (40%), Gaps = 50/328 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           ++ RY   + LGEG +G V + ID K  G+ VA+K +   K  +     A  EI++L+ L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHL 68
Query: 69  KSP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTL 121
            +         +++++ F H G++ +VFE +       I+         D I+       
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG-------------------QLKLADFGLARIFG 162
           K + F H   + H D+KP N+L                         +K+ DFG A    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---T 185
Query: 163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL---LNRRPFLQGSSDID 219
             D   +  V  R YRAPE++  A  +    DVW+ GCI  E        P       + 
Sbjct: 186 YDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 220 QLGKIFAAFGTATPSQWPDLAYLP----DYVEY----QYV--AAPPLRSLFPSAS---DD 266
            + +I          +     Y      D+ E+    +YV  A  PL+    S     + 
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 267 ALDLLSKMFTYDPKARITAQQALEHRYF 294
             DL+ KM  YDP  RIT ++AL+H +F
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 181
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 182 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 228
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 229 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
Query: 289 LEH 291
           L+H
Sbjct: 269 LQH 271

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 87
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 146
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 147 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKA 205
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 206 DIWSLGITAIELARGEP 222

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 120/247 (48%), Gaps = 38/247 (15%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--- 69
           RY+    LG G +  V+ A D      VA+K +R  K        A  EIKLL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDAD 76
Query: 70  --------SPHIIELIDAFPHKG----NLHLVFEFMETDLETVIRNTNIFLSP-ADIKSY 116
                   + HI++L+D F HKG    ++ +VFE +  +L  +I+       P   +K  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLIG------SHGQLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+       +  Q+K+AD G A  +   D  +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYT 193
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL----QGSS---DIDQLG 222
           + +  R YR+PE+L GA  +G G D+W+  C+  EL+    FL    +G S   D D + 
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELIT-GDFLFEPDEGHSYTKDDDHIA 251
Query: 223 KIFAAFG 229
           +I    G
Sbjct: 252 QIIELLG 258

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 67
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 126
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDSKA 185
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 186 DIWSLGITAIELARGEP 202

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--- 69
           RY+    LG G +  V+ A D      VA+K +R  K        A  EIKLL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDAD 76
Query: 70  --------SPHIIELIDAFPHKG----NLHLVFEFMETDLETVIRNTNIFLSP-ADIKSY 116
                   + HI++L+D F HKG    ++ +VFE +  +L  +I+       P   +K  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLIG------SHGQLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+       +  Q+K+AD G A  +   D  +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYT 193
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           + +  R YR+PE+L GA  +G G D+W+  C+  EL+
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELI 229

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 134/328 (40%), Gaps = 50/328 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           ++ RY   + LGEG +G V + ID K  G+ VA+K +   K  +     A  EI++L+ L
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHL 68
Query: 69  KSP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD-IKSYMQMTL 121
            +         +++++ F H G++ +VFE +       I+         D I+       
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG-------------------QLKLADFGLARIFG 162
           K + F H   + H D+KP N+L                         +K+ DFG A    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---T 185
Query: 163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL---LNRRPFLQGSSDID 219
             D   +  V  R YRAPE++  A  +    DVW+ GCI  E        P       + 
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 220 QLGKIFAAFGTATPSQWPDLAYLP----DYVEY----QYV--AAPPLRSLFPSAS---DD 266
            + +I          +     Y      D+ E+    +YV  A  PL+    S     + 
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 267 ALDLLSKMFTYDPKARITAQQALEHRYF 294
             DL+ KM  YDP  RIT ++AL+H +F
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  SP++
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 67
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKI 126
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+  HG++KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDSKA 185
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 186 DIWSLGITAIELARGEP 202

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           HRD+K  NLL+ +   +K+ADFG +    FG+    F     A  Y APEL  G K  G 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---APPYAAPELFQGKKYDGP 192
Query: 192 GVDVWAAGCIFAELLN 207
            VDVW+ G I   L++
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 133/308 (43%), Gaps = 50/308 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y  +EV+G G   VV  A      + VAIK+I L K +  ++   L+EI+ + +   P
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 73
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNT-------NIFLSPADIKSYMQMTLKG 123
           +I+    +F  K  L LV + +    +  +I++        +  L  + I + ++  L+G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQVFAR--WYR 178
           L + HK   +HRD+K  N+L+G  G +++ADFG++      G   R    + F     + 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++   + Y    D+W+ G    EL                     A G A   ++P 
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIEL---------------------ATGAAPYHKYPP 232
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDAL---------DLLSKMFTYDPKARITAQQAL 289
           +  L   ++      PP  SL     D  +          ++S     DP+ R TA + L
Sbjct: 233 MKVLMLTLQND----PP--SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 290 EHRYFSSA 297
            H++F  A
Sbjct: 287 RHKFFQKA 294

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            + ++   + ++  +  +  + +CH+K+++
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 187
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 188 DVWSLGVILYTLVS 201

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 144/323 (44%), Gaps = 58/323 (17%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV    + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++  P+II L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                     ++Y  D+ E            F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 ----------VSY--DFDE----------EFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEHRYFSSAPLPTEPNKLPRPAT 311
           L H + +  P+ T+   + R + 
Sbjct: 271 LRHPWIT--PVDTQQAMVRRESV 291

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 133/308 (43%), Gaps = 50/308 (16%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D Y  +EV+G G   VV  A      + VAIK+I L K +  ++   L+EI+ + +   P
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 68
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNT-------NIFLSPADIKSYMQMTLKG 123
           +I+    +F  K  L LV + +    +  +I++        +  L  + I + ++  L+G
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQVFAR--WYR 178
           L + HK   +HRD+K  N+L+G  G +++ADFG++      G   R    + F     + 
Sbjct: 129 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++   + Y    D+W+ G    EL                     A G A   ++P 
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIEL---------------------ATGAAPYHKYPP 227
Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDAL---------DLLSKMFTYDPKARITAQQAL 289
           +  L   ++      PP  SL     D  +          ++S     DP+ R TA + L
Sbjct: 228 MKVLMLTLQND----PP--SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
Query: 290 EHRYFSSA 297
            H++F  A
Sbjct: 282 RHKFFQKA 289

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 135/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA----------RIFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P     
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPA---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 194
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 107/206 (51%), Gaps = 18/206 (8%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EVLG+G +G   K    +TG+ + +K+  L +  E    T L+E+K+++ L+ P++++ I
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                   L+ + E+++   L  +I++ +     +   S+ +    G+A+ H   ++HRD
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 137 MKPNNLLIGSHGQLKLADFGLARI-------------FGSPDRRFTHQVFAR-WYRAPEL 182
           +  +N L+  +  + +ADFGLAR+                PDR+  + V    ++ APE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNR 208
           + G + Y   VDV++ G +  E++ R
Sbjct: 194 ING-RSYDEKVDVFSFGIVLCEIIGR 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 194
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H   + H D+KP N+++        ++K+ DFGLA           IFG+P+    
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE---- 182
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  +    
Sbjct: 183 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANV---- 229
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +A   ++ D        EY           F + S  A D + ++   DPK R+T Q +
Sbjct: 230 -SAVNYEFED--------EY-----------FSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
Query: 289 LEH 291
           L+H
Sbjct: 270 LQH 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 92/358 (25%), Positives = 148/358 (41%), Gaps = 57/358 (15%)
Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S +  D Y  +E +G G+Y V  + I   T    A+K I   K+      T   EI LL+
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDP----TEEIEI-LLR 71
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
             + P+II L D +     +++V E  +    L+ ++R    F S  +  + +    K +
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTV 129
Query: 125 AFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            + H + V+HRD+KP+N+L     G+   +++ DFG A+   + +       +   + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAP 189
Query: 181 ELLFGAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L   + Y A  D+W+ G  ++  L    PF  G  D  +  +I A  G+   S     
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGKFSLSG-- 244
Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                               + S SD A DL+SK    DP  R+TA   L H      P 
Sbjct: 245 ------------------GYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRH------PW 280
Query: 300 PTEPNKLPRPATKR-----------ASKASDFNPQEGPTVLSPPRKTRRVMPDREGFE 346
               ++LP+    R           A+  S  N  + P VL P    R  +  R G +
Sbjct: 281 IVHWDQLPQYQLNRQDAPHLVKGAXAATYSALNRNQSP-VLEPV--GRSTLAQRRGIK 335

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA++ I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           HRD+K  NLL+ +   +K+ADFG +    FG+    F     +  Y APEL  G K  G 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---SPPYAAPELFQGKKYDGP 192
Query: 192 GVDVWAAGCIFAELLN 207
            VDVW+ G I   L++
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VAIK I     K  +N T+L    RE++++K L  P+I
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+L+ E+            +  +   + +S  +  +  + +CH+K ++
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F +   +      A  Y APEL  G K  G  V
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEV 195
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 196 DVWSLGVILYTLVS 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 132/293 (45%), Gaps = 58/293 (19%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLK 66
           K+ D ++  ++LG+G++G V+ A   KT Q  AIK ++  +    + V  T + +  L  
Sbjct: 15  KIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGL 124
             + P +  +   F  K NL  V E++   DL   I++ + F LS A    Y    + GL
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGL 131
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVF 173
            F H K +++RD+K +N+L+   G +K+ADFG+ +             G+PD        
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPD-------- 183
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
              Y APE+L G K Y   VD W+ G +  E+L  +    G  +     ++F +     P
Sbjct: 184 ---YIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNP 235
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                  + P ++E                  +A DLL K+F  +P+ R+  +
Sbjct: 236 -------FYPRWLE-----------------KEAKDLLVKLFVREPEKRLGVR 264

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA++ I     K  +N ++L    RE++++K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRII----DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +  +   + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F   ++  T    +  Y APEL  G K  G  V
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKYDGPEV 194
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 195 DVWSLGVILYTLVS 208

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 88/345 (25%), Positives = 145/345 (42%), Gaps = 49/345 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A    T +  AIK ++  +  Q + V  T + +  L    K P + +L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++++ GL F HK+ +++R
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI-GLFFLHKRGIIYR 144
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           D+K +N+++ S G +K+ADFG+ +   + G   R F        Y APE++   + YG  
Sbjct: 145 DLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCG---TPDYIAPEII-AYQPYGKS 200
Query: 193 VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA 252
           VD WA G +  E+L  +P   G  D D+L +       + P                   
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPK------------------ 241
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPLPTEPNKLP 307
                    S S +A+ +   + T  P  R+       +   EH +F         N+  
Sbjct: 242 ---------SLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREI 292
Query: 308 RPATK---RASKASDFNP--QEGPTVLSPPRKTRRVMPDREGFEG 347
           +P  K       A +F+     G  VL PP +      D+  FEG
Sbjct: 293 QPPFKPKVCGKGAENFDKFFTRGQPVLXPPDQLVIANIDQSDFEG 337

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VAIK I     K  +N T+L    RE++++K L  P+I
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKII----DKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+L+ E+            +  +   + +S  +  +  + +CH+K ++
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  NLL+ +   +K+ADFG +  F    +  T    +  Y APEL  G K  G  V
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGSPPYAAPELFQGKKYDGPEV 192
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G I   L++
Sbjct: 193 DVWSLGVILYTLVS 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 34/274 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELID 78
           LG+G +G VY A + K+   VA+K +   + +KEGV     REI++   L  P+I+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            F  +  ++L+ E+    +L   ++ +  F       + M+     L +CH K V+HRD+
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSCTF-DEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
           KP NLL+G  G+LK+ADFG +    +P  R         Y  PE++ G + +   VD+W 
Sbjct: 150 KPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWC 206
Query: 198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            G +  ELL   P  + +S  +   +I                     V+ ++ A+ P  
Sbjct: 207 IGVLCYELLVGNPPFESASHNETYRRIVK-------------------VDLKFPASVP-- 245
Query: 258 SLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    A DL+SK+  ++P  R+   Q   H
Sbjct: 246 -------TGAQDLISKLLRHNPSERLPLAQVSAH 272

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 253
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 254 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 312
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 370
Query: 193 VDVWAAGCIFAELL-NRRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 371 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 254
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 193 VDVWAAGCIFAELL-NRRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL----REIKLLKELKSPHI 73
           + +G+G +  V  A    TG+ VA+K I     K  +N ++L    RE+++ K L  P+I
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKII----DKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           ++L +    +  L+LV E+            +      + ++  +  +  + +CH+K+++
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           HRD+K  NLL+ +   +K+ADFG +    FG+    F     A  Y APEL  G K  G 
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCG---APPYAAPELFQGKKYDGP 192
Query: 192 GVDVWAAGCIFAELLN 207
            VDVW+ G I   L++
Sbjct: 193 EVDVWSLGVILYTLVS 208

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 254
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 193 VDVWAAGCIFAELL-NRRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 13/233 (5%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++G G +G VY      TG+  A+K     +I++ KQ E +       + L+     P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 254
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           ++RD+KP N+L+  HG ++++D GLA  F    ++    V    Y APE+L     Y + 
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 193 VDVWAAGCIFAELL-NRRPFLQ-GSSDIDQLGKIFAAFGTATPSQW-PDLAYL 242
            D ++ GC+  +LL    PF Q  + D  ++ ++        P  + P+L  L
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 58/293 (19%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLK 66
           K+ D  L + +LG+G++G V+ A   KT Q  AIK ++  +    + V  T + +  L  
Sbjct: 16  KIEDFELHK-MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIF-LSPADIKSYMQMTLKGL 124
             + P +  +   F  K NL  V E++   DL   I++ + F LS A    Y    + GL
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGL 132
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVF 173
            F H K +++RD+K +N+L+   G +K+ADFG+ +             G+PD        
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPD-------- 184
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
              Y APE+L G K Y   VD W+ G +  E+L  +    G  +     ++F +     P
Sbjct: 185 ---YIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNP 236
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                  + P ++E                  +A DLL K+F  +P+ R+  +
Sbjct: 237 -------FYPRWLE-----------------KEAKDLLVKLFVREPEKRLGVR 265

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 128/291 (43%), Gaps = 38/291 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E ++    REI   + L+ 
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRH 73
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 132
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+ DFG ++   +   P       V    Y APE+L 
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLL 188
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 240
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           DYV      +P  R            L+S++F  DP  RI+  +   H +F
Sbjct: 241 DYVH----ISPECRH-----------LISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 3/197 (1%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K E +G+G++G V+K ID +T Q VAIK I L + ++ +     +EI +L +  S ++
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSSYV 83
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            +   ++     L ++ E++       +     F     I + ++  LKGL + H +  +
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKI 142
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y +  
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKA 201
Query: 194 DVWAAGCIFAELLNRRP 210
           D+W+ G    EL    P
Sbjct: 202 DIWSLGITAIELAKGEP 218

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL-- 76
           VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL  L   +++    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYA 69
Query: 77  -----------IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
                      + A   K  L +  E+ E   L  +I + N+     +     +  L+ L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---------------IFGSPDRRFT 169
           ++ H + ++HRD+KP N+ I     +K+ DFGLA+               + GS D   T
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD-NLT 188
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
             +    Y A E+L G   Y   +D+++ G IF E++   PF  G   ++ L K+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 106/235 (45%), Gaps = 35/235 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL-- 76
           VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL  L   +++    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYA 69
Query: 77  -----------IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
                      + A   K  L +  E+ E   L  +I + N+     +     +  L+ L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---------------IFGSPDRRFT 169
           ++ H + ++HRD+KP N+ I     +K+ DFGLA+               + GS D   T
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD-NLT 188
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
             +    Y A E+L G   Y   +D+++ G IF E++   PF  G   ++ L K+
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 38/291 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E +     REI   + L+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIAANVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 133
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+ DFG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           DYV      +P  R            L+S++F  DP  RI+  +   H +F
Sbjct: 242 DYVH----ISPECRH-----------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 93/351 (26%), Positives = 146/351 (41%), Gaps = 73/351 (20%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D + G   VA+K I+ + K KE     A  EI +L++
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA----ARLEINVLEK 86
Query: 68  L--KSPH----IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +  K P      +++ D F + G++ + FE +       +++ N    P     +M   L
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQL 146
Query: 122 -KGLAFCHKKWVLHRDMKPNNLL-IGSHGQL------------------KLADFGLARIF 161
            + + F H   + H D+KP N+L + S  +L                  ++ DFG A   
Sbjct: 147 CQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT-- 204
Query: 162 GSPDRRFTHQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
                 F H+     V  R YRAPE++     +    DVW+ GCI  E        Q   
Sbjct: 205 ------FDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHD 257
Query: 217 DIDQLGKIFAAFGTATPSQ-----------------WPDLAYLPDYVEYQYVAAPPLRSL 259
           + + L  +    G   PS+                 W +      YV        PLR  
Sbjct: 258 NREHLAMMERILG-PIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVREN---CKPLRRY 313
Query: 260 FPSASDD---ALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE-PNKL 306
             S +++     DL+  M  Y+P  R+T  +AL+H +F  A L  E PNKL
Sbjct: 314 LTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFF--ARLRAEPPNKL 362

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 30/282 (10%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           + K + +G+G++G VYK ID  T + VAIK I L + ++ +     +EI +L +  SP+I
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYI 79
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
                ++     L ++ E++       +      L    I + ++  LKGL + H +  +
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERKI 138
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           HRD+K  N+L+   G +KLADFG+A        +    V   ++ APE++     Y    
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYDFKA 197
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+W+ G    EL    P    +SD+  +  +F     + P+           +E Q+  +
Sbjct: 198 DIWSLGITAIELAKGEP---PNSDLHPMRVLFLIPKNSPPT-----------LEGQH--S 241
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            P +           + +      DP+ R TA++ L+H++ +
Sbjct: 242 KPFK-----------EFVEACLNKDPRFRPTAKELLKHKFIT 272

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T +  A   + K  L K  QKE ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 91  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 207 NYIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSC 246

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T +  A   + K  L K  QKE ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 91  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 207 NYIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSC 246

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T +  A   + K  L K  QKE ++
Sbjct: 15  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 74
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 75  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 191 NYIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSC 230

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVN 55
           + +V +  +   RY++   LG+G +   Y+  D  T +  A   + K  L K  QKE ++
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKS 115
                EI + K L +PH++     F     +++V E         +      ++  + + 
Sbjct: 91  ----TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M+ T++G+ + H   V+HRD+K  NL +     +K+ DFGLA        R        
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            Y APE+L   K +   VD+W+ GCI   LL  +P  + S 
Sbjct: 207 NYIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETSC 246

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEIXINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEIXINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEIXINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 68
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 69  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 225
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 226 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 134/307 (43%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEHRYFS 295
           L H + +
Sbjct: 271 LRHPWIT 277

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 134/307 (43%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEHRYFS 295
           L H + +
Sbjct: 271 LRHPWIT 277

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 38/291 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E ++    REI   + L+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 133
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+  FG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS----TVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           DYV      +P  R            L+S++F  DP  RI+  +   H +F
Sbjct: 242 DYVH----ISPECRH-----------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSXQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 38/291 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D ++ + VA+K I  G   E ++    REI   + L+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++CH 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 133
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+  FG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP----KDTVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           DYV      +P  R            L+S++F  DP  RI+  +   H +F
Sbjct: 242 DYVH----ISPECRH-----------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YGVV K     +GQ +A+K+IR     +      +     ++ +  P  +    A
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 80  FPHKGNLHLVFEFMETDLE----TVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKKW-VL 133
              +G++ +  E M+T L+     VI        P DI   + +++ K L   H K  V+
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL---FGAKQYG 190
           HRD+KP+N+LI + GQ+K+ DFG++        + T     + Y APE +      K Y 
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYS 235
Query: 191 AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKI 224
              D+W+ G    EL + R P+    +   QL ++
Sbjct: 236 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 270

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 142/310 (45%), Gaps = 44/310 (14%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K++ ++Y+  E LG G +G+V++ ++T + +T   K +++    + +     +EI +L  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNI 57
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIR-NTNIF-LSPADIKSYMQMTLKGLA 125
            +  +I+ L ++F     L ++FEF+ + L+   R NT+ F L+  +I SY+    + L 
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFI-SGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 126 FCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           F H   + H D++P N++  +     +K+ +FG AR    P   F     A  Y APE +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPE-V 174
Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                     D+W+ G +   LL+   PFL  ++      +I      A           
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNA----------- 218
Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE 302
               EY +         F   S +A+D + ++   + K+R+TA +AL+H        P  
Sbjct: 219 ----EYTFDEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQH--------PWL 261
Query: 303 PNKLPRPATK 312
             K+ R +TK
Sbjct: 262 KQKIERVSTK 271

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 136/307 (44%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I    
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANI---- 230
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                     ++Y  D+ E            F   S+ A D + K+   + + R+T Q+A
Sbjct: 231 --------TSVSY--DFDE----------EFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEHRYFS 295
           L H + +
Sbjct: 271 LRHPWIT 277

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K     +G   A+K ++    K         E  +L ++  P ++
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+     GL   H   ++
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALGLDHLHSLGII 152
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 153 YRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV-NRQGHSHSA 211
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 212 DWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKA 245

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 134/307 (43%), Gaps = 56/307 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I +  
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITS-- 232
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                            V Y +         F   S+ A D + K+   + + R+T Q+A
Sbjct: 233 -----------------VSYDFD-----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEHRYFS 295
           L H + +
Sbjct: 271 LRHPWIT 277

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 56/303 (18%)
Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +L+++   ++I L D + ++ ++ L+ E +              LS  +  S+++  L G
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR----------IFGSPDRRFT 169
           + + H K + H D+KP N+++         +KL DFGLA           IFG+P+    
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---- 183
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAF 228
                  + APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I    
Sbjct: 184 -------FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANI---- 230
Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                     ++Y  D+ E            F   S+ A D + K+   + + R+T Q+A
Sbjct: 231 --------TSVSY--DFDE----------EFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 289 LEH 291
           L H
Sbjct: 271 LRH 273

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 138/331 (41%), Gaps = 54/331 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D   G++ VA+K IR +GK +E     A  EI +LK+
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA----ARLEINVLKK 81
Query: 68  LKSPH------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +K          + + D F   G++ + FE +  +    ++  N    P     +M   L
Sbjct: 82  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 141
Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIF 161
              L F H+  + H D+KP N+L  +                   +  +++ADFG A   
Sbjct: 142 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 200
Query: 162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
                  T  V  R YR PE++     +    DVW+ GCI  E        Q   + + L
Sbjct: 201 --DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257
Query: 222 GKIFAAFGTATPSQWPD------------LAYLPDYVEYQYVA--APPLRSLFPSASDDA 267
             +    G   PS                L +  +  + +YV     PL+S     S + 
Sbjct: 258 VMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 316
Query: 268 L---DLLSKMFTYDPKARITAQQALEHRYFS 295
           +   DL+ +M  +DP  RIT  +AL H +F+
Sbjct: 317 VQLFDLMRRMLEFDPAQRITLAEALLHPFFA 347

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 138/331 (41%), Gaps = 54/331 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D   G++ VA+K IR +GK +E     A  EI +LK+
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA----ARLEINVLKK 72
Query: 68  LKSPH------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +K          + + D F   G++ + FE +  +    ++  N    P     +M   L
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIF 161
              L F H+  + H D+KP N+L  +                   +  +++ADFG A   
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 191
Query: 162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
                  T  V  R YR PE++     +    DVW+ GCI  E        Q   + + L
Sbjct: 192 --DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 222 GKIFAAFGTATPSQWPD------------LAYLPDYVEYQYVA--APPLRSLFPSASDDA 267
             +    G   PS                L +  +  + +YV     PL+S     S + 
Sbjct: 249 VMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307
Query: 268 L---DLLSKMFTYDPKARITAQQALEHRYFS 295
           +   DL+ +M  +DP  RIT  +AL H +F+
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 139/324 (42%), Gaps = 53/324 (16%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K   +   Q  A+K ++    K         E  +L E+  P I+
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   ++
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSA 207
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF-AAFGTATPSQWPDLAYLPDYVEYQYVA 252
           D W+ G +  E+L      QG    + +  I  A  G            +P ++      
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG------------MPQFL------ 249
Query: 253 APPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPLPTEPNKLP 307
                      S +A  LL  +F  +P  R+ A     ++   H +FS+     + NKL 
Sbjct: 250 -----------SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST----IDWNKLY 294
Query: 308 R--------PATKRASKASDFNPQ 323
           R        PAT R      F+P+
Sbjct: 295 RREIHPPFKPATGRPEDTFYFDPE 318

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 8/223 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-TALREIKLLKELKSPHIIELID 78
           +G+G++G V       T +  A+K +   K  E        +E+++++ L+ P ++ L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 79  AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           +F  + ++ +V + +   DL   ++  N+      +K ++   +  L +   + ++HRDM
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK--QYGAGVDV 195
           KP+N+L+  HG + + DF +A +    + + T     + Y APE+    K   Y   VD 
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200
Query: 196 WAAGCIFAELL-NRRPF-LQGSSDIDQLGKIFAAFGTATPSQW 236
           W+ G    ELL  RRP+ ++ S+   ++   F       PS W
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 35/235 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL  L   +++    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVXLLASLNHQYVVRYYA 69
Query: 79  AFPHKGN-------------LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           A+  + N             L +  E+ E   L  +I + N+     +     +  L+ L
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR---------------IFGSPDRRFT 169
           ++ H + ++HR++KP N+ I     +K+ DFGLA+               + GS D   T
Sbjct: 130 SYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD-NLT 188
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
             +    Y A E+L G   Y   +D ++ G IF E +   PF  G   ++ L K+
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXERVNILKKL 241

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 138/331 (41%), Gaps = 54/331 (16%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIR-LGKQKEGVNFTALREIKLLKE 67
           + +RY     LGEGT+G V + +D   G++ VA+K IR +GK +E     A  EI +LK+
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA----ARLEINVLKK 104
Query: 68  LKSPH------IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +K          + + D F   G++ + FE +  +    ++  N    P     +M   L
Sbjct: 105 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL 164
Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGS-------------------HGQLKLADFGLARIF 161
              L F H+  + H D+KP N+L  +                   +  +++ADFG A   
Sbjct: 165 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF- 223
Query: 162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL 221
                  T  V  R YR PE++     +    DVW+ GCI  E        Q   + + L
Sbjct: 224 --DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280
Query: 222 GKIFAAFGTATPSQWPD------------LAYLPDYVEYQYVA--APPLRSLFPSASDDA 267
             +    G   PS                L +  +  + +YV     PL+S     S + 
Sbjct: 281 VMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 339
Query: 268 L---DLLSKMFTYDPKARITAQQALEHRYFS 295
           +   DL+ +M  +DP  RIT  +AL H +F+
Sbjct: 340 VQLFDLMRRMLEFDPAQRITLAEALLHPFFA 370

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 38/291 (13%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D +  + VA+K I  G   E ++    REI   + L+ 
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG---EKIDENVKREIINHRSLRH 74
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L +V E+    +L   I N   F S  + + + Q  + G+++ H 
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYAHA 133
Query: 130 KWVLHRDMKP-NNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             V HRD+K  N LL GS   +LK+ADFG ++   +   P       V    Y APE+L 
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP----KSAVGTPAYIAPEVLL 189
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF     D ++              Q+     +P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILNVQYA----IP 241
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           DYV      +P  R            L+S++F  DP  RI+  +   H +F
Sbjct: 242 DYVH----ISPECRH-----------LISRIFVADPAKRISIPEIRNHEWF 277

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG YG V  A++  T + VA+K + + K+         +EI +   L   ++++  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINAMLNHENVVKF- 70
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 71  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 227
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 228 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + +G G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+M   D+ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 45/296 (15%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
              G     A  DV++ GC+  E+L   P   G S                         
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDS------------------------- 223
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALD-----LLSKMFTYDPKARITAQQALEHR 292
            PD V YQ+V   P+    PSA  + L      ++ K    +P+ R   Q A E R
Sbjct: 224 -PDSVAYQHVREDPIP---PSARHEGLSADLDAVVLKALAKNPENRY--QTAAEMR 273

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + +G G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+M   D+ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 75
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 194
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 195 AFGVLLWEI 203

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 75
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       FT    A++   + APE L    ++    D
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPESL-AYNKFSIKSD 192
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 193 VWAFGVLLWEI 203

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 129/323 (39%), Gaps = 46/323 (14%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           +DRY   + +G G +GV     D  T + VA+K I  G     ++    REI   + L+ 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRH 75
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I+   +      +L ++ E+    +L   I N   F S  + + + Q  L G+++CH 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF-SEDEARFFFQQLLSGVSYCHS 134
Query: 130 KWVLHRDMK-PNNLLIGSHG-QLKLADFGLAR---IFGSPDRRFTHQVFARWYRAPELLF 184
             + HRD+K  N LL GS   +LK+ DFG ++   +   P       V    Y APE+L 
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLL 190
Query: 185 GAKQYGAGVDVWAAGC-IFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             +  G   DVW+ G  ++  L+   PF       D    I                 +P
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--------IP 242
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
           D +                 S +   L+S++F  DP  RI+  +   H +F         
Sbjct: 243 DDIR---------------ISPECCHLISRIFVADPATRISIPEIKTHSWFL-------- 279
Query: 304 NKLPRPATKRASKASDFNPQEGP 326
             LP      ++  S F   E P
Sbjct: 280 KNLPADLMNESNTGSQFQEPEQP 302

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YGVV K     +GQ +A+K+IR     +      +     ++ +  P  +    A
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 80  FPHKGNLHLVFEFMETDLE----TVIRNTNIFLSPADIKSYMQMTL-KGLAFCHKKW-VL 133
              +G++ +  E M+T L+     VI        P DI   + +++ K L   H K  V+
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL---FGAKQYG 190
           HRD+KP+N+LI + GQ+K+ DFG++  +   D         + Y APE +      K Y 
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERINPELNQKGYS 191
Query: 191 AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKI 224
              D+W+ G    EL + R P+    +   QL ++
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 78
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 197
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 198 AFGVLLWEI 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LGEG  G V  A++  T + VA+K + + K+         +EI + K L   ++++  
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENVVKF- 69
Query: 78  DAFPHK--GNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             + H+  GN+  +F    +  E   R   +I +   D + +    + G+ + H   + H
Sbjct: 70  --YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 127
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARW-YRAPELLFGAKQYGAG 192
           RD+KP NLL+     LK++DFGLA +F   +R R  +++     Y APELL   + +   
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 193 VDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
           VDVW+ G +   +L    P+ Q S    +                       D+ E +  
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---------------------DWKEKKTY 226
Query: 252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             P     +       L LL K+   +P ARIT     + R+++
Sbjct: 227 LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 265

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 12/215 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G YG V K +   +GQ +A+K+IR    ++      +    +++    P+I++   A
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLS---PADIKSYMQM-TLKGLAFCHKKW-VLH 134
              +G+  +  E M T  +   +     L    P +I   + + T+K L    +   ++H
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149
Query: 135 RDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELL--FGAKQ-YG 190
           RD+KP+N+L+   G +KL DFG++ ++  S  +  T     R Y APE +    ++Q Y 
Sbjct: 150 RDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQGYD 207
Query: 191 AGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKI 224
              DVW+ G    EL   R P+ + +S  DQL ++
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 112/271 (41%), Gaps = 33/271 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELID 78
           LG G+YG V+K    + G+  A+K+     +        L E+   +++ + P  + L  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           A+   G L+L  E     L+         L  A +  Y++ TL  LA  H + ++H D+K
Sbjct: 125 AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVK 184
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAA 198
           P N+ +G  G+ KL DFGL    G+       +   R Y APELL G+  YG   DV++ 
Sbjct: 185 PANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQGS--YGTAADVFSL 241
Query: 199 GCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRS 258
           G    E+        G     QL +                 YLP   E+    +  LRS
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQ----------------GYLPP--EFTAGLSSELRS 283
Query: 259 LFPSASDDALDLLSKMFTYDPKARITAQQAL 289
                      +L  M   DPK R TA+  L
Sbjct: 284 -----------VLVMMLEPDPKLRATAEALL 303

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---GSPDRRFTHQVFARWYRAPE 181
            F H+  ++HRD+KP N+LI +   +K+ DFG+AR     G+   +    +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 137/297 (46%), Gaps = 47/297 (15%)
Query: 14  YLKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           +  ++VLG G  G +VY+ +     + VA+K+I      E  +F A RE++LL+E  + P
Sbjct: 26  FCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRIL----PECFSF-ADREVQLLRESDEHP 78
Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++I        +   ++  E     L+  +   +      +  + +Q T  GLA  H   
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 132 VLHRDMKPNNLLI---GSHGQLK--LADFGLARIFGSPDRRFTHQVFA---RWYRAPELL 183
           ++HRD+KP+N+LI    +HG++K  ++DFGL +        F+ +        + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 184 F--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                +     VD+++AGC+F  +++     +GS            FG +   Q   L  
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVIS-----EGSH----------PFGKSLQRQANIL-- 241
Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDAL--DLLSKMFTYDPKARITAQQALEHRYFSS 296
                    + A  L  L P   +D +  +L+ KM   DP+ R +A+  L+H +F S
Sbjct: 242 ---------LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 56/298 (18%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHI 73
           L  + LG G + VV + I   TGQ  A K ++  ++ +      L EI +L+  KS P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 74  IELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I L + + +   + L+ E+          +      +S  D+   ++  L+G+ + H+  
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 132 VLHRDMKPNNLLIGS---HGQLKLADFGLAR----------IFGSPDRRFTHQVFARWYR 178
           ++H D+KP N+L+ S    G +K+ DFG++R          I G+P+           Y 
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE-----------YL 200
Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L          D+W  G I +  L +  PF+                G      + 
Sbjct: 201 APEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFV----------------GEDNQETYL 243
Query: 238 DLAYLP-DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +++ +  DY E            F S S  A D +  +   +P+ R TA+  L H + 
Sbjct: 244 NISQVNVDYSE----------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 3/213 (1%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKL 64
           + K + +RY   + LG G    VY A DT     VAIK I +  ++KE       RE+  
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +L   +I+ +ID        +LV E++E    +    ++  LS     ++    L G+
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR-WYRAPELL 183
              H   ++HRD+KP N+LI S+  LK+ DFG+A+         T+ V     Y +PE  
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            G +      D+++ G +  E+L   P   G +
Sbjct: 185 KG-EATDECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 201
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 202 AFGVLLWEI 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D  LK + LGEG++ +  K +  K+ Q  A+K I   K+ E      +  +KL +    P
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCE--GHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L + F  + +  LV E +   +L   I+    F S  +    M+  +  ++  H  
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF-SETEASYIMRKLVSAVSHMHDV 125
Query: 131 WVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            V+HRD+KP NLL        ++K+ DFG AR+    ++      F   Y APELL    
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQN 184
Query: 188 QYGAGVDVWAAGCIFAELLN-RRPF------LQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            Y    D+W+ G I   +L+ + PF      L  +S ++ + KI     +     W ++ 
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV- 243
Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
                                  S +A DL+  + T DP  R+
Sbjct: 244 -----------------------SQEAKDLIQGLLTVDPNKRL 263

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 34/282 (12%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           ++  EVLG G +  V+      TG+  A+K I+  K     + +   EI +LK++K  +I
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLKKIKHENI 68
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L D +    + +LV + +   +L   I    ++ +  D    +Q  L  + + H+  +
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-TEKDASLVIQQVLSAVKYLHENGI 127
Query: 133 LHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
           +HRD+KP NLL  +   + ++ + DFGL+++    +   +       Y APE+L   K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVL-AQKPY 184
Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VD W+ G I   LL   P     ++     KI   +       W D+          
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI---------- 234
Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                         S+ A D +  +   DP  R T ++AL H
Sbjct: 235 --------------SESAKDFICHLLEKDPNERYTCEKALSH 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 82
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 142
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 199
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 200 VWAFGVLLWEI 210

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 81
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 141
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 198
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 199 VWAFGVLLWEI 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 27  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 86
Query: 69  KSPHIIELID---AFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ + D   A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 87  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 147 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 207 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 116/255 (45%), Gaps = 32/255 (12%)
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD--------LETVIRNTNIFLSPAD 112
           E++++ ++K+ + +       +   +++++E+ME D           + +N   F+    
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 113 IKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ 171
           IK  ++  L   ++ H +K + HRD+KP+N+L+  +G++KL+DFG +      D++    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGS 210
Query: 172 VFARWYRAPELLFGAKQY-GAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
                +  PE       Y GA VD+W+ G C++    N  PF    S ++    I     
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI----- 265
Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDAL-----DLLSKMFTYDPKARIT 284
                +  ++ Y  D   + Y    PL +   + S++ L     D L      +P  RIT
Sbjct: 266 -----RTKNIEYPLDRNHFLY----PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 285 AQQALEHRYFSSAPL 299
           ++ AL+H + +   +
Sbjct: 317 SEDALKHEWLADTNI 331

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 79
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL-AYNKFSIKSD 196
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 90
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 150
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 207
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 208 VWAFGVLLWEI 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 79
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 196
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 77
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 194
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 195 VWAFGVLLWEI 205

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K   +   Q  A+K ++    K         E  +L E+  P I+
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   ++
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGII 149
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 150 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSA 208
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 209 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 242

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 284
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HR++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 401
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 402 VWAFGVLLWEI 412

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 6/214 (2%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +VLG+G++G V+   K   +   Q  A+K ++    K         E  +L E+  P I+
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
           +L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   ++
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           +RD+KP N+L+   G +KL DFGL++     +++         Y APE++   + +    
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSA 207
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
           D W+ G +  E+L      QG    + +  I  A
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKEL 68
           ++DRY   E+LG G    V+ A D +  + VA+K +R    ++   +   R E +    L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 69  KSPHIIELI---DAFPHKGNL-HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P I+ +    +A    G L ++V E+++      I +T   ++P      +    + L
Sbjct: 70  NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE 181
            F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
              G     A  DV++ GC+  E+L   P   G S +
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 78
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 138
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESL-AYNKFSIKSD 195
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 196 VWAFGVLLWEI 206

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 7/189 (3%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 75
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 135
Query: 138 KPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
              N L+G +  +K+ADFGL+R+  G          F   + APE L    ++    DVW
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVW 194
Query: 197 AAGCIFAEL 205
           A G +  E+
Sbjct: 195 AFGVLLWEI 203

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 79
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 139
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESL-AYNKFSIKSD 196
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 197 VWAFGVLLWEI 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY+ +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 323
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   +++ EFM   +L   +R  N     A +  YM   +   + +  KK  +HR++
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNL 383
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L    ++    D
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL-AYNKFSIKSD 440
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 441 VWAFGVLLWEI 451

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 9/213 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G GT G V+K    KTG  +A+K++R    KE      +    +LK    P+I++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMK 138
           F    ++ +  E M T  E + +     +    +       +K L +  +K  V+HRD+K
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK 152
Query: 139 PNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFARWYRAPELLF----GAKQYGAGV 193
           P+N+L+   GQ+KL DFG++ R+    D+          Y APE +         Y    
Sbjct: 153 PSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 194 DVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIF 225
           DVW+ G    EL   + P+    +D + L K+ 
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKS 70
           D +L   VLG G +G V+      TG+  A KK+   + K+   +  A+ E K+L ++ S
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNI----FLSPADIKSYMQMTLKGLA 125
             I+ L  AF  K +L LV   M   D+   I N +     F  P  I  Y    + GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLE 303
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
             H++ +++RD+KP N+L+   G ++++D GLA    +   +         + APELL G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PF 211
            ++Y   VD +A G    E++  R PF
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           R+LKR   LGEG +G V    Y      TG+ VA+K +   K + G N  A   +EI++L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEIL 77
Query: 66  KELKSPHIIELIDAFPHKGN--LHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTL 121
           + L   +I++        G   + L+ EF+ +    E + +N N       +K  +Q+  
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC- 136
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFAR 175
           KG+ +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +     T +      VF  
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-- 194
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           WY APE L  +K Y A  DVW+ G    ELL         SD   +       G  T  Q
Sbjct: 195 WY-APECLMQSKFYIAS-DVWSFGVTLHELLT-----YCDSDSSPMALFLKMIG-PTHGQ 246
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                 +    E + +  P      P+  D+   L+ K + + P  R + Q  +E
Sbjct: 247 MTVTRLVNTLKEGKRLPCP------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 84/354 (23%), Positives = 141/354 (39%), Gaps = 67/354 (18%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  +    T +  A+K ++  +  Q + V  T + +  L    K P + +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++ + GL F   K +++R
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-GLFFLQSKGIIYR 145
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+ +             G+PD           Y APE++ 
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD-----------YIAPEII- 193
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             + YG  VD WA G +  E+L  +   +G  D D+L +       A P           
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPK---------- 242
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPL 299
                            S S +A+ +   + T  P  R+       +   EH +F     
Sbjct: 243 -----------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285
Query: 300 ------PTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEG 347
                   +P   P+   + A     F  +  P VL PP +      D+  FEG
Sbjct: 286 EKLERKEIQPPYKPKACGRNAENFDRFFTRH-PPVLXPPDQEVIRNIDQSEFEG 338

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           D++ + + LG G++G V      +TG   A+K   K ++ K KE +  T L E ++L+ +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHT-LNEKRILQAV 98
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEYL 157
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRA 179
           H   +++RD+KP NL+I   G +K+ DFGLA+        + G+P+           Y A
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPE-----------YLA 206
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAEL 205
           PE++  +K Y   VD WA G +  E+
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           R+LKR   LGEG +G V    Y      TG+ VA+K +   K + G N  A   +EI++L
Sbjct: 9   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEIL 65
Query: 66  KELKSPHIIELIDAFPHKGN--LHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTL 121
           + L   +I++        G   + L+ EF+ +    E + +N N       +K  +Q+  
Sbjct: 66  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC- 124
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFAR 175
           KG+ +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +     T +      VF  
Sbjct: 125 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-- 182
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           WY APE L  +K Y A  DVW+ G    ELL         SD   +       G  T  Q
Sbjct: 183 WY-APECLMQSKFYIAS-DVWSFGVTLHELLT-----YCDSDSSPMALFLKMIG-PTHGQ 234
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                 +    E + +  P      P+  D+   L+ K + + P  R + Q  +E
Sbjct: 235 MTVTRLVNTLKEGKRLPCP------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/353 (24%), Positives = 142/353 (40%), Gaps = 65/353 (18%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  +    T +  A+K ++  +  Q + V  T + +  L    K P + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+ V E++   DL   I+    F  P  +    ++ + GL F   K +++R
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-GLFFLQSKGIIYR 466
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+++ S G +K+ADFG+ +             G+PD           Y APE++ 
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPD-----------YIAPEII- 514
Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             + YG  VD WA G +  E+L  +   +G  D D+L +       A P           
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPK---------- 563
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPL 299
                            S S +A+ +   + T  P  R+       +   EH +F     
Sbjct: 564 -----------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606
Query: 300 PTEPNKLPRP-----ATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEG 347
                K  +P     A+ R ++  D      P VL PP +      D+  FEG
Sbjct: 607 EKLERKEIQPPYKPKASGRNAENFDRFFTRHPPVLXPPDQEVIRNIDQSEFEG 659

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + +G G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G++G V++  D +TG   A+KK+RL             E+     L SP I+ L  A
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGA 153
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +++       P D    Y+   L+GL + H + +LH D+
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCL--PEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G    L DFG A     PD      +   +      + APE++ G +   
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCL-QPDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCD 269
Query: 191 AGVDVWAAGCIFAELLN 207
           A VDVW++ C+   +LN
Sbjct: 270 AKVDVWSSCCMMLHMLN 286

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G++G V  A   +TG   A+K ++  +  Q + V  T   +  L      P + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L  V EF+   DL   I+ +  F   A  + Y    +  L F H K +++R
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEIISALMFLHDKGIIYR 148
Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYRAPELLF 184
           D+K +N+L+   G  KLADFG+ +             G+PD           Y APE+L 
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD-----------YIAPEIL- 196
Query: 185 GAKQYGAGVDVWAAGCIFAELL 206
               YG  VD WA G +  E+L
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEML 218

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G++G V++  D +TG   A+KK+RL           + E+     L SP I+ L  A
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGA 132
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +I+       P D    Y+   L+GL + H + +LH D+
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G +  L DFG A     PD      +   +      + APE++ G K   
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 248
Query: 191 AGVDVWAAGCIFAELLN 207
           A VD+W++ C+   +LN
Sbjct: 249 AKVDIWSSCCMMLHMLN 265

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 66
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFARWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++       F  +      +F  WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF--WY 184
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 185 -APESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G++G V++  D +TG   A+KK+RL             E+     L SP I+ L  A
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRL-------EVFRAEELMACAGLTSPRIVPLYGA 134
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +++       P D    Y+   L+GL + H + +LH D+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCL--PEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G    L DFG A     PD      +   +      + APE++ G +   
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCL-QPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCD 250
Query: 191 AGVDVWAAGCIFAELLN 207
           A VDVW++ C+   +LN
Sbjct: 251 AKVDVWSSCCMMLHMLN 267

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 115/229 (50%), Gaps = 22/229 (9%)
Query: 1   MAEVDLS--KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFT 57
           + E+DLS  +  A  +   E++G GTYG VYK    KTGQ  AIK + + G ++E +   
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK-- 68
Query: 58  ALREIKLLKELKSP-HIIELIDAFPHKG------NLHLVFEFMET-DLETVIRNTNIFLS 109
             +EI +LK+     +I     AF  K        L LV EF     +  +I+NT     
Sbjct: 69  --QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 110 PADIKSYM-QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRR 167
             +  +Y+ +  L+GL+  H+  V+HRD+K  N+L+  + ++KL DFG+ A++  +  RR
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 168 FTHQVFARWYRAPELLFGAKQ----YGAGVDVWAAGCIFAELLNRRPFL 212
            T  +   ++ APE++   +     Y    D+W+ G    E+    P L
Sbjct: 187 NTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 78
Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 198
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 199 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 88
Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 208
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 209 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 236

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 34/274 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 159
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 160 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 218
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA 253
           D+WA GCI  +L+   P  +  ++     KI                     +EY + AA
Sbjct: 219 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------------------LEYDFPAA 259
Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                 FP A     DL+ K+   D   R+  ++
Sbjct: 260 -----FFPKAR----DLVEKLLVLDATKRLGCEE 284

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           D++ + + LG G++G V      +TG   A+K   K ++ K KE +  T L E ++L+ +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHT-LNEKRILQAV 98
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEYL 157
Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRA 179
           H   +++RD+KP NL+I   G +++ DFGLA+        + G+P+           Y A
Sbjct: 158 HSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPE-----------YLA 206
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAEL 205
           PE++  +K Y   VD WA G +  E+
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E ME   DL   I      L     +S+    L+ +  CH  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 133
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 192 GRSAAVWSLGILLYDMV 208

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 118/238 (49%), Gaps = 17/238 (7%)
Query: 16  KREVLGEGTYGVVYKA-IDTKTGQT---VAIKKIRLG-KQKEGVNFTALREIKLLKELKS 70
           +++V+G G +G VYK  + T +G+    VAIK ++ G  +K+ V+F  L E  ++ +   
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF--LGEAGIMGQFSH 105
Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            +II L         + ++ E+ME   L+  +R  +   S   +   ++    G+ +   
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFG 185
              +HRD+   N+L+ S+   K++DFGL+R+    P+  +T    ++  RW  APE +  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW-TAPEAI-S 223
Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +++ +  DVW+ G +  E++    RP+ + S+  + +  I   F   TP   P   Y
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRLPTPMDCPSAIY 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLK 66
           A+ Y   +V+G G +G V + +  K  Q V     + K  + K+ +   F   R+I    
Sbjct: 74  AEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
              SP +++L  AF     L++V E+M   DL  ++ N ++    A  K Y    +  L 
Sbjct: 133 --NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLALD 188
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR------------IFGSPDRRFTHQVF 173
             H   ++HRD+KP+N+L+  HG LKLADFG                 G+PD        
Sbjct: 189 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD-------- 240
Query: 174 ARWYRAPELL---FGAKQYGAGVDVWAAGC-IFAELLNRRPFLQGS 215
              Y +PE+L    G   YG   D W+ G  +F  L+   PF   S
Sbjct: 241 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 283

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 20  LGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK L+  +I++
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDNIVK 78
Query: 76  LIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
                   G  NL L+ EF+    L   ++     +    +  Y     KG+ +   K  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 138
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWYRAPELLFGA 186
           +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY APE L  +
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 187 KQYGAGVDVWAAGCIFAELL 206
           K +    DVW+ G +  EL 
Sbjct: 196 K-FSVASDVWSFGVVLYELF 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 33/202 (16%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKK------IRLGKQKEGVNFTALREIKLLKELKSPHI 73
           LG G++G V+       G+  A+K       +RL KQ E  N   L    +L  +  P I
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERL----MLSIVTHPFI 68
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I +   F     + ++ +++E  +L +++R +  F +P   K Y       L + H K +
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-AKFYAAEVCLALEYLHSKDI 127
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYRAPELLF 184
           ++RD+KP N+L+  +G +K+ DFG A+        + G+PD           Y APE++ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD-----------YIAPEVV- 175
Query: 185 GAKQYGAGVDVWAAGCIFAELL 206
             K Y   +D W+ G +  E+L
Sbjct: 176 STKPYNKSIDWWSFGILIYEML 197

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 127/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 64  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV A  Y  PE    +  +++ G 
Sbjct: 182 KPANFLI-VDGMLKLIDFGIANQM-QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIEFPDI---- 292
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 293 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 331
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 332 NQMAKGTTEE 341

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G V++  D +TG   A+KK+RL           + E+     L SP I+ L  A
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGA 118
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +I+       P D    Y+   L+GL + H + +LH D+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G +  L DFG A     PD      +   +      + APE++ G K   
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 234
Query: 191 AGVDVWAAGCIFAELLN 207
           A VD+W++ C+   +LN
Sbjct: 235 AKVDIWSSCCMMLHMLN 251

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G V++  D +TG   A+KK+RL           + E+     L SP I+ L  A
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL-------EVFRVEELVACAGLSSPRIVPLYGA 134
Query: 80  FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPAD-IKSYMQMTLKGLAFCHKKWVLHRDM 137
                 +++  E +E   L  +I+       P D    Y+   L+GL + H + +LH D+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 138 KPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW------YRAPELLFGAKQYG 190
           K +N+L+ S G +  L DFG A     PD      +   +      + APE++ G K   
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCL-QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCD 250
Query: 191 AGVDVWAAGCIFAELLN 207
           A VD+W++ C+   +LN
Sbjct: 251 AKVDIWSSCCMMLHMLN 267

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 90
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 149
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 198
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 199 APEIIL-SKGYNKAVDWWALGVLIYEM 224

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 69
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 187
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 188 -APESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 14  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 71
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 189
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 190 -APESLTESK-FSVASDVWSFGVVLYELF 216

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 9   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 66
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P + +L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRA 179
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++       +      Q    WY A
Sbjct: 127 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 185
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PE L     +    DVW+ G +  EL  
Sbjct: 186 PESL-SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 10  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 67
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P + +L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRA 179
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++       +      Q    WY A
Sbjct: 128 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 186
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PE L     +    DVW+ G +  EL  
Sbjct: 187 PESL-SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 16  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 73
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 191
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 192 -APESLTESK-FSVASDVWSFGVVLYELF 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 13  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 70
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 188
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 189 -APESLTESK-FSVASDVWSFGVVLYELF 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 97
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 215
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 216 -APESLTESK-FSVASDVWSFGVVLYELF 242

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G YG VY  +  K   TVA+K ++     E   F  L+E  ++KE+K P++++L+  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEF--LKEAAVMKEIKHPNLVQLLGV 96
Query: 80  FPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLK-GLAFCHKKWVLHRDM 137
              +   ++V E+M   +L   +R  N     A +  YM   +   + +  KK  +HRD+
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDL 156
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVD 194
              N L+G +  +K+ADFGL+R+       +T    A++   + APE L     +    D
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESL-AYNTFSIKSD 213
Query: 195 VWAAGCIFAEL 205
           VWA G +  E+
Sbjct: 214 VWAFGVLLWEI 224

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 7   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 64
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 182
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 183 -APESLTESK-FSVASDVWSFGVVLYELF 209

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 15  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 72
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 190
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 191 -APESLTESK-FSVASDVWSFGVVLYELF 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 66
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 184
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 185 -APESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 66
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 184
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 185 -APESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 8   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 65
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 183
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 184 -APESLTESK-FSVASDVWSFGVVLYELF 210

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 70
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 130
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 187
Query: 196 WAAGCIFAELLN 207
           W+ G +  E+ +
Sbjct: 188 WSFGVLMWEVFS 199

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 90
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 149
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 198
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 199 APEIIL-SKGYNKAVDWWALGVLIYEM 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 118
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 177
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 226
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDKQKVVKLKQIEHT-LNEKRILQA 83
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 142
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----------YL 191
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 192 APEIIL-SKGYNKAVDWWALGVLIYEM 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 79
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P + +L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT----HQVFARWYRA 179
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++       +      Q    WY A
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 198
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PE L     +    DVW+ G +  EL  
Sbjct: 199 PESL-SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 68
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 185
Query: 196 WAAGCIFAELLN 207
           W+ G +  E+ +
Sbjct: 186 WSFGVLMWEVFS 197

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA 226
           D+WA GCI  +L+   P  +  ++    G IFA
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE----GLIFA 244

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 73
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 133
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 190
Query: 196 WAAGCIFAELLN 207
           W+ G +  E+ +
Sbjct: 191 WSFGVLMWEVFS 202

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 84
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 202
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 203 -APESLTESK-FSVASDVWSFGVVLYELF 229

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 88/320 (27%), Positives = 137/320 (42%), Gaps = 30/320 (9%)
Query: 6   LSKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
            S +  D Y L+ +VLGEG +  V   I+  T Q  A+K I   KQ   +     RE+++
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEM 63
Query: 65  LKELKSP-HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L + +   +++ELI+ F  +   +LVFE M         +     +  +    +Q     
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA---RIFGSPDRRFTHQVF---- 173
           L F H K + HRD+KP N+L     Q   +K+ DFGL    ++ G      T ++     
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 174 ARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
           +  Y APE++      A  Y    D+W+ G I   LL+  P   G    D         G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----CGWDRG 239
Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
            A P+    L       +Y++    P +  +   S  A DL+SK+   D K R++A Q L
Sbjct: 240 EACPACQNMLFESIQEGKYEF----PDKD-WAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
Query: 290 EHRYFSSAPLPTEPNKLPRP 309
           +H +          N LP P
Sbjct: 295 QHPWVQGC---APENTLPTP 311

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 161
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 162 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 220
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 221 DLWALGCIIYQLVAGLP 237

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 10  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 67
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------VFARWY 177
           + +   K  +HR++   N+L+ +  ++K+ DFGL ++       +  +      +F  WY
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF--WY 185
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 186 -APESLTESK-FSVASDVWSFGVVLYELF 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 27  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 84
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 202
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 203 -APESLTESK-FSVASDVWSFGVVLYELF 229

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSAXKSS 215
Query: 194 DVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA 226
           D+WA GCI  +L+   P  +  ++    G IFA
Sbjct: 216 DLWALGCIIYQLVAGLPPFRAGNE----GLIFA 244

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 157
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 158 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEKSACKSS 216
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 217 DLWALGCIIYQLVAGLP 233

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIE 75
           R VL EG +  VY+A D  +G+  A+K  RL   +E  N   ++E+  +K+L   P+I++
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 76  LIDAFP--------HKGNLHLVFEFMETDLETVIRNTNIF--LSPADIKSYMQMTLKGLA 125
              A           +    L+ E  +  L   ++       LS   +      T + + 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 126 FCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLA-RIFGSPDRRFTHQVFAR------- 175
             H++   ++HRD+K  NLL+ + G +KL DFG A  I   PD  ++ Q  A        
Sbjct: 151 HMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 176 ----WYRAPEL--LFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGS 215
                YR PE+  L+     G   D+WA GCI   L  R+ PF  G+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 134
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 135 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 193
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 194 DLWALGCIIYQLVAGLP 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 70
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLA 130
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 187
Query: 196 WAAGCIFAELLN 207
           W+ G +  E+ +
Sbjct: 188 WSFGVLMWEVFS 199

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 133
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 134 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 192
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 193 DLWALGCIIYQLVAGLP 209

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-- 75
           E++G G +G V+KA     G+T  IK+++   +K      A RE+K L +L   +I+   
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNIVHYN 70
Query: 76  -LIDAFPHK-------------GNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSYMQ 118
              D F +                L +  EF +   LE  I  R          ++ + Q
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           +T KG+ + H K +++RD+KP+N+ +    Q+K+ DFGL     +  +R   +   R Y 
Sbjct: 131 IT-KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLR-YM 188
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +PE +  ++ YG  VD++A G I AELL+
Sbjct: 189 SPEQI-SSQDYGKEVDLYALGLILAELLH 216

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 17  REVLGEGTYGVVYKAIDTKTG--QTVAIKKIR-LGKQKEGVNFTALREIKLLKELKSPHI 73
           ++V+GEG +G V KA   K G     AIK+++    + +  +F    E+ L K    P+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 85
Query: 74  IELIDAFPHKGNLHLVFEF---------------METDLETVIRN-TNIFLSPADIKSYM 117
           I L+ A  H+G L+L  E+               +ETD    I N T   LS   +  + 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
               +G+ +  +K  +HR++   N+L+G +   K+ADFGL+R      ++   ++  RW 
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 205
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
               L +    Y    DVW+ G +  E+++
Sbjct: 206 AIESLNYSV--YTTNSDVWSYGVLLWEIVS 233

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 12  DRYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK    LG+G +G V    Y  +   TG  VA+K+++     +  +F   REI++LK
Sbjct: 6   ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILK 63
Query: 67  ELKSPHIIEL--IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKG 123
            L S  I++   +   P +  L LV E++ +  L   ++     L  + +  Y     KG
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWYRA 179
           + +   +  +HRD+   N+L+ S   +K+ADFGLA++          R   Q    WY A
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-A 182
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN 207
           PE L     +    DVW+ G +  EL  
Sbjct: 183 PESL-SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ +   LG G++G V      +TG   A+K   L KQK    + +  T L E ++ + 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRIQQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +K+ADFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 215
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 216 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 131
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 132 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 190
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 191 DLWALGCIIYQLVAGLP 207

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 12  YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 68
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 127
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYG 186
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 218
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 219 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 269

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 215
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 216 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 157
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 158 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 216
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 217 DLWALGCIIYQLVAGLP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 214 DLWALGCIIYQLVAGLP 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 214 DLWALGCIIYQLVAGLP 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 216 DLWALGCIIYQLVAGLP 232

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 64  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 182 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 239
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 292
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 293 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 331
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 332 NQMAKGTTEE 341

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 216 DLWALGCIIYQLVAGLP 232

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 118
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 177
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 226
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 191
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 192 DLWALGCIIYQLVAGLP 208

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 12  DRYLK-REVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R+LK  + LG+G +G V    Y  +   TG+ VA+KK++   ++   +F   REI++LK
Sbjct: 12  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILK 69
Query: 67  ELKSPHIIELIDAFPHKG--NLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L+  +I++        G  NL L+ E++    L   ++     +    +  Y     KG
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------RWY 177
           + +   K  +HRD+   N+L+ +  ++K+ DFGL ++   P  +   +V         WY
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWY 187
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL 206
            APE L  +K +    DVW+ G +  EL 
Sbjct: 188 -APESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 64  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 181
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 182 KPANFLI-VDGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 239
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIEFPDI---- 292
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 293 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 331
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 332 NQMAKGTTEE 341

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 92
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 151
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 200
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 201 APEIIL-SKGYNKAVDWWALGVLIYEM 226

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 14  YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 70
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 129
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 130 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 188
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 220
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 221 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 271

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA--RWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++     ++     F     Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 214 DLWALGCIIYQLVAGLP 230

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 215
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 216 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 215
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 216 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 215
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 216 DLWALGCIIYQLVAGLP 232

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/334 (23%), Positives = 134/334 (40%), Gaps = 76/334 (22%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           +Y  +  +G+G+YGVV  AI+ +T    AIK +   K ++ +N   +     E++L+K+L
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKL 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM---------------------------------ET 95
             P+I  L + +  +  + LV E                                   E 
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 96  DLETVIRNTNIFLSPAD-------IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG 148
           + E +  + + F    D       I + M+     L + H + + HRD+KP N L  ++ 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 149 --QLKLADFGLARIFGSPDR----RFTHQVFARWYRAPELLFGAKQ-YGAGVDVWAAGCI 201
             ++KL DFGL++ F   +       T +    ++ APE+L    + YG   D W+AG +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 202 FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP 261
              LL       G +D D + ++          + P+           Y    PL     
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQV---LNKKLCFENPN-----------YNVLSPL----- 306
Query: 262 SASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                A DLLS +   +   R  A +AL+H + S
Sbjct: 307 -----ARDLLSNLLNRNVDERFDAMRALQHPWIS 335

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 45/293 (15%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K +R  +   K+ V  T + E ++L+  + P
Sbjct: 9   YLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP 65
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H +
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSR 124
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-EDNDYG 183
Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
             VD W  G +  E++  R PF   + D ++L                          ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY--NQDHERL--------------------------FE 215
Query: 250 YVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
            +    +R  FP + S +A  LL+ +   DPK R+      A++ +EHR+F S
Sbjct: 216 LILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK I+ G   E  +F  + E +++ +L  P +++L   
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-VAIKTIKEGSMSED-DF--IEEAEVMMKLSHPKLVQLYGV 90
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LVFEFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 150
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 207
Query: 196 WAAGCIFAELLN 207
           W+ G +  E+ +
Sbjct: 208 WSFGVLMWEVFS 219

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P + +L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-------SPH 72
           LG G YGVV K     +GQ  A+K+IR           +  + +LL +L         P 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIR-------ATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 73  IIELIDAFPHKGNLHLVFEFMETDLE----TVIRNTNIFLSPADIKSYMQMTL-KGLAFC 127
            +    A   +G++ +  E  +T L+     VI        P DI   + +++ K L   
Sbjct: 95  TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHL 152
Query: 128 HKKW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL--- 183
           H K  V+HRD+KP+N+LI + GQ+K  DFG++  +   D         + Y APE +   
Sbjct: 153 HSKLSVIHRDVKPSNVLINALGQVKXCDFGISG-YLVDDVAKDIDAGCKPYXAPERINPE 211
Query: 184 FGAKQYGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKI 224
              K Y    D+W+ G    EL + R P+    +   QL ++
Sbjct: 212 LNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 118
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 177
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPE-----------YL 226
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 227 APEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 138
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 139 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 197
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 198 DLWALGCIIYQLVAGLP 214

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 77  IDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +   L   IR    F      + Y    +  L + H K ++HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEKSASKSS 215
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 216 DLWALGCIIYQLVAGLP 232

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV++A +       AIK+IRL   +E      +RE+K L +L+ P I+   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 78  DAFPHKGN------------LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK--- 122
           +A+  K              L++  +    +      N    +   +    + + L+   
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR------------RFTH 170
            + F H K ++HRD+KP+N+       +K+ DFGL       +             R T 
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           QV  + Y +PE + G   Y   VD+++ G I  ELL
Sbjct: 190 QVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 36  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 154 KPANFLIVD-GMLKLIDFGIANQM-QPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 264
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 265 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 303
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 304 NQMAKGTTEE 313

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 84
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 143
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 192
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 193 APEIIL-SKGYNKAVDWWALGVLIYEM 218

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 153
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 154 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEKSACKSS 212
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 213 DLWALGCIIYQLVAGLP 229

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++  V  A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 153
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 154 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 212
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 213 DLWALGCIIYQLVAGLP 229

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P + +L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 123/306 (40%), Gaps = 35/306 (11%)
Query: 6   LSKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           L  K  D Y L  E+LGEG Y  V  A+  + G+  A+K I   KQ         RE++ 
Sbjct: 6   LPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE--KQAGHSRSRVFREVET 63
Query: 65  LKELK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L + + + +I+ELI+ F      +LVFE ++              +  +    ++     
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDR-------RFTHQVF 173
           L F H K + HRD+KP N+L  S  +   +K+ DF L       +          T    
Sbjct: 124 LDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 174 ARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID---QLGKIFA 226
           +  Y APE++      A  Y    D+W+ G +   +L+  P   G    D     G++  
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCR 243
Query: 227 AFGTATPSQWPDLAY-LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                      +  Y  PD               +   S +A DL+SK+   D K R++A
Sbjct: 244 VCQNKLFESIQEGKYEFPD-------------KDWAHISSEAKDLISKLLVRDAKQRLSA 290
Query: 286 QQALEH 291
            Q L+H
Sbjct: 291 AQVLQH 296

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      +TG   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 98
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P + +L  +F    NL++V E+    ++ + +R    F  P   + Y    +    +
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 157
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +K+ DFG A+        + G+P+           Y 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPE-----------YL 206
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 207 APEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 20  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 138 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 195
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 196 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 248
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 249 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 287
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 288 NQMAKGTTEE 297

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 17  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 135 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIEFPDI---- 245
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 246 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 284
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 285 NQMAKGTTEE 294

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 36  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 153
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 154 KPANFLIVD-GMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQI---INQISKLHAIIDPNHEIEFPDI---- 264
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 265 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 303
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 304 NQMAKGTTEE 313

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 38/286 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 84
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 144
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 145 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEVD 203
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           VW+ GCI   LL  +P  + S   +   +I         +++     +P ++        
Sbjct: 204 VWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNEYS----IPKHIN------- 245
Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 P A+     L+ KM   DP AR T  + L   +F+S  +P
Sbjct: 246 ------PVAA----SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NL+I   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIII-SKGYNKAVDWWALGVLIYEM 231

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 48/310 (15%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELI 77
           +G G    V++ ++ K  Q  AIK + L +       +   EI  L +L+  S  II L 
Sbjct: 16  IGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
           D       +++V E    DL + ++     + P + KSY +  L+ +   H+  ++H D+
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 133
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPEL---LFGAKQYG- 190
           KP N LI   G LKL DFG+A     PD        QV    Y  PE    +  +++ G 
Sbjct: 134 KPANFLI-VDGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 191
Query: 191 ------AGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                    DVW+ GCI   +   + PF Q    I+Q+ K+ A        ++PD+    
Sbjct: 192 SKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIEFPDI---- 244
Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEP 303
                                 D  D+L      DPK RI+  + L H Y      P   
Sbjct: 245 -------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV-- 283
Query: 304 NKLPRPATKR 313
           N++ +  T+ 
Sbjct: 284 NQMAKGTTEE 293

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 63  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 122 IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 177
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF---------GLARI---FGSPDRRF 168
           +  L   H    +HRD+KP+N+L+   G LKLADF         G+ R     G+PD   
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--- 234
Query: 169 THQVFARWYRAPELL---FGAKQYGAGVDVWAAGCIFAELL 206
                   Y +PE+L    G   YG   D W+ G    E+L
Sbjct: 235 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 134
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 193 GRSAAVWSLGILLYDMV 209

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 148
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 149 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 207 GRSAAVWSLGILLYDMV 223

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 149
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 150 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 208 GRSAAVWSLGILLYDMV 224

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 68  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 127 IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 182
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRA 179
           +  L   H    +HRD+KP+N+L+   G LKLADFG           R    V    Y +
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 180 PELL---FGAKQYGAGVDVWAAGCIFAELL 206
           PE+L    G   YG   D W+ G    E+L
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 149
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 150 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 208 GRSAAVWSLGILLYDMV 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIR------LGKQKEGVNFTALREIKLLKELKSP 71
           E++G G +G VY+A     G  VA+K  R      + +  E V     +E KL   LK P
Sbjct: 13  EIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVR----QEAKLFAMLKHP 66
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADI-KSYMQMTLKGLAFCHK 129
           +II L      + NL LV EF     L  V+    I   P DI  ++     +G+ + H 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI---PPDILVNWAVQIARGMNYLHD 123
Query: 130 KW---VLHRDMKPNNLLI--------GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
           +    ++HRD+K +N+LI         S+  LK+ DFGLAR +    +      +A  + 
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA--WM 181
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           APE++  A  +  G DVW+ G +  ELL      +G   ID L     A+G A
Sbjct: 182 APEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRG---IDGLA---VAYGVA 227

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 80
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEVD 199
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           VW+ GCI   LL  +P  + S     L + +        S       +P ++        
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSC----LKETYLRIKKNEYS-------IPKHIN------- 241
Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 P A+     L+ KM   DP AR T  + L   +F+S  +P
Sbjct: 242 ------PVAA----SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 277

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 148
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 149 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 207 GRSAAVWSLGILLYDMV 223

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 6/197 (3%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           ++LGEG++     A +  T +  AIK + +    KE       RE  ++  L  P  ++L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
              F     L+    + +  +L   IR    F      + Y    +  L + H K ++HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           D+KP N+L+     +++ DFG A++    S   R    V    Y +PELL   K      
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL-TEKSACKSS 213
Query: 194 DVWAAGCIFAELLNRRP 210
           D+WA GCI  +L+   P
Sbjct: 214 DLWALGCIIYQLVAGLP 230

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGLAR+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  ++
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYQM 231

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 134
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 193 GRSAAVWSLGILLYDMV 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 133
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 134 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 192 GRSAAVWSLGILLYDMV 208

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 149
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 150 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 208 GRSAAVWSLGILLYDMV 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 38/286 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 80
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVL-SKKGHSFEVD 199
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           VW+ GCI   LL  +P  + S   +   +I         +++     +P ++        
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNEYS----IPKHIN------- 241
Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 P A+     L+ KM   DP AR T  + L   +F+S  +P
Sbjct: 242 ------PVAA----SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 277

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 168
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 227 GRSAAVWSLGILLYDMV 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 134
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 135 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 193 GRSAAVWSLGILLYDMV 209

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 161
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 220 GRSAAVWSLGILLYDMV 236

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 142/311 (45%), Gaps = 70/311 (22%)
Query: 18  EVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKS-PHI 73
           ++LG G+ G VV++   +  G+ VA+K++        ++F   AL EIKLL E    P++
Sbjct: 39  KILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNV 89
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK--------SYMQMTLKGLA 125
           I    +      L++  E    +L+ ++ + N+  S  ++K        S ++    G+A
Sbjct: 90  IRYYCSETTDRFLYIALELCNLNLQDLVESKNV--SDENLKLQKEYNPISLLRQIASGVA 147
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ-------------LKLADFGLARIFGSPDRRFTHQV 172
             H   ++HRD+KP N+L+ +  +             + ++DFGL +   S    F   +
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 173 F----ARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNR--RPFL-QGSSDIDQLGK 223
                   +RAPELL  +  ++    +D+++ GC+F  +L++   PF  + S + + +  
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
           IF+           ++  L D            RSL   A+D    L+S+M  +DP  R 
Sbjct: 268 IFS---------LDEMKCLHD------------RSLIAEATD----LISQMIDHDPLKRP 302
Query: 284 TAQQALEHRYF 294
           TA + L H  F
Sbjct: 303 TAMKVLRHPLF 313

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 162
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 221 GRSAAVWSLGILLYDMV 237

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 102
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 162
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 163 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEVD 221
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           VW+ GCI   LL  +P  + S     L + +        S       +P ++        
Sbjct: 222 VWSIGCIMYTLLVGKPPFETSC----LKETYLRIKKNEYS-------IPKHIN------- 263
Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 P A+     L+ KM   DP AR T  + L   +F+S  +P
Sbjct: 264 ------PVAA----SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 299

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 176
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 235 GRSAAVWSLGILLYDMV 251

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 176
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 177 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 235 GRSAAVWSLGILLYDMV 251

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALRE 61
           DL  K  D Y   +V+G G +G V       T +  A+K   K  + K+ +   F   R+
Sbjct: 68  DLRMKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMT 120
           I       SP +++L  AF     L++V E+M   DL  ++ N ++    A  + Y    
Sbjct: 127 IMAFA--NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEV 182
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF---------GLARI---FGSPDRRF 168
           +  L   H    +HRD+KP+N+L+   G LKLADF         G+ R     G+PD   
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--- 239
Query: 169 THQVFARWYRAPELL---FGAKQYGAGVDVWAAGCIFAELL 206
                   Y +PE+L    G   YG   D W+ G    E+L
Sbjct: 240 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 104
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEVD 223
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           VW+ GCI   LL  +P  + S     L + +        S       +P ++        
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSC----LKETYLRIKKNEYS-------IPKHIN------- 265
Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 P A+     L+ KM   DP AR T  + L   +F+S  +P
Sbjct: 266 ------PVAA----SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 162
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 221 GRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 161
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 220 GRSAAVWSLGILLYDMV 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 162
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 221 GRSAAVWSLGILLYDMV 237

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 161
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 220 GRSAAVWSLGILLYDMV 236

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 18  EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           +V+G+G++G V    +KA +      V  KK  L K+KE  +  + R + LLK +K P +
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNV-LLKNVKHPFL 101
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + L  +F     L+ V +++   +L   ++    FL P   + Y       L + H   +
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASALGYLHSLNI 160
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--YRAPELLFGAKQYG 190
           ++RD+KP N+L+ S G + L DFGL +   + +   T   F     Y APE+L   + Y 
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL-HKQPYD 217
Query: 191 AGVDVWAAGCIFAELLNRRP 210
             VD W  G +  E+L   P
Sbjct: 218 RTVDWWCLGAVLYEMLYGLP 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 161
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 162 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 220 GRSAAVWSLGILLYDMV 236

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 142/311 (45%), Gaps = 70/311 (22%)
Query: 18  EVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKELKS-PHI 73
           ++LG G+ G VV++   +  G+ VA+K++        ++F   AL EIKLL E    P++
Sbjct: 39  KILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNV 89
Query: 74  IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK--------SYMQMTLKGLA 125
           I    +      L++  E    +L+ ++ + N+  S  ++K        S ++    G+A
Sbjct: 90  IRYYCSETTDRFLYIALELCNLNLQDLVESKNV--SDENLKLQKEYNPISLLRQIASGVA 147
Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQ-------------LKLADFGLARIFGSPDRRFTHQV 172
             H   ++HRD+KP N+L+ +  +             + ++DFGL +   S    F   +
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 173 F----ARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNR--RPFL-QGSSDIDQLGK 223
                   +RAPELL  +  ++    +D+++ GC+F  +L++   PF  + S + + +  
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
           IF+           ++  L D            RSL   A+D    L+S+M  +DP  R 
Sbjct: 268 IFS---------LDEMKCLHD------------RSLIAEATD----LISQMIDHDPLKRP 302
Query: 284 TAQQALEHRYF 294
           TA + L H  F
Sbjct: 303 TAMKVLRHPLF 313

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 162
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 163 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 221 GRSAAVWSLGILLYDMV 237

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNX 129
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 181
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 182 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 239
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 240 GRSAAVWSLGILLYDMV 256

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 156
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 157 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 214
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 215 GRSAAVWSLGILLYDMV 231

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 132
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 133 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 191 GRSAAVWSLGILLYDMV 207

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 135/316 (42%), Gaps = 47/316 (14%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 29  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 206 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 262
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
              PD+ +    + +QY   P +R  F       L+++S +           ++ +E  +
Sbjct: 263 DNCPDMLFELMRMCWQY--NPKMRPSF-------LEIISSI-----------KEEMEPGF 302
Query: 294 FSSAPLPTEPNKLPRP 309
              +   +E NKLP P
Sbjct: 303 REVSFYYSEENKLPEP 318

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 135/316 (42%), Gaps = 47/316 (14%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 29  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 85
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 145
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 206 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 262
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
              PD+ +    + +QY   P +R  F       L+++S +           ++ +E  +
Sbjct: 263 DNCPDMLFELMRMCWQY--NPKMRPSF-------LEIISSI-----------KEEMEPGF 302
Query: 294 FSSAPLPTEPNKLPRP 309
              +   +E NKLP P
Sbjct: 303 REVSFYYSEENKLPEP 318

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 129
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 38/286 (13%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVA---IKKIRLGK--QKEGVNFTALREIKLLKELKSPHII 74
           LG+G +   ++  D  T +  A   + K  L K  Q+E ++     EI + + L   H++
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM----EISIHRSLAHQHVV 78
Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                F     + +V E         +      L+  + + Y++  + G  + H+  V+H
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+K  NL +    ++K+ DFGLA        R         Y APE+L   K +   VD
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL-SKKGHSFEVD 197
Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           VW+ GCI   LL  +P  + S   +   +I         +++     +P ++        
Sbjct: 198 VWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNEYS----IPKHIN------- 239
Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 P A+     L+ KM   DP AR T  + L   +F+S  +P
Sbjct: 240 ------PVAA----SLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 106
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 166
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 224
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 254

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 6/204 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPHIIELI 77
           VLG+G +G V       TG+  A KK+   + K+      AL E ++L+++ S  ++ L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHR 135
            A+  K  L LV   M   DL+  I +      P A    Y      GL   H++ +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP N+L+  HG ++++D GLA +     +    +V    Y APE++   ++Y    D 
Sbjct: 311 DLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDW 368
Query: 196 WAAGCIFAELL-NRRPFLQGSSDI 218
           WA GC+  E++  + PF Q    I
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKI 392

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 136/320 (42%), Gaps = 30/320 (9%)
Query: 6   LSKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
            S +  D Y L+ +VLGEG +  V   I+  T Q  A+K I   KQ   +     RE+++
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVEM 63
Query: 65  LKELKSP-HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           L + +   +++ELI+ F  +   +LVFE M         +     +  +    +Q     
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA---RIFGSPDRRFTHQVF---- 173
           L F H K + HRD+KP N+L     Q   +K+ DF L    ++ G      T ++     
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 174 ARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
           +  Y APE++      A  Y    D+W+ G I   LL+  P   G    D         G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----CGWDRG 239
Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
            A P+    L       +Y++    P +  +   S  A DL+SK+   D K R++A Q L
Sbjct: 240 EACPACQNMLFESIQEGKYEF----PDKD-WAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
Query: 290 EHRYFSSAPLPTEPNKLPRP 309
           +H +          N LP P
Sbjct: 295 QHPWVQGC---APENTLPTP 311

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-- 75
           E++G G +G V+KA     G+T  I++++   +K      A RE+K L +L   +I+   
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEK------AEREVKALAKLDHVNIVHYN 71
Query: 76  -LIDAFPHK--------------------------GNLHLVFEFMET-DLETVI--RNTN 105
              D F +                             L +  EF +   LE  I  R   
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD 165
                  ++ + Q+T KG+ + H K ++HRD+KP+N+ +    Q+K+ DFGL     +  
Sbjct: 132 KLDKVLALELFEQIT-KGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +R   +   R Y +PE +  ++ YG  VD++A G I AELL+
Sbjct: 191 KRTRSKGTLR-YMSPEQI-SSQDYGKEVDLYALGLILAELLH 230

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PH 72
           +LG G +G VY  I       VAIK +   R+    E  N T +  E+ LLK++ S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 73  IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I L+D F    +  L+ E  E   DL   I      L     +S+    L+ +  CH  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNC 129
Query: 131 WVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
            VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE +   + +
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 190 GAGVDVWAAGCIFAELL 206
           G    VW+ G +  +++
Sbjct: 188 GRSAAVWSLGILLYDMV 204

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 269 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 323
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 324 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 439
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY--LPD 244
            ++    DVW+ G +  EL  +             G++           +P +    + D
Sbjct: 440 -RFTIKSDVWSFGILLTELTTK-------------GRV----------PYPGMVNREVLD 475
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 476 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 526
Query: 303 PNKLP 307
           P   P
Sbjct: 527 PQXQP 531

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 6/204 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPHIIELI 77
           VLG+G +G V       TG+  A KK+   + K+      AL E ++L+++ S  ++ L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSP-ADIKSYMQMTLKGLAFCHKKWVLHR 135
            A+  K  L LV   M   DL+  I +      P A    Y      GL   H++ +++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           D+KP N+L+  HG ++++D GLA +     +    +V    Y APE++   ++Y    D 
Sbjct: 311 DLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDW 368
Query: 196 WAAGCIFAELL-NRRPFLQGSSDI 218
           WA GC+  E++  + PF Q    I
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKI 392

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 140/323 (43%), Gaps = 62/323 (19%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EV+G G +GVV KA      + VAIK+I    +++      + E++ L  +  P+I++L 
Sbjct: 15  EVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKLY 68
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHK---KW 131
            A  +   + LV E+ E   L  V+       + + A   S+     +G+A+ H    K 
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 132 VLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           ++HRD+KP NLL+ + G  LK+ DFG A    +     T+   +  + APE +F    Y 
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPE-VFEGSNYS 182
Query: 191 AGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLG----KIFAAFGTATPSQWPDLAYLPDY 245
              DV++ G I  E++ RR PF       D++G    +I  A    T             
Sbjct: 183 EKCDVFSWGIILWEVITRRKPF-------DEIGGPAFRIMWAVHNGT------------- 222
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-----HRYFSSAPLP 300
                   PPL    P   +    L+++ ++ DP  R + ++ ++      RYF  A  P
Sbjct: 223 -------RPPLIKNLPKPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272
Query: 301 TE---PNKLPRPATKRASKASDF 320
            +    + LP     R     DF
Sbjct: 273 LQYPCQHSLPPGEDGRVEPYVDF 295

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 140/323 (43%), Gaps = 62/323 (19%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EV+G G +GVV KA      + VAIK+I    +++      + E++ L  +  P+I++L 
Sbjct: 14  EVVGRGAFGVVCKA--KWRAKDVAIKQIESESERKAF----IVELRQLSRVNHPNIVKLY 67
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHK---KW 131
            A  +   + LV E+ E   L  V+       + + A   S+     +G+A+ H    K 
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 132 VLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
           ++HRD+KP NLL+ + G  LK+ DFG A    +     T+   +  + APE +F    Y 
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPE-VFEGSNYS 181
Query: 191 AGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLG----KIFAAFGTATPSQWPDLAYLPDY 245
              DV++ G I  E++ RR PF       D++G    +I  A    T             
Sbjct: 182 EKCDVFSWGIILWEVITRRKPF-------DEIGGPAFRIMWAVHNGT------------- 221
Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE-----HRYFSSAPLP 300
                   PPL    P   +    L+++ ++ DP  R + ++ ++      RYF  A  P
Sbjct: 222 -------RPPLIKNLPKPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 301 TE---PNKLPRPATKRASKASDF 320
            +    + LP     R     DF
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDF 294

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+           Y 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----------YL 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           AP ++  +K Y   VD WA G +  E+
Sbjct: 206 APAIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 79
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 197
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G +G+V+        + VAIK IR G   E  +F  + E +++ +L  P +++L   
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE-DF--IEEAEVMMKLSHPKLVQLYGV 71
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + LV EFME   L   +R      +   +        +G+A+  +  V+HRD+ 
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+G +  +K++DFG+ R     D ++T     ++   + +PE +F   +Y +  DV
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 188
Query: 196 WAAGCIFAELLN 207
           W+ G +  E+ +
Sbjct: 189 WSFGVLMWEVFS 200

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 5/203 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A+K ++  L    E +++    +    +    P ++ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 135
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWW 194
Query: 197 AAGCIFAELL-NRRPF-LQGSSD 217
           A G +  E++  R PF + GSSD
Sbjct: 195 ALGVLMFEMMAGRSPFDIVGSSD 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 96
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 156
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 214
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 244

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 5/203 (2%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           V+G G+Y  V      KT +  A+K ++  L    E +++    +    +    P ++ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              F  +  L  V E++              L     + Y       L + H++ +++RD
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 131
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVW 196
           +K +N+L+ S G +KL D+G+ +    P    +       Y APE+L G + YG  VD W
Sbjct: 132 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWW 190
Query: 197 AAGCIFAELL-NRRPF-LQGSSD 217
           A G +  E++  R PF + GSSD
Sbjct: 191 ALGVLMFEMMAGRSPFDIVGSSD 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+G G+Y  V      KT +  A+K ++    KE VN     +I  ++  K  H+ E   
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVK----KELVNDD--EDIDWVQTEK--HVFEQAS 78
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK---------------G 123
             P    LH  F+  E+ L  VI     +++  D+  +MQ   K                
Sbjct: 79  NHPFLVGLHSCFQ-TESRLFFVIE----YVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 133
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H++ +++RD+K +N+L+ S G +KL D+G+ +    P    +       Y APE+L
Sbjct: 134 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 193
Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPF-LQGSSD 217
            G + YG  VD WA G +  E++  R PF + GSSD
Sbjct: 194 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 228

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 125/311 (40%), Gaps = 52/311 (16%)
Query: 10  VADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKE 67
           V D Y L ++VLG G  G V +    +TGQ  A+K +    K ++ V+          + 
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH-------WQA 59
Query: 68  LKSPHIIELIDAFP--HKGN--LHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTL 121
              PHI+ ++D +   H G   L ++ E ME       +    +   +  +    M+   
Sbjct: 60  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 119
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYR 178
             + F H   + HRD+KP NLL  S  +   LKL DFG A+   +         +  +Y 
Sbjct: 120 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYV 177
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKI----FAAFGTATP 233
           APE+L G ++Y    D+W+ G I   LL    PF   +      G         +G   P
Sbjct: 178 APEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 236
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
            +W ++                        S+DA  L+  +   DP  R+T  Q + H +
Sbjct: 237 -EWSEV------------------------SEDAKQLIRLLLKTDPTERLTITQFMNHPW 271
Query: 294 FS-SAPLPTEP 303
            + S  +P  P
Sbjct: 272 INQSMVVPQTP 282

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 125/311 (40%), Gaps = 52/311 (16%)
Query: 10  VADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKE 67
           V D Y L ++VLG G  G V +    +TGQ  A+K +    K ++ V+          + 
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH-------WQA 78
Query: 68  LKSPHIIELIDAFP--HKGN--LHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTL 121
              PHI+ ++D +   H G   L ++ E ME       +    +   +  +    M+   
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYR 178
             + F H   + HRD+KP NLL  S  +   LKL DFG A+   +         +  +Y 
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYV 196
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKI----FAAFGTATP 233
           APE+L G ++Y    D+W+ G I   LL    PF   +      G         +G   P
Sbjct: 197 APEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
            +W ++                        S+DA  L+  +   DP  R+T  Q + H +
Sbjct: 256 -EWSEV------------------------SEDAKQLIRLLLKTDPTERLTITQFMNHPW 290
Query: 294 FS-SAPLPTEP 303
            + S  +P  P
Sbjct: 291 INQSMVVPQTP 301

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 23  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 79
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 200 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 256
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 257 DNCPDMLFELMRMCWQY--NPKMRPSF 281

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/328 (23%), Positives = 147/328 (44%), Gaps = 74/328 (22%)
Query: 5   DLSKKVADRYLKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALRE 61
           +  + + +  +  ++LG G+ G VV++   +  G+ VA+K++        ++F   AL E
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALME 58
Query: 62  IKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK------ 114
           IKLL E    P++I    +      L++  E    +L+ ++ + N+  S  ++K      
Sbjct: 59  IKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNV--SDENLKLQKEYN 116
Query: 115 --SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-------------QLKLADFGLAR 159
             S ++    G+A  H   ++HRD+KP N+L+ +               ++ ++DFGL +
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 IFGSPDRRFTHQVF----ARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN-- 207
              S    F   +        +RAPELL  +      ++    +D+++ GC+F  +L+  
Sbjct: 177 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 208 RRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDD 266
           + PF  + S + + +  IF+           ++  L D            RSL   A+  
Sbjct: 237 KHPFGDKYSRESNIIRGIFS---------LDEMKCLHD------------RSLIAEAT-- 273
Query: 267 ALDLLSKMFTYDPKARITAQQALEHRYF 294
             DL+S+M  +DP  R TA + L H  F
Sbjct: 274 --DLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/328 (23%), Positives = 147/328 (44%), Gaps = 74/328 (22%)
Query: 5   DLSKKVADRYLKREVLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALRE 61
           +  + + +  +  ++LG G+ G VV++   +  G+ VA+K++        ++F   AL E
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQG--SFQGRPVAVKRML-------IDFCDIALME 58
Query: 62  IKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIK------ 114
           IKLL E    P++I    +      L++  E    +L+ ++ + N+  S  ++K      
Sbjct: 59  IKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNV--SDENLKLQKEYN 116
Query: 115 --SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-------------QLKLADFGLAR 159
             S ++    G+A  H   ++HRD+KP N+L+ +               ++ ++DFGL +
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 IFGSPDRRFTHQVF----ARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN-- 207
              S    F   +        +RAPELL  +      ++    +D+++ GC+F  +L+  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 208 RRPF-LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDD 266
           + PF  + S + + +  IF+           ++  L D            RSL   A+  
Sbjct: 237 KHPFGDKYSRESNIIRGIFS---------LDEMKCLHD------------RSLIAEAT-- 273
Query: 267 ALDLLSKMFTYDPKARITAQQALEHRYF 294
             DL+S+M  +DP  R TA + L H  F
Sbjct: 274 --DLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 18  EVLGEGTYGVVY---KAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELK-SP 71
           +VLG G YG V+   K     TG+  A+K ++     QK         E ++L+ ++ SP
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            ++ L  AF  +  LHL+ +++   +L T +     F +  +++ Y+   +  L   HK 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF-TEHEVQIYVGEIVLALEHLHKL 178
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLFGAKQ- 188
            +++RD+K  N+L+ S+G + L DFGL++ F + +    +       Y AP+++ G    
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 189 YGAGVDVWAAGCIFAELLN 207
           +   VD W+ G +  ELL 
Sbjct: 239 HDKAVDWWSLGVLMYELLT 257

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK----EGVNFTALREIKLLKE 67
           D++ + + LG G++G V      ++G   A+K   L KQK    + +  T L E ++L+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHT-LNEKRILQA 97
Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +++L  +F    NL++V E++   ++ + +R    F  P   + Y    +    +
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLTFEY 156
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR--------IFGSPDRRFTHQVFARWYR 178
            H   +++RD+KP NLLI   G +++ DFG A+        + G+P+             
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----------L 205
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAEL 205
           APE++  +K Y   VD WA G +  E+
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLG---KQKEGVNFTALREIKL 64
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++     + + G      +EI +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----QEIDI 86
Query: 65  LKELKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           L+ L   HII+        G  +L LV E++    L   +   +I L  A +  + Q   
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQIC 144
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------AR 175
           +G+A+ H +  +HRD+   N+L+ +   +K+ DFGLA+    P+    ++V         
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEXYRVREDGDSPVF 202
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR 208
           WY APE L   K Y A  DVW+ G    ELL  
Sbjct: 203 WY-APECLKEYKFYYAS-DVWSFGVTLYELLTH 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           V+G G+Y  V      KT +  A++ ++    KE VN     +I  ++  K  H+ E   
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVK----KELVNDD--EDIDWVQTEK--HVFEQAS 110
Query: 79  AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK---------------G 123
             P    LH  F+  E+ L  VI     +++  D+  +MQ   K                
Sbjct: 111 NHPFLVGLHSCFQ-TESRLFFVIE----YVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H++ +++RD+K +N+L+ S G +KL D+G+ +    P    +       Y APE+L
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 184 FGAKQYGAGVDVWAAGCIFAELL-NRRPF-LQGSSD 217
            G + YG  VD WA G +  E++  R PF + GSSD
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 22  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 199 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 255
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 256 DNCPDMLFELMRMCWQY--NPKMRPSF 280

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 20  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 76
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 77  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 136
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 197 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 253
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 254 DNCPDMLFELMRMCWQY--NPKMRPSF 278

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 13  RYLKREV-LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           R+LK ++ +G G++  VYK +DT+T   VA  +++  K  +        E + LK L+ P
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHP 85
Query: 72  HIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +I+   D++      K  + LV E   +  L+T ++   +      ++S+ +  LKGL F
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV-LRSWCRQILKGLQF 144
Query: 127 CHKKW--VLHRDMKPNNLLI-GSHGQLKLADFGLAR---------IFGSPDRRFTHQVFA 174
            H +   ++HRD+K +N+ I G  G +K+ D GLA          + G+P+         
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE--------- 195
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAG-CIFAELLNRRPF 211
             + APE     ++Y   VDV+A G C      +  P+
Sbjct: 196 --FXAPEXY--EEKYDESVDVYAFGXCXLEXATSEYPY 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 16  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 72
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 193 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 249
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 250 DNCPDMLFELMRMCWQY--NPKMRPSF 274

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 226
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 19  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 75
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 76  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 135
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 196 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 252
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 253 DNCPDMLFELMRMCWQY--NPKMRPSF 277

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 22  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 199 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 255
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 256 DNCPDMLFELMRMCWQY--NPKMRPSF 280

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 23  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 79
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 200 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 256
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 257 DNCPDMLFELMRMCWQY--NPKMRPSF 281

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 141/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 9   LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 63
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 64  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 114
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 115 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 171
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L              
Sbjct: 172 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL-------------- 214
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
                   D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 215 --------DQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 261
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 262 FTS----TEPQYQP 271

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 186 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 241 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 356
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY--LPD 244
            ++    DVW+ G +  EL  +             G++           +P +    + D
Sbjct: 357 -RFTIKSDVWSFGILLTELTTK-------------GRV----------PYPGMVNREVLD 392
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 393 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 443
Query: 303 PNKLP 307
           P   P
Sbjct: 444 PQXQP 448

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 141/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L              
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL-------------- 225
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
                   D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 226 --------DQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 272
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 273 FTS----TEPQYQP 282

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 66
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 67  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTEPCYTPYYVA 185
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 186 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++ G   + +     REI++L+ 
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ-LRSGWQREIEILRT 67
Query: 68  LKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L   HI++       +G  ++ LV E++    L   +    + L  A +  + Q   +G+
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGM 125
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYR 178
           A+ H +  +HR +   N+L+ +   +K+ DFGLA+    P+    ++V         WY 
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY- 182
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L   K Y A  DVW+ G    ELL 
Sbjct: 183 APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 138/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 226
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    YF+S    TE
Sbjct: 227 QVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS----TE 277
Query: 303 PNKLP 307
           P   P
Sbjct: 278 PQYQP 282

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIR--LGKQ-KEGVNFTALREIKL 64
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++   G Q + G      +EI +
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWK----QEIDI 69
Query: 65  LKELKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           L+ L   HII+       +G  +L LV E++    L   +   +I L  A +  + Q   
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQIC 127
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------AR 175
           +G+A+ H +  +HR++   N+L+ +   +K+ DFGLA+    P+    ++V         
Sbjct: 128 EGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVF 185
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           WY APE L   K Y A  DVW+ G    ELL 
Sbjct: 186 WY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 20  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 78
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 79  HVCRLL-GICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 195
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMT 215

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      + +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 79
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  +PE +   ++
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TSPEAI-AYRK 197
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+ + S+
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSN 227

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 141/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 11  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 65
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 66  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 116
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 117 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 173
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L              
Sbjct: 174 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL-------------- 216
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
                   D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 217 --------DQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 263
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 264 FTS----TEPQYQP 273

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 138/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 226
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    YF+S    TE
Sbjct: 227 QVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS----TE 277
Query: 303 PNKLP 307
           P   P
Sbjct: 278 PQYQP 282

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 14  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 70
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 71  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 130
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 191 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 247
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+      + +QY   P +R  F
Sbjct: 248 DNCPDMLLELMRMCWQY--NPKMRPSF 272

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 140/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 186 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 241 LVQLY-AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 356
Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY--LPD 244
            ++    DVW+ G +  EL  +             G++           +P +    + D
Sbjct: 357 -RFTIKSDVWSFGILLTELTTK-------------GRV----------PYPGMVNREVLD 392
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 393 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 443
Query: 303 PNKLP 307
           P   P
Sbjct: 444 PQXQP 448

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 139/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 13  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 67
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 68  LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 183
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 184 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 219
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 220 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 270
Query: 303 PNKLP 307
           P   P
Sbjct: 271 PQYQP 275

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 23  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 82  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 198
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++ G   + +     REI++L+ 
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ-LRSGWQREIEILRT 66
Query: 68  LKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L   HI++       +G  ++ LV E++    L   +    + L  A +  + Q   +G+
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGM 124
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYR 178
           A+ H +  +HR +   N+L+ +   +K+ DFGLA+    P+    ++V         WY 
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY- 181
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN 207
           APE L   K Y A  DVW+ G    ELL 
Sbjct: 182 APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 51  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 107
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 108 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 167
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   R
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 228 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 284
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+ +    + +QY   P +R  F
Sbjct: 285 DNCPDMLFELMRMCWQY--NPKMRPSF 309

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 13  RYLKR-EVLGEGTYGVV----YKAIDTKTGQTVAIKKIR--LGKQ-KEGVNFTALREIKL 64
           RYLK+   LGEG +G V    Y   +  TG+ VA+K ++   G Q + G      +EI +
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWK----QEIDI 69
Query: 65  LKELKSPHIIELIDAFPHKG--NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           L+ L   HII+       +G  +L LV E++    L   +   +I L  A +  + Q   
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQIC 127
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------AR 175
           +G+A+ H +  +HR++   N+L+ +   +K+ DFGLA+    P+    ++V         
Sbjct: 128 EGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVF 185
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           WY APE L   K Y A  DVW+ G    ELL 
Sbjct: 186 WY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 73
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 74  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 192
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 193 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 138/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 226
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    YF+S    TE
Sbjct: 227 QVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS----TE 277
Query: 303 PNKLP 307
           P   P
Sbjct: 278 PQYQP 282

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 15  LKR-EVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG--VNFTALREIKLLKELKS 70
           LKR +VLG G +G VYK I    G+TV I   I++  +  G   N   + E  ++  +  
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 71  PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           PH++ L+        + LV + M     LE V  + +   S   +   +Q+  KG+ +  
Sbjct: 77  PHLVRLL-GVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA-KGMMYLE 134
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFG 185
           ++ ++HRD+   N+L+ S   +K+ DFGLAR+    ++ +     ++  +W     + + 
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY- 193
Query: 186 AKQYGAGVDVWAAGCIFAELLN 207
            +++    DVW+ G    EL+ 
Sbjct: 194 -RKFTHQSDVWSYGVTIWELMT 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 139/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 17  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 71
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 72  LVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 187
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 188 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 223
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 224 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 274
Query: 303 PNKLP 307
           P   P
Sbjct: 275 PQYQP 279

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 139/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 186 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 241 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG- 356
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 357 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 392
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 393 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 443
Query: 303 PNKLP 307
           P   P
Sbjct: 444 PQYQP 448

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG-VNFTALREIKL-LKELKSPH 72
           K +VLG G +G V+K +    G+++ I   I++ + K G  +F A+ +  L +  L   H
Sbjct: 35  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+   P   +L LV +++    L   +R     L P  + ++     KG+ +  +  
Sbjct: 95  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           ++HR++   N+L+ S  Q+++ADFG+A +    D++  +   +   +W     + FG  +
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--K 211
Query: 189 YGAGVDVWAAGCIFAELLN 207
           Y    DVW+ G    EL+ 
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 20  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 78
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 79  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 195
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMT 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 72
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 73  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 191
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 192 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 74
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 75  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 193
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 194 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 112
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 231
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 232 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 82
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 83  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 201
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 202 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 68
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 187
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 188 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 111/228 (48%), Gaps = 16/228 (7%)
Query: 2   AEVDLSKKVADRYLK-REVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFT 57
             ++ +K++   Y+K  EV+G G +G V +      G+    VAIK ++ G   E     
Sbjct: 3   GSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQRRE 61
Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSY 116
            L E  ++ + + P+II L     +   + ++ EFME   L++ +R  +   +   +   
Sbjct: 62  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 121
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH---- 170
           ++    G+ +  +   +HRD+   N+L+ S+   K++DFGL+R     S D  +T     
Sbjct: 122 LRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           ++  RW  APE +   +++ +  D W+ G +  E+++   RP+   S+
Sbjct: 182 KIPIRW-TAPEAI-AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN 227

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 67
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 68  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 186
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 187 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 66
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 67  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 185
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 186 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 141/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+++   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKIRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L              
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL-------------- 225
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
                   D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 226 --------DQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 272
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 273 FTS----TEPQYQP 282

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 68
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 187
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 188 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 141/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 187 LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEK 241
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 242 LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 292
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGL R+    D  +T +  A++   + 
Sbjct: 293 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWT 349
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE  L+G  ++    DVW+ G +  EL  +             G++           +P
Sbjct: 350 APEAALYG--RFTIKSDVWSFGILLTELTTK-------------GRV----------PYP 384
Query: 238 DLAY--LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
            +    + D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 385 GMVNREVLDQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 439
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 440 FTS----TEPQXQP 449

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 118
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +    M+   +
Sbjct: 119 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 237
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D+W+ G I   LL   P
Sbjct: 238 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 66/304 (21%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 155 YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 211
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 270
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYR 178
           K V++RD+K  NL++   G +K+ DFGL +             G+P+           Y 
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------YL 319
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L ++        P    
Sbjct: 320 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP---- 372
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                              R+L P A      LLS +   DPK R+      A++ ++HR
Sbjct: 373 -------------------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 409
Query: 293 YFSS 296
           +F+ 
Sbjct: 410 FFAG 413

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 15  LKR-EVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG--VNFTALREIKLLKELKS 70
           LKR +VLG G +G VYK I    G+TV I   I++  +  G   N   + E  ++  +  
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 99
Query: 71  PHIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           PH++ L+        + LV + M     LE V  + +   S   +   +Q+  KG+ +  
Sbjct: 100 PHLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIA-KGMMYLE 157
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFG 185
           ++ ++HRD+   N+L+ S   +K+ DFGLAR+    ++ +     ++  +W     + + 
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY- 216
Query: 186 AKQYGAGVDVWAAGCIFAELLN 207
            +++    DVW+ G    EL+ 
Sbjct: 217 -RKFTHQSDVWSYGVTIWELMT 237

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 113/234 (48%), Gaps = 16/234 (6%)
Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHII 74
           V+G G +G V      +  K    VAIK +++G  +K+  +F  L E  ++ +   P+II
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNII 86
Query: 75  ELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L         + +V E+ME   L+T ++  +   +   +   ++    G+ +      +
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQY 189
           HRD+   N+LI S+   K++DFGL+R+    P+  +T    ++  RW  APE +   +++
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAPEAI-AFRKF 204
Query: 190 GAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +  DVW+ G +  E+++   RP+ + ++  D +  +   +   +P   P   Y
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERPYWEMTNQ-DVIKAVEEGYRLPSPMDCPAALY 257

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 140/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGCL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L              
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL-------------- 225
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
                   D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 226 --------DQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 272
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 273 FTS----TEPQYQP 282

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 139/305 (45%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 17  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 71
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 72  LVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D  +T +  A++   + APE  L+G 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYG- 187
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 188 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 223
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 224 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 274
Query: 303 PNKLP 307
           P   P
Sbjct: 275 PQYQP 279

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V + +    K    VAIK ++ G +K       +RE +++ +L +P+I+ LI
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLI 76
Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  L LV E      L   +      +  +++   +     G+ +  +K  +HRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           +   N+L+ +    K++DFGL++  G+ D  +T +   +W   + APE +   +++ +  
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRS 194
Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G    E L+  ++P+
Sbjct: 195 DVWSYGVTMWEALSYGQKPY 214

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 89/352 (25%), Positives = 144/352 (40%), Gaps = 91/352 (25%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE-------IKLLKELKSPH 72
           +GEGT+  VY          +A  ++++G +++     AL+        I++  EL+   
Sbjct: 29  IGEGTFSSVY----------LATAQLQVGPEEK----IALKHLIPTSHPIRIAAELQCLT 74
Query: 73  IIELID-----AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +    D      +  + N H+V      + E+ +   N  LS  +++ YM    K L   
Sbjct: 75  VAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-SLSFQEVREYMLNLFKALKRI 133
Query: 128 HKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFT----------------- 169
           H+  ++HRD+KP+N L      +  L DFGLA+  G+ D +                   
Sbjct: 134 HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ--GTHDTKIELLKFVQSEAQQERCSQN 191
Query: 170 ---------HQVFAR----WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGS 215
                     QV  R     +RAPE+L         +D+W+AG IF  LL+ R PF + S
Sbjct: 192 KCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251
Query: 216 SDIDQLGKIFAAFGT------------------ATPSQWPDLAYLPDYVEYQYVAAPPLR 257
            D+  L +I    G+                    P+Q  DL  L + +     + P L 
Sbjct: 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQ--DLRKLCERLRGMDSSTPKLT 309
Query: 258 SLFPSAS----------DDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
           S     +          D+A DLL K+   +P +RITA++AL H +F    L
Sbjct: 310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL 361

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G +G V+          VA+K  R     + +    L+E ++LK+   P+I+ LI
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 178
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT---LKGLAFCHKKWVL 133
                K  +++V E ++  D  T +R     L    +K+ +QM      G+ +   K  +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR---VKTLLQMVGDAAAGMEYLESKCCI 235
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR-----IFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           HRD+   N L+     LK++DFG++R     ++ +       QV  +W  APE L    +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG--LRQVPVKW-TAPEAL-NYGR 291
Query: 189 YGAGVDVWAAGCIFAE 204
           Y +  DVW+ G +  E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 20  LGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           LG G +G V + +    K    VAIK ++ G +K       +RE +++ +L +P+I+ LI
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLI 402
Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  L LV E      L   +      +  +++   +     G+ +  +K  +HR+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGV 193
           +   N+L+ +    K++DFGL++  G+ D  +T +   +W   + APE +   +++ +  
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-NFRKFSSRS 520
Query: 194 DVWAAGCIFAELLN 207
           DVW+ G    E L+
Sbjct: 521 DVWSYGVTMWEALS 534

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK I    G+ V    AIK +R     +  N   L E  ++  + SP
Sbjct: 21  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-NKEILDEAYVMAGVGSP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++  L+        + LV + M    L   +R     L   D+ ++     KG+++    
Sbjct: 80  YVSRLL-GICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQVFARWYRAPELLFGAK 187
            ++HRD+   N+L+ S   +K+ DFGLAR+    +  +     +V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL--RR 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
           ++    DVW+ G    EL+ 
Sbjct: 197 RFTHQSDVWSYGVTVWELMT 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 66/304 (21%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K  K  +   K+ V  T L E ++L+  + P
Sbjct: 152 YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 208
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 267
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLAR-----------IFGSPDRRFTHQVFARWYR 178
           K V++RD+K  NL++   G +K+ DFGL +             G+P+           Y 
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------YL 316
Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L ++        P    
Sbjct: 317 APEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP---- 369
Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                              R+L P A      LLS +   DPK R+      A++ ++HR
Sbjct: 370 -------------------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406
Query: 293 YFSS 296
           +F+ 
Sbjct: 407 FFAG 410

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 25  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 83
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 84  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 200
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 201 IYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 29  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 87
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 88  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 204
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 205 IYTHQSDVWSYGVTVWELMT 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 44  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 102
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 103 HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 219
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 220 IYTHQSDVWSYGVTVWELMT 239

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 140/314 (44%), Gaps = 72/314 (22%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIEL-----------IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
           +++L           +  +  KG+L    +F++ ++   +R   +    A I S      
Sbjct: 75  LVQLYAVVSEEPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIAS------ 125
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YR 178
            G+A+  +   +HRD+   N+L+G +   K+ADFGLAR+    D  +T +  A++   + 
Sbjct: 126 -GMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT 182
Query: 179 APE-LLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           APE  L+G  ++    DVW+ G +  EL    R P+  G  + + L              
Sbjct: 183 APEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL-------------- 225
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRY 293
                   D VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    Y
Sbjct: 226 --------DQVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDY 272
Query: 294 FSSAPLPTEPNKLP 307
           F+S    TEP   P
Sbjct: 273 FTS----TEPQYQP 282

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTVAIK-KIRLGKQKEG-VNFTALREIKL-LKELKSPH 72
           K +VLG G +G V+K +    G+++ I   I++ + K G  +F A+ +  L +  L   H
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+   P   +L LV +++    L   +R     L P  + ++     KG+ +  +  
Sbjct: 77  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           ++HR++   N+L+ S  Q+++ADFG+A +    D++  +   +   +W     + FG  +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG--K 193
Query: 189 YGAGVDVWAAGCIFAELLN 207
           Y    DVW+ G    EL+ 
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K ++  +   K+ V  T L E ++L+  + P
Sbjct: 14  YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 70
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 129
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--YRAPELLFGAK 187
           K V++RD+K  NL++   G +K+ DFGL +  G  D   T + F     Y APE+L    
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGA-TMKXFCGTPEYLAPEVL-EDN 186
Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            YG  VD W  G +  E++  R PF   + D ++L ++        P             
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP------------- 231
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFS 295
                     R+L P A      LLS +   DPK R+      A++ ++HR+F+
Sbjct: 232 ----------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 271

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K ++  +   K+ V  T L E ++L+  + P
Sbjct: 12  YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 68
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--YRAPELLFGAK 187
           K V++RD+K  NL++   G +K+ DFGL +  G  D   T + F     Y APE+L    
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGA-TMKXFCGTPEYLAPEVL-EDN 184
Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            YG  VD W  G +  E++  R PF   + D ++L ++        P             
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP------------- 229
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFS 295
                     R+L P A      LLS +   DPK R+      A++ ++HR+F+
Sbjct: 230 ----------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 269

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R     +  +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
            DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 225

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-- 74
           +E LG G +G V + I   TG+ VAIK+ R     +      L EI+++K+L  P+++  
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSA 78
Query: 75  -ELIDAF----PHKGNLHLVFEFMET-DLETVIRN--TNIFLSPADIKSYMQMTLKGLAF 126
            E+ D      P+   L L  E+ E  DL   +        L    I++ +      L +
Sbjct: 79  REVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQL---KLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
            H+  ++HRD+KP N+++    Q    K+ D G A+     +   T  V    Y APELL
Sbjct: 138 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELL 196
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKI 224
              K+Y   VD W+ G + F  +   RPFL     +   GK+
Sbjct: 197 -EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 237

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSP 71
           YLK  +LG+GT+G V    +  TG+  A+K ++  +   K+ V  T L E ++L+  + P
Sbjct: 13  YLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHP 69
Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-K 129
            +  L  +F     L  V E+    +L   +    +F S    + Y    +  L + H +
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF-SEDRARFYGAEIVSALDYLHSE 128
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--YRAPELLFGAK 187
           K V++RD+K  NL++   G +K+ DFGL +  G  D   T + F     Y APE+L    
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGA-TMKXFCGTPEYLAPEVL-EDN 185
Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            YG  VD W  G +  E++  R PF   + D ++L ++        P             
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFP------------- 230
Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFS 295
                     R+L P A      LLS +   DPK R+      A++ ++HR+F+
Sbjct: 231 ----------RTLGPEAK----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 270

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII-- 74
           +E LG G +G V + I   TG+ VAIK+ R     +      L EI+++K+L  P+++  
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSA 77
Query: 75  -ELIDAF----PHKGNLHLVFEFMET-DLETVIRN--TNIFLSPADIKSYMQMTLKGLAF 126
            E+ D      P+   L L  E+ E  DL   +        L    I++ +      L +
Sbjct: 78  REVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 127 CHKKWVLHRDMKPNNLLIGSHGQL---KLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
            H+  ++HRD+KP N+++    Q    K+ D G A+     +   T  V    Y APELL
Sbjct: 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPELL 195
Query: 184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKI 224
              K+Y   VD W+ G + F  +   RPFL     +   GK+
Sbjct: 196 -EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 22  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 80
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 81  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 197
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMT 217

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 137/305 (44%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 20  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  +++V E+M     L+ +      +L    +         G+A+  + 
Sbjct: 75  LVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D   T +  A++   + APE  L+G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYG- 190
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 191 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 226
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  DP+ R T +  QA    YF+S    TE
Sbjct: 227 QVERGYRMPCP-----PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS----TE 277
Query: 303 PNKLP 307
           P   P
Sbjct: 278 PQYQP 282

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT------ALREIKL 64
           + +Y     LG G +G V+ A+D +  + V +K I+  K  E              EI +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYM-QMTL 121
           L  ++  +II+++D F ++G   LV E   +  DL   I        P  + SY+ +  +
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP--LASYIFRQLV 140
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
             + +   K ++HRD+K  N++I     +KL DFG A  +    + F        Y APE
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYTFCGTIEYCAPE 199
Query: 182 LLFGAKQYGAGVDVWAAGC-IFAELLNRRPFLQ 213
           +L G    G  +++W+ G  ++  +    PF +
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 19/236 (8%)
Query: 6   LSKKVADRYLKRE------VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNF 56
            + KV    L RE      V+G G +G V         +  A+K   K  + K+ E   F
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 57  TALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKS 115
              R++  L    S  I  L  AF    NL+LV ++ +  DL T++      L     + 
Sbjct: 122 REERDV--LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG-LARIFGSPDRRFTHQVFA 174
           Y+   +  +   H+   +HRD+KP+N+L+  +G ++LADFG   ++      + +  V  
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 175 RWYRAPELL----FGAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
             Y +PE+L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 294

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 71
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 72  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 188
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 189 IYTHQSDVWSYGVTVWELMT 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G +G V+          VA+K  R     + +    L+E ++LK+   P+I+ LI
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHPNIVRLI 178
Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT---LKGLAFCHKKWVL 133
                K  +++V E ++  D  T +R     L    +K+ +QM      G+ +   K  +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR---VKTLLQMVGDAAAGMEYLESKCCI 235
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPELLFGAKQYG 190
           HRD+   N L+     LK++DFG++R         +    QV  +W  APE L    +Y 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPEAL-NYGRYS 293
Query: 191 AGVDVWAAGCIFAE 204
           +  DVW+ G +  E
Sbjct: 294 SESDVWSFGILLWE 307

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ S+  +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 573
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 574 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 605

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 19  VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHII 74
           V+G G +G V      +  K    VAIK +++G  +K+  +F  L E  ++ +   P+++
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDF--LCEASIMGQFDHPNVV 107
Query: 75  ELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L         + +V EFME   L+  +R  +   +   +   ++    G+ +      +
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFT---HQVFARWYRAPELLFGAKQY 189
           HRD+   N+L+ S+   K++DFGL+R+    P+  +T    ++  RW  APE +   +++
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW-TAPEAI-QYRKF 225
Query: 190 GAGVDVWAAGCIFAELLN--RRPFLQGSS 216
            +  DVW+ G +  E+++   RP+   S+
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSN 254

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 20  LGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKELKSPH 72
           +GEG +G V++A     +  +    VA+K +   K++   +  A   RE  L+ E  +P+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPN 111
Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRN----TNIFLSPADIKSYMQMT------- 120
           I++L+        + L+FE+M   DL   +R+    T   LS +D+ +  +++       
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 121 ------------LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR- 167
                         G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   S D   
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 168 --FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
                 +  RW   PE +F   +Y    DVWA G +  E+ +
Sbjct: 232 ADGNDAIPIRW-MPPESIF-YNRYTTESDVWAYGVVLWEIFS 271

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 89
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-----------NIFLSPADIKSY 116
             +++ L+ A    G  L ++ EF +  +L T +R+              FL+   +  Y
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFTHQVF 173
                KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+   ++ 
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 210 LKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 89
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 210 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 91
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+  
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 212 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 247

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VL  G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKI-RLGKQKEGVNFTALREIKLLKEL 68
           + RE LG+G++G+VY+ +     +      VAIK +      +E + F  L E  ++KE 
Sbjct: 16  MSRE-LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEF 72
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMT- 120
              H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM  
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 121 --LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-AR 175
               G+A+ +    +HRD+   N  +     +K+ DFG+ R     D  R+    +   R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W     L  G   +    DVW+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 193 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEGGLLDKP 249
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              PD+      + +QY   P +R  F
Sbjct: 250 DNCPDMLLELMRMCWQY--NPKMRPSF 274

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 89
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 210 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R     +  +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
            DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 23  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 81
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 82  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 198
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMT 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 82/305 (26%), Positives = 137/305 (44%), Gaps = 54/305 (17%)
Query: 15  LKREV-LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ EV LG+G +G V+  + T  G T VAIK ++ G          L+E +++K+L+   
Sbjct: 10  LRLEVKLGQGCFGEVW--MGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 64
Query: 73  IIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +++L  A   +  + +V E+M     L+ +   T  +L    +         G+A+  + 
Sbjct: 65  LVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGA 186
             +HRD++  N+L+G +   K+ADFGLAR+    D   T +  A++   + APE  L+G 
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYG- 180
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            ++    DVW+ G +  EL    R P+  G  + + L                      D
Sbjct: 181 -RFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVL----------------------D 216
Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ--QALEHRYFSSAPLPTE 302
            VE  Y    P     P   +   DL+ + +  +P+ R T +  QA    YF+S    TE
Sbjct: 217 QVERGYRMPCP-----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS----TE 267
Query: 303 PNKLP 307
           P   P
Sbjct: 268 PQYQP 272

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 126
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+  
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 247 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 282

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 16  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 74
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     +G+ +   +
Sbjct: 75  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 191
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 192 IYTHQSDVWSYGVTVWELMT 211

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 15  LKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           LKRE LGEG +G V     Y     +    VA+K ++        +F   RE +LL  L+
Sbjct: 17  LKRE-LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQ 73
Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR------------NTNIFLSPADIKSY 116
             HI++          L +VFE+M+  DL   +R            N    L+ + +   
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF- 173
            Q    G+ +   +  +HRD+   N L+G +  +K+ DFG++R   S D  R   H +  
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSD 217
            RW     +++  +++    DVW+ G +  E+    ++P+ Q S++
Sbjct: 194 IRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 89
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-----------NIFLSPADIKSY 116
             +++ L+ A    G  L ++ EF +  +L T +R+              FL+   +  Y
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFTHQVF 173
                KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+   ++ 
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 210 LKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 241

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 109/225 (48%), Gaps = 16/225 (7%)
Query: 5   DLSKKVADRYLK-REVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALR 60
           + +K++   Y+K  EV+G G +G V +      G+    VAIK ++ G   E      L 
Sbjct: 8   EFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK-GGYTERQRREFLS 66
Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQM 119
           E  ++ + + P+II L     +   + ++ EFME   L++ +R  +   +   +   ++ 
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVF 173
              G+ +  +   +HRD+   N+L+ S+   K++DFGL+R     S D   T     ++ 
Sbjct: 127 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
            RW  APE +   +++ +  D W+ G +  E+++   RP+   S+
Sbjct: 187 IRW-TAPEAI-AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AI ++R     +  N   L E  ++  + +P
Sbjct: 53  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKA-NKEILDEAYVMASVDNP 111
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 112 HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 170
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 228
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 229 IYTHQSDVWSYGVTVWELMT 248

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLG-KQKEGVNFTALREIKLLK 66
           A R    +++G G  G V        GQ    VAIK ++ G  +++  +F  L E  ++ 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF--LSEASIMG 105
Query: 67  ELKSPHIIELIDAFPHKGNLHLVF-EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +   P+II L +    +G L ++  E+ME   L+T +R  +   +   +   ++    G+
Sbjct: 106 QFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFT---HQVFARWYRAP 180
            +      +HRD+   N+L+ S+   K++DFGL+R+    PD  +T    ++  RW  AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW-TAP 223
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELL--NRRPF 211
           E +   + + +  DVW+ G +  E+L    RP+
Sbjct: 224 EAI-AFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 19  VLGEGTYGVVYKA--IDTKTGQT-VAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHII 74
           V+G+G +GVVY    ID    +   AIK + R+ + ++   F  LRE  L++ L  P+++
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--LREGLLMRGLNHPNVL 85
Query: 75  ELID-AFPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            LI    P +G  H++  +M   DL   IR+     +  D+ S+     +G+ +  ++  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK----- 187
           +HRD+   N ++     +K+ADFGLAR     DR +      R  R P      +     
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 188 QYGAGVDVWAAGCIFAELLNR 208
           ++    DVW+ G +  ELL R
Sbjct: 204 RFTTKSDVWSFGVLLWELLTR 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 80
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 201 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 78  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 136
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ S+  +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 137 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 195
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 196 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 227

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 73  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ S+  +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 190
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 191 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 222

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 80
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I+  PD  R+  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 201 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 109/224 (48%), Gaps = 16/224 (7%)
Query: 5   DLSKKVADRYLKRE-VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTAL 59
           + +K++    +K E V+G G +G V      +  K    VAIK ++ G   K+  +F  L
Sbjct: 21  EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF--L 78
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQ 118
            E  ++ +   P+II L         + ++ E+ME   L+  +R  +   +   +   ++
Sbjct: 79  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 138
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFA 174
               G+ +      +HRD+   N+L+ S+   K++DFG++R+    P+  +T    ++  
Sbjct: 139 GIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           RW  APE +   +++ +  DVW+ G +  E+++   RP+   S+
Sbjct: 199 RW-TAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 240

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ S+  +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 193
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 194 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 104 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 162
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ S+  +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 163 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 221
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 222 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 253

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VL  G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    +E ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 81  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ S+  +KL DFGL+R     +  +    ++  +W  APE +   +++ + 
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 197
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
            DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 198 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 230

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 79  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 137
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ S+  +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 138 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 196
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 197 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VL  G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 21  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 79
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 80  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 196
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMT 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-----TALREIKLLKEL 68
           +L  ++LG+G    V++    KTG   AIK          ++F       +RE ++LK+L
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN------NISFLRPVDVQMREFEVLKKL 64
Query: 69  KSPHIIELIDAFPHKGNLH--LVFEFMET-DLETVIRN-TNIF-LSPADIKSYMQMTLKG 123
              +I++L          H  L+ EF     L TV+   +N + L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 124 LAFCHKKWVLHRDMKPNNLL--IGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           +    +  ++HR++KP N++  IG  GQ   KL DFG AR     D +F        Y  
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEYLH 183
Query: 180 PELLFGA-------KQYGAGVDVWAAGCIF 202
           P++   A       K+YGA VD+W+ G  F
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF-----TALREIKLLKEL 68
           +L  ++LG+G    V++    KTG   AIK          ++F       +RE ++LK+L
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN------NISFLRPVDVQMREFEVLKKL 64
Query: 69  KSPHIIELIDAFPHKGNLH--LVFEFMET-DLETVIRN-TNIF-LSPADIKSYMQMTLKG 123
              +I++L          H  L+ EF     L TV+   +N + L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 124 LAFCHKKWVLHRDMKPNNLL--IGSHGQ--LKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           +    +  ++HR++KP N++  IG  GQ   KL DFG AR     D +F        Y  
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVXLYGTEEYLH 183
Query: 180 PELLFGA-------KQYGAGVDVWAAGCIF 202
           P++   A       K+YGA VD+W+ G  F
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 77
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 78  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 194
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           + LGEG +G V KA    +  + G  TVA+K +     KE  + + LR    E  +LK++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQV 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------- 107
             PH+I+L  A    G L L+ E+ +   L   +R +                       
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 108 ---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
              L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 165 D---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D   +R   ++  +W  A E LF    Y    DVW+ G +  E++ 
Sbjct: 204 DSXVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVT 247

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 16  KREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           K +VLG G +G VYK +    G+ V    AIK++R     +  N   L E  ++  + +P
Sbjct: 26  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNP 84
Query: 72  HIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           H+  L+        + L+ + M    L   +R     +    + ++     KG+ +   +
Sbjct: 85  HVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPELLFGAK 187
            ++HRD+   N+L+ +   +K+ DFG A++ G+ ++ +  +   V  +W     +L   +
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH--R 201
Query: 188 QYGAGVDVWAAGCIFAELLN 207
            Y    DVW+ G    EL+ 
Sbjct: 202 IYTHQSDVWSYGVTVWELMT 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 90
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT--------------NIFLSPADI 113
             +++ L+ A    G  L ++ EF +  +L T +R+                 FL+   +
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFTH 170
             Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   PD  R+   
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 211 RLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           + LGEG +G V KA    +  + G  TVA+K +     KE  + + LR    E  +LK++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQV 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------- 107
             PH+I+L  A    G L L+ E+ +   L   +R +                       
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 108 ---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
              L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 165 D---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D   +R   ++  +W  A E LF    Y    DVW+ G +  E++ 
Sbjct: 204 DSXVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVT 247

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 37/223 (16%)
Query: 18  EVLGEGTYGVVYKAID---TKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKS-PH 72
           +VLG G +G V  A     +KTG ++ +    L ++ +     AL  E+K++ +L S  +
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 73  IIELIDAFPHKGNLHLVFEFM-ETDLETVIR-----------------------NTNIFL 108
           I+ L+ A    G ++L+FE+    DL   +R                       + N+ L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV-L 169
Query: 109 SPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL-KLADFGLARIFGSPDRR 167
           +  D+  +     KG+ F   K  +HRD+   N+L+ +HG++ K+ DFGLAR   S D  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLARDIMS-DSN 227
Query: 168 FTHQVFARW---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +  +  AR    + APE LF    Y    DVW+ G +  E+ +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 18  EVLGEGTYGVVYKA----IDTKTG-QTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL 68
           + LGEG +G V KA    +  + G  TVA+K +     KE  + + LR    E  +LK++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSELRDLLSEFNVLKQV 83
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF-------------------- 107
             PH+I+L  A    G L L+ E+ +   L   +R +                       
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 108 ---LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP 164
              L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 165 D---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           D   +R   ++  +W  A E LF    Y    DVW+ G +  E++ 
Sbjct: 204 DSYVKRSQGRIPVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVT 247

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 11/213 (5%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQYGAGV 193
           RD+   N+L+ +   +KL DFGL+R    S   + +       + APE +   +++ +  
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSAS 573
Query: 194 DVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
           DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 574 DVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 605

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 89
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   PD  R+  
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 210 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 147
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE LF  + Y    DVW+ G +  E+  
Sbjct: 268 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 300

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL-LKEL 68
           + D  +  +VLG G  G V +  + +T +  A+K ++   +       A RE++L  +  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPK-------ARREVELHWRAS 112
Query: 69  KSPHIIELIDAFPH----KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLK 122
           + PHI+ ++D + +    +  L +V E ++  +L + I++  +   +  +     +   +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            + + H   + HRD+KP NLL  S   +  LKL DFG A+   S +   T   +  +Y A
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA 231
Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           PE+L G ++Y    D W+ G I   LL   P
Sbjct: 232 PEVL-GPEKYDKSCDXWSLGVIXYILLCGYP 261

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 80
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   PD  R+  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 201 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 109/224 (48%), Gaps = 16/224 (7%)
Query: 5   DLSKKVADRYLKRE-VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTAL 59
           + +K++    +K E V+G G +G V      +  K    VAIK ++ G   K+  +F  L
Sbjct: 6   EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF--L 63
Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQ 118
            E  ++ +   P+II L         + ++ E+ME   L+  +R  +   +   +   ++
Sbjct: 64  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 123
Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFA 174
               G+ +      +HRD+   N+L+ S+   K++DFG++R+    P+  +T    ++  
Sbjct: 124 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           RW  APE +   +++ +  DVW+ G +  E+++   RP+   S+
Sbjct: 184 RW-TAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 19  VLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            +GEG +G V++ I          VAIK  +     + V    L+E   +++   PHI++
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  +H
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQYGAG 192
           RD+   N+L+ +   +KL DFGL+R     +  +    ++  +W  APE +   +++ + 
Sbjct: 135 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI-NFRRFTSA 192
Query: 193 VDVWAAGCIFAELLNR--RPFLQGSSDIDQLGKI 224
            DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 193 SDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEF-----------------MET--DLETVIRNTNIFLSPAD 112
           +II L+ A    G L+++ E+                 ME   D+  V      F    D
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF---KD 158
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
           + S      +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
                 + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 219 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEF----------------METDLETVIRNTNIFLSPADIKSY 116
           I+ L+ A  H G + ++ E+                +ETD    I N+   LS  D+  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST--LSTRDLLHF 169
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR 
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARL 228
Query: 177 ---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE +F    Y    DVW+ G +  E+ +
Sbjct: 229 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +GEG +GVVYK     T  TVA+KK+   +    E +     +EIK++ + +  +++EL+
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-----KGLAFCHKKWV 132
                  +L LV+ +M     +++   +       +  +M+  +      G+ F H+   
Sbjct: 97  GFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYRAPELLFGA 186
           +HRD+K  N+L+      K++DFGLAR       +F   V          Y APE L G 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQTVMXSRIVGTTAYMAPEALRG- 209
Query: 187 KQYGAGVDVWAAGCIFAELLNRRP 210
            +     D+++ G +  E++   P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 35/216 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 91
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT-------------NIFLSPADIK 114
             +++ L+ A    G  L ++ EF +  +L T +R+                FL+   + 
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFTHQ 171
            Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   PD  R+   +
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           +  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 212 LPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 245

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 70/256 (27%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     LG G +  V+ + D +  + VA+K +   K  E    TAL EI+LLK +++  
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSD 94
Query: 73  --------IIELIDAFPHKG----NLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQM 119
                   +++L+D F   G    ++ +VFE +   L + +I++    L    +K  +Q 
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 120 TLKGLAFCHKKW-VLHRDMKPNNLLIGSHGQ----------------------------- 149
            L+GL + H K  ++H D+KP N+L+  + Q                             
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 150 --------------------LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
                               +K+AD G A       + FT  +  R YR+ E+L G+  Y
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQTRQYRSLEVLIGSG-Y 270
Query: 190 GAGVDVWAAGCIFAEL 205
               D+W+  C+  EL
Sbjct: 271 NTPADIWSTACMAFEL 286

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      +  K    VAIK ++ G   K+  +F  L E  ++ +   P+I
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF--LSEASIMGQFDHPNI 71
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ E+ME   L+  +R  +   +   +   ++    G+ +      
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY 131
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTH---QVFARWYRAPELLFGAKQ 188
           +HRD+   N+L+ S+   K++DFG++R+    P+  +T    ++  RW  APE +   ++
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-TAPEAI-AYRK 189
Query: 189 YGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           + +  DVW+ G +  E+++   RP+   S+
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSN 219

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +GEG +GVVYK     T  TVA+KK+   +    E +     +EIK++ + +  +++EL+
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-----KGLAFCHKKWV 132
                  +L LV+ +M     +++   +       +  +M+  +      G+ F H+   
Sbjct: 97  GFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYRAPELLFGA 186
           +HRD+K  N+L+      K++DFGLAR       +F   V          Y APE L G 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQTVMXXRIVGTTAYMAPEALRG- 209
Query: 187 KQYGAGVDVWAAGCIFAELLNRRP 210
            +     D+++ G +  E++   P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    K    VA+K I+ G   E   F   +E + + +L  P +++    
Sbjct: 16  LGSGQFGVV-KLGKWKGQYDVAVKMIKEGSMSEDEFF---QEAQTMMKLSHPKLVKFYGV 71
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  +++V E++    L   +R+    L P+ +        +G+AF      +HRD+ 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+     +K++DFG+ R     D ++   V  ++   + APE +F   +Y +  DV
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWSAPE-VFHYFKYSSKSDV 188
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 189 WAFGILMWEVFSLGKMPY 206

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 112/285 (39%), Gaps = 74/285 (25%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     LG G +  V+   D +  + VA+K +   K  +    TAL EIKLLK ++   
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVV---KSAQHYTETALDEIKLLKCVRESD 88
Query: 73  --------IIELIDAFPHKG----NLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQM 119
                   +++LID F   G    ++ +VFE +   L + +I++    L    +KS ++ 
Sbjct: 89  PSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQ 148
Query: 120 TLKGLAFCHKKW-VLHRDMKPNNLLI---------------------------------- 144
            L+GL + H K  ++H D+KP N+L+                                  
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 145 -------------GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
                            ++K+AD G A       + FT  +  R YR+ E+L GA  Y  
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWV---HKHFTEDIQTRQYRSIEVLIGAG-YST 264
Query: 192 GVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGKIFAAFGT 230
             D+W+  C+  EL       +  S      D D +  I    G+
Sbjct: 265 PADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGS 309

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 93
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 154 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 214 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 245

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 90
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 151 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 211 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 242

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           +GEG +GVVYK     T  TVA+KK+   +    E +     +EIK++ + +  +++EL+
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 78  DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-----KGLAFCHKKWV 132
                  +L LV+ +M     +++   +       +  +M+  +      G+ F H+   
Sbjct: 91  GFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 148
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYRAPELLFGA 186
           +HRD+K  N+L+      K++DFGLAR       +F   V          Y APE L G 
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLAR----ASEKFAQXVMXXRIVGTTAYMAPEALRG- 203
Query: 187 KQYGAGVDVWAAGCIFAELLNRRP 210
            +     D+++ G +  E++   P
Sbjct: 204 -EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLG-KQKEGVNFTALREIKLLK 66
           A R    +++G G  G V        GQ    VAIK ++ G  +++  +F  L E  ++ 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF--LSEASIMG 105
Query: 67  ELKSPHIIELIDAFPHKGNLHLVF-EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +   P+II L +    +G L ++  E+ME   L+T +R  +   +   +   ++    G+
Sbjct: 106 QFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFT---HQVFARWYRAP 180
            +      +HRD+   N+L+ S+   K++DFGL+R+    PD   T    ++  RW  AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW-TAP 223
Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELL--NRRPF 211
           E +   + + +  DVW+ G +  E+L    RP+
Sbjct: 224 EAI-AFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 88
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 149 CTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 209 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 240

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 20  LGEGTYGVVYKA----ID-TKTGQTVAIKKIRLGKQKEGVNFTALR----EIKLLKEL-K 69
           LG G +G V +A    ID T T +TVA+K +     KEG   +  R    E+K+L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSELKILIHIGH 80
Query: 70  SPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRNT---------------NIFLSPAD 112
             +++ L+ A    G  L ++ EF +  +L T +R+                  FL+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD--RRFT 169
           +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR I   PD  R+  
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            ++  +W  APE +F  + Y    DVW+ G +  E+ +
Sbjct: 201 ARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 236

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 12  DRYLKREVLGEGTYGVV-----YKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           D  LKRE LGEG +G V     Y    TK    VA+K ++        +F   RE +LL 
Sbjct: 16  DIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ--REAELLT 72
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR----NTNIFL--SPADIKSYMQM 119
            L+  HI++          L +VFE+M+  DL   +R    +  I +   P   K  + +
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 120 T---------LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRF 168
           +           G+ +   +  +HRD+   N L+G++  +K+ DFG++R   S D  R  
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 169 THQVF-ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
            H +   RW     +++  +++    DVW+ G I  E+    ++P+ Q S+
Sbjct: 193 GHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 70/256 (27%)
Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           RY     LG G +  V+ + D +  + VA+K +   K  E    TAL EI+LLK +++  
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSD 78
Query: 73  --------IIELIDAFPHKG----NLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQM 119
                   +++L+D F   G    ++ +VFE +   L + +I++    L    +K  +Q 
Sbjct: 79  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 138
Query: 120 TLKGLAFCHKKW-VLHRDMKPNNLLIGSHGQ----------------------------- 149
            L+GL + H K  ++H D+KP N+L+  + Q                             
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 150 --------------------LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQY 189
                               +K+AD G A       + FT  +  R YR+ E+L G+  Y
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDIQTRQYRSLEVLIGSG-Y 254
Query: 190 GAGVDVWAAGCIFAEL 205
               D+W+  C+  EL
Sbjct: 255 NTPADIWSTACMAFEL 270

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 18  EVLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V      +  K    VAIK ++ G  +K+  +F  L E  ++ +   P++
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF--LSEASIMGQFDHPNV 96
Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + ++ EFME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 156
Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVFARWYRAPELLFGA 186
           +HRD+   N+L+ S+   K++DFGL+R     + D  +T     ++  RW  APE +   
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW-TAPEAI-QY 214
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPF 211
           +++ +  DVW+ G +  E+++   RP+
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPY 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE LF  + Y    DVW+ G +  E+  
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE LF  + Y    DVW+ G +  E+  
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 14  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 68
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 69  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 122
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 176
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 235

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 29  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 83
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 84  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 137
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 138 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 191
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 250

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIE 75
           +E +G G++G V++A     G  VA+K +       E VN   LRE+ ++K L+ P+I+ 
Sbjct: 42  KEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVL 98
Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKW- 131
            + A     NL +V E++       + + +      D +  + M     KG+ + H +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 132 -VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+K  NLL+     +K+ DFGL+R+  S             + APE+L       
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPS-N 217
Query: 191 AGVDVWAAGCIFAEL 205
              DV++ G I  EL
Sbjct: 218 EKSDVYSFGVILWEL 232

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 25  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 79
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 80  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 133
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 134 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 187
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 246

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 17  REVLGEGTYGVVYKA--IDTKTGQT-VAIKKI-RLGKQKEGVNFTALREIKLLKELKSPH 72
            EV+G G +G VY    +D    +   A+K + R+    E   F  L E  ++K+   P+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPN 151
Query: 73  IIELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           ++ L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFG 185
             +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L   
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--Q 269
Query: 186 AKQYGAGVDVWAAGCIFAELLNR 208
            +++    DVW+ G +  EL+ R
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTR 292

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 24  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 78
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 79  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 132
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 133 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 186
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 245

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 32  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 204
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 205 WAFGVLMWEIYSLGKMPY 222

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  +  T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 86
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXX 206
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           ++ T+      + APE LF  + Y    DVW+ G +  E+  
Sbjct: 207 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++ E+  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +++ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 79
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 199
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 200 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 239

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 71
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 192 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 231

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 75
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 195
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 196 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 86
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 207 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 78
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 198
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 199 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 238

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 93
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QT 211
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 86
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           ++ T+      + APE LF  + Y    DVW+ G +  E+  
Sbjct: 207 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 86
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 207 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 94
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L    
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QT 212
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTR 234

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 98
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L    
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QT 216
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTR 238

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 94
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L    
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL--QT 212
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTR 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 12  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 67
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 184
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 185 WAFGVLMWEIYSLGKMPY 202

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 16  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 71
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 131
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 188
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 189 WAFGVLMWEIYSLGKMPY 206

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 93
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QT 211
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 91
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARI-----FGSPDRRFTHQVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR      F S   +   ++  +W     L    
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QT 209
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTR 231

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           LG G +G V+  + T  G T VAIK ++ G        + L E +++K+LK   +++L  
Sbjct: 17  LGNGQFGEVW--MGTWNGNTKVAIKTLKPGTMSPE---SFLEEAQIMKKLKHDKLVQLY- 70
Query: 79  AFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           A   +  +++V E+M     L+ +       L   ++         G+A+  +   +HRD
Sbjct: 71  AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 130
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPE-LLFGAKQYGAG 192
           ++  N+L+G+    K+ADFGLAR+    D   T +  A++   + APE  L+G  ++   
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYG--RFTIK 186
Query: 193 VDVWAAGCIFAELLNR 208
            DVW+ G +  EL+ +
Sbjct: 187 SDVWSFGILLTELVTK 202

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 17  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 72
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 132
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 189
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 190 WAFGVLMWEIYSLGKMPY 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 23  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 78
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 138
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T  V +++   +  PE+L  +K + +  D+
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDI 195
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 196 WAFGVLMWEIYSLGKMPY 213

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 12  DRYLKREVLGEGTYG--VVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G  V+ +AI     +      VA+K ++    ++ ++   + E+++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 127
Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+  + +L   ++               N    
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           ++ T+      + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 248 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 287

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEF----------------METDLETVIRNTNIFLSPADIKSY 116
           I+ L+ A  H G + ++ E+                +ETD    I N+    S  D+  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA--STRDLLHF 169
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR 
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARL 228
Query: 177 ---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE +F    Y    DVW+ G +  E+ +
Sbjct: 229 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       T +  A+K   K  + K+ E   F   R++  L       I 
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWIT 153
Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + +L+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 213
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR------------IFGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG                 G+PD           Y +PE
Sbjct: 214 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD-----------YISPE 262
Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 310

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           +V+G G +G V       T +  A+K   K  + K+ E   F   R++  L       I 
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWIT 137
Query: 75  ELIDAFPHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVL 133
            L  AF  + +L+LV ++ +  DL T++      L     + Y+   +  +   H+   +
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYV 197
Query: 134 HRDMKPNNLLIGSHGQLKLADFGLAR------------IFGSPDRRFTHQVFARWYRAPE 181
           HRD+KP+N+L+  +G ++LADFG                 G+PD           Y +PE
Sbjct: 198 HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPD-----------YISPE 246
Query: 182 LLF----GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQLGKIF 225
           +L     G  +YG   D W+ G C++  L    PF    S ++  GKI 
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 294

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 75
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           +  K  L +V ++ E + L   +  +        +    + T +G+ + H K ++HRD+K
Sbjct: 76  YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 135
Query: 139 PNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPEL--LFGAKQYGAGVD 194
            NN+ +     +K+ DFGLA +    S   +F     +  + APE+  +  +  Y    D
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 195 VWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           V+A G +  EL+  + P+    S+I+   +I    G  + S  PDL+
Sbjct: 196 VYAFGIVLYELMTGQLPY----SNINNRDQIIEMVGRGSLS--PDLS 236

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 18  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 74
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 75  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 195 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 252
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 253 NCPE--RVTDLMRMCWQFNPKMRPTF 276

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 21  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 255
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 256 NCPE--RVTDLMRMCWQFNPKMRPTF 279

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 111/240 (46%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 15  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 69
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 70  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 123
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HR+++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE    A
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPE----A 177
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 236

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 25  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 79
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 80  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 133
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 134 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 187
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 246

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 21  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 255
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 256 NCPE--RVTDLMRMCWQFNPNMRPTF 279

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 17  REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIE 75
           +E +G G++G V++A     G  VA+K +       E VN   LRE+ ++K L+ P+I+ 
Sbjct: 42  KEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVL 98
Query: 76  LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKW- 131
            + A     NL +V E++       + + +      D +  + M     KG+ + H +  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 132 -VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HR++K  NLL+     +K+ DFGL+R+  S             + APE+L       
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-N 217
Query: 191 AGVDVWAAGCIFAEL 205
              DV++ G I  EL
Sbjct: 218 EKSDVYSFGVILWEL 232

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 27  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRL 81
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 82  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 135
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 136 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 189
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 248

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTAL 59
           + + VA +    E +G+G YG V++   +  G+ VA+K      +K      E  N   L
Sbjct: 2   MQRTVAHQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML 59
Query: 60  REIKLL----KELKSPHI---IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
           R   +L     ++ S H    + LI  +   G+L+   +    D  + +R   I LS A 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR---IVLSIAS 116
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---- 168
             +++ + + G     K  + HRD+K  N+L+  +GQ  +AD GLA +      +     
Sbjct: 117 GLAHLHIEIFGTQ--GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 169 THQVFARWYRAPELLFGAKQYGA-----GVDVWAAGCIFAELLNR 208
             +V  + Y APE+L    Q         VD+WA G +  E+  R
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 28  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 82
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 83  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 136
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 137 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 190
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 249

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 112/230 (48%), Gaps = 18/230 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+ A   K  + VA+K ++ G          L E  ++K L+   +++L  A
Sbjct: 23  LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKL-HA 77
Query: 80  FPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPA-DIKSYMQMTLKGLAFCHKKWVLHRDM 137
              K  ++++ EFM +  L   +++      P   +  +     +G+AF  ++  +HRD+
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGAGV 193
           +  N+L+ +    K+ADFGLAR+    D  +T +  A++   + APE + FG+  +    
Sbjct: 138 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 193
Query: 194 DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           DVW+ G +  E++   R P+  G S+ + +  +   +    P   P+  Y
Sbjct: 194 DVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELY 242

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++  +  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 92
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL--QT 210
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTR 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+ A   K  + VA+K ++ G          L E  ++K L+   +++L  A
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKL-HA 250
Query: 80  FPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPA-DIKSYMQMTLKGLAFCHKKWVLHRDM 137
              K  ++++ EFM +  L   +++      P   +  +     +G+AF  ++  +HRD+
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGAGV 193
           +  N+L+ +    K+ADFGLAR+    D  +T +  A++   + APE + FG+  +    
Sbjct: 311 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 366
Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  E++   R P+
Sbjct: 367 DVWSFGILLMEIVTYGRIPY 386

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 20  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 74
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 75  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 128
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 129 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 182
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 241

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 21  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 75
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 76  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 129
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 130 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 183
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 242

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G +G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQFGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTAL 59
           + + VA +    E +G+G YG V++   +  G+ VA+K      +K      E  N   L
Sbjct: 31  VQRTVARQITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML 88
Query: 60  REIKLL----KELKSPHI---IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
           R   +L     ++ S H    + LI  +   G+L+   +    D  + +R   I LS A 
Sbjct: 89  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR---IVLSIAS 145
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---- 168
             +++ + + G     K  + HRD+K  N+L+  +GQ  +AD GLA +      +     
Sbjct: 146 GLAHLHIEIFGTQ--GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 203
Query: 169 THQVFARWYRAPELLFGAKQYGA-----GVDVWAAGCIFAELLNR 208
             +V  + Y APE+L    Q         VD+WA G +  E+  R
Sbjct: 204 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 20  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 76
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 77  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 197 WMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 254
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 255 NCPE--RVTDLMRMCWQFNPKMRPTF 278

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 21  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 255
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 256 NCPE--RVTDLMRMCWQFNPKMRPTF 279

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 20  LGEGTYGVVYKA----IDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSP 71
           LGEG +G V  A    ID    K   TVA+K ++    ++ ++   + E++++K + K  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 72  HIIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------NTNIFLSPA------DIKS 115
           +II L+ A    G L+++  +  + +L   +R         + +I   P       D+ S
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF 173
                 +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+   
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              + APE LF  + Y    DVW+ G +  E+ 
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 112
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 230
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTR 252

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 111
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 229
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTR 251

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 9/196 (4%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 32  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 139 PNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWA 197
             N L+   G +K++DFGL+R +    +       F   +  PE+L  +K + +  D+WA
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWA 206
Query: 198 AGCIFAEL--LNRRPF 211
            G +  E+  L + P+
Sbjct: 207 FGVLMWEIYSLGKMPY 222

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA--IDTKTGQT-VAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY    +D    +   A+K + R+    E   F  L E  ++K+   P++
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 85
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 203
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTR 225

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA--IDTKTGQT-VAIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY    +D    +   A+K + R+    E   F  L E  ++K+   P++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 93
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 211
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 13/187 (6%)
Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +++     +G G++G +Y   + +T + VAIK   +  +   +    L E K+ + L
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKIYRIL 59
Query: 69  KSPHIIELIDAFPHKGNLH-LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +    I  +  F  +G+ + LV + +   LE +    +  LS   +       +  + F 
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 128 HKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           H K  LHRD+KP+N L+G      Q+ + DFGLA+ +       THQ     YR  + L 
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS---THQHIP--YRENKNLT 174
Query: 185 GAKQYGA 191
           G  +Y +
Sbjct: 175 GTARYAS 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 91
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 209
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTR 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 90
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 208
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTR 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 88
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 206
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR 228

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 14  YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI 73
           YL  + LGEG +  V        G   A+K+I   +Q++     A RE  + +    P+I
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPNI 88
Query: 74  IELID-AFPHKGNLH---LVFEFME-----TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           + L+      +G  H   L+  F +      ++E  +++   FL+   I   +    +GL
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER-LKDKGNFLTEDQILWLLLGICRGL 147
Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG-----LARIFGSPD----RRFTHQVFAR 175
              H K   HRD+KP N+L+G  GQ  L D G        + GS      + +  Q    
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 176 WYRAPELLFGAKQYGA---GVDVWAAGCI-FAELLNRRPF 211
            YRAPE LF  + +       DVW+ GC+ +A +    P+
Sbjct: 208 SYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 92
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 210
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTR 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 18  EVLGEGTYGVVYKA-IDTKTGQTV--AIKKI-RLGKQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY   +    G+ +  A+K + R+    E   F  L E  ++K+   P++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 93
Query: 74  IELID-AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH-----QVFARWYRAPELLFGA 186
            +HRD+   N ++     +K+ADFGLAR     +    H     ++  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QT 211
Query: 187 KQYGAGVDVWAAGCIFAELLNR 208
           +++    DVW+ G +  EL+ R
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTAL 59
           + + VA      E +G+G YG V++   +  G+ VA+K      +K      E  N   L
Sbjct: 2   MQRTVARDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML 59
Query: 60  REIKLL----KELKSPHI---IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPAD 112
           R   +L     ++ S H    + LI  +   G+L+   +    D  + +R   I LS A 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR---IVLSIAS 116
Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---- 168
             +++ + + G     K  + HRD+K  N+L+  +GQ  +AD GLA +      +     
Sbjct: 117 GLAHLHIEIFGTQ--GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 169 THQVFARWYRAPELLFGAKQYGA-----GVDVWAAGCIFAELLNR 208
             +V  + Y APE+L    Q         VD+WA G +  E+  R
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 106/219 (48%), Gaps = 18/219 (8%)
Query: 7   SKKVADRYLKRE-VLGEGTYGVVYKA---IDTKTGQTVAIKKIRLG-KQKEGVNFTALRE 61
           SK++    +K E V+G G +G V      +  K    VAIK ++ G  +K+  +F  L E
Sbjct: 1   SKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF--LSE 58
Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMT 120
             ++ +   P++I L         + ++ EFME   L++ +R  +   +   +   ++  
Sbjct: 59  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 118
Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTH----QVFA 174
             G+ +      +HR +   N+L+ S+   K++DFGL+R     + D  +T     ++  
Sbjct: 119 AAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPF 211
           RW  APE +   +++ +  DVW+ G +  E+++   RP+
Sbjct: 179 RW-TAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEFM-ETDLETVIR---------------NTNIFLSPADIKSY 116
           I+ L+ A  H G + ++ E+    DL   +R               N    LS  D+  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR 
Sbjct: 172 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARL 230
Query: 177 ---YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
              + APE +F    Y    DVW+ G +  E+ +
Sbjct: 231 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           +  K  L +V ++ E + L   +  +        +    + T +G+ + H K ++HRD+K
Sbjct: 88  YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 139 PNNLLIGSHGQLKLADFGLA--RIFGSPDRRFTHQVFARWYRAPEL--LFGAKQYGAGVD 194
            NN+ +     +K+ DFGLA  +   S   +F     +  + APE+  +  +  Y    D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 195 VWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           V+A G +  EL+  + P+    S+I+   +I    G  + S  PDL+
Sbjct: 208 VYAFGIVLYELMTGQLPY----SNINNRDQIIEMVGRGSLS--PDLS 248

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 16/195 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+      + + VA+K ++ G          L E  L+K L+   ++ L   
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLVRLYAV 76
Query: 80  FPHKGNLHLVFEFM-ETDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              +  ++++ E+M +  L   +++      L P  I    Q+  +G+A+  +K  +HRD
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA-EGMAYIERKNYIHRD 135
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGAG 192
           ++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE + FG   +   
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC--FTIK 191
Query: 193 VDVWAAGCIFAELLN 207
            DVW+ G +  E++ 
Sbjct: 192 SDVWSFGILLYEIVT 206

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPD- 165
           ++  D+ SY     +G+ F   +  +HRD+   N+L+  +  +K+ DFGLAR I+ +PD 
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY 255
Query: 166 -RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
            R+   ++  +W  APE +F  K Y    DVW+ G +  E+ +
Sbjct: 256 VRKGDTRLPLKWM-APESIFD-KIYSTKSDVWSYGVLLWEIFS 296

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 29/267 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 21  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVF--AR 175
           +   G+A+ + K  +HRD+   N ++     +K+ DFG+ R I+ +   R   +     R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATP 233
           W  APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQP 254
Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF 260
              P+   + D +   +   P +R  F
Sbjct: 255 DNCPE--RVTDLMRMCWQFNPKMRPTF 279

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+      + + VA+K ++ G          L E  L+K L+   ++ L   
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLVRLYAV 75
Query: 80  FPHKGNLHLVFEFM-ETDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
              +  ++++ EFM +  L   +++      L P  I    Q+  +G+A+  +K  +HRD
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA-EGMAYIERKNYIHRD 134
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELL-FGAKQYGAG 192
           ++  N+L+      K+ADFGLAR+    D  +T +  A++   + APE + FG   +   
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC--FTIK 190
Query: 193 VDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +VW+ G +  E++   + P+  G ++ D +  +   +        PD  Y
Sbjct: 191 SNVWSFGILLYEIVTYGKIPY-PGRTNADVMSALSQGYRMPRMENCPDELY 240

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 13/211 (6%)
Query: 28  VYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-ALREIKLLKELKSPHIIELIDAFPHKGNL 86
           VY+A DT   + VA+K        + V  T   RE +    L+ PH++ + D     G L
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 87  HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG 145
           ++    +   DL   +R       P  +    Q+    L   H     HRD+KP N+L+ 
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIG-SALDAAHAAGATHRDVKPENILVS 168
Query: 146 SHGQLKLADFGLARIFGSPDRRFT---HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIF 202
           +     L DFG+A    + D + T   + V   +Y APE  F         D++A  C+ 
Sbjct: 169 ADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVL 225
Query: 203 AELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            E L   P  QG    DQL    A    A P
Sbjct: 226 YECLTGSPPYQG----DQLSVXGAHINQAIP 252

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +GVV K    +    VAIK I+ G   E      + E K++  L    +++L   
Sbjct: 17  LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 72
Query: 80  FPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
              +  + ++ E+M    L   +R          +    +   + + +   K  LHRD+ 
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 132
Query: 139 PNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQYGAGVDV 195
             N L+   G +K++DFGL+R     D  +T    +++   +  PE+L  +K + +  D+
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSK-FSSKSDI 189
Query: 196 WAAGCIFAEL--LNRRPF 211
           WA G +  E+  L + P+
Sbjct: 190 WAFGVLMWEIYSLGKMPY 207

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 12/176 (6%)
Query: 40  VAIKKI---RLGKQKEGVNFTAL-REIKLLKELKS--PHIIELIDAFPHKGNLHLVFEFM 93
           VAIK +   R+    E  N T +  E+ LLK++ S    +I L+D F    +  L+ E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 94  E--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQL 150
           E   DL   I      L     +S+    L+ +  CH   VLHRD+K  N+LI  + G+L
Sbjct: 139 EPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 197
Query: 151 KLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
           KL DFG   +    D  +T     R Y  PE +   + +G    VW+ G +  +++
Sbjct: 198 KLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 34/240 (14%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIEL 76
           E LG G  G V+  +    G T VA+K ++ G          L E  L+K+L+   ++ L
Sbjct: 19  ERLGAGQAGEVW--MGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL 73
Query: 77  IDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL-------KGLAFCHK 129
             A   +  ++++ E+ME          +   +P+ IK  +   L       +G+AF  +
Sbjct: 74  Y-AVVTQEPIYIITEYMENG-----SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGA 186
           +  +HRD++  N+L+      K+ADFGLAR+    D   T +  A++   + APE    A
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPE----A 181
Query: 187 KQYGAGV---DVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
             YG      DVW+ G +  E++   R P+  G ++ + +  +   +    P   P+  Y
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 21  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 77
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 78  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HR++   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 255
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 256 NCPE--RVTDLMRMCWQFNPNMRPTF 279

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 15  LKREVLGEGTYGVVYK--AIDTKTGQT---VAIKKIRLGKQ-KEGVNFTALREIKLLKEL 68
           L RE LG+G++G+VY+  A D   G+    VA+K +      +E + F  L E  ++K  
Sbjct: 22  LLRE-LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF--LNEASVMKGF 78
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIRN------TNIFLSPADIKSYMQMTL 121
              H++ L+          +V E M   DL++ +R+       N    P  ++  +QM  
Sbjct: 79  TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 122 K---GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARW 176
           +   G+A+ + K  +HR++   N ++     +K+ DFG+ R     D  R+    +    
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAEL--LNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           + APE L     +    D+W+ G +  E+  L  +P+ QG S+   L  +        P 
Sbjct: 199 WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDGGYLDQPD 256
Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF 260
             P+   + D +   +   P +R  F
Sbjct: 257 NCPE--RVTDLMRMCWQFNPNMRPTF 280

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 18/230 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR-EIKLLKELKSPHIIELID 78
           +G G++G VYK    K    VA+K +++        F A R E+ +L++ +  +I+ L  
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPE-QFQAFRNEVAVLRKTRHVNIL-LFM 98
Query: 79  AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM 137
            +  K NL +V ++ E + L   +           +    + T +G+ + H K ++HRDM
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 138 KPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAGV 193
           K NN+ +     +K+ DFGLA +    S  ++      +  + APE++       +    
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 194 DVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           DV++ G +  EL+    P+    S I+   +I    G    S  PDL+ L
Sbjct: 219 DVYSYGIVLYELMTGELPY----SHINNRDQIIFMVGRGYAS--PDLSKL 262

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +LL 
Sbjct: 42  DIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLT 98
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR----NTNIFLSPADIK------- 114
            L+  HI+           L +VFE+M   DL   +R    +  +     D+        
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 115 ---SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTH 170
              +       G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R   
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218
Query: 171 QVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSS 216
           +     RW     +L+  +++    DVW+ G +  E+    ++P+ Q S+
Sbjct: 219 RTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI----RLGKQKEGVNFTALREIKLLKELKS---- 70
           +LG+G +G V+          VAIK I     LG      + T   E+ LL ++ +    
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 71  PHIIELIDAFPHKGNLHLVFE--FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
           P +I L+D F  +    LV E      DL   I      L     + +    +  +  CH
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCH 156
Query: 129 KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
            + V+HRD+K  N+LI    G  KL DFG   +    D  +T     R Y  PE +   +
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEWISRHQ 214
Query: 188 QYGAGVDVWAAGCIFAELL 206
            +     VW+ G +  +++
Sbjct: 215 YHALPATVWSLGILLYDMV 233

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +LL 
Sbjct: 13  DIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLT 69
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR----NTNIFLSPADIK------- 114
            L+  HI+           L +VFE+M   DL   +R    +  +     D+        
Sbjct: 70  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 115 ---SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTH 170
              +       G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R   
Sbjct: 130 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 189
Query: 171 QVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSS 216
           +     RW     +L+  +++    DVW+ G +  E+    ++P+ Q S+
Sbjct: 190 RTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 237

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           D  LK E LGEG +G V+ A     +  +    VA+K ++   +    +F   RE +LL 
Sbjct: 19  DIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLT 75
Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFM-ETDLETVIR----NTNIFLSPADIK------- 114
            L+  HI+           L +VFE+M   DL   +R    +  +     D+        
Sbjct: 76  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 115 ---SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTH 170
              +       G+ +      +HRD+   N L+G    +K+ DFG++R I+ +   R   
Sbjct: 136 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 195
Query: 171 QVF--ARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSS 216
           +     RW     +L+  +++    DVW+ G +  E+    ++P+ Q S+
Sbjct: 196 RTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 243

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 39/292 (13%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-- 75
           EV   G +G V+KA      + VA+K   +  ++   N     E+  L  +K  +I++  
Sbjct: 30  EVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEY---EVYSLPGMKHENILQFI 84
Query: 76  --------------LIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
                         LI AF  KG+L    +F++ ++ +     +I  + A   +Y+   +
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLS---DFLKANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRA 179
            GL   HK  + HRD+K  N+L+ ++    +ADFGLA  F  G        QV  R Y A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 180 PELLFGAKQYGAG----VDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           PE+L GA  +       +D++A G +  EL +R     G  D     +    F      Q
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-----EYMLPF-EEEIGQ 255
Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDAL--DLLSKMFTYDPKARITA 285
            P L  + + V ++    P LR  +   +  A+  + + + + +D +AR++A
Sbjct: 256 HPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 87
Query: 80  FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMK 138
           +     L +V ++ E + L   +  +        +    + T +G+ + H K ++HRD+K
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 139 PNNLLIGSHGQLKLADFGLA--RIFGSPDRRFTHQVFARWYRAPEL--LFGAKQYGAGVD 194
            NN+ +     +K+ DFGLA  +   S   +F     +  + APE+  +  +  Y    D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 195 VWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           V+A G +  EL+  + P+    S+I+   +I    G  + S  PDL+
Sbjct: 208 VYAFGIVLYELMTGQLPY----SNINNRDQIIEMVGRGSLS--PDLS 248

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKEL 68
           D  L R +LGEG +G VY+ + T   G+ + +  ++  K+   ++     + E  ++K L
Sbjct: 25  DVVLNR-ILGEGFFGEVYEGVYTNHKGEKINVA-VKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
             PHI++LI     +    ++  +   +L   +      L    +  Y     K +A+  
Sbjct: 83  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 142
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGA 186
               +HRD+   N+L+ S   +KL DFGL+R     D  +    ++  +W     + F  
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 200
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFL 212
           +++    DVW       E+L+  ++PF 
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 21  GEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLKELKSPHIIELID 78
           GEG +GVVYK     T  TVA+KK+   +    E +     +EIK+  + +  +++EL+ 
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 79  AFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                 +L LV+ +       D  + +  T   LS        Q    G+ F H+   +H
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP-LSWHXRCKIAQGAANGINFLHENHHIH 147
Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF------ARWYRAPELLFGAKQ 188
           RD+K  N+L+      K++DFGLAR       +F   V          Y APE L G  +
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLAR----ASEKFAQXVXXSRIVGTTAYXAPEALRG--E 201
Query: 189 YGAGVDVWAAGCIFAELLNRRP 210
                D+++ G +  E++   P
Sbjct: 202 ITPKSDIYSFGVVLLEIITGLP 223

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 73  IIELIDAFPHKGNLHLVFEFM-------------ETDLETVIRNTNIFLSPADIKSYMQM 119
           I+ L+ A  H G + ++ E+              E DL+   +     L   D+  +   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD---KEDGRPLELRDLLHFSSQ 168
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--- 176
             +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR    
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARLPVK 227
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           + APE +F    Y    DVW+ G +  E+ +
Sbjct: 228 WMAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           LG G +G V+ A   K  + VA+K ++ G          L E  ++K L+   +++L  A
Sbjct: 190 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKL-HA 244
Query: 80  FPHKGNLHLVFEFM-ETDLETVIRNTNIFLSPA-DIKSYMQMTLKGLAFCHKKWVLHRDM 137
              K  ++++ EFM +  L   +++      P   +  +     +G+AF  ++  +HRD+
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL-FGAKQYGAGVDVW 196
           +  N+L+ +    K+ADFGLAR+      ++T         APE + FG+  +    DVW
Sbjct: 305 RAANILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGS--FTIKSDVW 353
Query: 197 AAGCIFAELLN--RRPF 211
           + G +  E++   R P+
Sbjct: 354 SFGILLMEIVTYGRIPY 370

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKEL 68
           D  L R +LGEG +G VY+ + T   G+ + +  ++  K+   ++     + E  ++K L
Sbjct: 9   DVVLNR-ILGEGFFGEVYEGVYTNHKGEKINVA-VKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
             PHI++LI     +    ++  +   +L   +      L    +  Y     K +A+  
Sbjct: 67  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 126
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGA 186
               +HRD+   N+L+ S   +KL DFGL+R     D  +    ++  +W     + F  
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 184
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFL 212
           +++    DVW       E+L+  ++PF 
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E+   G +G V+KA        VA+K   L  ++   ++ + REI     +K  ++++ I
Sbjct: 21  EIKARGRFGCVWKA--QLMNDFVAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFI 75
Query: 78  DAFPHKGNLH----LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK--W 131
            A     NL     L+  F +    T     NI ++  ++    +   +GL++ H+   W
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-ITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 132 ---------VLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAP 180
                    + HRD K  N+L+ S     LADFGLA  F  G P      QV  R Y AP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 181 ELLFGAKQYGAG----VDVWAAGCIFAELLNRRPFLQGSSD 217
           E+L GA  +       +D++A G +  EL++R     G  D
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD 235

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNF----TALREIKLLKEL-KSPH 72
           + LG G +G V +A     G+  A+ K+ +   K   +       + E+K++  L +  +
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 73  IIELIDAFPHKGNLHLVFEFM-------------ETDLETVIRNTNIFLSPADIKSYMQM 119
           I+ L+ A  H G + ++ E+              E DL+   +     L   D+  +   
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD---KEDGRPLELRDLLHFSSQ 160
Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW--- 176
             +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   + D  +  +  AR    
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-DSNYIVKGNARLPVK 219
Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLN 207
           + APE +F    Y    DVW+ G +  E+ +
Sbjct: 220 WMAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 12  DRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKEL 68
           D  L R +LGEG +G VY+ + T   G+ + +  ++  K+   ++     + E  ++K L
Sbjct: 13  DVVLNR-ILGEGFFGEVYEGVYTNHKGEKINVA-VKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
             PHI++LI     +    ++  +   +L   +      L    +  Y     K +A+  
Sbjct: 71  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGA 186
               +HRD+   N+L+ S   +KL DFGL+R     D  +    ++  +W     + F  
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-- 188
Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFL 212
           +++    DVW       E+L+  ++PF 
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 98
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKKWVLHRD 136
           +  K  L +V ++ E    ++  + +I  +  ++   + +   T +G+ + H K ++HRD
Sbjct: 99  YSTKPQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 156
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAG 192
           +K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +  Y   
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            DV+A G +  EL+  + P+    S+I+   +I    G    S  PDL+
Sbjct: 217 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLS--PDLS 259

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           VDL ++  + +  + ++G G +G VYK +  + G  VA+K+ R  +  +G+      EI+
Sbjct: 32  VDL-EEATNNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-RTPESSQGIE-EFETEIE 87
Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL- 121
            L   + PH++ LI     +  + L++++ME  +L+  +  +++       +  +++ + 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 122 --KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWY 177
             +GL + H + ++HRD+K  N+L+  +   K+ DFG+++     D+     V      Y
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRR 209
             PE  F   +     DV++ G +  E+L  R
Sbjct: 208 IDPE-YFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 99
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKKWVLHRD 136
           +  K  L +V ++ E    ++  + +I  +  ++   + +   T +G+ + H K ++HRD
Sbjct: 100 YSTKPQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAG 192
           +K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +  Y   
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            DV+A G +  EL+  + P+    S+I+   +I    G    S  PDL+
Sbjct: 218 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLS--PDLS 260

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKKWVLHRD 136
           +  K  L +V ++ E    ++  + +I  +  ++   + +   T +G+ + H K ++HRD
Sbjct: 77  YSTKPQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAG 192
           +K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +  Y   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            DV+A G +  EL+  + P+    S+I+   +I    G    S  PDL+
Sbjct: 195 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLS--PDLS 237

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 20/229 (8%)
Query: 20  LGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA 79
           +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+ L   
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMG 76
Query: 80  FPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM---TLKGLAFCHKKWVLHRD 136
           +  K  L +V ++ E    ++  + +I  +  ++   + +   T +G+ + H K ++HRD
Sbjct: 77  YSTKPQLAIVTQWCEG--SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQ--YGAG 192
           +K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +  Y   
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 193 VDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
            DV+A G +  EL+  + P+    S+I+   +I    G    S  PDL+
Sbjct: 195 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLS--PDLS 237
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	415
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-179
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-177
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-176
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-174
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-173
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-172
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-171
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-168
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-166
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-164
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-163
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-159
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-142
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-128
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-123
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-113
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-112
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-110
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-106
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-102
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-101
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-100
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-99
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-96
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-68
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-68
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-66
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-64
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-63
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-63
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-62
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-62
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-61
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-61
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-61
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-61
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-61
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-61
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-61
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-60
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-60
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-60
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-60
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-60
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-60
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-60
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-60
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-60
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-59
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-59
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-59
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-59
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-59
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-59
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-59
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-59
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-58
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-58
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-58
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-58
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-58
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-58
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-58
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-57
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-57
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-57
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-56
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-56
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-56
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-55
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-55
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-55
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-54
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-53
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-53
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-52
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-52
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-52
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-52
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-51
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-51
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-51
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-50
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-50
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-50
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-49
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-49
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-49
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-48
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-47
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-47
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-47
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-47
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-46
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-46
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-44
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-44
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-44
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-44
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-44
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-44
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-44
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-42
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-42
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-42
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-42
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-42
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-41
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-38
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-37
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-37
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-37
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-13
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-32
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-30
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-28
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-26
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-24
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-22
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-20
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-17
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  531 bits (1371), Expect = 0.0
 Identities = 185/348 (53%), Positives = 238/348 (68%), Gaps = 5/348 (1%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG---KQKEGVNFT 57
           MA +D+  +   RY K + LGEG +  VYKA D  T Q VAIKKI+LG   + K+G+N T
Sbjct: 1   MA-LDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT 58

Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           ALREIKLL+EL  P+II L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM
Sbjct: 59  ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 118

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            MTL+GL + H+ W+LHRD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWY
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY 178

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           RAPELLFGA+ YG GVD+WA GCI AELL R PFL G SD+DQL +IF   GT T  QWP
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
           D+  LPDYV ++     PL  +F +A DD LDL+  +F ++P ARITA QAL+ +YFS+ 
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

Query: 298 PLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGF 345
           P PT   +LPRP     +     NP             +  +P +  F
Sbjct: 299 PGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF 346

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  501 bits (1292), Expect = e-179
 Identities = 116/305 (38%), Positives = 159/305 (52%), Gaps = 3/305 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y K   +GEG+YGVV+K  +  TGQ VAIKK    +    +   ALREI++LK+LK P
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +++ L++ F  K  LHLVFE+ +  +   +      +    +KS    TL+ + FCHK  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
            +HRD+KP N+LI  H  +KL DFG AR+   P   +  +V  RWYR+PELL G  QYG 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY--- 248
            VDVWA GC+FAELL+  P   G SD+DQL  I    G   P      +    +      
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPR 308
                 PL   FP+ S  AL LL      DP  R+T +Q L H YF +     +  K   
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD 302

Query: 309 PATKR 313
              + 
Sbjct: 303 KPAEN 307

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  492 bits (1269), Expect = e-176
 Identities = 139/291 (47%), Positives = 182/291 (62%), Gaps = 2/291 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI  +G+LKLA+FGLAR FG P R ++ +V   WYR P++LFGAK Y  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 192 GVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-Q 249
            +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           Y A   L ++ P  +    DLL  +   +P  RI+A++AL+H YFS    P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  489 bits (1260), Expect = e-174
 Identities = 101/316 (31%), Positives = 155/316 (49%), Gaps = 3/316 (0%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           +   +L  +  ++Y    ++GEG+YG+V K  +  TG+ VAIKK       + V   A+R
Sbjct: 14  LGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT 120
           EIKLLK+L+  +++ L++    K   +LVFEF++  +   +      L    ++ Y+   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI 133

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           + G+ FCH   ++HRD+KP N+L+   G +KL DFG AR   +P   +  +V  RWYRAP
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ELL G  +YG  VDVWA GC+  E+    P   G SDIDQL  I    G   P       
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 241 YLPDYVEY---QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
             P +      +     PL   +P  S+  +DL  K    DP  R    + L H +F   
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

Query: 298 PLPTEPNKLPRPATKR 313
                 ++  +   ++
Sbjct: 314 GFAERFSQELQLKVQK 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  486 bits (1253), Expect = e-173
 Identities = 139/293 (47%), Positives = 187/293 (63%), Gaps = 3/293 (1%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           + + ++Y K E +GEGTYGVVYKA D   G+ VA+K+IRL  + EG+  TA+REI LLKE
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L  P+I+ LID    +  L LVFEFME DL+ V+      L  + IK Y+   L+G+A C
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           H+  +LHRD+KP NLLI S G LKLADFGLAR FG P R +TH+V   WYRAP++L G+K
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +Y   VD+W+ GCIFAE++  +P   G +D DQL KIF+  GT  P +WP +  LP + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255

Query: 248 YQY--VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
             +      P  S+ P    + +DLLS M  +DP  RI+A+ A+ H YF    
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  483 bits (1245), Expect = e-172
 Identities = 133/285 (46%), Positives = 180/285 (63%), Gaps = 2/285 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA +   G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH++   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQY 250
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y   +  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
               P  S      +  +DLLSKM   DP  RITA+QALEH YF 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  481 bits (1240), Expect = e-171
 Identities = 118/316 (37%), Positives = 177/316 (56%), Gaps = 5/316 (1%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y+K + LGEGTY  VYK     T   VA+K+IRL + +EG   TA+RE+ LLK+LK  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D    + +L LVFE+++ DL+  + +    ++  ++K ++   L+GLA+CH++ 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LKLADFGLAR    P + + ++V   WYR P++L G+  Y  
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV 251
            +D+W  GCIF E+   RP   GS+  +QL  IF   GT T   WP +    ++  Y Y 
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240

Query: 252 AAPP--LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
                 L S  P    D  DLL+K+  ++ + RI+A+ A++H +F S         LP  
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK--LPDT 298

Query: 310 ATKRASKASDFNPQEG 325
            +  A K      +  
Sbjct: 299 TSIFALKEIQLQKEAS 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  473 bits (1221), Expect = e-168
 Identities = 117/314 (37%), Positives = 170/314 (54%), Gaps = 12/314 (3%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           + ++ + E LG GTY  VYK ++  TG  VA+K+++L   +EG   TA+REI L+KELK 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGTPSTAIREISLMKELKH 62

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-----LSPADIKSYMQMTLKGLA 125
            +I+ L D    +  L LVFEFM+ DL+  + +  +      L    +K +    L+GLA
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG 185
           FCH+  +LHRD+KP NLLI   GQLKL DFGLAR FG P   F+ +V   WYRAP++L G
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182

Query: 186 AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           ++ Y   +D+W+ GCI AE++  +P   G++D +QL  IF   GT   S WP +  LP Y
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242

Query: 246 -VEYQYVAAPPLRSLFPSA-----SDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
               Q      LR +           + +D L  +   +P  R++A+QAL H +F+    
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302

Query: 300 PTEPNKLPRPATKR 313
                         
Sbjct: 303 HASMGGSRSHHHHH 316

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  467 bits (1204), Expect = e-166
 Identities = 136/296 (45%), Positives = 181/296 (61%), Gaps = 8/296 (2%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           DRY +   LGEGTYG VYKAIDT T +TVAIK+IRL  ++EGV  TA+RE+ LLKEL+  
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +IIEL     H   LHL+FE+ E DL+  + + N  +S   IKS++   + G+ FCH + 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRR 152

Query: 132 VLHRDMKPNNLLI-----GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            LHRD+KP NLL+          LK+ DFGLAR FG P R+FTH++   WYR PE+L G+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGS 212

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + Y   VD+W+  CI+AE+L + P   G S+IDQL KIF   G    + WP +  LPD+ 
Sbjct: 213 RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272

Query: 247 EY--QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           +   ++      R L     D+ LDLL+ M   DP  RI+A+ ALEH YFS     
Sbjct: 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  462 bits (1191), Expect = e-164
 Identities = 119/324 (36%), Positives = 170/324 (52%), Gaps = 13/324 (4%)

Query: 3   EVDLSKKVADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALRE 61
           E D   +   +Y     +GEG YG V+KA D K  G+ VA+K++R+   +EG+  + +RE
Sbjct: 2   EKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61

Query: 62  IKLLKELKS---PHIIELIDAF-----PHKGNLHLVFEFMETDLETVIRNT-NIFLSPAD 112
           + +L+ L++   P+++ L D         +  L LVFE ++ DL T +       +    
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
           IK  M   L+GL F H   V+HRD+KP N+L+ S GQ+KLADFGLARI+       T  V
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVV 180

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
              WYRAPE+L  +  Y   VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G   
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239

Query: 233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR 292
              WP    LP    +   +A P+        +   DLL K  T++P  RI+A  AL H 
Sbjct: 240 EEDWPRDVALPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 293 YFSSAPLPTEPNKLPRPATKRASK 316
           YF       E      P ++  S+
Sbjct: 299 YFQDLERCKENLDSHLPPSQNTSE 322

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  460 bits (1187), Expect = e-163
 Identities = 127/343 (37%), Positives = 186/343 (54%), Gaps = 27/343 (7%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
             +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75

Query: 71  PHIIELID--------AFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            +++ LI+            KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----RFTHQVFARWYR 178
           GL + H+  +LHRDMK  N+LI   G LKLADFGLAR F         R+T++V   WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
            PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP+
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255

Query: 239 LAYLPDYVEYQYVAAPP--LRSLFPS--ASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           +     Y + + V      ++    +      ALDL+ K+   DP  RI +  AL H +F
Sbjct: 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

Query: 295 SSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRR 337
            S P+P++   +              +       L+PPR+   
Sbjct: 316 WSDPMPSDLKGMLS-----------THLTSMFEYLAPPRRKHH 347

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  449 bits (1157), Expect = e-159
 Identities = 111/303 (36%), Positives = 159/303 (52%), Gaps = 15/303 (4%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG---VNFTALREIKLLKEL 68
            RY     +G G YG VYKA D  +G  VA+K +R+     G   +  + +RE+ LL+ L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 69  KS---PHIIELIDAF-----PHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQM 119
           ++   P+++ L+D         +  + LVFE ++ DL T +       L    IK  M+ 
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L+GL F H   ++HRD+KP N+L+ S G +KLADFGLARI+       T  V   WYRA
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRA 187

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE+L  +  Y   VD+W+ GCIFAE+  R+P   G+S+ DQLGKIF   G      WP  
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
             LP           P++S+ P   +    LL +M T++P  RI+A +AL+H Y      
Sbjct: 247 VSLPRGAFPPR-GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305

Query: 300 PTE 302
             E
Sbjct: 306 NPE 308

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  409 bits (1054), Expect = e-142
 Identities = 118/385 (30%), Positives = 173/385 (44%), Gaps = 48/385 (12%)

Query: 8   KKVADRYLK-REVLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           ++V D +      +G GTYG VYKA   D K  +  A+K+I       G++ +A REI L
Sbjct: 16  ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIAL 71

Query: 65  LKELKSPHIIELIDAFPHKGN--LHLVFEFMETDLETVIR--------NTNIFLSPADIK 114
           L+ELK P++I L   F    +  + L+F++ E DL  +I+           + L    +K
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIFGSPDRRFTH 170
           S +   L G+ + H  WVLHRD+KP N+L+       G++K+AD G AR+F SP +    
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 171 ---QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI--------- 218
               V   WYRAPELL GA+ Y   +D+WA GCIFAELL   P      +          
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251

Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEY----------QYVAAPPLRSLFPSASDDAL 268
           DQL +IF   G      W D+  +P++                    +          A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311

Query: 269 DLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPAT--KRASKASDFNPQEGP 326
            LL K+ T DP  RIT++QA++  YF   PLPT            KR     +    +G 
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGD 371

Query: 327 TVLSPPRKTRRVMPDREGFEGNANR 351
                 ++ ++      G     N+
Sbjct: 372 ---KKNQQQQQGNNHTNGTGHPGNQ 393

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  374 bits (962), Expect = e-128
 Identities = 112/388 (28%), Positives = 176/388 (45%), Gaps = 33/388 (8%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            +     Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE+++++
Sbjct: 49  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMR 102

Query: 67  ELKSPHIIELIDAFPHKGN------LHLVFEFMETDLETVIR---NTNIFLSPADIKSYM 117
           +L   +I+ L   F   G       L+LV +++   +  V R        L    +K YM
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIFGSPDRRFTHQVFARW 176
               + LA+ H   + HRD+KP NLL+      LKL DFG A+            + +R+
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRY 221

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YRAPEL+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q 
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281

Query: 237 PDLAYLPDYVEY---QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
            ++   P+Y E+   Q  A P  +   P    +A+ L S++  Y P AR+T  +A  H +
Sbjct: 282 REM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

Query: 294 FSSAPLPTE--PNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANR 351
           F     P    PN    P         +F  QE   + S P     ++P     +  A+ 
Sbjct: 340 FDELRDPNVKLPNGRDTP------ALFNFTTQE---LSSNPPLATILIPPHARIQAAAST 390

Query: 352 TDKIEEHAGETKNADGEIAGRNEQVPTS 379
                  +       G+         ++
Sbjct: 391 PTNATAASDANTGDRGQTNNAASASASN 418

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  362 bits (931), Expect = e-123
 Identities = 110/361 (30%), Positives = 183/361 (50%), Gaps = 30/361 (8%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            ++    Y   +V+G G++GVV++A   ++ + VAIKK+   K+ +       RE+++++
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMR 87

Query: 67  ELKSPHIIELIDAFPHKGN------LHLVFEFMETDLETVIR---NTNIFLSPADIKSYM 117
            +K P++++L   F   G+      L+LV E++   +    R        +    IK YM
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
              L+ LA+ H   + HRD+KP NLL+    G LKL DFG A+I           + +R+
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSYICSRY 206

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YRAPEL+FGA  Y   +D+W+ GC+ AEL+  +P   G S IDQL +I    GT +  Q 
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266

Query: 237 PDLAYLPDYVEYQY--VAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
             +   P+Y+E+++  +   P   +F P    DA+DL+S++  Y P AR+TA +AL H +
Sbjct: 267 KTM--NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

Query: 294 FSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREGFEGNANRTD 353
           F    L T   ++  P  +      ++  +E   +   P    R++P     E  +   D
Sbjct: 325 F--DELRTGEARM--PNGRELPPLFNWTKEE---LSVRPDLISRLVPQHAEAELLSRGID 377

Query: 354 K 354
            
Sbjct: 378 V 378

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  335 bits (860), Expect = e-113
 Identities = 98/302 (32%), Positives = 157/302 (51%), Gaps = 25/302 (8%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
             D Y     LG G Y  V++AI+    + V +K ++  K+K+       REIK+L+ L+
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLR 88

Query: 70  S-PHIIELIDAF--PHKGNLHLVFEF-METDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             P+II L D    P      LVFE    TD + + +     L+  DI+ YM   LK L 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALD 144

Query: 126 FCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           +CH   ++HRD+KP+N++I   H +L+L D+GLA  F  P + +  +V +R+++ PELL 
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLV 203

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPD---LA 240
             + Y   +D+W+ GC+ A ++ R+ PF  G  + DQL +I    GT     + D   + 
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 241 YLPDYVE-YQYVAAPPLRSLFPS-----ASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
             P + +     +         S      S +ALD L K+  YD ++R+TA++A+EH YF
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

Query: 295 SS 296
            +
Sbjct: 324 YT 325

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  331 bits (851), Expect = e-112
 Identities = 100/342 (29%), Positives = 157/342 (45%), Gaps = 38/342 (11%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S+K  DR+    + G+GT+G V    +  TG +VAIKK+    +         RE+++++
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQ 71

Query: 67  ELKS---PHIIELIDAFPHKGN-------LHLVFEFMETDLETVIR---NTNIFLSPADI 113
           +L     P+I++L   F   G        L++V E++   L    R      +   P  I
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131

Query: 114 KSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTH 170
           K ++   ++ +   H     V HRD+KP+N+L+  + G LKL DFG A+   SP      
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNVA 190

Query: 171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT 230
            + +R+YRAPEL+FG + Y   VD+W+ GCIFAE++   P  +G +   QL +I    G 
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250

Query: 231 ATPSQWPDLAYLPDYVEYQY--VAAPPLRSLF----PSASDDALDLLSKMFTYDPKARIT 284
            +      L   P + +         P  ++F       + +A DLLS +  Y P+ R+ 
Sbjct: 251 PSREVLRKLN--PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308

Query: 285 AQQALEHRYFSS--APLPTEPNKLPRPATKRASKASDFNPQE 324
             +AL H YF     P    PN    P          F P E
Sbjct: 309 PYEALCHPYFDELHDPATKLPNNKDLPEDL-----FRFLPNE 345

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  328 bits (843), Expect = e-110
 Identities = 99/383 (25%), Positives = 169/383 (44%), Gaps = 61/383 (15%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
             + +Y   + LG G++G+V +  D ++G+  A+KK+    +         RE+ ++K L
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVL 57

Query: 69  KSPHIIELIDAFPHKGN--------------------------------------LHLVF 90
              +II+L+D F   G+                                      L+++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 91  EFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH 147
           E++   L  V++    +   +    I  Y+    + + F H   + HRD+KP NLL+ S 
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177

Query: 148 -GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL 206
              LKL DFG A+    P       + +R+YRAPEL+ GA +Y   +D+W+ GC+F EL+
Sbjct: 178 DNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 207 NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY--VAAPPLRSLFPSAS 264
             +P   G + IDQL +I    GT T  Q   +   P Y E ++  + A   R + P  +
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGT 294

Query: 265 D-DALDLLSKMFTYDPKARITAQQALEHRYFSS----APLPTEPN-KLPRPATKRASKAS 318
              A+DLL ++  Y+P  RI   +A+ H +F           + N   P    +   +  
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLF 354

Query: 319 DFNPQEGPTVLSPPRKTRRVMPD 341
           +F+P E    + P     R++P 
Sbjct: 355 NFSPYE--LSIIPGNVLNRILPK 375

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  320 bits (822), Expect = e-106
 Identities = 108/353 (30%), Positives = 157/353 (44%), Gaps = 67/353 (18%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           + DRY  R ++G G+YG V +A D    + VAIKKI    +        LREI +L  L 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110

Query: 70  SPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             H+++++D    K       L++V E  ++D + + R T ++L+   IK+ +   L G+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGV 169

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------------- 165
            + H   +LHRD+KP N L+     +K+ DFGLAR    P+                   
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 166 --------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---------- 207
                   R+ T  V  RWYRAPEL+   + Y   +DVW+ GCIFAELLN          
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289

Query: 208 -RRPFLQGSS--------------------DIDQLGKIFAAFGTATPSQWPDLA--YLPD 244
            R P   GSS                    + DQL  IF   GT +      L       
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349

Query: 245 YVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
           Y+  +       L   FP++S DA+ LL +M  ++P  RIT  + L H +F  
Sbjct: 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  307 bits (788), Expect = e-102
 Identities = 110/322 (34%), Positives = 158/322 (49%), Gaps = 27/322 (8%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN--FT-------ALR 60
           +   Y  +  +  G+YG V   +D+  G  VAIK++             +        LR
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 61  EIKLLKELKSPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKS 115
           EI+LL     P+I+ L D F H        L+LV E M TDL  VI +  I +SP  I+ 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138

Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR 175
           +M   L GL   H+  V+HRD+ P N+L+  +  + + DF LAR   + D   TH V  R
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED-TADANKTHYVTHR 197

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           WYRAPEL+   K +   VD+W+AGC+ AE+ NR+   +GS+  +QL KI    GT     
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE- 256

Query: 236 WPDLAYLP-----DYVEYQ--YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
             D+         DY+      V A    ++ P+A   ALDL++KM  ++P+ RI+ +QA
Sbjct: 257 --DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 289 LEHRYFSSAPLPT-EPNKLPRP 309
           L H YF S   P      L   
Sbjct: 315 LRHPYFESLFDPLDLTEGLSER 336

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  304 bits (782), Expect = e-101
 Identities = 114/315 (36%), Positives = 157/315 (49%), Gaps = 40/315 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-------ALREI 62
           ++  +  + +LGEG YGVV  A    TG+ VAIKKI          F         LREI
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--------PFDKPLFALRTLREI 60

Query: 63  KLLKELKSPHIIELIDAF--PHKGNLH---LVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           K+LK  K  +II + +        N +   ++ E M+TDL  VI      LS   I+ ++
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFI 118

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ------ 171
             TL+ +   H   V+HRD+KP+NLLI S+  LK+ DFGLARI        +        
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 172 ----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
               V  RWYRAPE++  + +Y   +DVW+ GCI AEL  RRP   G     QL  IF  
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

Query: 228 FGTATPSQWPDLAYLP-----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA 281
            G  TP    DL  +      +Y++      A PL  +FP  +   +DLL +M  +DP  
Sbjct: 239 IG--TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296

Query: 282 RITAQQALEHRYFSS 296
           RITA++ALEH Y  +
Sbjct: 297 RITAKEALEHPYLQT 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  300 bits (770), Expect = e-100
 Identities = 100/310 (32%), Positives = 153/310 (49%), Gaps = 30/310 (9%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +  RY+  + LG G  G+V+ A+D    + VAIKKI L   +      ALREIK+++ L 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALREIKIIRRLD 66

Query: 70  SPHIIELIDAFPHKGN--------------LHLVFEFMETDLETVIRNTNIFLSPADIKS 115
             +I+++ +     G+              +++V E+METDL  V+      L     + 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP--LLEEHARL 124

Query: 116 YMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRR---FTHQ 171
           +M   L+GL + H   VLHRD+KP NL I +    LK+ DFGLARI           +  
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
           +  +WYR+P LL     Y   +D+WAAGCIFAE+L  +    G+ +++Q+  I  +    
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP-- 242

Query: 232 TPSQWPDLAYLP----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
              +  D   L      Y+         PL  L P  S +A+D L ++ T+ P  R+TA+
Sbjct: 243 VVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301

Query: 287 QALEHRYFSS 296
           +AL H Y S 
Sbjct: 302 EALSHPYMSI 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  298 bits (764), Expect = 9e-99
 Identities = 112/308 (36%), Positives = 154/308 (50%), Gaps = 34/308 (11%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT-------ALREI 62
           V  RY     +GEG YG+V  A D      VAIKKI          F         LREI
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLREI 76

Query: 63  KLLKELKSPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYM 117
           K+L   +  +II + D            +++V + METDL  +++  +  LS   I  ++
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFL 134

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF---THQVFA 174
              L+GL + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+           T  V  
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           RWYRAPE++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G  +PS
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG--SPS 252

Query: 235 QWPDLAYLPDYVEYQYVAA------PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
           Q  DL  + +     Y+ +       P   LFP+A   ALDLL KM T++P  RI  +QA
Sbjct: 253 Q-EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311

Query: 289 LEHRYFSS 296
           L H Y   
Sbjct: 312 LAHPYLEQ 319

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  294 bits (756), Expect = 1e-97
 Identities = 106/299 (35%), Positives = 146/299 (48%), Gaps = 21/299 (7%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +   Y+    +G G YG V  AID ++G+ VAIKK+    Q E     A RE+ LLK ++
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             ++I L+D F    +L       LV  FM+TDL+ ++       S   I+  +   LKG
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKG 138

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H   V+HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVI 195

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                Y   VD+W+ GCI AE+L  +   +G   +DQL +I    G         +  L 
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE---FVQKLN 252

Query: 244 -----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                 Y++            LFP AS  A DLL KM   D   R+TA QAL H +F  
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  293 bits (751), Expect = 1e-96
 Identities = 106/299 (35%), Positives = 154/299 (51%), Gaps = 20/299 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V   Y   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK ++
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             ++I L+D F     L       LV  FM TDL  ++++    L    I+  +   LKG
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKG 140

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE++
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVI 197

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
               +Y   VD+W+ GCI AE++  +   +GS  +DQL +I    G  TP     +  L 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG--TPPA-EFVQRLQ 254

Query: 244 -----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                +Y++    +      S+  +AS  A++LL KM   D + R+TA +AL H YF S
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  290 bits (745), Expect = 7e-96
 Identities = 106/299 (35%), Positives = 148/299 (49%), Gaps = 20/299 (6%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +K
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             ++I L+D F    +L       LV   M  DL  +++     L+   ++  +   L+G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRG 144

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           L + H   ++HRD+KP+NL +    +LK+ DFGLAR         T  V  RWYRAPE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM 201

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
                Y   VD+W+ GCI AELL  R    G+  IDQL  I    G  TP     L  + 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG--TPGA-ELLKKIS 258

Query: 244 -----DYVE-YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                +Y++    +      ++F  A+  A+DLL KM   D   RITA QAL H YF+ 
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  287 bits (737), Expect = 9e-94
 Identities = 115/348 (33%), Positives = 163/348 (46%), Gaps = 65/348 (18%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y+ + ++G G+YG VY A D  T + VAIKK+    +        LREI +L  LK
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83

Query: 70  SPHIIELIDAFPHKGN-----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           S +II L D            L++V E  ++DL+ + + T IFL+   IK+ +   L G 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGE 142

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP-------------------- 164
            F H+  ++HRD+KP N L+     +K+ DFGLAR   S                     
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 165 --DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-----------RRPF 211
              ++ T  V  RWYRAPEL+   + Y   +D+W+ GCIFAELLN           R P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 212 LQGSSD-----------------IDQLGKIFAAFGTATPSQWPDLAYLP-----DYVE-Y 248
             GSS                   DQL  IF   G  TP++  DL  +       Y++ +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIG--TPTE-DDLKNINKPEVIKYIKLF 319

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
            +     L+  +PS SDD ++LL  M  ++P  RIT  QAL+H Y   
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  279 bits (716), Expect = 3e-91
 Identities = 110/346 (31%), Positives = 169/346 (48%), Gaps = 51/346 (14%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  +Y   + LG+G YG+V+K+ID +TG+ VA+KKI    Q         REI +L EL 
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 70  S-PHIIELIDAFPHKGN--LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
              +I+ L++      +  ++LVF++METDL  VIR  NI L P   +  +   +K + +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR-ANI-LEPVHKQYVVYQLIKVIKY 124

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA------------ 174
            H   +LHRDMKP+N+L+ +   +K+ADFGL+R F +  R   +   +            
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 175 ---------RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
                    RWYRAPE+L G+ +Y  G+D+W+ GCI  E+L  +P   GSS ++QL +I 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244

Query: 226 AAFGTATPSQWPDLAYLP-----DYVE---------------YQYVAAPPLRSLFPSA-- 263
                  PS   D+  +        +E                       L  + P A  
Sbjct: 245 GVID--FPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 264 SDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
           +++ALDLL K+  ++P  RI+A  AL+H + S    P E       
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHI 347

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  277 bits (711), Expect = 1e-89
 Identities = 102/321 (31%), Positives = 144/321 (44%), Gaps = 31/321 (9%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F  +  L       LV E M+ +L  VI+     L    +   +   L G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCG 176

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G      T  V  R+YRAPE++
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVI 235

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL- 242
            G   Y   VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     +  L 
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE---FMKKLQ 291

Query: 243 PDYVEY----QYVAAPPLRSLFPSA------------SDDALDLLSKMFTYDPKARITAQ 286
           P    Y       A      LFP +            +  A DLLSKM   DP  RI+  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351

Query: 287 QALEHRYFSSAPLPTEPNKLP 307
            AL+H Y +    P E    P
Sbjct: 352 DALQHPYINVWYDPAEVEAPP 372

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  272 bits (697), Expect = 1e-88
 Identities = 97/310 (31%), Positives = 141/310 (45%), Gaps = 31/310 (10%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L+K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 70  SPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
             +II L++ F  + +L       +V E M+ +L  VI+     L    +   +   L G
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCG 139

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           +   H   ++HRD+KP+N+++ S   LK+ DFGLAR         T  V  R+YRAPE++
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVI 198

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
            G   Y   VD+W+ GCI  E++       G+  IDQ  K+    G  TP     +  L 
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG--TPCP-EFMKKLQ 254

Query: 244 D----YVE-YQYVAAPPLRSLFPSA------------SDDALDLLSKMFTYDPKARITAQ 286
                YVE     A      LFP              +  A DLLSKM   D   RI+  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 287 QALEHRYFSS 296
           +AL+H Y + 
Sbjct: 315 EALQHPYINV 324

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  218 bits (558), Expect = 1e-68
 Identities = 76/326 (23%), Positives = 120/326 (36%), Gaps = 68/326 (20%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--S 70
            Y   + +G G    V++ ++ +  Q  AIK + L +       +   EI  L +L+  S
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             II L D       +++V E    DL + ++       P + KSY +  L+ +   H+ 
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQH 146

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRRFTHQVFARWY 177
            ++H D+KP N LI   G LKL DFG+A                G+             Y
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV-----------NY 194

Query: 178 RAPELLFGA----------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA 226
             PE +              +     DVW+ GCI   +   + PF Q  + I +L  I  
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-- 252

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                 P+   +    PD                     D  D+L      DPK RI+  
Sbjct: 253 ----IDPNHEIEF---PDIP-----------------EKDLQDVLKCCLKRDPKQRISIP 288

Query: 287 QALEHRYFSSAPLPTEPNKLPRPATK 312
           + L H Y      P   N++ +  T+
Sbjct: 289 ELLAHPYVQIQTHPV--NQMAKGTTE 312

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  217 bits (555), Expect = 3e-68
 Identities = 69/319 (21%), Positives = 120/319 (37%), Gaps = 57/319 (17%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S + A  + +  VLG+G +G V KA +    +  AIKKIR  ++K     T L E+ LL 
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLA 57

Query: 67  ELKSPHIIELIDAFPHKGN-------------LHLVFEFMET-DLETVIRNTNIFLSPAD 112
            L   +++    A+  + N             L +  E+ E   L  +I + N+     +
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
                +  L+ L++ H + ++HRD+KP N+ I     +K+ DFGLA+             
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 173 FARW--------------YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI 218
                             Y A E+L G   Y   +D+++ G IF E++   PF  G   +
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV 235

Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD 278
           + L K+ +      P    +                               ++  +  +D
Sbjct: 236 NILKKLRSVSIEFPPDFDDNK------------------------MKVEKKIIRLLIDHD 271

Query: 279 PKARITAQQALEHRYFSSA 297
           P  R  A+  L   +    
Sbjct: 272 PNKRPGARTLLNSGWLPVK 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  213 bits (544), Expect = 4e-66
 Identities = 81/379 (21%), Positives = 131/379 (34%), Gaps = 73/379 (19%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--S 70
            Y   + +G G    V++ ++ +  Q  AIK + L +       +   EI  L +L+  S
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             II L D       +++V E    DL + ++       P + KSY +  L+ +   H+ 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQH 127

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRRFTHQVFARWY 177
            ++H D+KP N LI   G LKL DFG+A                G+ +           Y
Sbjct: 128 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN-----------Y 175

Query: 178 RAPELLFG----------AKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFA 226
             PE +              +     DVW+ GCI   +   + PF Q  + I +L  I  
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-- 233

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                 P+   +    PD                     D  D+L      DPK RI+  
Sbjct: 234 ----IDPNHEIEF---PDIP-----------------EKDLQDVLKCCLKRDPKQRISIP 269

Query: 287 QALEHRYF--SSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDREG 344
           + L H Y    + P+                +    N        S  +  + +     G
Sbjct: 270 ELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN-----SILKAAKTLYEHYSG 324

Query: 345 FEGNANRTDKIEEHAGETK 363
            E + + + K  E     K
Sbjct: 325 GESHNSSSSKTFEKKRGKK 343

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  208 bits (532), Expect = 3e-64
 Identities = 80/359 (22%), Positives = 146/359 (40%), Gaps = 51/359 (14%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           +   +L  +  ++Y++ + +GEG++G       T+ G+   IK+I + +        + R
Sbjct: 13  LGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVI-RNTNIFLSPADIKSYMQ 118
           E+ +L  +K P+I++  ++F   G+L++V ++ E  DL   I     +      I  +  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR--- 175
                L   H + +LHRD+K  N+ +   G ++L DFG+AR+  S          AR   
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS------TVELARACI 186

Query: 176 ---WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA 231
              +Y +PE+    K Y    D+WA GC+  EL   +  F +  S  + + KI       
Sbjct: 187 GTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKI------- 237

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                         +   +   PP+   +   S D   L+S++F  +P+ R +    LE 
Sbjct: 238 --------------ISGSF---PPVSLHY---SYDLRSLVSQLFKRNPRDRPSVNSILEK 277

Query: 292 RY-------FSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDRE 343
            +       F S  L  E   L   +   +       P  G   +S     +   P  +
Sbjct: 278 GFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAK 336

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  205 bits (525), Expect = 2e-63
 Identities = 72/315 (22%), Positives = 136/315 (43%), Gaps = 36/315 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTALREIKLLK 66
           K++ ++Y+  E LG G +G+V++ ++T + +T   K +++ G  +  V     +EI +L 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILN 56

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
             +  +I+ L ++F     L ++FEF+   D+   I  +   L+  +I SY+    + L 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 126 FCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
           F H   + H D++P N++  +     +K+ +FG AR    P   F     A  Y APE+ 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVH 175

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                     D+W+ G +   LL+   PFL   ++   +  I  A               
Sbjct: 176 QH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNA--------------- 218

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE 302
               EY +         F   S +A+D + ++   + K+R+TA +AL+H +         
Sbjct: 219 ----EYTFDEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269

Query: 303 PNKLPRPATKRASKA 317
              +     +R    
Sbjct: 270 TKVIRTLKHRRYYHT 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  207 bits (529), Expect = 2e-63
 Identities = 77/329 (23%), Positives = 120/329 (36%), Gaps = 46/329 (13%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--S 70
            Y   + +G G    V++ ++ +  Q  AIK + L +       +   EI  L +L+  S
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
             II L D       +++V E    DL + ++       P + KSY +  L+ +   H+ 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQH 174

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGA-- 186
            ++H D+KP N LI   G LKL DFG+A      +       QV A  Y  PE +     
Sbjct: 175 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 187 --------KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWP 237
                    +     DVW+ GCI   +   + PF Q  + I +L  I        P+   
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------IDPNHEI 287

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF--S 295
           +    PD                     D  D+L      DPK RI+  + L H Y    
Sbjct: 288 E---FPDIP-----------------EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327

Query: 296 SAPLPTEPNKLPRPATKRASKASDFNPQE 324
           + P+                +    N   
Sbjct: 328 THPVNQMAKGTTEEMKYVLGQLVGLNSPN 356

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  210 bits (535), Expect = 2e-62
 Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 33/311 (10%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
              V D Y   E LG G +GVV++  +  TG   A K +    + +       +EI+ + 
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMS 209

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L+ P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 126 FCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL 183
             H+   +H D+KP N++  +    +LKL DFGL      P +          + APE+ 
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVA 328

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G K  G   D+W+ G +   LL+   PF  G +D + L  + +                
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSC--------------- 371

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE 302
               ++    +      F   S+D  D + K+   DP  R+T  QALEH + +    P  
Sbjct: 372 ----DWNMDDSA-----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 303 PNKLPRPATKR 313
            +++P     +
Sbjct: 423 DSQIPSSRYTK 433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  201 bits (513), Expect = 8e-62
 Identities = 70/284 (24%), Positives = 107/284 (37%), Gaps = 33/284 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KS 70
             + +   LG G+YG V+K    + G+  A+K+     +        L E+   +++ + 
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P  + L  A+   G L+L  E     L+         L  A +  Y++ TL  LA  H +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++H D+KP N+ +G  G+ KL DFGL    G+       Q     Y APELL     YG
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELL--QGSYG 233

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
              DV++ G    E+        G     QL + +                         
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------------------------- 268

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              PP        S +   +L  M   DPK R TA+  L     
Sbjct: 269 --LPP--EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  202 bits (515), Expect = 1e-61
 Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 38/296 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTAL-REIK 63
                D Y   EV+G+G + VV + I+ +TGQ  A+K +         G++   L RE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL-ETVIR--NTNIFLSPADIKSYMQM 119
           +   LK PHI+EL++ +   G L++VFEFM+  DL   +++  +     S A    YM+ 
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARW 176
            L+ L +CH   ++HRD+KP+ +L+ S      +KL  FG+A   G        +V    
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           + APE++   + YG  VDVW  G I   LL    PF      +     I           
Sbjct: 199 FMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--FEGIIKG-------- 247

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      +Y+          +   S+ A DL+ +M   DP  RIT  +AL H
Sbjct: 248 -----------KYKMNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  201 bits (512), Expect = 1e-61
 Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 47/311 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
             +L  ++LG+G    V++    KTG   AIK    I   +  +      +RE ++LK+L
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64

Query: 69  KSPHIIELIDAF--PHKGNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSYMQMTLKG 123
              +I++L          +  L+ EF     L TV+   +    L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 124 LAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIF----------GSPDRRFT 169
           +    +  ++HR++KP N++           KL DFG AR            G+ +    
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE---- 180

Query: 170 HQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL 221
                  Y  P++   A       K+YGA VD+W+ G  F        PF +      + 
Sbjct: 181 -------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRN 232

Query: 222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLR-SLFPSASDDALDLLSKMFTYDPK 280
            ++     T  PS         +     +    P+  SL          +L+ +   D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292

Query: 281 ARITAQQALEH 291
                 Q    
Sbjct: 293 KCWGFDQFFAE 303

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  198 bits (506), Expect = 3e-61
 Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 53/301 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + Y     +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK P
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 72  HIIELIDAFPHKGN--LHLVFEFMET-DLETVI---RNTNIFLSPADIKSYMQMTLKGLA 125
           +I+   D    + N  L++V E+ E  DL +VI        +L    +   M      L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 126 FCHKK-----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR----- 175
            CH++      VLHRD+KP N+ +     +KL DFGLARI            FA+     
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DTSFAKTFVGT 179

Query: 176 -WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP 233
            +Y +PE +     Y    D+W+ GC+  EL     PF    S  +  GKI         
Sbjct: 180 PYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKI--------- 228

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                        E ++     +   +   SD+  +++++M       R + ++ LE+  
Sbjct: 229 ------------REGKF---RRIPYRY---SDELNEIITRMLNLKDYHRPSVEEILENPL 270

Query: 294 F 294
            
Sbjct: 271 I 271

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  199 bits (507), Expect = 3e-61
 Identities = 67/312 (21%), Positives = 114/312 (36%), Gaps = 60/312 (19%)

Query: 2   AEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE 61
               + K+    + + E++G G +G V+KA     G+T  IK+++   +K      A RE
Sbjct: 1   GAHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AERE 54

Query: 62  IKLLKELKSPHIIELIDAF----------------PHKGNLHLVFEFMET-DLETVI-RN 103
           +K L +L   +I+     +                     L +  EF +   LE  I + 
Sbjct: 55  VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 104 TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS 163
               L         +   KG+ + H K +++RD+KP+N+ +    Q+K+ DFGL     +
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG 222
             +R T       Y +PE +   + YG  VD++A G I AELL+      + S     L 
Sbjct: 175 DGKR-TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 232

Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR 282
                              + D                         LL K+ +  P+ R
Sbjct: 233 DG----------------IISDIF-----------------DKKEKTLLQKLLSKKPEDR 259

Query: 283 ITAQQALEHRYF 294
               + L     
Sbjct: 260 PNTSEILRTLTV 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  202 bits (516), Expect = 6e-61
 Identities = 68/325 (20%), Positives = 130/325 (40%), Gaps = 62/325 (19%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           +  + + +  +  ++LG G+ G V     +  G+ VA+K++ +          AL EIKL
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-----IALMEIKL 61

Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF------LSPADIKSYM 117
           L E    P++I    +      L++  E    +L+ ++ + N+           +  S +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGS-------------HGQLKLADFGLARIFGSP 164
           +    G+A  H   ++HRD+KP N+L+ +             + ++ ++DFGL +   S 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 165 DRRFTHQVFAR----WYRAPELLFGA------KQYGAGVDVWAAGCIFAELLN--RRPFL 212
              F   +        +RAPELL  +      ++    +D+++ GC+F  +L+  + PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF- 240

Query: 213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLS 272
                  +   I     +    +                          S   +A DL+S
Sbjct: 241 --GDKYSRESNIIRGIFSLDEMKCLHD---------------------RSLIAEATDLIS 277

Query: 273 KMFTYDPKARITAQQALEHRYFSSA 297
           +M  +DP  R TA + L H  F   
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPK 302

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  203 bits (519), Expect = 7e-61
 Identities = 92/307 (29%), Positives = 147/307 (47%), Gaps = 35/307 (11%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLL 65
           +   +DRY  + VLG+G++G V    D  TGQ  A+K I   + K+  +  +L RE++LL
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           K+L  P+I++L + F  KG  +LV E     +L   I +   F S  D    ++  L G+
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGI 139

Query: 125 AFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + HK  ++HRD+KP NLL+ S      +++ DFGL+  F    ++   ++   +Y APE
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPE 198

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     Y    DVW+ G I   LL    PF  G+++ D L K+                
Sbjct: 199 VL--HGTYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKG------------- 242

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                 +Y +         +   S+ A DL+ KM TY P  RI+A+ AL+H +  +    
Sbjct: 243 ------KYTFELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291

Query: 301 TEPNKLP 307
                +P
Sbjct: 292 QISVDVP 298

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  202 bits (515), Expect = 8e-61
 Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 45/298 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-P 71
            +  ++VLG G  G +         + VA+K+I      E  +F A RE++LL+E    P
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI----LPECFSF-ADREVQLLRESDEHP 78

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++I        +   ++  E     L+  +   +      +  + +Q T  GLA  H   
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 132 VLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFGSPDRRFTHQVFA---RWYRAPELL 183
           ++HRD+KP+N+LI            ++DFGL +        F+ +        + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 184 FGA--KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
                +     VD+++AGC+F  +++    PF  G S   Q   +  A            
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--GKSLQRQANILLGACSLDCLHPEKHE 256

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
                                      A +L+ KM   DP+ R +A+  L+H +F S 
Sbjct: 257 ------------------------DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  197 bits (504), Expect = 2e-60
 Identities = 87/322 (27%), Positives = 139/322 (43%), Gaps = 42/322 (13%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTAL- 59
             K + D Y+  + LG G  G V  A + KT + VAIK     K  +G  +E      + 
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYM 117
            EI++LK+L  P II++ + F  + + ++V E ME  +L + V+ N    L  A  K Y 
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYF 120

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFA 174
              L  + + H+  ++HRD+KP N+L+ S      +K+ DFG ++I G            
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGT 179

Query: 175 RWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTA 231
             Y APE+L       Y   VD W+ G I    L+   PF +  + +    +I +     
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            P  W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 240 IPEVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 292 RYFSSAPLPTEPNKLPRPATKR 313
            +     +  +   L     + 
Sbjct: 276 PWLQDEDMKRKFQDLLSEENES 297

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  196 bits (501), Expect = 2e-60
 Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 42/294 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREI 62
               A+RY    +LG+G++G V K  D  T Q  A+K I       K    +    LRE+
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI----LREV 72

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           +LLK+L  P+I++L +      + ++V E     +L   I     F S  D    ++   
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARIIKQVF 131

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            G+ + HK  ++HRD+KP N+L+ S      +K+ DFGL+  F   + +   ++   +Y 
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYI 190

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     Y    DVW+AG I   LL    PF  G ++ D L ++             
Sbjct: 191 APEVL--RGTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETG---------- 237

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    +Y +         + + SDDA DL+ KM T+ P  RITA Q LEH
Sbjct: 238 ---------KYAFDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  203 bits (517), Expect = 2e-60
 Identities = 90/302 (29%), Positives = 138/302 (45%), Gaps = 32/302 (10%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
              +++ Y + + LG G YG V    D  T    AIK IR        N   L E+ +LK
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L  P+I++L D F  K N +LV E  +  +L   I +   F +  D    ++  L G+ 
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-NEVDAAVIIKQVLSGVT 150

Query: 126 FCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP NLL+ S      +K+ DFGL+ +F    ++   ++   +Y APE+
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEV 209

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K+Y    DVW+ G I   LL   P   G +D + L K+     T    +W ++   
Sbjct: 210 L--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV--- 264

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE 302
                                S+ A DL+ +M  +D + RI+AQQALEH +        E
Sbjct: 265 ---------------------SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303

Query: 303 PN 304
             
Sbjct: 304 SG 305

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  199 bits (509), Expect = 2e-60
 Identities = 81/324 (25%), Positives = 136/324 (41%), Gaps = 43/324 (13%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKL 64
              V D Y   E LG G +GVV++ ++  TG+    K I       K  V      EI +
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV----KNEISI 101

Query: 65  LKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           + +L  P +I L DAF  K  + L+ EF+   +L   I   +  +S A++ +YM+   +G
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           L   H+  ++H D+KP N++  +     +K+ DFGLA     PD           + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPE 220

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ++   +  G   D+WA G +   LL+   PF  G  D++ L  +                
Sbjct: 221 IVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRC------------- 265

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS----- 295
                 ++++         F S S +A D +  +   +P+ R+T   ALEH +       
Sbjct: 266 ------DWEFDEDA-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314

Query: 296 -SAPLPTEPNKLPRPATKRASKAS 318
            ++ +P+      R   K      
Sbjct: 315 LTSRIPSSRYNKIRQKIKEKYADW 338

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  197 bits (502), Expect = 3e-60
 Identities = 74/315 (23%), Positives = 124/315 (39%), Gaps = 54/315 (17%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG---KQKEGVNFTALRE 61
           D+       +   + +G G +  VY+A     G  VA+KK+++      K   +   ++E
Sbjct: 25  DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKE 82

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYM 117
           I LLK+L  P++I+   +F     L++V E  +  DL  +I++       +    +  Y 
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR-- 175
                 L   H + V+HRD+KP N+ I + G +KL D GL R F S          A   
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSL 196

Query: 176 ----WYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL-GKIFAAFG 229
               +Y +PE +     Y    D+W+ GC+  E+   + PF     ++  L  KI     
Sbjct: 197 VGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----- 250

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSA--SDDALDLLSKMFTYDPKARITAQQ 287
                            +  Y   PPL    PS   S++   L++     DP+ R     
Sbjct: 251 ----------------EQCDY---PPL----PSDHYSEELRQLVNMCINPDPEKRPDVTY 287

Query: 288 ALEHRYFSSAPLPTE 302
             +      A   + 
Sbjct: 288 VYDVAKRMHACTASS 302

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  195 bits (499), Expect = 4e-60
 Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 43/295 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREI 62
           S K +D Y  +E LG+G + VV + +   TG   A K I       +  + +     RE 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL----EREA 56

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMT 120
           ++ ++L+ P+I+ L D+   +   +LVF+ +   +L E ++     F S AD    +Q  
Sbjct: 57  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQI 114

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWY 177
           L+ +A+CH   ++HR++KP NLL+ S      +KLADFGLA         +        Y
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGY 173

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            +PE+L     Y   VD+WA G I   LL    PF           +I A          
Sbjct: 174 LSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAG--------- 222

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                      Y Y +       + + + +A  L+  M T +PK RITA QAL+ 
Sbjct: 223 ----------AYDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  196 bits (500), Expect = 5e-60
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 44/301 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-------EGVNFTAL 59
           +    + Y  +E+LG G   VV + I   T +  A+K I +           + +    L
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL 71

Query: 60  REIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSY 116
           +E+ +L+++   P+II+L D +       LVF+ M+  +L + +       LS  + +  
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKI 129

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
           M+  L+ +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPS 188

Query: 177 YRAPELLFGA-----KQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGT 230
           Y APE++  +       YG  VD+W+ G I   LL    PF      +  L  I +    
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSG--- 244

Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                            YQ+ +       +   SD   DL+S+     P+ R TA++AL 
Sbjct: 245 ----------------NYQFGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

Query: 291 H 291
           H
Sbjct: 284 H 284

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  199 bits (509), Expect = 6e-60
 Identities = 91/346 (26%), Positives = 152/346 (43%), Gaps = 55/346 (15%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           VA RY   +V+G+G++G V KA D K  Q VA+K +R    ++  +  A  EI++L+ L+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLR 151

Query: 70  ------SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQMTLK 122
                 + ++I +++ F  + ++ + FE +  +L  +I+       S   ++ +    L+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            L   HK  ++H D+KP N+L+   G   +K+ DFG +       +R    + +R+YRAP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQSRFYRAP 268

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG----------- 229
           E++ GA+ YG  +D+W+ GCI AELL   P L G  + DQL  +    G           
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327

Query: 230 ----------------TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP---SASDDAL-D 269
                             T S    +         +    P  R          D    D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 270 LLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKRAS 315
            L +   +DP  R+T  QAL H +           +LP+P T   +
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRR--------RLPKPPTGEKT 425

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  201 bits (512), Expect = 7e-60
 Identities = 89/295 (30%), Positives = 136/295 (46%), Gaps = 34/295 (11%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
               A+RY    +LG+G++G V K  D  T Q  A+K I     K     T LRE++LLK
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +L  P+I++L +      + ++V E     +L   I     F S  D    ++    G+ 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARIIKQVFSGIT 135

Query: 126 FCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + HK  ++HRD+KP N+L+ S      +K+ DFGL+  F   + +   ++   +Y APE+
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYYIAPEV 194

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           L     Y    DVW+AG I   LL    PF  G ++ D L ++                 
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETG-------------- 237

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                +Y +         + + SDDA DL+ KM T+ P  RITA Q LEH +   
Sbjct: 238 -----KYAFDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  195 bits (497), Expect = 1e-59
 Identities = 68/324 (20%), Positives = 116/324 (35%), Gaps = 58/324 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
             +   + LG G +GVV++A +       AIK+IRL  ++       +RE+K L +L+ P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHP 63

Query: 72  HIIELIDAF------------PHKGNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSY 116
            I+   +A+              K  L++  +     +L+  +  R T      +     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR- 175
                + + F H K ++HRD+KP+N+       +K+ DFGL       +   T       
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 176 -----------WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
                       Y +PE + G   Y   VD+++ G I  ELL   PF      +  L  +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV 240

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
                                   ++   PP   LF         ++  M +  P  R  
Sbjct: 241 ---------------------RNLKF---PP---LFTQKYPCEYVMVQDMLSPSPMERPE 273

Query: 285 AQQALEHRYFSSAPLPTEPNKLPR 308
           A   +E+  F     P +     R
Sbjct: 274 AINIIENAVFEDLDFPGKTVLRQR 297

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  195 bits (498), Expect = 1e-59
 Identities = 75/321 (23%), Positives = 136/321 (42%), Gaps = 40/321 (12%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV+   + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTL 121
           +L+++   ++I L D + ++ ++ L+ E +   +L + + +     LS  +  S+++  L
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQIL 125

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            G+ + H K + H D+KP N+++         +KL DFGLA         F +      +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEF 184

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I +          
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV--------- 233

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                      Y +         F   S+ A D + K+   + + R+T Q+AL H + + 
Sbjct: 234 ----------SYDFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

Query: 297 APLPTEPNKLPRPATKRASKA 317
                   +          + 
Sbjct: 279 VDNQQAMVRRESVVNLENFRK 299

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  198 bits (505), Expect = 2e-59
 Identities = 87/315 (27%), Positives = 139/315 (44%), Gaps = 42/315 (13%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTAL- 59
             K + D Y+  + LG G  G V  A + KT + VAI+     K  +G  +E      + 
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYM 117
            EI++LK+L  P II++ + F  + + ++V E ME  +L + V+ N    L  A  K Y 
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYF 245

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFA 174
              L  + + H+  ++HRD+KP N+L+ S  +   +K+ DFG ++I G            
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGT 304

Query: 175 RWYRAPELLFGA--KQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
             Y APE+L       Y   VD W+ G I F  L    PF +  + +    +I +     
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            P  W ++                        S+ ALDL+ K+   DPKAR T ++AL H
Sbjct: 365 IPEVWAEV------------------------SEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 292 RYFSSAPLPTEPNKL 306
            +     +  +   L
Sbjct: 401 PWLQDEDMKRKFQDL 415

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  195 bits (498), Expect = 2e-59
 Identities = 71/322 (22%), Positives = 127/322 (39%), Gaps = 35/322 (10%)

Query: 8   KKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +   + Y L  + LG G + VV + I   TGQ  A K ++  ++ +      L EI +L+
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83

Query: 67  ELKS-PHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKG 123
             KS P +I L + + +   + L+ E+    ++    +      +S  D+   ++  L+G
Sbjct: 84  LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143

Query: 124 LAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
           + + H+  ++H D+KP N+L+ S    G +K+ DFG++R  G         +    Y AP
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAP 202

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L          D+W  G I   LL    PF+ G  + +    I               
Sbjct: 203 EILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQV------------ 248

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                     Y         F S S  A D +  +   +P+ R TA+  L H +      
Sbjct: 249 -------NVDYSEET-----FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296

Query: 300 PTEPNKLPRPATKRASKASDFN 321
               +     ++ +    S  +
Sbjct: 297 ENLFHPEETSSSSQTQDHSVRS 318

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  195 bits (496), Expect = 5e-59
 Identities = 70/340 (20%), Positives = 129/340 (37%), Gaps = 76/340 (22%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI---RLGKQKEGVNFTALREIK 63
             ++  +Y  +  +G+G+YGVV  AI+ +T    AIK +   ++ +           E++
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME----------------------------- 94
           L+K+L  P+I  L + +  +  + LV E                                
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 95  -----------TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLL 143
                        +     + +       I + M+     L + H + + HRD+KP N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200

Query: 144 IGSHG--QLKLADFGLARIFGSPDRRFTHQVFAR----WYRAPELLFGA-KQYGAGVDVW 196
             ++   ++KL DFGL++ F   +    + +  +    ++ APE+L    + YG   D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 197 AAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP 255
           +AG +   LL    PF  G +D D + ++                      +  +     
Sbjct: 261 SAGVLLHLLLMGAVPF-PGVNDADTISQVLNK-------------------KLCFENPN- 299

Query: 256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
               +   S  A DLLS +   +   R  A +AL+H + S
Sbjct: 300 ----YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  198 bits (506), Expect = 8e-59
 Identities = 92/317 (29%), Positives = 136/317 (42%), Gaps = 45/317 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA-------- 58
             K+ + Y K   LG G YG V    +       AIK I+  +  +G             
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 59  ---LREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIK 114
                EI LLK L  P+II+L D F  K   +LV EF E  +L   I N + F    D  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAA 149

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQ 171
           + M+  L G+ + HK  ++HRD+KP N+L+ +      +K+ DFGL+  F S D +   +
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKLRDR 208

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGT 230
           +   +Y APE+L   K+Y    DVW+ G I   LL    PF  G +D D + K+      
Sbjct: 209 LGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYY 265

Query: 231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
              + W ++                        SD+A +L+  M TYD   R TA++AL 
Sbjct: 266 FDFNDWKNI------------------------SDEAKELIKLMLTYDYNKRCTAEEALN 301

Query: 291 HRYFSSAPLPTEPNKLP 307
            R+          +   
Sbjct: 302 SRWIKKYANNINKSDQK 318

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  192 bits (490), Expect = 8e-59
 Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 44/296 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
              + D ++ +  LG G +G V+   +  +G    IK I   + +  +      EI++LK
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLK 75

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET----DLETVIRNTNIFLSPADIKSYMQMTLK 122
            L  P+II++ + F    N+++V E  E     +     +     LS   +   M+  + 
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            LA+ H + V+H+D+KP N+L      H  +K+ DFGLA +F   D   T+      Y A
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMA 194

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA---FGTATPSQ 235
           PE+    +      D+W+AG +   LL    PF  G+S  +   K       +      +
Sbjct: 195 PEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQKATYKEPNY----AVE 247

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              L                        +  A+DLL +M T DP+ R +A Q L H
Sbjct: 248 CRPL------------------------TPQAVDLLKQMLTKDPERRPSAAQVLHH 279

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  195 bits (497), Expect = 9e-59
 Identities = 91/323 (28%), Positives = 147/323 (45%), Gaps = 41/323 (12%)

Query: 7   SKKVADRY--LKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREI 62
              V   Y   K E+LG G +G V+K  +T TG  +A K I  R  K KE V      EI
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV----KNEI 137

Query: 63  KLLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
            ++ +L   ++I+L DAF  K ++ LV E+++  +L   I + +  L+  D   +M+   
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           +G+   H+ ++LH D+KP N+L  +    Q+K+ DFGLAR +  P  +         + A
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLA 256

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE++          D+W+ G I   LL+   PFL G +D + L  I A            
Sbjct: 257 PEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILAC----------- 303

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
                    +           F   S++A + +SK+   +   RI+A +AL+H + S   
Sbjct: 304 --------RWDLEDEE-----FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

Query: 299 LPTEPNKLPRPATKRASKASDFN 321
           L +  +   +    R S A DF 
Sbjct: 351 LHSRLSA--QKKKNRGSDAQDFV 371

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  192 bits (489), Expect = 1e-58
 Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 40/293 (13%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIKLL 65
           V D Y   E LG G + +V K     TG+  A   IKK RL   + GV+   + RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKG 123
           +E++ P+II L D F +K ++ L+ E +   +L + +       L+  +   +++  L G
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDG 120

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           + + H K + H D+KP N+++        ++KL DFG+A         F +      + A
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPEFVA 179

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A            
Sbjct: 180 PEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV----------- 226

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    Y +         F + S+ A D + ++   DPK R+T  Q+LEH
Sbjct: 227 --------NYDFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  193 bits (492), Expect = 1e-58
 Identities = 76/310 (24%), Positives = 136/310 (43%), Gaps = 40/310 (12%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           + V D Y   E LG G + VV K  +  TG   A   IKK R    + GV+   + RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL-ETVIRNTNIFLSPADIKSYMQMTL 121
           +LKE++ P++I L + + +K ++ L+ E +   +L + +       L+  +   +++  L
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQIL 124

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            G+ + H   + H D+KP N+++        ++K+ DFGLA         F +      +
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEF 183

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   +  G   D+W+ G I   LL+   PFL G +  + L  + A          
Sbjct: 184 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV--------- 232

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                      Y++         F + S  A D + ++   DPK R+T Q +L+H +   
Sbjct: 233 ----------NYEFEDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

Query: 297 APLPTEPNKL 306
                  ++ 
Sbjct: 278 KDTQQALSRK 287

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  196 bits (500), Expect = 2e-58
 Identities = 84/297 (28%), Positives = 134/297 (45%), Gaps = 35/297 (11%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           MA +    +  + Y   E LG+G + VV + +    GQ  A   I   K     +    R
Sbjct: 1   MATIT-CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER 59

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDL-ETVIRNTNIFLSPADIKSYMQ 118
           E ++ + LK P+I+ L D+   +G+ +L+F+ +   +L E ++     + S AD    +Q
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQ 117

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFAR 175
             L+ +  CH+  V+HR++KP NLL+ S      +KLADFGLA       + +       
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPS 234
            Y +PE+L     YG  VD+WA G I   LL    PF           +I A        
Sbjct: 178 GYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAG------- 228

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                        Y + +       + + + +A DL++KM T +P  RITA +AL+H
Sbjct: 229 ------------AYDFPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  193 bits (492), Expect = 3e-58
 Identities = 85/291 (29%), Positives = 129/291 (44%), Gaps = 35/291 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           S K +D Y  +E LG+G + VV + +   TG   A K I   K          RE ++ +
Sbjct: 24  STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +L+ P+I+ L D+   +   +LVF+ +   +L E ++     F S AD    +Q  L+ +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESI 141

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           A+CH   ++HR++KP NLL+ S      +KLADFGLA         +        Y +PE
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 200

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     Y   VD+WA G I   LL    PF           +I A              
Sbjct: 201 VLKK-DPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAG------------- 245

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  Y Y +       + + + +A  L+  M T +PK RITA QAL+ 
Sbjct: 246 ------AYDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  193 bits (492), Expect = 3e-58
 Identities = 82/300 (27%), Positives = 139/300 (46%), Gaps = 43/300 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALR 60
           +K+   +Y  ++V+G G   VV + +   TG   A+K + +  ++      E V     R
Sbjct: 89  AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148

Query: 61  EIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYM 117
           E  +L+++   PHII LID++     + LVF+ M   +L + +       LS  + +S M
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIM 206

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
           +  L+ ++F H   ++HRD+KP N+L+  + Q++L+DFG +     P  +         Y
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGY 265

Query: 178 RAPELLFGA-----KQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTA 231
            APE+L  +       YG  VD+WA G I   LL    PF        Q+  +       
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF----WHRRQIL-MLRMIMEG 320

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                          +YQ+ +       +   S    DL+S++   DP+AR+TA+QAL+H
Sbjct: 321 ---------------QYQFSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  193 bits (492), Expect = 3e-58
 Identities = 56/332 (16%), Positives = 90/332 (27%), Gaps = 65/332 (19%)

Query: 12  DRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELK 69
           +R LK  E L  G   VV+   D +  +  A+K   +G +        L         L 
Sbjct: 61  ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120

Query: 70  SPHIIELIDAF--------------------------PHKGNLHLVFEFMETDLETVIR- 102
                E  D                                N  L+      DLE +   
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180

Query: 103 -----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL 157
                          +       ++  A    K ++H    P+NL I   G+L L D   
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 158 ARIFGSPDRRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELL-NRRPFLQGS 215
               G+   R         Y   E L  +   +   ++ W  G     +     PF   +
Sbjct: 241 LWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMF 275
             I    K                  +P      + +  PL        D    L+ +  
Sbjct: 298 PGIKGSWKR-------------PSLRVPGTDSLAFGSCTPL-------PDFVKTLIGRFL 337

Query: 276 TYDPKARITAQQALEHRYF------SSAPLPT 301
            +D + R+   +A+E   F       S+ L T
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQLQNEISSSLST 369

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  193 bits (492), Expect = 4e-58
 Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 40/321 (12%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVA---IKKIRLGKQKEGVNFTAL-REIK 63
           +KV D Y   E LG G + +V K  +  TG   A   IKK +    + GV    + RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTL 121
           +L+++  P+II L D + ++ ++ L+ E +   +L + + +     LS  +  S+++  L
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQIL 125

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIFGSPDRRFTHQVFARWY 177
            G+ + H K + H D+KP N+++         +KL DFGLA         F +      +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEF 184

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   +  G   D+W+ G I   LL+   PFL G +  + L  I A          
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV--------- 233

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                      Y +         F   S+ A D + K+   + + R+T Q+AL H + + 
Sbjct: 234 ----------SYDFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

Query: 297 APLPTEPNKLPRPATKRASKA 317
                   +          K 
Sbjct: 279 VDTQQAMVRRESVVNLENFKK 299

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  188 bits (480), Expect = 2e-57
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 42/291 (14%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIKLLK 66
            +   Y     +G G++G V  A+   T    A KKI     +  +       +EI+++K
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF----KQEIEIMK 61

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGL 124
            L  P+II L + F    +++LV E     +L E V+         +D    M+  L  +
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAV 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           A+CHK  V HRD+KP N L  +      LKL DFGLA  F  P +    +V   +Y +P+
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQ 178

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     YG   D W+AG +   LL    PF    +D + + KI                
Sbjct: 179 VL--EGLYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREG------------- 222

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                  + +         + + S  A  L+ ++ T  PK RIT+ QALEH
Sbjct: 223 ------TFTFPEKD-----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  191 bits (488), Expect = 3e-57
 Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 47/311 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
             +L  ++LG+G    V++    KTG   AIK    I   +  +      +RE ++LK+L
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64

Query: 69  KSPHIIELIDAF--PHKGNLHLVFEFMET-DLETVI--RNTNIFLSPADIKSYMQMTLKG 123
              +I++L          +  L+ EF     L TV+   +    L  ++    ++  + G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 124 LAFCHKKWVLHRDMKPNNLLIGS----HGQLKLADFGLARIF----------GSPDRRFT 169
           +    +  ++HR++KP N++           KL DFG AR            G+ +    
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE---- 180

Query: 170 HQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL 221
                  Y  P++   A       K+YGA VD+W+ G  F        PF +      + 
Sbjct: 181 -------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRN 232

Query: 222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPL-RSLFPSASDDALDLLSKMFTYDPK 280
            ++     T  PS         +     +    P+  SL          +L+ +   D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292

Query: 281 ARITAQQALEH 291
                 Q    
Sbjct: 293 KCWGFDQFFAE 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  188 bits (480), Expect = 5e-57
 Identities = 69/312 (22%), Positives = 123/312 (39%), Gaps = 56/312 (17%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +  +   ++  EVLG G +  V+      TG+  A+K I+  K     + +   EI +LK
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLK 61

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGL 124
           ++K  +I+ L D +    + +LV + +   +L + ++       +  D    +Q  L  +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAV 119

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF---------GSPDRRFTHQV 172
            + H+  ++HRD+KP NLL  +     ++ + DFGL+++          G+P        
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP-------- 171

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTA 231
               Y APE+L   K Y   VD W+ G I   LL    PF    ++     KI       
Sbjct: 172 ---GYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPF-YEETESKLFEKIKEG---- 222

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    +   +              +   S+ A D +  +   DP  R T ++AL H
Sbjct: 223 ------YYEFESPF--------------WDDISESAKDFICHLLEKDPNERYTCEKALSH 262

Query: 292 RYFSSAPLPTEP 303
            +          
Sbjct: 263 PWIDGNTALHRD 274

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  187 bits (477), Expect = 2e-56
 Identities = 69/311 (22%), Positives = 100/311 (32%), Gaps = 48/311 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
            YL  + LGEG +  V        G   A+K+I   +Q++     A RE  + +    P+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE--AQREADMHRLFNHPN 87

Query: 73  IIELIDAF----PHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           I+ L+         K    L+  F +   L   I        FL+   I   +    +GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS-PDRRFTHQVFARW------- 176
              H K   HRD+KP N+L+G  GQ  L D G         +          W       
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 177 -YRAPELLFGAKQYGAG--VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTAT 232
            YRAPEL             DVW+ GC+   ++    P+       D +           
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ---- 263

Query: 233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR 292
                    +P    +               S     LL+ M T DP  R      L   
Sbjct: 264 -------LSIPQSPRH---------------SSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

Query: 293 YFSSAPLPTEP 303
                P P + 
Sbjct: 302 EALQPPAPGQH 312

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  188 bits (480), Expect = 3e-56
 Identities = 86/334 (25%), Positives = 143/334 (42%), Gaps = 56/334 (16%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
             DRY    ++G+G++G V KA D    + VAIK I+    K+     A  E++LL+ + 
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMN 108

Query: 70  SP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--LSPADIKSYMQMTL 121
                   +I+ L   F  + +L LVFE +  +L  ++RNTN F  +S    + + Q   
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN-FRGVSLNLTRKFAQQMC 167

Query: 122 KGLAFCH--KKWVLHRDMKPNNLLI--GSHGQLKLADFGLARIFGSPDRRFTHQVFARWY 177
             L F    +  ++H D+KP N+L+       +K+ DFG +       +R    + +R+Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFY 224

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS--- 234
           R+PE+L G   Y   +D+W+ GCI  E+    P   G++++DQ+ KI    G        
Sbjct: 225 RSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283

Query: 235 -----------------------------QWPDLAYLPDYVEYQYVAAPPLRSLFPSASD 265
                                        + P    L + +  +       R+     + 
Sbjct: 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343

Query: 266 DA----LDLLSKMFTYDPKARITAQQALEHRYFS 295
                  DL+ +M  YDPK RI    AL+H +F 
Sbjct: 344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  186 bits (475), Expect = 4e-56
 Identities = 81/337 (24%), Positives = 132/337 (39%), Gaps = 62/337 (18%)

Query: 7   SKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKI--RLGKQKEGVNFTALREIK 63
           S +  D Y L+ +VLGEG +  V   I+  T Q  A+K I  + G  +  V     RE++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV----FREVE 62

Query: 64  LLKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL 121
           +L + +   +++ELI+ F  +   +LVFE M    + + I     F +  +    +Q   
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF-NELEASVVVQDVA 121

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARW-- 176
             L F H K + HRD+KP N+L     Q   +K+ DF L       +   +         
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI-KLNGDCSPISTPELLT 180

Query: 177 ------YRAPELL----FGAKQYGAGVDVWAAGCI-----------FAELLNRRPFLQGS 215
                 Y APE++      A  Y    D+W+ G I                +   + +G 
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240

Query: 216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMF 275
           +       +F +                   +Y++         +   S  A DL+SK+ 
Sbjct: 241 ACPACQNMLFESIQEG---------------KYEFPDKD-----WAHISCAAKDLISKLL 280

Query: 276 TYDPKARITAQQALEHRYF----SSAPLPTEPNKLPR 308
             D K R++A Q L+H +         LPT P  L R
Sbjct: 281 VRDAKQRLSAAQVLQHPWVQGCAPENTLPT-PMVLQR 316

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  185 bits (472), Expect = 2e-55
 Identities = 83/319 (26%), Positives = 132/319 (41%), Gaps = 40/319 (12%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LL 65
           S +  D Y  +E +G G+Y V  + I   T    A+K I   K K         EI+ LL
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID--KSKRDP----TEEIEILL 70

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           +  + P+II L D +     +++V E M+  +L   I     F S  +  + +    K +
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-SEREASAVLFTITKTV 129

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ----LKLADFGLARIFGSPDRRFTHQVFARWYRAP 180
            + H + V+HRD+KP+N+L          +++ DFG A+   + +       +   + AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           E+L   + Y A  D+W+ G +   +L    PF  G  D  +  +I A  G+         
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSG-------- 238

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS-AP 298
                  ++           + S SD A DL+SKM   DP  R+TA   L H +      
Sbjct: 239 -------KFSLSGGY-----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

Query: 299 LPTEPNKLPRPATKRASKA 317
           LP     L R       K 
Sbjct: 287 LPQYQ--LNRQDAPHLVKG 303

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  185 bits (472), Expect = 4e-55
 Identities = 85/348 (24%), Positives = 141/348 (40%), Gaps = 50/348 (14%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP- 71
           RY+    LG G +  V+ A D      VA+K +R     +     A  EIKLL+ +    
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDAD 76

Query: 72  ----------HIIELIDAFPHKGN--LH--LVFEFMETDLETVI-RNTNIFLSPADIKSY 116
                     HI++L+D F HKG   +H  +VFE +  +L  +I +  +  +    +K  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLI------GSHGQLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+       +  Q+K+AD G A      D  +T
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYT 193

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQG------SSDIDQLGK 223
           + +  R YR+PE+L GA  +G G D+W+  C+  EL+      +       + D D + +
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252

Query: 224 IFAAFGTATP-----SQWPDLAYLPDYVEYQYVAAPP------LRSLFPSASDDA---LD 269
           I    G          ++    +    +               L   +  + D+A    D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312

Query: 270 LLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATKRASKA 317
            LS M   DP+ R  A   + H +        E     R      S  
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 360

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  183 bits (466), Expect = 9e-55
 Identities = 79/324 (24%), Positives = 128/324 (39%), Gaps = 41/324 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS- 70
           D  LK + LGEG++ +  K +  K+ Q  A+K I   K+ E       +EI  LK  +  
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEA---NTQKEITALKLCEGH 65

Query: 71  PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P+I++L + F  + +  LV E +   +L   I+    F S  +    M+  +  ++  H 
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF-SETEASYIMRKLVSAVSHMHD 124

Query: 130 KWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
             V+HRD+KP NLL         +K+ DFG AR+    ++      F   Y APELL   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQ 183

Query: 187 KQYGAGVDVWAAGCIFAELL-NRRPFL--QGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             Y    D+W+ G I   +L  + PF     S       +I                   
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG------------ 231

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF------SSA 297
              ++ +         + + S +A DL+  + T DP  R+       + +       SS 
Sbjct: 232 ---DFSFEGEA-----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283

Query: 298 PLPTEPNKLPRPATKRASKASDFN 321
           PL T        A       + F+
Sbjct: 284 PLMTPDILGSSGAAVHTCVKATFH 307

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  182 bits (463), Expect = 5e-54
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 38/288 (13%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           ++D +     LG G   +VY+     T +  A+K ++    K+ V      EI +L  L 
Sbjct: 51  LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLS 106

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DL-ETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            P+II+L + F     + LV E +   +L + ++     + S  D    ++  L+ +A+ 
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYL 164

Query: 128 HKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           H+  ++HRD+KP NLL  +      LK+ADFGL++I                Y APE+L 
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAPEILR 223

Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           G   YG  VD+W+ G I   LL    PF     D     +I                   
Sbjct: 224 G-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC---------------- 266

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
              EY +++       +   S +A DL+ K+   DPK R+T  QAL+H
Sbjct: 267 ---EYYFISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  180 bits (459), Expect = 1e-53
 Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 43/297 (14%)

Query: 7   SKKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
              V D Y L ++VLG G  G V +    +TGQ  A+K +      +     A +E+   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPK-----ARQEVDHH 75

Query: 66  KELKS-PHIIELIDAF----PHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQ 118
            +    PHI+ ++D +      K  L ++ E ME       +    +   +  +    M+
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFAR 175
                + F H   + HRD+KP NLL  S  +   LKL DFG A+             +  
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN--ALQTPCYTP 193

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           +Y APE+L G ++Y    D+W+ G I   LL    PF   ++       +          
Sbjct: 194 YYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPF-YSNTGQAISPGMKRRIRLG--- 248

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       +Y +         +   S+DA  L+  +   DP  R+T  Q + H
Sbjct: 249 ------------QYGFPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  179 bits (455), Expect = 8e-53
 Identities = 62/324 (19%), Positives = 125/324 (38%), Gaps = 59/324 (18%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL----- 59
            K  + Y     L +G +  +      K  +  A+K   K  L K+++            
Sbjct: 27  DKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIK 84

Query: 60  -------REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME--------TDLETVIRNT 104
                   E++++ ++K+ + +       +   +++++E+ME             + +N 
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 105 NIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-- 161
             F+    IK  ++  L   ++ H +K + HRD+KP+N+L+  +G++KL+DFG +     
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 162 -------GSPDRRFTHQVFARWYRAPELLFGAKQY-GAGVDVWAAGCIFAELLNRR-PFL 212
                  G+ +           +  PE       Y GA VD+W+ G     +     PF 
Sbjct: 205 KKIKGSRGTYE-----------FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF- 252

Query: 213 QGSSDIDQL-GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
                + +L   I          ++P       Y      +      L    S++ +D L
Sbjct: 253 SLKISLVELFNNIRTK-----NIEYPLDRNHFLYPLTNKKSTCSNNFL----SNEDIDFL 303

Query: 272 SKMFTYDPKARITAQQALEHRYFS 295
                 +P  RIT++ AL+H + +
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLA 327

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  175 bits (446), Expect = 3e-52
 Identities = 78/306 (25%), Positives = 135/306 (44%), Gaps = 51/306 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           + +    +LG+G++  VY+A    TG  VAIK   K  +   K G+      E+K+  +L
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQL 68

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           K P I+EL + F     ++LV E     ++   ++N     S  + + +M   + G+ + 
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFT-----HQVFARWYRAPE 181
           H   +LHRD+  +NLL+  +  +K+ADFGLA     P  + +T     +      Y +PE
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN------YISPE 182

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +      +G   DVW+ GC+F  LL  R PF    +  + L K+  A             
Sbjct: 183 IATR-SAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLA------------- 227

Query: 241 YLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                 +Y+           PS  S +A DL+ ++   +P  R++    L+H + S    
Sbjct: 228 ------DYE----------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271

Query: 300 PTEPNK 305
               ++
Sbjct: 272 TKSKDE 277

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  177 bits (450), Expect = 3e-52
 Identities = 75/336 (22%), Positives = 126/336 (37%), Gaps = 54/336 (16%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFT--ALREIKLLK 66
           ++ RY   + LGEG +G V + ID K G + VA+K ++    +    +   A  EI++L+
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDR----YCEAARSEIQVLE 66

Query: 67  ELKSP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQM 119
            L +         +++++ F H G++ +VFE +       I+           I+     
Sbjct: 67  HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-----------F 168
             K + F H   + H D+KP N+L       +  +  + R   +               +
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186

Query: 169 THQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK 223
             +     V  R YRAPE++     +    DVW+ GCI  E              + L  
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245

Query: 224 IFAAFGTATPS----------------QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDD- 266
           +    G                      W + +    YV     A  PL+    S   + 
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR---ACKPLKEFMLSQDVEH 302

Query: 267 --ALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
               DL+ KM  YDP  RIT ++AL+H +F      
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  177 bits (451), Expect = 4e-52
 Identities = 78/347 (22%), Positives = 130/347 (37%), Gaps = 52/347 (14%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQT-VAIKKIRLGKQKEGVNFT--ALREIKLLK 66
           + +RY     LGEGT+G V + +D   G++ VA+K IR    K    +   A  EI +LK
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVGK----YREAARLEINVLK 71

Query: 67  ELKSP------HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQM 119
           ++K          + + D F   G++ + FE +  +    ++  N        ++     
Sbjct: 72  KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-----------F 168
               L F H+  + H D+KP N+L  +     L +   +    S               F
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 169 THQ-----VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK 223
            H+     V  R YR PE++     +    DVW+ GCI  E        Q   + + L  
Sbjct: 192 DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

Query: 224 IFAAFGTATPSQW-------------PDLAYLPDYVEYQYVAAP--PLRSLFPSASDD-- 266
           +    G                      L +  +  + +YV     PL+S     S +  
Sbjct: 251 MEKILGP--IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308

Query: 267 -ALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPATK 312
              DL+ +M  +DP  RIT  +AL H +F+            R  ++
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  175 bits (445), Expect = 4e-52
 Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 62/320 (19%)

Query: 4   VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK 63
           + +  +    + + E +G G +G V+K +    G   AIK+ +           ALRE+ 
Sbjct: 3   MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 64  LLKEL-KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIR---NTNIFLSPADIKSYMQ 118
               L +  H++    A+    ++ +  E+     L   I        +   A++K  + 
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL-------------------KLADFGLAR 159
              +GL + H   ++H D+KP+N+ I                         K+ D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 160 IFGSPDRRFTHQVFA--RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD 217
              SP      QV      + A E+L     +    D++A            P  +    
Sbjct: 183 RISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 218 IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTY 277
             ++ +                              P +  +    S +  +LL  M   
Sbjct: 237 WHEIRQG---------------------------RLPRIPQVL---SQEFTELLKVMIHP 266

Query: 278 DPKARITAQQALEHRYFSSA 297
           DP+ R +A   ++H    SA
Sbjct: 267 DPERRPSAMALVKHSVLLSA 286

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  177 bits (451), Expect = 9e-52
 Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 41/291 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS- 70
           D  +  +VLG G  G V +  + +T +  A+K ++     +     A RE++L       
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPK-----ARREVELHWRASQC 114

Query: 71  PHIIELIDAF----PHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           PHI+ ++D +      +  L +V E ++       +    +   +  +    M+   + +
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   + HRD+KP NLL  S      LKL DFG A+   +     T   +  +Y APE
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPE 233

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L G ++Y    D+W+ G I   LL    PF   +  +     +                
Sbjct: 234 VL-GPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMG--------- 282

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +Y++         +   S++   L+  +   +P  R+T  + + H
Sbjct: 283 ------QYEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  174 bits (443), Expect = 3e-51
 Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 43/302 (14%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            ++       +  +G G++G V++  D +TG   A+KK+RL   +         E+    
Sbjct: 53  YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACA 105

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L SP I+ L  A      +++  E +E   L  +I+             Y+   L+GL 
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQALEGLE 164

Query: 126 FCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFAR-----WYRA 179
           + H + +LH D+K +N+L+ S G +  L DFG A          +            + A
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE++ G K   A VD+W++ C+   +LN   P+    +   +                  
Sbjct: 225 PEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW----TQYFRGPLCL------------- 266

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
              +           PP+R + PS +      + +    +P  R +A +       +   
Sbjct: 267 --KIAS-------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317

Query: 299 LP 300
           + 
Sbjct: 318 VG 319

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  172 bits (437), Expect = 5e-51
 Identities = 72/288 (25%), Positives = 133/288 (46%), Gaps = 54/288 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELI 77
            LG+G +G VY A + ++   +A+K +   + +K GV     RE+++   L+ P+I+ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
             F     ++L+ E+     +   ++  + F       +Y+      L++CH K V+HRD
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHSKRVIHRD 134

Query: 137 MKPNNLLIGSHGQLKLADFGLARIF---------GSPDRRFTHQVFARWYRAPELLFGAK 187
           +KP NLL+GS G+LK+ADFG +            G+ D           Y  PE++ G +
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD-----------YLPPEMIEG-R 182

Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            +   VD+W+ G +  E L  + PF + ++  +   +I             +  + PD+V
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV----------EFTF-PDFV 230

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                            ++ A DL+S++  ++P  R   ++ LEH + 
Sbjct: 231 -----------------TEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  174 bits (442), Expect = 8e-51
 Identities = 68/336 (20%), Positives = 123/336 (36%), Gaps = 60/336 (17%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT--ALREIKLLKE 67
           + + +L    +G+GT+G V         +  A+K +R   +K    +T  A  E  +LK+
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKK----YTRSAKIEADILKK 87

Query: 68  LKS-----PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF-LSPADIKSYMQMTL 121
           +++      +I++    F +  ++ L+FE +   L  +I   N       DIK Y    L
Sbjct: 88  IQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHG-------------------------QLKLADFG 156
           K L +  K  + H D+KP N+L+                              +KL DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS 216
            A  F          +  R YRAPE++     +    D+W+ GC+ AEL       +   
Sbjct: 208 CA-TFK--SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263

Query: 217 DIDQLGKIFAAFGTATPS----------------QWPDLAYLPDYVEYQYV-AAPPLRSL 259
            ++ L  + +       +                    LA+  +      +        L
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323

Query: 260 FPSASDDAL-DLLSKMFTYDPKARITAQQALEHRYF 294
           +     +   D L  +   DP  R +  + L+H++ 
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  180 bits (457), Expect = 1e-50
 Identities = 66/311 (21%), Positives = 109/311 (35%), Gaps = 41/311 (13%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLK 66
            +    +  +E LG G +G V + I   TG+ VAIK+ R  ++    N      EI+++K
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR--QELSPKNRERWCLEIQIMK 67

Query: 67  ELKSPHIIELIDAFPHKGNLH------LVFEFMET-DLETVI--RNTNIFLSPADIKSYM 117
           +L  P+++   +       L       L  E+ E  DL   +        L    I++ +
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIF----------GSP 164
                 L + H+  ++HRD+KP N+++    Q    K+ D G A+            G+ 
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187

Query: 165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI 224
                       Y APELL   K+Y   VD W+ G +  E +        +    Q    
Sbjct: 188 Q-----------YLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
                      + DL     +        P    L    +      L  M  +  + R T
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVL----PTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291

Query: 285 AQQALEHRYFS 295
             Q      F 
Sbjct: 292 DPQNPNVGCFQ 302

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  171 bits (436), Expect = 1e-50
 Identities = 75/322 (23%), Positives = 120/322 (37%), Gaps = 77/322 (23%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
            RY++   LG+G +   ++  D  T +  A K   K  L   K         EI + + L
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSL 72

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              H++     F     + +V E          R  ++         L+  + + Y++  
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLEL--------CRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFT 169
           + G  + H+  V+HRD+K  NL +    ++K+ DFGLA              G+P+    
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---- 180

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG 229
                  Y APE+L   K +   VDVW+ GCI   LL  +P  + S   +   +I     
Sbjct: 181 -------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-- 230

Query: 230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQA 288
                            EY            P   +  A  L+ KM   DP AR T  + 
Sbjct: 231 -----------------EYS----------IPKHINPVAASLIQKMLQTDPTARPTINEL 263

Query: 289 LEHRYFSSAPLPTEPNKLPRPA 310
           L   +F+S  +P    +LP   
Sbjct: 264 LNDEFFTSGYIPA---RLPITC 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  172 bits (439), Expect = 1e-50
 Identities = 76/341 (22%), Positives = 124/341 (36%), Gaps = 73/341 (21%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
            RY++   LG+G +   ++  D  T +  A K +      K         EI + + L  
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLK 122
            H++     F     + +V E          R  ++         L+  + + Y++  + 
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLEL--------CRRRSLLELHKRRKALTEPEARYYLRQIVL 152

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQ 171
           G  + H+  V+HRD+K  NL +    ++K+ DFGLA              G+P+      
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------ 206

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA 231
                Y APE+L   K +   VDVW+ GCI   LL  +P  + S   +   +I       
Sbjct: 207 -----YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---- 256

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALE 290
                          EY            P   +  A  L+ KM   DP AR T  + L 
Sbjct: 257 ---------------EYS----------IPKHINPVAASLIQKMLQTDPTARPTINELLN 291

Query: 291 HRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSP 331
             +F+S  +P    +LP        + S       P+   P
Sbjct: 292 DEFFTSGYIPA---RLPITCLTIPPRFSIAPSSLDPSNRKP 329

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  170 bits (432), Expect = 1e-49
 Identities = 75/342 (21%), Positives = 124/342 (36%), Gaps = 61/342 (17%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-P 71
           R   R VL EG +  VY+A D  +G+  A+K++ L  ++E      ++E+  +K+L   P
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNR-AIIQEVCFMKKLSGHP 86

Query: 72  HIIELIDAFPHK-----GNLHLVFEFME----TDLETVI-RNTNIFLSPADIKSYMQMTL 121
           +I++   A                   E      +E +    +   LS   +      T 
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 122 KGLAFCH--KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARW-- 176
           + +   H  K  ++HRD+K  NLL+ + G +KL DFG A      PD  ++ Q  A    
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 177 ---------YRAPEL--LFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKI 224
                    YR PE+  L+     G   D+WA GCI   L  R+ PF  G+       +I
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA-----KLRI 261

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
                                 +Y     PP      +       L+  M   +P+ R++
Sbjct: 262 VNG-------------------KYSI---PP----HDTQYTVFHSLIRAMLQVNPEERLS 295

Query: 285 AQQALEHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGP 326
             + +      +A     P        ++           GP
Sbjct: 296 IAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  167 bits (426), Expect = 3e-49
 Identities = 78/299 (26%), Positives = 127/299 (42%), Gaps = 46/299 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKELKS 70
           D    R VLG+GTYG+VY   D      +AIK+I     +       L  EI L K LK 
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKH 78

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPAD--IKSYMQMTLKGLAFC 127
            +I++ + +F   G + +  E +    L  ++R+    L   +  I  Y +  L+GL + 
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 128 HKKWVLHRDMKPNNLLIGSH-GQLKLADFGLA-RIFGSPDRRFTHQ--VFARWYRAPELL 183
           H   ++HRD+K +N+LI ++ G LK++DFG + R+ G      T    +    Y APE++
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ---YMAPEII 195

Query: 184 FGAKQ-YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQ-LGKIFA-AFGTATPSQWPDL 239
               + YG   D+W+ GC   E+   + PF     ++ +    +F        P      
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF----YELGEPQAAMFKVGMFKVHPE----- 246

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
             +P+                 S S +A   + K F  DP  R  A   L   +   + 
Sbjct: 247 --IPE-----------------SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  167 bits (426), Expect = 4e-49
 Identities = 56/291 (19%), Positives = 105/291 (36%), Gaps = 62/291 (21%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS- 70
           D  +  +VLG G  G V +  + +T +  A+K ++     +     A RE++L       
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPK-----ARREVELHWRASQC 70

Query: 71  PHIIELIDAF----PHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGL 124
           PHI+ ++D +      +  L +V E ++       +    +   +  +    M+   + +
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            + H   + HRD+KP NLL  S      LKL DFG A                      E
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------KE 169

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
                ++Y    D+W+ G I   LL    PF   +  +     +                
Sbjct: 170 TT--GEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMG--------- 217

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +Y++         +   S++   L+  +   +P  R+T  + + H
Sbjct: 218 ------QYEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  166 bits (423), Expect = 8e-49
 Identities = 80/306 (26%), Positives = 135/306 (44%), Gaps = 54/306 (17%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHIIELI 77
            LG+G +G VY A + +    +A+K +   + +KEGV     REI++   L+ P+I+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
           + F  +  ++L+ EF    +L   ++    F       ++M+     L +CH++ V+HRD
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHERKVIHRD 139

Query: 137 MKPNNLLIGSHGQLKLADFGLARIF---------GSPDRRFTHQVFARWYRAPELLFGAK 187
           +KP NLL+G  G+LK+ADFG +            G+ D           Y  PE++ G K
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD-----------YLPPEMIEG-K 187

Query: 188 QYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
            +   VD+W AG +  E L    PF    S  +   +I             DL + P ++
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNV----------DLKF-PPFL 235

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKL 306
                            SD + DL+SK+  Y P  R+  +  +EH +  +      P   
Sbjct: 236 -----------------SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278

Query: 307 PRPATK 312
               +K
Sbjct: 279 QSTQSK 284

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  166 bits (422), Expect = 1e-48
 Identities = 76/323 (23%), Positives = 137/323 (42%), Gaps = 81/323 (25%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL---------- 59
           +Y  ++ +G+G+YGVV  A +       A+K   K +L +Q                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 60  -----------REIKLLKELKSPHIIELID--AFPHKGNLHLVFEFMET-DLETVIRNTN 105
                      +EI +LK+L  P++++L++    P++ +L++VFE +    +  V     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 106 IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF---- 161
             LS    + Y Q  +KG+ + H + ++HRD+KP+NLL+G  G +K+ADFG++  F    
Sbjct: 134 --LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 162 -------GSPDRRFTHQVFARWYRAPELLFGA-KQY-GAGVDVWAAGCI-FAELLNRRPF 211
                  G+P            + APE L    K + G  +DVWA G   +  +  + PF
Sbjct: 192 ALLSNTVGTPA-----------FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 212 LQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLL 271
                 +    KI +                      ++   P      P  ++D  DL+
Sbjct: 241 -MDERIMCLHSKIKSQ-------------------ALEF---PD----QPDIAEDLKDLI 273

Query: 272 SKMFTYDPKARITAQQALEHRYF 294
           ++M   +P++RI   +   H + 
Sbjct: 274 TRMLDKNPESRIVVPEIKLHPWV 296

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  163 bits (414), Expect = 2e-47
 Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 45/294 (15%)

Query: 13  RYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           R+LK    +G G++  VYK +DT+T   VA  +++  K  +        E ++LK L+ P
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85

Query: 72  HIIELIDAF----PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +I+   D++      K  + LV E M +  L+T ++   +      ++S+ +  LKGL F
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV-LRSWCRQILKGLQF 144

Query: 127 CH--KKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRF---THQVFARWYRAP 180
            H     ++HRD+K +N+ I G  G +K+ D GLA +  +   +    T +    +  AP
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-AP 199

Query: 181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           E+    ++Y   VDV+A G    E+          S+     +I+    +       D  
Sbjct: 200 EM--YEEKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFD-- 252

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                                 A  +  +++      +   R + +  L H +F
Sbjct: 253 --------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  163 bits (414), Expect = 2e-47
 Identities = 72/325 (22%), Positives = 128/325 (39%), Gaps = 76/325 (23%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELK 69
           +YL  ++LGEG+YG V + +D++T    A+K   K +L ++         +EI+LL+ L+
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-RRIPNGEANVKKEIQLLRRLR 64

Query: 70  SPHIIELIDAFPH--KGNLHLVFEFMETDLETVIRNTNIF-------LSPADIKSYMQMT 120
             ++I+L+D   +  K  +++V E+    ++       +                Y    
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQ------EMLDSVPEKRFPVCQAHGYFCQL 118

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRR 167
           + GL + H + ++H+D+KP NLL+ + G LK++  G+A                GSP   
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA-- 176

Query: 168 FTHQVFARWYRAPELLFGAKQY-GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIF 225
                    ++ PE+  G   + G  VD+W+AG   +       PF +G +       I 
Sbjct: 177 ---------FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIG 226

Query: 226 AA-FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT 284
              +             +P                         DLL  M  Y+P  R +
Sbjct: 227 KGSY------------AIPGDC-----------------GPPLSDLLKGMLEYEPAKRFS 257

Query: 285 AQQALEHRYFSSAPLPTEPNKLPRP 309
            +Q  +H +F     P E      P
Sbjct: 258 IRQIRQHSWFRKKHPPAEAPVPIPP 282

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  161 bits (411), Expect = 3e-47
 Identities = 68/308 (22%), Positives = 112/308 (36%), Gaps = 74/308 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           + +   + LGEG YG V  A++  T + VA+K     R     E +     +EI + K L
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKML 62

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              ++++           +L  E+             +F        +   D + +    
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--------CSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRR 167
           + G+ + H   + HRD+KP NLL+     LK++DFGLA +F             G+    
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-- 172

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFA 226
                    Y APELL   + +   VDVW+ G +  A L    P+ Q S    +      
Sbjct: 173 ---------YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                               +       P + +        L LL K+   +P ARIT  
Sbjct: 224 K-------------------KTYL---NPWKKI----DSAPLALLHKILVENPSARITIP 257

Query: 287 QALEHRYF 294
              + R++
Sbjct: 258 DIKKDRWY 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  162 bits (412), Expect = 9e-47
 Identities = 61/307 (19%), Positives = 116/307 (37%), Gaps = 68/307 (22%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTAL-RE 61
            + + +Y     LG G +G V+ A+D +  + V +K     K+      E      +  E
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLET---VIRNTNIFLSPADIKSYMQ 118
           I +L  ++  +II+++D F ++G   LV E   + L+    + R+    L         +
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFR 137

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRF 168
             +  + +   K ++HRD+K  N++I     +KL DFG A             G+ +   
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE--- 194

Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA 227
                   Y APE+L G    G  +++W+ G   +  +    PF        +L +   A
Sbjct: 195 --------YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVEA 239

Query: 228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
                        + P  V                 S + + L+S +    P+ R T ++
Sbjct: 240 -----------AIHPPYLV-----------------SKELMSLVSGLLQPVPERRTTLEK 271

Query: 288 ALEHRYF 294
            +   + 
Sbjct: 272 LVTDPWV 278

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  162 bits (411), Expect = 1e-46
 Identities = 72/338 (21%), Positives = 122/338 (36%), Gaps = 77/338 (22%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKEL 68
           + +   + LGEG YG V  A++  T + VA+K     R     E +     +EI + K L
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKML 62

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMT 120
              ++++           +L  E+             +F        +   D + +    
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEY--------CSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-------------GSPDRR 167
           + G+ + H   + HRD+KP NLL+     LK++DFGLA +F             G+    
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP-- 172

Query: 168 FTHQVFARWYRAPELLFGAKQY-GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIF 225
                    Y APELL   +++    VDVW+ G +  A L    P+ Q S    +     
Sbjct: 173 ---------YVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                                +       P + +        L LL K+   +P ARIT 
Sbjct: 223 EK-------------------KTYL---NPWKKI----DSAPLALLHKILVENPSARITI 256

Query: 286 QQALEHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQ 323
               + R++ + PL     +    +   +   S F+  
Sbjct: 257 PDIKKDRWY-NKPLKKGAKRPRVTSGGVSESPSGFSKH 293

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  161 bits (410), Expect = 1e-46
 Identities = 76/312 (24%), Positives = 117/312 (37%), Gaps = 48/312 (15%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL-REIK 63
           + +  +Y    +LG G +G VY  I       VAIK   K R+    E  N T +  E+ 
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98

Query: 64  LLKELKS--PHIIELIDAFPHKGNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYMQM 119
           LLK++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+   
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQ 157

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
            L+ +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y 
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYS 215

Query: 179 APELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
            PE +   + +G    VW+ G + +  +    PF       +   +I             
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-------EHDEEIIRG---------- 258

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
              +    V                 S +   L+       P  R T ++   H +    
Sbjct: 259 -QVFFRQRV-----------------SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

Query: 298 PLPTEPNKLPRP 309
            LP E  ++   
Sbjct: 301 LLPQETAEIHLH 312

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  158 bits (400), Expect = 1e-44
 Identities = 46/340 (13%), Positives = 97/340 (28%), Gaps = 83/340 (24%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE----IKLLKEL 68
             ++  VLG+       +A D +TG++  +      ++        ++E    ++LL+ +
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 69  KSPHIIEL-------IDAFPHKG-----------------NLHLVFEFMETDLETVIR-- 102
           K+    ++        D                       +   ++  M+++L+T     
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 103 ----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
               +T+  L            ++ LA  H   ++H  ++P ++++   G + L  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 159 RIFGSPDRRFTHQVFARWYRAPELL----------FGAKQYGAGVDVWAAGCIFAELL-N 207
              G           +R +  PEL                     D WA G +   +   
Sbjct: 254 VRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 208 RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDA 267
             P     + +     IF            ++                            
Sbjct: 310 DLPI-TKDAALGGSEWIF--------RSCKNI------------------------PQPV 336

Query: 268 LDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
             LL     Y  + R+   QA+E   +           LP
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALP 375

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  156 bits (397), Expect = 1e-44
 Identities = 71/309 (22%), Positives = 127/309 (41%), Gaps = 53/309 (17%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
            Y   + +G+G +  V  A    TG+ VAIK I   +          RE++++K L  P+
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I++L +    +  L+L+ E+    ++   +      +   + +S  +  +  + +CH+K 
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPE 181
           ++HRD+K  NLL+ +   +K+ADFG +  F          G+P            Y APE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP-----------PYAAPE 183

Query: 182 LLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           L  G K  G  VDVW+ G I +  +    PF  G +  +   ++                
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRG-----------KY 231

Query: 241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
            +P Y+                 S D  +LL +    +P  R T +Q ++ R+ ++    
Sbjct: 232 RIPFYM-----------------STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274

Query: 301 TEPNKLPRP 309
            E      P
Sbjct: 275 DELKPFVEP 283

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  156 bits (397), Expect = 1e-44
 Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 63/299 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIK-----KIRLGKQKEGVNFTALREIKLLKE 67
            Y+ RE LGEG++G V  A   KT Q VA+K      ++       V     REI  LK 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----REISYLKL 65

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           L+ PHII+L D      ++ +V E+   +L   I      ++  + + + Q  +  + +C
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYC 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWY 177
           H+  ++HRD+KP NLL+  +  +K+ADFGL+ I           GSP+           Y
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-----------Y 173

Query: 178 RAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-FGTATPSQ 235
            APE++ G    G  VDVW+ G + +  L+ R PF       +   K+ +  +       
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSCVY------- 225

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                 +PD++                 S  A  L+ +M   DP  RIT Q+     +F
Sbjct: 226 -----VMPDFL-----------------SPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  155 bits (393), Expect = 1e-44
 Identities = 82/313 (26%), Positives = 122/313 (38%), Gaps = 71/313 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSP 71
            Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + P
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLKG 123
           HII+L        +  +V E+        +    +F        +   + +   Q  L  
Sbjct: 72  HIIKLYQVISTPTDFFMVMEY--------VSGGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVF 173
           + +CH+  V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+        
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 175

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-FGTA 231
              Y APE++ G    G  VD+W+ G I +A L    PF           KI    F   
Sbjct: 176 ---YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGGVF--- 228

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    Y+P+Y+                 +     LL  M   DP  R T +   EH
Sbjct: 229 ---------YIPEYL-----------------NRSVATLLMHMLQVDPLKRATIKDIREH 262

Query: 292 RYF-SSAPLPTEP 303
            +F    P    P
Sbjct: 263 EWFKQDLPSYLFP 275

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  156 bits (397), Expect = 2e-44
 Identities = 71/348 (20%), Positives = 130/348 (37%), Gaps = 65/348 (18%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL- 59
           +AE+         +     +G G++G VY A D +  + VAIKK+    ++    +  + 
Sbjct: 43  VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +E++ L++L+ P+ I+    +  +    LV E+       ++      L   +I +    
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA---RW 176
            L+GLA+ H   ++HRD+K  N+L+   G +KL DFG A          +   F     W
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANS---FVGTPYW 216

Query: 177 YRAPELLFGAKQ--YGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
             APE++    +  Y   VDVW+ G I   EL  R+P                      P
Sbjct: 217 M-APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP----------------------P 252

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLF------------PSASDDALDLLSKMFTYDPKA 281
                                 + +L+               S+   + +       P+ 
Sbjct: 253 ----------------LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296

Query: 282 RITAQQALEHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVL 329
           R T++  L+HR+      PT    L +       +  +   ++   +L
Sbjct: 297 RPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKIL 344

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  157 bits (399), Expect = 2e-44
 Identities = 67/358 (18%), Positives = 115/358 (32%), Gaps = 43/358 (12%)

Query: 11  ADRYLKREVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
              Y    V+G+G      V  A    TG+ V +++I L      +      E+ + K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             P+I+     F     L +V  FM      DL  +  +    ++   I   +Q  LK L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKAL 141

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG-LARIFGSPDRRFTHQVFAR-------W 176
            + H    +HR +K +++LI   G++ L+       +     R+     F +       W
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 177 YRAPELLF-GAKQYGAGVDVWAAGC--------------------IFAELLNRRPFLQGS 215
             +PE+L    + Y A  D+++ G                     +  +L    P L  +
Sbjct: 202 L-SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 216 SDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMF 275
           S I       +   +   S   D                P      + S      + +  
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTP--RPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 276 TYDPKARITAQQALEHRYFSSA-PLPTE--PNKLPRPATKRASKASDFNPQEGPTVLS 330
             +P AR +A   L H +F       +E  P  L         + S      G   L 
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLV 376

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  154 bits (390), Expect = 6e-44
 Identities = 90/328 (27%), Positives = 150/328 (45%), Gaps = 75/328 (22%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELK 69
            +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q  KE +    + EI +++E K
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI----INEILVMRENK 75

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +P+I+  +D++     L +V E++     TD+   +  T   +    I +  +  L+ L 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETC--MDEGQIAAVCRECLQALE 130

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLF 184
           F H   V+HRD+K +N+L+G  G +KL DFG  A+I     +R T  V   ++ APE++ 
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT 189

Query: 185 GAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             K YG  VD+W+ G I A E++   P                      P          
Sbjct: 190 R-KAYGPKVDIWSLG-IMAIEMIEGEP----------------------P---------- 215

Query: 244 DYVEYQYVAAPPLRSLF-------PS------ASDDALDLLSKMFTYDPKARITAQQALE 290
                 Y+   PLR+L+       P        S    D L++    D + R +A++ L+
Sbjct: 216 ------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269

Query: 291 HRYFSSAPLPTEPNKLPRPATKRASKAS 318
           H++   A    +P     P    A +A+
Sbjct: 270 HQFLKIA----KPLSSLTPLIAAAKEAT 293

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  154 bits (391), Expect = 6e-44
 Identities = 67/316 (21%), Positives = 115/316 (36%), Gaps = 52/316 (16%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTAL-REIK 63
           +     Y    +LG+G +G V+          VAIK   + R+       +      E+ 
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86

Query: 64  LLKELKS----PHIIELIDAFPHKGNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYM 117
           LL ++ +    P +I L+D F  +    LV E      DL   I      L     + + 
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFF 145

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARW 176
              +  +  CH + V+HRD+K  N+LI    G  KL DFG   +    D  +T     R 
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRV 203

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
           Y  PE +   + +     VW+ G + +  +    PF       ++  +I  A        
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF-------ERDQEILEA-------- 248

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
             +L + P +V                 S D   L+ +     P +R + ++ L   +  
Sbjct: 249 --EL-HFPAHV-----------------SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288

Query: 296 S--APLPTEPNKLPRP 309
           +    +P  P+K    
Sbjct: 289 TPAEDVPLNPSKGGPA 304

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  153 bits (389), Expect = 1e-43
 Identities = 71/310 (22%), Positives = 136/310 (43%), Gaps = 67/310 (21%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                   +GEG+ G+V  A +  +G+ VA+K + L KQ+         E+ ++++ +  
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHF 102

Query: 72  HIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +++E+  ++     L ++ EF++    TD+ + +R     L+   I +  +  L+ LA+ 
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYL 157

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H + V+HRD+K +++L+   G++KL+DFG  A+I     +R +  V   ++ APE++   
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISR- 215

Query: 187 KQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
             Y   VD+W+ G I   E+++  P                      P            
Sbjct: 216 SLYATEVDIWSLG-IMVIEMVDGEP----------------------P------------ 240

Query: 246 VEYQYVAAPPLRSLF------------PSA-SDDALDLLSKMFTYDPKARITAQQALEHR 292
               Y +  P++++                 S    D L +M   DP+ R TAQ+ L+H 
Sbjct: 241 ----YFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296

Query: 293 YFSSAPLPTE 302
           +     LP  
Sbjct: 297 FLLQTGLPEC 306

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  152 bits (386), Expect = 9e-43
 Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 25/306 (8%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            D + K   LG G  GVV+K     +G  +A K I L + K  +    +RE+++L E  S
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNS 90

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYM-QMTLKGLAFCH 128
           P+I+    AF   G + +  E M+   L+ V++       P  I   +    +KGL +  
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLR 148

Query: 129 KKW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           +K  ++HRD+KP+N+L+ S G++KL DFG++          +  V  R Y +PE L G  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SF-VGTRSYMSPERLQG-T 205

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            Y    D+W+ G    E+   R  +      +                 P        + 
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 248 YQYVAAPPLRSLF-----------PSA-----SDDALDLLSKMFTYDPKARITAQQALEH 291
              + + P  ++F           P       S +  D ++K    +P  R   +Q + H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325

Query: 292 RYFSSA 297
            +   +
Sbjct: 326 AFIKRS 331

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  153 bits (388), Expect = 1e-42
 Identities = 52/361 (14%), Positives = 102/361 (28%), Gaps = 79/361 (21%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALRE----IKLLKEL 68
             ++  VLG+       +A D +TG++  +      ++        ++E    ++LL+ +
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 69  KSP-------HIIELIDAFPHKG-----------------NLHLVFEFMETDLETVIR-- 102
           K+          I   D                       +   ++  M+++L+T     
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 103 ----NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA 158
               +T+  L            ++ LA  H   ++H  ++P ++++   G + L  F   
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 159 RIFGSPDRRFTHQVF-ARWYRAPELLFGAKQ----YGAGVDVWAAGCIFAELL-NRRPFL 212
              G+       + F      A  +L   +          D W  G     +     P  
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN- 317

Query: 213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLS 272
              + +     IF                +P  V                       LL 
Sbjct: 318 TDDAALGGSEWIF-----------RSCKNIPQPVR---------------------ALLE 345

Query: 273 KMFTYDPKARITAQQALEHRYFS------SAPLPTEPNKLPRPATKRASKASDFNPQEGP 326
               Y  + R+   QA+E   +       SA LP             A  +    P E  
Sbjct: 346 GFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAG 405

Query: 327 T 327
            
Sbjct: 406 A 406

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  150 bits (381), Expect = 2e-42
 Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 37/314 (11%)

Query: 1   MAEVDLSKK---VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT 57
           M+E   +       D Y  +EV+G G   VV  A      + VAIK+I L K +  ++  
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-E 59

Query: 58  ALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIF----LS 109
            L+EI+ + +   P+I+    +F  K  L LV + +      D+   I          L 
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119

Query: 110 PADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPD--R 166
            + I + ++  L+GL + HK   +HRD+K  N+L+G  G +++ADFG+ A +    D  R
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 167 RFTHQVFA---RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK 223
               + F     W  APE++   + Y    D+W+ G    EL               +  
Sbjct: 180 NKVRKTFVGTPCWM-APEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKV 235

Query: 224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI 283
           +        PS    +       +Y                     ++S     DP+ R 
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKY---------------GKSFRKMISLCLQKDPEKRP 280

Query: 284 TAQQALEHRYFSSA 297
           TA + L H++F  A
Sbjct: 281 TAAELLRHKFFQKA 294

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  150 bits (380), Expect = 2e-42
 Identities = 78/324 (24%), Positives = 129/324 (39%), Gaps = 74/324 (22%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
              V       + +     LG+G +G VYKA + +TG   A K I    ++E  ++  + 
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IV 65

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSY 116
           EI++L     P+I++L+ A+ H G L ++ EF        +   +   +  L+   I+  
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVV 122

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFA- 174
            +  L+ L F H K ++HRD+K  N+L+   G ++LADFG+ A+   +  +R +   F  
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIG 179

Query: 175 --RWYRAPELLFGA----KQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAA 227
              W  APE++         Y    D+W+ G I   E+    P                 
Sbjct: 180 TPYWM-APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP----------------- 220

Query: 228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF------------PSA-SDDALDLLSKM 274
                P                +    P+R L             PS  S +  D L   
Sbjct: 221 -----P----------------HHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIA 259

Query: 275 FTYDPKARITAQQALEHRYFSSAP 298
              +P+ R +A Q LEH + SS  
Sbjct: 260 LDKNPETRPSAAQLLEHPFVSSIT 283

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  150 bits (382), Expect = 5e-42
 Identities = 70/306 (22%), Positives = 117/306 (38%), Gaps = 70/306 (22%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQKEGVNFTALREIKLLKELKS 70
           DRY   + +G G +GV     D  T + VA+K I R     E V     REI   + L+ 
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRH 75

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLK 122
           P+I+   +      +L ++ E+             ++         S  + + + Q  L 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEY--------ASGGELYERICNAGRFSEDEARFFFQQLLS 127

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIF----------GSPDRRFTH 170
           G+++CH   + HRD+K  N L+      +LK+ DFG ++            G+P      
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA----- 182

Query: 171 QVFARWYRAPELLFGAKQY-GAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAAF 228
                 Y APE+L   ++Y G   DVW+ G   +  L+   PF +   +     K     
Sbjct: 183 ------YIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRI 234

Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
            +      PD   +                     S +   L+S++F  DP  RI+  + 
Sbjct: 235 LSVKY-SIPDDIRI---------------------SPECCHLISRIFVADPATRISIPEI 272

Query: 289 LEHRYF 294
             H +F
Sbjct: 273 KTHSWF 278

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  153 bits (388), Expect = 5e-42
 Identities = 82/303 (27%), Positives = 122/303 (40%), Gaps = 70/303 (23%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSP 71
            Y+  + LG GT+G V       TG  VA+K +   K +   V     REI+ LK  + P
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIF--------LSPADIKSYMQMTLKG 123
           HII+L        ++ +V E+        +    +F        L   + +   Q  L G
Sbjct: 77  HIIKLYQVISTPSDIFMVMEY--------VSGGELFDYICKNGRLDEKESRRLFQQILSG 128

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVF 173
           + +CH+  V+HRD+KP N+L+ +H   K+ADFGL+ +           GSP+        
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 180

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSDIDQLGKIFAA-FGTA 231
              Y APE++ G    G  VD+W++G I +A L    PF           KI    F   
Sbjct: 181 ---YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGIF--- 233

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                    Y P Y+                 +   + LL  M   DP  R T +   EH
Sbjct: 234 ---------YTPQYL-----------------NPSVISLLKHMLQVDPMKRATIKDIREH 267

Query: 292 RYF 294
            +F
Sbjct: 268 EWF 270

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  149 bits (378), Expect = 5e-42
 Identities = 87/317 (27%), Positives = 148/317 (46%), Gaps = 67/317 (21%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALR 60
           + E  L+K+  + +   E LGEG+YG VYKAI  +TGQ VAIK++ +    + +    ++
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IK 73

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSY 116
           EI ++++  SPH+++   ++    +L +V E+      +D+   IR  N  L+  +I + 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATI 130

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFAR 175
           +Q TLKGL + H    +HRD+K  N+L+ + G  KLADFG+  ++  +  +R T  +   
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTP 189

Query: 176 WYRAPELLFGAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPS 234
           ++ APE++     Y    D+W+ G I A E+   +P                      P 
Sbjct: 190 FWMAPEVIQE-IGYNCVADIWSLG-ITAIEMAEGKP----------------------P- 224

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLF------------PSA-SDDALDLLSKMFTYDPKA 281
                          Y    P+R++F            P   SD+  D + +     P+ 
Sbjct: 225 ---------------YADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQ 269

Query: 282 RITAQQALEHRYFSSAP 298
           R TA Q L+H +  SA 
Sbjct: 270 RATATQLLQHPFVRSAK 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  147 bits (374), Expect = 2e-41
 Identities = 76/301 (25%), Positives = 136/301 (45%), Gaps = 48/301 (15%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            + + K E +G+G++G V+K ID +T + VAIK I L + ++ +     +EI +L +  S
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDS 79

Query: 71  PHIIELIDAFPHKGNLHLVFEFME----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           P++ +   ++     L ++ E++      DL   +      L    I + ++  LKGL +
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGP--LDETQIATILREILKGLDY 134

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFA---RWYRAPEL 182
            H +  +HRD+K  N+L+  HG++KLADFG+  ++  +  +R T   F     W  APE+
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWM-APEV 190

Query: 183 LFGAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +     Y +  D+W+ G I A EL    P     S++  +  +F       P   P    
Sbjct: 191 IKQ-SAYDSKADIWSLG-ITAIELARGEPPH---SELHPMKVLF-----LIPKNNP---- 236

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
                       P L   +   S    + +      +P  R TA++ L+H++       T
Sbjct: 237 ------------PTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281

Query: 302 E 302
            
Sbjct: 282 S 282

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  140 bits (354), Expect = 1e-38
 Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 41/298 (13%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           AD       LG G YGVV K     +GQ +A+K+IR            L ++   ++ + 
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVD 64

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLS--PADIKSYM-QMTLKGLAF 126
            P  +    A   +G++ +  E M+T L+   +         P DI   +    +K L  
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 127 CHKKW-VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA--RWYRAPELL 183
            H K  V+HRD+KP+N+LI + GQ+K+ DFG++        +      A  + Y APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERI 181

Query: 184 FGAKQ---YGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
                   Y    D+W+ G    EL + R P+    +   QL ++               
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--------------- 226

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
                      V  P  +      S + +D  S+    + K R T  + ++H +F+  
Sbjct: 227 -----------VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (351), Expect = 6e-38
 Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 37/298 (12%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
           A+       +G G YG V K +   +GQ +A+K+IR     E      L ++  +++   
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSD 79

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLS---PADIKSYM-QMTLKGLA 125
            P+I++   A   +G+  +  E M T  +   +     L    P +I   +   T+K L 
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 126 FCHKKW-VLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELL 183
              +   ++HRD+KP+N+L+   G +KL DFG+  ++  S  +        R Y APE +
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERI 197

Query: 184 FGAKQ---YGAGVDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
             +     Y    DVW+ G    EL   R P+ + +S  DQL ++            P  
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--------VKGDPPQ 249

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
             L +  E ++             S   ++ ++   T D   R   ++ L+H +    
Sbjct: 250 --LSNSEEREF-------------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  137 bits (348), Expect = 1e-37
 Identities = 69/295 (23%), Positives = 115/295 (38%), Gaps = 36/295 (12%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELK 69
            +       +G GT G V+K    KTG  +A+K++R    KE      L ++  +LK   
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHD 82

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH- 128
            P+I++    F    ++ +  E M T  E + +     +    +       +K L +   
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
           K  V+HRD+KP+N+L+   GQ+KL DFG+  R+     +          Y APE +    
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPD 200

Query: 188 QYGAG----VDVWAAGCIFAEL-LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
                     DVW+ G    EL   + P+    +D + L K+          + P L  L
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--------LQEEPPL--L 250

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
           P ++ +               S D    +    T D + R    + LEH +    
Sbjct: 251 PGHMGF---------------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  139 bits (351), Expect = 2e-37
 Identities = 80/369 (21%), Positives = 133/369 (36%), Gaps = 90/369 (24%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
             RY     LG G +  V+ + D +  + VA+K   + K  E    TAL EI+LLK +++
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRN 92

Query: 71  --------PHIIELIDAFPHKGN--LH--LVFEFMETDLETVI-RNTNIFLSPADIKSYM 117
                     +++L+D F   G    H  +VFE +   L   I ++    L    +K  +
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152

Query: 118 QMTLKGLAFCHKKW-VLHRDMKPNNLLIG------------------------------- 145
           Q  L+GL + H K  ++H D+KP N+L+                                
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 146 ------------------SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
                                ++K+AD G A       + FT  +  R YR+ E+L G+ 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQTRQYRSLEVLIGSG 269

Query: 188 QYGAGVDVWAAGCIFAELLNRRPFLQG------SSDIDQLGKIFAAFGTATPSQWPDLAY 241
            Y    D+W+  C+  EL       +       + D D +  I    G           Y
Sbjct: 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328

Query: 242 LPDYV----EYQYVAAPPLRSLFPSA----------SDDALDLLSKMFTYDPKARITAQQ 287
             ++     + +++       LF             +    D L  M    P+ R TA +
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388

Query: 288 ALEHRYFSS 296
            L H + +S
Sbjct: 389 CLRHPWLNS 397

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  135 bits (342), Expect = 1e-36
 Identities = 89/352 (25%), Positives = 133/352 (37%), Gaps = 63/352 (17%)

Query: 1   MAEVDLSKKV--ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA 58
           + E+DLS     A  +   E++G GTYG VYK    KTGQ  AIK + +   +E      
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EI 67

Query: 59  LREIKLLKEL-KSPHIIELIDAF------PHKGNLHLVFEFME----TDLETVIRNTNIF 107
            +EI +LK+     +I     AF           L LV EF      TDL    +     
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-- 125

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL-ARIFGSPDR 166
           L    I    +  L+GL+  H+  V+HRD+K  N+L+  + ++KL DFG+ A++  +  R
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 167 RFTHQVFA---RWYRAPELL----FGAKQYGAGVDVWAAGCIFA-ELLNRRPFLQGSSDI 218
           R T   F     W  APE++         Y    D+W+ G I A E+    P L    D+
Sbjct: 186 RNT---FIGTPYWM-APEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL---CDM 237

Query: 219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYD 278
             +  +F       P                    P L+S     S      +      +
Sbjct: 238 HPMRALF-----LIPRNPA----------------PRLKS--KKWSKKFQSFIESCLVKN 274

Query: 279 PKARITAQQALEHRYFSSAPLPTEPNKL-----PRPATKRASKASDFNPQEG 325
              R   +Q ++H +    P   +          R   KR  K        G
Sbjct: 275 HSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDETEYEYSG 326

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  132 bits (333), Expect = 3e-35
 Identities = 53/316 (16%), Positives = 95/316 (30%), Gaps = 55/316 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
                  +LGEG +  VY+A      D K  Q   +K  +     E   +   + ++ LK
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLK 122

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVI----RNTNIFLSPADIKSYMQMTL 121
                  ++   A   +    LV E      L   I          +    + S+    L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGS-----------HGQLKLADFGLARIFGS--PDRRF 168
             +   H   ++H D+KP+N ++G+              L L D G +           F
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF 228
           T +     ++  E+L   K +   +D +        +L                     F
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCML---------------------F 280

Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF-------PSASDDALDLLSKMFTYDPKA 281
           GT    +       P+ +  +          F             +LDLL +      + 
Sbjct: 281 GTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

Query: 282 RITAQ-QALEHRYFSS 296
             T + +AL +R    
Sbjct: 341 HYTNKIRALRNRLIVL 356

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  130 bits (330), Expect = 3e-35
 Identities = 50/212 (23%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EVLG+G +G   K    +TG+ + +K++    ++    F  L+E+K+++ L+ P++++ I
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRCLEHPNVLKFI 73

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKWVL 133
                   L+ + E+++   L  +I++ +     +     +        G+A+ H   ++
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR---VSFAKDIASGMAYLHSMNII 130

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARI---------------FGSPDRRFTHQVFARWYR 178
           HRD+  +N L+  +  + +ADFGLAR+                    +R+T      W  
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM- 189

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRP 210
           APE++ G + Y   VDV++ G +  E++ R  
Sbjct: 190 APEMING-RSYDEKVDVFSFGIVLCEIIGRVN 220

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  130 bits (327), Expect = 2e-34
 Identities = 44/251 (17%), Positives = 85/251 (33%), Gaps = 45/251 (17%)

Query: 61  EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVI--RNTNIFLSPADIKSYM 117
           +I+ +    + + +  +     K  L++  +     +L+  +  R +             
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------ 165
               + + F H K ++HRD+KP+N+       +K+ DFGL       +            
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
              T QV  + Y +PE + G   Y   VD+++ G I  ELL    F      +  +  + 
Sbjct: 231 ATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV- 286

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                                  ++   P    LF         ++  M +  P  R  A
Sbjct: 287 --------------------RNLKF---PL---LFTQKYPQEHMMVQDMLSPSPTERPEA 320

Query: 286 QQALEHRYFSS 296
              +E+  F +
Sbjct: 321 TDIIENAIFEN 331

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 27/139 (19%), Positives = 54/139 (38%), Gaps = 2/139 (1%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           + +    +   + +G G +GVV++A +       AIK+IRL   +E      +RE+K L 
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKVMREVKALA 59

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMT-LKGLA 125
           +L+ P I+   +A+          E  E  L+    +  +          +++  +   +
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 126 FCHKKWVLHRDMKPNNLLI 144
             +    L        L I
Sbjct: 120 TKNTVGQLQPSSPKVYLYI 138

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  124 bits (313), Expect = 7e-33
 Identities = 47/220 (21%), Positives = 89/220 (40%), Gaps = 42/220 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-----REIKLLKELKSPH 72
           + +G+G +G+V+K    K    VAIK + LG  +             RE+ ++  L  P+
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH 128
           I++L           +V EF+   DL   + +    +  +     +++ L    G+ +  
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK---LRLMLDIALGIEYMQ 139

Query: 129 --KKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARIF--------GSPDRRFTHQVF 173
                ++HRD++  N+ + S  +      K+ADFGL++          G+          
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNF--------- 190

Query: 174 ARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELL-NRRPF 211
            +W  APE +    + Y    D ++   I   +L    PF
Sbjct: 191 -QW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  123 bits (311), Expect = 2e-32
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EV+G G +GVV KA      + VAIK+I    +++   F  + E++ L  +  P+I++L 
Sbjct: 14  EVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK--AF--IVELRQLSRVNHPNIVKLY 67

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHK---K 130
            A  +   + LV E+ E   L  V+      L        M   L   +G+A+ H    K
Sbjct: 68  GACLN--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 131 WVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGSPDRRFTHQVF-ARWYRAPELLFGAKQ 188
            ++HRD+KP NLL+ + G  LK+ DFG A    +     T+    A W  APE+  G   
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAW-MAPEVFEG-SN 179

Query: 189 YGAGVDVWAAGCIFAELLNRR-PF 211
           Y    DV++ G I  E++ RR PF
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF 203

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  123 bits (310), Expect = 2e-32
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 13/202 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G G++G V++A     G  VA+K +             LRE+ ++K L+ P+I+  +
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKK--W 131
            A     NL +V E++    L  ++  +       D +  + M     KG+ + H +   
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPP 159

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV-FARWYRAPELLFGAKQYG 190
           ++HR++K  NLL+     +K+ DFGL+R+  S             W  APE+L   +   
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW-MAPEVLRD-EPSN 217

Query: 191 AGVDVWAAGCIFAELLNRR-PF 211
              DV++ G I  EL   + P+
Sbjct: 218 EKSDVYSFGVILWELATLQQPW 239

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  121 bits (305), Expect = 8e-32
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 14/218 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G G++G VYK    K    VA+K + +             E+ +L++ +  +I+  +
Sbjct: 30  QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                   L +V ++ E   L   +  +        +    + T +G+ + H K ++HRD
Sbjct: 87  GYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR--APELLFG--AKQYGAG 192
           +K NN+ +     +K+ DFGLA            +  +      APE++    +  Y   
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 193 VDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFG 229
            DV+A G +  EL+  + P+    S+I+   +I    G
Sbjct: 206 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIEMVG 239

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 1e-31
 Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 55/305 (18%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G YG V+       G+ VA+K     ++     +    EI     ++  +I+  I
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGFI 97

Query: 78  DA----FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH- 128
            A          L+L+ ++ E   L   +++T +     D KS +++      GL   H 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL-----DAKSMLKLAYSSVSGLCHLHT 152

Query: 129 -------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWY 177
                  K  + HRD+K  N+L+  +G   +AD GLA  F       D     +V  + Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 178 RAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
             PE+L  +      Q     D+++ G I  E+  RR    G  +  QL      +    
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSGGIVEEYQL-----PYHDLV 266

Query: 233 PSQWPDLAYLPDYVEYQYVAA-----PPLRSLFPSASDDAL--DLLSKMFTYDPKARITA 285
           PS        P Y + + +       P   + + S         L+++ + ++P +R+TA
Sbjct: 267 PSD-------PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

Query: 286 QQALE 290
            +  +
Sbjct: 320 LRVKK 324

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  122 bits (308), Expect = 2e-31
 Identities = 73/364 (20%), Positives = 142/364 (39%), Gaps = 64/364 (17%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKSPHIIEL 76
            +G+G++G V       T +  A+K +   K  ++  V     +E+++++ L+ P ++ L
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-FKELQIMQGLEHPFLVNL 80

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVLH 134
             +F  + ++ +V + +   DL   ++    F     +K ++ ++ +  L +   + ++H
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF-KEETVKLFICELVM-ALDYLQNQRIIH 138

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF----------GSPDRRFTHQVFARWYRAPELLF 184
           RDMKP+N+L+  HG + + DF +A +           G+             Y APE+  
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP-----------YMAPEMFS 187

Query: 185 --GAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                 Y   VD W+ G    ELL  RRP+   SS      +I   F T   +       
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--TSSKEIVHTFETTVVT------- 238

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-TAQQALEHRYFSSAPLP 300
            P                    S + + LL K+   +P  R           Y +     
Sbjct: 239 YPSAW-----------------SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281

Query: 301 TEPNKLPRPATKRASKASDFNPQ---EGPTVLSPP---RKTRRVMPDREGFEGNANRTDK 354
               K   P         + +P    E   + S P   +K R    +++  + ++++T  
Sbjct: 282 AVFQKRLIPGFIPNKGRLNCDPTFELEEMILESKPLHKKKKRLAKKEKDMRKCDSSQTCL 341

Query: 355 IEEH 358
           ++EH
Sbjct: 342 LQEH 345

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  119 bits (300), Expect = 3e-31
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKELKSPHIIE 75
           E++G G +G VY+A     G  VA+K  R    ++         +E KL   LK P+II 
Sbjct: 13  EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKK- 130
           L      + NL LV EF     L  V+    I          +   +   +G+ + H + 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-----PPDILVNWAVQIARGMNYLHDEA 125

Query: 131 --WVLHRDMKPNNLLIG--------SHGQLKLADFGLARIFGSPDRRFTHQVF-ARWYRA 179
              ++HRD+K +N+LI         S+  LK+ DFGLAR +    +          W  A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAW-MA 182

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRR-PF 211
           PE++     +  G DVW+ G +  ELL    PF
Sbjct: 183 PEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  120 bits (302), Expect = 4e-31
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++G+G +G VY     +    VAI+ I + +  E       RE+   ++ +  +++  +
Sbjct: 39  ELIGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
            A     +L ++    +   L +V+R+  I L     +   Q  +KG+ + H K +LH+D
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFG---SPDRRFTHQVFARWYR--APELL-------- 183
           +K  N+    +G++ + DFGL  I G   +  R    ++   W    APE++        
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRR-PF 211
                +    DV+A G I+ EL  R  PF
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPF 243

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (298), Expect = 5e-31
 Identities = 40/207 (19%), Positives = 79/207 (38%), Gaps = 24/207 (11%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             L E   G ++K      G  + +K +++       +     E   L+    P+++ ++
Sbjct: 16  TKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 78  DAF--PHKGNLHLVFEFMET-DLETVIR-NTNIFLSPADIKSYMQMTL---KGLAFCH-- 128
            A   P   +  L+  +M    L  V+   TN  +  +     ++  L   +G+AF H  
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA---VKFALDMARGMAFLHTL 130

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
           +  +    +   +++I      +++   +   F SP R +       W  APE L   K 
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PAWV-APEALQK-KP 184

Query: 189 YGAG---VDVWAAGCIFAELLNRR-PF 211
                   D+W+   +  EL+ R  PF
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPF 211

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  118 bits (299), Expect = 7e-31
 Identities = 72/307 (23%), Positives = 122/307 (39%), Gaps = 59/307 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G+G YG V++   +  G+ VA+K      +K    +    E+     L+  +I+  I
Sbjct: 14  ECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGFI 68

Query: 78  DA----FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH- 128
            +          L L+  + E   L   ++ T +     D  S +++ L    GLA  H 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL-----DTVSCLRIVLSIASGLAHLHI 123

Query: 129 -------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWY 177
                  K  + HRD+K  N+L+  +GQ  +AD GLA +        D     +V  + Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 178 RAPELL-----FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
            APE+L              VD+WA G +  E+  RR    G  +  +       F    
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA-RRMVSNGIVEDYKP-----PFYDVV 237

Query: 233 PSQWPDLAYLPDYVEYQYVAA-----PPLRSLFPSASDDALDLLSKMFT----YDPKARI 283
           P+        P + + + V       P + + +   SD  L  L+K+       +P AR+
Sbjct: 238 PND-------PSFEDMRKVVCVDQQRPNIPNRWF--SDPTLTSLAKLMKECWYQNPSARL 288

Query: 284 TAQQALE 290
           TA +  +
Sbjct: 289 TALRIKK 295

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (295), Expect = 6e-30
 Identities = 66/308 (21%), Positives = 119/308 (38%), Gaps = 61/308 (19%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E +G+G +G V++      G+ VA+K     +++    +    EI     L+  +I+  I
Sbjct: 48  ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFI 102

Query: 78  DAFPHKGNLH----LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHK 129
            A            LV ++ E   L   +    +      ++  +++ L    GLA  H 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHLHM 157

Query: 130 KW--------VLHRDMKPNNLLIGSHGQLKLADFGLARIF----GSPDRRFTHQVFARWY 177
           +         + HRD+K  N+L+  +G   +AD GLA        + D    H+V  + Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 178 RAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT 232
            APE+L  +      +     D++A G +F E+  R                 +  G   
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR----------------CSIGGIHE 261

Query: 233 PSQWPDLAYLPDYVE----YQYVAAPPLRSLFPSA--SDDALDLLSKMFT----YDPKAR 282
             Q P    +P         + V    LR   P+   S +AL +++K+       +  AR
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

Query: 283 ITAQQALE 290
           +TA +  +
Sbjct: 322 LTALRIKK 329

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  116 bits (292), Expect = 1e-29
 Identities = 75/331 (22%), Positives = 121/331 (36%), Gaps = 60/331 (18%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E++G G YG VYK   +   + VA+K      ++    F   + I  +  ++  +I   I
Sbjct: 19  ELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFI 73

Query: 78  DA-----FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH 128
                     +    LV E+     L   +          D  S  ++     +GLA+ H
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLH 128

Query: 129 ---------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--------GSPDRRFTHQ 171
                    K  + HRD+   N+L+ + G   ++DFGL+           G  D     +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 172 VFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
           V    Y APE+L GA      +     VD++A G I+ E+  R   L     + +     
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ--- 245

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT-------YD 278
            AF T   +  P    +   V  +       R  FP A  +    +  +          D
Sbjct: 246 MAFQTEVGNH-PTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQD 299

Query: 279 PKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
            +AR+TAQ A E    +   +  E NK   P
Sbjct: 300 AEARLTAQXAEE--RMAELMMIWERNKSVSP 328

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  114 bits (288), Expect = 3e-29
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           EV   G +G V+KA      + VA+K   +  ++    +    E+  L  +K  +I++ I
Sbjct: 30  EVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFI 84

Query: 78  DAFPHKGNLH----LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH- 128
            A     ++     L+  F E   L   ++   +            +     +GLA+ H 
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV-----SWNELCHIAETMARGLAYLHE 139

Query: 129 ---------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWY 177
                    K  + HRD+K  N+L+ ++    +ADFGLA  F  G        QV  R Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199

Query: 178 RAPELLFGA----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP 233
            APE+L GA    +     +D++A G +  EL +R     G  D   L      F     
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML-----PFEEEIG 254

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFT----YDPKARITAQQAL 289
              P L  + + V ++    P LR  +       + +L +       +D +AR++A    
Sbjct: 255 QH-PSLEDMQEVVVHK-KKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVG 310

Query: 290 E 290
           E
Sbjct: 311 E 311

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  113 bits (286), Expect = 6e-29
 Identities = 68/294 (23%), Positives = 115/294 (39%), Gaps = 52/294 (17%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
           +LGEG++  V  A +  T +  AIK   K  + K+ + V +   RE  ++  L  P  ++
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYV-TRERDVMSRLDHPFFVK 94

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVL 133
           L   F     L+    + +  +L   IR    F      + Y  ++    L + H K ++
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVS-ALEYLHGKGII 152

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF---ARWYRAPELLFGAKQYG 190
           HRD+KP N+L+     +++ DFG A++     ++     F   A+ Y +PELL   K   
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ-YVSPELLTE-KSAC 210

Query: 191 AGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              D+WA GCI  +L+    PF   + +   +                          +Q
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFR--AGNEYLI--------------------------FQ 242

Query: 250 YVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARIT------AQQALEHRYFSS 296
            +        FP      A DL+ K+   D   R+             H +F S
Sbjct: 243 KIIKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (283), Expect = 1e-28
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 10/210 (4%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
           K + +RY   + LG G    VY A DT     VAIK I +  +++         RE+   
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNS 65

Query: 66  KELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
            +L   +I+ +ID        +LV E++E   L   I +    LS     ++    L G+
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGI 124

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPEL 182
              H   ++HRD+KP N+LI S+  LK+ DFG+A+         T+ V    + Y +PE 
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ-YFSPEQ 183

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPF 211
             G +      D+++ G +  E+L    PF
Sbjct: 184 AKG-EATDECTDIYSIGIVLYEMLVGEPPF 212

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (284), Expect = 1e-28
 Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 8/208 (3%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLK 66
                Y  R ++G G  G VY+A DT   + VA+K +      +   F     RE +   
Sbjct: 31  TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAG 89

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            L+ PH++ + D     G L++    +   DL  ++R     L+P    + ++     L 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALD 148

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-YRAPELLF 184
             H     HRD+KP N+L+ +     L DFG+A                   Y APE   
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208

Query: 185 GAKQYGAGVDVWAAGCIFAELL-NRRPF 211
                    D++A  C+  E L    P+
Sbjct: 209 E-SHATYRADIYALTCVLYECLTGSPPY 235

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (284), Expect = 3e-27
 Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 64/301 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKS---PHI 73
           ++G G +G VY      TG+  A+K +     K K+G     L E  +L  + +   P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 254

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           + +  AF     L  + + M   DL   +    +F S AD++ Y    + GL   H ++V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMHNRFV 313

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF---------GSPDRRFTHQVFARWYRAPELL 183
           ++RD+KP N+L+  HG ++++D GLA  F         G+             Y APE+L
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG-----------YMAPEVL 362

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQ-GSSDIDQLGKIFAAFGTATPSQWPDLAY 241
                Y +  D ++ GC+  +LL    PF Q  + D  ++                    
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------------- 402

Query: 242 LPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRYFS 295
                  +      +    P + S +   LL  +   D   R+      AQ+  E  +F 
Sbjct: 403 ------DRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 296 S 296
           S
Sbjct: 455 S 455

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  111 bits (280), Expect = 7e-27
 Identities = 88/404 (21%), Positives = 149/404 (36%), Gaps = 75/404 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG+G +G V       TG+  A KK+     K+++G     L E ++L+++ S  ++ L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSL 249

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
             A+  K  L LV   M   DL+  I +        A    Y      GL   H++ +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRF--THQVFARWYRAPELLFGAKQYG 190
           RD+KP N+L+  HG ++++D GLA     G   +    T       Y APE++   ++Y 
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG-----YMAPEVVKN-ERYT 363

Query: 191 AGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              D WA GC+  E++  + PF Q      +  ++                   +     
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPEE-------YSERF--- 412

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS-------A 297
                         S  A  L S++   DP  R+     +A++  EH  F         A
Sbjct: 413 --------------SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458

Query: 298 PLPTEPNKLPRPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG-------N 348
            +   P K P P         D           L P         D++ ++         
Sbjct: 459 GMLEPPFK-PDPQAIYCKDVLDIEQFSTVKGVELEP--------TDQDFYQKFATGSVPI 509

Query: 349 ANRTDKIEEHAGETKNADGEIAGRNEQVPTSVDFSIFAARPPSR 392
             + + +E    +  N  G     +  VP  +D+      PP +
Sbjct: 510 PWQNEMVETECFQELNVFGL----DGSVPPDLDWKGQPPAPPKK 549

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (268), Expect = 2e-26
 Identities = 81/351 (23%), Positives = 131/351 (37%), Gaps = 66/351 (18%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLL 65
             ++DRY   E+LG G    V+ A D +  + VA+K +R    ++  +F     RE +  
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNA 66

Query: 66  KELKSPHIIELID---AFPHKGNLH-LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMT 120
             L  P I+ + D   A    G L  +V E+++   L  ++      ++P      +   
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADA 125

Query: 121 LKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH--------QV 172
            + L F H+  ++HRD+KP N++I +   +K+ DFG+AR         T         Q 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ- 184

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA 231
               Y +PE   G     A  DV++ GC+  E+L    PF  G S               
Sbjct: 185 ----YLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDS--------------- 223

Query: 232 TPSQWPDLAYLPDYVEYQYV--AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL 289
                      P  V YQ+V     P  +     S D   ++ K    +P          
Sbjct: 224 -----------PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNP---------- 262

Query: 290 EHRYFSSAPLPTEPNKLPRPATKRASKASDFNPQEGPTVLSPPRKTRRVMP 340
           E+RY ++A +  +   L R       +A         T L          P
Sbjct: 263 ENRYQTAAEMRAD---LVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLSGP 310

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score =  107 bits (268), Expect = 2e-26
 Identities = 60/341 (17%), Positives = 91/341 (26%), Gaps = 84/341 (24%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN------FTALREIKLL 65
           ++  + E +GEG +G V++ I   T   VAIK I +                 L EI + 
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 66  KEL---------KSPHIIELIDAFPHKG------------------------------NL 86
           KEL         ++   I L      +G                               L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 87  HLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-VLHRDMKPNNLL 143
            +V EF     DLE +        S A  KS +      LA         HRD+   N+L
Sbjct: 138 FIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 144 IGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFA 203
           +      KL      +    P      QV    Y    L                  +F 
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPS--CGLQVSIIDYTLSRLE------------RDGIVVFC 240

Query: 204 ELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD---------LAYLPDY-VEYQYVAA 253
           ++        G  D D    I+        ++W +         L YL D  ++      
Sbjct: 241 DVSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT 298

Query: 254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                          +    M  +      +A   L     
Sbjct: 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (277), Expect = 2e-26
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 36/223 (16%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           VA +Y  +  +  G  G +Y A+D    G+ V +K +      E     A+ E + L E+
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA-MAMAERQFLAEV 136

Query: 69  KSPHIIELIDAFPHKGN-----LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLK 122
             P I+++ +   H         ++V E++    L+         L  A+  +Y+   L 
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILP 193

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR-------IFGSPDRRFTHQVFAR 175
            L++ H   +++ D+KP N+++ +  QLKL D G          ++G+P           
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLYGTPG---------- 242

Query: 176 WYRAPELLFGAKQYGAGV--DVWAAGCIFAELLNRRPFLQGSS 216
            ++APE++      G  V  D++  G   A L    P   G  
Sbjct: 243 -FQAPEIVRT----GPTVATDIYTVGRTLAALTLDLPTRNGRY 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  108 bits (271), Expect = 1e-25
 Identities = 84/384 (21%), Positives = 138/384 (35%), Gaps = 80/384 (20%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKSPHIIEL 76
           VLG G +G V+      TG+  A KK+     K+++G     + E K+L ++ S  I+ L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSL 250

Query: 77  IDAFPHKGNLHLVFEFME-----TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
             AF  K +L LV   M        +  V  +   F        Y    + GL   H++ 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIFYTAQIVSGLEHLHQRN 309

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---F--THQVFARWYRAPELLFGA 186
           +++RD+KP N+L+   G ++++D GLA    +   +   +  T       + APELL G 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG-----FMAPELLLG- 363

Query: 187 KQYGAGVDVWAAGCIFAELLN-RRPFLQ--GSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
           ++Y   VD +A G    E++  R PF       +  +L                      
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---------------------- 401

Query: 244 DYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS- 296
                Q V    +   +P   S  + D    +   DP+ R+     +      H  F   
Sbjct: 402 ----KQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

Query: 297 -----APLPTEPNKLPRPATKRASKASD---FNPQEGP-------------TVLSPPRKT 335
                      P  +P   T  A    D   F+  +G                 + P   
Sbjct: 456 SWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIPW 515

Query: 336 RRVMPDREGFEG-NANRTDKIEEH 358
           +  M +   F   N  R D ++ H
Sbjct: 516 QEEMIETGVFGDLNVWRPDGVDHH 539

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  104 bits (261), Expect = 2e-25
 Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 66/298 (22%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            LG G++G V+       G+  A+K   K  + + K+ V  T   E  +L  +  P II 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHT-NDERLMLSIVTHPFIIR 70

Query: 76  LIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHKKWVL 133
           +   F     + ++ +++E  +L +++R +  F      K Y  ++ L  L + H K ++
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCL-ALEYLHSKDII 128

Query: 134 HRDMKPNNLLIGSHGQLKLADFGLARIF--------GSPDRRFTHQVFARWYRAPELLFG 185
           +RD+KP N+L+  +G +K+ DFG A+          G+PD           Y APE++  
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD-----------YIAPEVVST 177

Query: 186 AKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
            K Y   +D W+ G +  E+L    PF    S+  +                        
Sbjct: 178 -KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT----------------------- 211

Query: 245 YVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
              Y+ +    LR  FP   ++D  DLLS++ T D   R+       +    H +F  
Sbjct: 212 ---YEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (265), Expect = 3e-25
 Identities = 69/301 (22%), Positives = 114/301 (37%), Gaps = 60/301 (19%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G G +G V         +  A+K +    + K+ E   F   R++  L    S  I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITT 138

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  AF    NL+LV ++    DL T++      L     + Y+   +  +   H+   +H
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF------------GSPDRRFTHQVFARWYRAPEL 182
           RD+KP+N+L+  +G ++LADFG                 G+PD           Y +PE+
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-----------YISPEI 247

Query: 183 L----FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           L     G  +YG   D W+ G    E+L         S ++  GKI             +
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------NHKE 298

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---HRYFS 295
               P  V                 S++A DL+ ++     + R+      +   H +FS
Sbjct: 299 RFQFPTQV--------------TDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343

Query: 296 S 296
            
Sbjct: 344 G 344

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  103 bits (260), Expect = 5e-25
 Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIK---KIRLGKQKEGVNFTALREIKLLKELKSPHIIE 75
            LG G++G V      ++G   A+K   K ++ K K+ +  T L E ++L+ +  P +++
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHT-LNEKRILQAVNFPFLVK 105

Query: 76  LIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F    NL++V E++   ++ + +R    F S    + Y    +    + H   +++
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIY 164

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF--------GSPDRRFTHQVFARWYRAPELLFGA 186
           RD+KP NLLI   G +++ DFG A+          G+P+             APE++   
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----------ALAPEIILS- 212

Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           K Y   VD WA G +  E+     PF   +    Q+                        
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI------------------------ 246

Query: 246 VEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARITAQQA-----LEHRYFSS 296
             Y+ + +  +R  FPS  S D  DLL  +   D   R    +        H++F++
Sbjct: 247 --YEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  102 bits (257), Expect = 5e-25
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 13  RYLK-REVLGEGTYGVVYKA----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LK  + LG+G +G V       +   TG+ VA+KK++   ++   +F   REI++LK 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIEILKS 67

Query: 68  LKSPHIIELIDA--FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+  +I++         + NL L+ E++    L   ++     +    +  Y     KG+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAP 180
            +   K  +HRD+   N+L+ +  ++K+ DFGL ++       F  +        WY AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-AP 186

Query: 181 E-LLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSSDIDQLGKI 224
           E L     ++    DVW+ G +  EL     +     +  +  +G  
Sbjct: 187 ESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 6e-25
 Identities = 54/227 (23%), Positives = 102/227 (44%), Gaps = 20/227 (8%)

Query: 13  RYLK-REVLGEGTYGVVYKA----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LK  + LG+G +G V       +   TG+ VA+KK++   ++   +F   REI++LK 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIEILKS 98

Query: 68  LKSPHIIELIDA--FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L+  +I++         + NL L+ E++    L   ++     +    +  Y     KG+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAP 180
            +   K  +HRD+   N+L+ +  ++K+ DFGL ++       +  +        WY AP
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-AP 217

Query: 181 E-LLFGAKQYGAGVDVWAAGCIFAELL--NRRPFLQGSSDIDQLGKI 224
           E L     ++    DVW+ G +  EL     +     +  +  +G  
Sbjct: 218 ESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  103 bits (259), Expect = 1e-24
 Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 66/305 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G G +  V      +TGQ  A+K +    + K+ E   F   R++  L       I +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQ 125

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  AF  +  L+LV E+    DL T++      +     + Y+   +  +   H+   +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIF------------GSPDRRFTHQVFARWYRAPEL 182
           RD+KP+N+L+   G ++LADFG                 G+PD           Y +PE+
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD-----------YLSPEI 234

Query: 183 L------FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL-GKIFAAFGTATPS 234
           L       G   YG   D WA G    E+   + PF   +    +  GKI          
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY--ADSTAETYGKIV--------- 283

Query: 235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE---H 291
            + +   LP                     ++A D + ++    P+ R+    A +   H
Sbjct: 284 HYKEHLSLPLVD--------------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328

Query: 292 RYFSS 296
            +F  
Sbjct: 329 PFFFG 333

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (250), Expect = 4e-24
 Identities = 42/310 (13%), Positives = 76/310 (24%), Gaps = 58/310 (18%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA--LREIKLLKE 67
              RY      G       ++A+DT   + VA+  +         +     L     L  
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ-GVLPDDVLQETLSRTLRLSR 87

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           +  P +  ++D    +    +V E++    L+ V   +    SP      MQ        
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADA 144

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            H+  V      P+ + +   G + LA                                 
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA----- 179

Query: 187 KQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
                  D+   G     LL NR P  +                +       D A  P  
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVR------------SGLAPAERDTAGQP-- 222

Query: 246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNK 305
                        +          + ++    D   R  +      +  ++    TE   
Sbjct: 223 --------IEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLG 274

Query: 306 LPRPATKRAS 315
               A   A+
Sbjct: 275 PIDEAPVSAA 284

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 86/361 (23%), Positives = 144/361 (39%), Gaps = 74/361 (20%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFT-ALREIKLLKELK 69
              K  +LG+G++G V+ A   KT Q  AIK ++       + V  T   + + L    +
Sbjct: 20  ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWE 76

Query: 70  SPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P +  +   F  K NL  V E++   DL   I++ + F        Y    + GL F H
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-RATFYAAEIILGLQFLH 135

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWY 177
            K +++RD+K +N+L+   G +K+ADFG+ +             G+PD           Y
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD-----------Y 184

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE+L G ++Y   VD W+ G +  E+L  + PF     D ++L               
Sbjct: 185 IAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH--GQDEEEL--------------- 226

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARITAQQAL-EHRYF 294
                      +  +        +P     +A DLL K+F  +P+ R+  +  + +H  F
Sbjct: 227 -----------FHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

Query: 295 SS---APLPTEPNKLP---RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFE 346
                  L  E  ++    RP  K     S+F+ +       LS   +      D+  F 
Sbjct: 274 REINWEEL--ERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFR 331

Query: 347 G 347
            
Sbjct: 332 N 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 11/188 (5%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLKELKSPHIIEL 76
           E +G G +G V+          VA+K  R     +    F  L+E ++LK+   P+I+ L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF--LQEARILKQYSHPNIVRL 177

Query: 77  IDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
           I     K  +++V E ++  D  T +R     L    +   +     G+ +   K  +HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPD---RRFTHQVFARWYRAPE-LLFGAKQYGA 191
           D+   N L+     LK++DFG++R              QV  +W  APE L +G  +Y +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYG--RYSS 294

Query: 192 GVDVWAAG 199
             DVW+ G
Sbjct: 295 ESDVWSFG 302

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 13  RYLK-REVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           R+LK    LG+G +G V           TG  VA+K+++     +  +F   REI++LK 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--QREIQILKA 80

Query: 68  LKSPHIIELID--AFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
           L S  I++       P + +L LV E++ +  L   ++     L  + +  Y     KG+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAP 180
            +   +  +HRD+   N+L+ S   +K+ADFGLA++       +  +        WY AP
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-AP 199

Query: 181 E-LLFGAKQYGAGVDVWAAGCIFAELL 206
           E L      +    DVW+ G +  EL 
Sbjct: 200 ESLSDN--IFSRQSDVWSFGVVLYELF 224

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 67/306 (21%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG G YG V+   K     TG+  A+K ++    + K K   +    R++ L    +SP
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSP 119

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYM-QMTLKGLAFCHK 129
            ++ L  AF  +  LHL+ +++   +L T +     F +  +++ Y+ ++ L  L   HK
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF-TEHEVQIYVGEIVL-ALEHLHK 177

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF------------GSPDRRFTHQVFARWY 177
             +++RD+K  N+L+ S+G + L DFGL++ F            G+ +           Y
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE-----------Y 226

Query: 178 RAPELLFGAKQ-YGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQ 235
            AP+++ G    +   VD W+ G +  ELL    PF        Q  +I      + P  
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSEPP- 284

Query: 236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALE 290
                  P  +                 S  A DL+ ++   DPK R+      A +  E
Sbjct: 285 ------YPQEM-----------------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321

Query: 291 HRYFSS 296
           H +F  
Sbjct: 322 HLFFQK 327

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 73/317 (23%), Positives = 119/317 (37%), Gaps = 62/317 (19%)

Query: 5   DLSKKVADRYLKRE------VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVN 55
           D   K+ D  +K E      V+G G +G V       T +  A+K +    + K+ +   
Sbjct: 56  DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115

Query: 56  FTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIK 114
           F   R+I  +    SP +++L  AF     L++V E+M   DL  ++ N ++       +
Sbjct: 116 FWEERDI--MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWAR 171

Query: 115 SYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA 174
            Y    +  L   H    +HRD+KP+N+L+   G LKLADFG                  
Sbjct: 172 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC----- 226

Query: 175 RW-------YRAPELLF---GAKQYGAGVDVWAAG-CIFAELLNRRPFLQGSSDIDQL-G 222
                    Y +PE+L    G   YG   D W+ G  ++  L+   PF   +  +     
Sbjct: 227 -DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGTYS 283

Query: 223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR 282
           KI           +PD   +                     S +A +L+    T D + R
Sbjct: 284 KIMNH---KNSLTFPDDNDI---------------------SKEAKNLICAFLT-DREVR 318

Query: 283 ITAQQALE---HRYFSS 296
           +      E   H +F +
Sbjct: 319 LGRNGVEEIKRHLFFKN 335

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 99.3 bits (247), Expect = 1e-22
 Identities = 88/359 (24%), Positives = 144/359 (40%), Gaps = 77/359 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFT-ALREIKLLKELKSPHIIE 75
           VLG+G++G V  +    T +  A+K ++     Q + V  T   + + L    K P + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQ 406

Query: 76  LIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F     L+ V E++   DL   I+    F  P     Y      GL F   K +++
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIGLFFLQSKGIIY 465

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+++ S G +K+ADFG+           + F G+PD           Y APE++
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-----------YIAPEII 514

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
              + YG  VD WA G +  E+L  + PF     D D+L                     
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDEDEL--------------------- 550

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
                +Q +    +   +P S S +A+ +   + T  P  R+       +   EH +F  
Sbjct: 551 -----FQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

Query: 297 ---APLPTEPNKLP---RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG 347
                L  E  ++    +P       A +F+      P VL+PP +      D+  FEG
Sbjct: 604 IDWEKL--ERKEIQPPYKP-KASGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEG 659

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 69/302 (22%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKSPHI 73
           VLG+G++G V+   K   +   Q  A+K ++    K ++ V     R+I  L E+  P I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFI 88

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++L  AF  +G L+L+ +F+   DL T +    +F +  D+K Y+      L   H   +
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAELALALDHLHSLGI 147

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWYRAPE 181
           ++RD+KP N+L+   G +KL DFGL++             G+ +           Y APE
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-----------YMAPE 196

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           ++   + +    D W+ G +  E+L    PF     D  +                    
Sbjct: 197 VVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ--GKDRKET------------------- 234

Query: 241 YLPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHRYF 294
                     +    L    P   S +A  LL  +F  +P  R+       ++   H +F
Sbjct: 235 -------MTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

Query: 295 SS 296
           S+
Sbjct: 286 ST 287

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 89/371 (23%), Positives = 152/371 (40%), Gaps = 84/371 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELKS 70
            YLK  +LG+GT+G V    +  TG+  A+K +R      K+ V  T + E ++L+  + 
Sbjct: 8   DYLK--LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRH 64

Query: 71  PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           P +  L  AF     L  V E+    +L   +    +F +    + Y    +  L + H 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHS 123

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYR 178
           + V++RD+K  NL++   G +K+ DFGL           + F G+P+           Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----------YL 172

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           APE+L     YG  VD W  G +  E++  R PF   + D ++L                
Sbjct: 173 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERL---------------- 213

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALEH 291
                     ++ +    +R  FP + S +A  LL+ +   DPK R+      A++ +EH
Sbjct: 214 ----------FELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 292 RYFSS---APLPTEPNKLP---RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMP--- 340
           R+F S     +     KL    +P          F+ +       ++PP +   +     
Sbjct: 262 RFFLSINWQDV--VQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLEL 319

Query: 341 ----DREGFEG 347
               ++E FE 
Sbjct: 320 DQREEQEMFED 330

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 19/201 (9%)

Query: 13  RYLK-REVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLK 66
           R+LK    LGEG +G V           TG+ VA+K ++       +      +EI++L+
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL--KKEIEILR 78

Query: 67  ELKSPHIIELIDAFPHKGN--LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L   +I++        G   + L+ EF+ +  L+  +      ++      Y     KG
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRA 179
           + +   +  +HRD+   N+L+ S  Q+K+ DFGL +   +    +T +        WY A
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-A 197

Query: 180 PE-LLFGAKQYGAGVDVWAAG 199
           PE L+    ++    DVW+ G
Sbjct: 198 PECLMQS--KFYIASDVWSFG 216

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 72/304 (23%), Positives = 121/304 (39%), Gaps = 71/304 (23%)

Query: 19  VLGEGTYGVVY---KAIDTKTGQTVAIKKIR----LGKQKEGVNFTALREIKLLKELKSP 71
           VLG+G YG V+   K     TG+  A+K ++    +   K+  +  A R I  L+E+K P
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHP 81

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            I++LI AF   G L+L+ E++   +L   +    IF        Y+      L   H+K
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF-MEDTACFYLAEISMALGHLHQK 140

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWYRA 179
            +++RD+KP N+++   G +KL DFGL +             G+ +           Y A
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE-----------YMA 189

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           PE+L     +   VD W+ G +  ++L    PF     +  +                  
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT--GENRKKT----------------- 229

Query: 239 LAYLPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALEHR 292
                       +    L    P   + +A DLL K+   +  +R+      A +   H 
Sbjct: 230 ---------IDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278

Query: 293 YFSS 296
           +F  
Sbjct: 279 FFRH 282

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 94.2 bits (235), Expect = 5e-22
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 15  LKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           +    LG G +G V + +     +   VAIK ++ G ++ +      +RE +++ +L +P
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM--MREAQIMHQLDNP 70

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+ LI        L LV E      L   +      +  +++   +     G+ +  +K
Sbjct: 71  YIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFG 185
             +HRD+   N+L+ +    K++DFGL++  G+ D  +T +       +WY APE + F 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFR 188

Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPF 211
             ++ +  DVW+ G    E L+  ++P+
Sbjct: 189 --KFSSRSDVWSYGVTMWEALSYGQKPY 214

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 79/360 (21%), Positives = 135/360 (37%), Gaps = 68/360 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFT-ALREIKLLKELKSPHIIE 75
           V+G G+Y  V      KT +  A+K ++       E +++    + +   +    P ++ 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVG 74

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  +  L  V E++   DL   ++           + Y       L + H++ +++
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISLALNYLHERGIIY 133

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ S G +KL D+G+             F G+P+           Y APE+L
Sbjct: 134 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-----------YIAPEIL 182

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G + YG  VD WA G +  E++  R PF    S  +                     YL
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------------TEDYL 227

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI------TAQQALEHRYFS 295
                +Q +    +R   P S S  A  +L      DPK R+             H +F 
Sbjct: 228 -----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

Query: 296 S---APLPTEPNKLP---RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG 347
           +     +  E  ++    +P         +F+ Q    P  L+P         D+  FEG
Sbjct: 281 NVDWDMM--EQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEG 338

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 90/362 (24%), Positives = 141/362 (38%), Gaps = 81/362 (22%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK----QKEGVNFT-ALREIKLLKELKSPHI 73
           VLG+G++G V  A   +TG   A+K ++  K    Q + V  T   + I L      P +
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK--KDVILQDDDVECTMTEKRI-LSLARNHPFL 86

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            +L   F     L  V EF+   DL   I+ +  F   A  + Y    +  L F H K +
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEARARFYAAEIISALMFLHDKGI 145

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIF-----------GSPDRRFTHQVFARWYRAPE 181
           ++RD+K +N+L+   G  KLADFG+ +             G+PD           Y APE
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD-----------YIAPE 194

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA 240
           +L     YG  VD WA G +  E+L    PF   + + D L                   
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE--AENEDDL------------------- 232

Query: 241 YLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI------TAQQALEHRY 293
                  ++ +    +   +P    +DA  +L    T +P  R+           L H +
Sbjct: 233 -------FEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

Query: 294 FSS---APLPTEPNKLP---RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGF 345
           F     A L     ++    RP  K     S+F+P   +   VL+P  +    M +++ F
Sbjct: 284 FKEIDWAQL--NHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEF 341

Query: 346 EG 347
             
Sbjct: 342 RN 343

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG G YG VY+ +  K   TVA+K ++    +    F  L+E  ++KE+K P++++L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EF--LKEAAVMKEIKHPNLVQLL 282

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +   +++ EFM   +L   +R  N   +S   +          + +  KK  +HR
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGV 193
           ++   N L+G +  +K+ADFGL+R+            +   +W  APE L    ++    
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-APESLA-YNKFSIKS 400

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVWA G +  E+      P+
Sbjct: 401 DVWAFGVLLWEIATYGMSPY 420

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 78/306 (25%), Positives = 131/306 (42%), Gaps = 68/306 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFTALREIKLLKELKS 70
            YLK  +LG+GT+G V    +  TG+  A+K ++      K+ V  T L E ++L+  + 
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRH 207

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH- 128
           P +  L  +F     L  V E+    +L   +    +F      + Y    +  L + H 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHS 266

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWY 177
           +K V++RD+K  NL++   G +K+ DFGL           + F G+P+           Y
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----------Y 315

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE+L     YG  VD W  G +  E++  R PF   + D ++L               
Sbjct: 316 LAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKL--------------- 357

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSA-SDDALDLLSKMFTYDPKARI-----TAQQALE 290
                      ++ +    +R  FP     +A  LLS +   DPK R+      A++ ++
Sbjct: 358 -----------FELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404

Query: 291 HRYFSS 296
           HR+F+ 
Sbjct: 405 HRFFAG 410

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 14/192 (7%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGKQKEGVNFTA-LREIKLLKELKSPHI 73
           E LG+G++GVV +      +    +VA+K ++     +       +RE+  +  L   ++
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E      L   +R          +  Y     +G+ +   K  
Sbjct: 84  IRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   NLL+ +   +K+ DFGL R     D  +  Q        W  APE L     
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APESLKTR-- 199

Query: 188 QYGAGVDVWAAG 199
            +    D W  G
Sbjct: 200 TFSHASDTWMFG 211

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 78/360 (21%), Positives = 135/360 (37%), Gaps = 68/360 (18%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFT-ALREIKLLKELKSPHIIE 75
           V+G G+Y  V      KT +  A++ ++       E +++    + +   +    P ++ 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVG 117

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L   F  +  L  V E++   DL   ++           + Y       L + H++ +++
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISLALNYLHERGIIY 176

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+K +N+L+ S G +KL D+G+             F G+P+           Y APE+L
Sbjct: 177 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-----------YIAPEIL 225

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
            G + YG  VD WA G +  E++  R PF    S  +                     YL
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------------TEDYL 270

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI------TAQQALEHRYFS 295
                +Q +    +R   P S S  A  +L      DPK R+             H +F 
Sbjct: 271 -----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

Query: 296 S---APLPTEPNKLP---RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG 347
           +     +  E  ++    +P         +F+ Q    P  L+P         D+  FEG
Sbjct: 324 NVDWDMM--EQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEG 381

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 16/192 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPH 72
           +VLG G +G VYK +      K    VAIK++R     K       L E  ++  + +PH
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEAYVMASVDNPH 78

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +  L+        + L+ + M    L   +R     +    + ++     KG+ +   + 
Sbjct: 79  VCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA-RWYRAPE-LLFGAK 187
           ++HRD+   N+L+ +   +K+ DFGLA++ G+ +            +W  A E +L    
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHR-- 194

Query: 188 QYGAGVDVWAAG 199
            Y    DVW+ G
Sbjct: 195 IYTHQSDVWSYG 206

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 13/193 (6%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ + LG G +G V K      K  +TVA+K ++       +    L E  ++++L +P+
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ +I       +  LV E  E   L   ++  N  +   +I   +     G+ +  +  
Sbjct: 80  IVRMI-GICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN 137

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGA 186
            +HRD+   N+L+ +    K++DFGL++   + +  +  Q       +WY APE + +  
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYY- 195

Query: 187 KQYGAGVDVWAAG 199
            ++ +  DVW+ G
Sbjct: 196 -KFSSKSDVWSFG 207

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 15/189 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG G YG VY+ +  K   TVA+K ++    +    F  L+E  ++KE+K P++++L+
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF--LKEAAVMKEIKHPNLVQLL 75

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +   +++ EFM   +L   +R  N   +S   +          + +  KK  +HR
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYG 190
           D+   N L+G +  +K+ADFGL+R+       +T    A    +W  APE L +   ++ 
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWT-APESLAYN--KFS 190

Query: 191 AGVDVWAAG 199
              DVWA G
Sbjct: 191 IKSDVWAFG 199

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 13  RYLK-REVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVN-FTALREIKLLK 66
           RYLK    LGEG +G V        +  TG+ VA+K ++     +  + +   +EI +L+
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW--KQEIDILR 88

Query: 67  ELKSPHIIELIDA--FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKG 123
            L   HII+           +L LV E++    L   +   +  +  A +  + Q   +G
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEG 146

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRA 179
           +A+ H +  +HRD+   N+L+ +   +K+ DFGLA+        +  +        WY A
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 205

Query: 180 PE-LLFGAKQYGAGVDVWAAG 199
           PE L     ++    DVW+ G
Sbjct: 206 PECLKEY--KFYYASDVWSFG 224

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 68/306 (22%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG--KQKEGVNFT-ALREIKLLKELK 69
            +L   VLG+G++G V  +    T +  A+K ++     Q + V  T   + + L    K
Sbjct: 23  NFLM--VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGK 79

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P + +L   F     L+ V E++   DL   I+    F  P     Y      GL F  
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIGLFFLQ 138

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWY 177
            K +++RD+K +N+++ S G +K+ADFG+           + F G+PD           Y
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-----------Y 187

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
            APE++   + YG  VD WA G +  E+L  + PF     D D+L               
Sbjct: 188 IAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE--GEDEDEL--------------- 229

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARI-----TAQQALE 290
                      +Q +    +   +P S S +A+ +   + T  P  R+       +   E
Sbjct: 230 -----------FQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276

Query: 291 HRYFSS 296
           H +F  
Sbjct: 277 HAFFRY 282

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 17/194 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY      +       A+K +       E   F  L E  ++K+   P++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 88

Query: 74  IELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ +   K 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA---RWYRAPE-LLFG 185
            +HRD+   N ++     +K+ADFGLAR     +              +W  A E L   
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQ 207

Query: 186 AKQYGAGVDVWAAG 199
             ++    DVW+ G
Sbjct: 208 --KFTTKSDVWSFG 219

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV      K    VA+K I+ G   E   F   +E + + +L  P +++  
Sbjct: 14  KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSE-DEF--FQEAQTMMKLSHPKLVKFY 69

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  +++V E++    L   +R+    L P+ +        +G+AF      +HRD
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD 129

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYGA 191
           +   N L+     +K++DFG+ R     D ++   V      +W  APE   +   +Y +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGTKFPVKWS-APEVFHYF--KYSS 184

Query: 192 GVDVWAAGCIFAELLN--RRPF 211
             DVWA G +  E+ +  + P+
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPY 206

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 92.7 bits (230), Expect = 2e-20
 Identities = 50/208 (24%), Positives = 100/208 (48%), Gaps = 17/208 (8%)

Query: 15  LKREVLGEGTYGVVYKAI-DTKTGQT-VAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           +    LG G +G V + +   +  Q  VAIK ++ G ++ +      +RE +++ +L +P
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM--MREAQIMHQLDNP 396

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+ LI        L LV E      L   +      +  +++   +     G+ +  +K
Sbjct: 397 YIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFG 185
             +HR++   N+L+ +    K++DFGL++  G+ D  +T +       +WY APE + F 
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFR 514

Query: 186 AKQYGAGVDVWAAGCIFAELLN--RRPF 211
             ++ +  DVW+ G    E L+  ++P+
Sbjct: 515 --KFSSRSDVWSYGVTMWEALSYGQKPY 540

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 65/299 (21%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIR---LGKQKEGVNFTALREIKLLKELKSPHIIE 75
           V+G+G++G V  A         A+K ++   + K+KE  +  + R + LLK +K P ++ 
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 103

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
           L  +F     L+ V +++   +L   ++    FL P   + Y       L + H   +++
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-RARFYAAEIASALGYLHSLNIVY 162

Query: 135 RDMKPNNLLIGSHGQLKLADFGL----------ARIF-GSPDRRFTHQVFARWYRAPELL 183
           RD+KP N+L+ S G + L DFGL             F G+P+           Y APE+L
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-----------YLAPEVL 211

Query: 184 FGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
              + Y   VD W  G +  E+L    PF   S +  ++                     
Sbjct: 212 HK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEM--------------------- 247

Query: 243 PDYVEYQYVAAPPLRSLFP-SASDDALDLLSKMFTYDPKARITAQQALE----HRYFSS 296
                Y  +   PL+     + ++ A  LL  +   D   R+ A+        H +FS 
Sbjct: 248 -----YDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 25/215 (11%)

Query: 5   DLSKKVADRYLKRE--------VLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKE 52
            L  +V D  +  E        V+G+G +GVVY        +     AIK +    + ++
Sbjct: 6   ALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ 65

Query: 53  GVNFTALREIKLLKELKSPHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSP 110
              F  LRE  L++ L  P+++ LI    P +G  H++  +M   DL   IR+     + 
Sbjct: 66  VEAF--LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123

Query: 111 ADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----R 166
            D+ S+     +G+ +  ++  +HRD+   N ++     +K+ADFGLAR     +    +
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183

Query: 167 RFTHQVF-ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
           +  H     +W  A E L     ++    DVW+ G
Sbjct: 184 QHRHARLPVKWT-ALESLQTY--RFTTKSDVWSFG 215

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 13/200 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G G +G+V+          VAIK IR G   E  +F  + E +++ +L  P +++L 
Sbjct: 14  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE-EDF--IEEAEVMMKLSHPKLVQLY 69

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  + LV EFME   L   +R      +   +        +G+A+  +  V+HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVFA-RWYRAPE-LLFGAKQYGAGV 193
           +   N L+G +  +K++DFG+ R          T   F  +W  +PE   F   +Y +  
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-SPEVFSFS--RYSSKS 186

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  E+ +  + P+
Sbjct: 187 DVWSFGVLMWEVFSEGKIPY 206

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG+G +G V+      T + VAIK ++ G       F  L+E +++K+L+   +++L 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE-AF--LQEAQVMKKLRHEKLVQLY 245

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +  +++V E+M    L   ++  T  +L    +         G+A+  +   +HR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFA-RWYRAPELLFGAKQYGAGV 193
           D++  N+L+G +   K+ADFGLAR I  +         F  +W  APE      ++    
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEAAL-YGRFTIKS 362

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  EL    R P+
Sbjct: 363 DVWSFGILLTELTTKGRVPY 382

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 25/202 (12%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPH 72
           ++LGEG +G V +     +  T   VA+K  K+    Q+E   F  L E   +K+   P+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF--LSEAACMKDFSHPN 97

Query: 73  IIELI-----DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI--KSYMQMTL--- 121
           +I L+      +        ++  FM+  DL T +  + +   P  I  ++ ++  +   
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWYR 178
            G+ +   +  LHRD+   N ++     + +ADFGL++   S D  R+        +W  
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI- 216

Query: 179 APE-LLFGAKQYGAGVDVWAAG 199
           A E L      Y +  DVWA G
Sbjct: 217 AIESLADR--VYTSKSDVWAFG 236

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 19/188 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G +G V        G  VA+K I+     +   F  L E  ++ +L+  ++++L+
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ--AF--LAEASVMTQLRHSNLVQLL 252

Query: 78  DA-FPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                 KG L++V E+M    L   +R+     L    +  +     + + +      +H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE-LLFGAKQYGA 191
           RD+   N+L+      K++DFGL +         +       +W  APE L     ++  
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP----VKWT-APEALREK--KFST 365

Query: 192 GVDVWAAG 199
             DVW+ G
Sbjct: 366 KSDVWSFG 373

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 88.4 bits (220), Expect = 4e-20
 Identities = 45/202 (22%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + +G+G +G V        G  VA+K I+     +   F  L E  ++ +L+  ++++L+
Sbjct: 27  QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ--AF--LAEASVMTQLRHSNLVQLL 80

Query: 78  DA-FPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
                 KG L++V E+M    L   +R+     L    +  +     + + +      +H
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140

Query: 135 RDMKPNNLLIGSHGQLKLADFGLAR--IFGSPDRRFTHQVFARWYRAPE-LLFGAKQYGA 191
           RD+   N+L+      K++DFGL +         +       +W  APE L     ++  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP----VKWT-APEALREK--KFST 193

Query: 192 GVDVWAAGCIFAEL--LNRRPF 211
             DVW+ G +  E+    R P+
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPY 215

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 19/220 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           +V+G G +G VYK +      K    VAIK ++ G  +K+ V+F  L E  ++ +    +
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF--LGEAGIMGQFSHHN 107

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           II L         + ++ E+ME   L+  +R  +   S   +   ++    G+ +     
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGA 186
            +HRD+   N+L+ S+   K++DFGL+R+                  RW  APE + +  
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-APEAISYR- 225

Query: 187 KQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKI 224
            ++ +  DVW+ G +  E++    RP+    S+ + +  I
Sbjct: 226 -KFTSASDVWSFGIVMWEVMTYGERPY-WELSNHEVMKAI 263

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 88.4 bits (220), Expect = 5e-20
 Identities = 46/192 (23%), Positives = 77/192 (40%), Gaps = 18/192 (9%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHI 73
            +LGEG +G VY+ +          VA+K  +          F  + E  ++K L  PHI
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF--MSEAVIMKNLDHPHI 75

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++LI     +    ++ E     +L   +      L    +  Y     K +A+      
Sbjct: 76  VKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   N+L+ S   +KL DFGL+R     D  +          +W  +PE + F   
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDED--YYKASVTRLPIKWM-SPESINFR-- 189

Query: 188 QYGAGVDVWAAG 199
           ++    DVW   
Sbjct: 190 RFTTASDVWMFA 201

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHI 73
           +V+G G +G V        +K   +VAIK +++G  +K+  +F  L E  ++ +   P+I
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF--LGEASIMGQFDHPNI 108

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L         + +V E+ME   L++ +R  +   +   +   ++    G+ +      
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   N+LI S+   K++DFGL R+                  RW  +PE + +   
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SPEAIAYR-- 225

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPF 211
           ++ +  DVW+ G +  E+++   RP+
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPY 251

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 16/192 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPH 72
           +VLG G +G VYK +      K    VAIK++R     K       L E  ++  + +PH
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEAYVMASVDNPH 78

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +  L+        + L+ + M    L   +R     +    + ++     KG+ +   + 
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE-LLFGAK 187
           ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +   V  +W  A E +L    
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALESILHR-- 194

Query: 188 QYGAGVDVWAAG 199
            Y    DVW+ G
Sbjct: 195 IYTHQSDVWSYG 206

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 16/192 (8%)

Query: 18  EVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPH 72
           +VLG G +G V+K +           V IK I     ++          +  +  L   H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV--TDHMLAIGSLDHAH 76

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           I+ L+       +L LV +++    L   +R     L P  + ++     KG+ +  +  
Sbjct: 77  IVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRAPE-LLFGAK 187
           ++HR++   N+L+ S  Q+++ADFG+A +    D++  +       +W  A E + FG  
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIHFG-- 192

Query: 188 QYGAGVDVWAAG 199
           +Y    DVW+ G
Sbjct: 193 KYTHQSDVWSYG 204

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
             +GEG +G V++ I          VAIK  +          F  L+E   +++   PHI
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF--LQEALTMRQFDHPHI 78

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  
Sbjct: 79  VKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAK 187
           +HRD+   N+L+ S+  +KL DFGL+R        +          +W  APE + F   
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWM-APESINFR-- 192

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKI 224
           ++ +  DVW  G    E+L    +PF QG  + D +G+I
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRI 230

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 26/203 (12%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIK--KIRLGKQKEGVNFTALREIKLLKELKSPH 72
            +LG+G +G V +A    +  +   VA+K  K  +    +   F  LRE   +KE   PH
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF--LREAACMKEFDHPH 86

Query: 73  IIELI------DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADI--KSYMQMTL-- 121
           + +L+       A        ++  FM+  DL   +  + I  +P ++  ++ ++  +  
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 122 -KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWY 177
             G+ +   +  +HRD+   N ++     + +ADFGL+R   S D  R+        +W 
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 178 RAPE-LLFGAKQYGAGVDVWAAG 199
            A E L      Y    DVWA G
Sbjct: 207 -ALESLADN--LYTVHSDVWAFG 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 90.3 bits (224), Expect = 9e-20
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
             LG+G +G V+      T + VAIK ++ G       F  L+E +++K+L+   +++L 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE-AF--LQEAQVMKKLRHEKLVQLY 328

Query: 78  DAFPHKGNLHLVFEFME-TDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
                +  +++V E+M    L   ++  T  +L    +         G+A+  +   +HR
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387

Query: 136 DMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVFA-RWYRAPELLFGAKQYGAGV 193
           D++  N+L+G +   K+ADFGLAR I  +         F  +W  APE      ++    
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-APEAAL-YGRFTIKS 445

Query: 194 DVWAAGCIFAELLN--RRPF 211
           DVW+ G +  EL    R P+
Sbjct: 446 DVWSFGILLTELTTKGRVPY 465

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 17/194 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
           EV+G G +G VY      +       A+K +       E   F  L E  ++K+   P++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF--LTEGIIMKDFSHPNV 152

Query: 74  IELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           + L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA-----RWYRAPE-LLFG 185
            +HRD+   N ++     +K+ADFGLAR     +    H         +W  A E L   
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQ 271

Query: 186 AKQYGAGVDVWAAG 199
             ++    DVW+ G
Sbjct: 272 --KFTTKSDVWSFG 283

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKSPHI 73
           +++G G  G V         +    VAIK ++ G  +++  +F  L E  ++ +   P+I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF--LSEASIMGQFDHPNI 112

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I L           +V E+ME   L+T +R  +   +   +   ++    G+ +      
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLAR-IFGSPDRRFTHQVF---ARWYRAPE-LLFGAK 187
           +HRD+   N+L+ S+   K++DFGL+R +   PD  +T        RW  APE + F   
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APEAIAFR-- 229

Query: 188 QYGAGVDVWAAGCIFAELLN--RRPF 211
            + +  DVW+ G +  E+L    RP+
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPY 255

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 25/202 (12%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             LG+G++G+VY+ +       +    VAIK +      +E + F  L E  ++KE    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF--LNEASVMKEFNCH 88

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN------TNIFLSPADIKSYMQMTL--- 121
           H++ L+          ++ E M   DL++ +R+       N  L+P  +   +QM     
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-ARWYR 178
            G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +   RW  
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 207

Query: 179 APE-LLFGAKQYGAGVDVWAAG 199
           +PE L  G   +    DVW+ G
Sbjct: 208 SPESLKDG--VFTTYSDVWSFG 227

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 40/159 (25%), Positives = 83/159 (52%), Gaps = 15/159 (9%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKI-RLGKQ--KEGVNFTALREIKLLKELKSPHIIE 75
           ++G G +G VYK +  + G  VA+K+      Q  +E   F    EI+ L   + PH++ 
Sbjct: 46  LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE---FET--EIETLSFCRHPHLVS 99

Query: 76  LIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKW 131
           LI     +  + L++++ME  +L+  +  +++       +  +++ +   +GL + H + 
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH 170
           ++HRD+K  N+L+  +   K+ DFG+++     D+  TH
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ--TH 196

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 88.8 bits (220), Expect = 4e-19
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 18  EVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHI 73
             +GEG +G V++ I          VAIK  +          F  L+E   +++   PHI
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF--LQEALTMRQFDHPHI 453

Query: 74  IELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           ++LI     +  + ++ E     +L + ++     L  A +  Y       LA+   K  
Sbjct: 454 VKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPE-LLFGAKQY 189
           +HRD+   N+L+ S+  +KL DFGL+R        +    ++  +W  APE + F   ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESINFR--RF 569

Query: 190 GAGVDVWAAGCIFAELLN--RRPF 211
            +  DVW  G    E+L    +PF
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPF 593

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 15/188 (7%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV      +    VAIK I+ G   E   F  + E K++  L    +++L 
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE-DEF--IEEAKVMMNLSHEKLVQLY 85

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  + ++ E+M    L   +R          +    +   + + +   K  LHRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYGA 191
           +   N L+   G +K++DFGL+R     D  +T  V +    RW   PE L++   ++ +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWS-PPEVLMYS--KFSS 200

Query: 192 GVDVWAAG 199
             D+WA G
Sbjct: 201 KSDIWAFG 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.8 bits (213), Expect = 8e-19
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
             LGEG +G V+ A        +    VA+K ++   +    +F   RE +LL  L+  H
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF--QREAELLTMLQHQH 104

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIR-----------NTNIFLSPADIKSYMQMT 120
           I+           L +VFE+M   DL   +R             ++   P  +   + + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 121 L---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF-A 174
                G+ +      +HRD+   N L+G    +K+ DFG++R   S D  R     +   
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224

Query: 175 RWYRAPE-LLFGAKQYGAGVDVWAAG 199
           RW   PE +L+   ++    DVW+ G
Sbjct: 225 RWM-PPESILYR--KFTTESDVWSFG 247

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
             LGEG +G V+ A       TK    VA+K ++        +F   RE +LL  L+  H
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF--QREAELLTNLQHEH 78

Query: 73  IIELIDAFPHKGNLHLVFEFMET-DLETVIR------------NTNIFLSPADIKSYMQM 119
           I++          L +VFE+M+  DL   +R                      +   + +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 120 TL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF- 173
                 G+ +   +  +HRD+   N L+G++  +K+ DFG++R   S D  R   H +  
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 174 ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
            RW   PE +++   ++    DVW+ G
Sbjct: 199 IRWM-PPESIMYR--KFTTESDVWSFG 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 35/202 (17%), Positives = 71/202 (35%), Gaps = 30/202 (14%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT-------VAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           E LG+GT+  ++K +  + G         V +K +    +    +F       ++ +L  
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF--FEAASMMSKLSH 71

Query: 71  PHIIELI----DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            H++                 LV EF++   L+T ++     ++        +     + 
Sbjct: 72  KHLVLNYGVCVCGDE----NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQL--------KLADFGLARIFGSPDRRFTHQVFARWY 177
           F  +  ++H ++   N+L+              KL+D G++      D     Q    W 
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWV 184

Query: 178 RAPELLFGAKQYGAGVDVWAAG 199
             PE +   K      D W+ G
Sbjct: 185 -PPECIENPKNLNLATDKWSFG 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 17/189 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           E LG G +G V+          VA+K ++ G       F  L E  L+K+L+   ++ L 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPD-AF--LAEANLMKQLQHQRLVRLY 74

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
            A   +  ++++ E+ME   L   ++  + I L+   +        +G+AF  ++  +HR
Sbjct: 75  -AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYG 190
           D++  N+L+      K+ADFGLAR+    D  +T +  A    +W  APE + +G   + 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT-APEAINYG--TFT 188

Query: 191 AGVDVWAAG 199
              DVW+ G
Sbjct: 189 IKSDVWSFG 197

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 17/189 (8%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +G V+ A   K  + VA+K ++ G       F  L E  ++K L+   +++L 
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV-EAF--LAEANVMKTLQHDKLVKLH 249

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHR 135
            A   K  ++++ EFM    L   ++ +         +  +     +G+AF  ++  +HR
Sbjct: 250 -AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308

Query: 136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA----RWYRAPE-LLFGAKQYG 190
           D++  N+L+ +    K+ADFGLAR+    D  +T +  A    +W  APE + FG   + 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT-APEAINFG--SFT 363

Query: 191 AGVDVWAAG 199
              DVW+ G
Sbjct: 364 IKSDVWSFG 372

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 19  VLGEGTYGVVYK-AIDTKTGQTVAIKKIRLGKQKEGVN----FTALREIKLLKELKSPHI 73
            +GEG +GVVYK  ++     TVA+KK+              F    EIK++ + +  ++
Sbjct: 38  KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQ--EIKVMAKCQHENL 92

Query: 74  IELIDAFPHKGN-LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTL---KGLAFCH 128
           +EL+  F   G+ L LV+ +M    L   +   +    P       ++      G+ F H
Sbjct: 93  VELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH 150

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH---QV---FARWYRAPEL 182
           +   +HRD+K  N+L+      K++DFGLAR         T    ++    A  Y APE 
Sbjct: 151 ENHHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQTVMTSRIVGTTA--YMAPEA 206

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPF 211
           L G  +     D+++ G +  E++      
Sbjct: 207 LRG--EITPKSDIYSFGVVLLEIITGLPAV 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 21/172 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V   +   + +G G +G +    +  T + VAIK   L   K         E +  K+L 
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAP-QLHLEYRFYKQLG 62

Query: 70  -SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLKGL 124
               I ++    P      +V E +   LE +    +   S   +K+     +Q+ +  +
Sbjct: 63  SGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFS---LKTVLMIAIQL-ISRM 118

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLK-----LADFGLARIFGSPDRRFTHQ 171
            + H K +++RD+KP N LIG  G        + DF LA+ +  P+   T +
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE---TKK 167

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 18/162 (11%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKE 67
           +V +RY     +G G++G +Y   D   G+ VAIK      +        L  E K+ K 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKM 60

Query: 68  LK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLK 122
           ++    I  +           +V E +   LE +    +   S   +K+      QM + 
Sbjct: 61  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS---LKTVLLLADQM-IS 116

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIF 161
            + + H K  +HRD+KP+N L+G       + + DFGLA+ +
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A     I +    TVA+K ++      E      + E+K+L  L + 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 86

Query: 71  PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRN-----------------TNIFLSPAD 112
            +I+ L+ A    G   ++ E+    DL   +R                    + L   D
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
           + S+     KG+AF   K  +HRD+   N+L+      K+ DFGLAR   +        +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE +F    Y    DVW+ G
Sbjct: 207 ARLPVKWM-APESIFNCV-YTFESDVWSYG 234

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 20/167 (11%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTAL-REIKLLKEL 68
           V   Y     +GEG++GV+++  +    Q VAIK      +    +   L  E +  K L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLL 62

Query: 69  K-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLKG 123
                I  +        +  LV + +   LE ++       S   +K+      QM L  
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS---VKTVAMAAKQM-LAR 118

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG-----QLKLADFGLARIFGSPD 165
           +   H+K +++RD+KP+N LIG         + + DFG+ + +  P 
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 20/176 (11%)

Query: 19  VLGEGTYGVVYKAIDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSPHIIELI 77
           +LG G +G VYK      G  VA+K+++    Q   + F    E++++      +++ L 
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT--EVEMISMAVHRNLLRLR 93

Query: 78  DAFPHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTL---KGLAFCHKKW-- 131
                     LV+ +M    + + +R       P D     ++ L   +GLA+ H     
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153

Query: 132 -VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPE 181
            ++HRD+K  N+L+    +  + DFGLA++    D + TH V         + APE
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTH-VTTAVRGTIGHIAPE 205

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 28/206 (13%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A             VA+K ++      E      + E+K++  L   
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTL-------- 121
            +I+ L+ A  H G + ++ E+    DL   +R  +  L      +    T         
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 122 -----KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVF- 173
                +G+AF   K  +HRD+   N+L+ +    K+ DFGLAR   +        +    
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 174 ARWYRAPELLFGAKQYGAGVDVWAAG 199
            +W  APE +F    Y    DVW+ G
Sbjct: 230 VKWM-APESIFDCV-YTVQSDVWSYG 253

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 80.0 bits (198), Expect = 7e-17
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 47/220 (21%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           + LGEG +G V KA            TVA+K ++      E  +   L E  +LK++  P
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL--LSEFNVLKQVNHP 86

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN-----------------------TNIF 107
           H+I+L  A    G L L+ E+ +   L   +R                            
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           L+  D+ S+     +G+ +  +  ++HRD+   N+L+    ++K++DFGL+R     D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206

Query: 166 RRFTHQVF-ARWYRAPELLFGAKQYGAGV-----DVWAAG 199
            + +      +W  A E LF        +     DVW+ G
Sbjct: 207 VKRSQGRIPVKWM-AIESLF------DHIYTTQSDVWSFG 239

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 39/194 (20%), Positives = 74/194 (38%), Gaps = 38/194 (19%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL 65
           L     ++++  + +G G +G++Y A  T   +  A   +++  Q+ G  F    E+K  
Sbjct: 31  LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFY 87

Query: 66  KELKSPHIIELIDAFPHKGNL-------------------HLVFEFMETDLETVIRNTNI 106
           + +     I+          L                    +V E +  DL+ +      
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT 147

Query: 107 F-----LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLADFGLAR 159
           F     L         +M L  L + H+   +H D+K  NLL+G  +  Q+ LAD+GL+ 
Sbjct: 148 FKKSTVLQLGI-----RM-LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Query: 160 IFGSPDRRFTHQVF 173
            +        H+ +
Sbjct: 202 RYCPNG---NHKQY 212

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKAI-------DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELK 69
           + LGEG +G V  A          K   TVA+K ++    +K+  +   + E++++K + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFME-------------TDLETVIRNTNIFLSPADIKS 115
              +II L+ A    G L+++ E+                 +E       +       K 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 116 YMQMTL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
            +  T    +G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE LF    Y    DVW+ G
Sbjct: 219 GRLPVKWM-APEALFDRV-YTHQSDVWSFG 246

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKAI-------DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELK 69
           + LGEG +G V  A               VA+K ++    +K+  +   + E++++K + 
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 132

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFME-------------TDLETVIRNTNIFLSPADIKS 115
              +II L+ A    G L+++ E+                 LE     ++        K 
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 116 YMQMTL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
            +       +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  ++ T+
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE LF    Y    DVW+ G
Sbjct: 253 GRLPVKWM-APEALFDRI-YTHQSDVWSFG 280

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 33/209 (15%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
           E LGE  +G VYK         +  Q VAIK ++   +      F    E  L   L+ P
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF--RHEAMLRARLQHP 72

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN----TNIFLSPADIKSYMQMTLKGL-A 125
           +++ L+        L ++F +    DL   +      +++  +  D      +       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 126 FCH-----------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQV 172
                            V H+D+   N+L+     +K++D GL R   + D  +   + +
Sbjct: 133 LVAQIAAGMEYLSSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 173 F-ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
              RW  APE +++G  ++    D+W+ G
Sbjct: 192 LPIRWM-APEAIMYG--KFSIDSDIWSYG 217

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 31/209 (14%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A       T T +TVA+K ++ G    E      + E+K+L  +   
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 90

Query: 71  PHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRN---------------TNIFLSPADI 113
            +++ L+ A     G L ++ EF +  +L T +R+                  FL+   +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 114 KSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQ 171
             Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR         R    
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 172 VF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
               +W  APE +F    Y    DVW+ G
Sbjct: 211 RLPLKWM-APETIFDRV-YTIQSDVWSFG 237

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTG--QTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS-PHI 73
           +V+GEG +G V KA   K G     AIK+++    + +  +F    E+++L +L   P+I
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF--AGELEVLCKLGHHPNI 88

Query: 74  IELIDAFPHKGNLHLVFEFME-------------TDLETVIRNTNIFLSPADIKSYMQMT 120
           I L+ A  H+G L+L  E+                + +      N   S    +  +   
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 121 L---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR 159
               +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 41/202 (20%), Positives = 79/202 (39%), Gaps = 25/202 (12%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             LG G +G VY+       +  +   VA+K +     +++ ++F  L E  ++ +    
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF--LMEALIISKFNHQ 93

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTL---KGL 124
           +I+  I          ++ E M   DL++ +R         S   +   + +      G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPD--RRFTHQVFA-RWYR 178
            +  +   +HRD+   N L+   G     K+ DFG+AR        R+    +   +W  
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM- 212

Query: 179 APE-LLFGAKQYGAGVDVWAAG 199
            PE  + G   + +  D W+ G
Sbjct: 213 PPEAFMEG--IFTSKTDTWSFG 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 18  EVLGEGTYGVVYKAI-------DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELK 69
           + LGEG +G V  A          K   TVA+K ++    +K+  +   + E++++K + 
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 144

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRN----TNIFLSPADIKSYMQMTLK- 122
              +II L+ A    G L+++ E+    +L   +R        +    +     QMT K 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 123 ----------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTH 170
                     G+ +   +  +HRD+   N+L+  +  +K+ADFGLAR   + D  ++ T+
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 171 QVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
                +W  APE LF    Y    DVW+ G
Sbjct: 265 GRLPVKWM-APEALFDRV-YTHQSDVWSFG 292

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 16/165 (9%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
            +V +++     +G G++G +Y   + +T + VAIK   +  +        L E K+ + 
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRI 58

Query: 68  LK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSY----MQMTLK 122
           L+    I  +           LV + +   LE +    +  LS   +K+      QM + 
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLS---LKTVLMLADQM-IN 114

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSP 164
            + F H K  LHRD+KP+N L+G      Q+ + DFGLA+ +   
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 39/216 (18%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             +GEG +G V++A        +    VA+K ++         +F   RE  L+ E  +P
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF--QREAALMAEFDNP 110

Query: 72  HIIELIDAFPHKGNLHLVFEFME---------------------TDLETVIRNTNIFLSP 110
           +I++L+        + L+FE+M                      +DL T  R ++    P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 111 ADIKSYMQMTL---KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
                 + +      G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   S D  
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 166 RRFTHQVF-ARWYRAPE-LLFGAKQYGAGVDVWAAG 199
           +   +     RW   PE + +   +Y    DVWA G
Sbjct: 231 KADGNDAIPIRWM-PPESIFYN--RYTTESDVWAYG 263

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 40/201 (19%), Positives = 77/201 (38%), Gaps = 23/201 (11%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKSP 71
             LG G +G VY+       +  +   VA+K +     +++ ++F  L E  ++ +    
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF--LMEALIISKFNHQ 134

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTL---KGL 124
           +I+  I          ++ E M   DL++ +R         S   +   + +      G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGSPD--RRFTHQVFA-RWYR 178
            +  +   +HRD+   N L+   G     K+ DFG+AR        R+    +   +W  
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM- 253

Query: 179 APELLFGAKQYGAGVDVWAAG 199
            PE       + +  D W+ G
Sbjct: 254 PPEAFMEGI-FTSKTDTWSFG 273

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 37/215 (17%)

Query: 18  EVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           +VLG G +G V  A       T     VA+K ++      E      + E+K++ +L S 
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL--MSELKMMTQLGSH 108

Query: 71  PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRN-----------TNIFLSPADIKSYMQ 118
            +I+ L+ A    G ++L+FE+    DL   +R+                   + +    
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 119 MTLK-----------GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           +T +           G+ F   K  +HRD+   N+L+     +K+ DFGLAR   S    
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228

Query: 166 RRFTHQVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
               +     +W  APE LF    Y    DVW+ G
Sbjct: 229 VVRGNARLPVKWM-APESLF-EGIYTIKSDVWSYG 261

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 35/194 (18%), Positives = 71/194 (36%), Gaps = 39/194 (20%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKK---IRLGKQKEGVNFTALREI 62
           ++   A  +     +G+G +G +Y A D  + ++V       +++     G  F    E+
Sbjct: 29  ITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLF---TEL 84

Query: 63  KLLKELKSPHIIELIDAFPHKGNL-------------------HLVFEFMETDLETVIRN 103
           K  +    P  I+          L                    ++ +   +DL+ +   
Sbjct: 85  KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144

Query: 104 TNIFLSPADIKS-YM---QMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLADFGL 157
                S    K+      ++ L  L + H+   +H D+K +NLL+   +  Q+ L D+GL
Sbjct: 145 NAKRFS---RKTVLQLSLRI-LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200

Query: 158 ARIFGSPDRRFTHQ 171
           A  +        H+
Sbjct: 201 AYRYCPEG---VHK 211

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 31/188 (16%), Positives = 62/188 (32%), Gaps = 44/188 (23%)

Query: 6   LSKKVADRYLKREVLGEGTYGVVYKAIDTKTG--------QTVAIK-------------- 43
           L+ K   ++  +        G++Y+A  T T         Q  ++K              
Sbjct: 36  LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95

Query: 44  KIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH-LVFEFMETDLETVIR 102
             R  K  +      + + K L       I   +    H+     LV   +   L++ + 
Sbjct: 96  FQRAAKPLQ------VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD 149

Query: 103 NTN--IF-----LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLA 153
            +   +      L  A      ++ L  L F H+   +H ++   N+ +      Q+ LA
Sbjct: 150 VSPKHVLSERSVLQVAC-----RL-LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLA 203

Query: 154 DFGLARIF 161
            +G A  +
Sbjct: 204 GYGFAFRY 211

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 28/95 (29%), Positives = 42/95 (44%), Gaps = 5/95 (5%)

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           L+   +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR        
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249

Query: 166 RRFTHQVF-ARWYRAPELLFGAKQYGAGVDVWAAG 199
            R        +W  APE +F  + Y    DVW+ G
Sbjct: 250 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFG 282

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 41/195 (21%), Positives = 74/195 (37%), Gaps = 18/195 (9%)

Query: 18  EVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLG-KQKEGVNFTALREIKLLKELKS- 70
           + LG G +G V +A       T T +TVA+K ++ G    E      + E+K+L  +   
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 85

Query: 71  PHIIELIDA-FPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            +++ L+ A     G L ++ EF +  +L T +R+      P   K       K      
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE-LLFGAK 187
                  D+K     I S      + F   +     +     +   + +   E L+  + 
Sbjct: 146 -----PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200

Query: 188 QYGAGVDVWAA-GCI 201
           Q   G++  A+  CI
Sbjct: 201 QVAKGMEFLASRKCI 215

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 2e-05
 Identities = 45/344 (13%), Positives = 96/344 (27%), Gaps = 88/344 (25%)

Query: 28  VYKAIDTKTGQTVAIKKIRLG---KQKEGV--NFTALREIKLLKELK--SPHIIELIDAF 80
           V   +   T   +++    +     + + +   +   R   L +E+   +P  + +I   
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336

Query: 81  PHKGNLHL-VFEFMETD-LETVIRNTNIFLSPADIKSYMQM-------------TLKGL- 124
              G      ++ +  D L T+I ++   L PA+ +                   L  + 
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396

Query: 125 ------------AFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQ 171
                          HK  ++ +   P    I      L+L            +    H+
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQ--PKESTISIPSIYLELK-------VKLENEYALHR 447

Query: 172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAEL---LNRRPFLQGSSDIDQLGKIFAAF 228
                Y  P+           +  +     ++ +   L          +I+   +    F
Sbjct: 448 SIVDHYNIPK----TFDSDDLIPPYLDQYFYSHIGHHL---------KNIEHPER-MTLF 493

Query: 229 GTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA 288
                  + D  +L   + +   A         +AS   L+ L ++  Y  K  I     
Sbjct: 494 ----RMVFLDFRFLEQKIRHDSTAW--------NASGSILNTLQQLKFY--KPYICDNDP 539

Query: 289 LEHRYFSSAPLPTEPNKLPRPATK-RASKASD------FNPQEG 325
              R  ++       + LP+       SK +D          E 
Sbjct: 540 KYERLVNAI-----LDFLPKIEENLICSKYTDLLRIALMAEDEA 578

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	415
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.28
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.76
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.44
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.97
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.94
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.86
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.7
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.68
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.59
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.26
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.09
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.85
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.04
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.52
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.21

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.4e-67  Score=491.79  Aligned_cols=263  Identities=24%  Similarity=0.379  Sum_probs=231.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|++.+.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+++|+.++|||||+++++|++++++||
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            35789999999999999999999999999999999986542 23334467899999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC--C
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP--D  165 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~--~  165 (415)
                      |||||+ |+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+...  .
T Consensus       110 vmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            999998 58999887654 5999999999999999999999999999999999999999999999999999987533  2


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.+|...-.                
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----------------  251 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY----------------  251 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------------
T ss_pred             ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            34567899999999999987 6689999999999999999999999999998888888876411                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ------ALEHRYFSSAPLPTE  302 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------~l~h~~~~~~~~~~~  302 (415)
                                  .+...+|+++++||.+||+.||++|||++|      +++||||++..|...
T Consensus       252 ------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          252 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence                        111246899999999999999999999887      689999999887654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-66  Score=494.57  Aligned_cols=258  Identities=25%  Similarity=0.431  Sum_probs=228.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++......  ....+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46799999999999999999999999999999999765432  3345789999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||+| +|.+++.+.  .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+........
T Consensus       151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99995 788777653  499999999999999999999999999999999999999999999999999998876666677


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||++|||||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|.......                  
T Consensus       229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~------------------  289 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR------------------  289 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC------------------
Confidence            8899999999999976 679999999999999999999999999998888888776532110                  


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                             ...++.+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       290 -------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          290 -------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             -------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                   111234689999999999999999999999999999998643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-66  Score=505.91  Aligned_cols=293  Identities=34%  Similarity=0.589  Sum_probs=247.2

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec---
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH---   82 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---   82 (415)
                      ....+.++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++|||||++++++..   
T Consensus        48 ~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           48 VTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP  127 (398)
T ss_dssp             CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred             CCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence            33456789999999999999999999999999999999997655444344567799999999999999999998753   


Q ss_pred             ---CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           83 ---KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        83 ---~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                         .+++|||||||+|+|..++.+. ..+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus       128 ~~~~~~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          128 YGEFKSVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TTTCCCEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cccCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence               4689999999999999988764 469999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCC----CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          160 IFGSP----DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       160 ~~~~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      .+...    .......+||++|||||++.+...|+.++||||+|||+|||++|.+||.+.+..+++..|+...+.+....
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            76432    23455689999999999998877789999999999999999999999999999999999999999887766


Q ss_pred             CCCCCCCccchh---cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          236 WPDLAYLPDYVE---YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       236 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      |...........   +......++...++.+|++++|||.+||++||++|||++|+|+||||+....
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            654432221111   1112233456678899999999999999999999999999999999986543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.5e-67  Score=499.58  Aligned_cols=258  Identities=25%  Similarity=0.472  Sum_probs=224.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|++|+|||||+++++|++++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            47999999999999999999999999999999999876655444556889999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           91 EFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||+ |+|.+++...+ ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.........
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9998 58999987653 457999999999999999999999999999999999999999999999999999775444445


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+.+|...-..                  
T Consensus       183 ~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------------  243 (350)
T 4b9d_A          183 RACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------------------  243 (350)
T ss_dssp             HHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------------------
T ss_pred             cccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------------
Confidence            56789999999999987 67999999999999999999999999999988888888764110                  


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                               .....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       244 ---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          244 ---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                     112346899999999999999999999999999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.4e-66  Score=478.33  Aligned_cols=256  Identities=30%  Similarity=0.480  Sum_probs=210.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.+|+.++|||||+++++|++++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999998765332 3344578999999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||||+|+|.+.+.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ....
T Consensus        92 mEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~  169 (275)
T 3hyh_A           92 IEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLK  169 (275)
T ss_dssp             EECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccC
Confidence            9999999999998754 5999999999999999999999999999999999999999999999999999876443 3345


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      +.+||+.|||||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.....                    
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~--------------------  229 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY--------------------  229 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------------------
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence            678999999999998855567899999999999999999999999888777777755311                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                              .+...+|+++++||.+||+.||++|||++|+++||||+.
T Consensus       230 --------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 --------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             --------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                    111245899999999999999999999999999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.4e-65  Score=496.27  Aligned_cols=258  Identities=25%  Similarity=0.429  Sum_probs=228.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++......  ....+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            46799999999999999999999999999999999865432  3446789999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||+| +|.+++...  .+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus       228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            99995 787777643  499999999999999999999999999999999999999999999999999998876666677


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||++|||||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|......                   
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-------------------  365 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------------------  365 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-------------------
Confidence            8899999999999976 67999999999999999999999999999988888877653211                   


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                            ....+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       366 ------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          366 ------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             ------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                  0122345699999999999999999999999999999998643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.3e-66  Score=485.15  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=220.8

Q ss_pred             ccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ++|++++.||+|+||+||+|++.   .+++.||||++.+..........+.+|+.+|++++|||||+++++|++++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            68999999999999999999884   467899999998765444444567789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||||+ |+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            999999 58888887654 5999999999999999999999999999999999999999999999999999977665666


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|.+...                  
T Consensus       183 ~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------------  243 (304)
T 3ubd_A          183 AYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL------------------  243 (304)
T ss_dssp             CCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred             ccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------------
Confidence            677899999999999987 6799999999999999999999999999998888888865311                  


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                                .+...+|+++++||.+||+.||++|||     ++|+++||||++..|.
T Consensus       244 ----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          244 ----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence                      112246899999999999999999998     5899999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-63  Score=462.20  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=214.2

Q ss_pred             cccE-eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec----CCe
Q 014985           11 ADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KGN   85 (415)
Q Consensus        11 ~~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~   85 (415)
                      ..+| ++.++||+|+||+||+|.+..++..||+|++............+.+|+.+|++++|||||+++++|.+    +..
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            3455 77888999999999999999999999999998665444444567899999999999999999999865    456


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEec-CCcEEEeeeccceec
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGS-HGQLKLADFGLARIF  161 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~  161 (415)
                      +|||||||+ |+|.+++.+. ..+++..++.|+.||+.||+|||++|  |+||||||+||||+. +|++||+|||+|+..
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            899999999 5888888764 45999999999999999999999999  999999999999984 799999999999864


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .  .......+||+.|||||++.+  .|+.++|||||||+||||++|.+||.+.++...+.......  ..+        
T Consensus       183 ~--~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~--~~~--------  248 (290)
T 3fpq_A          183 R--ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKP--------  248 (290)
T ss_dssp             C--TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCC--------
T ss_pred             C--CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC--CCC--------
Confidence            3  234456789999999999865  59999999999999999999999998876665544432210  000        


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                     .......++++++||.+||+.||++|||++|+|+||||+.
T Consensus       249 ---------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                           1122345889999999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.5e-63  Score=470.61  Aligned_cols=253  Identities=26%  Similarity=0.384  Sum_probs=217.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .+.|++.++||+|+||+||+|+++.+|+.||||+++....       ..+|+.+|+.++|||||+++++|.+++.+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4679999999999999999999999999999999975432       237999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeeccceecCCCCC--
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~~~--  166 (415)
                      |||+ |+|.+++.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....  
T Consensus       130 Ey~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             eccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999 58888887654 599999999999999999999999999999999999999987 699999999987643321  


Q ss_pred             ---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 ---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                         .....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|...                
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------------  271 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----------------  271 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS----------------
T ss_pred             ceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC----------------
Confidence               1234579999999999987 67999999999999999999999999988776666666542                


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHH-------------hcCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA-------------LEHRYFSSA  297 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~-------------l~h~~~~~~  297 (415)
                               .+++..+.+.+|+++.+||.+||+.||.+|||+.|+             |+|||+...
T Consensus       272 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          272 ---------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             ---------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             ---------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence                     122334556789999999999999999999999997             568998654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.4e-61  Score=464.89  Aligned_cols=283  Identities=24%  Similarity=0.413  Sum_probs=221.8

Q ss_pred             ccccccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      ..+.++|++.+.||+|+||+||+|+++   .+++.||+|++....    ....+.+|+++|+.+ +|||||+++++|++.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            457899999999999999999999875   467899999986432    233577899999998 699999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccceec
Q 014985           84 GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARIF  161 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~~~  161 (415)
                      +++|+|||||+ |+|.+.+.    .+++..++.|++||+.||+|||++||+||||||+|||++.+ +++||+|||+|+..
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999998 58888774    38999999999999999999999999999999999999977 89999999999865


Q ss_pred             CCCC----------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCC-
Q 014985          162 GSPD----------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL-  212 (415)
Q Consensus       162 ~~~~----------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf-  212 (415)
                      ....                            ...+..+||++|||||++.+...|+.++||||+|||+|||++|++|| 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            4322                            12345689999999999988777999999999999999999999655 


Q ss_pred             CCCCcHHHHHHHHHHhCCCCCC--------------CCCCCCC--Cccchh----------cccccCCCccccCCCCCHH
Q 014985          213 QGSSDIDQLGKIFAAFGTATPS--------------QWPDLAY--LPDYVE----------YQYVAAPPLRSLFPSASDD  266 (415)
Q Consensus       213 ~~~~~~~~~~~i~~~~~~~~~~--------------~~~~~~~--~~~~~~----------~~~~~~~~~~~~~~~~s~~  266 (415)
                      .+.++.+++..|+..+|.....              ..+....  ......          ............++.+|++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            6677889999998877642110              0000000  000000          0000001112335678999


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          267 ALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       267 ~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ++|||.+||++||++|+|++|+|+||||++.+
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.8e-60  Score=447.36  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=198.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC------
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG------   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------   84 (415)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|++++|||||+++++|.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            45799999999999999999999999999999999765422 22345779999999999999999999986544      


Q ss_pred             ------eEEEEeeccc-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeee
Q 014985           85 ------NLHLVFEFME-TDLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (415)
Q Consensus        85 ------~~~lv~e~~~-g~L~~~i~~~~~--~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DF  155 (415)
                            ++|+|||||. |+|.+++.....  ..++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence                  4799999998 588888876532  2456678999999999999999999999999999999999999999999


Q ss_pred             ccceecCCCCC------------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q 014985          156 GLARIFGSPDR------------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK  223 (415)
Q Consensus       156 G~a~~~~~~~~------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  223 (415)
                      |+|+.......            ..+..+||+.|||||++.+ ..|+.++|||||||++|||++   ||.+.  .+....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence            99987644321            2345689999999999987 679999999999999999996   55432  222222


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      +........                        ...++..++.+.+||.+||+.||++|||+.|+|+||||++..++.
T Consensus       237 ~~~~~~~~~------------------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          237 LTDVRNLKF------------------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHTTCC------------------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHhcCCC------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            222211111                        111223367889999999999999999999999999998866543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-59  Score=481.65  Aligned_cols=271  Identities=28%  Similarity=0.463  Sum_probs=236.8

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +.+.++|++.+.||+|+||+||+|+++.+|+.||+|++......  ....+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            34678999999999999999999999999999999999764422  2345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC--CcEEEeeeccceecCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSP  164 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~--~~vkL~DFG~a~~~~~~  164 (415)
                      ||||||+ |+|.+++......+++..++.|++||+.||+|||++||+||||||+|||++.+  |.+||+|||+|+.+.. 
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-  309 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-  309 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence            9999998 58999998777779999999999999999999999999999999999999854  8999999999998754 


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      .......+||++|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++..|........            
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~------------  376 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------------  376 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC------------
T ss_pred             CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC------------
Confidence            344556789999999999987 6799999999999999999999999999999988888765422111            


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKL  306 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~~~  306 (415)
                                  ...++.+|+++++||.+||+.||.+|||++|+|+||||+...++......
T Consensus       377 ------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~  426 (573)
T 3uto_A          377 ------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI  426 (573)
T ss_dssp             ------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEE
T ss_pred             ------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhC
Confidence                        13345679999999999999999999999999999999988776654433

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-59  Score=479.09  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=218.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC-ccchHH---HHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG-VNFTAL---REIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~-~~~~~~---~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      -.++|++.++||+|+||+||+|+++.+|+.||||++.+...... ......   +++.+++.++|||||+++++|++.++
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            36889999999999999999999999999999999976542221 122233   34667778899999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      +|||||||. |+|..++.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus       267 lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999 58888887654 5999999999999999999999999999999999999999999999999999986443


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH---HHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID---QLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                        ...+.+||+.|||||++.+...|+.++||||||||+|||++|.+||.+.+..+   ....+...    .         
T Consensus       346 --~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~----~---------  410 (689)
T 3v5w_A          346 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----A---------  410 (689)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----C---------
T ss_pred             --CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----C---------
Confidence              34567999999999999765679999999999999999999999998754322   22222221    0         


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLPT  301 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~~  301 (415)
                                     ..+...+|+++++||.+||+.||.+|++     ++||++||||.+..|..
T Consensus       411 ---------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          411 ---------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             ---------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence                           0122356999999999999999999998     79999999999987643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-57  Score=428.36  Aligned_cols=287  Identities=47%  Similarity=0.819  Sum_probs=255.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            68999999999999999999999999999999998766555555667899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++|+++..+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  161 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE  161 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence            99999999998877889999999999999999999999999999999999999999999999999999887666666778


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      +||+.|+|||++.+...++.++|||||||++|+|++|. |+|.+.+..+.+..++...+.+....|+.....+++..+..
T Consensus       162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T 3o0g_A          162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM  241 (292)
T ss_dssp             CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred             ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence            89999999999987666899999999999999999765 66888888999999999999999999988776665543322


Q ss_pred             cc-CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          251 VA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       251 ~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      .. ........+.++.++.+||.+||+.||++|||++|+++||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            22 2234455677899999999999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.7e-58  Score=435.11  Aligned_cols=293  Identities=48%  Similarity=0.869  Sum_probs=255.0

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ...+.+.++|++.+.||+|+||+||+|.+. +|+.||+|++............+.+|+.+++.++||||+++++++.+..
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            346778999999999999999999999985 5899999999766554444456789999999999999999999999999


Q ss_pred             eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .+|+||||++|+|...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99999999999999999988778999999999999999999999999999999999999999999999999999988766


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      .......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..+...++.+.+..|+....++.
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence            66667788999999999998767789999999999999999999999999999999999999999999988887666554


Q ss_pred             chhc--ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          245 YVEY--QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       245 ~~~~--~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      +...  ......++....+.+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            4322  22334455666788899999999999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-58  Score=436.32  Aligned_cols=255  Identities=21%  Similarity=0.297  Sum_probs=208.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|++.   ..||||+++...........+.+|+.+|++++|||||++++++.. +.+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            467889999999999999999653   369999987654444444567899999999999999999998854 5789999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC--CCc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP--DRR  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~--~~~  167 (415)
                      |||+ |+|.+++......+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....  ...
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            9999 6899999887778999999999999999999999999999999999999999999999999999876432  233


Q ss_pred             ccccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 FTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ....+||+.|||||++.+.  ..|+.++|||||||+||||+||++||.+.+....+..+...-.                
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~----------------  254 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY----------------  254 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC----------------
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----------------
Confidence            4567899999999999642  3589999999999999999999999998887766665544211                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                            ..+.+....+.+++++.+||.+||+.||++|||+.|++++
T Consensus       255 ------~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          255 ------ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ------CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ------CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                  1122233445678999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.3e-58  Score=432.75  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=211.1

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|.+.+.||+|+||+||+|++.     .++..||||++....  ......+.+|+.+|++++|||||++++++.+++.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            578999999999999999999865     357889999987542  2223457899999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEE
Q 014985           86 LHLVFEFME-TDLETVIRNTN------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL  152 (415)
                      +|||||||+ |+|.+++.+.+            ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++++||
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEE
Confidence            999999999 68999987642            46999999999999999999999999999999999999999999999


Q ss_pred             eeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhC
Q 014985          153 ADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (415)
Q Consensus       153 ~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  229 (415)
                      +|||+|+.......  ......||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+.....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~  248 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  248 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999987644332  2234568999999999976 569999999999999999998 8999999988888887766421


Q ss_pred             CCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..                           ..+.+++++.+||.+||+.||++|||+.|+++
T Consensus       249 ~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~  282 (299)
T 4asz_A          249 LQ---------------------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHT  282 (299)
T ss_dssp             CC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC---------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            11                           12245889999999999999999999999953

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.2e-57  Score=432.54  Aligned_cols=251  Identities=21%  Similarity=0.336  Sum_probs=206.7

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|.+.++||+|+||+||+|++.     .++..||||++....  ......+.+|+.+|++++|||||+++++|.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            578999999999999999999864     367899999986432  2233467899999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcE
Q 014985           86 LHLVFEFME-TDLETVIRNTN--------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQL  150 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~--------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~v  150 (415)
                      +|||||||+ |+|.+++.+..              ..+++..+..|+.||+.||.|||+++||||||||+||||+.++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence            999999999 68998887542              358999999999999999999999999999999999999999999


Q ss_pred             EEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHH
Q 014985          151 KLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (415)
Q Consensus       151 kL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  227 (415)
                      ||+|||+|+......  ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+...
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998764333  22345678999999999977 669999999999999999998 89999999888888777654


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ....                           ....+++++.+||.+||+.||++|||+.|++++
T Consensus       277 ~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          277 RELE---------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CCCC---------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCC---------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2111                           112458999999999999999999999999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-56  Score=422.30  Aligned_cols=284  Identities=47%  Similarity=0.863  Sum_probs=245.5

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||+||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            6899999999999999999998 678999999998766555555667899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++|+|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            99999999998877779999999999999999999999999999999999999999999999999998876555556667


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh-ccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~  250 (415)
                      .+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++......|+.....+.+.. +..
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence            8899999999997766789999999999999999999999999999999999999999988888887655544321 122


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ....++....+.+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            2233445566778999999999999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-56  Score=433.89  Aligned_cols=297  Identities=59%  Similarity=1.030  Sum_probs=257.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||+|++......   ......+.+|+.+++.++||||++++++|.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3578999999999999999999999999999999998754322   2223467799999999999999999999999999


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      .|+||||++|+|...+......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus        87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            99999999999999998877779999999999999999999999999999999999999999999999999999876666


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..++...+.+....|++...++++
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            66677889999999999977667899999999999999999999999999999999999999999999999998888777


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNK  305 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~~  305 (415)
                      ..+......++...++.++.++.+||.+||+.||++|||++|+|+||||+..+.+.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~  306 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ  306 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCccc
Confidence            666555555666677889999999999999999999999999999999998766554433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4e-57  Score=427.95  Aligned_cols=253  Identities=20%  Similarity=0.288  Sum_probs=213.1

Q ss_pred             ccccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      -.+.+++.+.||+|+||+||+|...     .+++.||||++.... .......+.+|+.++++++|||||++++++.+++
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            3577899999999999999999753     467899999987543 2233456889999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG  148 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~  148 (415)
                      .+|||||||+ |+|.+++....               ..+++..+..|+.||+.||+|||+++||||||||+||||+.++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence            9999999999 68999986532               3589999999999999999999999999999999999999999


Q ss_pred             cEEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHH
Q 014985          149 QLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIF  225 (415)
Q Consensus       149 ~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  225 (415)
                      ++||+|||+|+......  ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999998753322  23455788999999999976 569999999999999999998 899999998888777765


Q ss_pred             HHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .....                           ...+.+++++.+|+.+||+.||++|||+.||+++
T Consensus       262 ~~~~~---------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          262 NRQVL---------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43111                           1123458899999999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-56  Score=425.78  Aligned_cols=287  Identities=39%  Similarity=0.743  Sum_probs=241.6

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999987544322 22234479999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |++|+|..++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  160 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE  160 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence            99999999999887789999999999999999999999999999999999999999999999999998776555566677


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      ++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.......+..+.+.
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (324)
T 3mtl_A          161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP  240 (324)
T ss_dssp             --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred             cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence            88999999999987677899999999999999999999999999999999999999999999988876554433333222


Q ss_pred             --cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          252 --AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       252 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                        .........+.+++++.+||.+||+.||++|||++|+|+||||.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence              222334556788999999999999999999999999999999987543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.2e-55  Score=418.46  Aligned_cols=288  Identities=40%  Similarity=0.739  Sum_probs=232.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            5789999999999999999999999999999999976542 233346779999999999999999999999999999999


Q ss_pred             ecccCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           91 EFMETDLETVIRNTN-----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        91 e~~~g~L~~~i~~~~-----~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ||++|+|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus        83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            999999999887642     358999999999999999999999999999999999999999999999999999876655


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..++...+.+....|+.....+.+
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence            55667789999999999987667899999999999999999999999999999999999999998888888766554433


Q ss_pred             hhccc-ccCCCc-----cccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          246 VEYQY-VAAPPL-----RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       246 ~~~~~-~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ..... .....+     ......++.++.+||.+||+.||++|||++|+|+||||.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence            21100 000111     1122357899999999999999999999999999999986443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-55  Score=422.60  Aligned_cols=292  Identities=46%  Similarity=0.809  Sum_probs=236.4

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.+...+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            34568899999999999999999999999999999999976655444445567899999999999999999999999999


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe-----cCCcEEEeeeccceec
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-----SHGQLKLADFGLARIF  161 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~-----~~~~vkL~DFG~a~~~  161 (415)
                      |+||||++|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||+++..
T Consensus       109 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            9999999999999987654 499999999999999999999999999999999999995     4456999999999887


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..........++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|+....
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            66666667778899999999998766789999999999999999999999999999999999999999988888877655


Q ss_pred             Cccchhc-ccccCCCcccc-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          242 LPDYVEY-QYVAAPPLRSL-FPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~~~~~-~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      .+.+... .......+... ...+++++.+||.+||+.||++|||++|+|+||||++..+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            5443221 01111111111 1236899999999999999999999999999999998655

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-55  Score=442.57  Aligned_cols=292  Identities=36%  Similarity=0.634  Sum_probs=225.8

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee-----cC
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-----HK   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~   83 (415)
                      .+.++|++.++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||++++++|.     ..
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            4678999999999999999999999999999999999754433333445778999999999999999999984     34


Q ss_pred             CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..+|+||||++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          130 DELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CCEEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             ceEEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            679999999999999998764 4599999999999999999999999999999999999999999999999999987643


Q ss_pred             CC---------------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc---------
Q 014985          164 PD---------------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN---------  207 (415)
Q Consensus       164 ~~---------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~---------  207 (415)
                      ..                           ...+..+||++|+|||++.....|+.++||||||||+|||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            22                           134566889999999988665779999999999999999998         


Q ss_pred             --CCCCCCCCC--------------------cHHHHHHHHHHhCCCCCCCCCCCCCCccc---hhcccccCCCccccCCC
Q 014985          208 --RRPFLQGSS--------------------DIDQLGKIFAAFGTATPSQWPDLAYLPDY---VEYQYVAAPPLRSLFPS  262 (415)
Q Consensus       208 --g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  262 (415)
                        |.++|.+.+                    ..+++..|+..+|.+....+.........   ..+.......+...++.
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              788888765                    36788888888887765433322111000   00111223345567788


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          263 ASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       263 ~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      +++++++||.+||++||++|||++|+|+||||....++.
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            899999999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=411.79  Aligned_cols=289  Identities=38%  Similarity=0.723  Sum_probs=240.4

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc---cCCccchHHHHHHHHHhcC---CCCeeeEEee
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELK---SPHIIELIDA   79 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~---~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~   79 (415)
                      ++..+.++|++.+.||+|+||+||+|++..+|+.||+|++.....   .........+|+.+++.++   ||||++++++
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            456778999999999999999999999999999999999875432   2222335667888877775   9999999999


Q ss_pred             eecCC-----eEEEEeecccCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEe
Q 014985           80 FPHKG-----NLHLVFEFMETDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLA  153 (415)
Q Consensus        80 ~~~~~-----~~~lv~e~~~g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~  153 (415)
                      +....     .+++||||++|+|..++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            97655     5899999999999999887643 48999999999999999999999999999999999999999999999


Q ss_pred             eeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          154 DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       154 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      |||+++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++...+....
T Consensus       163 Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          163 DFGLARIYSY-QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCSCTTTSTT-CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eCccccccCC-CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999986643 333456788999999999977 55899999999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ..|+.....+... +......+.....+.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          241 DDWPRDVSLPRGA-FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TTSCSSCSSCGGG-SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhccchhhccccc-cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            8888765554321 22223344556678899999999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.9e-55  Score=433.21  Aligned_cols=293  Identities=38%  Similarity=0.650  Sum_probs=238.7

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK----   83 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----   83 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++...    
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            3468999999999999999999999999999999999976543333344677999999999999999999999766    


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ..+|+||||++|+|...+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus       102 ~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          102 FDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CCCEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             CCeEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence             579999999999999998764 459999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----------------------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-----------CC
Q 014985          163 SPD----------------------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-----------RR  209 (415)
Q Consensus       163 ~~~----------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-----------g~  209 (415)
                      ...                      ...+..+||++|+|||++.....|+.++||||||||+|||++           |.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            432                      124677899999999998666779999999999999999997           67


Q ss_pred             CCCCCCC-----------------cHHHHHHHHHHhCCCCCCCCCCCCCCcc--ch-hcccccCCCccccCCCCCHHHHH
Q 014985          210 PFLQGSS-----------------DIDQLGKIFAAFGTATPSQWPDLAYLPD--YV-EYQYVAAPPLRSLFPSASDDALD  269 (415)
Q Consensus       210 ~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~s~~~~~  269 (415)
                      |+|.+.+                 ..+++..|+..+|.+....+........  +. .........+...++.+++++.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            7787765                 4788899999998876543332211000  00 11112223345567889999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          270 LLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       270 li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      ||.+||+.||++|||++|+|+||||....++.
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            99999999999999999999999999876554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-55  Score=423.34  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=208.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-----CcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeec-C
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPH-K   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~-~   83 (415)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||.+...... .....+.+|+.+|++++| ||||+++++|.. +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            47899999999999999999987654     368999998754332 223457889999999976 899999999865 4


Q ss_pred             CeEEEEeeccc-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC
Q 014985           84 GNLHLVFEFME-TDLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~---------------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~  147 (415)
                      +.+|||||||+ |+|.+++++.               ...+++..+..|+.||+.||+|||+++||||||||+|||++.+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence            57899999999 6899998753               2348999999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHH
Q 014985          148 GQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKI  224 (415)
Q Consensus       148 ~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  224 (415)
                      +.+||+|||+|+.......  ..+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999987644332  3345678999999999987 569999999999999999998 89999987654444443


Q ss_pred             HH-HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          225 FA-AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .. ....                           .....+++++.+||.+||+.||++|||+.||++|
T Consensus       301 i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            33 2111                           1112358999999999999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-55  Score=431.56  Aligned_cols=291  Identities=35%  Similarity=0.642  Sum_probs=226.5

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      +...+.++|++.+.||+|+||+||+|.+..+|+.||||++..............+|+.+++.+. ||||++++++|...+
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            3567889999999999999999999999999999999998755444344445678999999997 999999999997544


Q ss_pred             --eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 --~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                        .+|+|||||+|+|...+...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             CCEEEEEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence              79999999999999998764  48999999999999999999999999999999999999999999999999998753


Q ss_pred             CC---------------------CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHH
Q 014985          163 SP---------------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL  221 (415)
Q Consensus       163 ~~---------------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  221 (415)
                      ..                     ....+..+||++|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            31                     123445689999999999987677999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCcc--ch----hcccccCCCccccC-------------CCCCHHHHHHHHHhcCCCCCCC
Q 014985          222 GKIFAAFGTATPSQWPDLAYLPD--YV----EYQYVAAPPLRSLF-------------PSASDDALDLLSKMFTYDPKAR  282 (415)
Q Consensus       222 ~~i~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~-------------~~~s~~~~~li~~~L~~dP~~R  282 (415)
                      ..++..++.+....+........  ..    .............+             ..+++++.+||.+||+.||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            99999888765433221110000  00    00000011111111             2678999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCC
Q 014985          283 ITAQQALEHRYFSSAP  298 (415)
Q Consensus       283 pt~~e~l~h~~~~~~~  298 (415)
                      ||++|+|+||||+...
T Consensus       321 ~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          321 ISANDALKHPFVSIFH  336 (388)
T ss_dssp             CCHHHHTTSTTTTTTC
T ss_pred             CCHHHHhCCHHHHHhc
Confidence            9999999999998643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.9e-54  Score=413.70  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=227.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+.+|
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            44578999999999999999999999999999999999866544444456779999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... .
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  168 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G  168 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred             EEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence            9999997 58888887654 4999999999999999999999999999999999999999999999999999876443 3


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.....                 
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  231 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----------------  231 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence            456678999999999998855556899999999999999999999999888877777765311                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                 .....+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       232 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          232 -----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             -----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence                       01123589999999999999999999999999999998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-54  Score=417.26  Aligned_cols=292  Identities=42%  Similarity=0.749  Sum_probs=246.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-------   82 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------   82 (415)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4689999999999999999999999999999999997766655556677899999999999999999999876       


Q ss_pred             -CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           83 -KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 -~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                       .+.+|+||||++|+|...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence             4578999999999999999887778999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC----CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          162 GSP----DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       162 ~~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      ...    .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+...+..|+
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            422    2334566789999999999876778999999999999999999999999999999999999999998888887


Q ss_pred             CCCCCccchhcccccCC--CccccC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAP--PLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~--~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      .......+.........  ......  ...++++.+||.+||+.||++|||++|+|+||||...+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            65443322211111100  000000  01377899999999999999999999999999998765544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-54  Score=418.81  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=220.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      -.++|++.+.||+|+||+||+|++..+|+.||||++.+... .........+|+.+++.+ +||||++++++|.+.+.+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            36899999999999999999999999999999999976432 222334567899999988 7999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||.| +|...+.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus       101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            99999985 788877765 4599999999999999999999999999999999999999999999999999987555555


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|.....                 
T Consensus       180 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-----------------  241 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----------------  241 (353)
T ss_dssp             ------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             cccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            5667789999999999976 5689999999999999999999999999998888888866311                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRYFSSAPLP  300 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~h~~~~~~~~~  300 (415)
                                 .+...++.++.+||.+||+.||.+||++      +++++||||.+..|.
T Consensus       242 -----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          242 -----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                       1112358999999999999999999998      999999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-54  Score=408.54  Aligned_cols=291  Identities=40%  Similarity=0.664  Sum_probs=230.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +.++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            46899999999999999999999999999999999876544433344567899999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||++|+++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99999877776666666799999999999999999999999999999999999999999999999999998766555566


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc-
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-  248 (415)
                      ..++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++...+..+............ 
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            7789999999999987677899999999999999999999999999999998888887665433211000000000000 


Q ss_pred             --ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          249 --QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       249 --~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                        ...........++.++.++.+||.+||+.||.+|||++|+++||||++....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence              0001122333456789999999999999999999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.5e-54  Score=413.15  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=226.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++.+... .......+.+|+.+|+.++||||++++++|...+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            5799999999999999999999999999999999976432 223334577899999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||++| +|...+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.........
T Consensus        84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            999985 787777654 458999999999999999999999999999999999999999999999999998755555556


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.....                   
T Consensus       163 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------  222 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------------  222 (337)
T ss_dssp             CCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             cccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            67789999999999976 5689999999999999999999999998887777766654210                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                               .+...+++++.+||.+||+.||.+||     +++|+++||||.+..|.
T Consensus       223 ---------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          223 ---------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence                     11124589999999999999999999     89999999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-53  Score=414.34  Aligned_cols=265  Identities=27%  Similarity=0.438  Sum_probs=228.3

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      ...+.++|.+.+.||+|+||+||+|.+..+|+.||+|++........    ....+.+|+.+|+.++||||++++++|.+
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            35678999999999999999999999999999999999987653322    23457799999999999999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC----cEEEeeecc
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGL  157 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~----~vkL~DFG~  157 (415)
                      ...+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999997 578887765 44699999999999999999999999999999999999998877    799999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      +...... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+........     
T Consensus       166 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----  238 (361)
T 2yab_A          166 AHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD-----  238 (361)
T ss_dssp             CEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-----
T ss_pred             ceEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-----
Confidence            9876543 33456789999999999976 5689999999999999999999999999988888777754311110     


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                         ...++.++.++++||.+||..||.+|||++|+++||||....
T Consensus       239 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          239 -------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             -------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                               123346689999999999999999999999999999998643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-54  Score=434.43  Aligned_cols=284  Identities=35%  Similarity=0.571  Sum_probs=228.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||++++++|...     
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            457899999999999999999999999999999999986543333445677999999999999999999999654     


Q ss_pred             -CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 -GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 -~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                       ..+|+||||++|++...+..   .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus       139 ~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             46899999999999888754   38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      . .......+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|+..+|.+.+..+......
T Consensus       216 ~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          216 T-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             C-CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            4 334556789999999999987 56899999999999999999999999999999999999999998776544332110


Q ss_pred             cc-chhc-ccccCCCccccCCC------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PD-YVEY-QYVAAPPLRSLFPS------------ASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~-~~~~-~~~~~~~~~~~~~~------------~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .. +... .......+...++.            .++++++||.+||+.||++|||++|+|+||||+..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            00 0000 00001111122221            15779999999999999999999999999999854

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-54  Score=418.29  Aligned_cols=287  Identities=36%  Similarity=0.584  Sum_probs=234.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC---
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---   84 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+   
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            45688999999999999999999999999999999998665443333445778999999999999999999997653   


Q ss_pred             ---eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           85 ---NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        85 ---~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                         .+|+||||++++|..++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~~~~~lv~e~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          101 DFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             TCCCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCceEEEEEecCCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence               56999999988999888763  4899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..   .....++|++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..++...+.++...+.....
T Consensus       179 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          179 DS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            43   345678899999999998766799999999999999999999999999999999999999988765433222110


Q ss_pred             Ccc--c-hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          242 LPD--Y-VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~--~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...  + ..........+...++.+++++.+||.+||+.||.+|||++|+|+||||.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            000  0 001112233455677888999999999999999999999999999999987543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.1e-53  Score=415.72  Aligned_cols=261  Identities=23%  Similarity=0.344  Sum_probs=219.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      -.++|++.++||+|+||+||+|+++.+++.||+|++.+..... .....+.+|..++.++ +||||++++++|.+.+.+|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3679999999999999999999999999999999998654332 2334577899999887 8999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||.| +|...+.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus       130 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            99999985 787777764 4599999999999999999999999999999999999999999999999999987555555


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc--------HH-HHHHHHHHhCCCCCCCCC
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--------ID-QLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~-~~~~i~~~~~~~~~~~~~  237 (415)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+...        .+ ....+... .        
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~--------  278 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-Q--------  278 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-C--------
T ss_pred             ccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-c--------
Confidence            6677899999999999987 5689999999999999999999999975321        12 22222221 0        


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRYFSSAPLP  300 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~h~~~~~~~~~  300 (415)
                                         ..+...++.++++||.+||+.||.+||++      +|+++||||.+..|.
T Consensus       279 -------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          279 -------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             -------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence                               01223468999999999999999999984      899999999987664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-53  Score=423.97  Aligned_cols=264  Identities=30%  Similarity=0.449  Sum_probs=229.6

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ...+.++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||++++++|.+.+..
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            44678999999999999999999999999999999999987654444445678999999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe---cCCcEEEeeeccceecC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~---~~~~vkL~DFG~a~~~~  162 (415)
                      |+|||||.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        86 ~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999985 788888765 4599999999999999999999999999999999999998   45789999999998876


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+..........        
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  235 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP--------  235 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT--------
T ss_pred             CCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc--------
Confidence            66666667889999999999976 568999999999999999999999999998888888877653322222        


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                      .++.+++++++||.+||+.||++|||+.|+|+||||+.
T Consensus       236 ----------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          236 ----------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             ----------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             ----------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence                            22356899999999999999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.7e-53  Score=398.35  Aligned_cols=259  Identities=28%  Similarity=0.482  Sum_probs=225.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++......  ....+.+|+.+++.++||||++++++|...+.+|+
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            3578999999999999999999999999999999998754332  23457789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||++ |+|.+++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.........
T Consensus        95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            999997 5788877664  4899999999999999999999999999999999999999999999999999987666666


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......                
T Consensus       173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------------  235 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE----------------  235 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC----------------
T ss_pred             cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence            667889999999999987 568999999999999999999999999888777776665431110                


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                               ......++..+.+||.+||+.||++|||++|+++||||+..
T Consensus       236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          236 ---------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             ---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ---------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                     01112458899999999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.4e-53  Score=418.65  Aligned_cols=269  Identities=23%  Similarity=0.325  Sum_probs=230.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++.++||+|+||+||+|++..+++.||+|++.+... .......+.+|+.++..++||||++++++|.+.+.+|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            5899999999999999999999999999999999976432 222334577899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-c
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~  167 (415)
                      ||||. |+|..++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....... .
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            99997 689999887667799999999999999999999999999999999999999999999999999987654333 3


Q ss_pred             ccccccccceeCccccc----CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          168 FTHQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ....+||+.|+|||++.    +...|+.++|||||||++|||++|.+||.+.+..+.+.+|+.......           
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------  301 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-----------  301 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc-----------
Confidence            34568999999999986    235689999999999999999999999999998888888765321110           


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~~~~  302 (415)
                                  +....+.+|+++++||.+||..+|++  |++++|+++||||++..|...
T Consensus       302 ------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          302 ------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             ------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             ------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                        11122346999999999999998888  999999999999999887654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-53  Score=417.52  Aligned_cols=267  Identities=25%  Similarity=0.325  Sum_probs=228.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|.+.++||+|+||+||+|++..+++.||+|++.+... .......+.+|+.+++.++||||++++++|.+...+|+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            36799999999999999999999999999999999976432 22333457789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||||+ |+|..++...  .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....... 
T Consensus       147 V~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            999997 5888887654  489999999999999999999999999999999999999999999999999987654432 


Q ss_pred             cccccccccceeCcccccCCc---CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 RFTHQVFARWYRAPELLFGAK---QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .....+||+.|+|||++.+..   .|+.++|||||||++|||++|.+||.+.+..+...+|.........          
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------  294 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF----------  294 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC----------
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC----------
Confidence            334678999999999997633   2789999999999999999999999999988888888654211110          


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKA--RITAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpt~~e~l~h~~~~~~~~~~~  302 (415)
                                    ...+.+|.++++||.+||+.+|.+  |++++||++||||++..|...
T Consensus       295 --------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          295 --------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             --------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             --------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence                          011246899999999999999988  999999999999998877543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.4e-53  Score=408.05  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=225.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..++|.+.+.||+|+||.||+|+++.+|+.||+|++..... .........+|..++..+ +||||++++++|++.+.+|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            46899999999999999999999999999999999976432 122334567899999877 9999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||. |+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus        95 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence            9999998 58888887644 589999999999999999999999999999999999999999999999999987554455


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.....                 
T Consensus       174 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------------  235 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-----------------  235 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             cccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence            5667889999999999977 5689999999999999999999999999888877777754310                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ-QALEHRYFSSAPLP  300 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~-e~l~h~~~~~~~~~  300 (415)
                                 .+...++.++.+||.+||+.||++||++. ++++||||.+..|.
T Consensus       236 -----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          236 -----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             -----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence                       11123589999999999999999999998 99999999987653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.6e-54  Score=416.70  Aligned_cols=287  Identities=36%  Similarity=0.584  Sum_probs=222.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK----   83 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----   83 (415)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||++++++|...    
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            3467999999999999999999999999999999999875443333344567899999999999999999998654    


Q ss_pred             --CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           84 --GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        84 --~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                        ..+|+|+||++++|..++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          105 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             GCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             cCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence              56899999999888888765  35999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..   .....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+++..++..++.+....+.....
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          183 AD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             cc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            43   244568899999999998767799999999999999999999999999999999999999988766543332211


Q ss_pred             Ccc--ch-hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          242 LPD--YV-EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~--~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...  +. .........+...++.+++++.+||.+||+.||.+|||++|+|+||||.....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            100  00 01111223445667788999999999999999999999999999999986543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-53  Score=412.70  Aligned_cols=281  Identities=30%  Similarity=0.580  Sum_probs=228.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-------   82 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------   82 (415)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++......      ..+|+.+++.++||||++++++|..       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            468999999999999999999999999999999998654321      2279999999999999999999843       


Q ss_pred             -------------------------------CCeEEEEeecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhh
Q 014985           83 -------------------------------KGNLHLVFEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCH  128 (415)
Q Consensus        83 -------------------------------~~~~~lv~e~~~g~L~~~i~---~~~~~l~~~~~~~i~~qil~aL~~lH  128 (415)
                                                     ...+++||||++|+|...+.   ..+..+++..++.++.||+.||+|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           34589999999998777765   34567999999999999999999999


Q ss_pred             hCCccccCCCCCcEEEe-cCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc
Q 014985          129 KKWVLHRDMKPNNLLIG-SHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN  207 (415)
Q Consensus       129 ~~~ivHrDlkp~NILi~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~  207 (415)
                      ++||+||||||+|||++ .++.+||+|||+|+..... ......++|+.|+|||++.+...++.++|||||||++|+|++
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            99999999999999998 6899999999999876433 334556789999999999876679999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccC-CCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014985          208 RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQ  286 (415)
Q Consensus       208 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~  286 (415)
                      |.+||.+.+..+++..+...++.+..+.+...........+.......+...+ ...+.++.+||.+||+.||.+|||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            99999999999999999999887655432211110001111111122233333 35799999999999999999999999


Q ss_pred             HHhcCCCCCCC
Q 014985          287 QALEHRYFSSA  297 (415)
Q Consensus       287 e~l~h~~~~~~  297 (415)
                      |+++||||...
T Consensus       318 e~l~hp~f~~~  328 (383)
T 3eb0_A          318 EAMAHPFFDHL  328 (383)
T ss_dssp             HHHTSGGGHHH
T ss_pred             HHhcCHHHHHH
Confidence            99999999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.7e-53  Score=410.22  Aligned_cols=263  Identities=31%  Similarity=0.456  Sum_probs=226.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ...+.++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||++++++|.+.+..
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            45678899999999999999999999999999999999986654433344677899999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEEEeeeccceecC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vkL~DFG~a~~~~  162 (415)
                      |+|||||.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       104 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999985 787877654 4589999999999999999999999999999999999998654   59999999998765


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+.........         
T Consensus       183 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------  251 (362)
T 2bdw_A          183 DS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---------  251 (362)
T ss_dssp             TC-CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------
T ss_pred             CC-cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc---------
Confidence            33 33455789999999999976 56899999999999999999999999998888777777654221111         


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                     ..++.+++++++||.+||+.||++|||+.|+|+||||..
T Consensus       252 ---------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          252 ---------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             ---------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             ---------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                           112345899999999999999999999999999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-53  Score=406.03  Aligned_cols=260  Identities=24%  Similarity=0.419  Sum_probs=227.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||+|.+....   .....+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            57899999999999999999999999999999999986432   223356789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec--CCcEEEeeeccceecCCCC
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~--~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||||+| +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++...... 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            9999985 898888776667999999999999999999999999999999999999987  789999999999876543 


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+........             
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  223 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------------  223 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-------------
T ss_pred             CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-------------
Confidence            34456778999999999976 4579999999999999999999999999988888887766422111             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                 ...++.++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       224 -----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          224 -----------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -----------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -----------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                       12334668999999999999999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-52  Score=412.97  Aligned_cols=284  Identities=35%  Similarity=0.637  Sum_probs=230.1

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC--
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--   84 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--   84 (415)
                      +.....+|.+.+.||+|+||+||+|++..++. +|+|++......      ..+|+.+++.++||||++++++|...+  
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            45567899999999999999999999887766 888887643221      127999999999999999999985433  


Q ss_pred             ----eEEEEeecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe-cCCcEEEeeec
Q 014985           85 ----NLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADFG  156 (415)
Q Consensus        85 ----~~~lv~e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~-~~~~vkL~DFG  156 (415)
                          .+|+||||++++++..+..   ....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence                4889999999987776543   355699999999999999999999999999999999999999 78999999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      +|+...... .....++|++|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++..+...++.+....+
T Consensus       188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998764332 3445678999999999987677999999999999999999999999999999999999998887654432


Q ss_pred             CCCCCCccchhc--ccccCCCccc-cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          237 PDLAYLPDYVEY--QYVAAPPLRS-LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       237 ~~~~~~~~~~~~--~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      ....  +.+...  ......++.. +.+.+++++.+||.+||+.||.+|||+.|+++||||+.....
T Consensus       267 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          267 KTMN--PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHC--GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HhhC--hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            2111  111111  1111222222 234589999999999999999999999999999999876543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1e-52  Score=416.39  Aligned_cols=281  Identities=35%  Similarity=0.614  Sum_probs=228.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec------C
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------K   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~   83 (415)
                      ...+|.+.+.||+|+||+||+|++..+|+.||||++.....      ...+|+.+|+.++||||++++++|..      .
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            35589999999999999999999999999999999865322      12379999999999999999998843      2


Q ss_pred             CeEEEEeecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeeccce
Q 014985           84 GNLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLAR  159 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~  159 (415)
                      .++++||||+++++...+..   ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++
T Consensus       126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            24779999999988776653   45679999999999999999999999999999999999999965 678999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      ...... .....++|++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..++..++.+....|...
T Consensus       206 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          206 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             ECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             hcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            764432 3345688999999999987667999999999999999999999999999999999999998887654333211


Q ss_pred             CCCccchhc--ccccCCCccc-cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          240 AYLPDYVEY--QYVAAPPLRS-LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       240 ~~~~~~~~~--~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      .  +.+..+  ......++.. +.+.+++++++||.+||+.||.+|||+.|+++||||.....
T Consensus       285 ~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          285 N--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             C--SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             C--hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            1  011111  1111222222 23467899999999999999999999999999999986543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-51  Score=394.68  Aligned_cols=289  Identities=39%  Similarity=0.718  Sum_probs=245.1

Q ss_pred             cccccEeeeeeecccCceEEEEEEEC-CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEeeee---
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDT-KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFP---   81 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~---   81 (415)
                      ...++|++.+.||+|+||.||+|.+. .+|+.||+|++............+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35689999999999999999999995 6788999999986655444455677888888777   8999999999987   


Q ss_pred             --cCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           82 --HKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        82 --~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                        .....++||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence              567899999999999999988754 34899999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.
T Consensus       168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCC-CCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            865432 23445678999999999976 4589999999999999999999999999999999999999998888777776


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      ....+... +............+.++..+.+||.+||..||.+|||+.++++||||+.....
T Consensus       246 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          246 DVALPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             TCSSCGGG-SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccchhh-hcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            54443322 12223344556677889999999999999999999999999999999876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.4e-53  Score=408.14  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=226.2

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~   86 (415)
                      ...++|.+.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|..++..+ .||||++++++|++.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            347899999999999999999999999999999999976532 223334567899999988 799999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+. |+|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999998 58888887654 49999999999999999999999999999999999999999999999999998754444


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.....                
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------  238 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------------  238 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred             cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            55567789999999999976 5689999999999999999999999999888888877765311                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                                  .+...++.++.+||.+||+.||.+||+     ++++++||||....|.
T Consensus       239 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          239 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                        111245899999999999999999994     7999999999987664

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-52  Score=400.81  Aligned_cols=258  Identities=23%  Similarity=0.361  Sum_probs=224.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      -.++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||++++++|.+...+|+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence            368899999999999999999999999999999999764322 2233456789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||+.| +|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....   .
T Consensus        84 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~  159 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---V  159 (318)
T ss_dssp             EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---C
T ss_pred             EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---c
Confidence            9999985 888887764 4599999999999999999999999999999999999999999999999999987643   2


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+.....                  
T Consensus       160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  220 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------  220 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------------
T ss_pred             cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence            345689999999999976 5689999999999999999999999999888888877765310                  


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                                .+.+.++.++.+||.+||+.||++|+     +++++++||||.+..|.
T Consensus       221 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          221 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                      11234589999999999999999999     89999999999987653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.6e-53  Score=407.61  Aligned_cols=292  Identities=35%  Similarity=0.627  Sum_probs=235.2

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      +-....++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++...+.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            44556899999999999999999999999999999999987655443334456789999999999999999999999999


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      .|+||||++|+++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999999988777776666679999999999999999999999999999999999999999999999999998776655


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.++.+.+..+....+...+..+......+..
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            55666789999999999987667899999999999999999999999999999999888887765433211000000000


Q ss_pred             h---hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 V---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .   ........+....++.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            0   001112223344567789999999999999999999999999999999753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.9e-53  Score=403.03  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=191.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----e
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----N   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~   85 (415)
                      +..+|.+.+.||+|+||+||+|++  +|+.||||++.....   .......|+..+..++|||||++++++..++    .
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            467899999999999999999976  589999999864321   1112234666777899999999999987653    6


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--------CccccCCCCCcEEEecCCcEEEeeec
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK--------WVLHRDMKPNNLLIGSHGQLKLADFG  156 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~--------~ivHrDlkp~NILi~~~~~vkL~DFG  156 (415)
                      +|||||||+ |+|.+++...  .+++..+..++.|++.||+|||++        +|+||||||+||||+.++++||+|||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            899999999 6888888764  389999999999999999999987        89999999999999999999999999


Q ss_pred             cceecCCCCC----cccccccccceeCcccccCCc-----CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH--------
Q 014985          157 LARIFGSPDR----RFTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDID--------  219 (415)
Q Consensus       157 ~a~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------  219 (415)
                      +|+.......    .....+||+.|||||++.+..     .|+.++|||||||+||||+||.+||....+.+        
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            9987654432    223468999999999997532     36789999999999999999988775432110        


Q ss_pred             ---HHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          220 ---QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       220 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                         ....+.......                   ...+.+....  ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~-------------------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQ-------------------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTS-------------------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcc-------------------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               000111100000                   0001111111  1123568899999999999999999999863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-52  Score=403.01  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=219.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      -.++|++.+.||+|+||.||+|+++.+++.||+|++.+..... .....+.+|+.+++.+ +||||++++++|.+.+.+|
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   86 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF   86 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence            3678999999999999999999999999999999998654322 2223466899999988 8999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||+. |+|...+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus        87 lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            9999998 57888776643 599999999999999999999999999999999999999999999999999987554555


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---------cHHHHHHHHHHhCCCCCCCCC
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---------DIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||....         .......+... .        
T Consensus       166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~--------  235 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-Q--------  235 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-C--------
T ss_pred             cccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-C--------
Confidence            5667789999999999977 568999999999999999999999997532         11222222221 0        


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA------QQALEHRYFSSAPLP  300 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~------~e~l~h~~~~~~~~~  300 (415)
                                         ..+...++.++.+||.+||+.||.+||++      +++++||||.+..|.
T Consensus       236 -------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          236 -------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence                               01123468999999999999999999985      899999999987653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-52  Score=412.74  Aligned_cols=269  Identities=24%  Similarity=0.316  Sum_probs=228.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.++..++||||++++++|++.+.+|+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            36899999999999999999999999999999999975432 22233457789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||||. |+|..++.+.+..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++....... 
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence            999997 689999887666799999999999999999999999999999999999999999999999999987654333 


Q ss_pred             cccccccccceeCcccccC------CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          167 RFTHQVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .....+||+.|+|||++.+      ...|+.++|||||||++|||++|.+||.+.+..+.+.+|........        
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  290 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------  290 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------
Confidence            2345689999999999962      24689999999999999999999999999988888887764311000        


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCCCCCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKAR---ITAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~e~l~h~~~~~~~~~~~  302 (415)
                                     +......+|+++++||.+||. +|.+|   ++++|+++||||.+..|...
T Consensus       291 ---------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          291 ---------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             ---------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             ---------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                           011123568999999999999 99998   59999999999999887654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-52  Score=403.84  Aligned_cols=261  Identities=30%  Similarity=0.468  Sum_probs=220.4

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      +.....++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus         3 i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             -CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            4566789999999999999999999999999999999999754322 233446779999999999999999999999999


Q ss_pred             eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      ..|+||||++|+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        83 ~~~lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-  160 (336)
T 3h4j_B           83 DIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-  160 (336)
T ss_dssp             EEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred             EEEEEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence            999999999999999987754 499999999999999999999999999999999999999999999999999987643 


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      .......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.........+                    
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------------------  220 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------------------  220 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------------
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------------
Confidence            333456789999999999987555578999999999999999999999765321110000                    


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                              ..........+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus       221 --------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          221 --------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             --------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             --------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                    00011223346899999999999999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.4e-53  Score=407.46  Aligned_cols=263  Identities=32%  Similarity=0.498  Sum_probs=221.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC---CccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE---GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++.......   .....+.+|+.+++.++||||++++++|.+.+
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG   99 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            346789999999999999999999999999999999997543221   12345779999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc---EEEeeecc
Q 014985           85 NLHLVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGL  157 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~---vkL~DFG~  157 (415)
                      .+|+|||||+ |+|...+.+.   +..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999 5787777543   345899999999999999999999999999999999999987655   99999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      +.............+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.. .+....+.......      
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~------  251 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM------  251 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC------
Confidence            9987665555566789999999999976 568999999999999999999999998753 34444444321110      


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                        ....++.++.++++||.+||+.||++|||+.|+++||||..
T Consensus       252 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          252 ------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             ------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence                              01223456899999999999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-52  Score=408.26  Aligned_cols=285  Identities=37%  Similarity=0.639  Sum_probs=236.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----C
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----G   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~   84 (415)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...     .
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            35799999999999999999999999999999999874322 22224567899999999999999999998654     4


Q ss_pred             eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      ..|+||||++|+|..++...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          104 DVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             CEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             eEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            79999999999999988764  4899999999999999999999999999999999999999999999999999876433


Q ss_pred             CC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 DR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..   .....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+.....
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            21   234568999999999987767789999999999999999999999999999999999998888765443322111


Q ss_pred             Cccc---hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          242 LPDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       242 ~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ....   .........++...++.++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            1000   0011112233455667889999999999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.3e-52  Score=400.94  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=226.1

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||++++++|.+...+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            357899999999999999999999999999999999976532 2233345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ |+|..++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....  
T Consensus       118 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999997 58888887654 4999999999999999999999999999999999999999999999999999876432  


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....                 
T Consensus       195 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------------  255 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-----------------  255 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             -cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence             345689999999999977 5689999999999999999999999999888888777765311                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                                 .+...++.++.+||.+||+.||.+||+     ++++++||||.+..|.
T Consensus       256 -----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          256 -----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence                       111245899999999999999999998     9999999999987653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-52  Score=397.42  Aligned_cols=263  Identities=26%  Similarity=0.434  Sum_probs=225.8

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcCCCCeeeEEeeeecC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHK   83 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   83 (415)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++........    ....+.+|+.+|+.++||||++++++|.+.
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4578899999999999999999999999999999999986543321    234577999999999999999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC----cEEEeeeccc
Q 014985           84 GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA  158 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~----~vkL~DFG~a  158 (415)
                      ..+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999997 578887765 45699999999999999999999999999999999999999887    8999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......       
T Consensus       166 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------  236 (326)
T 2y0a_A          166 HKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF-------  236 (326)
T ss_dssp             EECCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred             eECCCC-CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc-------
Confidence            876433 23455679999999999976 568999999999999999999999999988887777765531110       


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                       ....++.++..+.+||.+||+.||.+|||+.|+|+||||...
T Consensus       237 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          237 -----------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             -----------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -----------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                             112334568999999999999999999999999999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.8e-53  Score=415.09  Aligned_cols=290  Identities=38%  Similarity=0.690  Sum_probs=225.4

Q ss_pred             ccccccEee-eeeecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee--ec
Q 014985            8 KKVADRYLK-REVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF--PH   82 (415)
Q Consensus         8 ~~~~~~y~~-~~~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~   82 (415)
                      ..+.+.|.+ .++||+|+||+||+|++.  .+++.||||++....    ....+.+|+.+|+.++||||++++++|  ..
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            356788988 458999999999999965  578899999986432    233577999999999999999999999  45


Q ss_pred             CCeEEEEeecccCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE----ecCCcE
Q 014985           83 KGNLHLVFEFMETDLETVIRNT--------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQL  150 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~--------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi----~~~~~v  150 (415)
                      ...+|+||||++|+|...+...        ...+++..++.++.||+.||+|||++||+||||||+||||    +.++.+
T Consensus        92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            7799999999999999888632        1248999999999999999999999999999999999999    677899


Q ss_pred             EEeeeccceecCCCC---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---------H
Q 014985          151 KLADFGLARIFGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---------I  218 (415)
Q Consensus       151 kL~DFG~a~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------~  218 (415)
                      ||+|||+|+......   ......+||++|+|||++.+...|+.++|||||||++|+|++|.+||.+...         .
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998765432   2344578899999999998766799999999999999999999999987654         5


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCccchhccccc------CCC----ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014985          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVA------APP----LRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (415)
Q Consensus       219 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~  288 (415)
                      +++..++..++.+....|+....++.........      ...    +.......+..+.+||.+||+.||.+|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            8899999999999998898776665543211100      000    011122347889999999999999999999999


Q ss_pred             hcCCCCCCCCCCC
Q 014985          289 LEHRYFSSAPLPT  301 (415)
Q Consensus       289 l~h~~~~~~~~~~  301 (415)
                      |+||||...+++.
T Consensus       332 L~hp~f~~~~~~~  344 (405)
T 3rgf_A          332 MQDPYFLEDPLPT  344 (405)
T ss_dssp             HTSGGGTSSSCCC
T ss_pred             hcChhhccCCCCc
Confidence            9999999866554

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.4e-52  Score=406.13  Aligned_cols=265  Identities=21%  Similarity=0.398  Sum_probs=221.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||++++++|.+.+.+
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3347899999999999999999999999999999999976542 223334577899999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+.| +|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++.... .
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~  168 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-E  168 (384)
T ss_dssp             EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-T
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-C
Confidence            999999985 77777665 45699999999999999999999999999999999999999999999999999987643 3


Q ss_pred             CcccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc--HHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 RRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD--IDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ......+||+.|+|||++.+  ...|+.++|||||||++|+|++|.+||.+.+.  ...+...+....            
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------  236 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------  236 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------------
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------------
Confidence            44566789999999999964  24589999999999999999999999976432  222222221111            


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCCCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-AQQALEHRYFSSAPLPT  301 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~l~h~~~~~~~~~~  301 (415)
                                     ......++.++.+||.+||+.||.+||+ ++++++||||.+..|..
T Consensus       237 ---------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~  282 (384)
T 4fr4_A          237 ---------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA  282 (384)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred             ---------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence                           0112345899999999999999999998 99999999999887643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.6e-52  Score=397.70  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=215.9

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            46789999999999999999999999999999999987554322 23467899999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--  165 (415)
                      |||||+| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....  
T Consensus        83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           83 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999985 77776654 4459999999999999999999999999999999999999999999999999998653322  


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..............               
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------  226 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------  226 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------------
Confidence            23346789999999999987555578999999999999999999999876654332222221100               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                ....+..++.++.+||.+||+.||++|||++|+++||||...
T Consensus       227 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                      001123458999999999999999999999999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-52  Score=407.74  Aligned_cols=263  Identities=22%  Similarity=0.344  Sum_probs=220.3

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHH-HHhcCCCCeeeEEeeeecCCeE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKL-LKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ...++|++.+.||+|+||.||+|+++.+++.||+|++.+.... ......+.+|..+ ++.++||||++++++|.+.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            3568999999999999999999999999999999999865432 2223345567776 5778999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+.| +|...+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            999999985 7887776644 58999999999999999999999999999999999999999999999999998755555


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....|.....                
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------  256 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----------------  256 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC----------------
T ss_pred             CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------------
Confidence            55667889999999999976 5689999999999999999999999999888888877765310                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA----QQALEHRYFSSAPLPT  301 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~l~h~~~~~~~~~~  301 (415)
                                  .+.+.++.++.+||.+||+.||.+||++    .++++||||....|..
T Consensus       257 ------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          257 ------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             ------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence                        1123568999999999999999999986    7999999999876643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.2e-52  Score=406.44  Aligned_cols=285  Identities=36%  Similarity=0.594  Sum_probs=233.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE--
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL--   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~--   86 (415)
                      .+.++|.+.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||++++++|...+..  
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            467899999999999999999999999999999999976544444445677899999999999999999999877654  


Q ss_pred             ----EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           87 ----HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ----~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                          |+||||++|+|...+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          119 FYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             ceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence                9999999999888764   339999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..   ....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+......
T Consensus       196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            32   345678999999999987667899999999999999999999999999999999999988876654332221110


Q ss_pred             ccc---hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          243 PDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       243 ~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...   ..........+...++.+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence            000   001111222344556788999999999999999999999999999999986543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.6e-52  Score=398.40  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=215.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCcc--CCccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      ....++|++.+.||+|+||.||+|++.   .+|+.||+|++......  ......+.+|+.+++.++||||++++++|..
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            345789999999999999999999985   68999999999765322  1223346689999999999999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      .+.+|+||||+. |+|...+...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999998 58888877644 5899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....            
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------  238 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------------  238 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------------
T ss_pred             ccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------------
Confidence            444444556789999999999976 5689999999999999999999999999888888777765311            


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                                      .+.+.++.++.+||.+||..||.+||     +++|+++||||....+
T Consensus       239 ----------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          239 ----------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ----------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                            11234589999999999999999999     8999999999987654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.2e-51  Score=396.10  Aligned_cols=292  Identities=38%  Similarity=0.634  Sum_probs=237.2

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--   83 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--   83 (415)
                      ....+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++...  
T Consensus         5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            455678999999999999999999999999999999999864322 22233566899999999999999999987654  


Q ss_pred             ---CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           84 ---GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        84 ---~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                         ...|+||||++|+|...+...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           84 ENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             TTCCCEEEEECCCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CccceEEEEEeccCccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence               689999999999999988763  489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCC
Q 014985          161 FGSPDR----------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGT  230 (415)
Q Consensus       161 ~~~~~~----------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  230 (415)
                      ......          .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            643221          1234578999999999876567899999999999999999999999999999999999888876


Q ss_pred             CCCCCCCCCCCCccchh----cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          231 ATPSQWPDLAYLPDYVE----YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      +................    ........+...++.+++++.+||.+||+.||++|||++|+++||||+....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence            55332211111111000    11112233455667889999999999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-52  Score=393.79  Aligned_cols=259  Identities=26%  Similarity=0.348  Sum_probs=213.0

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .+..+.++|++.++||+|+||+||+|++..+|+.||||++...............|+..+..+ +||||++++++|.+.+
T Consensus        51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            345567899999999999999999999999999999999865443333333445566666555 8999999999999999


Q ss_pred             eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           85 NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .+|+||||++|+|...+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus       131 ~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          131 ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999999999999999888878999999999999999999999999999999999999999999999999999876443


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       .......||+.|+|||++.+  .++.++|||||||++|||++|..+|.+.....   .+...   .             
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~---~-------------  268 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQG---Y-------------  268 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTT---C-------------
T ss_pred             -CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhcc---C-------------
Confidence             23445678999999999876  58999999999999999999976665432222   11110   0             


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                ......+.+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       269 ----------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ----------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                      001223456899999999999999999999999999999974

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-51  Score=402.90  Aligned_cols=262  Identities=28%  Similarity=0.455  Sum_probs=225.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.++|.+.+.||+|+||+||+|.+..+|+.||+|++......  ....+.+|+.+|+.++||||++++++|.+...+|+
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence            4678999999999999999999999999999999998754322  22357789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec--CCcEEEeeeccceecCCCC
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~--~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||||. |+|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++..... 
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-  204 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  204 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence            999998 5888888776667999999999999999999999999999999999999974  477999999999876543 


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+........             
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------  270 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------------  270 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            23345678999999999976 5689999999999999999999999999888888777755321111             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                 ...+..+++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       271 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          271 -----------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -----------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                       122345689999999999999999999999999999998643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-52  Score=391.61  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=212.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC------------------------CccchHHHHHHHH
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE------------------------GVNFTALREIKLL   65 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~------------------------~~~~~~~~E~~il   65 (415)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.......                        .....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            4789999999999999999999999999999999997654211                        1124577899999


Q ss_pred             HhcCCCCeeeEEeeeec--CCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcE
Q 014985           66 KELKSPHIIELIDAFPH--KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNL  142 (415)
Q Consensus        66 ~~l~hp~Iv~l~~~~~~--~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NI  142 (415)
                      +.++||||+++++++.+  .+.+|+||||++| +|..++  ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            99999999999999986  6789999999985 554432  234599999999999999999999999999999999999


Q ss_pred             EEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcC--CCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH
Q 014985          143 LIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ  220 (415)
Q Consensus       143 Li~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  220 (415)
                      |++.++++||+|||+++.............||+.|+|||++.+...  ++.++|||||||++|+|++|.+||.+.+....
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999999987665555566789999999999976432  47789999999999999999999988776665


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      ...+.....     .+                     ...+.+++++.+||.+||+.||++|||+.|+++||||+
T Consensus       249 ~~~~~~~~~-----~~---------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQAL-----EF---------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCC-----CC---------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccC-----CC---------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            555543210     00                     11235689999999999999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-52  Score=407.51  Aligned_cols=284  Identities=34%  Similarity=0.563  Sum_probs=219.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----   84 (415)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||++++++|...+    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            4678999999999999999999999999999999999865443333445778999999999999999999997654    


Q ss_pred             --eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           85 --NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        85 --~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                        .+|+||||++|+|...+..   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              7899999999999988863   38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+.+..+......
T Consensus       179 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          179 TS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc-cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            32 23445688999999999987 56899999999999999999999999999999999999887776654333221100


Q ss_pred             cc-chhc-ccccCCCcccc-----CCC-------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PD-YVEY-QYVAAPPLRSL-----FPS-------ASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~-~~~~-~~~~~~~~~~~-----~~~-------~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .. +... .......+...     +|.       .+.++++||.+||+.||++|||++|+|+||||+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            00 0000 00000000011     111       25689999999999999999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-52  Score=415.88  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=215.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|++.++||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||++++++|...+.+|+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            46889999999999999999999999999999999975432 22223346689999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||||++| +|...+... ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++++||+|||+|+.......
T Consensus       226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            9999985 777777654 459999999999999999999998 9999999999999999999999999999987555555


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+.....                 
T Consensus       305 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----------------  366 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----------------  366 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred             ccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence            5667889999999999977 5689999999999999999999999998887777777654211                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                                 .+...+++++.+||.+||+.||.+||     +++|+++||||.+..+.
T Consensus       367 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          367 -----------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -----------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                       11234589999999999999999999     99999999999987653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-51  Score=409.90  Aligned_cols=283  Identities=30%  Similarity=0.538  Sum_probs=229.3

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc------CCCCeeeEEeeee
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL------KSPHIIELIDAFP   81 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~   81 (415)
                      +.+.++|++.+.||+|+||+||+|.+..+++.||||++....   .....+.+|+.+++.+      +|+||++++++|.
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            457889999999999999999999999999999999986432   2223456788888887      5679999999999


Q ss_pred             cCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc--EEEeeeccc
Q 014985           82 HKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLA  158 (415)
Q Consensus        82 ~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~--vkL~DFG~a  158 (415)
                      ...++|+||||++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||++
T Consensus       170 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999999999999998764 35999999999999999999999999999999999999999987  999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +....   .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+...++.+....+..
T Consensus       250 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          250 CYEHQ---RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             EETTC---CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eecCC---cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            87543   2345688999999999987 5689999999999999999999999999999999999999888765432111


Q ss_pred             CCCC---------ccchhccc---------------------ccCCCccc-cCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014985          239 LAYL---------PDYVEYQY---------------------VAAPPLRS-LFPSASDDALDLLSKMFTYDPKARITAQQ  287 (415)
Q Consensus       239 ~~~~---------~~~~~~~~---------------------~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  287 (415)
                      ....         +.+.....                     .....+.. +....++++.+||.+||++||++|||++|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence            1000         00000000                     00000111 11235788999999999999999999999


Q ss_pred             HhcCCCCCCC
Q 014985          288 ALEHRYFSSA  297 (415)
Q Consensus       288 ~l~h~~~~~~  297 (415)
                      +|+||||+..
T Consensus       406 ~L~Hpw~~~~  415 (429)
T 3kvw_A          406 ALRHPWLRRR  415 (429)
T ss_dssp             HHTSTTTC--
T ss_pred             HhCChhhccC
Confidence            9999999863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-51  Score=399.22  Aligned_cols=289  Identities=32%  Similarity=0.556  Sum_probs=221.9

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC---
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---   84 (415)
                      ....++|.+.+.||+|+||+||+|.+..+|+.||||++....   .......+|+..++.++||||++++++|...+   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            345789999999999999999999999999999999986533   22335667888899999999999999986533   


Q ss_pred             ----eEEEEeecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhh--hCCccccCCCCCcEEEec-CCcEEEee
Q 014985           85 ----NLHLVFEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCH--KKWVLHRDMKPNNLLIGS-HGQLKLAD  154 (415)
Q Consensus        85 ----~~~lv~e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH--~~~ivHrDlkp~NILi~~-~~~vkL~D  154 (415)
                          .+++||||++|+|...+..   ....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence                3889999999988776653   4566899999999999999999999  999999999999999997 89999999


Q ss_pred             eccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       155 FG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+...
T Consensus       176 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          176 FGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            9999876543 334456789999999999776678999999999999999999999999999999999999887766543


Q ss_pred             CCCCCCCCccchhcccccCCCccccC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLF----PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      .+..................++...+    ...+.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence            22211111011111111111222222    2357899999999999999999999999999999875443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-51  Score=402.97  Aligned_cols=289  Identities=20%  Similarity=0.229  Sum_probs=219.4

Q ss_pred             cccEeeeeeeccc--CceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEG--TYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .++|++.+.||+|  +||+||+|++..+|+.||||++............+.+|+.+++.++||||++++++|...+.+|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            7899999999999  99999999999999999999998765444444567789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-
Q 014985           89 VFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-  165 (415)
                      |||||+ |+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....... 
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            999998 5888887764 3559999999999999999999999999999999999999999999999999986542211 


Q ss_pred             ------CcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC--CC
Q 014985          166 ------RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS--QW  236 (415)
Q Consensus       166 ------~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~  236 (415)
                            ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+..........  ..
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI  263 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence                  122335788999999999764 468999999999999999999999999877666655443321100000  00


Q ss_pred             CCC------------CCCccchh----cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          237 PDL------------AYLPDYVE----YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       237 ~~~------------~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      +..            ....+...    .......+.......+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            000            00000000    0000011112344567999999999999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.8e-51  Score=382.75  Aligned_cols=263  Identities=31%  Similarity=0.455  Sum_probs=226.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++...+..|
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence            46789999999999999999999999999999999999765544434445778999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc---EEEeeeccceecCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~---vkL~DFG~a~~~~~  163 (415)
                      +||||+.| +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        82 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999985 787777665 45899999999999999999999999999999999999987655   99999999987654


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.........          
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  228 (284)
T 3kk8_A          161 S-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------  228 (284)
T ss_dssp             S-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------
T ss_pred             C-ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----------
Confidence            3 33345678999999999976 56899999999999999999999999998888777776654222211          


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                    ..+..+++++.+||.+||+.||++|||++|+++||||...
T Consensus       229 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          229 --------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             --------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             --------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence                          1223458999999999999999999999999999999764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-51  Score=397.67  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=216.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..+.++|++.+.||+|+||+||+|.++.+|+.||+|++.....      ...+|+.++.++ +||||++++++|.+...+
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            3578999999999999999999999999999999999975432      234789999888 799999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC----CcEEEeeeccceec
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIF  161 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~----~~vkL~DFG~a~~~  161 (415)
                      |+|||||. |+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+..+    +.+||+|||+++..
T Consensus        92 ~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999998 5888888764 459999999999999999999999999999999999998543    35999999999987


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC---CcHHHHHHHHHHhCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS---SDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      ..........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.   +..+.+..+.......       
T Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-------  242 (342)
T 2qr7_A          171 RAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL-------  242 (342)
T ss_dssp             BCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC-------
T ss_pred             cCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc-------
Confidence            665555667789999999999976 45889999999999999999999999863   3344444443321111       


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                       ....++.+++++++||.+||..||++|||+.++++||||..
T Consensus       243 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          243 -----------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             -----------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             -----------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence                             11223456999999999999999999999999999999965

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.8e-51  Score=396.13  Aligned_cols=282  Identities=23%  Similarity=0.368  Sum_probs=225.6

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-----CCCeeeEEeeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----SPHIIELIDAFP   81 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-----hp~Iv~l~~~~~   81 (415)
                      +..+.++|.+.++||+|+||+||+|++..+++.||||++....   .......+|+.+++.+.     ||||++++++|.
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            4567899999999999999999999999999999999986322   12234567999999997     999999999999


Q ss_pred             cCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec--------------
Q 014985           82 HKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--------------  146 (415)
Q Consensus        82 ~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~--------------  146 (415)
                      ..+..|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.              
T Consensus       107 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            999999999999889999988754 35999999999999999999999999999999999999975              


Q ss_pred             -----------CCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC
Q 014985          147 -----------HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS  215 (415)
Q Consensus       147 -----------~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  215 (415)
                                 ++.+||+|||+++.....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                       788999999999875432   345678999999999987 56899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCCCCCCCCCCCc--cchh-----cccccC-----------CCccccCCCCCHHHHHHHHHhcCC
Q 014985          216 SDIDQLGKIFAAFGTATPSQWPDLAYLP--DYVE-----YQYVAA-----------PPLRSLFPSASDDALDLLSKMFTY  277 (415)
Q Consensus       216 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~-----~~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~  277 (415)
                      +..+.+..+....+..+...+.......  .+..     ..+...           ..........++.+.+||.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            9999888888776544321110000000  0000     000000           000001112357888999999999


Q ss_pred             CCCCCCCHHHHhcCCCCC
Q 014985          278 DPKARITAQQALEHRYFS  295 (415)
Q Consensus       278 dP~~Rpt~~e~l~h~~~~  295 (415)
                      ||++|||++|+|+||||+
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999995

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-51  Score=429.12  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=228.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      -.++|.++++||+|+||+||+|++..+++.||||++.+... ..........|..++..+ .||+|++++++|++.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            35789999999999999999999999999999999976432 223344567899999987 6899999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |||||++ |+|..++...+ .+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            9999998 57888877654 599999999999999999999999999999999999999999999999999997655555


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|.....                 
T Consensus       498 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----------------  559 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-----------------  559 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-----------------
T ss_pred             ccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence            6667889999999999976 5689999999999999999999999999988888888764211                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-----QQALEHRYFSSAPLPT  301 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~-----~e~l~h~~~~~~~~~~  301 (415)
                                 .+...++.++++||.+||+.||.+|+++     +||++||||.+..|..
T Consensus       560 -----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          560 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             -----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence                       1123468999999999999999999997     9999999999887643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.7e-51  Score=412.86  Aligned_cols=261  Identities=33%  Similarity=0.514  Sum_probs=221.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|++.+.||+|+||+||+|++..++..||+|++............+.+|+.+++.++||||++++++|.+...+|
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34678999999999999999999999999999999999876655555567889999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeeccceecCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~a~~~~~  163 (415)
                      +|||||. |+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++.....
T Consensus       113 lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999998 47888777654 48999999999999999999999999999999999999764   4599999999987654


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+.........          
T Consensus       192 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------  258 (494)
T 3lij_A          192 Q-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS----------  258 (494)
T ss_dssp             T-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS----------
T ss_pred             C-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------
Confidence            3 34456789999999999864  5899999999999999999999999999988888887664322211          


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                    ..++.+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       259 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          259 --------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             --------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             --------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence                          223456899999999999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-51  Score=414.11  Aligned_cols=263  Identities=33%  Similarity=0.526  Sum_probs=225.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|++.++||+|+||+||+|.+..+++.||||++............+.+|+.++++++||||+++++++.+...+|
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            45789999999999999999999999999999999999765544444556789999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe---cCCcEEEeeeccceecCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~---~~~~vkL~DFG~a~~~~~  163 (415)
                      +|||||. |+|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus        98 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999998 57888877654 599999999999999999999999999999999999995   456799999999986643


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+.........          
T Consensus       177 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------  243 (486)
T 3mwu_A          177 N-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------  243 (486)
T ss_dssp             C-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----------
T ss_pred             C-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----------
Confidence            3 34456789999999999976  4899999999999999999999999999888888887664221111          


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                    ..++.+|+++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       244 --------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          244 --------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             --------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             --------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                          12234589999999999999999999999999999997643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-50  Score=387.26  Aligned_cols=264  Identities=26%  Similarity=0.420  Sum_probs=226.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++........    ....+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            35678999999999999999999999999999999999986543322    23457789999999999999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC----cEEEeeecc
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGL  157 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~----~vkL~DFG~  157 (415)
                      ....|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999997 588887765 44589999999999999999999999999999999999999888    799999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      +...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......      
T Consensus       166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------  237 (321)
T 2a2a_A          166 AHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF------  237 (321)
T ss_dssp             CEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC------
T ss_pred             ceecCcc-ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc------
Confidence            9876543 23455678999999999976 568999999999999999999999999988877777665421100      


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                        ....++.++..+.+||.+||..||++|||++|+++||||+..
T Consensus       238 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          238 ------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             ------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             ------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence                              012234568999999999999999999999999999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=398.48  Aligned_cols=285  Identities=36%  Similarity=0.598  Sum_probs=230.8

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe--
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN--   85 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--   85 (415)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+.  
T Consensus        20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence            346789999999999999999999999999999999997654433334457789999999999999999999977654  


Q ss_pred             ----EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           86 ----LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        86 ----~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                          +|+||||++|+|...+..   .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                599999999988776642   4899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          162 GSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       162 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ...   ....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.....
T Consensus       177 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          177 DAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            332   34567899999999997766789999999999999999999999999999999999988877654332221111


Q ss_pred             Ccc--c-hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          242 LPD--Y-VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       242 ~~~--~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ...  + ..........+...++.+++++.+||.+||+.||++|||++|+++||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            000  0 00011112234455677899999999999999999999999999999998644

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.3e-51  Score=390.96  Aligned_cols=269  Identities=24%  Similarity=0.412  Sum_probs=225.5

Q ss_pred             cccccccEeee-eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985            7 SKKVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus         7 ~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      .+.+.++|.+. +.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.+. ||||++++++|...+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            35678999998 8999999999999999999999999999876544444556789999999995 599999999999999


Q ss_pred             eEEEEeecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeeccce
Q 014985           85 NLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLAR  159 (415)
Q Consensus        85 ~~~lv~e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG~a~  159 (415)
                      ..|+||||+.| +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            99999999985 777776543 356999999999999999999999999999999999999987   7899999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      ...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.........      
T Consensus       183 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------  254 (327)
T 3lm5_A          183 KIGHAC-ELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------  254 (327)
T ss_dssp             EC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------
T ss_pred             ccCCcc-ccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc------
Confidence            764432 3345678999999999976 56899999999999999999999999998888877777654322221      


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                                        ..++.++..+.+||.+||+.||.+|||++++|+||||+...+..
T Consensus       255 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          255 ------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             ------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             ------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                              22345689999999999999999999999999999999876644

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.6e-51  Score=393.61  Aligned_cols=259  Identities=26%  Similarity=0.416  Sum_probs=222.9

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...++|.+.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++...+..|
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            3457799999999999999999999999999999999765332 222345678999999999999999999999999999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      +||||+.|++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....    
T Consensus       131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----  206 (348)
T 1u5q_A          131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  206 (348)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence            9999999999999987777899999999999999999999999999999999999999999999999999987543    


Q ss_pred             ccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 FTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ....+||+.|+|||++.+  ...++.++|||||||++|||++|.+||.+.+....+..+.......              
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------------  272 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------  272 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence            234678999999999853  3568999999999999999999999999888777766655431100              


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                  .....++..+.+||.+||+.||++|||++++++||||...
T Consensus       273 ------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          273 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                        0112458899999999999999999999999999999754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-50  Score=380.48  Aligned_cols=263  Identities=29%  Similarity=0.424  Sum_probs=216.5

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      +....+.++|.+.+.||+|+||+||+|.+..++..+|+|++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus        15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            34456889999999999999999999999999999999999765432 22345778999999999999999999999999


Q ss_pred             eEEEEeecccC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeecc
Q 014985           85 NLHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGL  157 (415)
Q Consensus        85 ~~~lv~e~~~g-~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~  157 (415)
                      ..|+||||++| +|.+.+...   +..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            99999999984 888887543   4669999999999999999999999999999999999999   4567899999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      +...... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+......       
T Consensus       174 a~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------  243 (285)
T 3is5_A          174 AELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN-------  243 (285)
T ss_dssp             CCC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred             ceecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc-------
Confidence            9876443 23445678999999999854  5789999999999999999999999988766665554332110       


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                        .......+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       244 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          244 ------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             ------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             ------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                              01112235899999999999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-51  Score=398.53  Aligned_cols=289  Identities=37%  Similarity=0.610  Sum_probs=228.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc---------cchHHHHHHHHHhcCCCCeeeEEe
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV---------NFTALREIKLLKELKSPHIIELID   78 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~---------~~~~~~E~~il~~l~hp~Iv~l~~   78 (415)
                      ..+.++|.+.+.||+|+||.||+|.+.. |+.||||++.........         ...+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            4568999999999999999999998755 899999998654432221         145778999999999999999999


Q ss_pred             eee-----cCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEe
Q 014985           79 AFP-----HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLA  153 (415)
Q Consensus        79 ~~~-----~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~  153 (415)
                      +|.     ....+|+||||++|+|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            983     344789999999999999999887789999999999999999999999999999999999999999999999


Q ss_pred             eeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          154 DFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       154 DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      |||++..... ........+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..
T Consensus       177 Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCccccccc-ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            9999975433 233445678999999999987667899999999999999999999999999999999999888776543


Q ss_pred             CCCCCCCCC--ccch--hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          234 SQWPDLAYL--PDYV--EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       234 ~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ..+......  .++.  .........+....+..++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            221100000  0000  0011122233455677899999999999999999999999999999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=390.99  Aligned_cols=260  Identities=28%  Similarity=0.426  Sum_probs=204.6

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||++.....    ...+.+|+.+++.++||||++++++|...+..|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            4578899999999999999999999999999999999875432    234668999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeeccceecCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG~a~~~~~  163 (415)
                      +||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       125 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             EEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999998 5788877654 45899999999999999999999999999999999999975   88999999999987643


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH-HHHHHHHHhCCCCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-QLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+..+.......           
T Consensus       204 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----------  270 (349)
T 2w4o_A          204 Q-VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----------  270 (349)
T ss_dssp             ----------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----------
T ss_pred             c-cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----------
Confidence            2 23345678999999999976 568999999999999999999999988776655 344443321100           


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                   ....++.++.++.+||.+||+.||++|||+.|+++||||.+..
T Consensus       271 -------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 -------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                         1122345689999999999999999999999999999998643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-51  Score=392.98  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=195.3

Q ss_pred             cccccEeee---eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCC
Q 014985            9 KVADRYLKR---EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKG   84 (415)
Q Consensus         9 ~~~~~y~~~---~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~   84 (415)
                      .+.++|.+.   +.||+|+||+||+|.+..+|+.||||++...     ......+|+.+++.+. ||||++++++|.+..
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            456788876   7899999999999999999999999998643     2235668999999997 999999999999999


Q ss_pred             eEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEEEeeecccee
Q 014985           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARI  160 (415)
Q Consensus        85 ~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vkL~DFG~a~~  160 (415)
                      ..|+||||++| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999985 888888764 5699999999999999999999999999999999999998766   899999999998


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc-------HHHHHHHHHHhCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD-------IDQLGKIFAAFGTATP  233 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~  233 (415)
                      ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.       .+.+..+...    ..
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~----~~  233 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG----DF  233 (325)
T ss_dssp             CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT----CC
T ss_pred             cCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC----CC
Confidence            7666666667788999999999976 5689999999999999999999999987543       2233332211    00


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                          ......++.+++++++||.+||+.||.+|||+.|+++||||++.
T Consensus       234 --------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          234 --------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             --------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             --------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                                00112223568999999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-50  Score=384.53  Aligned_cols=257  Identities=24%  Similarity=0.422  Sum_probs=219.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ..|...+.||+|+||.||+|++..+|+.||||++.....  .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            358888999999999999999999999999999975432  223457789999999999999999999999999999999


Q ss_pred             cccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      |++| +|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus       123 ~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          123 FLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             CCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             cCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            9985 66666553  35999999999999999999999999999999999999999999999999999887655545566


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......    .+              
T Consensus       201 ~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~--------------  261 (321)
T 2c30_A          201 LVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP----KL--------------  261 (321)
T ss_dssp             CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC----CC--------------
T ss_pred             ccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----Cc--------------
Confidence            789999999999976 56899999999999999999999999988877776665442110    00              


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                             .....+++.+.+||.+||+.||++|||+.++++||||....
T Consensus       262 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          262 -------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             -------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             -------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                   11123578999999999999999999999999999998644

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.4e-51  Score=397.63  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.....   ....+.+|+.+++.++||||++++++|...+.+|+|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999975432   234577999999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc--EEEeeeccceecCCCCC
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--LKLADFGLARIFGSPDR  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~--vkL~DFG~a~~~~~~~~  166 (415)
                      |||+. |+|...+...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ..
T Consensus        95 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-~~  172 (361)
T 3uc3_A           95 MEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS  172 (361)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             EEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-cC
Confidence            99997 58888876644 5999999999999999999999999999999999999987765  99999999975422 22


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+...+..... .+          
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~----------  241 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-SI----------  241 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-CC----------
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-CC----------
Confidence            3345679999999999987554445599999999999999999999876543333333222111100 00          


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                 .....+++++.+||.+||+.||++|||+.|+++||||...
T Consensus       242 -----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          242 -----------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -----------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -----------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                       0112458999999999999999999999999999999653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-51  Score=414.45  Aligned_cols=263  Identities=25%  Similarity=0.375  Sum_probs=223.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...++|.+.++||+|+||.||+|+++.+|+.||+|++.+.... ......+.+|+.+++.++||||++++++|.+...+|
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            3468999999999999999999999999999999999765432 223345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           88 LVFEFME-TDLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      +||||++ |+|...+...   ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999998 5788887654   34699999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc----HHHHHHHHHHhCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD----IDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      ........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.    .+....+....           
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-----------  409 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-----------  409 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-----------
T ss_pred             CCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-----------
Confidence            5555556789999999999987 5689999999999999999999999987642    33333333210           


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                                       ..+.+.++.++.+||.+||+.||.+||+     ++++++||||.+..|.
T Consensus       410 -----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          410 -----------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             -----------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence                             0112356899999999999999999995     5899999999987654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.7e-51  Score=416.14  Aligned_cols=263  Identities=26%  Similarity=0.401  Sum_probs=221.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...++|.+.++||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            3468899999999999999999999999999999999764322 223345678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           88 LVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      +||||+. |+|...+...+ ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999997 58888877643 349999999999999999999999999999999999999999999999999998764432


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---HHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                       .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.   ...+........    .        
T Consensus       341 -~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~----~--------  406 (576)
T 2acx_A          341 -TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP----E--------  406 (576)
T ss_dssp             -CEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC----C--------
T ss_pred             -cccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc----c--------
Confidence             3445689999999999977 5689999999999999999999999987643   222222222110    0        


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                                     .+...+++++++||.+||+.||.+||     +++|+++||||.+..|.
T Consensus       407 ---------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          407 ---------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ---------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                           11234689999999999999999999     79999999999987653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-51  Score=402.68  Aligned_cols=286  Identities=27%  Similarity=0.456  Sum_probs=225.2

Q ss_pred             ccccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC--------CCCeee
Q 014985            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--------SPHIIE   75 (415)
Q Consensus         4 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~--------hp~Iv~   75 (415)
                      +.+++.+.++|++.++||+|+||+||+|++..+++.||||++....   .....+.+|+.+++.++        |+||++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            4556778899999999999999999999999999999999986432   22345678999999995        788999


Q ss_pred             EEeeee----cCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCC-
Q 014985           76 LIDAFP----HKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHG-  148 (415)
Q Consensus        76 l~~~~~----~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~-  148 (415)
                      ++++|.    ...++|+||||++|+++..+.... ..+++..++.++.||+.||+|||++ ||+||||||+||||+.++ 
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred             eecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence            999997    566899999999999999887664 5699999999999999999999998 999999999999999775 


Q ss_pred             ------------------------------------------------cEEEeeeccceecCCCCCcccccccccceeCc
Q 014985          149 ------------------------------------------------QLKLADFGLARIFGSPDRRFTHQVFARWYRAP  180 (415)
Q Consensus       149 ------------------------------------------------~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aP  180 (415)
                                                                      .+||+|||+++....   .....+||+.|+||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aP  262 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCC
Confidence                                                            799999999987643   34556889999999


Q ss_pred             ccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC------cHHHHHHHHHHhCCCCCCCCCCCCCCccch----hccc
Q 014985          181 ELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGKIFAAFGTATPSQWPDLAYLPDYV----EYQY  250 (415)
Q Consensus       181 E~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~  250 (415)
                      |++.+ ..++.++|||||||++|+|++|.+||.+.+      ..+.+..+...++..+...+........+.    ....
T Consensus       263 E~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          263 EVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99987 458999999999999999999999998765      566777777777754322110000000000    0000


Q ss_pred             ccC-CCc---------cccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          251 VAA-PPL---------RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       251 ~~~-~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ... .+.         .......+.++.+||.+||+.||++|||++|+|+||||++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000 000         0011123567899999999999999999999999999963

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6e-51  Score=411.16  Aligned_cols=262  Identities=34%  Similarity=0.561  Sum_probs=226.6

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++++++||||++++++|.+.+.+
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            45789999999999999999999999999999999999766543 33344678999999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeeccceecC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~a~~~~  162 (415)
                      |+|||||. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       102 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999998 5788877754 459999999999999999999999999999999999999   467899999999998764


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+.........         
T Consensus       181 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------  248 (484)
T 3nyv_A          181 AS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL---------  248 (484)
T ss_dssp             CC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---------
T ss_pred             cc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC---------
Confidence            43 34456689999999999976  5899999999999999999999999999988888887664221111         


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                     ..++.+|+++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       249 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          249 ---------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             ---------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             ---------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence                           1123458999999999999999999999999999999754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.8e-51  Score=398.19  Aligned_cols=260  Identities=29%  Similarity=0.448  Sum_probs=217.8

Q ss_pred             ccccEee--eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLK--REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~--~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +.+.|.+  .+.||+|+||.||+|.+..+|+.||+|++......  ....+.+|+.+++.++||||++++++|...+.+|
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  162 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV  162 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3455655  67899999999999999999999999999764322  2345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE--ecCCcEEEeeeccceecCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI--GSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi--~~~~~vkL~DFG~a~~~~~~  164 (415)
                      +||||++ |+|.+.+......+++..++.++.||+.||+|||++||+||||||+|||+  +.++++||+|||+++.....
T Consensus       163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9999998 58888887766679999999999999999999999999999999999999  45678999999999876543


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++.+.+..+........            
T Consensus       243 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------  308 (373)
T 2x4f_A          243 -EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------------  308 (373)
T ss_dssp             -CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC------------
T ss_pred             -cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC------------
Confidence             33445679999999999876 5689999999999999999999999999998888888876422111            


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                  ...++.+++++++||.+||+.||.+|||+.|+|+||||...
T Consensus       309 ------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          309 ------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             ------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             ------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence                        12234568999999999999999999999999999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-50  Score=409.95  Aligned_cols=263  Identities=32%  Similarity=0.509  Sum_probs=223.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-----------CccchHHHHHHHHHhcCCCCeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-----------GVNFTALREIKLLKELKSPHIIE   75 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~   75 (415)
                      ...+.++|.+.+.||+|+||+||+|.+..+++.||+|++.......           .....+.+|+.+++.++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            3457899999999999999999999999999999999997654321           23345778999999999999999


Q ss_pred             EEeeeecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEE
Q 014985           76 LIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLK  151 (415)
Q Consensus        76 l~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vk  151 (415)
                      ++++|.+...+|+|||||. |+|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+|
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999998 48888887654 499999999999999999999999999999999999999876   699


Q ss_pred             EeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       152 L~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      |+|||+++..... ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus       190 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          190 IVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             ECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999999876543 34456789999999999864  58999999999999999999999999999888888876642111


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .                        ...++.+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus       267 ~------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          267 D------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             C------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             C------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            1                        12234568999999999999999999999999999999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-50  Score=406.10  Aligned_cols=261  Identities=29%  Similarity=0.450  Sum_probs=225.7

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      +....++|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            455689999999999999999999999999999999999764322 2233457799999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      +|+|||||+ |+|.+++.+ +..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999997 578887765 456999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+......++.....               
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------  233 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---------------  233 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------------
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------------
Confidence             3345678999999999998755557899999999999999999999999888877777654311               


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                   .....+++++.+||.+||+.||.+|||++|+++||||...
T Consensus       234 -------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 -------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                         0112358899999999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=390.24  Aligned_cols=291  Identities=34%  Similarity=0.633  Sum_probs=226.2

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee-----
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-----   81 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----   81 (415)
                      +..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....  ......+.+|+.+++.++||||+++++++.     
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            4567899999999999999999999999999999999987543  222345678999999999999999998873     


Q ss_pred             ---------cCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe-cCCcEE
Q 014985           82 ---------HKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLK  151 (415)
Q Consensus        82 ---------~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~-~~~~vk  151 (415)
                               .....|+||||++|+|.+.+..  ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     4468999999999999988864  4589999999999999999999999999999999999998 567999


Q ss_pred             EeeeccceecCCCC---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHh
Q 014985          152 LADFGLARIFGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAF  228 (415)
Q Consensus       152 L~DFG~a~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  228 (415)
                      |+|||+++......   .......+|.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998764321   233455678899999998775678999999999999999999999999999888888887765


Q ss_pred             CCCCCCCCCCCC-CCccchhcc-cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          229 GTATPSQWPDLA-YLPDYVEYQ-YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       229 ~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      .......+.... ..+.+.... .....++....+.++.++.+||.+||+.||.+|||++|+++||||+...++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            433221111000 001111000 0112234455677899999999999999999999999999999998766554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.2e-50  Score=378.59  Aligned_cols=265  Identities=29%  Similarity=0.476  Sum_probs=222.9

Q ss_pred             CcccccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeee
Q 014985            2 AEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus         2 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      .++.-.....++|.+.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A            4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             ------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            34444556689999999999999999999999999999999998754322 22334577899999999999999999999


Q ss_pred             ecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           81 PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        81 ~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      .+.+..|+||||++ |+|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            99999999999998 58888887654 48999999999999999999999999999999999999999999999999997


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+.....          
T Consensus       163 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  229 (284)
T 2vgo_A          163 HAPSL--RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----------  229 (284)
T ss_dssp             ECSSS--CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------
T ss_pred             cCccc--ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc----------
Confidence            65432  2345678999999999976 5689999999999999999999999998877776665543200          


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                        .+.+.++.++.+||.+||..||.+|||++++++||||....
T Consensus       230 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 ------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                              11234589999999999999999999999999999998543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-50  Score=375.96  Aligned_cols=259  Identities=31%  Similarity=0.468  Sum_probs=222.5

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|++.+.||+|+||+||+|.+..++..+|+|++......  ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            45788999999999999999999999999999999998754332  2345778999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeeccceecCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~a~~~~~  163 (415)
                      +||||++| +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999985 7877776644 48999999999999999999999999999999999999   7789999999999987654


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . .......+|+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+........           
T Consensus       162 ~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  227 (277)
T 3f3z_A          162 G-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP-----------  227 (277)
T ss_dssp             T-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------
T ss_pred             c-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence            3 34455678999999999865  389999999999999999999999999888887777765421111           


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   ...+..+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          228 -------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             -------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             -------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence                         1122345899999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-50  Score=375.16  Aligned_cols=259  Identities=27%  Similarity=0.456  Sum_probs=196.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            457899999999999999999999999999999998754322 2223457789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||++ ++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            999998 5888888877677999999999999999999999999999999999999999999999999999887655444


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..+..                     
T Consensus       169 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------------  226 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------------  226 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---------------------
T ss_pred             ceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---------------------
Confidence            556678999999999876 5678999999999999999999999987654333221100                     


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                             ........++.++.+||.+||+.||++|||++++++||||...
T Consensus       227 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 -------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             -------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             -------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                   0001223468999999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.9e-50  Score=375.82  Aligned_cols=259  Identities=21%  Similarity=0.326  Sum_probs=214.4

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      .....+.++|++.+.||+|+||+||+|.+..+++.||+|++............+.+|+.++..+ +||||+++++++.+.
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~   83 (289)
T 1x8b_A            4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED   83 (289)
T ss_dssp             -CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred             cccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence            4556788999999999999999999999999999999999987655444455678899999999 999999999999999


Q ss_pred             CeEEEEeecccC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-----------
Q 014985           84 GNLHLVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-----------  148 (415)
Q Consensus        84 ~~~~lv~e~~~g-~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-----------  148 (415)
                      +..|+||||++| +|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++           
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            999999999985 898888764   25589999999999999999999999999999999999998544           


Q ss_pred             --------cEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH
Q 014985          149 --------QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ  220 (415)
Q Consensus       149 --------~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  220 (415)
                              .+||+|||++.......    ...||+.|+|||++.+...++.++|||||||++|+|++|.+++.....   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                    79999999998865433    345889999999998755677899999999999999999987754432   


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ...+...                           ......+.+++++.+||.+||+.||++|||+.|+++||||.+.
T Consensus       237 ~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 WHEIRQG---------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHTT---------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHHcC---------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            2222111                           0112223568999999999999999999999999999999863

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-50  Score=394.60  Aligned_cols=285  Identities=30%  Similarity=0.532  Sum_probs=225.6

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CC-----CeeeEEee
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SP-----HIIELIDA   79 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~~~   79 (415)
                      .++.+.++|++.+.||+|+||+||+|.+..+++.||||++....   .....+.+|+.+++.++ |+     +|++++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            34667899999999999999999999999999999999986432   12234567888888885 44     49999999


Q ss_pred             eecCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh--hCCccccCCCCCcEEEe--cCCcEEEee
Q 014985           80 FPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCH--KKWVLHRDMKPNNLLIG--SHGQLKLAD  154 (415)
Q Consensus        80 ~~~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH--~~~ivHrDlkp~NILi~--~~~~vkL~D  154 (415)
                      |...+++|+||||++|+|.+++.... ..+++..++.++.||+.||.|||  ++||+||||||+||||+  .++.+||+|
T Consensus       125 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             eccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999999999999999998764 45999999999999999999999  57999999999999995  467899999


Q ss_pred             eccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       155 FG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ||+++.....   ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+...++.++..
T Consensus       205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccCceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999886432   345788999999999987 468999999999999999999999999999999999999988765433


Q ss_pred             CCCCCCCCccchh------ccc---------ccCCC---ccccC-----------CC-------CCHHHHHHHHHhcCCC
Q 014985          235 QWPDLAYLPDYVE------YQY---------VAAPP---LRSLF-----------PS-------ASDDALDLLSKMFTYD  278 (415)
Q Consensus       235 ~~~~~~~~~~~~~------~~~---------~~~~~---~~~~~-----------~~-------~s~~~~~li~~~L~~d  278 (415)
                      .++.......+..      +..         ...+.   +....           .+       .++++++||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence            2221110000000      000         00000   00000           00       0147899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014985          279 PKARITAQQALEHRYFSSA  297 (415)
Q Consensus       279 P~~Rpt~~e~l~h~~~~~~  297 (415)
                      |++|||++|+|+||||+..
T Consensus       361 P~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTTSCCHHHHTTSGGGCC-
T ss_pred             hhhCCCHHHHhcCcccccC
Confidence            9999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.7e-50  Score=386.35  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=225.6

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            345789999999999999999999999999999999987653222 2334567899999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       117 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999 5777776654 458999999999999999999999999999999999999999999999999998876555


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.....                
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------  258 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------------  258 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------------
T ss_pred             ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC----------------
Confidence            55566788999999999977 5689999999999999999999999998877766665544210                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                                  .+...++..+.+||.+||+.||++|||++|+++||||+....+
T Consensus       259 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          259 ------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                        1112457899999999999999999999999999999876543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5e-50  Score=378.03  Aligned_cols=266  Identities=25%  Similarity=0.375  Sum_probs=226.3

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ......++|.+.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   88 (294)
T 2rku_A            9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND   88 (294)
T ss_dssp             EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence            34456889999999999999999999999999999999987654322 22345678999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..|+||||++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999 5777766654 4589999999999999999999999999999999999999999999999999988765


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....              
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------  232 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------  232 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------------
T ss_pred             CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--------------
Confidence            5555556778999999999976 5689999999999999999999999998877666655433200              


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                                    .....++..+.+||.+||+.||++|||++|+++||||.....+.
T Consensus       233 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          233 --------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             --------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence                          11224578999999999999999999999999999998765433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.4e-50  Score=379.03  Aligned_cols=260  Identities=25%  Similarity=0.359  Sum_probs=202.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++............+.++..+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            46899999999999999999999999999999999876543333333344555668889999999999999999999999


Q ss_pred             eecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           90 FEFMETDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        90 ~e~~~g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||++|+|..++..   .+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++++||+|||+++......
T Consensus        85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            99999988777654   456799999999999999999999998 99999999999999999999999999998764432


Q ss_pred             CcccccccccceeCcccc---cCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC-cHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 RRFTHQVFARWYRAPELL---FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                       ......||+.|+|||++   .....++.++|||||||++|+|++|..||.... ....+..+.......          
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  233 (290)
T 3fme_A          165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ----------  233 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC----------
T ss_pred             -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC----------
Confidence             23345788999999997   334568899999999999999999999998743 344444433321100          


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                      .....++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus       234 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          234 ----------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             ----------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ----------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence                            011245889999999999999999999999999999974

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.7e-50  Score=394.22  Aligned_cols=256  Identities=25%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             cccccEeee-eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHH-hcCCCCeeeEEeeeec----
Q 014985            9 KVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK-ELKSPHIIELIDAFPH----   82 (415)
Q Consensus         9 ~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~----   82 (415)
                      .+.++|.+. ++||+|+||+||+|.+..+|+.||||++...       ..+.+|+.++. ..+||||++++++|..    
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            356777776 7999999999999999999999999998632       24668998874 4589999999999875    


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeecc
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGL  157 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG~  157 (415)
                      ..++|+|||||. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            667999999998 58999887653 35999999999999999999999999999999999999997   78899999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH----HHHHHHHHhCCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID----QLGKIFAAFGTATP  233 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~  233 (415)
                      ++.... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+...    ....+........ 
T Consensus       211 a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~-  287 (400)
T 1nxk_A          211 AKETTS-HNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-  287 (400)
T ss_dssp             CEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-
T ss_pred             ccccCC-CCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC-
Confidence            987643 233456788999999999966 568999999999999999999999998764321    2222222100000 


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                             ...+..++.++.+||.+||+.||++|||+.|+++||||...
T Consensus       288 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          288 -----------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             -----------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                                   11234568999999999999999999999999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.9e-50  Score=386.31  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=214.7

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC------ccchHHHHHHHHHhcCCCCeeeEEeeee
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKELKSPHIIELIDAFP   81 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~E~~il~~l~hp~Iv~l~~~~~   81 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||++........      ....+.+|+.+++.++||||++++++|.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4578899999999999999999999999999999999987653222      2334568999999999999999999999


Q ss_pred             cCCeEEEEeeccc-C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           82 HKGNLHLVFEFME-T-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      +.+.+++||||+. | +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999986 5 777777654 459999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      ..... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||......      .   .          
T Consensus       179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~---~----------  238 (335)
T 3dls_A          179 YLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------V---E----------  238 (335)
T ss_dssp             ECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------T---T----------
T ss_pred             ECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------H---h----------
Confidence            76543 33445678999999999987555588999999999999999999998652110      0   0          


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                     ........+++++.+||.+||+.||++|||++++++||||+.
T Consensus       239 ---------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          239 ---------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             ---------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ---------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence                           000111235899999999999999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.7e-50  Score=383.63  Aligned_cols=266  Identities=27%  Similarity=0.377  Sum_probs=210.9

Q ss_pred             cccccccccEeee-eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec
Q 014985            5 DLSKKVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (415)
Q Consensus         5 ~~~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~   82 (415)
                      .+...+.++|.+. +.||+|+||+||+|.+..+++.||||++....  ......+.+|+.+++++ +||||+++++++.+
T Consensus         5 ~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A            5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             SSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3466788999995 78999999999999999999999999997543  22344677999999985 79999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc---EEEeeeccc
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFGLA  158 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~---vkL~DFG~a  158 (415)
                      .+.+|+||||++ |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            999999999998 68888887654 5899999999999999999999999999999999999998776   999999998


Q ss_pred             eecCCCC-------CcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH---------
Q 014985          159 RIFGSPD-------RRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---------  218 (415)
Q Consensus       159 ~~~~~~~-------~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------  218 (415)
                      .......       ......+||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+..         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            7653211       12334568999999999864    134789999999999999999999999876431         


Q ss_pred             ------HHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014985          219 ------DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (415)
Q Consensus       219 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~  292 (415)
                            .....+.....                        ......++.++.++++||.+||+.||.+|||++|+++||
T Consensus       242 ~~~~~~~~~~~i~~~~~------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKY------------------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             CHHHHHHHHHHHHHCCC------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             chhHHHHHHHHHhccCc------------------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence                  12222221100                        000112235689999999999999999999999999999


Q ss_pred             CCCCC
Q 014985          293 YFSSA  297 (415)
Q Consensus       293 ~~~~~  297 (415)
                      ||++.
T Consensus       298 ~~~~~  302 (316)
T 2ac3_A          298 WVQGC  302 (316)
T ss_dssp             TCC--
T ss_pred             hhcCC
Confidence            99864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-50  Score=390.09  Aligned_cols=267  Identities=27%  Similarity=0.424  Sum_probs=219.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc---cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||+|++.....   .......+.+|+.+++.++||||++++++|.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            3568999999999999999999999999999999999875432   2233346778999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 014985           85 NLHLVFEFME-TDLETVIRNT---------------------------------------NIFLSPADIKSYMQMTLKGL  124 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~---------------------------------------~~~l~~~~~~~i~~qil~aL  124 (415)
                      ..|+|||||+ |+|.+.+...                                       ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999998 5787777420                                       11246788999999999999


Q ss_pred             HHhhhCCccccCCCCCcEEEecCC--cEEEeeeccceecCCCC----CcccccccccceeCcccccCC-cCCCCcccHHH
Q 014985          125 AFCHKKWVLHRDMKPNNLLIGSHG--QLKLADFGLARIFGSPD----RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWA  197 (415)
Q Consensus       125 ~~lH~~~ivHrDlkp~NILi~~~~--~vkL~DFG~a~~~~~~~----~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwS  197 (415)
                      +|||++||+||||||+|||++.++  .+||+|||+++.+....    .......||+.|+|||++.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998776  89999999998763322    123566789999999998653 56899999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCC
Q 014985          198 AGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTY  277 (415)
Q Consensus       198 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  277 (415)
                      |||++|+|++|..||.+.+..+....+........                        ...+..+++++.+||.+||+.
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE------------------------NPNYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT------------------------SGGGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC------------------------CcccccCCHHHHHHHHHHcCC
Confidence            99999999999999999988888877765321111                        111223589999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCC
Q 014985          278 DPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       278 dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ||.+|||+.++++||||+...
T Consensus       318 ~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          318 NVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             CTTTSCCHHHHHHSHHHHTTS
T ss_pred             ChhHCCCHHHHhcChhhccCh
Confidence            999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.5e-50  Score=377.15  Aligned_cols=258  Identities=26%  Similarity=0.447  Sum_probs=217.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ...++|++.+.||+|+||+||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            4578999999999999999999999999999999998654322 223345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ |+|...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....  .
T Consensus        86 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--~  162 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--S  162 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--c
Confidence            9999999 57888776653 489999999999999999999999999999999999999999999999999865432  2


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....                 
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------  224 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----------------  224 (279)
T ss_dssp             -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------------
T ss_pred             cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------------
Confidence            3345678999999999976 5678999999999999999999999998887777766644211                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                 .....++.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       225 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          225 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             -----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                       11123588999999999999999999999999999998643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=377.54  Aligned_cols=265  Identities=29%  Similarity=0.450  Sum_probs=217.3

Q ss_pred             ccccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC
Q 014985            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (415)
Q Consensus         4 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   83 (415)
                      .++.+...++|.+.+.||+|+||.||+|.+..+|+.||+|.+....    ....+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            3456667899999999999999999999999999999999987542    234678899999999999999999999999


Q ss_pred             CeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 ~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      +..|+||||++| +|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999985 8888887667779999999999999999999999999999999999999999999999999998876


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..........|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....    ..       
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~-------  244 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP----PT-------  244 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----CC-------
T ss_pred             hhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC----cc-------
Confidence            55555556788999999999976 5689999999999999999999999988776665544433210    00       


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                    ......++..+.+||.+||..||.+|||+.++++||||....
T Consensus       245 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          245 --------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             --------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             --------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                          011123478999999999999999999999999999998643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-50  Score=384.67  Aligned_cols=279  Identities=32%  Similarity=0.585  Sum_probs=217.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeec--CCeE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPH--KGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~   86 (415)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....     ...+.+|+.+++.++ ||||+++++++..  ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            3689999999999999999999999999999999986322     235778999999997 9999999999987  6789


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeeccceecCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSP  164 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~  164 (415)
                      ++||||+.| +|..++..    +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999995 66666543    89999999999999999999999999999999999999776 8999999999876443


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCC-CCCCcHHHHHHHHHHhCCCCCCCCCC---CC
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFL-QGSSDIDQLGKIFAAFGTATPSQWPD---LA  240 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~---~~  240 (415)
                       .......+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++......+..   ..
T Consensus       185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence             33455688999999999987677899999999999999999999766 55566677776666554311000000   00


Q ss_pred             CCccchhc-ccccCCCccc-----cCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          241 YLPDYVEY-QYVAAPPLRS-----LFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       241 ~~~~~~~~-~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ..+..... .......+..     ....+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            00000000 0000000111     1123689999999999999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-49  Score=376.86  Aligned_cols=260  Identities=25%  Similarity=0.421  Sum_probs=221.0

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|.+.+.||+|+||+||+|.+..+|+.||+|++......  ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY   82 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence            45789999999999999999999999999999999999854322  2235778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeeccceecCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~a~~~~~  163 (415)
                      +||||++ |+|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999998 58888877654 58999999999999999999999999999999999999   7788999999999976432


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                        .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........           
T Consensus       162 --~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------  227 (304)
T 2jam_A          162 --GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE-----------  227 (304)
T ss_dssp             --BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-----------
T ss_pred             --CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence              23345578999999999976 5689999999999999999999999999888777777765422111           


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                   ....+.++.++.+||.+||..||.+|||++|+++||||...
T Consensus       228 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          228 -------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             -------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             -------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                         12234568999999999999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.9e-50  Score=382.75  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC---
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG---   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---   84 (415)
                      ..+.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++||||++++++|.+..   
T Consensus         2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            356789999999999999999999999999999999997654 2333456789999999999999999999885433   


Q ss_pred             ------------------------------------------------------eEEEEeecccC-CHHHHHHhcCC--C
Q 014985           85 ------------------------------------------------------NLHLVFEFMET-DLETVIRNTNI--F  107 (415)
Q Consensus        85 ------------------------------------------------------~~~lv~e~~~g-~L~~~i~~~~~--~  107 (415)
                                                                            .+|+|||||+| +|.+++.....  .
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999985 88888876432  3


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC------------Cccccccccc
Q 014985          108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD------------RRFTHQVFAR  175 (415)
Q Consensus       108 l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~------------~~~~~~~~t~  175 (415)
                      .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......            ......+||+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            5666789999999999999999999999999999999999999999999998875542            2234567899


Q ss_pred             ceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCC
Q 014985          176 WYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPP  255 (415)
Q Consensus       176 ~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (415)
                      .|+|||++.+ ..++.++|||||||++|+|++|..++..     ....+.......                        
T Consensus       241 ~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~------------------------  290 (332)
T 3qd2_B          241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK------------------------  290 (332)
T ss_dssp             GGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC------------------------
T ss_pred             CccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC------------------------
Confidence            9999999987 5689999999999999999998765421     111111111100                        


Q ss_pred             ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          256 LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       256 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ....++..++++.+||.+||+.||.+|||++|+++||||++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            01112233678899999999999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.5e-50  Score=391.73  Aligned_cols=259  Identities=27%  Similarity=0.369  Sum_probs=210.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC--CCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .++|.+.+.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.++  ||||+++++++...+.+|+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            4679999999999999999998765 899999999876544434456789999999997  4999999999999999999


Q ss_pred             EeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--
Q 014985           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        89 v~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--  166 (415)
                      |||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.....  
T Consensus       134 v~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            99977789999988754 589999999999999999999999999999999999995 68899999999987643322  


Q ss_pred             cccccccccceeCcccccCC----------cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCCCCCCC
Q 014985          167 RFTHQVFARWYRAPELLFGA----------KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  235 (415)
                      .....+||+.|+|||++.+.          ..|+.++||||||||+|+|++|.+||.+..+. ..+..+...   .....
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~---~~~~~  288 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP---NHEIE  288 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT---TSCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc---cccCC
Confidence            23456899999999998651          35889999999999999999999999876443 333333211   11101


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                             .....+.++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       289 -----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          289 -----------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             -----------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             -----------------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                                   1112378899999999999999999999999999997543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-49  Score=387.06  Aligned_cols=262  Identities=31%  Similarity=0.526  Sum_probs=221.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC------ccchHHHHHHHHHhc-CCCCeeeEEeee
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------VNFTALREIKLLKEL-KSPHIIELIDAF   80 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~E~~il~~l-~hp~Iv~l~~~~   80 (415)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.||||++........      ....+.+|+.+++.+ +||||++++++|
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            3456889999999999999999999999999999999976542211      123456899999999 799999999999


Q ss_pred             ecCCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           81 PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        81 ~~~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      ...+..|+||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            999999999999985 788877654 459999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccC-----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ..... ......+||+.|+|||++.+     ...++.++|||||||++|+|++|.+||.+.+....+..+........  
T Consensus       249 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  325 (365)
T 2y7j_A          249 HLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS--  325 (365)
T ss_dssp             ECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred             ccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence            76543 33456789999999999853     23588999999999999999999999998887777766655311110  


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                            ...+..++..+.+||.+||+.||++|||++++++||||+
T Consensus       326 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          326 ----------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             ----------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             ----------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence                                  112234588999999999999999999999999999996

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=384.18  Aligned_cols=260  Identities=26%  Similarity=0.353  Sum_probs=209.2

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC--CCeeeEEeeeecCCeE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHKGNL   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~   86 (415)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++............+.+|+.+|+.++|  |||+++++++.....+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            3578899999999999999999987 468999999998665444334557789999999987  9999999999999999


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      |+|||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.......
T Consensus        85 ~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           85 YMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            999998888999999875 4589999999999999999999999999999999999996 68899999999987644332


Q ss_pred             --cccccccccceeCcccccC----------CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCCCCC
Q 014985          167 --RFTHQVFARWYRAPELLFG----------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATP  233 (415)
Q Consensus       167 --~~~~~~~t~~y~aPE~l~~----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~  233 (415)
                        .....+||+.|+|||++.+          ...++.++|||||||++|+|++|.+||....+. ..+..+.   .....
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~  239 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPNHE  239 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTTSC
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---cCCcc
Confidence              2345679999999999853          245888999999999999999999999875443 2222221   11111


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ..                       .....+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       240 ~~-----------------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          240 IE-----------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CC-----------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             cC-----------------------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            11                       112336789999999999999999999999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.3e-50  Score=383.47  Aligned_cols=282  Identities=27%  Similarity=0.482  Sum_probs=225.8

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEE-CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCC------CeeeEE
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAID-TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP------HIIELI   77 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp------~Iv~l~   77 (415)
                      ..++.+.++|++.+.||+|+||+||+|.+ ..+++.||+|++....   .....+.+|+.+++.++|+      +|++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            45677889999999999999999999998 5678999999986432   2233567899999998765      499999


Q ss_pred             eeeecCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec----------
Q 014985           78 DAFPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS----------  146 (415)
Q Consensus        78 ~~~~~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~----------  146 (415)
                      ++|...+++|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.          
T Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999999999999999998764 35899999999999999999999999999999999999987          


Q ss_pred             ---------CCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc
Q 014985          147 ---------HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (415)
Q Consensus       147 ---------~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  217 (415)
                               ++.+||+|||+++.....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                     668999999999875432   345678999999999976 5689999999999999999999999999998


Q ss_pred             HHHHHHHHHHhCCCCCCC----------------CCCCCCCccchhcccccCCCccc---cCCCCCHHHHHHHHHhcCCC
Q 014985          218 IDQLGKIFAAFGTATPSQ----------------WPDLAYLPDYVEYQYVAAPPLRS---LFPSASDDALDLLSKMFTYD  278 (415)
Q Consensus       218 ~~~~~~i~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~d  278 (415)
                      .+.+..+....+..+...                |..........   .....++..   .....++++.+||.+||+.|
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV---SRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHH---HHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchh---hhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            888888877766443211                11100000000   000001111   11123577999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCC
Q 014985          279 PKARITAQQALEHRYFSS  296 (415)
Q Consensus       279 P~~Rpt~~e~l~h~~~~~  296 (415)
                      |.+|||+.|+++||||+.
T Consensus       317 P~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          317 PAKRITLREALKHPFFDL  334 (339)
T ss_dssp             TTTSCCHHHHTTSGGGGG
T ss_pred             cccccCHHHHhcCHHHHH
Confidence            999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-49  Score=375.43  Aligned_cols=265  Identities=26%  Similarity=0.383  Sum_probs=217.5

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++...+..
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            3456899999999999999999999999999999999986542  22334577899999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||++| +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999985 7877777766779999999999999999999999999999999999999999999999999986432222


Q ss_pred             CcccccccccceeCccccc----CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 RRFTHQVFARWYRAPELLF----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .......||+.|+|||++.    ....++.++|||||||++|+|++|.+||...+....+..+.......          
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  241 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------  241 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----------
Confidence            2233457889999999984    33568899999999999999999999999888777666654421100          


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                     ......++..+.+||.+||..||.+|||+.++++||||....
T Consensus       242 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          242 ---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                           011123478999999999999999999999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.1e-50  Score=387.23  Aligned_cols=284  Identities=27%  Similarity=0.439  Sum_probs=227.3

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCC-cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC------eeeEE
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTG-QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH------IIELI   77 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l~   77 (415)
                      .+++.+.++|++.+.||+|+||+||+|.+..++ ..||+|++....   .....+.+|+.+++.++|++      ++.++
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            456778999999999999999999999998877 689999986432   22335668999999997655      89999


Q ss_pred             eeeecCCeEEEEeecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE------------
Q 014985           78 DAFPHKGNLHLVFEFMETDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI------------  144 (415)
Q Consensus        78 ~~~~~~~~~~lv~e~~~g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi------------  144 (415)
                      +++...++.|+||||++|+++..+.... ..+++..++.++.||+.||+|||++||+||||||+|||+            
T Consensus        89 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            9999999999999999999999887764 469999999999999999999999999999999999999            


Q ss_pred             -------ecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc
Q 014985          145 -------GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD  217 (415)
Q Consensus       145 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  217 (415)
                             +.++.+||+|||+++.....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                   66789999999999875432   345678999999999976 5689999999999999999999999999998


Q ss_pred             HHHHHHHHHHhCCCCCCC----------------CCCCCCCccchhcccccCCCcccc---CCCCCHHHHHHHHHhcCCC
Q 014985          218 IDQLGKIFAAFGTATPSQ----------------WPDLAYLPDYVEYQYVAAPPLRSL---FPSASDDALDLLSKMFTYD  278 (415)
Q Consensus       218 ~~~~~~i~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~d  278 (415)
                      .+.+..+....+..+...                |+......   .+......++...   ....+.++.+||.+||+.|
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDG---RYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHH---HHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchh---ccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            888888877776543211                11100000   0000001111111   1122467899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014985          279 PKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       279 P~~Rpt~~e~l~h~~~~~~~  298 (415)
                      |++|||+.|+++||||++..
T Consensus       322 P~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGGCC
T ss_pred             hhhCcCHHHHhcChhhcCCC
Confidence            99999999999999998743

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-49  Score=371.38  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=219.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++........    ....+.+|+.+++.++||||+++++++.+..
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            467899999999999999999999999999999999976543322    2345778999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC----cEEEeeeccce
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLAR  159 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~----~vkL~DFG~a~  159 (415)
                      ..|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             eEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999997 5888887654 4589999999999999999999999999999999999999877    89999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      ...... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......         
T Consensus       161 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  229 (283)
T 3bhy_A          161 KIEAGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD---------  229 (283)
T ss_dssp             ECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC---------
T ss_pred             eccCCC-cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC---------
Confidence            764432 3345678999999999876 56899999999999999999999999988877766665432110         


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                     .....++.++..+.+||.+||..||++|||+.++++||||+..
T Consensus       230 ---------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          230 ---------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             ---------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ---------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence                           0112334568999999999999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-50  Score=380.76  Aligned_cols=280  Identities=21%  Similarity=0.282  Sum_probs=216.9

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC--e
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--N   85 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~   85 (415)
                      ..+.++|++.++||+|+||+||+|.+..+|+.||||++........ ...+.+|+.+++.++||||+++++++....  .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-HHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            4567899999999999999999999999999999999875433222 345678999999999999999999987655  8


Q ss_pred             EEEEeeccc-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE----ecCCcEEEeeeccc
Q 014985           86 LHLVFEFME-TDLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGLA  158 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~--~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi----~~~~~vkL~DFG~a  158 (415)
                      .|+||||+. |+|..++.....  .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            899999998 588888876432  38999999999999999999999999999999999999    77788999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccC-------CcCCCCcccHHHHHHHHHHHHcCCCCCCCCC----cHHHHHHHHHH
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFG-------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSS----DIDQLGKIFAA  227 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~  227 (415)
                      +...... ......||+.|+|||++..       ...++.++|||||||++|||++|.+||....    ..+.+..+...
T Consensus       164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8765433 3445678999999999852       2568999999999999999999999997543    34445555443


Q ss_pred             hCCCCCCCCCCCCCCccchhcccc-cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYV-AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                      .   ++..+......... .+.+. ..+....+...++..+.+||.+||+.||++|||++|+|+||-
T Consensus       243 ~---p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 K---PSGAISGVQKAENG-PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             C---CTTCCEEEECSTTC-CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             C---CcccchhhhcccCC-ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            2   22222211111100 00010 111111222345678999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=376.13  Aligned_cols=264  Identities=25%  Similarity=0.438  Sum_probs=217.8

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc--CCccchHHHHHHHHHhcCCCCeeeEEeee--ecCC
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK--EGVNFTALREIKLLKELKSPHIIELIDAF--PHKG   84 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~   84 (415)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++......  ......+.+|+.+++.++||||+++++++  .+..
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            4678999999999999999999999999999999998754321  22334577899999999999999999998  4556


Q ss_pred             eEEEEeecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            89999999998888877654 45699999999999999999999999999999999999999999999999999987643


Q ss_pred             C--CCcccccccccceeCcccccCCc-CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          164 P--DRRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       164 ~--~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .  ........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.....           
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-----------  230 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY-----------  230 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-----------
Confidence            2  22334567899999999987632 347799999999999999999999998877766666544210           


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                                       .....+++.+.+||.+||..||.+|||++|+++||||.....+
T Consensus       231 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          231 -----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             -----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             -----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence                             1122458899999999999999999999999999999875443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-50  Score=396.78  Aligned_cols=264  Identities=30%  Similarity=0.472  Sum_probs=206.5

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc------CCccchHHHHHHHHHhcCCCCeeeEEeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      ...+.++|.+.+.||+|+||+||+|.+..+++.||+|++......      ......+.+|+.+|++++||||+++++++
T Consensus       130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            355789999999999999999999999999999999999765321      12223577899999999999999999998


Q ss_pred             ecCCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cEEEeeec
Q 014985           81 PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QLKLADFG  156 (415)
Q Consensus        81 ~~~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~vkL~DFG  156 (415)
                      .. +..|+||||+.| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            54 568999999985 77676654 45699999999999999999999999999999999999997554   59999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      +++..... ......+||+.|+|||++.+  ...|+.++|||||||++|+|++|.+||.+......+.......      
T Consensus       288 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~------  360 (419)
T 3i6u_A          288 HSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG------  360 (419)
T ss_dssp             TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT------
T ss_pred             cceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC------
Confidence            99876432 33445788999999999853  3567889999999999999999999998764433222222110      


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                       ........++.+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus       361 -----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          361 -----------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             -----------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -----------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence                             001112334457899999999999999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-50  Score=384.31  Aligned_cols=265  Identities=23%  Similarity=0.358  Sum_probs=215.2

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      .+..+.++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            45678999999999999999999999999999999999997654322 22235678999999999999999999987654


Q ss_pred             ----eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           85 ----NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        85 ----~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                          ..|+||||++ |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence                3599999997 58888877654 58999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCC---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          160 IFGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       160 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ......   ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....       
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-------  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred             cccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------
Confidence            764432   22334568999999999987 5689999999999999999999999999887776666544211       


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                       .+.....+.++.++.+||.+||+.||.+||++.+++.|+|+..
T Consensus       237 -----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 -----------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -----------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                             1112233457899999999999999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-49  Score=371.80  Aligned_cols=266  Identities=27%  Similarity=0.453  Sum_probs=222.8

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-------CccchHHHHHHHHHhcC-CCCeeeEEe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-------GVNFTALREIKLLKELK-SPHIIELID   78 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-------~~~~~~~~E~~il~~l~-hp~Iv~l~~   78 (415)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||||++.......       .....+.+|+.+++++. ||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            3457899999999999999999999999999999999997654211       11234568999999995 999999999


Q ss_pred             eeecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           79 AFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        79 ~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      ++...+..|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999998 5888888764 4589999999999999999999999999999999999999999999999999


Q ss_pred             ceecCCCCCcccccccccceeCccccc-----CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLF-----GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      +...... .......+++.|+|||++.     ....++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus       171 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          171 SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  249 (298)
T ss_dssp             CEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             hhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence            9876443 3345567899999999985     234588999999999999999999999998887777766655322111


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      .                        ...+.++..+.+||.+||+.||.+|||+.|+++||||....
T Consensus       250 ~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          250 S------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             T------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             c------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            1                        11224588999999999999999999999999999998654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.3e-49  Score=369.64  Aligned_cols=261  Identities=26%  Similarity=0.388  Sum_probs=216.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            3578999999999999999999999999999999998754332 233457789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--  165 (415)
                      ||||++| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           83 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999985 77776654 4459999999999999999999999999999999999999999999999999998653322  


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH-HHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-LGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      .......|++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.... ...+... ..              
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--------------  226 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT--------------  226 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT--------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc--------------
Confidence            2234567899999999997755457889999999999999999999987654322 2222110 00              


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                 .....+.++..+.+||.+||+.||.+|||++|+++||||+..
T Consensus       227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             -----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence                       001123458999999999999999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.4e-49  Score=369.26  Aligned_cols=256  Identities=24%  Similarity=0.348  Sum_probs=212.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec----CCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~   86 (415)
                      ...|.+.+.||+|+||+||+|.+..++..||+|++............+.+|+.+++.++||||++++++|..    ...+
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            556899999999999999999999999999999998655444444567789999999999999999998865    4568


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEe-cCCcEEEeeeccceecC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIG-SHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~-~~~~vkL~DFG~a~~~~  162 (415)
                      |+||||++ |+|.+++... ..+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999998 4888887764 45899999999999999999999999  99999999999998 78999999999997643


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...............  .          
T Consensus       184 ~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~----------  247 (290)
T 1t4h_A          184 AS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--K----------  247 (290)
T ss_dssp             TT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--C----------
T ss_pred             cc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--C----------
Confidence            32  3345678999999999865  489999999999999999999999988666555443322100  0          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   ........++++.+||.+||+.||.+|||++++++||||++
T Consensus       248 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 -------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                         01122244789999999999999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-48  Score=369.84  Aligned_cols=259  Identities=25%  Similarity=0.406  Sum_probs=223.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .....++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++......
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            3456788999999999999999999999999999999997654332 334677899999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||++| +|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        96 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999985 77777654  458999999999999999999999999999999999999999999999999998876555


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.....                
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  236 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------------  236 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----------------
T ss_pred             cccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC----------------
Confidence            45566788999999999976 5688999999999999999999999988777666555433210                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                 ......++..+.+||.+||..||.+|||+.++++||||..
T Consensus       237 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          237 -----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             -----------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             -----------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence                       0122345889999999999999999999999999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.2e-49  Score=377.58  Aligned_cols=264  Identities=31%  Similarity=0.492  Sum_probs=212.7

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc------CCccchHHHHHHHHHhcCCCCeeeEEeee
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      +..+.++|.+.+.||+|+||.||+|.+..+++.||||++......      ......+.+|+.+++.++||||+++++++
T Consensus         5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            567889999999999999999999999999999999998754321      12233577899999999999999999999


Q ss_pred             ecCCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc---EEEeeec
Q 014985           81 PHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLADFG  156 (415)
Q Consensus        81 ~~~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~---vkL~DFG  156 (415)
                      .... .|+||||+.| +|.+.+.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            7655 8999999985 78777764 456999999999999999999999999999999999999987664   9999999


Q ss_pred             cceecCCCCCcccccccccceeCccccc--CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHH-HHHHHHhCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQL-GKIFAAFGTATP  233 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~  233 (415)
                      ++...... .......||+.|+|||++.  +...++.++|||||||++|+|++|.+||........+ ..+.....    
T Consensus       163 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----  237 (322)
T 2ycf_A          163 HSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY----  237 (322)
T ss_dssp             TCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC----
T ss_pred             cceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc----
Confidence            99876432 2234457899999999974  3456889999999999999999999999876543222 22222100    


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                          .......+.++.++.+||.+||..||++|||++++++||||...
T Consensus       238 --------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 --------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             --------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             --------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                                01122334568999999999999999999999999999999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4e-49  Score=372.29  Aligned_cols=265  Identities=24%  Similarity=0.337  Sum_probs=214.6

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecC
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   83 (415)
                      .+++.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            457788999999999999999999999999999999999987654322 2234567899999999999999999999999


Q ss_pred             CeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           84 GNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        84 ~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      +.+|+||||++| +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999985 8888877654 59999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC-CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          163 SPD-RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       163 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+...........   ..         
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---~~---------  229 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD---SV---------  229 (294)
T ss_dssp             ------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS---CC---------
T ss_pred             cccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc---cC---------
Confidence            433 22344678999999999987 56899999999999999999999999988776655443321   00         


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                 ........+.+++.+.++|.+||..||.+||+..+.+.+.|.
T Consensus       230 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          230 -----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             -----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             -----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence                       000123345678999999999999999999966666666554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-49  Score=370.35  Aligned_cols=259  Identities=28%  Similarity=0.440  Sum_probs=219.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee--ecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF--PHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--~~~~~~~   87 (415)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++  .....+|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            46899999999999999999999999999999999987654444445677899999999999999999987  4467899


Q ss_pred             EEeecccC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC-----ccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           88 LVFEFMET-DLETVIRNT---NIFLSPADIKSYMQMTLKGLAFCHKKW-----VLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~---~~~l~~~~~~~i~~qil~aL~~lH~~~-----ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                      +||||++| +|.+++...   ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            99999985 888888653   345899999999999999999999999     999999999999999999999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +.............|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......        
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------  234 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--------  234 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred             eeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--------
Confidence            876554433445678899999999977 46889999999999999999999999988877766666543111        


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                         .....++.++.+||.+||+.||.+|||+.|+++|+|+..
T Consensus       235 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          235 -------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                               112245899999999999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-50  Score=386.66  Aligned_cols=264  Identities=25%  Similarity=0.406  Sum_probs=212.4

Q ss_pred             cccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCc--cCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~--~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|++.+.||+|+||+||+|++.   .+|+.||||++.....  .......+.+|+.+++.+ .||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            489999999999999999999984   5889999999865432  112223455799999999 6999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .+|+||||++ |+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            9999999998 58888887654 599999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-CcccccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          164 PD-RRFTHQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       164 ~~-~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .. ......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+........         
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  282 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---------  282 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---------
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC---------
Confidence            22 233456789999999999753 4578999999999999999999999976543222222221110000         


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                                     ....+.++..+.+||.+||..||.+||     +++|+++||||....+
T Consensus       283 ---------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          283 ---------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             ---------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                           112234588999999999999999999     9999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.5e-49  Score=375.37  Aligned_cols=259  Identities=21%  Similarity=0.277  Sum_probs=207.2

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...++|.+.+.||+|+||+||+|.+  +|..||+|++............+.+|+.++++++||||+++++++...+.+|+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3478999999999999999999976  57899999987655443334457789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           89 VFEFMET-DLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~--~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ||||+.| +|.+++.....  .+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999985 88888875432  3899999999999999999999999  99999999999999999999999999987655


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......             
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------  257 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------------  257 (309)
T ss_dssp             ----------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------------
T ss_pred             cccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------------
Confidence            5444556788999999999977 56899999999999999999999999988877766555332111             


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--h~~~~~  296 (415)
                                   ......+++++.+||.+||+.||.+|||++++++  ++++..
T Consensus       258 -------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 -------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                         1122356899999999999999999999999998  566654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-50  Score=395.49  Aligned_cols=249  Identities=17%  Similarity=0.209  Sum_probs=200.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHH---HHHHhcCCCCeeeEE-------ee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREI---KLLKELKSPHIIELI-------DA   79 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~---~il~~l~hp~Iv~l~-------~~   79 (415)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            5889999999999999999999999999999999986532 223334577899   555566899999998       66


Q ss_pred             eecCC-----------------eEEEEeecccCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHhhhCCcccc
Q 014985           80 FPHKG-----------------NLHLVFEFMETDLETVIRNTNIFLS-------PADIKSYMQMTLKGLAFCHKKWVLHR  135 (415)
Q Consensus        80 ~~~~~-----------------~~~lv~e~~~g~L~~~i~~~~~~l~-------~~~~~~i~~qil~aL~~lH~~~ivHr  135 (415)
                      +...+                 ..|+||||++|+|.+++..... ++       +..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            65543                 3899999999999999986532 34       47888899999999999999999999


Q ss_pred             CCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCC----------cCCCCcccHHHHHHHHHHH
Q 014985          136 DMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA----------KQYGAGVDVWAAGCIFAEL  205 (415)
Q Consensus       136 Dlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~el  205 (415)
                      ||||+||||+.+|.+||+|||+++..+.   .....+| +.|+|||++.+.          ..|+.++|||||||++|||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999986433   3445567 889999999764          2689999999999999999


Q ss_pred             HcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014985          206 LNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA  285 (415)
Q Consensus       206 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~  285 (415)
                      ++|.+||.+.+.......+                                ....+.+++++.+||.+||+.||++|||+
T Consensus       307 ltg~~Pf~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWI--------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHSSCCC------CCSGGG--------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHCCCCCcccccccchhhh--------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999999765422111110                                11124668999999999999999999999


Q ss_pred             HHHhcCCCCCC
Q 014985          286 QQALEHRYFSS  296 (415)
Q Consensus       286 ~e~l~h~~~~~  296 (415)
                      .|+++||||+.
T Consensus       355 ~e~l~hp~f~~  365 (377)
T 3byv_A          355 LQAMETPEYEQ  365 (377)
T ss_dssp             HHHHTSHHHHH
T ss_pred             HHHhhChHHHH
Confidence            99999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=373.26  Aligned_cols=260  Identities=27%  Similarity=0.372  Sum_probs=211.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-----   82 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~-----   82 (415)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.....   ....+.+|+.+++.+ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            457899999999999999999999999999999999875432   234677899999999 79999999999976     


Q ss_pred             -CCeEEEEeecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           83 -KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        83 -~~~~~lv~e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                       .+.+|+||||++| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             5689999999985 888888764 2468999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      .............||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+....+..+.....   +  
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--  252 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---P--  252 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---C--
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---c--
Confidence            76554444456678999999999863    24588999999999999999999999988877666655433210   0  


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                           ......++..+.+||.+||..||.+|||++++++||||...
T Consensus       253 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 ---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                 01123458999999999999999999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.3e-49  Score=366.82  Aligned_cols=260  Identities=28%  Similarity=0.430  Sum_probs=213.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      +....++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            45567999999999999999999999999999999999875432 22233457789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999998 58888887654 4899999999999999999999999999999999999999999999999999876443


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      . ......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....               
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  228 (276)
T 2h6d_A          165 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------------  228 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------
T ss_pred             c-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------------
Confidence            2 234557889999999998754457899999999999999999999988877666665543211               


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   .....++..+.+||.+||+.||.+|||+.++++||||+.
T Consensus       229 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          229 -------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                         011234789999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-48  Score=367.92  Aligned_cols=263  Identities=33%  Similarity=0.528  Sum_probs=223.6

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++...+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            45678999999999999999999999999999999999987655444555678999999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---CcEEEeeeccceecC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~vkL~DFG~a~~~~  162 (415)
                      |+||||+. ++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999998 57888776654 48999999999999999999999999999999999999764   469999999998664


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. .......+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........          
T Consensus       176 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  242 (287)
T 2wei_A          176 QN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----------  242 (287)
T ss_dssp             CC-SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred             CC-CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----------
Confidence            33 23344568889999999876  489999999999999999999999999887777766654311100          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                    ...+..++.++.+||.+||..||++|||+.|+++||||...
T Consensus       243 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          243 --------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             --------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             --------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence                          11223568999999999999999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-49  Score=375.66  Aligned_cols=270  Identities=25%  Similarity=0.388  Sum_probs=198.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            478999999999999999999999989999999988654322 2233567899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           90 FEFME-TDLETVIRN-------TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~-------~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      |||++ |+|.+++..       ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            99997 588888764       2455899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC-----CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          162 GSPD-----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       162 ~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ....     .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+..................... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  250 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG-  250 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc-
Confidence            4322     1223457899999999987645689999999999999999999999988776655544332111000000 


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                       .........++.++.+||.+||+.||.+|||+.++++||||....
T Consensus       251 -----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          251 -----------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             ---------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             -----------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence                             011223346689999999999999999999999999999998643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-49  Score=385.10  Aligned_cols=264  Identities=17%  Similarity=0.156  Sum_probs=194.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhc--CCCCeeeEE-------eee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKEL--KSPHIIELI-------DAF   80 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l--~hp~Iv~l~-------~~~   80 (415)
                      ...|.+.+.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999998765322 2233455675444444  699988865       344


Q ss_pred             ecC-----------------CeEEEEeecccCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHhhhCCccccCC
Q 014985           81 PHK-----------------GNLHLVFEFMETDLETVIRNTNIFLSPADI------KSYMQMTLKGLAFCHKKWVLHRDM  137 (415)
Q Consensus        81 ~~~-----------------~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~------~~i~~qil~aL~~lH~~~ivHrDl  137 (415)
                      ...                 .++|+|||||+|+|.+++...+..++....      ..++.||+.||+|||++||+||||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            322                 348999999999999999876544555555      677799999999999999999999


Q ss_pred             CCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccC-CcCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q 014985          138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSS  216 (415)
Q Consensus       138 kp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  216 (415)
                      ||+||||+.+|++||+|||+|+..+..   .....+|+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+..
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999876432   224566789999999965 2468999999999999999999999998753


Q ss_pred             cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          217 DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       217 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ...             ...+....      ..............+.+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus       298 ~~~-------------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          298 PGI-------------KGSWKRPS------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             TTC-------------TTCCCBCC------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             ccc-------------ccchhhhh------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            210             00000000      00000011111223477999999999999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4e-49  Score=382.70  Aligned_cols=286  Identities=26%  Similarity=0.406  Sum_probs=217.2

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      +....++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  106 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI  106 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence            44567899999999999999999999999999999999876532 22234577899999999999999999999999999


Q ss_pred             EEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           87 HLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      |+||||++| +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++++||+|||++......
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999985 8888887654 489999999999999999999996 9999999999999999999999999998755221


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC---
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY---  241 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---  241 (415)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+............+....   
T Consensus       186 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             --C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             --cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence              2334678999999999977 5689999999999999999999999988765544332211111000000000000   


Q ss_pred             -C--------c-----cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          242 -L--------P-----DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       242 -~--------~-----~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                       .        +     ...... ............++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -----------CCCHHHHHHHH-HHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccCCCCcccchhhhhHH-hccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence             0        0     000000 000111111224689999999999999999999999999999997643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-48  Score=368.18  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=204.9

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec------
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------   82 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------   82 (415)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++....   .....+.+|+.+++.++||||+++++++.+      
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            46789999999999999999999999999999999986422   223456789999999999999999998754      


Q ss_pred             -------CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEee
Q 014985           83 -------KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        83 -------~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                             ....|+||||++ |+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   457899999998 589999987776789999999999999999999999999999999999999999999999


Q ss_pred             eccceecCCC--------------CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH
Q 014985          155 FGLARIFGSP--------------DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ  220 (415)
Q Consensus       155 FG~a~~~~~~--------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  220 (415)
                      ||++......              ........|++.|+|||++.+...++.++|||||||++|+|++  +++.+.+..+.
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--p~~~~~~~~~~  237 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI  237 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--CCSSHHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--ccCCchhHHHH
Confidence            9999865432              1223456788999999999875578999999999999999998  33222222333


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ...+... ...    ++                   .......+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       238 ~~~~~~~-~~~----~~-------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          238 LKKLRSV-SIE----FP-------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHST-TCC----CC-------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHhcccc-ccc----cC-------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            3332211 000    00                   1122345788999999999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.8e-49  Score=382.91  Aligned_cols=282  Identities=28%  Similarity=0.494  Sum_probs=216.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-----------CCCeeeEEe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----------SPHIIELID   78 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~l~~   78 (415)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.....   ....+.+|+.+++.++           ||||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            36799999999999999999999999999999999864321   2234668999999886           899999999


Q ss_pred             eeecCC----eEEEEeecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecC-----
Q 014985           79 AFPHKG----NLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSH-----  147 (415)
Q Consensus        79 ~~~~~~----~~~lv~e~~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~-----  147 (415)
                      ++...+    .+++||||++++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||||+.+     
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            987654    79999999988999998874 34599999999999999999999998 99999999999999643     


Q ss_pred             -CcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC------cHHH
Q 014985          148 -GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQ  220 (415)
Q Consensus       148 -~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~  220 (415)
                       +.+||+|||+++.....   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+      +.+.
T Consensus       174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence             47999999999876432   345678999999999987 558999999999999999999999998764      5667


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccch-------hcccccCCCc-------cccCCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYV-------EYQYVAAPPL-------RSLFPSASDDALDLLSKMFTYDPKARITAQ  286 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~  286 (415)
                      +..+...++..+...+........+.       ........++       ....+.++.++.+||.+||+.||.+|||++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            77777777654321110000000000       0000000000       011123467899999999999999999999


Q ss_pred             HHhcCCCCCCCC
Q 014985          287 QALEHRYFSSAP  298 (415)
Q Consensus       287 e~l~h~~~~~~~  298 (415)
                      |+|+||||+...
T Consensus       330 ell~hp~f~~~~  341 (373)
T 1q8y_A          330 GLVNHPWLKDTL  341 (373)
T ss_dssp             HHHTCGGGTTCT
T ss_pred             HHhhChhhhccc
Confidence            999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.7e-48  Score=376.75  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=210.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeee
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDT-------KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP   81 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~   81 (415)
                      ..++|++.+.||+|+||+||+|.+.       .++..||+|++..... ......+.+|+.+++.+ +||||++++++|.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            4689999999999999999999874       3456799999875432 22234577899999999 8999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~  145 (415)
                      ..+.+|+||||+. |+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+||||+
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            9999999999998 58988887653               2489999999999999999999999999999999999999


Q ss_pred             cCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHH
Q 014985          146 SHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG  222 (415)
Q Consensus       146 ~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  222 (415)
                      .+|.+||+|||+++.......  ......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+...
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999987654332  2334556788999999977 568999999999999999999 999999877666555


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .+.....                           ......++.++.+||.+||+.||.+|||+.|++++
T Consensus       317 ~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          317 LLKEGHR---------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHTTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5433211                           01123458899999999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=371.06  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=211.8

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ...++|.+.+.||+|+||+||+|.+..++.   .||||++..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            357899999999999999999999986665   499999875432 2223457789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .|+||||++ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999997 5888888777777999999999999999999999999999999999999999999999999999876543


Q ss_pred             CC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          165 DR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       165 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ..   ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.......         
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---------  274 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---------  274 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred             ccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---------
Confidence            32   2223345678999999976 468999999999999999998 999999988887777665432111         


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                        ....+++++.+||.+||..||.+|||+.++++
T Consensus       275 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          275 ------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                              12245889999999999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.1e-48  Score=369.56  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=210.7

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++.....    ...+.+|+.+++.+ +||||+++++++......|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            457899999999999999999999999999999999875432    23577899999999 9999999999999999999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc-----EEEeeeccceecC
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARIFG  162 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~-----vkL~DFG~a~~~~  162 (415)
                      +||||++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||+++.+.
T Consensus        82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999988999999877677999999999999999999999999999999999999998887     9999999999765


Q ss_pred             CCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 014985          163 SPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---DQLGKIFAAFGTAT  232 (415)
Q Consensus       163 ~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~  232 (415)
                      ....       .....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..   +.+..+....... 
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-  239 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-  239 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-
Confidence            4332       2346789999999999987 56899999999999999999999999885432   3333332211000 


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                            +........+ ++.+||..||..||.+||+++++++
T Consensus       240 ----------------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 ----------------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             ----------------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ----------------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                                  0011112234 8999999999999999999988876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-47  Score=361.38  Aligned_cols=256  Identities=20%  Similarity=0.229  Sum_probs=216.2

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGN   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~   85 (415)
                      +..+.++|++.+.||+|+||+||+|.+..+|+.||+|++.....    ...+.+|+.+++.+ .|+||+++++++.....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            45578899999999999999999999999999999999864432    23577899999999 79999999999999999


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc-----EEEeeecccee
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ-----LKLADFGLARI  160 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~-----vkL~DFG~a~~  160 (415)
                      .|+||||++|+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.
T Consensus        81 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           81 NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             eEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999988999999887777999999999999999999999999999999999999988776     99999999987


Q ss_pred             cCCCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---cHHHHHHHHHHhCC
Q 014985          161 FGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---DIDQLGKIFAAFGT  230 (415)
Q Consensus       161 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~  230 (415)
                      ......       ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+   ....+..+..... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  238 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-  238 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-
Confidence            654432       2345678999999999976 568999999999999999999999998853   3333333332211 


Q ss_pred             CCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                            ..+.....+.+++++.+||.+||+.||++|||++++++
T Consensus       239 ----------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          239 ----------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             ----------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ----------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence                                  11223344567899999999999999999999999876

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=361.01  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=207.6

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeecc
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFM   93 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~   93 (415)
                      |....+||+|+||+||+|.+..++..||+|.+....  ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            334449999999999999999999999999987543  223345778999999999999999999999999999999999


Q ss_pred             c-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-CCcEEEeeeccceecCCCCCccc
Q 014985           94 E-TDLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        94 ~-g~L~~~i~~~~~--~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      . |+|..++.....  .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence            7 688888876532  4678999999999999999999999999999999999998 89999999999988755444445


Q ss_pred             ccccccceeCcccccCC-cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGA-KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...|++.|+|||++.+. ..++.++|||||||++|+|++|..||...................                 
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  244 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-----------------  244 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-----------------
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-----------------
Confidence            66789999999998653 237889999999999999999999997655443222111111100                 


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                              ......++.++.+||.+||+.||++|||++++++||||...
T Consensus       245 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          245 --------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             --------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             --------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence                    11223468999999999999999999999999999999754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-48  Score=372.16  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=193.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..++|.+.+.||+|+||+||+|.+..++.   .||+|++............+.+|+.+++.++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            36789999999999999999999877765   899999876544444445678999999999999999999999877655


Q ss_pred             ------EEEeecccC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEee
Q 014985           87 ------HLVFEFMET-DLETVIRNTN-----IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLAD  154 (415)
Q Consensus        87 ------~lv~e~~~g-~L~~~i~~~~-----~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~D  154 (415)
                            ++||||+.| +|..++....     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence                  999999995 8888876432     2589999999999999999999999999999999999999999999999


Q ss_pred             eccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCC
Q 014985          155 FGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTA  231 (415)
Q Consensus       155 FG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  231 (415)
                      ||+++.......  ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....  
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--  257 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--  257 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             ccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--
Confidence            999987644332  2233455778999999976 568999999999999999999 8999998887777666543211  


Q ss_pred             CCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCCCCCCCC
Q 014985          232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-------AQQALEHRYFSSAP  298 (415)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------~~e~l~h~~~~~~~  298 (415)
                                               ....+.+++++.+||.+||+.||.+|||       ++++++|+|+....
T Consensus       258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence                                     1122345899999999999999999999       67788899997643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=380.21  Aligned_cols=261  Identities=19%  Similarity=0.267  Sum_probs=215.0

Q ss_pred             ccccccccEeeeeeecccCceEEEEEE-----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      +.....++|.+.+.||+|+||+||+|.     +..+++.||||++..... ......+.+|+.+++.++||||+++++++
T Consensus        65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            344557899999999999999999998     456778999999864322 22233567899999999999999999999


Q ss_pred             ecCCeEEEEeeccc-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---cE
Q 014985           81 PHKGNLHLVFEFME-TDLETVIRNTN------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---QL  150 (415)
Q Consensus        81 ~~~~~~~lv~e~~~-g~L~~~i~~~~------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---~v  150 (415)
                      ......|+|||||. |+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99999999999997 58999987654      3589999999999999999999999999999999999999655   49


Q ss_pred             EEeeeccceecCCC--CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHH
Q 014985          151 KLADFGLARIFGSP--DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAA  227 (415)
Q Consensus       151 kL~DFG~a~~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  227 (415)
                      ||+|||+++.....  ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999754221  223345667889999999976 568999999999999999998 99999998887777666543


Q ss_pred             hCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      ...                           .....++..+.+||.+||+.||.+|||+.+++++.++.
T Consensus       303 ~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 GRM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            211                           11124578999999999999999999999999987753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-48  Score=372.37  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=214.7

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC----CccchHHHHHHHHHhcC--CCCeeeEEe
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE----GVNFTALREIKLLKELK--SPHIIELID   78 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~----~~~~~~~~E~~il~~l~--hp~Iv~l~~   78 (415)
                      ...+.+.++|++.+.||+|+||+||+|.+..+++.||||++.......    .....+.+|+.+++.++  |+||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            345568899999999999999999999999999999999997654332    12234568999999996  599999999


Q ss_pred             eeecCCeEEEEeeccc--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe-cCCcEEEeee
Q 014985           79 AFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADF  155 (415)
Q Consensus        79 ~~~~~~~~~lv~e~~~--g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~-~~~~vkL~DF  155 (415)
                      ++...+..++|||++.  ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            9999999999999997  6888888764 4589999999999999999999999999999999999999 7899999999


Q ss_pred             ccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          156 GLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       156 G~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      |+++.....  ......||+.|+|||++.+...++.++|||||||++|+|++|..||.....      +...  .     
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~-----  259 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q-----  259 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C-----
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c-----
Confidence            999876532  344567899999999997655557889999999999999999999975321      1110  0     


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                                           ......+++++.+||.+||+.||++|||++++++||||.....
T Consensus       260 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          260 ---------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             ---------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ---------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                                 0112346899999999999999999999999999999987543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-48  Score=375.11  Aligned_cols=279  Identities=18%  Similarity=0.325  Sum_probs=220.4

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCcc---------------chHHHHHHHHHhcCCC
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN---------------FTALREIKLLKELKSP   71 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~---------------~~~~~E~~il~~l~hp   71 (415)
                      .....++|++.+.||+|+||.||+|.+  +|+.||+|++..........               ..+.+|+.+++.++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            345578999999999999999999998  89999999997654322211               5678999999999999


Q ss_pred             CeeeEEeeeecCCeEEEEeecccC-CHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcE
Q 014985           72 HIIELIDAFPHKGNLHLVFEFMET-DLETV------IRNT-NIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNL  142 (415)
Q Consensus        72 ~Iv~l~~~~~~~~~~~lv~e~~~g-~L~~~------i~~~-~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NI  142 (415)
                      ||+++++++.+.+..|+||||++| +|.++      +... ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999996 77776      4432 4669999999999999999999999 9999999999999


Q ss_pred             EEecCCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCC-cccHHHHHHHHHHHHcCCCCCCCCCc-HHH
Q 014985          143 LIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA-GVDVWAAGCIFAELLNRRPFLQGSSD-IDQ  220 (415)
Q Consensus       143 Li~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~-~~~  220 (415)
                      |++.++.+||+|||++......  ......++..|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+.
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999999999999876443  4456678999999999987545665 99999999999999999999998877 555


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          221 LGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       221 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ...+.....     .++....  ..  .............+.++.++.+||.+||+.||.+|||++|+++||||....
T Consensus       262 ~~~i~~~~~-----~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          262 FNNIRTKNI-----EYPLDRN--HF--LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHTSCCC-----CCCCSSS--SS--TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHhccCc-----CCccchh--hh--hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            555432211     1111000  00  000000111222356799999999999999999999999999999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-48  Score=358.34  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=212.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++......   ...+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            579999999999999999999986 5678999999754332   245789999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Ccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~~  168 (415)
                      ||++ |+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            9998 57888888777779999999999999999999999999999999999999999999999999998654322 122


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......                
T Consensus       165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~----------------  227 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------  227 (269)
T ss_dssp             TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC----------------
T ss_pred             cCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC----------------
Confidence            33455778999999976 558999999999999999999 999999988877777665432111                


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                 .....+.++.+||.+||+.||++|||+.++++|
T Consensus       228 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          228 -----------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                       112347899999999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.9e-48  Score=366.22  Aligned_cols=261  Identities=24%  Similarity=0.327  Sum_probs=200.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++............+..+..+++.++||||+++++++...+.+|+|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            36899999999999999999999999999999999986544333333344555678888999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||+++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....... ..
T Consensus       103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~  181 (318)
T 2dyl_A          103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AK  181 (318)
T ss_dssp             ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cc
Confidence            99997777777666567799999999999999999999995 99999999999999999999999999997654322 23


Q ss_pred             cccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          169 THQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      ....+|+.|+|||++.+    ...++.++|||||||++|+|++|..||... ...+.+..+......    .        
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~--------  249 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP----L--------  249 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC----C--------
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC----C--------
Confidence            45578899999999852    346889999999999999999999999874 444555555442110    0        


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                   ......++.++.+||.+||+.||.+|||++++++||||..
T Consensus       250 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          250 -------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             -------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             -------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence                         0112245899999999999999999999999999999974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=364.04  Aligned_cols=253  Identities=22%  Similarity=0.369  Sum_probs=207.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -.++|++.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            368999999999999999999999999999999988542  222334577899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc-
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR-  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~-  167 (415)
                      |||+. |+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ 
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            99998 5899988887777999999999999999999999999999999999999999999999999999876443321 


Q ss_pred             -------------ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          168 -------------FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       168 -------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                                   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........              
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--------------  230 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--------------  230 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--------------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--------------
Confidence                         125678999999999977 6689999999999999999999988765321000              


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                            ....... ..    ......+.+++.+.+||.+||+.||++|||+.++++
T Consensus       231 ------~~~~~~~-~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          231 ------DFGLNVR-GF----LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             ------TSSBCHH-HH----HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------HHhhhhh-cc----ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  0000000 00    001123456889999999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.5e-47  Score=354.59  Aligned_cols=250  Identities=22%  Similarity=0.284  Sum_probs=212.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++......   ...+.+|+.+++.++||||+++++++...+..|+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            4689999999999999999999775 5678999998754322   23577899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-c
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~  167 (415)
                      |||++ |+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            99998 579888887766799999999999999999999999999999999999999999999999999987644332 2


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........              
T Consensus       162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  226 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR--------------  226 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--------------
T ss_pred             ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC--------------
Confidence            233445677999999976 458899999999999999998 9999998887777666543311111              


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                   ....++.+.+||.+||+.||.+|||+.+++++
T Consensus       227 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          227 -------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         12347899999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-47  Score=360.98  Aligned_cols=260  Identities=26%  Similarity=0.357  Sum_probs=207.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC--CCCeeeEEeeeecCCeEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--SPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++  ||||+++++++...+..|
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            4678999999999999999999875 5899999999765544334456778999999997  499999999999999999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      +|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ 
T Consensus       105 lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          105 MVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EEECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred             EEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence            999988889999988654 589999999999999999999999999999999999996 58999999999987644322 


Q ss_pred             -cccccccccceeCcccccCC----------cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCCCCCC
Q 014985          167 -RFTHQVFARWYRAPELLFGA----------KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPS  234 (415)
Q Consensus       167 -~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  234 (415)
                       ......||+.|+|||++.+.          ..++.++|||||||++|+|++|..||...... ..+..+..   .... 
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~-  258 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PNHE-  258 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---TTSC-
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh---cccc-
Confidence             22345789999999998651          35788999999999999999999999776443 22222211   1100 


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                            .......+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       259 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          259 ----------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             ----------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ----------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence                                  011123478899999999999999999999999999998643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.1e-47  Score=356.82  Aligned_cols=250  Identities=20%  Similarity=0.296  Sum_probs=209.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -.++|++.+.||+|+||+||+|.+. ++..||+|++......   ...+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            4689999999999999999999876 6678999998754322   24577999999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Cc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~  167 (415)
                      |||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            99997 68988888766679999999999999999999999999999999999999999999999999998654322 12


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+........              
T Consensus       178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------------  242 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR--------------  242 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--------------
T ss_pred             ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC--------------
Confidence            233445778999999976 458999999999999999998 9999999888777776654322111              


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                   ....++.+.+||.+||+.||.+|||+.++++|
T Consensus       243 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          243 -------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                         12347899999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-47  Score=370.34  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=212.8

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCC-------CcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeee
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAF   80 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-------~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~   80 (415)
                      ...++|++.+.||+|+||+||+|.+..+       +..||+|++..... ......+.+|+.+++.+ +||||+++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3468999999999999999999987543       35799999875432 22234577899999999 999999999999


Q ss_pred             ecCCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE
Q 014985           81 PHKGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI  144 (415)
Q Consensus        81 ~~~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi  144 (415)
                      ...+.+|+||||+. |+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999998 58998887654               358999999999999999999999999999999999999


Q ss_pred             ecCCcEEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHH
Q 014985          145 GSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQL  221 (415)
Q Consensus       145 ~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  221 (415)
                      +.++.+||+|||+++......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999998765433  23344566788999999987 568999999999999999999 99999988777666


Q ss_pred             HHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          222 GKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       222 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ..+......                           .....+++++.+||.+||+.||++|||+.|++++
T Consensus       304 ~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          304 KLLKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHTTCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555432111                           1113458899999999999999999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-47  Score=375.34  Aligned_cols=251  Identities=21%  Similarity=0.319  Sum_probs=210.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            5789999999999999999999999999999999874422 122235668999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc-
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF-  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~-  168 (415)
                      ||++ |+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... 
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            9998 68999988776679999999999999999999999999999999999999999999999999998754322111 


Q ss_pred             -cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          169 -THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       169 -~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       ....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......                
T Consensus       272 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------  334 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL----------------  334 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC----------------
T ss_pred             CCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence             12234667999999975 458999999999999999998 99999988777665554332111                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 .....+++++.+||.+||+.||++|||++++++
T Consensus       335 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 -----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                       111235789999999999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-47  Score=371.04  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=208.2

Q ss_pred             ccccEeeeeeecccCceEEEEEE-----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      -.++|++.+.||+|+||.||+|.     +..+++.||||++...... .....+.+|+.+++++ .||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            36899999999999999999998     5567789999999754322 2233577899999999 789999999998775


Q ss_pred             C-eEEEEeeccc-CCHHHHHHhcCC-------------------------------------------------------
Q 014985           84 G-NLHLVFEFME-TDLETVIRNTNI-------------------------------------------------------  106 (415)
Q Consensus        84 ~-~~~lv~e~~~-g~L~~~i~~~~~-------------------------------------------------------  106 (415)
                      + .+++|||||. |+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 4999999998 588888876532                                                       


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--Ccccccccc
Q 014985          107 ----------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA  174 (415)
Q Consensus       107 ----------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~t  174 (415)
                                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  .......+|
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                      18999999999999999999999999999999999999999999999999998764332  233456678


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccC
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAA  253 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (415)
                      +.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+.+..........                      
T Consensus       259 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------  315 (359)
T 3vhe_A          259 LKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------  315 (359)
T ss_dssp             GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred             ceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------------
Confidence            88999999976 568999999999999999998 999998877555544444331111                      


Q ss_pred             CCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          254 PPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       254 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                          .....+++++.+||.+||+.||.+|||+.|+++|
T Consensus       316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                1112358899999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-47  Score=366.19  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=205.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcE----EEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|++.+.||+|+||+||+|.+..++..    +|+|.+..... ......+.+|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            68999999999999999999999888876    66776643322 222334568999999999999999999986 5678


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++||||+. |+|.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            99999998 68988888766679999999999999999999999999999999999999999999999999998764433


Q ss_pred             C--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          166 R--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       166 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......            
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------  236 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL------------  236 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC------------
T ss_pred             ccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC------------
Confidence            2  2344567778999999976 458999999999999999999 99999988766665555332111            


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                     ......+.++.+||.+||..||.+|||+.+++++
T Consensus       237 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 ---------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           1111246788999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=365.09  Aligned_cols=254  Identities=23%  Similarity=0.369  Sum_probs=201.9

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC----CccchHHHHHHHHHhc----CCCCeeeEEe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE----GVNFTALREIKLLKEL----KSPHIIELID   78 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~----~~~~~~~~E~~il~~l----~hp~Iv~l~~   78 (415)
                      .+.+.++|++.+.||+|+||.||+|.+..+++.||+|++.......    .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3567889999999999999999999999999999999997654321    1223345799999999    8999999999


Q ss_pred             eeecCCeEEEEeec-cc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe-cCCcEEEeee
Q 014985           79 AFPHKGNLHLVFEF-ME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG-SHGQLKLADF  155 (415)
Q Consensus        79 ~~~~~~~~~lv~e~-~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~-~~~~vkL~DF  155 (415)
                      ++...+..++|||| +. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999999999 55 68888887654 589999999999999999999999999999999999999 7899999999


Q ss_pred             ccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          156 GLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       156 G~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      |++......  ......|+..|+|||++.+...++.++|||||||++|+|++|..||.....      +....       
T Consensus       185 g~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~-------  249 (312)
T 2iwi_A          185 GSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE-------  249 (312)
T ss_dssp             SSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC-------
T ss_pred             chhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc-------
Confidence            999876543  344567899999999987645445689999999999999999999975321      11110       


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                           ..+...++.++.+||.+||+.||++|||++|+++||||...
T Consensus       250 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          250 ---------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             ---------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence                                 01123458999999999999999999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-46  Score=352.22  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=210.4

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCcc-----chHHHHHHHHHhcCCCCeeeEEeee
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVN-----FTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~-----~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      ++....++|++.+.||+|+||+||+|.+..+++.||+|++..........     ..+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            34556899999999999999999999999999999999987654332211     4577899999999999999999999


Q ss_pred             ecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCc-----EEE
Q 014985           81 PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQ-----LKL  152 (415)
Q Consensus        81 ~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~-----vkL  152 (415)
                      .+..  ++||||+. |+|.+.+......+++..++.++.||+.||+|||++|  |+||||||+|||++.++.     +||
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7765  69999998 6898998887778999999999999999999999999  999999999999988876     999


Q ss_pred             eeeccceecCCCCCcccccccccceeCcccccC-CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH--HHHHHHHhC
Q 014985          153 ADFGLARIFGSPDRRFTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ--LGKIFAAFG  229 (415)
Q Consensus       153 ~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~  229 (415)
                      +|||+++....   ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....  ...+... +
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~  246 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-G  246 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-C
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-C
Confidence            99999985432   3455678999999999843 34578899999999999999999999987654333  2222211 1


Q ss_pred             CCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      ..                         ......+++++.+||.+||+.||.+|||+.++++
T Consensus       247 ~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 LR-------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            00                         1122356899999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-47  Score=366.90  Aligned_cols=260  Identities=27%  Similarity=0.409  Sum_probs=184.9

Q ss_pred             ccccccEeeee-eecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHH-HHHHhcCCCCeeeEEeeeec---
Q 014985            8 KKVADRYLKRE-VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREI-KLLKELKSPHIIELIDAFPH---   82 (415)
Q Consensus         8 ~~~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~-~il~~l~hp~Iv~l~~~~~~---   82 (415)
                      ..+.++|.+.+ +||+|+||+||+|.+..+|+.||||++....       ...+|+ ..++.++||||++++++|..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            45789999955 6999999999999999999999999986421       223333 44677799999999999876   


Q ss_pred             -CCeEEEEeecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeec
Q 014985           83 -KGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFG  156 (415)
Q Consensus        83 -~~~~~lv~e~~~g-~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG  156 (415)
                       ...+|+|||||+| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             4568999999985 8999888654 36999999999999999999999999999999999999986   4559999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      +++.....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+........    
T Consensus       177 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  249 (336)
T 3fhr_A          177 FAKETTQN--ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ----  249 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             cceecccc--ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc----
Confidence            99876432  3345678999999999865 5588999999999999999999999987654433222111110000    


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                      .......+..++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus       250 ----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          250 ----------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ----------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                            000012234568999999999999999999999999999999763

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-47  Score=356.43  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=200.6

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ....++|++.+.||+|+||+||+|.+..+   +..||+|++..... ......+.+|+.+++.++||||+++++++. ++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            44578999999999999999999998654   45799998765322 222345778999999999999999999984 56


Q ss_pred             eEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..|+||||+.| +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            78999999994 89999887776799999999999999999999999999999999999999999999999999987644


Q ss_pred             CCC-cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          164 PDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       164 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....            
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------  235 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------  235 (281)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred             ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------------
Confidence            322 2233456778999999975 568999999999999999996 9999998887776666543211            


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                     ....+.+++++.+||.+||..||++|||+.+++++
T Consensus       236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                           11223568999999999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.7e-47  Score=363.54  Aligned_cols=252  Identities=21%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEE----EEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~----avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..++|.+.+.||+|+||+||+|.+..+++.+    |+|.+.... .......+.+|+.+++.++||||+++++++.... 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            3789999999999999999999998887755    677665332 2223346788999999999999999999998765 


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .++|+||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            778888888 6899999887778999999999999999999999999999999999999999999999999999876544


Q ss_pred             CCc--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 DRR--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ...  .....+|..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......           
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  238 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-----------  238 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred             cccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-----------
Confidence            332  233455778999999976 568999999999999999999 99999987766555444322110           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                      ...+..+.++.+||.+||+.||.+|||+.+++++
T Consensus       239 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 ----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                            1123457899999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.6e-47  Score=363.99  Aligned_cols=261  Identities=24%  Similarity=0.378  Sum_probs=191.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHH-HHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+|+. +++.++||||+++++++...+..|+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            3689999999999999999999999999999999997653322 2223445555 7778899999999999999999999


Q ss_pred             EeecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           89 VFEFMETDLETVIRN----TNIFLSPADIKSYMQMTLKGLAFCHKK-WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        89 v~e~~~g~L~~~i~~----~~~~l~~~~~~~i~~qil~aL~~lH~~-~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ||||++|+|..++..    ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus        99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A           99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            999999988887763    245699999999999999999999999 999999999999999999999999999987643


Q ss_pred             CCCcccccccccceeCccccc---CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLF---GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .. ......||+.|+|||++.   ....++.++|||||||++|+|++|..||.+.+.. +.+..+       ...     
T Consensus       179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~-----  245 (327)
T 3aln_A          179 SI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-------VKG-----  245 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-------CCS-----
T ss_pred             cc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-------hcC-----
Confidence            32 233457899999999984   2355899999999999999999999999764321 111000       000     


Q ss_pred             CCCccchhcccccCCC-ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPP-LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                  ..+. .......++..+.+||.+||+.||.+|||+.++++||||..
T Consensus       246 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          246 ------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             ------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence                        0000 01122456899999999999999999999999999999964

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.7e-47  Score=355.95  Aligned_cols=260  Identities=20%  Similarity=0.289  Sum_probs=203.1

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      +..+...++|++.+.||+|+||+||+|.+.   ..+|+|++............+.+|+.+++.++||||+++++++ ...
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            445667889999999999999999999654   3599999976654444445678899999999999999999965 566


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..++||||+. ++|...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            7899999998 688888877777799999999999999999999999999999999999999999999999999986543


Q ss_pred             C--CCcccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          164 P--DRRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       164 ~--~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .  ........||+.|+|||++..  ...++.++|||||||++|+|++|..||.+....+.+..+.......        
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  244 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS--------  244 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC--------
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC--------
Confidence            2  223345678999999999862  3557889999999999999999999999887777666655432111        


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    +.+......+++.+.+||.+||+.||.+|||+.++++
T Consensus       245 --------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          245 --------------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------------CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                          1112233456899999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.2e-46  Score=353.03  Aligned_cols=256  Identities=18%  Similarity=0.210  Sum_probs=209.6

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEee-eecCCe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA-FPHKGN   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-~~~~~~   85 (415)
                      ...+.++|++.+.||+|+||+||+|++..+|+.||+|++.....    ...+.+|+.+++.++|++++..+.. +.....
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             cceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            34578999999999999999999999999999999999865432    2357789999999999876655554 466788


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeeccceecC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFG  162 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~a~~~~  162 (415)
                      .++||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99999999889999998777779999999999999999999999999999999999999   488999999999998765


Q ss_pred             CCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---HHHHHHHHHHhCCCC
Q 014985          163 SPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTAT  232 (415)
Q Consensus       163 ~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~  232 (415)
                      ....       ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.   ...+..+.....   
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  235 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---
T ss_pred             ccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc---
Confidence            4432       2345678999999999977 5589999999999999999999999987432   222322222100   


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                          ..+.....+.+++++.+||.+||+.||.+|||+.++++
T Consensus       236 --------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          236 --------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             --------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             --------------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                01112233456899999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.7e-47  Score=356.31  Aligned_cols=256  Identities=18%  Similarity=0.215  Sum_probs=204.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEee-eecCCe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA-FPHKGN   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-~~~~~~   85 (415)
                      ...+.++|++.+.||+|+||+||+|.+..+++.||+|++......    ..+.+|+.+++.++|++++..+.. +.....
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            446789999999999999999999999999999999987654332    357789999999998776666554 577788


Q ss_pred             EEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeeccceecC
Q 014985           86 LHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFG  162 (415)
Q Consensus        86 ~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~a~~~~  162 (415)
                      .++||||++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        80 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           80 NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             eEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            99999999889999998777779999999999999999999999999999999999999   788999999999998765


Q ss_pred             CCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 014985          163 SPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---DQLGKIFAAFGTAT  232 (415)
Q Consensus       163 ~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~  232 (415)
                      ....       ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..   ..+..+....    
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  234 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----  234 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH----
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc----
Confidence            4332       2335678999999999977 55899999999999999999999999875422   2222221110    


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         ...+.......+++++.+||.+||+.||++|||+.++++
T Consensus       235 -------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          235 -------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -------------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                               001122333456899999999999999999999999886

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.2e-47  Score=377.76  Aligned_cols=264  Identities=25%  Similarity=0.382  Sum_probs=202.3

Q ss_pred             ccccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec
Q 014985            4 VDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (415)
Q Consensus         4 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~   82 (415)
                      .++...+.+.|.+.+.||+|+||+||.+ ...+|+.||||++....     ...+.+|+.+++++ +||||+++++++.+
T Consensus         7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   80 (434)
T 2rio_A            7 PNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETT   80 (434)
T ss_dssp             -CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             cchhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            4567778999999999999999999875 45689999999986432     23467899999986 89999999999999


Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---------
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIF------LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---------  147 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~------l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---------  147 (415)
                      .+.+|+|||||+|+|.+++......      .++..++.++.||+.||+|||++||+||||||+|||++.+         
T Consensus        81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            9999999999999999998765421      1233457799999999999999999999999999999764         


Q ss_pred             ----CcEEEeeeccceecCCCCC----cccccccccceeCcccccC------CcCCCCcccHHHHHHHHHHHHc-CCCCC
Q 014985          148 ----GQLKLADFGLARIFGSPDR----RFTHQVFARWYRAPELLFG------AKQYGAGVDVWAAGCIFAELLN-RRPFL  212 (415)
Q Consensus       148 ----~~vkL~DFG~a~~~~~~~~----~~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwSlG~il~ell~-g~~pf  212 (415)
                          +++||+|||+++.......    .....+||+.|+|||++.+      ...++.++|||||||++|||++ |.+||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                4899999999998754332    2335679999999999965      2458999999999999999998 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014985          213 QGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (415)
Q Consensus       213 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~  292 (415)
                      .+....+  ..+.......  ....   .                ...+.++.++.+||.+||+.||.+|||+.++++||
T Consensus       241 ~~~~~~~--~~i~~~~~~~--~~~~---~----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          241 GDKYSRE--SNIIRGIFSL--DEMK---C----------------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             CSTTTHH--HHHHHTCCCC--CCCT---T----------------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             CCchhhH--HHHhcCCCCc--cccc---c----------------cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence            7665443  2233221110  0000   0                00112367899999999999999999999999999


Q ss_pred             CCCC
Q 014985          293 YFSS  296 (415)
Q Consensus       293 ~~~~  296 (415)
                      ||..
T Consensus       298 ~f~~  301 (434)
T 2rio_A          298 LFWP  301 (434)
T ss_dssp             GGSC
T ss_pred             ccCC
Confidence            9964

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-47  Score=366.22  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=210.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            4689999999999999999999987     3558999999875432 222345778999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTN-----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPN  140 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~-----------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~  140 (415)
                      ..|+||||++ |+|.+++....                       ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            9999999998 58988887642                       56899999999999999999999999999999999


Q ss_pred             cEEEecCCcEEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCc
Q 014985          141 NLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSD  217 (415)
Q Consensus       141 NILi~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  217 (415)
                      |||++.++.+||+|||+++......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus       204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            9999999999999999998654322  22334567888999999876 458999999999999999998 9999998887


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          218 IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       218 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .+....+.....                           ......++.++.+||.+||+.||.+|||+.+++++
T Consensus       283 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          283 EEVIYYVRDGNI---------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCc---------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            776665543211                           01123458899999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-47  Score=377.84  Aligned_cols=279  Identities=21%  Similarity=0.297  Sum_probs=213.1

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC--
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--   84 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--   84 (415)
                      ...+.++|.+.++||+|+||+||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++....  
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            3456889999999999999999999999999999999987543322 2345678999999999999999999997655  


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE----ecCCcEEEeeecc
Q 014985           85 NLHLVFEFME-TDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI----GSHGQLKLADFGL  157 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi----~~~~~vkL~DFG~  157 (415)
                      ..|+|||||. |+|.+++....  ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999998 58888876543  238999999999999999999999999999999999999    6777899999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccCC-------cCCCCcccHHHHHHHHHHHHcCCCCCCCCC----cHHHHHHHHH
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFGA-------KQYGAGVDVWAAGCIFAELLNRRPFLQGSS----DIDQLGKIFA  226 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~  226 (415)
                      ++..... ......+||+.|+|||++.+.       ..++.++|||||||++|||++|..||.+..    ..+.+..+..
T Consensus       163 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          163 ARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             CEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             ceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            9876443 334456789999999998541       457889999999999999999999997533    3444444444


Q ss_pred             HhCCCCCCCCCCCCCCcc-chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          227 AFGTATPSQWPDLAYLPD-YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .   .++..+........ ...+.. ..+....+...++..+.+||.+||+.||++|||+.|++++
T Consensus       242 ~---~p~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          242 G---KPSGAISGVQKAENGPIDWSG-DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             S---CCTTCCEEEECSTTCCEEEES-SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             C---CCcccchhheeccCCCcccCc-cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            2   22222221111100 000100 1111122223456788999999999999999999998653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.2e-47  Score=359.30  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=210.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|++..... ......+.+|+.+++.++||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            4789999999999999999999883     4558999999875432 222345678999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNI-----------------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPN  140 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~-----------------------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~  140 (415)
                      ..|+||||+. |+|.+++.....                       .+++..++.++.||+.||.|||++||+||||||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence            9999999998 688888876432                       3899999999999999999999999999999999


Q ss_pred             cEEEecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCc
Q 014985          141 NLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSD  217 (415)
Q Consensus       141 NILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  217 (415)
                      |||++.++.+||+|||+++.......  ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987654332  2234456788999999976 558999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          218 IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       218 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ......+.....                           ......+++++.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          259 ERLFNLLKTGHR---------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhcCCc---------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            655544432210                           11223568999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.7e-47  Score=357.81  Aligned_cols=271  Identities=19%  Similarity=0.305  Sum_probs=202.4

Q ss_pred             ccccccccEeeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP   81 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   81 (415)
                      ..+...++|++.+.||+|+||+||+|+    +..+++.||+|++....  ......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345568999999999999999999998    56789999999986432  122235678999999999999999999885


Q ss_pred             c--CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           82 H--KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        82 ~--~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                      .  ...+|+||||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456899999997 5899998877667999999999999999999999999999999999999999999999999999


Q ss_pred             eecCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          159 RIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       159 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      +.......   ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......  ...   ..+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~---~~~~~~~~~  235 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR---MIGNDKQGQ  235 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHH---HHCTTCCTH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHh---hhcCccccc
Confidence            87644322   2233456778999999976 56899999999999999999999887643211  111   111000000


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .      ....................+++++.+||.+||+.||++|||+.|+++
T Consensus       236 ~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          236 M------IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             H------HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             h------hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0      000000000000111223456899999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=377.62  Aligned_cols=256  Identities=25%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..+|.+.++||+|+||+||. ....+|+.||||++.....     ..+.+|+.+|+.+ +||||+++++++.+....|+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            35799999999999999764 4467899999999864322     2356899999999 799999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---C--CcEEEeeeccceecCCC
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---H--GQLKLADFGLARIFGSP  164 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~--~~vkL~DFG~a~~~~~~  164 (415)
                      ||||+|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+|+.....
T Consensus        97 ~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            999999999999887766777778899999999999999999999999999999953   2  35889999999876433


Q ss_pred             C---CcccccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          165 D---RRFTHQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       165 ~---~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      .   ......+||+.|+|||++.+  ...++.++|||||||++|||++ |.+||......... .+   .+.......  
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~~~~--  250 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSLDCL--  250 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCCTTS--
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCcccc--
Confidence            2   23345679999999999974  3457789999999999999999 88998665443322 11   111110000  


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                         ......+..+.+||.+||+.||.+|||++++++||||...
T Consensus       251 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          251 -------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             -------------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             -------------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                               0001225668999999999999999999999999999753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=360.66  Aligned_cols=251  Identities=22%  Similarity=0.355  Sum_probs=201.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEE----EEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTV----AIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~----avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..++|++.+.||+|+||+||+|.+..+++.+    |+|.+.... .......+.+|+.+++.++||||+++++++.... 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            3689999999999999999999998888765    555554322 2233446788999999999999999999998765 


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .++|+||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            778888887 6899999887778999999999999999999999999999999999999999999999999999876443


Q ss_pred             CC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          165 DR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       165 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ..  ......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......           
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-----------  238 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-----------  238 (327)
T ss_dssp             ---------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----------
T ss_pred             cccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            32  2233455778999999976 568999999999999999999 99999988776655544332111           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                      ...+.++.++.+||.+||..||.+|||+.|+++
T Consensus       239 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 ----------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ----------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                            112345889999999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=361.67  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=208.5

Q ss_pred             cccEeeeeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|.+.+.||+|+||+||+|.+     ..++..||+|++..... ......+.+|+.+++++ +||||+++++++...+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            68999999999999999999997     34567899999975432 23345678999999999 8999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 014985           85 NLHLVFEFME-TDLETVIRNTNI----------------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~----------------------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~N  141 (415)
                      ..|+||||++ |+|.+++.....                      .+++..++.++.||+.||.|||++||+||||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            9999999998 589998876543                      37899999999999999999999999999999999


Q ss_pred             EEEecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcH
Q 014985          142 LLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDI  218 (415)
Q Consensus       142 ILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  218 (415)
                      ||++.++.+||+|||++........  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            9999999999999999987644332  2234556788999999876 568999999999999999998 99999887765


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014985          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (415)
Q Consensus       219 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~  292 (415)
                      .....+......                          ......+++++.+||.+||..||.+|||+.++++|-
T Consensus       282 ~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          282 ANFYKLIQNGFK--------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhcCCC--------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            555444432100                          011224588999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-46  Score=354.22  Aligned_cols=249  Identities=16%  Similarity=0.245  Sum_probs=206.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCC-------cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTG-------QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      +...++|.+.+.||+|+||+||+|.+..++       ..||+|++....  ......+.+|+.+++.++||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            345789999999999999999999988877       479999986432  22334577899999999999999999999


Q ss_pred             ecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc--------EE
Q 014985           81 PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ--------LK  151 (415)
Q Consensus        81 ~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~--------vk  151 (415)
                      ...+..|+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999998 6899988877666999999999999999999999999999999999999999887        99


Q ss_pred             EeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHHHhCC
Q 014985          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGT  230 (415)
Q Consensus       152 L~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~  230 (415)
                      |+|||++.....    .....+|..|+|||++.+...++.++|||||||++|+|++| .+||......... .+..... 
T Consensus       162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~-  235 (289)
T 4fvq_A          162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRH-  235 (289)
T ss_dssp             ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC-
T ss_pred             eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccC-
Confidence            999999875432    22345778899999998756789999999999999999995 5666555444333 2222100 


Q ss_pred             CCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                                 ...+..+.++.+||.+||+.||.+|||+.++++|
T Consensus       236 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          236 ---------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ---------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                       1112336789999999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=348.06  Aligned_cols=249  Identities=22%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......   ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            578999999999999999999986 6788999998754332   246788999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Ccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RRF  168 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~~  168 (415)
                      ||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            9998 58999888777779999999999999999999999999999999999999999999999999998653321 122


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......                
T Consensus       163 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------  225 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------  225 (267)
T ss_dssp             TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC----------------
T ss_pred             ccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC----------------
Confidence            33456778999999975 458899999999999999999 899999888777766654431111                


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                 .....+..+.+||.+||+.||++|||+.+++++
T Consensus       226 -----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          226 -----------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       112347899999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-46  Score=352.86  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=214.4

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      --....++|.+.+.||+|+||+||+|.+..++..||+|++....   .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34456899999999999999999999999999999999986432   223457789999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           86 LHLVFEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999 6899888764 34589999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          164 PDR-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       164 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      ... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+......           
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-----------  231 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-----------  231 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------
T ss_pred             CccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-----------
Confidence            332 2333456778999999976 468999999999999999999 99999887766655554332111           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                      .....+++.+.+||.+||..||.+|||+.++++
T Consensus       232 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          232 ----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                            112345889999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-46  Score=353.25  Aligned_cols=261  Identities=25%  Similarity=0.454  Sum_probs=198.5

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecC
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHK   83 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   83 (415)
                      +.+....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus        25 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           25 DMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34556688999999999999999999999999999999999764322 22334567899999999999999999999999


Q ss_pred             CeEEEEeecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           84 GNLHLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        84 ~~~~lv~e~~~g-~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      +..++||||+.| +|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            999999999995 78777754   35568999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC-cHHHHHHHHHHhCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      .............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....+........      ++ 
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~-  256 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD------YP-  256 (310)
T ss_dssp             --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC------SC-
T ss_pred             eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc------CC-
Confidence            76555444455678999999999976 568999999999999999999999987653 2222222111100      00 


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                        ......++.++.+||.+||..||.+|||+.+++++
T Consensus       257 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          257 ------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                              00112458899999999999999999999999873

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-46  Score=352.23  Aligned_cols=273  Identities=21%  Similarity=0.314  Sum_probs=208.1

Q ss_pred             ccccccccccEeeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEee
Q 014985            4 VDLSKKVADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA   79 (415)
Q Consensus         4 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~   79 (415)
                      ++......++|++.+.||+|+||.||+|+    +..+++.||+|++...... .....+.+|+.+++.++||||++++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGI   91 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence            44455567889999999999999999998    5678999999998755422 233467789999999999999999999


Q ss_pred             eecC--CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeec
Q 014985           80 FPHK--GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFG  156 (415)
Q Consensus        80 ~~~~--~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG  156 (415)
                      +...  ..+|+||||++ |+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            9876  67899999998 58999987777779999999999999999999999999999999999999999999999999


Q ss_pred             cceecCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCC
Q 014985          157 LARIFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATP  233 (415)
Q Consensus       157 ~a~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  233 (415)
                      ++........   ......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+....  ....   ...+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~---~~~~~~~~  245 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--ALFL---KMIGPTHG  245 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHH---HHHCSCCG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--hHHh---hccCCccc
Confidence            9988755442   2334567888999999976 457899999999999999999998754221  1110   00000000


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                           .  ...................+.+++++.+||.+||+.||.+|||+.++++
T Consensus       246 -----~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          246 -----Q--MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -----G--GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -----c--cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                 0  0000000000001111233467899999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.6e-47  Score=369.53  Aligned_cols=251  Identities=21%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             cccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+.||+|+||.||+|++.   .++..||||++..... ......+.+|+.++++++||||+++++++...+.+|
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            578999999999999999999876   4677899999875432 222345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ |+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence            9999997 689999887777799999999999999999999999999999999999999999999999999987644322


Q ss_pred             c---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+.......           
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-----------  270 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-----------  270 (373)
T ss_dssp             -----------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-----------
T ss_pred             cceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence            1   122234667999999976 568999999999999999997 999998888777666554321111           


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                      ....++..+.+||.+||+.||.+||++.++++
T Consensus       271 ----------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 ----------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ----------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                            11235789999999999999999999999886

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-46  Score=355.45  Aligned_cols=257  Identities=23%  Similarity=0.299  Sum_probs=199.9

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            3446789999999999999999999999999999999987543322 223456789999999999999999999999999


Q ss_pred             EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .|+||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999985 888888765 45899999999999999999999999999999999999999999999999999876443


Q ss_pred             C-CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          165 D-RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       165 ~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..... ......               
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~---------------  250 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQA---------------  250 (309)
T ss_dssp             ---------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSC---------------
T ss_pred             ccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccC---------------
Confidence            2 23345678999999999976 56889999999999999999999999876544222 222210               


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-CHHHHhc
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-TAQQALE  290 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-t~~e~l~  290 (415)
                               .+......+.++.++.+||.+||+.||++|| +++++++
T Consensus       251 ---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          251 ---------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                     0111233456789999999999999999999 7888776

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.7e-46  Score=355.19  Aligned_cols=254  Identities=25%  Similarity=0.321  Sum_probs=211.2

Q ss_pred             ccccEeeeeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      ..++|.+.+.||+|+||.||+|.+     ..+++.||+|++...... .....+.+|+.+++++ +||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            368999999999999999999985     456789999998754321 2234577899999999 999999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe
Q 014985           84 GNLHLVFEFME-TDLETVIRNTNI-----------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~~-----------------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~  145 (415)
                      +..|+||||++ |+|.+++.....                 .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            99999999998 589998876543                 489999999999999999999999999999999999999


Q ss_pred             cCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHH
Q 014985          146 SHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG  222 (415)
Q Consensus       146 ~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  222 (415)
                      .++.+||+|||++........  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+........
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            999999999999987654432  1234456778999999876 568999999999999999998 999998877655555


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .+.......                          .....++.++.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          259 KMIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCCCC--------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            544431110                          0112458899999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.4e-46  Score=357.70  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=210.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEEC-------CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeee
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDT-------KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFP   81 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~   81 (415)
                      -.++|++.+.||+|+||+||+|.+.       .++..||+|++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            4689999999999999999999976       4567899999875432 12233567899999999 8999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTNI---------------FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~~---------------~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~  145 (415)
                      ..+.+|+||||+. |+|.+++.....               .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            9999999999998 588888876432               389999999999999999999999999999999999999


Q ss_pred             cCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHH
Q 014985          146 SHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLG  222 (415)
Q Consensus       146 ~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  222 (415)
                      .++.+||+|||+++.......  ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            999999999999987654332  2234456788999999876 458999999999999999999 999999887776666


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .+......                           .....++.++.+||.+||..||.+|||+.+++++
T Consensus       271 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          271 LLKEGHRM---------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55443111                           1123458899999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.3e-47  Score=361.28  Aligned_cols=255  Identities=21%  Similarity=0.345  Sum_probs=211.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      ....++|.+.+.||+|+||.||+|.+.     .+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            345789999999999999999999876     35788999998644321 122346789999999999999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEE
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKL  152 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~---------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL  152 (415)
                      .+..|+||||+. |+|.+++....         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence            999999999998 58888886532         35799999999999999999999999999999999999999999999


Q ss_pred             eeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhC
Q 014985          153 ADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFG  229 (415)
Q Consensus       153 ~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  229 (415)
                      +|||+++......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            9999998654332  12234456888999999876 558999999999999999999 8899998877766665543210


Q ss_pred             CCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                                 ......++..+.+||.+||+.||.+|||+.+++++
T Consensus       259 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                       11123458899999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-46  Score=366.07  Aligned_cols=261  Identities=13%  Similarity=0.132  Sum_probs=200.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC-----CcEEEEEEeecCCccC---------CccchHHHHHHHHHhcCCCCeeeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT-----GQTVAIKKIRLGKQKE---------GVNFTALREIKLLKELKSPHIIEL   76 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~~avK~i~~~~~~~---------~~~~~~~~E~~il~~l~hp~Iv~l   76 (415)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++.......         ........|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45999999999999999999998765     5889999987543210         011123356667777889999999


Q ss_pred             EeeeecC----CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe--cCCcE
Q 014985           77 IDAFPHK----GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQL  150 (415)
Q Consensus        77 ~~~~~~~----~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~--~~~~v  150 (415)
                      ++++...    .+.|+||||++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++  .++.+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            9998764    56899999998899999988777899999999999999999999999999999999999999  88999


Q ss_pred             EEeeeccceecCCCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC-cHHHHH
Q 014985          151 KLADFGLARIFGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS-DIDQLG  222 (415)
Q Consensus       151 kL~DFG~a~~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~  222 (415)
                      ||+|||+++.+.....       .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. +.....
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            9999999987643221       1234558999999999977 558999999999999999999999998643 332222


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .........          ++.......        ....++.++.+||..||..||.+||++.++++
T Consensus       273 ~~~~~~~~~----------~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYREN----------IASLMDKCF--------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHC----------HHHHHHHHS--------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhh----------HHHHHHHhc--------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            221111000          000000000        01355899999999999999999999999876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-47  Score=361.40  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=211.3

Q ss_pred             cccccccccEeeeeeecccCceEEEEEE-----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEee
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAI-----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDA   79 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~   79 (415)
                      ++.+...++|.+.+.||+|+||.||+|.     +..++..||+|++..... ......+.+|+.+++.++||||++++++
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (327)
T 2yfx_A           23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGV  101 (327)
T ss_dssp             GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            4556678999999999999999999998     566788999999864322 2223357789999999999999999999


Q ss_pred             eecCCeEEEEeeccc-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC---Cc
Q 014985           80 FPHKGNLHLVFEFME-TDLETVIRNTN------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQ  149 (415)
Q Consensus        80 ~~~~~~~~lv~e~~~-g~L~~~i~~~~------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~---~~  149 (415)
                      +......|+||||++ |+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.+   +.
T Consensus       102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence            999999999999996 68999888754      348999999999999999999999999999999999999854   46


Q ss_pred             EEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHH
Q 014985          150 LKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       150 vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  226 (415)
                      +||+|||++.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999997653322  22334567888999999876 468999999999999999998 9999998877766655543


Q ss_pred             HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                      ....                           .....++..+.+||.+||+.||.+|||+.+++++.|+.
T Consensus       261 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          261 GGRM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2110                           11234588999999999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.7e-46  Score=345.86  Aligned_cols=249  Identities=16%  Similarity=0.199  Sum_probs=209.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC--CeE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK--GNL   86 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~   86 (415)
                      .-.++|.+.+.||+|+||+||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++.+.  ...
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            34689999999999999999999874  88999999987654444445678999999999999999999999877  789


Q ss_pred             EEEeeccc-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           87 HLVFEFME-TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      ++||||++ |+|.+++..... .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999998 589988876543 5899999999999999999999999  9999999999999999999999999876432


Q ss_pred             CCCCcccccccccceeCcccccCCcC--CCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQ--YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .     ....+|+.|+|||++.+...  ++.++|||||||++|+|++|..||.+.+..+....+......          
T Consensus       165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------  229 (271)
T 3kmu_A          165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR----------  229 (271)
T ss_dssp             C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred             c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----------
Confidence            2     34577899999999976332  233799999999999999999999988877776665442111          


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                      ....+.+++++.+||.+||+.||++|||++++++
T Consensus       230 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          230 ----------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            1122356899999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-46  Score=348.40  Aligned_cols=253  Identities=21%  Similarity=0.331  Sum_probs=209.7

Q ss_pred             cccEeeee-eecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKRE-VLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~-~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++..... ......+.+|+.+++.++||||+++++++ ..+..|
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            57787776 9999999999999854  4678899999876432 22334577899999999999999999999 456799


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++| +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            99999995 88888877767799999999999999999999999999999999999999999999999999987754332


Q ss_pred             c---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....             
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-------------  231 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------------  231 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-------------
T ss_pred             eeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-------------
Confidence            2   223455788999999975 458899999999999999998 9999998887776655543210             


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                                    ....+.+++++.+||.+||+.||.+||++.+++++.+
T Consensus       232 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          232 --------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             --------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                          1122356899999999999999999999999998643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.5e-46  Score=346.52  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=194.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC--CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE--GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .++|.+.+.||+|+||+||+|.+.  |+.||+|++.......  .....+.+|+.+++.++||||+++++++...+..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            578999999999999999999874  8899999987654322  223457789999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---ccccCCCCCcEEEec--------CCcEEEeeec
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW---VLHRDMKPNNLLIGS--------HGQLKLADFG  156 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~---ivHrDlkp~NILi~~--------~~~vkL~DFG  156 (415)
                      ||||++| +|..++.  +..+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||
T Consensus        84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999985 6666664  345999999999999999999999999   899999999999986        6789999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ++.......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......      
T Consensus       162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------  232 (271)
T 3dtc_A          162 LAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA------  232 (271)
T ss_dssp             C---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC------
T ss_pred             ccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC------
Confidence            998764332  234578999999999876 56899999999999999999999999988776665544321100      


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                          ......+++.+.+||.+||+.||.+|||+.|++++
T Consensus       233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 --------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                11223458899999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.3e-46  Score=350.04  Aligned_cols=250  Identities=20%  Similarity=0.316  Sum_probs=204.6

Q ss_pred             cccEeeee-eecccCceEEEEEE--ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKRE-VLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~-~LG~G~~g~Vy~~~--~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+ .||+|+||+||+|.  +..+++.||+|++............+.+|+.+++.++||||+++++++ ..+..|
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            57899988 99999999999995  456778999999976544443345678899999999999999999999 567789


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            9999998 5788887764 4599999999999999999999999999999999999999999999999999987654432


Q ss_pred             c---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....             
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------  238 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------  238 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------
T ss_pred             cccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            2   223345678999999976 457889999999999999999 9999998877666555433210             


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    ....+.++..+.+||.+||+.||.+||++.++++
T Consensus       239 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 --------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          1112356899999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.5e-46  Score=357.27  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=208.3

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEE--EEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTV--AIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~--avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      +..-.++|.+.+.||+|+||.||+|++..++..+  |+|.+..... ......+.+|+.+++++ +||||+++++++.+.
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            3445689999999999999999999998888865  9998875332 22334678899999999 899999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~  147 (415)
                      +.+|+||||++ |+|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence            99999999997 58988887643               468999999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHH
Q 014985          148 GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       148 ~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  226 (415)
                      +.+||+|||+++.... ........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus       179 ~~~kL~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             GCEEECCTTCEESSCE-ECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CeEEEcccCcCccccc-cccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            9999999999974322 122233456778999999876 458899999999999999998 9999998877666555432


Q ss_pred             HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ...                           ......+++.+.+||.+||..||.+|||+++++++
T Consensus       257 ~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 GYR---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TCC---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            210                           01122458899999999999999999999999885

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-46  Score=356.32  Aligned_cols=253  Identities=20%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCC----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..++|.+.+.||+|+||+||+|.+..++    ..||+|++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            3678999999999999999999876553    3599999875432 2223357789999999999999999999999999


Q ss_pred             EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .|+||||++| +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999985 899988877777999999999999999999999999999999999999999999999999999876443


Q ss_pred             CC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          165 DR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       165 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ..   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......          
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----------  269 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----------  269 (333)
T ss_dssp             ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred             cccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC----------
Confidence            22   1223345778999999976 568999999999999999998 99999888777766665432111          


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                       .....++..+.+||.+||+.||.+||++.+++++
T Consensus       270 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 -----------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             1112457899999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-46  Score=358.80  Aligned_cols=266  Identities=26%  Similarity=0.318  Sum_probs=198.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----eE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----NL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~~   86 (415)
                      .++|++.++||+|+||+||+|.+.  ++.||||++....   .......+|+.+++.++||||+++++++....    .+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            689999999999999999999765  7899999986432   22234456999999999999999999997744    47


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC----------CccccCCCCCcEEEecCCcEEEeee
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK----------WVLHRDMKPNNLLIGSHGQLKLADF  155 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~----------~ivHrDlkp~NILi~~~~~vkL~DF  155 (415)
                      |+|||||+ |+|.+++....  +++..++.++.||+.||.|||++          ||+||||||+|||++.++++||+||
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999998 58888887643  89999999999999999999999          9999999999999999999999999


Q ss_pred             ccceecCCCCC--cccccccccceeCcccccCC----cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhC
Q 014985          156 GLARIFGSPDR--RFTHQVFARWYRAPELLFGA----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFG  229 (415)
Q Consensus       156 G~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  229 (415)
                      |+++.......  .....+||+.|+|||++.+.    ..++.++|||||||++|||++|.+||.+..+............
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987654332  23446789999999999763    3456788999999999999999999987543111000000000


Q ss_pred             CCCCCCCCCCCCCccchhcccccCCCccccCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          230 TATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .      +......... ......+.+...++  ..+.++.+||.+||+.||++|||+.++++
T Consensus       256 ~------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          256 H------PSLEDMQEVV-VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             S------CCHHHHHHHH-TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C------Cchhhhhhhh-hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0      0000000000 00000111111111  12456999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=362.29  Aligned_cols=261  Identities=16%  Similarity=0.151  Sum_probs=201.0

Q ss_pred             cccccEeeeeeecccCceEEEEEEECC---CCcEEEEEEeecCCccC---------CccchHHHHHHHHHhcCCCCeeeE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKE---------GVNFTALREIKLLKELKSPHIIEL   76 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~---------~~~~~~~~E~~il~~l~hp~Iv~l   76 (415)
                      ...++|.+.+.||+|+||+||+|.+..   ++..+|+|++.......         .....+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            346799999999999999999999987   78899999987653210         012235578889999999999999


Q ss_pred             Eeeeec----CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC--cE
Q 014985           77 IDAFPH----KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG--QL  150 (415)
Q Consensus        77 ~~~~~~----~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~--~v  150 (415)
                      ++++..    ....|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999877    77899999999778888887654 699999999999999999999999999999999999999887  99


Q ss_pred             EEeeeccceecCCCC-------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHH
Q 014985          151 KLADFGLARIFGSPD-------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLG  222 (415)
Q Consensus       151 kL~DFG~a~~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~  222 (415)
                      ||+|||+++.+....       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. .+.....
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999998763221       12245678999999999987 56899999999999999999999999653 2333332


Q ss_pred             HHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          223 KIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP--SASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       223 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ..........+          .          .+....+  .++.++.+||.+||..||++|||++++++.
T Consensus       272 ~~~~~~~~~~~----------~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          272 TAKTNLLDELP----------Q----------SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHTTT----------H----------HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhhccccc----------H----------HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22222111000          0          0011112  568999999999999999999999999873

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.9e-46  Score=347.85  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=205.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC---CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..++|.+.+.||+|+||+||+|.+..   ++..||+|.+...... .....+.+|+.+++.++||||+++++++.++ ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            46899999999999999999998654   3346999998754322 2234577899999999999999999998754 56


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            89999999 58999888777779999999999999999999999999999999999999999999999999998764432


Q ss_pred             C-cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 R-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......             
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-------------  233 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-------------  233 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-------------
T ss_pred             ccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-------------
Confidence            2 2234456778999999965 568999999999999999998 99999877766666555443111             


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                    .....+++.+.+||.+||..||.+|||+.+++++
T Consensus       234 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          234 --------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                          1112357899999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.6e-46  Score=353.42  Aligned_cols=254  Identities=21%  Similarity=0.293  Sum_probs=199.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC---CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC--
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK---TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG--   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--   84 (415)
                      -.++|.+.+.||+|+||.||+|.+..   ++..||+|.+............+.+|+.+++.++||||+++++++....  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            36899999999999999999998765   4568999998765444333445778999999999999999999987655  


Q ss_pred             ---eEEEEeeccc-CCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeee
Q 014985           85 ---NLHLVFEFME-TDLETVIRN-----TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (415)
Q Consensus        85 ---~~~lv~e~~~-g~L~~~i~~-----~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DF  155 (415)
                         ..|+||||++ |+|..++..     ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence               4599999999 588888753     3356999999999999999999999999999999999999999999999999


Q ss_pred             ccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          156 GLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       156 G~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      |++.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......  
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--  268 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--  268 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--
T ss_pred             CcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--
Confidence            9998764432  22233456778999999976 568999999999999999999 88999988776666555432111  


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                               .....+++++.+||.+||..||.+|||+.+++++
T Consensus       269 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 -------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     1123458899999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=358.46  Aligned_cols=251  Identities=23%  Similarity=0.390  Sum_probs=187.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeee--------e
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAF--------P   81 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~--------~   81 (415)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.....  .....+.+|+.+++++. ||||+++++++        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            5699999999999999999999999999999999854422  22335678999999996 99999999998        3


Q ss_pred             cCCeEEEEeecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEecCCcEEEeeecc
Q 014985           82 HKGNLHLVFEFMETDLETVIRN--TNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        82 ~~~~~~lv~e~~~g~L~~~i~~--~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      ....+++||||++|+|.+++..  ....+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            4456899999999999998865  3456999999999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCCC------------cccccccccceeCccccc--CCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHH
Q 014985          158 ARIFGSPDR------------RFTHQVFARWYRAPELLF--GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGK  223 (415)
Q Consensus       158 a~~~~~~~~------------~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  223 (415)
                      ++.......            ......+|+.|+|||++.  ....++.++|||||||++|+|++|..||.+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            987644321            112456889999999983  235678899999999999999999999976544322211


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                      ..   .                           .......+..+.+||.+||+.||.+|||+.|++++-+
T Consensus       265 ~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          265 KY---S---------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -C---C---------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cc---c---------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            00   0                           0111234677999999999999999999999998743

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.1e-46  Score=348.20  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=209.6

Q ss_pred             cccccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--
Q 014985            5 DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--   82 (415)
Q Consensus         5 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--   82 (415)
                      .+...+.++|++.+.||+|+||.||+|.+..+|+.||+|.+....      ..+.+|+.+++.++||||+++++++..  
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            346678899999999999999999999999999999999987542      246689999999999999999998854  


Q ss_pred             --------------CCeEEEEeecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec
Q 014985           83 --------------KGNLHLVFEFMET-DLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (415)
Q Consensus        83 --------------~~~~~lv~e~~~g-~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~  146 (415)
                                    ...+|+||||++| +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence                          4568999999995 898888754 356999999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHH
Q 014985          147 HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  226 (415)
                      ++.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..+|...  ......+..
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~  233 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD  233 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred             CCCEEECcchhheeccccc-cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence            9999999999998765433 3345678999999999977 56899999999999999999998776421  111111110


Q ss_pred             HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                          .                          .....++..+.+||.+||..||.+|||+.|+++|.+.-
T Consensus       234 ----~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 ----G--------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             ----T--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----c--------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                0                          01123578999999999999999999999999997754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=348.82  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=204.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE-
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL-   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~-   86 (415)
                      .-.|.+.++||+|+||+||+|.+..++.   .+|+|.+..... ......+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            3456778999999999999998765544   799999864322 12234567899999999999999999999776654 


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++||||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            99999997 68999998877779999999999999999999999999999999999999999999999999998653321


Q ss_pred             ----CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          166 ----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       166 ----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                          .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......          
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----------  247 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL----------  247 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC----------
T ss_pred             ccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC----------
Confidence                23344567888999999976 568999999999999999999 56777776666555554332111          


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                       .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       248 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 -----------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                             112245789999999999999999999999886

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-45  Score=370.41  Aligned_cols=255  Identities=19%  Similarity=0.232  Sum_probs=211.1

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNL   86 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~   86 (415)
                      ..+.++|++.++||+|+||.||+|.+..+++.||||++......    ..+.+|+.+++.++| ++|..+..++......
T Consensus         3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            46789999999999999999999999999999999987654332    357789999999988 5566666677788899


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE---ecCCcEEEeeeccceecCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLI---GSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi---~~~~~vkL~DFG~a~~~~~  163 (415)
                      |+||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+..
T Consensus        79 ~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             EEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            9999999889999998777789999999999999999999999999999999999999   6889999999999988654


Q ss_pred             CCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCc---HHHHHHHHHHhCCCCC
Q 014985          164 PDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSD---IDQLGKIFAAFGTATP  233 (415)
Q Consensus       164 ~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~  233 (415)
                      ...       .....+||..|+|||++.+ ..++.++|||||||+||||++|..||.+...   .+.+..+.....    
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----  233 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----  233 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----
T ss_pred             CccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----
Confidence            432       2236678999999999987 5689999999999999999999999987654   233333322100    


Q ss_pred             CCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         ......+...++.++.+||..||..||++||++.+|++
T Consensus       234 -------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 -------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             -------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                               01112233456899999999999999999999988764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.6e-46  Score=355.61  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=209.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCc-----EEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      ..++|.+.+.||+|+||+||+|.+..+++     .||+|.+...... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            36889999999999999999999877664     7999998754322 2234577899999999 899999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc
Q 014985           84 GNLHLVFEFME-TDLETVIRNT-------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ  149 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~-------------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~  149 (415)
                      +.+|+||||++ |+|.+++...             ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence            99999999998 5898888653             345899999999999999999999999999999999999999999


Q ss_pred             EEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHH
Q 014985          150 LKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFA  226 (415)
Q Consensus       150 vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  226 (415)
                      +||+|||++........  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+..
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            99999999986643322  2234456778999999876 568999999999999999998 8999988766555555444


Q ss_pred             HhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .....                          ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       282 ~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          282 DGYQM--------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCC--------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            31110                          1112347899999999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.6e-46  Score=349.58  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=203.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCC---cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee-ecCCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~   85 (415)
                      -..+|.+.+.||+|+||+||+|.+..++   ..+|+|.+...... .....+.+|+.++++++||||+++++++ ..++.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3568999999999999999999875443   36899988653221 2234567899999999999999999984 56678


Q ss_pred             EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .|+||||++| +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            8999999985 899998877777999999999999999999999999999999999999999999999999999866432


Q ss_pred             C----CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          165 D----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       165 ~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .    .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.......        
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  252 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL--------  252 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC--------
T ss_pred             chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC--------
Confidence            2    22334556788999999976 568999999999999999999 678888877666655554321111        


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         ....+++.+.+||.+||+.||.+|||+.++++
T Consensus       253 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          253 -------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                               11234789999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6e-46  Score=359.38  Aligned_cols=254  Identities=14%  Similarity=0.128  Sum_probs=203.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCC--------CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeee-------
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKT--------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIE-------   75 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~--------~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~-------   75 (415)
                      .++|++.+.||+|+||+||+|.+..+        ++.||+|++...       ..+.+|+.+++.++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            58999999999999999999999874        889999998743       25778999999999999987       


Q ss_pred             --------EEeeeec-CCeEEEEeecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe
Q 014985           76 --------LIDAFPH-KGNLHLVFEFMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG  145 (415)
Q Consensus        76 --------l~~~~~~-~~~~~lv~e~~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~  145 (415)
                              +++++.. ....|+||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence                    5566655 6789999999977999999865 35699999999999999999999999999999999999999


Q ss_pred             cCC--cEEEeeeccceecCCCCC-------cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Q 014985          146 SHG--QLKLADFGLARIFGSPDR-------RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS  216 (415)
Q Consensus       146 ~~~--~vkL~DFG~a~~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  216 (415)
                      .++  .+||+|||+++.+.....       ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            998  899999999987543221       2234578999999999977 568999999999999999999999998764


Q ss_pred             -cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          217 -DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       217 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                       ..+.+......+........                  ........++.++.+||.+||..||.+|||++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFV------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEE------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhhhh------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             44444333332211111000                  000112245899999999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.6e-46  Score=375.50  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=211.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -.++|.+.+.||+|+||.||+|.+..++..||||++.....   ....+.+|+.+|++++||||+++++++.....+|+|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            36789999999999999999999999899999999865432   234678999999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           90 FEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||+. |+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....... 
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            99998 68999988643 4589999999999999999999999999999999999999999999999999987643322 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......               
T Consensus       375 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------  438 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---------------  438 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---------------
T ss_pred             ecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence            2223445678999999976 458999999999999999998 99999988766655554332111               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       439 ------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          439 ------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                        112345889999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8e-46  Score=352.40  Aligned_cols=254  Identities=24%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEE-----CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHK   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~   83 (415)
                      ..++|.+.+.||+|+||+||+|.+     ..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++...
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            468999999999999999999985     456789999998754322 2233577899999999 689999999998765


Q ss_pred             C-eEEEEeeccc-CCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec
Q 014985           84 G-NLHLVFEFME-TDLETVIRNTNIF---------------LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (415)
Q Consensus        84 ~-~~~lv~e~~~-g~L~~~i~~~~~~---------------l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~  146 (415)
                      + .+|+||||++ |+|.+++......               +++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            4 5999999998 5888888765432               889999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHH
Q 014985          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  223 (415)
                      ++++||+|||+++.......  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            99999999999987644332  2334567888999999976 568999999999999999998 9999988765444433


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      .......                          ......+++.+.++|.+||+.||.+|||+.++++|
T Consensus       263 ~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          263 RLKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccCcc--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3332110                          01112358899999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-45  Score=366.32  Aligned_cols=243  Identities=20%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-eEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-NLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-~~~lv   89 (415)
                      .++|++.+.||+|+||.||+|.+.  |+.||||++....    ....+.+|+.+|++++||||+++++++.... .+|+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            578999999999999999999764  7899999986543    3346789999999999999999999976654 79999


Q ss_pred             eeccc-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||+. |+|.+++...+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            99998 589999887654 37999999999999999999999999999999999999999999999999998653322  


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                       ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......                
T Consensus       344 -~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------------  405 (450)
T 1k9a_A          344 -DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------------  405 (450)
T ss_dssp             ----CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC----------------
T ss_pred             -cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence             23356778999999976 568999999999999999998 99999987766666555432111                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 .....+++++.+||.+||+.||.+|||+.++++
T Consensus       406 -----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          406 -----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                       112345899999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.9e-46  Score=354.80  Aligned_cols=266  Identities=22%  Similarity=0.315  Sum_probs=206.1

Q ss_pred             cccEeeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee--cCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP--HKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~   84 (415)
                      .++|++.+.||+|+||.||+|+    +..+++.||+|++.....  .....+.+|+.+++.++||||+++++++.  ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            6899999999999999999998    567889999999875422  22235778999999999999999999875  566


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .+|+||||++ |+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            7999999997 688888887666799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          164 PDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       164 ~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...   ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.........     ....  ....+...
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~--~~~~~~~~  251 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGC--ERDVPALS  251 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC------CCHHH
T ss_pred             CCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hccc--ccccccHH
Confidence            432   2234567888999999876 45789999999999999999999888654322110     0000  00000000


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                         ..  .............+.+++++.+||.+||+.||.+|||+.+++++
T Consensus       252 ---~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          252 ---RL--LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ---HH--HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HH--HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               00  00000001112234568999999999999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.4e-46  Score=356.94  Aligned_cols=268  Identities=19%  Similarity=0.272  Sum_probs=205.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...++|.+.+.||+|+||+||+|.+ .+|+.||+|++........ ...+.+|+.+++.++||||+++++++...+..++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C-CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH-HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            3578999999999999999999974 4689999999876543322 2357899999999999999999999999999999


Q ss_pred             EeecccC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CccccCCCCCcEEEecCCcEEEeeeccceec
Q 014985           89 VFEFMET-DLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKK---WVLHRDMKPNNLLIGSHGQLKLADFGLARIF  161 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~---~~l~~~~~~~i~~qil~aL~~lH~~---~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~  161 (415)
                      ||||+.| +|.+++....   ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            9999985 8888887643   3489999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc-ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-----CcHHHHHHHHHHhCCCCCCC
Q 014985          162 GSPDRR-FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-----SDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       162 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~  235 (415)
                      ...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...     ........+...........
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             CcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            544332 344568999999999976 45899999999999999999999999521     11111111100000000000


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY  293 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~  293 (415)
                      ..+              ........+..+..+.+|+.+||+.||.+|||+.++++|-.
T Consensus       264 ~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVD--------------VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSC--------------TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcC--------------hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            000              00000111223578999999999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-45  Score=367.73  Aligned_cols=248  Identities=21%  Similarity=0.343  Sum_probs=208.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -.++|.+.+.||+|+||+||+|.+. ++..||||++....   .....+.+|+.+|+.++||||+++++++. .+.+|+|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            3678999999999999999999875 46789999987543   22346789999999999999999999986 6678999


Q ss_pred             eeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           90 FEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||+. |+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence            99998 68999887542 3589999999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+........             
T Consensus       341 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------  406 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------  406 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-------------
T ss_pred             ccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence            1223345677999999975 468999999999999999999 9999999888887777655422111             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    ...+++++.+||.+||+.||++|||++++++
T Consensus       407 --------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          407 --------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                          1235789999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.4e-45  Score=341.44  Aligned_cols=248  Identities=21%  Similarity=0.352  Sum_probs=206.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|.+.+.||+|+||.||+|.+. ++..||+|++.....   ....+.+|+.+++.++||||+++++++. .+..|+|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            4689999999999999999999875 567899999865432   2345778999999999999999999986 4568999


Q ss_pred             eeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           90 FEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||+. |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99997 58888876532 2589999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......               
T Consensus       166 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------  229 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---------------  229 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred             cccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---------------
Confidence            2233455778999999975 458899999999999999999 89999988877766665432111               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                  .....++.++.+||.+||..||++|||+.++++
T Consensus       230 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          230 ------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                        111245889999999999999999999999887

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-46  Score=359.09  Aligned_cols=266  Identities=20%  Similarity=0.280  Sum_probs=206.3

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...++|.+.+.||+|+||+||+|.+ .+|+.||+|++....  ......+.+|+.+++.++||||+++++++...+..|+
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            3578999999999999999999985 468999999876542  2233457789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           89 VFEFME-TDLETVIRNTN---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~---~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      ||||++ |+|.+++....   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999998 57877775443   35899999999999999999999999999999999999999999999999999875432


Q ss_pred             C--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH---HHHhCCCCCCCCCCC
Q 014985          165 D--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI---FAAFGTATPSQWPDL  239 (415)
Q Consensus       165 ~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~  239 (415)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+   ............   
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  268 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI---  268 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS---
T ss_pred             cccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh---
Confidence            2  22334568999999999876 46899999999999999999999998765432211100   011010000000   


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHR  292 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~  292 (415)
                                 ..........+..+..+.+|+.+||+.||++|||+.|++++-
T Consensus       269 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          269 -----------VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             -----------SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -----------cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                       000001112223467899999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.7e-45  Score=344.72  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=196.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHh--cCCCCeeeEEeeeec--
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE--LKSPHIIELIDAFPH--   82 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~--   82 (415)
                      ...+.++|++.+.||+|+||+||+|.+  +|+.||||++....     .....+|.+++..  ++||||+++++++..  
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            356789999999999999999999977  68999999986432     2234567777766  799999999998543  


Q ss_pred             --CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--------hCCccccCCCCCcEEEecCCcEE
Q 014985           83 --KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH--------KKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        83 --~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH--------~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                        ...+|+||||++ |+|.+++..  ..+++..++.++.||+.||+|||        ++||+||||||+|||++.++++|
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence              456899999998 588888854  35899999999999999999999        99999999999999999999999


Q ss_pred             EeeeccceecCCCCCc----ccccccccceeCcccccCCc-----CCCCcccHHHHHHHHHHHHcC----------CCCC
Q 014985          152 LADFGLARIFGSPDRR----FTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNR----------RPFL  212 (415)
Q Consensus       152 L~DFG~a~~~~~~~~~----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g----------~~pf  212 (415)
                      |+|||+++........    ....+||+.|+|||++.+..     .++.++|||||||++|||++|          .+||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999999876544332    23457899999999997643     244789999999999999999          7777


Q ss_pred             CCCC----cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014985          213 QGSS----DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (415)
Q Consensus       213 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~  288 (415)
                      ....    ....+..+......  ....+                  ........+.++.+||.+||+.||++|||+.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQ--RPNIP------------------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCC--CCCCC------------------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCC--CCCCC------------------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            5532    22222222111000  00000                  000111235789999999999999999999999


Q ss_pred             hc
Q 014985          289 LE  290 (415)
Q Consensus       289 l~  290 (415)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=351.27  Aligned_cols=253  Identities=26%  Similarity=0.327  Sum_probs=200.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee----cCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP----HKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~----~~~~~   86 (415)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....  .....+.+|+.+++.++||||+++++++.    .....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            5789999999999999999999999999999999865322  22345678999999999999999999986    34578


Q ss_pred             EEEeecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           87 HLVFEFMET-DLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~g-~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      |+||||+.| +|.+++..   .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999995 88888765   35679999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCC---------cccccccccceeCcccccCCc--CCCCcccHHHHHHHHHHHHcCCCCCCCCCcH-HHHHHHHHHhCC
Q 014985          163 SPDR---------RFTHQVFARWYRAPELLFGAK--QYGAGVDVWAAGCIFAELLNRRPFLQGSSDI-DQLGKIFAAFGT  230 (415)
Q Consensus       163 ~~~~---------~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~  230 (415)
                      ....         ......||+.|+|||++.+..  .++.++|||||||++|+|++|..||...... +........ . 
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~-  263 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-Q-  263 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C-
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-c-
Confidence            2111         112345688999999986532  3688999999999999999999998531100 001111100 0 


Q ss_pred             CCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                              ......+.++.++.+||.+||+.||.+|||+.+++++
T Consensus       264 ------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 ------------------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                                    0001123568999999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-46  Score=360.91  Aligned_cols=251  Identities=22%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCC---cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee-ecCCeEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF-PHKGNLH   87 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~~~   87 (415)
                      ..|.+.+.||+|+||+||+|.+..++   ..+|+|.+.... .......+.+|+.++++++||||+++++++ ..++..|
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            45889999999999999999875433   468999886432 222234577899999999999999999985 4566889


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +||||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999998 589999987777799999999999999999999999999999999999999999999999999986543221


Q ss_pred             ----cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          167 ----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       167 ----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                          ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+......           
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~-----------  315 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-----------  315 (373)
T ss_dssp             ----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC-----------
T ss_pred             ccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence                1233456778999999976 568999999999999999999 78899887665555444332110           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                      .....++..+.+||.+||..||++|||+.+++++
T Consensus       316 ----------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          316 ----------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                            1112457899999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.7e-45  Score=364.24  Aligned_cols=254  Identities=23%  Similarity=0.388  Sum_probs=205.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -.++|++.+.||+|+||.||+|.+.. +..||||++.....   ....+.+|+.+|++++||||+++++++.. +..|+|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            36789999999999999999999865 46799999875432   23467899999999999999999999876 678999


Q ss_pred             eeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-
Q 014985           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-  166 (415)
                      |||+. |+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            99998 5899888753 34589999999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+.......              
T Consensus       337 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------------  401 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------------  401 (452)
T ss_dssp             ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--------------
T ss_pred             cccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence            2223445678999999876 468999999999999999999 999999988877776664432111              


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSS  296 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--h~~~~~  296 (415)
                                   ..+.+++.+.+||.+||+.||++|||++++++  ..++..
T Consensus       402 -------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          402 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                         12345889999999999999999999999987  355543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-45  Score=344.88  Aligned_cols=254  Identities=21%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECC-CCc--EEEEEEeecCCcc-CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTK-TGQ--TVAIKKIRLGKQK-EGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      ..++|++.+.||+|+||+||+|.+.. +++  .||+|++...... ......+.+|+.+++.++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            46899999999999999999998643 333  6899998754322 223345778999999999999999999997765 


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP  164 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~  164 (415)
                      .++||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            889999998 6899998877667999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          165 DRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       165 ~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...   .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+......          
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  243 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER----------  243 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC----------
T ss_pred             ccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC----------
Confidence            321   233456778999999976 457899999999999999999 99999988877766655432100          


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                      ......++.++.+||.+||..||.+|||+.+++++
T Consensus       244 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          244 ----------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                            01123458999999999999999999999999873

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.3e-45  Score=344.77  Aligned_cols=240  Identities=23%  Similarity=0.409  Sum_probs=191.0

Q ss_pred             ccccccEeee-eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHH-HhcCCCCeeeEEeeeec---
Q 014985            8 KKVADRYLKR-EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLL-KELKSPHIIELIDAFPH---   82 (415)
Q Consensus         8 ~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~---   82 (415)
                      ..+.++|.+. +.||+|+||.||+|.+..+++.||+|++...       ....+|+.++ +.++||||++++++|..   
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            3466777776 8899999999999999999999999998632       2466899888 66699999999999876   


Q ss_pred             -CCeEEEEeecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeec
Q 014985           83 -KGNLHLVFEFMET-DLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFG  156 (415)
Q Consensus        83 -~~~~~lv~e~~~g-~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG  156 (415)
                       ...+|+||||++| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             6789999999985 8999888754 36999999999999999999999999999999999999998   7889999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ++.....                       ..++.++|||||||++|+|++|.+||.+.+.......+...         
T Consensus       166 ~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---------  213 (299)
T 3m2w_A          166 FAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---------  213 (299)
T ss_dssp             TCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS---------
T ss_pred             ccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH---------
Confidence            9875421                       34778999999999999999999999776443221110000         


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                               .  ..............+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus       214 ---------~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          214 ---------I--RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             ---------S--CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             ---------H--hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence                     0  0000000111224578999999999999999999999999999999764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=374.85  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             cccEeeee-eecccCceEEEEEEECC--CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKRE-VLGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~-~LG~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+ .||+|+||.||+|.+..  ++..||||++..... ......+.+|+.+|+.++||||+++++++.. +.+|
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            34555555 89999999999997753  556799999876432 2334567899999999999999999999976 5699


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||. |+|.+++......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            9999998 578888877777799999999999999999999999999999999999999999999999999987643332


Q ss_pred             c---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 R---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .   .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......            
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------  558 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------  558 (613)
T ss_dssp             ----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC------------
T ss_pred             eeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence            2   122344578999999975 568999999999999999998 99999998888877666543111            


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     ...+.+++++.+||.+||..||.+||++.++++
T Consensus       559 ---------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          559 ---------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ---------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           112345899999999999999999999999854

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=339.49  Aligned_cols=241  Identities=28%  Similarity=0.427  Sum_probs=191.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|.+.  ++.||+|++...    .....+.+|+.++++++||||+++++++.+  ..|+||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            578999999999999999999764  789999998532    223457789999999999999999999874  478999


Q ss_pred             eccc-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhh---CCccccCCCCCcEEEecCCc-EEEeeeccceecCC
Q 014985           91 EFME-TDLETVIRNTNI--FLSPADIKSYMQMTLKGLAFCHK---KWVLHRDMKPNNLLIGSHGQ-LKLADFGLARIFGS  163 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~--~l~~~~~~~i~~qil~aL~~lH~---~~ivHrDlkp~NILi~~~~~-vkL~DFG~a~~~~~  163 (415)
                      ||++ |+|.+++.....  .++...+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9998 588888876543  47899999999999999999999   89999999999999998887 79999999986533


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH--HHHHHHHHhCCCCCCCCCCCCC
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID--QLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  ....+..  +.           
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-----------  221 (307)
T 2eva_A          159 H---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-----------  221 (307)
T ss_dssp             ---------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC-----------
T ss_pred             c---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC-----------
Confidence            2   234568999999999976 568999999999999999999999998654322  2111111  10           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    .......++..+.+||.+||+.||.+|||++++++
T Consensus       222 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 --------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             --------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                          01122356899999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.9e-45  Score=376.45  Aligned_cols=244  Identities=21%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             eeeecccCceEEEEEEE--CCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc
Q 014985           17 REVLGEGTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   94 (415)
                      .+.||+|+||+||+|.+  ..+++.||||++............+.+|+.+|+.++|||||++++++.. +..++|||||.
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            34899999999999954  4567899999997654444445568899999999999999999999965 56899999998


Q ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC---cccc
Q 014985           95 -TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR---RFTH  170 (415)
Q Consensus        95 -g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~---~~~~  170 (415)
                       |+|.+++.. +..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....   ....
T Consensus       453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred             CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence             578888765 45699999999999999999999999999999999999999999999999999987644332   2233


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+|..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......                   
T Consensus       532 ~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-------------------  591 (635)
T 4fl3_A          532 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-------------------  591 (635)
T ss_dssp             ---CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred             CCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence            456778999999976 568999999999999999998 99999998887777666543211                   


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                              .....++.++.+||.+||+.||++|||++++++
T Consensus       592 --------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 --------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                    112345899999999999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.3e-45  Score=340.84  Aligned_cols=244  Identities=20%  Similarity=0.314  Sum_probs=195.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec-CCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH-KGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~l   88 (415)
                      ..++|++.+.||+|+||+||++.+.  |+.||+|++....    ....+.+|+.+++.++||||+++++++.. .+..|+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            3689999999999999999999764  8899999986432    33457789999999999999999998654 457999


Q ss_pred             EeecccC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           89 VFEFMET-DLETVIRNTNI-FLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~-~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      ||||++| +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999985 89888876532 37899999999999999999999999999999999999999999999999998654322 


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                        ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....                
T Consensus       172 --~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------  232 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------------  232 (278)
T ss_dssp             ------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC----------------
T ss_pred             --cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence              23456778999999976 568999999999999999998 9999988776555544422110                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 ......+++.+.+||.+||..||.+|||+.++++
T Consensus       233 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          233 -----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                       1122345899999999999999999999999876

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.1e-45  Score=348.59  Aligned_cols=256  Identities=22%  Similarity=0.317  Sum_probs=200.8

Q ss_pred             ccccccE-eeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            8 KKVADRY-LKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         8 ~~~~~~y-~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      ..+.++| ++++.||+|+||+||++.    +..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            3466666 999999999999998875    445788999999875422 1223457789999999999999999999987


Q ss_pred             --CCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           83 --KGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        83 --~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                        ...+|+||||++ |+|.+++....  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence              468999999998 58888876543  8999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCC---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH-----------HHHHHH
Q 014985          160 IFGSPDR---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDID-----------QLGKIF  225 (415)
Q Consensus       160 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----------~~~~i~  225 (415)
                      .......   ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......           ....+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            8755432   2334567888999999976 457899999999999999999999886542210           011111


Q ss_pred             HHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .....                       .........++.++.+||.+||+.||.+|||+.++++
T Consensus       262 ~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          262 ELLER-----------------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHT-----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhc-----------------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            11000                       0011223456899999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.7e-45  Score=353.36  Aligned_cols=242  Identities=19%  Similarity=0.237  Sum_probs=195.3

Q ss_pred             cccEeeeeeecccCceEEEEE-----EECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC---CCCeeeEEeeeec
Q 014985           11 ADRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPH   82 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~-----~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~   82 (415)
                      .++|.+.+.||+|+||+||+|     .+..+++.||+|++....     ...+.+|+.+++.+.   |+||+++++++..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            578999999999999999999     477889999999986432     235667888888887   8999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-----------
Q 014985           83 KGNLHLVFEFME-TDLETVIRN----TNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-----------  146 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~----~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-----------  146 (415)
                      .+..|+|||||+ |+|.+++..    ....+++..++.++.||+.||+|||++||+||||||+||||+.           
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            999999999998 688888875    3456999999999999999999999999999999999999998           


Q ss_pred             CCcEEEeeeccceecC--CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Q 014985          147 HGQLKLADFGLARIFG--SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKI  224 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~--~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  224 (415)
                      ++.+||+|||+|+...  .........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.......     
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----  292 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----  292 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence            8999999999998653  23345566789999999999987 558999999999999999999998885432100     


Q ss_pred             HHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                 +              .....+...  ..++.+.+++..||+.+|.+|++..+.+.
T Consensus       293 -----------~--------------~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          293 -----------C--------------KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             -----------E--------------EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             -----------e--------------eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                       0              000000111  12677899999999999999965544443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.6e-45  Score=345.44  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=203.1

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc--cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      |...+.||+|+||+||+|.+  +++.||+|++.....  .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44459999999999999965  688999999875432  22334457789999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC--
Q 014985           92 FME-TDLETVIRNT--NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--  166 (415)
Q Consensus        92 ~~~-g~L~~~i~~~--~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~--  166 (415)
                      |++ |+|.+++...  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            997 6888888643  34599999999999999999999999999999999999999999999999999987644322  


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      ......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+..+..........       +.++.
T Consensus       191 ~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~  261 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT-------IEDYI  261 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-------HHHHS
T ss_pred             cccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-------hhhhc
Confidence            2334578999999999865  47899999999999999999999998765443333332221111000       00000


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                            ...+....+..+..+.+||.+||..||.+|||+.+++++
T Consensus       262 ------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          262 ------DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             ------CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                  000111112235778999999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=347.78  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=206.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..++|++.+.||+|+||.||+|.+..   .+|+|++............+.+|+.+++.++||||+++++++.+...+++|
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            36899999999999999999998754   499999987655444445567899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCC----
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP----  164 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~----  164 (415)
                      |||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....    
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            99998 588888877666799999999999999999999999999999999999998 689999999998764321    


Q ss_pred             -CCcccccccccceeCcccccC--------CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          165 -DRRFTHQVFARWYRAPELLFG--------AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       165 -~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                       ........|++.|+|||++.+        ...++.++|||||||++|+|++|..||.+.+.......+.......    
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  262 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN----  262 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC----
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC----
Confidence             223344568899999999864        2357889999999999999999999999887776665554321100    


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                            .....++.++.+||.+||..||.+|||+.++++
T Consensus       263 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          263 ----------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             ----------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                  001135788999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-45  Score=364.48  Aligned_cols=249  Identities=16%  Similarity=0.164  Sum_probs=194.4

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc-CCccchHHHHHHHHHhcCC-CCeee--------------
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK-EGVNFTALREIKLLKELKS-PHIIE--------------   75 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~-~~~~~~~~~E~~il~~l~h-p~Iv~--------------   75 (415)
                      ..|.+.++||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+++.+.| +|...              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4588999999999999999999999999999998744322 2234457789999999987 32111              


Q ss_pred             -------EEeeeec-----CCeEEEEeecccCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 014985           76 -------LIDAFPH-----KGNLHLVFEFMETDLETVIR------NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDM  137 (415)
Q Consensus        76 -------l~~~~~~-----~~~~~lv~e~~~g~L~~~i~------~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDl  137 (415)
                             +..++..     ...++++|+++.|+|.+++.      ..+..+++..+..++.||+.||+|||++||+||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                   1111111     23578999999999998884      22344778889999999999999999999999999


Q ss_pred             CCCcEEEecCCcEEEeeeccceecCCCCCcccccccccceeCccccc---------CCcCCCCcccHHHHHHHHHHHHcC
Q 014985          138 KPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF---------GAKQYGAGVDVWAAGCIFAELLNR  208 (415)
Q Consensus       138 kp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~---------~~~~~~~~~DiwSlG~il~ell~g  208 (415)
                      ||+||||+.++.+||+|||+++..+..   ....+| +.|+|||++.         ....|+.++|||||||++|||++|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999999875433   445667 8899999993         335588899999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014985          209 RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (415)
Q Consensus       209 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~  288 (415)
                      +.||.+.+..+....+                                ....+.+++++.+||.+||+.||++|||+.++
T Consensus       314 ~~Pf~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          314 DLPNTDDAALGGSEWI--------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             SCCCCTTGGGSCSGGG--------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCcchhhhHHHH--------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999765432111100                                11123568999999999999999999999999


Q ss_pred             hcCCCCCC
Q 014985          289 LEHRYFSS  296 (415)
Q Consensus       289 l~h~~~~~  296 (415)
                      ++||||..
T Consensus       362 l~~~~~~~  369 (413)
T 3dzo_A          362 METPEYEQ  369 (413)
T ss_dssp             TTSHHHHH
T ss_pred             HhCHHHHH
Confidence            99999964

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=342.88  Aligned_cols=270  Identities=20%  Similarity=0.311  Sum_probs=204.4

Q ss_pred             cccccccEeeeeeecccCceEEEEEE----ECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAI----DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH   82 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   82 (415)
                      .....++|++.+.||+|+||.||+|.    +..+|+.||+|++....  ......+.+|+.+++.++||||+++++++..
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            34457889999999999999999998    46688999999987532  2223457789999999999999999998866


Q ss_pred             CC--eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           83 KG--NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        83 ~~--~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      .+  .+++||||++ |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            44  7899999998 58999998877779999999999999999999999999999999999999999999999999998


Q ss_pred             ecCCCCCc---ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          160 IFGSPDRR---FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       160 ~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      ........   .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.....  ...   ...+......+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~---~~~~~~~~~~~  267 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFM---RMIGNDKQGQM  267 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHH---HHHCTTCCTHH
T ss_pred             hccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHH---Hhhccccchhh
Confidence            87544321   223456778999999976 4578999999999999999999988754211  110   01110000000


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      .     .... ...............++.++.+||.+||..||++|||+.++++
T Consensus       268 ~-----~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 I-----VFHL-IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             H-----HHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             h-----HHHH-HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0     0000 0000000001123456899999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-44  Score=367.49  Aligned_cols=254  Identities=23%  Similarity=0.390  Sum_probs=210.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      -.++|++.+.||+|+||.||+|.+.. +..||||++.....   ....+.+|+.+|+.++||||+++++++.. +.+|+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            36789999999999999999999865 46799999875432   23467899999999999999999999876 678999


Q ss_pred             eeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-C
Q 014985           90 FEFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-R  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~  166 (415)
                      |||+. |+|.+++... +..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence            99998 5899988753 3458999999999999999999999999999999999999999999999999998654321 1


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+.......              
T Consensus       420 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------------  484 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------------  484 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC--------------
T ss_pred             cccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence            1223345677999999876 468999999999999999999 899999988877776664431111              


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC--CCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH--RYFSS  296 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h--~~~~~  296 (415)
                                   ..+.++.++.+||.+||+.||++|||++++++.  .+|..
T Consensus       485 -------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          485 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                         123458899999999999999999999999873  55543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=343.19  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=192.6

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhc--CCCCeeeEEeeeecC-
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL--KSPHIIELIDAFPHK-   83 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~~~~~-   83 (415)
                      ...+.++|++.+.||+|+||.||+|.+.  |+.||||++....     .....+|..++..+  +||||+++++++... 
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3557899999999999999999999875  8999999985432     12344566665554  999999999998877 


Q ss_pred             ---CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC--------CccccCCCCCcEEEecCCcEE
Q 014985           84 ---GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK--------WVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        84 ---~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~--------~ivHrDlkp~NILi~~~~~vk  151 (415)
                         ..+|+||||++ |+|.+++...  .+++..++.++.|++.||.|||++        ||+||||||+|||++.++.+|
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence               78999999998 4898888764  489999999999999999999999        999999999999999999999


Q ss_pred             EeeeccceecCCCCCc----ccccccccceeCcccccCCcCCCC------cccHHHHHHHHHHHHcC----------CCC
Q 014985          152 LADFGLARIFGSPDRR----FTHQVFARWYRAPELLFGAKQYGA------GVDVWAAGCIFAELLNR----------RPF  211 (415)
Q Consensus       152 L~DFG~a~~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~------~~DiwSlG~il~ell~g----------~~p  211 (415)
                      |+|||+++........    ....+||+.|+|||++.+.. ++.      ++|||||||++|||++|          ..|
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            9999999876443322    23567899999999997633 344      38999999999999999          555


Q ss_pred             CCCCC----cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014985          212 LQGSS----DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ  287 (415)
Q Consensus       212 f~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  287 (415)
                      |....    ..............  ....+                  .......++.++.+||.+||+.||.+|||+.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKL--RPSFP------------------NRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCC--CCCCC------------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhhhcCCCCchhhhHHHHhhhcc--Ccccc------------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            54321    11122111110000  00000                  00001134577999999999999999999999


Q ss_pred             HhcC
Q 014985          288 ALEH  291 (415)
Q Consensus       288 ~l~h  291 (415)
                      +++|
T Consensus       322 ll~~  325 (337)
T 3mdy_A          322 VKKT  325 (337)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1e-45  Score=379.97  Aligned_cols=283  Identities=23%  Similarity=0.286  Sum_probs=207.8

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec----
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----   82 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----   82 (415)
                      +....++|++.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++..    
T Consensus         9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A            9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            3455689999999999999999999999999999999986542 22223456789999999999999999998765    


Q ss_pred             --CCeEEEEeeccc-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCc---EEEee
Q 014985           83 --KGNLHLVFEFME-TDLETVIRNTN--IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQ---LKLAD  154 (415)
Q Consensus        83 --~~~~~lv~e~~~-g~L~~~i~~~~--~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~---vkL~D  154 (415)
                        .+..|+|||||+ |+|..++....  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              677899999997 58888887643  25899999999999999999999999999999999999997765   99999


Q ss_pred             eccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCC
Q 014985          155 FGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPS  234 (415)
Q Consensus       155 FG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  234 (415)
                      ||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...........   ......
T Consensus       168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~  242 (676)
T 3qa8_A          168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNE  242 (676)
T ss_dssp             CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C-----
T ss_pred             ccccccccccc-ccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccch
Confidence            99998765432 3455688999999999976 568999999999999999999999998764432211100   000000


Q ss_pred             CCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          235 QWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      .............+.. ..+......+.+++.+.+||.+||..||++|||+.|+++||||..
T Consensus       243 ~~~~~~~l~g~~~~~~-~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSS-VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             -CCSCCCCSSSCCCCS-SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhhhhcccccccc-ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            0000000000000100 011112233446789999999999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=346.32  Aligned_cols=275  Identities=24%  Similarity=0.306  Sum_probs=191.1

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee-----cC
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-----HK   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~   83 (415)
                      .-.++|++.+.||+|+||+||+|.+  +++.||||++......   ......|+..+..++||||+++++.+.     ..
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh---hHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            3478999999999999999999965  6899999998643221   111223444455689999999997542     33


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---------CccccCCCCCcEEEecCCcEEEe
Q 014985           84 GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK---------WVLHRDMKPNNLLIGSHGQLKLA  153 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~---------~ivHrDlkp~NILi~~~~~vkL~  153 (415)
                      ..+|+|||||+ |+|.+++....  .++..++.++.||+.||.|||++         ||+||||||+|||++.++.+||+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            46899999997 58888887654  58899999999999999999999         99999999999999999999999


Q ss_pred             eeccceecCCC--------CCcccccccccceeCcccccCC------cCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcH
Q 014985          154 DFGLARIFGSP--------DRRFTHQVFARWYRAPELLFGA------KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDI  218 (415)
Q Consensus       154 DFG~a~~~~~~--------~~~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~  218 (415)
                      |||+++.....        .......+||+.|+|||++.+.      ..++.++|||||||++|||++|. ++|.+.+..
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            99999876432        1223356789999999999762      34667899999999999999996 555543311


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcccc---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc-----
Q 014985          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL---FPSASDDALDLLSKMFTYDPKARITAQQALE-----  290 (415)
Q Consensus       219 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~-----  290 (415)
                      +....+....+..     +........ .......+.+...   ....++++.+||.+||+.||++|||+.|+++     
T Consensus       243 ~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          243 EYQMAFQTEVGNH-----PTFEDMQVL-VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCTTHHHHCSS-----CCHHHHHHH-HTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCC-----chHHHHHhh-hcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            1000000000000     000000000 0000000111111   1123567999999999999999999999955     


Q ss_pred             -CCCCCC
Q 014985          291 -HRYFSS  296 (415)
Q Consensus       291 -h~~~~~  296 (415)
                       ++|-.+
T Consensus       317 l~~~~~~  323 (336)
T 3g2f_A          317 MMIWERN  323 (336)
T ss_dssp             HHCCCC-
T ss_pred             HHHHHhc
Confidence             677654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.7e-44  Score=369.97  Aligned_cols=251  Identities=24%  Similarity=0.392  Sum_probs=207.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCC---CcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKT---GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      ..++|++.+.||+|+||+||+|.+..+   +..+|+|.+..... ......+.+|+.+++.++||||+++++++. ++..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            468899999999999999999998654   45799998764322 222345778999999999999999999985 4678


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+||||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            99999998 68999888777679999999999999999999999999999999999999999999999999998764432


Q ss_pred             C-cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          166 R-RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       166 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      . ......+++.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......             
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-------------  611 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------------  611 (656)
T ss_dssp             --------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-------------
T ss_pred             ceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            2 2233456778999999976 568999999999999999997 99999998888877776553111             


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                    ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus       612 --------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 --------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                          112345899999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.8e-46  Score=357.17  Aligned_cols=248  Identities=21%  Similarity=0.234  Sum_probs=190.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc------CCccchHHHHHHHHHhcC---------CCCeee
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK------EGVNFTALREIKLLKELK---------SPHIIE   75 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~------~~~~~~~~~E~~il~~l~---------hp~Iv~   75 (415)
                      .++|++.+.||+|+||+||+|++  +|+.||||++......      ......+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            58899999999999999999987  6899999999876432      112245778999999986         555555


Q ss_pred             EE-----------------eeeec-------------CCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 014985           76 LI-----------------DAFPH-------------KGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL  124 (415)
Q Consensus        76 l~-----------------~~~~~-------------~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL  124 (415)
                      ++                 ++|.+             .+.+|+|||||.| +++..+.+  ..+++..++.++.||+.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            54                 44443             7899999999984 46666644  4589999999999999999


Q ss_pred             HHhh-hCCccccCCCCCcEEEecCC--------------------cEEEeeeccceecCCCCCcccccccccceeCcccc
Q 014985          125 AFCH-KKWVLHRDMKPNNLLIGSHG--------------------QLKLADFGLARIFGSPDRRFTHQVFARWYRAPELL  183 (415)
Q Consensus       125 ~~lH-~~~ivHrDlkp~NILi~~~~--------------------~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l  183 (415)
                      +||| ++||+||||||+||||+.++                    .+||+|||+|+.....     ..+||+.|+|||++
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence            9999 99999999999999999987                    8999999999876532     35889999999999


Q ss_pred             cCCcCCCCcccHHHHHHH-HHHHHcCCCCCCCCCc-HHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCC
Q 014985          184 FGAKQYGAGVDVWAAGCI-FAELLNRRPFLQGSSD-IDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFP  261 (415)
Q Consensus       184 ~~~~~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (415)
                      .+..  +.++||||||++ .++++.|..||.+... ......+.......                     ........+
T Consensus       250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~  306 (336)
T 2vuw_A          250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK---------------------TKCNTPAMK  306 (336)
T ss_dssp             CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS---------------------SCCCSHHHH
T ss_pred             cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC---------------------cccchhhhh
Confidence            8733  889999998777 7778899988853211 11222222211110                     001112223


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHh-cCCCCC
Q 014985          262 SASDDALDLLSKMFTYDPKARITAQQAL-EHRYFS  295 (415)
Q Consensus       262 ~~s~~~~~li~~~L~~dP~~Rpt~~e~l-~h~~~~  295 (415)
                      .+++++++||.+||++|     |++|+| +||||+
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            45889999999999987     999999 999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.6e-43  Score=337.96  Aligned_cols=256  Identities=24%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHh--cCCCCeeeEEeeeecCC
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE--LKSPHIIELIDAFPHKG   84 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~~   84 (415)
                      ...+.++|.+.+.||+|+||+||+|.+  +|+.||||++....     ...+.+|+.+++.  ++||||+++++++....
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            345678999999999999999999987  58999999985322     2346689999888  79999999999998776


Q ss_pred             ----eEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--------hCCccccCCCCCcEEEecCCcEE
Q 014985           85 ----NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH--------KKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        85 ----~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH--------~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                          .+|+||||++| +|.+++.+.  .+++..++.++.||+.||.|||        ++||+||||||+|||++.++++|
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence                89999999995 898888764  4899999999999999999999        89999999999999999999999


Q ss_pred             EeeeccceecCCCCC----cccccccccceeCcccccCCcC-----CCCcccHHHHHHHHHHHHcC----------CCCC
Q 014985          152 LADFGLARIFGSPDR----RFTHQVFARWYRAPELLFGAKQ-----YGAGVDVWAAGCIFAELLNR----------RPFL  212 (415)
Q Consensus       152 L~DFG~a~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~-----~~~~~DiwSlG~il~ell~g----------~~pf  212 (415)
                      |+|||++........    ......||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            999999987654432    2345678999999999976422     23689999999999999999          6666


Q ss_pred             CCCC----cHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014985          213 QGSS----DIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA  288 (415)
Q Consensus       213 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~  288 (415)
                      ....    ..+.+......  .......+.                  .......+..+.+||.+||+.||++|||+.++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCE--QKLRPNIPN------------------RWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTT--SCCCCCCCG------------------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccCcCcccHHHHHHHHHH--HHhCCCCcc------------------cccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence            5542    12222221110  000000000                  00011224678999999999999999999999


Q ss_pred             hcC
Q 014985          289 LEH  291 (415)
Q Consensus       289 l~h  291 (415)
                      ++|
T Consensus       328 ~~~  330 (342)
T 1b6c_B          328 KKT  330 (342)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-42  Score=325.42  Aligned_cols=232  Identities=16%  Similarity=0.093  Sum_probs=187.6

Q ss_pred             cc-cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            7 SK-KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         7 ~~-~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      +. .+.++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.+++.++||||+++++++...+
T Consensus        25 g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           25 GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             TCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             CCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            44 56789999999999999999999999999999999997654322 22245778999999999999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      ..|+||||++ ++|.+++.. +  .....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|       
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-S--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-C--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             cEEEEEEecCCCCHHHHHhc-C--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999998 578887743 2  4666788899999999999999999999999999999999999998443       


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                                   |++        .++.++|||||||++|+|++|..||.+.+..+.+.                     
T Consensus       175 -------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------------------  212 (286)
T 3uqc_A          175 -------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------------------  212 (286)
T ss_dssp             -------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------------------
T ss_pred             -------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------------------
Confidence                         443        26889999999999999999999998754321000                     


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ..........+......+.+++++.+||.+||+.||.+| |+.|+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            000000011122334556789999999999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-43  Score=369.14  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             ccccccccEeeeeeecccCceEEEEEEECC-CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC
Q 014985            6 LSKKVADRYLKREVLGEGTYGVVYKAIDTK-TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG   84 (415)
Q Consensus         6 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   84 (415)
                      .++.+.++|++.+.||+|+||+||+|.+.. +|+.||||++..... ......+.+|+.++++++||||++++++|...+
T Consensus        74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            345678999999999999999999999976 789999998864322 122335678999999999999999999998766


Q ss_pred             e-----EEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccc
Q 014985           85 N-----LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLA  158 (415)
Q Consensus        85 ~-----~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a  158 (415)
                      .     .|+||||++| +|...+..   .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence            5     7999999995 66555443   59999999999999999999999999999999999999875 8999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +.....    ...+||+.|+|||++.+  .++.++|||||||++|+|++|.++|.+...                ...+.
T Consensus       229 ~~~~~~----~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------~~~~~  286 (681)
T 2pzi_A          229 SRINSF----GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYV----------------DGLPE  286 (681)
T ss_dssp             EETTCC----SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEEC----------------SSCCT
T ss_pred             hhcccC----CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccc----------------ccccc
Confidence            876443    45678999999999865  358899999999999999999988765210                00000


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                        .......++.+.+||.+||+.||.+||+..+++.|+|+.
T Consensus       287 ------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 ------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                              000001257899999999999999999999999998864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=7.3e-37  Score=312.85  Aligned_cols=185  Identities=16%  Similarity=0.048  Sum_probs=134.3

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEeecCCccC--------CccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEEEE
Q 014985           19 VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE--------GVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        19 ~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~--------~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++.|++|.+..++....|+.||+|++.+.....        .....+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4567888888888888899999999998654221        1223477899999999 699999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||||+| +|.+.+... +.+++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.........
T Consensus       321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            999996 777777654 457654   478999999999999999999999999999999999999999999877666667


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR  209 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~  209 (415)
                      ...+||+.|||||++.+  .+..++|+||+|+++|+|.++.
T Consensus       397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             cCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            78899999999999976  3677899999999998887664

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.1e-29  Score=258.18  Aligned_cols=184  Identities=17%  Similarity=0.174  Sum_probs=139.4

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc------cchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV------NFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~------~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ...+.||+|+||+||+|  ...++.+++|+..........      ...+.+|+.++++++||||+++..++...+..|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            44678999999999999  566889999987653322111      1235789999999999999955444445667799


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||||+ |+|.+++..         +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+++........
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            999998 688888765         5689999999999999999999999999999998  9999999999987543221


Q ss_pred             -------ccccccccceeCcccccC-CcCCCCcccHHHHHHHHHHHHcCCCC
Q 014985          168 -------FTHQVFARWYRAPELLFG-AKQYGAGVDVWAAGCIFAELLNRRPF  211 (415)
Q Consensus       168 -------~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwSlG~il~ell~g~~p  211 (415)
                             ....+||++|||||++.+ ...|+..+|+||..+-..+.+.++..
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence                   235688999999999864 13478889999998888887765543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.1e-26  Score=217.29  Aligned_cols=157  Identities=18%  Similarity=0.293  Sum_probs=119.7

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----------------ccchHHHHHHHHHhcCCCCeeeEEe
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----------------VNFTALREIKLLKELKSPHIIELID   78 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----------------~~~~~~~E~~il~~l~hp~Iv~l~~   78 (415)
                      .+.+.||+|+||.||+|.+ .+|+.||+|+++.......                ....+.+|+.+++.++  | +++.+
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~  168 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK  168 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred             EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence            3449999999999999999 8899999999975432111                1234678999999999  4 56666


Q ss_pred             eeecCCeEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           79 AFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        79 ~~~~~~~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      ++.. +..|+||||++| +|.+ +.     .  .....++.||+.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus       169 ~~~~-~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          169 VYAW-EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EEEE-ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             EEec-cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            5544 456999999986 6766 31     1  33457999999999999999999999999999999 99999999999


Q ss_pred             ceecCCCCCcccccccccceeCcccccC---------CcCCCCcccHHHH
Q 014985          158 ARIFGSPDRRFTHQVFARWYRAPELLFG---------AKQYGAGVDVWAA  198 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~aPE~l~~---------~~~~~~~~DiwSl  198 (415)
                      |+....             |+|||.+.+         ...|+..+|+|.+
T Consensus       239 a~~~~~-------------~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          239 SVEVGE-------------EGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             CEETTS-------------TTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             CeECCC-------------CCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            985422             788998742         1235566677653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=3.3e-23  Score=191.16  Aligned_cols=140  Identities=18%  Similarity=0.201  Sum_probs=108.6

Q ss_pred             cEeeeeeecccCceEEEEEEECCCCcE--EEEEEeecCCccCC----------------------ccchHHHHHHHHHhc
Q 014985           13 RYLKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEG----------------------VNFTALREIKLLKEL   68 (415)
Q Consensus        13 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~avK~i~~~~~~~~----------------------~~~~~~~E~~il~~l   68 (415)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||+++.......                      ....+.+|+.+|+.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378899999999999999998778888  99999765421100                      012467899999999


Q ss_pred             CCCCe--eeEEeeeecCCeEEEEeecccC------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCC
Q 014985           69 KSPHI--IELIDAFPHKGNLHLVFEFMET------DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKP  139 (415)
Q Consensus        69 ~hp~I--v~l~~~~~~~~~~~lv~e~~~g------~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH-~~~ivHrDlkp  139 (415)
                      .|++|  ..+++.    ...++||||+++      .|.+....    .++..+..++.||+.||.||| ++||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            88754  444432    346899999963      45554332    235577889999999999999 99999999999


Q ss_pred             CcEEEecCCcEEEeeeccceecC
Q 014985          140 NNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus       140 ~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      +|||++.  .++|+|||+|....
T Consensus       200 ~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEETT
T ss_pred             HHEEEcC--cEEEEECcccccCC
Confidence            9999988  89999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=3.1e-20  Score=178.76  Aligned_cols=140  Identities=19%  Similarity=0.194  Sum_probs=99.4

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC------------ccc--------hHHHHHHHHHhcCCCCe
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG------------VNF--------TALREIKLLKELKSPHI   73 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~------------~~~--------~~~~E~~il~~l~hp~I   73 (415)
                      |.+.+.||.|+||.||+|.+. +|+.||||+++.......            ...        .+.+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999874 699999999865321100            000        12346666666644433


Q ss_pred             --eeEEeeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC---
Q 014985           74 --IELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG---  148 (415)
Q Consensus        74 --v~l~~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~---  148 (415)
                        ...++..    ..+|||||++|..+..+      .....+..++.||+.+|.+||++|||||||||+||||+.+|   
T Consensus       176 ~vp~p~~~~----~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQS----RHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEEE----TTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeecc----CceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence              2223222    13699999997433221      12234567889999999999999999999999999999887   


Q ss_pred             -------cEEEeeeccceecCCC
Q 014985          149 -------QLKLADFGLARIFGSP  164 (415)
Q Consensus       149 -------~vkL~DFG~a~~~~~~  164 (415)
                             .+.|+||+-+.....+
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETTST
T ss_pred             cccccccceEEEEeCCcccCCCC
Confidence                   3899999987765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=8.4e-14  Score=128.03  Aligned_cols=141  Identities=12%  Similarity=0.135  Sum_probs=110.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..+.|++...+|.|+.+.||++..  .+..+++|........  ....+.+|+.+++.+. +..+.++++++...+..|+
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            457799999999999999999963  4689999998643211  1235778999999995 5678889999988899999


Q ss_pred             EeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh--------------------------------------
Q 014985           89 VFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK--------------------------------------  129 (415)
Q Consensus        89 v~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~--------------------------------------  129 (415)
                      ||||++| ++...+      .+......++.++..+|..||+                                      
T Consensus        88 v~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           88 LMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999998 444431      1222344678899999999998                                      


Q ss_pred             ---------------------CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 ---------------------KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ---------------------~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                                           ..++|+|++|.|||++.++.+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 4589999999999998755567999998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=1.4e-12  Score=119.29  Aligned_cols=136  Identities=14%  Similarity=0.063  Sum_probs=99.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEeeeecCCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDAFPHKGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~~~l   88 (415)
                      ...|.+....+.|..+.||++. ..+|..+++|.....     ....+.+|+.+++.+.+.+  +.+++.++...+..|+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            4456665555567779999995 356778999986543     1235678999999986544  5668888888888999


Q ss_pred             EeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC-------------------------------------
Q 014985           89 VFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW-------------------------------------  131 (415)
Q Consensus        89 v~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~-------------------------------------  131 (415)
                      ||||++|..+. ..    ..+.   ..++.++...|..||+..                                     
T Consensus        93 v~e~i~G~~l~-~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL-SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT-TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC-cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999984333 11    1221   256677777788888643                                     


Q ss_pred             ---------------------ccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          132 ---------------------VLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       132 ---------------------ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                                           ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 99999999999998766667999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.28  E-value=9.3e-12  Score=119.81  Aligned_cols=142  Identities=18%  Similarity=0.251  Sum_probs=104.6

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEee--cCCccCCccchHHHHHHHHHhcCC--CCeeeEEeeeecC---CeE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIR--LGKQKEGVNFTALREIKLLKELKS--PHIIELIDAFPHK---GNL   86 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~--~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~---~~~   86 (415)
                      ....+.|+.|.++.||++..  .+..+++|+..  ..... .....+.+|+.+++.+..  ..+.+++.++.+.   +..
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            34577899999999999964  35688899765  32211 122357789999999974  4578888888766   458


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-------------------------------------  129 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-------------------------------------  129 (415)
                      |+||||++|..+..  ..-..+++.....++.+++..|..||+                                     
T Consensus       117 ~~vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          117 FYIMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEEEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999999843211  111236788888999999999999997                                     


Q ss_pred             ---------------------CCccccCCCCCcEEEecCCc--EEEeeecccee
Q 014985          130 ---------------------KWVLHRDMKPNNLLIGSHGQ--LKLADFGLARI  160 (415)
Q Consensus       130 ---------------------~~ivHrDlkp~NILi~~~~~--vkL~DFG~a~~  160 (415)
                                           .+++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 35999999999999997753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=3.6e-11  Score=112.97  Aligned_cols=183  Identities=17%  Similarity=0.158  Sum_probs=117.0

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCC--eeeEEeeeecCC---eEEEEe
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPH--IIELIDAFPHKG---NLHLVF   90 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~--Iv~l~~~~~~~~---~~~lv~   90 (415)
                      .+.++.|....||++.     ..+++|.....    .....+.+|+.+|+.+. +..  +.+++......+   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            5668999999999972     56889975422    12335678999999884 322  445555443333   358999


Q ss_pred             ecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------
Q 014985           91 EFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK----------------------------------------  129 (415)
Q Consensus        91 e~~~g~-L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~----------------------------------------  129 (415)
                      ++++|. +......   .++......++.++...|..||+                                        
T Consensus        96 ~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             ECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999983 3322221   26777788888888888888885                                        


Q ss_pred             ------------------CCccccCCCCCcEEEec--CCcEEEeeeccceecCCCCCcccccccccceeCccccc-----
Q 014985          130 ------------------KWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF-----  184 (415)
Q Consensus       130 ------------------~~ivHrDlkp~NILi~~--~~~vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~-----  184 (415)
                                        ..++|+|++|.||+++.  ++.+.|+||+.+... .+............-..|+...     
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              23799999999999998  456889999998764 2221111110000001222110     


Q ss_pred             -CC-------cCCCCcccHHHHHHHHHHHHcCCCCC
Q 014985          185 -GA-------KQYGAGVDVWAAGCIFAELLNRRPFL  212 (415)
Q Consensus       185 -~~-------~~~~~~~DiwSlG~il~ell~g~~pf  212 (415)
                       +.       .....-.+.|++|.++|.+.+|.++|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             00       00112258999999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.76  E-value=6.7e-08  Score=90.68  Aligned_cols=133  Identities=18%  Similarity=0.126  Sum_probs=89.7

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCC---CeeeEEeeee-cCCeEEEEeec
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP---HIIELIDAFP-HKGNLHLVFEF   92 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~~~-~~~~~~lv~e~   92 (415)
                      .+.++.|....||++     |..+++|+-..    ......+.+|+.+|+.+.+.   .|.+++.+.. ..+..|+||||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            566899999999998     56788897421    11223567899999999752   2556666663 45678899999


Q ss_pred             ccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 014985           93 METD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK-----------------------------------------  130 (415)
Q Consensus        93 ~~g~-L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~-----------------------------------------  130 (415)
                      ++|. +......   .++......++.++...|..||+.                                         
T Consensus        95 i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           95 VQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             cCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9984 3321111   134444444555555555555432                                         


Q ss_pred             -------------------CccccCCCCCcEEEec---CCc-EEEeeeccceec
Q 014985          131 -------------------WVLHRDMKPNNLLIGS---HGQ-LKLADFGLARIF  161 (415)
Q Consensus       131 -------------------~ivHrDlkp~NILi~~---~~~-vkL~DFG~a~~~  161 (415)
                                         .++|+|++|.|||++.   ++. +.|+||+.+...
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               3699999999999987   455 489999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.68  E-value=1.1e-07  Score=87.22  Aligned_cols=132  Identities=16%  Similarity=0.130  Sum_probs=90.1

Q ss_pred             eecccCce-EEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEEEEeecccCC
Q 014985           19 VLGEGTYG-VVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHLVFEFMETD   96 (415)
Q Consensus        19 ~LG~G~~g-~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~lv~e~~~g~   96 (415)
                      .+..|..| .||+......+..+++|.-...     ....+.+|..+|+.+.. --|.+++.++.+.+..|+|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445444 7999877777788999986532     22346689999998853 22677888888889999999999984


Q ss_pred             -HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---------------------------------------------
Q 014985           97 -LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK---------------------------------------------  130 (415)
Q Consensus        97 -L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~---------------------------------------------  130 (415)
                       +.......     ......+..++...|..||+.                                             
T Consensus       106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence             43332211     112233444455555555521                                             


Q ss_pred             -------------CccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          131 -------------WVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       131 -------------~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                                   .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         168999999999998877677999999864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.51  E-value=5.9e-07  Score=87.32  Aligned_cols=78  Identities=17%  Similarity=0.145  Sum_probs=49.9

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCc--c---CCccchHHHHHHHHHhcCC--CC-eeeEEeeeecCCeEE
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ--K---EGVNFTALREIKLLKELKS--PH-IIELIDAFPHKGNLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~--~---~~~~~~~~~E~~il~~l~h--p~-Iv~l~~~~~~~~~~~   87 (415)
                      ..+.||.|.++.||++.+...++.+++|.......  .   .........|..+|+.+..  +. +.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46789999999999997666678899998653211  0   1122345679999988743  33 4455543  234467


Q ss_pred             EEeecccC
Q 014985           88 LVFEFMET   95 (415)
Q Consensus        88 lv~e~~~g   95 (415)
                      +||||++|
T Consensus       112 lvmE~l~g  119 (397)
T 2olc_A          112 TVMEDLSH  119 (397)
T ss_dssp             EEECCCTT
T ss_pred             EEEEeCCC
Confidence            99999986

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.44  E-value=8.5e-07  Score=83.99  Aligned_cols=136  Identities=17%  Similarity=0.214  Sum_probs=77.9

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC--CCeeeEEe------eeecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS--PHIIELID------AFPHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~------~~~~~~~~~l   88 (415)
                      .+.|+.|..+.||++...  +..+++|......      ..+..|+.+++.|..  -.+.+++.      +....+..++
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            455667788999999653  3459999886421      223345666665531  12333332      1234677899


Q ss_pred             EeecccCC-H--------------HHHHHhcCCCC-------------CHH--------H--------------------
Q 014985           89 VFEFMETD-L--------------ETVIRNTNIFL-------------SPA--------D--------------------  112 (415)
Q Consensus        89 v~e~~~g~-L--------------~~~i~~~~~~l-------------~~~--------~--------------------  112 (415)
                      ||+|++|. +              +..++.....+             ...        .                    
T Consensus       109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  188 (346)
T 2q83_A          109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY  188 (346)
T ss_dssp             EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred             EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            99999972 1              12222211101             010        0                    


Q ss_pred             ---HHHHHHHHHHHHHHhh-------------hCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          113 ---IKSYMQMTLKGLAFCH-------------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       113 ---~~~i~~qil~aL~~lH-------------~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                         +..+..++..++++|+             ..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence               1112222334566665             25799999999999998888899999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.43  E-value=3.6e-07  Score=87.39  Aligned_cols=81  Identities=5%  Similarity=0.012  Sum_probs=54.3

Q ss_pred             eeeeee-cccCceEEEEEEECC------CCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCC---CCeeeEEeeeecC
Q 014985           15 LKREVL-GEGTYGVVYKAIDTK------TGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKS---PHIIELIDAFPHK   83 (415)
Q Consensus        15 ~~~~~L-G~G~~g~Vy~~~~~~------~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~~~~~   83 (415)
                      ...+.| +.|..+.+|++....      ++..+++|....... .......+.+|+.+++.+..   -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            445778 899999999986430      156789997543220 00012356789999988843   3467777776554


Q ss_pred             ---CeEEEEeecccC
Q 014985           84 ---GNLHLVFEFMET   95 (415)
Q Consensus        84 ---~~~~lv~e~~~g   95 (415)
                         +..|+||||++|
T Consensus       103 ~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             TTTSSCEEEEECCCC
T ss_pred             CccCCceEEEEecCC
Confidence               457899999987

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.97  E-value=3.2e-05  Score=75.66  Aligned_cols=79  Identities=8%  Similarity=-0.054  Sum_probs=46.9

Q ss_pred             hhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccccc--ccceeCcccccCCcC--CCCcccHHHHHHHHH
Q 014985          128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVF--ARWYRAPELLFGAKQ--YGAGVDVWAAGCIFA  203 (415)
Q Consensus       128 H~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~--t~~y~aPE~l~~~~~--~~~~~DiwSlG~il~  203 (415)
                      +...++|+|++|.|||++.++ ++|+||+.+.... +.......+.  ...|.+|+.......  -....++.++...+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            456799999999999998877 9999999987532 1111111111  123666655421100  111234457777777


Q ss_pred             HHHcC
Q 014985          204 ELLNR  208 (415)
Q Consensus       204 ell~g  208 (415)
                      +++.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.96  E-value=3.4e-05  Score=71.78  Aligned_cols=132  Identities=13%  Similarity=0.177  Sum_probs=75.5

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEEeecc-c
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVFEFM-E   94 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv~e~~-~   94 (415)
                      .+.|+.|....+|++      ..+++|+......   ......+|+.+++.+....+ .+++..+.+  .-++|+||+ +
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCC
Confidence            788999999999999      5688898754311   11234568888887743333 456655433  346899999 6


Q ss_pred             CC-HH------------------HHHHhcCCCCC-----HHHHHHHHHH--------------HHHHHH----Hhh----
Q 014985           95 TD-LE------------------TVIRNTNIFLS-----PADIKSYMQM--------------TLKGLA----FCH----  128 (415)
Q Consensus        95 g~-L~------------------~~i~~~~~~l~-----~~~~~~i~~q--------------il~aL~----~lH----  128 (415)
                      |. +.                  ..++.....+.     ...+..+...              +...+.    .+.    
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            62 11                  01111111111     1111111111              111111    111    


Q ss_pred             hCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       129 ~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            123899999999999 5677899999998875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.94  E-value=0.00013  Score=63.56  Aligned_cols=97  Identities=16%  Similarity=0.074  Sum_probs=66.6

Q ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccccccc
Q 014985           96 DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA  174 (415)
Q Consensus        96 ~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH-~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~~~t  174 (415)
                      +|...+...+.+++++++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|.|-+.+ +.+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            688888888999999999999999999987762 12222344567999999999987764 1111            011


Q ss_pred             cceeCcccccCCcCCCCcccHHHHHHHHHHHHc
Q 014985          175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN  207 (415)
Q Consensus       175 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~  207 (415)
                      ..+.|||...  ...+.+.=|||||+++|.-+-
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1277888763  345678899999999999884

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.86  E-value=7.8e-05  Score=69.77  Aligned_cols=73  Identities=21%  Similarity=0.133  Sum_probs=56.9

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC---CCCeeeEEeeeecCCeEEEEeec
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK---SPHIIELIDAFPHKGNLHLVFEF   92 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~~~lv~e~   92 (415)
                      -.+.|+.|....+|++..  .+..+++|.....     ....+..|...|+.|.   ...+.+++.+....+..|+||||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            457789999999999963  4678999986532     1234667999888884   35678888888878899999999


Q ss_pred             ccC
Q 014985           93 MET   95 (415)
Q Consensus        93 ~~g   95 (415)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            986

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.70  E-value=7e-05  Score=70.16  Aligned_cols=138  Identities=14%  Similarity=0.047  Sum_probs=77.0

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEee------eecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDA------FPHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~------~~~~~~~~l   88 (415)
                      .+.|+.|....+|++...  +..+++|......    ....+..|+.++..+....  +.+++..      ....+..++
T Consensus        27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eeccCCCcccceEEEEeC--CccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            556788888999999643  3368899876421    1224557888887774222  2333321      123466789


Q ss_pred             EeecccCCH---------------HHHHHhcCCC--------CCHHHHHH---------------HHHHHHHHHHHhhh-
Q 014985           89 VFEFMETDL---------------ETVIRNTNIF--------LSPADIKS---------------YMQMTLKGLAFCHK-  129 (415)
Q Consensus        89 v~e~~~g~L---------------~~~i~~~~~~--------l~~~~~~~---------------i~~qil~aL~~lH~-  129 (415)
                      ||+|++|..               +..+......        .....-..               +...+...++.+.+ 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999998731               1112221100        11110000               00113334445542 


Q ss_pred             ------CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 ------KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ------~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                            .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  4699999999999998776568999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.68  E-value=0.0001  Score=72.23  Aligned_cols=72  Identities=11%  Similarity=0.135  Sum_probs=49.6

Q ss_pred             eeeeecccCceEEEEEEECC-------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEE
Q 014985           16 KREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~   87 (415)
                      -.+.|+.|....||++....       .+..+++|+....    .....+.+|+.+++.+...++ .++++.+.+    .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            45678899999999997643       2578999987321    111345579999888854333 567776643    2


Q ss_pred             EEeecccC
Q 014985           88 LVFEFMET   95 (415)
Q Consensus        88 lv~e~~~g   95 (415)
                      +|+||++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            89999986

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.66  E-value=0.0003  Score=66.23  Aligned_cols=33  Identities=27%  Similarity=0.370  Sum_probs=28.2

Q ss_pred             hCCccccCCCCCcEEEecC----CcEEEeeeccceec
Q 014985          129 KKWVLHRDMKPNNLLIGSH----GQLKLADFGLARIF  161 (415)
Q Consensus       129 ~~~ivHrDlkp~NILi~~~----~~vkL~DFG~a~~~  161 (415)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3469999999999999874    67999999998753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.59  E-value=0.00038  Score=66.88  Aligned_cols=137  Identities=12%  Similarity=0.141  Sum_probs=80.6

Q ss_pred             eeeecccCceEEEEEEECC-------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.|..|....+|++....       .++.|++|+...  .. .......+|..+++.+.. .-..++++.+.++    +
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--IL-QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----R  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--cc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----c
Confidence            4567788889999997532       357899998522  11 122345589999988843 2235677776542    8


Q ss_pred             EeecccCCH-----------H-------HHHHhcCCC----CC--HHHHHHHHHHHHH-------------------HHH
Q 014985           89 VFEFMETDL-----------E-------TVIRNTNIF----LS--PADIKSYMQMTLK-------------------GLA  125 (415)
Q Consensus        89 v~e~~~g~L-----------~-------~~i~~~~~~----l~--~~~~~~i~~qil~-------------------aL~  125 (415)
                      ||||++|..           .       ..+......    ..  ...+..|..++-.                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998721           0       111111111    11  2455555554422                   123


Q ss_pred             Hhh----h----CCccccCCCCCcEEEecC----CcEEEeeecccee
Q 014985          126 FCH----K----KWVLHRDMKPNNLLIGSH----GQLKLADFGLARI  160 (415)
Q Consensus       126 ~lH----~----~~ivHrDlkp~NILi~~~----~~vkL~DFG~a~~  160 (415)
                      .|.    .    ..++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    2    249999999999999876    7899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.56  E-value=0.0012  Score=65.07  Aligned_cols=73  Identities=18%  Similarity=0.190  Sum_probs=48.6

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe-eeEEeeeecCCeEEEEeeccc
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI-IELIDAFPHKGNLHLVFEFME   94 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~~~lv~e~~~   94 (415)
                      -.+.|+.|....+|++.....+..+++|+.....  . ......+|..+++.|...++ .++++.+.  +.  +||||++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~  184 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD  184 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence            4567889999999999765445788999864321  1 11123579999999975554 56777773  22  5999998


Q ss_pred             C
Q 014985           95 T   95 (415)
Q Consensus        95 g   95 (415)
                      |
T Consensus       185 G  185 (458)
T 2qg7_A          185 G  185 (458)
T ss_dssp             S
T ss_pred             C
Confidence            6

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.55  E-value=0.00017  Score=69.01  Aligned_cols=73  Identities=11%  Similarity=0.165  Sum_probs=44.1

Q ss_pred             eeeeecccCceEEEEEEECC--------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC-eeeEEeeeecCCeE
Q 014985           16 KREVLGEGTYGVVYKAIDTK--------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNL   86 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~--------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~   86 (415)
                      -.+.|+.|....+|++....        .+..+++|+......   .......|..+++.+...+ +.++++.+.  +  
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~--  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTFN--G--  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEecC--C--
Confidence            35677889899999997543        136888887643211   1113457888888885433 446665552  2  


Q ss_pred             EEEeecccC
Q 014985           87 HLVFEFMET   95 (415)
Q Consensus        87 ~lv~e~~~g   95 (415)
                      ++||||++|
T Consensus       110 ~~v~e~i~G  118 (369)
T 3c5i_A          110 GRIEEWLYG  118 (369)
T ss_dssp             EEEEECCCS
T ss_pred             cEEEEEecC
Confidence            689999987

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.00093  Score=62.55  Aligned_cols=136  Identities=16%  Similarity=0.155  Sum_probs=77.9

Q ss_pred             eeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC--eeeEEee-----eecCCeEEEEe
Q 014985           18 EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH--IIELIDA-----FPHKGNLHLVF   90 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~-----~~~~~~~~lv~   90 (415)
                      ..|+ |....||++.. .+|+.+++|.......   ....+..|..+++.+....  +++++..     ....+..++||
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~  106 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  106 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence            4566 88889998843 3466799998763321   1234567888888774222  3444432     22356678999


Q ss_pred             ecccCC------HH---------HHHHhc--C------CCCCHHHH----------------------HHHHHHHHHHHH
Q 014985           91 EFMETD------LE---------TVIRNT--N------IFLSPADI----------------------KSYMQMTLKGLA  125 (415)
Q Consensus        91 e~~~g~------L~---------~~i~~~--~------~~l~~~~~----------------------~~i~~qil~aL~  125 (415)
                      +|++|.      ..         ..++..  .      ...+....                      ...+..++..+.
T Consensus       107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~  186 (328)
T 1zyl_A          107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT  186 (328)
T ss_dssp             ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence            999872      11         011111  0      01111110                      111122222222


Q ss_pred             Hh----hhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          126 FC----HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       126 ~l----H~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      -+    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22    234589999999999998 4 799999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.0012  Score=60.65  Aligned_cols=79  Identities=11%  Similarity=0.042  Sum_probs=54.4

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC---CCeeeEEeeeecCCeE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS---PHIIELIDAFPHKGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~~~~~~~~   86 (415)
                      ......-++.+|.|..+.||++.. .+|+.|++|+-.....  .....+..|+..|+.|..   --+.+++.+.    .-
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~   85 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR   85 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence            355667788999999999999974 5788999997653321  122345679999998842   2245555443    23


Q ss_pred             EEEeecccC
Q 014985           87 HLVFEFMET   95 (415)
Q Consensus        87 ~lv~e~~~g   95 (415)
                      ++||||+.+
T Consensus        86 ~lv~e~l~~   94 (288)
T 3f7w_A           86 TLAMEWVDE   94 (288)
T ss_dssp             EEEEECCCC
T ss_pred             eEEEEeecc
Confidence            689999874

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.26  E-value=0.0034  Score=59.20  Aligned_cols=31  Identities=19%  Similarity=0.427  Sum_probs=27.9

Q ss_pred             CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999998875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.85  E-value=0.0041  Score=60.52  Aligned_cols=73  Identities=12%  Similarity=0.178  Sum_probs=48.1

Q ss_pred             eeeeecccCceEEEEEEECCC-------CcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEE
Q 014985           16 KREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~-------~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~   87 (415)
                      -++.|..|-...+|++.....       ++.|++|+.....   .......+|..+++.+.. .-..++++.+.  +  +
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            456678888999999976521       5789999854321   112234579998888853 23455665443  2  6


Q ss_pred             EEeecccC
Q 014985           88 LVFEFMET   95 (415)
Q Consensus        88 lv~e~~~g   95 (415)
                      +||||++|
T Consensus       147 ~I~efI~G  154 (424)
T 3mes_A          147 RIEEFIDG  154 (424)
T ss_dssp             EEEECCCS
T ss_pred             EEEEEeCC
Confidence            88999997

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.04  E-value=0.023  Score=54.85  Aligned_cols=29  Identities=28%  Similarity=0.430  Sum_probs=25.1

Q ss_pred             ccccCCCCCcEEEe------cCCcEEEeeecccee
Q 014985          132 VLHRDMKPNNLLIG------SHGQLKLADFGLARI  160 (415)
Q Consensus       132 ivHrDlkp~NILi~------~~~~vkL~DFG~a~~  160 (415)
                      ++|+|+.+.|||+.      +++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            68999999999994      456799999999864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.52  E-value=0.054  Score=53.27  Aligned_cols=62  Identities=15%  Similarity=0.073  Sum_probs=16.1

Q ss_pred             eeeeecccCceEEEEEEECCCCcEEEE------EEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeee
Q 014985           16 KREVLGEGTYGVVYKAIDTKTGQTVAI------KKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAF   80 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~~~~~~av------K~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   80 (415)
                      +.+.||   ||.||++........||+      |..............+.+|..+++.++|||+++.+.+-
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            455666   999999977654567888      66544333333334567899999999999999887653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.21  E-value=2.3  Score=36.85  Aligned_cols=90  Identities=17%  Similarity=0.108  Sum_probs=62.4

Q ss_pred             HHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HhhhCCccccCCC
Q 014985           61 EIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA-FCHKKWVLHRDMK  138 (415)
Q Consensus        61 E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~-~lH~~~ivHrDlk  138 (415)
                      |+.+|.. .||++  -...-.+++.+.+.++.-. +..+..++.    ++....+.++.+|+.... ++  ..-+|--|.
T Consensus        41 e~~lL~~-~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~  111 (219)
T 4ano_A           41 ELEVLKE-VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVC  111 (219)
T ss_dssp             GGGGGGG-SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCC
T ss_pred             HHHHHhc-cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEe
Confidence            4444433 57888  3334466777777777664 334445543    788898989888876655 33  444677899


Q ss_pred             CCcEEEecCCcEEEeeeccce
Q 014985          139 PNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus       139 p~NILi~~~~~vkL~DFG~a~  159 (415)
                      |+||+++.++.++|.-.|+-.
T Consensus       112 P~NL~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             GGGEEECTTCCEEESCCEETT
T ss_pred             CceEEEeCCCcEEEEEcCCcc
Confidence            999999999999998887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	415
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-103
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-88
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-88
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-87
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-86
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-81
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-81
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-77
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-77
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-77
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-76
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-76
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-76
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-74
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-74
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-73
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-72
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-72
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-72
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-71
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-69
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-69
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-69
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-68
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-66
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-62
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-61
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-61
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-56
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-55
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-54
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-52
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-52
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-50
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-27

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  305 bits (781), Expect = e-103
 Identities = 175/295 (59%), Positives = 221/295 (74%), Gaps = 3/295 (1%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ---KEGVNFTALREIKLLKELKSPHII 74
           + LGEG +  VYKA D  T Q VAIKKI+LG +   K+G+N TALREIKLL+EL  P+II
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 75  ELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLH 134
            L+DAF HK N+ LVF+FMETDLE +I++ ++ L+P+ IK+YM MTL+GL + H+ W+LH
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 135 RDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVD 194
           RD+KPNNLL+  +G LKLADFGLA+ FGSP+R +THQV  RWYRAPELLFGA+ YG GVD
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 195 VWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           +WA GCI AELL R PFL G SD+DQL +IF   GT T  QWPD+  LPDYV ++     
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP 309
           PL  +F +A DD LDL+  +F ++P ARITA QAL+ +YFS+ P PT   +LPRP
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  267 bits (684), Expect = 2e-88
 Identities = 133/284 (46%), Positives = 180/284 (63%), Gaps = 2/284 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           ++Y   E +GEGTYGVVYKA +   G+T A+KKIRL K+ EG+  T +REI +LKELK  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I++L D    K  L LVFE ++ DL+ ++      L     KS++   L G+A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI   G+LK+ADFGLAR FG P R++TH++   WYRAP++L G+K+Y  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 192 GVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV-EYQY 250
            +D+W+ GCIFAE++N  P   G S+ DQL +IF   GT     WP++  LP Y   +  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
               P  S      +  +DLLSKM   DP  RITA+QALEH YF
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  267 bits (684), Expect = 3e-88
 Identities = 141/297 (47%), Positives = 184/297 (61%), Gaps = 2/297 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + + K E +GEGTYGVVYKA +  TG+ VA+KKIRL  + EGV  TA+REI LLKEL  P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L+D    +  L+LVFEF+  DL+  +  +    +    IKSY+   L+GLAFCH  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            VLHRD+KP NLLI + G +KLADFGLAR FG P R +TH+V   WYRAPE+L G K Y 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY-VEYQ 249
             VD+W+ GCIFAE++ RR    G S+IDQL +IF   GT     WP +  +PDY   + 
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKL 306
             A      + P   +D   LLS+M  YDP  RI+A+ AL H +F     P    +L
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  266 bits (681), Expect = 1e-87
 Identities = 125/308 (40%), Positives = 177/308 (57%), Gaps = 16/308 (5%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K   +G+GT+G V+KA   KTGQ VA+KK+ +  +KEG   TALREIK+L+ LK  
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 72  HIIELIDAF--------PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +++ LI+            KG+++LVF+F E DL  ++ N  +  + ++IK  MQM L G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG----SPDRRFTHQVFARWYRA 179
           L + H+  +LHRDMK  N+LI   G LKLADFGLAR F     S   R+T++V   WYR 
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PELL G + YG  +D+W AGCI AE+  R P +QG+++  QL  I    G+ TP  WP++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 240 AYLPDYVEYQYVAAPPL----RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                Y + + V         R         ALDL+ K+   DP  RI +  AL H +F 
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309

Query: 296 SAPLPTEP 303
           S P+P++ 
Sbjct: 310 SDPMPSDL 317

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  262 bits (670), Expect = 3e-86
 Identities = 139/291 (47%), Positives = 182/291 (62%), Gaps = 2/291 (0%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y K E +GEGTYG V+KA + +T + VA+K++RL    EGV  +ALREI LLKELK  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           +I+ L D       L LVFEF + DL+    + N  L P  +KS++   LKGL FCH + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGA 191
           VLHRD+KP NLLI  +G+LKLA+FGLAR FG P R ++ +V   WYR P++LFGAK Y  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 192 GVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY-Q 249
            +D+W+AGCIFAEL N  RP   G+   DQL +IF   GT T  QWP +  LPDY  Y  
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
           Y A   L ++ P  +    DLL  +   +P  RI+A++AL+H YFS    P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  250 bits (640), Expect = 7e-81
 Identities = 80/337 (23%), Positives = 137/337 (40%), Gaps = 31/337 (9%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V D Y   E LG G +GVV++  +  TG   A K +    + +       +EI+ +  L+
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMSVLR 81

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P ++ L DAF     + +++EFM   +L   + + +  +S  +   YM+   KGL   H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 129 KKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           +   +H D+KP N++  +    +LKL DFGL      P +          + APE+  G 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEG- 199

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           K  G   D+W+ G +   LL+      G +D + L  + +       S +  +       
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI------- 252

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKL 306
                            S+D  D + K+   DP  R+T  QALEH + +    P   +++
Sbjct: 253 -----------------SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295

Query: 307 PRPATKRASKASDFNPQEGPTVLSPPRKTRRVMPDRE 343
           P     +   +        P  L P  +       R+
Sbjct: 296 PSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRK 332

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 7e-81
 Identities = 107/311 (34%), Positives = 152/311 (48%), Gaps = 14/311 (4%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V  RY     +GEG YG+V  A D      VAIKKI   + +       LREIK+L   +
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFR 64

Query: 70  SPHIIELIDAF-----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +II + D           +++LV   M  DL  +++  +  LS   I  ++   L+GL
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGL 122

Query: 125 AFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQVFARWYRAPE 181
            + H   VLHRD+KP+NLL+ +   LK+ DFGLAR+           T  V  RWYRAPE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           ++  +K Y   +D+W+ GCI AE+L+ RP   G   +DQL  I    G+ +      +  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 242 LPDY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
           L      +   +    P   LFP+A   ALDLL KM T++P  RI  +QAL H Y     
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

Query: 299 LPTEPNKLPRP 309
            P++      P
Sbjct: 303 DPSDEPIAEAP 313

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (615), Expect = 3e-77
 Identities = 102/329 (31%), Positives = 164/329 (49%), Gaps = 22/329 (6%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
            +     Y   +V+G G++GVVY+A    +G+ VAIKK+   K+ +       RE+++++
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NRELQIMR 68

Query: 67  ELKSPHIIELIDAFPHKGN------LHLVFEFMETDLETVIRN---TNIFLSPADIKSYM 117
           +L   +I+ L   F   G       L+LV +++   +  V R+       L    +K YM
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 118 QMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPDRRFTHQVFARW 176
               + LA+ H   + HRD+KP NLL+      LKL DFG A+     +   ++ + +R+
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY 187

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           YRAPEL+FGA  Y + +DVW+AGC+ AELL  +P   G S +DQL +I    GT T  Q 
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLF-PSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
            ++       ++  + A P   +F P    +A+ L S++  Y P AR+T  +A  H +F 
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307

Query: 296 SAPLPTEPNKLPRPATKRASKASDFNPQE 324
               P     +  P  +      +F  QE
Sbjct: 308 ELRDPN----VKLPNGRDTPALFNFTTQE 332

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 5e-77
 Identities = 103/310 (33%), Positives = 154/310 (49%), Gaps = 14/310 (4%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V   Y   + +G G YG V  A+D +TG  VAIKK+    Q E     A RE++LLK +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 69  KSPHIIELIDAFPHKG------NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           +  ++I L+D F          + +LV  FM TDL  ++++    L    I+  +   LK
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLK 132

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEV 189

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +    +Y   VD+W+ GCI AE++  +   +GS  +DQL +I    GT        L   
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                      +      S+  +AS  A++LL KM   D + R+TA +AL H YF S   
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 300 PTEPNKLPRP 309
             +  ++ + 
Sbjct: 310 TEDEPQVQKY 319

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 5e-77
 Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 21/303 (6%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D + K   LG G  GVV+K     +G  +A K I L  +    N   +RE+++L E  SP
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSP 64

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH-KK 130
           +I+    AF   G + +  E M+      +      +    +       +KGL +   K 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            ++HRD+KP+N+L+ S G++KL DFG++      D      V  R Y +PE L G   Y 
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYS 181

Query: 191 AGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY- 248
              D+W+ G    E+   R P     +   +L       G A  +             Y 
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 249 --------------QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
                           V  PP +      S +  D ++K    +P  R   +Q + H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 295 SSA 297
             +
Sbjct: 302 KRS 304

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 4e-76
 Identities = 73/289 (25%), Positives = 125/289 (43%), Gaps = 32/289 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           D +     LG+G +G VYKA + +T    A K I    ++E  ++  + EI +L     P
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHP 69

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I++L+DAF ++ NL ++ EF     ++ V+      L+ + I+   + TL  L + H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFG----A 186
            ++HRD+K  N+L    G +KLADFG++       +R    +   ++ APE++       
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           + Y    DVW+ G    E+    P     + +  L KI                      
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-------------------- 229

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS 295
                + PP  +     S +  D L K    +  AR T  Q L+H + +
Sbjct: 230 -----SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  237 bits (606), Expect = 9e-76
 Identities = 81/342 (23%), Positives = 142/342 (41%), Gaps = 36/342 (10%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
             V D Y   E LG G +GVV++ ++  TG+    K I      +   +T   EI ++ +
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQ 82

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           L  P +I L DAF  K  + L+ EF+   +L   I   +  +S A++ +YM+   +GL  
Sbjct: 83  LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 127 CHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            H+  ++H D+KP N++  +     +K+ DFGLA    +PD           + APE++ 
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVD 201

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             +  G   D+WA G +   LL+      G  D++ L  +           +  +     
Sbjct: 202 R-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----- 255

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF----SSAPLP 300
                              S +A D +  +   +P+ R+T   ALEH +     S+    
Sbjct: 256 -------------------SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

Query: 301 TEPNKLPRPATKRASKASDFN-PQEGPTVLSPPRKTRRVMPD 341
              ++  +   K   K +D+  PQ     ++     R+  P 
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQ 338

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 9e-76
 Identities = 113/295 (38%), Positives = 160/295 (54%), Gaps = 13/295 (4%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
            +Y     +GEG YG V+KA D K  G+ VA+K++R+   +EG+  + +RE+ +L+ L++
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 71  ---PHIIELIDAF-----PHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTL 121
              P+++ L D         +  L LVFE ++ D    + +     +    IK  M   L
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
           +GL F H   V+HRD+KP N+L+ S GQ+KLADFGLARI+ S     T  V   WYRAPE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPE 185

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +L     Y   VD+W+ GCIFAE+  R+P  +GSSD+DQLGKI    G      WP    
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
           LP    +   +A P+        +   DLL K  T++P  RI+A  AL H YF  
Sbjct: 245 LPRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 1e-74
 Identities = 64/335 (19%), Positives = 131/335 (39%), Gaps = 35/335 (10%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE 67
           K++ ++Y+  E LG G +G+V++ ++T + +T   K +++    +       +EI +L  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            +  +I+ L ++F     L ++FEF+   D+   I  +   L+  +I SY+    + L F
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 127 CHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
            H   + H D++P N++  +     +K+ +FG AR     D          +Y       
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-- 175

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
                    D+W+ G +   LL+        ++   +  I  A  T     + ++     
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----- 230

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPN 304
                              S +A+D + ++   + K+R+TA +AL+H +           
Sbjct: 231 -------------------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

Query: 305 KLPRPATKRASKA---SDFNPQEGPTVLSPPRKTR 336
            +     +R        D N       +S     R
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIR 306

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 3e-74
 Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 29/291 (9%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           + +   + LGEG YG V  A++  T + VA+K + + +  +       +EI + K L   
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHE 63

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW 131
           ++++           +L  E+            +I +   D + +    + G+ + H   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 132 VLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQY 189
           + HRD+KP NLL+     LK++DFGLA +F   + +R          Y APELL   + +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 190 GAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ 249
              VDVW+ G +   +L         SD  Q    +                        
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------------------ 219

Query: 250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP 300
                   + +       L LL K+   +P ARIT     + R+++  PL 
Sbjct: 220 -KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK-PLK 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (586), Expect = 2e-73
 Identities = 80/308 (25%), Positives = 139/308 (45%), Gaps = 35/308 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +Y + E +G+G  G VY A+D  TGQ VAI+++ L +Q +      + EI +++E K+P
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+  +D++     L +V E++    L  V+  T +      I +  +  L+ L F H  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN 135

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V+HRD+K +N+L+G  G +KL DFG          + +  V   ++ APE++   K YG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG 194

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ G +  E++   P     + +  L  I    GT        L           
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKL----------- 242

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRPA 310
                        S    D L++    D + R +A++ L+H++   A    +P     P 
Sbjct: 243 -------------SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA----KPLSSLTPL 285

Query: 311 TKRASKAS 318
              A +A+
Sbjct: 286 IAAAKEAT 293

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 1e-72
 Identities = 107/308 (34%), Positives = 149/308 (48%), Gaps = 14/308 (4%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G YG V  A DTKTG  VA+KK+    Q         RE++LLK +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 69  KSPHIIELIDAFPHKGNLH------LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
           K  ++I L+D F    +L       LV   M  DL  +++     L+   ++  +   L+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILR 132

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           GL + H   ++HRD+KP+NL +    +LK+ DFGLAR     D   T  V  RWYRAPE+
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEI 189

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           +     Y   VD+W+ GCI AELL  R    G+  IDQL  I    GT        ++  
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249

Query: 243 PDYVEYQYVAAPP---LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL 299
                 Q +   P     ++F  A+  A+DLL KM   D   RITA QAL H YF+    
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309

Query: 300 PTEPNKLP 307
           P +     
Sbjct: 310 PDDEPVAD 317

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  226 bits (577), Expect = 6e-72
 Identities = 85/319 (26%), Positives = 136/319 (42%), Gaps = 33/319 (10%)

Query: 7   SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++ + D Y  R+VLG G +  V  A D +T + VAIK I   K  EG   +   EI +L 
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLH 62

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           ++K P+I+ L D +   G+L+L+ + +   +L   I     F +  D    +   L  + 
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVK 121

Query: 126 FCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
           + H   ++HRD+KP NLL  S     ++ ++DFGL+++   P    +       Y APE+
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEV 180

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
           L   K Y   VD W+ G I   LL   P     +D     +I  A        W D+   
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI--- 236

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS-SAPLPT 301
                                SD A D +  +   DP+ R T +QAL+H + +    L  
Sbjct: 237 ---------------------SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 302 EPNKLPRPATKRASKASDF 320
             ++      K+    S +
Sbjct: 276 NIHQSVSEQIKKNFAKSKW 294

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 9e-72
 Identities = 72/286 (25%), Positives = 131/286 (45%), Gaps = 32/286 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
           + +     LG+G +G VY A + ++   +A+K +   + +K GV     RE+++   L+ 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P+I+ L   F     ++L+ E+                      +Y+      L++CH K
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V+HRD+KP NLL+GS G+LK+ADFG +    +P  R T       Y  PE++ G + + 
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTTLCGTLDYLPPEMIEG-RMHD 182

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD+W+ G +  E L  +P  + ++  +   +I     T            PD+V    
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----------FPDFV---- 227

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
                        ++ A DL+S++  ++P  R   ++ LEH + ++
Sbjct: 228 -------------TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  225 bits (574), Expect = 2e-71
 Identities = 96/300 (32%), Positives = 157/300 (52%), Gaps = 25/300 (8%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-S 70
           D Y     LG G Y  V++AI+    + V +K ++  K+K+       REIK+L+ L+  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGG 89

Query: 71  PHIIELIDAF--PHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           P+II L D    P      LVFE +  TD + + +     L+  DI+ YM   LK L +C
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 145

Query: 128 HKKWVLHRDMKPNNLLIGS-HGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
           H   ++HRD+KP+N++I   H +L+L D+GLA  +  P + +  +V +R+++ PELL   
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDY 204

Query: 187 KQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY 245
           + Y   +D+W+ GC+ A ++ R+ PF  G  + DQL +I    GT     + D   +   
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 246 VEYQYVAAPPLRSLFPS---------ASDDALDLLSKMFTYDPKARITAQQALEHRYFSS 296
             +  +     R  +            S +ALD L K+  YD ++R+TA++A+EH YF +
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  218 bits (556), Expect = 3e-69
 Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 40/297 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-------GKQKEGVNFTALREIKL 64
           + Y  +E+LG G   VV + I   T +  A+K I +        ++ + +    L+E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 65  LKELKS-PHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLK 122
           L+++   P+II+L D +       LVF+ M+  +L   +    + LS  + +  M+  L+
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPEL 182
            +   HK  ++HRD+KP N+L+     +KL DFG +     P  +         Y APE+
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEI 180

Query: 183 LFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           +  +       YG  VD+W+ G I   LL   P       +  L  I +        +W 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
           D                         SD   DL+S+     P+ R TA++AL H +F
Sbjct: 241 DY------------------------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  219 bits (559), Expect = 3e-69
 Identities = 76/327 (23%), Positives = 131/327 (40%), Gaps = 33/327 (10%)

Query: 1   MAEVDLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRL-GKQKEGVNFTAL 59
           +AE+         +     +G G++G VY A D +  + VAIKK+   GKQ        +
Sbjct: 4   VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63

Query: 60  REIKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQM 119
           +E++ L++L+ P+ I+    +  +    LV E+       ++      L   +I +    
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
            L+GLA+ H   ++HRD+K  N+L+   G +KL DFG A I           V   ++ A
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMA 179

Query: 180 PELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
           PE++      QY   VDVW+ G    EL  R+P L   + +  L  I          Q  
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNE 230

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA 297
             A    +                  S+   + +       P+ R T++  L+HR+    
Sbjct: 231 SPALQSGHW-----------------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273

Query: 298 PLPTEPNKLPRPATKRASKASDFNPQE 324
             PT    L +       +  +   ++
Sbjct: 274 RPPTVIMDLIQRTKDAVRELDNLQYRK 300

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 4e-69
 Identities = 73/294 (24%), Positives = 115/294 (39%), Gaps = 39/294 (13%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS 70
           A+ Y     +G G+YG   K      G+ +  K++  G   E      + E+ LL+ELK 
Sbjct: 3   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 71  PHIIELIDAF--PHKGNLHLVFEFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGL 124
           P+I+   D         L++V E+ E  DL +VI        +L    +   M      L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 125 AFCHKK-----WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
             CH++      VLHRD+KP N+ +     +KL DFGLARI           V   +Y +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE +     Y    D+W+ GC+  EL    P     S  +  GKI               
Sbjct: 183 PEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------------- 226

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRY 293
                            R +    SD+  +++++M       R + ++ LE+  
Sbjct: 227 ------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 4e-69
 Identities = 101/323 (31%), Positives = 149/323 (46%), Gaps = 25/323 (7%)

Query: 5   DLSKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKL 64
           D +  V  RY   + +G G  G+V  A D    + VAIKK+    Q +     A RE+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 65  LKELKSPHIIELIDAFPHKG------NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQ 118
           +K +   +II L++ F  +       +++LV E M+ +L  VI+          +   + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLY 126

Query: 119 MTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYR 178
             L G+   H   ++HRD+KP+N+++ S   LK+ DFGLAR  G      T  V  R+YR
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYR 185

Query: 179 APELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD 238
           APE++ G       VD+W+ GCI  E++  +    G   IDQ  K+    GT  P     
Sbjct: 186 APEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 239 L-AYLPDYVEYQ-YVAAPPLRSLFPSA------------SDDALDLLSKMFTYDPKARIT 284
           L   + +YVE +   A      LFP +            +  A DLLSKM   DP  RI+
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Query: 285 AQQALEHRYFSSAPLPTEPNKLP 307
              AL+H Y +    P E    P
Sbjct: 305 VDDALQHPYINVWYDPAEVEAPP 327

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 5e-68
 Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 34/299 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTA----LREIK 63
           + V D Y   E LG G + VV K  +  TG   A K I+  + K      +     RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 64  LLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKG 123
           +LKE++ P++I L + + +K ++ L+ E +              L+  +   +++  L G
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 124 LAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLARIFGSPDRRFTHQVFARWYRA 179
           + + H   + H D+KP N+++        ++K+ DFGLA         F +      + A
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVA 184

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE++   +  G   D+W+ G I   LL+      G +  + L  + A         + + 
Sbjct: 185 PEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP 298
                                   S  A D + ++   DPK R+T Q +L+H +     
Sbjct: 244 ------------------------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-66
 Identities = 64/298 (21%), Positives = 109/298 (36%), Gaps = 38/298 (12%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLK 66
           KK  + +   ++LGEG++  V  A +  T +  AIK +      KE       RE  ++ 
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            L  P  ++L   F     L+    + +                   + Y    +  L +
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLF 184
            H K ++HRD+KP N+L+     +++ DFG A++     +  R    V    Y +PELL 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             K      D+WA GCI  +L+   P  +  ++     KI           +P+      
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----EYDFPE------ 231

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA------LEHRYFSS 296
                                 A DL+ K+   D   R+  ++         H +F S
Sbjct: 232 -----------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-62
 Identities = 67/328 (20%), Positives = 128/328 (39%), Gaps = 41/328 (12%)

Query: 8   KKVADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIK-LL 65
             + D Y +  +VLG G  G V +  + +T +  A+K ++   +       A RE++   
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHW 59

Query: 66  KELKSPHIIELIDAF----PHKGNLHLVFEFME-TDLETVIR-NTNIFLSPADIKSYMQM 119
           +  + PHI+ ++D +      +  L +V E ++  +L + I+   +   +  +    M+ 
Sbjct: 60  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119

Query: 120 TLKGLAFCHKKWVLHRDMKPNNLLIGSH---GQLKLADFGLARIFGSPDRRFTHQVFARW 176
             + + + H   + HRD+KP NLL  S      LKL DFG A+   S +   T   +  +
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPY 178

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           Y APE+L   ++Y    D+W+ G I   LL   P    +  +     +            
Sbjct: 179 YVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--- 234

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS- 295
                                  +   S++   L+  +   +P  R+T  + + H +   
Sbjct: 235 -----------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

Query: 296 SAPLPTEPNKLPRPATKRASKASDFNPQ 323
           S  +P  P    R   +   +  D   +
Sbjct: 278 STKVPQTPLHTSRVLKEDKERWEDVKEE 305

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 1e-61
 Identities = 69/305 (22%), Positives = 110/305 (36%), Gaps = 46/305 (15%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFT----ALREIKLLK 66
             +Y    +LG G +G VY  I       VAIK +   +  +            E+ LLK
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 67  ELKSPH--IIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLK 122
           ++ S    +I L+D F    +  L+ E  E   DL   I      L     +S+    L+
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLE 121

Query: 123 GLAFCHKKWVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPE 181
            +  CH   VLHRD+K  N+LI  + G+LKL DFG   +    D  +T     R Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPE 179

Query: 182 LLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
            +   + +G    VW+ G +  +++      +   +I +    F                
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--------------- 224

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPT 301
                                 S +   L+       P  R T ++   H +     LP 
Sbjct: 225 -------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265

Query: 302 EPNKL 306
           E  ++
Sbjct: 266 ETAEI 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  200 bits (510), Expect = 2e-61
 Identities = 67/295 (22%), Positives = 113/295 (38%), Gaps = 38/295 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLG----KQKEGVNFTALREIKLLKE 67
           + +    ++G G +G VY      TG+  A+K +       KQ E +       + L+  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
              P I+ +  AF     L  + + M   DL   +    +F S AD++ Y    + GL  
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGA 186
            H ++V++RD+KP N+L+  HG ++++D GLA  F       +       Y APE+L   
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQKG 180

Query: 187 KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
             Y +  D ++ GC+  +LL      +     D+  +I     T                
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSF------- 232

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSS 296
                            S +   LL  +   D   R+      AQ+  E  +F S
Sbjct: 233 -----------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-61
 Identities = 65/291 (22%), Positives = 117/291 (40%), Gaps = 39/291 (13%)

Query: 13  RYLK-REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           R+LK    +G G++  VYK +DT+T   VA  +++  K  +        E ++LK L+ P
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 72  HIIELIDAF----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +I+   D++      K  + LV E M +            +    ++S+ +  LKGL F 
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 128 HKK--WVLHRDMKPNNLLI-GSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLF 184
           H +   ++HRD+K +N+ I G  G +K+ D GLA +           +    + APE+  
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYE 186

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
              +Y   VDV+A G    E+           +  Q+                       
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------------- 221

Query: 245 YVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARITAQQALEHRYF 294
              Y+ V +    + F   A  +  +++      +   R + +  L H +F
Sbjct: 222 ---YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 8e-61
 Identities = 81/346 (23%), Positives = 140/346 (40%), Gaps = 40/346 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QKEGVNFTALREIKLLKELK 69
           + ++  ++LG+G++G V+ A   KT Q  AIK ++       + V  T + +  L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 70  SPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
            P +  +   F  K NL  V E++   DL   I++ + F   +    Y    + GL F H
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
            K +++RD+K +N+L+   G +K+ADFG+ +     D +         Y APE+L G ++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QK 179

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           Y   VD W+ G +  E+L  +    G  + +    I             D  + P ++  
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----------RMDNPFYPRWL-- 226

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA-QQALEHRYFSSAPLPTEPNKLP 307
                            +A DLL K+F  +P+ R+       +H  F          K  
Sbjct: 227 ---------------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271

Query: 308 ----RPATKRASKASDFNPQ--EGPTVLSPPRKTRRVMPDREGFEG 347
               RP  K     S+F+ +       LS   +      D+  F  
Sbjct: 272 DPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRN 317

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-60
 Identities = 53/285 (18%), Positives = 109/285 (38%), Gaps = 31/285 (10%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
            +    + +G G++G VYK    K    VA+K + +             E+ +L++ +  
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 72  HIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           +I+  +  +     L +V ++ E + L   +           +    + T +G+ + H K
Sbjct: 65  NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIF--GSPDRRFTHQVFARWYRAPELLFGAKQ 188
            ++HRD+K NN+ +     +K+ DFGLA +    S   +F     +  + APE++    +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 189 --YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
             Y    DV+A G +  EL+  +      ++ DQ+  +                      
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-------------------- 223

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
             +   +P L  +  +       L+++        R    Q L  
Sbjct: 224 --RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 33/292 (11%)

Query: 8   KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLK 66
             ++DRY   E+LG G    V+ A D +  + VA+K +R    +         RE +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 67  ELKSPHIIELIDAF----PHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLK 122
            L  P I+ + D      P     ++V E+++      I +T   ++P      +    +
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 123 GLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ---VFARWYRA 179
            L F H+  ++HRD+KP N++I +   +K+ DFG+AR         T     +    Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 180 PELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL 239
           PE   G     A  DV++ GC+  E+L   P   G S +    +          ++   L
Sbjct: 183 PEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                   S D   ++ K    +P+ R      +  
Sbjct: 242 ------------------------SADLDAVVLKALAKNPENRYQTAAEMRA 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-56
 Identities = 57/283 (20%), Positives = 109/283 (38%), Gaps = 35/283 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                 + +G G +G+V+          VAIK IR G   E  +F  + E +++ +L  P
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE-EDF--IEEAEVMMKLSHP 60

Query: 72  HIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
            +++L      +  + LVFEFME   L   +R      +   +        +G+A+  + 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ-VFARWYRAPELLFGAKQY 189
            V+HRD+   N L+G +  +K++DFG+ R         +    F   + +PE+     +Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 190 GAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
            +  DVW+ G +  E+ +  +   +  S+ + +  I   F    P               
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA------------ 227

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                          S     +++  +   P+ R    + L  
Sbjct: 228 ---------------STHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 59/291 (20%), Positives = 107/291 (36%), Gaps = 38/291 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
             +     LG G++G V+       G+  A+K ++     +         E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P II +   F     + ++ +++E      +   +        K Y       L + H K
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            +++RD+KP N+L+  +G +K+ DFG A+                 Y APE++   K Y 
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST-KPYN 179

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             +D W+ G +  E+L        S+ +    KI  A       ++P             
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----ELRFP------------- 221

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
                     P  ++D  DLLS++ T D   R+       +    H +F  
Sbjct: 222 ----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-54
 Identities = 70/337 (20%), Positives = 123/337 (36%), Gaps = 41/337 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
           + +   ++LG+GT+G V    +  TG+  A+K +R      +      + E ++L+  + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P +  L  AF     L  V E+          +     +    + Y    +  L + H +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            V++RD+K  NL++   G +K+ DFGL +   S             Y APE+L     YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 183

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD W  G +  E++  R              I          ++P             
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----LMEEIRFP------------- 225

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLPTEPNK 305
                      + S +A  LL+ +   DPK R+      A++ +EHR+F S        K
Sbjct: 226 ----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275

Query: 306 LP----RPATKRASKASDFNPQ--EGPTVLSPPRKTR 336
                 +P          F+ +       ++PP +  
Sbjct: 276 KLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYD 312

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 6e-54
 Identities = 54/321 (16%), Positives = 104/321 (32%), Gaps = 42/321 (13%)

Query: 9   KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +V +RY     +G G++G +Y   D   G+ VAIK   +  +   +      E K+ K +
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMM 59

Query: 69  KSPHIIELIDAFPHKGNLH-LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
           +    I  I     +G+ + +V E +   LE +    +   S   +       +  + + 
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 128 HKKWVLHRDMKPNNLLIGSHG---QLKLADFGLARIFGSPD-------RRFTHQVFARWY 177
           H K  +HRD+KP+N L+G       + + DFGLA+ +           R   +      Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 178 RAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP 237
            +     G  +     D+ + G +           QG     +  K              
Sbjct: 180 ASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----------- 227

Query: 238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRYF 294
                      +   + P+  L      +    L+   +     +       Q   + + 
Sbjct: 228 ---------ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

Query: 295 SSAPLPTEP---NKLPRPATK 312
                       N L   A++
Sbjct: 279 RQGFSYDYVFDWNMLKFGASR 299

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 51/284 (17%), Positives = 99/284 (34%), Gaps = 41/284 (14%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                 + +G+G +G V        G  VA+K I+     +      L E  ++ +L+  
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF----LAEASVMTQLRHS 60

Query: 72  HIIELIDAF-PHKGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCH 128
           ++++L+      KG L++V E+M    L   +R+     L    +  +     + + +  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQ 188
               +HRD+   N+L+      K++DFGL +   S             + APE L   K+
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALRE-KK 176

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +    DVW+ G +  E+    R         D + ++   +    P   P          
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP---------- 226

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                +++   +  D   R +  Q  E 
Sbjct: 227 -----------------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-53
 Identities = 55/291 (18%), Positives = 111/291 (38%), Gaps = 39/291 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           +     E LG G +G V+          VA+K ++ G          L E  L+K+L+  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQ 68

Query: 72  HIIELIDAFPHKGNLHLVFEFMETDL--ETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            ++ L      +  ++++ E+ME     + +   + I L+   +        +G+AF  +
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           +  +HRD++  N+L+      K+ADFGLAR+   +         F   + APE +     
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GT 186

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +    DVW+ G +  E++ + R    G ++ + +  +   +    P   P          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP---------- 236

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSS 296
                            ++   L+   +   P+ R T          +F++
Sbjct: 237 -----------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 7e-53
 Identities = 49/277 (17%), Positives = 97/277 (35%), Gaps = 35/277 (12%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELI 77
           + LG G +GVV      +    VAIK I+ G   E      + E K++  L    +++L 
Sbjct: 10  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLY 65

Query: 78  DAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRD 136
                +  + ++ E+M    L   +R          +    +   + + +   K  LHRD
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125

Query: 137 MKPNNLLIGSHGQLKLADFGLARIFGSPD-RRFTHQVFARWYRAPELLFGAKQYGAGVDV 195
           +   N L+   G +K++DFGL+R     +        F   +  PE+L    ++ +  D+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDI 184

Query: 196 WAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAP 254
           WA G +  E+ +  +   +  ++ +    I        P                     
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS----------------- 227

Query: 255 PLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                     +    ++   +      R T +  L +
Sbjct: 228 ----------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 62/300 (20%), Positives = 120/300 (40%), Gaps = 39/300 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
           +       LG+G +G V+      T + VAIK ++ G          L+E +++K+L+  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE---AFLQEAQVMKKLRHE 72

Query: 72  HIIELIDAFPHKGNLHLVFEFMETD--LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
            +++L      +  +++V E+M     L+ +   T  +L    +         G+A+  +
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFTHQVFARWYRAPELLFGAKQ 188
              +HRD++  N+L+G +   K+ADFGLAR+    +        F   + APE      +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
           +    DVW+ G +  EL    R    G  + + L ++   +    P + P          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP---------- 240

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSSAPLPTEPNK 305
                            +   DL+ + +  +P+ R T +        YF+S     +P +
Sbjct: 241 -----------------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 52/294 (17%), Positives = 92/294 (31%), Gaps = 38/294 (12%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           V   Y     +GEG++GV+++  +    Q VAIK          +      E +  K L 
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLA 58

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCH 128
               I  +        +  LV + +   LE ++       S   +    +  L  +   H
Sbjct: 59  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 129 KKWVLHRDMKPNNLLIGS-----HGQLKLADFGLARIFGSPD-------RRFTHQVFARW 176
           +K +++RD+KP+N LIG         + + DFG+ + +  P        R   +      
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 177 YRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW 236
           Y +     G ++     D+ A G +F   L      QG        K             
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--------- 228

Query: 237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                       +   + PLR L     ++    +         A         
Sbjct: 229 -----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-52
 Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 37/311 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGK--QKEGVNFTALREIKLLK 66
           + +   +VLG G YG V+         TG+  A+K ++     QK         E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 67  ELK-SPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLA 125
            ++ SP ++ L  AF  +  LHL+ +++         +     +  +++ Y+   +  L 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT--HQVFARWYRAPELL 183
             HK  +++RD+K  N+L+ S+G + L DFGL++ F + +            +     + 
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 184 FGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
            G   +   VD W+ G +  ELL          + +   +I      + P    ++    
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM---- 259

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAP 298
                               S  A DL+ ++   DPK R+      A +  EH +F    
Sbjct: 260 --------------------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299

Query: 299 LPTEPNKLPRP 309
                 K    
Sbjct: 300 WDDLAAKKVPA 310

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  173 bits (439), Expect = 8e-52
 Identities = 60/299 (20%), Positives = 114/299 (38%), Gaps = 35/299 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP 71
                +  LG G YG VY+ +  K   TVA+K ++    +       L+E  ++KE+K P
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73

Query: 72  HIIELIDAFPHKGNLHLVFEFME--TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK 129
           ++++L+     +   +++ EFM     L+ +       +S   +          + +  K
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARIF-GSPDRRFTHQVFARWYRAPELLFGAKQ 188
           K  +HRD+   N L+G +  +K+ADFGL+R+  G          F   + APE L    +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 189 YGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY 248
           +    DVWA G +  E+           D+ Q+                          Y
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------------------Y 226

Query: 249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSSAPLPTEPNK 305
           + +             +   +L+   + ++P  R +  +  +     F  + +  E  K
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  174 bits (441), Expect = 3e-51
 Identities = 79/338 (23%), Positives = 134/338 (39%), Gaps = 51/338 (15%)

Query: 13  RYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK--- 69
           RY+    LG G +  V+ A D      VA+K +R  K        A  EIKLL+ +    
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDAD 70

Query: 70  --------SPHIIELIDAF----PHKGNLHLVFEFMETD-LETVIRNTNIFLSPADIKSY 116
                   + HI++L+D F    P+  ++ +VFE +  + L  + +  +  +    +K  
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 117 MQMTLKGLAFCHKKW-VLHRDMKPNNLLIGSHG------QLKLADFGLARIFGSPDRRFT 169
            +  L GL + H++  ++H D+KP N+L+          Q+K+AD G A  +        
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS------DIDQLGK 223
                R YR+PE+L G   +G G D+W+  C+  EL+      +         D D + +
Sbjct: 191 QT---REYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 224 IFAAFGTATPSQWPDLAYLPDYVE-------YQYVAAPPLRSLFPS-------ASDDALD 269
           I    G        +  Y   +            +   PL  +           + +  D
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 270 LLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLP 307
            LS M   DP+ R  A   + H +     L  E  ++P
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKD-TLGMEEIRVP 343

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 4e-51
 Identities = 57/291 (19%), Positives = 116/291 (39%), Gaps = 40/291 (13%)

Query: 15  LKREVLGEGTYGVVYKAI--DTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH 72
           L+ + LG G +G V K      K  +TVA+K ++       +    L E  ++++L +P+
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 73  IIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
           I+ +I     + +  LV E  E          N  +   +I   +     G+ +  +   
Sbjct: 70  IVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW---YRAPELLFGAKQY 189
           +HRD+   N+L+ +    K++DFGL++   + +  +  Q   +W   + APE +    ++
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKF 187

Query: 190 GAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
            +  DVW+ G +  E  +  ++P+ +G    +    +        P+  P          
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCP---------- 236

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ---ALEHRYFS 295
                             +  DL++  +TYD + R         L + Y+ 
Sbjct: 237 -----------------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-51
 Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 35/303 (11%)

Query: 10  VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +A   + +E +G+G +G V++      G+ VA+K     +++    +    EI     L+
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS---WFREAEIYQTVMLR 55

Query: 70  SPHIIELIDAFPHKGN----LHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGL 124
             +I+  I A          L LV ++ E   L   +      ++   +      T  GL
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGL 113

Query: 125 AFCH--------KKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSP----DRRFTHQV 172
           A  H        K  + HRD+K  N+L+  +G   +AD GLA    S     D    H+V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 173 FARWYRAPELLFGA-----KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAA 227
             + Y APE+L  +      +     D++A G +F E+  R        D          
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL------P 227

Query: 228 FGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ 287
           +    PS            E +     P R     A      ++ + +  +  AR+TA +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 288 ALE 290
             +
Sbjct: 288 IKK 290

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-50
 Identities = 62/298 (20%), Positives = 121/298 (40%), Gaps = 43/298 (14%)

Query: 12  DRYLKREV-LGEGTYGVVYKAID--TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           D  L  ++ LG G +G V + +    K    VAIK ++ G +K       +RE +++ +L
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQL 66

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
            +P+I+ LI        L LV E      L   +      +  +++   +     G+ + 
Sbjct: 67  DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR---WYRAPELLF 184
            +K  +HRD+   N+L+ +    K++DFGL++  G+ D  +T +   +    + APE + 
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 185 GAKQYGAGVDVWAAGCIFAELLN--RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL 242
             +++ +  DVW+ G    E L+  ++P+ +     + +  I        P + P     
Sbjct: 186 F-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP----- 238

Query: 243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ---QALEHRYFSSA 297
                                  +   L+S  + Y  + R       Q +   Y+S A
Sbjct: 239 ----------------------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 5e-50
 Identities = 58/285 (20%), Positives = 103/285 (36%), Gaps = 34/285 (11%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLGKQKEGVNFTALREIKLLKEL 68
           +R      +GEG +G V++ I          VAIK  +     + V    L+E   +++ 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQF 65

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             PHI++LI     +  + ++ E     +L + ++     L  A +  Y       LA+ 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAK 187
             K  +HRD+   N+L+ S+  +KL DFGL+R           +               +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 188 QYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV 246
           ++ +  DVW  G    E+L       QG  + D +G+I                      
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------------- 225

Query: 247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                       + P+       L++K + YDP  R    +    
Sbjct: 226 --------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (431), Expect = 7e-50
 Identities = 62/291 (21%), Positives = 105/291 (36%), Gaps = 38/291 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKELKS 70
           D++ + + LG G++G V      ++G   A+K +   K  K       L E ++L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 71  PHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKK 130
           P +++L  +F    NL++V E++               S    + Y    +    + H  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 131 WVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYG 190
            +++RD+KP NLLI   G +++ DFG A+                   APE++   K Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILS-KGYN 216

Query: 191 AGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY 250
             VD WA G +  E+    P       I    KI                  P +     
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-----------VSGKVRFPSHF---- 261

Query: 251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSS 296
                        S D  DLL  +   D   R             H++F++
Sbjct: 262 -------------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 9e-49
 Identities = 61/313 (19%), Positives = 109/313 (34%), Gaps = 62/313 (19%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQT-----VAIKKIRLGKQKEGVNFTALREIKLLK 66
           +     +VLG G +G V  A      +T     VA+K ++            + E+K++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE-ALMSELKMMT 95

Query: 67  ELKS-PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTN------------------- 105
           +L S  +I+ L+ A    G ++L+FE+    DL   +R+                     
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 106 ---IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG 162
                L+  D+  +     KG+ F   K  +HRD+   N+L+     +K+ DFGLAR   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 163 SPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDID 219
           S        +      + APE LF    Y    DVW+ G +  E+ +       G     
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYD 278
              K+                                +   P  A+++   ++   + +D
Sbjct: 275 NFYKLI---------------------------QNGFKMDQPFYATEEIYIIMQSCWAFD 307

Query: 279 PKARITAQQALEH 291
            + R +       
Sbjct: 308 SRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 5e-48
 Identities = 48/288 (16%), Positives = 92/288 (31%), Gaps = 35/288 (12%)

Query: 12  DRYLKREVLGEGTYGVVYKAI---DTKTGQTVAIKKIRLGK-QKEGVNFTALREIKLLKE 67
                 E LG+G++GVV +      +    +VA+K ++     +       +RE+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 68  LKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
           L   ++I L         + +V E      L   +R          +  Y     +G+ +
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFAR--WYRAPELLF 184
              K  +HRD+   NLL+ +   +K+ DFGL R     D  +  Q   +  +        
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 185 GAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP 243
             + +    D W  G    E+    +    G +    L KI                   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------------------- 227

Query: 244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 D  +++ + + + P+ R T     + 
Sbjct: 228 -------DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  163 bits (414), Expect = 6e-48
 Identities = 52/290 (17%), Positives = 105/290 (36%), Gaps = 39/290 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLGKQKEGVNFTALREIKLLKEL 68
                 +V+G G +G V        G+    VAIK ++ G  ++      L E  ++ + 
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIMGQF 84

Query: 69  KSPHIIELIDAFPHKGNLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFC 127
             P++I L         + ++ EFME   L++ +R  +   +   +   ++    G+ + 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 128 HKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFARW-----YRAPEL 182
                +HRD+   N+L+ S+   K++DFGL+R         T+           + APE 
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 183 LFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +   +++ +  DVW+ G +  E+++         ++ D +  I   +    P   P    
Sbjct: 205 IQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP---- 259

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                       L+   +  D   R    Q +  
Sbjct: 260 -----------------------SALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-47
 Identities = 67/307 (21%), Positives = 111/307 (36%), Gaps = 57/307 (18%)

Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +R    + LG G +G V +A     I +    TVA+K ++            + E+K+L 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL-MSELKVLS 81

Query: 67  ELKS-PHIIELIDAFPHKGNLHLVFEFME-TDLETVIR-----------------NTNIF 107
            L +  +I+ L+ A    G   ++ E+    DL   +R                 +  + 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR 167
           L   D+ S+     KG+AF   K  +HRD+   N+L+      K+ DFGLAR   +    
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 168 F--THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKI 224
               +      + APE +F    Y    DVW+ G    EL +       G     +  K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPS-ASDDALDLLSKMFTYDPKARI 283
                                           R L P  A  +  D++   +  DP  R 
Sbjct: 261 I---------------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293

Query: 284 TAQQALE 290
           T +Q ++
Sbjct: 294 TFKQIVQ 300

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-46
 Identities = 50/287 (17%), Positives = 104/287 (36%), Gaps = 34/287 (11%)

Query: 11  ADRYLKREVLGEGTYGVVYKAIDTKTGQT----VAIKKIRLGKQKEGVNFTALREIKLLK 66
              + K +VLG G +G VYK +    G+     VAIK++R     +      L E  ++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAF 126
            + +PH+  L+          +        L   +R     +    + ++     KG+ +
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 127 CHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQVFA--RWYRAPELLF 184
              + ++HRD+   N+L+ +   +K+ DFGLA++ G+ ++ +  +       + A E + 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 185 GAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD 244
             + Y    DVW+ G    EL+             ++                       
Sbjct: 187 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------------- 222

Query: 245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                 +         P  + D   ++ K +  D  +R   ++ +  
Sbjct: 223 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 50/300 (16%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTG--QTVAIKKIRLGKQKEGVNFTALREIKLLKELK 69
           +    ++V+GEG +G V KA   K G     AIK+++    K+        E+++L +L 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLG 68

Query: 70  S-PHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF---------------LSPAD 112
             P+II L+ A  H+G L+L  E+    +L   +R + +                LS   
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 113 IKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQV 172
           +  +     +G+ +  +K  +HRD+   N+L+G +   K+ADFGL+R      ++   ++
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 173 FARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTA 231
             RW     L +    Y    DVW+ G +  E+++       G +  +   K+   +   
Sbjct: 189 PVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 232 TPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
            P                               D+  DL+ + +   P  R +  Q L  
Sbjct: 247 KPLNC---------------------------DDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 39/284 (13%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQT---VAIKKIRLGKQKEGVNFTALREIKLLKELKSPHII 74
           EV+G G +G VY              A+K +        V+   L E  ++K+   P+++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 91

Query: 75  ELIDA-FPHKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWV 132
            L+      +G+  +V  +M+  DL   IRN     +  D+  +     KG+ F   K  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

Query: 133 LHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD----RRFTHQVFARWYRAPELLFGAKQ 188
           +HRD+   N ++     +K+ADFGLAR     +       T       + A E L   K 
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211

Query: 189 YGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE 247
                DVW+ G +  EL+    P     +  D    +        P   P          
Sbjct: 212 TTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP---------- 260

Query: 248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                            D   +++ K +    + R +  + +  
Sbjct: 261 -----------------DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (404), Expect = 2e-46
 Identities = 59/311 (18%), Positives = 115/311 (36%), Gaps = 61/311 (19%)

Query: 12  DRYLKREVLGEGTYGVVYKA-----IDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           +       +GEG +G V++A     +  +    VA+K ++     +       RE  L+ 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMA 71

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF------------------ 107
           E  +P+I++L+        + L+FE+M   DL   +R+ +                    
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 108 -----LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG 162
                LS A+     +    G+A+  ++  +HRD+   N L+G +  +K+ADFGL+R   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 163 SPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDID 219
           S D  +   +      +  PE +F   +Y    DVWA G +  E+ +       G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 220 QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDP 279
            +                            YV    + +   +   +  +L+   ++  P
Sbjct: 251 VI---------------------------YYVRDGNILACPENCPLELYNLMRLCWSKLP 283

Query: 280 KARITAQQALE 290
             R +      
Sbjct: 284 ADRPSFCSIHR 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 56/289 (19%), Positives = 108/289 (37%), Gaps = 40/289 (13%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLG-KQKEGVNFTALREIKLLK 66
               +++V+G G +G VYK +   +       VAIK ++ G  +K+ V+F  L E  ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF--LGEAGIMG 64

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFMETDL-ETVIRNTNIFLSPADIKSYMQMTLKGLA 125
           +    +II L         + ++ E+ME    +  +R  +   S   +   ++    G+ 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 126 FCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQVFARWYRAPEL 182
           +      +HRD+   N+L+ S+   K++DFGL+R+           +       + APE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 183 LFGAKQYGAGVDVWAAGCIFAELL-NRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY 241
           +   K   A  DVW+ G +  E++          S+ + +  I   F   TP   P    
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP---- 239

Query: 242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE 290
                                       L+ + +  +   R      + 
Sbjct: 240 -----------------------SAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 4e-43
 Identities = 54/298 (18%), Positives = 105/298 (35%), Gaps = 47/298 (15%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           ++      LG+G++G+VY+ +       +    VAIK +             L E  ++K
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMK 78

Query: 67  ELKSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIRNTNIF---------LSPADIKSY 116
           E    H++ L+          ++ E M   DL++ +R+              S + +   
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 117 MQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFA 174
                 G+A+ +    +HRD+   N ++     +K+ DFG+ R     D  R+    +  
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 175 RWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATP 233
             + +PE L     +    DVW+ G +  E+        QG S+   L  +         
Sbjct: 199 VRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------- 249

Query: 234 SQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH 291
                                 L     +  D   +L+   + Y+PK R +  + +  
Sbjct: 250 -------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 6e-43
 Identities = 62/306 (20%), Positives = 120/306 (39%), Gaps = 54/306 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAIDTKT-------GQTVAIKKIRLGKQKEGVNFTALREIKL 64
           DR +  + LGEG +G V  A               VA+K ++    ++ ++   + E+++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEM 71

Query: 65  LKEL-KSPHIIELIDAFPHKGNLHLVFEFME-TDLETVIR---------------NTNIF 107
           +K + K  +II L+ A    G L+++ E+    +L   ++               N    
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 108 LSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-- 165
           LS  D+ S      +G+ +   K  +HRD+   N+L+     +K+ADFGLAR     D  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIF 225
           ++ T+      + APE LF  + Y    DVW+ G +  E+            +++L    
Sbjct: 192 KKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---- 246

Query: 226 AAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITA 285
                                 ++ +          + +++   ++   +   P  R T 
Sbjct: 247 ----------------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284

Query: 286 QQALEH 291
           +Q +E 
Sbjct: 285 KQLVED 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 5e-42
 Identities = 63/305 (20%), Positives = 109/305 (35%), Gaps = 52/305 (17%)

Query: 12  DRYLKREVLGEGTYGVVYKAID-----TKTGQTVAIKKIRLGKQKEGVNFTALREIKLLK 66
           DR    + LG G +G V +A       T T +TVA+K ++ G               L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 67  ELKSPHIIELIDAFPHKGN-LHLVFEFME-TDLETVIRN---------------TNIFLS 109
                +++ L+ A    G  L ++ EF +  +L T +R+                  FL+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 110 PADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RR 167
              +  Y     KG+ F   +  +HRD+   N+L+     +K+ DFGLAR         R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFA 226
                    + APE +F  + Y    DVW+ G +  E+ +       G    ++  +   
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL- 250

Query: 227 AFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ 286
                   +       PDY                  + +    +   +  +P  R T  
Sbjct: 251 --------KEGTRMRAPDYT-----------------TPEMYQTMLDCWHGEPSQRPTFS 285

Query: 287 QALEH 291
           + +EH
Sbjct: 286 ELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  105 bits (262), Expect = 2e-27
 Identities = 26/202 (12%), Positives = 68/202 (33%), Gaps = 41/202 (20%)

Query: 18  EVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK----------------QKEGVNFTALRE 61
           +++GEG    V+     +      +K  ++G                        +A  E
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 62  IKLLKELKSPHIIELIDAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTL 121
            + L++L+   + ++     +     ++ E ++             +   +    + M L
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVLDMIL 113

Query: 122 KGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF----THQVFARWY 177
           + +A  + + ++H D+   N+L+   G + + DF  +   G    R       +    ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 178 RAPELLFGAKQYGAGVDVWAAG 199
                    + Y    D+ +A 
Sbjct: 173 S--------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	415
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.26
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.45
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.31
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.0

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-66  Score=488.79  Aligned_cols=295  Identities=59%  Similarity=1.049  Sum_probs=261.7

Q ss_pred             eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCcc---CCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           15 LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQK---EGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        15 ~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      +.+++||+|+||+||+|+++.+|+.||||++......   +.....+.+|+.+|++++|||||+++++|.+++++|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            3578999999999999999999999999999765432   2234567899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ||.|+++..+...+..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            99998888888777889999999999999999999999999999999999999999999999999999877666666678


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYV  251 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (415)
                      +||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|.+.++.+....|++.............
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            89999999999987677899999999999999999999999999999999999999999999999888777766666666


Q ss_pred             cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 014985          252 AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTEPNKLPRP  309 (415)
Q Consensus       252 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~~~~~~~~  309 (415)
                      ...++...++.+++++++||.+||+.||++|||++|+|+||||++.+.|..+...|+|
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p  298 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP  298 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence            6666777888999999999999999999999999999999999988877776666655

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-62  Score=463.36  Aligned_cols=289  Identities=48%  Similarity=0.864  Sum_probs=250.9

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      |+|++++.||+|+||+||+|.+..+|+.||||++......+.....+.+|+++|++++|||||+++++|.+.+++|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            79999999999999999999999999999999997765555555678899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcccc
Q 014985           92 FMETDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTH  170 (415)
Q Consensus        92 ~~~g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~  170 (415)
                      ||.|+++..+... ...+++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||+|+...........
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence            9998877776544 556999999999999999999999999999999999999999999999999999988776767777


Q ss_pred             cccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh-cc
Q 014985          171 QVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQ  249 (415)
Q Consensus       171 ~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~  249 (415)
                      .+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++.++....+.+....|+.....++... +.
T Consensus       162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T d1gz8a_         162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP  241 (298)
T ss_dssp             CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred             ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence            89999999999988767778999999999999999999999999999999999999999888777776655544322 22


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLP  300 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~  300 (415)
                      ...........+.+|.++++||.+||+.||++|||++|+|+||||++...|
T Consensus       242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            223334455677889999999999999999999999999999999876544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-63  Score=461.57  Aligned_cols=256  Identities=28%  Similarity=0.486  Sum_probs=225.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|++..+|+.||||++......  ....+.+|+.+|++++|||||+++++|.+++++|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            46899999999999999999999999999999999764332  2345789999999999999999999999999999999


Q ss_pred             ecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||+| +|..++.+.  .+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+........
T Consensus        97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            99995 777666543  499999999999999999999999999999999999999999999999999998866666667


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+...... .                 
T Consensus       175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~-----------------  235 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-E-----------------  235 (293)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-C-----------------
T ss_pred             ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-C-----------------
Confidence            7889999999999987 66899999999999999999999999998888887776654111 0                 


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                             ....+.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       236 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 -------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                   0112346899999999999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-63  Score=460.91  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=217.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++......+ ....+.+|+.+|++++|||||+++++|.+++.+|+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            3678999999999999999999999999999999998654332 234678999999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--C
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--R  166 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--~  166 (415)
                      ||||+ |+|.+++.+ +..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......  .
T Consensus        82 mEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          82 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            99998 488877754 4569999999999999999999999999999999999999999999999999998764332  3


Q ss_pred             cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          167 RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       167 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....+||+.|||||++.+...++.++|||||||++|||++|++||...++............                 
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-----------------  223 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-----------------  223 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-----------------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Confidence            345678999999999998755567889999999999999999999987665444333322111                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                              .....++.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       224 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         224 --------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             --------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             --------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                    001112356899999999999999999999999999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-63  Score=454.86  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=222.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            4789999999999999999999999999999999976543 233344577899999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||||+ |+|..++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....  ...
T Consensus        85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--CCC
T ss_pred             EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--Ccc
Confidence            99999 58888877644 599999999999999999999999999999999999999999999999999987543  334


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+...-.                   
T Consensus       162 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------------------  221 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------------------  221 (263)
T ss_dssp             EETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------------
T ss_pred             cccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence            56789999999999987 5689999999999999999999999999888877777654210                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                               .+...+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       222 ---------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 ---------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ---------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                     111245899999999999999999999999999999964

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=460.56  Aligned_cols=259  Identities=27%  Similarity=0.385  Sum_probs=225.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .|.|++++.||+|+||+||+|++..+|+.||+|++.....  .....+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            4689999999999999999999999999999999976432  22346779999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      |||. |+|..++.+....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..........
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            9998 578888777777799999999999999999999999999999999999999999999999999987644444455


Q ss_pred             ccccccceeCcccccC----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          170 HQVFARWYRAPELLFG----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ..+||+.|+|||++.+    ...|+.++|||||||++|||++|.+||.+.+..+.+.++......               
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~---------------  233 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP---------------  233 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC---------------
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence            6789999999999842    356899999999999999999999999998888888777653110               


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                .....+.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       234 ----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ----------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ----------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ----------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                      01112345899999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=459.59  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=224.5

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+++|++++|||||+++++|.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            35789999999999999999999999999999999976542 23334467899999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--  165 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--  165 (415)
                      |||||+ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....  
T Consensus        86 vmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            999999 57888777654 59999999999999999999999999999999999999999999999999999875332  


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.+|...-.                
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----------------  227 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY----------------  227 (288)
T ss_dssp             -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----------------
T ss_pred             cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence            33456789999999999987 5689999999999999999999999999988888877754210                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCCCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ------ALEHRYFSSAPLPTE  302 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------~l~h~~~~~~~~~~~  302 (415)
                                  .+...+|+++++||.+||+.||++|||++|      +++||||++..|...
T Consensus       228 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         228 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             ------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence                        111246899999999999999999999987      688999998876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-61  Score=454.40  Aligned_cols=284  Identities=47%  Similarity=0.863  Sum_probs=249.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      |+|++++.||+|+||+||+|+++ +|+.||||++......+.....+.+|+.+|++++|||||+++++|.+.+..|++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            79999999999999999999985 78999999998776666666678899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      |+.|+++..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|.............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            99999999888888889999999999999999999999999999999999999999999999999999877666666667


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh-ccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE-YQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~  250 (415)
                      ++++.|+|||.+.+...++.++|||||||++|||++|++||.+.++.+++.++....+.+....|++......... ...
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV  240 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence            8899999999998877889999999999999999999999999999999999999999998888887766554332 222


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                      ....+.....+.+++++.|||.+||+.||++|||++|+|+||||+.
T Consensus       241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            2334455667789999999999999999999999999999999963

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.1e-62  Score=467.31  Aligned_cols=267  Identities=28%  Similarity=0.462  Sum_probs=232.4

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ..+.++|++.+.||+|+||+||+|++..+|+.||||++......  ....+.+|+.+|++++|||||+++++|.+++++|
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45678999999999999999999999999999999999754322  2345778999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec--CCcEEEeeeccceecCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS--HGQLKLADFGLARIFGSP  164 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~--~~~vkL~DFG~a~~~~~~  164 (415)
                      +|||||+ |+|.+.+.+....+++..++.|+.||+.||+|||++||+||||||+|||++.  +|.+||+|||+|+.....
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999998 5888988777777999999999999999999999999999999999999964  578999999999877543


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                       ......+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+........            
T Consensus       180 -~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------  245 (350)
T d1koaa2         180 -QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------------  245 (350)
T ss_dssp             -SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC------------
T ss_pred             -cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence             34456789999999999987 5689999999999999999999999999998888888876422111            


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPLPTE  302 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~~~~  302 (415)
                                  ...++.+|+++++||.+||+.||++|||++|+|+||||+....+..
T Consensus       246 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  291 (350)
T d1koaa2         246 ------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  291 (350)
T ss_dssp             ------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSC
T ss_pred             ------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCc
Confidence                        1233456899999999999999999999999999999987665443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-62  Score=454.19  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=210.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--CCeEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--KGNLHL   88 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l   88 (415)
                      .|+|++.+.||+|+||+||+|+++.+|+.||+|++......+.....+.+|+++|++++|||||++++++.+  .+.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            578999999999999999999999999999999998766544444567899999999999999999999854  457899


Q ss_pred             Eeeccc-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC-----ccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           89 VFEFME-TDLETVIRN---TNIFLSPADIKSYMQMTLKGLAFCHKKW-----VLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~---~~~~l~~~~~~~i~~qil~aL~~lH~~~-----ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                      |||||+ |+|.+++.+   .+..+++..++.++.||+.||+|||++|     |+||||||+||||+.+|.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999998 588888764   3567999999999999999999999976     9999999999999999999999999999


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      ............+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+...-.          
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~----------  231 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----------  231 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----------
T ss_pred             ecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            87665555667889999999999976 5689999999999999999999999999888887777755311          


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                       ..+...+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus       232 -----------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 -----------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                             11223468999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-62  Score=459.05  Aligned_cols=263  Identities=29%  Similarity=0.434  Sum_probs=211.3

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .+.+.++|++.+.||+|+||+||+|+++.+|+.||||++........ ...+.+|+.+|++++|||||+++++|.+++.+
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34678999999999999999999999999999999999986543322 23566899999999999999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe---cCCcEEEeeeccceecC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG---SHGQLKLADFGLARIFG  162 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~---~~~~vkL~DFG~a~~~~  162 (415)
                      |+|||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+.   .+|.+||+|||+|+...
T Consensus        83 ~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999998 5888888764 4599999999999999999999999999999999999995   47899999999998764


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                      .. ......+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+........          
T Consensus       162 ~~-~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------  229 (307)
T d1a06a_         162 PG-SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----------  229 (307)
T ss_dssp             ------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC----------
T ss_pred             CC-CeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC----------
Confidence            33 33456789999999999977 5689999999999999999999999999888888777765321111          


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                    ....+.+|+++++||.+||+.||++|||++|+++||||++.
T Consensus       230 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 --------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             --------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             --------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                          12334679999999999999999999999999999999753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-62  Score=463.97  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=227.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|++...+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            5789999999999999999999999999999999986542 223344577999999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||||+ |+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.........
T Consensus        84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            99999 5777776654 458999999999999999999999999999999999999999999999999999876656666


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+...-.                   
T Consensus       163 ~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~-------------------  222 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------------  222 (337)
T ss_dssp             CCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-------------------
Confidence            77899999999999987 5689999999999999999999999999988877777655310                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                               .+...+|+++++||.+||+.||.+|+     +++|+++||||.+..|
T Consensus       223 ---------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         223 ---------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ---------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                     11234689999999999999999999     4999999999987654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-61  Score=463.14  Aligned_cols=261  Identities=28%  Similarity=0.463  Sum_probs=229.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHL   88 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.++|++++.||+|+||+||+|++..+|+.||||++......  ....+.+|+.+|++++|||||+++++|.+++.+|+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i  103 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL  103 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4678999999999999999999999999999999999765422  23356789999999999999999999999999999


Q ss_pred             Eeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe--cCCcEEEeeeccceecCCCC
Q 014985           89 VFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIG--SHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        89 v~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~--~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |||||+ |+|.+.+.+.+..+++..++.++.||+.||+|||++||+||||||+||||+  .+|++||+|||+|+.... .
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-~  182 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-D  182 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-T
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-C
Confidence            999999 578888877777799999999999999999999999999999999999998  578999999999998754 3


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..+........             
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------  248 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------------  248 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred             CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence            34556788999999999977 5689999999999999999999999999999988888876432211             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                                 ...++.+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus       249 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 -----------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                       12345679999999999999999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-61  Score=450.51  Aligned_cols=264  Identities=26%  Similarity=0.433  Sum_probs=227.2

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcCCCCeeeEEeeeecC
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELKSPHIIELIDAFPHK   83 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   83 (415)
                      +.+.++|++.+.||+|+||+||+|+++.+|+.||||++.+......    ....+.+|+.+|++++|||||+++++|.+.
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3477899999999999999999999999999999999986553322    234577999999999999999999999999


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC----cEEEeeeccc
Q 014985           84 GNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG----QLKLADFGLA  158 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~----~vkL~DFG~a  158 (415)
                      +++|+|||||+ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|    .+||+|||+|
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999 58888877654 599999999999999999999999999999999999998876    4999999999


Q ss_pred             eecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          159 RIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       159 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      +..... .......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..+...-..        
T Consensus       165 ~~~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------  234 (293)
T d1jksa_         165 HKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE--------  234 (293)
T ss_dssp             EECTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred             hhcCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence            887543 34456788999999999976 56899999999999999999999999999888888777543111        


Q ss_pred             CCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                      .....++.+|.++++||.+||+.||++|||++|+++||||+...
T Consensus       235 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         235 ----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             ----------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             ----------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                            11233456799999999999999999999999999999998644

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-61  Score=453.31  Aligned_cols=256  Identities=26%  Similarity=0.421  Sum_probs=221.7

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .+.|++++.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|++++|||||+++++|.+++.+|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            346999999999999999999999999999999998654332 2234577899999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||||.|+++..+...+..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....    ..
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~  169 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN  169 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CC
Confidence            99999877776666667799999999999999999999999999999999999999999999999999986533    34


Q ss_pred             ccccccceeCcccccC--CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchh
Q 014985          170 HQVFARWYRAPELLFG--AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVE  247 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  247 (415)
                      ..+||+.|||||++.+  ...|+.++|||||||++|||++|.+||.+.+..+.+..+.......                
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------  233 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------  233 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------------
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence            5689999999999864  2458999999999999999999999999988888777766531110                


Q ss_pred             cccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          248 YQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       248 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                .....+|+++++||.+||+.||++|||++|+|+||||..
T Consensus       234 ----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         234 ----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ----------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ----------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                      011245899999999999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-60  Score=447.50  Aligned_cols=287  Identities=40%  Similarity=0.718  Sum_probs=244.3

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCC-CcEEEEEEeecCCccCCccchHHHHHHHHHhc---CCCCeeeEEeeee----
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKT-GQTVAIKKIRLGKQKEGVNFTALREIKLLKEL---KSPHIIELIDAFP----   81 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~----   81 (415)
                      ..++|++++.||+|+||+||+|++..+ ++.||||++......+.....+.+|+.+|+.|   +||||++++++|.    
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            358999999999999999999999776 56799999987665555555677888888776   7999999999984    


Q ss_pred             -cCCeEEEEeecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccce
Q 014985           82 -HKGNLHLVFEFMETDLETVIR-NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLAR  159 (415)
Q Consensus        82 -~~~~~~lv~e~~~g~L~~~i~-~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~  159 (415)
                       ...++|++||||+|+++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence             345789999999987665544 445669999999999999999999999999999999999999999999999999987


Q ss_pred             ecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCC
Q 014985          160 IFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDL  239 (415)
Q Consensus       160 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (415)
                      .... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.++.+++.+++...+.+....|+..
T Consensus       165 ~~~~-~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSF-QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCG-GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhcc-cccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            6432 334567789999999999977 66999999999999999999999999999999999999999999888888766


Q ss_pred             CCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          240 AYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...+.... ......+.....+.+++++++||.+||+.||++|||++|+|+||||++...
T Consensus       243 ~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         243 VALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccchhhhh-ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            55544332 222334455667789999999999999999999999999999999987543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-62  Score=462.02  Aligned_cols=282  Identities=26%  Similarity=0.411  Sum_probs=214.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      ..|+|++++.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.+|++++|||||+++++|.+.+++|+|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3689999999999999999999999999999999997653 233345678999999999999999999999999999999


Q ss_pred             eecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      ||||.| +|..++.+.+ .+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+....  ..
T Consensus        83 mEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~  159 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SM  159 (322)
T ss_dssp             EECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--HT
T ss_pred             EEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--Cc
Confidence            999995 7888777654 59999999999999999999997 5999999999999999999999999999987532  22


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHH-HHHHHHHhCCCCCCC----CCCCC--
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQ-LGKIFAAFGTATPSQ----WPDLA--  240 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~----~~~~~--  240 (415)
                      ....+||++|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+. ...+....+......    ++...  
T Consensus       160 ~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            345789999999999988 5699999999999999999999999987654332 222222211111000    00000  


Q ss_pred             -----CCccc--h-hcccc-cCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          241 -----YLPDY--V-EYQYV-AAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       241 -----~~~~~--~-~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                           ..+..  . ..... ...+.......+|.++++||.+||+.||++|||++|+|+||||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                 00000  0 00000 000000111235899999999999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-60  Score=451.64  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=224.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            4689999999999999999999999999999999976442 223344577899999999999999999999999999999


Q ss_pred             eecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccc
Q 014985           90 FEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFT  169 (415)
Q Consensus        90 ~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~  169 (415)
                      ||||.|+.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....   ..
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~  159 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TY  159 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---cc
Confidence            999996544444445566899999999999999999999999999999999999999999999999999986443   34


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhcc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQ  249 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  249 (415)
                      ..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+.++...-.                    
T Consensus       160 ~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------------------  218 (316)
T d1fota_         160 TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------------------  218 (316)
T ss_dssp             CCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC--------------------
T ss_pred             cccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC--------------------
Confidence            5789999999999976 5689999999999999999999999999988888888765311                    


Q ss_pred             cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          250 YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       250 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                              .+.+.++++++++|.+||..||.+|+     |++++++||||++..|.
T Consensus       219 --------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         219 --------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             --------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                    11234689999999999999999996     89999999999987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-60  Score=440.22  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=212.4

Q ss_pred             ccccE-eeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec----CC
Q 014985           10 VADRY-LKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH----KG   84 (415)
Q Consensus        10 ~~~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~   84 (415)
                      ...+| ++.+.||+|+||+||+|.+..++..||+|++............+.+|+++|++++|||||+++++|.+    ..
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            34556 67789999999999999999999999999998665444444567899999999999999999999864    45


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccCCCCCcEEEe-cCCcEEEeeecccee
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKW--VLHRDMKPNNLLIG-SHGQLKLADFGLARI  160 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~--ivHrDlkp~NILi~-~~~~vkL~DFG~a~~  160 (415)
                      .+|+|||||+ |+|.+++.+. ..+++..++.++.||+.||+|||++|  |+||||||+||||+ .++.+||+|||+|+.
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            6899999998 5787877664 45999999999999999999999999  99999999999996 578999999999986


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...  ......+||+.|+|||++.+  .|+.++|||||||++|||++|++||.+..+...+.+....  ...+       
T Consensus       165 ~~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~~-------  231 (270)
T d1t4ha_         165 KRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVKP-------  231 (270)
T ss_dssp             CCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCCC-------
T ss_pred             ccC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCCC-------
Confidence            432  23446789999999999865  5899999999999999999999999877665554333211  0000       


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFS  295 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~  295 (415)
                                      .......++++++||.+||+.||++|||++|+|+||||+
T Consensus       232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                            112234588999999999999999999999999999995

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-59  Score=437.39  Aligned_cols=286  Identities=47%  Similarity=0.825  Sum_probs=252.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++++.||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++||||++++++|.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            68999999999999999999999999999999998776555556678899999999999999999999999999999999


Q ss_pred             cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCccccc
Q 014985           92 FMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRFTHQ  171 (415)
Q Consensus        92 ~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~~~~  171 (415)
                      ++.|+++..+......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+............
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~  161 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE  161 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence            99987777777777789999999999999999999999999999999999999999999999999999887766666677


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      .+++.|+|||++.+...++.++|||||||++|||++|. |+|.+.+..+.+..+....+......|+......+......
T Consensus       162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (292)
T d1unla_         162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM  241 (292)
T ss_dssp             CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred             ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence            78899999999987667899999999999999999987 55778888889999999999988888887766555443332


Q ss_pred             cc-CCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          251 VA-APPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       251 ~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      .. ........+.+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence            22 223445567889999999999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-59  Score=435.11  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=225.9

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCc-------cchHHHHHHHHHhcC-CCCeeeEEeeee
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGV-------NFTALREIKLLKELK-SPHIIELIDAFP   81 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~-------~~~~~~E~~il~~l~-hp~Iv~l~~~~~   81 (415)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++.+.......       ...+.+|+.++++++ ||||++++++|.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            358999999999999999999999999999999999876543221       224678999999997 999999999999


Q ss_pred             cCCeEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           82 HKGNLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        82 ~~~~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      +++++|||||||+ |+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            9999999999998 58999887654 599999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCCCcccccccccceeCcccccC-----CcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFG-----AKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQ  235 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  235 (415)
                      .... ......+||+.|+|||++.+     ...++.++||||+||+||+|++|++||.+.+..+....+...-....   
T Consensus       160 ~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~---  235 (277)
T d1phka_         160 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG---  235 (277)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             ccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            7543 34456789999999999853     34578999999999999999999999999998888877766421111   


Q ss_pred             CCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          236 WPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                           ....+.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       236 ---------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         236 ---------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             ---------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ---------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                                 1123356999999999999999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=444.19  Aligned_cols=289  Identities=42%  Similarity=0.750  Sum_probs=237.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec--------
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH--------   82 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--------   82 (415)
                      .++|++++.||+|+||+||+|++..+|+.||||++......+.....+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            699999999999999999999999999999999998776666666678899999999999999999998754        


Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      .+++|+|||||+++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            45689999999998888888777889999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCC
Q 014985          163 SPD----RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPD  238 (415)
Q Consensus       163 ~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (415)
                      ...    ......+||++|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+....+...+..+..
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  248 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  248 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence            322    2334467999999999998877899999999999999999999999999999999999999999888776665


Q ss_pred             CCCCccchhcccccCC--CccccC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          239 LAYLPDYVEYQYVAAP--PLRSLF--PSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       239 ~~~~~~~~~~~~~~~~--~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ................  .....+  ...+++++|||.+||+.||++|||++|+|+||||+..+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence            5433322222111111  011111  124788999999999999999999999999999986544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-59  Score=449.25  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=225.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            5899999999999999999999999999999999975432 223334578999999999999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      |||+. |+|...+.+.+ .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....   .
T Consensus       120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---c
Confidence            99999 57777776554 5999999999999999999999999999999999999999999999999999986433   3


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+....+.++.....                   
T Consensus       196 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------------------  255 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------------------  255 (350)
T ss_dssp             CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------------
T ss_pred             ccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------------
Confidence            45789999999999987 6689999999999999999999999999988888888765411                   


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPLP  300 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~~  300 (415)
                               ...+.+|+++.+||.+||+.||.+|+     |++++++||||.+..|.
T Consensus       256 ---------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         256 ---------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             ---------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence                     11234689999999999999999995     99999999999987653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-60  Score=450.26  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=227.9

Q ss_pred             ccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985            8 KKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         8 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +++.|+|++.+.||+|+||+||+|.++.+|+.||||++......   ...+.+|+++|+.++|||||+++++|++++++|
T Consensus         1 ~~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELV   77 (321)
T ss_dssp             CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred             CCCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            35789999999999999999999999999999999999764322   235678999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC--CcEEEeeeccceecCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH--GQLKLADFGLARIFGSP  164 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~--~~vkL~DFG~a~~~~~~  164 (415)
                      +|||||+ |+|.+++...+..+++..++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.... 
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-  156 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-  156 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence            9999999 58999888777679999999999999999999999999999999999999854  4799999999987644 


Q ss_pred             CCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          165 DRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       165 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      .......++|+.|+|||.+.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.......             
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------------  222 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-------------  222 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-------------
T ss_pred             CCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence            333456778999999999876 568999999999999999999999999999988888887642111             


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                 ....++.+|+++++||.+||+.||.+|||++|+++||||+.
T Consensus       223 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         223 -----------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -----------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                       12334567999999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-60  Score=448.84  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=224.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCc-cCCccchHHHHHHHHH-hcCCCCeeeEEeeeecCCeEEEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQ-KEGVNFTALREIKLLK-ELKSPHIIELIDAFPHKGNLHLV   89 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~-~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~lv   89 (415)
                      |+|++.+.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++. .++|||||+++++|.+++++|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            789999999999999999999999999999999976432 2223334566777665 68999999999999999999999


Q ss_pred             eeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCcc
Q 014985           90 FEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRRF  168 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~~  168 (415)
                      ||||+ |+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.........
T Consensus        82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999 5788877654 458999999999999999999999999999999999999999999999999999876666666


Q ss_pred             cccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          169 THQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       169 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+....  .                 
T Consensus       161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~-----------------  220 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P-----------------  220 (320)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-----------------
T ss_pred             cccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C-----------------
Confidence            77889999999999987 568999999999999999999999999998888887775421  0                 


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCCCCCCCCC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQ-QALEHRYFSSAPL  299 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~-e~l~h~~~~~~~~  299 (415)
                               .+...+|+++++||.+||+.||.+|||+. ++++||||++..+
T Consensus       221 ---------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 ---------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ---------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                     11124689999999999999999999995 8999999987654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-59  Score=449.90  Aligned_cols=284  Identities=36%  Similarity=0.586  Sum_probs=233.8

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC-----
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG-----   84 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----   84 (415)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++......+.....+.+|+.+|+.++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            789999999999999999999999999999999999765444444456789999999999999999999997654     


Q ss_pred             -eEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 -NLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 -~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                       ++|+|||||+++|...+...  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecccccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             57999999987887777643  499999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                         ..+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+..+...+.......
T Consensus       174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence               34567899999999999876778999999999999999999999999999999999998887776543322211110


Q ss_pred             cc---hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          244 DY---VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       244 ~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ..   ..........+....+.+++++++||.+||..||++|||++|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            00   01112233445566778899999999999999999999999999999998654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-59  Score=450.95  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=217.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHH---HHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTAL---REIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~---~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+..... .....+.   +|+.+++.++|||||+++++|.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            478999999999999999999999999999999997543221 1122233   357777788899999999999999999


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      |+|||||. |+|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            99999999 5788887765 45899999999999999999999999999999999999999999999999999976543 


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                       .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.... ........             
T Consensus       161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~~~-------------  225 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMA-------------  225 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSSCC-------------
T ss_pred             -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccCC-------------
Confidence             345678999999999997656799999999999999999999999987654433322 22111111             


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCCCCCCCC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARIT-----AQQALEHRYFSSAPLP  300 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----~~e~l~h~~~~~~~~~  300 (415)
                                 ......+|+++++||.+||+.||++|||     ++|+++||||++..|.
T Consensus       226 -----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         226 -----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence                       1122356999999999999999999999     7999999999987653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=444.77  Aligned_cols=281  Identities=34%  Similarity=0.578  Sum_probs=229.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec------CC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------KG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~   84 (415)
                      .-+|..+++||+|+||+||+|++..+|+.||||++......      ..+|+.+|++++||||++++++|..      ..
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            34799999999999999999999999999999999754321      2379999999999999999999843      34


Q ss_pred             eEEEEeecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeecccee
Q 014985           85 NLHLVFEFMETDLETVIR---NTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARI  160 (415)
Q Consensus        85 ~~~lv~e~~~g~L~~~i~---~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~  160 (415)
                      ++|+|||||++++...+.   .....+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            689999999987766654   3456799999999999999999999999999999999999999775 899999999987


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      .... ......+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++..++..+|......|....
T Consensus       173 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         173 LVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            6443 334557889999999999877789999999999999999999999999999999999999988876543332211


Q ss_pred             CCccchhcccccCCC-ccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPP-LRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      .......+......+ .....+.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            110000111111111 2233456899999999999999999999999999999998643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-59  Score=433.71  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=212.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC----ccchHHHHHHHHHhcC--CCCeeeEEeeeecC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG----VNFTALREIKLLKELK--SPHIIELIDAFPHK   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~----~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~   83 (415)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++........    ....+.+|+.+|++++  |||||+++++|.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            56899999999999999999999999999999999986543221    1223568999999997  89999999999999


Q ss_pred             CeEEEEeecccC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-CcEEEeeecccee
Q 014985           84 GNLHLVFEFMET--DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH-GQLKLADFGLARI  160 (415)
Q Consensus        84 ~~~~lv~e~~~g--~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~-~~vkL~DFG~a~~  160 (415)
                      +.+|+||||+.|  ++..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            999999999974  666666654 459999999999999999999999999999999999999954 7999999999987


Q ss_pred             cCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          161 FGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       161 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ...  ...+..+||+.|+|||++.+...++.++|||||||++|||++|.+||.+.+      .+....            
T Consensus       161 ~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~------------  220 (273)
T d1xwsa_         161 LKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ------------  220 (273)
T ss_dssp             CCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC------------
T ss_pred             ccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc------------
Confidence            543  344567899999999999775656788999999999999999999997642      122210            


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                                      ..+.+.+|+++++||.+||+.||++|||++|+++||||++..
T Consensus       221 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         221 ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ----------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                            012235689999999999999999999999999999998654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-58  Score=437.63  Aligned_cols=260  Identities=25%  Similarity=0.430  Sum_probs=211.0

Q ss_pred             ccccccEeeee-eecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHh-cCCCCeeeEEeeeec---
Q 014985            8 KKVADRYLKRE-VLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKE-LKSPHIIELIDAFPH---   82 (415)
Q Consensus         8 ~~~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~---   82 (415)
                      ..+.++|.+.+ .||+|+||+||+|++..+|+.||||++...       ..+.+|+.++.+ ++|||||+++++|++   
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            34678998875 699999999999999999999999998632       246789998765 489999999999875   


Q ss_pred             -CCeEEEEeeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeec
Q 014985           83 -KGNLHLVFEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFG  156 (415)
Q Consensus        83 -~~~~~lv~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG  156 (415)
                       +.++|+|||||+ |+|.+++.+.+ ..+++..++.|+.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             467999999998 58999998653 46999999999999999999999999999999999999985   4679999999


Q ss_pred             cceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCC
Q 014985          157 LARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQW  236 (415)
Q Consensus       157 ~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  236 (415)
                      +|+..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...+..... .+
T Consensus       160 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~  236 (335)
T d2ozaa1         160 FAKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EF  236 (335)
T ss_dssp             TCEECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SC
T ss_pred             eeeeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CC
Confidence            99876543 34456789999999999976 56999999999999999999999999887765555444332111100 00


Q ss_pred             CCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCC
Q 014985          237 PDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSS  296 (415)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~  296 (415)
                                       +  ....+.+|+++++||.+||+.||++|||+.|+++||||..
T Consensus       237 -----------------~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         237 -----------------P--NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -----------------C--TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -----------------C--CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence                             0  0112346899999999999999999999999999999964

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=436.54  Aligned_cols=286  Identities=37%  Similarity=0.631  Sum_probs=230.8

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHK-----   83 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----   83 (415)
                      .+.++|++++.||+|+||+||+|.+..+|+.||||++..... ......+++|+.+|++++||||+++++++...     
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            456899999999999999999999999999999999975432 22233577899999999999999999998654     


Q ss_pred             CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .++|+++++++|+|.+++...  .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            357788777778999998754  499999999999999999999999999999999999999999999999999987543


Q ss_pred             CC---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          164 PD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       164 ~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                      ..   ......+||+.|+|||++.....|+.++||||+||++|+|++|.+||.+.+..++...+...+..+.........
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            32   234567799999999999776778999999999999999999999999999888888887776654332111111


Q ss_pred             CCcc---chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCC
Q 014985          241 YLPD---YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSA  297 (415)
Q Consensus       241 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~  297 (415)
                      ....   ..........++...++.+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            1000   00111222334556778899999999999999999999999999999999854

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-57  Score=417.61  Aligned_cols=255  Identities=20%  Similarity=0.278  Sum_probs=211.2

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|+.   +..||||+++...........+.+|+.+|++++|||||++++++. ++.+|+||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence            57899999999999999999964   346999999876555555556789999999999999999999874 45789999


Q ss_pred             eccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC--Cc
Q 014985           91 EFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD--RR  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~--~~  167 (415)
                      |||+ |+|.+++...+..+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+......  ..
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            9999 68999998877789999999999999999999999999999999999999999999999999998764322  33


Q ss_pred             ccccccccceeCcccccCC--cCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccc
Q 014985          168 FTHQVFARWYRAPELLFGA--KQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDY  245 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  245 (415)
                      .....||+.|||||++.+.  ..|+.++|||||||++|||++|+.||.+.+....+..+...-.                
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------------  226 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY----------------  226 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----------------
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----------------
Confidence            4566889999999998642  3589999999999999999999999998887766655544311                


Q ss_pred             hhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          246 VEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                            ..+......+.+++++.+||.+||+.||++|||++|++++
T Consensus       227 ------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         227 ------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                  1122234445678999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-57  Score=434.29  Aligned_cols=285  Identities=36%  Similarity=0.580  Sum_probs=229.6

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeec------
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPH------   82 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------   82 (415)
                      .+.++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+|++++|||||+++++|..      
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            34689999999999999999999999999999999998655444444467799999999999999999999853      


Q ss_pred             CCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecC
Q 014985           83 KGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFG  162 (415)
Q Consensus        83 ~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~  162 (415)
                      ...+++++++++|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++... 
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~-  171 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-  171 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC-
T ss_pred             CceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc-
Confidence            234566666656788888754  35999999999999999999999999999999999999999999999999999764 


Q ss_pred             CCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          163 SPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       163 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                        ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+......+......
T Consensus       172 --~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         172 --DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             --TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             --CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence              334456788999999999888677899999999999999999999999999999999999988776544322211111


Q ss_pred             ccch---hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          243 PDYV---EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       243 ~~~~---~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ....   .........+...++.+++++++||.+||+.||.+|||++|+|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            0000   0111122334455678899999999999999999999999999999998643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.2e-57  Score=419.91  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=210.9

Q ss_pred             cccccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccC-CccchHHHHHHHHHhcCCCCeeeEEeeeecCC-
Q 014985            7 SKKVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKE-GVNFTALREIKLLKELKSPHIIELIDAFPHKG-   84 (415)
Q Consensus         7 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~-~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-   84 (415)
                      +..+.++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++++...+ 
T Consensus         2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            4678899999999999999999999999999999999998654432 23345778999999999999999999987654 


Q ss_pred             ---eEEEEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985           85 ---NLHLVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus        85 ---~~~lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                         .+|+|||||+| +|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+..
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             CCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence               48999999995 677666554 4599999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC---CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          161 FGSPD---RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       161 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      .....   ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.++...-..       
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-------  232 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-------  232 (277)
T ss_dssp             CC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-------
T ss_pred             hccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-------
Confidence            53332   24456689999999999976 56899999999999999999999999999888887776553111       


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYF  294 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~  294 (415)
                                       +.....+.+|+++.+||.+||+.||.+||+..+.+.|+|.
T Consensus       233 -----------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         233 -----------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             -----------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -----------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence                             1123345679999999999999999999954444445553

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=434.69  Aligned_cols=284  Identities=33%  Similarity=0.506  Sum_probs=222.0

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee------cC
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP------HK   83 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------~~   83 (415)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|.      ..
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            558999999999999999999999999999999999876544444446789999999999999999999995      34


Q ss_pred             CeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           84 GNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        84 ~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .++|+|||||.|+++..+..   .+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++....
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            68999999999998887743   489999999999999999999999999999999999999999999999999886643


Q ss_pred             CCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          164 PDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       164 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                       .......++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.++...+.++....+.+.+..|.......
T Consensus       172 -~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         172 -SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             -ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence             334456688999999999987 578999999999999999999999999999999999999888876555443321110


Q ss_pred             cchhcc--------------cccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCC
Q 014985          244 DYVEYQ--------------YVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAP  298 (415)
Q Consensus       244 ~~~~~~--------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~  298 (415)
                      ......              ....+.........|+++++||.+||..||++|||++|+|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            000000              0000000111112477899999999999999999999999999998643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.9e-56  Score=426.80  Aligned_cols=281  Identities=31%  Similarity=0.518  Sum_probs=217.7

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeec--CCeE
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPH--KGNL   86 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~~   86 (415)
                      ..++|+++++||+|+||+||+|++..+|+.||||++....     ...+.+|+.+|+.++ ||||++++++|..  ..++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            3689999999999999999999999999999999986432     235778999999996 9999999999974  4579


Q ss_pred             EEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-cEEEeeeccceecCCCC
Q 014985           87 HLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHG-QLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~-~vkL~DFG~a~~~~~~~  165 (415)
                      |+|||||.++.+..+   ...+++..++.+++||+.||+|||++||+||||||+||||+.++ .+||+|||+|+..... 
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-  183 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-  183 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence            999999996433322   23499999999999999999999999999999999999999755 6999999999876443 


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCC-CcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGS-SDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      ......++|+.|+|||++.+...|+.++|||||||++|+|++|..||... +..++...+...++.+....+........
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            34566788999999999988777899999999999999999999877655 45566666666555321111100000000


Q ss_pred             chhccc----ccCCCc-----cccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCCCCCCC
Q 014985          245 YVEYQY----VAAPPL-----RSLFPSASDDALDLLSKMFTYDPKARITAQQALEHRYFSSAPL  299 (415)
Q Consensus       245 ~~~~~~----~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h~~~~~~~~  299 (415)
                      ...+..    ......     ......+|++++|||.+||++||++|||++|+|+||||++..+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            000000    000001     1122346899999999999999999999999999999987654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-56  Score=409.12  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=203.3

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||+||+|.+. +++.||||++.....   ....+.+|++++++++|||||++++++...+.+|+|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            58999999999999999999875 567899999875332   23467899999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-ccc
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~~  169 (415)
                      ||. |+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+++....... ...
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            998 688888887777799999999999999999999999999999999999999999999999999987654432 233


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...||..|+|||++.+ ..|+.++|||||||++|||++ |.+||...+..+.+..+........                
T Consensus       161 ~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----------------  223 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------------  223 (263)
T ss_dssp             ----CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC----------------
T ss_pred             ceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC----------------
Confidence            4678899999999977 568999999999999999998 5788888777777777655422111                


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                 ....++++.+||.+||+.||++|||++|+++|
T Consensus       224 -----------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         224 -----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                       12347899999999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.9e-56  Score=416.72  Aligned_cols=252  Identities=19%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc---EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ---TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|++.++||+|+||+||+|++..+|+   .||||.+...... .....+.+|+.+|++++|||||++++++...+.+|
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            5789999999999999999999987765   5888887644322 22335789999999999999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||+ |+|..++......+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.......
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            9999999 578888887777799999999999999999999999999999999999999999999999999987643322


Q ss_pred             -----cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCC
Q 014985          167 -----RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLA  240 (415)
Q Consensus       167 -----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (415)
                           ......||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+......+         
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---------  253 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---------  253 (299)
T ss_dssp             ------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---------
T ss_pred             cceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence                 1223457889999999976 568999999999999999998 899999988887777765432111         


Q ss_pred             CCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          241 YLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                        ....++.++.+||.+||+.||++|||+.|++++
T Consensus       254 ------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                              122458899999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.2e-56  Score=415.15  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=208.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....   ....+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            5789999999999999999999999999999999865432   2346789999999999999999999999999999999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-c
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~  167 (415)
                      |||+ |+|..++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+....... .
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence            9999 6888888654 45689999999999999999999999999999999999999999999999999987644332 2


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....|+..|+|||++.+ ..|+.++|||||||++|||++|. +||.+.+..+....+.....                 
T Consensus       173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-----------------  234 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-----------------  234 (287)
T ss_dssp             ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-----------------
T ss_pred             eccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-----------------
Confidence            334457888999999876 56899999999999999999965 55555544443333322110                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                ......+++++.+||.+||+.||++|||++|+++
T Consensus       235 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         235 ----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                      0122346899999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=418.46  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=210.0

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCc-----EEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQ-----TVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|++.++||+|+||+||+|++..+++     .||+|.+..... ......+.+|+.+|+++ +|||||+++++|.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            3789999999999999999999876554     699998865432 23334678899999998 8999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 014985           85 NLHLVFEFME-TDLETVIRNTN----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~----------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~N  141 (415)
                      .+|+|||||+ |+|.+++.+..                      ..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            9999999998 68999987653                      248899999999999999999999999999999999


Q ss_pred             EEEecCCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcH
Q 014985          142 LLIGSHGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDI  218 (415)
Q Consensus       142 ILi~~~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  218 (415)
                      ||++.++++||+|||+|+.......  ......||+.|||||++.+ ..|+.++|||||||++|||++ |.+||.+.+..
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987644433  2345667999999999976 568999999999999999997 89999988776


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       219 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      +.+.++...-...                          .....+++++++||.+||+.||++|||++||++|
T Consensus       274 ~~~~~~~~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQNGFKM--------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCC--------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6666665431100                          1123458999999999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=410.74  Aligned_cols=255  Identities=22%  Similarity=0.357  Sum_probs=212.8

Q ss_pred             cccEeeeee-ecccCceEEEEEEECC--CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREV-LGEGTYGVVYKAIDTK--TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~-LG~G~~g~Vy~~~~~~--~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|.+.+. ||+|+||+||+|.+..  ++..||||++...... .....+.+|+.+|++++|||||++++++.. +.+|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            467888885 9999999999998754  3457999998754322 223457899999999999999999999965 4689


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||+ |+|.+++...+..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            9999999 588888877777799999999999999999999999999999999999999999999999999998755432


Q ss_pred             ---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 ---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                         ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+..+...            
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~------------  231 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------  231 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC------------
T ss_pred             ccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence               2234567889999999976 468999999999999999998 89999998888777766543111            


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCCCCC
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQA---LEHRYFS  295 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~---l~h~~~~  295 (415)
                                     ...+.+++++.+||.+||+.||++|||+.++   |+|+|++
T Consensus       232 ---------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         232 ---------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ---------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                           1223568999999999999999999999888   5678764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=403.73  Aligned_cols=248  Identities=20%  Similarity=0.300  Sum_probs=215.2

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEee
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFE   91 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   91 (415)
                      ++|++.+.||+|+||+||+|+++ +++.||||++......   ...+++|+.++++++||||+++++++.+++.+|+|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            57899999999999999999974 7789999999865432   3468899999999999999999999999999999999


Q ss_pred             ccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-ccc
Q 014985           92 FME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-RFT  169 (415)
Q Consensus        92 ~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~~~  169 (415)
                      |++ |++..++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            998 678888887777899999999999999999999999999999999999999999999999999987644332 334


Q ss_pred             ccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhc
Q 014985          170 HQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEY  248 (415)
Q Consensus       170 ~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  248 (415)
                      ...+|..|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....+........                
T Consensus       160 ~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------  222 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----------------  222 (258)
T ss_dssp             CSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC----------------
T ss_pred             ccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence            5678899999999976 568999999999999999998 8999999998888777754322111                


Q ss_pred             ccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          249 QYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       249 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                 ....++++.+||.+||+.||++|||++++++|
T Consensus       223 -----------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         223 -----------PHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                       12347899999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=409.86  Aligned_cols=253  Identities=21%  Similarity=0.367  Sum_probs=210.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|.++ ++..||||++.....   ....+.+|+.+|++++|||||++++++.+ +.+|+||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            579999999999999999999875 567899999875432   23467899999999999999999998754 5679999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC-c
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR-R  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~-~  167 (415)
                      |||+ |+|.+.+... +..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....... .
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999 5777766443 23589999999999999999999999999999999999999999999999999998754432 3


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||...+..+.+..+.......               
T Consensus       167 ~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---------------  230 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---------------  230 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------------
T ss_pred             ccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------------
Confidence            345678889999999976 568999999999999999998 567777777777666654321111               


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSS  296 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--h~~~~~  296 (415)
                                  ....+++++.+||.+||+.||++|||++++++  |+||++
T Consensus       231 ------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         231 ------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                        11245889999999999999999999999998  788864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=408.46  Aligned_cols=247  Identities=21%  Similarity=0.350  Sum_probs=200.5

Q ss_pred             eeecccCceEEEEEEEC--CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEeeccc-
Q 014985           18 EVLGEGTYGVVYKAIDT--KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVFEFME-   94 (415)
Q Consensus        18 ~~LG~G~~g~Vy~~~~~--~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~-   94 (415)
                      ++||+|+||+||+|.+.  .+++.||||++............+.+|+.+|++++|||||++++++.. +..|+|||||+ 
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999754  456789999997654444444568899999999999999999999965 46789999999 


Q ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc---cccc
Q 014985           95 TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR---FTHQ  171 (415)
Q Consensus        95 g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~---~~~~  171 (415)
                      |+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........   ....
T Consensus        92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            578777765 455999999999999999999999999999999999999999999999999999876544322   2345


Q ss_pred             ccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccchhccc
Q 014985          172 VFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYVEYQY  250 (415)
Q Consensus       172 ~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (415)
                      .||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+......                    
T Consensus       171 ~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--------------------  229 (277)
T d1xbba_         171 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------------------  229 (277)
T ss_dssp             CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------------
T ss_pred             CCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence            68889999999976 568999999999999999997 89999998877766665432110                    


Q ss_pred             ccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh---cCCCC
Q 014985          251 VAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQAL---EHRYF  294 (415)
Q Consensus       251 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l---~h~~~  294 (415)
                             .....+++++.+||.+||+.||++|||+++++   +|+|+
T Consensus       230 -------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         230 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                   11234589999999999999999999999984   56654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=417.29  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=218.3

Q ss_pred             cccEeeeeeecccCceEEEEEEEC---CCCcEEEEEEeecCCc--cCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT---KTGQTVAIKKIRLGKQ--KEGVNFTALREIKLLKELKS-PHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~~avK~i~~~~~--~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~   84 (415)
                      .++|++++.||+|+||+||+|++.   .+|+.||||++.....  .......+.+|+++|++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            588999999999999999999874   4689999999875432  22233456689999999987 89999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCC
Q 014985           85 NLHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGS  163 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~  163 (415)
                      .+|+||||+. |+|...+...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999 57888777654 478999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-CcccccccccceeCcccccCCc-CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          164 PD-RRFTHQVFARWYRAPELLFGAK-QYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       164 ~~-~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .. .......|++.|+|||.+.+.. .++.++|||||||+||+|++|..||.+.+..+....+........+        
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--------  253 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------  253 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--------
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--------
Confidence            33 3345677899999999997643 4788999999999999999999999888766555555443221111        


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCCCCCCC
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARI-----TAQQALEHRYFSSAPL  299 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~l~h~~~~~~~~  299 (415)
                                      .+...+|+++.+||.+||+.||.+||     |++|+++||||+...+
T Consensus       254 ----------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         254 ----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             ----------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence                            12234689999999999999999999     5899999999987654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=403.26  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=200.9

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC---cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|++.+.||+|+||+||+|++..++   ..||||.+..... ......+.+|+.+|++++|||||++++++. ++.+|
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            479999999999999999999987654   4688888754332 222345779999999999999999999995 56789


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-  165 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-  165 (415)
                      +|||||. |++..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            9999999 57888887777789999999999999999999999999999999999999999999999999998764433 


Q ss_pred             CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCcc
Q 014985          166 RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPD  244 (415)
Q Consensus       166 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  244 (415)
                      .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+.....               
T Consensus       164 ~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---------------  227 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---------------  227 (273)
T ss_dssp             -------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------
T ss_pred             eeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence            23345667899999999976 568999999999999999997 8999999888887777654311               


Q ss_pred             chhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          245 YVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                  ....+.+++++.+||.+||..||++|||+.|+++|
T Consensus       228 ------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 ------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        11234568999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=407.01  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCCc----EEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTGQ----TVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      ++|+++++||+|+||+||+|.+..+|+    .||+|++..... ......+.+|+.++++++|||||++++++.++. .+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ee
Confidence            569999999999999999999988876    578887754322 223446789999999999999999999998755 55


Q ss_pred             EEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +++||+. |+|.+.+......+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.......
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            6666666 789999988888899999999999999999999999999999999999999999999999999987654433


Q ss_pred             c--ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCc
Q 014985          167 R--FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLP  243 (415)
Q Consensus       167 ~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  243 (415)
                      .  .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+......             
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~-------------  232 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------------  232 (317)
T ss_dssp             --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-------------
T ss_pred             cccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence            2  234567899999999977 568999999999999999998 78999988777666665543211             


Q ss_pred             cchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          244 DYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                    ...+.+++++.+||.+||+.||.+|||+.|+++|
T Consensus       233 --------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         233 --------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             --------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                          1123458899999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=401.16  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEEEEe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLHLVF   90 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   90 (415)
                      .++|++.+.||+|+||+||+|++..+ ..||||++.....   ....+.+|+.++++++|||||++++++.+ +.+|+||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            57899999999999999999998655 5799999875433   23468899999999999999999999954 5678999


Q ss_pred             eccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC-Cc
Q 014985           91 EFME-TDLETVIRNT-NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD-RR  167 (415)
Q Consensus        91 e~~~-g~L~~~i~~~-~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~-~~  167 (415)
                      |||. |+|..++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+...... ..
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            9999 5677776543 3469999999999999999999999999999999999999999999999999998764333 23


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+|+.+.+..+.+..+......                
T Consensus       171 ~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~----------------  233 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------  233 (285)
T ss_dssp             -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------
T ss_pred             eccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence            344678999999999976 568999999999999999998 46777777777777766543211                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCCCCCC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE--HRYFSSA  297 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~--h~~~~~~  297 (415)
                                 ...+.+++++++||.+||+.||++|||++++++  ++||+..
T Consensus       234 -----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                       122345899999999999999999999999988  8899764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=398.84  Aligned_cols=250  Identities=20%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             ccEeeeeeecccCceEEEEEEECCCC----cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCeEE
Q 014985           12 DRYLKREVLGEGTYGVVYKAIDTKTG----QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        12 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   87 (415)
                      +.|.+.++||+|+||+||+|.+..++    ..||||++....... ....+.+|+.+|++++|||||++++++.+.+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            56999999999999999999876654    469999986543322 2335779999999999999999999999999999


Q ss_pred             EEeecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC
Q 014985           88 LVFEFMET-DLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR  166 (415)
Q Consensus        88 lv~e~~~g-~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~  166 (415)
                      +|||||.+ ++...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            99999995 67777777777899999999999999999999999999999999999999999999999999987643322


Q ss_pred             ---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCC
Q 014985          167 ---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYL  242 (415)
Q Consensus       167 ---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (415)
                         ......||..|+|||++.+ ..|+.++|||||||++|||++| .+|+.+.+..+.+..+......            
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~------------  232 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------------  232 (283)
T ss_dssp             --------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC------------
T ss_pred             cceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC------------
Confidence               2234567889999999977 5689999999999999999985 5777766666665555432111            


Q ss_pred             ccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          243 PDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     .....++..+.+||.+||+.||++|||+.|+++
T Consensus       233 ---------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 ---------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                           111235789999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=389.61  Aligned_cols=252  Identities=21%  Similarity=0.309  Sum_probs=200.1

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-CCc--EEEEEEeecCCccCC-ccchHHHHHHHHHhcCCCCeeeEEeeeecCCeE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-TGQ--TVAIKKIRLGKQKEG-VNFTALREIKLLKELKSPHIIELIDAFPHKGNL   86 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~~avK~i~~~~~~~~-~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   86 (415)
                      .++|++.+.||+|+||+||+|+... +++  .||||++........ ....+.+|+.+|++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999997643 333  689999876543332 23457899999999999999999999965 467


Q ss_pred             EEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCC
Q 014985           87 HLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPD  165 (415)
Q Consensus        87 ~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~  165 (415)
                      ++|||||+ |++.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            89999998 68888887777779999999999999999999999999999999999999999999999999999874443


Q ss_pred             C---cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCC
Q 014985          166 R---RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAY  241 (415)
Q Consensus       166 ~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (415)
                      .   ......++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+...-..           
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-----------  233 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-----------  233 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-----------
T ss_pred             CcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC-----------
Confidence            2   2233456788999999977 568999999999999999998 89999999888888776542100           


Q ss_pred             CccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          242 LPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                     ....+.++.++.+||.+||..||++|||+.||++
T Consensus       234 ---------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         234 ---------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           0122356899999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-52  Score=393.02  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=209.7

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|++.+.||+|+||+||+|+++     .+++.||||++..... ......+.+|+.+|++++||||+++++++...+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            578999999999999999999875     3567899999865432 2223457899999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 014985           86 LHLVFEFME-TDLETVIRNTN-----------------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNN  141 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~-----------------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~N  141 (415)
                      .++||||++ |+|.+++....                       ..+++..+..++.||+.||+|||++|||||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            999999998 68888886532                       238899999999999999999999999999999999


Q ss_pred             EEEecCCcEEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcH
Q 014985          142 LLIGSHGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDI  218 (415)
Q Consensus       142 ILi~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~  218 (415)
                      |||+.++.+||+|||+|+......  ...+...+++.|+|||++.+ ..|+.++|||||||++|||++|. +||.+.++.
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            999999999999999998653332  23345678889999999976 56899999999999999999985 889998888


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          219 DQLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       219 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      +.+..+.....                           ......+++++.+||.+||+.||++|||+.||++
T Consensus       250 e~~~~v~~~~~---------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVIYYVRDGNI---------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCC---------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            88777654311                           1122356889999999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=391.17  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=196.5

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec-C
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH-K   83 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~-~   83 (415)
                      .++|++.+.||+|+||+||+|.+..     +++.||||++....... ....+.+|+.++.++ .|+||+.+++++.. +
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            4789999999999999999998754     45689999986543322 233466788888777 57899999988755 4


Q ss_pred             CeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC
Q 014985           84 GNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSH  147 (415)
Q Consensus        84 ~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~  147 (415)
                      ..+++|||||+ |+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            57899999999 68888886532               348999999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHH
Q 014985          148 GQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKI  224 (415)
Q Consensus       148 ~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i  224 (415)
                      +++||+|||+|+.......  ......||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999987644332  3345678999999999977 5689999999999999999986 5788877655555444


Q ss_pred             HHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          225 FAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                      ...-..                          ......+++++.+||.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEGTR--------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHTCC--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCC--------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            332110                          01122458999999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-51  Score=386.98  Aligned_cols=262  Identities=18%  Similarity=0.217  Sum_probs=211.4

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC-eeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~   87 (415)
                      .++++|++.+.||+|+||+||+|++..+|+.||||++.....    ...+.+|+++++.++|++ |+.+.+++.+.+..+
T Consensus         4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            567899999999999999999999999999999999876432    235778999999998766 555566778888999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec---CCcEEEeeeccceecCCC
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS---HGQLKLADFGLARIFGSP  164 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~---~~~vkL~DFG~a~~~~~~  164 (415)
                      +||||++|++...+......+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.+...
T Consensus        80 ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99999999999998888888999999999999999999999999999999999999864   457999999999987543


Q ss_pred             C-------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcHHHHHHHHHHhCCCCCCCCC
Q 014985          165 D-------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDIDQLGKIFAAFGTATPSQWP  237 (415)
Q Consensus       165 ~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  237 (415)
                      .       ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+....+.....        
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~--------  230 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--------  230 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH--------
T ss_pred             ccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc--------
Confidence            2       22345679999999999987 5689999999999999999999999988765544433322100        


Q ss_pred             CCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHH---HhcCCCCC
Q 014985          238 DLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQ---ALEHRYFS  295 (415)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e---~l~h~~~~  295 (415)
                                  .....+.....+.+++++.+||.+||+.||++||++.+   +|+|+|.+
T Consensus       231 ------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         231 ------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                        00111223445567899999999999999999999874   56777654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=385.32  Aligned_cols=244  Identities=20%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee-cCCeEEEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLV   89 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv   89 (415)
                      .++|++.+.||+|+||.||+|.+  +|..||||+++...    ....+.+|++++++++||||+++++++. ..+.+|+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            46799999999999999999987  47899999986432    3346789999999999999999999884 45678999


Q ss_pred             eeccc-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCCc
Q 014985           90 FEFME-TDLETVIRNTN-IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDRR  167 (415)
Q Consensus        90 ~e~~~-g~L~~~i~~~~-~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~~  167 (415)
                      |||++ |+|.+++.+.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++.....   
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99998 68888886543 34899999999999999999999999999999999999999999999999999875332   


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+...                 
T Consensus       157 ~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-----------------  218 (262)
T d1byga_         157 QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------  218 (262)
T ss_dssp             -----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----------------
T ss_pred             CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence            334567888999999976 568999999999999999998 7899998877777666533211                 


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                ....+.+++++.+||.+||..||.+|||+.+++++
T Consensus       219 ----------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         219 ----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                      11223458999999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=388.92  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=204.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCC-------cEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeec
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTG-------QTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPH   82 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~   82 (415)
                      .++|++.+.||+|+||.||+|++..++       ..||||++....... ....+.+|+..+.++ +|||||+++++|.+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            589999999999999999999876554       379999987544322 234567899988888 79999999999999


Q ss_pred             CCeEEEEeeccc-CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec
Q 014985           83 KGNLHLVFEFME-TDLETVIRNTN---------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (415)
Q Consensus        83 ~~~~~lv~e~~~-g~L~~~i~~~~---------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~  146 (415)
                      ++.+|+|||||. |+|.+++....               ..+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            999999999999 68888886553               34899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccceecCCCC--CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHH
Q 014985          147 HGQLKLADFGLARIFGSPD--RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  223 (415)
                      ++.+||+|||+++......  .......+++.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~  249 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  249 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            9999999999998764433  23345678889999999976 579999999999999999997 7899988877666555


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      +......                           .....+++++.+||.+||+.||++|||+.|+++
T Consensus       250 i~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         250 LKEGHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHTTCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            4332110                           112345899999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=392.11  Aligned_cols=251  Identities=26%  Similarity=0.360  Sum_probs=206.3

Q ss_pred             cccEeeeeeecccCceEEEEEEECCCCcE--EEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCCeEE
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTKTGQT--VAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKGNLH   87 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   87 (415)
                      .++|++.++||+|+||+||+|.++.+|..  ||||.+...... .....+.+|+.+|+++ +|||||++++++.+++.+|
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            47999999999999999999999888875  667776543332 2344678999999999 7999999999999999999


Q ss_pred             EEeeccc-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEE
Q 014985           88 LVFEFME-TDLETVIRNT---------------NIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLK  151 (415)
Q Consensus        88 lv~e~~~-g~L~~~i~~~---------------~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vk  151 (415)
                      +|||||+ |+|.+++...               ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceE
Confidence            9999999 6888888643               35699999999999999999999999999999999999999999999


Q ss_pred             EeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCC
Q 014985          152 LADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGT  230 (415)
Q Consensus       152 L~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~  230 (415)
                      |+|||+|+...... ......||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+..... 
T Consensus       168 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~-  244 (309)
T d1fvra_         168 IADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-  244 (309)
T ss_dssp             ECCTTCEESSCEEC-CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-
T ss_pred             Eccccccccccccc-cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-
Confidence            99999998653322 2234568889999999976 56899999999999999999965 78988877776666543211 


Q ss_pred             CCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          231 ATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                                ......+++++++||.+||+.||++|||+.|++++
T Consensus       245 --------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 --------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             --------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                      01123458999999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.1e-51  Score=381.28  Aligned_cols=254  Identities=20%  Similarity=0.234  Sum_probs=213.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCC-CCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKS-PHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~   87 (415)
                      .+.++|++.+.||+|+||+||+|++..+|+.||||++.....    ...+.+|+++++.++| +||+.+++++..+...|
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            467899999999999999999999999999999999865432    2356789999999986 89999999999999999


Q ss_pred             EEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-----CCcEEEeeeccceecC
Q 014985           88 LVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS-----HGQLKLADFGLARIFG  162 (415)
Q Consensus        88 lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~-----~~~vkL~DFG~a~~~~  162 (415)
                      +||||++|+|..++...+..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+.
T Consensus        78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999999999999888878999999999999999999999999999999999999974     5789999999998764


Q ss_pred             CCC-------CcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 014985          163 SPD-------RRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSSDI---DQLGKIFAAFGTAT  232 (415)
Q Consensus       163 ~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~  232 (415)
                      ...       ......+||+.|||||++.+ ..++.++|||||||++|||++|..||.+....   ....++....    
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~----  232 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK----  232 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc----
Confidence            332       23345679999999999987 66899999999999999999999999875433   2233332210    


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                         ...+.+.+.+.+++++.+++..|+..+|++||+.+.+.+
T Consensus       233 -------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 -------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                               111234455667899999999999999999999776644

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=383.74  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=210.8

Q ss_pred             cccEeeeeeecccCceEEEEEEEC-----CCCcEEEEEEeecCCccCCccchHHHHHHHHHhc-CCCCeeeEEeeeecCC
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDT-----KTGQTVAIKKIRLGKQKEGVNFTALREIKLLKEL-KSPHIIELIDAFPHKG   84 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~   84 (415)
                      .++|++.++||+|+||.||+|.+.     .+++.||||++...... .....+.+|+.+++.+ +|||||++++++.+..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            589999999999999999999753     46679999999765432 2233577899999999 6999999999999999


Q ss_pred             eEEEEeeccc-CCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec
Q 014985           85 NLHLVFEFME-TDLETVIRNTN-----------------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGS  146 (415)
Q Consensus        85 ~~~lv~e~~~-g~L~~~i~~~~-----------------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~  146 (415)
                      .+|+|||||+ |+|..++....                 ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence            9999999998 58888876542                 25899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHc-CCCCCCCCCcHHHHHH
Q 014985          147 HGQLKLADFGLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLN-RRPFLQGSSDIDQLGK  223 (415)
Q Consensus       147 ~~~vkL~DFG~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  223 (415)
                      ++.+||+|||+++.......  ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+.+
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999997654332  2344678999999999976 568999999999999999998 7788888777666666


Q ss_pred             HHHHhCCCCCCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          224 IFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       224 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                      +...-...                          .....++.++.+||.+||+.||++|||++||++
T Consensus       260 ~i~~~~~~--------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKEGFRM--------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHTCCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCC--------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            65431100                          111235899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=385.62  Aligned_cols=251  Identities=21%  Similarity=0.337  Sum_probs=210.6

Q ss_pred             cccEeeeeeecccCceEEEEEEECC-----CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCCe
Q 014985           11 ADRYLKREVLGEGTYGVVYKAIDTK-----TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKGN   85 (415)
Q Consensus        11 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   85 (415)
                      .++|.+.+.||+|+||+||+|.+..     ++..||||++...... .....+.+|+.++++++|||||++++++.....
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            5899999999999999999998753     3578999998754322 223357799999999999999999999999999


Q ss_pred             EEEEeeccc-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeee
Q 014985           86 LHLVFEFME-TDLETVIRNTN---------IFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADF  155 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~---------~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DF  155 (415)
                      .++|||||. |+|..++....         ..++...+..++.|++.||.|||+++|+||||||+||||+.++++||+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence            999999998 68888775431         24688999999999999999999999999999999999999999999999


Q ss_pred             ccceecCCCCC--cccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcC-CCCCCCCCcHHHHHHHHHHhCCCC
Q 014985          156 GLARIFGSPDR--RFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNR-RPFLQGSSDIDQLGKIFAAFGTAT  232 (415)
Q Consensus       156 G~a~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~  232 (415)
                      |+|+.......  ......+|+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.....   
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~---  253 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---  253 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC---
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC---
Confidence            99987644332  2334468899999999976 5688999999999999999998 589998888888777654311   


Q ss_pred             CCCCCCCCCCccchhcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014985          233 PSQWPDLAYLPDYVEYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALE  290 (415)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~  290 (415)
                                              ....+.+++.+.+||.+||+.||++|||+.++++
T Consensus       254 ------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         254 ------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                    1112345789999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=378.11  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=195.2

Q ss_pred             eeeecccCceEEEEEEECCCC---cEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeee-cCCeEEEEeec
Q 014985           17 REVLGEGTYGVVYKAIDTKTG---QTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFP-HKGNLHLVFEF   92 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~e~   92 (415)
                      .++||+|+||+||+|.+..++   ..||||++..... ......+.+|+++|++++||||+++++++. .++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            678999999999999986654   3689999864322 222345789999999999999999999875 46789999999


Q ss_pred             cc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeeccceecCCCCC----c
Q 014985           93 ME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGLARIFGSPDR----R  167 (415)
Q Consensus        93 ~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~~~~~~~----~  167 (415)
                      |+ |+|.+++......+++..+..++.|++.||.|||++||+||||||+||||++++.+||+|||+++.......    .
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            99 577778877777788999999999999999999999999999999999999999999999999987643322    2


Q ss_pred             ccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCC-CCCCCCCcHHHHHHHHHHhCCCCCCCCCCCCCCccch
Q 014985          168 FTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRR-PFLQGSSDIDQLGKIFAAFGTATPSQWPDLAYLPDYV  246 (415)
Q Consensus       168 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  246 (415)
                      .....||..|+|||.+.+ ..++.++|||||||++|||++|. ||+...+..+....+..+...                
T Consensus       191 ~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~----------------  253 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----------------  253 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC----------------
T ss_pred             cccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence            334568899999999876 56899999999999999999965 444444444444444332110                


Q ss_pred             hcccccCCCccccCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          247 EYQYVAAPPLRSLFPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       247 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                                 ...+.+++++.+||.+||+.||++||++.|+++|
T Consensus       254 -----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 -----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                       1112457899999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-49  Score=381.21  Aligned_cols=291  Identities=26%  Similarity=0.442  Sum_probs=213.7

Q ss_pred             cccccccc-ccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-----------CC
Q 014985            4 VDLSKKVA-DRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-----------SP   71 (415)
Q Consensus         4 ~~~~~~~~-~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-----------hp   71 (415)
                      +.+++.+. +||+++++||+|+||+||+|++..+|+.||||+++....   ......+|+.+++.+.           |+
T Consensus         4 ~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~   80 (362)
T d1q8ya_           4 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGAN   80 (362)
T ss_dssp             CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred             CCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence            45677776 469999999999999999999999999999999975422   2234568999988875           57


Q ss_pred             CeeeEEeeeec--CCeEEEEeeccc--CCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEe
Q 014985           72 HIIELIDAFPH--KGNLHLVFEFME--TDLET-VIRNTNIFLSPADIKSYMQMTLKGLAFCHK-KWVLHRDMKPNNLLIG  145 (415)
Q Consensus        72 ~Iv~l~~~~~~--~~~~~lv~e~~~--g~L~~-~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-~~ivHrDlkp~NILi~  145 (415)
                      ||+++++++..  ....+++++++.  ++... ........+++..++.++.||+.||+|||+ +||+||||||+||||+
T Consensus        81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~  160 (362)
T d1q8ya_          81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME  160 (362)
T ss_dssp             TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred             ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence            89999988754  345666666665  33333 334445679999999999999999999998 8999999999999998


Q ss_pred             cCCc------EEEeeeccceecCCCCCcccccccccceeCcccccCCcCCCCcccHHHHHHHHHHHHcCCCCCCCCC---
Q 014985          146 SHGQ------LKLADFGLARIFGSPDRRFTHQVFARWYRAPELLFGAKQYGAGVDVWAAGCIFAELLNRRPFLQGSS---  216 (415)
Q Consensus       146 ~~~~------vkL~DFG~a~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---  216 (415)
                      .++.      ++|+|||.+.....   .....+||+.|+|||++.+ ..|+.++|||||||++++|++|++||.+.+   
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             ccCcccccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            7653      99999999987543   3356789999999999986 568999999999999999999999997653   


Q ss_pred             ---cHHHHHHHHHHhCCCCCCCCCCCCCCccch-------hcccccCCCc-------cccCCCCCHHHHHHHHHhcCCCC
Q 014985          217 ---DIDQLGKIFAAFGTATPSQWPDLAYLPDYV-------EYQYVAAPPL-------RSLFPSASDDALDLLSKMFTYDP  279 (415)
Q Consensus       217 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP  279 (415)
                         ..+.+..++..+|......+..........       ........+.       .......+++++|||.+||.+||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence               345667777777764322111100000000       0000000000       01112346789999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCCCCC
Q 014985          280 KARITAQQALEHRYFSSAPLPT  301 (415)
Q Consensus       280 ~~Rpt~~e~l~h~~~~~~~~~~  301 (415)
                      .+|||++|+|+||||++.....
T Consensus       317 ~~Rpta~e~L~Hp~f~~~~~~~  338 (362)
T d1q8ya_         317 RKRADAGGLVNHPWLKDTLGME  338 (362)
T ss_dssp             TTCBCHHHHHTCGGGTTCTTCT
T ss_pred             hHCcCHHHHhcCcccCCCCCcc
Confidence            9999999999999999655433

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=371.57  Aligned_cols=256  Identities=23%  Similarity=0.292  Sum_probs=190.6

Q ss_pred             ccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCeeeEEeeeecCC----e
Q 014985           10 VADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHIIELIDAFPHKG----N   85 (415)
Q Consensus        10 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~   85 (415)
                      +.++|.+.+.||+|+||+||+|++  +|+.||||++......   ......|+..++.++|||||++++++...+    .
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            467899999999999999999975  6899999998643221   112234556667889999999999986543    6


Q ss_pred             EEEEeeccc-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh--------CCccccCCCCCcEEEecCCcEEEeeec
Q 014985           86 LHLVFEFME-TDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK--------KWVLHRDMKPNNLLIGSHGQLKLADFG  156 (415)
Q Consensus        86 ~~lv~e~~~-g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~--------~~ivHrDlkp~NILi~~~~~vkL~DFG  156 (415)
                      +|+|||||. |+|..++.+.  .+++.....++.|++.||.|||+        +||+||||||+||||+.++++||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            899999998 6888888764  38999999999999999999996        599999999999999999999999999


Q ss_pred             cceecCCCCC----cccccccccceeCcccccCCc-----CCCCcccHHHHHHHHHHHHcCCCCCCCCCcHH--------
Q 014985          157 LARIFGSPDR----RFTHQVFARWYRAPELLFGAK-----QYGAGVDVWAAGCIFAELLNRRPFLQGSSDID--------  219 (415)
Q Consensus       157 ~a~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------  219 (415)
                      +++.......    .....+||+.|+|||++.+..     .++.++|||||||+||||+||.+||.......        
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            9987744332    234578999999999986532     25678999999999999999998775432110        


Q ss_pred             ---HHHHHHHHhCCCCCCCCCCCCCCccchhcccccCCCcccc--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014985          220 ---QLGKIFAAFGTATPSQWPDLAYLPDYVEYQYVAAPPLRSL--FPSASDDALDLLSKMFTYDPKARITAQQALEH  291 (415)
Q Consensus       220 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~l~h  291 (415)
                         ....+.......                   ...+.+...  .......+.+|+.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~-------------------~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQ-------------------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTS-------------------CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcc-------------------ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               000000000000                   000111111  11123468899999999999999999999863

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.8e-27  Score=207.55  Aligned_cols=165  Identities=16%  Similarity=0.177  Sum_probs=121.9

Q ss_pred             EeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCC--------c--------cchHHHHHHHHHhcCCCCeeeEE
Q 014985           14 YLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEG--------V--------NFTALREIKLLKELKSPHIIELI   77 (415)
Q Consensus        14 y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~--------~--------~~~~~~E~~il~~l~hp~Iv~l~   77 (415)
                      |.+.++||+|+||+||+|.+. +|+.||||+++.......        .        .....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999884 789999998764321100        0        11234688899999999999988


Q ss_pred             eeeecCCeEEEEeecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCcEEEeeecc
Q 014985           78 DAFPHKGNLHLVFEFMETDLETVIRNTNIFLSPADIKSYMQMTLKGLAFCHKKWVLHRDMKPNNLLIGSHGQLKLADFGL  157 (415)
Q Consensus        78 ~~~~~~~~~~lv~e~~~g~L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~~~ivHrDlkp~NILi~~~~~vkL~DFG~  157 (415)
                      ++..    .+++|||+++....       .++...+..++.|++.+|.|||++||+||||||+|||+++++ ++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence            7643    26999999974321       255666788999999999999999999999999999998655 99999999


Q ss_pred             ceecCCCCCcccccccccceeC------cccccCCcCCCCcccHHHHHHH
Q 014985          158 ARIFGSPDRRFTHQVFARWYRA------PELLFGAKQYGAGVDVWAAGCI  201 (415)
Q Consensus       158 a~~~~~~~~~~~~~~~t~~y~a------PE~l~~~~~~~~~~DiwSlG~i  201 (415)
                      |.....+....        |..      .+.+ . +.|+.++|+||+.--
T Consensus       149 a~~~~~~~~~~--------~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         149 SVEVGEEGWRE--------ILERDVRNIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             CEETTSTTHHH--------HHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             cccCCCCCcHH--------HHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence            98765443211        111      1111 1 458899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=2.6e-08  Score=88.78  Aligned_cols=142  Identities=13%  Similarity=0.153  Sum_probs=92.5

Q ss_pred             cccccEeeeeeecccCceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcC-CCCeeeEEeeeecCCeEE
Q 014985            9 KVADRYLKREVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELK-SPHIIELIDAFPHKGNLH   87 (415)
Q Consensus         9 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~   87 (415)
                      .+.+.|++.+..+.++.+.||++.  ..+..+++|........  ....+.+|..++..+. +--+.+++.+..+++..|
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            346778877776666668999983  56677888877543322  2335678999988874 323677788888889999


Q ss_pred             EEeecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------
Q 014985           88 LVFEFMETD-LETVIRNTNIFLSPADIKSYMQMTLKGLAFCHK-------------------------------------  129 (415)
Q Consensus        88 lv~e~~~g~-L~~~i~~~~~~l~~~~~~~i~~qil~aL~~lH~-------------------------------------  129 (415)
                      +||++++|. +.......      .....++.++...+..||+                                     
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999984 32221110      0111122222222333331                                     


Q ss_pred             ----------------------CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 ----------------------KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ----------------------~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                                            ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  1279999999999998766667999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.26  E-value=3.1e-06  Score=79.79  Aligned_cols=77  Identities=14%  Similarity=0.039  Sum_probs=48.4

Q ss_pred             eeeecccCceEEEEEEECCCCcEEEEEEeecCC--cc---CCccchHHHHHHHHHhcC-C--CCeeeEEeeeecCCeEEE
Q 014985           17 REVLGEGTYGVVYKAIDTKTGQTVAIKKIRLGK--QK---EGVNFTALREIKLLKELK-S--PHIIELIDAFPHKGNLHL   88 (415)
Q Consensus        17 ~~~LG~G~~g~Vy~~~~~~~~~~~avK~i~~~~--~~---~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~~~~~~l   88 (415)
                      .+.||.|....||++.+..+++.+++|.-....  ..   .....+...|+..|+.+. +  ..+.+++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            557899999999999887778899999754311  11   111224557888888773 2  3455666443  344578


Q ss_pred             EeecccC
Q 014985           89 VFEFMET   95 (415)
Q Consensus        89 v~e~~~g   95 (415)
                      |||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999985

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.14  E-value=5.2e-06  Score=72.90  Aligned_cols=71  Identities=14%  Similarity=0.077  Sum_probs=49.8

Q ss_pred             eecccC-ceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCC--CeeeEEeeeecCCeEEEEeecccC
Q 014985           19 VLGEGT-YGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSP--HIIELIDAFPHKGNLHLVFEFMET   95 (415)
Q Consensus        19 ~LG~G~-~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~~~~~~~~~lv~e~~~g   95 (415)
                      .+..|. -+.||++.. ..+..+++|......     ...+..|+..++.+...  -+.+++.+..+.+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            444554 368999863 456678889754332     22466788888877432  356778888888899999999987

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.45  E-value=0.00022  Score=66.64  Aligned_cols=72  Identities=13%  Similarity=0.117  Sum_probs=49.1

Q ss_pred             eeeeecccCceEEEEEEECC-------CCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCC-eeeEEeeeecCCeEE
Q 014985           16 KREVLGEGTYGVVYKAIDTK-------TGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPH-IIELIDAFPHKGNLH   87 (415)
Q Consensus        16 ~~~~LG~G~~g~Vy~~~~~~-------~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~   87 (415)
                      .++.|+.|-.-.+|++....       .++.|.+++....   .. .....+|..+++.+.-.+ ..++++++.+    .
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            35678999999999997653       3456777765421   11 224557999999885434 4577777754    4


Q ss_pred             EEeecccC
Q 014985           88 LVFEFMET   95 (415)
Q Consensus        88 lv~e~~~g   95 (415)
                      +|+||++|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            88999986

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.31  E-value=0.00041  Score=62.95  Aligned_cols=130  Identities=17%  Similarity=0.187  Sum_probs=74.4

Q ss_pred             ceEEEEEEECCCCcEEEEEEeecCCccCCccchHHHHHHHHHhcCCCCe--eeEE-----eeeecCCeEEEEeecccCC-
Q 014985           25 YGVVYKAIDTKTGQTVAIKKIRLGKQKEGVNFTALREIKLLKELKSPHI--IELI-----DAFPHKGNLHLVFEFMETD-   96 (415)
Q Consensus        25 ~g~Vy~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~E~~il~~l~hp~I--v~l~-----~~~~~~~~~~lv~e~~~g~-   96 (415)
                      --.||++.. .+|..|++|+.+....   ....+..|...+..|....|  +..+     ..+...+..+.++++++|. 
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            468999963 5688899999764422   23346678888888742221  1111     2234567788999998861 


Q ss_pred             -----HH---------HHHHhc--C------CC-------------------CCHH---HHHHHHHHHHHHHHHhh----
Q 014985           97 -----LE---------TVIRNT--N------IF-------------------LSPA---DIKSYMQMTLKGLAFCH----  128 (415)
Q Consensus        97 -----L~---------~~i~~~--~------~~-------------------l~~~---~~~~i~~qil~aL~~lH----  128 (415)
                           ..         ..+...  .      ..                   ++..   .....+..++..+.-+-    
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence                 11         111110  0      00                   1111   12222333333332221    


Q ss_pred             hCCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          129 KKWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       129 ~~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      ..++||+|+.|.|||++. + ..++||+.|+.
T Consensus       191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            236899999999999964 4 45899998874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.00  E-value=0.001  Score=59.70  Aligned_cols=31  Identities=26%  Similarity=0.250  Sum_probs=27.6

Q ss_pred             CCccccCCCCCcEEEecCCcEEEeeecccee
Q 014985          130 KWVLHRDMKPNNLLIGSHGQLKLADFGLARI  160 (415)
Q Consensus       130 ~~ivHrDlkp~NILi~~~~~vkL~DFG~a~~  160 (415)
                      .|+||+|+.++||+++.++..-|+||+.|+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            5799999999999999887778999999864